PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bennett, H; McEwan, P; Sugrue, D; Kalsekar, A; Yuan, Y				Bennett, Hayley; McEwan, Phil; Sugrue, Daniel; Kalsekar, Anupama; Yuan, Yong			Assessing the Long-Term Impact of Treating Hepatitis C Virus (HCV)-Infected People Who Inject Drugs in the UK and the Relationship between Treatment Uptake and Efficacy on Future Infections	PLOS ONE			English	Article							OPIATE SUBSTITUTION THERAPY; GENOTYPE 1; ANTIVIRAL TREATMENT; SYRINGE PROGRAMS; USERS; HCV; SOFOSBUVIR; PREVALENCE; NEEDLE; SPREAD	Objective The prevalence of the hepatitis C virus (HCV) remains high amongst people who inject drugs (PWID) and accounts for the majority of newly acquired infections. This study aims to quantify the value of treatment amongst PWID with more efficacious treatments and at increased uptake rates, with respect to the avoidance of future infections and subsequent long-term complications of HCV. Methods A dynamic HCV transmission and disease progression model was developed, incorporating acute and chronic infection and their long-term complications (decompensated cirrhosis, cancer, liver transplant and mortality), with the potential for HCV transmission to other PWID prior to successful treatment. The model was populated with prevalence and therapy data from a UK setting. Scenarios of current standard of care (SoC) treatment efficacy and uptake were compared to anticipated sustained virologic response (SVR) rates of 90-100% and increased uptake over varied horizons. Results SoC led to modest reductions in prevalence; >5% after 200 years. New treatments achieving 90% SVR could reduce prevalence below 5% within 60 years at current uptake rates or within 5 years if all patients are treated. Amongst 4,240 PWID, chronic HCV infections avoided as a result of increasing treatment uptake over the period 2015-2027 ranged from 20-580 and 34-912 with SoC and 90% SVR rates respectively. The reduction in downstream HCV infections due to increasing treatment uptake resulted in an approximate discounted gain of 300 life-years (from avoiding reduced life expectancy from HCV infection) and a gain of 1,700 QALYs (from avoiding the disutility of HCV infection and related complications), with a projected 5.4 pound million cost saving. Conclusion While improved SVR profiles led to reductions in modelled prevalence, increased treatment uptake was the key driver of future infections avoided. Increased treatment among PWID with new more efficacious therapies could significantly change the future dynamics, cost and health burden of HCV-related disease.	[Bennett, Hayley; McEwan, Phil; Sugrue, Daniel] Hlth Econ & Outcomes Res Ltd, Cardiff, S Glam, Wales; [McEwan, Phil] Swansea Univ, Swansea Ctr Hlth Econ, Swansea, W Glam, Wales; [Kalsekar, Anupama; Yuan, Yong] BMS Global Hlth Econ & Outcomes Res, Princeton, NJ USA	Health Economics & Outcomes Research Ltd; Swansea University	Bennett, H (corresponding author), Hlth Econ & Outcomes Res Ltd, Cardiff, S Glam, Wales.	hayley.bennettwilton@heor.co.uk			Bristol-Myers Squibb	Bristol-Myers Squibb(Bristol-Myers Squibb)	Funding for this study and writing of the manuscript was provided to Health Economics & Outcomes Research Ltd by Bristol-Myers Squibb. Bristol-Myers Squibb provided support in the form of salaries for authors AK & YY, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. All authors jointly decided to publish the manuscript.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Allen EJ, 2012, INT J DRUG POLICY, V23, P346, DOI 10.1016/j.drugpo.2012.07.006; Aspinall EJ, 2013, CLIN INFECT DIS, V57, pS80, DOI 10.1093/cid/cit306; Cornish R, 2010, BMJ, V341; Corson S, 2012, MATH MED BIOL, V29, P205, DOI 10.1093/imammb/dqr011; Dimova RB, 2013, CLIN INFECT DIS, V56, P806, DOI 10.1093/cid/cis1007; Dore GJ, 2012, MED J AUSTRALIA, V196, P629, DOI 10.5694/mja11.11531; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Gane EJ, 2013, NEW ENGL J MED, V368, P34, DOI 10.1056/NEJMoa1208953; Grebely J, 2010, EUR J GASTROEN HEPAT, V22, P270, DOI 10.1097/MEG.0b013e32832a8c4c; Hallinan R, 2007, DRUG ALCOHOL DEPEN, V88, P49, DOI 10.1016/j.drugalcdep.2006.09.018; Harris KA, 2010, J ADDICT MED, V4, P20, DOI 10.1097/ADM.0b013e3181add3de; Hay G, 2004, ESTIMATING THE NATIO; Health Protection Scotland and University of the West of Scotland, 2007, NEEDLE EXCHANGE SURV; Hellard M, 2014, HEPATOLOGY, V59, P366, DOI 10.1002/hep.26623; Hellard M, 2009, CLIN INFECT DIS, V49, P561, DOI 10.1086/600304; Hellard ME, 2012, MED J AUSTRALIA, V196, P638, DOI 10.5694/mja11.10981; Hickman M, 2009, J PUBLIC HEALTH-UK, V31, P374, DOI 10.1093/pubmed/fdp067; Hutchinson SJ, 2006, INT J DRUG POLICY, V17, P211, DOI 10.1016/j.drugpo.2006.02.008; Innes HA, 2012, EUR J GASTROEN HEPAT, V24, P646, DOI 10.1097/MEG.0b013e32835201a4; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kemp PA, 2006, HEALTH SOC CARE COMM, V14, P319, DOI 10.1111/j.1365-2524.2006.00624.x; Kimber J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3172; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Lindenburg CEA, 2011, EUR J GASTROEN HEPAT, V23, P23, DOI 10.1097/MEG.0b013e328340c451; Manns M, 2014, LANCET, V384, P1597, DOI 10.1016/S0140-6736(14)61059-X; Martin NK, 2013, HEPATOLOGY, V58, P1598, DOI 10.1002/hep.26431; Martin NK, 2013, CLIN INFECT DIS, V57, pS39, DOI 10.1093/cid/cit296; Martin NK, 2011, J HEPATOL, V54, P1137, DOI 10.1016/j.jhep.2010.08.029; Martin NK, 2011, J THEOR BIOL, V274, P58, DOI 10.1016/j.jtbi.2010.12.041; McEwan P, 2013, VALUE HLTH REGIONAL, V3, P5; McEwan P, 2013, HEPATOLOGY, V58, P54, DOI 10.1002/hep.26304; McEwan P, 2013, APPL HEALTH ECON HEA, V11, P53, DOI 10.1007/s40258-012-0002-0; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Mondelli MU, 2005, J HEPATOL, V42, pS108, DOI 10.1016/j.jhep.2004.10.017; National Institute for Health and Care Excellence (NICE, TECHNOLOGY APPRAISAL; Poordad F, 2013, NEW ENGL J MED, V368, P45, DOI 10.1056/NEJMoa1208809; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Public Health England, HEPATITIS C IN THE U; Public Health England, DATA TABLES OF THE U; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Sweeting MJ, 2009, AM J EPIDEMIOL, V170, P352, DOI 10.1093/aje/kwp141; The All-Party Parliamentary Hepatology Group, IN THE DARK AN AUDIT; Turner KME, 2011, ADDICTION, V106, P1978, DOI 10.1111/j.1360-0443.2011.03515.x; University of the West of Scotland, 2008, THE NEEDLE EXCHANGE; Vickerman P, 2012, ADDICTION, V107, P1984, DOI 10.1111/j.1360-0443.2012.03932.x; Vickerman P, 2011, DRUG ALCOHOL DEPEN, V113, P83, DOI 10.1016/j.drugalcdep.2010.08.001; Zeiler I, 2010, DRUG ALCOHOL DEPEN, V110, P228, DOI 10.1016/j.drugalcdep.2010.03.006	49	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125846	10.1371/journal.pone.0125846	http://dx.doi.org/10.1371/journal.pone.0125846			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938458	Green Published, gold, Green Submitted			2022-12-27	WOS:000353943000106
J	Li, AQ; Zhou, SL; Li, M; Xu, Y; Shui, RH; Yu, BH; Yang, WT				Li, An-qi; Zhou, Shu-ling; Li, Ming; Xu, Yan; Shui, Ruo-hong; Yu, Bao-hua; Yang, Wen-tao			Clinicopathologic Characteristics of Oestrogen Receptor-Positive/Progesterone Receptor-Negative/Her2-Negative Breast Cancer According to a Novel Definition of Negative Progesterone Receptor Status: A Large Population-Based Study from China	PLOS ONE			English	Article							ADJUVANT TAMOXIFEN; ENDOCRINE THERAPY; HORMONE-RECEPTOR; PREDICTIVE-VALUE; EXPRESSION; KI67; ASSOCIATION; PROGNOSIS; EFFICACY; INVASION	Purpose A lack of progesterone receptor (PgR) expression in oestrogen receptor-positive (ER+) tumours is associated with worse survival. PgR status is usually defined as positive or negative using 1% positive nuclei as a cut-off point. In this study, we aimed to assess the clinicopathologic characteristics of ER+/PgR-/HER2-tumours by comparing them with ER +/PgR+/HER2-tumours using a PgR cut-off point of 20% as a divisive criterion. Methods We analysed 1,522 patients with primary breast cancer who had undergone surgery at the Cancer Center of Fudan University between 2012 and 2014. Age, grade, tumour size, lymph node status and lymphovascular invasion were assessed. Multinomial logistic regression, linear regression and chi-square test models were applied to assess associations between ER, PR and clinical features. Results ER+/PgR-/HER2-tumours showed poorer clinicopathologic characteristics relative to ER +/PgR+/HER2-tumours using a PgR threshold of 20% instead of 1%. The clinicopathologic characteristics did not differ between tumours with purely negative PgR expression and tumours with a PgR percentage ranging from 1% to 19%. The prognostic significance of PR expression appeared more pronounced in patients under a high Ki-67 status than those under a low Ki-67 status. Conclusions Based on these findings, we propose the use of a novel threshold of 20% to define PgR status. Nevertheless, the impact of this new criterion on patient management and clinical treatment requires additional study.	[Li, An-qi; Zhou, Shu-ling; Li, Ming; Xu, Yan; Shui, Ruo-hong; Yu, Bao-hua; Yang, Wen-tao] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200433, Peoples R China; [Li, An-qi; Zhou, Shu-ling; Li, Ming; Xu, Yan; Shui, Ruo-hong; Yu, Bao-hua; Yang, Wen-tao] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Yang, WT (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200433, Peoples R China.	yangwt2000@163.com						Arpino G, 2005, JNCI-J NATL CANCER I, V97, P1254, DOI 10.1093/jnci/dji249; Assersohn L, 2003, BREAST CANCER RES TR, V82, P113, DOI 10.1023/B:BREA.0000003968.45511.3f; Bardou VJ, 2003, J CLIN ONCOL, V21, P1973, DOI 10.1200/JCO.2003.09.099; Cancello G, 2013, ANN ONCOL, V24, P661, DOI 10.1093/annonc/mds430; Creighton CJ, 2009, BREAST CANCER RES TR, V114, P287, DOI 10.1007/s10549-008-0017-2; Cui XJ, 2005, J CLIN ONCOL, V23, P7721, DOI 10.1200/JCO.2005.09.004; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Dowsett M, 2006, ANN ONCOL, V17, P818, DOI 10.1093/annonc/mdl016; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; Dunnwald LK, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1639; Fasching PA, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-486; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; HORWITZ KB, 1975, SCIENCE, V189, P726, DOI 10.1126/science.168640; Jacquemier J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2249; Kim MJ, 2006, HUM PATHOL, V37, P1217, DOI 10.1016/j.humpath.2006.04.015; Liu SZ, 2010, BREAST CANCER RES TR, V119, P53, DOI 10.1007/s10549-009-0318-0; Luoh SW, 2014, BREAST J, V20, P46, DOI 10.1111/tbj.12200; Maisonneuve P, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3679; Mohammed RAA, 2011, J PATHOL, V223, P358, DOI 10.1002/path.2810; Park S, 2013, ANN SURG ONCOL, V20, P1505, DOI 10.1245/s10434-012-2772-x; Prat A, 2013, J CLIN ONCOL, V31, P203, DOI 10.1200/JCO.2012.43.4134; Purdie CA, 2014, BRIT J CANCER, V110, P565, DOI 10.1038/bjc.2013.756; Viale G, 2008, JNCI-J NATL CANCER I, V100, P207, DOI 10.1093/jnci/djm289; Viale G, 2008, J CLIN ONCOL, V26, P5569, DOI 10.1200/JCO.2008.17.0829; Wolff AC, 2007, ARCH PATHOL LAB MED, V131, P18, DOI 10.1043/1543-2165(2007)131[18:ASOCCO]2.0.CO;2	26	11	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125067	10.1371/journal.pone.0125067	http://dx.doi.org/10.1371/journal.pone.0125067			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938238	Green Submitted, gold, Green Published			2022-12-27	WOS:000353943000043
J	Arcanjo, AF; LaRocque-de-Freitas, IF; Rocha, JDB; Zamith, D; Costa-da-Silva, AC; Nunes, MP; Mesquita-Santos, FP; Morrot, A; Filardy, AA; Mariano, M; Bandeira-Melo, C; DosReis, GA; Decote-Ricardo, D; Freire-de-Lima, CG				Arcanjo, Angelica F.; LaRocque-de-Freitas, Isabel F.; Rocha, Juliana Dutra B.; Zamith, Daniel; Costa-da-Silva, Ana Caroline; Nunes, Marise Pinheiro; Mesquita-Santos, Fabio P.; Morrot, Alexandre; Filardy, Alessandra A.; Mariano, Mario; Bandeira-Melo, Christianne; DosReis, George A.; Decote-Ricardo, Debora; Freire-de-Lima, Celio Geraldo			The PGE(2)/IL-10 Axis Determines Susceptibility of B-1 Cell-Derived Phagocytes (B-1CDP) to Leishmania major Infection	PLOS ONE			English	Article							BIPHENOTYPIC B/MACROPHAGE CELLS; B-CELLS; LIPID DROPLETS; MONONUCLEAR PHAGOCYTE; APOPTOTIC CELLS; IMMUNE-RESPONSE; T-CELLS; EXPRESSION; PARASITE; MACROPHAGES	B-1 cells can be differentiated from B-2 cells because they are predominantly located in the peritoneal and pleural cavities and have distinct phenotypic patterns and activation properties. A mononuclear phagocyte derived from B-1 cells (B-1CDP) has been described. As the B-1CDP cells migrate to inflammatory/infectious sites and exhibit phagocytic capacity, the microbicidal ability of these cells was investigated using the Leishmania major infection model in vitro. The data obtained in this study demonstrate that B-1CDP cells are more susceptible to infection than peritoneal macrophages, since B-1CDP cells have a higher number of intracellular amastigotes forms and consequently release a larger number of promastigotes. Exacerbated infection by Leishmania major required lipid bodies/PGE(2) and IL-10 by B-1CDP cells. Both infection and the production of IL-10 were decreased when PGE(2) production was blocked by NSAIDs. The involvement of IL-10 in this mechanism was confirmed, since B-1CDP cells from IL-10 KO mice are more competent to control Leishmania major infection than cells from wild type mice. These findings further characterize the B-1CDP cells as an important mononuclear phagocyte that plays a previously unrecognized role in host responses to Leishmania major infection, most likely via PGE(2)-driven production of IL-10.	[Arcanjo, Angelica F.; LaRocque-de-Freitas, Isabel F.; Rocha, Juliana Dutra B.; Zamith, Daniel; Costa-da-Silva, Ana Caroline; Mesquita-Santos, Fabio P.; Filardy, Alessandra A.; Bandeira-Melo, Christianne; DosReis, George A.; Freire-de-Lima, Celio Geraldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil; [LaRocque-de-Freitas, Isabel F.; Decote-Ricardo, Debora] Univ Fed Rural Rio de Janeiro, Dept Vet, Rio De Janeiro, Brazil; [Nunes, Marise Pinheiro] Fiocruz MS, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil; [Morrot, Alexandre] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, BR-21941 Rio De Janeiro, Brazil; [Mariano, Mario] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal Rural do Rio de Janeiro (UFRRJ); Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Universidade Federal de Sao Paulo (UNIFESP)	Decote-Ricardo, D (corresponding author), Univ Fed Rural Rio de Janeiro, Dept Vet, Rio De Janeiro, Brazil.	decotericardo@ufrrj.br; celio@biof.ufrj.br	Mariano, Mario/L-2557-2015; Filardy, Alessandra/AAH-6034-2020; Zamith-Miranda, Daniel/E-8877-2013; de Melo, Christianne Bandeira/B-7724-2009; Decote-Ricardo, Debora/O-6480-2019; Bandeira-Melo, Christianne/X-5619-2019; de Lima, Celio Geraldo Freire/A-9057-2012	Filardy, Alessandra/0000-0003-4098-3235; Zamith-Miranda, Daniel/0000-0001-7532-2432; de Melo, Christianne Bandeira/0000-0003-3305-3865; Bandeira-Melo, Christianne/0000-0003-3305-3865; Costa da silva, Ana Caroline/0000-0002-2729-5836; DosReis, George/0000-0002-8924-4727	Brazilian National Research Council (CNPq); Rio de Janeiro State Science Foundation (FAPERJ)	Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Rio de Janeiro State Science Foundation (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by Brazilian National Research Council (CNPq) and Rio de Janeiro State Science Foundation (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Almeida SR, 2001, INT IMMUNOL, V13, P1193, DOI 10.1093/intimm/13.9.1193; ARIASNEGRETE S, 1995, BIOCHEM BIOPH RES CO, V208, P582, DOI 10.1006/bbrc.1995.1378; Askenase PW, 1999, INT ARCH ALLERGY IMM, V118, P145, DOI 10.1159/000024052; Babai B, 1999, CLIN EXP IMMUNOL, V117, P123; Bandeira-Melo C, 2011, METHODS MOL BIOL, V717, P277, DOI 10.1007/978-1-61779-024-9_16; Barbeiro DF, 2011, IMMUNOBIOLOGY, V216, P302, DOI 10.1016/j.imbio.2010.08.002; BARRALNETTO M, 1992, SCIENCE, V257, P545, DOI 10.1126/science.1636092; Bonamin LV, EVID BASED COMPLEMEN; Borrello MA, 1999, J IMMUNOL, V163, P3605; Bozza PT, 2007, PHARMACOL THERAPEUT, V113, P30, DOI 10.1016/j.pharmthera.2006.06.006; Bozza PT, 2009, BBA-MOL CELL BIOL L, V1791, P540, DOI 10.1016/j.bbalip.2009.01.005; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Charron AJ, 2002, J CELL SCI, V115, P3049; Cocchiaro JL, 2008, P NATL ACAD SCI USA, V105, P9379, DOI 10.1073/pnas.0712241105; Cruz-Leal Y, 2014, INT IMMUNOL, V26, P427, DOI 10.1093/intimm/dxu042; CUMANO A, 1992, NATURE, V356, P612, DOI 10.1038/356612a0; Cunningham AC, 2002, EXP MOL PATHOL, V72, P132, DOI 10.1006/exmp.2002.2418; D'Avila H, 2011, J INFECT DIS, V204, P951, DOI 10.1093/infdis/jir432; Freire-de-Lima CG, 2006, J BIOL CHEM, V281, P38376, DOI 10.1074/jbc.M605146200; Freire-de-Lima CG, 2000, NATURE, V403, P199, DOI 10.1038/35003208; Fujimoto T, 2004, SEIKAGAKU, V76, P578; Ghosn EEB, 2006, J LEUKOCYTE BIOL, V80, P36, DOI 10.1189/jlb.1005603; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Gomes NA, 2000, INT IMMUNOL, V12, P1227, DOI 10.1093/intimm/12.9.1227; Graf BA, 1999, EUR J IMMUNOL, V29, P3793, DOI 10.1002/(SICI)1521-4141(199911)29:11<3793::AID-IMMU3793>3.0.CO;2-3; GREENSPAN P, 1985, J LIPID RES, V26, P781; HARDY RR, 1987, EUR J IMMUNOL, V17, P1769, DOI 10.1002/eji.1830171214; HAYAKAWA K, 1983, J EXP MED, V157, P202, DOI 10.1084/jem.157.1.202; HAYAKAWA K, 1986, EUR J IMMUNOL, V16, P1313, DOI 10.1002/eji.1830161021; HERZENBERG LA, 1986, IMMUNOL REV, V93, P81, DOI 10.1111/j.1600-065X.1986.tb01503.x; HOERAUF A, 1994, INT IMMUNOL, V6, P1117, DOI 10.1093/intimm/6.8.1117; Jackson KE, 2004, MOL MICROBIOL, V54, P109, DOI 10.1111/j.1365-2958.2004.04284.x; Joss A, 2000, EUR J IMMUNOL, V30, P1683, DOI 10.1002/1521-4141(200006)30:6<1683::AID-IMMU1683>3.0.CO;2-A; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Kane MM, 2001, J IMMUNOL, V166, P1141, DOI 10.4049/jimmunol.166.2.1141; Katoh S, 1990, Dev Immunol, V1, P113, DOI 10.1155/1990/28760; KIPPS TJ, 1989, ADV IMMUNOL, V47, P117, DOI 10.1016/S0065-2776(08)60663-X; Li J, 2006, NAT IMMUNOL, V7, P1116, DOI 10.1038/ni1389; Liese J, 2008, IMMUNOBIOLOGY, V213, P377, DOI 10.1016/j.imbio.2007.12.005; Lopes JD, 2009, AN ACAD BRAS CIENC, V81, P489, DOI 10.1590/S0001-37652009000300013; Laurindo MFL, 2013, IMMUNOBIOLOGY, V218, P609, DOI 10.1016/j.imbio.2012.07.032; Luna-Gomes T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090582; MASMOUDI H, 1990, INT IMMUNOL, V2, P515, DOI 10.1093/intimm/2.6.515; Mattos KA, 2011, CELL MICROBIOL, V13, P259, DOI 10.1111/j.1462-5822.2010.01533.x; Melo RCN, 2003, CELL BIOL INT, V27, P853, DOI 10.1016/S1065-6995(03)00173-2; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.iy.11.040193.001121; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; MURAKAMI K, 1994, VIROLOGY, V202, P458, DOI 10.1006/viro.1994.1362; MURAKAMI Y, 1995, IMMUNOLOGY, V86, P238; OGARRA A, 1992, EUR J IMMUNOL, V22, P711, DOI 10.1002/eji.1830220314; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Padigel UM, 2003, J IMMUNOL, V171, P3705, DOI 10.4049/jimmunol.171.7.3705; Palos MC, 2012, INFLAMM RES, V61, P1187, DOI 10.1007/s00011-012-0514-y; PENNELL CA, 1988, J IMMUNOL, V141, P2788; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Pinheiro RO, 2009, MICROBES INFECT, V11, P181, DOI 10.1016/j.micinf.2008.11.006; Popi AF, 2009, IMMUNOBIOLOGY, V214, P664, DOI 10.1016/j.imbio.2008.12.007; Popi AF, 2009, IMMUNOLOGY, V126, P114, DOI 10.1111/j.1365-2567.2008.02883.x; Popi AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034570; Pugliese LS, 2012, IMMUNOBIOLOGY, V217, P336, DOI 10.1016/j.imbio.2011.07.014; RABINOVITCH M, 1995, TRENDS CELL BIOL, V5, P85, DOI 10.1016/S0962-8924(00)88955-2; RENZ H, 1988, J IMMUNOL, V141, P2388; Santos-Lima EC, 2001, EUR J IMMUNOL, V31, P634, DOI 10.1002/1521-4141(200102)31:2&lt;634::AID-IMMU634&gt;3.0.CO;2-H; SCHANDENE L, 1994, J IMMUNOL, V152, P4368; SPENCKER T, 1995, BIOCHEM BIOPH RES CO, V216, P540, DOI 10.1006/bbrc.1995.2656; Stolina M, 2000, J IMMUNOL, V164, P361, DOI 10.4049/jimmunol.164.1.361; Takeshita H, 1998, INT IMMUNOL, V10, P435, DOI 10.1093/intimm/10.4.435; Thies FG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062805; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415	70	24	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124888	10.1371/journal.pone.0124888	http://dx.doi.org/10.1371/journal.pone.0124888			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933287	Green Published, gold, Green Submitted			2022-12-27	WOS:000353887100062
J	Bukowska-Osko, I; Pawelczyk, A; Perlejewski, K; Kubisa, N; Cortes, KC; Rosinska, M; Ploski, R; Fic, M; Kazmierczak, J; Popiel, M; Zabek, P; Horban, A; Radkowski, M; Laskus, T				Bukowska-Osko, Iwona; Pawelczyk, Agnieszka; Perlejewski, Karol; Kubisa, Natalia; Cortes, Kamila Caraballo; Rosinska, Magdalena; Ploski, Rafal; Fic, Maria; Kazmierczak, Justyna; Popiel, Marta; Zabek, Piotr; Horban, Andrzej; Radkowski, Marek; Laskus, Tomasz			Genetic Variability of Hepatitis C Virus (HCV) 5' Untranslated Region in HIV/HCV Coinfected Patients Treated with Pegylated Interferon and Ribavirin	PLOS ONE			English	Article							CHRONICALLY INFECTED PATIENTS; QUASI-SPECIES HETEROGENEITY; VIRAL BREAKTHROUGH; HIV; EVOLUTION; THERAPY; MORTALITY; PERSISTENCE; MUTATIONS; DEATH	Association between hepatitis C virus (HCV) quasispecies and treatment outcome among patients with chronic hepatitis C has been the subject of many studies. However, these studies focused mainly on viral variable regions (E1 and E2) and usually did not include human immunodeficiency virus (HIV)-positive patients. The aim of the present study was to analyze heterogeneity of the 5'untranslated region (5'UTR) in HCV/HIV coinfected patients treated with interferon and ribavirin. The HCV 5'UTR was amplified from serum and peripheral blood mononuclear cells (PBMC) samples in 37 HCV/HIV coinfected patients treated for chronic hepatitis C. Samples were collected right before treatment, and at 2, 4, 6, 8, 12, 20, 24, 36, 44, 48, 60, and 72 weeks. Heterogeneity of the 5'UTR was analyzed by single strand conformational polymorphism (SSCP), cloning and sequencing. Sustained virological response (SVR) was achieved in 46% of analyzed HCV/HIV co-infected patients. Stable SSCP band pattern was observed in 22 patients (62.9%) and SVR rate among these patients was 23%. Decline in the number of bands and/or shift in band positions were found in 6 patients (17.1%), 5 (83%) of whom achieved SVR (p=0.009). A novel viral genotype was identified in all but one of these patients. In 5 of these 6 patients a new genotype was dominant. 5'UTR heterogeneity may correlate with interferon and ribavirin treatment outcome. In the analyzed group of HCV/HIV coinfected patients, viral quasispecies stability during treatment favored viral persistence, whereas decrease in the number of variants and/or emergence of new variants was associated with SVR. Among injection drug users (IDU) patients, a new genotype may become dominant during treatment, probably due to the presence of mixed infections with various strains, which have different susceptibility to treatment.	[Bukowska-Osko, Iwona; Pawelczyk, Agnieszka; Perlejewski, Karol; Kubisa, Natalia; Cortes, Kamila Caraballo; Fic, Maria; Kazmierczak, Justyna; Popiel, Marta; Radkowski, Marek; Laskus, Tomasz] Med Univ Warsaw, Dept Immunopathol, Warsaw, Poland; [Rosinska, Magdalena] Natl Inst Hyg, Dept Epidemiol, PL-00791 Warsaw, Poland; [Ploski, Rafal] Med Univ Warsaw, Dept Med Genet, Warsaw, Poland; [Zabek, Piotr; Horban, Andrzej] Hosp Infect Dis, Warsaw, Poland	Medical University of Warsaw; National Institute of Hygiene (NIH); Medical University of Warsaw	Bukowska-Osko, I (corresponding author), Med Univ Warsaw, Dept Immunopathol, Warsaw, Poland.	ibukowska@wum.edu.pl	Caraballo Cortes, Kamila/W-2011-2018; Rosińska, Magdalena/Q-2068-2018; Perlejewski, Karol/V-3854-2018; Cortés, Kamila Caraballo/ABB-9291-2020; Pawełczyk, Agnieszka/M-4934-2018; Bukowska-Ośko, Iwona/V-3859-2018; Rosińska, Magdalena/K-5857-2019; Radkowski, Marek/V-3860-2018	Caraballo Cortes, Kamila/0000-0002-7924-7852; Rosińska, Magdalena/0000-0002-6256-7809; Perlejewski, Karol/0000-0002-3782-6442; Cortés, Kamila Caraballo/0000-0002-7924-7852; Pawełczyk, Agnieszka/0000-0001-9336-8258; Bukowska-Ośko, Iwona/0000-0002-0216-7184; Rosińska, Magdalena/0000-0002-6256-7809; Radkowski, Marek/0000-0003-1808-679X; Ploski, Rafal/0000-0001-6286-5526				Ananthakrishnan AN, 2010, J VIRAL HEPATITIS, V17, P720, DOI 10.1111/j.1365-2893.2009.01232.x; Biebricher CK, 2005, VIRUS RES, V107, P117, DOI 10.1016/j.virusres.2004.11.002; Bolcic F, 2012, ARCH VIROL, V157, P703, DOI 10.1007/s00705-012-1230-1; Booth JCL, 1998, HEPATOLOGY, V27, P223, DOI 10.1002/hep.510270134; Bukowska-Osko I, 2014, J VIRAL HEPATITIS, V21, P551, DOI 10.1111/jvh.12182; Chambers TJ, 2005, J VIROL, V79, P3071, DOI 10.1128/JVI.79.5.3071-3083.2005; Domingo E, 2006, CURR TOP MICROBIOL, V299, P51; El Awady MK, 2009, WORLD J GASTROENTERO, V15, P1480, DOI 10.3748/wjg.15.1480; Farci P, 2000, SCIENCE, V288, P339, DOI 10.1126/science.288.5464.339; Farci P, 2002, P NATL ACAD SCI USA, V99, P3081, DOI 10.1073/pnas.052712599; Feliu A, 2004, LIVER TRANSPLANT, V10, P1131, DOI 10.1002/lt.20206; Flint S.J., 2004, PRINCIPLES VIROLOGY, VSecond; Gallegos-Orozco JF, 2006, J VIRAL HEPATITIS, V13, P489, DOI 10.1111/j.1365-2893.2006.00724.x; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Katano Y, 2007, HEPATO-GASTROENTEROL, V54, P854; Khaliq S, 2014, ARCH VIROL, V159, P1, DOI 10.1007/s00705-013-1780-x; Lara J, 2012, ANTIVIR THER, V17, P1471, DOI 10.3851/IMP2478; Laskus T, 2004, GASTROENTEROLOGY, V127, P764, DOI 10.1053/j.gastro.2004.06.005; Laskus T, 1996, VIROLOGY, V220, P171, DOI 10.1006/viro.1996.0297; Laskus T, 2000, J VIROL, V74, P1014, DOI 10.1128/JVI.74.2.1014-1017.2000; Laskus T, 2001, J VIROL, V75, P2059, DOI 10.1128/JVI.75.5.2059-2066.2001; Lewden C, 2005, INT J EPIDEMIOL, V34, P121, DOI 10.1093/ije/dyh307; Moreau I, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-78; Nasu A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024907; Ni YH, 1999, J MED VIROL, V58, P132, DOI 10.1002/(SICI)1096-9071(199906)58:2&lt;132::AID-JMV6&gt;3.0.CO;2-V; Pham TNQ, 2004, J VIROL, V78, P5867, DOI 10.1128/JVI.78.11.5867-5874.2004; Quesnel-Vallieres M, 2008, J CLIN VIROL, V43, P236, DOI 10.1016/j.jcv.2008.06.019; Radkowski M, 2005, HEPATOLOGY, V41, P106, DOI 10.1002/hep.20518; Rockstroh JK, 2004, LANCET INFECT DIS, V4, P437, DOI 10.1016/S1473-3099(04)01059-X; Sherman KE, 2010, J INFECT DIS, V201, P712, DOI 10.1086/650490; Soler M, 2002, VIROLOGY, V298, P160, DOI 10.1006/viro.2002.1494; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Torriani FJ, 2004, NEW ENGL J MED, V351, P438, DOI 10.1056/NEJMoa040842; Toyoda H, 1997, J HEPATOL, V26, P975, DOI 10.1016/S0168-8278(97)80105-5; van der Helm J, 2013, GASTROENTEROLOGY, V144, P751, DOI 10.1053/j.gastro.2012.12.026; Vuillermoz I, 2004, J MED VIROL, V74, P41, DOI 10.1002/jmv.20144; Wandeler G, 2012, CLIN INFECT DIS, V55, P1408, DOI 10.1093/cid/cis694; Weber R, 2013, HIV MED, V14, P195, DOI 10.1111/j.1468-1293.2012.01051.x; Xu ZK, 2008, J VIROL, V82, P9417, DOI 10.1128/JVI.00896-08; Zekri ARN, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-16	40	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125604	10.1371/journal.pone.0125604	http://dx.doi.org/10.1371/journal.pone.0125604			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932941	Green Submitted, Green Published, gold			2022-12-27	WOS:000353887100121
J	Jia, GQ; Liu, XT; Schnable, JC; Niu, ZG; Wang, CF; Li, YH; Wang, SJ; Wang, SY; Liu, JR; Guo, EH; Zhi, H; Diao, XM				Jia, Guanqing; Liu, Xiaotong; Schnable, James C.; Niu, Zhengang; Wang, Chunfang; Li, Yuhui; Wang, Shujun; Wang, Suying; Liu, Jinrong; Guo, Erhu; Zhi, Hui; Diao, Xianmin			Microsatellite Variations of Elite Setaria Varieties Released during Last Six Decades in China	PLOS ONE			English	Article							FOXTAIL MILLET; POPULATION-STRUCTURE; GENETIC DIVERSITY; AGRONOMIC TRAITS; ASSOCIATION; ITALICA; L.; DOMESTICATION; SEQUENCE; ENVIRONMENT	Crop improvement is a multifaceted micro-evolutionary process, involving changes in breeding approaches, planting configurations and consumption preferences of human beings. Recent research has started to identify the specific genes or genomic regions correlate to improved agronomic traits, however, an apparent blank between the genetic structure of crop elite varieties and their improving histories in diverse modern breeding programs is still in existence. Foxtail millet (Setaria italica) was one of the earliest cereal crops to be domesticated and served as a staple crop for early civilizations in China, where it is still widely grown today. In the present trial, a panel of foxtail millet elite varieties, which were released in the last sixty years in different geographical regions of China, was characterized using microsatellite markers (SSRs). A clear separation of two subpopulations corresponding to the two eco-geographical regions of foxtail millet production in China was identified by the dataset, which also indicated that in more recently released elite varieties, large quantities of accessions have been transferred from spring-sowing to summer-sowing ecotypes, likely as a result of breeding response to planting configurations. An association mapping study was conducted to identify loci controlling traits of major agronomic interest. Furthermore, selective sweeps involved in improvement of foxtail millet were identified as multi-diverse minor effect loci controlling different agronomic traits during the long-term improvement of elite varieties. Our results highlight the effect of transition of planting configuration and breeding preference on genetic evolvement of crop species.	[Jia, Guanqing; Liu, Xiaotong; Schnable, James C.; Niu, Zhengang; Wang, Chunfang; Zhi, Hui; Diao, Xianmin] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100193, Peoples R China; [Li, Yuhui; Guo, Erhu] Shanxi Acad Agr Sci, Inst Millet Crops, Changzhi, Shanxi, Peoples R China; [Wang, Shujun; Wang, Suying; Liu, Jinrong] Anyang Acad Agr Sci, Inst Millet Crops, Anyang, Henan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Shanxi Agricultural University	Diao, XM (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100193, Peoples R China.	diaoxianmin@caas.cn		Schnable, James/0000-0001-6739-5527; Liu, Xiaotong/0000-0002-9256-297X	Key Technologies R&D Program of China during the 12th Five-Year Plan period [2011BAD06B01-2, 2014BAD07B01]; National High Technology Research and Development Program of China (863 Program) [2013AA102603]; National Natural Science Foundation of China [31171560, 31301328]; Fundamental Research Funds of ICS-CAAS [2013007]; Beijing Natural Science Foundation [6142019]; China Agricultural Research System [CARS07-12.5-A02]; Agricultural Science and Technology Innovation Program of CAAS	Key Technologies R&D Program of China during the 12th Five-Year Plan period; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds of ICS-CAAS; Beijing Natural Science Foundation(Beijing Natural Science Foundation); China Agricultural Research System; Agricultural Science and Technology Innovation Program of CAAS	This work was supported by the Key Technologies R&D Program of China during the 12th Five-Year Plan period (2011BAD06B01-2, 2014BAD07B01), National High Technology Research and Development Program of China (863 Program) (2013AA102603), the National Natural Science Foundation of China (31171560, 31301328), Fundamental Research Funds of ICS-CAAS (Grant to Guanqing Jia, 2013007), Beijing Natural Science Foundation (6142019), China Agricultural Research System (CARS07-12.5-A02) and The Agricultural Science and Technology Innovation Program of CAAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, MOL TECHNIQUES TAXON; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Diao X, 2011, INDUSTRIAL PRODUCTIO, P20; Diao XM, 2014, FRONT AGRIC SCI ENG, V1, P16, DOI 10.15302/J-FASE-2014011; Doust AN, 2005, GENETICS, V169, P1659, DOI 10.1534/genetics.104.035543; Doust AN, 2004, P NATL ACAD SCI USA, V101, P9045, DOI 10.1073/pnas.0402892101; Doust AN, 2014, P NATL ACAD SCI USA, V111, P6178, DOI 10.1073/pnas.1308940110; Doust AN, 2009, PLANT PHYSIOL, V149, P137, DOI 10.1104/pp.108.129627; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fu YB, 2003, CROP SCI, V43, P1989, DOI 10.2135/cropsci2003.1989; Fu YB, 2010, MOL ECOL RESOUR, V10, P389, DOI 10.1111/j.1755-0998.2009.02752.x; Gupta S, 2014, PLANT CELL REP, V33, P881, DOI 10.1007/s00299-014-1564-0; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Jia GQ, 2013, J EXP BOT, V64, P3645, DOI 10.1093/jxb/ert198; Jia GQ, 2013, NAT GENET, V45, P957, DOI 10.1038/ng.2673; Jia XP, 2009, THEOR APPL GENET, V118, P821, DOI 10.1007/s00122-008-0942-9; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Karki S, 2013, RICE, V6, DOI 10.1186/1939-8433-6-28; Lata C, 2013, CRIT REV BIOTECHNOL, V33, P328, DOI 10.3109/07388551.2012.716809; Li PH, 2011, J EXP BOT, V62, P3031, DOI 10.1093/jxb/err096; Li YH, 2010, NEW PHYTOL, V188, P242, DOI 10.1111/j.1469-8137.2010.03344.x; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu ZL, 2011, CROP SCI, V51, P1655, DOI 10.2135/cropsci2010.11.0643; Lu HY, 2009, P NATL ACAD SCI USA, V106, P7367, DOI 10.1073/pnas.0900158106; Matsuoka Y, 2002, P NATL ACAD SCI USA, V99, P6080, DOI 10.1073/pnas.052125199; Mauro-Herrera M, 2013, G3-GENES GENOM GENET, V3, P283, DOI 10.1534/g3.112.005207; Miura K, 2010, NAT GENET, V42, P545, DOI 10.1038/ng.592; Piao SL, 2010, NATURE, V467, P43, DOI 10.1038/nature09364; Pritchard JK, 2000, GENETICS, V155, P945; Qie LF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101868; Vetriventhan M, 2012, PLANT GENET RESOUR-C, V10, P214, DOI 10.1017/S1479262112000287; Wang CF, 2012, G3-GENES GENOM GENET, V2, P769, DOI 10.1534/g3.112.002907; Wang T, 1996, SCI AGR SINCA, V29, P96; Xin LJ, 2009, CHINESE GEOGR SCI, V19, P97, DOI 10.1007/s11769-009-0103-x; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yang XY, 2012, P NATL ACAD SCI USA, V109, P3726, DOI 10.1073/pnas.1115430109; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195; [朱会义 ZHU Huiyi], 2007, [自然资源学报, Journal of Natural Resources], V22, P907	42	10	24	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125688	10.1371/journal.pone.0125688	http://dx.doi.org/10.1371/journal.pone.0125688			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932649	Green Published, gold, Green Submitted			2022-12-27	WOS:000353887100127
J	Le, MTH; Holton, S; Nguyen, HT; Wolfe, R; Fisher, J				Le, Minh T. H.; Holton, Sara; Huong Thanh Nguyen; Wolfe, Rory; Fisher, Jane			Poly-Victimisation among Vietnamese High School Students: Prevalence and Demographic Correlates	PLOS ONE			English	Article							SEXUAL-ABUSE; CHINESE ADOLESCENTS; NATIONAL SAMPLE; RISK BEHAVIORS; MENTAL-HEALTH; YOUNG-ADULTS; CHILDREN; EXPOSURE; VIOLENCE; YOUTH	Background Exposure to multiple forms of violence, including abuse and crime is termed poly-victimisation. There has been increasing research interest in poly-victimisation among children and adolescents in high income countries. However, experiences among adolescents living in low-and lower-middle-income countries are yet to be examined. Aims To establish the prevalence of lifetime exposure to poly-victimisation and demographic characteristics of victims among high school students in Vietnam. Methods A cross-sectional survey with a self-report, anonymous questionnaire was conducted in ten high schools in Hanoi, Vietnam between October 2013 and January 2014. Poly-victimisation was assessed using the Juvenile Victimisation Questionnaire Revised 2 (JVQ R2). Results A total of 1,606/1,745 (92.0%) eligible students provided data and were included in the analyses. Lifetime exposure to at least one form of victimisation was reported by 94.3%(95% CI: 92.5-95.4%) of participants and lifetime exposure to more than 10 forms by 31.1% (95% CI: 27.8-33.5%). Poly-victimisation was associated with experiencing more adverse life events, having a chronic disease or disability, living with a step-parent, experiencing family life as unhappy, being disciplined at school, and living in a rural area. Poly-victimisation experiences differed among students from the three types of high schools in Vietnam. Conclusions These data reveal the prevalence and multi-factorial risks of exposure to poly-victimisation among adolescents in Vietnam. Prevalence rates of different forms of victimisation among Vietnamese students, including those previously un-investigated, were higher than those reported in other settings. Poly-victimisation was also common among them. There were certain subgroups who were more vulnerable to poly-victimisation. Further research to understand the broader aspects of adolescence in Vietnam, including poly-victimisation, is thus recommended. Special attention should be paid to specific subgroups in the prevention of violence against children and adolescents in this setting. Education to raise awareness about poly-victimisation among the community is needed.	[Le, Minh T. H.; Holton, Sara; Fisher, Jane] Monash Univ, Sch Publ Hlth & Prevent Med, Jean Hailes Res Unit, Melbourne, Vic 3004, Australia; [Huong Thanh Nguyen] Hanoi Sch Publ Hlth, Fac Social Sci Behav & Hlth Educ, Hanoi, Vietnam; [Wolfe, Rory] Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia	Monash University; Hanoi University of Public Health; Monash University	Le, MTH (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Jean Hailes Res Unit, Melbourne, Vic 3004, Australia.	minh.thi.le@monash.edu	Holton, Sara/X-9883-2019; Fisher, Jane/I-1569-2014	Holton, Sara/0000-0001-9294-7872; Fisher, Jane/0000-0002-1959-6807; Le, Minh/0000-0003-4820-0450; Wolfe, Rory/0000-0002-2126-1045; Nguyen, Huong/0000-0002-9493-9590	Monash International Postgraduate Research Scholarship; Monash University; Graduate Women Victoria; Monash University Professorial Fellowship; Jean Hailes Professorial Fellowship, Perpetual Trustees	Monash International Postgraduate Research Scholarship(Monash University); Monash University(Monash University); Graduate Women Victoria; Monash University Professorial Fellowship; Jean Hailes Professorial Fellowship, Perpetual Trustees	This research is funded by a Monash International Postgraduate Research Scholarship, a Monash Graduate Scholarship from Monash University and a 2013 Scholarship for International Female Student from the Graduate Women Victoria to ML. JF is supported by a Monash University Professorial Fellowship and the Jean Hailes Professorial Fellowship which is supported by a grant from Perpetual Trustees. The funders have no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akmatov MK, 2011, INT J EPIDEMIOL, V40, P219, DOI 10.1093/ije/dyq168; Akmatov Manas K, 2008, BMC Womens Health, V8, P15, DOI 10.1186/1472-6874-8-15; Al-Fayez GA, 2012, SOC PSYCH PSYCH EPID, V47, P53, DOI 10.1007/s00127-010-0311-2; [Anonymous], 2015, INTERNET USERS PERCE; [Anonymous], AD HLTH; BAYATPOUR M, 1992, J ADOLESCENT HEALTH, V13, P128, DOI 10.1016/1054-139X(92)90079-Q; Bo Giao Duc va Dao tao, 2010, BAO CAO KET QUA THI; Brown DW, 2009, B WORLD HEALTH ORGAN, V87, P447, DOI 10.2471/BLT.07.047423; Chan KL, 2013, PREV MED, V56, P207, DOI 10.1016/j.ypmed.2012.12.018; Choo WY, 2011, J ADOLESCENT HEALTH, V49, P627, DOI 10.1016/j.jadohealth.2011.04.020; Dong FH, 2013, SCAND J PSYCHOL, V54, P415, DOI 10.1111/sjop.12059; Elliott AN, 2009, CHILD MALTREATMENT, V14, P330, DOI 10.1177/1077559509332262; Fergusson DM, 2008, CHILD ABUSE NEGLECT, V32, P607, DOI 10.1016/j.chiabu.2006.12.018; Finkelhor D, 2005, CHILD ABUSE NEGLECT, V29, P1297, DOI 10.1016/j.chiabu.2005.06.005; Finkelhor D, 2005, CHILD ABUSE NEGLECT, V29, P383, DOI 10.1016/j.chiabu.2004.11.001; Finkelhor D., 2008, CHILDHOOD VICTIMIZAT; Finkelhor D, 2007, DEV PSYCHOPATHOL, V19, P149, DOI 10.1017/S0954579407070083; Finkelhor D, 2007, CHILD ABUSE NEGLECT, V31, P479, DOI 10.1016/j.chiabu.2006.03.012; Finkelhor D, 2007, CHILD ABUSE NEGLECT, V31, P7, DOI 10.1016/j.chiabu.2006.06.008; Finkelhor D, 2009, PEDIATRICS, V124, P1411, DOI 10.1542/peds.2009-0467; Finkelhor D, 2009, CHILD ABUSE NEGLECT, V33, P403, DOI 10.1016/j.chiabu.2008.09.012; Fry D, 2012, TRAUMA VIOLENCE ABUS, V13, P209, DOI 10.1177/1524838012455873; Gilbert R, 2009, LANCET, V373, P167, DOI 10.1016/S0140-6736(08)61707-9; Hahm HC, 2012, WOMEN HEALTH ISS, V22, pE35, DOI 10.1016/j.whi.2011.07.003; Higgins D.J., 1998, J FAM STUD, V4, P53, DOI DOI 10.5172/JFS.4.1.53; Higgins D. L., 2000, CHILD ABUSE REV, V9, P6, DOI [10. 1002/(SICI)1099-0852(200001/02)9:1&LT;6::AID-CAR579&GT;3. 0. CO;2-W, DOI 10.1002/(SICI)1099-0852(200001/02)9:1<6::AID-CAR579>3.0.CO;2-W]; Huong TN, 2010, B WORLD HEALTH ORGAN, V88, P22, DOI [10.2471/BLT.08-060061, 10.2471/BLT.08.060061]; IBM Corp, 2011, IBM SPSS STAT WIND V; Institute for Digital Research and Education, 2014, STAT COMP SEM MULT 1; Kaminer D, 2013, PEACE CONFL, V19, P112, DOI 10.1037/a0032487; Kracke K., 2011, JUVENILE VICTIMIZATI; Lauritsen JM, 2003, EPIDATA 3 1 COMPREHE; Lehrer JA, 2010, J WOMENS HEALTH, V19, P893, DOI 10.1089/jwh.2009.1583; Lema VM, 1997, E AFR MED J, V74, P743; Lin DH, 2011, CHILD ABUSE NEGLECT, V35, P680, DOI 10.1016/j.chiabu.2011.05.006; Little R.J.A., 2002, STAT ANAL MISSING DA; Le MTH, 2014, J INTERPERS VIOLENCE, V29, P889, DOI 10.1177/0886260513505710; Minh THL, 2012, J ADOLESCENT HEALTH, V51, P339, DOI 10.1016/j.jadohealth.2011.12.027; Moore EE, 2010, CHILD ABUSE NEGLECT, V34, P379, DOI 10.1016/j.chiabu.2010.01.004; Moran P, 2011, PSYCHOL MED, V41, P1311, DOI 10.1017/S0033291710001789; Nguyen, 2006, THESIS QUEENSLAND U; Price-Robertson R, 2013, FAMILY MATTERS, P84; Rubin DB, 1987, MULTIPLE IMPUTATION, DOI [10.1002/sim.6008, DOI 10.1002/SIM.6008]; So Giao Duc va Dao Tao Ha Noi, 2014, THONG KE DIEM TRUNG; Soler L, 2012, EUR CHILD ADOLES PSY, V21, P645, DOI 10.1007/s00787-012-0301-x; StataCorp, 2011, STAT STAT SOFTW REL, P173; The General Statistics Office of Vietnam, 2006, SURV ASS VIETN YOUTH; The General Statistics Office of Vietnam, 2011, VIETN POP HOUS CENS, DOI [10.3402/gha.v5i0.9334, DOI 10.3402/GHA.V5I0.9334]; The General Statistics Office of Vietnam, 2011, SURV ASS VIETN YOUTH; The General Statistics Office of Vietnam, 2012, AV POP PROV; The World Bank, MEAS LIV STAND; Phuong TB, 2013, GLOBAL HEALTH ACTION, V6, P78, DOI 10.3402/gha.v6i0.18876; Turner HA, 2006, SOC SCI MED, V62, P13, DOI 10.1016/j.socscimed.2005.05.030; Turner HA, 2003, J YOUTH ADOLESCENCE, V32, P89, DOI 10.1023/A:1021853600645; Turner HA, 2013, J HEALTH SOC BEHAV, V54, P257, DOI 10.1177/0022146513479384; Turner HA, 2010, AM J PREV MED, V38, P323, DOI 10.1016/j.amepre.2009.11.012; World Health Organization, 2002, WORLD REPORT VIOLENC	57	21	21	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125189	10.1371/journal.pone.0125189	http://dx.doi.org/10.1371/journal.pone.0125189			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH2XA	25933056	Green Published, gold			2022-12-27	WOS:000353887100088
J	Lu, Z; Cao, SB; Zhou, HB; Hua, L; Zhang, SS; Cao, JY				Lu, Zheng; Cao, Shengbo; Zhou, Hongbo; Hua, Ling; Zhang, Shishuo; Cao, Jiyue			Mechanism of Arctigenin-Induced Specific Cytotoxicity against Human Hepatocellular Carcinoma Cell Lines: Hep G2 and SMMC7721	PLOS ONE			English	Article							NF-KAPPA-B; BCL-2 FAMILY-MEMBERS; INDUCED APOPTOSIS; CANCER-CELLS; TRANSCRIPTION FACTORS; KINASE ACTIVATION; IN-VITRO; P53; MITOCHONDRIA; DEATH	Arctigenin (ARG) has been previously reported to exert high biological activities including anti-inflammatory, antiviral and anticancer. In this study, the anti-tumor mechanism of ARG towards human hepatocellular carcinoma (HCC) was firstly investigated. We demonstrated that ARG could induce apoptosis in Hep G2 and SMMC7721 cells but not in normal hepatic cells, and its apoptotic effect on Hep G2 was stronger than that on SMMC7721. Furthermore, the following study showed that ARG treatment led to a loss in the mitochondrial out membrane potential, up-regulation of Bax, down-regulation of Bcl-2, a release of cytochrome c, caspase-9 and caspase-3 activation and a cleavage of poly (ADP-ribose) polymerase in both Hep G2 and SMMC7721 cells, suggesting ARG-induced apoptosis was associated with the mitochondria mediated pathway. Moreover, the activation of caspase-8 and the increased expression levels of Fas/FasL and TNF-alpha revealed that the Fas/FasL-related pathway was also involved in this process. Additionally, ARG induced apoptosis was accompanied by a deactivation of PI3K/p-Akt pathway, an accumulation of p53 protein and an inhibition of NF-kappa B nuclear translocation especially in Hep G2 cells, which might be the reason that Hep G2 was more sensitive than SMMC7721 cells to ARG treatment.	[Lu, Zheng; Cao, Shengbo; Zhou, Hongbo; Zhang, Shishuo; Cao, Jiyue] Huazhong Agr Univ, Coll Vet Med, Wuhan, Peoples R China; [Hua, Ling] Southwest Univ, Dept Vet Med, Chongqing, Peoples R China	Huazhong Agricultural University; Southwest University - China	Cao, JY (corresponding author), Huazhong Agr Univ, Coll Vet Med, Wuhan, Peoples R China.	caojiyue@mail.hzau.edu.cn						Ahmad N, 2000, ARCH BIOCHEM BIOPHYS, V376, P338, DOI 10.1006/abbi.2000.1742; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Awale S, 2006, CANCER RES, V66, P1751, DOI 10.1158/0008-5472.CAN-05-3143; Bragado P, 2007, APOPTOSIS, V12, P1733, DOI 10.1007/s10495-007-0082-8; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Bruix J, 2004, CANCER CELL, V5, P215, DOI 10.1016/S1535-6108(04)00058-3; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Chao X, 2010, BIOMED PHARMACOTHER, V64, P600, DOI 10.1016/j.biopha.2010.08.008; Chiao PJ, 2002, CANCER, V95, P1696, DOI 10.1002/cncr.10829; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Cho MK, 2004, INT IMMUNOPHARMACOL, V4, P1419, DOI 10.1016/j.intimp.2004.06.011; Colgate EC, 2007, CANCER LETT, V246, P201, DOI 10.1016/j.canlet.2006.02.015; Cosentino K, 2014, CHEM PHYS LIPIDS, V181, P62, DOI 10.1016/j.chemphyslip.2014.04.001; Cotter TG, 2009, NAT REV CANCER, V9, P501, DOI 10.1038/nrc2663; Dai Y, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-392; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Galluzzi L, 2006, ONCOGENE, V25, P4812, DOI 10.1038/sj.onc.1209598; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Gu Y, 2012, BIOCHEM PHARMACOL, V84, P468, DOI 10.1016/j.bcp.2012.06.002; Harris CC, 1996, CARCINOGENESIS, V17, P1187, DOI 10.1093/carcin/17.6.1187; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hsieh CJ, 2014, FREE RADICAL BIO MED, V67, P159, DOI 10.1016/j.freeradbiomed.2013.10.004; Huttemann M, 2011, MITOCHONDRION, V11, P369, DOI 10.1016/j.mito.2011.01.010; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jeong JB, 2011, INT IMMUNOPHARMACOL, V11, P1573, DOI 10.1016/j.intimp.2011.05.016; Jeong SJ, 2008, VIROLOGY, V370, P264, DOI 10.1016/j.virol.2007.09.003; Kalra N, 2007, LIFE SCI, V80, P2137, DOI 10.1016/j.lfs.2007.04.009; Kim JY, 2010, J CELL PHYSIOL, V224, P33, DOI 10.1002/jcp.22085; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Li X, 2010, CANCER LETT, V293, P109, DOI 10.1016/j.canlet.2010.01.002; Lu JH, 2006, FEBS LETT, V580, P3539, DOI 10.1016/j.febslet.2006.05.031; Makin G, 2000, CELL TISSUE RES, V301, P143, DOI 10.1007/s004419900160; Marsoni S, 2004, ANN ONCOL, V15, P229, DOI 10.1093/annonc/mdh931; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; MIYASHITA T, 1994, ONCOGENE, V9, P1799; Moritani S, 1996, BIOL PHARM BULL, V19, P1515, DOI 10.1248/bpb.19.1515; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Penolazzi L, 2003, BIOCHEM PHARMACOL, V66, P1189, DOI 10.1016/S0006-2952(03)00470-2; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Sui XB, 2014, CANCER LETT, V344, P174, DOI 10.1016/j.canlet.2013.11.019; Sun Y, 2013, CHEM-BIOL INTERACT, V201, P1, DOI 10.1016/j.cbi.2012.11.005; Susanti S, 2013, PHYTOMEDICINE, V21, P39, DOI 10.1016/j.phymed.2013.08.003; Swarup V, 2008, J ANTIMICROB CHEMOTH, V61, P679, DOI 10.1093/jac/dkm503; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Umehara K, 1996, CHEM PHARM BULL, V44, P2300, DOI 10.1248/cpb.44.2300; Wahl C, 2003, INT J MED MICROBIOL, V293, P377, DOI 10.1078/1438-4221-00274; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang XD, 2001, GENE DEV, V15, P2922; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhao F, 2009, J ETHNOPHARMACOL, V122, P457, DOI 10.1016/j.jep.2009.01.038	63	27	27	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125727	10.1371/journal.pone.0125727	http://dx.doi.org/10.1371/journal.pone.0125727			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933104	Green Published, gold, Green Submitted			2022-12-27	WOS:000353887100130
J	Omair, MA; Alahmadi, A; Johnson, SR				Omair, Mohammed A.; Alahmadi, Abdulaziz; Johnson, Sindhu R.			Safety and Effectiveness of Mycophenolate in Systemic Sclerosis. A Systematic Review	PLOS ONE			English	Article							INTERSTITIAL LUNG-DISEASE; QUALITY-OF-LIFE; MOFETIL; SODIUM; AZATHIOPRINE; FIBROSIS; CYCLOPHOSPHAMIDE; EXPERIENCE; EFFICACY; THERAPY	Background Mycophenolate is increasingly being used in the rheumatic diseases. Its main adverse effects are gastrointestinal, myelosuppression, and infection. These may limit use in systemic sclerosis (SSc) since gastrointestinal involvement is common. The objective of this study is to evaluate gastrointestinal adverse events of mycophenolate in SSc. Secondarily we evaluated other adverse events, and the effectiveness of mycophenolate in skin and lung disease. Methods A literature search of Medline, Embase, Cochrane Central Register of Controlled Trials, and CINAHL (inception-2013) was performed. Studies reporting use of mycophenolate in SSc patients, adverse events, modified Rodnan skin score (MRSS), forced vital capacity (FVC), or diffusing capacity of carbon monoxide (DLCO) were included. The primary outcome was gastrointestinal events occurring after the initiation of mycophenolate. Secondary safety outcomes included myelosuppression, infection, malignancy, and death after the initiation of mycophenolate. Results 617 citations were identified and 21 studies were included. 487 patients were exposed to mycophenolate. The mean disease duration ranged between 0.8-14.1 years. There were 18 deaths and 90 non-lethal adverse events. The non-lethal adverse events included 43 (47.7%) gastrointestinal events, 34 (26%) infections, 6 (5%) cytopenias and 2 (2%) malignancies. The most common gastrointestinal events included diarrhea (n= 18 (14%)), nausea (n= 12 (9%)), and abdominal pain (n= 3 (2%)). The rate of discontinuation ranged between 8%-40%. Seven observational studies reported improvement or stabilization in FVC, and 5 studies report stabilization or improvement in MRSS. Conclusion Mycophenolate- associated gastrointestinal adverse events are common in SSc, but not severe enough to preclude its use. Observational data suggests mycophenolate may be effective in improving or stabilizing interstitial lung disease, and skin involvement.	[Omair, Mohammed A.; Alahmadi, Abdulaziz; Johnson, Sindhu R.] Mt Sinai Hosp, Toronto Western Hosp, Dept Med, Div Rheumatol,Toronto Scleroderma Program, Toronto, ON M5G 1X5, Canada; [Johnson, Sindhu R.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Omair, Mohammed A.] King Saud Univ, Dept Med, Div Rheumatol, Riyadh, Saudi Arabia	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University Health Network Toronto; University of Toronto; King Saud University	Johnson, SR (corresponding author), Mt Sinai Hosp, Toronto Western Hosp, Dept Med, Div Rheumatol,Toronto Scleroderma Program, Toronto, ON M5G 1X5, Canada.	Sindhu.Johnson@uhn.ca	Omair, Mohammed/AFF-8735-2022; Omair, Mohammed/AAK-9357-2021	Omair, Mohammed/0000-0002-9373-5473; Omair, Mohammed/0000-0002-9373-5473	Freda Fejer Fund for Scleroderma; Norton-Evans Fund for Scleroderma Research; Canadian Institutes of Health Research Clinician Scientist Award	Freda Fejer Fund for Scleroderma; Norton-Evans Fund for Scleroderma Research; Canadian Institutes of Health Research Clinician Scientist Award(Canadian Institutes of Health Research (CIHR))	Dr. Sindhu Johnson is supported by the Freda Fejer Fund for Scleroderma, Norton-Evans Fund for Scleroderma Research and a Canadian Institutes of Health Research Clinician Scientist Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison AC, 2000, IMMUNOPHARMACOLOGY, V47, P85, DOI 10.1016/S0162-3109(00)00188-0; Gonzalez-Nieto JA, 2011, ARCH BRONCONEUMOL, V47, P575, DOI 10.1016/j.arbres.2011.06.007; Arns W, 2005, CLIN TRANSPLANT, V19, P199, DOI 10.1111/j.1399-0012.2004.00318.x; Badid C, 2000, KIDNEY INT, V58, P51, DOI 10.1046/j.1523-1755.2000.00140.x; Bandelier C, 2009, SWISS MED WKLY, V139, P41, DOI smw-12441; Behrend M, 2001, DRUG SAFETY, V24, P645, DOI 10.2165/00002018-200124090-00002; Berezne A, 2008, J RHEUMATOL, V35, P1064; Bunnapradist S, 2008, CLIN TRANSPLANT, V22, P815, DOI 10.1111/j.1399-0012.2008.00892.x; Busquets J, 2010, RHEUMATOLOGY, V49, P1069, DOI 10.1093/rheumatology/keq024; Chizzolini C, 2008, CURR OPIN RHEUMATOL, V20, P707, DOI 10.1097/BOR.0b013e32830c45ae; Cuomo G, 2009, ARTHRITIS RHEUMATISM, V60, P1735; Cuomo G, 2009, RHEUMATOL INT, V29, P1529, DOI 10.1007/s00296-009-0879-6; Derk CT, 2009, RHEUMATOLOGY, V48, P1595, DOI 10.1093/rheumatology/kep295; Djamali A, 2010, TRANSPLANTATION, V90, P387, DOI 10.1097/TP.0b013e3181e6ae0a; Dooley MA, 2011, NEW ENGL J MED, V365, P1886, DOI 10.1056/NEJMoa1014460; Forbes A, 2009, RHEUMATOLOGY, V48, P36, DOI 10.1093/rheumatology/ken485; Gerbino AJ, 2008, CHEST, V133, P455, DOI 10.1378/chest.06-2861; Gulamhusein A, 2009, J RHEUMATOL, V36, P460, DOI 10.3899/jrheum.080611; Hahn BH, 2012, ARTHRIT CARE RES, V64, P797, DOI 10.1002/acr.21664; Herrick AL, 2010, J RHEUMATOL, V37, P116, DOI 10.3899/jrheum.090668; Houssiau FA, 2010, ANN RHEUM DIS, V69, P2083, DOI 10.1136/ard.2010.131995; Hueso M, 1998, TRANSPLANTATION, V66, P1727, DOI 10.1097/00007890-199812270-00027; Johnson SR, 2006, J RHEUMATOL, V33, P1117; Khanna D, 2009, ARTHRIT RHEUM-ARTHR, V61, P1257, DOI 10.1002/art.24730; Koutroumpas A, 2010, CLIN RHEUMATOL, V29, P1167, DOI 10.1007/s10067-010-1498-z; Kowal-Bielecka O, 2009, ANN RHEUM DIS, V68, P620, DOI 10.1136/ard.2008.096677; Le EN, 2011, ANN RHEUM DIS, V70, P1104, DOI 10.1136/ard.2010.142000; Liossis SNC, 2006, RHEUMATOLOGY, V45, P1005, DOI 10.1093/rheumatology/kei211; Medsger TA, 1999, J RHEUMATOL, V26, P2159; Mendoza FA, 2012, J RHEUMATOL, V39, P1241, DOI 10.3899/jrheum.111229; Nihtyanova SI, 2007, RHEUMATOLOGY, V46, P442, DOI 10.1093/rheumatology/kel244; Nikpour M, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3544; Omair MA, 2012, CLIN EXP RHEUMATOL, V30, pS55; Omair MA, 2012, J RHEUMATOL, V39, P992, DOI 10.3899/jrheum.110826; Panopoulos ST, 2013, LUNG, V191, P483, DOI 10.1007/s00408-013-9499-8; Petrova DT, 2010, THER DRUG MONIT, V32, P405, DOI 10.1097/FTD.0b013e3181e44260; Phumethum V, 2011, J RHEUMATOL, V38, P289, DOI 10.3899/jrheum.100361; Simeon-Aznar CP, 2011, CLIN RHEUMATOL, V30, P1393, DOI 10.1007/s10067-011-1823-1; Plastiras SC, 2006, RHEUMATOLOGY, V45, P1572, DOI 10.1093/rheumatology/kel335; Quillinan NP, 2009, CURR OPIN RHEUMATOL, V21, P636, DOI 10.1097/BOR.0b013e3283310d57; Roos N, 2007, J PHARMACOL EXP THER, V321, P583, DOI 10.1124/jpet.106.117051; Rosenbloom J, 2008, ARTHRITIS RHEUM, V58, P2219, DOI 10.1002/art.23634; Saketkoo LA, 2009, AM J MED SCI, V337, P329, DOI 10.1097/MAJ.0b013e31818d094b; Sanford M, 2008, DRUGS, V68, P2505, DOI 10.2165/0003495-200868170-00007; Senecal JL, 2005, J RHEUMATOL, V32, P1643; Staatz CE, 2007, CLIN PHARMACOKINET, V46, P13, DOI 10.2165/00003088-200746010-00002; Stratton RJ, 2001, RHEUMATOLOGY, V40, P84, DOI 10.1093/rheumatology/40.1.84; Swigris JJ, 2006, CHEST, V130, P30, DOI 10.1016/S0012-3692(15)50949-5; Tzouvelekis A, 2012, PULM MED, V2012, DOI 10.1155/2012/143637; Vanthuyne M, 2007, CLIN EXP RHEUMATOL, V25, P287; Zamora AC, 2008, RESP MED, V102, P150, DOI 10.1016/j.rmed.2007.07.021; Zeher M, 2011, LUPUS, V20, P1484, DOI 10.1177/0961203311418269	52	46	51	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124205	10.1371/journal.pone.0124205	http://dx.doi.org/10.1371/journal.pone.0124205			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933090	gold, Green Published, Green Submitted			2022-12-27	WOS:000353887100032
J	Ometto, L; Li, MA; Bresadola, L; Barbaro, E; Neteler, M; Varotto, C				Ometto, Lino; Li, Mingai; Bresadola, Luisa; Barbaro, Enrico; Neteler, Markus; Varotto, Claudio			Demographic History, Population Structure, and Local Adaptation in Alpine Populations of Cardamine impatiens and Cardamine resedifolia	PLOS ONE			English	Article							FREEZING TOLERANCE; CLINAL VARIATION; SELECTION; PLANT; SOFTWARE; DIFFERENTIATION; ASSOCIATION; DIVERGENCE; EVOLUTION; ENVIRONMENTS	Species evolution depends on numerous and distinct forces, including demography and natural selection. For example, local adaptation and population structure affect the evolutionary history of species living along environmental clines. This is particularly relevant in plants, which are often characterized by limited dispersal ability and the need to respond to abiotic and biotic stress factors specific to the local environment. Here we study the demographic history and the possible existence of local adaptation in two related species of Brassicaceae, Cardamine impatiens and Cardamine resedifolia, which occupy separate habitats along the elevation gradient. Previous genome-wide analyses revealed the occurrence of distinct selective pressures in the two species, with genes involved in cold response evolving particularly fast in C. resedifolia. In this study we surveyed patterns of molecular evolution and genetic variability in a set of 19 genes, including neutral and candidate genes involved in cold response, across 10 populations each of C. resedifolia and C. impatiens from the Italian Alps (Trentino). We inferred the population structure and demographic history of the two species, and tested the occurrence of signatures of local adaptation in these genes. The results indicate that, despite a slightly higher population differentiation in C. resedifolia than in C. impatiens, both species are only weakly structured and that populations sampled at high altitude experience less gene flow than low-altitude ones. None of the genes showed signatures of positive selection, suggesting that they do not seemto play relevant roles in the current evolutionary processes of adaptation to alpine environments of these species.	[Ometto, Lino; Li, Mingai; Bresadola, Luisa; Barbaro, Enrico; Neteler, Markus; Varotto, Claudio] Fdn Edmund Mach, Res & Innovat Ctr, Dept Biodivers & Mol Ecol, I-38010 San Michele All Adige, TN, Italy	Fondazione Edmund Mach	Varotto, C (corresponding author), Fdn Edmund Mach, Res & Innovat Ctr, Dept Biodivers & Mol Ecol, Via E Mach 1, I-38010 San Michele All Adige, TN, Italy.	claudio.varotto@fmach.it	Neteler, Markus/C-6328-2008; Bresadola, Luisa/D-8976-2019; Ometto, Lino/C-3609-2008	Neteler, Markus/0000-0003-1916-1966; Ometto, Lino/0000-0002-2679-625X; Varotto, Claudio/0000-0001-5018-087X; Barbaro, Enrico/0000-0003-1809-4394; Li, Mingai/0000-0003-2074-1546	Autonomous Province of Trento (Italy), under the ACE-SAP project [23]; ACE-SAP project; Edmund Mach Foundation	Autonomous Province of Trento (Italy), under the ACE-SAP project; ACE-SAP project; Edmund Mach Foundation	To carry out this work CV received funding by the Autonomous Province of Trento (Italy), under the ACE-SAP project (regulation number 23, June 12th 2008, of the Servizio istruzione e formazione del secondo grado, Universita e ricerca [former Servizio Universita e Ricerca Scientifica]; (http://www.uniricerca.provincia.tn.it/)). The postdoc position of LO was funded by the ACE-SAP project. ML, EB, MN and CV positions were funded through core funding of the Edmund Mach Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeschimann D, 2004, FLORA ALPINA; Aitken SN, 2008, EVOL APPL, V1, P95, DOI 10.1111/j.1752-4571.2007.00013.x; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Baxter I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001193; Becker U, 2008, OIKOS, V117, P1865, DOI 10.1111/j.0030-1299.2008.16939.x; Becker U, 2006, OECOLOGIA, V150, P506, DOI 10.1007/s00442-006-0534-9; Bernhardsson C, 2012, MOL ECOL, V21, P2197, DOI 10.1111/j.1365-294X.2012.05524.x; Bierne N, 2010, EVOLUTION, V64, P3254, DOI 10.1111/j.1558-5646.2010.01050.x; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Charlesworth B, 2009, NAT REV GENET, V10, P195, DOI 10.1038/nrg2526; Chen J, 2012, GENETICS, V191, P865, DOI 10.1534/genetics.112.140749; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Cullings KW, 1992, MOL ECOL, V1, P233, DOI 10.1111/j.1365-294X.1992.tb00182.x; Depaulis F, 1998, MOL BIOL EVOL, V15, P1788, DOI 10.1093/oxfordjournals.molbev.a025905; Doyle J. J., 1987, PHYTOCHEM B, P11; Drummond A. J., 2010, GENEIOUS V5 3; Eckert AJ, 2010, GENETICS, V185, P969, DOI 10.1534/genetics.110.115543; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Falush D, 2003, GENETICS, V164, P1567; Fior S, 2013, NEW PHYTOL, V198, P579, DOI 10.1111/nph.12163; Fischer MC, 2013, MOL ECOL; Fournier-Level A, 2011, SCIENCE, V334, P86, DOI 10.1126/science.1209271; Freedman AH, 2010, MOL ECOL, V19, P3773, DOI 10.1111/j.1365-294X.2010.04684.x; Gardner KM, 2006, MOL ECOL, V15, P1321, DOI 10.1111/j.1365-294X.2005.02835.x; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Guillot G, 2008, BIOINFORMATICS, V24, P1406, DOI 10.1093/bioinformatics/btn136; Hendry AP, 2004, EVOLUTION, V58, P2319; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Joshi J, 2001, ECOL LETT, V4, P536, DOI 10.1046/j.1461-0248.2001.00262.x; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Jump AS, 2005, ECOL LETT, V8, P1010, DOI 10.1111/j.1461-0248.2005.00796.x; Keller I, 2011, MOL ECOL, V20, P1888, DOI 10.1111/j.1365-294X.2011.05067.x; Keller SR, 2011, GENETICS, V188, P941, DOI 10.1534/genetics.111.128041; KIMATA M, 1983, BOT MAG TOKYO, V96, P299, DOI 10.1007/BF02488175; Kronholm I, 2012, EVOLUTION, V66, P2287, DOI 10.1111/j.1558-5646.2012.01590.x; Leuenberger C, 2010, GENETICS, V184, P243, DOI 10.1534/genetics.109.109058; Li HP, 2011, MOL BIOL EVOL, V28, P365, DOI 10.1093/molbev/msq211; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lihova J, 2009, J BIOGEOGR, V36, P104, DOI 10.1111/j.1365-2699.2008.01998.x; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Namroud MC, 2008, MOL ECOL, V17, P3599, DOI 10.1111/j.1365-294X.2008.03840.x; Neteler M, 2010, REMOTE SENS-BASEL, V2, P333, DOI 10.3390/rs1020333; Ometto L, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-7; Pritchard JK, 2000, GENETICS, V155, P945; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rozas J, 2001, GENETICS, V158, P1147; Roze D, 2003, GENETICS, V165, P2153; Santamaria L, 2003, ECOLOGY, V84, P2454, DOI 10.1890/02-0431; Schonswetter P, 2005, MOL ECOL, V14, P3547, DOI 10.1111/j.1365-294X.2005.02683.x; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; St Onge KR, 2011, MOL ECOL, V20, P3306, DOI 10.1111/j.1365-294X.2011.05189.x; Steyaert Sam M. J. G., 2009, Ekologia (Bratislava), V28, P191, DOI 10.4149/ekol_2009_02_191; Stinchcombe JR, 2004, P NATL ACAD SCI USA, V101, P4712, DOI 10.1073/pnas.0306401101; Stoletzki N, 2011, MOL BIOL EVOL, V28, P63, DOI 10.1093/molbev/msq249; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; Turner TL, 2010, NAT GENET, V42, P260, DOI 10.1038/ng.515; Veeramah KR, 2012, MOL BIOL EVOL, V29, P617, DOI 10.1093/molbev/msr212; Vittoz P, 2009, BASIC APPL ECOL, V10, P508, DOI 10.1016/j.baae.2009.02.001; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wegmann D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-116; Whitlock MC, 2003, GENETICS, V164, P767; Whitlock MC, 1997, GENETICS, V146, P427; Woodward F.I., 1987, CLIMATE PLANT DISTRI; Wright S, 1931, GENETICS, V16, P0097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhen Y, 2008, MOL BIOL EVOL, V25, P2547, DOI 10.1093/molbev/msn196; Zhen Y, 2008, NEW PHYTOL, V177, P419, DOI 10.1111/j.1469-8137.2007.02262.x	73	7	7	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125199	10.1371/journal.pone.0125199	http://dx.doi.org/10.1371/journal.pone.0125199			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933225	Green Published, Green Submitted, gold			2022-12-27	WOS:000353887100090
J	Sporndly-Nees, E; Ekstedt, E; Magnusson, U; Fakhrzadeh, A; Hendriks, CLL; Holm, L				Sporndly-Nees, Ellinor; Ekstedt, Elisabeth; Magnusson, Ulf; Fakhrzadeh, Azadeh; Hendriks, Cris L. Luengo; Holm, Lena			Effect of Pre-Fixation Delay and Freezing on Mink Testicular Endpoints for Environmental Research	PLOS ONE			English	Article							BLACK-TAILED DEER; KODIAK ISLAND; TESTIS; RAT; CONTAMINANTS; CHEMICALS; EXPOSURE; WILDLIFE; GATA-4; SIZE	There is growing interest in using wild animals to monitor the real-life cocktail effect of environmental chemicals on male reproduction. However, practical difficulties, such as long distances to the laboratory, generally prolong the time between euthanisation and specimen handling. For instance, tissue fixation is often performed on frozen material or on material where deterioration has started, which may affect tissue morphology. This study examined the effect of pre-fixation delay and freezing on mink testicular endpoints in order to determine robust endpoints in suboptimally handled specimens. Sexually mature farmed mink (n=30) selected at culling were divided into six groups and subjected to different time intervals between euthanisation and fixation or freezing: 0 hours (fixed immediately post mortem), 6 hours, 18 hours, 30 hours, 42 hours, or frozen 6 hours post mortem and thawed overnight. Unaffected endpoints when pre-fixation storage was extended to 30 hours included: area and diameter of the seminiferous tubules, length and weight of the testes, and acrosomes marked with Gata-4. Epithelial height, Sertoli cells marked with Gata-4 and cell morphology were affected endpoints after 6 hours of storage. Freezing the tissue prior to fixation severely altered cell morphology and reduced testicular weight, tubular diameter and area. Morphological changes seen after 6 hours included shredded germ cells and excess cytoplasm in seminiferous tubular lumen, chromatin rearrangements and increased germ cell death. Extended delay before fixation and freezing affected many endpoints in the mink testicular tissue. Some of these endpoints may mimic chemically induced effects, which is important to consider when evaluating specimens from wild animals for environmental toxicity.	[Sporndly-Nees, Ellinor; Ekstedt, Elisabeth; Holm, Lena] Swedish Univ Agr Sci, Fac Vet Med & Anim Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden; [Magnusson, Ulf] Swedish Univ Agr Sci, Fac Vet Med & Anim Sci, Dept Clin Sci, Uppsala, Sweden; [Fakhrzadeh, Azadeh; Hendriks, Cris L. Luengo] Uppsala Univ, Ctr Image Anal, Dept Informat Technol, Div Visual Informat & Interact, Uppsala, Sweden	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Uppsala University	Sporndly-Nees, E (corresponding author), Swedish Univ Agr Sci, Fac Vet Med & Anim Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden.	Ellinor.Sporndly-Nees@slu.se	Fakhrzadeh, Azadeh/ABF-3485-2021; Luengo Hendriks, Cris L./B-1097-2008	Magnusson, Ulf/0000-0002-7087-6820; Luengo Hendriks, Cris L./0000-0002-8279-1760				Alam MS, 2010, REPRODUCTION, V139, P427, DOI 10.1530/REP-09-0226; [Anonymous], 2012, NAT METHODS, V9, P627, DOI 10.1038/nmeth.2102; Bailey SA, 2004, TOXICOL PATHOL, V32, P448, DOI 10.1080/01926230490465874; Barrett W A, 1997, Med Image Anal, V1, P331, DOI 10.1016/S1361-8415(97)85005-0; Basu N, 2007, ENVIRON RES, V103, P130, DOI 10.1016/j.envres.2006.04.005; Bellingham M, 2012, INT J ANDROL, V35, P317, DOI 10.1111/j.1365-2605.2011.01234.x; Bergman A., 2013, STATE SCI ENDOCRINE, DOI DOI 10.1016/J; Berndtson WE, 2011, J ANDROL, V32, P2, DOI 10.2164/jandrol.109.008870; Berndtson WE, 2010, J ANDROL, V31, P607, DOI 10.2164/jandrol.110.010116; Berndtson WE, 2010, J ANDROL, V31, P593, DOI 10.2164/jandrol.109.008920; Bryant BH, 2007, TOXICOL PATHOL, V35, P665, DOI 10.1080/01926230701459994; Bubenik GA, 2002, Z JAGDWISS, V48, P234, DOI 10.1007/BF02189694; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Chodorowski A, 2005, PROC SPIE, V5747, P1589, DOI 10.1117/12.594944; Creasy DM, 2003, BIRTH DEFECTS RES B, V68, P408, DOI 10.1002/bdrb.10041; Creasy DM, 1997, TOXICOL PATHOL, V25, P119, DOI 10.1177/019262339702500201; Creasy DM, 2001, TOXICOL PATHOL, V29, P64, DOI 10.1080/019262301301418865; Dallinga JW, 2002, HUM REPROD, V17, P1973, DOI 10.1093/humrep/17.8.1973; Falcao AX, 1998, GRAPH MODEL IM PROC, V60, P233, DOI 10.1006/gmip.1998.0475; Fox GA, 2001, ENVIRON HEALTH PERSP, V109, P853, DOI 10.2307/3454647; Hildreth E, 1980, P ROY SOC LONDON, V207, P182; Jimenez-Severiano H, 2005, J ANIM SCI, V83, P2111; Karadzic R, 2010, ROM J LEG MED, V18, P247, DOI 10.4323/rjlm.2010.247; KELCE WR, 1995, NATURE, V375, P581, DOI 10.1038/375581a0; Ketola I, 2002, EUR J ENDOCRINOL, V147, P397, DOI 10.1530/eje.0.1470397; KIHLSTROM JE, 1992, AMBIO, V21, P563; Lanning LL, 2002, TOXICOL PATHOL, V30, P507, DOI 10.1080/01926230290105695; Latendresse JR, 2002, TOXICOL PATHOL, V30, P524, DOI 10.1080/01926230290105721; LEE HC, 1991, IEEE T SIGNAL PROCES, V39, P1181, DOI 10.1109/78.80971; Mathur PP, 2011, ASIAN J ANDROL, V13, P585, DOI 10.1038/aja.2011.40; McClusky LM, 2009, J MOL HISTOL, V40, P287, DOI 10.1007/s10735-009-9240-3; McCoard SA, 2001, BIOL REPROD, V64, P689, DOI 10.1095/biolreprod64.2.689; PELLETIER RM, 1986, AM J ANAT, V175, P91, DOI 10.1002/aja.1001750109; Persson S., 2012, ACTA VET SCAND S1, V54, pS9, DOI DOI 10.1186/1751-0147-54-S1-S9; Petrelli G, 2001, EUR J EPIDEMIOL, V17, P675, DOI 10.1023/A:1015511625099; Predes FD, 2010, INT J EXP PATHOL, V91, P125, DOI 10.1111/j.1365-2613.2009.00692.x; Ramos-Vara JA, 2009, VET PATHOL, V46, P893, DOI 10.1354/vp.08-VP-0287-R-BC; Regulation (EC) No 1069/ 2009 of the European Parliament and of the Council, 2009, OFFICIAL J EUROPEAN; Ryokkynen A, 2005, TOXICOL APPL PHARM, V202, P132, DOI 10.1016/j.taap.2004.06.012; Saradha B, 2006, ENVIRON TOXICOL PHAR, V21, P34, DOI 10.1016/j.etap.2005.06.004; Scudamore C. L., 2011, Comparative Clinical Pathology, V20, P95, DOI 10.1007/s00580-010-1149-4; Sharpe RM, 1995, ENVIRON HEALTH PERSP, V103, P1136, DOI 10.2307/3432610; Sohoni P, 1998, J ENDOCRINOL, V158, P327, DOI 10.1677/joe.0.1580327; Sonne C, 2006, ENVIRON SCI TECHNOL, V40, P5668, DOI 10.1021/es060836n; Toman R, 2012, J ENVIRON SCI HEAL A, V47, P1272, DOI 10.1080/10934529.2012.672130; Tomita Yukari, 2004, Leg Med (Tokyo), V6, P25, DOI 10.1016/j.legalmed.2003.09.001; Veeramachaneni DNR, 2006, ENVIRON HEALTH PERSP, V114, P51, DOI 10.1289/ehp.8052; Vos JG, 2000, CRIT REV TOXICOL, V30, P71, DOI 10.1080/10408440091159176	48	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125139	10.1371/journal.pone.0125139	http://dx.doi.org/10.1371/journal.pone.0125139			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933113	Green Published, gold, Green Submitted			2022-12-27	WOS:000353887100081
J	Stoel, M; Pool, J; de Vries-Idema, J; Zaaraoui-Boutahar, F; Bijl, M; Andeweg, AC; Wilschut, J; Huckriede, A				Stoel, Maaike; Pool, Judith; de Vries-Idema, Jacqueline; Zaaraoui-Boutahar, Fatiha; Bijl, Maarten; Andeweg, Arno C.; Wilschut, Jan; Huckriede, Anke			Innate Responses Induced by Whole Inactivated Virus or Subunit Influenza Vaccines in Cultured Dendritic Cells Correlate with Immune Responses In Vivo	PLOS ONE			English	Article							SYSTEMS BIOLOGY; IMMUNOGENICITY; ANTIGENICITY; VACCINATION; IFN	Vaccine development involves time-consuming and expensive evaluation of candidate vaccines in animal models. As mediators of both innate and adaptive immune responses dendritic cells (DCs) are considered to be highly important for vaccine performance. Here we evaluated how far the response of DCs to a vaccine in vitro is in line with the immune response the vaccine evokes in vivo. To this end, we investigated the response of murine bone marrow-derived DCs to whole inactivated virus (WIV) and subunit (SU) influenza vaccine preparations. These vaccine preparations were chosen because they differ in the immune response they evoke in mice with WIV being superior to SU vaccine through induction of higher virus-neutralizing antibody titers and a more favorable Th1-skewed response phenotype. Stimulation of DCs with WIV, but not SU vaccine, resulted in a cytokine response that was comparable to that of DCs stimulated with live virus. Similarly, the gene expression profiles of DCs treated with WIV or live virus were similar and differed from that of SU vaccine-treated DCs. More specifically, exposure of DCs to WIV resulted in differential expression of genes in known antiviral pathways, whereas SU vaccine did not. The stronger antiviral and more Th1-related response of DCs to WIV as compared to SU vaccine correlates well with the superior immune response found in mice. These results indicate that in vitro stimulation of DCs with novel vaccine candidates combined with the assessment of multiple parameters, including gene signatures, may be a valuable tool for the selection of vaccine candidates.	[Stoel, Maaike; Pool, Judith; de Vries-Idema, Jacqueline; Wilschut, Jan; Huckriede, Anke] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands; [Zaaraoui-Boutahar, Fatiha; Bijl, Maarten; Andeweg, Arno C.] Erasmus Univ, Dept Virosci, Rotterdam, Netherlands	University of Groningen; Erasmus University Rotterdam	Huckriede, A (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands.	a.l.w.huckriede@umcg.nl	Huckriede, Anke/P-3558-2019	Huckriede, Anke/0000-0002-2646-5143	VIRGO consortium - Netherlands Genomics Initiative; Dutch Government [FES0908]	VIRGO consortium - Netherlands Genomics Initiative; Dutch Government	This study was financially supported by the VIRGO consortium, which is funded by the Netherlands Genomics Initiative and by the Dutch Government (FES0908). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALKOVIC ES, 1987, ANTIVIR RES, V8, P151, DOI 10.1016/0166-3542(87)90068-4; BERNSTEIN DI, 1982, PEDIATRICS, V69, P404; Budimir N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063163; Budimir N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030898; Chang WLW, 2007, J IMMUNOL, V178, P1457, DOI 10.4049/jimmunol.178.3.1457; Coro ES, 2006, J IMMUNOL, V176, P4343, DOI 10.4049/jimmunol.176.7.4343; COUTELIER JP, 1987, J EXP MED, V165, P64, DOI 10.1084/jem.165.1.64; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; FAZEKAS G, 1994, EUR J IMMUNOL, V24, P3063, DOI 10.1002/eji.1830241222; Geeraedts F, 2011, ADV EXP MED BIOL, V780, P161, DOI 10.1007/978-1-4419-5632-3_13; Geeraedts F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000138; Geeraedts F, 2008, INFLUENZA OTHER RESP, V2, P41, DOI 10.1111/j.1750-2659.2008.00038.x; Hagenaars N, 2008, VACCINE, V26, P6555, DOI 10.1016/j.vaccine.2008.09.057; Halbroth BR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103392; Heer AK, 2007, J IMMUNOL, V178, P2182, DOI 10.4049/jimmunol.178.4.2182; Hovden AO, 2005, SCAND J IMMUNOL, V62, P36, DOI 10.1111/j.1365-3083.2005.01633.x; Huang Da Wei, 2009, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1311s27; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; KARK JD, 1981, MED MICROBIOL IMMUN, V170, P55, DOI 10.1007/BF02123797; Kaufmann SHE, 2011, LANCET INFECT DIS, V11, P633, DOI 10.1016/S1473-3099(11)70146-3; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Nabel GJ, 2013, NEW ENGL J MED, V368, P551, DOI 10.1056/NEJMra1204186; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Plotkin SA, 2011, NAT REV MICROBIOL, V9, P889, DOI 10.1038/nrmicro2668; Proietti E, 2002, J IMMUNOL, V169, P375, DOI 10.4049/jimmunol.169.1.375; Pulendran B, 2004, IMMUNOL REV, V199, P227, DOI 10.1111/j.0105-2896.2004.00144.x; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Rappuoli R, 2011, NAT REV IMMUNOL, V11, P865, DOI 10.1038/nri3085; Seubert A, 2008, J IMMUNOL, V180, P5402, DOI 10.4049/jimmunol.180.8.5402; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; Stephenson I, 2003, LANCET, V362, P1959, DOI 10.1016/S0140-6736(03)15014-3; Wilschut JC, 2006, VACCINATION CORNERST, P150	37	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125228	10.1371/journal.pone.0125228	http://dx.doi.org/10.1371/journal.pone.0125228			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933037	gold, Green Published, Green Submitted			2022-12-27	WOS:000353887100094
J	Brindle, NR; Joyce, JA; Rostker, F; Lawlor, ER; Swigart-Brown, L; Evan, G; Hanahan, D; Shchors, K				Brindle, Nicola R.; Joyce, Johanna A.; Rostker, Fanya; Lawlor, Elizabeth R.; Swigart-Brown, Lamorna; Evan, Gerard; Hanahan, Douglas; Shchors, Ksenya			Deficiency for the Cysteine Protease Cathepsin L Impairs Myc-Induced Tumorigenesis in a Mouse Model of Pancreatic Neuroendocrine Cancer	PLOS ONE			English	Article							C-MYC; ANGIOGENIC SWITCH; INDUCED APOPTOSIS; GENE-EXPRESSION; HUMAN-MELANOMA; IN-VITRO; AUTOPHAGY; CELLS; ACTIVATION; INHIBITION	Motivated by the recent implication of cysteine protease cathepsin L as a potential target for anti-cancer drug development, we used a conditional MycER(TAM); Bcl-x(L) model of pancreatic neuroendocrine tumorigenesis (PNET) to assess the role of cathepsin L in Myc-induced tumor progression. By employing a cysteine cathepsin activity probe in vivo and in vitro, we first established that cathepsin activity increases during the initial stages of MycER(TAM); Bcl-x(L) tumor development. Among the cathepsin family members investigated, only cathepsin L was predominately produced by beta-tumor cells in neoplastic pancreata and, consistent with this, cathepsin L mRNA expression was rapidly upregulated following Myc activation in the beta cell compartment. By contrast, cathepsins B, S and C were highly enriched in tumor-infiltrating leukocytes. Genetic deletion of cathepsin L had no discernible effect on the initiation of neoplastic growth or concordant angiogenesis. However, the tumors that developed in the cathepsin L-deficient background were markedly reduced in size relative to their typical wild-type counterparts, indicative of a role for cathepsin L in enabling expansive tumor growth. Thus, genetic blockade of cathepsin L activity is inferred to retard Myc-driven tumor growth, encouraging the potential utility of pharmacological inhibitors of cysteine cathepsins in treating late stage tumors.	[Brindle, Nicola R.; Hanahan, Douglas; Shchors, Ksenya] Ecole Polytech Fed Lausanne, Swiss Fed Inst Technol Lausanne, Swiss Inst Expt Canc Res ISREC, CH-1015 Lausanne, Switzerland; [Joyce, Johanna A.; Rostker, Fanya; Lawlor, Elizabeth R.; Swigart-Brown, Lamorna; Evan, Gerard; Shchors, Ksenya] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Joyce, Johanna A.; Rostker, Fanya; Lawlor, Elizabeth R.; Swigart-Brown, Lamorna; Evan, Gerard; Shchors, Ksenya] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Joyce, Johanna A.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Memorial Sloan Kettering Cancer Center	Shchors, K (corresponding author), Ecole Polytech Fed Lausanne, Swiss Fed Inst Technol Lausanne, Swiss Inst Expt Canc Res ISREC, CH-1015 Lausanne, Switzerland.	ksenya.shchors@epfl.ch			National Cancer Institute (NCI); European Research Council (ERC); Ecole polytechnique federale de Lausanne (EPFL); NCI; National Institute of Health (NIH) [CA106039]; Cancer Research UK [19013, 12077] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [F32CA106039] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); European Research Council (ERC)(European Research Council (ERC)); Ecole polytechnique federale de Lausanne (EPFL); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by National Cancer Institute (NCI), The European Research Council (ERC) and by core support from The Ecole polytechnique federale de Lausanne (EPFL) to D.H NCI to GE, F32-CA106039 National Institute of Health (NIH) to KS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1996, J CELL BIOCHEM, V61, P514, DOI 10.1002/(SICI)1097-4644(19960616)61:4<514::AID-JCB4>3.0.CO;2-R; Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Baudino TA, 2002, GENE DEV, V16, P2530, DOI 10.1101/gad.1024602; Benhar M, 2001, MOL CELL BIOL, V21, P6913, DOI 10.1128/MCB.21.20.6913-6926.2001; Berdowska I, 2004, CLIN CHIM ACTA, V342, P41, DOI 10.1016/j.cccn.2003.12.016; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Berquin IM, 1996, ADV EXP MED BIOL, V389, P281; Boudreau F, 2007, FASEB J, V21, P3853, DOI 10.1096/fj.07-8113com; Chan CH, 2010, NAT CELL BIOL, V12, P457, DOI 10.1038/ncb2047; Chapel A, 2013, MOL CELL PROTEOMICS, V12, P1572, DOI 10.1074/mcp.M112.021980; Christofori G, 1999, TRENDS BIOCHEM SCI, V24, P73, DOI 10.1016/S0968-0004(98)01343-7; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Dennemarker J, 2010, ONCOGENE, V29, P1611, DOI 10.1038/onc.2009.466; Droga-Mazovec G, 2008, J BIOL CHEM, V283, P19140, DOI 10.1074/jbc.M802513200; EMMERTBUCK MR, 1994, AM J PATHOL, V145, P1285; Gocheva V, 2006, GENE DEV, V20, P543, DOI 10.1101/gad.1407406; Gocheva V, 2007, CELL CYCLE, V6, P60, DOI 10.4161/cc.6.1.3669; Gocheva V, 2010, GENE DEV, V24, P241, DOI 10.1101/gad.1874010; Gonzalez-Polo RA, 2005, J CELL SCI, V118, P3091, DOI 10.1242/jcs.02447; Greenbaum D, 2000, CHEM BIOL, V7, P569, DOI 10.1016/S1074-5521(00)00014-4; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hermeking H, 2000, P NATL ACAD SCI USA, V97, P2229, DOI 10.1073/pnas.050586197; Joyce JA, 2004, CANCER CELL, V5, P443, DOI 10.1016/S1535-6108(04)00111-4; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kiffin R, 2004, MOL BIOL CELL, V15, P4829, DOI 10.1091/mbc.E04-06-0477; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Lah TT, 1998, BIOL CHEM, V379, P125; Lankelma JM, 2010, LIFE SCI, V86, P225, DOI 10.1016/j.lfs.2009.11.016; Lawlor ER, 2006, CANCER RES, V66, P4591, DOI 10.1158/0008-5472.CAN-05-3826; Levicar N, 2003, CANCER GENE THER, V10, P141, DOI 10.1038/sj.cgt.7700546; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Mahmood DFD, 2011, J BIOL CHEM, V286, P28858, DOI 10.1074/jbc.M111.273292; Marino G, 2014, NAT REV MOL CELL BIO, V15, P81, DOI 10.1038/nrm3735; Matarrese P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-207; Meara JP, 1996, J MED CHEM, V39, P3357, DOI 10.1021/jm950445b; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Osthus RC, 2000, J BIOL CHEM, V275, P21797, DOI 10.1074/jbc.C000023200; PAVELIC K, 1995, J PATHOL, V177, P395, DOI 10.1002/path.1711770410; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Pham CTN, 1999, P NATL ACAD SCI USA, V96, P8627, DOI 10.1073/pnas.96.15.8627; Rebbaa A, 2009, ANTICANCER RES, V29, P4473; Roth W, 2000, FASEB J, V14, P2075, DOI 10.1096/fj.99-0970com; Rousselet N, 2004, CANCER RES, V64, P146, DOI 10.1158/0008-5472.CAN-03-1717; Shchors K, 2013, ONCOGENE, V32, P502, DOI 10.1038/onc.2012.60; Shchors K, 2006, GENE DEV, V20, P2527, DOI 10.1101/gad.1455706; Soucek L, 2007, NAT MED, V13, P1211, DOI 10.1038/nm1649; Stypmann J, 2002, P NATL ACAD SCI USA, V99, P6234, DOI 10.1073/pnas.092637699; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; Tsuneoka M, 2003, CELL STRUCT FUNCT, V28, P195; Turk D, 2003, ACTA CRYSTALLOGR D, V59, P203, DOI 10.1107/S0907444902021479; Turk V, 2002, ADV ENZYME REGUL, V42, P285, DOI 10.1016/S0065-2571(01)00034-6; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; Yuneva MO, 2012, CELL METAB, V15, P157, DOI 10.1016/j.cmet.2011.12.015	54	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0120348	10.1371/journal.pone.0120348	http://dx.doi.org/10.1371/journal.pone.0120348			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927437	Green Published, Green Submitted, gold			2022-12-27	WOS:000353713100003
J	Domenech, M; Damian, D; Ardanuy, C; Linares, J; Fenoll, A; Garcia, E				Domenech, Mirian; Damian, Diana; Ardanuy, Carmen; Linares, Josefina; Fenoll, Asuncion; Garcia, Ernesto			Emerging, Non-PCV13 Serotypes 11A and 35B of Streptococcus pneumoniae Show High Potential for Biofilm Formation In Vitro	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; NASOPHARYNGEAL CARRIAGE; HAEMOPHILUS-INFLUENZAE; STAPHYLOCOCCUS-AUREUS; COLONIZATION; CHILDREN	Background Since the use of pneumococcal conjugate vaccines PCV7 and PCV13 in children became widespread, invasive pneumococcal disease (IPD) has dramatically decreased. Nevertheless, there has been a rise in incidence of Streptococcus pneumoniae non-vaccine serotypes (NVT) colonising the human nasopharynx. Nasopharyngeal colonisation, an essential step in the development of S. pneumoniae-induced IPD, is associated with biofilm formation. Although the capsule is the main pneumococcal virulence factor, the formation of pneumococcal biofilms might, in fact, be limited by the presence of capsular polysaccharide (CPS). Methodology/Principal Findings We used clinical isolates of 16 emerging, non-PCV13 serotypes as well as isogenic transformants of the same serotypes. The biofilm formation capacity of isogenic transformants expressing CPSs from NVT was evaluated in vitro to ascertain whether this trait can be used to predict the emergence of NVT. Fourteen out of 16 NVT analysed were not good biofilm formers, presumably because of the presence of CPS. In contrast, serotypes 11A and 35B formed >= 45% of the biofilm produced by the non-encapsulated M11 strain. Conclusions/Significance This study suggest that emerging, NVT serotypes 11A and 35B deserve a close surveillance.	[Domenech, Mirian; Damian, Diana; Garcia, Ernesto] CSIC, Ctr Invest Biol, Madrid, Spain; [Domenech, Mirian; Ardanuy, Carmen; Linares, Josefina; Garcia, Ernesto] CIBER Enfermedades Resp CIBERES, Madrid, Spain; [Ardanuy, Carmen; Linares, Josefina] Univ Barcelona, Hosp Univ Bellvitge, Fdn Privada, Inst Invest Biomed Bellvitge, Barcelona, Spain; [Fenoll, Asuncion] Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Domenech, M (corresponding author), CSIC, Ctr Invest Biol, Madrid, Spain.	mirid@cib.csic.es	Ardanuy, Carmen/C-4463-2015; Liñares, Josefina/N-9450-2014; Domenech, Mirian/G-2561-2018	Domenech, Mirian/0000-0002-0942-8180; Ardanuy, Carmen/0000-0003-0225-607X; Partearroyo Lacaba, Olvido/0000-0002-1692-4481	Ministerio de Economia y Competi-tividad [SAF2012-39444-C02-01/02, PI11/0763]	Ministerio de Economia y Competi-tividad(Spanish Government)	This work was supported by grants from the Ministerio de Economia y Competi-tividad (SAF2012-39444-C02-01/02 and PI11/0763). CIBER de Enfermedades Respiratorias (CIBERES) is an initiative of Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardanuy C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043619; Auranen K, 2013, VACCINE, V32, P153, DOI 10.1016/j.vaccine.2013.08.061; Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; Brady AM, 2014, J INFECT DIS, V210, P1155, DOI 10.1093/infdis/jiu195; Calix JJ, 2014, J CLIN MICROBIOL, V52, P758, DOI 10.1128/JCM.02695-13; Camilli R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076309; Charalambous BM, 2012, CURR OPIN PULM MED, V18, P222, DOI 10.1097/MCP.0b013e328352103b; Chiba N, 2014, EMERG INFECT DIS, V20, P1132, DOI 10.3201/eid2007.131485; Crook DW, 2004, PNEUMOCCOCUS, P136; del Amo E, 2014, EUR J CLIN MICROBIOL; Domenech A, 2014, ANTIMICROB AGENTS CH, V58, P2393, DOI 10.1128/AAC.02669-13; Domenech M, 2014, ENVIRON MICROBIOL, V16, P1193, DOI 10.1111/1462-2920.12370; Domenech M, 2012, MICROB BIOTECHNOL, V5, P455, DOI 10.1111/j.1751-7915.2011.00294.x; Domenech M, 2009, ENVIRON MICROBIOL, V11, P2542, DOI 10.1111/j.1462-2920.2009.01979.x; Feldman Charles, 2014, F1000Prime Rep, V6, P82, DOI 10.12703/P6-82; Goldblatt D, 2013, VACCINE, V32, P146, DOI 10.1016/j.vaccine.2013.06.040; Grabenstein JD, 2012, CLIN MICROBIOL INFEC, V18, P15, DOI 10.1111/j.1469-0691.2012.03943.x; Grau I, 2014, INT J INFECT DIS, V25, P59, DOI 10.1016/j.ijid.2013.12.013; Hammitt LL, 2014, LANCET GLOB HEALTH, V2, pE397, DOI 10.1016/S2214-109X(14)70224-4; Hausdorff WP, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-4; Henriques-Normark B, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010215; Hsu HE, 2009, NEW ENGL J MED, V360, P244, DOI 10.1056/NEJMoa0800836; Kamerling JP., 2000, STREPTOCOCCUS PNEUMO, P81; Kaplan SL, 2013, PEDIATR INFECT DIS J, V32, P203, DOI 10.1097/INF.0b013e318275614b; Li Y, 2013, INFECT IMMUN, V81, P4519, DOI 10.1128/IAI.00724-13; Marks LR, 2013, MBIO, V4, DOI 10.1128/mBio.00438-13; Marks LR, 2012, MBIO, V3, DOI 10.1128/mBio.00200-12; Martin JM, 2014, PEDIATR INFECT DIS J, V33, pE286, DOI 10.1097/INF.0000000000000445; McElligott M, 2014, VACCINE, V32, P3495, DOI 10.1016/j.vaccine.2014.04.047; Mendes RE, 2014, ANTIMICROB AGENTS CH, V58, P4923, DOI 10.1128/AAC.02976-14; Moscoso M, 2006, J BACTERIOL, V188, P7785, DOI 10.1128/JB.00673-06; Munoz R, 1999, J BACTERIOL, V181, P6214; Nunes MC, 2015, VACCINE, V33, P628, DOI 10.1016/j.vaccine.2014.12.023; Nzenze SA, 2014, VACCINE, V32, P5520, DOI 10.1016/j.vaccine.2014.06.091; Richter SS, 2014, ANTIMICROB AGENTS CH, V58, P6484, DOI 10.1128/AAC.03344-14; Saha S, 2015, VACCINE, V33, P713, DOI 10.1016/j.vaccine.2014.11.040; Said MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060273; Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]; Simonsen L, 2014, LANCET RESP MED, V2, P387, DOI 10.1016/S2213-2600(14)70032-3; Skinner JM, 2011, VACCINE, V29, P8870, DOI 10.1016/j.vaccine.2011.09.078; Steens A, 2013, VACCINE, V31, P6232, DOI 10.1016/j.vaccine.2013.10.032; van den Bergh MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047711; van Gils EJM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020229; van Hoek AJ, 2014, VACCINE, V32, P4349, DOI 10.1016/j.vaccine.2014.03.017; Vernatter J, 2013, CURR OPIN INFECT DIS, V26, P277, DOI 10.1097/QCO.0b013e3283608419; Weinberger DM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000476; World Health Organization, 2012, WKLY EPIDEMIOL REC, V87, P12	47	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125636	10.1371/journal.pone.0125636	http://dx.doi.org/10.1371/journal.pone.0125636			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927917	Green Published, gold			2022-12-27	WOS:000353713100108
J	Gao, XJJ; Clandinin, TR; Luo, LQ				Gao, Xiaojing J.; Clandinin, Thomas R.; Luo, Liqun			Extremely Sparse Olfactory Inputs Are Sufficient to Mediate Innate Aversion in Drosophila	PLOS ONE			English	Article							ODOR DISCRIMINATION; CHEMOSENSORY RECEPTORS; GENE-EXPRESSION; NEURONS; ORGANIZATION; RESPONSES; SYSTEM; ATTRACTION; POPULATION; CHEMOTAXIS	Innate attraction and aversion to odorants are observed throughout the animal kingdom, but how olfactory circuits encode such valences is not well understood, despite extensive anatomical and functional knowledge. In Drosophila melanogaster, similar to 50 types of olfactory receptor neurons (ORNs) each express a unique receptor gene, and relay information to a cognate type of projection neurons (PNs). To examine the extent to which the population activity of ORNs is required for olfactory behavior, we developed a genetic strategy to block all ORN outputs, and then to restore output in specific types. Unlike attraction, aversion was unaffected by simultaneous silencing of many ORNs, and even single ORN types previously shown to convey neutral valence sufficed to mediate aversion. Thus, aversion may rely on specific activity patterns in individual ORNs rather than the number or identity of activated ORNs. ORN activity is relayed into the brain by downstream circuits, with excitatory PNs (ePN) representing a major output. We found that silencing the majority of ePNs did not affect aversion, even when ePNs directly downstream of single restored ORN types were silenced. Our data demonstrate the robustness of olfactory aversion, and suggest that its circuit mechanism is qualitatively different from attraction.	[Gao, Xiaojing J.; Luo, Liqun] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Gao, Xiaojing J.; Luo, Liqun] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Clandinin, Thomas R.; Luo, Liqun] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Gao, XJJ (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	xjgao@stanford.edu	Gao, Xiaojing/K-2376-2016	Gao, Xiaojing/0000-0002-3094-1456; Luo, Liqun/0000-0001-5467-9264	Enlight Foundation Interdisciplinary Fellowship; NIH [R01-DC005982, R01-EY022638]; NATIONAL EYE INSTITUTE [R01EY022638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005982] Funding Source: NIH RePORTER	Enlight Foundation Interdisciplinary Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	XJG is supported by an Enlight Foundation Interdisciplinary Fellowship. LL is an investigator of the Howard Hughes Medical Institute. This study was also supported by NIH grants R01-DC005982 (LL) and R01-EY022638 (TRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; Ai M, 2010, NATURE, V468, P691, DOI 10.1038/nature09537; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Caron SJC, 2013, NATURE, V497, P113, DOI 10.1038/nature12063; Choi GB, 2011, CELL, V146, P1003, DOI 10.1016/j.cell.2011.07.041; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; DasGupta S, 2008, CURR BIOL, V18, P1668, DOI 10.1016/j.cub.2008.08.071; Estes PS, 2000, J NEUROGENET, V13, P233, DOI 10.3109/01677060009084496; Faucher CP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056361; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Fraenkel GS, 1961, ORIENTATION ANIMALS; Gao XJJ, 2013, CURR BIOL, V23, P1163, DOI 10.1016/j.cub.2013.05.008; Gohl DM, 2011, NAT METHODS, V8, P231, DOI 10.1038/NMETH.1561; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hong WZ, 2009, NAT NEUROSCI, V12, P1542, DOI 10.1038/nn.2442; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Joo WJ, 2013, NEURON, V78, P673, DOI 10.1016/j.neuron.2013.03.022; Katsov AY, 2008, NEURON, V59, P322, DOI 10.1016/j.neuron.2008.05.022; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Knaden M, 2012, CELL REPORTS, V1, P392, DOI 10.1016/j.celrep.2012.03.002; Kreher SA, 2008, NEURON, V59, P110, DOI 10.1016/j.neuron.2008.06.010; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Liang L, 2013, NEURON, V79, P917, DOI 10.1016/j.neuron.2013.06.014; Lin HH, 2013, SCIENCE, V340, P1338, DOI 10.1126/science.1236693; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Newsome TP, 2000, DEVELOPMENT, V127, P851; Parnas M, 2013, NEURON, V79, P932, DOI 10.1016/j.neuron.2013.08.006; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Potter CJ, 2010, CELL, V141, P536, DOI 10.1016/j.cell.2010.02.025; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Semmelhack JL, 2009, NATURE, V459, P218, DOI 10.1038/nature07983; Silbering AF, 2011, J NEUROSCI, V31, P13357, DOI 10.1523/JNEUROSCI.2360-11.2011; Smear M, 2013, NAT NEUROSCI, V16, P1687, DOI 10.1038/nn.3519; Stensmyr MC, 2012, CELL, V151, P1345, DOI 10.1016/j.cell.2012.09.046; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Su CY, 2012, NATURE, V492, P66, DOI 10.1038/nature11712; Su CY, 2011, P NATL ACAD SCI USA, V108, P5075, DOI 10.1073/pnas.1100369108; Su CY, 2009, CELL, V139, P45, DOI 10.1016/j.cell.2009.09.015; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Sweeney LB, 2007, NEURON, V53, P185, DOI 10.1016/j.neuron.2006.12.022; Tanaka NK, 2012, J COMP NEUROL, V520, P4067, DOI 10.1002/cne.23142; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Wang YL, 2003, CURR BIOL, V13, P1900, DOI 10.1016/j.cub.2003.10.003; Wes PD, 2001, NATURE, V410, P698, DOI 10.1038/35070581; Wu JS, 2006, NAT PROTOC, V1, P2110, DOI 10.1038/nprot.2006.336	50	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125986	10.1371/journal.pone.0125986	http://dx.doi.org/10.1371/journal.pone.0125986			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927233	gold, Green Submitted, Green Published			2022-12-27	WOS:000353713100121
J	Landgraf, D; Long, J; Der-Avakian, A; Streets, M; Welsh, DK				Landgraf, Dominic; Long, Jaimie; Der-Avakian, Andre; Streets, Margo; Welsh, David K.			Dissociation of Learned Helplessness and Fear Conditioning in Mice: A Mouse Model of Depression	PLOS ONE			English	Article							DORSAL RAPHE NUCLEUS; TAIL SUSPENSION TEST; ANIMAL-MODELS; STRESSOR CONTROLLABILITY; UNCONTROLLABLE STRESS; REVEALS PERSISTENT; EXPOSURE; CLOCK; RATS; INTERFERENCE	The state of being helpless is regarded as a central aspect of depression, and therefore the learned helplessness paradigm in rodents is commonly used as an animal model of depression. The term 'learned helplessness' refers to a deficit in escaping from an aversive situation after an animal is exposed to uncontrollable stress specifically, with a control/comparison group having been exposed to an equivalent amount of controllable stress. A key feature of learned helplessness is the transferability of helplessness to different situations, a phenomenon called 'trans-situationality'. However, most studies in mice use learned helplessness protocols in which training and testing occur in the same environment and with the same type of stressor. Consequently, failures to escape may reflect conditioned fear of a particular environment, not a general change of the helpless state of an animal. For mice, there is no established learned helplessness protocol that includes the trans-situationality feature. Here we describe a simple and reliable learned helplessness protocol for mice, in which training and testing are carried out in different environments and with different types of stressors. We show that with our protocol approximately 50% of mice develop learned helplessness that is not attributable to fear conditioning.	[Landgraf, Dominic; Long, Jaimie; Welsh, David K.] Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA; [Landgraf, Dominic; Long, Jaimie; Welsh, David K.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Landgraf, Dominic; Long, Jaimie; Welsh, David K.] Univ Calif San Diego, Ctr Circadian Biol, La Jolla, CA 92093 USA; [Der-Avakian, Andre] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Streets, Margo] Univ Calif San Diego, Anim Phenotyping Core, La Jolla, CA 92093 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Welsh, DK (corresponding author), Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA.	welshdk@ucsd.edu	Der-Avakian, Andre/AAI-7734-2020; Der-Avakian, Andre/Q-5201-2018	Landgraf, Dominic/0000-0002-1328-1871	U.S. Department of Veterans Affairs [1I01BX001146]; NARSAD	U.S. Department of Veterans Affairs(US Department of Veterans Affairs); NARSAD(NARSAD)	This research was funded by the U.S. Department of Veterans Affairs, Grant number: 1I01BX001146, URL: http://www.va.gov/ and the NARSAD Young Investigator Award to David K. Welsh, URL: https://bbrfoundation.org/yi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON LY, 1978, J ABNORM PSYCHOL, V87, P49, DOI 10.1037/0021-843X.87.1.49; Amat J, 2005, NAT NEUROSCI, V8, P365, DOI 10.1038/nn1399; Anisman H., 2001, CURR PROTOC NEUROSCI, DOI DOI 10.1002/0471142301.11S0810CSIL.; Azzinnari D, 2014, NEUROPHARMACOLOGY, V85, P328, DOI 10.1016/j.neuropharm.2014.05.039; Baratta MV, 2007, NEUROSCIENCE, V146, P1495, DOI 10.1016/j.neuroscience.2007.03.042; Can A, 2012, JOVE-J VIS EXP, DOI 10.3791/3769; Chourbaji S, 2005, BRAIN RES PROTOC, V16, P70, DOI 10.1016/j.brainresprot.2005.09.002; Chourbaji S, 2005, BEHAV BRAIN RES, V164, P100, DOI 10.1016/j.bbr.2005.06.003; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Drugan RC, 1997, BRAIN RES PROTOC, V2, P69, DOI 10.1016/S1385-299X(97)00031-7; Duman CH, 2010, VITAM HORM, V82, P1, DOI 10.1016/S0083-6729(10)82001-1; Grahn RE, 2000, BEHAV BRAIN RES, V112, P33, DOI 10.1016/S0166-4328(00)00161-3; Greenwood BN, 2010, BEHAV BRAIN RES, V211, P71, DOI 10.1016/j.bbr.2010.03.012; Landgraf D, 2014, BEHAV NEUROSCI, V128, P344, DOI 10.1037/a0036029; Maier SF, 2001, BIOL PSYCHIAT, V49, P763, DOI 10.1016/S0006-3223(00)01095-7; MAIER SF, 1984, PROG NEURO-PSYCHOPH, V8, P435, DOI 10.1016/S0278-5846(84)80032-9; Maier SF, 2005, NEUROSCI BIOBEHAV R, V29, P829, DOI 10.1016/j.neubiorev.2005.03.021; Maier SF, 1998, COGNITIVE THER RES, V22, P595, DOI 10.1023/A:1018794104325; MAIER SF, 1995, BEHAV NEUROSCI, V109, P404, DOI 10.1037/0735-7044.109.3.404; Maier SF, 2015, NEUROBIOL STRESS, V1, P12, DOI 10.1016/j.ynstr.2014.09.003; Ohl F, 2005, HANDB EXP PHARM, V169, P35; Pryce CR, 2012, NEUROPHARMACOLOGY, V62, P358, DOI 10.1016/j.neuropharm.2011.08.012; Radulovic J, 1998, BEHAV BRAIN RES, V95, P179, DOI 10.1016/S0166-4328(98)00039-4; RAPS CS, 1982, J ABNORM PSYCHOL, V91, P102, DOI 10.1037/0021-843X.91.2.102; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; SELIGMAN ME, 1968, J ABNORM PSYCHOL, V73, P256, DOI 10.1037/h0025831; SELIGMAN ME, 1972, ANNU REV MED, V23, P407, DOI 10.1146/annurev.me.23.020172.002203; SELIGMAN ME, 1967, J EXP PSYCHOL, V74, P1, DOI 10.1037/h0024514; SHANKS N, 1988, BEHAV NEUROSCI, V102, P894, DOI 10.1037/0735-7044.102.6.894; Shumake J, 2005, BEHAV BRAIN RES, V164, P222, DOI 10.1016/j.bbr.2005.06.016; Steru L, 1985, PSYCHOPHARMACOLOGY B, V853, P367; Vollmayr B, 2001, BRAIN RES PROTOC, V8, P1, DOI 10.1016/S1385-299X(01)00067-8; Vollmayr B, 2004, BEHAV BRAIN RES, V150, P217, DOI 10.1016/S0166-4328(03)00259-6; Vollmayr B, 2013, CELL TISSUE RES, V354, P171, DOI 10.1007/s00441-013-1654-2; WEISS JM, 1968, J COMP PHYSIOL PSYCH, V65, P251, DOI 10.1037/h0025562; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Young JW, 2011, BRIT J PHARMACOL, V164, P1263, DOI 10.1111/j.1476-5381.2011.01318.x	38	31	32	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125892	10.1371/journal.pone.0125892	http://dx.doi.org/10.1371/journal.pone.0125892			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928892	gold, Green Published			2022-12-27	WOS:000353713100120
J	Metzler, MA; Venkatesh, SG; Lakshmanan, J; Carenbauer, AL; Perez, SM; Andres, SA; Appana, S; Brock, GN; Wittliff, JL; Darling, DS				Metzler, Melissa A.; Venkatesh, Srirangapatnam G.; Lakshmanan, Jaganathan; Carenbauer, Anne L.; Perez, Sara M.; Andres, Sarah A.; Appana, Savitri; Brock, Guy N.; Wittliff, James L.; Darling, Douglas S.			A Systems Biology Approach Identifies a Regulatory Network in Parotid Acinar Cell Terminal Differentiation	PLOS ONE			English	Article							RADIATION-INDUCED XEROSTOMIA; UNFOLDED PROTEIN RESPONSE; ACTIVATED-RECEPTOR-GAMMA; SECRETORY PROTEIN; SALIVARY-GLANDS; STROMAL CELLS; NECK-CANCER; EXPRESSION; XBP1; MIST1	Objective The transcription factor networks that drive parotid salivary gland progenitor cells to terminally differentiate, remain largely unknown and are vital to understanding the regeneration process. Methodology A systems biology approach was taken to measure mRNA and microRNA expression in vivo across acinar cell terminal differentiation in the rat parotid salivary gland. Laser capture microdissection (LCM) was used to specifically isolate acinar cell RNA at times spanning the month-long period of parotid differentiation. Results Clustering of microarray measurements suggests that expression occurs in four stages. mRNA expression patterns suggest a novel role for Pparg which is transiently increased during mid postnatal differentiation in concert with several target gene mRNAs. 79 microRNAs are significantly differentially expressed across time. Profiles of statistically significant changes of mRNA expression, combined with reciprocal correlations of microRNAs and their target mRNAs, suggest a putative network involving Klf4, a differentiation inhibiting transcription factor, which decreases as several targeting microRNAs increase late in differentiation. The network suggests a molecular switch (involving Prdm1, Sox11, Pax5, miR-200a, and miR-30a) progressively decreases repression of Xbp1 gene transcription, in concert with decreased translational repression by miR-214. The transcription factor Xbp1 mRNA is initially low, increases progressively, and may be maintained by a positive feedback loop with Atf6. Transfection studies show that Xbp1Mist1 promoter. In addition, Xbp1 and Mist1 each activate the parotid secretory protein (Psp) gene, which encodes an abundant salivary protein, and is a marker of terminal differentiation. Conclusion This study identifies novel expression patterns of Pparg, Klf4, and Sox11 during parotid acinar cell differentiation, as well as numerous differentially expressed microRNAs. Network analysis identifies a novel stemness arm, a genetic switch involving transcription factors and microRNAs, and transition to an Xbp1 driven differentiation network. This proposed network suggests key regulatory interactions in parotid gland terminal differentiation.	[Metzler, Melissa A.; Venkatesh, Srirangapatnam G.; Lakshmanan, Jaganathan; Carenbauer, Anne L.; Perez, Sara M.; Darling, Douglas S.] Univ Louisville, Dept Oral Immunol & Infect Dis, Louisville, KY 40292 USA; [Metzler, Melissa A.; Andres, Sarah A.; Wittliff, James L.; Darling, Douglas S.] Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40292 USA; [Metzler, Melissa A.; Venkatesh, Srirangapatnam G.; Andres, Sarah A.; Wittliff, James L.; Darling, Douglas S.] Univ Louisville, Inst Mol Div & Drug Design, Louisville, KY 40292 USA; [Appana, Savitri; Brock, Guy N.] Univ Louisville, Dept Bioinformat & Biostat, Louisville, KY 40292 USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville	Metzler, MA (corresponding author), Univ Louisville, Dept Oral Immunol & Infect Dis, Louisville, KY 40292 USA.	melissa.metzler@louisville.edu	Darling, Douglas S/D-4573-2009	Darling, Douglas/0000-0002-9039-1169; brock, guy/0000-0001-5317-079X	National Institute of Dental and Craniofacial Research [R01DE019243, F31DE022679]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F31DE022679, R01DE019243] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by R01DE019243 National Institute of Dental and Craniofacial Research (http://www.nidcr.nih.gov/) to DSD, and F31DE022679 National Institute of Dental and Craniofacial Research (http://www.nidcr.nih.gov/) to MAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdolhosseini M, 2012, MOL CELL BIOCHEM, V359, P1, DOI 10.1007/s11010-011-0991-2; Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Amerongen AVN, 2002, ORAL DIS, V8, P12, DOI 10.1034/j.1601-0825.2002.1o816.x; Andres SA, 2011, ENDOCRINE, V40, P212, DOI 10.1007/s12020-011-9522-x; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Vegliante MC, 2013, BLOOD, V121, P2175, DOI 10.1182/blood-2012-06-438937; Chambers MS, 2004, HEAD NECK-J SCI SPEC, V26, P796, DOI 10.1002/hed.20045; Chiquet-Ehrismann R, 2004, INT J BIOCHEM CELL B, V36, P986, DOI 10.1016/j.biocel.2003.12.002; Cittelly DM, 2013, ONCOGENE, V32, P2555, DOI 10.1038/onc.2012.275; CLAUSS IM, 1993, DEV DYNAM, V197, P146, DOI 10.1002/aja.1001970207; Dirix P, 2006, CANCER-AM CANCER SOC, V107, P2525, DOI 10.1002/cncr.22302; Duan QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031518; Evans RL, 2000, J BIOL CHEM, V275, P26720; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gadi J, 2013, J BIOL CHEM, V288, P25400, DOI 10.1074/jbc.M112.413377; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guchelaar HJ, 1997, SUPPORT CARE CANCER, V5, P281, DOI 10.1007/s005200050075; Guggenheimer J, 2003, J AM DENT ASSOC, V134, P61, DOI 10.14219/jada.archive.2003.0018; Huh WJ, 2010, GASTROENTEROLOGY, V139, P2038, DOI 10.1053/j.gastro.2010.08.050; Iwakoshi NN, 2007, J EXP MED, V204, P2267, DOI 10.1084/jem.20070525; Jacobs JL, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh157; Jensen SB, 2010, SUPPORT CARE CANCER, V18, P1061, DOI 10.1007/s00520-010-0837-6; Johnson CL, 2004, MECH DEVELOP, V121, P261, DOI 10.1016/j.mod.2004.01.003; Knox SM, 2010, SCIENCE, V329, P1645, DOI 10.1126/science.1192046; Lai JK, 2012, J CELL SCI, V125, P4853, DOI 10.1242/jcs.108910; Lai L, 2008, GENE DEV, V22, P1948, DOI 10.1101/gad.1661708; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Lemercier C, 2000, GENE, V242, P209, DOI 10.1016/S0378-1119(99)00523-5; Lemercier C, 1997, DEV BIOL, V182, P101, DOI 10.1006/dbio.1996.8454; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu XS, 2008, CELL RES, V18, P1177, DOI 10.1038/cr.2008.309; Lombaert IMA, 2013, STEM CELL REP, V1, P604, DOI 10.1016/j.stemcr.2013.10.013; MIKKELSEN TR, 1992, NUCLEIC ACIDS RES, V20, P2249, DOI 10.1093/nar/20.9.2249; Mills JC, 2012, BIOESSAYS, V34, P10, DOI 10.1002/bies.201100089; Min IM, 2008, CELL STEM CELL, V2, P380, DOI 10.1016/j.stem.2008.01.015; Mukunyadzi P, 2003, MODERN PATHOL, V16, P1218, DOI 10.1097/01.MP.0000096042.70559.7E; Musselmann K, 2011, J DENT RES, V90, P1078, DOI 10.1177/0022034511413131; Nanduri LSY, 2013, RADIOTHER ONCOL, V108, P458, DOI 10.1016/j.radonc.2013.05.020; Nanduri LSY, 2011, RADIOTHER ONCOL, V99, P367, DOI 10.1016/j.radonc.2011.05.085; Nera KP, 2006, IMMUNITY, V24, P283, DOI 10.1016/j.immuni.2006.02.003; Nguyen HV, 2000, J PHYSIOL-LONDON, V523, P139, DOI 10.1111/j.1469-7793.2000.t01-2-00139.x; Oh S, 2011, BIOINFORMATICS, V27, P78, DOI 10.1093/bioinformatics/btq613; Pin CL, 2001, J CELL BIOL, V155, P519, DOI 10.1083/jcb.200105060; Quissell DO, 1998, IN VITRO CELL DEV-AN, V34, P58; Quissell DO, 1998, EUR J MORPHOL, V36, P50; Rebustini IT, 2012, DEVELOPMENT, V139, P191, DOI 10.1242/dev.070151; REDMAN RS, 1971, DEV BIOL, V25, P248, DOI 10.1016/0012-1606(71)90030-3; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Sivakumar S, 1998, ANAT REC, V252, P485; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Tamm C, 2011, J CELL SCI, V124, P1136, DOI 10.1242/jcs.075796; Tian XL, 2010, MOL CELL BIOL, V30, P1269, DOI 10.1128/MCB.01328-09; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Tsang KY, 2007, PLOS BIOL, V5, P568, DOI 10.1371/journal.pbio.0050044; Venkatesh SG, 2011, J DENT RES, V90, P1085, DOI 10.1177/0022034511410699; Warner DR, 2014, MICRORNA EXPRESSION; Wei W, 2011, MOL CELL BIOL, V31, P4692, DOI 10.1128/MCB.05979-11; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Wittliff JL, 2010, TECHNIQUES CONFOCAL, P463; Wu HC, 2013, J CELL BIOCHEM, V114, P1969, DOI 10.1002/jcb.24534; Xu GS, 2012, BLOOD, V119, P4205, DOI 10.1182/blood-2011-05-353300; Yamamoto K, 2004, J BIOCHEM, V136, P343, DOI 10.1093/jb/mvh122; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang XY, 2009, INT J CANCER, V124, P2855, DOI 10.1002/ijc.24298	68	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125153	10.1371/journal.pone.0125153	http://dx.doi.org/10.1371/journal.pone.0125153			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928148	Green Submitted, Green Published, gold			2022-12-27	WOS:000353713100071
J	Thach, DT; Fisher, J; Hanieh, S; Tran, T; Simpson, JA; Tran, H; Biggs, BA				Thach Duc Tran; Fisher, Jane; Hanieh, Sarah; Tran, Tuan; Simpson, Julie Anne; Tran, Ha; Biggs, Beverley-Ann			Antenatal Iron Supplementation Regimens for Pregnant Women in Rural Vietnam and Subsequent Haemoglobin Concentration and Anaemia among Their Infants	PLOS ONE			English	Article							COMMON MENTAL-DISORDERS; DEFICIENCY	Background Little evidence about the effects of antenatal iron supplementation on infant anaemia is available. The aim was to compare effects on six-month-old infants' Haemoglobin (Hb) concentration and anaemia of daily iron-folic acid (IFA), twice-weekly IFA with or without other micronutrients (MMN) and usual antenatal care in rural Vietnam. Methods and Findings Secondary data analysis from: a prospective population-based observational study (OS) which examined effects of antenatal psychosocial factors, anaemia and iron deficiency on infant development and health; and a three-arm cluster randomised trial (CRT) of different antenatal iron supplementation regimens. In the OS 497 women (<20 weeks gestation) from 50 randomly-selected communes participated, and in the CRT 1,258 pregnant women (<16 weeks gestation) in 104 communes were allocated randomly to trial arms. The main outcome was six-month-old infant Hb concentration. Baseline data included women's socio-demographic characteristics, reproductive health, Hb and serum ferritin. Mean differences in infant Hb and odds ratios of infant anaemia between CRT arms and OS were calculated by multivariable regression models, controlling for baseline differences and clustering, using robust standard errors. Infant anaemia prevalence was 68.6% in the OS, 47.2% daily IFA, 53.5% weekly IFA, and 50.3% MMN conditions. After adjustment, mean infant haemoglobin levels in daily IFA (mean difference = 0.95 g/dL; 95% CI 0.7-11.18); weekly IFA (0.91; 95% CI 0.69-1.12) and MMN (1.04; 95% CI 0.8-1.27) were higher than in the OS. After adjustment there were lower odds ratios of anaemia among infants in the daily IFA (OR = 0.31; 95% CI 0.22-0.43), weekly IFA (0.38; 95% CI 0.26-0.54) and MMN (0.33; 95% CI 0.23-0.48) groups than in the OS. Conclusions Infant anaemia is a public health problem in Vietnam and other resource-constrained countries. All supplementation regimens could have clinically significant benefits for Hb and reduce anaemia risk among six-month-old infants. Universal provision of free intermittent iron supplements is warranted.	[Thach Duc Tran; Tran, Tuan; Tran, Ha] Res & Training Ctr Community Dev, Hanoi, Vietnam; [Thach Duc Tran; Fisher, Jane] Monash Univ, Sch Publ Hlth & Prevent Med, Jean Hailes Res Unit, Melbourne, Vic 3004, Australia; [Hanieh, Sarah; Biggs, Beverley-Ann] Univ Melbourne, Royal Melbourne Hosp, Dept Med RMH WH, Melbourne, Vic 3050, Australia; [Simpson, Julie Anne] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic, Australia	Monash University; Royal Melbourne Hospital; University of Melbourne; University of Melbourne	Thach, DT (corresponding author), Res & Training Ctr Community Dev, Hanoi, Vietnam.	indthach@yahoo.com	TRAN, THACH DUC/H-7734-2014; Mireku, Michael/D-5262-2016; Fisher, Jane/I-1569-2014	TRAN, THACH DUC/0000-0002-4686-8601; Tran, Tuan/0000-0002-4947-9169; Fisher, Jane/0000-0002-1959-6807	Australian Research Council [DP0986594]; National Health and Medical Research Council of Australia [628751]; Monash University; Jean Hailes Professorial Fellowship	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Monash University(Monash University); Jean Hailes Professorial Fellowship	The Observational study was funded by Australian Research Council Discovery Project Grant DP0986594. This Trial was funded through a grant from the National Health and Medical Research Council of Australia (Grant number 628751). JF is supported by a Professorial Fellowship from Monash University and the Jean Hailes Professorial Fellowship. TDT is supported by a Bridging Postdoctoral Research Fellowship from Monash University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa R, 2006, PUBLIC HEALTH NUTR, V9, P443, DOI 10.1079/PHN2005851; Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; Black RE, 2008, LANCET, V371, P17, DOI DOI 10.1016/S0140-6736(08)60052-5.PUBMED:18183655; Fisher J, 2013, INT HEALTH, V5, P29, DOI 10.1093/inthealth/ihs012; Fisher J, 2010, B WORLD HEALTH ORGAN, V88, P737, DOI 10.2471/BLT.09.067066; Grantham-McGregor S, 2001, J NUTR, V131, p649S, DOI 10.1093/jn/131.2.649S; Hanieh S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001470; Kawai K, 2011, B WORLD HEALTH ORGAN, V89, P402, DOI 10.2471/BLT.10.083758; Khan NC, 2007, ASIA PAC J CLIN NUTR, V16, P152; Lozoff B, 2007, FOOD NUTR BULL, V28, pS560, DOI 10.1177/15648265070284S409; Lu WP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088496; Minister of Health, 2001, VIETN NAT NUTR STRAT; Pena-Rosas JP, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009997; Pena-Rosas JP, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004736.pub3; Preziosi P, 1997, AM J CLIN NUTR, V66, P1178, DOI 10.1093/ajcn/66.5.1178; Szajewska H, 2010, AM J CLIN NUTR, V91, P1684, DOI 10.3945/ajcn.2010.29191; Tran TD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078162; Tran TD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074876; Tran TD, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-8; Trinh Lieu Thi Thuy, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P927; Unicef/UNU/WHO, 1999, UNICEF UNU WHO WORKS; WHO, 2001, IRON DEFICIENCY ANAE; World Health Organization, 2011, GUID INT IR FOL AC S	23	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125740	10.1371/journal.pone.0125740	http://dx.doi.org/10.1371/journal.pone.0125740			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928545	Green Published, Green Submitted, gold			2022-12-27	WOS:000353713100116
J	Wen, HC; Chuu, CP; Chen, CY; Shiah, SG; Kung, HJ; King, KL; Su, LC; Chang, SC; Chang, CH				Wen, Hui-Chin; Chuu, Chih-Pin; Chen, Chen-Yu; Shiah, Shine-Gwo; Kung, Hsing-Jien; King, Kuang-Liang; Su, Liang-Chen; Chang, Shi-Chuan; Chang, Chung-Ho			Elevation of Soluble Guanylate Cyclase Suppresses Proliferation and Survival of Human Breast Cancer Cells	PLOS ONE			English	Article							OXIDE SYNTHASE ACTIVITY; NITRIC-OXIDE; BRADYKININ RECEPTORS; EXPRESSION; EPIGENETICS; INHIBITOR; APOPTOSIS	Nitric oxide (NO) is an essential signaling molecule in biological systems. Soluble guanylate cyclase (sGC), composing of alpha 1 and beta 1 subunit, is the receptor for NO. Using radioimmunoassay, we discovered that activation of sGC by treatment with bradykinin or sodium nitroprusside (SNP) is impaired in MCF-7 and MDA-MB-231 breast cancer cells as compared to normal breast epithelial 184A1 cells. The 184A1 cells expressed both sGC alpha 1 and sGC beta 1 mRNAs. However, levels of sGC beta 1 mRNAs were relatively lower in MCF-7 cells while both mRNA of sGC subunits were absent in MDA-MB-231 cells. Treatment with DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine (5-aza-dC) increased mRNA levels of both sGC alpha 1 and sGC beta 1 in MDA-MB-231 cells but only sGC beta 1 mRNAs in MCF-7 cells. The 5-aza-dC treatment increased the SNP-induced cGMP production in MCF-7 and MDA-MB-231, but not in 184A1 cells. Bisulfite sequencing revealed that the promoter of sGCa1 in MDA-MB-231 cells and promoter of sGC beta 1 in MCF-7 cells were methylated. Promoter hypermethylation of sGC alpha 1 and sGC beta 1 was found in 1 out of 10 breast cancer patients. Over-expression of both sGC subunits in MDA-MB-231 cells induced apoptosis and growth inhibition in vitro as well as reduced tumor incidence and tumor growth rate of MDA-MB-231 xenografts in nude mice. Elevation of sGC reduced protein abundance of Bcl-2, Bcl-xL, Cdc2, Cdc25A, Cyclin B1, Cyclin D1, Cdk6, c-Myc, and Skp2 while increased protein expression of p53. Our study demonstrated that down-regulation of sGC, partially due to promoter methylation, provides growth and survival advantage in human breast cancer cells.	[Wen, Hui-Chin; Chuu, Chih-Pin; Chen, Chen-Yu; Su, Liang-Chen; Chang, Chung-Ho] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Miaoli County, Taiwan; [Shiah, Shine-Gwo] Natl Hlth Res Inst, Natl Inst Canc Res, Zhunan, Miaoli County, Taiwan; [Kung, Hsing-Jien] Natl Hlth Res Inst, Inst Mol & Genom Med, Zhunan, Miaoli County, Taiwan; [King, Kuang-Liang] Taipei Vet Gen Hosp, Dept Surg, Div Gen Surg, Taipei, Taiwan; [Chang, Shi-Chuan] Taipei Vet Gen Hosp, Chest Dept, Taipei, Taiwan; [Chang, Shi-Chuan] Natl Yang Ming Univ, Inst Emergency & Crit Care Med, Taipei 112, Taiwan; [Chang, Chung-Ho] China Med Univ, Grad Inst Basic Med Sci, PhD Program Aging, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; China Medical University Taiwan	Chang, SC (corresponding author), Taipei Vet Gen Hosp, Chest Dept, Taipei, Taiwan.	scchang@vghtpe.gov.tw; changch@nhri.org.tw	Chuu, Chih-Pin/N-6697-2019		National Health Research Institutes, Taiwan [CS-103-PP-03, CA-103-SP-01]; National Science Council, Taiwan [NSC 95-2314-B-309-007-MY3, NSC 95-2314-B-309-003-MY3]; Ministry of Science and Technology, Taiwan [MOST 103-2325-B-400-001]; Micro-Western Array core facility, sequencing core facility, and cell sorting core facility of National Health Research Institutes; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER	National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Micro-Western Array core facility, sequencing core facility, and cell sorting core facility of National Health Research Institutes; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by CS-103-PP-03 and CA-103-SP-01 (National Health Research Institutes, Taiwan) and NSC 95-2314-B-309-007-MY3 and NSC 95-2314-B-309-003-MY3 (National Science Council, Taiwan) for CHC; MOST 103-2325-B-400-001 (Ministry of Science and Technology, Taiwan) in Taiwan for CPC. The authors are thankful for the support from the Micro-Western Array core facility, sequencing core facility, and cell sorting core facility of National Health Research Institutes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa Y, 2010, J HEPATOL, V52, P586, DOI 10.1016/j.jhep.2010.01.003; ARNOLD WP, 1977, P NATL ACAD SCI USA, V74, P3203, DOI 10.1073/pnas.74.8.3203; Blaukat A, 2003, ANDROLOGIA, V35, P17, DOI 10.1046/j.1439-0272.2003.00533.x; BRAUGHLER JM, 1979, P NATL ACAD SCI USA, V76, P219, DOI 10.1073/pnas.76.1.219; Cai J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095974; Chen ZJ, 2004, HYPERTENSION, V44, P963, DOI 10.1161/01.HYP.0000145859.94894.23; Chen ZJ, 2002, CANCER LETT, V177, P181, DOI 10.1016/S0304-3835(01)00788-1; Chuu CP, 2012, CANCER PREV RES, V5, P788, DOI 10.1158/1940-6207.CAPR-12-0004-T; Chuu CP, 2011, CANCER SCI, V102, P2022, DOI 10.1111/j.1349-7006.2011.02043.x; Conran N, 2004, BRIT J HAEMATOL, V124, P547, DOI 10.1111/j.1365-2141.2004.04810.x; Derbyshire ER, 2012, ANNU REV BIOCHEM, V81, P533, DOI 10.1146/annurev-biochem-050410-100030; Fukumura D, 2006, NAT REV CANCER, V6, P521, DOI 10.1038/nrc1910; GARG UC, 1989, J CLIN INVEST, V83, P1774, DOI 10.1172/JCI114081; Girault I, 2003, CLIN CANCER RES, V9, P4415; Guh JH, 1998, MOL PHARMACOL, V53, P467, DOI 10.1124/mol.53.3.467; Hall JM, 1997, GEN PHARMACOL, V28, P1, DOI 10.1016/S0306-3623(96)00174-7; Haramis G, 2008, BRIT J PHARMACOL, V155, P804, DOI 10.1038/bjp.2008.312; Hinshelwood RA, 2008, J MOL MED, V86, P1315, DOI 10.1007/s00109-008-0386-3; IGNARRO LJ, 1982, P NATL ACAD SCI-BIOL, V79, P2870, DOI 10.1073/pnas.79.9.2870; Jeannin JF, 2008, NITRIC OXIDE-BIOL CH, V19, P158, DOI 10.1016/j.niox.2008.04.024; Jovanovic J, 2010, MOL ONCOL, V4, P242, DOI 10.1016/j.molonc.2010.04.002; Lin C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056499, 10.1371/journal.pone.0080883, 10.1371/journal.pone.0065734, 10.1371/journal.pone.0070187]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MONCADA S, 1991, PHARMACOL REV, V43, P109; Morbidelli L, 1996, AM J PHYSIOL-HEART C, V270, pH411, DOI 10.1152/ajpheart.1996.270.1.H411; Moreau ME, 2005, J PHARMACOL SCI, V99, P6, DOI 10.1254/jphs.SRJ05001X; Mujoo K, 2010, NITRIC OXIDE-BIOL CH, V22, P43, DOI 10.1016/j.niox.2009.11.007; Murad F, 2006, NEW ENGL J MED, V355, P2003, DOI 10.1056/NEJMsa063904; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Olson SY, 2008, NITRIC OXIDE-BIOL CH, V19, P170, DOI 10.1016/j.niox.2008.04.005; Parrella P, 2010, BREAST CARE, V5, P66, DOI 10.1159/000309138; Pervin S, 2008, NITRIC OXIDE-BIOL CH, V19, P103, DOI 10.1016/j.niox.2008.04.016; Pervin S, 2010, CURR PHARM DESIGN, V16, P451, DOI 10.2174/138161210790232130; Regoli D, 1996, REGUL PEPTIDES, V65, P83, DOI 10.1016/0167-0115(96)00076-6; Sen S, 2013, FREE RADICAL BIO MED, V57, P210, DOI 10.1016/j.freeradbiomed.2012.10.545; THOMSEN LL, 1995, BRIT J CANCER, V72, P41, DOI 10.1038/bjc.1995.274; Tse GMK, 2005, J CLIN PATHOL, V58, P600, DOI 10.1136/jcp.2004.023028; Vakkala M, 2000, CLIN CANCER RES, V6, P2408; Vetter M, 2003, HYPERTENSION, V41, P1136, DOI 10.1161/01.HYP.0000068201.48340.3B; Walter U, 1989, REV PHYSIOL BIOCH P, V113, P41; Yang CM, 1999, CELL SIGNAL, V11, P853, DOI 10.1016/S0898-6568(99)00056-X; Yang SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058100	42	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125518	10.1371/journal.pone.0125518	http://dx.doi.org/10.1371/journal.pone.0125518			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928539	Green Published, Green Submitted, gold			2022-12-27	WOS:000353713100096
J	Zhang, XW; Qu, YY; Ma, Q; Zhang, ZJ; Li, DX; Wang, JW; Shen, WL; Shen, E; Zhou, JT				Zhang, Xuwang; Qu, Yuanyuan; Ma, Qiao; Zhang, Zhaojing; Li, Duanxing; Wang, Jingwei; Shen, Wenli; Shen, E.; Zhou, Jiti			Illumina MiSeq Sequencing Reveals Diverse Microbial Communities of Activated Sludge Systems Stimulated by Different Aromatics for Indigo Biosynthesis from Indole	PLOS ONE			English	Article							BACTERIAL DIVERSITY; NAPHTHALENE DIOXYGENASE; RIBOSOMAL-RNA; WATER; GENES; WASTE; DEGRADATION; DERIVATIVES; EXPRESSION; DYESTUFFS	Indole, as a typical N-heteroaromatic compound existed in coking wastewater, can be used for bio-indigo production. The microbial production of indigo from indole has been widely reported during the last decades using culture-dependent methods, but few studies have been carried out by microbial communities. Herein, three activated sludge systems stimulated by different aromatics, i.e. naphthalene plus indole (G1), phenol plus indole (G2) and indole only (G3), were constructed for indigo production from indole. During the operation, G1 produced the highest indigo yield in the early stage, but it switched to G3 in the late stage. Based on LC-MS analysis, indigo was the major product in G1 and G3, while the purple product 2-(7-oxo-1H-indol-6(7H)-ylidene) indolin-3-one was dominant in G2. Illumina MiSeq sequencing of 16S rRNA gene amplicons was applied to analyze the microbial community structure and composition. Detrended correspondence analysis (DCA) and dissimilarity tests showed that the overall community structures of three groups changed significantly during the operation (P<0.05). Nevertheless, the bacteria assigned to phylum Proteobacteria, family Comamonadaceae, and genera Diaphorobacter, Comamonas and Aquamicrobium were commonly shared dominant populations. Pearson correlations were calculated to discern the relationship between microbial communities and indigo yields. The typical indigo-producing populations Comamonas and Pseudomonas showed no positive correlations with indigo yields, while there emerged many other genera that exhibited positive relationships, such as Aquamicrobium, Truepera and Pusillimonas, which had not been reported for indigo production previously. The present study should provide new insights into indigo bio-production by microbial communities from indole.	[Zhang, Xuwang; Qu, Yuanyuan; Ma, Qiao; Zhang, Zhaojing; Li, Duanxing; Wang, Jingwei; Shen, Wenli; Shen, E.; Zhou, Jiti] Dalian Univ Technol, Sch Environm Sci & Technol, Key Lab Ind Ecol & Environm Engn, Minist Educ, Dalian, Peoples R China	Dalian University of Technology	Qu, YY (corresponding author), Dalian Univ Technol, Sch Environm Sci & Technol, Key Lab Ind Ecol & Environm Engn, Minist Educ, Dalian, Peoples R China.	qyy@dlut.edu.cn	Zhang, Xuwang/L-7097-2019; ma, qiao/AAK-2605-2021; Ma, Qiao/L-1317-2015	Ma, Qiao/0000-0003-0614-2192	National Natural Science Foundation of China [21176040]; Program for New Century Excellent Talents in University [NCET-13-0077]; Fundamental Research Funds for the Central Universities [DUT14YQ107]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China (No. 21176040), the Program for New Century Excellent Talents in University (No. NCET-13-0077), and the Fundamental Research Funds for the Central Universities (No. DUT14YQ107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khalid T, 2012, CRIT REV ENV SCI TEC, V42, P1631, DOI 10.1080/10643389.2011.569872; Albuquerque L, 2005, FEMS MICROBIOL LETT, V247, P161, DOI 10.1016/j.femsle.2005.05.002; Allen CCR, 1997, APPL ENVIRON MICROB, V63, P151, DOI 10.1128/AEM.63.1.151-155.1997; BLACK JA, 1983, FUND APPL TOXICOL, V3, P353, DOI 10.1016/S0272-0590(83)80004-9; Cao BY, 2011, J BACTERIOL, V193, P4021, DOI 10.1128/JB.05242-11; Chang YC, 2013, APPL BIOCHEM BIOTECH, V170, P381, DOI 10.1007/s12010-013-0191-5; Chase JM, 2010, SCIENCE, V328, P1388, DOI 10.1126/science.1187820; Dedysh SN, 2005, J BACTERIOL, V187, P3884, DOI 10.1128/JB.187.11.3884-3888.2005; Doukyu N, 2002, APPL MICROBIOL BIOT, V58, P543, DOI 10.1007/s00253-001-0919-y; Doukyu N, 1998, BIOSCI BIOTECH BIOCH, V62, P1075, DOI 10.1271/bbb.62.1075; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; ENSLEY BD, 1983, SCIENCE, V222, P167, DOI 10.1126/science.6353574; Fetzner S, 1998, APPL MICROBIOL BIOT, V49, P237, DOI 10.1007/s002530051164; Gillam EMJ, 1999, BIOCHEM BIOPH RES CO, V265, P469, DOI 10.1006/bbrc.1999.1702; Gillam EMJ, 2001, IUBMB LIFE, V52, P271, DOI 10.1080/152165401317291110; Kim JY, 2005, LETT APPL MICROBIOL, V41, P163, DOI 10.1111/j.1472-765X.2005.01734.x; Kim JY, 2003, LETT APPL MICROBIOL, V36, P343, DOI 10.1046/j.1472-765X.2003.01279.x; Kleerebezem R, 2007, CURR OPIN BIOTECH, V18, P207, DOI 10.1016/j.copbio.2007.05.001; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liang B, 2014, WATER RES, V54, P137, DOI 10.1016/j.watres.2014.01.052; Ma JX, 2013, WATER RES, V47, P859, DOI 10.1016/j.watres.2012.11.013; Ma Q, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00102-15; Ma Q, 2015, BIORESOURCE TECHNOL, V179, P436, DOI 10.1016/j.biortech.2014.12.041; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Marshall CW, 2013, CURR OPIN BIOTECH, V24, P391, DOI 10.1016/j.copbio.2013.03.016; McClay K, 2005, APPL ENVIRON MICROB, V71, P5476, DOI 10.1128/AEM.71.9.5476-5483.2005; Moreno-Ruiz E, 2003, J BACTERIOL, V185, P2026, DOI 10.1128/JB.185.6.2026-2030.2003; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; O'Connor KE, 1998, BIOTECHNOL LETT, V20, P219, DOI 10.1023/A:1005361415496; OConnor KE, 1997, APPL ENVIRON MICROB, V63, P4287, DOI 10.1128/AEM.63.11.4287-4291.1997; Padoley KV, 2008, BIORESOURCE TECHNOL, V99, P4029, DOI 10.1016/j.biortech.2007.01.047; Pathak H, 2010, APPL BIOCHEM BIOTECH, V160, P1616, DOI 10.1007/s12010-009-8638-4; Purkhold U, 2000, APPL ENVIRON MICROB, V66, P5368, DOI 10.1128/AEM.66.12.5368-5382.2000; Qu YY, 2012, BIOTECHNOL LETT, V34, P353, DOI 10.1007/s10529-011-0778-2; Qu YY, 2010, BIORESOURCE TECHNOL, V101, P4527, DOI 10.1016/j.biortech.2010.01.033; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Singh D, 2013, BIODEGRADATION, V24, P645, DOI 10.1007/s10532-012-9612-3; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093422; Wang XH, 2012, APPL ENVIRON MICROB, V78, P7042, DOI 10.1128/AEM.01617-12; Wang Y, 2012, APPL ENVIRON MICROB, V78, P8264, DOI 10.1128/AEM.01821-12; Wu JF, 2006, APPL ENVIRON MICROB, V72, P1759, DOI 10.1128/AEM.72.3.1759-1765.2006; Zhang T, 2009, WATER RES, V43, P5209, DOI 10.1016/j.watres.2009.08.054; Zhang T, 2012, ISME J, V6, P1137, DOI 10.1038/ismej.2011.188; Zhang XW, 2013, PROCESS BIOCHEM, V48, P581, DOI 10.1016/j.procbio.2013.02.008; Zhou JZ, 2014, P NATL ACAD SCI USA, V111, pE836, DOI 10.1073/pnas.1324044111; Zhou JZ, 2013, MBIO, V4, DOI 10.1128/mBio.00584-12	48	32	38	2	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125732	10.1371/journal.pone.0125732	http://dx.doi.org/10.1371/journal.pone.0125732			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928424	Green Published, Green Submitted, gold			2022-12-27	WOS:000353713100115
J	Hartl, B; Hofmann, E; Gangl, K; Hartner-Tiefenthaler, M; Kirchler, E				Hartl, Barbara; Hofmann, Eva; Gangl, Katharina; Hartner-Tiefenthaler, Martina; Kirchler, Erich			Does the Sole Description of a Tax Authority Affect Tax Evasion? - The Impact of Described Coercive and Legitimate Power	PLOS ONE			English	Article							EMPIRICAL-ANALYSIS; UNITED-STATES; AUDIT; UNCERTAINTY; TRUST; MODEL	Following the classic economic model of tax evasion, taxpayers base their tax decisions on economic determinants, like fine rate and audit probability. Empirical findings on the relationship between economic key determinants and tax evasion are inconsistent and suggest that taxpayers may rather rely on their beliefs about tax authority's power. Descriptions of the tax authority's power may affect taxpayers' beliefs and as such tax evasion. Experiment 1 investigates the impact of fines and beliefs regarding tax authority's power on tax evasion. Experiments 2-4 are conducted to examine the effect of varying descriptions about a tax authority's power on participants' beliefs and respective tax evasion. It is investigated whether tax evasion is influenced by the description of an authority wielding coercive power (Experiment 2), legitimate power (Experiment 3), and coercive and legitimate power combined (Experiment 4). Further, it is examined whether a contrast of the description of power (low to high power; high to low power) impacts tax evasion (Experiments 2-4). Results show that the amount of fine does not impact tax payments, whereas participants' beliefs regarding tax authority's power significantly shape compliance decisions. Descriptions of high coercive power as well as high legitimate power affect beliefs about tax authority's power and positively impact tax honesty. This effect still holds if both qualities of power are applied simultaneously. The contrast of descriptions has little impact on tax evasion. The current study indicates that descriptions of the tax authority, e.g., in information brochures and media reports, have more influence on beliefs and tax payments than information on fine rates. Methodically, these considerations become particularly important when descriptions or vignettes are used besides objective information.	[Hartl, Barbara; Hofmann, Eva; Gangl, Katharina; Kirchler, Erich] Univ Vienna, Vienna, Austria; [Hartner-Tiefenthaler, Martina] Vienna Univ Technol, A-1040 Vienna, Austria	University of Vienna; Technische Universitat Wien	Hartl, B (corresponding author), Univ Vienna, Vienna, Austria.	barbara.hartl@univie.ac.at	Kirchler, Erich Kirchler/K-7985-2013	Kirchler, Erich Kirchler/0000-0003-4731-1650; Hartner-Tiefenthaler, Martina/0000-0003-1597-3975; Gangl, Katharina/0000-0001-6009-3358; Hartl, Barbara/0000-0002-5041-7002	Austrian Science Fund (FWF) [P24863-G16]; Austrian Science Fund (FWF) [P 24863] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This research was financed by grant number P24863-G16 from the Austrian Science Fund (FWF) (http://www.fwf.ac.at/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLINGHAM M. G., 1972, J PUBLIC ECON, V1, P323, DOI 10.1016/0047-2727(72)90010-2; ALM J, 1992, J PUBLIC ECON, V48, P21, DOI 10.1016/0047-2727(92)90040-M; ALM J, 1992, AM ECON REV, V82, P1018; Alm J., 2012, PAPER PRESENTED CESI, V13, P33; Alm J, 2012, INT TAX PUBLIC FINAN, V19, P54, DOI 10.1007/s10797-011-9171-2; Alm J, 2009, J PUBLIC ECON, V93, P392, DOI 10.1016/j.jpubeco.2008.10.007; Andreoni J, 1998, J ECON LIT, V36, P818; [Anonymous], 2006, J SOCIO-ECON, DOI DOI 10.1016/J.SOCEC.2005.11.065; BECKER GS, 1968, J POLIT ECON, V76, P169, DOI 10.1086/259394; Braithwaite V, 2003, AUST J SOC ISSUES, V38, P335; Brodbeck FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081558; Cadsby CB, 2006, EXP ECON, V9, P343, DOI 10.1007/s10683-006-7053-8; Cebula RJ, 1997, AM J ECON SOCIOL, V56, P173, DOI 10.1111/j.1536-7150.1997.tb03459.x; Dato-on MC, 2003, PSYCHOL MARKET, V20, P707, DOI 10.1002/mar.10093; Davis DD., 1993, EXP ECON, DOI [10.1515/9780691233376, DOI 10.1515/9780691233376]; Dubin J, 1987, EFFECT AUDIT RATES C; DUBIN JA, 1988, NATL TAX J, V41, P61; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; FRENCH JRP, 1960, J ABNORM SOC PSYCH, V61, P93, DOI 10.1037/h0041522; FRIEDLAND N, 1978, J PUBLIC ECON, V10, P107, DOI 10.1016/0047-2727(78)90008-7; Gangl K, 2015, NEW IDEAS PSYCHOL, V37, P13, DOI 10.1016/j.newideapsych.2014.12.001; Gang K, 2013, FINANZARCHIV, V69, P487, DOI 10.1628/001522113X675683; Gerxhani K, 2004, EUR ECON REV, V48, P729, DOI 10.1016/j.euroecorev.2003.08.014; Hanousek J, 2004, KYKLOS, V57, P237, DOI 10.1111/j.0023-5962.2004.00252.x; Hasseldine J, 2007, CONTEMP ACCOUNT RES, V24, P171, DOI 10.1506/P207-004L-4205-7NX0; Hofmann E, 2014, LAW POLICY; Jiang L, 2013, PLOS ONE, V8; Kim, 2005, J PUBLIC ECON THEORY, V7, P521; Kirchler E., 2007, EC PSYCHOL TAX BEHAV; Kirchler E, 2008, J ECON PSYCHOL, V29, P210, DOI 10.1016/j.joep.2007.05.004; Kleven HJ, 2011, ECONOMETRICA, V79, P651, DOI 10.3982/ECTA9113; Kogler C, 2013, J ECON PSYCHOL, V34, P169, DOI 10.1016/j.joep.2012.09.010; Mark, 1992, J ACCOUNT LIT, V11, P1; Mayo, 1933, HUMAN PROBLEMS IND C; MILGRAM S., 1974, OBEDIENCE AUTHORITY; Muehlbacher S, 2012, J SOCIO-ECON, V41, P289, DOI 10.1016/j.socec.2012.01.006; Ortega D., 2013, 082013 CAF; Pommerehne WW, 1996, PUBLIC CHOICE, V88, P161, DOI 10.1007/BF00130416; Rahim MA, 2001, INT J CONFL MANAGE, V12, P191, DOI 10.1108/eb022855; Raven B. H., 1974, PERSPECTIVES SOCIAL, P150; RAVEN BH, 1993, J SOC ISSUES, V49, P227, DOI 10.1111/j.1540-4560.1993.tb01191.x; Raven BH, 1998, J APPL SOC PSYCHOL, V28, P307, DOI 10.1111/j.1559-1816.1998.tb01708.x; RAVEN BH, 1958, SOCIOMETRY, V21, P83, DOI 10.2307/2785895; Shang J, 2009, ECON J, V119, P1422, DOI 10.1111/j.1468-0297.2009.02267.x; Slemrod J, 2001, J PUBLIC ECON, V79, P455, DOI 10.1016/S0047-2727(99)00107-3; Slemrod J, 2007, J ECON PERSPECT, V21, P25, DOI 10.1257/jep.21.1.25; Sonsino D, 2010, EXP ECON, V13, P309, DOI 10.1007/s10683-010-9243-7; Srinivasan T. N., 1973, J PUBLIC ECON, V2, P339, DOI [10.1016/0047-2727(73)90024-8, DOI 10.1016/0047-2727(73)90024-8]; Torgler B, 2008, ECON ANAL POLICY, V38, P313, DOI 10.1016/S0313-5926(08)50023-3; Turner JC, 2005, EUR J SOC PSYCHOL, V35, P1, DOI 10.1002/ejsp.244; TYLER TOM R., 2006, CONTEMP SOCIOL, DOI [DOI 10.2307/2076193, 10.1515/9781400828609]; Verboon P, 2011, J ECON PSYCHOL, V32, P120, DOI 10.1016/j.joep.2010.09.007; Wahl I, 2010, LAW POLICY, V32, P383, DOI 10.1111/j.1467-9930.2010.00327.x; Wenzel M, 2004, LAW HUMAN BEHAV, V28, P547, DOI 10.1023/B:LAHU.0000046433.57588.71; WITTE AD, 1985, NATL TAX J, V38, P1; Zizzo DJ, 2010, EXP ECON, V13, P75, DOI 10.1007/s10683-009-9230-z	56	30	30	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123355	10.1371/journal.pone.0123355	http://dx.doi.org/10.1371/journal.pone.0123355			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0LO	25923770	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600043
J	Meeus, I; Parmentier, L; Billiet, A; Maebe, K; Van Nieuwerburgh, F; Deforce, D; Wackers, F; Vandamme, P; Smagghe, G				Meeus, Ivan; Parmentier, Laurian; Billiet, Annelies; Maebe, Kevin; Van Nieuwerburgh, Filip; Deforce, Dieter; Wackers, Felix; Vandamme, Peter; Smagghe, Guy			16S rRNA Amplicon Sequencing Demonstrates that Indoor-Reared Bumblebees (Bombus terrestris) Harbor a Core Subset of Bacteria Normally Associated with the Wild Host	PLOS ONE			English	Article							GUT MICROBIOTA; DIGESTIVE-TRACT; SP NOV.; BEES; DIVERSITY; PATTERNS; DECLINES; HONEYBEE; BIFIDOBACTERIA; CONSERVATION	A MiSeq multiplexed 16S rRNA amplicon sequencing of the gut microbiota of wild and indoor-reared Bombus terrestris (bumblebees) confirmed the presence of a core set of bacteria, which consisted of Neisseriaceae (Snodgrassella), Orbaceae (Gilliamella), Lactobacillaceae (Lactobacillus), and Bifidobacteriaceae (Bifidobacterium). In wild B. terrestris we detected several non-core bacteria having a more variable prevalence. Although Enterobacteriaceae are unreported by non next-generation sequencing studies, it can become a dominant gut resident. Furthermore the presence of some non-core lactobacilli were associated with the relative abundance of bifidobacteria. This association was not observed in indoor-reared bumblebees lacking the non-core bacteria, but having a more standardized microbiota compared to their wild counterparts. The impact of the bottleneck microbiota of indoor-reared bumblebees when they are used in the field for pollination purpose is discussed.	[Meeus, Ivan; Parmentier, Laurian; Billiet, Annelies; Maebe, Kevin; Smagghe, Guy] Univ Ghent, Fac Biosci Engn, Dept Crop Protect, Lab Agrozool, B-9000 Ghent, Belgium; [Van Nieuwerburgh, Filip; Deforce, Dieter] Univ Ghent, Fac Pharmaceut Sci, Lab Pharmaceut Biotechnol, B-9000 Ghent, Belgium; [Wackers, Felix] Biobest NV, B-2260 Westerlo, Belgium; [Vandamme, Peter] Univ Ghent, Fac Sci, Dept Biochem & Microbiol, Microbiol Lab, B-9000 Ghent, Belgium	Ghent University; Ghent University; Ghent University	Meeus, I (corresponding author), Univ Ghent, Fac Biosci Engn, Dept Crop Protect, Lab Agrozool, Coupure Links 653, B-9000 Ghent, Belgium.	ivan.meeus@ugent.be; guy.smagghe@UGent.be	Smagghe, Guy/AAE-8914-2019; Vandamme, Peter AR/B-7967-2009; Vandamme, Peter/ABG-3431-2021; Van Nieuwerburgh, Filip/H-9697-2015	Smagghe, Guy/0000-0001-8334-3313; Vandamme, Peter AR/0000-0002-5581-7937; Vandamme, Peter/0000-0002-5581-7937; Van Nieuwerburgh, Filip/0000-0001-8815-5485; Maebe, Kevin/0000-0002-3741-2143	Fund for Scientific Research-Flanders (FWO-Vlaanderen); Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT, Brussels, Belgium); Biobest NV	Fund for Scientific Research-Flanders (FWO-Vlaanderen)(FWO); Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT, Brussels, Belgium)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Biobest NV	This study was supported by the Fund for Scientific Research-Flanders (FWO-Vlaanderen; www.fwo.be) and the Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT, Brussels, Belgium, www.iwt.be). Biobest NV provided support in the form of salary for author FW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Babendreier D, 2007, FEMS MICROBIOL ECOL, V59, P600, DOI 10.1111/j.1574-6941.2006.00249.x; Behar A, 2005, MOL ECOL, V14, P2637, DOI 10.1111/j.1365-294X.2005.02615.x; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Brown MJF, 2009, APIDOLOGIE, V40, P410, DOI 10.1051/apido/2009019; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Cariveau PD, 2014, ISME J, P1, DOI [10.1038/ismej.2014.99, DOI 10.1038/ISMEJ.2014.99]; Demirci M, 2013, FOLIA MICROBIOL, V58, P201, DOI 10.1007/s12223-012-0199-1; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Engel P, 2013, INT J SYST EVOL MICR, V63, P3646, DOI 10.1099/ijs.0.049569-0; Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025; Engel P, 2012, P NATL ACAD SCI USA, V109, P11002, DOI 10.1073/pnas.1202970109; Furst MA, 2014, NATURE, V506, P364, DOI 10.1038/nature12977; Goulson D, 2005, BIOL CONSERV, V122, P1, DOI 10.1016/j.biocon.2004.06.017; GOULSON D, 2003, BUMBLEBEES THEIR BEH; Hamdi C, 2011, J APPL ENTOMOL, V135, P524, DOI 10.1111/j.1439-0418.2010.01609.x; Killer J, 2011, INT J SYST EVOL MICR, V61, P1315, DOI 10.1099/ijs.0.022525-0; Killer J, 2010, ANAEROBE, V16, P165, DOI 10.1016/j.anaerobe.2009.07.007; Koch H, 2013, MOL ECOL, V22, P2028, DOI 10.1111/mec.12209; Koch H, 2011, P NATL ACAD SCI USA, V108, P19288, DOI 10.1073/pnas.1110474108; Koch H, 2011, MICROB ECOL, V62, P121, DOI 10.1007/s00248-011-9854-3; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Maebe K, 2014, APIDOLOGIE, V45, P189, DOI 10.1007/s13592-013-0237-2; Maebe K, 2013, APIDOLOGIE, V44, P188, DOI 10.1007/s13592-012-0170-9; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; Meeus I, 2013, APIDOLOGIE, V44, P708, DOI 10.1007/s13592-013-0222-9; Meeus I, 2011, CONSERV BIOL, V25, P662, DOI 10.1111/j.1523-1739.2011.01707.x; Mohr KI, 2007, APPL MICROBIOL BIOT, V75, P573, DOI 10.1007/s00253-007-0846-7; Mohr KI, 2006, ENVIRON MICROBIOL, V8, P258, DOI 10.1111/j.1462-2920.2005.00893.x; Moran NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036393; Mulder CPH, 2004, OIKOS, V107, P50, DOI 10.1111/j.0030-1299.2004.13110.x; Murray TE, 2013, BIOL CONSERV, V159, P269, DOI 10.1016/j.biocon.2012.10.021; Newton ILG, 2012, BMC MICROBIOL, V12, DOI [10.1186/1471-2180-12-12, DOI 10.1186/1471-2180-12-12]; Parmentier L, 2014, ENVIRON MONIT ASSESS, V186, P2357, DOI 10.1007/s10661-013-3543-2; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Podgwaite JD, 2013, J ENTOMOL SCI, V48, P128; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Pridal P, 1997, ACTA UNIV AGRIC ET S, V8, P59; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Vasanthakumar A, 2006, ENVIRON ENTOMOL, V35, P1710, DOI 10.1603/0046-225X(2006)35[1710:COGBIL]2.0.CO;2; Velthuis HHW, 2006, APIDOLOGIE, V37, P421, DOI 10.1051/apido:2006019; Ventura M, 2012, TRENDS MICROBIOL, V20, P467, DOI 10.1016/j.tim.2012.07.002; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Wang Y, 2012, METHODS ECOL EVOL, V3, P471, DOI 10.1111/j.2041-210X.2012.00190.x; Warton DI, 2008, AUSTRAL ECOL, V33, P290, DOI 10.1111/j.1442-9993.2007.01816.x; Warton DI, 2012, METHODS ECOL EVOL, V3, P89, DOI 10.1111/j.2041-210X.2011.00127.x; Warton DI, 2005, ENVIRONMETRICS, V16, P275, DOI 10.1002/env.702; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Williams PH, 2009, APIDOLOGIE, V40, P367, DOI 10.1051/apido/2009025; Winfree R, 2009, ECOLOGY, V90, P2068, DOI 10.1890/08-1245.1	50	32	33	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125152	10.1371/journal.pone.0125152	http://dx.doi.org/10.1371/journal.pone.0125152			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923917	Green Submitted, Green Published, gold			2022-12-27	WOS:000353711600129
J	Bishop, PJ; Walmsley, CW; Phillips, MJ; Quayle, MR; Boisvert, CA; McHenry, CR				Bishop, Peter J.; Walmsley, Christopher W.; Phillips, Matthew J.; Quayle, Michelle R.; Boisvert, Catherine A.; McHenry, Colin R.			Oldest Pathology in a Tetrapod Bone Illuminates the Origin of Terrestrial Vertebrates	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; STEM TETRAPOD; OSSINODUS-PUERI; TRABECULAR BONE; EARLY EVOLUTION; PECTORAL FIN; PANDERICHTHYS; MAINTENANCE; SKELETON; BEHAVIOR	The origin of terrestrial tetrapods was a key event in vertebrate evolution, yet how and when it occurred remains obscure, due to scarce fossil evidence. Here, we show that the study of palaeopathologies, such as broken and healed bones, can help elucidate poorly understood behavioural transitions such as this. Using high-resolution finite element analysis, we demonstrate that the oldest known broken tetrapod bone, a radius of the primitive stem tetrapod Ossinodus pueri from the mid-Visean (333 million years ago) of Australia, fractured under a high-force, impact-type loading scenario. The nature of the fracture suggests that it most plausibly occurred during a fall on land. Augmenting this are new osteological observations, including a preferred directionality to the trabecular architecture of cancellous bone. Together, these results suggest that Ossinodus, one of the first large (>2m length) tetrapods, spent a significant proportion of its life on land. Our findings have important implications for understanding the temporal, biogeographical and physiological contexts under which terrestriality in vertebrates evolved. They push the date for the origin of terrestrial tetrapods further back into the Carboniferous by at least two million years. Moreover, they raise the possibility that terrestriality in vertebrates first evolved in large tetrapods in Gondwana rather than in small European forms, warranting a re-evaluation of this important evolutionary event.	[Bishop, Peter J.] Queensland Museum, Ancient Environm Program, Hendra, Qld 4011, Australia; [Bishop, Peter J.; Phillips, Matthew J.] Queensland Univ Technol, Sch Earth Environm & Biol Sci, Brisbane, Qld 4000, Australia; [Bishop, Peter J.] Griffith Univ, Ctr Musculoskeletal Res, Southport, Qld 4222, Australia; [Walmsley, Christopher W.; Quayle, Michelle R.; McHenry, Colin R.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia; [Boisvert, Catherine A.] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic 3800, Australia	Queensland Museum; Queensland University of Technology (QUT); Griffith University; Monash University; Australian Regenerative Medicine Institute; Monash University	Bishop, PJ (corresponding author), Queensland Museum, Ancient Environm Program, 122 Gerler Rd, Hendra, Qld 4011, Australia.	peter.bishop@qm.qld.gov.au; m9.phillips@qut.edu.au	Phillips, Matthew J/J-1365-2012; Boisvert, Catherine A/A-9782-2019	Phillips, Matthew J/0000-0003-1532-449X; Boisvert, Catherine A/0000-0002-0618-7270	QUT research grant; ARC grant [DR0986471]; Monash University research grant; ARC QEII Fellowship [DP110101127]; Human Frontiers Research Program [LT000130/2009-L]; ARC Discovery Project [DP 1096002]	QUT research grant; ARC grant(Australian Research Council); Monash University research grant; ARC QEII Fellowship(Australian Research Council); Human Frontiers Research Program; ARC Discovery Project(Australian Research Council)	MJP is supported by a QUT research grant, CRM by an ARC grant (DR0986471) and a Monash University research grant, and CAB by an ARC QEII Fellowship DP110101127, a Human Frontiers Research Program (LT000130/2009-L), and an ARC Discovery Project DP 1096002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlberg PE, 2008, NATURE, V453, P1199, DOI 10.1038/nature06991; Ahlberg PE, 2011, SPEC PAP PALAEONTOL, P17, DOI 10.1111/j.1475-4983.2011.01077.x; AMIS AA, 1995, INJURY, V26, P163, DOI 10.1016/0020-1383(95)93494-3; Anderson E.M., 1951, DYNAMICS FAULTING; Anonymous, 2006, Bulletin of the New Mexico Museum of Natural History and Science, P1; BIEWENER AA, 1986, J EXP BIOL, V123, P383; Bishop PJ, 2014, ALCHERINGA, V38, P209, DOI 10.1080/03115518.2014.861320; Boisvert CA, 2005, NATURE, V438, P1145, DOI 10.1038/nature04119; Boisvert CA, 2008, NATURE, V456, P636, DOI 10.1038/nature07339; Clack J. A., 2012, GAINING GROUND ORIGI; Clack JA., 2005, J SYST PALAEONTOL, V2, P311, DOI [10.1017/S1477201904001506, DOI 10.1017/S1477201904001506]; Coates MI, 1995, B MUS NATL HIST NA C, V17C, P359; Currey J.D., 2002, BONES STRUCTURE MECH; Daeschler EB, 2006, NATURE, V440, P757, DOI 10.1038/nature04639; Donoghue OA, 2011, SPORTS HEALTH, V3, P303, DOI 10.1177/1941738111403872; Dumont ER, 2005, ANAT REC PART A, V283A, P319, DOI 10.1002/ar.a.20165; Erickson GM, 2002, ANAT RECORD, V268, P115, DOI 10.1002/ar.10145; Hanna RR, 2002, J VERTEBR PALEONTOL, V22, P76, DOI 10.1671/0272-4634(2002)022[0076:MIAIIA]2.0.CO;2; Huiskes R, 2000, NATURE, V405, P704, DOI 10.1038/35015116; International Commission on Radiological Protection, 1975, ICRP PUBLICATION, V23; Ketcham RA, 2004, J MICROSC-OXFORD, V213, P158, DOI 10.1111/j.1365-2818.2004.01277.x; LEBEDEV OA, 1995, ZOOL J LINN SOC-LOND, V114, P307, DOI 10.1006/zjls.1995.0027; MASON ML, 1954, BRIT J SURG, V42, P123, DOI 10.1002/bjs.18004217203; McHenry CR, 2007, P NATL ACAD SCI USA, V104, P16010, DOI 10.1073/pnas.0706086104; Milner AC, 1998, ZOOL J LINN SOC-LOND, V122, P211, DOI 10.1111/j.1096-3642.1998.tb02530.x; Paton RL, 1999, NATURE, V398, P508, DOI 10.1038/19071; Rayfield EJ, 2007, ANNU REV EARTH PL SC, V35, P541, DOI 10.1146/annurev.earth.35.031306.140104; ROLFE WDI, 1994, T ROY SOC EDIN-EARTH, V84, P175; Ruimerman R, 2005, J BIOMECH, V38, P931, DOI 10.1016/j.jbiomech.2004.03.037; Shubin NH, 2004, SCIENCE, V304, P90, DOI 10.1126/science.1094295; Shubin NH, 2006, NATURE, V440, P764, DOI 10.1038/nature04637; Smithson TR, 2012, P NATL ACAD SCI USA, V109, P4532, DOI 10.1073/pnas.1117332109; Thulborn T, 1996, NATURE, V381, P777, DOI 10.1038/381777a0; Tsafnat N, 2011, J ANAT, V218, P40, DOI 10.1111/j.1469-7580.2010.01289.x; Tsubota K, 2009, J BIOMECH, V42, P1088, DOI 10.1016/j.jbiomech.2009.02.030; Vogel S., 2003, COMP BIOMECHANICS LI; Walmsley CW, 2013, PEERJ, V1, DOI 10.7717/peerj.204; Wang H, 2012, J BIOMECH, V45, P2417, DOI 10.1016/j.jbiomech.2012.06.024; Wang XMM, 2004, ORYX, V38, P197, DOI 10.1017/S0030605304000341; Warren A, 2004, PALAEONTOLOGY, V47, P151, DOI 10.1111/j.0031-0239.2004.00353.x; Warren A, 2002, ALCHERINGA, V26, P459, DOI 10.1080/03115510208619536; Warren A, 2007, J VERTEBR PALEONTOL, V27, P850, DOI 10.1671/0272-4634(2007)27[850:NDOOPA]2.0.CO;2; Wirtz DC, 2000, J BIOMECH, V33, P1325, DOI 10.1016/S0021-9290(00)00069-5	43	21	21	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125723	10.1371/journal.pone.0125723	http://dx.doi.org/10.1371/journal.pone.0125723			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938463	gold, Green Published, Green Submitted			2022-12-27	WOS:000353943000096
J	Ide, T; Komoto, S; Higo-Moriguchi, K; Htun, KW; Myint, YY; Myat, TW; Thant, KZ; Thu, HM; Win, MM; Oo, HN; Htut, T; Wakuda, M; Dennis, FE; Haga, K; Fujii, Y; Katayama, K; Rahman, S; Van Nguyen, S; Umeda, K; Oguma, K; Tsuji, T; Taniguchi, K				Ide, Tomihiko; Komoto, Satoshi; Higo-Moriguchi, Kyoko; Htun, Khaing Win; Myint, Yi Yi; Myat, Theingi Win; Thant, Kyaw Zin; Hlaing Myat Thu; Win, Mo Mo; Oo, Htun Naing; Than Htut; Wakuda, Mitsutaka; Dennis, Francis Ekow; Haga, Kei; Fujii, Yoshiki; Katayama, Kazuhiko; Rahman, Shofiqur; Sa Van Nguyen; Umeda, Kouji; Oguma, Keiji; Tsuji, Takao; Taniguchi, Koki			Whole Genomic Analysis of Human G12P[6] and G12P[8] Rotavirus Strains that Have Emerged in Myanmar	PLOS ONE			English	Article							HOSPITAL-BASED SURVEILLANCE; GROUP-A ROTAVIRUSES; PHYLOGENETIC ANALYSIS; GENOTYPE CONSTELLATION; CLOSE RELATIONSHIP; G12 GENOTYPE; CHILDREN; DIARRHEA; PORCINE; INDIA	G12 rotaviruses are emerging rotavirus strains causing severe diarrhea in infants and young children worldwide. However, the whole genomes of only a few G12 strains have been fully sequenced and analyzed. In this study, we sequenced and characterized the complete genomes of six G12 strains (RVA/Human-tc/MMR/A14/2011/G12P[8], RVA/ Human-tc/MMR/A23/2011/G12P[6], RVA/Human-tc/MMR/A25/2011/G12P[8], RVA/ Human-tc/MMR/P02/2011/G12P[8], RVA/Human-tc/MMR/P39/2011/G12P[8], and RVA/ Human-tc/MMR/P43/2011/G12P[8]) detected in six stool samples from children with acute gastroenteritis in Myanmar. On whole genomic analysis, all six Myanmarese G12 strains were found to have a Wa-like genetic backbone: G12-P[8]-I1-R1-C1-M1-A1-N1-T1-E1-H1 for strains A14, A25, P02, P39, and P43, and G12-P[6]-I1-R1-C1-M1-A1-N1-T1-E1-H1 for strain A23. Phylogenetic analysis showed that most genes of the six strains examined in this study were genetically related to globally circulating human G1, G3, G9, and G12 strains. Of note is that the NSP4 gene of strain A23 exhibited the closest relationship with the cognate genes of human-like bovine strains as well as human strains, suggesting the occurrence of reassortment between human and bovine strains. Furthermore, strains A14, A25, P02, P39, and P43 were very closely related to one another in all the 11 gene segments, indicating derivation of the five strains from a common origin. On the other hand, strain A23 consistently formed distinct clusters as to all the 11 gene segments, indicating a distinct origin of strain A23 from that of strains A14, A25, P02, P39, and P43. To our knowledge, this is the first report on whole genome-based characterization of G12 strains that have emerged in Myanmar. Our observations will provide important insights into the evolutionary dynamics of spreading G12 rotaviruses in Asia.	[Ide, Tomihiko; Komoto, Satoshi; Higo-Moriguchi, Kyoko; Wakuda, Mitsutaka; Taniguchi, Koki] Fujita Hlth Univ, Sch Med, Dept Virol & Parasitol, Toyoake, Aichi 47011, Japan; [Htun, Khaing Win] Nay Pyi Taw Gen Hosp Cent Myanmar, Nay Pyi Taw, Myanmar; [Myint, Yi Yi] Dept Med Res Upper Myanmar, Pyin Oo Lwin, Myanmar; [Myat, Theingi Win; Thant, Kyaw Zin; Hlaing Myat Thu; Win, Mo Mo] Dept Med Res Lower Myanmar, Yangon, Myanmar; [Oo, Htun Naing] Dept Tradit Med Cent Myanmar, Nay Pyi Taw, Myanmar; [Than Htut] Minist Hlth Cent Myanmar, Nay Pyi Taw, Myanmar; [Dennis, Francis Ekow; Haga, Kei; Fujii, Yoshiki; Katayama, Kazuhiko] Natl Inst Infect Dis, Dept Virol 2, Musashimurayama, Tokyo, Japan; [Dennis, Francis Ekow] Univ Ghana, Coll Hlth Sci, Noguchi Mem Inst Med Res, Dept Electron Microscopy & Histopathol, Legon, Ghana; [Rahman, Shofiqur; Sa Van Nguyen; Umeda, Kouji] EW Nutr Japan, Immunol Res Inst Gifu, Gifu, Japan; [Oguma, Keiji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Bacteriol, Okayama, Japan; [Tsuji, Takao] Fujita Hlth Univ, Sch Med, Dept Microbiol, Toyoake, Aichi 47011, Japan	Fujita Health University; National Institute of Infectious Diseases (NIID); University of Ghana; Okayama University; Fujita Health University	Komoto, S (corresponding author), Fujita Hlth Univ, Sch Med, Dept Virol & Parasitol, Toyoake, Aichi 47011, Japan.	satoshik@fujita-hu.ac.jp	Fujii, Yoshiki/GOE-3566-2022	Katayama, Kazuhiko/0000-0002-7692-1151	MEXT-Supported Program for the Strategic Research Foundation at Private Universities; Ministry of Health, Labor, and Welfare of Japan; Grants-in-Aid for Scientific Research [26461516] Funding Source: KAKEN	MEXT-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by the MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2010-2014 (KT), and Grants-in-Aid for Research on Emerging and Reemerging Infectious Diseases from the Ministry of Health, Labor, and Welfare of Japan (KT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed K, 2010, VIRUS GENES, V40, P347, DOI 10.1007/s11262-010-0463-x; Ahmed K, 2010, ARCH VIROL, V155, P71, DOI 10.1007/s00705-009-0552-0; Ahmed S, 2012, Mymensingh Med J, V21, P497; Alam MM, 2009, VIRUS RES, V144, P280, DOI 10.1016/j.virusres.2009.03.015; Ansari S, 2013, J MED MICROBIOL, V62, P114, DOI 10.1099/jmm.0.048124-0; Chakravarti A, 2010, SE ASIAN J TROP MED, V41, P1145; Das S, 2003, J CLIN MICROBIOL, V41, P2760, DOI 10.1128/JCM.41.6.2760-2762.2003; Dennis FE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100699; Estes M.K., 2013, FIELDS VIROLOGY, V6th, P1347; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ghosh S, 2011, FUTURE MICROBIOL, V6, P1049, DOI [10.2217/FMB.11.90, 10.2217/fmb.11.90]; Ghosh S, 2011, INFECT GENET EVOL, V11, P1481, DOI 10.1016/j.meegid.2011.05.014; Kahn G, 2012, INDIAN PEDIATR, V49, P467, DOI 10.1007/s13312-012-0076-7; Kang G, 2013, VACCINE, V31, P2879, DOI 10.1016/j.vaccine.2013.04.030; Kang G, 2009, J INFECT DIS, V200, pS147, DOI 10.1086/605031; Kawai K, 2012, VACCINE, V30, P1244, DOI 10.1016/j.vaccine.2011.12.092; Khananurak K, 2010, INFECT GENET EVOL, V10, P537, DOI 10.1016/j.meegid.2010.02.003; Komoto S, 2006, P NATL ACAD SCI USA, V103, P4646, DOI 10.1073/pnas.0509385103; Komoto S, 2014, VET MICROBIOL, V174, P577, DOI 10.1016/j.vetmic.2014.09.033; Komoto S, 2014, INFECT GENET EVOL, V27, P277, DOI 10.1016/j.meegid.2014.08.002; Komoto S, 2013, J GEN VIROL, V94, P1568, DOI 10.1099/vir.0.051011-0; Le VP, 2008, J MED VIROL, V80, P175, DOI 10.1002/jmv.21044; Maes P, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-238; Malik YS, 2014, INFECT GENET EVOL, V25, P20, DOI 10.1016/j.meegid.2014.04.004; Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07; Matthijnssens J, 2012, CURR OPIN VIROL, V2, P426, DOI 10.1016/j.coviro.2012.04.007; Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z; Matthijnssens J, 2010, MOL BIOL EVOL, V27, P2431, DOI 10.1093/molbev/msq137; Matthijnssens J, 2009, FUTURE MICROBIOL, V4, P1303, DOI [10.2217/fmb.09.96, 10.2217/FMB.09.96]; Moe K, 2005, J INFECT DIS, V192, pS111, DOI 10.1086/431509; Moe K, 2009, VACCINE, V27, pF89, DOI 10.1016/j.vaccine.2009.08.068; Mukherjee A, 2010, INFECT GENET EVOL, V10, P311, DOI 10.1016/j.meegid.2010.01.002; Mullick S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112970; Park J, 2014, ACCIDENT ANAL PREV, V70, P167, DOI 10.1016/j.aap.2014.03.016; Paul S K, 2010, Mymensingh Med J, V19, P16; Paul S K, 2009, Mymensingh Med J, V18, P190; Paul SK, 2008, ARCH VIROL, V153, P1999, DOI 10.1007/s00705-008-0212-9; Phan VTM, 2011, AM J TROP MED HYG, V85, P768, DOI 10.4269/ajtmh.2011.11-0364; Pietsch C, 2009, EMERG INFECT DIS, V15, P1512, DOI 10.3201/eid1509.090497; Pongsuwanna Y, 2002, J CLIN MICROBIOL, V40, P1390, DOI 10.1128/JCM.40.4.1390-1394.2002; Pongsuwannna Y, 2010, J MED VIROL, V82, P157, DOI 10.1002/jmv.21596; Pun SB, 2007, EMERG INFECT DIS, V13, P482, DOI 10.3201/eid1303.061367; Rahman M, 2007, J VIROL, V81, P2382, DOI 10.1128/JVI.01622-06; Ramani S, 2007, J CLIN MICROBIOL, V45, P432, DOI 10.1128/JCM.01710-06; Ray P, 2007, J CLIN MICROBIOL, V45, P3824, DOI 10.1128/JCM.01288-07; Samajdar S, 2006, J CLIN VIROL, V36, P183, DOI 10.1016/j.jcv.2006.03.006; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Sharma S, 2008, J CLIN MICROBIOL, V46, P1343, DOI 10.1128/JCM.02358-07; Sherchand JB, 2009, J INFECT DIS, V200, pS182, DOI 10.1086/605046; Shinozaki K, 2004, J MED VIROL, V73, P612, DOI 10.1002/jmv.20134; Stupka JA, 2012, J CLIN VIROL, V54, P162, DOI 10.1016/j.jcv.2012.02.011; Tamim S, 2013, INFECT GENET EVOL, V14, P161, DOI 10.1016/j.meegid.2012.10.009; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TANIGUCHI K, 1990, J VIROL, V64, P5640, DOI 10.1128/JVI.64.11.5640-5644.1990; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Theamboonlers A, 2014, INFECT GENET EVOL, V21, P295, DOI 10.1016/j.meegid.2013.11.020; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trojnar E, 2013, J GEN VIROL, V94, P136, DOI 10.1099/vir.0.047381-0; Uchida R, 2006, J CLIN MICROBIOL, V44, P3499, DOI 10.1128/JCM.01089-06; URASAWA S, 1990, ARCH VIROL, V113, P279, DOI 10.1007/BF01316680; Vainio K, 2013, APMIS, V121, P447, DOI 10.1111/apm.12014; Wakuda M, 2003, J CLIN MICROBIOL, V41, P5764, DOI 10.1128/JCM.41.12.5764-5769.2003; Wangchuk S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110795; Wulan WN, 2010, EMERG INFECT DIS, V16, P159, DOI 10.3201/eid1601.091010; Zhirakovskaia EV, 2012, MOL GENET MIKROBIOL, V4, P33	65	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0124965	10.1371/journal.pone.0124965	http://dx.doi.org/10.1371/journal.pone.0124965			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938434	gold, Green Published, Green Submitted			2022-12-27	WOS:000353943000035
J	Lee, MS; Yu, M; Kim, KY; Park, GH; Kwack, K; Kim, KP				Lee, Min-Soo; Yu, Mi; Kim, Kyoung-Yeon; Park, Geun-Hee; Kwack, KyuBum; Kim, Keun P.			Functional Validation of Rare Human Genetic Variants Involved in Homologous Recombination Using Saccharomyces cerevisiae	PLOS ONE			English	Article							DOUBLE HOLLIDAY JUNCTIONS; RAD51 FILAMENT FORMATION; DOUBLE-STRAND BREAK; DNA-DAMAGE; REPAIR GENES; BRCA2; PROTEIN; REPLICATION; BINDING; MUTATIONS	Systems for the repair of DNA double-strand breaks (DSBs) are necessary to maintain genome integrity and normal functionality of cells in all organisms. Homologous recombination (HR) plays an important role in repairing accidental and programmed DSBs in mitotic and meiotic cells, respectively. Failure to repair these DSBs causes genome instability and can induce tumorigenesis. Rad51 and Rad52 are two key proteins in homologous pairing and strand exchange during DSB-induced HR; both are highly conserved in eukaryotes. In this study, we analyzed pathogenic single nucleotide polymorphisms (SNPs) in human RAD51 and RAD52 using the Polymorphism Phenotyping (PolyPhen) and Sorting Intolerant from Tolerant (SIFT) algorithms and observed the effect of mutations in highly conserved domains of RAD51 and RAD52 on DNA damage repair in a Saccharomyces cerevisiae-based system. We identified a number of rad51 and rad52 alleles that exhibited severe DNA repair defects. The functionally inactive SNPs were located near ATPase active site of Rad51 and the DNA binding domain of Rad52. The rad51-F317I, rad52-R52W, and rad52-G107C mutations conferred hypersensitivity to methyl methane sulfonate (MMS)-induced DNA damage and were defective in HR-mediated DSB repair. Our study provides a new approach for detecting functional and loss-of-function genetic polymorphisms and for identifying causal variants in human DNA repair genes that contribute to the initiation or progression of cancer.	[Lee, Min-Soo; Yu, Mi; Park, Geun-Hee; Kim, Keun P.] Chung Ang Univ, Dept Life Sci, Seoul 156756, South Korea; [Kim, Kyoung-Yeon; Kwack, KyuBum] CHA Univ, Dept Biomed Sci, Songnam, South Korea	Chung Ang University; Pochon Cha University	Kwack, K (corresponding author), CHA Univ, Dept Biomed Sci, Songnam, South Korea.	kbkwack@cha.ac.kr; kpkim@cau.ac.kr	LEE, MINSOO/HGE-5845-2022		National Research Foundation (NRF) of Korea - Ministry of Science, ICT & Future Planning [2012-M3A9C6050367, 2012R1A1A1010578, 2014R1A2A1A11051584]; NRF of Korea - Ministry of Education [2009-0093821]	National Research Foundation (NRF) of Korea - Ministry of Science, ICT & Future Planning; NRF of Korea - Ministry of Education	This research was supported by a National Research Foundation (NRF) of Korea grant funded by the Ministry of Science, ICT & Future Planning (2012-M3A9C6050367; 2012R1A1A1010578; 2014R1A2A1A11051584). KBK was supported by a NRF of Korea funded by the Ministry of Education (2009-0093821). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai N, 2011, J BIOL CHEM, V286, P17607, DOI 10.1074/jbc.M110.216739; Buisson R, 2010, NAT STRUCT MOL BIOL, V17, P1247, DOI 10.1038/nsmb.1915; Burhans WC, 2007, NUCLEIC ACIDS RES, V35, P7545, DOI 10.1093/nar/gkm1059; BURTSCHER HJ, 1988, MUTAT RES, V194, P1, DOI 10.1016/0167-8817(88)90050-8; Bzymek M, 2010, NATURE, V464, P937, DOI 10.1038/nature08868; CALDERON IL, 1983, CURR GENET, V7, P93, DOI 10.1007/BF00365632; Carreira A, 2009, CELL, V136, P1032, DOI 10.1016/j.cell.2009.02.019; Cha RS, 2000, GENE DEV, V14, P493; Chen FQ, 1997, MUTAT RES-DNA REPAIR, V384, P205, DOI 10.1016/S0921-8777(97)00020-7; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; Esashi F, 2007, NAT STRUCT MOL BIOL, V14, P468, DOI 10.1038/nsmb1245; Esta A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003833; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Flott S, 2011, EMBO REP, V12, P833, DOI 10.1038/embor.2011.127; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Hays SL, 1998, MOL CELL BIOL, V18, P4400, DOI 10.1128/MCB.18.7.4400; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Honda M, 2011, EMBO J, V30, P3368, DOI 10.1038/emboj.2011.238; Hong S, 2013, MOL CELLS, V36, P446, DOI 10.1007/s10059-013-0215-6; Hong S, 2013, MOL CELL, V51, P440, DOI 10.1016/j.molcel.2013.08.008; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Jasin M, 2002, ONCOGENE, V21, P8981, DOI 10.1038/sj.onc.1206176; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; Kim KP, 2010, CELL, V143, P924, DOI 10.1016/j.cell.2010.11.015; Kleckner N, 2006, CHROMOSOMA, V115, P175, DOI 10.1007/s00412-006-0055-7; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Lancaster JM, 1996, NAT GENET, V13, P238, DOI 10.1038/ng0696-238; Lee SE, 2003, MOL CELL BIOL, V23, P8913, DOI 10.1128/MCB.23.23.8913-8923.2003; Liu J, 2010, NAT STRUCT MOL BIOL, V17, P1260, DOI 10.1038/nsmb.1904; Miyagawa K, 2002, EMBO J, V21, P175, DOI 10.1093/emboj/21.1.175; Mott C, 2011, DNA REPAIR, V10, P408, DOI 10.1016/j.dnarep.2011.01.007; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Nimonkar AV, 2009, P NATL ACAD SCI USA, V106, P3077, DOI 10.1073/pnas.0813247106; North JA, 2013, NUCLEIC ACIDS RES, V41, P7302, DOI 10.1093/nar/gkt411; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Pellegrini L, 2004, TRENDS BIOCHEM SCI, V29, P310, DOI 10.1016/j.tibs.2004.04.009; Petalcorin MIR, 2007, P NATL ACAD SCI USA, V104, P8299, DOI [10.1073/pnas.0702805104, 10.1073/pnas.0702808104]; PRAKASH L, 1977, GENETICS, V86, P33; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Reva BA, 1998, FOLD DES, V3, P141, DOI 10.1016/S1359-0278(98)00019-4; Sasaki M, 2010, NAT REV MOL CELL BIO, V11, P182, DOI 10.1038/nrm2849; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; Shin DS, 2003, EMBO J, V22, P4566, DOI 10.1093/emboj/cdg429; Sugiyama T, 2009, J MOL BIOL, V390, P45, DOI 10.1016/j.jmb.2009.05.009; Tanaka K, 2000, J BIOL CHEM, V275, P26316, DOI 10.1074/jbc.M910306199; Tischfield JA, 1997, AM J HUM GENET, V61, P995, DOI 10.1086/301617; Wesoly J, 2006, MOL CELL BIOL, V26, P976, DOI 10.1128/MCB.26.3.976-989.2006; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Worth CL, 2011, NUCLEIC ACIDS RES, V39, pW215, DOI 10.1093/nar/gkr363; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837; Yang HJ, 2005, NATURE, V433, P653, DOI 10.1038/nature03234; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	54	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0124152	10.1371/journal.pone.0124152	http://dx.doi.org/10.1371/journal.pone.0124152			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938495	Green Published, Green Submitted, gold			2022-12-27	WOS:000353943000018
J	Singh, AK; Manjasetty, B; Balasubramani, GL; Koul, S; Kaushik, A; Ekka, MK; Singh, V; Kumaran, S				Singh, Appu Kumar; Manjasetty, Babu; Balasubramani, G. L.; Koul, Sukirte; Kaushik, Abhishek; Ekka, Mary Krishna; Singh, Vijay; Kumaran, S.			Crystal Structure of Fad35R from Mycobacterium tuberculosis H37Rv in the Apo-State	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; TRANSCRIPTIONAL REGULATOR; TETR FAMILY; TETRACYCLINE REPRESSOR; ETHIONAMIDE RESISTANCE; ACID BIOSYNTHESIS; ESCHERICHIA-COLI; BINDING; PROTEINS; REFINEMENT	Fad35R from Mycobacterium tuberculosis binds to the promoter site of Fad35 operon and its DNA binding activities are reduced in the presence of tetracycline and palmitoyl-CoA. We resolved the crystal structure of Fad35R using single-wavelength anomalous diffraction method (SAD). Fad35R comprises canonical DNA binding domain (DBD) and ligand binding domain (LBD), but displays several distinct structural features. Two recognition helices of two monomers in the homodimer are separated by similar to 48 angstrom and two core triangle-shaped ligand binding cavities are well exposed to solvent. Structural comparison with DesT and QacR structures suggests that ligand binding-induced movement of alpha 7, which adopts a straight conformation in the Fad35R, may be crucial to switch the conformational states between repressive and derepressive forms. Two DBDs are packed asymmetrically, creating an alternative dimer interface which coincides with the possible tetramer interface that connects the two canonical dimers. Quaternary state of alternative dimer mimics a closed-state structure in which two recognition helices are distanced at similar to 35 and ligand binding pockets are inaccessible. Results of biophysical studies indicate that Fad35R has the propensity to oligomerize in solution in the presence of tetracycline. We present the first structure of a FadR homologue from mycobacterium and the structure reveals DNA and ligand binding features of Fad35R and also provides a view on alternative quaternary states that mimic open and closed forms of the regulator.	[Singh, Appu Kumar; Balasubramani, G. L.; Koul, Sukirte; Kaushik, Abhishek; Ekka, Mary Krishna; Singh, Vijay; Kumaran, S.] CSIR, GN Ramachandran Prot Ctr, Inst Microbial Technol, Chandigarh 160036, India; [Manjasetty, Babu] European Mol Biol Lab, Grenoble Outstn, F-38000 Grenoble, France; [Manjasetty, Babu] Univ Grenoble Alpes, CNRS, EMBL, Unit Virus Host Cell Interact, F-38000 Grenoble, France	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Kumaran, S (corresponding author), CSIR, GN Ramachandran Prot Ctr, Inst Microbial Technol, Chandigarh 160036, India.	skumaran@imtech.res.in	Manjasetty, Babu A/F-8366-2013	Manjasetty, Babu A/0000-0002-8229-4748	CSIR, India; DST, India; Department of Biotechnology (DBT), India; CSIR; DBT India	CSIR, India(Council of Scientific & Industrial Research (CSIR) - India); DST, India(Department of Science & Technology (India)); Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India); CSIR(Council of Scientific & Industrial Research (CSIR) - India); DBT India(Department of Biotechnology (DBT) India)	AKS, SK, AK and MM received research fellowships from CSIR, India. GLB received a fellowship from DST, India. VS received one from the Department of Biotechnology (DBT), India. CSIR and DBT India funded this research and DBT, India, sponsored data collection at ESRF, Grenoble, France. We gratefully acknowledge access to In-house X-ray and 3-D structural biology facilities at IMTECH and ESRF, Grenoble, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand S, 2012, FEBS J, V279, P3214, DOI 10.1111/j.1742-4658.2012.08707.x; Biswas RK, 2013, MICROBIOL-SGM, V159, P913, DOI 10.1099/mic.0.066654-0; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Christen S, 2006, J BIOL CHEM, V281, P23129, DOI 10.1074/jbc.M603486200; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cowtan K, 2000, ACTA CRYSTALLOGR D, V56, P1612, DOI 10.1107/S0907444900013263; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dover LG, 2004, J MOL BIOL, V340, P1095, DOI 10.1016/j.jmb.2004.06.003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engohang-Ndong J, 2004, MOL MICROBIOL, V51, P175, DOI 10.1046/j.1365-2958.2003.03809.x; Ezezika OC, 2007, ACTA CRYSTALLOGR F, V63, P361, DOI 10.1107/S1744309107019185; Filippova Ekaterina V., 2011, Journal of Structural and Functional Genomics, V12, P149, DOI 10.1007/s10969-011-9112-4; Gao LY, 2003, MOL MICROBIOL, V49, P1547, DOI 10.1046/j.1365-2958.2003.03667.x; Gu RY, 2007, J MOL BIOL, V372, P583, DOI 10.1016/j.jmb.2007.06.072; HAYDON DJ, 1991, FEMS MICROBIOL LETT, V79, P291, DOI 10.1016/0378-1097(91)90101-F; Hayes D, 1995, PROGRAM SEDNTERP SED; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Itou H, 2010, J MOL BIOL, V403, P174, DOI 10.1016/j.jmb.2010.07.042; Kendall SL, 2010, MICROBIOL-SGM, V156, P1362, DOI 10.1099/mic.0.034538-0; Krissinel E, 1995, J COMPUT CHEM, V31, P133; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Le TBK, 2011, NUCLEIC ACIDS RES, V39, P9433, DOI 10.1093/nar/gkr640; Le TBK, 2011, J MOL BIOL, V408, P40, DOI 10.1016/j.jmb.2011.02.035; Lee W, 2013, J BIOL CHEM, V288, P6788, DOI 10.1074/jbc.M112.445056; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller DJ, 2010, NAT STRUCT MOL BIOL, V17, P971, DOI 10.1038/nsmb.1847; Mondino S, 2013, MOL MICROBIOL, V89, P372, DOI 10.1111/mmi.12282; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Orth P, 2000, NAT STRUCT BIOL, V7, P215; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Reichheld SE, 2009, P NATL ACAD SCI USA, V106, P22263, DOI 10.1073/pnas.0911566106; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schumacher MA, 2002, EMBO J, V21, P1210, DOI 10.1093/emboj/21.5.1210; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Vindal V, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-289; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	42	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0124333	10.1371/journal.pone.0124333	http://dx.doi.org/10.1371/journal.pone.0124333			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938298	Green Published, Green Submitted, gold			2022-12-27	WOS:000353943000023
J	Yousif, AM; Minopoli, M; Bifulco, K; Ingangi, V; Di Carluccio, G; Merlino, F; Motti, ML; Grieco, P; Carriero, MV				Yousif, Ali Munaim; Minopoli, Michele; Bifulco, Katia; Ingangi, Vincenzo; Di Carluccio, Gioconda; Merlino, Francesco; Motti, Maria Letizia; Grieco, Paolo; Carriero, Maria Vincenza			Cyclization of the Urokinase Receptor-Derived Ser-Arg-Ser-Arg-Tyr Peptide Generates a Potent Inhibitor of Trans-Endothelial Migration of Monocytes	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR; TRANSENDOTHELIAL MIGRATION; CELL-MIGRATION; DEFICIENT MICE; IN-VITRO; FORM; UPAR; ANGIOGENESIS; RECRUITMENT; THERAPIES	The receptor for the urokinase-type plasminogen activator (uPAR) is a widely recognized master regulator of cell migration and uPAR(88-92) is the minimal sequence required to induce cell motility. We and others have previously documented that the uPAR88-92 sequence, even in the form of synthetic linear peptide (SRSRY), interacts with the formyl peptide receptor type 1 (FPR1), henceforth inducing cell migration of several cell lines, including monocytes. FPR1 is mainly expressed by mammalian phagocytic leukocytes and plays a crucial role in chemotaxis. In this study, we present evidence that the cyclization of the SRSRY sequence generates a new potent and stable inhibitor of monocyte trafficking. In rat basophilic leukaemia RBL-2H3/ETFR cells expressing high levels of constitutively activated FPR1, the cyclic SRSRY peptide ([SRSRY]) blocks FPR1 mediated cell migration by interfering with both internalization and ligand-uptake of FPR1. Similarly to RBL-2H3/ETFR cells, [SRSRY] competes with fMLF for binding to FPR1 and prevents agonist-induced FPR1 internalization in human monocyte THP-1 cells. Unlike scramble [RSSYR], [SRSRY] inhibits fMLF-directed migration of monocytes in a dose-dependent manner, with IC50 value of 0.01 nM. PMA-differentiated THP-1 cell exposure to fMLF gradient causes a marked cytoskeletal re-organization with the formation of F-actin rich pseudopodia that are prevented by the addition of [SRSRY]. Furthermore, [SRSRY] prevents migration of human primary monocytes and trans-endothelial migration of monocytes. Our findings indicate that [SRSRY] is a new FPR1 inhibitor which may suggest the development of new drugs for treating pathological conditions sustained by increased motility of monocytes, such as chronic inflammatory diseases.	[Yousif, Ali Munaim; Merlino, Francesco; Grieco, Paolo] Univ Naples Federico II, Dept Pharm, Naples, Italy; [Minopoli, Michele; Bifulco, Katia; Ingangi, Vincenzo; Di Carluccio, Gioconda; Carriero, Maria Vincenza] IRCCS Ist Nazl Tumori Fdn G Pascale, Dept Expt Oncol, Neoplast Progress Unit, Naples, Italy; [Ingangi, Vincenzo] Univ Naples 2, SUN, Naples, Italy; [Motti, Maria Letizia] Univ Parthenope, Naples, Italy; [Grieco, Paolo] Univ Naples Federico II, CIRPEB Ctr Interuniv Ric Peptidi Bioattivi, CNR, Inst Biostruct & Bioimaging,DFM Scarl, I-80134 Naples, Italy	University of Naples Federico II; IRCCS Fondazione Pascale; Universita della Campania Vanvitelli; Parthenope University Naples; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); University of Naples Federico II	Carriero, MV (corresponding author), IRCCS Ist Nazl Tumori Fdn G Pascale, Dept Expt Oncol, Neoplast Progress Unit, Naples, Italy.	mariolinacarriero@yahoo.it	Carriero, Maria Vincenza/K-1240-2018; Minopoli, Michele/ABE-5674-2020; Ingangi, Vincenzo/I-2422-2018; Minopoli, Michele/J-8633-2018; Grieco, Paolo/AAB-9034-2019; Ingangi, Vincenzo/AAA-3512-2019; Merlino, Francesco/K-7866-2019	Carriero, Maria Vincenza/0000-0002-9768-2997; Minopoli, Michele/0000-0002-5407-481X; Ingangi, Vincenzo/0000-0001-5237-8353; Minopoli, Michele/0000-0002-5407-481X; Grieco, Paolo/0000-0002-6854-8123; Merlino, Francesco/0000-0002-9607-229X; Yousif, Ali Munaim/0000-0002-5651-0961; Di Carluccio, Gioconda/0000-0002-3571-9889	AIRC (Associazione Italiana per la Ricerca sul Cancro) [14225]; Italian Ministry of Health [RF-2010-2316780]; Regione Campania-Laboratori Pubblici project "Hauteville"	AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy); Regione Campania-Laboratori Pubblici project "Hauteville"	This work was supported by AIRC (Associazione Italiana per la Ricerca sul Cancro) 2013, project 14225, by Italian Ministry of Health RF-2010-2316780 and by Regione Campania-Laboratori Pubblici project "Hauteville". Authors did not receive any funding from commercial sources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae YS, 2003, MOL PHARMACOL, V64, P841, DOI 10.1124/mol.64.4.841; Barinka C, 2006, J MOL BIOL, V363, P482, DOI 10.1016/j.jmb.2006.08.063; Bifulco K, 2010, J THROMB HAEMOST, V8, P2789, DOI 10.1111/j.1538-7836.2010.04075.x; Bifulco K, 2008, FEBS LETT, V582, P1141, DOI 10.1016/j.febslet.2008.03.001; Bifulco K, 2014, ONCOTARGET, V5, P4154, DOI 10.18632/oncotarget.1930; Bifulco K, 2013, MOL CANCER THER, V12, P1981, DOI 10.1158/1535-7163.MCT-13-0077; Bifulco K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044806; Blasi F, 1997, IMMUNOL TODAY, V18, P415, DOI 10.1016/S0167-5699(97)01121-3; Carriero MV, 2014, MOL CANCER THER, V13, P1092, DOI 10.1158/1535-7163.MCT-13-0949; Carriero MV, 2011, CURR PHARM DESIGN, V17, P1944; Carriero MV, 2009, MOL CANCER THER, V8, P2708, DOI 10.1158/1535-7163.MCT-09-0174; Furlan F, 2004, J CELL SCI, V117, P2909, DOI 10.1242/jcs.01149; GAO JL, 1993, J BIOL CHEM, V268, P25395; Gardsvoll H, 2011, J BIOL CHEM, V286, P33544, DOI 10.1074/jbc.M111.220087; Gargiulo L, 2005, J BIOL CHEM, V280, P25225, DOI 10.1074/jbc.M412605200; Griffith JW, 2013, EUR J IMMUNOL, V43, P1430, DOI 10.1002/eji.201243183; Gyetko MR, 2000, J IMMUNOL, V165, P1513, DOI 10.4049/jimmunol.165.3.1513; Gyetko MR, 2004, J LEUKOCYTE BIOL, V76, P648, DOI 10.1189/jlb.0104023; Gyetko MR, 2001, J IMMUNOL, V167, P5539, DOI 10.4049/jimmunol.167.10.5539; Huttunen R, 2011, J INTERN MED, V270, P32, DOI 10.1111/j.1365-2796.2011.02363.x; Le YY, 2002, TRENDS IMMUNOL, V23, P541, DOI 10.1016/S1471-4906(02)02316-5; Lee HY, 2013, BIOCHEM BIOPH RES CO, V433, P255, DOI 10.1016/j.bbrc.2013.03.002; Liu MY, 2012, INT IMMUNOPHARMACOL, V14, P283, DOI 10.1016/j.intimp.2012.07.015; Mackay CR, 2008, NAT IMMUNOL, V9, P988, DOI 10.1038/ni.f.210; Miettinen HM, 1997, J IMMUNOL, V159, P4045; Mondino A, 2004, TRENDS IMMUNOL, V25, P450, DOI 10.1016/j.it.2004.06.004; Montuori N, 2002, J BIOL CHEM, V277, P46932, DOI 10.1074/jbc.M207494200; Montuori N, 2012, INFEZ MED S2, V20, P8; Montuori N, 2011, CELL MOL LIFE SCI, V68, P2453, DOI 10.1007/s00018-010-0564-7; Plesner T, 1997, STEM CELLS, V15, P398, DOI 10.1002/stem.150398; PLOUG M, 1994, FEBS LETT, V349, P163, DOI 10.1016/0014-5793(94)00674-1; PLOUG M, 1991, J BIOL CHEM, V266, P1926; Rao T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059415; Resnati M, 2002, P NATL ACAD SCI USA, V99, P1359, DOI 10.1073/pnas.022652999; Rijneveld AW, 2002, J IMMUNOL, V168, P3507, DOI 10.4049/jimmunol.168.7.3507; Ronald JA, 2001, J LEUKOCYTE BIOL, V70, P601; Salmi M, 2012, EUR J IMMUNOL, V42, P284, DOI 10.1002/eji.201142223; Thuno M, 2009, DIS MARKERS, V27, P157, DOI [10.1155/2009/504294, 10.3233/DMA-2009-0657]; Tsubota Y, 2013, J IMMUNOL, V190, P4236, DOI 10.4049/jimmunol.1300046; Xu X, 2012, J MOL BIOL, V416, P629, DOI 10.1016/j.jmb.2011.12.058; Yuan C, 2007, CELL MOL LIFE SCI, V64, P1033, DOI 10.1007/s00018-007-6498-z	41	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0126172	10.1371/journal.pone.0126172	http://dx.doi.org/10.1371/journal.pone.0126172			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938482	Green Submitted, Green Published, gold			2022-12-27	WOS:000353943000147
J	Bernard, LP; Zhang, HY				Bernard, Laura P.; Zhang, Huaye			MARK/Par1 Kinase Is Activated Downstream of NMDA Receptors through a PKA-Dependent Mechanism	PLOS ONE			English	Article							LONG-TERM POTENTIATION; DENDRITIC SPINE MORPHOLOGY; SYNAPTIC PLASTICITY; PROTEIN-KINASE; PHOSPHORYLATION; POLARITY; PSD-95; LKB1; NEURONS; SYNAPTOGENESIS	The Par1 kinases, also known as microtubule affinity-regulating kinases (MARKs), are important for the establishment of cell polarity from worms to mammals. Dysregulation of these kinases has been implicated in autism, Alzheimer's disease and cancer. Despite their important function in health and disease, it has been unclear how the activity of MARK/Par1 is regulated by signals from cell surface receptors. Here we show that MARK/Par1 is activated downstream of NMDA receptors in primary hippocampal neurons. Further, we show that this activation is dependent on protein kinase A (PKA), through the phosphorylation of Ser431 of Par4/LKB1, the major upstream kinase of MARK/Par1. Together, our data reveal a novel mechanism by which MARK/Par1 is activated at the neuronal synapse.	[Bernard, Laura P.; Zhang, Huaye] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Zhang, HY (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA.	huaye.zhang@rutgers.edu			National Institutes of Health grant [NS065183]; Rutgers Robert Wood Johnson Medical School; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS065183] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rutgers Robert Wood Johnson Medical School; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grant NS065183 and startup funds from the Rutgers Robert Wood Johnson Medical School to H.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banko JL, 2004, J NEUROCHEM, V91, P462, DOI 10.1111/j.1471-4159.2004.02734.x; BASARSKY TA, 1994, J NEUROSCI, V14, P6402; Beique JC, 2003, J PHYSIOL-LONDON, V546, P859, DOI 10.1113/jphysiol.2002.031369; Blumer JB, 2003, J BIOL CHEM, V278, P23217, DOI 10.1074/jbc.C200686200; Colgan LA, 2013, ANN REV PHYSL; COOPER DMF, 1995, NATURE, V374, P421, DOI 10.1038/374421a0; Dell'Acqua ML, 2006, EUR J CELL BIOL, V85, P627, DOI 10.1016/j.ejcb.2006.01.010; Fu M, 2012, NATURE, V483, P92, DOI 10.1038/nature10844; Giordano G, 2005, J NEUROCHEM, V94, P808, DOI 10.1111/j.1471-4159.2005.03235.x; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hayashi K, 2011, J NEUROSCI, V31, P12094, DOI 10.1523/JNEUROSCI.0751-11.2011; Hezel AF, 2008, MOL CELL BIOL, V28, P2414, DOI 10.1128/MCB.01621-07; Hoey SE, 2009, J NEUROSCI, V29, P4442, DOI 10.1523/JNEUROSCI.6017-08.2009; Hou HL, 2013, J CELL BIOL, V203, P521, DOI 10.1083/jcb.201303035; Hu XD, 2011, J NEUROSCI, V31, P15597, DOI 10.1523/JNEUROSCI.2445-11.2011; Ivanov A, 2006, J PHYSIOL-LONDON, V572, P789, DOI 10.1113/jphysiol.2006.105510; Jaworski J, 2009, NEURON, V61, P85, DOI 10.1016/j.neuron.2008.11.013; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Kwon HB, 2011, NATURE, V474, P100, DOI 10.1038/nature09986; Lai CSW, 2012, NATURE, V483, P87, DOI 10.1038/nature10792; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Matenia D, 2009, TRENDS BIOCHEM SCI, V34, P332, DOI 10.1016/j.tibs.2009.03.008; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Merriam EB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027688; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Nieto-Vazquez I, 2008, DIABETES, V57, P3211, DOI 10.2337/db07-1062; Perkinton MS, 2002, J NEUROCHEM, V80, P239, DOI 10.1046/j.0022-3042.2001.00699.x; Repetto D, 2014, J NEUROSCI, V34, P1542, DOI 10.1523/JNEUROSCI.2341-13.2014; Roberson ED, 1996, J BIOL CHEM, V271, P30436, DOI 10.1074/jbc.271.48.30436; Sala C, 2014, PHYSIOL REV, V94, P141, DOI 10.1152/physrev.00012.2013; Shelly M, 2011, DEV NEUROBIOL, V71, P508, DOI 10.1002/dneu.20884; Stein V, 2003, J NEUROSCI, V23, P5503; Sun M, 2013, JOVE-J VIS EXP, DOI 10.3791/50808; Timm T, 2003, EMBO J, V22, P5090, DOI 10.1093/emboj/cdg447; Wang JW, 2007, J NEUROSCI, V27, P574, DOI 10.1523/JNEUROSCI.5094-06.2007; Wu Q, 2012, J BIOL CHEM, V287, P30781, DOI 10.1074/jbc.M112.351452; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Xu WF, 2011, CURR OPIN NEUROBIOL, V21, P306, DOI 10.1016/j.conb.2011.03.001; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Yao WD, 2004, NEURON, V41, P625, DOI 10.1016/S0896-6273(04)00048-0; Yasuda H, 2003, NAT NEUROSCI, V6, P15, DOI 10.1038/nn985; Yu WD, 2012, HUM MOL GENET, V21, P1384, DOI 10.1093/hmg/ddr576; Zhu D, 2002, AMINO ACIDS, V23, P11, DOI 10.1007/s00726-001-0103-9; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	46	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124816	10.1371/journal.pone.0124816	http://dx.doi.org/10.1371/journal.pone.0124816			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932647	Green Published, Green Submitted, gold			2022-12-27	WOS:000353887100057
J	Du, HW; Shi, LL; Chen, P; Yang, WK; Xun, YP; Yang, CH; Zhao, LQ; Zhou, YB; Chen, GY				Du, Hongwu; Shi, Lili; Chen, Peng; Yang, Weikang; Xun, Yiping; Yang, Chunhe; Zhao, Lanqing; Zhou, Yabin; Chen, Guangyu			Prohibitin Is Involved in Patients with IgG4 Related Disease	PLOS ONE			English	Article							IGG4-RELATED SYSTEMIC-DISEASE; AUTOIMMUNE PANCREATITIS; TUBULOINTERSTITIAL NEPHRITIS; SCLEROSING PANCREATITIS; IDENTIFICATION; AUTOANTIBODIES; FIBROSIS; ANTIBODY	Objective IgG4-related disease (IgG4-RD) is a chronic systemic disease involved in many organs and tissues. As only limited autoantigens have been found since the beginning of this century, the aim of this study was to reveal new candidate autoantigens of IgG4-RD. Methods Multiple cell lines including HT-29, EA.hy926, HEK 293 and HepG2 were used to test the binding ability of circulating autoantibodies from IgG4-RD sera. The amino-acid sequence was then analyzed by matrix-assisted laser desorption/ionization time-of-flight tandem (MALDI-TOF/TOF) mass spectrometry. After the cloning and expression of recombinant putative autoantigen in a bacterial expression system, the corresponding immuno assay was set up and utilized to observe the prevalence of serum autoantibodies in a large set of confirmed clinical samples. Results One positive autoantigen was identified as prohibitin. ELISA analysis showed that a majority of patients with IgG4-RD have antibodies against prohibitin. Anti-prohibitin antibodies were present in the sera of patients with definite autoimmune pancreatitis (25/34; 73.5%), Mikulicz's disease (8/15; 53.3%), retroperitoneal fibrosis (6/11; 54.5%), other probable IgG4-RD (26/29; 89.7%) and Sjogren's syndrome (4/30; 13.3%) but not in apparently healthy donors (1/70; 1.4%). Conclusions An association between prohibitin and patients with some IgG4-RD was observed, although the results were quite heterogeneous among different individuals within autoimmune pancreatitis, Mikulicz's disease and retroperitoneal fibrosis.	[Du, Hongwu; Shi, Lili; Chen, Peng; Yang, Weikang; Xun, Yiping; Yang, Chunhe; Zhao, Lanqing; Zhou, Yabin] Univ Sci & Technol Beijing, Sch Chem & Biol Engn, Lab 112, Beijing 100083, Peoples R China; [Chen, Guangyu] ImmunoHunt Corp, Beijing, Peoples R China	University of Science & Technology Beijing	Du, HW (corresponding author), Univ Sci & Technol Beijing, Sch Chem & Biol Engn, Lab 112, Beijing 100083, Peoples R China.	hongwudu@ustb.edu.cn		Xun, Yiping/0000-0001-6367-8407	Fundamental Research Funds for the Central Universities, Program for New Century Excellent Talents in University; National Natural Science Foundation of China [21105113, 31371203]	Fundamental Research Funds for the Central Universities, Program for New Century Excellent Talents in University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Fundamental Research Funds for the Central Universities, Program for New Century Excellent Talents in University and the National Natural Science Foundation of China (No. 21105113; No. 31371203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ImmunoHunt Corporation provided support in the form of a salary for author GYC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada M, 2006, PANCREAS, V33, P20, DOI 10.1097/01.mpa.0000226881.48204.fd; Cornell LD, 2007, AM J SURG PATHOL, V31, P1586, DOI 10.1097/PAS.0b013e318059b87c; Deshpande V, 2006, AM J SURG PATHOL, V30, P1537, DOI 10.1097/01.pas.0000213331.09864.2c; Du HW, 2013, BIOANALYSIS, V5, P2269, DOI 10.4155/bio.13.195; Endo T, 2009, DIABETES, V58, P732, DOI 10.2337/db08-0493; Frulloni L, 2009, NEW ENGL J MED, V361, P2135, DOI 10.1056/NEJMoa0903068; Gill J, 2009, HUM PATHOL, V40, P881, DOI 10.1016/j.humpath.2008.10.020; Guma M, 2012, BEST PRACT RES CL RH, V26, P425, DOI 10.1016/j.berh.2012.07.001; Hamano H, 2002, LANCET, V359, P1403, DOI 10.1016/S0140-6736(02)08359-9; Homma M, 1985, SCAND J RHEUMATOL, V61, P26; KAWAGUCHI K, 1991, HUM PATHOL, V22, P387, DOI 10.1016/0046-8177(91)90087-6; Khosroshahi A, 2011, CURR OPIN RHEUMATOL, V23, P57, DOI 10.1097/BOR.0b013e3283418057; Kim Y, 2012, NUCLEIC ACIDS RES, V40, pW525, DOI 10.1093/nar/gks438; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Masaki Y, 2011, J CLIN EXP HEMATOP, V51, P13, DOI 10.3960/jslrt.51.13; Mikulicz JV, 1938, MODERN CLASSICS, P165; Mishra S, 2005, TRENDS MOL MED, V11, P192, DOI 10.1016/j.molmed.2005.02.004; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Nishi H, 2007, NEPHROL DIAL TRANSPL, V22, P1273, DOI 10.1093/ndt/gfl672; Okazaki K, 2000, GASTROENTEROLOGY, V118, P573, DOI 10.1016/S0016-5085(00)70264-2; Okazaki K, 2011, CLIN REV ALLERG IMMU, V41, P126, DOI 10.1007/s12016-010-8214-2; Peters B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-132; Saeki T, 2010, KIDNEY INT, V78, P1016, DOI 10.1038/ki.2010.271; Sidney John, 2008, Immunome Res, V4, P2, DOI 10.1186/1745-7580-4-2; Stone JH, 2012, SEMIN DIAGN PATHOL, V29, P177, DOI 10.1053/j.semdp.2012.08.002; Theiss AL, 2011, BBA-MOL CELL RES, V1813, P1137, DOI 10.1016/j.bbamcr.2011.01.033; Umehara H, 2012, MOD RHEUMATOL, V22, P21, DOI 10.1007/s10165-011-0571-z; Wallace ZS, 2012, SURV OPHTHALMOL, V57, P26, DOI 10.1016/j.survophthal.2011.07.004; Xun YP, 2014, BIOCHEM BIOPH RES CO, V451, P389, DOI 10.1016/j.bbrc.2014.07.126; YOSHIDA K, 1995, DIGEST DIS SCI, V40, P1561, DOI 10.1007/BF02285209; Zen Y, 2005, HUM PATHOL, V36, P710, DOI 10.1016/j.humpath.2005.05.011; Zen Y, 2011, CURR OPIN RHEUMATOL, V23, P114, DOI 10.1097/BOR.0b013e3283412f4a; Zhou TB, 2012, NEPHROLOGY, V17, P189, DOI 10.1111/j.1440-1797.2011.01522.x	33	44	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125331	10.1371/journal.pone.0125331	http://dx.doi.org/10.1371/journal.pone.0125331			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932630	Green Submitted, Green Published, gold			2022-12-27	WOS:000353887100099
J	Pasdar, EA; Smits, M; Stapelberg, M; Bajzikova, M; Stantic, M; Goodwin, J; Yan, B; Stursa, J; Kovarova, J; Sachaphibulkij, K; Bezawork-Geleta, A; Sobol, M; Filimonenko, A; Tomasetti, M; Zobalova, R; Hozak, P; Dong, LF; Neuzil, J				Pasdar, Elham Alizadeh; Smits, Michael; Stapelberg, Michael; Bajzikova, Martina; Stantic, Marina; Goodwin, Jacob; Yan, Bing; Stursa, Jan; Kovarova, Jaromira; Sachaphibulkij, Karishma; Bezawork-Geleta, Ayenachew; Sobol, Margaryta; Filimonenko, Anatoly; Tomasetti, Marco; Zobalova, Renata; Hozak, Pavel; Dong, Lan-Feng; Neuzil, Jiri			Characterisation of Mesothelioma-Initiating Cells and Their Susceptibility to Anti-Cancer Agents	PLOS ONE			English	Article							MALIGNANT PLEURAL MESOTHELIOMA; EMBRYONIC STEM-CELLS; ALPHA-TOCOPHERYL SUCCINATE; DRUG-RESISTANCE; SELF-RENEWAL; BRAIN-TUMORS; CANCER; MITOCHONDRIAL; CD24; DIFFERENTIATION	Malignant mesothelioma (MM) is an aggressive type of tumour causing high mortality. One reason for this paradigm may be the existence of a subpopulation of tumour-initiating cells (TICs) that endow MM with drug resistance and recurrence. The objective of this study was to identify and characterise a TIC subpopulation in MM cells, using spheroid cultures, mesospheres, as a model of MM TICs. Mesospheres, typified by the stemness markers CD24, ABCG2 and OCT4, initiated tumours in immunodeficient mice more efficiently than adherent cells. CD24 knock-down cells lost the sphere-forming capacity and featured lower tumorigenicity. Upon serial transplantation, mesospheres were gradually more efficiently tumrigenic with increased level of stem cell markers. We also show that mesospheres feature mitochondrial and metabolic properties similar to those of normal and cancer stem cells. Finally, we show that mesothelioma-initiating cells are highly susceptible to mitochondrially targeted vitamin E succinate. This study documents that mesospheres can be used as a plausible model of mesothelioma-initiating cells and that they can be utilised in the search for efficient agents against MM.	[Pasdar, Elham Alizadeh; Smits, Michael; Stapelberg, Michael; Stantic, Marina; Goodwin, Jacob; Yan, Bing; Sachaphibulkij, Karishma; Bezawork-Geleta, Ayenachew; Zobalova, Renata; Dong, Lan-Feng; Neuzil, Jiri] Griffith Univ, Sch Med Sci, Southport, Qld 4215, Australia; [Bajzikova, Martina; Kovarova, Jaromira; Zobalova, Renata; Neuzil, Jiri] Acad Sci Czech Republic, Inst Biotechnol, Prague, Czech Republic; [Stursa, Jan] Univ Hosp Hradec Kralove, Biomed Res Ctr, Hradec Kralove, Czech Republic; [Sobol, Margaryta; Filimonenko, Anatoly; Hozak, Pavel] Acad Sci Czech Republic, Inst Mol Genet, Prague, Czech Republic; [Tomasetti, Marco] Polytech Univ Marche, Dept Mol & Clin Sci, Ancona, Italy	Griffith University; Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; University Hospital Hradec Kralove; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Marche Polytechnic University	Neuzil, J (corresponding author), Griffith Univ, Sch Med Sci, Southport, Qld 4215, Australia.	j.neuzil@griffith.edu.au	Stursa, Jan/J-4255-2014; Bajzikova, Martina/H-4781-2014; DONG, LANFENG/S-8805-2019; Hozak, Pavel/AAB-5359-2021; Kovarova, Jaromira/H-4812-2014; Neuzil, Jiri/H-7204-2014	Hozak, Pavel/0000-0003-1901-1394; Neuzil, Jiri/0000-0002-2478-2460; Bezawork-Geleta, Ayenachew/0000-0001-5404-5093; Stantic, Marina/0000-0002-2800-5538; Dong, Lanfeng/0000-0002-9857-6352; Zobalova, Renata/0000-0002-9097-4700; Bezawork-Geleta, Ayenachew/0000-0003-2739-8023; Goodwin, Jacob/0000-0002-3834-3071	Australian Research Council; Cancer Council Queensland; European Regional Development Fund (the BIOCEV project) [CZ.1.05/1.1.00/02.0109]; Douglas Francis Green PhD Scholarship; Griffith University Research Fellowship	Australian Research Council(Australian Research Council); Cancer Council Queensland(Cancer Council Queensland); European Regional Development Fund (the BIOCEV project); Douglas Francis Green PhD Scholarship; Griffith University Research Fellowship	The work was supported in part by grants from the Australian Research Council, Cancer Council Queensland, and the European Regional Development Fund (the BIOCEV project, CZ.1.05/1.1.00/02.0109) to JN. EAP was supported by the Douglas Francis Green PhD Scholarship provided by the Queensland Asbestos-Related Disease Society. LFD was supported by the Griffith University Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong L, 2010, STEM CELLS, V28, P661, DOI 10.1002/stem.307; Baas P, 2002, SEMIN ONCOL, V29, P62, DOI 10.1053/sonc.2002.30231; Barrientos A., 2009, CURR PROTOC HUM GENE, V19, P13, DOI DOI 10.1002/0471142905.HG1903S63; Baumann P, 2005, CANCER RES, V65, P10783, DOI 10.1158/0008-5472.CAN-05-0619; Birket MJ, 2011, J CELL SCI, V124, P348, DOI 10.1242/jcs.072272; Carbone M, 1997, NAT MED, V3, P908, DOI 10.1038/nm0897-908; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Cho YM, 2006, BIOCHEM BIOPH RES CO, V348, P1472, DOI 10.1016/j.bbrc.2006.08.020; Chung S, 2010, J MOL CELL CARDIOL, V48, P725, DOI 10.1016/j.yjmcc.2009.12.014; Cortes-Dericks L, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-304; Cortes-Dericks L, 2010, INT J ONCOL, V37, P437, DOI 10.3892/ijo_00000692; Deguen B, 1998, INT J CANCER, V77, P554, DOI 10.1002/(SICI)1097-0215(19980812)77:4<554::AID-IJC14>3.0.CO;2-6; Destro A, 2006, LUNG CANCER, V51, P207, DOI 10.1016/j.lungcan.2005.10.016; Di Meglio F, 2010, J MOL CELL CARDIOL, V49, P719, DOI 10.1016/j.yjmcc.2010.05.013; Dong LF, 2011, J BIOL CHEM, V286, P3717, DOI 10.1074/jbc.M110.186643; Dong LF, 2009, CLIN CANCER RES, V15, P1593, DOI 10.1158/1078-0432.CCR-08-2439; Easwaran H, 2014, MOL CELL, V54, P716, DOI 10.1016/j.molcel.2014.05.015; Gnaiger E, 1995, J BIOENERG BIOMEMBR, V27, P583, DOI 10.1007/BF02111656; Gordon GJ, 2005, CLIN CANCER RES, V11, P4406, DOI 10.1158/1078-0432.CCR-04-2181; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Herrick SE, 2007, INT J ARTIF ORGANS, V30, P527, DOI 10.1177/039139880703000611; Herrick SE, 2004, INT J BIOCHEM CELL B, V36, P621, DOI 10.1016/j.biocel.2003.11.002; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Jackaman C, 2003, J IMMUNOL, V171, P5051, DOI 10.4049/jimmunol.171.10.5051; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Kao SCH, 2011, PATHOLOGY, V43, P128, DOI 10.1097/PAT.0b013e328342016c; Kobayashi CI, 2012, J CELL PHYSIOL, V227, P421, DOI 10.1002/jcp.22764; Kovarova J, 2014, REDOX REP, V19, P16, DOI 10.1179/1351000213Y.0000000064; Kristiansen G, 2003, BRIT J CANCER, V88, P231, DOI 10.1038/sj.bjc.6600702; Lee TKW, 2011, CELL STEM CELL, V9, P50, DOI 10.1016/j.stem.2011.06.005; Lonergan T, 2007, MITOCHONDRION, V7, P289, DOI 10.1016/j.mito.2007.05.002; Lu LW, 2000, EUR J IMMUNOL, V30, P2686, DOI 10.1002/1521-4141(200009)30:9<2686::AID-IMMU2686>3.0.CO;2-F; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Neuzil J, 2001, FASEB J, V15, P403, DOI 10.1096/fj.00-0251com; PASS HI, 1995, ANN THORAC SURG, V59, P835, DOI 10.1016/0003-4975(95)00045-M; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Prigione A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027352; Ramos-Mejia V, 2012, STEM CELLS DEV, V21, P1145, DOI 10.1089/scd.2011.0248; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rice J, 2011, INT J HEALTH SERV, V41, P239, DOI 10.2190/HS.41.2.d; Robinson BWS, 2005, NEW ENGL J MED, V353, P1591, DOI 10.1056/NEJMra050152; Rohlena J, 2011, ANTIOXID REDOX SIGN, V15, P2923, DOI 10.1089/ars.2011.4192; Rota LM, 2012, J MAMMARY GLAND BIOL, V17, P119, DOI 10.1007/s10911-012-9258-0; Sagiv E, 2008, CANCER RES, V68, P2803, DOI 10.1158/0008-5472.CAN-07-6463; Saunders NA, 2012, EMBO MOL MED, V4, P675, DOI 10.1002/emmm.201101131; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Smith SC, 2006, CANCER RES, V66, P1917, DOI 10.1158/0008-5472.CAN-05-3855; St John JC, 2005, CLONING STEM CELLS, V7, P141, DOI 10.1089/clo.2005.7.141; Stapelberg M, 2014, FREE RADICAL BIO MED, V67, P41, DOI 10.1016/j.freeradbiomed.2013.10.003; Steele JPC, 2005, ANN ONCOL, V16, P345, DOI 10.1093/annonc/mdi094; TASWELL C, 1981, J IMMUNOL, V126, P1614; Tomasetti M, 2004, INT J CANCER, V109, P641, DOI 10.1002/ijc.20062; Tomasetti Marco, 2009, Curr Mol Pharmacol, V2, P190; Vermeulen L, 2012, LANCET ONCOL, V13, pE83, DOI 10.1016/S1470-2045(11)70257-1; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Yang XR, 2009, CLIN CANCER RES, V15, P5518, DOI 10.1158/1078-0432.CCR-09-0151; Ye XQ, 2011, INT J CANCER, V129, P820, DOI 10.1002/ijc.25944; Zhang J, 2011, EMBO J, V30, P4860, DOI 10.1038/emboj.2011.401; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028; Zucali PA, 2011, CANCER TREAT REV, V37, P543, DOI 10.1016/j.ctrv.2011.01.001	65	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0119549	10.1371/journal.pone.0119549	http://dx.doi.org/10.1371/journal.pone.0119549			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932953	Green Published, gold			2022-12-27	WOS:000353887100002
J	Schats, R; Bijker, EM; van Gemert, GJ; Graumans, W; van de Vegte-Bolmer, M; van Lieshout, L; Haks, MC; Hermsen, CC; Scholzen, A; Visser, LG; Sauerwein, RW				Schats, Remko; Bijker, Else M.; van Gemert, Geert-Jan; Graumans, Wouter; van de Vegte-Bolmer, Marga; van Lieshout, Lisette; Haks, Marielle C.; Hermsen, Cornelus C.; Scholzen, Anja; Visser, Leo G.; Sauerwein, Robert W.			Heterologous Protection against Malaria after Immunization with Plasmodium falciparum Sporozoites	PLOS ONE			English	Article							INOCULATION; IMMUNITY	Background Sterile protection in >90% of volunteers against homologous Plasmodium falciparum infection has been achieved only using the controlled human malaria infection (CHMI) model. This efficient model involves whole parasite immunizations under chloroquine prophylaxis (CPS-immunization), requiring only 30-45 mosquitoes bites infected with P. falciparum-sporozoites. Given the large diversity of P. falciparum parasites, it is essential to assess protection against heterologous parasite strains. Methods In an open-label follow-up study, 16 volunteers previously CPS-immunized and challenged with P. falciparum NF54 (West-Africa) in a dose de-escalation and challenge trial were rechallenged with clone NF135. C10 (Cambodia) at 14 months after the last immunization (NCT01660854). Results Two out of thirteen NF54 protected volunteers previously fully protected against NF54 were also fully protected against NF135. C10, while 11/13 showed a delayed patency (median prepatent period of 10.5 days (range 9.0-15.5) versus 8.5 days in 5 malaria-naive controls (p = 0.0005). Analysis of patency by qPCR indicated a 91 to >99% estimated reduction of liver parasite load in 7/11 partially protected subjects. Three volunteers previously not protected against NF54, were also not protected against NF135. C10. Conclusion This study shows that CPS-immunization can induce heterologous protection for a period of more than one year, which is a further impetus for clinical development of whole parasite vaccines.	[Schats, Remko; Haks, Marielle C.; Visser, Leo G.] Leiden Univ, Med Ctr, Dept Infect Dis, NL-2300 RC Leiden, Netherlands; [Bijker, Else M.; van Gemert, Geert-Jan; Graumans, Wouter; van de Vegte-Bolmer, Marga; Hermsen, Cornelus C.; Scholzen, Anja; Sauerwein, Robert W.] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6500 HB Nijmegen, Netherlands; [van Lieshout, Lisette] Leiden Univ, Med Ctr, Dept Med Microbiol, NL-2300 RC Leiden, Netherlands; [van Lieshout, Lisette] Leiden Univ, Med Ctr, Dept Parasitol, NL-2300 RC Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Sauerwein, RW (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, POB 9101, NL-6500 HB Nijmegen, Netherlands.	Robert.Sauerwein@radboudumc.nl	Graumans, Wouter/D-9610-2016; Scholzen, Anja/D-1046-2013; Sauerwein, Robert/C-8519-2013; Bijker, Else/P-8051-2015; Visser, Leo/AAH-5755-2021; Hermsen, C.C./L-4368-2015; Bijker, Else/ABF-1664-2021	Graumans, Wouter/0000-0003-3952-6491; Scholzen, Anja/0000-0001-6481-6090; Bijker, Else/0000-0002-2367-5874; Visser, Leo/0000-0002-3600-9782	Top Institute Pharma [T4-102]	Top Institute Pharma	This work was supported by Top Institute Pharma; project code T4-102. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bijker EM, 2013, P NATL ACAD SCI USA, V110, P7862, DOI 10.1073/pnas.1220360110; Bijker EM, 2014, J INFECT DIS; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Hermsen CC, 2001, MOL BIOCHEM PARASIT, V118, P247, DOI 10.1016/S0166-6851(01)00379-6; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Roestenberg M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038434; Roestenberg M, 2011, LANCET, V377, P1770, DOI 10.1016/S0140-6736(11)60360-7; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Teirlinck AC, 2013, J INFECT DIS, V207, P656, DOI 10.1093/infdis/jis725	10	41	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124243	10.1371/journal.pone.0124243	http://dx.doi.org/10.1371/journal.pone.0124243			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933168	Green Submitted, Green Published, gold			2022-12-27	WOS:000353887100033
J	Van Handel, MM; Branson, BM				Van Handel, Michelle M.; Branson, Bernard M.			Monitoring HIV Testing in the United States: Consequences of Methodology Changes to National Surveys	PLOS ONE			English	Article								Objective In 2011, the National Health Interview Survey (NHIS), an in-person household interview, revised the human immunodeficiency virus (HIV) section of the survey and the Behavioral Risk Factor Surveillance System (BRFSS), a telephone-based survey, added cellphone numbers to its sampling frame. We sought to determine how these changes might affect assessment of HIV testing trends. Methods We used linear regression with pairwise contrasts with 2003-2013 data from NHIS and BRFSS to compare percentages of persons aged 18-64 years who reported HIV testing in landline versus cellphone-only households before and after 2011, when NHIS revised its in-person questionnaire and BRFSS added cellphone numbers to its telephone-based sample. Results In NHIS, the percentage of persons in cellphone-only households increased 13-fold from 2003 to 2013. The percentage ever tested for HIV was 6%-10% higher among persons in cellphone-only than landline households. The percentage ever tested for HIV increased significantly from 40.2% in 2003 to 45.0% in 2010, but was significantly lower in 2011 (40.6%) and 2012 (39.7%). In BRFSS, the percentage ever tested decreased significantly from 45.9% in 2003 to 40.2% in 2010, but increased to 42.9% in 2011 and 43.5% in 2013. Conclusions HIV testing estimates were lower after NHIS questionnaire changes but higher after BRFSS methodology changes. Data before and after 2011 are not comparable, complicating assessment of trends.	[Van Handel, Michelle M.; Branson, Bernard M.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Van Handel, MM (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.	ioq4@cdc.gov						Anonymous, 2008, Morbidity and Mortality Weekly Report, V57, P845; Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; [Anonymous], OMB STAND GUID STAT; [Anonymous], 2010, NAT HIV AIDS STRAT U; [Anonymous], HIV TESTING US BASEL; [Anonymous], FEDCASIC WASH DC MAR; [Anonymous], 2011, WIRELESS SUBSTITUTIO; [Anonymous], 2013 NHIS QUEST SAMP; [Anonymous], QUEST ORD; [Anonymous], 2011 NAT HIV INT SUR; [Anonymous], QUESTIONS ANSWERS AT; [Anonymous], BRFSS 2013 SUMM DAT; Blumberg SJ, 2006, AM J PUBLIC HEALTH, V96, P926, DOI 10.2105/AJPH.2004.057885; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P1110; Cohen Stacy M., 2011, Morbidity and Mortality Weekly Report, V60, P1618; Gundersen DA, 2014, AM J EPIDEMIOL, V179, P39, DOI 10.1093/aje/kwt226; Hu SS, 2011, AM J EPIDEMIOL, V173, P703, DOI 10.1093/aje/kwq442; Johnson A. Satcher, 2010, Morbidity and Mortality Weekly Report, V59, P1550; Peytchev A, 2013, PUBLIC OPIN QUART, V77, P283, DOI 10.1093/poq/nft003; Pierannunzi Carol, 2012, Morbidity and Mortality Weekly Report, V61, P410; Schwarz N, 1999, AM PSYCHOL, V54, P93, DOI 10.1037/0003-066X.54.2.93; Viall Abigail H., 2011, Morbidity and Mortality Weekly Report, V60, P805	22	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125637	10.1371/journal.pone.0125637	http://dx.doi.org/10.1371/journal.pone.0125637			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0MA	25927983	Green Published, gold, Green Submitted			2022-12-27	WOS:000353713100109
J	Wang, WP; Liu, JL; Zhao, BZ; Zhang, JB; Li, XP; Yan, YF				Wang Weipeng; Liu Jianli; Zhao Bingzi; Zhang Jiabao; Li Xiaopeng; Yan Yifan			Critical Evaluation of Particle Size Distribution Models Using Soil Data Obtained with a Laser Diffraction Method	PLOS ONE			English	Article							WATER-RETENTION CURVE; HYDRAULIC CONDUCTIVITY; PIPETTE-METHOD; PARAMETERS; TEXTURE; PERFORMANCE; FRACTIONS; EQUATION	Mathematical descriptions of classical particle size distribution (PSD) data are often used to estimate soil hydraulic properties. Laser diffraction methods (LDM) now provide more detailed PSD measurements, but deriving a function to characterize the entire range of particle sizes is a major challenge. The aim of this study was to compare the performance of eighteen PSD functions for fitting LDM data sets from a wide range of soil textures. These models include five lognormal models, five logistic models, four van Genuchten models, two Fredlund models, a logarithmic model, and an Andersson model. The fits were evaluated using Akaike's information criterion (AIC), adjusted R-2, and root-mean-square error (RMSE). The results indicated that the Fredlund models (FRED3 and FRED4) had the best performance for most of the soils studied, followed by one logistic growth function extension model (MLOG3) and three lognormal models (ONLG3, ORLG3, and SHCA3). The performance of most PSD models was better for soils with higher silt content and poorer for soils with higher clay and sand content. The FRED4 model best described the PSD of clay, silty clay, clay loam, silty clay loam, silty loam, loam, and sandy loam, whereas FRED3, MLOG3, ONLG3, ORLG3, and SHCA3 showed better performance for most soils studied.	[Wang Weipeng; Liu Jianli; Zhao Bingzi; Zhang Jiabao; Li Xiaopeng; Yan Yifan] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China; [Wang Weipeng; Yan Yifan] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Soil Science, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, JL (corresponding author), Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China.	Jlliu@issas.ac.cn			National Basic Research Program of China (973 Program) [2011CB100506]; National Natural Science Foundation of China [41171179]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Basic Research Program of China (973 Program No. 2011CB100506)-LJL; National Natural Science Foundation of China (Contract No. 41171179)-LJL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson S, 1990, 26 MINERALJORDENS MU, P7; Arriaga FJ, 2006, SOIL SCI, V171, P663, DOI 10.1097/01.ss.0000228056.92839.88; Bah AR, 2009, SOIL SCI SOC AM J, V73, P1101, DOI 10.2136/sssaj2007.0433; Bittelli M, 1999, SOIL SCI SOC AM J, V63, P782, DOI 10.2136/sssaj1999.634782x; BUCHAN GD, 1993, SOIL SCI SOC AM J, V57, P901, DOI 10.2136/sssaj1993.03615995005700040004x; BUCHAN GD, 1989, SOIL SCI, V147, P155, DOI 10.1097/00010694-198903000-00001; Buurman P, 2001, GEOL MIJNBOUW-N J G, V80, P49, DOI 10.1017/S0016774600022319; CARRERA J, 1986, WATER RESOUR RES, V22, P199, DOI 10.1029/WR022i002p00199; Eshel G, 2004, SOIL SCI SOC AM J, V68, P736, DOI 10.2136/sssaj2004.0736; Filgueira RR, 2006, GEODERMA, V134, P327, DOI 10.1016/j.geoderma.2006.03.008; Fredlund MD, 2000, CAN GEOTECH J, V65, P638; Gee G.W., 1986, AGRONOMY MONOGROPH, V9, P383, DOI DOI 10.2136/SSSAB00KSER5.1.2ED.C15; GEE GW, 1979, SOIL SCI SOC AM J, V43, P1004, DOI 10.2136/sssaj1979.03615995004300050038x; Hajnos M, 2006, GEODERMA, V135, P307, DOI 10.1016/j.geoderma.2006.01.010; HAVERKAMP R, 1986, SOIL SCI, V142, P325, DOI 10.1097/00010694-198612000-00001; Hwang SI, 2006, GEODERMA, V133, P421, DOI 10.1016/j.geoderma.2005.08.006; Hwang SI, 2004, GEODERMA, V123, P363, DOI 10.1016/j.geoderma.2004.03.003; Hwang SI, 2002, SOIL SCI SOC AM J, V66, P1143, DOI 10.2136/sssaj2002.1143; Jaky J., 1944, SOIL MECH; Jauhiainen M, 2004, RELATIONSHIPS PARTIC, P165; Konert M, 1997, SEDIMENTOLOGY, V44, P523, DOI 10.1046/j.1365-3091.1997.d01-38.x; Miller BA, 2012, SOIL SCI SOC AM J, V76, P1719, DOI 10.2136/sssaj2011.0303; Minasny B, 1999, GEODERMA, V93, P225, DOI 10.1016/S0016-7061(99)00061-0; Nemes A, 1999, GEODERMA, V90, P187, DOI 10.1016/S0016-7061(99)00014-2; Pieri L, 2006, GEODERMA, V135, P118, DOI 10.1016/j.geoderma.2005.11.009; Press WH, 1992, NMNERICAL RECIPES FO, V77; Rousseva SS, 1997, EUR J SOIL SCI, V48, P749, DOI 10.1046/j.1365-2389.1997.00113.x; Ryzak M, 2011, J PLANT NUTR SOIL SC, V174, P624, DOI 10.1002/jpln.201000255; SHIOZAWA S, 1991, SOIL SCI, V152, P427, DOI 10.1097/00010694-199112000-00004; Shiozawa s, 1992, INT J ROCK MECH MIN, V29, P211; Skaggs TH, 2001, SOIL SCI SOC AM J, V65, P1038, DOI 10.2136/sssaj2001.6541038x; Slawinski C., 2006, International Agrophysics, V20, P55; Smettem KRJ, 1996, AUST J SOIL RES, V34, P695, DOI 10.1071/SR9960695; THORNLEY JHM, 1990, ANN BOT-LONDON, V66, P309, DOI 10.1093/oxfordjournals.aob.a088029; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892, DOI 10.2136/sssaj1980.03615995004400050002x; WALKER PH, 1986, SOIL SCI SOC AM J, V50, P394, DOI 10.2136/sssaj1986.03615995005000020028x; Wang WP, 2013, SOIL SCI, V178, P194, DOI 10.1097/SS.0b013e31829908be; Zhuang J, 2001, SOIL SCI, V166, P308, DOI 10.1097/00010694-200105000-00002	38	15	15	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125048	10.1371/journal.pone.0125048	http://dx.doi.org/10.1371/journal.pone.0125048			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927441	Green Submitted, gold, Green Published			2022-12-27	WOS:000353713100063
J	Kartsev, NN; Fursova, NK; Pachkunov, DM; Bannov, VA; Eruslanov, BV; Svetoch, EA; Dyatlov, IA				Kartsev, Nikolay N.; Fursova, Nadezhda K.; Pachkunov, Dmitry M.; Bannov, Vasiliy A.; Eruslanov, Boris V.; Svetoch, Edward A.; Dyatlov, Ivan A.			Molecular Characterization of Enterotoxin-Producing Escherichia coli Collected in 2011-2012, Russia	PLOS ONE			English	Article							MULTIPLEX PCR; GENES; SEROGROUPS; RESISTANCE; DIARRHEA; O45	Enterotoxin-producing Escherichia coli (ETEC) are one of themain causative agents of diarrhea in children especially in developing countries and travel diarrhoea in adults. Pathogenic properties of ETEC associated with their ability to produce a heat-stable (ST) and/or heat-labile (LT) enterotoxins, as well as adhesins providing bacterial adhesion to intestinal epithelial cells. This study presents the molecular characterization of the ETEC isolates collected from the Central and Far-Eastern regions of Russia in 2011-2012. It was shown that all ETEC under study (n=18) had the heat-labile enterotoxin-coding operon elt, and had no the genes of the heat-stable enterotoxin operon est. DNA sequencing revealed two types of nucleotide exchanges in the eltB gene coding subunit B of LT in isolates collected from Cherepovets city (Central region, Russia) and Vladivostok city (Far-East region, Russia). Only one ETEC strain carried genes cfaA, cfaB, cfaC and cfaD coding adhesion factor CFA/I. Expression of LT in four ETEC isolates in the agglutination reaction was detected using a latex test-system. The isolates were assigned to serogroups O142 (n = 6), O6 (n = 4), O25 (n = 5), O26 (n = 2), and O115 (n = 1). Genotyping showed that they belonged to an earlier described sequence-type ST4 (n = 3) as well as to 11 novel sequence-types ST1043, ST1312, ST3697, ST3707, ST3708, ST3709, ST3710, ST3755, ST3756, ST3757 and ST4509. The ETEC isolates displayed different levels of antimicrobial resistance. Eight isolates were resistant to only one drug, three isolates-to two drugs, one isolate-to three drugs, two isolates-to four antibacterials, and only one isolate to each of the five, six and ten antibacterials simultaneously. Genetic determinants of the resistance to beta-lactams and other classes of antibacterials on the ETEC genomes were identified. There are blaTEM (n = 10), bla(CTX-M-15) (n = 1), class 1 integron (n = 3) carrying resistance cassettes to aminoglycosides and sulphonamides dfrA17-aadA5 and dfrA12-orfF-aadA2. One isolate ETE-C_Ef-6 was found to be amultidrug-resistant (MDR) pathogen that carried both the beta-lactamase gene and class 1 integron. These data suggest the circulation of ETEC in Russia. Further investigations are necessary to study the spread of the revealed ETEC sequence types (STs) and serotypes. Their role in the etiology of diarrhea should be also estimated.	[Kartsev, Nikolay N.; Fursova, Nadezhda K.; Bannov, Vasiliy A.; Eruslanov, Boris V.; Svetoch, Edward A.; Dyatlov, Ivan A.] State Res Ctr Appl Microbiol & Biotechnol, Dept Mol Microbiol, Obolensk, Russia; [Pachkunov, Dmitry M.] Volga State Technol Univ, Dept Innovat Res, Yoshkar Ola, Russia		Kartsev, NN (corresponding author), State Res Ctr Appl Microbiol & Biotechnol, Dept Mol Microbiol, Obolensk, Russia.	karcev.nikolay@mail.ru	Kartsev, Nikolay/G-5910-2017; Fursova, Nadezhda K/K-1133-2017	Fursova, Nadezhda K/0000-0001-6053-2621; Kartsev, Nikolay/0000-0002-2006-9131	Rospotrebnadzor [037, 039]	Rospotrebnadzor	Grant 037, Rospotrebnadzor, Grant 039, Rospotrebnadzor.	Ansaruzzaman M, 2007, J MED MICROBIOL, V56, P217, DOI 10.1099/jmm.0.46473-0; Belaia YA, 2005, MODERN SCI TECH, V10, P35; Clarke SC, 2001, DIAGN MICR INFEC DIS, V41, P93, DOI 10.1016/S0732-8893(01)00303-0; DebRoy C, 2005, APPL ENVIRON MICROB, V71, P4919, DOI 10.1128/AEM.71.8.4919-4924.2005; Del Canto F, 2011, J CLIN MICROBIOL, V49, P3198, DOI 10.1128/JCM.02473-10; Dupont HL, 2009, ALIMENT PHARM THER, V30, P187, DOI 10.1111/j.1365-2036.2009.04028.x; Egorova SA, 2011, INFEKTSIYA IMMUN, V1, P181; Froehlich B, 2005, J BACTERIOL, V187, P6509, DOI 10.1128/JB.187.18.6509-6516.2005; Jian Zhang, 2008, TENCON 2008 - 2008 IEEE Region 10 Conference, DOI 10.1109/TENCON.2008.4766399; Jobling MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029898; Johnson TJ, 2009, MICROBIOL MOL BIOL R, V73, P750, DOI 10.1128/MMBR.00015-09; Kim JS, 2014, J MICROBIOL BIOTECHN, V24, P421, DOI 10.4014/jmb.1401.01023; Konishi N, 2011, J CLIN MICROBIOL, V49, P3348, DOI 10.1128/JCM.02576-10; Li D, 2010, J MICROBIOL METH, V82, P71, DOI 10.1016/j.mimet.2010.04.008; MANIATIS T, 1982, MOL CLONING LAB MANU; MUNDELL DH, 1976, INFECT IMMUN, V14, P383, DOI 10.1128/IAI.14.2.383-388.1976; Nada RA, 2011, J CLIN MICROBIOL, V49, P1403, DOI 10.1128/JCM.02006-10; Paddock Z, 2012, VET MICROBIOL, V156, P381, DOI 10.1016/j.vetmic.2011.11.017; Paredes-Paredes M, 2011, J TRAVEL MED, V18, P121, DOI 10.1111/j.1708-8305.2010.00488.x; Pazhani GP, 2011, INDIAN J MED RES, V134, P214; Pryamchuk S. D., 2010, Antibiotiki i Khimioterapiya, V55, P3; Rajkhowa S, 2009, J APPL MICROBIOL, V106, P455, DOI 10.1111/j.1365-2672.2008.04013.x; Rodas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018313; Shahrokhi N, 2011, J INFECT DEV COUNTR, V5, P248; Steinsland H, 2010, J CLIN MICROBIOL, V48, P2916, DOI 10.1128/JCM.02432-09; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Turner SM, 2006, FEMS MICROBIOL LETT, V263, P10, DOI 10.1111/j.1574-6968.2006.00401.x; Walker RI, 2015, VACCINE, V33, P954, DOI 10.1016/j.vaccine.2014.11.049; Wang QA, 2010, MOL CELL PROBE, V24, P286, DOI 10.1016/j.mcp.2010.06.002; Wolf MK, 1997, CLIN MICROBIOL REV, V10, P569, DOI 10.1128/CMR.10.4.569; Zimmer M, 2003, AVIAN DIS, V47, P101, DOI 10.1637/0005-2086(2003)047[0101:DOCJSI]2.0.CO;2	31	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123357	10.1371/journal.pone.0123357	http://dx.doi.org/10.1371/journal.pone.0123357			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923803	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600044
J	Meng, XK; Zhang, YX; Bao, HB; Liu, ZW				Meng, Xiangkun; Zhang, Yixi; Bao, Haibo; Liu, Zewen			Sequence Analysis of Insecticide Action and Detoxification-Related Genes in the Insect Pest Natural Enemy Pardosa pseudoannulata	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; PYRETHROID RESISTANCE; NEONICOTINOID INSECTICIDES; IMIDACLOPRID RESISTANCE; DROSOPHILA-MELANOGASTER; CYTOCHROME-P450 GENES; EUROPEAN POPULATIONS; POINT MUTATION; IDENTIFICATION; SENSITIVITY	The pond wolf spider Pardosa pseudoannulata, an important natural predatory enemy of rice planthoppers, is found widely distributed in paddy fields. However, data on the genes involved in insecticide action, detoxification, and response are very limited for P. pseudoannulata, which inhibits the development and appropriate use of selective insecticides to control insect pests on rice. We used transcriptome construction from adult spider cephalothoraxes to analyze and manually identify genes enconding metabolic enzymes and target receptors related to insecticide action and detoxification, including 90 cytochrome P450s, 14 glutathione S-transferases (GSTs), 17 acetylcholinesterases (AChEs), 17 nicotinic acetylcholine receptors (nAChRs), and 17 gamma-aminobutyric acid (GABA) receptors, as well as 12 glutamate-gated chloride channel (GluCl) unigenes. Sequence alignment and phylogenetic analysis revealed the different subclassifications of P450s and GSTs, some important sequence diversities in nAChRs and GABA receptors, polymorphism in AChEs, and high similarities in GluCls. For P450s in P. pseudoannulata, the number of unigenes belonging to the CYP2 clade was much higher than that in CYP3 and CYP4 clades. The results differed from insects in which most P450 genes were in CYP3 and CYP4 clades. For GSTs, most unigenes belonged to the delta and sigma classes, and no epsilon GST class gene was found, which differed from the findings for insects and acarina. Our results will be useful for studies on insecticide action, selectivity, and detoxification in the spider and other related animals, and the sequence differences in target genes between the spider and insects will provide important information for the design of selective insecticides.	[Meng, Xiangkun; Zhang, Yixi; Bao, Haibo; Liu, Zewen] Nanjing Agr Univ, Coll Plant Protect, Key Lab Integrated Management Crop Dis & Pests, Minist Educ, Nanjing 210095, Jiangsu, Peoples R China; [Bao, Haibo] Jiangsu Acad Agr Sci, Inst Plant Protect, Nanjing 210014, Jiangsu, Peoples R China	Nanjing Agricultural University; Jiangsu Academy of Agricultural Sciences	Liu, ZW (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Key Lab Integrated Management Crop Dis & Pests, Minist Educ, Nanjing 210095, Jiangsu, Peoples R China.	liuzewen@njau.edu.cn			National High Technology Research and Development Program of China (Program 863) [2011AA10A207, 2012AA101502]; National Natural Science Foundation of China [31322045, 31130045, 31171869]; Jiangsu Science Program for Distinguished Young Scholars [BK20130028]; National Key Technology Research and Development Program [2012BAD19B01]	National High Technology Research and Development Program of China (Program 863)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Science Program for Distinguished Young Scholars; National Key Technology Research and Development Program(National Key Technology R&D Program)	This work was supported by the National High Technology Research and Development Program of China (Program 863: 2011AA10A207 and 2012AA101502), ZWL; the National Natural Science Foundation of China (31322045, 31130045, and 31171869), ZWL; the Jiangsu Science Program for Distinguished Young Scholars (BK20130028), ZWL; and the National Key Technology Research and Development Program (2012BAD19B01), ZWL (http://www.most.gov.cn/; http://www.jstd.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bass C, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-51; Casida JE, 2013, ANNU REV ENTOMOL, V58, P99, DOI 10.1146/annurev-ento-120811-153645; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Daborn PJ, 2007, INSECT BIOCHEM MOLEC, V37, P512, DOI 10.1016/j.ibmb.2007.02.008; David JP, 2005, P NATL ACAD SCI USA, V102, P4080, DOI 10.1073/pnas.0409348102; Deng HM, 2009, J INSECT PHYSIOL, V55, P1174, DOI 10.1016/j.jinsphys.2009.08.017; Ding ZP, 2013, INSECT BIOCHEM MOLEC, V43, P1021, DOI 10.1016/j.ibmb.2013.08.005; Domingues LN, 2013, VET PARASITOL, V198, P172, DOI 10.1016/j.vetpar.2013.08.023; Feng LF, 2014, AQUAT TOXICOL, V149, P126, DOI 10.1016/j.aquatox.2014.02.004; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Han H, 2014, CROP PROT, V65, P57, DOI 10.1016/j.cropro.2014.06.026; Huang HS, 1998, INSECT BIOCHEM MOLEC, V28, P651, DOI 10.1016/S0965-1748(98)00049-6; Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56; Kehoe J, 2009, J MOL EVOL, V69, P125, DOI 10.1007/s00239-009-9256-z; Kim JI, 2012, J ASIA-PAC ENTOMOL, V15, P401, DOI 10.1016/j.aspen.2012.02.008; Kita T, 2014, INSECT BIOCHEM MOLEC, V45, P1, DOI 10.1016/j.ibmb.2013.11.004; Kwon DH, 2010, INSECT MOL BIOL, V19, P583, DOI 10.1111/j.1365-2583.2010.01017.x; Kwon DH, 2012, PESTIC BIOCHEM PHYS, V103, P94, DOI 10.1016/j.pestbp.2012.04.003; Lee SH, 2010, INSECT MOL BIOL, V19, P599, DOI 10.1111/j.1365-2583.2010.01024.x; Liu ZW, 2008, AFR J BIOTECHNOL, V7, P4935; Liu ZW, 2005, P NATL ACAD SCI USA, V102, P8420, DOI 10.1073/pnas.0502901102; Lou YG, 2014, BIOL CONTROL, V68, P103, DOI 10.1016/j.biocontrol.2013.09.018; Malekmohammadi M, 2012, PESTIC BIOCHEM PHYS, V104, P150, DOI 10.1016/j.pestbp.2012.06.004; Matsuda K, 2001, TRENDS PHARMACOL SCI, V22, P573, DOI 10.1016/S0165-6147(00)01820-4; Meng XK, 2015, NEUROSCI LETT, V584, P123, DOI 10.1016/j.neulet.2014.10.013; Nakao T, 2010, PESTIC BIOCHEM PHYS, V97, P262, DOI 10.1016/j.pestbp.2010.03.006; Oakeshott JG, 2010, INSECT MOL BIOL, V19, P147, DOI 10.1111/j.1365-2583.2009.00961.x; Pavlidi N, 2012, PESTIC BIOCHEM PHYS, V104, P132, DOI 10.1016/j.pestbp.2012.07.003; Pavlidi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066533; Pekar S, 2012, PEST MANAG SCI, V68, P1438, DOI 10.1002/ps.3397; Pridgeon JW, 2003, GENE, V314, P157, DOI 10.1016/S0378-1119(03)00725-X; Puinean AM, 2013, J NEUROCHEM, V124, P590, DOI 10.1111/jnc.12029; Puinean AM, 2013, PEST MANAG SCI, V69, P195, DOI 10.1002/ps.3300; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Rasool Akhtar, 2014, Insect Biochemistry and Molecular Biology, V53, P54, DOI 10.1016/j.ibmb.2014.07.006; Riga M, 2014, INSECT BIOCHEM MOLEC, V46, P43, DOI 10.1016/j.ibmb.2014.01.006; Shi XG, 2012, J FOOD AGRIC ENVIRON, V10, P1227; Song F, 2009, INSECT BIOCHEM MOLEC, V39, P833, DOI 10.1016/j.ibmb.2009.09.009; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang Liang-De, 2014, Chinese Journal of Applied Entomology, V51, P13, DOI 10.7679/j.issn.2095-1353.2014.002; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tijet N, 2001, GENE, V262, P189, DOI 10.1016/S0378-1119(00)00533-3; Tomizawa M, 2005, ANNU REV PHARMACOL, V45, P247, DOI 10.1146/annurev.pharmtox.45.120403.095930; Villatte F, 2000, PESTIC BIOCHEM PHYS, V67, P95, DOI 10.1006/pest.2000.2478; Vontas JG, 2001, BIOCHEM J, V357, P65, DOI 10.1042/0264-6021:3570065; Wei DD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080046; Wondji CS, 2011, INSECT BIOCHEM MOLEC, V41, P484, DOI 10.1016/j.ibmb.2011.03.012; Xu ZF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094779; Yang X, 2013, PESTIC BIOCHEM PHYS, V107, P343, DOI 10.1016/j.pestbp.2013.10.002; Zhai Qihui, 1995, Acta Entomologica Sinica, V38, P493; Zhang YX, 2014, INSECT BIOCHEM MOLEC, V46, P25, DOI 10.1016/j.ibmb.2014.01.004; Zheng Y, 2003, INSECT BIOCHEM MOLEC, V33, P595, DOI 10.1016/S0965-1748(03)00038-9; Zimmer CT, 2014, INSECT BIOCHEM MOLEC, V45, P18, DOI 10.1016/j.ibmb.2013.11.008; Zimmer CT, 2011, PESTIC BIOCHEM PHYS, V100, P264, DOI 10.1016/j.pestbp.2011.04.011	57	21	20	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125242	10.1371/journal.pone.0125242	http://dx.doi.org/10.1371/journal.pone.0125242			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923714	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600138
J	Wingate, LT; Coleman, MS; Posey, DL; Zhou, WG; Olson, CK; Maskery, B; Cetron, MS; Painter, JA				Wingate, La'Marcus T.; Coleman, Margaret S.; Posey, Drew L.; Zhou, Weigong; Olson, Christine K.; Maskery, Brian; Cetron, Martin S.; Painter, John A.			Cost-Effectiveness of Screening and Treating Foreign-Born Students for Tuberculosis before Entering the United States	PLOS ONE			English	Article							US-BOUND IMMIGRANTS; PULMONARY TUBERCULOSIS; FOLLOW-UP; TB; PREVALENCE; INFECTION; COUNTRIES; SYSTEM; IMPACT	Introduction The Centers for Disease Control and Prevention is considering implementation of overseas medical screening of student-visa applicants to reduce the numbers of active tuberculosis cases entering the United States. Objective To evaluate the costs, cases averted, and cost-effectiveness of screening for, and treating, tuberculosis in United States-bound students from countries with varying tuberculosis prevalence. Methods Costs and benefits were evaluated from two perspectives, combined and United States only. The combined perspective totaled overseas and United States costs and benefits from a societal perspective. The United States only perspective was a domestic measure of costs and benefits. A decision tree was developed to determine the cost-effectiveness of tuberculosis screening and treatment from the combined perspective. Results From the United States only perspective, overseas screening programs of Chinese and Indian students would prevent the importation of 157 tuberculosis cases annually, and result in $2.7 million in savings. From the combined perspective, screening programs for Chinese students would cost more than $2.8 million annually and screening programs for Indian students nearly $440,000 annually. From the combined perspective, the incremental cost for each tuberculosis case averted by screening Chinese and Indian students was $22,187 and $15,063, respectively. Implementing screening programs for German students would prevent no cases in most years, and would result in increased costs both overseas and in the United States. The domestic costs would occur because public health departments would need to follow up on students identified overseas as having an elevated risk of tuberculosis. Conclusions Tuberculosis screening and treatment programs for students seeking long term visas to attend United States schools would reduce the number of tuberculosis cases imported. Implementing screening in high-incidence countries could save the United States millions of dollars annually; however there would be increased costs incurred overseas for students and their families.	[Wingate, La'Marcus T.; Coleman, Margaret S.; Posey, Drew L.; Zhou, Weigong; Olson, Christine K.; Maskery, Brian; Cetron, Martin S.; Painter, John A.] Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Wingate, LT (corresponding author), Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Atlanta, GA 30333 USA.	latewing@gmail.com						Adams Deborah A., 2012, Morbidity and Mortality Weekly Report, V59, P1; Agency for Healthcare Research and Quality, HCUPN TOOL ID TRACK; Alvarez GG, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-3; Ananthakrishnan R, 2012, LUNG INDIA, V29, P221, DOI 10.4103/0970-2113.99103; [Anonymous], 2003, AM J RESP CRIT CARE, V167, P603; [Anonymous], 1996, COST EFFECTIVENESS H; Berrington de Gonzalez A, 2004, LANCET, V363, P345, DOI 10.1016/S0140-6736(04)15433-0; Bhat J, 2009, INT J EPIDEMIOL, V38, P1026, DOI 10.1093/ije/dyp222; Board of Governors of the Federal Reserve System, FORE EXCH RAT; Bureau of Labor Statistics, CONS PRIC IND ALL RU; Bureau of Labor Statistics, 2011, OCC EMPL WAG MAY 201; Burman WJ, 1997, CHEST, V112, P63, DOI 10.1378/chest.112.1.63; Cain KP, 2008, JAMA-J AM MED ASSOC, V300, P405, DOI 10.1001/jama.300.4.405; Centers for Disease Control and Prevention, DIV GLOB MIGR QUAR; Centers for Disease Control and Prevention, TUB SCREEN TREATM TE; Centers for Disease Control and Prevention, ONL TUB INF SYST; Centers for Disease Control and Prevention, CLIN HLTH SYST RES B; Centers for Medicare and Medicaid Services, OV MED PHYS SCHED; Centers for Medicare and Medicaid Services, CLIN LAB FEE SCHED; Chadha VK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042625; Claassens M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058689; Coleman MS, 2014, TRAVEL MED INFECT DI, V12, P63, DOI 10.1016/j.tmaid.2013.10.016; Columbia University, REF RAT WITHDR; Department of Homeland Security, 2012, YB IMM STAT 2012 REF; Department of Transportation Federal Highway Administration, SUMM TRAV TRENDS NAT; Diel R, 2012, EUR RESPIR J, V40, P143, DOI 10.1183/09031936.00204611; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Emory University, WITHD; Energy Information Administration, 1949, MOT VEH MIL FUEL CON; Energy Information Administration, 2013, MONTL EN REV JUL 201; Erkens C, 2008, EUR RESPIR J, V32, P153, DOI 10.1183/09031936.00137907; Global Alliance for TB Drug Development, AN GLOB TB DRUG MARK; Grieco EM, LENGTH VISIT NONIMIG; Haddix AC, 2003, PREVENTION EFFECTIVE; Holland DP, 2009, AM J RESP CRIT CARE, V179, P1055, DOI 10.1164/rccm.200901-0153OC; Institute of International Education, PERC EUR HIGH EC 3 C; Institute of International Education, NEW INT STUD ENR 200; Institute of International Education, INT STUD TOT PLAC EO; Khachetourians N., 2012, 5 REASONS WHY US IS; Khan K, 2002, NEW ENGL J MED, V347, P1850, DOI 10.1056/NEJMsa021099; Kowada A, 2012, MOL DIAGN THER, V16, P181, DOI 10.2165/11633610-000000000-00000; Landefeld JS, 2008, J ECON PERSPECT, V22, P193, DOI 10.1257/jep.22.2.193; Lee D, 2013, MMWR SURVEILL SUMM, V62, P1; Linas BP, 2011, AM J RESP CRIT CARE, V184, P590, DOI 10.1164/rccm.201101-0181OC; Liu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032158; Liu YC, 2009, NEW ENGL J MED, V360, P2406, DOI 10.1056/NEJMoa0809497; Meng QY, 2004, INT J HEALTH PLAN M, V19, pS45, DOI 10.1002/hpm.774; Miramontes R, 2013, MMWR-MORBID MORTAL W, V62, P201; Monger R., 2012, US LEGAL PERMANENT R; Monger R., 2011, NONIMMIGRANT ADM US; National Center for Education Statistics, AV GRAD 1 PROF TUIT; National Center for Education Statistics, 2011, AV UND TUIT FEES ROO; New York University, FALL SPRING UND REF; Okada K, 2012, INT J TUBERC LUNG D, V16, P1619, DOI 10.5588/ijtld.12.0201; Organisation for Economic and Co-operation and Development, CONS PRIC; Oxlade O, 2007, INT J TUBERC LUNG D, V11, P16; Pantoja A, 2009, INT J TUBERC LUNG D, V13, P698; Porco TC, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-157; Posey DL, 2014, MMWR-MORBID MORTAL W, V63, P234; Purdue University, TUIT REF; Schwartzman K, 2000, AM J RESP CRIT CARE, V161, P780, DOI 10.1164/ajrccm.161.3.9902005; Shepardson D, 2013, INT J TUBERC LUNG D, V17, P1531, DOI 10.5588/ijtld.13.0423; Tadesse T, 2013, INT J TUBERC LUNG D, V17, P630, DOI 10.5588/ijtld.12.0449; Taylor Z, 2000, INT J TUBERC LUNG D, V4, P931; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; Tempera J., 2013, US TODAY; Texas A& M University, TUIT FEE SCHED; The Pennsylvania State University, TUIT ADJ POL; The World Bank, HOUS FIN CONS EXP ET; World Bank, GDP PER CAP PPP; World Health Organization, GLOB TUB REP 2013; World Health Organziation, COUNTR SPEC UN COSTS; Yang XY, 2008, INT J INFECT DIS, V12, P534, DOI 10.1016/j.ijid.2008.02.011	73	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124116	10.1371/journal.pone.0124116	http://dx.doi.org/10.1371/journal.pone.0124116			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25924009	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600069
J	Li, HX; Liu, CX; Zhang, HB; Xu, WF; Liu, JH; Chen, Y; Li, TX; Li, B; Wu, ZQ; Xia, TL				Li, Huixin; Liu, Chunxiao; Zhang, Haibin; Xu, Wenfeng; Liu, Jianhua; Chen, Yong; Li, Tangxuan; Li, Bin; Wu, Zhenquan; Xia, Taolin			The Use of Unidirectional Barbed Suture for Urethrovesical Anastomosis during Robot-Assisted Radical Prostatectomy: A Systematic Review and Meta-Analysis of Efficacy and Safety	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; VESICOURETHRAL ANASTOMOSIS; POSTERIOR RECONSTRUCTION; STANDARD MONOFILAMENT; POLYGLYCONATE SUTURE; TIME; IMPACT	Background Unidirectional barbed suture (UBS) has been widely used for surgery in recent years, especially for urethrovesical anastomosis (UVA) during robot-assisted radical prostatectomy (RARP). However, the efficacy and safety comparing it with conventional non-barbed suture (CS) for UVA is still controversial. Aims The objective of this study is to assess the current evidence regarding the efficacy and safety of UBS compared with CS for UVA during RARP. Methods We comprehensively searched PubMed, Embase, The Cochrane Library, SinoMed (Chinese) and other databases on Oct. 9, 2014 to conduct a systematic review and meta-analysis of all randomized controlled trials (RCTs) and other comparative studies evaluating these two types of suture. The outcome measures included anastomosis time operative time, posterior reconstruction (PR) time, postoperative leakage (PL) rate and continence rates at different time points (4-6 weeks, 3 months, 6-12 months) after surgery. Secondary outcomes included estimated blood loss (EBL) and length of catheterization (LOC). Results Three RCTs and six observational studies including 786 cases were identified. Meta-analysis of extractable data showed that use of UBS could significantly reduce anastomosis time (weighted mean difference [WMD]:-3.98min; 95% confidence interval [CI], -6.02 -1.95; p = 0.0001), operative time (WMD:-10.06min; 95% CI, -15.45--4.67; p = 0.0003) and PR time (WMD:-0.93min; 95% CI, -1.52--0.34; p = 0.002). No significant difference was found in PL rate, EBL, LOC, or continence rates at 4-6 weeks, 3 months and 6-12 months after surgery. Conclusions Our meta-analysis indicates that UBS appears to be safe and efficient as CS for UVA during RARP with not only shorter anastomosis time, operative time, PR time, but also equivalent PL rate, EBL, LOC, and continence rates at 4-6 weeks, 3 months and 6-12 months after surgery. For the inherent limitations of the eligible studies, future more persuasive RCTs are needed to confirm and update our findings.	[Li, Huixin; Zhang, Haibin; Xu, Wenfeng; Liu, Jianhua; Chen, Yong; Li, Tangxuan; Li, Bin; Wu, Zhenquan; Xia, Taolin] Sun Yat Sen Univ, Foshan Affiliated Hosp, Peoples Hosp Foshan 1, Dept Urol, Foshan, Guangdong, Peoples R China; [Li, Huixin; Liu, Chunxiao] Southern Med Univ, Dept Urol, Zhujiang Hosp, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Southern Medical University - China	Li, HX (corresponding author), Sun Yat Sen Univ, Foshan Affiliated Hosp, Peoples Hosp Foshan 1, Dept Urol, Foshan, Guangdong, Peoples R China.	HuixinLi116@gmail.com	Liu, Bingya/GMW-5655-2022	Liu, Bingya/0000-0002-4406-3762				Coelho RF, 2010, EUR UROL, V57, P945, DOI 10.1016/j.eururo.2010.02.001; Coughlin G, 2008, BJU INT, V102, P1482, DOI 10.1111/j.1464-410X.2008.08090.x; Desai D, 2013, BJU INT, V111, P62; Hemal AK, 2012, INT UROL NEPHROL, V44, P125, DOI 10.1007/s11255-011-9967-0; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hozo SP., 2005, BMC MED RES METHODOL, V5, P1, DOI [10.1186/1471-2288-5-13, DOI 10.1186/1471-2288-5-13]; Hu JC, 2006, J UROLOGY, V175, P541, DOI 10.1016/S0022-5347(05)00156-4; Escudero JUJ, 2012, ARCH ESP UROL, V65, P752; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Manganiello M, 2012, INT BRAZ J UROL, V38, P89, DOI 10.1590/S1677-55382012000100013; Massoud W, 2013, UROLOGY, V82, P90, DOI 10.1016/j.urology.2013.02.002; Menon M, 2002, UROLOGY, V60, P864, DOI 10.1016/S0090-4295(02)01881-2; Menon M, 2003, J UROLOGY, V169, P2289, DOI 10.1097/01.ju.0000067464.53313.dd; Phillips B.C., 2009, LEVELS EVIDENCE GRAD; Polland AR, 2011, J ENDOUROL, V25, P1493, DOI 10.1089/end.2010.0668; Rocco F, 2006, J UROLOGY, V175, P2201, DOI 10.1016/S0022-5347(06)00262-X; Sammon J, 2011, UROLOGY, V78, P572, DOI 10.1016/j.urology.2011.03.069; Shalhav AL, 2006, UROLOGY, V68, P508, DOI 10.1016/j.urology.2006.03.071; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Su LM, 2011, CAMPBELL WALSH UROLO, V103, P2841; Taggart DP, 2001, LANCET, V358, P870, DOI 10.1016/S0140-6736(01)06069-X; Tewari AK, 2010, J ENDOUROL, V24, P1645, DOI 10.1089/end.2010.0316; Van Velthoven RF, 2003, UROLOGY, V61, P699, DOI 10.1016/S0090-4295(02)02543-8; Wells GA, 2012, NEWCASTLE OTTAWA SCA, DOI [10.2307/632432, DOI 10.2307/632432]; Williams SB, 2010, EUR UROL, V58, P875, DOI 10.1016/j.eururo.2010.07.021; Zorn KC, 2012, BJU INT, V109, P1526, DOI 10.1111/j.1464-410X.2011.10763.x	26	42	43	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131167	10.1371/journal.pone.0131167	http://dx.doi.org/10.1371/journal.pone.0131167			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	25928635	Green Published, Green Submitted, gold			2022-12-27	WOS:000358154400037
J	Bi, FG; Shi, ZL; Liu, A; Guo, P; Yan, SG				Bi, Fanggang; Shi, Zhongli; Liu, An; Guo, Peng; Yan, Shigui			Anterior Cruciate Ligament Reconstruction in a Rabbit Model Using Silk-Collagen Scaffold and Comparison with Autograft	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; POLYMER FIBER SCAFFOLD; IN-VITRO EVALUATION; CROSS-LINKING; TENDON AUTOGRAFT; PATELLAR TENDON; HYBRID SCAFFOLD; REGENERATION; MATRIX; DESIGN	The objective of the present study was to perform an in vivo assessment of a novel silk-collagen scaffold for anterior cruciate ligament (ACL) reconstruction. First, a silk-collagen scaffold was fabricated by combining sericin-extracted knitted silk fibroin mesh and type I collagen to mimic the components of the ligament. Scaffolds were electron-beam sterilized and rolled up to replace the ACL in 20 rabbits in the scaffold group, and autologous semitendinosus tendons were used to reconstruct the ACL in the autograft control group. At 4 and 16 weeks after surgery, grafts were retrieved and analyzed for neoligament regeneration and tendon-bone healing. To evaluate neoligament regeneration, H&E and immunohistochemical staining was performed, and to assess tendon-bone healing, micro-CT, biomechanical test, H&E and Russell-Movat pentachrome staining were performed. Cell infiltration increased over time in the scaffold group, and abundant fibroblast-like cells were found in the core of the scaffold graft at 16 weeks postoperatively. Tenascin-C was strongly positive in newly regenerated tissue at 4 and 16 weeks postoperatively in the scaffold group, similar to observations in the autograft group. Compared with the autograft group, tendon-bone healing was better in the scaffold group with trabecular bone growth into the scaffold. The results indicate that the silk-collagen scaffold has considerable potential for clinical application.	[Bi, Fanggang; Shi, Zhongli; Liu, An; Guo, Peng; Yan, Shigui] Zhejiang Univ, Sch Med, Dept Orthoped Surg, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Yan, SG (corresponding author), Zhejiang Univ, Sch Med, Dept Orthoped Surg, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China.	zjubfg@163.com	guo, peng/AAG-4052-2019; Guo, Peng/GWC-0572-2022	Yan, Shigui/0000-0001-9096-2868; Guo, Peng/0000-0002-2006-6205	National Natural Science Foundation of China [81171687]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81171687). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8; Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4; Altman GH, 2002, J BIOMECH ENG-T ASME, V124, P742, DOI 10.1115/1.1519280; Bach BR, 1998, AM J SPORT MED, V26, P30, DOI 10.1177/03635465980260012201; Bourke SL, 2004, TISSUE ENG, V10, P43, DOI 10.1089/107632704322791682; Buma P, 2004, INT ORTHOP, V28, P91, DOI 10.1007/s00264-003-0515-0; Chen JL, 2010, BIOMATERIALS, V31, P9438, DOI 10.1016/j.biomaterials.2010.08.011; Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120; Chen X, 2008, BIOMATERIALS, V29, P3683, DOI 10.1016/j.biomaterials.2008.05.017; Cooper JA, 2005, BIOMATERIALS, V26, P1523, DOI 10.1016/j.biomaterials.2004.05.014; Cooper JA, 2007, P NATL ACAD SCI USA, V104, P3049, DOI 10.1073/pnas.0608837104; Cornwell KG, 2007, J BIOMED MATER RES A, V80A, P362, DOI 10.1002/jbm.a.30893; Dong Y, 2012, INT J MOL SCI, V13, P13605, DOI 10.3390/ijms131013605; Fan HB, 2008, BIOMATERIALS, V29, P3324, DOI 10.1016/j.biomaterials.2008.04.012; Fini M, 2007, J ORTHOP RES, V25, P98, DOI 10.1002/jor.20295; Freeman JW, 2007, J BIOMECH, V40, P2029, DOI 10.1016/j.jbiomech.2006.09.025; Funakoshi T, 2005, AM J SPORT MED, V33, P1193, DOI 10.1177/0363546504272689; Garvin J, 2003, TISSUE ENG, V9, P967, DOI 10.1089/107632703322495619; Gentleman E, 2003, BIOMATERIALS, V24, P3805, DOI 10.1016/S0142-9612(03)00206-0; GREENWALD D, 1994, J SURG RES, V56, P372, DOI 10.1006/jsre.1994.1058; Griffin L Y, 2000, J Am Acad Orthop Surg, V8, P141; Hansson A, 2012, CARBOHYD POLYM, V90, P1494, DOI 10.1016/j.carbpol.2012.07.020; Hokugo A, 2006, BIOMATERIALS, V27, P61, DOI 10.1016/j.biomaterials.2005.05.030; James R, 2011, METHODS MOL BIOL, V726, P243, DOI 10.1007/978-1-61779-052-2_16; Kaeding CC, 2011, SPORTS HEALTH, V3, P73, DOI 10.1177/1941738110386185; Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003; Laurencin CT, 2005, BIOMATERIALS, V26, P7530, DOI 10.1016/j.biomaterials.2005.05.073; Lee AJ, 2012, J SURG RES, V178, P206, DOI 10.1016/j.jss.2012.01.052; Lim JK, 2004, ARTHROSCOPY, V20, P899, DOI 10.1016/j.arthro.2004.06.035; Lin VS, 1999, TISSUE ENG, V5, P443, DOI 10.1089/ten.1999.5.443; Little D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096526; Lu HH, 2005, BIOMATERIALS, V26, P4805, DOI 10.1016/j.biomaterials.2004.11.050; Mackie EJ, 1996, J ANAT, V188, P157; Majima T, 2007, P I MECH ENG H, V221, P537, DOI 10.1243/09544119JEIM203; Majima T, 2005, J ORTHOP SCI, V10, P302, DOI 10.1007/s00776-005-0891-y; Masuko T, 2005, BIOMATERIALS, V26, P5339, DOI 10.1016/j.biomaterials.2005.01.062; Murphy AR, 2008, BIOMATERIALS, V29, P2829, DOI 10.1016/j.biomaterials.2008.03.039; Nistor MT, 2011, COLLOID SURFACE B, V87, P382, DOI 10.1016/j.colsurfb.2011.05.046; Oka S, 2013, TISSUE ENG PT A, V19, P1233, DOI [10.1089/ten.tea.2012.0325, 10.1089/ten.TEA.2012.0325]; Ouyang HW, 2004, AM J SPORT MED, V32, P321, DOI 10.1177/0095399703258682; Park MJ, 2001, INT ORTHOP, V25, P35, DOI 10.1007/s002640000199; Petrigliano FA, 2006, ARTHROSCOPY, V22, P441, DOI 10.1016/j.arthro.2006.01.017; Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3; Piontek T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082462; Rahaman MN, 2005, BIOTECHNOL BIOENG, V91, P261, DOI 10.1002/bit.20292; Sahoo S, 2006, TISSUE ENG, V12, P91, DOI 10.1089/ten.2006.12.91; Soon MYH, 2007, AM J SPORT MED, V35, P962, DOI 10.1177/0363546507300057; Torres DS, 2000, BIOMATERIALS, V21, P1607; Tovar N, 2012, J BIOMED MATER RES A, V100A, P2913, DOI 10.1002/jbm.a.34229; Walters VI, 2012, CONNECT TISSUE RES, V53, P255, DOI 10.3109/03008207.2011.634532; Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008; Weadock KS, 1996, J BIOMED MATER RES, V32, P221, DOI 10.1002/(SICI)1097-4636(199610)32:2<221::AID-JBM11>3.0.CO;2-M; Woo SLY, 1999, CLIN ORTHOP RELAT R, pS312; Yamane S, 2005, BIOMATERIALS, V26, P611, DOI 10.1016/j.biomaterials.2004.03.013	54	45	48	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125900	10.1371/journal.pone.0125900	http://dx.doi.org/10.1371/journal.pone.0125900			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938408	Green Submitted, Green Published, gold			2022-12-27	WOS:000353943000114
J	Akie, TE; Liu, LJ; Nam, M; Lei, S; Cooper, MP				Akie, Thomas E.; Liu, Lijun; Nam, Minwoo; Lei, Shi; Cooper, Marcus P.			OXPHOS-Mediated Induction of NAD(+) Promotes Complete Oxidation of Fatty Acids and Interdicts Non-Alcoholic Fatty Liver Disease	PLOS ONE			English	Article							HEPATIC INSULIN-RESISTANCE; PROTEIN-KINASE-C; MITOCHONDRIAL ABNORMALITIES; OXIDASE DEFICIENCY; RESPIRATORY-CHAIN; PPAR-ALPHA; STEATOHEPATITIS; ACTIVATION; HOMEOSTASIS; STEATOSIS	OXPHOS is believed to play an important role in non-alcoholic fatty liver disease (NAFLD), however, precise mechanisms whereby OXPHOS influences lipid homeostasis are incompletely understood. We previously reported that ectopic expression of LRPPRC, a protein that increases cristae density and OXPHOS, promoted fatty acid oxidation in cultured primary hepatocytes. To determine the biological significance of that observation and define underlying mechanisms, we have ectopically expressed LRPPRC in mouse liver in the setting of NAFLD. Interestingly, ectopic expression of LRPPRC in mouse liver completely interdicted NAFLD, including inflammation. Consistent with mitigation of NAFLD, two markers of hepatic insulin resistance-ROS and PKC epsilon activity-were both modestly reduced. As reported by others, improvement of NAFLD was associated with improved whole-body insulin sensitivity. Regarding hepatic lipid homeostasis, the ratio of NAD(+) to NADH was dramatically increased in mouse liver replete with LRPPRC. Pharmacological activators and inhibitors of the cellular respiration respectively increased and decreased the [NAD(+)]/[NADH] ratio, indicating respiration-mediated control of the [NAD(+)]/[NADH] ratio. Supporting a prominent role for NAD(+), increasing the concentration of NAD(+) stimulated complete oxidation of fatty acids. Importantly, NAD(+) rescued impaired fatty acid oxidation in hepatocytes deficient for either OXPHOS or SIRT3. These data are consistent with a model whereby augmented hepatic OXPHOS increases NAD(+), which in turn promotes complete oxidation of fatty acids and protects against NAFLD.	[Akie, Thomas E.; Liu, Lijun; Nam, Minwoo; Lei, Shi; Cooper, Marcus P.] Univ Massachusetts, Sch Med, Dept Med, Div Cardiovasc Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Cooper, MP (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Cardiovasc Med, Worcester, MA 01605 USA.	marcus.cooper@umassmed.edu			National Institute of Diabetes and Digestive and Kidney Disease grant [5R01DK089185]; Diabetes Endocrinology Research Center Pilot (DERC); Feasibility Program at the University of Massachusetts Medical School; University of Massachusetts Medical School DERC [DK32520]; Diabetes Research Center grant [DK32520]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089185, P30DK032520] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Disease grant; Diabetes Endocrinology Research Center Pilot (DERC); Feasibility Program at the University of Massachusetts Medical School; University of Massachusetts Medical School DERC; Diabetes Research Center grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institute of Diabetes and Digestive and Kidney Disease grant 5R01DK089185 (to M.P. Cooper) and the Diabetes Endocrinology Research Center Pilot (DERC) and Feasibility Program at the University of Massachusetts Medical School (to M.P. Cooper). M.P. Cooper is a member of the University of Massachusetts Medical School DERC (DK32520), and core resources supported by Diabetes Research Center grant DK32520 were also used.	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Bellafante E, 2013, HEPATOLOGY, V57, P1343, DOI 10.1002/hep.26222; Bellentani S, 2000, ANN INTERN MED, V132, P112, DOI 10.7326/0003-4819-132-2-200001180-00004; Bellentani S, 2010, DIGEST DIS, V28, P155, DOI 10.1159/000282080; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Caldwell SH, 1999, J HEPATOL, V31, P430, DOI 10.1016/S0168-8278(99)80033-6; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002; Cooper MP, 2006, GENE DEV, V20, P2996, DOI 10.1101/gad.1483906; Cortez-Pinto H, 1999, JAMA-J AM MED ASSOC, V282, P1659, DOI 10.1001/jama.282.17.1659; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Eaton S, 1996, BIOCHEM J, V319, P633, DOI 10.1042/bj3190633; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Ganji SH, 2014, AM J PHYSIOL-GASTR L, V306, pG320, DOI 10.1152/ajpgi.00181.2013; Gohil VM, 2010, J BIOL CHEM, V285, P13742, DOI 10.1074/jbc.M109.098400; Goncalves LA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-169; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Jornayvaz FR, 2012, CELL METAB, V15, P574, DOI 10.1016/j.cmet.2012.03.005; Jornayvaz FR, 2011, P NATL ACAD SCI USA, V108, P5748, DOI 10.1073/pnas.1103451108; Karamanlidis G, 2013, CELL METAB, V18, P239, DOI 10.1016/j.cmet.2013.07.002; Kendrick AA, 2011, BIOCHEM J, V433, P505, DOI 10.1042/BJ20100791; Kim HJ, 2011, J PROTEOME RES, V10, P722, DOI 10.1021/pr100892r; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Kumashiro N, 2011, P NATL ACAD SCI USA, V108, P16381, DOI 10.1073/pnas.1113359108; Lelliott CJ, 2007, ARTERIOSCL THROM VAS, V27, P2707, DOI 10.1161/ATVBAHA.107.155739; Liu LJ, 2014, J CLIN INVEST, V124, P768, DOI 10.1172/JCI69413; Liu LJ, 2011, J BIOL CHEM, V286, P41253, DOI 10.1074/jbc.M111.276121; MERANTE F, 1993, AM J HUM GENET, V53, P481; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; MORIN C, 1993, AM J HUM GENET, V53, P488; Mourier A, 2014, HUM MOL GENET, V23, P2580, DOI 10.1093/hmg/ddt652; Noguchi Y, 2009, J BIOL CHEM, V284, P33425, DOI 10.1074/jbc.M109.049478; Perez-Carreras M, 2003, HEPATOLOGY, V38, P999, DOI 10.1053/jhep.2003.50398; Perry RJ, 2013, CELL METAB, V18, P740, DOI 10.1016/j.cmet.2013.10.004; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Qu X, 1999, J ENDOCRINOL, V162, P207, DOI 10.1677/joe.0.1620207; Ruzzenente B, 2012, EMBO J, V31, P443, DOI 10.1038/emboj.2011.392; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Sasarman F, 2010, MOL BIOL CELL, V21, P1315, DOI 10.1091/mbc.E10-01-0047; Seki S, 2002, J HEPATOL, V37, P56, DOI 10.1016/S0168-8278(02)00073-9; Sondheimer N, 2010, BIOCHEMISTRY-US, V49, P7467, DOI 10.1021/bi1008479; White DL, 2012, CLIN GASTROENTEROL H, V10, P1342, DOI 10.1016/j.cgh.2012.10.001	47	22	23	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125617	10.1371/journal.pone.0125617	http://dx.doi.org/10.1371/journal.pone.0125617			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933096	Green Submitted, Green Published, gold			2022-12-27	WOS:000353887100123
J	Drazic, A; Kutzner, E; Winter, J; Eisenreich, W				Drazic, Adrian; Kutzner, Erika; Winter, Jeannette; Eisenreich, Wolfgang			Metabolic Response of Escherichia coli upon Treatment with Hypochlorite at Sub-Lethal Concentrations	PLOS ONE			English	Article							REDOX-REGULATED CHAPERONE; OXIDATIVE STRESS; TRANSCRIPTION FACTOR; METHIONINE OXIDATION; ACID; PROTEIN; DAMAGE; MODEL; IDENTIFICATION; NEUTROPHILS	Hypochlorite is a reactive oxygen species that is worldwide as an antibacterial disinfectant. Hypochlorite exposure is known to cause oxidative damage to DNA and proteins. As a response to these effects, the metabolite profiles of organisms treated with sub-lethal doses of hypochlorite are assumed to be severely modified; however, the nature of these changes is hardly understood. Therefore, using nuclear magnetic resonance spectroscopy and gas chromatography-coupled mass spectrometry, we analyzed the time-dependent impact of hypochlorite exposure with a sub-lethal concentration (50 mu M) on the metabolite profile of the Escherichia coli strain MG1655. Principle component analysis clearly distinguished between the metabolite profiles of bacteria treated for 0, 5,10, 20, 40, or 60 min. Major changes in the relative amounts of fatty acids, acetic acid, and formic acid occurred within the first 5 min. Comparative gas chromatography-coupled mass spectrometry analyses revealed that the amounts of free methionine and alanine were significantly decreased in the treated cells, demonstrating their susceptibility to hypochlorite exposure. The concentrations of succinate, urea, orotic acid, 2-aminobutyric acid, and 2-hydroxybutyric acid were also severely affected, indicating general changes in the metabolic network by hypochlorite. However, most metabolite levels relaxed to the reference values of untreated cells after 4060 min, reflecting the capability of E. coli to rapidly adapt to environmental stress factors such as the presence of sub-lethal oxidant levels.	[Drazic, Adrian; Winter, Jeannette] Tech Univ Munich, Lehrstuhl Biotechnol, CiPSM, Garching, Germany; [Kutzner, Erika; Eisenreich, Wolfgang] Tech Univ Munich, Lehrstuhl Biochem, Garching, Germany	Technical University of Munich; Technical University of Munich	Winter, J (corresponding author), Tech Univ Munich, Lehrstuhl Biotechnol, CiPSM, Lichtenbergstr 4, Garching, Germany.	winter.jeannette@gmail.com; wolfgang.eisenreich@ch.tum.de	Drazic, Adrian/AAC-6120-2019; Eisenreich, Wolfgang/A-1258-2013	Drazic, Adrian/0000-0001-9263-5502; Eisenreich, Wolfgang/0000-0002-9832-8279	Deutsche Forschungsgemeinschaft [DR 998/2-1, SPP 1316, EI 384/6]; Elitenetzwerk Bayern	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Elitenetzwerk Bayern	Adrian Drazic thanks the Deutsche Forschungsgemeinschaft (DR 998/2-1) and the Elitenetzwerk Bayern for funding. Wolfgang Eisenreich and Erika Kutzner thank the Deutsche Forschungsgemeinschaft (SPP 1316; EI 384/6) for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antelmann H, 2005, PROTEOMICS, V5, P3684, DOI 10.1002/pmic.200401218; CANDEIAS LP, 1994, FREE RADICAL RES, V20, P241, DOI 10.3109/10715769409147520; Chang DE, 2002, MOL MICROBIOL, V45, P289, DOI 10.1046/j.1365-2958.2002.03001.x; Chesney JA, 1996, J BACTERIOL, V178, P2131, DOI 10.1128/jb.178.7.2131-2135.1996; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; Deng KP, 2011, APPL ENVIRON MICROB, V77, P3952, DOI 10.1128/AEM.02420-10; Drazic A, 2014, BBA-PROTEINS PROTEOM, V1844, P1367, DOI 10.1016/j.bbapap.2014.01.001; Drazic A, 2014, J BIOL CHEM, V289, P977, DOI 10.1074/jbc.M113.521401; Drazic A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075683; Drazic A, 2013, P NATL ACAD SCI USA, V110, P9493, DOI 10.1073/pnas.1300578110; Dukan S, 1997, APPL ENVIRON MICROB, V63, P4204, DOI 10.1128/AEM.63.11.4204-4209.1997; Dukan S, 1996, J BACTERIOL, V178, P6145, DOI 10.1128/jb.178.21.6145-6150.1996; Dukan S, 1998, GENE DEV, V12, P3431, DOI 10.1101/gad.12.21.3431; Gabbita SP, 1999, J NEUROCHEM, V73, P1660, DOI 10.1046/j.1471-4159.1999.0731660.x; Gebendorfer KM, 2012, J BIOL CHEM, V287, P6892, DOI 10.1074/jbc.M111.287219; Gray MJ, 2014, MOL CELL, V53, P689, DOI 10.1016/j.molcel.2014.01.012; Gray MJ, 2013, ANNU REV MICROBIOL, V67, P141, DOI 10.1146/annurev-micro-102912-142520; Gray MJ, 2013, J BIOL CHEM, V288, P13789, DOI 10.1074/jbc.M113.454421; Grosser N, 2004, BIOCHEM BIOPH RES CO, V314, P351, DOI 10.1016/j.bbrc.2003.12.089; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Hazen SL, 1998, J BIOL CHEM, V273, P4997, DOI 10.1074/jbc.273.9.4997; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Jozefczuk S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.18; Kirkpatrick C, 2001, J BACTERIOL, V183, P6466, DOI 10.1128/JB.183.21.6466-6477.2001; Kumar A, 2012, CURR SCI INDIA, V102, P288; Leichert LI, 2008, P NATL ACAD SCI USA, V105, P8197, DOI 10.1073/pnas.0707723105; Leonhartsberger S, 2002, J MOL MICROB BIOTECH, V4, P269; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Mermod M, 2012, BIOMETALS, V25, P33, DOI 10.1007/s10534-011-9510-x; Miller RA, 1997, CLIN MICROBIOL REV, V10, P1; Morales EH, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-63; Pan TWM, 1996, PROG NUCL MAGN RESON, V28, P161, DOI DOI 10.1016/0079-6565(95)01017-3; Parker BW, 2013, J BIOL CHEM, V288, P32574, DOI 10.1074/jbc.M113.503516; Ralser M., 2007, J BIOL, V6, P10, DOI [DOI 10.1186/jbiol61, 10.1186/jbiol61]; Roos D, 2002, SCIENCE, V296, P669, DOI 10.1126/science.1071271; Rosen H, 2009, P NATL ACAD SCI USA, V106, P18686, DOI 10.1073/pnas.0909464106; Rui B, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-122; Schauer N, 2005, FEBS LETT, V579, P1332, DOI 10.1016/j.febslet.2005.01.029; Shen T, 2013, MOL BIOSYST, V9, P121, DOI 10.1039/c2mb25285f; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; Tkachenko A G, 2001, Mikrobiologiia, V70, P487; Valdivia-Gonzalez M, 2012, BIOMETALS, V25, P451, DOI 10.1007/s10534-012-9518-x; VANDENBERG J, 1994, METHOD ENZYMOL, V233, P639; VISSERS MCM, 1994, FREE RADICAL BIO MED, V16, P703, DOI 10.1016/0891-5849(94)90185-6; Wang SY, 2009, APPL ENVIRON MICROB, V75, P6110, DOI 10.1128/AEM.00914-09; WILLETTS NS, 1967, BIOCHEM J, V103, P453, DOI 10.1042/bj1030453; Winter J, 2008, CELL, V135, P691, DOI 10.1016/j.cell.2008.09.024; Winter J, 2005, MOL CELL, V17, P381, DOI 10.1016/j.molcel.2004.12.027; Yuan W, 2009, J BIOL CHEM, V284, P26908, DOI 10.1074/jbc.M109.005496	50	19	19	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125823	10.1371/journal.pone.0125823	http://dx.doi.org/10.1371/journal.pone.0125823			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932918	Green Published, gold			2022-12-27	WOS:000353887100135
J	Todd, DA; Gulledge, TV; Britton, ER; Oberhofer, M; Leyte-Lugo, M; Moody, AN; Shymanovich, T; Grubbs, LF; Juzumaite, M; Graf, TN; Oberlies, NH; Faeth, SH; Laster, SM; Cech, NB				Todd, Daniel A.; Gulledge, Travis V.; Britton, Emily R.; Oberhofer, Martina; Leyte-Lugo, Martha; Moody, Ashley N.; Shymanovich, Tatsiana; Grubbs, Laura F.; Juzumaite, Monika; Graf, Tyler N.; Oberlies, Nicholas H.; Faeth, Stanley H.; Laster, Scott M.; Cech, Nadja B.			Ethanolic Echinacea purpurea Extracts Contain a Mixture of Cytokine-Suppressive and Cytokine-Inducing Compounds, Including Some That Originate from Endophytic Bacteria	PLOS ONE			English	Article							VITRO MACROPHAGE ACTIVATION; CAFFEIC ACID-DERIVATIVES; INFLAMMATORY CYTOKINES; CELL-CULTURES; PATHOGENESIS; ALKAMIDES; LIPOPOLYSACCHARIDES; LIPOPROTEINS; ALKYLAMIDES; INFECTIONS	Echinacea preparations, which are used for the prevention and treatment of upper respiratory infections, account for 10% of the dietary supplement market in the U.S., with sales totaling more than $ 100 million annually. In an attempt to shed light on Echinacea's mechanism of action, we evaluated the effects of a 75% ethanolic root extract of Echinacea purpurea, prepared in accord with industry methods, on cytokine and chemokine production from RAW 264.7 macrophage-like cells. We found that the extract displayed dual activities; the extract could itself stimulate production of the cytokine TNF-alpha, and also suppress production of TNF-alpha in response to stimulation with exogenous LPS. Liquid: liquid partitioning followed by normal-phase flash chromatography resulted in separation of the stimulatory and inhibitory activities into different fractions, confirming the complex nature of this extract. We also studied the role of alkylamides in the suppressive activity of this E. purpurea extract. Our fractionation method concentrated the alkylamides into a single fraction, which suppressed production of TNF-alpha, CCL3, and CCL5; however fractions that did not contain detectable alkylamides also displayed similar suppressive effects. Alkylamides, therefore, likely contribute to the suppressive activity of the extract but are not solely responsible for that activity. From the fractions without detectable alkylamides, we purified xanthienopyran, a compound not previously known to be a constituent of the Echinacea genus. Xanthienopyran suppressed production of TNF-alpha suggesting that it may contribute to the suppressive activity of the crude ethanolic extract. Finally, we show that ethanolic extracts prepared from E. purpurea plants grown under sterile conditions and from sterilized seeds, do not contain LPS and do not stimulate macrophage production of TNF-alpha, supporting the hypothesis that the macrophage-stimulating activity in E. purpurea extracts can originate from endophytic bacteria. Together, our findings indicate that ethanolic E. purpurea extracts contain multiple constituents that differentially regulate cytokine production by macrophages.	[Todd, Daniel A.; Britton, Emily R.; Leyte-Lugo, Martha; Moody, Ashley N.; Graf, Tyler N.; Oberlies, Nicholas H.; Cech, Nadja B.] Univ N Carolina, Dept Chem & Biochem, Greensboro, NC 27412 USA; [Gulledge, Travis V.; Juzumaite, Monika; Laster, Scott M.] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA; [Oberhofer, Martina; Shymanovich, Tatsiana; Grubbs, Laura F.; Faeth, Stanley H.] Univ N Carolina, Dept Biol, Greensboro, NC 27412 USA	University of North Carolina; University of North Carolina Greensboro; University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Greensboro	Cech, NB (corresponding author), Univ N Carolina, Dept Chem & Biochem, Greensboro, NC 27412 USA.	nadja_cech@uncg.edu	Oberlies, Nicholas/D-8162-2011; Leyte-Lugo, Martha/O-6682-2019; Shymanovich, Tatsiana/R-4958-2019	Oberlies, Nicholas/0000-0002-0354-8464; Graf, Tyler/0000-0003-4145-2815; Leyte-Lugo, Martha/0000-0003-4940-6194; Britton, Emily/0000-0002-5331-7963; Todd, Daniel/0000-0003-2199-1029	National Center for Complementary and Alternative Medicine (NCCAM) [1R15AT007259]; National Institutes of Health; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R15AT007259] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine (NCCAM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This project was supported by grant # 1R15AT007259 from the National Center for Complementary and Alternative Medicine (NCCAM), a component of the National Institutes of Health.	Barrett B, 2010, ANN INTERN MED, V153, P769, DOI 10.7326/0003-4819-153-12-201012210-00003; BAUER R, 1991, PLANTA MED, V57, P447, DOI 10.1055/s-2006-960147; BAUER R, 1989, PLANTA MED, P367, DOI 10.1055/s-2006-962030; Cech NB, 2010, INT IMMUNOPHARMACOL, V10, P1268, DOI 10.1016/j.intimp.2010.07.009; Cech NB, 2006, J CHROMATOGR A, V1103, P219, DOI 10.1016/j.chroma.2005.11.008; Coimbra S, 2012, INT J DERMATOL, V51, P389, DOI 10.1111/j.1365-4632.2011.05154.x; Duque GA, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00491; Eads D, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-2; EMMENDORFFER AC, 1999, IMMUNOMODULATORY AGE, P89; Fonseca FN, 2014, INT IMMUNOPHARMACOL, V19, P94, DOI 10.1016/j.intimp.2013.12.019; Fukuyama S, 2011, CURR OPIN IMMUNOL, V23, P481, DOI 10.1016/j.coi.2011.07.016; Jawad M, 2012, EVID-BASED COMPL ALT, V2012, P7; Karsch-Volk M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000530.pub3; Kennedy JL, 2012, CURR OPIN VIROL, V2, P287, DOI 10.1016/j.coviro.2012.03.008; Lalone CA, 2007, J AGR FOOD CHEM, V55, P7314, DOI 10.1021/jf063711a; LaLone CA, 2009, J AGR FOOD CHEM, V57, P8820, DOI 10.1021/jf901202y; Lee CL, 2008, PLANTA MED, V74, P1276, DOI 10.1055/s-2008-1081295; LEUCHTMANN A, 1988, MYCOLOGIA, V80, P192, DOI 10.2307/3807793; LUETTIG B, 1989, J NATL CANCER I, V81, P669, DOI 10.1093/jnci/81.9.669; MAHMOUD AA, 1995, TETRAHEDRON LETT, V36, P8985, DOI 10.1016/0040-4039(95)01966-L; Maurer M, 2004, INT J BIOCHEM CELL B, V36, P1882, DOI 10.1016/j.biocel.2003.10.019; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Mueller M, 2004, J BIOL CHEM, V279, P26307, DOI 10.1074/jbc.M401231200; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Pugh ND, 2008, INT IMMUNOPHARMACOL, V8, P1023, DOI 10.1016/j.intimp.2008.03.007; Pugh ND, 2013, PLANTA MED, V79, P9, DOI 10.1055/s-0032-1328023; Raduner S, 2006, J BIOL CHEM, V281, P14192, DOI 10.1074/jbc.M601074200; Sasagawa M, 2006, INT IMMUNOPHARMACOL, V6, P1214, DOI 10.1016/j.intimp.2006.02.003; Sharma M, 2009, ANTIVIR RES, V83, P165, DOI 10.1016/j.antiviral.2009.04.009; Spelman K, 2009, INT IMMUNOPHARMACOL, V9, P1260, DOI 10.1016/j.intimp.2009.08.009; Tamta H, 2008, J AGR FOOD CHEM, V56, P10552, DOI 10.1021/jf8023722; Taylor JA, 2003, JAMA-J AM MED ASSOC, V290, P2824, DOI 10.1001/jama.290.21.2824; U.S. Nutrition Industry Overview, 2009, NUTRITION BUSINESS J, V14, P1; Vohra S, 2009, CAN J PHYSIOL PHARM, V87, P371, DOI [10.1139/Y09-021, 10.1139/y09-021]; WAGNER H, 1988, PHYTOCHEMISTRY, V27, P119, DOI 10.1016/0031-9422(88)80601-0	36	38	40	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124276	10.1371/journal.pone.0124276	http://dx.doi.org/10.1371/journal.pone.0124276			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933416	Green Published, Green Submitted, gold			2022-12-27	WOS:000353887100035
J	Zafar, A; Ahmad, S; Rizvi, A; Ahmad, M				Zafar, Atif; Ahmad, Sabahuddin; Rizvi, Asim; Ahmad, Masood			Novel Non-Peptide Inhibitors against SmCL1 of Schistosoma mansoni: In Silico Elucidation, Implications and Evaluation via Knowledge Based Drug Discovery	PLOS ONE			English	Article							3-DIMENSIONAL STRUCTURES; CYSTEINE PROTEINASES; SCORING FUNCTION; MODELS; CHEMOTHERAPY; RECOGNITION; PREDICTION; DIGESTION; ALIGNMENT; QUALITY	Schistosomiasis is a major endemic disease known for excessive mortality and morbidity in developing countries. Because praziquantel is the only drug available for its treatment, the risk of drug resistance emphasizes the need to discover new drugs for this disease. Cathepsin SmCL1 is the critical target for drug design due to its essential role in the digestion of host proteins for growth and development of Schistosoma mansoni. Inhibiting the function of SmCL1 could control the wide spread of infections caused by S. mansoni in humans. With this objective, a homology modeling approach was used to obtain theoretical three-dimensional (3D) structure of SmCL1. In order to find the potential inhibitors of SmCL1, a plethora of in silico techniques were employed to screen non-peptide inhibitors against SmCL1 via structure-based drug discovery protocol. Receiver operating characteristic (ROC) curve analysis and molecular dynamics (MD) simulation were performed on the results of docked protein-ligand complexes to identify top ranking molecules against the modelled 3D structure of SmCL1. MD simulation results suggest the phytochemical Simalikalactone-D as a potential lead against SmCL1, whose pharmacophore model may be useful for future screening of potential drug molecules. To conclude, this is the first report to discuss the virtual screening of non-peptide inhibitors against SmCL1 of S. mansoni, with significant therapeutic potential. Results presented herein provide a valuable contribution to identify the significant leads and further derivatize them to suitable drug candidates for antischistosomal therapy.	[Zafar, Atif; Rizvi, Asim; Ahmad, Masood] Aligarh Muslim Univ, Fac Life Sci, Dept Biochem, Aligarh 202002, Uttar Pradesh, India; [Ahmad, Sabahuddin] Jamia Millia Islamia, Fac Nat Sci, Dept Comp Sci, New Delhi 110025, India	Aligarh Muslim University; Jamia Millia Islamia	Ahmad, M (corresponding author), Aligarh Muslim Univ, Fac Life Sci, Dept Biochem, Aligarh 202002, Uttar Pradesh, India.	masood_amua@yahoo.co.in	Ahmad, Sabahuddin/I-4919-2015	Ahmad, Sabahuddin/0000-0002-8762-4670; Rizvi, Asim/0000-0003-0771-0227				Abdulla MH, 2007, PLOS MED, V4, P130, DOI 10.1371/journal.pmed.0040014; Abdulla MH, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000478; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Benkert P, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-35; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Blau L, 2013, EUR J MED CHEM, V67, P142, DOI 10.1016/j.ejmech.2013.04.022; Botros SS, 2007, EXPERT OPIN DRUG DIS, V2, pS35, DOI 10.1517/17460441.2.S1.S35; Brady CP, 2000, ARCH BIOCHEM BIOPHYS, V380, P46, DOI 10.1006/abbi.2000.1905; Brady CP, 1999, INFECT IMMUN, V67, P368, DOI 10.1128/IAI.67.1.368-374.1999; Brinen LS, 2000, STRUCT FOLD DES, V8, P831, DOI 10.1016/S0969-2126(00)00173-8; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Caffrey CR, 2007, CURR OPIN CHEM BIOL, V11, P433, DOI 10.1016/j.cbpa.2007.05.031; Caffrey CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004413; Caffrey CR, 2004, TRENDS PARASITOL, V20, P241, DOI 10.1016/j.pt.2004.03.004; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; DALTON JP, 1995, PARASITOL TODAY, V11, P299, DOI 10.1016/0169-4758(95)80045-X; Dalton JP, 1996, INFECT IMMUN, V64, P1328, DOI 10.1128/IAI.64.4.1328-1334.1996; Burger MCD, 2014, J NAT PROD, V77, P2418, DOI 10.1021/np500453x; DeLano WL, 1997, PYMOL MOL GRAPHIC SY; Delcroix M, 2006, J BIOL CHEM, V281, P39316, DOI 10.1074/jbc.M607128200; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; DRENTH J, 1968, NATURE, V218, P929, DOI 10.1038/218929a0; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Farid A, 2013, Pak J Biol Sci, V16, P1849, DOI 10.3923/pjbs.2013.1849.1861; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Filimonov DA, 1996, BIOACTIVE COMPOUND D, P47; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gray DJ, 2010, LANCET INFECT DIS, V10, P733, DOI 10.1016/S1473-3099(10)70099-2; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; GURUPRASAD K, 1990, PROTEIN ENG, V4, P155, DOI 10.1093/protein/4.2.155; IKAI A, 1980, J BIOCHEM-TOKYO, V88, P1895; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; King CH, 2010, ACTA TROP, V113, P95, DOI 10.1016/j.actatropica.2009.11.012; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Larsson P, 2008, PROTEIN SCI, V17, P990, DOI 10.1110/ps.073344908; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Moreira DRM, 2014, CHEMMEDCHEM, V9, P177, DOI 10.1002/cmdc.201300354; MCKERROW JH, 1988, PARASITOL TODAY, V4, P334, DOI 10.1016/0169-4758(88)90002-6; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mugumbate G, 2013, J COMPUT AID MOL DES, V27, P859, DOI 10.1007/s10822-013-9685-z; Okimoto N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000528; Perez B, 2013, J COMPUT AID MOL DES, V27, P823, DOI 10.1007/s10822-013-9682-2; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sajid M, 2002, MOL BIOCHEM PARASIT, V120, P1, DOI 10.1016/S0166-6851(01)00438-8; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Scott WRP, 1999, J PHYS CHEM A, V103, P3596, DOI 10.1021/jp984217f; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; SMITH AM, 1994, MOL BIOCHEM PARASIT, V67, P11, DOI 10.1016/0166-6851(94)90091-4; Southan C, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-20; Stirewalt M.A., 1974, Advances Parasit, V12, P115, DOI 10.1016/S0065-308X(08)60388-7; Tort J, 1999, ADV PARASIT, V43, P161, DOI 10.1016/S0065-308X(08)60243-2; Walker AJ, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-203; Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803; Wasilewski MM, 1996, MOL BIOCHEM PARASIT, V81, P179, DOI 10.1016/0166-6851(96)02703-X; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wiggers HJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002370; Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264	65	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0123996	10.1371/journal.pone.0123996	http://dx.doi.org/10.1371/journal.pone.0123996			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933436	Green Published, Green Submitted, gold			2022-12-27	WOS:000353887100028
J	Bhat, A; Greulich, MM; Martins, EP				Bhat, Anuradha; Greulich, Melissa M.; Martins, Emilia P.			Behavioral Plasticity in Response to Environmental Manipulation among Zebrafish (Danio rerio) Populations	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; SOCIAL-ENVIRONMENT; HABITAT STABILITY; EVOLUTION; PREDATOR; INFORMATION; AGGRESSION; EXPERIENCE; MONOPOLIZATION; RECOGNITION	Plastic responses can have adaptive significance for organisms occurring in unpredictable environments, migratory species and organisms occupying novel environments. Zebrafish (Danio rerio) occur in a wide range of habitats and environments that fluctuate frequently across seasons and habitats. We expect wild populations of fish to be behaviorally more flexible than fish reared in conventional laboratory and hatchery environments. We measured three behavioral traits among 2 wild (U and PN) and 1 laboratory bred (SH) zebrafish populations in four environments differing in water flow and vegetation regimes. We found that the degree of plasticity varied with the type of behavior and also among populations. In general, vegetation increased aggression and water flow decreased latency to feed after a disturbance, but the patterns were population dependent. For example, while wild U fish fed more readily after a disturbance in vegetated and/or flowing habitats, fish from the wild PN population and lab-reared SH strain showed little variation in foraging across different environmental conditions. Zebrafish from all the three populations were more aggressive when tested in an arena with vegetation. In contrast, while there was an inter-population difference in shoaling distances, variation in shoaling distance across environmental conditions within populations was not significant. These results suggest that both foraging and aggression in zebrafish are more plastic and influenced by immediate context than is shoaling distance, which may have a stronger genetic basis. Our findings point to different underlying mechanisms influencing the expression of these traits and warrants further investigations.	[Bhat, Anuradha; Greulich, Melissa M.; Martins, Emilia P.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Bhat, Anuradha; Greulich, Melissa M.; Martins, Emilia P.] Indiana Univ, Ctr Integrat Study Anim Behav, Bloomington, IN USA; [Bhat, Anuradha] Indian Inst Sci Educ & Res Kolkata, Dept Biol Sci, Mohanpur, India	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indian Institute of Science Education & Research (IISER) - Kolkata	Bhat, A (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	anuradhabhat@iiserkol.ac.in		Martins, Emilia/0000-0002-8952-3240	National Science Foundation [IOB-0543491, IOS-1257562]; Summer Research Experience for Undergraduates program in Animal Behavior at Indiana University - National Science Foundation [0453403]; Division Of Environmental Biology [1257562] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Summer Research Experience for Undergraduates program in Animal Behavior at Indiana University - National Science Foundation; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by funds from National Science Foundation award to EPM (IOB-0543491 and IOS-1257562) and the Summer Research Experience for Undergraduates program in Animal Behavior at Indiana University (funded by National Science Foundation Grant number 0453403). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Ariyomo TO, 2013, BEHAV GENET, V43, P161, DOI 10.1007/s10519-013-9585-y; Asbury DA, 2007, EVOL ECOL RES, V9, P801; Barman R.P., 1991, Records of the Zoological Survey of India Occasional Paper, V137, P1; Basquill SP, 1998, CAN J ZOOL, V76, P770, DOI 10.1139/cjz-76-4-770; Bhat A, 2003, ENVIRON BIOL FISH, V68, P25, DOI 10.1023/A:1026017119070; Brown C, 1999, ETHOLOGY, V105, P491, DOI 10.1046/j.1439-0310.1999.00442.x; Brown C, 2003, J FISH BIOL, V63, P187, DOI 10.1111/j.1095-8649.2003.00208.x; Brown C, 2001, J FISH BIOL, V59, P471, DOI [10.1006/jfbi.2001.1689, 10.1111/j.1095-8649.2001.tb02354.x]; Brydges NM, 2008, ANIM BEHAV, V75, P935, DOI 10.1016/j.anbehav.2007.08.005; Chipps SR, 2004, OECOLOGIA, V138, P32, DOI 10.1007/s00442-003-1396-z; CHIVERS DP, 1995, ETHOLOGY, V99, P286; Engeszer RE, 2007, ANIM BEHAV, V74, P1269, DOI 10.1016/j.anbehav.2007.01.032; Engeszer RE, 2007, ZEBRAFISH, V4, P21, DOI 10.1089/zeb.2006.9997; Foster SA, 1999, TRENDS ECOL EVOL, V14, P190, DOI 10.1016/S0169-5347(98)01577-8; Hamilton IM, 2002, CAN J ZOOL, V80, P2164, DOI 10.1139/Z02-199; Hazlett B.A., 1988, NATO ASI (Advanced Science Institutes) Series Series A Life Sciences, P317; Jarvi T., 1993, NORDIC J FRESHWATER, V68, P63; Kelley JL, 2003, FISH FISH, V4, P216, DOI 10.1046/j.1467-2979.2003.00126.x; Ketterson ED, 1999, AM NAT, V154, pS4, DOI 10.1086/303280; Laland KN, 1997, ANIM BEHAV, V53, P1161, DOI 10.1006/anbe.1996.0318; Lawrence C, 2007, AQUACULTURE, V269, P1, DOI 10.1016/j.aquaculture.2007.04.077; MAGURRAN AE, 1988, ETHOLOGY, V78, P153; Marks C, 2005, COPEIA, P901, DOI 10.1643/0045-8511(2005)005[0901:DEACAI]2.0.CO;2; McClure MM, 2006, J FISH BIOL, V69, P553, DOI 10.1111/j.1095-8649.2006.01125.x; Moretz JA, 2007, ENVIRON BIOL FISH, V80, P91, DOI 10.1007/s10641-006-9122-4; Moretz JA, 2007, BEHAV ECOL, V18, P556, DOI 10.1093/beheco/arm011; Norton WHJ, 2011, J NEUROSCI, V31, P13796, DOI 10.1523/JNEUROSCI.2892-11.2011; Odling-Smee L, 2003, ANIM BEHAV, V65, P701, DOI 10.1006/anbe.2003.2082; Parrish JD, 2000, STUD AVIAN BIOL-SER, P53; Pitcher T.J., 1986, P294; Pritchard VL, 2001, ANIM BEHAV, V62, P1085, DOI 10.1006/anbe.2001.1858; Rehage JS, 2005, BEHAV ECOL SOCIOBIOL, V57, P256, DOI 10.1007/s00265-004-0850-1; Salvanes AGV, 2005, BEHAV ECOL SOCIOBIOL, V59, P250, DOI 10.1007/s00265-005-0031-x; Salvanes AGV, 2007, ANIM BEHAV, V74, P805, DOI 10.1016/j.anbehav.2007.02.007; Salvanes AGV, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1331; SCHEINER SM, 1993, ANNU REV ECOL SYST, V24, P35, DOI 10.1146/annurev.es.24.110193.000343; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Sih A, 2003, ANIM BEHAV, V65, P29, DOI 10.1006/anbe.2002.2025; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sih Andrew, 2004, P112; Spence R, 2006, J FISH BIOL, V69, P1435, DOI 10.1111/j.1095-8649.2006.01206.x; Spence R, 2008, BIOL REV, V83, P13, DOI 10.1111/j.1469-185X.2007.00030.x; SPSS, 2006, SPSS US MAN REL 11 5; STEARNS SC, 1989, BIOSCIENCE, V39, P436, DOI 10.2307/1311135; Sundstrom LF, 2001, ANIM BEHAV, V61, P249, DOI 10.1006/anbe.2000.1593; VIA S, 1985, EVOLUTION, V39, P505, DOI [10.2307/2408649, 10.1111/j.1558-5646.1985.tb00391.x]; West-Eberhard Mary Jane, 2003, pi; WESTEBERHARD MJ, 1989, ANNU REV ECOL SYST, V20, P249, DOI 10.1146/annurev.es.20.110189.001341	50	45	46	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125097	10.1371/journal.pone.0125097	http://dx.doi.org/10.1371/journal.pone.0125097			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927838	gold, Green Submitted, Green Published			2022-12-27	WOS:000353713100067
J	Bullard, KM; Ali, MK; Imperatore, G; Geiss, LS; Saydah, SH; Albu, JB; Cowie, CC; Sohler, N; Albright, A; Gregg, EW				Bullard, Kai McKeever; Ali, Mohammed K.; Imperatore, Giuseppina; Geiss, Linda S.; Saydah, Sharon H.; Albu, Jeanine B.; Cowie, Catherine C.; Sohler, Nancy; Albright, Ann; Gregg, Edward W.			Receipt of Glucose Testing and Performance of Two US Diabetes Screening Guidelines, 2007-2012	PLOS ONE			English	Article							COST-EFFECTIVENESS; CONTROLLED-TRIAL; NATIONAL-HEALTH; SECULAR CHANGES; UNITED-STATES; FOLLOW-UP; PREVENTION; PREVALENCE; ADULTS; RISK	Background Screening guidelines are used to help identify prediabetes and diabetes before implementing evidence-based prevention and treatment interventions. We examined screening practices benchmarking against two US guidelines, and the capacity of each guideline to identify dysglycemia. Methods Using 2007-2012 National Health and Nutrition Examination Surveys, we analyzed nationally-representative, cross-sectional data from 5,813 fasting non-pregnant adults aged >= 20 years without self-reported diabetes. We examined proportions of adults eligible for diagnostic glucose testing and those who self-reported receiving testing in the past three years, as recommended by the American Diabetes Association (ADA) and the US Preventive Services Task Force (USPSTF-2008) guidelines. For each screening guideline, we also assessed sensitivity, specificity, and positive (PPV) and negative predictive values in identifying dysglycemia (defined as fasting plasma glucose >= 100 mg/dl or hemoglobin A1c >= 5.7%). Results In 2007-2012, 73.0% and 23.7% of US adults without diagnosed diabetes met ADA and USPSTF-2008 criteria for screening, respectively; and 91.5% had at least one major risk factor for diabetes. Of those ADA- or USPSTF-eligible adults, about 51% reported being tested within the past three years. Eligible individuals not tested were more likely to be lower educated, poorer, uninsured, or have no usual place of care compared to tested eligible adults. Among adults with >= 1 major risk factor, 45.7% reported being tested, and dysglycemia yields (i.e., PPV) ranged from 45.8% (high-risk ethnicity) to 72.6% (self-reported prediabetes). ADA criteria and having any risk factor were more sensitive than the USPSTF-2008 guideline (88.8-97.7% vs. 31.0%) but less specific (13.5-39.7% vs. 82.1%) in recommending glucose testing, resulting in lower PPVs (47.7-54.4% vs. 58.4%). Conclusion Diverging recommendations and variable performance of different guidelines may be impeding national diabetes prevention and treatment efforts. Efforts to align screening recommendations may result in earlier identification of adults at high risk for prediabetes and diabetes.	[Bullard, Kai McKeever; Ali, Mohammed K.; Imperatore, Giuseppina; Geiss, Linda S.; Saydah, Sharon H.; Albright, Ann; Gregg, Edward W.] Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA 30333 USA; [Albu, Jeanine B.] Columbia Univ, St Lukes Roosevelt Hosp Ctr, Dept Med, New York, NY USA; [Cowie, Catherine C.] NIH, NIDDK, Bethesda, MD 20892 USA; [Sohler, Nancy] CUNY City Coll, Sophie Davis Sch Biomed Educ, New York, NY 10031 USA	Centers for Disease Control & Prevention - USA; Columbia University; Mount Sinai St. Luke's; Mount Sinai West; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); City University of New York (CUNY) System; City College of New York (CUNY); Sophie Davis School of Biomedical Education	Bullard, KM (corresponding author), Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA 30333 USA.	kbullard@cdc.gov	Ali, Mohammed K/N-9833-2013	Gregg, Edward/0000-0003-2381-6822; Ali, Mohammed/0000-0001-7266-2503	NIDDK NIH HHS [P60 DK020541, P30 DK020541] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020541, P60DK020541] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Albright AL, 2013, AM J PREV MED, V44, pS346, DOI 10.1016/j.amepre.2012.12.009; Ali MK, 2013, NEW ENGL J MED, V368, P1613, DOI 10.1056/NEJMsa1213829; Am Diabetes Assoc, 2006, DIABETES CARE, V29, pS4; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Bullard KM, 2013, DIABETES CARE, V36, P2286, DOI 10.2337/dc12-2563; Calonge N, 2008, ANN INTERN MED, V148, P846, DOI 10.7326/0003-4819-148-11-200806030-00007; Casagrande SS, 2013, AM J PREV MED, V45, P167, DOI 10.1016/j.amepre.2013.02.026; Centers for Disease Control, 2020, NATL DIABETES STAT R; Centers for Disease Control and Prevention [Internet]. Hyattsville: National Center for Health Statistics (NCHS), HYATTSV NAT CTR HLTH; Cheng YLJ, 2013, DIABETES CARE, V36, P2690, DOI 10.2337/dc12-2074; Chung S, 2014, AM J PREV MED, V47, P375, DOI 10.1016/j.amepre.2014.05.012; Eborall HC, 2007, BMJ-BRIT MED J, V335, P486, DOI 10.1136/bmj.39303.723449.55; Echouffo-Tcheugui JB, 2011, EPIDEMIOL REV, V33, P63, DOI 10.1093/epirev/mxq020; Engelgau MM, 2012, LANCET, V380, P1716, DOI 10.1016/S0140-6736(12)61682-1; Gerstein HC, 2007, DIABETES RES CLIN PR, V78, P305, DOI 10.1016/j.diabres.2007.05.004; Gillies CL, 2008, BMJ-BRIT MED J, V336, P1180, DOI 10.1136/bmj.39545.585289.25; Glumer C, 2006, DIABETOLOGIA, V49, P1536, DOI 10.1007/s00125-006-0248-x; HARRIS MI, 1992, DIABETES CARE, V15, P815, DOI 10.2337/diacare.15.7.815; Herman WH, 2012, DIABETES CARE, V35, P723, DOI 10.2337/dc11-1468; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Li YF, 2013, MMWR-MORBID MORTAL W, V62, P209; Lindstrom J, 2013, DIABETOLOGIA, V56, P284, DOI 10.1007/s00125-012-2752-5; National Institute for Health and Care Excellence, 2013, NICE GUID, pPH38; Park P, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-350; Perreault L, 2012, LANCET, V379, P2243, DOI 10.1016/S0140-6736(12)60525-X; Plantinga LC, 2010, CLIN J AM SOC NEPHRO, V5, P673, DOI 10.2215/CJN.07891109; Ratner RE, 2011, DIABETES CARE, V34, P1054, DOI 10.2337/dc10-1987; Selvin E, 2014, ANN INTERN MED, V160, P517, DOI 10.7326/M13-2411; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sheehy AM, 2010, MAYO CLIN PROC, V85, P27, DOI 10.4065/mcp.2009.0289; U.S. Preventive Services Task Force [Internet]. Rockville: USPSTF Program Office, TOP UPD PROGR ABN GL; Wilson JMG, 1968, PRINCIPLES PRACTICE; World Health Organization, 2006, DEF DIAGN DIAB MELL	34	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125249	10.1371/journal.pone.0125249	http://dx.doi.org/10.1371/journal.pone.0125249			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928306	gold, Green Published, Green Submitted			2022-12-27	WOS:000353713100073
J	Donohoe, OH; Henshilwood, K; Way, K; Hakimjavadi, R; Stone, DM; Walls, D				Donohoe, Owen H.; Henshilwood, Kathy; Way, Keith; Hakimjavadi, Roya; Stone, David M.; Walls, Dermot			Identification and Characterization of Cyprinid Herpesvirus-3 (CyHV-3) Encoded MicroRNAs	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; KOI HERPESVIRUS; SMALL RNAS; COMMON CARP; CANONICAL MICRORNAS; EVOLUTIONARY FLUX; OFFSET RNAS; TINY RNAS; EXPRESSION; DISEASE	MicroRNAs (miRNAs) are a class of small non-coding RNAs involved in post-transcriptional gene regulation. Some viruses encode their own miRNAs and these are increasingly being recognized as important modulators of viral and host gene expression. Cyprinid herpesvirus 3 (CyHV-3) is a highly pathogenic agent that causes acute mass mortalities in carp (Cyprinus carpio carpio) and koi (Cyprinus carpio koi) worldwide. Here, bioinformatic analyses of the CyHV-3 genome suggested the presence of non-conserved precursor miRNA (pre-miRNA) genes. Deep sequencing of small RNA fractions prepared from in vitro CyHV-3 infections led to the identification of potential miRNAs and miRNA-offset RNAs (moRNAs) derived from some bioinformatically predicted pre-miRNAs. DNA microarray hybridization analysis, Northern blotting and stem-loop RT-qPCR were then used to definitively confirm that CyHV-3 expresses two pre-miRNAs during infection in vitro. The evidence also suggested the presence of an additional four high-probability and two putative viral pre-miRNAs. MiRNAs from the two confirmed pre-miRNAs were also detected in gill tissue from CyHV-3-infected carp. We also present evidence that one confirmed miRNA can regulate the expression of a putative CyHV-3-encoded dUTPase. Candidate homologues of some CyHV-3 pre-miRNAs were identified in CyHV-1 and CyHV-2. This is the first report of miRNA and moRNA genes encoded by members of the Alloherpesviridae family, a group distantly related to the Herpesviridae family. The discovery of these novel CyHV-3 genes may help further our understanding of the biology of this economically important virus and their encoded miRNAs may have potential as biomarkers for the diagnosis of latent CyHV-3.	[Donohoe, Owen H.; Henshilwood, Kathy] Inst Marine, Oranmore, Co Galway, Ireland; [Donohoe, Owen H.; Hakimjavadi, Roya; Walls, Dermot] Dublin City Univ, Sch Biotechnol, Dublin 9, Ireland; [Donohoe, Owen H.; Hakimjavadi, Roya; Walls, Dermot] Dublin City Univ, Natl Ctr Sensor Res, Dublin 9, Ireland; [Way, Keith; Stone, David M.] Nothe, Cefas, Weymouth, Dorset, England	Marine Institute Ireland; Dublin City University; Dublin City University; Centre for Environment Fisheries & Aquaculture Science	Walls, D (corresponding author), Dublin City Univ, Sch Biotechnol, Dublin 9, Ireland.	dermot.walls@dcu.ie		Donohoe, Owen/0000-0002-1068-5248; Walls, Dermot/0000-0002-2244-2294	Marine Institute Research Fellowship programme; Defra; Programme for Research in Third Level Institutions (PRTLI) Cycle 5 [The Bioanalysis and Therapeutics (BioAT) programme at DCU].; European Regional Development Fund (ERDF), European Union Structural Funds Programme;  [FC1193];  [FC1202]	Marine Institute Research Fellowship programme; Defra(Department for Environment, Food & Rural Affairs (DEFRA)); Programme for Research in Third Level Institutions (PRTLI) Cycle 5 [The Bioanalysis and Therapeutics (BioAT) programme at DCU].; European Regional Development Fund (ERDF), European Union Structural Funds Programme; ; 	This work was supported by the Marine Institute Research Fellowship programme (https://www.marine.ie; OHD), Defra (https://www.gov.uk/government/organisations/department-for-environment-food-rural-affairs; research contracts FC1193 and FC1202; KW), the Programme for Research in Third Level Institutions (PRTLI) (http://www.hea.ie/en/prtli,official; RH, DW) Cycle 5 [The Bioanalysis and Therapeutics (BioAT) programme at DCU]. The PRTLI is co-funded through the European Regional Development Fund (ERDF), part of the European Union Structural Funds Programme 2007-2013 (http://eustructuralfunds.gov.ie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S29; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Amen MA, 2011, J VIROL, V85, P7296, DOI 10.1128/JVI.00505-11; Aoki T, 2007, J VIROL, V81, P5058, DOI 10.1128/JVI.00146-07; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Berezikov E, 2011, GENOME RES, V21, P203, DOI 10.1101/gr.116657.110; Berezikov E, 2010, NAT GENET, V42, P6, DOI 10.1038/ng0110-6; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Bortoluzzi S, 2012, BLOOD, V119, pE120, DOI 10.1182/blood-2011-07-368001; Bortoluzzi S, 2011, TRENDS MOL MED, V17, P473, DOI 10.1016/j.molmed.2011.05.005; Buck AH, 2007, J VIROL, V81, P13761, DOI 10.1128/JVI.01290-07; Cai Xuezhong, 2006, PLoS Pathogens, V2, P236, DOI 10.1371/journal.ppat.0020023; Cai XZ, 2005, P NATL ACAD SCI USA, V102, P5570, DOI 10.1073/pnas.0408192102; Campion EM, 2014, J VIROL, V88, P5001, DOI 10.1128/JVI.03642-13; Cazalla D, 2011, MOL CELL, V43, P982, DOI 10.1016/j.molcel.2011.07.025; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen CJ, 2011, J VIROL, V85, P4487, DOI 10.1128/JVI.02557-10; Chen SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012745; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cui C, 2006, J VIROL, V80, P5499, DOI 10.1128/JVI.00200-06; Cullen BR, 2011, GENE DEV, V25, P1881, DOI 10.1101/gad.17352611; Davison AJ, 2002, VET MICROBIOL, V86, P69, DOI 10.1016/S0378-1135(01)00492-8; Davison AJ, 2013, J VIROL, V87, P2908, DOI 10.1128/JVI.03206-12; Davison AJ, 2009, ARCH VIROL, V154, P171, DOI 10.1007/s00705-008-0278-4; Eide KE, 2011, J VIROL, V85, P4954, DOI 10.1128/JVI.01384-10; Engelsma MY, 2013, DIS AQUAT ORGAN, V107, P113, DOI 10.3354/dao02666; Fernandez-Valverde SL, 2010, RNA, V16, P1881, DOI 10.1261/rna.2379610; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Gilad O, 2004, DIS AQUAT ORGAN, V60, P179, DOI 10.3354/dao060179; Glaunsinger BA, 2006, ADV VIRUS RES, V66, P337, DOI 10.1016/S0065-3527(06)66007-7; Gotesman M, 2013, DIS AQUAT ORGAN, V105, P163, DOI 10.3354/dao02614; Grey F, 2008, MED MICROBIOL IMMUN, V197, P261, DOI 10.1007/s00430-007-0070-1; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Grundhoff A, 2006, RNA, V12, P733, DOI 10.1261/rna.2326106; Grundhoff A, 2011, VIROLOGY, V411, P325, DOI 10.1016/j.virol.2011.01.002; Gu Shuo, 2010, Silence, V1, P11, DOI 10.1186/1758-907X-1-11; Gu S, 2009, NAT STRUCT MOL BIOL, V16, P144, DOI 10.1038/nsmb.1552; Haenen OLM, 2004, B EUR ASSOC FISH PAT, V24, P293; Hafner M, 2011, RNA, V17, P1697, DOI 10.1261/rna.2799511; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Hanson L, 2011, VIRUSES-BASEL, V3, P2160, DOI 10.3390/v3112160; Hedrick RP, 2000, J AQUAT ANIM HEALTH, V12, P44, DOI [10.1577/1548-8667(2000)012<0044:AHAWMM>2.0.CO;2, 10.1577/1548-8667(2000)012&lt;0044:AHAWMM&gt;2.0.CO;2]; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Ilouze M, 2006, MICROBIOL MOL BIOL R, V70, P147, DOI 10.1128/MMBR.70.1.147-156.2006; Ilouze M, 2012, VIRUS RES, V169, P98, DOI 10.1016/j.virusres.2012.07.015; Ilouze M, 2011, ECOL RES, V26, P885, DOI 10.1007/s11284-010-0694-2; Ji XH, 2008, CURR TOP MICROBIOL, V320, P99; Jiang H, 2008, BIOINFORMATICS, V24, P2395, DOI 10.1093/bioinformatics/btn429; Jiang P, 2007, NUCLEIC ACIDS RES, V35, pW339, DOI 10.1093/nar/gkm368; Jurak I, 2010, J VIROL, V84, P4659, DOI 10.1128/JVI.02725-09; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kincaid RP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003018; Koscianska E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028548; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kuchenbauer F, 2008, GENOME RES, V18, P1787, DOI 10.1101/gr.077578.108; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Langenberger D, 2009, BIOINFORMATICS, V25, P2298, DOI 10.1093/bioinformatics/btp419; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee LW, 2010, RNA, V16, P2170, DOI 10.1261/rna.2225110; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li Y, 2012, NUCLEIC ACIDS RES, V40, P4298, DOI 10.1093/nar/gks043; Liao IC, 2009, ASIA PAC J CLIN NUTR, V18, P564; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin HR, 2011, P NATL ACAD SCI USA, V108, P5148, DOI 10.1073/pnas.1102033108; Lin YT, 2010, RNA, V16, P1540, DOI 10.1261/rna.1967910; Linsen SEV, 2009, NAT METHODS, V6, P474, DOI 10.1038/nmeth0709-474; Lu J, 2008, NAT GENET, V40, P351, DOI 10.1038/ng.73; Lu J, 2010, NAT GENET, V42, P9, DOI 10.1038/ng0110-9; Meshesha Mesfin K, 2012, Open Virol J, V6, P38, DOI 10.2174/1874357901206010038; Michel B, 2010, J GEN VIROL, V91, P452, DOI 10.1099/vir.0.015198-0; Michel B, 2010, EMERG INFECT DIS, V16, P1835, DOI 10.3201/eid1612.100593; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Neukirch M, 1999, BULL EUR ASSN FISH P, V19, P221; Nozawa M, 2010, GENOME BIOL EVOL, V2, P180, DOI 10.1093/gbe/evq009; Pearson H, 2004, NATURE, V427, P577, DOI 10.1038/427577a; Penades JR, 2013, CURR OPIN MICROBIOL, V16, P163, DOI 10.1016/j.mib.2013.02.005; Perelberg A, 2003, ISR J AQUACULT-BAMID, V55, P5; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Pokorova D, 2005, VET MED-CZECH, V50, P139, DOI 10.17221/5607-VETMED; Pratt ZL, 2009, VIROLOGY, V386, P387, DOI 10.1016/j.virol.2009.01.006; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Rakus K, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-85; Reed AN, 2014, J VIROL, V88, P9297, DOI 10.1128/JVI.00990-14; Reese TA, 2010, J VIROL, V84, P10344, DOI 10.1128/JVI.00707-10; Riley KJL, 2010, J VIROL, V84, P5148, DOI 10.1128/JVI.00110-10; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Seo GJ, 2008, J VIROL, V82, P9823, DOI 10.1128/JVI.01144-08; Shi WY, 2009, NAT STRUCT MOL BIOL, V16, P183, DOI 10.1038/nsmb.1536; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; Sorefan Karim, 2012, Silence, V3, P4, DOI 10.1186/1758-907X-3-4; sourceforge.net, 2013, MICRORNA DISCOVERY B; St-Hilaire S, 2005, DIS AQUAT ORGAN, V67, P15, DOI 10.3354/dao067015; Su H, 2009, GENE DEV, V23, P304, DOI 10.1101/gad.1749809; Sullivan CS, 2007, METHOD ENZYMOL, V427, P3, DOI 10.1016/S0076-6879(07)27001-6; Taft RJ, 2010, NAT STRUCT MOL BIOL, V17, P1030, DOI 10.1038/nsmb.1841; Takane K, 2011, JPN J INFECT DIS, V64, P357; Tang S, 2009, J VIROL, V83, P1433, DOI 10.1128/JVI.01723-08; Toedling J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032724; Tsutsumi A, 2011, NAT STRUCT MOL BIOL, V18, P1153, DOI 10.1038/nsmb.2125; Umbach JL, 2010, VIROLOGY, V405, P592, DOI 10.1016/j.virol.2010.06.036; Umbach JL, 2010, J VIROL, V84, P695, DOI 10.1128/JVI.02013-09; Umbach JL, 2009, J VIROL, V83, P10677, DOI 10.1128/JVI.01185-09; Waltzek TB, 2005, J GEN VIROL, V86, P1659, DOI 10.1099/vir.0.80982-0; Waltzek TB, 2009, DIS AQUAT ORGAN, V84, P179, DOI 10.3354/dao02023; Walz N, 2010, J VIROL, V84, P716, DOI 10.1128/JVI.01302-09; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Wu HQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007566; Wu YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030988; Xu JR, 2013, J VIROL METHODS, V187, P372, DOI 10.1016/j.jviromet.2012.11.015; Yao YX, 2008, J VIROL, V82, P4007, DOI 10.1128/JVI.02659-07; Yao YX, 2007, J VIROL, V81, P7164, DOI 10.1128/JVI.00112-07; Yao YX, 2012, J GEN VIROL, V93, P1530, DOI 10.1099/vir.0.040634-0; Zhang WX, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r81; Zhu JY, 2010, J VIROL, V84, P10266, DOI 10.1128/JVI.01119-10	130	18	19	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125434	10.1371/journal.pone.0125434	http://dx.doi.org/10.1371/journal.pone.0125434			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928140	Green Published, gold, Green Submitted			2022-12-27	WOS:000353713100091
J	Liu, YP; Zhu, PT; Wang, YY; Wei, ZH; Tao, L; Zhu, ZJ; Sheng, XB; Wang, SL; Ruan, JS; Liu, ZG; Cao, YZ; Shan, YL; Sun, LH; Wang, AY; Chen, WX; Lu, Y				Liu, Yuping; Zhu, Pingting; Wang, Yingyu; Wei, Zhonghong; Tao, Li; Zhu, Zhijie; Sheng, Xiaobo; Wang, Siliang; Ruan, Junshan; Liu, Zhaoguo; Cao, Yuzhu; Shan, Yunlong; Sun, Lihua; Wang, Aiyun; Chen, Wenxing; Lu, Yin			Antimetastatic Therapies of the Polysulfide Diallyl Trisulfide against Triple-Negative Breast Cancer (TNBC) via Suppressing MMP2/9 by Blocking NF-kappa B and ERK/MAPK Signaling Pathways	PLOS ONE			English	Article							CELL-CYCLE ARREST; MATRIX METALLOPROTEINASES; APOPTOSIS INDUCTION; EXPRESSION; PROLIFERATION; STRATEGIES; MIGRATION; MMP-9; MAPK	Background Migration and invasion are two crucial steps of tumor metastasis. Blockage of these steps may be an effective strategy to reduce the risk. The objective of the present study was to investigate the effects of diallyl trisulfide (DATS), a natural organosulfuric compound with most sulfur atoms found in garlic, on migration and invasion in triple negative breast cancer (TNBC) cells. Molecular mechanisms underlying the anticancer effects of DATS were further investigated. Methods and Results MDA-MB-231 cells and HS 578t breast cancer cells were treated with different concentrations of DATS. DATS obviously suppressed the migration and invasion of two cell lines and changed the morphological. Moreover, DATS inhibited the mRNA/protein/enzymes activities of MMP2/9 via attenuating the NF-kappa B pathway. DATS also inhibited ERK/MAPK rather than p38 and JNK. Conclusion DATS inhibits MMP2/9 activity and the metastasis of TNBC cells, and emerges as a potential anti-cancer agent. The inhibitory effects are associated with down-regulation of the transcriptional activities of NF-kappa B and ERK/MAPK signaling pathways.	[Liu, Yuping; Zhu, Pingting; Wang, Yingyu; Wei, Zhonghong; Tao, Li; Zhu, Zhijie; Sheng, Xiaobo; Wang, Siliang; Ruan, Junshan; Liu, Zhaoguo; Cao, Yuzhu; Shan, Yunlong; Sun, Lihua; Wang, Aiyun; Chen, Wenxing; Lu, Yin] Nanjing Univ Chinese Med, Sch Pharm, Nanjing 210023, Jiangsu, Peoples R China; [Zhu, Pingting] Yangzhou Univ, Coll Med, Yangzhou 225009, Jiangsu, Peoples R China; [Wang, Aiyun; Chen, Wenxing; Lu, Yin] Nanjing Univ Chinese Med, Jiangsu Collaborat Innovat Ctr Tradit Chinese Med, Nanjing 210023, Jiangsu, Peoples R China	Nanjing University of Chinese Medicine; Yangzhou University; Nanjing University of Chinese Medicine	Lu, Y (corresponding author), Nanjing Univ Chinese Med, Sch Pharm, Nanjing 210023, Jiangsu, Peoples R China.	profyinlu@163.com	Tao, Li/AAF-4654-2021; Chen, Wenxing/GSI-9910-2022	Chen, Wenxing/0000-0003-4571-7622	National Natural Science Foundation of China [81173174, 81403260, 81202655]; National Key Technology Research & Development Program [2008BAI51B02]; Ph.D. Programs Foundation of Ministry of Education of China [20113237110008]; Chinese Postdoctoral Science Foundation [2014M551639]; Postdoctoral Science Foundation of Jiangsu province [1401138C]; Doctoral Innovation Project of Jiangsu Province [KYLX_0977]; Jiangsu College graduate research and innovation projects [KYLX_0977, CXZZ13_0627]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology Research & Development Program; Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Chinese Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Postdoctoral Science Foundation of Jiangsu province(China Postdoctoral Science Foundation); Doctoral Innovation Project of Jiangsu Province; Jiangsu College graduate research and innovation projects	This work was supported by the National Natural Science Foundation of China (No. 81173174, 81403260 and 81202655); The National Key Technology Research & Development Program (No. 2008BAI51B02); Ph.D. Programs Foundation of Ministry of Education of China (No. 20113237110008); Chinese Postdoctoral Science Foundation (2014M551639); Postdoctoral Science Foundation of Jiangsu province (1401138C); Doctoral Innovation Project of Jiangsu Province (KYLX_0977); Jiangsu College graduate research and innovation projects (No. KYLX_0977; CXZZ13_0627). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antosiewicz J, 2006, CANCER RES, V66, P5379, DOI 10.1158/0008-5472.CAN-06-0356; Arslan C, 2009, EXPERT OPIN PHARMACO, V10, P2081, DOI 10.1517/14656560903117309; Berra E, 1995, EMBO J, V14, P6157, DOI 10.1002/j.1460-2075.1995.tb00306.x; Calvo-Gomez O, 2004, J CHROMATOGR A, V1036, P91, DOI 10.1016/j.chroma.2004.02.072; Chandra-Kuntal K, 2013, BREAST CANCER RES TR, V138, P69, DOI 10.1007/s10549-013-2440-2; Chandra-Kuntal K, 2010, CANCER PREV RES, V3, P1473, DOI 10.1158/1940-6207.CAPR-10-0123; Eckhardt BL, 2012, NAT REV DRUG DISCOV, V11, P479, DOI 10.1038/nrd2372; Elias AD, 2010, AM J CLIN ONCOL-CANC, V33, P637, DOI 10.1097/COC.0b013e3181b8afcf; Ferlay J, 2012, GLOBOCAN 2012 ESTIMA; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Galeone C, 2009, PUBLIC HEALTH NUTR, V12, P1576, DOI 10.1017/S1368980008003820; Garg P, 2010, CANCER RES, V70, P792, DOI 10.1158/0008-5472.CAN-09-3166; Gershtein ES, 2010, B EXP BIOL MED+, V150, P71, DOI 10.1007/s10517-010-1072-3; Gilkes DM, 2014, NAT REV CANCER, V14, P430, DOI 10.1038/nrc3726; Gong YX, 2014, CANCERS, V6, P1298, DOI 10.3390/cancers6031298; Hadler-Olsen E, 2013, TUMOR BIOL, V34, P2041, DOI 10.1007/s13277-013-0842-8; Hayden MS, 2014, SEMIN IMMUNOL, V26, P253, DOI 10.1016/j.smim.2014.05.004; Hong BH, 2013, MOL NUTR FOOD RES, V57, P886, DOI 10.1002/mnfr.201200715; Hosono T, 2005, J BIOL CHEM, V280, P41487, DOI 10.1074/jbc.M507127200; Irvin WJ, 2008, EUR J CANCER, V44, P2799, DOI 10.1016/j.ejca.2008.09.034; Jakubikova J, 2006, NEOPLASMA, V53, P191; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Lai KC, 2013, ENVIRON TOXICOL, V28, P479, DOI 10.1002/tox.20737; Levi F, 1999, BRIT J CANCER, V79, P1283, DOI 10.1038/sj.bjc.6690206; Li WJ, 2012, ACTA BIOCH BIOPH SIN, V44, P577, DOI 10.1093/abbs/gms033; Luo Y, 2009, BIOCHEMISTRY-US, V48, P1838, DOI 10.1021/bi8020789; Malki A, 2009, CANCER BIOL THER, V8, P2174, DOI 10.4161/cbt.8.22.9882; Mehner C, 2014, ONCOTARGET, V5, P2736, DOI 10.18632/oncotarget.1932; Nkrumah-Elie YM, 2012, FOOD CHEM TOXICOL, V50, P2524, DOI 10.1016/j.fct.2012.04.010; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Reddy KB, 1999, INT J CANCER, V82, P268, DOI 10.1002/(SICI)1097-0215(19990719)82:2<268::AID-IJC18>3.3.CO;2-W; Shin DY, 2014, ENVIRON TOXICOL PHAR, V37, P74, DOI 10.1016/j.etap.2013.11.002; Tan AR, 2008, CANCER J, V14, P343, DOI 10.1097/PPO.0b013e31818d839b; Tsubura A, 2011, ANTI-CANCER AGENT ME, V11, P249, DOI 10.2174/187152011795347441; Uekita T, 2014, MOL CANCER RES IN PR; Wu XJ, 2009, ENVIRON MOL MUTAGEN, V50, P266, DOI 10.1002/em.20467; Xin JW, 2009, TRIGGERS PATHWAYS AN, V50, P266; Yi L, 2013, FOOD CHEM TOXICOL, V57, P362, DOI 10.1016/j.fct.2013.04.001	38	51	54	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0123781	10.1371/journal.pone.0123781	http://dx.doi.org/10.1371/journal.pone.0123781			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927362	Green Published, Green Submitted, gold			2022-12-27	WOS:000353713100022
J	Lo, K; Cheung, C; Lee, A; Tam, WWS; Keung, V				Lo, Kenneth; Cheung, Calvin; Lee, Albert; Tam, Wilson W. S.; Keung, Vera			Associations between Parental Feeding Styles and Childhood Eating Habits: A Survey of Hong Kong Pre-School Children	PLOS ONE			English	Article							VEGETABLE CONSUMPTION; FOOD-CONSUMPTION; FRUIT; BEHAVIOR; RISK; VALIDATION	Childhood obesity is a global public health issue, including in the Chinese setting, and its prevalence has increased dramatically throughout the last decade. Since the origins of childhood obesity may lie in the pre-school period, factors relating to very young children's food consumption should be investigated. Parental influence, including feeding style, is the major determinant of childhood dietary behaviour through altering food provision and social environment. However, the applicability of previous research on parental feeding styles was limited by small sample size. To evaluate the influence of parental feeding styles on children's dietary patterns, a cross-sectional study was conducted among 4553 pre-schoolers in Hong Kong. Information was obtained about dietary intake and how regularly they had breakfast, using previous health surveillance surveys taken among primary school students. Parental feeding styles were assessed by a validated Parental Feeding Style Questionnaire and categorized into 'instrumental feeding', 'emotional feeding', 'prompting and encouragement to eat' and 'control over eating'. Multivariable analysis was performed, adjusted for demographic information. Instrumental and/or emotional feeding was found to relate to inadequate consumption of fruit, vegetables and breakfast, and positively correlated with intake of high-energy-density food. Encouragement on eating was associated with more frequent consumption of fruits, vegetables, dairy products and breakfast. Control over eating correlated with more frequent consumption of fruits, vegetables and breakfast, and less consumption of dairy products and high-energy-density food. The present study has provided evidence on the associations between parental feeding styles and dietary patterns of Hong Kong pre-school children from a reasonably large population. Parents should avoid instrumental and emotional feeding, and implement control and encouragement to promote healthy food intake. Longitudinal studies and interventions on parental feeding style are required to confirm the research findings.	[Lo, Kenneth; Lee, Albert] Chinese Univ Hong Kong, Fac Med, JC Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Cheung, Calvin; Keung, Vera] Chinese Univ Hong Kong, Ctr Hlth Educ & Hlth Promot, Hong Kong, Hong Kong, Peoples R China; [Tam, Wilson W. S.] Natl Univ Singapore, Yong Loo Lin Sch Med, Alice Lee Ctr Nursing Studies, Singapore 117548, Singapore	Chinese University of Hong Kong; Chinese University of Hong Kong; National University of Singapore	Lee, A (corresponding author), Chinese Univ Hong Kong, Fac Med, JC Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China.	alee@cuhk.edu.hk	Lo, Kenneth/ABB-6248-2020; TAM, Wilson W.S./H-5890-2019; Tam, Wilson/K-1664-2019	Lo, Kenneth/0000-0003-4624-2737; TAM, Wilson W.S./0000-0003-0641-3060; 	Pfizer for Nutrition Education for Kindergartens	Pfizer for Nutrition Education for Kindergartens	This study was supported by a sponsorship from Pfizer for Nutrition Education for Kindergartens. No grant number and URL are available. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birch LL, 2001, PEDIATR CLIN N AM, V48, P893, DOI 10.1016/S0031-3955(05)70347-3; Blissett J, 2011, APPETITE, V57, P826, DOI 10.1016/j.appet.2011.05.318; Boeing H, 2012, EUR J NUTR, V51, P637, DOI 10.1007/s00394-012-0380-y; Chen HY, 2010, J CLIN NURS, V19, P234, DOI 10.1111/j.1365-2702.2009.02896.x; Deparment of Health, 2012, BACKGR STARTSMART SC; Department of Health, 2011, 3 6 YEARS OLD FOOD P; Department of Health, 2011, NUTR GUID CHILDR AG; Elwood PC, 2010, LIPIDS, V45, P925, DOI 10.1007/s11745-010-3412-5; Faith MS, 2004, OBES RES, V12, P1711, DOI 10.1038/oby.2004.212; Hennessy E, 2012, J ACAD NUTR DIET, V112, P142, DOI 10.1016/j.jada.2011.08.030; Hubbs-Tait L, 2008, J AM DIET ASSOC, V108, P1154, DOI 10.1016/j.jada.2008.04.008; Hughes SO, 2007, J DEV BEHAV PEDIATR, V28, P100, DOI 10.1097/01.DBP.0000267561.34199.a9; Hurley KM, 2011, J NUTR, V141, P495, DOI 10.3945/jn.110.130047; Jansen E, 2012, EARLY CHILD DEV CARE, V182, P967, DOI 10.1080/03004430.2012.678593; Lazarte CE, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-61; Lee A, 2004, PUBLIC HEALTH, V118, P88, DOI 10.1016/S0033-3506(03)00174-4; Lee A, 2013, PUBLIC HEALTH, V127, P182, DOI 10.1016/j.puhe.2012.11.001; Loth KA, 2013, APPETITE, V60, P140, DOI 10.1016/j.appet.2012.09.019; Moens E, 2007, J PEDIATR PSYCHOL, V32, P52, DOI 10.1093/jpepsy/jsl011; Monge-Rojas R, 2010, APPETITE, V55, P253, DOI 10.1016/j.appet.2010.06.010; NEWMAN J, 1992, J EXP CHILD PSYCHOL, V53, P200, DOI 10.1016/0022-0965(92)90049-C; O'Connor TM, 2010, PUBLIC HEALTH NUTR, V13, P91, DOI 10.1017/S1368980009005916; Ogden J, 2006, APPETITE, V47, P100, DOI 10.1016/j.appet.2006.03.330; Patrick H, 2005, APPETITE, V44, P243, DOI 10.1016/j.appet.2002.07.001; Pearson N, 2009, PUBLIC HEALTH NUTR, V12, P267, DOI 10.1017/S1368980008002589; Sleddens EFC, 2010, APPETITE, V54, P30, DOI 10.1016/j.appet.2009.09.002; Smith KJ, 2010, AM J CLIN NUTR, V92, P1316, DOI 10.3945/ajcn.2010.30101; Song Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053069; Tam W, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1194; Vaughn AE, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-61; Wardle J, 2002, OBES RES, V10, P453, DOI 10.1038/oby.2002.63	31	30	33	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124753	10.1371/journal.pone.0124753	http://dx.doi.org/10.1371/journal.pone.0124753			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0MA	25927836	Green Published, gold, Green Submitted			2022-12-27	WOS:000353713100047
J	Manning, J; Reynolds, G; Saygin, ZM; Hofmann, SG; Pollack, M; Gabrieli, JDE; Whitfield-Gabrieli, S				Manning, Joshua; Reynolds, Gretchen; Saygin, Zeynep M.; Hofmann, Stefan G.; Pollack, Mark; Gabrieli, John D. E.; Whitfield-Gabrieli, Susan			Altered Resting-State Functional Connectivity of the Frontal-Striatal Reward System in Social Anxiety Disorder	PLOS ONE			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; ANTERIOR CINGULATE; HUMAN BRAIN; FMRI; ANTICIPATION; ADOLESCENTS; VALUATION; NETWORKS	We investigated differences in the intrinsic functional brain organization (functional connectivity) of the human reward system between healthy control participants and patients with social anxiety disorder. Functional connectivity was measured in the resting-state via functional magnetic resonance imaging (fMRI). 53 patients with social anxiety disorder and 33 healthy control participants underwent a 6-minute resting-state fMRI scan. Functional connectivity of the reward system was analyzed by calculating whole-brain temporal correlations with a bilateral nucleus accumbens seed and a ventromedial prefrontal cortex seed. Patients with social anxiety disorder, relative to the control group, had (1) decreased functional connectivity between the nucleus accumbens seed and other regions associated with reward, including ventromedial prefrontal cortex; (2) decreased functional connectivity between the ventromedial prefrontal cortex seed and lateral prefrontal regions, including the anterior and dorsolateral prefrontal cortices; and (3) increased functional connectivity between both the nucleus accumbens seed and the ventromedial prefrontal cortex seed with more posterior brain regions, including anterior cingulate cortex. Social anxiety disorder appears to be associated with widespread differences in the functional connectivity of the reward system, including markedly decreased functional connectivity between reward regions and between reward regions and lateral prefrontal cortices, and markedly increased functional connectivity between reward regions and posterior brain regions.	[Manning, Joshua; Saygin, Zeynep M.; Gabrieli, John D. E.; Whitfield-Gabrieli, Susan] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Reynolds, Gretchen; Gabrieli, John D. E.; Whitfield-Gabrieli, Susan] MIT, Poitras Ctr Affect Disorders Res, Cambridge, MA 02139 USA; [Manning, Joshua; Saygin, Zeynep M.; Gabrieli, John D. E.; Whitfield-Gabrieli, Susan] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Reynolds, Gretchen; Hofmann, Stefan G.] Boston Univ, Dept Psychol, Boston, MA 02215 USA; [Pollack, Mark] Rush Univ, Med Ctr, Chicago, IL 60612 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Boston University; Rush University	Manning, J (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	joshuam@mit.edu	Hofmann, Stefan G/B-8769-2014; Gabrieli, John/AAJ-2869-2020; Saygin, Zeynep M./AAV-4951-2020	Hofmann, Stefan G/0000-0002-3548-9681; 	National Institutes of Health from the National Institute of Mental Health [R01MH078308, R01MH075889]; Poitras Center for Affective Disorder Research at the McGovern Institute for Brain Research at the Massachusetts Institute of Technology, Cambridge, MA; Massachusetts Institute of Technology, Cambridge, MA; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078308, R01MH075889] Funding Source: NIH RePORTER	National Institutes of Health from the National Institute of Mental Health; Poitras Center for Affective Disorder Research at the McGovern Institute for Brain Research at the Massachusetts Institute of Technology, Cambridge, MA; Massachusetts Institute of Technology, Cambridge, MA; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	SGH and MP were funded by National Institutes of Health grants R01MH078308 and R01MH075889 from the National Institute of Mental Health. The study was funded by the Poitras Center for Affective Disorder Research at the McGovern Institute for Brain Research at the Massachusetts Institute of Technology, Cambridge, MA. JM was funded by the Janet and Sheldon Razin Fellowship at the Massachusetts Institute of Technology, Cambridge, MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; [Anonymous], 2008, STAT PARAMETRIC MAPP; Bar-Haim Y, 2009, PSYCHOL SCI, V20, P1009, DOI 10.1111/j.1467-9280.2009.02401.x; Bartra O, 2013, NEUROIMAGE, V76, P412, DOI 10.1016/j.neuroimage.2013.02.063; Baur V, 2013, HUM BRAIN MAPP, V34, P437, DOI 10.1002/hbm.21447; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Bewernick BH, 2010, BIOL PSYCHIAT, V67, P110, DOI 10.1016/j.biopsych.2009.09.013; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blair K, 2006, J NEUROSCI, V26, P11379, DOI 10.1523/JNEUROSCI.1640-06.2006; Bruhl AB, 2011, BRAIN RES, V1378, P72, DOI 10.1016/j.brainres.2010.12.084; Cauda F, 2011, J COGNITIVE NEUROSCI, V23, P2864, DOI 10.1162/jocn.2011.21624; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Freitas-Ferrari MC, 2010, PROG NEURO-PSYCHOPH, V34, P565, DOI 10.1016/j.pnpbp.2010.02.028; Fujiwara J, 2009, J NEUROPHYSIOL, V101, P3284, DOI 10.1152/jn.90909.2008; Glascher J, 2009, CEREB CORTEX, V19, P483, DOI 10.1093/cercor/bhn098; Guyer AE, 2006, J NEUROSCI, V26, P6399, DOI 10.1523/JNEUROSCI.0666-06.2006; Hahn A, 2011, NEUROIMAGE, V56, P881, DOI 10.1016/j.neuroimage.2011.02.064; Helfinstein SM, 2011, NEUROPSYCHOLOGIA, V49, P479, DOI 10.1016/j.neuropsychologia.2010.12.015; Hofmann Stefan G., 2007, Cognitive Behaviour Therapy, V36, P193, DOI 10.1080/16506070701421313; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Liao W, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0015283, DOI 10.1371/JOURNAL.PONE.0015283]; Liebowitz M R, 1987, Mod Probl Pharmacopsychiatry, V22, P141; Margulies DS, 2007, NEUROIMAGE, V37, P579, DOI 10.1016/j.neuroimage.2007.05.019; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Phan KL, 2009, BIOL PSYCHIAT, V66, P691, DOI 10.1016/j.biopsych.2009.02.028; Qiu CJ, 2011, PSYCHIAT RES-NEUROIM, V194, P47, DOI 10.1016/j.pscychresns.2011.01.010; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Sladky R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050050; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Thesen S, 2000, MAGNET RESON MED, V44, P457, DOI 10.1002/1522-2594(200009)44:3<457::AID-MRM17>3.0.CO;2-R; Triantafyllou C, 2011, NEUROIMAGE, V55, P597, DOI 10.1016/j.neuroimage.2010.11.084; Turner SM, 1989, SOCIAL PHOBIA ANXIET; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Wechsler D., 1981, WAIS R MANUAL WECHSL	38	28	29	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125286	10.1371/journal.pone.0125286	http://dx.doi.org/10.1371/journal.pone.0125286			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928647	Green Published, gold			2022-12-27	WOS:000353713100077
J	Pacilli, A; Lamacchia, O; Fontana, A; Copetti, M; Cignarelli, M; Trischitta, V; De Cosmo, S				Pacilli, Antonio; Lamacchia, Olga; Fontana, Andrea; Copetti, Massimiliano; Cignarelli, Mauro; Trischitta, Vincenzo; De Cosmo, Salvatore			Target Values of Cardiovascular Risk Factors Are Not Associated with All-Cause Mortality in Patients with Type 2 Diabetes Mellitus	PLOS ONE			English	Article							GLUCOSE CONTROL; BLOOD-PRESSURE; FOLLOW-UP; METAANALYSIS; CHOLESTEROL; PEOPLE; DISEASE; EVENTS; COMPLICATIONS; PREVENTION	Background To investigate prospectively the relationship between target values of glycated hemoglobin, blood pressure and LDL-cholesterol, as considered in a combined fashion, and all-cause mortality in patients with type 2 diabetes mellitus. Methods Two cohorts of patients with type 2 diabetes mellitus, the Gargano Mortality Study (n=810) and the Foggia Mortality Study (n=929), were investigated. A weighted target risk score was built as a weight linear combination of the recommended targets reached by each patient. Results In the Gargano Mortality Study and in the Foggia Mortality Study (mean follow up=7.4 and 5.5 years, respectively), 161 (19.9%) and 220 (23.7%) patients died, with an age and sex adjusted annual incidence rate of 2.1 and 2.8 per 100 person-years, respectively. In both study samples the weighted target risk score tended to be linearly associated with all-cause mortality (HR for one point increment=1.30, 95% CI: 1.11-1.53, p=0.001, and HR=1.08, 95% CI: 0.95-1.24, p=0.243, respectively). When the two cohorts were pooled and analyzed together, a clear association between weighted target risk score and all-cause mortality was observed (HR for one point increment=1.17, 95% CI: 1.05-1.30, p=0.004). This counter-intuitive association was no longer observable in a model including age, sex, body mass index, smoking habit, estimated glomerular filtration rate, albuminuria and anti-diabetic, anti-hypertensive and anti-dyslipidemic treatment as covariates (HR for one point increment=0.99, 95% CI: 0.87-1.12, p=0.852). Conclusions In a real life clinical set of patients with type 2 diabetes mellitus, the combination of recommended target values of established cardiovascular risk factors is not associated with allcause mortality.	[Pacilli, Antonio; De Cosmo, Salvatore] IRCCS Casa Sollievo Sofferenza, Dept Med Sci, Unit Internal Med, San Giovanni Rotondo, Italy; [Lamacchia, Olga; Cignarelli, Mauro] Univ Foggia, Dept Surg & Med Sci, Unit Endocrinol & Metab Dis, Foggia, FG, Italy; [Fontana, Andrea; Copetti, Massimiliano] IRCCS Casa Sollievo Sofferenza, Unit Biostat, San Giovanni Rotondo, Italy; [Trischitta, Vincenzo] IRCCS Casa Sollievo Sofferenza, Res Unit Diabet & Endocrine Dis, San Giovanni Rotondo, Italy; [Trischitta, Vincenzo] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy	IRCCS Casa Sollievo Della Sofferenza; University of Foggia; IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza; Sapienza University Rome	De Cosmo, S (corresponding author), IRCCS Casa Sollievo Sofferenza, Dept Med Sci, Unit Internal Med, San Giovanni Rotondo, Italy.	sdecosm@tin.it	COPETTI, MASSIMILIANO/K-3186-2016; De Cosmo, Salvatore/J-7420-2016; Fontana, Andrea/J-8584-2016; TRISCHITTA, Vincenzo/K-1487-2016	COPETTI, MASSIMILIANO/0000-0002-7960-5947; De Cosmo, Salvatore/0000-0001-8787-8286; Fontana, Andrea/0000-0002-6660-5315; TRISCHITTA, Vincenzo/0000-0003-1174-127X	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	Support was provided by the Italian Ministry of Health grants RF2009 (SDC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Boussageon R, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4169; Bryg R J, 1999, Curr Hypertens Rep, V1, P337, DOI 10.1007/s11906-999-0043-4; Chiang HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109501; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Currie CJ, 2010, LANCET, V375, P481, DOI 10.1016/S0140-6736(09)61969-3; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; De Cosmo S, 2013, DIABETES CARE, V36, P2830, DOI 10.2337/dc12-1906; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2998, DOI 10.1001/jama.288.23.2998; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Ghali WA, 2001, JAMA-J AM MED ASSOC, V286, P1494, DOI 10.1001/jama.286.12.1494; Goldman N, 2006, J GERONTOL A-BIOL, V61, P1070, DOI 10.1093/gerona/61.10.1070; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Griffin SJ, 2011, LANCET, V378, P156, DOI 10.1016/S0140-6736(11)60698-3; Hemmingsen B, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6898; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; ISO H, 1994, J CLIN EPIDEMIOL, V47, P961, DOI 10.1016/0895-4356(94)90110-4; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI DOI 10.1001/JAMA.2013.284427; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Kelly TN, 2009, ANN INTERN MED, V151, P394, DOI 10.7326/0003-4819-151-6-200909150-00137; Khaw KT, 2001, BMJ-BRIT MED J, V322, P15, DOI 10.1136/bmj.322.7277.15; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lithovius R, 2015, ACTA DIABETOL, V52, P31, DOI 10.1007/s00592-014-0595-x; Nicholas J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068008; Olkin I, 1998, BIOMETRICS, V54, P317, DOI 10.2307/2534018; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Ronnback M, 2006, HYPERTENSION, V47, P168, DOI 10.1161/01.HYP.0000199667.30253.b7; Schatz IJ, 2001, LANCET, V358, P351, DOI 10.1016/S0140-6736(01)05553-2; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Turnbull FM, 2009, DIABETOLOGIA, V52, P2288, DOI 10.1007/s00125-009-1470-0; Vamos EP, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5567; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; Zoungas S, 2010, NEW ENGL J MED, V363, P1410, DOI 10.1056/NEJMoa1003795	40	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124536	10.1371/journal.pone.0124536	http://dx.doi.org/10.1371/journal.pone.0124536			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928715	Green Submitted, Green Published, gold			2022-12-27	WOS:000353713100038
J	Sivanandhan, G; Dev, GK; Theboral, J; Selvaraj, N; Ganapathi, A; Manickavasagam, M				Sivanandhan, Ganeshan; Dev, Gnajothi Kapil; Theboral, Jeevaraj; Selvaraj, Natesan; Ganapathi, Andy; Manickavasagam, Markandan			Sonication, Vacuum Infiltration and Thiol Compounds Enhance the Agrobacterium-Mediated Transformation Frequency of Withania somnifera (L.) Dunal	PLOS ONE			English	Article							WITHANOLIDES PRODUCTION; ROOT CULTURES; GENE; CLONING; REGENERATION; EXPRESSION; EFFICIENCY; WITHAFERIN; SELECTION; CITRUS	In the present study, we have established a stable transformation protocol via Agrobacterium tumafacines for the pharmaceutically important Withania somnifera. Six day-old nodal explants were used for 3 day co-cultivation with Agrobacterium tumefaciens strain LBA4404 harbouring the vector pCAMIBA2301. Among the different injury treatments, sonication, vacuum infiltration and their combination treatments tested, a vacuum infiltration for 10 min followed by sonication for 10 sec with A. tumefaciens led to a higher transient GUS expression (84% explants expressing GUS at regenerating sites). In order to improve gene integration, thiol compounds were added to co-cultivation medium. A combined treatment of L-Cys at 100 mg/l, STS at 125 mg/l, DTT at 75 mg/l resulted in a higher GUS expression (90%) in the nodal explants. After 3 days of co-cultivation, the explants were subjected to three selection cycles with increasing concentrations of kanamycin [100 to 115 mg/l]. The integration and expression of gusA gene in T0 and T1 transgenic plants were confirmed by polymerase chain reaction (PCR), and Southern blott analysis. These transformed plants (T0 and T1) were fertile and morphologically normal. From the present investigation, we have achieved a higher transformation efficiency of (10%). Withanolides (withanolide A, withanolide B, withanone and withaferin A) contents of transformed plants (T0 and T1) were marginally higher than control plants.	[Sivanandhan, Ganeshan; Dev, Gnajothi Kapil; Theboral, Jeevaraj; Ganapathi, Andy; Manickavasagam, Markandan] Bharathidasan Univ, Sch Biotechnol, Dept Biotechnol & Genet Engn, Plant Mol Biol Lab, Tiruchirappalli 620024, Tamil Nadu, India; [Selvaraj, Natesan] Periyar EVR Coll Autonomous, Dept Bot, Plant Tissue Culture Lab, Tiruchirappalli 620023, Tamil Nadu, India; [Sivanandhan, Ganeshan] Chungnam Natl Univ, Coll Agr & Life Sci, Dept Hort, Mol Genet & Genom Lab, Taejon 305764, South Korea	Bharathidasan University; Chungnam National University	Sivanandhan, G (corresponding author), Bharathidasan Univ, Sch Biotechnol, Dept Biotechnol & Genet Engn, Plant Mol Biol Lab, Tiruchirappalli 620024, Tamil Nadu, India.	gsivabdu@gmail.com; manickbiotech@gmail.com		, G Kapildev/0000-0001-5448-4838	Council of Scientific and Industrial Research (CSIR) [38(1180/08/EMR-II)]; University Grants Commissions (UGC), Government of India; Council of Scientific and Industrial Research (CSIR), Government of India	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commissions (UGC), Government of India; Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This research was supported by Council of Scientific and Industrial Research (CSIR) [38(1180/08/EMR-II)]. Prof. A. Ganapathi is thankful to the University Grants Commissions (UGC), Government of India, for the award of UGC-BSR (Basic Scientific Research Fellowship). The first author thankfully acknowledges the Council of Scientific and Industrial Research (CSIR), Government of India, for the award of CSIR-SRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, Altern Med Rev, V9, P211; Bakshi S, 2011, PLANT CELL REP, V30, P2281, DOI 10.1007/s00299-011-1133-8; Beranova M, 2008, PLANT CELL TISS ORG, V94, P253, DOI 10.1007/s11240-007-9335-z; Berger S, 2007, J EXP BOT, V58, P4019, DOI 10.1093/jxb/erm298; Bhat WW, 2012, GENE, V499, P25, DOI 10.1016/j.gene.2012.03.004; Bond JE, 1998, PLANT CELL REP, V18, P229, DOI 10.1007/s002990050562; Chatterjee S, 2010, PHYTOCHEMISTRY, V71, P1085, DOI 10.1016/j.phytochem.2010.04.001; De Clercq J, 2002, PLANT CELL REP, V21, P333, DOI 10.1007/s00299-002-0518-0; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Dutta I, 2013, PLANT CELL TISS ORG, V112, P289, DOI 10.1007/s11240-012-0236-4; Frame BR, 2002, PLANT PHYSIOL, V129, P13, DOI 10.1104/pp.000653; Franklin G, 2007, PLANT SCI, V172, P1193, DOI 10.1016/j.plantsci.2007.02.017; GOLDBERG JB, 1984, J BACTERIOL, V158, P1115, DOI 10.1128/JB.158.3.1115-1121.1984; Gupta P, 2013, PROTOPLASMA, V250, P285, DOI 10.1007/s00709-012-0410-x; Heath MC, 2000, CURR OPIN PLANT BIOL, V3, P315, DOI 10.1016/S1369-5266(00)00087-X; JEFFERSON RA, 1987, EMBO J, V6, P3901; Joubert P, 2002, PLANT SCI, V162, P733, DOI 10.1016/S0168-9452(02)00012-2; Kole C, 2009, COMPENDIUM TRANSGENI, P115, DOI DOI 10.1002/9781405181099.K0307; Kothari SK, 2003, J HORTIC SCI BIOTECH, V78, P422, DOI 10.1080/14620316.2003.11511642; Liu ZC, 2005, MOL BREEDING, V16, P189, DOI 10.1007/s11032-005-6616-2; Mehrotra M, 2011, PLANT CELL REP, V30, P1603, DOI 10.1007/s00299-011-1071-5; Mirjalili HM, 2009, ENG LIFE SCI, V9, P197, DOI 10.1002/elsc.200800081; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Olhoft PM, 2003, PLANTA, V216, P723, DOI 10.1007/s00425-002-0922-2; Olhoft PM, 2001, PLANT CELL REP, V20, P706, DOI 10.1007/s002990100379; Olhoft PM, 2001, PLANT CELL REP, V20, P731, DOI 10.1007/s002990100388; Padmanabhan P, 2009, PLANT CELL REP, V28, P31, DOI 10.1007/s00299-008-0618-6; Pandey V, 2010, PLANT CELL REP, V29, P133, DOI 10.1007/s00299-009-0805-0; Park BJ, 2005, PLANT CELL REP, V24, P494, DOI 10.1007/s00299-005-0973-5; Pathak MR, 2008, PLANT CELL TISS ORG, V93, P65, DOI 10.1007/s11240-008-9344-6; de Oliveira MLP, 2009, PLANT CELL REP, V28, P387, DOI 10.1007/s00299-008-0646-2; Rajesh M, 2013, PLANT CELL TISS ORG, V114, P71, DOI 10.1007/s11240-013-0307-1; Ray S, 1999, PLANT SCI, V146, P1, DOI 10.1016/S0168-9452(99)00077-1; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sangwan RS, 2004, CURR SCI INDIA, V86, P461; Sharma M, 2011, PLANT CELL TISS ORG, V105, P93, DOI 10.1007/s11240-010-9846-x; Shilpa KS, 2010, PLANT CELL TISS ORG, V103, P387, DOI 10.1007/s11240-010-9792-7; Simoh S, 2009, J PLANT PHYSIOL, V166, P1005, DOI 10.1016/j.jplph.2008.11.015; Sivanandhan G, 2012, IND CROP PROD, V37, P124, DOI 10.1016/j.indcrop.2011.11.022; Sivanandhan G, 2013, PROTOPLASMA, V250, P885, DOI 10.1007/s00709-012-0471-x; Sivanandhan G, 2013, PLANT CELL TISS ORG, V114, P121, DOI 10.1007/s11240-013-0297-z; Sivanandhan G, 2013, ACTA PHYSIOL PLANT, V35, P715, DOI 10.1007/s11738-012-1112-x; Sivanandhan G, 2012, NAT PROD COMMUN, V7, P1271; Sivanandhan G, 2012, APPL BIOCHEM BIOTECH, V168, P681, DOI 10.1007/s12010-012-9809-2; Sivanandhan G, 2011, ACTA PHYSIOL PLANT, V33, P2279, DOI 10.1007/s11738-011-0768-y; Sonia, 2007, PLANT CELL REP, V26, P187, DOI 10.1007/s00299-006-0224-4; Tang W, 2001, PLANTA, V213, P981, DOI 10.1007/s004250100566; Trick HN, 1997, TRANSGENIC RES, V6, P329, DOI 10.1023/A:1018470930944; Vasil IK, 1999, MOL IMPROVEMENT CERE, P43, DOI 10.1007/978-94-011-4802-3_4; Vergauwe A, 1996, PLANT CELL REP, V15, P929, DOI 10.1007/BF00231590; Yasmeen A, 2009, PLANT MOL BIOL REP, V27, P20, DOI 10.1007/s11105-008-0044-5; Zeng P, 2004, PLANT CELL REP, V22, P478, DOI 10.1007/s00299-003-0712-8	52	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124693	10.1371/journal.pone.0124693	http://dx.doi.org/10.1371/journal.pone.0124693			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927703	gold, Green Submitted, Green Published			2022-12-27	WOS:000353713100046
J	Uphoff, CC; Lange, S; Denkmann, SA; Garritsen, HSP; Drexler, HG				Uphoff, Cord C.; Lange, Sandra; Denkmann, Sabine A.; Garritsen, Henk S. P.; Drexler, Hans G.			Prevalence and Characterization of Murine Leukemia Virus Contamination in Human Cell Lines	PLOS ONE			English	Article							IDENTIFICATION; RETROVIRUSES; INACTIVATION; COMPLEMENT	Contaminations of cell cultures with microbiological organisms are well documented and can be managed in cell culture laboratories applying reliable detection, elimination and prevention strategies. However, the presence of viral contaminations in cell cultures is still a matter of debate and cannot be determined with general detection methods. In the present study we screened 577 human cell lines for the presence of murine leukemia viruses (MLV). Nineteen cell lines were found to be contaminated with MLV, including 22RV1 which is contaminated with the xenotropic murine leukemia virus-related virus variant of MLV. Of these, 17 cell lines were shown to produce active retroviruses determined by product enhanced reverse transcriptase PCR assay for reverse transcriptase activity. The contaminated cell lines derive from various solid tumor types as well as from leukemia and lymphoma types. A contamination of primary human cells from healthy volunteers could not be substantiated. Sequence analyses of 17 MLV PCR products and five complete MLV genomes of different infected cell lines revealed at least three groups of related MLV genotypes. The viruses harvested from the supernatants of infected cell cultures were infectious to uninfected cell cultures. In the course of the study we found that contamination of human genomic DNA preparations with murine DNA can lead to false-positive results. Presumably, xeno-transplantations of the human tumor cells into immune-deficient mice to determine the tumorigenicity of the cells are mainly responsible for the MLV contaminations. Furthermore, the use of murine feeder layer cells during the establishment of human cell lines and a cross-contamination with MLV from infected cultures might be sources of infection. A screening of cell cultures for MLV contamination is recommended given a contamination rate of 3.3%.	[Uphoff, Cord C.; Lange, Sandra; Denkmann, Sabine A.; Drexler, Hans G.] Leibniz Inst DSMZ German Collect Microorganisms &, Dept Human & Anim Cell Lines, Braunschweig, Germany; [Garritsen, Henk S. P.] Municipal Hosp, Inst Clin Transfus Med, Braunschweig, Germany	Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ)	Uphoff, CC (corresponding author), Leibniz Inst DSMZ German Collect Microorganisms &, Dept Human & Anim Cell Lines, Braunschweig, Germany.	cup@dsmz.de						ALTORKI N, 1993, CANCER-AM CANCER SOC, V72, P649, DOI 10.1002/1097-0142(19930801)72:3<649::AID-CNCR2820720305>3.0.CO;2-L; BARBEY S, 1990, INT J CANCER, V45, P546, DOI 10.1002/ijc.2910450329; BEPLER G, 1987, J CANCER RES CLIN, V113, P31, DOI 10.1007/BF00389964; Camps J, 2006, LEUKEMIA RES, V30, P923, DOI 10.1016/j.leukres.2005.11.013; CHAMPELOVIER P, 1994, LEUKEMIA RES, V18, P903, DOI 10.1016/0145-2126(94)90102-3; Chang A, 1997, J VIROL METHODS, V65, P45, DOI 10.1016/S0166-0934(96)02168-4; Cmarik JL, 2011, VIRUSES-BASEL, V3, P2442, DOI 10.3390/v3122442; Deichmann M, 2005, ARCH DERMATOL RES, V296, P345, DOI 10.1007/s00403-004-0501-4; Dirks Wilhelm G, 2013, Methods Mol Biol, V946, P27, DOI 10.1007/978-1-62703-128-8_3; Drexler HG, 2006, LEUKEMIA RES, V30, P911, DOI 10.1016/j.leukres.2006.02.015; Drexler HG, 2015, DSMZ CATALOGUE HUMAN; Hempel HA, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00156; Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92; Hue S, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-111; Kakisi OK, 2013, TRANSFUSION MED, V23, P142, DOI 10.1111/tme.12049; Kozak CA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-101; KUFF EL, 1988, ADV CANCER RES, V51, P183, DOI 10.1016/S0065-230X(08)60223-7; Lee YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055669; Malmsten A, 1998, J VIROL METHODS, V75, P9, DOI 10.1016/S0166-0934(98)00091-3; MCALLISTER RM, 1972, NATURE-NEW BIOL, V235, P3, DOI 10.1038/newbio235003a0; Miller AD, 1997, J VIROL, V71, P4531, DOI 10.1128/JVI.71.6.4531-4535.1997; Oakes B, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-109; Paprotka T, 2011, SCIENCE, V333, P97, DOI 10.1126/science.1205292; Rabson A. B., 1997, P205; Raisch KP, 2003, VIROLOGY, V308, P83, DOI 10.1016/S0042-6822(02)00074-0; Rein A, 2011, ADV VIROL, V2011, DOI 10.1155/2011/403419; SALTMAN DL, 1988, BLOOD, V72, P2026, DOI 10.1182/blood.V72.6.2026.2026; Sfanos KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020874; SHERWIN SA, 1978, INT J CANCER, V21, P6, DOI 10.1002/ijc.2910210103; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Stang A, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-86; Stocking C, 2008, CELL MOL LIFE SCI, V65, P3383, DOI 10.1007/s00018-008-8497-0; TAKEUCHI Y, 1994, J VIROL, V68, P8001, DOI 10.1128/JVI.68.12.8001-8007.1994; Takeuchi Y, 2008, J VIROL, V82, P12585, DOI 10.1128/JVI.01726-08; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Uphoff C C, 2001, Hum Cell, V14, P244; Uphoff CC, 2002, IN VITRO CELL DEV-AN, V38, P79; Uphoff CC, 2010, ENCY IND BIOTECHNOLO, P3611; Uphoff CC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/904767; WELSH RM, 1975, NATURE, V257, P612, DOI 10.1038/257612a0; WELSH RM, 1977, J IMMUNOL, V118, P348; Zhang YA, 2011, CANCER BIOL THER, V12, P617, DOI 10.4161/cbt.12.7.15955; Zheng HQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029050	43	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125622	10.1371/journal.pone.0125622	http://dx.doi.org/10.1371/journal.pone.0125622			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927683	Green Submitted, Green Published, gold			2022-12-27	WOS:000353713100106
J	Velaga, S; Ukena, SN; Dringenberg, U; Alter, C; Pardo, J; Kershaw, O; Franzke, A				Velaga, Sarvari; Ukena, Sya N.; Dringenberg, Ulrike; Alter, Christina; Pardo, Julian; Kershaw, Olivia; Franzke, Anke			Granzyme A Is Required for Regulatory T-Cell Mediated Prevention of Gastrointestinal Graft-versus-Host Disease	PLOS ONE			English	Article							DEATH; TRANSPLANTATION; PERFORIN; SUPPRESSION; PROTECTS; PATHWAY; ROLES	In our previous work we could identify defects in human regulatory T cells (Tregs) likely favoring the development of graft-versus-host disease (GvHD) following allogeneic stem cell transplantation (SCT). Treg transcriptome analyses comparing GvHD and immune tolerant patients uncovered regulated gene transcripts highly relevant for Treg cell function. Moreover, granzyme A (GZMA) also showed a significant lower expression at the protein level in Tregs of GvHD patients. GZMA induces cytolysis in a perforin-dependent, FAS-FASL independent manner and represents a cell-contact dependent mechanism for Tregs to control immune responses. We therefore analyzed the functional role of GZMA in a murine standard model for GvHD. For this purpose, adoptively transferred CD4(+)CD25(+) Tregs from gzmA(-/-) mice were analyzed in comparison to their wild type counterparts for their capability to prevent murine GvHD. GzmA(-/-) Tregs home efficiently to secondary lymphoid organs and do not show phenotypic alterations with respect to activation and migration properties to inflammatory sites. Whereas gzmA(-/-) Tregs are highly suppressive in vitro, Tregs require GZMA to rescue hosts from murine GvHD, especially regarding gastrointestinal target organ damage. We herewith identify GZMA as critical effector molecule of human Treg function for gastrointestinal immune response in an experimental GvHD model.	[Velaga, Sarvari; Ukena, Sya N.; Dringenberg, Ulrike; Alter, Christina; Franzke, Anke] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany; [Pardo, Julian] Biomed Res Ctr Aragon CIBA, Immune Effector Cells Grp ICE, Zaragoza, Spain; [Kershaw, Olivia] Free Univ Berlin, Dept Vet Pathol, Berlin, Germany	Hannover Medical School; Free University of Berlin	Franzke, A (corresponding author), Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany.	franzke.anke@mh-hannover.de	Franzke, Anke/AAE-7883-2021; Pardo, Julian/K-6764-2014	Pardo, Julian/0000-0003-0154-0730	German Jose Carreras leukemia foundation [DJCLS F12/05]; ARAID foundation; Ministerio de Economia y Competitividad [SAF2011-25390]; Fondo Social Europeo	German Jose Carreras leukemia foundation; ARAID foundation; Ministerio de Economia y Competitividad(Spanish Government); Fondo Social Europeo(European Social Fund (ESF)European Commission)	This work was supported by the German Jose Carreras leukemia foundation (grant DJCLS F12/05). JP was supported by ARAID foundation, grant SAF2011-25390 from Ministerio de Economia y Competitividad and Fondo Social Europeo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BE, 2004, BLOOD, V104, P1565, DOI 10.1182/blood-2004-01-0328; Arias MA, 2014, CELL REP, V8, P419, DOI 10.1016/j.celrep.2014.06.012; Bird CH, 1998, MOL CELL BIOL, V18, P6387, DOI 10.1128/MCB.18.11.6387; Cai SF, 2010, BLOOD, V115, P1669, DOI 10.1182/blood-2009-07-233676; Cao XF, 2007, IMMUNITY, V27, P635, DOI 10.1016/j.immuni.2007.08.014; Cohen JL, 2002, J EXP MED, V196, P401, DOI 10.1084/jem.20020090; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; DIIANNI M, 2011, BLOOD, V117, P3921, DOI [DOI 10.1182/blood-2010-10-311894, DOI 10.1182/BLOOD-2010-10-311894]; Edinger M, 2003, NAT MED, V9, P1144, DOI 10.1038/nm915; Ermann J, 2005, BLOOD, V105, P2220, DOI 10.1182/blood-2004-05-2044; Gondek DC, 2008, J IMMUNOL, V181, P4752, DOI 10.4049/jimmunol.181.7.4752; Gondek DC, 2005, J IMMUNOL, V174, P1783, DOI 10.4049/jimmunol.174.4.1783; Grossman WJ, 2004, BLOOD, V104, P2840, DOI 10.1182/blood-2004-03-0859; Grossman WJ, 2004, IMMUNITY, V21, P589, DOI 10.1016/j.immuni.2004.09.002; Hoffmann P, 2002, J EXP MED, V196, P389, DOI 10.1084/jem.20020399; Loebbermann J, 2012, MUCOSAL IMMUNOL, V5, P161, DOI 10.1038/mi.2011.62; Martelli MF, 2014, BLOOD, V124, P638, DOI 10.1182/blood-2014-03-564401; Pardo J, 2008, CELL DEATH DIFFER, V15, P567, DOI 10.1038/sj.cdd.4402289; Pardo J, 2009, MICROBES INFECT, V11, P452, DOI 10.1016/j.micinf.2009.02.004; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Susanto O, 2013, CELL DEATH DIFFER, V20, P1183, DOI 10.1038/cdd.2013.59; Taylor PA, 2002, BLOOD, V99, P3493, DOI 10.1182/blood.V99.10.3493; Ukena SN, 2011, EXP HEMATOL, V39, P1152, DOI 10.1016/j.exphem.2011.08.010; Ukena SN, 2011, BLOOD, V118, pE82, DOI 10.1182/blood-2011-05-352708	24	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124927	10.1371/journal.pone.0124927	http://dx.doi.org/10.1371/journal.pone.0124927			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928296	Green Submitted, Green Published, gold			2022-12-27	WOS:000353713100053
J	Brameyer, S; Heermann, R				Brameyer, Sophie; Heermann, Ralf			Specificity of Signal-Binding via Non-AHL LuxR-Type Receptors	PLOS ONE			English	Article							ESCHERICHIA-COLI; QUORUM; PROTEIN; TRAR; AUTOINDUCER	Quorum sensing is a typical communication system among Gram-negative bacteria used to control group-coordinated behavior via small diffusible molecules dependent on cell number. The key components of a quorum sensing system are a LuxI-type synthase, producing acyl-homoserine lactones (AHLs) as signaling molecules, and a LuxR-type receptor that detects AHLs to control expression of specific target genes. Six conserved amino acids are present in the signal-binding domain of AHL-sensing LuxR-type proteins, which are important for ligand-binding and -specificity as well as shaping the ligand-binding pocket. However, many proteobacteria possess LuxR-type regulators without a cognate LuxI synthase, referred to as LuxR solos. The two LuxR solos PluR and PauR from Photorhabdus luminescens and Photorhabdus asymbiotica, respectively, do not sense AHLs. Instead PluR and PauR sense alpha-pyrones and dialkylresorcinols, respectively, and are part of cell-cell communication systems contributing to the overall virulence of these Photorhabdus species. However, PluR and PauR both harbor substitutions in the conserved amino acid motif compared to that in AHL sensors, which appeared to be important for binding the corresponding signaling molecules. Here we analyze the role of the conserved amino acids in the signal-binding domain of these two non-AHL LuxR-type receptors for their role in signal perception. Our studies reveal that the conserved amino acid motif alone is essential but not solely responsible for ligand-binding.	[Brameyer, Sophie; Heermann, Ralf] Univ Munich, Biozentrum, Bereich Mikrobiol, Martinsried, Germany	University of Munich	Heermann, R (corresponding author), Univ Munich, Biozentrum, Bereich Mikrobiol, Martinsried, Germany.	heermann@lmu.de	Heermann, Ralf/E-1793-2013; Heermann, Ralf/CAF-8609-2022	Heermann, Ralf/0000-0003-0631-6156; Brameyer, Sophie/0000-0002-6779-2343	Deutsche Forschungsgemeinschaft [HE5247/4-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was funded by the Deutsche Forschungsgemeinschaft (www.dfg.de) under grant number HE5247/4-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Brachmann AO, 2013, NAT CHEM BIOL, V9, P573, DOI [10.1038/NCHEMBIO.1295, 10.1038/nchembio.1295]; Brameyer S, 2015, P NATL ACAD SCI USA, V112, P572, DOI 10.1073/pnas.1417685112; Brameyer S, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00166; Chugani S, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00152; Churchill MEA, 2011, CHEM REV, V111, P68, DOI 10.1021/cr1000817; Fuchs SW, 2013, ANGEW CHEM INT EDIT, V52, P4108, DOI 10.1002/anie.201210116; Gonzalez JF, 2013, TRENDS PLANT SCI, V18, P167, DOI 10.1016/j.tplants.2012.09.007; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Kim T, 2014, ACTA CRYSTALLOGR D, V70, P694, DOI 10.1107/S1399004713032355; Koch B, 2005, MICROBIOL-SGM, V151, P3589, DOI 10.1099/mic.0.27954-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Luo ZQ, 2003, J BIOL CHEM, V278, P13173, DOI 10.1074/jbc.M210035200; Nasser W, 2007, ANAL BIOANAL CHEM, V387, P381, DOI 10.1007/s00216-006-0702-0; Patankar AV, 2009, FEMS MICROBIOL REV, V33, P739, DOI 10.1111/j.1574-6976.2009.00163.x; Sambrook J., 2001, MOL CLONING LAB MANU; SHADEL GS, 1990, J BACTERIOL, V172, P3980, DOI 10.1128/jb.172.7.3980-3987.1990; Subramoni S, 2009, MICROBIOL-SGM, V155, P1377, DOI 10.1099/mic.0.026849-0; Trott AE, 2001, J BACTERIOL, V183, P387, DOI 10.1128/JB.183.1.387-392.2001; Vannini A, 2002, EMBO J, V21, P4393, DOI 10.1093/emboj/cdf459; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; WEBER K, 1969, J BIOL CHEM, V244, P4406; Welch M, 2000, EMBO J, V19, P631, DOI 10.1093/emboj/19.4.631; WOODCOCK DM, 1989, NUCLEIC ACIDS RES, V17, P3469, DOI 10.1093/nar/17.9.3469; Zhu J, 2001, P NATL ACAD SCI USA, V98, P1507, DOI 10.1073/pnas.98.4.1507	26	20	21	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124093	10.1371/journal.pone.0124093	http://dx.doi.org/10.1371/journal.pone.0124093			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923884	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600068
J	Segers, JL; Broders, HG				Segers, Jordi L.; Broders, Hugh G.			Carbon (delta C-13) and Nitrogen (delta N-15) Stable Isotope Signatures in Bat Fur Indicate Swarming Sites Have Catchment Areas for Bats from Different Summering Areas	PLOS ONE			English	Article							LONG-EARED BAT; MIGRATORY CONNECTIVITY; MYOTIS-SEPTENTRIONALIS; GENETIC CONNECTIVITY; DIETARY NICHE; NOVA-SCOTIA; BROWN BATS; BODY-SIZE; POPULATION; MOVEMENTS	Migratory patterns of bats are not well understood and traditional methods to study this, like capture-mark-recapture, may not provide enough detail unless there are many records. Stable isotope profiles of many animal species have been used to make inferences about migration. Each year Myotis lucifugus and M. septentrionalis migrate from summering roosts to swarming caves and mines in the fall, but the pattern of movement between them is not well understood. In this study, fur delta C-13 and delta N-15 values of 305 M. lucifugus and 200 M. septentrionalis were analyzed to make inferences about migration patterns between summering areas and swarming sites in Nova Scotia, Canada. We expected that there would be greater variability in delta C-13 and delta N-15 among individuals at swarming sites because it was believed that these sites are used by individuals originating from many summering areas. There was extensive overlap in the standard ellipse area, corrected for small sample sizes (SEA(c)), of bats at swarming sites and much less overlap in SEA(c) among groups sampled at summering areas. Meaningful inference could not be made on M. septentrionalis because their low variation in SEA(c) may have been the result of sampling only 3 summering areas. However, for M. lucifugus, swarming sites had larger SEA(c) than summering areas and predictive discriminant analysis assigned swarming bats to multiple summering areas, supporting the contention that swarming bats are mixed aggregations of bats from several summering areas. Together, these data support the contention that swarming sites have catchment areas for bats from multiple summering areas and it is likely that the catchment areas for swarming sites overlap. These data suggest that delta C-13 and delta N-15 profiling of bat fur offer some potential to make inferences about regional migration in bats.	[Segers, Jordi L.; Broders, Hugh G.] St Marys Univ, Dept Biol, Halifax, NS B3H 3C3, Canada	Saint Marys University - Canada	Broders, HG (corresponding author), St Marys Univ, Dept Biol, Halifax, NS B3H 3C3, Canada.	hugh.broders@smu.ca		Broders, Hugh/0000-0002-6151-8079	Saint Mary's University; NSERC; Nova Scotia Power Inc.; Shearwind Inc.; Eon Wind Electric	Saint Mary's University; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Nova Scotia Power Inc.; Shearwind Inc.; Eon Wind Electric	This work was supported by the Saint Mary's University (http://www.smu.ca/) to JLS and HGB, NSERC (http://www.nserc-crsng.gc.ca/index_eng.asp) to HGB, Nova Scotia Power Inc., (https://www.nspower.ca/en/home/default.aspx) to HGB, Shearwind Inc., (http://www.shearwind.com/) to HGB and Eon Wind Electric, (http://www.eonwind.com/) to HGB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041195; Arnold BD, 2007, AM MIDL NAT, V157, P374, DOI 10.1674/0003-0031(2007)157[374:PSASDI]2.0.CO;2; Baerwald EF, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00380.1; BARCLAY RMR, 1991, AM NAT, V137, P693, DOI 10.1086/285188; Berger J, 2008, PLOS BIOL, V6, P1365, DOI 10.1371/journal.pbio.0060165; Blem C.R., 1980, P175; Boulet M, 2007, MOL ECOL, V16, P4223, DOI 10.1111/j.1365-294X.2007.03476.x; Broders HG, 2004, J MAMMAL, V85, P273, DOI 10.1644/BWG-102; Broders HG, 2014, ACTA CHIROPTEROL, V16, P315, DOI 10.3161/150811014X687279; Burns LE, 2014, ECOL EVOL, V4, P4130, DOI 10.1002/ece3.1266; Carlisle AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030492; CONSTANTINE D. G., 1957, JOUR MAMMAL, V38, P461, DOI 10.2307/1376398; Constantine D. G., 1958, Journal of Mammalogy, V39, P344, DOI 10.2307/1376143; Coulton DW, 2010, WATERBIRDS, V33, P10, DOI 10.1675/063.033.0102; Crawford K, 2008, MAMMAL REV, V38, P87, DOI 10.1111/j.1365-2907.2008.00120.x; Cryan PM, 2014, ECOL APPL, V24, P602, DOI 10.1890/13-0752.1; Cryan PM, 2004, J MAMMAL, V85, P995, DOI 10.1644/BRG-202; Davis DS, 1996, NATURAL HIST NOVA SC, V2; Davis W. H., 1965, Journal of Mammalogy, V46, P296, DOI 10.2307/1377850; Elewa AMT, 2010, MIGRATION ORGANISMS; FAURE PA, 1993, J EXP BIOL, V178, P173; FENTON M B, 1980, Mammalian Species, P1, DOI 10.2307/3503792; FENTON MB, 1969, CAN J ZOOLOG, V47, P597, DOI 10.1139/z69-103; Fleming TH, 2003, BAT ECOLOGY, P156; Forman R.T.T., 1986, LANDSCAPE ECOL; Fraser EE, 2013, CAN J ZOOL, V91, P533, DOI 10.1139/cjz-2013-0072; Fraser EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031419; Fry B., 2006, STABLE ISOTOPE ECOLO; Gomez-Diaz E, 2007, ECOL APPL, V17, P1484, DOI 10.1890/06-1232.1; Griffin D. R., 1936, Journal of Mammalogy, V17, P235, DOI 10.2307/1374420; Harrod C, 2005, OECOLOGIA, V144, P673, DOI 10.1007/s00442-005-0161-x; HEATON THE, 1986, CHEM GEOL, V59, P87, DOI [10.1016/0168-9622(86)90059-X, 10.1016/0009-2541(86)90046-X]; Hebert CE, 2001, ENVIRON SCI TECHNOL, V35, P3482, DOI 10.1021/es001970p; Hellberg ME, 2002, B MAR SCI, V70, P273; Hobson KA, 2005, AUK, V122, P1037, DOI 10.1642/0004-8038(2005)122[1037:SIATDO]2.0.CO;2; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jardine T D, 2003, CAN MANUSCR REP FISH, P39; Kellman LM, 2003, AGR ECOSYST ENVIRON, V95, P87, DOI 10.1016/S0167-8809(02)00168-8; Kelly JF, 2005, ECOL APPL, V15, P1487, DOI 10.1890/04-1704; Knick ST, 2013, OECOLOGIA, V2013, P1; Knox Jones J., 1967, Transactions of the Kansas Academy of Science, V70, P184; KOHL DH, 1971, SCIENCE, V174, P1331, DOI 10.1126/science.174.4016.1331; Krouse HR, 1988, STABLE ISOTOPES ECOL; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; LEWIS SE, 1995, J MAMMAL, V76, P481, DOI 10.2307/1382357; Litvin SY, 2004, CAN J FISH AQUAT SCI, V61, P1851, DOI 10.1139/F04-121; Lovette IJ, 2004, CONSERV BIOL, V18, P156, DOI 10.1111/j.1523-1739.2004.00239.x; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Moore Frank R., 1995, P121; Moseley M, 2007, INT J SPELEOL, V36, P1, DOI 10.5038/1827-806X.36.1.1; Nagorsen DW, 1993, BATS BRIT COLUMBIA R; Norquay KJO, 2013, J MAMMAL, V94, P506, DOI 10.1644/12-MAMM-A-065.1; Owen SF, 2002, ROOST TREE SELECTION; Pain DJ, 2004, OECOLOGIA, V138, P168, DOI 10.1007/s00442-003-1416-z; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Phillips DL, 2001, OECOLOGIA, V127, P166, DOI 10.1007/s004420000571; POLIS GA, 1984, AM NAT, V123, P541, DOI 10.1086/284221; Polis GA, 1996, AM NAT, V147, P396, DOI 10.1086/285858; Randall J, 2014, ACTA CHIROPTEROL, V16, P109, DOI 10.3161/150811014X683327; Ratcliffe JM, 2003, ANIM BEHAV, V66, P847, DOI 10.1006/anbe.2003.2297; Richter HV, 2008, J ZOOL, V275, P172, DOI 10.1111/j.1469-7998.2008.00425.x; Rivers NM, 2006, BIOL CONSERV, V127, P215, DOI 10.1016/j.biocon.2005.08.010; Robinson Scott K., 1994, Bird Conservation International, V4, P233; Rubenstein DR, 2004, TRENDS ECOL EVOL, V19, P256, DOI 10.1016/j.tree.2004.03.017; Rundel PW, 1989, ECOL STUD, V68; Sanderson FJ, 2006, BIOL CONSERV, V131, P93, DOI 10.1016/j.biocon.2006.02.008; Scharf FS, 2000, MAR ECOL PROG SER, V208, P229, DOI 10.3354/meps208229; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Tiunov MP, 2007, ACTA CHIROPTEROL, V9, P538, DOI 10.3161/1733-5329(2007)9[538:SMIMPC]2.0.CO;2; UCHIDA SEINOSUKE, 1932, BIRD BANDING, V3, P1; Veith M, 2004, HEREDITY, V93, P342, DOI 10.1038/sj.hdy.6800509; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; Wilcove DS, 2008, PLOS BIOL, V6, P1361, DOI 10.1371/journal.pbio.0060188; Zazzo A, 2011, RAPID COMMUN MASS SP, V25, P2371, DOI 10.1002/rcm.5131	76	10	10	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125755	10.1371/journal.pone.0125755	http://dx.doi.org/10.1371/journal.pone.0125755			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923696	Green Submitted, Green Published, gold			2022-12-27	WOS:000353711600161
J	Taylor, AW; Shi, ZM; Montgomerie, A; Dal Grande, E; Campostrini, S				Taylor, Anne W.; Shi, Zumin; Montgomerie, Alicia; Dal Grande, Eleonora; Campostrini, Stefano			The Use of a Chronic Disease and Risk Factor Surveillance System to Determine the Age, Period and Cohort Effects on the Prevalence of Obesity and Diabetes in South Australian Adults-2003-2013	PLOS ONE			English	Article							BODY-MASS INDEX; UNITED-STATES; BIRTH COHORT; OVERWEIGHT; PREVENTION; MORTALITY; EPIDEMIC; ADULTS; TRENDS	Background Age, period and cohort (APC) analyses, using representative, population-based descriptive data, provide additional understanding behind increased prevalence rates. Methods Data on obesity and diabetes from the South Australian (SA) monthly chronic disease and risk factor surveillance system from July 2002 to December 2013 (n = 59,025) were used. Age was the self-reported age of the respondent at the time of the interview. Period was the year of the interview and cohort was age subtracted from the survey year. Cohort years were 1905 to 1995. All variables were treated as continuous. The age-sex standardised prevalence for obesity and diabetes was calculated using the Australia 2011 census. The APC models were constructed with "apcfit" in Stata. Results The age-sex standardised prevalence of obesity and diabetes increased in 2002-2013 from 18.6% to 24.1% and from 6.2% to 7.9%. The peak age for obesity was approximately 70 years with a steady increasing rate from 20 to 70 years of age. The peak age for diabetes was approximately 80 years. There were strong cohort effects and no period effects for both obesity and diabetes. The magnitude of the cohort effect is much more pronounced for obesity than for diabetes. Conclusion The APC analyses showed a higher than expected peak age for both obesity and diabetes, strong cohort effects with an acceleration of risk after 1960s for obesity and after 1940s for diabetes, and no period effects. By simultaneously considering the effects of age, period and cohort we have provided additional evidence for effective public health interventions.	[Taylor, Anne W.; Shi, Zumin; Montgomerie, Alicia; Dal Grande, Eleonora] Univ Adelaide, Populat Res & Outcome Studies, Discipline Med, Adelaide, SA 5005, Australia; [Taylor, Anne W.; Campostrini, Stefano] Ca Foscari Univ, Venice, Italy	University of Adelaide; Universita Ca Foscari Venezia	Taylor, AW (corresponding author), Univ Adelaide, Populat Res & Outcome Studies, Discipline Med, Adelaide, SA 5005, Australia.	Anne.Taylor@adelaide.edu.au	Taylor, Anne w/F-5708-2010; Shi, Zumin/A-1093-2009	Taylor, Anne w/0000-0002-4422-7974; Shi, Zumin/0000-0002-3099-3299; Dal Grande, Eleonora/0000-0002-5919-3893; Campostrini, Stefano/0000-0002-7113-4458				Allman-Farinelli MA, 2008, EUR J CLIN NUTR, V62, P898, DOI 10.1038/sj.ejcn.1602769; Allman-Farinelli MA, 2009, BRIT J NUTR, V101, P609, DOI 10.1017/S0007114508019879; Appleton SL, 2013, DIABETES CARE, V36, P2388, DOI 10.2337/dc12-1971; Australian Institute of Health and Welfare, 2011, AUSTR I HLTH WELF DI; Carstensen B, 2007, STAT MED, V26, P3018, DOI 10.1002/sim.2764; Chrisopoulos S, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-381; Dal Grande E, 2005, AUST NZ J PUBL HEAL, V29, P343, DOI 10.1111/j.1467-842X.2005.tb00205.x; de Koning L, 2011, INT J EPIDEMIOL, V40, P996, DOI 10.1093/ije/dyr053; Diouf I, 2010, EPIDEMIOLOGY, V21, P360, DOI 10.1097/EDE.0b013e3181d5bff5; Harkonen JT, 2011, ALCOHOL ALCOHOLISM, V46, P349, DOI 10.1093/alcalc/agr025; Hart CL, 2007, DIABETIC MED, V24, P73, DOI 10.1111/j.1464-5491.2007.02016.x; Hussain A, 2007, DIABETES RES CLIN PR, V76, P317, DOI 10.1016/j.diabres.2006.09.020; Jiang T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-889; Keyes KM, 2010, SOC SCI MED, V70, P1100, DOI 10.1016/j.socscimed.2009.12.018; Kwon JW, 2008, DIABETES CARE, V31, P255, DOI 10.2337/dc07-0531; Lee JM, 2010, INT J OBESITY, V34, P614, DOI 10.1038/ijo.2009.235; Mcgee DL, 2005, ANN EPIDEMIOL, V15, P87, DOI 10.1016/j.annepidem.2004.05.012; Mokdad AH, 1999, JAMA-J AM MED ASSOC, V282, P1519, DOI 10.1001/jama.282.16.1519; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Popkin BM, 1998, NUTR REV, V56, P106; Population Research and Outcome Studies South Australian Monitoring and Surveillance System (SAMSS) technical report, 2004, 104 SA DEP HLTH; Reither EN, 2009, SOC SCI MED, V69, P1439, DOI 10.1016/j.socscimed.2009.08.040; Robinson WR, 2012, INT J OBESITY, P1; Rogers RG, 2003, J BIOSOC SCI, V35, P107, DOI 10.1017/S002193200300107X; Rutherford MJ, 2010, STATA J, V10, P606, DOI 10.1177/1536867X1101000405; Simpson RW, 2003, DIABETES RES CLIN PR, V59, P165, DOI 10.1016/S0168-8227(02)00275-9; Smith HL, 2008, SOCIOL METHOD RES, V36, P287, DOI 10.1177/0049124107310636; Taylor AW, 2006, AUST NZ J PUBL HEAL, V30, P238, DOI 10.1111/j.1467-842X.2006.tb00864.x; Tu YK, 2012, EPIDEMIOLOGY, V23, P583, DOI 10.1097/EDE.0b013e31824d57a9; Tu YK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019401; World Health Organization(WHO), BMI CLASS	31	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125233	10.1371/journal.pone.0125233	http://dx.doi.org/10.1371/journal.pone.0125233			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0LO	25923664	gold, Green Published, Green Submitted			2022-12-27	WOS:000353711600136
J	Wang, HY; Sun, LZ; Tan, WP				Wang, Haiyan; Sun, Liangzhong; Tan, Weiping			Clinical Features of Children with Pulmonary Microscopic Polyangiitis: Report of 9 Cases	PLOS ONE			English	Article							ANTINEUTROPHIL CYTOPLASMIC ANTIBODY; ANCA-POSITIVE VASCULITIS; WEGENERS-GRANULOMATOSIS; PATHOLOGICAL FEATURES; ALVEOLAR HEMORRHAGE; CLASSIFICATION; MAINTENANCE; LEFLUNOMIDE; INVOLVEMENT; REMISSION	Kidneys and lungs are the most common organs involved in microscopic polyangiitis (MPA). A retrospective analysis of pediatric MPA patients with pulmonary lesions over the past 10 years was performed to investigate clinical features of MPA in children with pulmonary lesions. There were 9 patients enrolled in our study, including 2 boys and 7 girls, with a median age of 6.6 years at the time of disease onset and a median disease course of 2 months. All of the patients exhibited tachypnea, and 7 exhibited cough and hemoptysis. The most common presentation on pulmonary imaging was ground glass or patchy shadows, which were observed in 6 cases. Seven patients manifested with hematuria and proteinuria, with renal histopathology of fibrinoid necrosis/exudation of the glomerular capillaries. All of the patients presented with normocytic normochromic anemia. Of the 9 patients, 7 were positive for perinuclear antineutrophil cytoplasmic antibody (p-ANCA) and/or myeloperoxidase (MPO), and 2 were positive for p-ANCA/MPO and cytoplasmic ANCA/proteinase 3. Eight patients had normal complement 3 (C3) levels, and one had an elevated C3 level. Five of the 9 patients were positive for antinuclear antibody ANA, and 4 were positive for double strand DNA (ds-DNA) antibody (3 were positive for both). The 7 patients who exhibited renal involvement received steroid plus cyclophosphamide (CTX) treatment. Of these patients, 4 achieved various degrees of remission, 2 were at the beginning of induction therapy, and one was lost to follow-up. Two patients with isolated pulmonary involvement received steroid plus leflunomide treatment and achieved complete remission. Diffuse alveolar hemorrhage was the most frequent presentation of lung involvement in children with MPA, and tachypnea, cough, hemoptysis and anemia were the common clinical symptoms. The majority of these patients exhibited hematuria, proteinuria and renal insufficiency. The efficacy of steroid plus CTX or leflunomide was evident in these patients.	[Wang, Haiyan; Tan, Weiping] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Pediat, Guangzhou 510275, Guangdong, Peoples R China; [Sun, Liangzhong] Sun Yat Sen Univ, Affiliated Hosp 1, Childrens Kidney Dis Ctr, Dept Pediat, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Tan, WP (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Pediat, Guangzhou 510275, Guangdong, Peoples R China.	weiptan@163.com	Sun, Liangzhong/GQH-9346-2022					Bakkaloglu A, 2001, ARCH DIS CHILD, V85, P427, DOI 10.1136/adc.85.5.427; Bosch X, 2007, JAMA-J AM MED ASSOC, V298, P655, DOI 10.1001/jama.298.6.655; Bosch X, 2006, LANCET, V368, P404, DOI 10.1016/S0140-6736(06)69114-9; Chen M, 2005, POSTGRAD MED J, V81, P723, DOI 10.1136/pgmj.2005.034215; Chung SA, 2010, RHEUM DIS CLIN N AM, V36, P545, DOI 10.1016/j.rdc.2010.04.003; Collins CE, 2005, CURR OPIN PULM MED, V11, P447, DOI 10.1097/01.mcp.0000170520.63874.fb; Eleftheriou D, 2012, Monaldi Arch Chest Dis, V77, P141; Fishbein GA, 2011, SEMIN RESP CRIT CARE, V32, P254, DOI 10.1055/s-0031-1279823; Fujimoto S, 2006, CLIN J AM SOC NEPHRO, V1, P1016, DOI 10.2215/CJN.01461005; Guan Na, 2013, Zhonghua Er Ke Za Zhi, V51, P283; Hauer HA, 2002, KIDNEY INT, V62, P1732, DOI 10.1046/j.1523-1755.2002.00605.x; Hazlewood GS, 2014, JOINT BONE SPINE, V81, P337, DOI 10.1016/j.jbspin.2013.11.006; Ioachimescu OC, 2008, CLEV CLIN J MED, V75, P258, DOI 10.3949/ccjm.75.4.258; Jayne D, 2007, RHEUMATOLOGY, V46, P1047, DOI 10.1093/rheumatology/kem050; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Jin Jian-jun, 2011, Zhonghua Jie He He Hu Xi Za Zhi, V34, P339; Kamesh L, 2002, J AM SOC NEPHROL, V13, P1953, DOI 10.1097/01.ASN.0000016442.33680.3E; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Li Hui, 2009, Zhonghua Er Ke Za Zhi, V47, P487; Lionaki S, 2012, ARTHRITIS RHEUM-US, V64, P3452, DOI 10.1002/art.34562; Metzler C, 2004, RHEUMATOLOGY, V43, P315, DOI 10.1093/rheumatology/keh009; Mukhtyar C, 2009, ANN RHEUM DIS, V68, P310, DOI 10.1136/ard.2008.088096; Ozen S, 2006, ANN RHEUM DIS, V65, P936, DOI 10.1136/ard.2005.046300; Peco-Antic A, 2006, PEDIATR NEPHROL, V21, P46, DOI 10.1007/s00467-005-2063-x; Ramsey Jennifer, 2010, Curr Rheumatol Rep, V12, P420, DOI 10.1007/s11926-010-0136-8; SCHWARTZ GJ, 1987, PEDIATR CLIN N AM, V34, P571; Sun LZ, 2014, J RHEUMATOL, V41, P1712, DOI 10.3899/jrheum.131300; Tzelepis GE, 2010, EUR RESPIR J, V36, P116, DOI 10.1183/09031936.00110109; Tzouvelekis A, 2012, EUR RESPIR J, V40, P505, DOI 10.1183/09031936.00216311; Visavachaipan Nithat, 2010, J Med Assoc Thai, V93 Suppl 1, pS139; Xu H, 2007, PEDIATRICS, P317; Yamato K, 2012, PEDIATR INT, V54, P541, DOI 10.1111/j.1442-200X.2011.03503.x; Yu F, 2007, AM J KIDNEY DIS, V49, P607, DOI 10.1053/j.ajkd.2007.01.021; Yu Feng, 2003, Zhonghua Er Ke Za Zhi, V41, P831	34	4	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124352	10.1371/journal.pone.0124352	http://dx.doi.org/10.1371/journal.pone.0124352			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923706	Green Submitted, Green Published, gold			2022-12-27	WOS:000353711600077
J	Brockett, AT; LaMarca, EA; Gould, E				Brockett, Adam T.; LaMarca, Elizabeth A.; Gould, Elizabeth			Physical Exercise Enhances Cognitive Flexibility as Well as Astrocytic and Synaptic Markers in the Medial Prefrontal Cortex	PLOS ONE			English	Article							VOLUNTARY EXERCISE; DENTATE GYRUS; BRAIN; MEMORY; MICE; NEUROGENESIS; HIPPOCAMPUS; PLASTICITY; PROLIFERATION; PROTEIN	Physical exercise enhances a wide range of cognitive functions in humans. Running-induced cognitive enhancement has also been demonstrated in rodents but with a strong emphasis on tasks that require the hippocampus. Additionally, studies designed to identify mechanisms that underlie cognitive enhancement with physical exercise have focused on running-induced changes in neurons with little attention paid to such changes in astrocytes. To further our understanding of how the brain changes with physical exercise, we investigated whether running alters performance on cognitive tasks that require the prefrontal cortex and whether any such changes are associated with astrocytic, as well as neuronal, plasticity. We found that running enhances performance on cognitive tasks known to rely on the prefrontal cortex. By contrast, we found no such improvement on a cognitive task known to rely on the perirhinal cortex. Moreover, we found that running enhances synaptic, dendritic and astrocytic measures in several brain regions involved in cognition but that changes in the latter measures were more specific to brain regions associated with cognitive improvements. These findings suggest that physical exercise induces widespread plasticity in both neuronal and nonneuronal elements and that both types of changes may be involved in running-induced cognitive enhancement.	[Gould, Elizabeth] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA	Princeton University; Princeton University	Gould, E (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA.	goulde@princeton.edu			National Institutes of Health [R21NS087460]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS087460] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding was provided by National Institutes of Health R21NS087460. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaei Hojjatallah, 2007, Pathophysiology, V14, P105, DOI 10.1016/j.pathophys.2007.07.001; Allen A, 2013, BEHAV BRAIN RES, V240, P95, DOI 10.1016/j.bbr.2012.11.025; Alves CRR, 2014, PERCEPT MOTOR SKILL, V118, P63, DOI 10.2466/22.06.PMS.118k10w4; ANDREWS JS, 1995, PHYSIOL BEHAV, V57, P785, DOI 10.1016/0031-9384(94)00336-X; Aoyama M, 2012, J NEUROSCI RES, V90, P2272, DOI 10.1002/jnr.23117; Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Berchtold NC, 2010, NEUROSCIENCE, V167, P588, DOI 10.1016/j.neuroscience.2010.02.050; Bernardi C, 2014, NEURAL PLAST, V2013, P709; Birrell JM, 2000, J NEUROSCI, V20, P4320; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Eadie BD, 2005, J COMP NEUROL, V486, P39, DOI 10.1002/cne.20493; Gallo V, 2014, NEURON, V83, P283, DOI 10.1016/j.neuron.2014.06.010; Greenwood BN, 2009, HIPPOCAMPUS, V19, P988, DOI 10.1002/hipo.20534; Gurden H, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00021; Han XN, 2013, CELL STEM CELL, V12, P342, DOI 10.1016/j.stem.2012.12.015; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Kozorovitskiy Y, 2005, P NATL ACAD SCI USA, V102, P17478, DOI 10.1073/pnas.0508817102; Kramer AF, 2007, TRENDS COGN SCI, V11, P342, DOI 10.1016/j.tics.2007.06.009; Leuner B, 2010, J NEUROSCI, V30, P13499, DOI 10.1523/JNEUROSCI.3388-10.2010; Lima A, 2014, MOL PSYCHIATR, V19, P834, DOI 10.1038/mp.2013.182; Marlatt MW, 2012, DEV NEUROBIOL, V72, P943, DOI 10.1002/dneu.22009; Masley S, 2009, J CLIN PSYCHOL MED S, V16, P186, DOI 10.1007/s10880-009-9159-6; O'Reilly RC, 2002, CEREB CORTEX, V12, P246, DOI 10.1093/cercor/12.3.246; Salis AS, 2013, PERCEPT MOTOR SKILL, V116, P918, DOI 10.2466/29.22.PMS.116.3.918-928; Saur L, 2014, BRAIN STRUCT FUNCT, V219, P293, DOI 10.1007/s00429-012-0500-8; Schmidt-Kassow M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064172; Stranahan AM, 2007, HIPPOCAMPUS, V17, P1017, DOI 10.1002/hipo.20348; Stranahan AM, 2006, NAT NEUROSCI, V9, P526, DOI 10.1038/nn1668; Turner KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093411; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Viola GG, 2009, BRAIN RES, V1274, P47, DOI 10.1016/j.brainres.2009.04.007; Vivar Carmen, 2013, Curr Top Behav Neurosci, V15, P189, DOI 10.1007/7854_2012_220; Voss MW, 2013, TRENDS COGN SCI, V17, P525, DOI 10.1016/j.tics.2013.08.001	35	78	80	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0124859	10.1371/journal.pone.0124859	http://dx.doi.org/10.1371/journal.pone.0124859			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938418	Green Published, gold			2022-12-27	WOS:000353943000034
J	Jasmin, C; Anas, A; Nair, S				Jasmin, C.; Anas, Abdulaziz; Nair, Shanta			Bacterial Diversity Associated with Cinachyra cavernosa and Haliclona pigmentifera, Cohabiting Sponges in the Coral Reef Ecosystem of Gulf of Mannar, Southeast Coast of India	PLOS ONE			English	Article							MICROBIAL COMMUNITY; IDENTIFICATION; ABUNDANCE; TRANSMISSION; PROFILES; INSIGHTS; DISTANCE; SEA	Sponges are abundant, diverse and functionally important organisms of coral reef ecosystems. Sponge-associated microorganisms have been receiving greater attention because of their significant contribution to sponge biomass, biogeochemical cycles and biotechnological potentials. However, our understanding of the sponge microbiome is limited to a few species of sponges from restricted geographical locations. Here, we report for the first time the bacterial diversity of two cohabiting sponges, viz. Cinachyra cavernosa and Haliclona pigmentifera, as well as that in the ambient water from the coral reef ecosystems of the Gulf of Mannar, located along the southeast coast of India. Two hundred and fifty two clones in the 16S rRNA gene library of these sponges were grouped into eight distinct phyla, of which four belonged to the core group that are associated only with sponges. Phylogenetic analysis of the core bacteria showed close affinity to other sponge-associated bacteria from different geographical locations. gamma-Proteobacteria, Chloroflexi, Planctomycetes and Deferribacter were the core groups in C. cavernosa while beta and delta-Proteobacteria performed this role in H. pigmentifera. We observed greater OTU diversity for C. cavernosa (H-I 2.07) compared to H. pigmentifera (H-I 1.97). UniFrac analysis confirmed the difference in bacterial diversity of the two sponge species and also between the sponges and the reef water (p<0.001). The results of our study restate the existence of a host driven force in shaping the sponge microbiome.	[Jasmin, C.; Anas, Abdulaziz] CSIR, Natl Inst Oceanog, Reg Ctr, Cochin 682018, Kerala, India; [Nair, Shanta] CSIR, Natl Inst Oceanog, Panaji 403004, Goa, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute of Oceanography (NIO); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute of Oceanography (NIO)	Anas, A (corresponding author), CSIR, Natl Inst Oceanog, Reg Ctr, Cochin 682018, Kerala, India.	anas@nio.org	Abdulaziz, Anas/AAI-5681-2020	Abdulaziz, Anas/0000-0002-1396-3645	Department of Science and Technology, Government of India [SR/WOS-A/LS-339/2009]	Department of Science and Technology, Government of India(Department of Science & Technology (India))	CJ is grateful to Department of Science and Technology, Government of India for the research grant SR/WOS-A/LS-339/2009. This is NIO contribution No. 5718.	Alex A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051834; Althoff K, 1998, MAR BIOL, V130, P529, DOI 10.1007/s002270050273; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Avila E, PORIFERA RES BIODIVE, P147; Bell JJ, 2008, ESTUAR COAST SHELF S, V79, P341, DOI 10.1016/j.ecss.2008.05.002; Bostrom KH, 2004, LIMNOL OCEANOGR-METH, V2, P365, DOI 10.4319/lom.2004.2.365; Bruck WM, 2010, ISME J, V4, P686, DOI 10.1038/ismej.2009.149; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cuvelier ML, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00581; de Goeij JM, 2013, SCIENCE, V342, P108, DOI 10.1126/science.1241981; Dupont S, 2013, FEMS MICROBIOL ECOL, V86, P520, DOI 10.1111/1574-6941.12178; Erwin PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026806; Fieseler L, 2006, ENVIRON MICROBIOL, V8, P612, DOI 10.1111/j.1462-2920.2005.00937.x; Friedrich AB, 2001, FEMS MICROBIOL ECOL, V38, P105, DOI 10.1111/j.1574-6941.2001.tb00888.x; Giles EC, 2013, FEMS MICROBIOL ECOL, V83, P232, DOI 10.1111/j.1574-6941.2012.01467.x; Hardoim CCP, 2009, APPL ENVIRON MICROB, V75, P3331, DOI 10.1128/AEM.02101-08; Hardoim CCP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053029; Hentschel U, 2002, APPL ENVIRON MICROB, V68, P4431, DOI 10.1128/AEM.68.9.4431-4440.2002; Hill M, 2006, MAR BIOL, V148, P1221, DOI 10.1007/s00227-005-0164-5; Izumi H, 2013, ANTON LEEUW INT J G, V104, P533, DOI 10.1007/s10482-013-0003-5; Kamke J, 2010, ISME J, V4, P498, DOI 10.1038/ismej.2009.143; Kim IG, 2005, INT J SYST EVOL MICR, V55, P885, DOI 10.1099/ijs.0.63308-0; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lee OO, 2011, ISME J, V5, P650, DOI 10.1038/ismej.2010.165; Li ZY, 2006, J EXP MAR BIOL ECOL, V329, P75, DOI 10.1016/j.jembe.2005.08.014; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Montalvo NF, 2011, APPL ENVIRON MICROB, V77, P7207, DOI 10.1128/AEM.05285-11; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Ouyang YC, 2010, MAR BIOTECHNOL, V12, P318, DOI 10.1007/s10126-009-9223-0; REISWIG HM, 1973, J EXP MAR BIOL ECOL, V14, P231; Schmidt EW, 2000, MAR BIOL, V136, P969, DOI 10.1007/s002270000273; Schmitt S, 2011, FEMS MICROBIOL ECOL, V78, P497, DOI 10.1111/j.1574-6941.2011.01179.x; Schmitt S, 2008, APPL ENVIRON MICROB, V74, P7694, DOI 10.1128/AEM.00878-08; Selvin J, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-72; Selvin J, 2009, MICROBIOL RES, V164, P352, DOI 10.1016/j.micres.2007.05.005; Simister RL, 2012, ENVIRON MICROBIOL, V14, P517, DOI 10.1111/j.1462-2920.2011.02664.x; Sipkema D, 2010, MAR BIOL, V157, P627, DOI 10.1007/s00227-009-1347-2; Sipkema D, 2009, MICROB ECOL, V58, P903, DOI 10.1007/s00248-009-9534-8; Stabili L, 2014, MICROB ECOL, V67, P186, DOI 10.1007/s00248-013-0312-2; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Taylor MW, 2013, ISME J, V7, P438, DOI 10.1038/ismej.2012.111; Thomas P.A., 1986, P205; Thoms C, 2003, MAR BIOL, V142, P685, DOI 10.1007/s00227-002-1000-9; Trindade-Silva AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039905; Van Soest RWM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035105; Webster N, 2013, MOL ECOL, V22, P1854, DOI 10.1111/mec.12213; Webster NS, 2013, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00444; Webster NS, 2010, ENVIRON MICROBIOL, V12, P2070, DOI 10.1111/j.1462-2920.2009.02065.x; Webster NS, 2001, APPL ENVIRON MICROB, V67, P434, DOI 10.1128/AEM.67.1.434-444.2001; Webster NS, 2001, MAR BIOL, V138, P843, DOI 10.1007/s002270000503; Weisz JB, 2007, MAR BIOL, V152, P475, DOI 10.1007/s00227-007-0708-y; WILKINSON CR, 1980, HYDROBIOLOGIA, V75, P241, DOI 10.1007/BF00006488; Wright ES, 2012, APPL ENVIRON MICROB, V78, P717, DOI 10.1128/AEM.06516-11; Wright JJ, 2014, ISME J, V8, P455, DOI 10.1038/ismej.2013.152; Yu YN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-57; Zhou MY, 2009, MICROB ECOL, V58, P582, DOI 10.1007/s00248-009-9506-z	57	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0123222	10.1371/journal.pone.0123222	http://dx.doi.org/10.1371/journal.pone.0123222			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938436	Green Submitted, Green Published, gold			2022-12-27	WOS:000353943000005
J	Rikkers, W; de Haan, KB; Lawrence, D; McKenzie, A; Hancock, K; Haines, H; Christensen, D; Zubrick, SR				Rikkers, Wavne; de Haan, Katrina Boterhoven; Lawrence, David; McKenzie, Anne; Hancock, Kirsten; Haines, Hayley; Christensen, Daniel; Zubrick, Stephen R.			Two Methods for Engaging with the Community in Setting Priorities for Child Health Research: Who Engages?	PLOS ONE			English	Article							CONSUMER INVOLVEMENT; PUBLIC DELIBERATION; CHALLENGES; CITIZENS; QUALITY; ETHICS; FUTURE; ISSUES	Objective The aims of this study were to assess participatory methods for obtaining community views on child health research. Background Community participation in research is recognised as an important part of the research process; however, there has been inconsistency in its implementation and application in Australia. The Western Australian Telethon Kids Institute Participation Program employs a range of methods for fostering active involvement of community members in its research. These include public discussion forums, called Community Conversations. While participation levels are good, the attendees represent only a sub-section of the Western Australian population. Therefore, we conducted a telephone survey of randomly selected households to evaluate its effectiveness in eliciting views from a broader cross-section of the community about our research agenda and community participation in research, and whether the participants would be representative of the general population. We also conducted two Conversations, comparing the survey as a recruitment tool and normal methods using the Participation Program. Results While the telephone survey was a good method for eliciting community views about research, there were marked differences in the profile of study participants compared to the general population (e.g. 78% vs 50% females). With a 26% response rate, the telephone survey was also more expensive than a Community Conversation. The cold calling approach proved an unsuccessful recruitment method, with only two out of a possible 816 telephone respondents attending a Conversation. Conclusion While the results showed that both of the methods produced useful input for our research program, we could not conclude that either method gained input that was representative of the entire community. The Conversations were relatively low-cost and provided more in-depth information about one subject, whereas the telephone survey provided information across a greater range of subjects, and allowed more quantitative analysis.	[Rikkers, Wavne; de Haan, Katrina Boterhoven; Lawrence, David; Hancock, Kirsten; Christensen, Daniel; Zubrick, Stephen R.] Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia; [McKenzie, Anne; Haines, Hayley] Univ Western Australia, Sch Populat Hlth, Nedlands, WA 6009, Australia	Telethon Kids Institute; University of Western Australia; University of Western Australia	Rikkers, W (corresponding author), Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia.	wavne.rikkers@telethonkids.org.au	Zubrick, Stephen R/CAI-1970-2022; Lawrence, David/C-8292-2009; Christensen, Daniel/I-2018-2019; Hancock, Kirsten/T-1836-2019; McKenzie, Anne/K-5912-2015	Zubrick, Stephen R/0000-0002-6369-1713; Lawrence, David/0000-0003-4700-1425; Christensen, Daniel/0000-0002-9684-5782; McKenzie, Anne/0000-0002-5596-8495; Hancock, Kirsten/0000-0001-6213-2488; Rikkers, Wavne/0000-0002-2795-7414	National Health and Medical Research Council [572742]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by Program Grant 572742 from National Health and Medical Research Council, www.nhmrc.gov.au. SZ and DL were the main recipients of the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson J, 2003, HEALTH POLICY, V66, P95, DOI 10.1016/S0168-8510(03)00048-4; Abelson J, 2003, SOC SCI MED, V57, P239, DOI 10.1016/S0277-9536(02)00343-X; Abelson J, 2013, J PUBLIC DELIBER, V9; Abelson J, 2012, HASTINGS CENT REP, V42, P27, DOI 10.1002/hast.30; Auditor General Victoria, 2012, AUDITOR GEN VICTORIA; Australian Bureau of Statistics, 2010, GEN SOC SURV SUMM RE; Australian Bureau of Statistics, 2013, AUSTR DEM STAT JUN 2; Australian Communications and Media Authority, 2013, AUSTR CUT CORD; Australian Research Council, 2012, ANN REP 2011 2012 AU; Banfield M, 2007, AUSTR NZ J PSYCIAT E, P1; Beresford P, 2005, EPIDEMIOL PSICHIAT S, V14, P4, DOI 10.1017/S1121189X0000186X; Beresford P, 2007, HEALTH SOC CARE COMM, V15, P306, DOI 10.1111/j.1365-2524.2007.00688.x; Blacksher E, 2012, HASTINGS CENT REP, V42, P14, DOI 10.1002/hast.26; Blumberg S, 2009, AM J PUBLIC HLTH, V99, P10; Boote J, 2002, HEALTH POLICY, V61, P213, DOI 10.1016/S0168-8510(01)00214-7; Boote J, 2015, HEALTH EXPECT, V18, P44, DOI 10.1111/hex.12007; Bosnjak M, 2002, ONLINE SOCIAL SCI, V81, P92; Brown J., 2005, WORLD CAFE SHAPING O; Bryman A., 2012, SOCIAL RES METHODS, DOI DOI 10.1007/978-1-349-21149-4_10; Burgess M, 2008, PERS MED, V5, P285, DOI 10.2217/17410541.5.3.285; Cancer Australia, 2011, NAT FRAM CONS INV CA; De Vries R, 2010, SOC SCI MED, V70, P1896, DOI 10.1016/j.socscimed.2010.02.031; DuBois JM, 2011, CURR OPIN PSYCHIATR, V24, P208, DOI 10.1097/YCO.0b013e3283459422; Elliott J., 2006, PARTICIPATORY METHOD, V2nd; Goold SD, 2012, HASTINGS CENT REP, V42, P24, DOI 10.1002/hast.29; Hancock K., 2013, REPORT DEP ED EMPLOY; Hood NE, 2010, CTS-CLIN TRANSL SCI, V3, P19, DOI 10.1111/j.1752-8062.2010.00179.x; Johri M, 2009, J MED ETHICS, V35, P57, DOI 10.1136/jme.2008.024810; Jones HM, 2013, HEALTH RES POLICY SY, V11, DOI 10.1186/1478-4505-11-26; Kempf AM, 2007, ANNU REV PUBL HEALTH, V28, P113, DOI 10.1146/annurev.publhealth.28.021406.144059; Leung MW, 2004, INT J EPIDEMIOL, V33, P499, DOI 10.1093/ije/dyh010; Link MW, 2011, PUBLIC OPIN QUART, V75, P613, DOI 10.1093/poq/nfr040; McKenzie A., 2011, HLTH VOICES J CO JUN; McKenzie A, 2007, CONSUMER COMMUNITY P; Mitton C, 2009, HEALTH POLICY, V91, P219, DOI 10.1016/j.healthpol.2009.01.005; National Health and Medical Research Council, 2012, NHMRC ANN REP 2011 1; National Health and Medical Research Council, 2005, MOD FRAM CONS COMM P; National Health and Medical Research Council and Consumers' Health Forum of Australia, 2002, SUMM STAT CONS COMM; National Health and Medical Research Council and Consumers' Health Forum of Australia, 2005, RES PACK CONS COMM P; National Health and Medical Research Council and Consumers' Health Forum of Australia, 2002, STAT CONS COMM PART, DOI [10.1186/1478-4505-11-26, DOI 10.1186/1478-4505-11-26]; O'Doherty KC, 2012, SOC SCI MED, V75, P1604, DOI 10.1016/j.socscimed.2012.06.026; O'Donnell M, 2004, HEALTH POLICY, V70, P281, DOI 10.1016/j.healthpol.2004.04.004; Sapienza JN, 2007, AMBUL PEDIATR, V7, P247, DOI 10.1016/j.ambp.2007.01.004; Saunders Carla, 2011, Health Promot J Austr, V22, P196; Saunders C, 2010, HEALTH RES POLICY SY, V8, DOI 10.1186/1478-4505-8-34; Secko DM, 2009, SOC SCI MED, V68, P781, DOI 10.1016/j.socscimed.2008.11.020; Taras HL, 2015, HEALTH EXPECT, V18, P2753, DOI 10.1111/hex.12249; Telethon Kids Institute, CONS COMM PART POL 2; Thompson J, 2009, HEALTH EXPECT, V12, P209, DOI 10.1111/j.1369-7625.2009.00532.x; Volunteering Australia, 2012, 2011 NAT SURV VOL IS; Ward PR, 2010, J SOCIOL, V46, P63, DOI 10.1177/1440783309351771; Zubrick S. R., 2009, AUSTRALASIAN EPIDEMI, V16, P6	52	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125969	10.1371/journal.pone.0125969	http://dx.doi.org/10.1371/journal.pone.0125969			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH3PP	25938240	Green Submitted, gold, Green Published			2022-12-27	WOS:000353943000123
J	Bandera, A; Gori, A; Sabbatini, F; Madeddu, G; Bonora, S; Libertone, R; Mastroianni, C; Bonfanti, P; Monforte, AD; Cozzi-Lepri, A				Bandera, Alessandra; Gori, Andrea; Sabbatini, Francesca; Madeddu, Giordano; Bonora, Stefano; Libertone, Raffaella; Mastroianni, Claudio; Bonfanti, Paolo; Monforte, Antonella d'Arminio; Cozzi-Lepri, Alessandro		Icona Fdn Study Grp	Evaluation of the Prognostic Value of Impaired Renal Function on Clinical Progression in a Large Cohort of HIV-Infected People Seen for Care in Italy	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; ANTIRETROVIRAL THERAPY; HIV-1-INFECTED PATIENTS; RISK-FACTOR; CYSTATIN C; ASSOCIATION; CREATININE; EVENTS; INSUFFICIENCY	Whilst renal dysfunction, especially mild impairment (60<eGFR<90ml/min), has been often described in HIV-infected population, its potential contribution to HIV evolution and risk of cerebro-cardiovascular disease (CCVD) has not been clarified. Data from HIV-1 infected patients enrolled in the Italian Cohort of Antiretroviral-Naive (Icona) Foundation Study collected between January 2000 and February 2014 with at least two creatinine values available. eGFR (CKD-epl) and renal dysfunction defined using a priori cut-offs of 60 (severely impaired) and 90 ml/min/1.73m(2) (mildly impaired). Characteristics of patients were described after stratification in these groups and compared using chi-square test (categorical variables) or Kruskal Wallis test comparing median values. Follow-up accrued from baseline up to the date of the CCVD or AIDS related events or death or last available visit. Kaplan Meier curves were used to estimate the cumulative probability of occurrence of the events over time. Adjusted analysis was performed using a proportional hazards Cox regression model. We included 7,385 patients, observed for a median follow-up of 43 months (interquartile range [IQR]: 21-93 months). Over this time, 130 cerebro-cardiovascular events (including 11 deaths due to CCVD) and 311 AIDS-related events (including 45 deaths) were observed. The rate of CCVD events among patients with eGFR >90, 60-89, <60 ml/min, was 2.91 (95% CI 2.30-3.67), 4.63 (95% CI 3.51-6.11) and 11.9 (95% CI 6.19-22.85) per 1,000 PYFU respectively, with an unadjusted hazard ratio (HR) of 4.14 (95% CI 2.07-8.29) for patients with eGFR < 60 ml/min and 1.58 (95% CI 1.10-2.27) for eGFR 60-89 compared to those with eGFR >= 90. Of note, these estimates are adjusted for traditional cardiovascular risk factors (e.g. smoking, diabetes, hypertension, dyslipidemia). Incidence of AIDS-related events was 9.51 (95% CI 8.35-10.83), 6.04 (95% CI 4.74-7.71) and 25.0 (95% CI 15.96-39.22) per 1,000 PYFU, among patients with eGFR >90, 60-89, <60 ml/min, respectively, with an unadjusted HR of 2.49 (95% CI 1.56-3.97) for patients with eGFR <60 ml/min and 0.68 (95% CI 0.52-0.90) for eGFR 60-89. The risk of AIDS events was significantly lower in mild renal dysfunction group even after adjustment for HIV-related characteristics. Our data confirm that impaired renal function is an important risk marker for CCVD events in the HIV-population; importantly, even those with mild renal impairment (90<eGFR<60) seem to be at increased risk of cerebro-cardiovascular morbidity and mortality.	[Bandera, Alessandra; Gori, Andrea; Sabbatini, Francesca] Univ Milano Bicocca, San Gerardo Hosp, Dept Internal Med, Div Infect Dis, Monza, Italy; [Madeddu, Giordano] Univ Sassari, Dept Infect Dis, I-07100 Sassari, Italy; [Bonora, Stefano] Univ Turin, Amedeo di Savoia Hosp, Dept Infect Dis, Turin, Italy; [Libertone, Raffaella] Natl Inst Infect Dis Lazzaro Spallanzani, Rome, Italy; [Mastroianni, Claudio] Univ La Sapienza, Dept Infect & Trop Dis, Latina, Italy; [Bonfanti, Paolo] Alessandro Manzoni Hosp, Infect Dis Unit, Lecce, Italy; [Monforte, Antonella d'Arminio] Univ Milan, San Paolo Hosp, Clin Infect Dis & Trop Med, Milan, Italy; [Cozzi-Lepri, Alessandro] UCL, London, England	San Gerardo Hospital; University of Milano-Bicocca; University of Sassari; University of Turin; IRCCS Lazzaro Spallanzani; Sapienza University Rome; San Paolo-Polo Universitaria Hospital; University of Milan; University of London; University College London	Bandera, A (corresponding author), Univ Milano Bicocca, San Gerardo Hosp, Dept Internal Med, Div Infect Dis, Monza, Italy.	alessandra.bandera@unimib.it	bonora, stefano/AAC-2993-2019; Cingolani, antonella/J-8921-2018; PELLICANO', GIOVANNI FRANCESCO/W-4077-2019; MASTROIANNI, Claudio Maria/O-9741-2019; MADEDDU, Giordano/AAP-4342-2020; perno, carlo federico/O-1544-2016; Castagna, Antonella/K-3280-2018; Ursini, Tamara/AAB-3891-2019; Di Biagio, Antonio/J-4901-2019; Bonfanti, Paolo/AAK-9800-2020; Rusconi, Stefano/H-9263-2012; Bandera, Alessandra/AAC-6081-2022; nicastri, emanuele/K-7780-2016; Antinori, Andrea/K-7125-2016; Ippolito, Giuseppe/J-7207-2017; QUIROS ROLDAN, Maria Eugenia/K-7586-2015; TINCATI, CAMILLA/K-4501-2018; De Luca, Andrea/G-8810-2011; MARCHETTI, GIULIA CARLA/K-4384-2018; Balotta, Claudia/L-7295-2017; LAZZARIN, Adriano/K-3607-2018; GALLI, MASSIMO/L-7282-2017	bonora, stefano/0000-0002-7537-3341; Cingolani, antonella/0000-0002-3793-2755; PELLICANO', GIOVANNI FRANCESCO/0000-0002-9640-8742; MASTROIANNI, Claudio Maria/0000-0002-1286-467X; MADEDDU, Giordano/0000-0001-6099-2273; Castagna, Antonella/0000-0002-8338-9714; Ursini, Tamara/0000-0002-6012-0667; Di Biagio, Antonio/0000-0003-1436-5089; Bonfanti, Paolo/0000-0001-7289-8823; Rusconi, Stefano/0000-0002-0375-9990; nicastri, emanuele/0000-0002-5606-8712; Antinori, Andrea/0000-0003-2121-4684; CECCHERINI SILBERSTEIN, FRANCESCA/0000-0002-6024-5101; QUIROS ROLDAN, Maria Eugenia/0000-0003-1452-9100; BORGIA, Guglielmo/0000-0002-1281-1041; Ammassari, Adriana/0000-0002-0284-0340; TINCATI, CAMILLA/0000-0002-3083-2962; De Luca, Andrea/0000-0002-9561-9193; SANTORO, Carmen Rita/0000-0001-7806-8548; Segala, Daniela/0000-0001-6133-0386; MARCHETTI, GIULIA CARLA/0000-0002-4498-4828; Castelli, Francesco/0000-0001-9161-7804; Gianotti, Nicola/0000-0002-7182-5080; COSTANTINI, ANDREA/0000-0003-1588-7030; Guaraldi, Giovanni/0000-0002-5724-3914; Cinque, Paola/0000-0003-2448-5957; PERNO, CARLO FEDERICO/0000-0002-0825-5388; LAPADULA, Giuseppe/0000-0002-9976-8102; Bandera, Alessandra/0000-0003-1626-0328; PUZZOLANTE, CINZIA/0000-0002-1179-1341; Balotta, Claudia/0000-0002-1107-9119; BANDERA, ALESSANDRA/0000-0001-9440-4601; Vanino, Elisa/0000-0003-3510-1429; ANGARANO, Gioacchino/0000-0003-3207-7523; Andreoni, Massimo/0000-0002-3205-9758; Ippolito, Giuseppe/0000-0002-1076-2979; LAZZARIN, Adriano/0000-0003-2551-7754; CAUDA, Roberto/0000-0002-1498-4229; Girardi, Enrico/0000-0001-8182-5896; GALLI, MASSIMO/0000-0001-8887-6215; Puoti, Massimo/0000-0003-3278-7138; d'Arminio Monforte, Antonella/0000-0003-0073-1789; Galli, Laura/0000-0001-8046-0290; Capobianchi, Maria Rosaria/0000-0003-3465-0071; MONNO, Laura/0000-0002-2713-4258; Tebano, Gianpiero/0000-0003-1891-4823	AbbVie; Briston Myers-Squibb; Gilead; Jannsen; Merck Sharp Dohme; ViiV Italy	AbbVie(AbbVie); Briston Myers-Squibb; Gilead(Gilead Sciences); Jannsen; Merck Sharp Dohme(Merck & Company); ViiV Italy	ICONA Foundation Study is sponsored by unrestricted grants from AbbVie, Briston Myers-Squibb, Gilead, Jannsen, Merck Sharp & Dohme, ViiV Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi AI, 2010, CIRCULATION, V121, P651, DOI 10.1161/CIRCULATIONAHA.109.898585; Fernando SK, 2008, AM J MED SCI, V335, P89, DOI 10.1097/MAJ.0b013e31812e6b34; Gardner LI, 2003, JAIDS-J ACQ IMM DEF, V32, P203, DOI 10.1097/00126334-200302010-00013; Gupta SK, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-31; Hernan MA, 2006, J EPIDEMIOL COMMUN H, V60, P578, DOI 10.1136/jech.2004.029496; Ho JE, 2012, AIDS, V26, P1115, DOI 10.1097/QAD.0b013e328352ce54; Inker LA, 2012, JAIDS-J ACQ IMM DEF, V61, P302, DOI 10.1097/QAI.0b013e31826a6c4f; Kottgen A, 2007, J AM SOC NEPHROL, V18, P1307, DOI 10.1681/ASN.2006101159; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lichtenstein KA, 2010, CLIN INFECT DIS, V51, P435, DOI 10.1086/655144; Lucas GM, 2014, HIV MED, V15, P116, DOI 10.1111/hiv.12087; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; Mocroft A, 2007, AIDS, V21, P1119, DOI 10.1097/QAD.0b013e3280f774ee; Mulenga LB, 2008, AIDS, V22, P1821, DOI 10.1097/QAD.0b013e328307a051; Sackoff JE, 2006, ANN INTERN MED, V145, P397, DOI 10.7326/0003-4819-145-6-200609190-00003; Schiffrin EL, 2007, CIRCULATION, V116, P85, DOI 10.1161/CIRCULATIONAHA.106.678342; Sorli ML, 2008, JAIDS-J ACQ IMM DEF, V48, P506, DOI 10.1097/QAI.0b013e31817bbecb; Stevens LA, 2010, AM J KIDNEY DIS, V56, P486, DOI 10.1053/j.ajkd.2010.03.026; Szczech LA, 2004, CLIN INFECT DIS, V39, P1199, DOI 10.1086/424013; Tordato F, 2011, HIV MED, V12, P4, DOI 10.1111/j.1468-1293.2010.00855.x; Wyatt CM, 2007, AIDS, V21, P2101, DOI 10.1097/QAD.0b013e3282ef1bb4	21	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124252	10.1371/journal.pone.0124252	http://dx.doi.org/10.1371/journal.pone.0124252			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933346	gold, Green Published, Green Submitted			2022-12-27	WOS:000353887100034
J	Berendes, D; Levy, K; Knee, J; Handzel, T; Hill, VR				Berendes, David; Levy, Karen; Knee, Jackie; Handzel, Thomas; Hill, Vincent R.			Ascaris and Escherichia coli Inactivation in an Ecological Sanitation System in Port-au-Prince, Haiti	PLOS ONE			English	Article							FECAL SLUDGE; EGGS; SURVIVAL; SUUM; COMPOST; EFFICIENCY; URINE; FECES	The goal of this study was to evaluate the microbial die-off in a latrine waste composting system in Port-au-Prince, Haiti. Temperature data and samples were collected from compost aged 0 - 12+ months. Samples collected from compost bin centers and corners at two depths were assessed for moisture content, E. coli concentration, and Ascaris spp. viability. Center temperatures in compost bins were all above 58 degrees C, while corner temperatures were 10 - 20 degrees C lower. Moisture content was 67 +/- 10% in all except the oldest compost. A 4-log reduction in E. coli was observed over the first sixteen weeks of composting at both locations and depths, after which E. coli was undetectable (LOD: 142 MPN g(-1) dry weight). In new compost, 10.4% and 8.3% of Ascaris eggs were viable and fully embryonated, respectively. Percent viability dropped to zero in samples older than six weeks. These findings indicate that the Haitian EcoSan composting process was effective in inactivating E. coliand Ascaris spp. in latrine waste within sixteen weeks. This study is one of the first to document efficacy of an ecological sanitation system under field conditions and provides insight into composting methods and monitoring for other international settings.	[Berendes, David; Levy, Karen] Emory Univ, Rollins Sch Publ Hlth, Dept Environm Hlth, Atlanta, GA 30322 USA; [Berendes, David; Handzel, Thomas] Ctr Dis Control & Prevent, Emergency Response & Recovery Branch, Div Global Hlth Protect, Atlanta, GA USA; [Hill, Vincent R.] Ctr Dis Control & Prevent, Environm Microbiol Lab, Waterborne Dis Prevent Branch, Div Food Waterborne & Environm Dis, Atlanta, GA 30329 USA	Emory University; Rollins School Public Health; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Hill, VR (corresponding author), Ctr Dis Control & Prevent, Environm Microbiol Lab, Waterborne Dis Prevent Branch, Div Food Waterborne & Environm Dis, Atlanta, GA 30329 USA.	veh2@cdc.gov	Knee, Jackie/AAB-4434-2021	Knee, Jackie/0000-0002-0834-8488	Emergency Response and Recovery Branch in the Division of Global Health Protection; Environmental Microbiology Laboratory of the Waterborne Disease Prevention Branch in the Division of Food, Waterborne, and Environmental Diseases at the Centers for Disease Control and Prevention	Emergency Response and Recovery Branch in the Division of Global Health Protection; Environmental Microbiology Laboratory of the Waterborne Disease Prevention Branch in the Division of Food, Waterborne, and Environmental Diseases at the Centers for Disease Control and Prevention	Materials, salaries, travel, and logistics for this work were supported by funds from the Emergency Response and Recovery Branch in the Division of Global Health Protection and the Environmental Microbiology Laboratory of the Waterborne Disease Prevention Branch in the Division of Food, Waterborne, and Environmental Diseases at the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, STANDARD METHODS EXA; Bowman DD, 2003, WATER RES, V37, P2063, DOI 10.1016/S0043-1354(02)00597-3; Buckley CA, 2008, RES UD VIDP URINE DI; Butkus MA, 2011, APPL ENVIRON MICROB, V77, P363, DOI 10.1128/AEM.01675-10; Chien BT, BIOL STUDY RETENTION; Corrales LF, 2006, TROP MED INT HEALTH, V11, P1821, DOI 10.1111/j.1365-3156.2006.01737.x; Decrey L, 2011, WATER RES, V45, P4960, DOI 10.1016/j.watres.2011.06.042; DINEPA, 2013, GUID TECHN FIL TRAIT; Eccles JP, 2004, J APPL MICROBIOL, V96, P375, DOI 10.1046/j.1365-2672.2004.02165.x; Edberg SC, 2000, J APPL MICROBIOL, V88, p106S, DOI 10.1111/j.1365-2672.2000.tb05338.x; Endale YT, 2012, WASTE MANAGE RES, V30, P750, DOI 10.1177/0734242X11432190; Esrey SA, 2001, WATER SCI TECHNOL, V43, P177; Fidjeland J, 2013, WATER RES, V47, P6014, DOI 10.1016/j.watres.2013.07.024; Ghiglietti R., 1995, Parassitologia (Rome), V37, P229; Gong CM, 2005, J ENVIRON SCI-CHINA, V17, P770; Green W, 2005, WATER SCI TECHNOL, V51, P29, DOI 10.2166/wst.2005.0348; Jensen PKM, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-57; Kato S, 2003, INT J ENVIRON HEAL R, V13, P169, DOI 10.1080/0960312031000098071; Kone D, 2007, WATER RES, V41, P4397, DOI 10.1016/j.watres.2007.06.024; Langergraber G, 2005, ENVIRON INT, V31, P433, DOI 10.1016/j.envint.2004.08.006; Magri ME, 2013, APPL ENVIRON MICROB, V79, P2156, DOI 10.1128/AEM.03920-12; McKinley JW, 2012, APPL ENVIRON MICROB, V78, P5133, DOI 10.1128/AEM.00631-12; Mehl J, 2011, J WATER HEALTH, V9, P187, DOI 10.2166/wh.2010.138; Moe CL, 2003, 2 INT S EC SAN; Muirhead RW, 2004, LETT APPL MICROBIOL, V39, P383, DOI 10.1111/j.1472-765X.2004.01604.x; Nordin A, 2009, APPL ENVIRON MICROB, V75, P662, DOI 10.1128/AEM.01250-08; PEASEY A, 2000, HLTH ASPECTS DRY SAN; Pecson BM, 2007, WATER RES, V41, P2893, DOI 10.1016/j.watres.2007.03.040; Pourcher AM, 2005, J APPL MICROBIOL, V99, P528, DOI 10.1111/j.1365-2672.2005.02642.x; Preneta N, 2013, J WATER SANIT HYG DE, V3, P649, DOI 10.2166/washdev.2013.145; Redlinger T, 2001, APPL ENVIRON MICROB, V67, P4036, DOI 10.1128/AEM.67.9.4036-4040.2001; Schonning C, 2004, GUIDELINES SAFE USE; Stenstrom TA, REDUCTION EFFICIENCY; Szabova E, 2010, WASTE MANAGE, V30, P426, DOI 10.1016/j.wasman.2009.09.035; Tonner-Klank L, 2007, WASTE MANAGE, V27, P1144, DOI 10.1016/j.wasman.2006.04.021; UNICEF and WHO, 2012, PROGR DRINKING WATER; US EPA, 1999, BIOS GEN US DISP US; USEPA, 1995, BIOS MAN HDB 1C; USEPA, 1999, ENVIRONMENTAL REGULA; WHO, 2006, WHO GUID SAF US WAST	40	22	22	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125336	10.1371/journal.pone.0125336	http://dx.doi.org/10.1371/journal.pone.0125336			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932948	gold, Green Published, Green Submitted			2022-12-27	WOS:000353887100100
J	Cooley, LF; Martin, RK; Zellner, HB; Irani, AM; Uram-Tuculescu, C; El Shikh, ME; Conrad, DH				Cooley, Lauren Folgosa; Martin, Rebecca K.; Zellner, Hannah B.; Irani, Anne-Marie; Uram-Tuculescu, Cora; El Shikh, Mohey Eldin; Conrad, Daniel H.			Increased B Cell ADAM10 in Allergic Patients and Th2 Prone Mice	PLOS ONE			English	Article							TNF-ALPHA; DISINTEGRIN; CD23; FORM	ADAM10, as the sheddase of the low affinity IgE receptor (CD23), promotes IgE production and thus is a unique target for attenuating allergic disease. Herein, we describe that B cell levels of ADAM10, specifically, are increased in allergic patients and Th2 prone WT mouse strains (Balb/c and A/J). While T cell help augments ADAM10 expression, Balb WT B cells exhibit increased ADAM10 in the naive state and even more dramatically increased ADAM10 after anti-CD40/IL4 stimulation compared C57 (Th1 prone) WT B cells. Furthermore, ADAM17 and TNF are reduced in allergic patients and Th2 prone mouse strains (Balb/c and A/J) compared to Th1 prone controls. To further understand this regulation, ADAM17 and TNF were studied in C57Bl/6 and Balb/c mice deficient in ADAM10. C57-ADAM10(B-/-) were more adept at increasing ADAM17 levels and thus TNF cleavage resulting in excess follicular TNF levels and abnormal secondary lymphoid tissue architecture not noted in Balb-ADAM10(B-/-). Moreover, the level of B cell ADAM10 as well as Th context is critical for determining IgE production potential. Using a murine house dust mite airway hypersensitivity model, we describe that high B cell ADAM10 level in a Th2 context (Balb/c WT) is optimal for disease induction including bronchoconstriction, goblet cell metaplasia, mucus, inflammatory cellular infiltration, and IgE production. Balb/c mice deficient in B cell ADAM10 have attenuated lung and airway symptoms compared to Balb WT and are actually most similar to C57 WT (Th1 prone). C57-ADAM10(B-/-) have even further reduced symptomology. Taken together, it is critical to consider both innate B cell levels of ADAM10 and ADAM17 as well as Th context when determining host susceptibility to allergic disease. High B cell ADAM10 and low ADAM17 levels would help diagnostically in predicting Th2 disease susceptibility; and, we provide support for the use ADAM10 inhibitors in treating Th2 disease.	[Cooley, Lauren Folgosa] Virginia Commonwealth Univ, Ctr Clin & Translat Res, Richmond, VA 23298 USA; [Cooley, Lauren Folgosa; Martin, Rebecca K.; Zellner, Hannah B.; Conrad, Daniel H.] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Irani, Anne-Marie] Virginia Commonwealth Univ, Dept Pediat, Div Allergy & Immunol, Richmond, VA 23298 USA; [Uram-Tuculescu, Cora] Virginia Commonwealth Univ, Dept Pathol, Div Anat Pathol, Richmond, VA 23298 USA; [El Shikh, Mohey Eldin] Queen Mary Univ London, William Harvey Res Inst, Expt Med & Rheumatol, London, England	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; University of London; Queen Mary University London	Conrad, DH (corresponding author), Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA.	dconrad@vcu.edu		Martin, Rebecca/0000-0001-9948-5463; El Shikh, Mohey Eldin/0000-0003-4395-0375	NIAID/NIH [R01 AI018697-33A1S1, RO1AI18697]; American Asthma Foundation AAF [11-0094]; VCU School of Medicine; Massey Cancer Center Core [P30 CA16059]; NIH-NINDS center core grant [5P30N5S047463]; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM093857] Funding Source: NIH RePORTER	NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Asthma Foundation AAF; VCU School of Medicine; Massey Cancer Center Core; NIH-NINDS center core grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by grant RO1AI18697 from NIAID/NIH, R01 AI018697-33A1S1 NIAID/NIH, American Asthma Foundation 11-0094 AAF, and a bridge grant from the VCU School of Medicine. Flow cytometry support from the Massey Cancer Center Core P30 CA16059 is also acknowledged. Microscopy was performed at the VCU Department of Neurobiology and Anatomy Facility, supported in part with funding from NIH-NINDS center core grant 5P30N5S047463.	Chaimowitz NS, 2011, J IMMUNOL, V187, P5114, DOI 10.4049/jimmunol.1102172; Conrad DH, 2007, CURR ALLERGY ASTHM R, V7, P331, DOI 10.1007/s11882-007-0050-y; Di Lorenzo G, 1999, ALLERGY ASTHMA PROC, V20, P119, DOI 10.2500/108854199778612590; Dussault AA, 2006, BIOL PROCED ONLINE, V8, P1, DOI 10.1251/bpo114; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Folgosa L, 2013, J IMMUNOL, V191, P5951, DOI 10.4049/jimmunol.1302042; Frasca D, 2012, J IMMUNOL, V188, P279, DOI 10.4049/jimmunol.1003964; Gibb DR, 2010, J EXP MED, V207, P623, DOI 10.1084/jem.20091990; Gueders MM, 2009, INFLAMM RES, V58, P845, DOI 10.1007/s00011-009-0054-2; Hirota JA, 2010, CLIN EXP ALLERGY, V40, P820, DOI 10.1111/j.1365-2222.2010.03458.x; Johansson SGO, 2004, EXPERT REV MOL DIAGN, V4, P273, DOI 10.1586/14737159.4.3.273; Kawakami M, 2012, CELL IMMUNOL, V275, P24, DOI 10.1016/j.cellimm.2012.03.009; Kelly AE, 1998, J IMMUNOL, V161, P6696; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Mathews JA, 2011, ALLERGY, V66, P1193, DOI 10.1111/j.1398-9995.2011.02614.x; Norton SK, 2012, J ALLERGY CLIN IMMUN, V130, P761, DOI 10.1016/j.jaci.2012.04.023; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Sahu N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011348; Tumanov AV, 2010, BLOOD, V116, P3456, DOI 10.1182/blood-2009-10-249177; van Rijt LS, 2004, J IMMUNOL METHODS, V288, P111, DOI 10.1016/j.jim.2004.03.004; Walsh GM, 2009, CURR MED CHEM, V16, P4774, DOI 10.2174/092986709789909639; Walsh GM, 2009, CURR OPIN MOL THER, V11, P329; WATANABE N, 1989, INFECT IMMUN, V57, P1405, DOI 10.1128/IAI.57.5.1405-1408.1989; Weskamp G, 2006, NAT IMMUNOL, V7, P1293, DOI 10.1038/ni1399	24	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124331	10.1371/journal.pone.0124331	http://dx.doi.org/10.1371/journal.pone.0124331			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933166	Green Published, Green Submitted, gold			2022-12-27	WOS:000353887100040
J	Zhao, LJ; Wang, JJ; Huang, RB				Zhao, Laijun; Wang, Jiajia; Huang, Rongbing			Immunization against the Spread of Rumors in Homogenous Networks	PLOS ONE			English	Article							SMALL-WORLD NETWORKS; COMPLEX NETWORKS; DYNAMICS; PROPAGATION; MODEL	Since most rumors are harmful, how to control the spread of such rumors is important. In this paper, we studied the process of "immunization" against rumors by modeling the process of rumor spreading and changing the termination mechanism for the spread of rumors to make the model more realistic. We derived mean-field equations to describe the dynamics of the rumor spread. By carrying out steady-state analysis, we derived the spreading threshold value that must be exceeded for the rumor to spread. We further discuss a possible strategy for immunization against rumors and obtain an immunization threshold value that represents the minimum level required to stop the rumor from spreading. Numerical simulations revealed that the average degree of the network and parameters of transformation probability significantly influence the spread of rumors. More importantly, the simulations revealed that immunizing a higher proportion of individuals is not necessarily better because of the waste of resources and the generation of unnecessary information. So the optimal immunization rate should be the immunization threshold.	[Zhao, Laijun; Wang, Jiajia] Shanghai Jiao Tong Univ, Sino US Global Logist Inst, Shanghai 200030, Peoples R China; [Zhao, Laijun; Wang, Jiajia] Shanghai Jiao Tong Univ, Antai Coll Econ & Management, Shanghai 200052, Peoples R China; [Huang, Rongbing] York Univ, Sch Adm Studies, Toronto, ON M3J 1P3, Canada	Shanghai Jiao Tong University; Shanghai Jiao Tong University; York University - Canada	Wang, JJ (corresponding author), Shanghai Jiao Tong Univ, Sino US Global Logist Inst, Shanghai 200030, Peoples R China.	wangjjsjz@126.com			National Natural Science Foundation of China [71373155, 90924030]; Shanghai Pujiang Program [14PJC073]; China Postdoctoral Science Foundation [2014M561481]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study is supported by grants from the National Natural Science Foundation of China (project No. 71373155 and No. 90924030) (L. Zhao), Shanghai Pujiang Program(project No. 14PJC073) (L. Zhao) and China Postdoctoral Science Foundation (project No. 2014M561481) (J. Wang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Daley D., 1965, IMA J APPL MATH, V1, P42, DOI [DOI 10.1093/IMAMAT/1.1.42, 10.1093/imamat/1.1.42]; DALEY DJ, 1964, NATURE, V204, P1118, DOI 10.1038/2041118a0; Dechun Liu, 2011, 2011 3rd International Conference on Multimedia Information Networking and Security, P278, DOI 10.1109/MINES.2011.109; Fu XC, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.036113; Huang JY, 2011, J SYST SCI COMPLEX, V24, P449, DOI 10.1007/s11424-011-8303-1; Kim J. H., 2011, PACIS 2011 P, P98; Kosfeld M, 2005, J MATH ECON, V41, P646, DOI 10.1016/j.jmateco.2004.05.001; Madar N, 2004, EUR PHYS J B, V38, P269, DOI 10.1140/epjb/e2004-00119-8; Maki D.P., 1973, MATH MODELS APPL EMP; Moreno Y, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066130; Moreno Y, 2002, EUR PHYS J B, V26, P521, DOI 10.1140/epjb/e20020122; Nekovee M, 2007, PHYSICA A, V374, P457, DOI 10.1016/j.physa.2006.07.017; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Pan Zao-feng, 2006, Journal of System Simulation, V18, P2346; Pastor-Satorras R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.036104; Singh A, 2013, ACTA PHYS POL B, V44, P5, DOI 10.5506/APhysPolB.44.5; SUDBURY A, 1985, J APPL PROBAB, V22, P443, DOI 10.2307/3213787; Thomas SA, 2007, SOCIOL SPECTRUM, V27, P679, DOI 10.1080/02732170701534200; Yan G, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.016108; Yang L., 2012, CHINA DAILY; Zanette DH, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041908; Zanette DH, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.050901; Zanette DH, 2002, PHYSICA A, V309, P445, DOI 10.1016/S0378-4371(02)00618-0; Zhao LJ, 2013, PHYSICA A, V392, P987, DOI 10.1016/j.physa.2012.10.031; Zhao LJ, 2012, PHYSICA A, V391, P3978, DOI 10.1016/j.physa.2012.02.004	26	65	66	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124978	10.1371/journal.pone.0124978	http://dx.doi.org/10.1371/journal.pone.0124978			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933430	gold, Green Published, Green Submitted			2022-12-27	WOS:000353887100070
J	Dhyani, A; Tibolla, G; Baragetti, A; Garlaschelli, K; Pellegatta, F; Grigore, L; Norata, GD; Catapano, AL				Dhyani, Ashish; Tibolla, Gianpaolo; Baragetti, Andrea; Garlaschelli, Katia; Pellegatta, Fabio; Grigore, Liliana; Norata, Giuseppe Danilo; Catapano, Alberico Luigi			IDOL N342S Variant, Atherosclerosis Progression and Cardiovascular Disorders in the Italian General Population	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; INTIMA-MEDIA THICKNESS; CHOLESTEROL UPTAKE; 9 PCSK9; CELLS; HYPERCHOLESTEROLEMIA	Inducible degrader of the low density lipoprotein receptor (IDOL), is an E3 ubiquitin ligase that negatively modulates low density lipoprotein receptor (LDL-R) expression. Genomewide association studies (GWAS) indicated that genetic variants in IDOL gene contributes to variation in LDL-C plasma levels and the detailed analysis of a specific locus resulted in the identification of the functional common single nucleotide polymorphism (SNP) rs9370867 (c. G1025A, p.N342S) associates with increased LDL-R degradation and increased LDL-C levels. These findings, however, were not confirmed in two other independent cohorts and no data about the impact of this variant on atherosclerosis progression and cardiovascular risk are available. Aim of this study was to investigate the association between a functional variant in IDOL and atherosclerosis progression in an Italian general population. 1384 subjects enrolled in the PLIC study (Progression of Lesions in the Intima of Carotid) were genotyped by Q-PCR allelic discrimination and the association with anthropometric parameters, plasma lipids and the carotid intima media thickness (cIMT) and the impact on cardiovascular disease (CVD) incidence were investigated. The N342S variant was not associated with changes of the plasma lipid profile among GG, AG or AA carriers, including total cholesterol (249 +/- 21, 249 +/- 19 and 248 +/- 21 mg/dl respectively), LDL-C (158 +/- 25, 161 +/- 22 and 160 +/- 23 mg/dL), cIMT (0.74 +/- 0.14, 0.75 +/- 0.17 and 0.77 +/- 0.15 mm) and CVD incidence. In agreement, the expression of LDLR and the uptake of LDL was similar in macrophages derived from GG and AA carriers. Taken together our findings indicate that the N342S variant does not impact plasma lipid profile and is not associated with atherosclerosis progression and CVD in the general population, suggesting that other variants in the IDOL gene might be functionally linked with cholesterol metabolism.	[Dhyani, Ashish; Tibolla, Gianpaolo; Norata, Giuseppe Danilo; Catapano, Alberico Luigi] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy; [Tibolla, Gianpaolo; Grigore, Liliana; Catapano, Alberico Luigi] IRCCS MultiMed, Milan, Italy; [Baragetti, Andrea; Garlaschelli, Katia; Pellegatta, Fabio; Grigore, Liliana; Norata, Giuseppe Danilo] Bassini Hosp, SISA Ctr Study Atherosclerosis, Cinisello Balsamo, Italy; [Norata, Giuseppe Danilo] Queen Mary Univ, Barts & London Sch Med & Dent, Blizard Inst, Ctr Diabet, London, England	University of Milan; IRCCS Multimedica; University of London; Queen Mary University London	Norata, GD (corresponding author), Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy.	danilo.norata@unimi.it; alberico.catapano@unimi.it	Catapano, alberico/AAC-2827-2019; Baragetti, Andrea/K-2829-2018; Norata, Giuseppe Danilo/AAC-2863-2019	Catapano, alberico/0000-0002-7593-2094; Baragetti, Andrea/0000-0002-6216-1999; Norata, Giuseppe Danilo/0000-0002-6081-1257	Telethon Foundation [GGP13002]; Piano di Sviluppo UNIMI- Linea B; SISA Lombardia; SITeCS	Telethon Foundation(Fondazione Telethon); Piano di Sviluppo UNIMI- Linea B; SISA Lombardia; SITeCS	GDN is supported by Telethon Foundation (GGP13002) and Piano di Sviluppo UNIMI- Linea B 2013. ALC is supported by a grant from SISA Lombardia and SITeCS. None of this support was used directly for the study.	Ammirati E, 2014, NUTR METAB CARDIOVAS, V24, P751, DOI 10.1016/j.numecd.2014.01.006; Ammirati E, 2012, J AM HEART ASSOC, V1, P27, DOI 10.1161/JAHA.111.000125; Baragetti A, 2015, J INTERN MED, V277, P478, DOI 10.1111/joim.12282; Baragetti A, 2014, NUTR METAB CARDIOVAS, V24, P518, DOI 10.1016/j.numecd.2013.10.030; Baragetti A, 2013, J INTERN MED, V274, P252, DOI 10.1111/joim.12081; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Calkin AC, 2014, CIRC RES, V115, P442, DOI 10.1161/CIRCRESAHA.115.304440; Catapano AL, 2011, ATHEROSCLEROSIS, V217, P3, DOI 10.1016/j.atherosclerosis.2011.06.028; Chasman DI, 2012, CIRC-CARDIOVASC GENE, V5, P257, DOI 10.1161/CIRCGENETICS.111.961144; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; Ferri N, 2012, ATHEROSCLEROSIS, V220, P381, DOI 10.1016/j.atherosclerosis.2011.11.026; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; HOBBS HH, 1990, ANNU REV GENET, V24, P133, DOI 10.1146/annurev.ge.24.120190.001025; Lorenz MW, 2012, LANCET, V379, P2053, DOI 10.1016/S0140-6736(12)60441-3; Norata GD, 2007, J INTERN MED, V262, P104, DOI 10.1111/j.1365-2796.2007.01787.x; Norata GD, 2010, NUTR METAB CARDIOVAS, V20, P56, DOI 10.1016/j.numecd.2009.01.011; Norata GD, 2014, ANNU REV PHARMACOL, V54, P273, DOI 10.1146/annurev-pharmtox-011613-140025; Norata GD, 2010, ATHEROSCLEROSIS, V212, P100, DOI 10.1016/j.atherosclerosis.2010.05.015; Norata GD, 2010, ATHEROSCLEROSIS, V208, P177, DOI 10.1016/j.atherosclerosis.2009.06.023; Predazzi IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031086; Santos Paulo C J L, 2014, Pharmacogenet Genomics, V24, P548, DOI 10.1097/FPC.0000000000000089; Santos PCJL, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-83; Sorrentino V, 2013, EUR HEART J, V34, P1292, DOI 10.1093/eurheartj/ehs472; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tibolla G, 2011, NUTR METAB CARDIOVAS, V21, P835, DOI 10.1016/j.numecd.2011.06.002; Waterworth DM, 2010, ARTERIOSCL THROM VAS, V30, P2264, DOI 10.1161/ATVBAHA.109.201020; Weissglas-Volkov D, 2011, J CLIN INVEST, V121, P3062, DOI 10.1172/JCI45504; YEN CF, 1994, J IMMUNOL METHODS, V177, P55, DOI 10.1016/0022-1759(94)90143-0; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974; Zhang L, 2012, ARTERIOSCL THROM VAS, V32, P2541, DOI 10.1161/ATVBAHA.112.250571	30	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0122414	10.1371/journal.pone.0122414	http://dx.doi.org/10.1371/journal.pone.0122414			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927920	Green Published, gold, Green Submitted			2022-12-27	WOS:000353713100008
J	Rivollat, M; Mendisco, F; Pemonge, MH; Safi, A; St-Marc, D; Bremond, A; Couture-Veschambre, C; Rottier, S; Deguilloux, MF				Rivollat, Maite; Mendisco, Fanny; Pemonge, Marie-Helene; Safi, Audrey; St-Marc, Didier; Bremond, Antoine; Couture-Veschambre, Christine; Rottier, Stephane; Deguilloux, Marie-France			When the Waves of European Neolithization Met: First Paleogenetic Evidence from Early Farmers in the Southern Paris Basin	PLOS ONE			English	Article							ANCIENT DNA; GENETIC DISCONTINUITY; SEQUENCE; SUPPORTS; DIFFERS; REMAINS	An intense debate concerning the nature and mode of Neolithic transition in Europe has long received much attention. Recent publications of paleogenetic analyses focusing on ancient European farmers from Central Europe or the Iberian Peninsula have greatly contributed to this debate, providing arguments in favor of major migrations accompanying European Neolithization and highlighting noticeable genetic differentiation between farmers associated with two archaeologically defined migration routes: the Danube valley and the Mediterranean Sea. The aim of the present study was to fill a gap with the first paleogenetic data of Neolithic settlers from a region (France) where the two great currents came into both direct and indirect contact with each other. To this end, we analyzed the Gurgy 'Les Noisats' group, an Early/Middle Neolithic necropolis in the southern part of the Paris Basin. Interestingly, the archaeological record from this region highlighted a clear cultural influence from the Danubian cultural sphere but also notes exchanges with the Mediterranean cultural area. To unravel the processes implied in these cultural exchanges, we analyzed 102 individuals and obtained the largest Neolithic mitochondrial gene pool so far (39 HVS-I mitochondrial sequences and haplogroups for 55 individuals) from a single archaeological site from the Early/Middle Neolithic period. Pairwise F-ST values, haplogroup frequencies and shared informative haplotypes were calculated and compared with ancient and modern European and Near Eastern populations. These descriptive analyses provided patterns resulting from different evolutionary scenarios; however, the archaeological data available for the region suggest that the Gurgy group was formed through equivalent genetic contributions of farmer descendants from the Danubian and Mediterranean Neolithization waves. However, these results, that would constitute the most ancient genetic evidence of admixture between farmers from both Central and Mediterranean migration routes in the European Neolithization debate, are subject to confirmation through appropriate model-based approaches.	[Rivollat, Maite; Mendisco, Fanny; Pemonge, Marie-Helene; Safi, Audrey; St-Marc, Didier; Bremond, Antoine; Couture-Veschambre, Christine; Rottier, Stephane; Deguilloux, Marie-France] Univ Bordeaux, Prehist Actuel Culture Environm Anthropolol, UMR 5199, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux	Rivollat, M (corresponding author), Univ Bordeaux, Prehist Actuel Culture Environm Anthropolol, UMR 5199, Bordeaux, France.	maite.rivollat@u-bordeaux.fr			region of Bourgogne, France; Service Regional de l'Archeologie de Bourgogne [89 198 008]; Research National Agency as a program of prospects investments [ANR-10-LABX-52]; Ministere de l'Enseignement Superieur et de la Recherche; Conseil Regional d'Aquitaine [20030304002FA, 20040305003FA]; European Union, FEDER [2003227]; Investissements d'avenir, Convention attributive d'aide [ANR-10-EQPX-16-01]	region of Bourgogne, France; Service Regional de l'Archeologie de Bourgogne; Research National Agency as a program of prospects investments; Ministere de l'Enseignement Superieur et de la Recherche; Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); European Union, FEDER; Investissements d'avenir, Convention attributive d'aide(French National Research Agency (ANR))	This study benefitted from excavation grant support from the region of Bourgogne, France, and the Service Regional de l'Archeologie de Bourgogne (89 198 008). This research is funded by a ministerial grant from the Research National Agency as a program of prospects investments ANR-10-LABX-52 (project 'Diversite biologique et culturelle de l'Homme de la fin de la Prehistoire a la Protohistoire'; dir: SR; Universite de Bordeaux 1, LaScArBx-ANR; 2012-14) and has also been performed thanks to the PhD research grant from the Ministere de l'Enseignement Superieur et de la Recherche for MR. Part of the experiments (SNPs analyses) presented were performed at the Genomic and Sequencing Facility of Bordeaux (grants from the Conseil Regional d'Aquitaine no 20030304002FA and 20040305003FA and from the European Union, FEDER no 2003227 and from Investissements d'avenir, Convention attributive d'aide No ANR-10-EQPX-16-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMMERMAN AJ, 1984, NEOLITHIC TRANSITION; Anderson S, 1981, SEQUENCE ORG HUMAN M; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bollongino R, 2013, SCIENCE, V342, P479, DOI 10.1126/science.1245049; Bonnardin S., 2009, PARURE FUNERAIRE NEO; Bramanti B, 2009, SCIENCE, V326, P137, DOI 10.1126/science.1176869; Brandt G, 2013, SCIENCE, V342, P257, DOI 10.1126/science.1241844; Brotherton P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2656; Burger J, 2007, P NATL ACAD SCI USA, V104, P3736, DOI 10.1073/pnas.0607187104; Burnez-Lanotte L, 2008, AUTOUR RECHERCHES CL, V44; Caramelli D, 2003, P NATL ACAD SCI USA, V100, P6593, DOI 10.1073/pnas.1130343100; Caramelli D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002700; Chambon P., 2013, TRANSITION RUPTURES, V1, P213; Chambon P., 2007, CISTES CHAMBLANDES P, P75; Chikhi L, 1998, P NATL ACAD SCI USA, V95, P9053, DOI 10.1073/pnas.95.15.9053; Childe V.G., 1925, DAWN EUROPEAN CIVILI; Constantin C, 1998, ANTHR PREHISTOIRE, V109, P207; Constantin C, 1997, NEOLITHIQUE DANUBIEN, P207; Constantin C, 2004, B SOC PREHISTORIQUE, V101, P75; Cooper A, 2000, SCIENCE, V289, P1139; Deguilloux MF, 2011, AM J PHYS ANTHROPOL, V144, P108, DOI 10.1002/ajpa.21376; Delsate D., 2009, B SOC PREHIST LUXEMB, V31, P7; Demoule J.-P., 2007, REVOLUTION NEOLITHIQ; Demoule J-P, 2007, REVOLUTION NEOLITHIQ, P42; Demoule J-P, 2007, REVOLUTION NEOLITHIQ, P60; Di Benedetto G, 2000, EUR J HUM GENET, V8, P669, DOI 10.1038/sj.ejhg.5200514; Diaz N, 2004, ANTROPO, V7, P39; Dubouloz J., 2003, BULL SOC PREHIST FR, V100, P671, DOI DOI 10.3406/BSPF200312903; Ermini L, 2008, CURR BIOL, V18, P1687, DOI 10.1016/j.cub.2008.09.028; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fu QM, 2013, CURR BIOL, V23, P553, DOI 10.1016/j.cub.2013.02.044; Gabriel MN, 2001, J FORENSIC SCI, V46, P247; Gamba C, 2012, MOL ECOL, V21, P45, DOI 10.1111/j.1365-294X.2011.05361.x; Gamba C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6257; Guilaine J, 1997, CONTACTS SUD NORD NE, P301; Haak W, 2005, SCIENCE, V310, P1016, DOI 10.1126/science.1118725; Haak W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000536; Haak W, 2008, P NATL ACAD SCI USA, V105, P18226, DOI 10.1073/pnas.0807592105; Hauzeur A., 2002, PREHISTORIE GRANDE P, P167; Hervella M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034417; Jeunesse C, 1995, GALLIA PREHISTOIRE, V37, P115; Krause J, 2010, CURR BIOL, V20, P231, DOI 10.1016/j.cub.2009.11.068; Lacan M, 2011, P NATL ACAD SCI USA, V108, P18255, DOI 10.1073/pnas.1113061108; Lacan M, 2011, P NATL ACAD SCI USA, V108, P9788, DOI 10.1073/pnas.1100723108; Lazaridis I, 2014, BIORXIV; Lee E, 2014, ARCHAEOL ANTHROP SCI, V6, P199, DOI 10.1007/s12520-013-0173-0; Lee EJ, 2012, AM J PHYS ANTHROPOL, V148, P571, DOI 10.1002/ajpa.22074; Lichardus-Itten M., 1986, NEOLITHIQUE FRANCE H, P147; Malmstrom H, 2009, CURR BIOL, V19, P1758, DOI 10.1016/j.cub.2009.09.017; Melchior L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011898; Mendisco F, 2011, ELECTROPHORESIS, V32, P386, DOI 10.1002/elps.201000483; Price TD, 2000, EUROPES 1 FARMERS; Rasteiro R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060944; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Rottier S, 2007, CISTES CHAMBLANDES P, VXLIII, P99; Rottier S, 2005, BULL SOC PREHIST FR, V102, P641, DOI 10.3406/bspf.2005.13148; Rubane Sidera I., 2008, FIN TRADITIONS DANUB, V44, P209; Sampietro ML, 2007, P ROY SOC B-BIOL SCI, V274, P2161, DOI 10.1098/rspb.2007.0465; Sanchez-Ouinto F, 2012, CURR BIOL, V22, P1494, DOI 10.1016/j.cub.2012.06.005; Sarkissian CD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003296; Senepart I, 2007, REVOLUTION NEOLITHIQ, P26; Sidera I, 2010, NOUVEAU REGARD NEOLI; Sidera I., 2010, J C MELANGEA CASA VE, V40, P17; Skoglund P, 2014, SCIENCE, V344, P747, DOI 10.1126/science.1253448; Sykes B, 1999, PHILOS T ROY SOC B, V354, P131, DOI 10.1098/rstb.1999.0366; Thomas A., 2011, THESIS BORDEAUX; Vander Linden M, 2011, INVESTIGATING ARCHAEOLOGICAL CULTURES: MATERIAL CULTURE, VARIABILITY, AND TRANSMISSION, P289, DOI 10.1007/978-1-4419-6970-5_15; Wakeley J., 2009, COALESCENT THEORY; Whittle A., 1996, EUROPE NEOLITHIC CRE; Zvelebil M, 2001, DOCUMENTA PRAEHISTOR, pXXVIII	70	36	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125521	10.1371/journal.pone.0125521	http://dx.doi.org/10.1371/journal.pone.0125521			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928633	Green Submitted, Green Published, gold			2022-12-27	WOS:000353713100097
J	Sanderson, M; Lipworth, L; Shen-Miller, D; Nechuta, S; Beeghly-Fadiel, A; Shrubsole, MJ; Zheng, W				Sanderson, Maureen; Lipworth, Loren; Shen-Miller, David; Nechuta, Sarah; Beeghly-Fadiel, Alicia; Shrubsole, Martha J.; Zheng, Wei			Energy-Related Indicators and Breast Cancer Risk among White and Black Women	PLOS ONE			English	Article							AFRICAN-AMERICAN WOMEN; BODY-MASS INDEX; RECREATIONAL PHYSICAL-ACTIVITY; HORMONE-RECEPTOR STATUS; MULTIETHNIC POPULATION; WEIGHT CHANGE; COHORT; SIZE; PREMENOPAUSAL; OBESITY	Energy-related indicators, including physical activity, energy intake, body mass index (BMI) and adult weight change, have been linked to breast cancer risk. Very few studies of these associations have been conducted among black women, therefore we used the Nashville Breast Health Study (NBHS) to determine whether similar effects were seen in black and white women. The NBHS is a population-based case-control study of breast cancer among women age 25 to 75 years conducted between 2001 and 2010 in and around the Nashville Metropolitan area. Telephone interviews and self-administered food frequency questionnaires were completed with 2,614 incident breast cancer cases ascertained through hospitals and the statewide cancer registry, and 2,306 controls selected using random digit dialing. Among premenopausal white and black women, there was little effect of adult exercise or other energy-related indicators on breast cancer risk, regardless of tumor estrogen receptor (ER) status. The beneficial effect of adult exercise on postmenopausal breast cancer appeared to be comparable between white and black women (highest tertile relative to none -white odds ratio [OR] 0.8, 95% confidence interval [CI] 0.6-1.0, p for trend=0.05; black OR 0.7, 95% CI 0.4-1.1, p for trend=0.07); however, among black women the reduction was limited to those with ER-positive disease. White and black women should be encouraged to engage in more physical activity to reduce their risk of postmenopausal breast cancer.	[Sanderson, Maureen] Meharry Med Coll, Dept Family & Community Med, Nashville, TN 37208 USA; [Lipworth, Loren; Nechuta, Sarah; Beeghly-Fadiel, Alicia; Shrubsole, Martha J.; Zheng, Wei] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Vanderbilt Epidemiol Ctr, Div Epidemiol,Dept Med,Sch Med, Nashville, TN 37235 USA; [Shen-Miller, David] Tennessee State Univ, Dept Psychol, Nashville, TN 37203 USA	Meharry Medical College; Vanderbilt University; Tennessee State University	Sanderson, M (corresponding author), Meharry Med Coll, Dept Family & Community Med, Nashville, TN 37208 USA.	msanderson@mmc.edu	Shrubsole, Martha J/K-5052-2015; zhang, weihua/GXV-1334-2022; Zheng, Wei/O-3351-2013; Nechuta, Sarah/AAG-4025-2020	Shrubsole, Martha J/0000-0002-5591-7575; Zheng, Wei/0000-0003-1226-070X; Nechuta, Sarah/0000-0003-2773-6678	US National Cancer Institute [R01CA100374, U54CA163069]; Ingram Professorship funds; Vanderbilt-Ingram Cancer Center [P30CA68485]; NATIONAL CANCER INSTITUTE [R01CA100374, P30CA068485, U54CA163072, U54CA163069, U54CA163066] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007586] Funding Source: NIH RePORTER	US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ingram Professorship funds; Vanderbilt-Ingram Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by research grants (R01CA100374, U54CA163069) from the US National Cancer Institute, as well as Ingram Professorship funds. The survey for this study was conducted by the Survey Research Shared Resource, which is supported in part by the Vanderbilt-Ingram Cancer Center (P30CA68485).	Adams-Campbell LL, 2001, J NATL MED ASSOC, V93, P267; AdamsCampbell LL, 1996, OBES RES, V4, P451, DOI 10.1002/j.1550-8528.1996.tb00253.x; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Amadou A, 2013, OBES REV, V14, P665, DOI 10.1111/obr.12028; BARNESJOSIAH D, 1995, CANCER CAUSE CONTROL, V6, P112, DOI 10.1007/BF00052771; Bernstein L, 2005, JNCI-J NATL CANCER I, V97, P1671, DOI 10.1093/jnci/dji374; Berstad P, 2010, CANCER EPIDEM BIOMAR, V19, P1532, DOI 10.1158/1055-9965.EPI-10-0025; Brinton LA, 1997, INT J CANCER, V73, P349, DOI 10.1002/(SICI)1097-0215(19971104)73:3<349::AID-IJC8>3.0.CO;2-#; Cheraghi Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051446; Cleary MP, 1997, P SOC EXP BIOL MED, V216, P28, DOI 10.3181/00379727-216-44153B; Cohen SS, 2013, CANCER PREV RES, V6, P566, DOI 10.1158/1940-6207.CAPR-13-0045; Cui Y, 2014, CLIN CANCER RES, V20, P1169, DOI 10.1158/1078-0432.CCR-13-2094; Emaus MJ, 2014, INT J CANCER, V135, P2887, DOI 10.1002/ijc.28926; Friedenreich CM, 2004, EXERC SPORT SCI REV, V32, P180; Gilliland FD, 2001, AM J EPIDEMIOL, V154, P442, DOI 10.1093/aje/154.5.442; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; Hall IJ, 2005, AM J EPIDEMIOL, V161, P40, DOI 10.1093/aje/kwh331; Hall IJ, 2000, AM J EPIDEMIOL, V151, P754, DOI 10.1093/oxfordjournals.aje.a010275; Han XS, 2014, INT J CANCER, V135, P2900, DOI 10.1002/ijc.28930; Harvie M, 2003, Obes Rev, V4, P157, DOI 10.1046/j.1467-789X.2003.00108.x; Hildebrand JS, 2013, CANCER EPIDEM BIOMAR, V22, P1906, DOI 10.1158/1055-9965.EPI-13-0407; Huang ZP, 1997, JAMA-J AM MED ASSOC, V278, P1407, DOI 10.1001/jama.278.17.1407; John EM, 2003, CANCER EPIDEM BIOMAR, V12, P1143; John EM, 2011, AM J EPIDEMIOL, V173, P201, DOI 10.1093/aje/kwq345; Kataria, 2016, SAUDI J SPORTS MED, V16, P139; Mayberry Robert M., 1994, Annals of Epidemiology, V4, P205, DOI 10.1016/1047-2797(94)90098-1; McCullough LE, 2012, CANCER-AM CANCER SOC, V118, P4860, DOI 10.1002/cncr.27433; McTiernan A, 2003, JAMA-J AM MED ASSOC, V290, P1331, DOI 10.1001/jama.290.10.1331; McTiernan A, 2005, ONCOLOGY-NY, V19, P871; Michels KB, 2012, INT J CANCER, V130, P902, DOI 10.1002/ijc.26069; Monninkhof EM, 2007, EPIDEMIOLOGY, V18, P137, DOI 10.1097/01.ede.0000251167.75581.98; Munsell MF, 2014, EPIDEMIOL REV, V36, P114, DOI 10.1093/epirev/mxt010; Silvera SAN, 2006, BREAST CANCER RES TR, V97, P97, DOI 10.1007/s10549-005-9098-3; Palmer JR, 2007, CANCER EPIDEM BIOMAR, V16, P1795, DOI 10.1158/1055-9965.EPI-07-0336; Patel AV, 2003, CANCER CAUSE CONTROL, V14, P519, DOI 10.1023/A:1024895613663; Ratnasinghe LD, 2010, NUTR CANCER, V62, P425, DOI 10.1080/01635580903441295; SCHATZKIN A, 1987, J NATL CANCER I, V78, P213; Sheppard VB, 2011, ETHNIC DIS, V21, P406; Shin A, 2007, INT J CANCER, V121, P136, DOI 10.1002/ijc.22664; Shin A, 2009, BREAST CANCER RES TR, V113, P153, DOI 10.1007/s10549-008-9903-x; Steindorf K, 2013, INT J CANCER, V132, P1667, DOI 10.1002/ijc.27778; Stephenson GD, 2003, NUTR CANCER, V45, P1, DOI 10.1207/S15327914NC4501_1; Sue LY, 2009, CANCER EPIDEM BIOMAR, V18, P2842, DOI 10.1158/1055-9965.EPI-09-0087; Suzuki R, 2010, CANCER CAUSE CONTROL, V21, P1787, DOI 10.1007/s10552-010-9605-7; Tehard B, 2006, CANCER EPIDEM BIOMAR, V15, P57, DOI 10.1158/1055-9965.EPI-05-0603; Thune I, 1997, NEW ENGL J MED, V336, P1269, DOI 10.1056/NEJM199705013361801; Zhang FF, 2013, BREAST CANCER RES TR, V137, P541, DOI 10.1007/s10549-012-2342-8; Zhu KM, 2005, ANN EPIDEMIOL, V15, P123, DOI 10.1016/j.annepidem.2004.05.011	48	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125058	10.1371/journal.pone.0125058	http://dx.doi.org/10.1371/journal.pone.0125058			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927530	gold, Green Published, Green Submitted			2022-12-27	WOS:000353713100064
J	Toblli, JE; Di Gennaro, F				Toblli, Jorge Eduardo; Di Gennaro, Federico			Switching Patients with Non-Dialysis Chronic Kidney Disease from Oral Iron to Intravenous Ferric Carboxymaltose: Effects on Erythropoiesis-Stimulating Agent Requirements, Costs, Hemoglobin and Iron Status	PLOS ONE			English	Article							CHRONIC-RENAL-FAILURE; RANDOMIZED CONTROLLED-TRIAL; ANEMIC PATIENTS; HEMODIALYSIS-PATIENTS; HEART-FAILURE; IV IRON; SUPPLEMENTATION; DEFICIENCY; THERAPY; SUCROSE	Background Patients with non-dialysis-dependent chronic kidney disease (ND-CKD) often receive an erythropoiesis-stimulating agent (ESA) and oral iron treatment. This study evaluated whether a switch from oral iron to intravenous ferric carboxymaltose can reduce ESA requirements and improve iron status and hemoglobin in patients with ND-CKD. Methods This prospective, single arm and single-center study included adult patients with ND-CKD (creatinine clearance <= 40 mL/min), hemoglobin 11-12 g/dL and iron deficiency (ferritin <100 mu g/L or transferrin saturation <20%), who were regularly treated with oral iron and ESA during 6 months prior to inclusion. Study patients received an intravenous ferric carboxymaltose dose of 1,000 mg iron, followed by a 6-months ESA/ferric carboxymaltose maintenance regimen (target: hemoglobin 12 g/dL, transferrin saturation >20%). Outcome measures were ESA dose requirements during the observation period after initial ferric carboxymaltose treatment (primary endpoint); number of hospitalizations and transfusions, renal function before and after ferric carboxymaltose administration, number of adverse reactions (secondary endpoints). Hemoglobin, mean corpuscular volume, ferritin and transferrin saturation were measured monthly from baseline until end of study. Creatinine clearance, proteinuria, C-reactive protein, aspartate aminotransferase, alanine aminotransferase and alkaline phosphatase bimonthly from baseline until end of study. Results Thirty patients were enrolled (age 70.1 +/- 11.4 years; mean +/- SD). Mean ESA consumption was significantly reduced by 83.2 +/- 10.9% (from 41,839 +/- 3,668 IU/patient to 6,879 +/- 4,271 IU/patient; p<0.01). Hemoglobin increased by 0.7 +/- 0.3 g/dL, ferritin by 196.0 +/- 38.7 mu g/L and transferrin saturation by 5.3 +/- 2.9% (month 6 vs. baseline; all p<0.01). No ferric carboxymaltose-related adverse events were reported and no patient withdrew or required transfusions during the study. Conclusion Among patients with ND-CKD and stable normal or borderline hemoglobin, switching from oral iron to intravenous ferric carboxymaltose was associated with significant improvements in hematological and iron parameters and a significant reduction in ESA dose requirements in this single-center pilot study.	[Toblli, Jorge Eduardo; Di Gennaro, Federico] Hosp Aleman, Dept Nephrol, Buenos Aires, DF, Argentina	Hospital Aleman; University of Buenos Aires	Toblli, JE (corresponding author), Hosp Aleman, Dept Nephrol, Buenos Aires, DF, Argentina.	jorgetoblli@fibertel.com.ar			Vifor (International) AG, Switzerland	Vifor (International) AG, Switzerland	The study and medical writing support were sponsored by Vifor (International) AG, Switzerland. The funders had no role in study design, data collection and analysis, or decision to publish.	Aapro M, 2012, ANN ONCOL, V23, P1954, DOI 10.1093/annonc/mds112; Anker SD, 2009, NEW ENGL J MED, V361, P2436, DOI 10.1056/NEJMoa0908355; Chang CH, 2002, CLIN NEPHROL, V57, P136; Charytan C, 2005, NEPHRON CLIN PRACT, V100, pC55, DOI 10.1159/000085049; Descombes E, 2000, NEPHRON, V84, P196, DOI 10.1159/000045574; DeVita MV, 2003, CLIN NEPHROL, V60, P335; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Favrat B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094217; FISHBANE S, 1995, AM J KIDNEY DIS, V26, P41, DOI 10.1016/0272-6386(95)90151-5; Fishbane S, 2009, CLIN J AM SOC NEPHRO, V4, P57, DOI 10.2215/CJN.01670408; Foley RN, 2000, KIDNEY INT, V58, P1325, DOI 10.1046/j.1523-1755.2000.00289.x; Group KAW, 2012, KIDNEY INT, V2, P279, DOI DOI 10.1038/kisup.2012.37; Hedenus M, 2007, LEUKEMIA, V21, P627, DOI 10.1038/sj.leu.2404562; Hsu CY, 2002, J AM SOC NEPHROL, V13, P2783, DOI 10.1097/01.ASN.0000034200.82278.DC; Kulnigg-Dabsch S, 2013, INFLAMM BOWEL DIS, V19, P1609, DOI 10.1097/MIB.0b013e318281f4db; Kulnigg-Dabsch S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034520; Li H, 2008, BLOOD PURIFICAT, V26, P151, DOI 10.1159/000113529; Locatelli Francesco, 2004, Nephrol Dial Transplant, V19 Suppl 2, pii1, DOI 10.1093/ndt/gfh1032; Luporsi Elisabeth, 2012, J Med Econ, V15, P225, DOI 10.3111/13696998.2011.639823; Macdougall IC, 2014, NEPHROL DIAL TRANSPL, V29, P843, DOI 10.1093/ndt/gft424; Macdougall IC, 1999, KIDNEY INT, V55, pS61, DOI 10.1046/j.1523-1755.1999.055Suppl.69061.x; Macdougall IC, 1996, KIDNEY INT, V50, P1694, DOI 10.1038/ki.1996.487; Macdougall IC, 1999, AM J KIDNEY DIS, V34, pS40, DOI 10.1053/ajkd.1999.v34.aajkd0344b0040; McClellan W, 2004, CURR MED RES OPIN, V20, P1501, DOI 10.1185/030079904X2763; Mircescu G, 2006, NEPHROL DIAL TRANSPL, V21, P120, DOI 10.1093/ndt/gfi087; Munoz M, 2012, EXPERT OPIN PHARMACO, V13, P907, DOI 10.1517/14656566.2012.669373; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Ponikowski P, 2015, EUR HEART J, V36, P657, DOI 10.1093/eurheartj/ehu385; Post JB, 2006, INT UROL NEPHROL, V38, P719, DOI 10.1007/s11255-006-0035-0; Qunibi WY, 2011, NEPHROL DIAL TRANSPL, V26, P1599, DOI 10.1093/ndt/gfq613; Richardson D, 2001, AM J KIDNEY DIS, V38, P109, DOI 10.1053/ajkd.2001.25203; Rozen-Zvi B, 2008, AM J KIDNEY DIS, V52, P897, DOI 10.1053/j.ajkd.2008.05.033; Schiesser D, 2006, NEPHROL DIAL TRANSPL, V21, P2841, DOI 10.1093/ndt/gfl419; Sepandj F, 1996, NEPHROL DIAL TRANSPL, V11, P319, DOI 10.1093/oxfordjournals.ndt.a027260; Silverberg DS, 1996, AM J KIDNEY DIS, V27, P234, DOI 10.1016/S0272-6386(96)90546-6; Silverberg DS, 2001, CLIN NEPHROL, V55, P212; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Stoves J, 2001, NEPHROL DIAL TRANSPL, V16, P967, DOI 10.1093/ndt/16.5.967; Szucs TD, 2011, ONCOLOGY-BASEL, V81, P45, DOI 10.1159/000330738; Van Wyck DB, 2005, KIDNEY INT, V68, P2846, DOI 10.1111/j.1523-1755.2005.00758.x; Weiner DE, 2005, J AM SOC NEPHROL, V16, P1803, DOI 10.1681/ASN.2004070597	41	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125528	10.1371/journal.pone.0125528	http://dx.doi.org/10.1371/journal.pone.0125528			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928811	Green Submitted, Green Published, gold			2022-12-27	WOS:000353713100099
J	Hao, W; Wang, SJ; Liu, HJ; Zhou, BR; Wang, XW; Jiang, TB				Hao, Wei; Wang, Shengji; Liu, Huajing; Zhou, Boru; Wang, Xinwang; Jiang, Tingbo			Development of SSR Markers and Genetic Diversity in White Birch (Betula platyphylla)	PLOS ONE			English	Article							FRAGMENT LENGTH POLYMORPHISMS; MICROSATELLITE MARKERS; LINKAGE MAP; DNA MARKERS; IDENTIFICATION; BARLEY; LOCI; L.	In order to study genetic diversity of white birch (Betula platyphylla), 544 primer pairs were designed based on the genome-wide Solexa sequences. Among them, 215 primer pairs showed polymorphism between five genotypes and 111 primer pairs that presented clear visible bands in genotyping 41 white birch plants that were collected from 6 different geographical regions. A total of 717 alleles were obtained at 111 loci with a range of 2 to 12 alleles per locus. The results of statistic analysis showed that polymorphic frequency of the alleles ranged from 17% to 100% with a mean of 55.85%; polymorphism information content (PIC) of the loci was from 0.09 to 0.58 with a mean of 0.30; and gene diversity between the tested genotypes was from 0.01 to 0.66 with a mean of 0.36. The results also indicated that major allele frequency ranged from 0.39 to 1.00 with an mean of 0.75; expected heterozygosity from 0.22 to 0.54 with a mean of 0.46; observed heterozygosity from 0.02 to 0.95 with a mean of 0.26; Nei's index from 0.21 to 0.54 with a mean of 0.46; and Shannon's Information from 0.26 to 0.87 with a mean of 0.66. The 41 white birch genotypes at the 111 selected SSR loci showed low to moderate similarity (0.025-0.610), indicating complicated genetic diversity among the white birch collections. The UPGMA-based clustering analysis of the allelic constitution of 41 white birch genotypes at 111 SSR loci suggested that the six different geographical regions can be further separated into four clusters at a similarity coefficient of 0.22. Genotypes from Huanren and Liangshui provenances were grouped into Cluster I, genotypes from Xiaobeihu and Qingyuan provenances into Cluster II, genotypes from Finland provenance into Cluster III, and genotypes from Maoershan into Cluster IV. The information provided in this study could help for genetic improvement and germplasm conservation, evaluation and utilization in white birch tree breeding program.	[Hao, Wei; Wang, Shengji; Liu, Huajing; Zhou, Boru; Wang, Xinwang; Jiang, Tingbo] Northeast Forestry Univ, State Key Lab Tree Genet & Breeding, Harbin, Peoples R China; [Liu, Huajing] Northeast Forestry Univ, Coll Resources & Environm Sci, Harbin, Peoples R China; [Wang, Xinwang] Texas A&M Syst, Texas A&M AgriLife Res & Extens Ctr, Dallas, TX USA	Northeast Forestry University - China; Northeast Forestry University - China; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research	Wang, XW (corresponding author), Northeast Forestry Univ, State Key Lab Tree Genet & Breeding, Harbin, Peoples R China.	xw-wang@tamu.edu; tbjiang@yahoo.com		Wang, Shengji/0000-0001-9914-7800	National High-Tech Research and Development Program of China [2011AA100202, 2013AA102701]; Innovation Project of State Key Laboratory of Tree Genetics and Breeding, Northeast Forestry University	National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Innovation Project of State Key Laboratory of Tree Genetics and Breeding, Northeast Forestry University	This work was supported by National High-Tech Research and Development Program of China (2011AA100202, 2013AA102701) and The Innovation Project of State Key Laboratory of Tree Genetics and Breeding, Northeast Forestry University.	Birren B., 1987, NONMAMMALIAN GENOMIC, P75; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Feingold S, 2005, THEOR APPL GENET, V111, P456, DOI 10.1007/s00122-005-2028-2; Guo Y, 2012, GENET RESOUR CROP EV, V59, P1543, DOI 10.1007/s10722-011-9783-5; Jiang TB, 2011, MOL BREEDING, V27, P347, DOI 10.1007/s11032-010-9436-y; Kostova A, 2006, J CROP IMPROV, V16, P37, DOI 10.1300/J411v16n01_03; Kulju KKM, 2004, MOL ECOL NOTES, V4, P471, DOI 10.1111/j.1471-8286.2004.00704.x; Li JW., 2011, CHINA VEGETABLES, V20, P1; LI P, 1995, CHEM IND FOR PROD, V15, P13; Liu ZW, 1996, THEOR APPL GENET, V93, P869, DOI 10.1007/BF00224088; Lu Yong-quan, 2011, Journal of Forestry Research (Harbin), V22, P201, DOI 10.1007/s11676-011-0150-3; Ogyu K, 2003, MOL ECOL NOTES, V3, P268, DOI 10.1046/j.1471-8286.2003.00419.x; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pekkinen M, 2005, GENOME, V48, P619, DOI 10.1139/G05-031; Perez F, 2005, MAR BIOTECHNOL, V7, P554, DOI 10.1007/s10126-004-5099-1; Powell W, 1996, TRENDS PLANT SCI, V1, P215, DOI 10.1016/1360-1385(96)86898-1; Rohlf FJ, 1997, NTSYS PC VERSION 2 0; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Truong C, 2005, MOL ECOL NOTES, V5, P96, DOI 10.1111/j.1471-8286.2004.00848.x; [屠德鹏 TU Depeng], 2011, [草业科学, Pratacultural Science], V28, P746; Tu M, 2007, BIOCHEM GENET, V45, P789, DOI 10.1007/s10528-007-9118-6; Wang QiuYu, 2007, Scientia Silvae Sinicae, V43, P37; Wang YanMin, 2008, Scientia Silvae Sinicae, V44, P78; Weng Y, 2007, INSECT MOL BIOL, V16, P613, DOI 10.1111/j.1365-2583.2007.00757.x; Wu B, 2002, MOL ECOL NOTES, V2, P413, DOI 10.1046/j.1471-8286.2002.00260.x; [许靖诗 Xu Jingshi], 2012, [中南林业科技大学学报, Journal of Central South University of Forestry & Technology], V32, P80	27	5	6	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125235	10.1371/journal.pone.0125235	http://dx.doi.org/10.1371/journal.pone.0125235			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923698	Green Published, gold			2022-12-27	WOS:000353711600137
J	Du Mont, J; Macdonald, S; Kosa, D; Elliot, S; Spencer, C; Yaffe, M				Du Mont, Janice; Macdonald, Sheila; Kosa, Daisy; Elliot, Shannon; Spencer, Charmaine; Yaffe, Mark			Development of a Comprehensive Hospital-Based Elder Abuse Intervention: An Initial Systematic Scoping Review	PLOS ONE			English	Review							FINANCIAL ABUSE; PREVALENCE; NEGLECT; CARE; INDICATORS; GUIDELINES; MORTALITY; PROGRAMS	Introduction Elder abuse, a universal human rights problem, is associated with many negative consequences. In most jurisdictions, however, there are no comprehensive hospital-based interventions for elder abuse that address the totality of needs of abused older adults: psychological, physical, legal, and social. As the first step towards the development of such an intervention, we undertook a systematic scoping review. Objectives Our primary objective was to systematically extract and synthesize actionable and applicable recommendations for components of a multidisciplinary intersectoral hospital-based elder abuse intervention. A secondary objective was to summarize the characteristics of the responses reviewed, including methods of development and validation. Methods The grey and scholarly literatures were systematically searched, with two independent reviewers conducting the title, abstract and full text screening. Documents were considered eligible for inclusion if they: 1) addressed a response (e.g., an intervention) to elder abuse, 2) contained recommendations for responding to abused older adults with potential relevance to a multidisciplinary and intersectoral hospital-based elder abuse intervention; and 3) were available in English. Analysis The extracted recommendations for care were collated, coded, categorized into themes, and further reviewed for relevancy to a comprehensive hospital-based response. Characteristics of the responses were summarized using descriptive statistics. Results 649 recommendations were extracted from 68 distinct elder abuse responses, 149 of which were deemed relevant and were categorized into 5 themes: Initial contact; Capacity and consent; Interview with older adult, caregiver, collateral contacts, and/or suspected abuser; Assessment: physical/forensic, mental, psychosocial, and environmental/functional; and care plan. Only 6 responses had been evaluated, suggesting a significant gap between development and implementation of recommendations. Discussion To address the lack of evidence to support the recommendations extracted in this review, in a future study, a group of experts will formally evaluate each recommendation for its inclusion in a comprehensive hospital-based response.	[Du Mont, Janice; Kosa, Daisy; Elliot, Shannon] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada; [Du Mont, Janice] Univ Toronto, Dalla Lana Sch Publ Hlth Sci, Toronto, ON, Canada; [Macdonald, Sheila; Kosa, Daisy; Elliot, Shannon] Ontario Network Sexual Assault, Domest Violence Treatments Ctr, Toronto, ON, Canada; [Spencer, Charmaine] Simon Fraser Univ, Gerontol Res Ctr, Burnaby, BC V5A 1S6, Canada; [Yaffe, Mark] McGill Univ, Dept Family Med, Montreal, PQ H3A 2T5, Canada; [Yaffe, Mark] St Marys Hosp, Dept Family Med, Montreal, PQ, Canada	University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; Simon Fraser University; McGill University; McGill University	Du Mont, J (corresponding author), Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada.	janice.dumont@wchospital.ca			Atkinson Foundation; Canadian Institutes of Health Research [SCI-131864]	Atkinson Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Janice Du Mont was supported in part by the Atkinson Foundation. Funding for this review was obtained from the Canadian Institutes of Health Research (Funding Reference Number: SCI-131864, http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acierno R, 2010, AM J PUBLIC HEALTH, V100, P292, DOI 10.2105/AJPH.2009.163089; Anetzberger GJ, 2000, GERONTOLOGIST, V40, P492, DOI 10.1093/geront/40.4.492; [Anonymous], 2007, REACH OUT INT DOM VI; [Anonymous], 2011, GUID DEV ELD AB PROT; [Anonymous], 2011, PROT LAW ENF RESP VI; [Anonymous], 2014, SANE PROGR LIST; [Anonymous], SAF PLANN OLD PERS; [Anonymous], 2011, ELD AB ASS TOOL KIT; [Anonymous], 2014, DEF MEAS ELD AB TOOL; [Anonymous], 2005, ELD AB NETW TRAIN MA; [Anonymous], 2009, RES SERV WORK OLD WO; [Anonymous], 2005, COORD COMM RESP AGR; [Anonymous], 2009, RESP AG VICT GOV PRA; [Anonymous], AB MISTR NEGL AB D 2; [Anonymous], 2005, AD VICT AB PROT; [Anonymous], 2007, ELD AB PROT; [Anonymous], 2013, FIN EXPL; [Anonymous], 2008, ELD AB WHAT YOU NEED; [Anonymous], 2013, COMM OP ELD AB WOM H; [Anonymous], 2010, ELD AB ASS INT REF G; [Anonymous], 2012, COMM RES GUID SERV; [Anonymous], 2010, ELD AB ASS INT REF G; [Anonymous], AB VULN AD; [Anonymous], 2009, ELD AB NEGL FAM VIOL; [Anonymous], 2012, ACT ELD AB PREV PROG; [Anonymous], 2006, AB NEGL OLD VULN PER; [Anonymous], 2011, PROT RESP AB OLD PEO; [Anonymous], 2007, ELD SEX ASS TECHN AS; [Anonymous], 2008, FREE HARM TOOLS; [Anonymous], 2006, PROC GUID HANDL ELD; [Anonymous], 2011, STRAT OCC THER ADDR; Bass DM, 2001, J ELDER ABUSE NEGL, V13, P23, DOI 10.1300/J084v13n02_03; Beaulieu M, 2010, HAND ETHICAL DECISIO; Bomba PA, 2006, J GERONTOL SOC WORK, V46, P103, DOI 10.1300/J083v46n03_06; Boulkedid R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020476; Brandle Bonnie, 2006, Care Manag J, V7, P64, DOI 10.1891/cmaj.7.2.64; Brown K.M., 2010, QUICK REFERENCE ADUL; Brown Kathleen, 2004, Nurse Pract, V29, P22, DOI 10.1097/00006205-200408000-00004; Burgess AW, 2005, AM J NURS, V105, P66, DOI 10.1097/00000446-200510000-00037; Campbell R, 2005, TRAUMA VIOLENCE ABUS, V6, P313, DOI 10.1177/1524838005280328; Chang ALS, 2013, J AM ACAD DERMATOL, V68, DOI 10.1016/j.jaad.2013.01.001; Colbert M, 2013, ADULT PROTECTIVE SER; Connolly M. T, 2014, ELDER JUSTICE ROADMA; Connors K, 2010, FINANCIAL ABUSE SPEC; Cooper C, 2008, AGE AGEING, V37, P151, DOI 10.1093/ageing/afm194; Daly JM, 2005, J ELDER ABUSE NEGL, V17, P1, DOI 10.1300/J084v17n01_01; Daly JM., 2010, ELDER ABUSE PREVENTI; DeLiema M, 2012, J AM GERIATR SOC, V60, P1333, DOI 10.1111/j.1532-5415.2012.04025.x; Dong XQ, 2011, GERONTOLOGY, V57, P549, DOI 10.1159/000321881; Dong XQ, 2013, JAMA INTERN MED, V173, P911, DOI 10.1001/jamainternmed.2013.238; Dong XQ, 2013, J ELDER ABUSE NEGL, V25, P97, DOI 10.1080/08946566.2013.751811; Dong XQ, 2013, GERONTOLOGY, V59, P132, DOI 10.1159/000341652; Dong XQ, 2012, AM J EMERG MED, V30, P553, DOI 10.1016/j.ajem.2011.02.008; Du Mont J, 2014, MED LAW, V33, P189; Egger M, 1998, BMJ, V316; Erlingsson CL, 2003, J ELDER ABUSE NEGL, V15, P185, DOI 10.1300/J084v15n03_11; Ethier L, 2000, ELDER ABUSE RESOURCE; Fanslow J.L., 2006, FAMILY VIOLENCE INTE; Fisher BS, 2011, J INTERPERS VIOLENCE, V26, P254, DOI 10.1177/0886260510362877; Fulmer Terry, 2003, J Gerontol Nurs, V29, P4; Gargon E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099111; Gray-Vickrey P, 2000, Nursing, V30, P34; Greenbaum AR, 2006, PLAST RECONSTR SURG, V118, p46E, DOI 10.1097/01.prs.0000227620.31296.2c; GRIMSHAW JM, 1993, LANCET, V342, P1317, DOI 10.1016/0140-6736(93)92244-N; Ha L, 2013, AN EMPIRICAL EXAMINA; Heath H, 2007, VULNERABLE ADULTS PR; Hirsch CH, 1999, WESTERN J MED, V170, P353; Horning SM, 2013, CLIN CASE STUD, V12, P373, DOI 10.1177/1534650113496143; Hussain T, 2009, INT J MED INFORM, V78, P354, DOI 10.1016/j.ijmedinf.2008.11.001; Kartes L, 1997, EDLER ABUSE RESOURCE; Koin D, 2003, J ELDER ABUSE NEGL, V15, P109, DOI 10.1300/J084v15n03_07; Kruger RM, 1999, POSTGRAD MED, V106, P169; Lachs MS, 1998, JAMA-J AM MED ASSOC, V280, P428, DOI 10.1001/jama.280.5.428; Lachs MS, 2004, LANCET, V364, P1263, DOI 10.1016/S0140-6736(04)17144-4; Lafata MJ, 2001, OCCUP THER MENT HLTH, V16, P141; Levac D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-69; Lynch SH, 1997, AM J NURS, V97, P27; Malks B, 2003, J ELDER ABUSE NEGL, V15, P55, DOI 10.1300/J084v15n03_04; Manthorpe J, 2012, INT PSYCHOGERIATR, V24, P1454, DOI 10.1017/S1041610212000348; Marshall CE, 2000, GERIATRICS, V55, P42; Missen H, GUIDE ELDER ABUSE PR; Neale AV, 1996, GERONTOLOGIST, V36, P502, DOI 10.1093/geront/36.4.502; Nerenberg L, 2004, IDENTIFYING RESPONDI; Newberry Andrea M, 2008, Psychol Health Med, V13, P438, DOI 10.1080/13548500701694219; OGG J, 1992, BRIT MED J, V305, P998, DOI 10.1136/bmj.305.6860.998; Oh J, 2006, INT J NURS STUD, V43, P203, DOI 10.1016/j.ijnurstu.2005.03.005; Perista H, 2013, MIND GAP IMPROVING I; Pham E, 2009, GERIATR AGING, V12, P323; Phelan A, 2012, EUR GERIATR MED, V3, pS125; Pierce-Weeks J, 2013, SEXUAL VIOLENCE LATE; Ploeg J, 2009, J ELDER ABUSE NEGL, V21, P187, DOI 10.1080/08946560902997181; Podnieks E, 1993, J ELDER ABUSE NEGL, V4; Podnieks E, 2010, J ELDER ABUSE NEGL, V22, P164, DOI 10.1080/08946560903445974; Poole C, 2012, J ELDER ABUSE NEGL, V24, P120, DOI 10.1080/08946566.2011.646503; Quinn M. J., 1997, ELDER ABUSE NEGLECT; Samaan Z, 2013, J MULTIDISCIP HEALTH, V6, P169, DOI 10.2147/JMDH.S43952; Schofield MJ, 2013, J AM GERIATR SOC, V61, P679, DOI 10.1111/jgs.12212; Shaneyfelt T, 1998, JAMA-J AM MED ASSOC, V281, P1900; Siegel S, 2013, LOOK HURT SERVICE GU; Swagerty D, 2003, CLIN FAMILY PRACTICE, V5, P195; Tomita S, 2006, HDB SOCIAL WORK HLTH; Vacarro JV, 1996, VICTIMS VIOLENCE PRA, P293; Welfel ER, 2000, J COUNS DEV, V78, P284, DOI 10.1002/j.1556-6676.2000.tb01909.x; Wiseman M, 2008, J CAN DENT ASSOC, V74, P715; Woolf S, 2012, IMPLEMENT SCI, V7; World Health Organization, 2012, ARE YOU READY WHAT Y; World Health Organization, 2011, ELD MALTR FACT SHEET; World Health Organization, 2002, WORLD REPORT VIOLENC; World Health Organization, 2002, FACTS AB ELD; World Health Organization, 2012, WHO HDB GUID DEV	110	23	23	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125105	10.1371/journal.pone.0125105	http://dx.doi.org/10.1371/journal.pone.0125105			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH3PP	25938414	Green Published, Green Submitted, gold			2022-12-27	WOS:000353943000044
J	Murphy, SF; Schaeffer, AJ; Done, J; Wong, L; Bell-Cohn, A; Roman, K; Cashy, J; Ohlhausen, M; Thumbikat, P				Murphy, Stephen F.; Schaeffer, Anthony J.; Done, Joseph; Wong, Larry; Bell-Cohn, Ashlee; Roman, Kenny; Cashy, John; Ohlhausen, Michelle; Thumbikat, Praveen			IL17 Mediates Pelvic Pain in Experimental Autoimmune Prostatitis (EAP)	PLOS ONE			English	Article							INTERLEUKIN-1 RECEPTOR ANTAGONIST; PERIPHERAL-NERVE INJURY; REGULATORY T-CELLS; MULTIPLE-SCLEROSIS; NEUROPATHIC PAIN; GRO-ALPHA; NEUTROPHIL INFILTRATION; MAST-CELLS; TH17 CELLS; IFN-GAMMA	Chronic pelvic pain syndrome (CPPS) is the most common form of prostatitis, accounting for 90-95% of all diagnoses. It is a complex multi-symptom syndrome with unknown etiology and limited effective treatments. Previous investigations highlight roles for inflammatory mediators in disease progression by correlating levels of cytokines and chemokines with patient reported symptom scores. It is hypothesized that alteration of adaptive immune mechanisms results in autoimmunity and subsequent development of pain. Mouse models of CPPS have been developed to delineate these immune mechanisms driving pain in humans. Using the experimental autoimmune prostatitis (EAP) in C57BL/6 mice model of CPPS we examined the role of CD4+T-cell subsets in the development and maintenance of prostate pain, by tactile allodynia behavioral testing and flow cytometry. In tandem with increased CD4+IL17A+ T-cells upon EAP induction, prophylactic treatment with an anti-IL17 antibody one-day prior to EAP induction prevented the onset of pelvic pain. Therapeutic blockade of IL17 did not reverse pain symptoms indicating that IL17 is essential for development but not maintenance of chronic pain in EAP. Furthermore we identified a cytokine, IL7, to be associated with increased symptom severity in CPPS patients and is increased in patient prostatic secretions and the prostates of EAP mice. IL7 is fundamental to development of IL17 producing cells and plays a role in maturation of auto-reactive T-cells, it is also associated with autoimmune disorders including multiple sclerosis and type-1 diabetes. More recently a growing body of research has pointed to IL17's role in development of neuropathic and chronic pain. This report presents novel data on the role of CD4+IL17+ T-cells in development and maintenance of pain in EAP and CPPS.	[Murphy, Stephen F.; Schaeffer, Anthony J.; Done, Joseph; Wong, Larry; Bell-Cohn, Ashlee; Roman, Kenny; Cashy, John; Ohlhausen, Michelle; Thumbikat, Praveen] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Thumbikat, P (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA.	thumbikat@northwestern.edu	Thumbikat, Praveen/AAQ-1782-2021	Thumbikat, Praveen/0000-0002-5454-4172; Roman, Kenny/0000-0002-8302-0829	National Institute Of Diabetes And Digestive And Kidney Diseases [R01DK083609, K01DK079019, R01DK094898]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083609, K01DK079019, R01DK094898] Funding Source: NIH RePORTER	National Institute Of Diabetes And Digestive And Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was supported by award number R01DK083609, K01DK079019 and R01DK094898 from the National Institute Of Diabetes And Digestive And Kidney Diseases. No author states a conflict of interest.	Arend WP, 2000, ANN RHEUM DIS, V59, P60, DOI 10.1136/ard.59.suppl_1.i60; Austin PJ, 2012, PAIN, V153, P1916, DOI 10.1016/j.pain.2012.06.005; Benwell RK, 2010, CLIN IMMUNOL, V134, P178, DOI 10.1016/j.clim.2009.09.013; Bikker A, 2012, RHEUMATOLOGY, V51, P996, DOI 10.1093/rheumatology/ker448; Carlson T, 2008, J EXP MED, V205, P811, DOI 10.1084/jem.20072404; Cha L, 2014, J IMMUNOL; Day YJ, 2014, PAIN, V155, P1293, DOI 10.1016/j.pain.2014.04.004; Desireddi NV, 2008, J UROLOGY, V179, P1857, DOI 10.1016/j.juro.2008.01.028; Done JD, 2012, J UROLOGY, V187, P1473, DOI 10.1016/j.juro.2011.11.116; Fletcher JM, 2010, CLIN EXP IMMUNOL, V162, P1, DOI 10.1111/j.1365-2249.2010.04143.x; Grigorian A, 2012, ANN NY ACAD SCI, V1253, P49, DOI 10.1111/j.1749-6632.2011.06391.x; Haas J, 2011, EUR J IMMUNOL, V41, P845, DOI 10.1002/eji.201041139; Hedelin HH, 2009, SCAND J UROL NEPHROL, V43, P373, DOI 10.3109/00365590903164514; Heninger AK, 2012, J IMMUNOL, V189, P5649, DOI 10.4049/jimmunol.1201286; Huang M, 2002, J CLIN INVEST, V109, P931, DOI 10.1172/JCI200214685; Hueber AJ, 2010, J IMMUNOL, V184, P3336, DOI 10.4049/jimmunol.0903566; Iolyeva M, 2013, BLOOD, V122, P2271, DOI 10.1182/blood-2013-01-478073; Kim CF, 2011, J PAIN, V12, P370, DOI 10.1016/j.jpain.2010.08.003; Kleinewietfeld M, 2013, SEMIN IMMUNOL, V25, P305, DOI 10.1016/j.smim.2013.10.009; Kreft KL, 2012, GENES IMMUN, V13, P587, DOI 10.1038/gene.2012.34; Kuriya G, 2013, DIABETOLOGIA, V56, P1773, DOI 10.1007/s00125-013-2935-8; Lee LF, 2012, P NATL ACAD SCI USA, V109, P12674, DOI 10.1073/pnas.1203795109; Lenz M, 2013, PAIN, V154, P2142, DOI 10.1016/j.pain.2013.06.039; Liu HP, 2013, EUR J IMMUNOL, V43, P1716, DOI 10.1002/eji.201242889; Magri V, 2010, J UROLOGY, V184, P2339, DOI 10.1016/j.juro.2010.08.025; Mahal Brandon A, 2011, Curr Urol Rep, V12, P297, DOI 10.1007/s11934-011-0196-y; McNamee KE, 2011, PAIN, V152, P1838, DOI 10.1016/j.pain.2011.03.035; Meng XZ, 2013, PAIN, V154, P294, DOI 10.1016/j.pain.2012.10.022; Michel ML, 2012, P NATL ACAD SCI USA, V109, P17549, DOI 10.1073/pnas.1204327109; Miller CN, 2013, INT IMMUNOL, V25, P471, DOI 10.1093/intimm/dxt012; Morrison PJ, 2013, MUCOSAL IMMUNOL, V6, P1143, DOI 10.1038/mi.2013.11; Murphy AC, 2010, BRAIN BEHAV IMMUN, V24, P641, DOI 10.1016/j.bbi.2010.01.014; Murphy SF, 2014, NAT REV UROL, V11, P259, DOI 10.1038/nrurol.2014.63; Myles IA, 2013, NAT IMMUNOL, V14, P804, DOI 10.1038/ni.2637; Niu YZ, 2014, J HUAZHONG U SCI-MED, V34, P591, DOI 10.1007/s11596-014-1321-1; Noma N, 2011, NEUROSCI LETT, V493, P86, DOI 10.1016/j.neulet.2011.01.079; Penaranda C, 2012, P NATL ACAD SCI USA, V109, P12668, DOI 10.1073/pnas.1203692109; Piconese S, 2009, BLOOD, V114, P2639, DOI 10.1182/blood-2009-05-220004; Pontari M, 2013, CURR OPIN UROL, V23, P565, DOI 10.1097/MOU.0b013e3283656a55; Quick ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060987; Quick ML, 2012, AM J PHYSIOL-REG I, V303, pR580, DOI 10.1152/ajpregu.00240.2012; Rivero VE, 1998, J AUTOIMMUN, V11, P603, DOI 10.1006/jaut.1998.0248; Roman K, 2014, PAIN; Rudick CN, 2008, AM J PHYSIOL-REG I, V294, pR1268, DOI 10.1152/ajpregu.00836.2007; Rudick CN, 2011, INFECT IMMUN, V79, P628, DOI 10.1128/IAI.00910-10; Samplaski MK, 2012, J UROLOGY, V188, P1788, DOI 10.1016/j.juro.2012.07.036; Sayed BA, 2011, J IMMUNOL, V186, P3294, DOI 10.4049/jimmunol.1003574; Schiff MH, 2000, ANN RHEUM DIS, V59, P103, DOI 10.1136/ard.59.suppl_1.i103; Schuh CD, 2014, PAIN, V155, P545, DOI 10.1016/j.pain.2013.12.006; Shoskes DA, 2010, UROLOGY, V75, P1249, DOI 10.1016/j.urology.2010.01.021; Shoskes DA, 2009, UROLOGY, V73, P538, DOI 10.1016/j.urology.2008.09.074; Singh R.P., 2014, AUTOIMMUN REV; Steinman L, 1996, CELL, V85, P299, DOI 10.1016/S0092-8674(00)81107-1; Tang JH, 1997, J IMMUNOL, V159, P117; THEYER G, 1992, LAB INVEST, V66, P96; Tran CN, 2014, CAN J UROL, V21, P7195; Wagenlehner FME, 2013, WORLD J UROL, V31, P711, DOI 10.1007/s00345-013-1055-x; Webster KE, 2014, MUCOSAL IMMUNOL, V7, P1058, DOI 10.1038/mi.2013.122; West EE, 2013, J CLIN INVEST, V123, P2604, DOI 10.1172/JCI67008; Witowski J, 2000, J IMMUNOL, V165, P5814, DOI 10.4049/jimmunol.165.10.5814; Wuyts A, 1999, EUR J BIOCHEM, V260, P421, DOI 10.1046/j.1432-1327.1999.00166.x; Younas M, 2013, J IMMUNOL, V191, P3161, DOI 10.4049/jimmunol.1203547; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957; Zuvich RL, 2010, HUM GENET, V127, P525, DOI 10.1007/s00439-010-0789-4	64	17	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125623	10.1371/journal.pone.0125623	http://dx.doi.org/10.1371/journal.pone.0125623			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933188	gold, Green Published, Green Submitted			2022-12-27	WOS:000353887100124
J	Bosmans, G; Braet, C; Heylen, J; De Raedt, R				Bosmans, Guy; Braet, Caroline; Heylen, Joke; De Raedt, Rudi			Children's Attentional Processing of Mother and Proximity Seeking	PLOS ONE			English	Article							SECURE BASE SCRIPT; ATTACHMENT SECURITY; EMOTIONAL DISORDERS; SOCIAL INFORMATION; PEER RELATIONSHIPS; BEHAVIOR PROBLEMS; MIDDLE CHILDHOOD; WORKING MODELS; LIFE EVENTS; ANXIETY	Attachment expectations regarding the availability of mother as a source for support are supposed to influence distressed children's support seeking behavior. Because research is needed to better understand the mechanisms related to support seeking behavior, this study tested the hypothesis that the cognitive processing of mother-related information is linked to proximity and support seeking behavior. Uncertainty in maternal support has been shown to be characterized by a biased attentional encoding of mother, reducing the breadth of children's attentional field around her. We investigated whether this attentional bias is related to how long distressed children wait before seeking their mother's proximity. Thirty-three children (9-11 years) participated in this study that consisted of experimental tasks to measure attentional breadth and to observe proximity seeking behavior and of questionnaires to measure confidence in maternal support and experienced distress. Results suggested that distressed children with a more narrow attentional field around their mother wait longer to seek her proximity. Key Message: These findings provide a first support for the hypothesis that the attentional processing of mother is related to children's attachment behavior.	[Bosmans, Guy; Heylen, Joke] Univ Leuven, Parenting & Special Educ Res Grp, Leuven, Belgium; [Braet, Caroline] Univ Ghent, Dept Dev Personal & Social Psychol, B-9000 Ghent, Belgium; [De Raedt, Rudi] Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium	KU Leuven; Ghent University; Ghent University	Bosmans, G (corresponding author), Univ Leuven, Parenting & Special Educ Res Grp, Leuven, Belgium.	guy.bosmans@ppw.kuleuven.be	De Raedt, Rudi/A-3269-2012; De Raedt, Rudi/AAL-4093-2021; Bosmans, Guy/L-8822-2015	De Raedt, Rudi/0000-0001-6781-4808; De Raedt, Rudi/0000-0001-6781-4808; Bosmans, Guy/0000-0001-9057-6027; Braet, Caroline/0000-0003-2458-287X	Research Foundation Flanders (FWO) [G.0934.12]; Research Fund KULeuven, Belgium [OT/12/043, CREA/12/004]	Research Foundation Flanders (FWO)(FWO); Research Fund KULeuven, Belgium(KU Leuven)	This research was supported by Grant G.0934.12 of the Research Foundation Flanders (FWO), and Grants OT/12/043 and CREA/12/004 from the Research Fund KULeuven, Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam EK, 2002, DEV PSYCHOL, V38, P792, DOI 10.1037//0012-1649.38.5.792; Aiken L. S., 1991, MULTIPLE REGRESSION; Ainsworth M., 1978, PATTERNS ATTACHMENT; AINSWORTH MDS, 1985, B NEW YORK ACAD MED, V61, P792; Allen JP, 2007, CHILD DEV, V78, P1222, DOI 10.1111/j.1467-8624.2007.01062.x; Ammaniti M, 2005, ATTACHMENT IN MIDDLE CHILDHOOD, P115; Anderson CJ, 2003, PSYCHOL BULL, V129, P139, DOI 10.1037//0033-2909.129.1.139; [Anonymous], REV CHILD DEV RES; ARMSDEN GC, 1987, J YOUTH ADOLESCENCE, V16, P427, DOI 10.1007/BF02202939; Baert S, 2011, INT J COGN THER, V4, P208, DOI 10.1521/ijct.2011.4.2.208; Bakker F, 1989, HANDLEIDING BIJ ZELF; Ball K., 1988, J OPT SOC AM, V1, P2210, DOI DOI 10.1364/J0SAA.5.002210; Bar-Haim Y, 2000, J CHILD PSYCHOL PSYC, V41, P381, DOI 10.1017/S0021963099005272; Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; Belsky J, 2001, DEV PSYCHOL, V37, P801, DOI 10.1037/0012-1649.37.6.801; Belsky J, 1996, PSYCHOL SCI, V7, P111, DOI 10.1111/j.1467-9280.1996.tb00339.x; Bosmans G, 2007, J CLIN CHILD ADOLESC, V36, P557, DOI 10.1080/15374410701662717; Bosmans G, 2013, COGNITIVE THER RES, V37, P829, DOI 10.1007/s10608-013-9526-3; Bosmans G, 2009, J CLIN CHILD ADOLESC, V38, P872, DOI 10.1080/15374410903258926; Bowlby J., 1973, SEPARATION ANXIETY A, V2; Bowlby J., 1969, ATTACHMENT, V1st Edn; Bowlby J, 1988, SECURE BASE CLIN APP; Cassidy J, 1994, Monogr Soc Res Child Dev, V59, P228, DOI 10.2307/1166148; Charlesworth L., 2008, DIMENSIONS HUMAN BEH, V5, P177; CRICK NR, 1994, PSYCHOL BULL, V115, P74, DOI 10.1037/0033-2909.115.1.74; Crowell JA, 2002, DEV PSYCHOL, V38, P679, DOI 10.1037//0012-1649.38.5.679; Dalgleish T, 2003, J CLIN CHILD ADOLESC, V32, P10, DOI 10.1207/S15374424JCCP3201_02; DeKleyen M., 2008, HDB ATTACHMENT THEOR, P93; Derryberry D., 1994, HEARTS EYE EMOTIONAL, P167, DOI [10.1016/B978-0-12-410560-7.50014-4, DOI 10.1016/B978-0-12-410560-7.50014-4]; Dwyer KM, 2005, HUM DEV, V48, P155, DOI 10.1159/000085519; Dykas MJ, 2011, PSYCHOL BULL, V137, P19, DOI 10.1037/a0021367; EASTERBROOK JA, 1959, PSYCHOL REV, V66, P183, DOI 10.1037/h0047707; EASTERBROOKS MA, 1993, DEV PSYCHOPATHOL, V5, P389, DOI 10.1017/S095457940000448X; Eldar S, 2008, BEHAV RES THER, V46, P450, DOI 10.1016/j.brat.2008.01.012; Eysenck M.W., 2015, ANXIETY COGNITIVE PE, DOI 10.4324/9780203775677; Fraley RC, 2007, J PERS, V75, P1157, DOI 10.1111/j.1467-6494.2007.00471.x; Gable P, 2010, COGNITION EMOTION, V24, P322, DOI 10.1080/02699930903378305; Gunnar MR, 2009, PSYCHONEUROENDOCRINO, V34, P953, DOI 10.1016/j.psyneuen.2009.02.010; Hayes AF, 2009, BEHAV RES METHODS, V41, P924, DOI 10.3758/BRM.41.3.924; Kaplan R. L., 2012, FRONT PSYCHOL, V3, P1, DOI DOI 10.3389/FPSYG.2012.00001; Kerns K.A., 2008, HDB ATTACHMENT THEOR, P366; Kerns KA, 1996, DEV PSYCHOL, V32, P457, DOI 10.1037/0012-1649.32.3.457; Kirsh SJ, 1997, CHILD DEV, V68, P1143, DOI 10.2307/1132297; MACLEOD C, 1993, J ABNORM PSYCHOL, V102, P238, DOI 10.1037/0021-843X.102.2.238; MACLEOD C, 1986, J ABNORM PSYCHOL, V95, P15, DOI 10.1037/0021-843X.95.1.15; MacLeod C, 2009, J ABNORM PSYCHOL, V118, P89, DOI 10.1037/a0014878; Maier MA, 2004, INT J BEHAV DEV, V28, P180, DOI 10.1080/01650250344000398; MAIN M, 1988, DEV PSYCHOL, V24, P415, DOI 10.1037/0012-1649.24.3.415; MAIN M, 1985, MONOGR SOC RES CHILD, V50, P66, DOI 10.2307/3333827; Mayseless O, 2005, ATTACHMENT IN MIDDLE CHILDHOOD, P1; Mesman J, 2000, J AM ACAD CHILD PSY, V39, P1371, DOI 10.1097/00004583-200011000-00011; Mezulis AH, 2006, DEV PSYCHOL, V42, P1012, DOI 10.1037/0012-1649.42.6.1012; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MOGG K, 1987, J ABNORM PSYCHOL, V96, P94, DOI 10.1037/0021-843X.96.2.94; MOGG K, 1995, BRIT J CLIN PSYCHOL, V34, P17, DOI 10.1111/j.2044-8260.1995.tb01434.x; Moss E, 2004, DEV PSYCHOL, V40, P519, DOI 10.1037/0012-1649.40.4.519; Psouni E, 2014, ATTACH HUM DEV, V16, P22, DOI 10.1080/14616734.2013.804329; Ridenour TA, 2006, J YOUTH ADOLESCENCE, V35, P1037, DOI 10.1007/s10964-006-9070-5; Rutter M, 1995, J CHILD PSYCHOL PSYC, V126, P520; SHOULDICE A, 1992, J CHILD PSYCHOL PSYC, V33, P331, DOI 10.1111/j.1469-7610.1992.tb00870.x; SIMPSON JA, 1992, J PERS SOC PSYCHOL, V62, P434, DOI 10.1037/0022-3514.62.3.434; Slough N M, 1990, New Dir Child Dev, P67; Spielberger C.D., 1973, STAIC PRELIMINARY MA; SROUFE LA, 1977, CHILD DEV, V48, P1184, DOI 10.1111/j.1467-8624.1977.tb03922.x; SROUFE LA, 1984, CHILD DEV, V55, P17, DOI 10.2307/1129832; Thompson R, 2008, ATTACH HUM DEV, V10, P347, DOI 10.1080/14616730802461334; Vandevivere E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103476; Waters E, 1983, EVERETT DEV REV, V3, P79, DOI DOI 10.1016/0273-2297(83)90010-2; Waters TEA, 2013, ATTACH HUM DEV, V15, P316, DOI 10.1080/14616734.2013.782657	69	29	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124038	10.1371/journal.pone.0124038	http://dx.doi.org/10.1371/journal.pone.0124038			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0MA	25927921	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000353713100028
J	da Silva, IM; Hill, N; Shimadzu, H; Soares, AMVM; Dornelas, M				da Silva, Isabel Marques; Hill, Nick; Shimadzu, Hideyasu; Soares, Amadeu M. V. M.; Dornelas, Maria			Spillover Effects of a Community-Managed Marine Reserve	PLOS ONE			English	Article							ECOSYSTEM-BASED MANAGEMENT; PROTECTED AREAS; REEF FISH; LONG-TERM; CORAL; POPULATIONS; RECOVERY; BOUNDARIES; ABUNDANCE; BENEFITS	The value of no-take marine reserves as fisheries-management tools is controversial, particularly in high-poverty areas where human populations depend heavily on fish as a source of protein. Spillover, the net export of adult fish, is one mechanism by which no-take marine reserves may have a positive influence on adjacent fisheries. Spillover can contribute to poverty alleviation, although its effect is modulated by the number of fishermen and fishing intensity. In this study, we quantify the effects of a community-managed marine reserve in a high poverty area of Northern Mozambique. For this purpose, underwater visual censuses of reef fish were undertaken at three different times: 3 years before (2003), at the time of establishment (2006) and 6 years after the marine reserve establishment (2012). The survey locations were chosen inside, outside and on the border of the marine reserve. Benthic cover composition was quantified at the same sites in 2006 and 2012. After the reserve establishment, fish sizes were also estimated. Regression tree models show that the distance from the border and the time after reserve establishment were the variables with the strongest effect on fish abundance. The extent and direction of the spillover depends on trophic group and fish size. Poisson Generalized Linear Models show that, prior to the reserve establishment, the survey sites did not differ but, after 6 years, the abundance of all fish inside the reserve has increased and caused spillover of herbivorous fish. Spillover was detected 1 km beyond the limit of the reserve for small herbivorous fishes. Six years after the establishment of a community-managed reserve, the fish assemblages have changed dramatically inside the reserve, and spillover is benefitting fish assemblages outside the reserve.	[da Silva, Isabel Marques] Univ Lurio, Dept Zool, Pemba, Mozambique; [da Silva, Isabel Marques; Soares, Amadeu M. V. M.] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Hill, Nick] Zool Soc London, Conservat Programmes, London, England; [Shimadzu, Hideyasu; Dornelas, Maria] Univ St Andrews, Sch Biol, Ctr Biol Divers, St Andrews, Fife, Scotland; [Shimadzu, Hideyasu; Dornelas, Maria] Univ St Andrews, Sch Biol, Scottish Oceans Inst, St Andrews, Fife, Scotland; [Soares, Amadeu M. V. M.] Univ Aveiro, CESAM, P-3800 Aveiro, Portugal	Universidade de Aveiro; Zoological Society of London; University of St Andrews; University of St Andrews; Universidade de Aveiro	da Silva, IM (corresponding author), Univ Lurio, Dept Zool, Pemba, Mozambique.	fish.isabel@gmail.com	Soares, Amadeu/A-8304-2008; Shimadzu, Hideyasu/E-5649-2010; Dornelas, Maria/E-3595-2010	Soares, Amadeu/0000-0003-0879-9470; Shimadzu, Hideyasu/0000-0003-0919-8829; Dornelas, Maria/0000-0003-2077-7055; Hill, Nicholas Anthony Owen/0000-0002-5921-0091; Marques da Silva, Isabel/0000-0002-5510-7636	FCT(Fundacao para Ciencia e Tecnologia) [SFRH/BD/51413/ 2011]; WWF Mozambique; Zoological Society of London; Vamizi lodge and Ideia Wild; ERC project BIOTIME; Scottish Funding Council (MASTS) [HR09011]; Fundacao Calouste Gulbenkian; Oceanario de Lisboa	FCT(Fundacao para Ciencia e Tecnologia)(Portuguese Foundation for Science and Technology); WWF Mozambique; Zoological Society of London; Vamizi lodge and Ideia Wild; ERC project BIOTIME; Scottish Funding Council (MASTS); Fundacao Calouste Gulbenkian(European Commission); Oceanario de Lisboa	MS is grateful to FCT(Fundacao para Ciencia e Tecnologia), for supporting this work through a Doctoral scholarship (SFRH/BD/51413/ 2011). We thank WWF Mozambique, the Zoological Society of London, Martin Andersson, Vamizi lodge and Ideia Wild for supporting this work. MD and HS thank the ERC project BIOTIME for support. MD is grateful for support from the Scottish Funding Council (MASTS - grant reference HR09011). IMS and AS thank Fundacao Calouste Gulbenkian and Oceanario de Lisboa for support given through the 2010 Galardao Gulbenkian/Oceanario de Lisboa to the project "Conhecer para Preservar a Biodiversidade Marinha de Pemba (Cabo Delgado, Mocambique)-Ordenacao Socio-Ambiental para a Sustentabilidade"	Abesamis RA, 2005, ECOL APPL, V15, P1798, DOI 10.1890/05-0174; Abesamis RA, 2006, AQUAT CONSERV, V16, P349, DOI 10.1002/aqc.730; Adams VM, 2011, BIOL CONSERV, V144, P350, DOI 10.1016/j.biocon.2010.09.012; Ashworth JS, 2005, BIOL CONSERV, V121, P333, DOI 10.1016/j.biocon.2004.05.006; Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; Bertzk B, 2012, PROTECTED PLANET REP; Birkeland C, 2004, BIOSCIENCE, V54, P1021, DOI 10.1641/0006-3568(2004)054[1021:RDTCR]2.0.CO;2; BOHNSACK JA, 1993, OCEANUS, V36, P63; Burke L., 2011, REEFS RISK REVISITED; Chapman MR, 1999, MAR ECOL PROG SER, V181, P81, DOI 10.3354/meps181081; Christie MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015715; Cinner J, 2005, ECOL SOC, V10; Claudet J, 2006, BIOL CONSERV, V130, P349, DOI 10.1016/j.biocon.2005.12.030; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Cressey D, 2011, NATURE, V480, P166, DOI 10.1038/480166a; Day JC, 2002, OCEAN COAST MANAGE, V45, P139, DOI 10.1016/S0964-5691(02)00052-2; De'ath G, 2006, MVPART MULTIVARIATE; Dulvy NK, 2013, AQUAT CONSERV, V23, P357, DOI 10.1002/aqc.2358; English S., 1997, SURVEY MANUAL TROPIC; Fenner Douglas, 2012, Diversity, V4, P105, DOI 10.3390/d4010105; Foale S., 2004, ASIA PAC VIEWP, V45, P373; Forcada A, 2009, MAR ECOL PROG SER, V379, P197, DOI 10.3354/meps07892; Fox J., 2009, CAR COMPANION APPL R; Froese R., 2000, FISHBASE CONCEPTS DE; Gell F. R., 2002, FISHERY EFFECTS MARI, DOI 10.1016/s1386-5056(02)00038-2; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; Graham NAJ, 2003, ENVIRON CONSERV, V30, P200, DOI 10.1017/S0376892903000195; Graham NAJ, 2011, OCEANOGR MAR BIOL, V49, P105; Halpern BS, 2012, NATURE, V488, P615, DOI 10.1038/nature11397; Halpern BS, 2010, P NATL ACAD SCI USA, V107, P18312, DOI 10.1073/pnas.0908503107; Halpern BS, 2003, ECOL APPL, V13, pS117; Halpern BS, 2003, P ROY SOC B-BIOL SCI, V270, P1871, DOI 10.1098/rspb.2003.2405; Halpern BS, 2002, ECOL LETT, V5, P361, DOI 10.1046/j.1461-0248.2002.00326.x; Hastings A, 2003, ECOLOGICAL APLICATIO, V13, P565; Hilborn R, 2013, P NATL ACAD SCI USA, V110, P9187, DOI 10.1073/pnas.1308962110; Hill Nicholas A. O., 2009, Western Indian Ocean Journal of Marine Science, V8, P113; Hooker SK, 2004, BIOSCIENCE, V54, P27, DOI 10.1641/0006-3568(2004)054[0027:MRAATF]2.0.CO;2; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; *ISRS, 2004, 1 ISRS; Januchowski-Hartley FA, 2013, ECOL LETT, V16, P191, DOI 10.1111/ele.12028; Jennings S, 2000, REV FISH BIOL FISHER, V10, P209, DOI 10.1023/A:1016619102955; Jones PJS, 2001, REV FISH BIOL FISHER, V11, P197, DOI 10.1023/A:1020327007975; Kellner JB, 2007, FISHING LINE NEAR MA; Klein CJ, 2008, CONSERV LETT, V1, P44, DOI 10.1111/j.1755-263X.2008.00005.x; legendre P, 2012, PRACTICALS USING R S; Lizaso JLS, 2000, ENVIRON CONSERV, V27, P144, DOI 10.1017/S0376892900000187; Lubchenco J, 2003, ECOL APPL, V13, pS3; McCay BJ, 2011, CONSERV BIOL, V25, P1130, DOI 10.1111/j.1523-1739.2011.01771.x; McClanahan TR, 2011, AQUAT CONSERV, V21, P658, DOI 10.1002/aqc.1225; McClanahan T.R., 1997, P1533; MCCLANAHAN TR, 1990, OECOLOGIA, V83, P362, DOI 10.1007/BF00317561; McClanahan TR, 2001, ECOL APPL, V11, P559, DOI 10.2307/3060909; McClanahan TR, 2005, MAR ECOL PROG SER, V294, P241, DOI 10.3354/meps294241; McClanahan TR, 1996, CONSERV BIOL, V10, P1187, DOI 10.1046/j.1523-1739.1996.10041187.x; McClanahan TR, 2000, ECOL APPL, V10, P1792, DOI 10.2307/2641239; McClanahan TR, 2007, ECOLOGICAL APLICATIO, V17, P1044; McClanahan TR, 2009, MARINE ECOLOGICAL PR, V396; Micheli F, 2004, ECOL APPL, V14, P1709, DOI 10.1890/03-5260; Molloy PP, 2009, J APPL ECOL, V46, P743, DOI 10.1111/j.1365-2664.2009.01662.x; Mora C, 2011, MAR ECOL PROG SER, V434, P251, DOI 10.3354/meps09214; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Obura D, 2009, RESILIENCE ASSESSMEN; Oksanen J., 2005, VEGAN R FUNCTIONS VE; Palumbi SR, 2004, ANNU REV ENV RESOUR, V29, P31, DOI 10.1146/annurev.energy.29.062403.102254; POLUNIN NVC, 1993, MAR ECOL PROG SER, V100, P167, DOI 10.3354/meps100167; Roberts C.M., 2001, CONSERV PRACT, V2, P10, DOI [DOI 10.1111/J.1526-4629.2001.TB00012.X, 10.1111/j.1526-4629.2001.tb00012.x]; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; Roberts CM, 2000, B MAR SCI, V66, P581; Rosendo S, 2011, OCEAN COAST MANAGE, V54, P55, DOI 10.1016/j.ocecoaman.2010.10.009; Russ GR, 2011, ECOL APPL, V21, P241, DOI 10.1890/09-1197.1; Russ GR, 2004, ECOL APPL, V14, P597, DOI 10.1890/03-5076; Russ GR, 2005, MAR ECOL PROG SER, V292, P1, DOI 10.3354/meps292001; Russ GR, 1996, MAR ECOL PROG SER, V132, P1, DOI 10.3354/meps132001; Samoilys MA, 1997, MANUAL ASSESSING FIS; Samoilys MA, 2007, BIOL CONSERV, V136, P584, DOI 10.1016/j.biocon.2007.01.003; Sanchirico J.N., 2000, MARINE PROTECTED ARE; Selig ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009278; Stobart B, 2009, MAR ECOL PROG SER, V384, P47, DOI 10.3354/meps08007; Team RDC, 2019, R LANG ENV STAT COMP; Willis TJ, 2003, ENV CONSERVATION, V30; Wiomsa, 2011, MIGR FISH FISH W IND; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	83	29	29	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0111774	10.1371/journal.pone.0111774	http://dx.doi.org/10.1371/journal.pone.0111774			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927235	Green Published, gold, Green Submitted			2022-12-27	WOS:000353713100001
J	Ejarque-Ortiz, A; Sola, C; Martinez-Barriocanal, A; Schwartz, S; Martin, M; Peluffo, H; Sayos, J				Ejarque-Ortiz, Aroa; Sola, Carme; Martinez-Barriocanal, Agueda; Schwartz, Simo, Jr.; Martin, Margarita; Peluffo, Hugo; Sayos, Joan			The Receptor CMRF35-Like Molecule-1 (CLM-1) Enhances the Production of LPS-Induced Pro-Inflammatory Mediators during Microglial Activation	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; NEGATIVE REGULATION; CELLS; ASSOCIATION; EXPRESSION; SIGNALS; BINDING; FAMILY; SENSOR	CMRF35-like molecule-1 (CLM-1) belongs to a receptor family mainly expressed in myeloid cells that include activating and inhibitory receptors. CLM-1 contains two ITIMs and a single immunoreceptor tyrosine-based switch motif (ITSM), although also displays a binding site for p85 alpha regulatory subunit of PI3K. By using murine primary microglial cultures, we show the presence of all CLM members in microglial cells and characterize the expression of CLM-1 both in basal conditions and during microglial activation. The TLR4 agonist lipopolysaccharide (LPS) and the TLR3 agonist polyinosinic-polycytidylic acid (Poly I:C) induce an increase in microglial CLM-1 mRNA levels in vitro, whereas the TLR2/6 heterodimer agonist peptidoglycan (PGN) produces a marked decrease. In this study we also describe a new soluble isoform of CLM-1 that is detected at mRNA and protein levels in basal conditions in primary microglial cultures. Interestingly, CLM-1 engagement enhances the transcription of the pro-inflammatory mediators TNF alpha, COX-2 and NOS-2 in microglial cells challenged with LPS. These results reveal that CLM-1 can acts as a co-activating receptor and suggest that this receptor could play a key role in the regulation of microglial activation.	[Ejarque-Ortiz, Aroa; Martinez-Barriocanal, Agueda; Sayos, Joan] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, CIBBIM Nanomed Program, Immunobiol Grp,Inst Recerca VHIR, E-08193 Barcelona, Spain; [Schwartz, Simo, Jr.] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Drug Delivery & Targeting Grp, CIBBIM Nanomed Program,Inst Recerca VHIR, E-08193 Barcelona, Spain; [Ejarque-Ortiz, Aroa; Martinez-Barriocanal, Agueda; Schwartz, Simo, Jr.; Sayos, Joan] Inst Salud Carlos III, Networking Res Ctr Bioengn Biomat & Nanomed CIBBE, Barcelona, Spain; [Sola, Carme] Inst Invest Biomed August Pi & Sunyer IDIBAPS, CSIC, Inst Invest Biomed Barcelona, Dept Cerebral Ischemia & Neurodegenerat, Barcelona, Spain; [Martin, Margarita] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer, Fac Med, Biochem Unit, Barcelona 7, Spain; [Peluffo, Hugo] Inst Pasteur Montevideo, Neurodegenerat Lab, Montevideo, Uruguay; [Peluffo, Hugo] UDELAR, Fac Med, Dept Histol & Embryol, Montevideo, Uruguay	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Instituto de Salud Carlos III; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Universidad de la Republica, Uruguay	Ejarque-Ortiz, A (corresponding author), Univ Autonoma Barcelona, Hosp Univ Vall dHebron, CIBBIM Nanomed Program, Immunobiol Grp,Inst Recerca VHIR, E-08193 Barcelona, Spain.	aroa.ejarque@vhir.org; joan.sayos@vhir.org	Sayos, Joan/B-6119-2009; Martinez, Agueda/AAB-7186-2019; Schwartz, Simo/H-7776-2012; Peluffo, Hugo/AER-6323-2022; Andorra, Margarita Martin/H-2025-2015	Sayos, Joan/0000-0002-4664-3461; Martinez, Agueda/0000-0002-8809-160X; Peluffo, Hugo/0000-0001-6111-8668; Andorra, Margarita Martin/0000-0002-9245-4899; Schwartz, Simo/0000-0001-8297-7971; Sola, Carme/0000-0002-4012-816X	Fondo de Investigaciones Sanitarias [PI1100045]; Fundacio "La Marato de Tv3" [110532, 110533]; Comision Sectorial de Investigacion Cientifica (CSIC-UDELAR); Agencia de Gestio d'Ajuts Universitaris i de Recerca de Catalunya (AGAUR) [2009 SGR 493]; Agencia Nacional de Investigacion e Innovacion (ANII); PEDECIBA; FOCEM (MERCOSUR Structural Convergence Fund) [COF 03/1111]	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Fundacio "La Marato de Tv3"; Comision Sectorial de Investigacion Cientifica (CSIC-UDELAR); Agencia de Gestio d'Ajuts Universitaris i de Recerca de Catalunya (AGAUR)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Agencia Nacional de Investigacion e Innovacion (ANII); PEDECIBA; FOCEM (MERCOSUR Structural Convergence Fund)	This work was supported by grants from Fondo de Investigaciones Sanitarias (PI1100045), Fundacio "La Marato de Tv3" (110532 and 110533), Comision Sectorial de Investigacion Cientifica (CSIC-UDELAR), Agencia de Gestio d'Ajuts Universitaris i de Recerca de Catalunya (AGAUR) (2009 SGR 493), Agencia Nacional de Investigacion e Innovacion (ANII), PEDECIBA, and FOCEM (MERCOSUR Structural Convergence Fund), COF 03/1111. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Errico D, 2004, EUR J IMMUNOL, V34, P3690, DOI 10.1002/eji.200425433; Biber K, 2007, TRENDS NEUROSCI, V30, P596, DOI 10.1016/j.tins.2007.08.007; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Choi S-C, 2011, J IMMUNOL; Chung D, 1950, J IMMUNOLOGY; Clark GJ, 2009, TRENDS IMMUNOL, V30, P209, DOI 10.1016/j.it.2009.02.003; Ejarque-Ortiz A, 2007, GLIA, V55, P178, DOI 10.1002/glia.20446; Gao HM, 2008, TRENDS IMMUNOL, V29, P357, DOI 10.1016/j.it.2008.05.002; Gibot S, 2004, J EXP MED, V200, P1419, DOI 10.1084/jem.20040708; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Izawa K, 2007, J BIOL CHEM, V282, P17997, DOI 10.1074/jbc.M701100200; Izawa K, 2012, IMMUNITY, V37, P827, DOI 10.1016/j.immuni.2012.08.018; Izawa K, 2009, J IMMUNOL, V183, P925, DOI 10.4049/jimmunol.0900552; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Martinez-Barriocanal A, 2006, J IMMUNOL, V177, P2819, DOI 10.4049/jimmunol.177.5.2819; Moshkovits I, 2014, MUCOSAL IMMUNOL, V7, P292, DOI 10.1038/mi.2013.47; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Peluffo H, 2012, BRAIN PATHOL, V22, P318, DOI 10.1111/j.1750-3639.2011.00537.x; Perry VH, 2013, SEMIN IMMUNOPATHOL, V35, P601, DOI 10.1007/s00281-013-0382-8; Piccio L, 2008, BRAIN, V131, P3081, DOI 10.1093/brain/awn217; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Schmid CD, 2002, J NEUROCHEM, V83, P1309, DOI 10.1046/j.1471-4159.2002.01243.x; Shi LY, 2006, BLOOD, V108, P2678, DOI 10.1182/blood-2006-04-015404; Shik D, 2014, ALLERGY, V69, P719, DOI 10.1111/all.12388; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Takahashi K, 2007, PLOS MED, V4, P675, DOI 10.1371/journal.pmed.0040124; Tian L, 2014, NAT COMMUN, P5; Wang Y, 2010, J NEUROSCI, V30, P3482, DOI 10.1523/JNEUROSCI.3940-09.2010; Xi H, 2010, J EXP MED, V207, P7, DOI 10.1084/jem.20091508	31	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0123928	10.1371/journal.pone.0123928	http://dx.doi.org/10.1371/journal.pone.0123928			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927603	Green Submitted, gold, Green Published			2022-12-27	WOS:000353713100025
J	Li, H; Yu, BQ; Li, JF; Su, LP; Yan, M; Zhang, J; Li, C; Zhu, ZG; Liu, BY				Li, Hao; Yu, Beiqin; Li, Jianfang; Su, Liping; Yan, Min; Zhang, Jun; Li, Chen; Zhu, Zhenggang; Liu, Bingya			Characterization of Differentially Expressed Genes Involved in Pathways Associated with Gastric Cancer	PLOS ONE			English	Article							POOR-PROGNOSIS; CELL-PROLIFERATION; DOWN-REGULATION; UP-REGULATION; TUMORIGENESIS; CONTRIBUTES; METASTASIS; INVASION; RECEPTOR; MARKER	To explore the patterns of gene expression in gastric cancer, a total of 26 paired gastric cancer and noncancerous tissues from patients were enrolled for gene expression microarray analyses. Limma methods were applied to analyze the data, and genes were considered to be significantly differentially expressed if the False Discovery Rate (FDR) value was < 0.01, P-value was < 0.01 and the fold change (FC) was >2. Subsequently, Gene Ontology (GO) categories were used to analyze the main functions of the differentially expressed genes. According to the Kyoto Encyclopedia of Genes and Genomes (KEGG) database, we found pathways significantly associated with the differential genes. Gene-Act network and co-expression network were built respectively based on the relationships among the genes, proteins and compounds in the database. 2371 mRNAs and 350 lncRNAs considered as significantly differentially expressed genes were selected for the further analysis. The GO categories, pathway analyses and the Gene-Act network showed a consistent result that up-regulated genes were responsible for tumorigenesis, migration, angiogenesis and microenvironment formation, while down-regulated genes were involved in metabolism. These results of this study provide some novel findings on coding RNAs, lncRNAs, pathways and the co-expression network in gastric cancer which will be useful to guide further investigation and target therapy for this disease.	[Li, Hao; Yu, Beiqin; Li, Jianfang; Su, Liping; Yan, Min; Zhang, Jun; Li, Chen; Zhu, Zhenggang; Liu, Bingya] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Digest Surg, Shanghai Key Lab Gastr Neoplasms,Ruijin Hosp, Shanghai 200025, Peoples R China; [Li, Hao; Zhang, Jun] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Oncol, Shanghai 200025, Peoples R China; [Yan, Min; Li, Chen; Zhu, Zhenggang] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Surg, Shanghai 200025, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Liu, BY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Digest Surg, Shanghai Key Lab Gastr Neoplasms,Ruijin Hosp, Shanghai 200025, Peoples R China.	byliu@sjtu.edu.cn	Liu, Bingya/GMW-5655-2022	Liu, Bingya/0000-0002-4406-3762	National Natural Science Foundation of China [81172324, 91229106, 81272749, 81372231]; Science and Technology Commission of Shanghai Municipality [13ZR1425600]; Key Projects in the National Science & Technology Pillar Program of China [2014BAI09B03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Key Projects in the National Science & Technology Pillar Program of China	This work was supported by grants for analysis from the National Natural Science Foundation of China [No. 81172324, No. 91229106, No. 81272749, and No. 81372231], Science and Technology Commission of Shanghai Municipality [No. 13ZR1425600], and Key Projects in the National Science & Technology Pillar Program of China (No. 2014BAI09B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Azim HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062451; Behrends S, 2000, BIOCHEM BIOPH RES CO, V271, P64, DOI 10.1006/bbrc.2000.2596; Cao W, 2013, INT J GENOMICS, V2013, DOI 10.1155/2013/480534; Cao XY, 2012, WORLD J GASTROENTERO, V18, P7357, DOI 10.3748/wjg.v18.i48.7357; Choi EH, 2009, CLIN CHIM ACTA, V406, P45, DOI 10.1016/j.cca.2009.05.008; Cui JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017819; Cui JA, 2011, NUCLEIC ACIDS RES, V39, P1197, DOI 10.1093/nar/gkq960; Czekierdowski A, 2008, J PHYSIOL PHARMACOL, V59, P53; Dai J, 2014, TUMOR BIOL, V35, P4199, DOI 10.1007/s13277-013-1550-0; Dong R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/317853; Eftang LL, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-586; Fahlbusch FB, 2013, PLACENTA, V34, P1027, DOI 10.1016/j.placenta.2013.08.005; Fino KK, 2012, AM J PHYSIOL-GASTR L, V302, pG1244, DOI 10.1152/ajpgi.00460.2011; Fukuda Michiko N, 2012, Front Biosci (Elite Ed), V4, P342; Gorski DH, 2003, J SURG RES, V111, P91, DOI 10.1016/S0022-4804(03)00042-8; Gu XX, 2014, TUMOR BIOL, V35, P2167, DOI 10.1007/s13277-013-1287-9; Guo GJ, 2014, FEBS LETT, V588, P1780, DOI 10.1016/j.febslet.2014.03.038; Hartl D, 2009, J IMMUNOL, V182, P5098, DOI 10.4049/jimmunol.0803446; Huang J, 2014, INT J ONCOL, V44, P1293, DOI 10.3892/ijo.2014.2298; Huang XH, 2008, J CANCER RES CLIN, V134, P705, DOI 10.1007/s00432-007-0342-6; International Agency for Research on Cancer (IARC), GLOBOCAN2012 DATABSE; Jung SH, 2010, GASTRIC CANCER, V13, P123, DOI 10.1007/s10120-010-0550-7; Junnila S, 2010, GENE CHROMOSOME CANC, V49, P28, DOI 10.1002/gcc.20715; Kim O, 2014, J CELL PHYSIOL, V229, P762, DOI 10.1002/jcp.24496; Laborde E, 2010, CELL DEATH DIFFER, V17, P1373, DOI 10.1038/cdd.2010.80; Leir SH, 2011, EXP CELL RES, V317, P2408, DOI 10.1016/j.yexcr.2011.07.021; Li H, 2014, ONCOTARGET, V5, P2318, DOI 10.18632/oncotarget.1913; Li H, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-110; Liu CH, 2001, BIOCHEM BIOPH RES CO, V288, P129, DOI 10.1006/bbrc.2001.5737; Lorenzi T, 2013, INT J CANCER, V133, P2650, DOI 10.1002/ijc.28280; Luo ZY, 2011, J CANCER RES CLIN, V137, P1713, DOI 10.1007/s00432-011-1042-9; Thang NM, 2013, REPROD SCI, V20, P1184, DOI 10.1177/1933719113477485; Nookaew I, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-41; Ohlsson L, 2012, BRIT J CANCER, V107, P150, DOI 10.1038/bjc.2012.220; Okano M, 2013, ONCOL REP, V30, P2903, DOI 10.3892/or.2013.2761; Okugawa T, 2012, DIGEST DIS SCI, V57, P1562, DOI 10.1007/s10620-012-2043-5; Oshima T, 2014, ANTICANCER RES, V34, P2303; Planque C, 2010, CLIN CHEM, V56, P987, DOI 10.1373/clinchem.2009.138917; Praml C, 2003, ONCOGENE, V22, P4765, DOI 10.1038/sj.onc.1206684; Qu Y, 2014, INT J ONCOL, V44, P1512, DOI 10.3892/ijo.2014.2328; Qu Y, 2013, EUR J CANCER, V49, P3718, DOI 10.1016/j.ejca.2013.07.011; Rizzato C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073100; Sanchez C, 2012, MOL CELL ENDOCRINOL, V349, P170, DOI 10.1016/j.mce.2011.10.010; Sato T, 2013, J SURG ONCOL, V108, P364, DOI 10.1002/jso.23425; Schubert T, 2012, INT J MOL MED, V30, P1133, DOI 10.3892/ijmm.2012.1098; Seiz L, 2012, BIOL CHEM, V393, P391, DOI 10.1515/hsz-2011-0264; Sha SM, 2013, DIGEST LIVER DIS, V45, P422, DOI 10.1016/j.dld.2012.12.004; Shibutani M, 2013, ANTICANCER RES, V33, P3301; Sun M, 2014, TUMOR BIOL, V35, P1065, DOI 10.1007/s13277-013-1142-z; Takeno A, 2008, BRIT J CANCER, V99, P1307, DOI 10.1038/sj.bjc.6604682; Tomas A, 2014, TRENDS CELL BIOL, V24, P26, DOI 10.1016/j.tcb.2013.11.002; Vainionpaa N, 2007, LAB INVEST, V87, P780, DOI 10.1038/labinvest.3700592; Vallon M, 2010, EXP CELL RES, V316, P412, DOI 10.1016/j.yexcr.2009.10.013; Wang RF, 2013, EXP MOL PATHOL, V95, P350, DOI 10.1016/j.yexmp.2013.10.008; Wang YF, 2013, TUMOR BIOL, V34, P1685, DOI 10.1007/s13277-013-0703-5; Wei M, 2010, MOL CANCER THER, V9, P1764, DOI 10.1158/1535-7163.MCT-09-1162; Xiao JW, 2012, ASIAN PAC J CANCER P, V13, P5897, DOI 10.7314/APJCP.2012.13.11.5897; Yan J, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0879-6; Yoshida T, 2014, INT J CANCER, V134, P1445, DOI 10.1002/ijc.28470; Zhang YQ, 2014, ACTA BIOCH BIOPH SIN, V46, P283, DOI 10.1093/abbs/gmu001	61	42	43	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125013	10.1371/journal.pone.0125013	http://dx.doi.org/10.1371/journal.pone.0125013			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928635	Green Published, gold, Green Submitted			2022-12-27	WOS:000353713100057
J	Matsuzaki, S; Hiratsuka, T; Taniguchi, M; Shingaki, K; Kubo, T; Kiya, K; Fujiwara, T; Kanazawa, S; Kanematsu, R; Maeda, T; Takamura, H; Yamada, K; Miyoshi, K; Hosokawa, K; Tohyama, M; Katayama, T				Matsuzaki, Shinsuke; Hiratsuka, Toru; Taniguchi, Manabu; Shingaki, Kenta; Kubo, Tateki; Kiya, Koichiro; Fujiwara, Toshihiro; Kanazawa, Shigeyuki; Kanematsu, Ryutaro; Maeda, Tameyasu; Takamura, Hironori; Yamada, Kohe; Miyoshi, Ko; Hosokawa, Ko; Tohyama, Masaya; Katayama, Taiichi			Physiological ER Stress Mediates the Differentiation of Fibroblasts	PLOS ONE			English	Article							PLASMA-CELL DIFFERENTIATION; SMOOTH MUSCLE ACTIN; TRANSCRIPTION FACTOR; GRANULATION-TISSUE; TRANSDUCER OASIS; CONTRACTION; APOPTOSIS; ALPHA; BETA; MYOFIBROBLASTS	Recently, accumulating reports have suggested the importance of endoplasmic reticulum (ER) stress signaling in the differentiation of several tissues and cells, including myoblasts and osteoblasts. Secretory cells are easily subjected to ER stress during maturation of their secreted proteins. Skin fibroblasts produce and release several proteins, such as collagens, matrix metalloproteinases (MMPs), the tissue inhibitors of metalloproteinases (TIMPs) and glycosaminoglycans (GAGs), and the production of these proteins is increased at wound sites. Differentiation of fibroblasts into myofibroblasts is one of the key factors for wound healing and that TGF-beta can induce fibroblast differentiation into myofibroblasts, which express a-smooth muscle actin. Well-differentiated myofibroblasts show increased production of collagen and TGF-beta, and bring about wound healing. In this study, we examined the effects of ER stress signaling on the differentiation of fibroblasts, which is required for wound healing, using constitutively ER stress-activated primary cultured fibroblasts. The cells expressed positive a-smooth muscle actin signals without TGF-beta stimulation compared with control fibroblasts. Gel-contraction assays suggested that ER stress-treated primary fibroblasts caused stronger shrinkage of collagen gels than control cells. These results suggest that ER stress signaling could accelerate the differentiation of fibroblasts to myofibroblasts at injured sites. The present findings may provide important insights for developing therapies to improve wound healing.	[Matsuzaki, Shinsuke; Hiratsuka, Toru; Taniguchi, Manabu; Shingaki, Kenta; Maeda, Tameyasu; Tohyama, Masaya] Osaka Univ, Dept Anat & Neurosci, Grad Sch Med, Osaka, Japan; [Matsuzaki, Shinsuke; Kanematsu, Ryutaro; Takamura, Hironori; Yamada, Kohe; Miyoshi, Ko; Tohyama, Masaya; Katayama, Taiichi] Osaka Univ, United Grad Sch Child Dev, Dept Child Dev & Mol Brain Sci, Suita, Osaka, Japan; [Matsuzaki, Shinsuke; Takamura, Hironori; Yamada, Kohe; Miyoshi, Ko] Osaka Univ, United Grad Sch Child Dev, Mol Res Ctr Childrens Mental Dev, Suita, Osaka, Japan; [Shingaki, Kenta] Noevir Co Ltd, Dept Res & Dev, Higashiomi, Shiga, Japan; [Kubo, Tateki; Kiya, Koichiro; Fujiwara, Toshihiro; Kanazawa, Shigeyuki; Hosokawa, Ko] Osaka Univ, Grad Sch Med, Dept Plast Surg, Suita, Osaka, Japan; [Yamada, Kohe] Hamamatsu Univ Sch Med, Res Ctr Child Mental Dev, Hamamatsu, Shizuoka 4313192, Japan; [Tohyama, Masaya] Kinki Univ, Res Inst Tradit Oriental Med, Div Mol Brain Sci, Sayama, Osaka, Japan	Osaka University; Osaka University; Osaka University; Osaka University; Hamamatsu University School of Medicine; Kindai University (Kinki University)	Matsuzaki, S (corresponding author), Osaka Univ, Dept Anat & Neurosci, Grad Sch Med, Osaka, Japan.	matsuzaki@ugscd.osaka-u.ac.jp		Hiratsuka, Toru/0000-0002-5359-2690	Program for Creating Future Wisdom, Osaka University [60403193, 23790224]; Cosmetology Research Foundation; Osaka University Graduate School of Medicine; Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers [S2603]	Program for Creating Future Wisdom, Osaka University; Cosmetology Research Foundation; Osaka University Graduate School of Medicine; Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers	This work was supported by Grant-in-Aid for Young Scientists (B) #60403193 https://kaken.nii.ac.jp/d/p/21790181.ja.html, Grant-in-Aid for Young Scientists (B) #23790224 https://kaken.nii.ac.jp/d/p/23790224.ja.html, The Program for Creating Future Wisdom, Osaka University, selected in 2014. http://www.osaka-u.ac.jp/en/news/topics/2014/07/20140717_01, Project MEET, Osaka University Graduate School of Medicine http://www.dmi.med.osaka-u.ac.jp/meet/index.html, and Cosmetology Research Foundation http://www.cosmetology.or.jp/.Noevir Co., Ltd., provided partial support in the form of a salary for author SK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers (Grant No. S2603). The specific roles of the authors are articulated in the 'author contributions' section.	Asada R, 2012, J BIOL CHEM, V287, P8144, DOI 10.1074/jbc.M111.332593; Butler PD, 2011, J SURG RES, V167, P151, DOI 10.1016/j.jss.2009.04.036; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; DANS MJ, 1994, J INVEST DERMATOL, V102, P118, DOI 10.1111/1523-1747.ep12371743; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; DESMOULIERE A, 1992, EXP CELL RES, V201, P64, DOI 10.1016/0014-4827(92)90348-C; GABBIANI G, 1972, AM J PATHOL, V66, P131; GABBIANI G, 1972, J EXP MED, V135, P719, DOI 10.1084/jem.135.4.719; Garner Warren L., 1995, Wound Repair and Regeneration, V3, P185, DOI 10.1046/j.1524-475X.1995.30210.x; GLUCKSMANN A, 1951, BIOL REV, V26, P59, DOI 10.1111/j.1469-185X.1951.tb00774.x; Hetz C, 2003, EMBO J, V22, P5435, DOI 10.1093/emboj/cdg537; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Hu QR, 2006, HUM MOL GENET, V15, P3379, DOI 10.1093/hmg/ddl414; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Iwakoshi NN, 2003, IMMUNOL REV, V194, P29, DOI 10.1034/j.1600-065X.2003.00057.x; Katayama T, 1999, NAT CELL BIOL, V1, P479, DOI 10.1038/70265; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kondo S, 2011, IUBMB LIFE, V63, P233, DOI 10.1002/iub.433; Ladin Daniel A., 1995, Wound Repair and Regeneration, V3, P6, DOI 10.1046/j.1524-475X.1995.30106.x; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Modarressi A, 2010, J INVEST DERMATOL, V130, P2818, DOI 10.1038/jid.2010.224; MONTESANO R, 1988, P NATL ACAD SCI USA, V85, P4894, DOI 10.1073/pnas.85.13.4894; Moulin V, 1998, EXP CELL RES, V238, P283, DOI 10.1006/excr.1997.3827; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Murray CJ, 1992, WOUNDHEALING BIOCH C, P500; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakanishi K, 2007, FASEB J, V21, P2994, DOI 10.1096/fj.06-6408com; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; RUDOLPH R, 1992, WOUND HEALING BIOCH, P96; Saito A, 2011, J BIOL CHEM, V286, P4809, DOI 10.1074/jbc.M110.152900; Saito A, 2009, NAT CELL BIOL, V11, P1197, DOI 10.1038/ncb1962; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Tanaka K, 2013, BIOCHEM BIOPH RES CO, V438, P463, DOI 10.1016/j.bbrc.2013.07.126; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Vedrenne N, 2012, PATHOL BIOL, V60, P20, DOI 10.1016/j.patbio.2011.10.002	37	39	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0123578	10.1371/journal.pone.0123578	http://dx.doi.org/10.1371/journal.pone.0123578			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928708	Green Published, gold, Green Submitted			2022-12-27	WOS:000353713100018
J	Qian, L; Zhang, Y; Zheng, L; Shang, YQ; Gao, JH; Liu, YJ				Qian, Long; Zhang, Yi; Zheng, Li; Shang, Yuqing; Gao, Jia-Hong; Liu, Yijun			Frequency Dependent Topological Patterns of Resting-State Brain Networks	PLOS ONE			English	Article							EMPIRICAL MODE DECOMPOSITION; FUNCTIONAL CONNECTIVITY; PARCELLATION; ORGANIZATION; SPECIFICITY; GRAPHS	The topological organization underlying brain networks has been extensively investigated using resting-state fMRI, focusing on the low frequency band from 0.01 to 0.1 Hz. However, the frequency specificities regarding the corresponding brain networks remain largely unclear. In the current study, a data-driven method named complementary ensemble empirical mode decomposition (CEEMD) was introduced to separate the time series of each voxel into several intrinsic oscillation rhythms with distinct frequency bands. Our data indicated that the whole brain BOLD signals could be automatically divided into five specific frequency bands. After applying the CEEMD method, the topological patterns of these five temporally correlated networks were analyzed. The results showed that global topological properties, including the network weighted degree, network efficiency, mean characteristic path length and clustering coefficient, were observed to be most prominent in the ultra-low frequency bands from 0 to 0.015 Hz. Moreover, the saliency of small-world architecture demonstrated frequency-density dependency. Compared to the empirical mode decomposition method (EMD), CEEMD could effectively eliminate the mode-mixing effects. Additionally, the robustness of CEEMD was validated by the similar results derived from a split-half analysis and a conventional frequency division method using the rectangular window band-pass filter. Our findings suggest that CEEMD is a more effective method for extracting the intrinsic oscillation rhythms embedded in the BOLD signals than EMD. The application of CEEMD in fMRI data analysis will provide in-depth insight in investigations of frequency specific topological patterns of the dynamic brain networks.	[Qian, Long; Zheng, Li; Liu, Yijun] Peking Univ, Dept Biomed Engn, Beijing 100871, Peoples R China; [Zhang, Yi] Xidian Univ, Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China; [Shang, Yuqing] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Gao, Jia-Hong] Peking Univ, Ctr MRI Res, Beijing 100871, Peoples R China	Peking University; Xidian University; National University of Singapore; Peking University	Liu, YJ (corresponding author), Peking Univ, Dept Biomed Engn, Beijing 100871, Peoples R China.	yjliufl@gmail.com	Zhang, Yi/J-7496-2017	Zhang, Yi/0000-0003-0859-9735; Qian, Long/0000-0002-9707-1096	National Natural Science Foundation of China [81470816, 81271549, 61431013, 61131003, 81201081]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China under Grant Nos. 81470816, 81271549, 61431013, 61131003, 81201081.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Baggio HC, 2014, HUM BRAIN MAPP, V35, P4620, DOI 10.1002/hbm.22499; Bai F, 2012, J NEUROSCI, V32, P4307, DOI 10.1523/JNEUROSCI.5061-11.2012; Baria AT, 2011, J NEUROSCI, V31, P7910, DOI 10.1523/JNEUROSCI.1296-11.2011; Boubela RN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00168; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Chen L, 2015, NEUROIMAGE, V104, P452, DOI 10.1016/j.neuroimage.2014.10.027; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Hayasaka S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00880; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Hosseini SMH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040709; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Itahashi T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094115; Kalcher K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093375; Liang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032766; Liu Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036949, 10.1371/journal.pone.0032127, 10.1371/journal.pone.0040003, 10.1186/1746-1596-7-49]; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Maggioni E, 2014, J NEUROSCI METH, V228, P86, DOI 10.1016/j.jneumeth.2014.03.004; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Niazy RK, 2011, PROG BRAIN RES, V193, P259, DOI 10.1016/B978-0-444-53839-0.00017-X; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salvador R, 2008, NEUROIMAGE, V39, P279, DOI 10.1016/j.neuroimage.2007.08.018; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Salvador R, 2005, PHILOS T R SOC B, V360, P937, DOI 10.1098/rstb.2005.1645; Siegel M, 2012, NAT REV NEUROSCI, V13, P121, DOI 10.1038/nrn3137; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Song XP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086818; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Tian LX, 2011, NEUROIMAGE, V54, P191, DOI 10.1016/j.neuroimage.2010.07.066; Tomasi D, 2011, NEUROIMAGE, V57, P908, DOI 10.1016/j.neuroimage.2011.05.024; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wu CWW, 2008, NEUROIMAGE, V42, P1047, DOI 10.1016/j.neuroimage.2008.05.035; Wu ZH, 2009, ADV DATA SCI ADAPT, V1, P1, DOI 10.1142/S1793536909000047; Xie HB, 2006, COMPUT METH PROG BIO, V82, P114, DOI 10.1016/j.cmpb.2006.02.009; Yeh JR, 2010, ADV DATA SCI ADAPT, V2, P135, DOI 10.1142/S1793536910000422; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	50	32	32	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124681	10.1371/journal.pone.0124681	http://dx.doi.org/10.1371/journal.pone.0124681			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927525	Green Submitted, Green Published, gold			2022-12-27	WOS:000353713100044
J	Skurikhin, EG; Pershina, OV; Reztsova, AM; Ermakova, NN; Khmelevskaya, ES; Krupin, VA; Stepanova, IE; Artamonov, AV; Bekarev, AA; Madonov, PG; Dygai, AM				Skurikhin, Evgenii Germanovich; Pershina, Olga Victorovna; Reztsova, Alena Mikhaylovna; Ermakova, Natalia Nikolaevna; Khmelevskaya, Ekaterina Sergeevna; Krupin, Vycheslav Andreevich; Stepanova, Inna Ernestovna; Artamonov, Andrew Vladimirovich; Bekarev, Andrew Alexandrovich; Madonov, Pavel Gennadjevich; Dygai, Alexander Mikhaylovich			Modulation of Bleomycin-Induced Lung Fibrosis by Pegylated Hyaluronidase and Dopamine Receptor Antagonist in Mice	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; HEMATOPOIETIC STEM-CELL; BETA-ADRENERGIC RECEPTORS; PROGENITOR CELLS; BACTERIAL-INFECTION; COLLAGEN; MODEL; DIFFERENTIATION; PATHOGENESIS; PROGRESS	Hyaluronidases are groups of enzymes that degrade hyaluronic acid (HA). To stop enzymatic hydrolysis we modified testicular hyaluronidase (HYAL) by activated polyethylene oxide with the help of electron-beam synthesis. As a result we received pegylated hyaluronidase (pegHYAL). Spiperone is a selective D-2 dopamine receptor antagonist. It was demonstrated on the model of a single bleomycin damage of alveolar epithelium that during the inflammatory phase monotherapy by pegHYAL or spiperone reduced the populations of hematopoietic stem /progenitor cells in the lung parenchyma. PegHYAL also reduced the levels of transforming growth factor (TGF)-beta, interleukin (IL)-1 beta, tumor necrosis factor (TNF)-alpha in the serum and lungs, while spiperone reduced the level of the serum IL-1 beta. Polytherapy by spiperone and pegHYAL caused the increase of the quantity of hematopoietic stem/progenitor cells in the lungs. Such an influx of blood cell precursors was observed on the background of considerable fall level of TGF-beta and the increase level of TNF-alpha in the serum and lungs. These results show pegHYAL reduced the bleomycin-induced fibrosis reaction (production and accumulation of collagen) in the lung parenchyma. This effect was observed at a single and repetitive bleomycin damage of alveolar epithelium, the antifibrotic activity of pegHYAL surpassing the activity of testicular HYAL. The antifibrotic effect of pegHYAL is enhanced by an additional instillation of spiperone. Therapy by pegHYAL causes the flow of CD31(-)CD34(-)CD45(-)CD44(+)CD73(+)CD90(+)CD106(+)-cells into the fibrous lungs. These cells are incapable of differentiating into fibroblast cells. Spiperone instillation separately or together with pegHYAL reduced the MSC-like cells considerably. These data enable us to assume, that pegHYAL is a new and promising instrument both for preventive and therapy of toxic pneumofibrosis. The blockage of D-2 dopamine receptors with the following change of hyaluronan matrix can be considered as a new strategy in treatment of pneumofibrosis.	[Skurikhin, Evgenii Germanovich; Pershina, Olga Victorovna; Reztsova, Alena Mikhaylovna; Ermakova, Natalia Nikolaevna; Khmelevskaya, Ekaterina Sergeevna; Krupin, Vycheslav Andreevich; Stepanova, Inna Ernestovna; Dygai, Alexander Mikhaylovich] Res Inst Pharmacol & Regenerat Med, Dept Pathophysiol & Regenerat Med, Tomsk, Russia; [Artamonov, Andrew Vladimirovich; Bekarev, Andrew Alexandrovich; Madonov, Pavel Gennadjevich] Ltd Liabil Co Sci Future Management, Novosibirsk, Russia	Russian Academy of Sciences; Tomsk National Research Medical Center; E. D. Goldberg Research Institute of Pharmacology & Regenerative Medicine	Pershina, OV (corresponding author), Res Inst Pharmacol & Regenerat Med, Dept Pathophysiol & Regenerat Med, Tomsk, Russia.	ovpershina@gmail.com	Khmelevskaya, Ekaterina S/J-3886-2017; Krupin, Viacheslav/N-7125-2016; Skurikhin, Evgenii Germanovich/H-4038-2017; Pershina, Olga Viktorovna/C-6782-2017; Ermakova, Natalia/J-3865-2017; Dygai, Alexander Mikhailovich/A-4528-2015; Stepanova, Inna/AAZ-4710-2021; Madonov, Pavel G./A-7692-2019	Khmelevskaya, Ekaterina S/0000-0003-1776-4149; Krupin, Viacheslav/0000-0001-8263-7184; Skurikhin, Evgenii Germanovich/0000-0001-7445-4767; Pershina, Olga Viktorovna/0000-0002-0468-0272; Ermakova, Natalia/0000-0002-6268-2938; Dygai, Alexander Mikhailovich/0000-0001-6286-5315; Stepanova, Inna/0000-0001-6497-3117; Madonov, Pavel G./0000-0002-1093-8938	Scientific Future Management	Scientific Future Management	The authors received no specific funding for this work. Scientific Future Management provided support in the form of salaries for authors AVA, AAB and PGM but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini Carlo, 2006, Proc Am Thorac Soc, V3, P357, DOI 10.1513/pats.200601-010TK; Amenta F., 2002, Italian Journal of Anatomy and Embryology, V107, P145; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Banks DE, 2003, INTERSTITIAL LUNG DI, P402; Baumgartner KB, 2000, AM J EPIDEMIOL, V152, P307, DOI 10.1093/aje/152.4.307; BERG RA, 1981, J CLIN INVEST, V67, P1457, DOI 10.1172/JCI110175; Bitencourt CS, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-3; BOSINGSCHNEIDER R, 1976, CELL IMMUNOL, V27, P121, DOI 10.1016/0008-8749(76)90160-X; Bringardner BD, 2008, ANTIOXID REDOX SIGN, V10, P287, DOI 10.1089/ars.2007.1897; BROWN JE, 1977, J CLIN INVEST, V60, P70, DOI 10.1172/JCI108771; Bruzzone P, 2002, PULM PHARMACOL THER, V15, P393, DOI 10.1006/pupt.2002.0368; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chen JY, 2005, NAT REV CANCER, V5, P102, DOI 10.1038/nrc1547; Christophis C, 2011, BIOPHYS J, V101, P585, DOI 10.1016/j.bpj.2011.05.045; Chua F, 2005, AM J RESP CELL MOL, V33, P9, DOI 10.1165/rcmb.2005-0062TR; De Luca K, 2009, LEUKEMIA, V23, P2063, DOI 10.1038/leu.2009.155; Delpech B, 1997, J INTERN MED, V242, P41, DOI 10.1046/j.1365-2796.1997.00172.x; Denham JW, 2002, RADIOTHER ONCOL, V63, P129, DOI 10.1016/S0167-8140(02)00060-9; Dentener MA, 2005, THORAX, V60, P114, DOI 10.1136/thx.2003.020842; DEPELCHIN A, 1981, IMMUNOL LETT, V3, P207, DOI 10.1016/0165-2478(81)90076-6; Dygai AM, 2011, B EXP BIOL MED+, V152, P173, DOI 10.1007/s10517-011-1480-z; Esplin BL, 2011, J IMMUNOL, V186, P5367, DOI 10.4049/jimmunol.1003438; Fabre A, 2008, EUR RESPIR J, V32, P426, DOI 10.1183/09031936.00126907; Fipula D, 2008, ADV DRUG DELIVER REV, V60, P29, DOI 10.1016/j.addr.2007.02.001; Fubini B, 2003, FREE RADICAL BIO MED, V34, P1507, DOI 10.1016/S0891-5849(03)00149-7; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; GIRI SN, 1987, EXP LUNG RES, V13, P401, DOI 10.3109/01902148709069601; Gustafson T, 2007, RESP MED, V101, P2207, DOI 10.1016/j.rmed.2007.02.027; Hall NR, 1981, PSYCHONEUROIMMUNOLOG, P521; Hinds KD, 2005, PROTEIN CONJUGATION, P119; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Hoshino T, 2009, AM J RESP CELL MOL, V41, P661, DOI 10.1165/rcmb.2008-0182OC; Hubbard R, 2000, LANCET, V355, P466; Ito T, 2004, J BIOL CHEM, V279, P25326, DOI 10.1074/jbc.M403135200; Izbicki G, 2002, INT J EXP PATHOL, V83, P111, DOI 10.1046/j.1365-2613.2002.00220.x; Jha AK, 2011, BIOMATERIALS, V32, P2466, DOI 10.1016/j.biomaterials.2010.12.024; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Jun D, 2011, STEM CELLS, V29, P725, DOI 10.1002/stem.604; Kadler KE, 2008, CURR OPIN CELL BIOL, V20, P495, DOI 10.1016/j.ceb.2008.06.008; Kelly BG, 2002, AM J RESP CRIT CARE, V166, P510, DOI 10.1164/rccm.2103058; Kemparaju K, 2006, CELL BIOCHEM FUNCT, V24, P7, DOI 10.1002/cbf.1261; Khalil N, 2004, CAN MED ASSOC J, V171, P153, DOI 10.1503/cmaj.1030055; Khandare J, 2006, PROG POLYM SCI, V31, P359, DOI 10.1016/j.progpolymsci.2005.09.004; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Knop K, 2010, ANGEW CHEM INT EDIT, V49, P6288, DOI 10.1002/anie.200902672; KOBAYASHI Y, 1995, J VASC RES, V32, P200, DOI 10.1159/000159094; Kolb-Maurer A, 2004, FEMS IMMUNOL MED MIC, V40, P147, DOI 10.1016/S0928-8244(03)00305-5; LANDMANN RMA, 1984, J RECEPTOR RES, V4, P37, DOI 10.3109/10799898409042538; Le Blanc K, 2005, CYTOTHERAPY, V7, P36, DOI 10.1080/14653240510018118; Loebinger MR, 2008, CLIN SCI, V114, P99, DOI 10.1042/CS20070073; Mahendran S, 2012, QJM-INT J MED, V105, P929, DOI 10.1093/qjmed/hcs076; Malavia NK, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-27; Massberg S, 2007, CELL, V131, P994, DOI 10.1016/j.cell.2007.09.047; MILES K, 1984, INT J IMMUNOPHARMACO, V6, P171, DOI 10.1016/0192-0561(84)90014-6; MLADENOVIC J, 1984, BRIT J HAEMATOL, V56, P323; Moeller A, 2008, INT J BIOCHEM CELL B, V40, P362, DOI 10.1016/j.biocel.2007.08.011; Moodley Y, 2009, AM J PATHOL, V175, P303, DOI 10.2353/ajpath.2009.080629; MORLEY A, 1971, P SOC EXP BIOL MED, V138, P57; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; Ortiz LA, 1998, EXP LUNG RES, V24, P721, DOI 10.3109/01902149809099592; Pinheiro GA, 2008, INT J OCCUP ENV HEAL, V14, P117, DOI 10.1179/oeh.2008.14.2.117; PRATT RM, 1975, DEV BIOL, V44, P298, DOI 10.1016/0012-1606(75)90400-5; PRENTO P, 1993, HISTOCHEMISTRY, V99, P163, DOI 10.1007/BF00571877; Ratajczak MZ, 2008, CURR OPIN HEMATOL, V15, P293, DOI 10.1097/MOH.0b013e328302c7ca; Rodriguez S, 2009, BLOOD, V114, P4064, DOI 10.1182/blood-2009-04-214916; Savani RC, 2000, AM J RESP CELL MOL, V23, P475, DOI 10.1165/ajrcmb.23.4.3944; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Scumpia PO, 2010, J IMMUNOL, V184, P2247, DOI 10.4049/jimmunol.0903652; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Singh M, 2010, ASIAN PAC J CANCER P, V11, P257; Siniscalco Dario, 2008, Ther Adv Respir Dis, V2, P173, DOI 10.1177/1753465808092340; Skurikhin EG, 2013, OPEN C P J, V4, P31, DOI [10.2174/2210289201304010031, DOI 10.2174/2210289201304010031]; Skurikhin EG, 2014, J STEM CELL RES THER, V4, P210, DOI [10.4172/2157-7633.1000210, DOI 10.4172/2157-7633.1000210]; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Steele M, 2003, INTERSTITIAL LUNG DI, P418; Strutz F, 2001, KIDNEY INT, V59, P579, DOI 10.1046/j.1523-1755.2001.059002579.x; Taskar Varsha S, 2006, Proc Am Thorac Soc, V3, P293, DOI 10.1513/pats.200512-131TK; TOOLE BP, 1971, DEV BIOL, V26, P28, DOI 10.1016/0012-1606(71)90104-7; Tzilas V, 2009, AM J MED SCI, V338, P481, DOI 10.1097/MAJ.0b013e3181ad5984; USUKI J, 1995, PATHOL INT, V45, P552, DOI 10.1111/j.1440-1827.1995.tb03503.x; VANFURTH R, 1980, REV INFECT DIS, V2, P104; Vaughan MB, 2000, EXP CELL RES, V257, P180, DOI 10.1006/excr.2000.4869; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Webber J, 2009, J BIOL CHEM, V284, P9083, DOI 10.1074/jbc.M806989200; WEINSTOCK JV, 1989, J IMMUNOL, V142, P3256; Weissman DN, 2003, INTERSTITIAL LUNG DI, P387; Wenzel SE, 2002, J IMMUNOL, V169, P4613, DOI 10.4049/jimmunol.169.8.4613; Wynn TA, 2003, ANNU REV IMMUNOL, V21, P425, DOI 10.1146/annurev.immunol.21.120601.141142; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Xynos A, 2010, STEM CELLS, V28, P965, DOI 10.1002/stem.418; ZAHNISER NR, 1989, CLIN PHARMACOL THER, V45, P469, DOI 10.1038/clpt.1989.60; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	95	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125065	10.1371/journal.pone.0125065	http://dx.doi.org/10.1371/journal.pone.0125065			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927611	Green Submitted, gold, Green Published			2022-12-27	WOS:000353713100065
J	Caballero, JA; Lepora, NF; Gurney, KN				Caballero, Javier A.; Lepora, Nathan F.; Gurney, Kevin N.			Probabilistic Decision Making with Spikes: From ISI Distributions to Behaviour via Information Gain	PLOS ONE			English	Article							PIERONS LAW; STIMULUS-INTENSITY; TARGET SELECTION; BASAL GANGLIA; NEURAL BASIS; CORTEX; CHOICE; TIME; MODELS; NEURONS	Computational theories of decision making in the brain usually assume that sensory 'evidence' is accumulated supporting a number of hypotheses, and that the first accumulator to reach threshold triggers a decision in favour of its associated hypothesis. However, the evidence is often assumed to occur as a continuous process whose origins are somewhat abstract, with no direct link to the neural signals - action potentials or 'spikes' - that must ultimately form the substrate for decision making in the brain. Here we introduce a new variant of the well-known multi-hypothesis sequential probability ratio test (MSPRT) for decision making whose evidence observations consist of the basic unit of neural signalling - the inter-spike interval (ISI) - and which is based on a new form of the likelihood function. We dub this mechanism s-MSPRT and show its precise form for a range of realistic ISI distributions with positive support. In this way we show that, at the level of spikes, the refractory period may actually facilitate shorter decision times, and that the mechanism is robust against poor choice of the hypothesized data distribution. We show that s-MSPRT performance is related to the Kullback-Leibler divergence (KLD) or information gain between ISI distributions, through which we are able to link neural signalling to psychophysical observation at the behavioural level. Thus, we find the mean information needed for a decision is constant, thereby offering an account of Hick's law (relating decision time to the number of choices). Further, the mean decision time of s-MSPRT shows a power law dependence on the KLD offering an account of Pieron's law (relating reaction time to stimulus intensity). These results show the foundations for a research programme in which spike train analysis can be made the basis for predictions about behavior in multi-alternative choice tasks.	[Caballero, Javier A.; Gurney, Kevin N.] Univ Sheffield, Dept Psychol, Sheffield S10 2TN, S Yorkshire, England; [Caballero, Javier A.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Lepora, Nathan F.] Univ Bristol, Dept Engn Math, Bristol, Avon, England; [Lepora, Nathan F.] Univ Bristol, Bristol Robot Lab, Bristol, Avon, England; [Lepora, Nathan F.] Univ W England, Bristol BS16 1QY, Avon, England	University of Sheffield; University of Manchester; University of Bristol; University of Bristol; University of West England; University of West England	Gurney, KN (corresponding author), Univ Sheffield, Dept Psychol, Sheffield S10 2TN, S Yorkshire, England.	k.gurney@shef.ac.uk		Lepora, Nathan/0000-0001-5327-1523	National Council of Science and Technology (CONACyT); Engineering and Physical Sciences Research Council (EPSRC) [EP/J019690/1]; EPSRC [EP/J019690/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/J019690/1] Funding Source: researchfish	National Council of Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	JC was funded by a postgraduate fellowship from the National Council of Science and Technology (CONACyT, http://www.conacyt.mx/); KG was partly funded by the Engineering and Physical Sciences Research Council (EPSRC, www.epsrc.ac.uk) grant 'Green Brain' EP/J019690/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley R, 1997, P ROY SOC B-BIOL SCI, V264, P1775, DOI 10.1098/rspb.1997.0246; BAIR W, 1994, J NEUROSCI, V14, P2870; Bao SW, 2004, NAT NEUROSCI, V7, P974, DOI 10.1038/nn1293; Barbieri R, 2001, J NEUROSCI METH, V105, P25, DOI 10.1016/S0165-0270(00)00344-7; BAUM CW, 1994, IEEE T INFORM THEORY, V40, P1994, DOI 10.1109/18.340472; Beck JM, 2012, NEURON, V74, P30, DOI 10.1016/j.neuron.2012.03.016; Beck JM, 2008, NEURON, V60, P1142, DOI 10.1016/j.neuron.2008.09.021; Bogacz R, 2007, NEURAL COMPUT, V19, P442, DOI 10.1162/neco.2007.19.2.442; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Bogacz R, 2011, NEURAL COMPUT, V23, P817, DOI 10.1162/NECO_a_00103; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Britten KH, 1992, NSA20041, P1; BRUSS FT, 1991, ADV APPL PROBAB, V23, P612, DOI 10.2307/1427625; Caballero JA, 2010, BMC NEUROSCI, V11, pP25, DOI [10.1186/1471-2202-11-S1-P25, DOI 10.1186/1471-2202-11-S1-P25]; Caballero JA, 2011, BMC NEUROSCI, V12, pP137, DOI [10.1186/1471-2202-12-S1-P137, DOI 10.1186/1471-2202-12-S1-P137]; Caballero JA, 2013, BMC NEUROSCI, V14, pP153, DOI [10.1186/1471-2202-14-S1-P153, DOI 10.1186/1471-2202-14-S1-P153]; Caballero JA, 2012, THESIS U SHEFFIELD S; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; Chacron MJ, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.080601; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Churchland AK, 2008, NAT NEUROSCI, V11, P693, DOI 10.1038/nn.2123; Churchland AK, 2012, CURR OPIN NEUROBIOL, V22, P920, DOI 10.1016/j.conb.2012.04.009; Churchland MM, 2006, J NEUROSCI, V26, P3697, DOI 10.1523/JNEUROSCI.3762-05.2006; Cisek P, 2010, ANNU REV NEUROSCI, V33, P269, DOI 10.1146/annurev.neuro.051508.135409; de Lafuente V, 2005, NAT NEUROSCI, V8, P1698, DOI 10.1038/nn1587; Ding L, 2012, CEREB CORTEX, V22, P1052, DOI 10.1093/cercor/bhr178; Ding L, 2010, J NEUROSCI, V30, P15747, DOI 10.1523/JNEUROSCI.2894-10.2010; Ditterich J, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00184; Dragalin VP, 2000, IEEE T INFORM THEORY, V46, P1366, DOI 10.1109/18.850677; Drugowitsch J, 2012, J NEUROSCI, V32, P3612, DOI 10.1523/JNEUROSCI.4010-11.2012; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; GERSTEIN GL, 1964, BIOPHYS J, V4, P41, DOI 10.1016/S0006-3495(64)86768-0; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Hernandez A, 2010, NEURON, V66, P300, DOI 10.1016/j.neuron.2010.03.031; Hick WE, 1952, Q J EXP PSYCHOL, V4, P11, DOI 10.1080/17470215208416600; Horwitz GD, 1999, SCIENCE, V284, P1158, DOI 10.1126/science.284.5417.1158; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; Hyman R, 1953, THESIS J HOPKINS U; Jeyabalaratnam J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064294; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; KULLBACK S, 1987, AM STAT, V41, P340; Kveraga K, 2002, EXP BRAIN RES, V146, P307, DOI 10.1007/s00221-002-1168-8; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; Law CT, 2008, NAT NEUROSCI, V11, P505, DOI 10.1038/nn2070; LEONARD JA, 1959, Q J EXP PSYCHOL, V11, P76, DOI 10.1080/17470215908416294; Lepora NF, 2012, NEURAL COMPUT, V24, P2924, DOI 10.1162/NECO_a_00360; Lindner B, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.022901; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Maimon G, 2009, NEURON, V62, P426, DOI 10.1016/j.neuron.2009.03.021; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; McMillen T, 2006, J MATH PSYCHOL, V50, P30, DOI 10.1016/j.jmp.2005.10.003; Mehaffey WH, 2005, J NEUROSCI, V25, P9968, DOI 10.1523/JNEUROSCI.2682-05.2005; Mel BW, 1998, J NEUROSCI, V18, P4325; Moreno-Bote R, 2014, NAT NEUROSCI, V17, P1410, DOI 10.1038/nn.3807; Muniak MA, 2007, J NEUROSCI, V27, P11687, DOI 10.1523/JNEUROSCI.1486-07.2007; Nawrot MP, 2008, J NEUROSCI METH, V169, P374, DOI 10.1016/j.jneumeth.2007.10.013; Nemenman I, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.056111; Niwa M, 2008, J NEUROSCI, V28, P4435, DOI 10.1523/JNEUROSCI.5564-07.2008; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Pieron H, 1952, SENSATIONS THEIR FUN; Pieron H, 1913, ANN PSYCHOL, V20, P17; Pins D, 1996, PERCEPT PSYCHOPHYS, V58, P390, DOI 10.3758/BF03206815; Prescott SA, 2003, P NATL ACAD SCI USA, V100, P2076, DOI 10.1073/pnas.0337591100; Purcell BA, 2012, J NEUROSCI, V32, P3433, DOI 10.1523/JNEUROSCI.4622-11.2012; Purcell BA, 2010, PSYCHOL REV, V117, P1113, DOI 10.1037/a0020311; Rao RPN, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00146; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; RECANZONE GH, 1993, J NEUROSCI, V13, P87; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1031, DOI 10.1152/jn.1992.67.5.1031; Resulaj A, 2009, NATURE, V461, P263, DOI 10.1038/nature08275; Roitman JD, 2002, J NEUROSCI, V22, P9475; SCHALL JD, 1993, NATURE, V366, P467, DOI 10.1038/366467a0; Seow SC, 2005, HUM-COMPUT INTERACT, V20, P315, DOI 10.1207/s15327051hci2003_3; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Smith PL, 2010, J MATH PSYCHOL, V54, P266, DOI 10.1016/j.jmp.2009.12.002; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Stafford T, 2004, PSYCHONOMIC B REV, V11; Stafford T, 2011, COGNITIVE SCI, V35, P1553, DOI 10.1111/j.1551-6709.2011.01195.x; Stanford TR, 2010, NAT NEUROSCI, V13, P379, DOI 10.1038/nn.2485; Steimer A, 2013, NEURAL COMPUT, V25, P2303, DOI 10.1162/NECO_a_00477; STEPHENS MA, 1974, J AM STAT ASSOC, V69, P730, DOI 10.2307/2286009; Tal D, 1997, NEURAL COMPUT, V9, P305, DOI 10.1162/neco.1997.9.2.305; Teukolsky S.A., 2007, NUMERICAL RECIPES, V3rd; Thas O, 2009, SPRINGER SERIES STAT; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; Usher M, 2002, J MATH PSYCHOL, V46, P704, DOI 10.1006/jmps.2002.1420; van Maanen L, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2011.00143; Veeravalli VV, 1995, IEEE T INFORM THEORY, V41, P1994, DOI 10.1109/18.476323; VICKERS D, 1970, Ergonomics, V13, P37, DOI 10.1080/00140137008931117; Wald A, 1944, ANN MATH STAT, V15, P283, DOI 10.1214/aoms/1177731235; Wald A, 1947, WILEY PUBLICATIONS M; Zhang JX, 2010, NEURAL COMPUT, V22, P1113, DOI 10.1162/neco.2009.05-09-1025	96	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124787	10.1371/journal.pone.0124787	http://dx.doi.org/10.1371/journal.pone.0124787			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0LO	25923907	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000353711600104
J	Liu, J; Zhang, W				Liu, Jin; Zhang, Wei			The Influence of the Environment and Clothing on Human Exposure to Ultraviolet Light	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; PROTECTION; RADIATION; TRANSMISSION; POLLUTION; IMPACT	Objection The aim of this study is to determine the effect of clothing and the environment on human exposure to ultraviolet light. Methods The ultraviolet (ultraviolet A and ultraviolet B) light intensity was measured, and air quality parameters were recorded in 2014 in Beijing, China. Three types of clothing (white polyester cloth, pure cotton white T-shirt, and pure cotton black T-shirt) were individually placed on a mannequin. The ultraviolet (ultraviolet A and ultraviolet B) light intensities were measured above and beneath each article of clothing, and the percentage of ultraviolet light transmission through the clothing was calculated. Results (1) The ultraviolet light transmission was significantly higher through white cloth than through black cloth; the transmission was significantly higher through polyester cloth than through cotton. (2) The weather significantly influenced ultraviolet light transmission through white polyester cloth; transmission was highest on clear days and lowest on overcast days (ultraviolet A: P=0.000; ultraviolet B: P=0.008). (3) Air quality parameters (air quality index and particulate matter 2.5 and 10) were inversely related to the ultraviolet light intensity that reached the earth's surface. Ultraviolet B transmission through white polyester cloth was greater under conditions of low air pollution compared with high air pollution. Conclusion Clothing color and material and different types of weather affected ultraviolet light transmission; for one particular cloth, the transmission decreased with increasing air pollution.	[Liu, Jin; Zhang, Wei] Capital Med Univ, Beijing Obstet & Gynecol Hosp, Beijing, Peoples R China	Capital Medical University	Zhang, W (corresponding author), Capital Med Univ, Beijing Obstet & Gynecol Hosp, Beijing, Peoples R China.	zw2966@sina.com						Agarwal KS, 2002, ARCH DIS CHILD, V87, P111, DOI 10.1136/adc.87.2.111; Bogh MKB, 2012, SCAND J CLIN LAB INV, V72, P24, DOI 10.3109/00365513.2012.681929; Buka Irena, 2006, Paediatr Child Health, V11, P513; Chen B, 2015, ENVIRON SCI POLLUT R, V22, P5139, DOI 10.1007/s11356-014-4024-z; Davis S, 1997, INT J DERMATOL, V36, P374, DOI 10.1046/j.1365-4362.1997.00046.x; Gallagher RP, 2006, PROG BIOPHYS MOL BIO, V92, P119, DOI 10.1016/j.pbiomolbio.2006.02.011; Gambichler T, 2001, BRIT J DERMATOL, V144, P484, DOI 10.1046/j.1365-2133.2001.04072.x; Gao Q, 2011, BIOMED ENVIRON SCI, V24, P499, DOI 10.3967/0895-3988.2011.05.007; Gies P, 2007, PHOTODERMATOL PHOTO, V23, P264, DOI 10.1111/j.1600-0781.2007.00309.x; Godar DE, 2012, ENVIRON HEALTH PERSP, V120, P139, DOI 10.1289/ehp.1003195; Hosseinpanah F, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-519; Kelishadi R, 2014, PAEDIATR INT CHILD H, V34, P50, DOI 10.1179/2046905513Y.0000000080; Lips P, 2001, ENDOCR REV, V22, P477, DOI 10.1210/er.22.4.477; Lucas RM, 2008, INT J EPIDEMIOL, V37, P654, DOI 10.1093/ije/dyn017; Salih FM, 2004, PHOTODERMATOL PHOTO, V20, P53, DOI 10.1111/j.1600-0781.2004.00068.x; Seckmeyer G, 2013, PHOTOCHEM PHOTOBIOL, V89, P974, DOI 10.1111/php.12074; STANFORD DG, 1995, MED J AUSTRALIA, V162, P422, DOI 10.5694/j.1326-5377.1995.tb139972.x; Wang SQ, 2001, J AM ACAD DERMATOL, V44, P767, DOI 10.1067/mjd.2001.112384; Webb AR, 2006, PROG BIOPHYS MOL BIO, V92, P17, DOI 10.1016/j.pbiomolbio.2006.02.004; Wilson CA, 2006, TEXT RES J, V76, P216, DOI 10.1177/0040517506060907	20	15	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124758	10.1371/journal.pone.0124758	http://dx.doi.org/10.1371/journal.pone.0124758			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923778	Green Submitted, Green Published, gold			2022-12-27	WOS:000353711600103
J	Hughes, SF; Thomas-Wright, SJ; Banwell, J; Williams, R; Moyes, AJ; Mushtaq, S; Abdulmajed, M; Shergill, I				Hughes, Stephen Fon; Thomas-Wright, Samantha Jayne; Banwell, Joseph; Williams, Rachel; Moyes, Alyson Jayne; Mushtaq, Sohail; Abdulmajed, Mohamed; Shergill, Iqbal			A Pilot Study to Evaluate Haemostatic Function, following Shock Wave Lithotripsy (SWL) for the Treatment of Solitary Kidney Stones	PLOS ONE			English	Article							D-DIMER; COAGULATION; SURGERY; INJURY; DISEASE; MARKERS; DAMAGE	Purpose The number of patients undergoing shock wave lithotripsy (SWL) in the UK for solitary unilateral kidney stones is increasing annually. The development of postoperative complications such as haematuria and sepsis following SWL is likely to increase. Comparing a range of biological markers with the aim of monitoring or predicting postoperative complications following SWL has not been extensively researched. The main purpose of this pilot-study was to test the hypothesis that SWL results in changes to haemostatic function. Subsequently, this pilot-study would form a sound basis to undertake future investigations involving larger cohorts. Methods Twelve patients undergoing SWL for solitary unilateral kidney stones were recruited. From patients (8 male and 4 females) aged between 31-72 years (median-43 years), venous blood samples were collected pre-operatively (baseline), at 30, 120 and 240 minutes post-operatively. Specific haemostatic biomarkers [platelet counts, prothrombin time (PT), activated partial thromboplastin time (aPTT), fibrinogen, D-dimer, von Willebrand Factor (vWF), sE-selectin and plasma viscosity (PV)] were measured. Results Platelet counts and fibrinogen concentration were significantly decreased following SWL (p = 0.027 and p = 0.014 respectively), while D-dimer and vWF levels significantly increased following SWL (p = 0.019 and p = 0.001 respectively). PT, APTT, sE-selectin and PV parameters were not significantly changed following SWL (p>0.05). Conclusions Changes to specific biomarkers such as plasma fibrinogen and vWF suggest that these represent a more clinically relevant assessment of the extent of haemostatic involvement following SWL. Analysis of such markers, in the future, may potentially provide valuable data on "normal" response after lithotripsy, and could be expanded to identify or predict those patients at risk of coagulopathy following SWL. The validation and reliability will be assessed through the assessment of larger cohorts.	[Hughes, Stephen Fon; Williams, Rachel; Moyes, Alyson Jayne] Univ Chester, Dept Biol Sci, Chester, Cheshire, England; [Hughes, Stephen Fon; Moyes, Alyson Jayne; Mushtaq, Sohail; Abdulmajed, Mohamed; Shergill, Iqbal] Univ Chester, North Wales & North West Urol Res Ctr NW2URC, Chester, Cheshire, England; [Thomas-Wright, Samantha Jayne] BCUHB Wrexham Maelor Hosp, Dept Haematol, Wrexham, North Wales, Wales; [Banwell, Joseph] BCUHB Wrexham Maelor Hosp, Dept Clin Biochem, Wrexham, North Wales, Wales; [Mushtaq, Sohail] Univ Chester, Dept Clin Sci & Nutr, Chester, Cheshire, England; [Moyes, Alyson Jayne; Abdulmajed, Mohamed; Shergill, Iqbal] BCUHB Wrexham Maelor Hosp, Dept Urol, Wrexham, North Wales, Wales	University of Chester; University of Chester; University of Chester	Hughes, SF (corresponding author), Univ Chester, Dept Biol Sci, Chester, Cheshire, England.	stephen.hughes@chester.ac.uk		Mushtaq, Sohail/0000-0001-9980-8031	Institute of Biomedical Science (IBMS); University of Chester (Research & Knowledge Transfer Office)	Institute of Biomedical Science (IBMS); University of Chester (Research & Knowledge Transfer Office)	The authors would like to acknowledge the Institute of Biomedical Science (IBMS) and the University of Chester (Research & Knowledge Transfer Office) for their financial support.	Alessandro D, 2012, SCI WORLD J; Bates SM, 2012, SEMIN THROMB HEMOST, V38, P673, DOI 10.1055/s-0032-1326782; BLANN AD, 1994, EUR J VASCULAR SURG, V8, P10, DOI 10.1016/S0950-821X(05)80112-4; Blann AD, 1996, HAEMOSTASIS, V26, P72; de Moerloose P, 2001, THROMB HAEMOSTASIS, V85, P185; Dedej T, 2013, G CHIR, V34, P202, DOI 10.11138/gchir/2013.34.7.202; Foster W, 2009, RHEUMATOLOGY, V48, P285, DOI 10.1093/rheumatology/ken486; Handa RK, 2010, UROL RES, V38, P301, DOI 10.1007/s00240-010-0297-y; Handa RK, 2009, BJU INT, V103, P1270, DOI 10.1111/j.1464-410X.2008.08277.x; Harr JN, 2013, J TRAUMA ACUTE CARE, V74, P756, DOI 10.1097/TA.0b013e3182826d7e; Hughes SF, 2006, BRIT J BIOMED SCI, V63, P166, DOI 10.1080/09674845.2006.11732743; Hughes SF, 2013, EUR J MED RES, V18, DOI 10.1186/2047-783X-18-40; Hughes SF, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-2; Lee YJ, 2007, RADIOL CLIN N AM, V45, P581, DOI 10.1016/j.rcl.2007.04.004; McAteer JA, 2008, SEMIN NEPHROL, V28, P200, DOI 10.1016/j.semnephrol.2008.01.003; Romero Victoriano, 2010, Rev Urol, V12, pe86; Schuetz P, 2011, SHOCK, V36, P104, DOI 10.1097/SHK.0b013e31821e4e04; Turney BW, 2012, BJU INT, V109, P1082, DOI 10.1111/j.1464-410X.2011.10495.x; UMEKAWA T, 1993, UROL INT, V50, P159, DOI 10.1159/000282475; Wyble CW, 1997, J SURG RES, V73, P107, DOI 10.1006/jsre.1997.5207; Yang L, 2013, J THROMB HAEMOST, V11, P1519, DOI 10.1111/jth.12304	21	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125840	10.1371/journal.pone.0125840	http://dx.doi.org/10.1371/journal.pone.0125840			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938233	gold, Green Published, Green Submitted			2022-12-27	WOS:000353943000103
J	Liu, CC; Chen, ZC; Wang, T; Tang, DD; Hitchman, G; Sun, JZ; Zhao, XY; Wang, LJ; Chen, AT				Liu, Congcong; Chen, Zhencai; Wang, Ting; Tang, Dandan; Hitchman, Glenn; Sun, Jiangzhou; Zhao, Xiaoyue; Wang, Lijun; Chen, Antao			Predicting Stroop Effect from Spontaneous Neuronal Activity: A Study of Regional Homogeneity	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; INFERIOR FRONTAL-CORTEX; RESTING STATE FMRI; PREFRONTAL CORTEX; FUNCTIONAL CONNECTIVITY; INDIVIDUAL-DIFFERENCES; RESPONSE-INHIBITION; NEURAL MECHANISMS; STOP SIGNAL; HUMAN BRAIN	The Stroop effect is one of the most robust and well-studied phenomena in cognitive psychology and cognitive neuroscience. However, little is known about the relationship between intrinsic brain activity and the individual differences of this effect. In the present study, we explored this issue by examining whether resting-state functional magnetic resonance imaging (rs-fMRI) signals could predict individual differences in the Stroop effect of healthy individuals. A partial correlation analysis was calculated to examine the relationship between regional homogeneity (ReHo) and Stroop effect size, while controlling for age, sex, and framewise displacement (FD). The results showed positive correlations in the left inferior frontal gyrus (LIFG), the left insula, the ventral anterior cingulate cortex (vACC), and the medial frontal gyrus (MFG), and negative correlation in the left precentral gyrus (LPG). These results indicate the possible influences of the LIFG, the left insula, and the LPG on the efficiency of cognitive control, and demonstrate that the key nodes of default mode network (DMN) may be important in goal-directed behavior and/or mental effort during cognitive control tasks.	[Liu, Congcong; Chen, Zhencai; Wang, Ting; Tang, Dandan; Hitchman, Glenn; Sun, Jiangzhou; Zhao, Xiaoyue; Wang, Lijun; Chen, Antao] Southwest Univ, Fac Psychol, Key Lab Cognit & Personal, Minist Educ, Chongqing, Peoples R China; [Wang, Ting] Chongqing Univ Arts & Sci, Lab Cognit & Mental Hlth, Chongqing, Peoples R China	Southwest University - China; Chongqing University of Arts & Sciences	Chen, AT (corresponding author), Southwest Univ, Fac Psychol, Key Lab Cognit & Personal, Minist Educ, Chongqing, Peoples R China.	xscat@swu.edu.cn	Chen, Zhencai/AAD-9136-2019; Hitchman, Glenn/F-6974-2014	Hitchman, Glenn/0000-0003-3268-5246	National Natural Science Foundation of China [31170980, 81271477]; Foundation for the Author of National Excellent Doctoral Dissertation of PR China [201107]; New Century Excellent Talents in University [NCET-11-0698]; Fundamental Research Funds for the Central Universities [SWU1009001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for the Author of National Excellent Doctoral Dissertation of PR China(Foundation for the Author of National Excellent Doctoral Dissertation of China); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (31170980, 81271477), the Foundation for the Author of National Excellent Doctoral Dissertation of PR China (201107), New Century Excellent Talents in University (NCET-11-0698), and the Fundamental Research Funds for the Central Universities (SWU1009001).	Aron AR, 2006, J NEUROSCI, V26, P2424, DOI 10.1523/JNEUROSCI.4682-05.2006; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Balota DA, 2010, PSYCHOL AGING, V25, P208, DOI 10.1037/a0017474; BENCH CJ, 1993, NEUROPSYCHOLOGIA, V31, P907, DOI 10.1016/0028-3932(93)90147-R; Bishop S, 2004, NAT NEUROSCI, V7, P184, DOI 10.1038/nn1173; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2012, NEUROIMAGE, V62, P938, DOI 10.1016/j.neuroimage.2012.01.090; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Brown GG, 1999, J INT NEUROPSYCH SOC, V5, P308, DOI 10.1017/S1355617799544020; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Cao QJ, 2006, NEUROREPORT, V17, P1033, DOI 10.1097/01.wnr.0000224769.92454.5d; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Carter CS, 1999, REV NEUROSCIENCE, V10, P49; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Chao HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072032; Chen ZC, 2013, NEUROIMAGE, V66, P577, DOI 10.1016/j.neuroimage.2012.10.028; Churchwell JC, 2013, DEV COGN NEUROS-NETH, V6, P80, DOI 10.1016/j.dcn.2013.07.001; Davidson DJ, 2003, AGING NEUROPSYCHOL C, V10, P85, DOI 10.1076/anec.10.2.85.14463; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Duchek JM, 2013, NEUROPSYCHOLOGY, V27, P516, DOI 10.1037/a0033402; DUM RP, 1991, J NEUROSCI, V11, P667; Egner T, 2011, J COGNITIVE NEUROSCI, V23, P3903, DOI 10.1162/jocn_a_00064; Floden D, 2011, J COGNITIVE NEUROSCI, V23, P867, DOI 10.1162/jocn.2010.21492; Forstmann BU, 2008, J NEUROSCI, V28, P9790, DOI 10.1523/JNEUROSCI.1465-08.2008; Forstmann BU, 2008, J COGNITIVE NEUROSCI, V20, P1854, DOI 10.1162/jocn.2008.20122; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; George M S, 1994, Hum Brain Mapp, V1, P194, DOI 10.1002/hbm.460010305; George M. S., 1997, J NEUROPSYCHIATRY CL; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hamilton AC, 2005, COGN AFFECT BEHAV NE, V5, P1; HE SQ, 1993, J NEUROSCI, V13, P952; Hlustik P, 2004, J CLIN NEUROPHYSIOL, V21, P180; Jiang LL, 2015, BRAIN STRUCT FUNCT, V220, P2485, DOI 10.1007/s00429-014-0795-8; Johansen-Berg H, 2004, P NATL ACAD SCI USA, V101, P13335, DOI 10.1073/pnas.0403743101; Kalanthroff E, 2013, J EXP PSYCHOL HUMAN, V39, P579, DOI 10.1037/a0027429; Kendall M., 1990, DIV HODDER STOUGHTON, P29; Kornblum S, 1999, J EXP PSYCHOL HUMAN, V25, P688, DOI 10.1037/0096-1523.25.3.688; Laird AR, 2005, HUM BRAIN MAPP, V25, P6, DOI 10.1002/hbm.20129; Leung HC, 2000, CEREB CORTEX, V10, P552, DOI 10.1093/cercor/10.6.552; Liu Xianglin, 2010, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V35, P25, DOI 10.3969/j.issn.1672-7347.2010.01.004; MacLeod CM, 2000, TRENDS COGN SCI, V4, P383, DOI 10.1016/S1364-6613(00)01530-8; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Mazoyer B, 2001, BRAIN RES BULL, V54, P287, DOI 10.1016/S0361-9230(00)00437-8; Mead LA, 2002, J INT NEUROPSYCH SOC, V8, P735, DOI 10.1017/S1355617702860015; Melcher T, 2008, BRAIN RES REV, V59, P96, DOI 10.1016/j.brainresrev.2008.06.003; Milham MP, 2003, COGNITIVE BRAIN RES, V17, P212, DOI 10.1016/S0926-6410(03)00108-3; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MUAKKASSA KF, 1979, BRAIN RES, V177, P176, DOI 10.1016/0006-8993(79)90928-4; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; PARDO JV, 1990, P NATL ACAD SCI USA, V87, P256, DOI 10.1073/pnas.87.1.256; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Qiu CJ, 2011, PSYCHIAT RES-NEUROIM, V194, P47, DOI 10.1016/j.pscychresns.2011.01.010; Reichle ME, 2010, TRENDS COGN SCI, V14, P180, DOI 10.1016/j.tics.2010.01.008; Rushworth MFS, 2007, CURR OPIN NEUROBIOL, V17, P220, DOI 10.1016/j.conb.2007.03.001; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; SOKOLOFF L, 1955, J CLIN INVEST, V34, P1101, DOI 10.1172/JCI103159; Steinhauser M, 2009, J EXP PSYCHOL HUMAN, V35, P1398, DOI 10.1037/a0016467; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stuss DT, 2001, NEUROPSYCHOLOGIA, V39, P771, DOI 10.1016/S0028-3932(01)00013-6; Swick D, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-102; Takeuchi H, 2012, NEUROIMAGE, V59, P2899, DOI 10.1016/j.neuroimage.2011.09.064; Taylor SF, 1997, NEUROIMAGE, V6, P81, DOI 10.1006/nimg.1997.0285; Thompson-Schill SL, 1999, NEURON, V23, P513, DOI 10.1016/S0896-6273(00)80804-1; Thompson-Schill SL, 1998, P NATL ACAD SCI USA, V95, P15855, DOI 10.1073/pnas.95.26.15855; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; Tian LX, 2012, NEUROIMAGE, V60, P539, DOI 10.1016/j.neuroimage.2011.11.098; Wang LQ, 2011, NEUROSCI LETT, V488, P275, DOI 10.1016/j.neulet.2010.11.046; Wang T, 2014, NEUROIMAGE, V90, P146, DOI 10.1016/j.neuroimage.2013.12.055; Whalen PJ, 1998, BIOL PSYCHIAT, V44, P1219, DOI 10.1016/S0006-3223(98)00251-0; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yin Y, 2012, NEUROSCI BULL, V28, P541, DOI 10.1007/s12264-012-1261-3; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhu XL, 2012, BIOL PSYCHIAT, V71, P611, DOI 10.1016/j.biopsych.2011.10.035; Zuo XN, 2013, NEUROIMAGE, V65, P374, DOI 10.1016/j.neuroimage.2012.10.017	80	16	17	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0124405	10.1371/journal.pone.0124405	http://dx.doi.org/10.1371/journal.pone.0124405			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938442	gold, Green Published, Green Submitted			2022-12-27	WOS:000353943000025
J	McMichael, L; Edson, D; McLaughlin, A; Mayer, D; Kopp, S; Meers, J; Field, H				McMichael, Lee; Edson, Daniel; McLaughlin, Amanda; Mayer, David; Kopp, Steven; Meers, Joanne; Field, Hume			Haematology and Plasma Biochemistry of Wild Black Flying-Foxes, (Pteropus alecto) in Queensland, Australia	PLOS ONE			English	Article							REFERENCE RANGES; HENDRA VIRUS; BATS; VALUES; ANESTHESIA; GIGANTEUS; INFECTION; RESERVOIR; STRESS; SERUM	This paper establishes reference ranges for hematologic and plasma biochemistry values in wild Black flying-foxes (Pteropus alecto) captured in South East Queensland, Australia. Values were found to be consistent with those of other Pteropus species. Four hundred and forty-seven animals were sampled over 12 months and significant differences were found between age, sex, reproductive and body condition cohorts in the sample population. Mean values for each cohort fell within the determined normal adult reference range, with the exception of elevated levels of alkaline phosphatase in juvenile animals. Hematologic and biochemistry parameters of injured animals showed little or no deviation from the normal reference values for minor injuries, while two animals with more severe injury or abscessation showed leucocytosis, anaemia, thrombocytosis, hyperglobulinemia and hypoalbuminemia.	[McMichael, Lee; Kopp, Steven; Meers, Joanne] Univ Queensland, Sch Vet Sci, Gatton, Qld 4343, Australia; [McMichael, Lee; Edson, Daniel; McLaughlin, Amanda] Dept Agr Fisheries & Forestry, Biosecur Queensland, Brisbane, Qld 4108, Australia; [Mayer, David] Dept Agr Fisheries & Forestry, Brisbane, Qld 4103, Australia; [Field, Hume] EcoHlth Alliance, New York, NY 10001 USA	University of Queensland; Queensland Department of Agriculture & Fisheries; Queensland Department of Agriculture & Fisheries; EcoHealth Alliance	McMichael, L (corresponding author), Univ Queensland, Sch Vet Sci, Gatton, Qld 4343, Australia.	lee.mcmichael@uqconnect.edu.au	McMichael, Lee UQ/C-7948-2018; Aktolun, Cumali/K-8514-2018; Mayer, David G/F-8616-2011; Kopp, Steven/G-8223-2014	McMichael, Lee UQ/0000-0002-7675-4859; Aktolun, Cumali/0000-0002-6245-9349; Mayer, David G/0000-0001-9564-9176; Kopp, Steven/0000-0001-7912-4556	Australian Biosecurity Co-operative Research Council; National Hendra virus research program	Australian Biosecurity Co-operative Research Council; National Hendra virus research program	LM received PhD scholarship funding from the now closed Australian Biosecurity Co-operative Research Council and the field work was carried out in collaboration with Queensland government funding through the National Hendra virus research program.	AGAR NS, 1992, COMP BIOCHEM PHYS B, V101, P9, DOI 10.1016/0305-0491(92)90150-P; [Anonymous], 2004, ECOLOGY HENDRA VIRUS; Barr JA, 2012, J GEN VIROL, V93, P2590, DOI 10.1099/vir.0.045385-0; Breed AC, 2011, PLOS ONE, V6, P1, DOI DOI 10.1371/J0URNAL.P0NE.0028816; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Churchill S, 2008, AUSTR BATS, V2nd; Clark P., 2004, HAEMATOLOGY AUSTR MA; Clarke J, 2013, J WILDLIFE DIS, V49, P831, DOI 10.7589/2011-12-345; Day RL, 2001, J ZOO WILDLIFE MED, V32, P206, DOI 10.1638/1042-7260(2001)032[0206:TEOTAW]2.0.CO;2; Epstein JH, 2008, EMERG INFECT DIS, V14, P1309, DOI 10.3201/eid1408.071492; GASCOYNE SC, 1994, VET REC, V134, P7, DOI 10.1136/vr.134.1.7; Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711; GenStat, 2013, GENSTAT WIND REL 15; Hall J, 2014, J WILDLIFE DIS, V50, P447, DOI 10.7589/2013-09-245; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Heard DJ, 2006, J ZOO WILDLIFE MED, V37, P245, DOI 10.1638/02-064.1; Heard DJ, 1998, J ZOO WILDLIFE MED, V29, P14; Heard DJ, 1997, J ZOO WILDLIFE MED, V28, P464; Hossain MB, 2013, BANGL J VET MED, V11, P2308; Jonsson NN, 2004, VET REC, V154, P664, DOI 10.1136/vr.154.21.664; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; McCullagh P, 1989, GEN LINEAR MODELS; McLaughlin AB, 2007, J ZOO WILDLIFE MED, V38, P446, DOI 10.1638/1042-7260(2007)38[446:PBAHVF]2.0.CO;2; McMichael LA, 2014, ECOHEALTH, V11, P400, DOI 10.1007/s10393-014-0954-7; MURRAY K, 1995, SCIENCE, V268, P94, DOI 10.1126/science.7701348; O'Brien GM, 2001, AUSTR BAT SOC NEWSL, V16, P10; Olsson AR, 2002, THESIS J COOK U N QU; Pacioni C, 2013, J WILDLIFE DIS, V49, P816, DOI 10.7589/2011-09-275; Plowright RK, 2008, P ROY SOC B-BIOL SCI, V275, P861, DOI 10.1098/rspb.2007.1260; Pourrut X, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-159; Ruykys L, 2012, AUST VET J, V90, P331, DOI 10.1111/j.1751-0813.2012.00956.x; Thrall M., 2004, VET HAEMATOLOGY CLIN; THRUSFIELD MT, 1997, VET EPIDEMIOLOGY; Webb NJ, 1996, P ROY SOC B-BIOL SCI, V263, P497, DOI 10.1098/rspb.1996.0075; Welbergen JA, 2011, OECOLOGIA, V165, P629, DOI 10.1007/s00442-010-1856-1; Wells RMG, 2000, COMP HAEMATOL INT, V10, P68, DOI 10.1007/s005800070010; WIGHTMAN J, 1987, COMP BIOCHEM PHYS B, V88, P305, DOI 10.1016/0305-0491(87)90119-2	38	16	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125741	10.1371/journal.pone.0125741	http://dx.doi.org/10.1371/journal.pone.0125741			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938493	Green Published, gold, Green Submitted			2022-12-27	WOS:000353943000097
J	Sun, J; Zheng, JY; Tang, LJ; Healy, J; Sinnett, D; Dai, YE				Sun, Jian; Zheng, Jinyu; Tang, Linjun; Healy, Jasmine; Sinnett, Daniel; Dai, Yue-e			Association between CEBPE Variant and Childhood Acute Leukemia Risk: Evidence from a Meta-Analysis of 22 Studies	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; SUSCEPTIBILITY LOCI; 10Q21.2; ARID5B; 7P12.2; POLYMORPHISMS; CHILDREN; 14Q11.2; SURVIVAL; ETIOLOGY	The CCAAT/enhancer binding proteins (CEBPs) have been involved in the etiology of acute leukemia (AL) and investigated in numerous genetic association studies, however, the results were inconclusive. The current meta-analysis was conducted to clarify the effect of CEBPE rs2239633 variant on childhood AL risk. Electronic literature search was performed on August 15, 2014, from databases of Medline, PubMed, Embase, and Web of Science. A total of 22 case-control studies were eligible for the pooled analysis. The results demonstrated that rs2239633 A allele was significantly associated with a decreased risk of childhood AL (A vs G: OR=0.87, 95% CI = 0.80, 0.94, p<0.001), especially in B-cell ALL subgroup (A vs G: OR = 0.79, 95% CI = 0.74, 0.83, p<0.001), but not among T-cell ALL or AML subgroups. In the stratified analysis by ethnicity, the association was observed in Europeans (A vs G: OR = 0.80, 95% CI = 0.76, 0.84, p<0.001) but not in Asian and mixed populations. Moreover, the results of sensitivity and cumulative meta-analysis indicated the robustness of our results. Also, Begg's and Egger's tests did not indicate any evidence of obvious asymmetry. In summary, our study provided evidence that CEBPE rs2239633 variant is associated with decreased risk of childhood B-cell ALL in Europeans.	[Sun, Jian] Huaian Matenal & Child Hlth Hosp, Dept Anesthesiol, Huaian, Jiangsu, Peoples R China; [Zheng, Jinyu] Xuzhou Med Coll, Affiliated Huaian Hosp, Dept Neurosurg, Huaian, Peoples R China; [Tang, Linjun] Tongling Peoples Hosp, Dept Neurosurg, Tongling, Anhui, Peoples R China; [Healy, Jasmine; Sinnett, Daniel] St Justine Univ Hosp, Res Ctr, Montreal, PQ, Canada; [Sinnett, Daniel] Univ Montreal, Fac Med, Dept Pediat, Montreal, PQ H3C 3J7, Canada; [Dai, Yue-e] Nanjing Med Univ, Nanjing Childrens Hosp, Nanjing, Jiangsu, Peoples R China	Xuzhou Medical University; Universite de Montreal; Universite de Montreal; Nanjing Medical University	Dai, YE (corresponding author), Nanjing Med Univ, Nanjing Childrens Hosp, Nanjing, Jiangsu, Peoples R China.	yueedai@163.com	sinnett, daniel/S-4589-2017	sinnett, daniel/0000-0003-3625-6676	Science and Technology Development Foundation of Nanjing Medical University [2014NLMU144]	Science and Technology Development Foundation of Nanjing Medical University	The study was supported by Science and Technology Development Foundation of Nanjing Medical University (No. 2014NLMU144). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015419; Akasaka T, 2007, BLOOD, V109, P3451, DOI 10.1182/blood-2006-08-041012; Armstrong SA, 2005, J CLIN ONCOL, V23, P6306, DOI 10.1200/JCO.2005.05.047; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bhatia S, 2002, BLOOD, V100, P1957, DOI 10.1182/blood-2002-02-0395; Copas J, 2000, Biostatistics, V1, P247, DOI 10.1093/biostatistics/1.3.247; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dores GM, 2012, BLOOD, V119, P34, DOI 10.1182/blood-2011-04-347872; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ellinghaus E, 2012, LEUKEMIA, V26, P902, DOI 10.1038/leu.2011.302; Emerenciano M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-127; GALBRAITH RF, 1988, STAT MED, V7, P889, DOI 10.1002/sim.4780070807; Gibson BES, 2011, BRIT J HAEMATOL, V155, P366, DOI 10.1111/j.1365-2141.2011.08851.x; Greaves M, 2006, NAT REV CANCER, V6, P193, DOI 10.1038/nrc1816; He J, 2015, LEUKEMIA LYMPHOMA, V56, P763, DOI 10.3109/10428194.2014.935370; Healy J, 2010, HAEMATOL-HEMATOL J, V95, P1608, DOI 10.3324/haematol.2010.022459; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hunger SP, 2012, J CLIN ONCOL, V30, P1663, DOI 10.1200/JCO.2011.37.8018; Inaba H, 2013, LANCET, V381, P1943, DOI 10.1016/S0140-6736(12)62187-4; Li SH, 2015, LEUKEMIA LYMPHOMA, V56, P978, DOI 10.3109/10428194.2014.939965; Lim JYS, 2014, CANCER-AM CANCER SOC, V120, P955, DOI 10.1002/cncr.28531; Lu XC, 2014, AM J EPIDEMIOL, V179, P267, DOI 10.1093/aje/kwt262; Orsi L, 2012, LEUKEMIA, V26, P2561, DOI 10.1038/leu.2012.148; Papaemmanuil E, 2009, NAT GENET, V41, P1006, DOI 10.1038/ng.430; Pastorczak A, 2011, LEUKEMIA RES, V35, P1534, DOI 10.1016/j.leukres.2011.07.034; Prasad RB, 2010, BLOOD, V115, P1765, DOI 10.1182/blood-2009-09-241513; PUI CH, 1995, NEW ENGL J MED, V332, P1618, DOI 10.1056/NEJM199506153322407; Qin LY, 2014, TUMOR BIOL, V35, P2521, DOI 10.1007/s13277-013-1333-7; Ross JA, 2013, PEDIATR BLOOD CANCER, V60, P31, DOI 10.1002/pbc.24131; Rubnitz JE, 2012, BLOOD, V119, P5980, DOI 10.1182/blood-2012-02-392506; Rubnitz JE, 2010, LANCET ONCOL, V11, P543, DOI 10.1016/S1470-2045(10)70090-5; Schmiegelow K, 2008, LEUKEMIA, V22, P2137, DOI 10.1038/leu.2008.212; Tang QQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078810; Vijayakrishnan J, 2010, LEUKEMIA LYMPHOMA, V51, P1870, DOI 10.3109/10428194.2010.511356; Wang C, 2015, ANN HEMATOL, V94, P181, DOI 10.1007/s00277-014-2186-x; Wang YP, 2013, GENE, V524, P203, DOI 10.1016/j.gene.2013.04.028; Wiemels J, 2012, CHEM-BIOL INTERACT, V196, P59, DOI 10.1016/j.cbi.2012.01.007; Xu H, 2013, JNCI-J NATL CANCER I, V105, P733, DOI 10.1093/jnci/djt042; Zintzaras E, 2008, J CLIN EPIDEMIOL, V61, P634, DOI 10.1016/j.jclinepi.2007.12.011	40	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125657	10.1371/journal.pone.0125657	http://dx.doi.org/10.1371/journal.pone.0125657			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938438	Green Submitted, Green Published, gold			2022-12-27	WOS:000353943000085
J	Chang, XL; Riemann, M; Liu, Q; Nick, P				Chang, Xiaoli; Riemann, Michael; Liu, Qiong; Nick, Peter			Actin as Deathly Switch? How Auxin Can Suppress Cell-Death Related Defence	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; PHOSPHATIDIC-ACID; GENE-EXPRESSION; PLANT; CYTOSKELETON; GROWTH; IMMUNITY; BINDING; GLUTATHIONYLATION; SUPERFAMILY	Plant innate immunity is composed of two layers - a basal immunity, and a specific effector-triggered immunity, which is often accompanied by hypersensitive cell death. Initiation of cell death depends on a complex network of signalling pathways. The phytohormone auxin as central regulator of plant growth and development represents an important component for the modulation of plant defence. In our previous work, we showed that cell death is heralded by detachment of actin from the membrane. Both, actin response and cell death, are triggered by the bacterial elicitor harpin in grapevine cells. In this study we investigated, whether harpin-triggered actin bundling is necessary for harpin-triggered cell death. Since actin organisation is dependent upon auxin, we used different auxins to suppress actin bundling. Extracellular alkalinisation and transcription of defence genes as the basal immunity were examined as well as cell death. Furthermore, organisation of actin was observed in response to pharmacological manipulation of reactive oxygen species and phospholipase D. We find that induction of defence genes is independent of auxin. However, auxin can suppress harpin-induced cell death and also counteract actin bundling. We integrate our findings into a model, where harpin interferes with an auxin dependent pathway that sustains dynamic cortical actin through the activity of phospholipase D. The antagonism between growth and defence is explained by mutual competition for signal molecules such as superoxide and phosphatidic acid. Perturbations of the auxin-actin pathway might be used to detect disturbed integrity of the plasma membrane and channel defence signalling towards programmed cell death.	[Chang, Xiaoli] Sichuan Agr Univ, Coll Agr, Dept Plant Pathol, Chengdu 611130, Peoples R China; [Riemann, Michael; Liu, Qiong; Nick, Peter] Univ Karlsruhe, Inst Bot, Mol Cell Biol, D-76128 Karlsruhe, Germany	Sichuan Agricultural University; Helmholtz Association; Karlsruhe Institute of Technology	Chang, XL (corresponding author), Sichuan Agr Univ, Coll Agr, Dept Plant Pathol, Chengdu 611130, Peoples R China.	xl_changkit@126.com	Liu, Qiong/AAD-5099-2019	Riemann, Michael/0000-0003-0287-2112	fellowships of the Chinese Scholarship Council; BACCHUS Interreg project	fellowships of the Chinese Scholarship Council; BACCHUS Interreg project	This work was supported by fellowships of the Chinese Scholarship Council to Xiaoli Chang for living expenses and by funds from the BACCHUS Interreg project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Campanoni P, 2005, PLANT PHYSIOL, V137, P939, DOI 10.1104/pp.104.053843; Cernadas RA, 2009, PLANT SCI, V177, P190, DOI 10.1016/j.plantsci.2009.05.006; Chang X, 2010, PLOS ONE, V6; Chang X, 2010, PLOS ONE, V7; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; Crawford LE, 1996, J BIOL CHEM, V271, P26863, DOI 10.1074/jbc.271.43.26863; Deeks MJ, 2012, CURR BIOL, V22, P1595, DOI 10.1016/j.cub.2012.06.041; Deeks MJ, 2010, J CELL SCI, V123, P1209, DOI 10.1242/jcs.065557; Ding XH, 2008, PLANT CELL, V20, P228, DOI 10.1105/tpc.107.055657; Dixon DP, 2005, PLANT PHYSIOL, V138, P2233, DOI 10.1104/pp.104.058917; Durst S, 2014, J PLANT PHYSIOL, V171, P97, DOI 10.1016/j.jplph.2013.10.007; Durst S, 2013, J PLANT PHYSIOL, V170, P1057, DOI 10.1016/j.jplph.2013.03.002; FELIX G, 1993, PLANT J, V4, P307, DOI 10.1046/j.1365-313X.1993.04020307.x; Ferrari S, 2008, PLANT PHYSIOL, V146, P669, DOI 10.1104/pp.107.109686; Franklin-Tong VE, 2008, BIOCHEM J, V413, P389, DOI 10.1042/BJ20080320; Fu J, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00074; GAFF DF, 1971, J EXP BOT, V22, P756, DOI 10.1093/jxb/22.3.756; Gopalan Suresh, 2008, BMC Res Notes, V1, P126, DOI 10.1186/1756-0500-1-126; Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682; Guan X, 2013, J EXP BOT, V64, P1805, DOI 10.1093/jxb/ert042; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Henty-Ridilla JL, 2014, PLANT CELL, V26, P340, DOI 10.1105/tpc.113.122499; Henty-Ridilla JL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003290; Hohenberger P, 2011, BBA-BIOMEMBRANES, V1808, P2304, DOI 10.1016/j.bbamem.2011.05.019; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kazan K, 2009, TRENDS PLANT SCI, V14, P373, DOI 10.1016/j.tplants.2009.04.005; Koivusalo M, 2009, J BIOL CHEM, V284, P6595, DOI 10.1074/jbc.R800049200; Kortekamp A, 2006, PLANT PHYSIOL BIOCH, V44, P58, DOI 10.1016/j.plaphy.2006.01.008; KURKDJIAN A, 1989, ANNU REV PLANT PHYS, V40, P271, DOI 10.1146/annurev.pp.40.060189.001415; Lager I, 2010, PLANT CELL ENVIRON, V33, P1513, DOI 10.1111/j.1365-3040.2010.02161.x; Lassing I, 2007, J MOL BIOL, V370, P331, DOI 10.1016/j.jmb.2007.04.056; Li JJ, 2012, PLANT CELL, V24, P3742, DOI 10.1105/tpc.112.103945; Liu Q, 2013, BBA-BIOMEMBRANES, V1828, P2111, DOI 10.1016/j.bbamem.2013.04.027; Maisch J, 2007, PLANT PHYSIOL, V143, P1695, DOI 10.1104/pp.106.094052; Moldovan L, 1999, ANTIOXID REDOX SIGN, V1, P29, DOI 10.1089/ars.1999.1.1-29; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Nicaise V, 2009, PLANT PHYSIOL, V150, P1638, DOI 10.1104/pp.109.139709; Nick P, 2000, PROTOPLASMA, V211, P234, DOI 10.1007/BF01304491; Nick P, 2010, PLANT SIGNAL BEHAV, V5, P94, DOI 10.4161/psb.5.2.10337; Nick P, 2009, PLANT PHYSIOL, V151, P155, DOI 10.1104/pp.109.140111; Qiao F, 2010, J EXP BOT, V61, P4021, DOI 10.1093/jxb/erq221; Qiao F, 2010, J EXP BOT, V61, P503, DOI 10.1093/jxb/erp319; Rahman A, 2007, PLANT J, V50, P514, DOI 10.1111/j.1365-313X.2007.03068.x; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Ressad F, 1998, J BIOL CHEM, V273, P20894, DOI 10.1074/jbc.273.33.20894; Savatin DV, 2011, PLANT PHYSIOL, V157, P1163, DOI 10.1104/pp.111.184663; Smertenko A, 2011, CELL DEATH DIFFER, V18, P1263, DOI 10.1038/cdd.2011.39; Smertenko A, 2014, PLANT CELL MONOGR, V22, P131, DOI 10.1007/978-3-642-41787-0_5; Spoel SH, 2008, CELL HOST MICROBE, V3, P348, DOI 10.1016/j.chom.2008.05.009; Stamp N, 2003, Q REV BIOL, V78, P23, DOI 10.1086/367580; Su H, 2007, J INTEGR PLANT BIOL, V49, P1183, DOI 10.1111/j.1672-9072.2007.00546.x; Tampakaki AP, 2010, ANNU REV PHYTOPATHOL, V48, P347, DOI 10.1146/annurev-phyto-073009-114407; Testerink C, 2011, J EXP BOT, V62, P2349, DOI 10.1093/jxb/err079; Tsuda K, 2010, CURR OPIN PLANT BIOL, V13, P459, DOI 10.1016/j.pbi.2010.04.006; Waller F, 1997, PROTOPLASMA, V200, P154, DOI 10.1007/BF01283291; Wang D, 2007, CURR BIOL, V17, P1784, DOI 10.1016/j.cub.2007.09.025; Wang J, 2001, J BIOL CHEM, V276, P47763, DOI 10.1074/jbc.C100415200; Weernink PAO, 2007, N-S ARCH PHARMACOL, V374, P399, DOI 10.1007/s00210-007-0131-4; WEI ZM, 1992, SCIENCE, V257, P85, DOI 10.1126/science.1621099; Wong HL, 2007, PLANT CELL, V19, P4022, DOI 10.1105/tpc.107.055624; Wu HM, 2011, PLANT CELL, V23, P1208, DOI 10.1105/tpc.111.083907; Zust T, 2011, P ROY SOC B-BIOL SCI, V278, P2598, DOI 10.1098/rspb.2010.2475	63	22	24	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125498	10.1371/journal.pone.0125498	http://dx.doi.org/10.1371/journal.pone.0125498			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933033	Green Published, Green Submitted, gold			2022-12-27	WOS:000353887100115
J	Chitete, L; Puoane, T				Chitete, Lusungu; Puoane, Thandi			What Health Service Provider Factors Are Associated with Low Delivery of HIV Testing to Children with Acute Malnutrition in Dowa District of Malawi?	PLOS ONE			English	Article							NUTRITION; CARE	Background The Community-based Management of Acute Malnutrition is the national program for treating acute malnutrition in Malawi. Under this program's guidelines all children enrolled should undergo an HIV test, so that those infected can receive appropriate treatment and care. However, the national data of 2012 shows a low delivery of testing. Prior studies have investigated client-related factors affecting uptake of HIV testing in Community-based Management of Acute Malnutrition program. Lacking is the information on the service provider factors that are associated with the delivery of testing. This study investigated service provider factors that affect delivery of HIV testing among children enrolled in the program and explored ways in which this could be improved. Methods A descriptive study that used qualitative methods of data collection. Client registers were reviewed to obtain the number of children enrolled in Community-based Management of Acute Malnutrition and the number of children who were tested for HIV over a 12-month period. In-depth interviews were conducted with Community-based Management of Acute Malnutrition and HIV Testing and Counselling focal persons to investigate factors affecting HIV test delivery. Descriptive statistics were used to analyze data from client registers. Information from interviews was analyzed using a thematic approach. Results Quantitative data revealed that 1738 (58%) of 2981 children enrolled in Community-based Management of Acute Malnutrition were tested for HIV. From in-depth interviews four themes emerged, that is, lack of resources for HIV tests; shortage of staff skilled in HIV testing and counseling; lack of commitment among staff in referring children for HIV testing; and inadequately trained staff. Conclusion There is a need for a functioning health system to help reduce child mortality resulting from HIV related conditions.	[Chitete, Lusungu; Puoane, Thandi] Univ Western Cape, Sch Publ Hlth, Cape Town, Western Cape Pr, South Africa	University of the Western Cape	Chitete, L (corresponding author), Univ Western Cape, Sch Publ Hlth, Cape Town, Western Cape Pr, South Africa.	Lusunguchitete@gmail.com						Annan RA, 2011, TREATMENT SEVERE ACU; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Bahwere P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-106; Fergusson P, 2010, MATERN CHILD NUTR, V6, P89, DOI 10.1111/j.1740-8709.2009.00191.x; GRAMLICH LM, 1995, J NUTR BIOCHEM, V6, P2, DOI 10.1016/0955-2863(94)00001-3; Hendricks MK, 2007, MATERN CHILD NUTR, V3, P322, DOI 10.1111/j.1740-8709.2007.00116.x; Jenniskens F, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1071; Lufesi NN, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-86; Makwiza I, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-13; Manongi Rachel N, 2006, Hum Resour Health, V4, P6, DOI 10.1186/1478-4491-4-6; Mccoy D, 2008, HUM RESOUR HEALTH, V6, DOI 10.1186/1478-4491-6-16; Ministry of Health, 2007, GUID PED HIV TEST CO; Ministry of Health, 2011, NAT CMAM DAT; Ministry of Health, INT GUID MAN AC MALN; National Statistical Office, 2010, DEM HLTH SURV; National Statistical Office, 2008, POP HOUS CENS; Palmer D, 2006, REPROD HEALTH MATTER, V14, P27, DOI 10.1016/S0968-8080(06)27244-6; Puoane T, 2006, Curationis, V29, P73; Thurstans S, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-22; UNAIDS, 2010, GLOB REP UNAIDS REP, DOI [10.1189/jlb.0811394, DOI 10.1189/JLB.0811394]	20	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0123021	10.1371/journal.pone.0123021	http://dx.doi.org/10.1371/journal.pone.0123021			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933164	gold, Green Published, Green Submitted			2022-12-27	WOS:000353887100012
J	Duan, WJ; Guo, PF; Gan, P				Duan, Wenjie; Guo, Pengfei; Gan, Pei			Relationships among Trait Resilience, Virtues, Post-traumatic Stress Disorder, and Post-traumatic Growth	PLOS ONE			English	Article							CONNOR-DAVIDSON RESILIENCE; SCALE CD-RISC; LIFE EVENTS; TRAUMA; CHINESE; PTSD; QUESTIONNAIRE; VALIDATION; CHARACTER; STRENGTHS	The present study aims to examine the relationship between trait resilience and virtues in the context of trauma. A total of 537 participants who attended the preliminary investigation and completed the Life Events Checklist were screened. Of these participants, 142 suffered from personal traumatic experiences in the past year; these individuals were qualified and invited to respond to online questionnaires to assess trait resilience, virtues (i.e., Conscientiousness, Vitality, and Relationship), post-traumatic stress disorder (PTSD) symptoms, and post-traumatic growth (PTG). The following questionnaires were used: Connor-Davidson Resilience Scale-Revised, Chinese Virtues Questionnaire, PTSD Checklist-Specific, and Post-traumatic Growth Inventory-Chinese. Only 95 participants who manifested self-reported PTSD symptoms and PTG were involved in the current analyses. Trauma was positively and significantly correlated with PTSD in the current sample. Results indicated that trait resilience was positively associated with virtues and PTG; by contrast, PTSD scores were negatively but not significantly related to most of these factors. The three virtues contributed to PTG to a greater extent than trait resilience in non-PTSD and PTSD groups. However, trait resilience remained a significant predictor in the PTSD group even when the three virtues were controlled. The relationship between trait resilience and PTG was moderated by PTSD type (non-PTSD group vs. PTSD group). Our results further suggested that trait resilience and virtues were conceptually related but functionally different constructs. Trait resilience and virtues are positively related; thus, these factors contributed variances to PTG in the context of trauma; however, trait resilience is only manifested when virtues are controlled and when individuals are diagnosed as PTSD. Furthermore, implications and limitations of this study are discussed.	[Duan, Wenjie] City Univ Hong Kong, Dept Appl Social Sci, Hong Kong, Hong Kong, Peoples R China; [Guo, Pengfei] Hosp TCM, Luzhou Med Coll, Luzhou, Sichuan, Peoples R China; [Gan, Pei] Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China	City University of Hong Kong; Southwest Medical University; Chongqing Medical University	Guo, PF (corresponding author), Hosp TCM, Luzhou Med Coll, Luzhou, Sichuan, Peoples R China.	lyzyydb@163.com	guo, peng/AAG-4052-2019; Guo, Peng/GWC-0572-2022; Duan, Wenjie/C-8722-2016	Duan, Wenjie/0000-0002-1251-3685				Agaibi CE, 2005, TRAUMA VIOLENCE ABUS, V6, P195, DOI 10.1177/1524838005277438; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; [Anonymous], 2014, PERSPECTIVES INTERSE, DOI [DOI 10.1007/978-94-017-8654-6_4, DOI 10.1037/A0019759]; Barton S, 2013, J TRAUMA STRESS, V26, P718, DOI 10.1002/jts.21863; Bensimon M, 2012, PERS INDIV DIFFER, V52, P782, DOI 10.1016/j.paid.2012.01.011; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Calhoun L.G., 2006, HDB POSTTRAUMATIC GR; Campbell-Sills L, 2007, J TRAUMA STRESS, V20, P1019, DOI 10.1002/jts.20271; Carver CS, 1998, J SOC ISSUES, V54, P245, DOI 10.1111/0022-4537.641998064; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Dekel S, 2011, J CLIN PSYCHOL, V67, P241, DOI 10.1002/jclp.20747; Duan W, 2012, HONG KONG J MENT HLT, V38, P24; Duan WJ, 2015, PEERJ, V3, DOI 10.7717/peerj.883; Duan WJ, 2015, J AM COLL HEALTH, V63, P32, DOI 10.1080/07448481.2014.963109; Duan WJ, 2014, J HAPPINESS STUD, V15, P1347, DOI 10.1007/s10902-013-9479-y; Duan WJ, 2013, RES SOCIAL WORK PRAC, V23, P336, DOI 10.1177/1049731513477214; Duan WJ, 2012, RES SOCIAL WORK PRAC, V22, P680, DOI 10.1177/1049731512450074; Fowers B., 2005, VIRTUE PYCHOLOGY PUR; Gehrke A, 2006, TRAUMATOLOGY, V12, P229, DOI DOI 10.1177/1534765606294992; Gosling SD, 2004, AM PSYCHOL, V59, P93, DOI 10.1037/0003-066X.59.2.93; Gray MJ, 2004, ASSESSMENT, V11, P330, DOI 10.1177/1073191104269954; Hagenaars MA, 2011, J AFFECT DISORDERS, V132, P192, DOI 10.1016/j.jad.2011.02.017; Hampson SE, 2008, HDB PERSONALITY THEO; Hayes A. F., 2013, INTRO MEDIATION MODE, DOI DOI 10.1111/JEDM.12050; Ho SMY, 2014, ROUTL STUD ETH MORAL, V28, P215; Ho SMY, 2004, PSYCHO-ONCOLOGY, V13, P377, DOI 10.1002/pon.758; Hutchinson AMK, 2011, HUMAN PURSUIT OF WELL-BEING: A CULTURAL APPROACH, P133, DOI 10.1007/978-94-007-1375-8_12; Iacoviello BM, 2009, COGNITIVE THER RES, V33, P187, DOI 10.1007/s10608-008-9197-7; Johnson RJ, 2007, APPL PSYCHOL-INT REV, V56, P428, DOI 10.1111/j.1464-0597.2007.00296.x; King DB, 2014, CAN PSYCHOL, V55, P240, DOI 10.1037/a0038087; Lepore SJ., 2006, HDB POSTTRAUMATIC GR, P24; McCrae RR, 2011, DESIGNING POSITIVE P, P193, DOI DOI 10.1093/ACPROF:OSO/9780195373585.003.0013; Niemiec R.M., 2013, WELL BEING CULTURES, DOI DOI 10.1007/978-94-007-4611-4_2; Ogle CM, 2013, CLIN PSYCHOL SCI, V1, P426, DOI 10.1177/2167702613485076; Peterson C, 2003, PSYCHOL SCI, V14, P381, DOI 10.1111/1467-9280.24482; Peterson C., 2006, J HAPPINESS STUD, V7, P289, DOI [10.1007/s10902-005-3645-9, DOI 10.1007/S10902-005-3645-9]; Peterson C., 2007, J POSIT PSYCHOL, V2, P149, DOI DOI 10.1080/17439760701228938; Peterson C, 2008, J TRAUMA STRESS, V21, P214, DOI 10.1002/jts.20332; PETERSON CHRISTOPHER, 2004, CHARACTER STRENGTHS; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Prati G, 2009, J LOSS TRAUMA, V14, P364, DOI 10.1080/15325020902724271; Robbins B. D., 2008, HUMANISTIC PSYCHOL, V36, P96, DOI [DOI 10.1080/08873260802110988, 10.1080/08873260802110988]; Seligman MEP, 2005, AM PSYCHOL, V60, P410, DOI 10.1037/0003-066X.60.5.410; Sumalla EC, 2009, CLIN PSYCHOL REV, V29, P24, DOI 10.1016/j.cpr.2008.09.006; Tang XQ, 2016, RES SOCIAL WORK PRAC, V26, P591, DOI 10.1177/1049731514557832; Tedeschi RG, 2004, PSYCHOL INQ, V15, P1, DOI 10.1207/s15327965pli1501_01; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Weathers F.W., 1993, PTSD CHECKLIST PCL R; Yang ZH, 2015, INT J PSYCHOL, V50, P128, DOI 10.1002/ijop.12081; Yehuda R, 2007, J TRAUMA STRESS, V20, P435, DOI 10.1002/jts.20260; Zhang YH, 2014, J MENT HEALTH, V23, P231, DOI 10.3109/09638237.2014.924050; [张永红 Zhang Yonghong], 2014, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V22, P470; Zhang YH, 2014, CHILD ADOL PSYCH MEN, V8, DOI 10.1186/1753-2000-8-8	54	53	58	5	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125707	10.1371/journal.pone.0125707	http://dx.doi.org/10.1371/journal.pone.0125707			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH2XA	25932954	Green Published, gold, Green Submitted			2022-12-27	WOS:000353887100128
J	Hatziagelaki, E; Herder, C; Tsiavou, A; Teichert, T; Chounta, A; Nowotny, P; Pacini, G; Dimitriadis, G; Roden, M				Hatziagelaki, Erifili; Herder, Christian; Tsiavou, Anastasia; Teichert, Tom; Chounta, Athina; Nowotny, Peter; Pacini, Giovanni; Dimitriadis, George; Roden, Michael			Serum Chemerin Concentrations Associate with Beta-Cell Function, but Not with Insulin Resistance in Individuals with Non-Alcoholic Fatty Liver Disease (NAFLD)	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; METABOLIC SYNDROME; DIABETES-MELLITUS; BARIATRIC SURGERY; NATURAL-HISTORY; ADIPOSE-TISSUE; WEIGHT-LOSS; OBESITY; SENSITIVITY; STEATOHEPATITIS	The novel adipokine chemerin has been related to insulin-resistant states such as obesity and non alcoholic fatty liver disease (NAFLD). However, its association with insulin resistance and beta cell function remains controversial. The main objective was to examine whether serum chemerin levels associate with insulin sensitivity and beta cell function independently of body mass index (BMI), by studying consecutive outpatients of the hepatology clinics of a European university hospital. Individuals (n=196) with NAFLD were stratified into persons with normal glucose tolerance (NGT; n=110), impaired glucose tolerance (IGT; n=51) and type 2 diabetes (T2D; n=35) and the association between serum chemerin and measures of insulin sensitivity and beta cell function as assessed during fasting and during oral glucose tolerance test (OGTT) was measured. Our results showed that serum chemerin positively associated with BMI (P=0.0007) and C peptide during OGTT (P<0.004), but not with circulating glucose, insulin, lipids or liver enzymes (all P>0.18). No BMI independent relationships of chemerin with fasting and OGTT derived measures of insulin sensitivity were found (P>0.5). Chemerin associated positively with fasting beta cell function as well as the OGTT derived insulinogenic index IGI_cp and the adaptation index after adjustment for age, sex and BMI (P=0.002-0.007), and inversely with the insulin/C peptide ratio (P=0.007). Serum chemerin neither related to the insulinogenic index IGI_ins nor the disposition index. In conclusion, circulating chemerin is likely linked to enhanced beta cell function but not to insulin sensitivity in patients with NAFLD.	[Hatziagelaki, Erifili; Tsiavou, Anastasia; Dimitriadis, George] Univ Athens, Attikon Univ Gen Hosp, Res Inst, Dept Internal Med 2, Athens, Greece; [Hatziagelaki, Erifili; Tsiavou, Anastasia; Dimitriadis, George] Univ Athens, Attikon Univ Gen Hosp, Ctr Diabet, Athens, Greece; [Herder, Christian; Teichert, Tom; Nowotny, Peter; Roden, Michael] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany; [Herder, Christian; Teichert, Tom; Nowotny, Peter; Roden, Michael] German Ctr Diabet Res, Partner Dusseldorf, Dusseldorf, Germany; [Chounta, Athina] Attikon Univ Gen Hosp, Dept Internal Med 4, Athens, Greece; [Pacini, Giovanni] CNR, Inst Neurosci, Metab Unit, Padua, Italy; [Roden, Michael] Univ Hosp Dusseldorf, Dept Endocrinol & Diabetol, Dusseldorf, Germany	National & Kapodistrian University of Athens; University Hospital Attikon; National & Kapodistrian University of Athens; University Hospital Attikon; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; University Hospital Attikon; Consiglio Nazionale delle Ricerche (CNR); Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital	Roden, M (corresponding author), Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany.	michael.roden@ddz.uni-duesseldorf.de	Roden, Michael/AAD-3843-2019		German Federal Ministry of Health (Berlin, Germany); Ministry of Innovation, Science and Research of the State of North Rhine Westphalia (Dusseldorf, Germany); German Federal Ministry of Education and Research (BMBF); Helmholtz Alliance Imaging and Curing Environmental Metabolic Diseases (ICEMED)	German Federal Ministry of Health (Berlin, Germany); Ministry of Innovation, Science and Research of the State of North Rhine Westphalia (Dusseldorf, Germany); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Helmholtz Alliance Imaging and Curing Environmental Metabolic Diseases (ICEMED)	The German Diabetes Center is funded by the German Federal Ministry of Health (Berlin, Germany) and the Ministry of Innovation, Science and Research of the State of North Rhine Westphalia (Dusseldorf, Germany). This study was supported in part by grants from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.) and from the Helmholtz Alliance Imaging and Curing Environmental Metabolic Diseases (ICEMED). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Alfadda AA, 2012, MOL CELLS, V33, P591, DOI 10.1007/s10059-012-0012-7; Bozaoglu K, 2007, ENDOCRINOLOGY, V148, P4687, DOI 10.1210/en.2007-0175; Bozaoglu K, 2009, J CLIN ENDOCR METAB, V94, P3085, DOI 10.1210/jc.2008-1833; Catalan V, 2013, SURG OBES RELAT DIS, V9, P306, DOI 10.1016/j.soard.2011.11.001; Chakaroun R, 2012, METABOLISM, V61, P706, DOI 10.1016/j.metabol.2011.10.008; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Chu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034710; Docke S, 2013, EUR J ENDOCRINOL, V169, P547, DOI 10.1530/EJE-13-0112; Dong BK, 2011, INTERNAL MED, V50, P1093, DOI 10.2169/internalmedicine.50.5025; El-Mesallamy HO, 2011, DIABETIC MED, V28, P1194, DOI 10.1111/j.1464-5491.2011.03353.x; Emanuel E, 2008, HEPATOLOGY, V48, P2086, DOI 10.1002/hep.22622; Ernst MC, 2010, TRENDS ENDOCRIN MET, V21, P660, DOI 10.1016/j.tem.2010.08.001; Ernst MC, 2010, ENDOCRINOLOGY, V151, P1998, DOI 10.1210/en.2009-1098; Fatima SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057113; Genuth S, 2003, DIABETES CARE, V26, P3160; Jialal I, 2013, J CLIN ENDOCR METAB, V98, pE514, DOI 10.1210/jc.2012-3673; Kim SH, 2014, CLIN ENDOCRINOL, V80, P825, DOI 10.1111/cen.12249; Kloting N, 2010, AM J PHYSIOL-ENDOC M, V299, pE506, DOI 10.1152/ajpendo.00586.2009; Kralisch S, 2009, REGUL PEPTIDES, V154, P102, DOI 10.1016/j.regpep.2009.02.010; Kukla M, 2010, SCAND J GASTROENTERO, V45, P235, DOI 10.3109/00365520903443852; Landgraf K, 2012, J CLIN ENDOCR METAB, V97, pE556, DOI 10.1210/jc.2011-2937; Lehrke M, 2009, EUR J ENDOCRINOL, V161, P339, DOI 10.1530/EJE-09-0380; Lin XH, 2012, CLIN LAB, V58, P539; Mari A, 2001, DIABETES CARE, V24, P539, DOI 10.2337/diacare.24.3.539; Meder W, 2003, FEBS LETT, V555, P495, DOI 10.1016/S0014-5793(03)01312-7; Ouwens DM, 2012, ARCH PHYSIOL BIOCHEM, V118, P135, DOI 10.3109/13813455.2012.654800; Pacini G, 2003, BEST PRACT RES CL EN, V17, P305, DOI 10.1016/S1521-690X(03)00042-3; Pfau D, 2010, DIABETES CARE, V33, P171, DOI 10.2337/dc09-1351; Pinto HC, 1996, DIGEST DIS SCI, V41, P172, DOI 10.1007/BF02208601; POWELL EE, 1990, HEPATOLOGY, V11, P74, DOI 10.1002/hep.1840110114; Ress C, 2010, EUR J CLIN INVEST, V40, P277, DOI 10.1111/j.1365-2362.2010.02255.x; Sell H, 2010, J CLIN ENDOCR METAB, V95, P2892, DOI 10.1210/jc.2009-2374; Shin HY, 2012, CLIN ENDOCRINOL, V77, P47, DOI 10.1111/j.1365-2265.2011.04217.x; Stefanov T, 2014, ENDOCRINE, V45, P382, DOI 10.1007/s12020-013-0003-2; Stepan H, 2011, REGUL PEPTIDES, V168, P69, DOI 10.1016/j.regpep.2011.03.005; Tabak AG, 2009, LANCET, V373, P2215, DOI 10.1016/S0140-6736(09)60619-X; Takahashi M, 2008, FEBS LETT, V582, P573, DOI 10.1016/j.febslet.2008.01.023; Takahashi M, 2013, ENDOCR J, V60, P37, DOI 10.1507/endocrj.EJ12-0201; Takahashi M, 2011, SCI REP-UK, V1, DOI 10.1038/srep00123; Tura A, 2006, DIABETES RES CLIN PR, V72, P298, DOI 10.1016/j.diabres.2005.10.005; Yan Q, 2012, ENDOCRINE, V41, P281, DOI 10.1007/s12020-011-9550-6; Yilmaz Y, 2011, SCAND J GASTROENTERO, V46, P91, DOI 10.3109/00365521.2010.516452; Yilmaz Y, 2009, WORLD J GASTROENTERO, V15, P4346, DOI 10.3748/wjg.15.4346; Yoshimura T, 2008, J EXP MED, V205, P2187, DOI 10.1084/jem.20081736; Zabel BA, 2005, J BIOL CHEM, V280, P34661, DOI 10.1074/jbc.M504868200	46	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124935	10.1371/journal.pone.0124935	http://dx.doi.org/10.1371/journal.pone.0124935			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933030	Green Submitted, Green Published, gold			2022-12-27	WOS:000353887100066
J	Kryst, J; Kawalec, P; Pilc, A				Kryst, Joanna; Kawalec, Pawel; Pilc, Andrzej			Efavirenz-Based Regimens in Antiretroviral-Naive HIV-Infected Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Review							REVERSE-TRANSCRIPTASE INHIBITORS; ELVITEGRAVIR/COBICISTAT/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE; ONCE-DAILY DOLUTEGRAVIR; OPEN-LABEL TRIAL; COMBINATION THERAPY; INITIAL TREATMENT; DOUBLE-BLIND; BOOSTED ATAZANAVIR; PROTEASE INHIBITOR; POSITIVE PATIENTS	Efavirenz, a non-nucleoside reverse-transcriptase inhibitor (NNRTI) is one of the most commonly prescribed antiretroviral drugs. The present article provides a systematic overview and meta-analysis of clinical trials comparing efavirenz and other active drugs currently recommended for treatment of HIV-infected, antiretroviral-naive patients. Electronic databases (Pubmed, Embase, the Cochrane Library, Trip Database) were searched up till 23 December 2013 for randomized controlled clinical trials published as a peer-reviewed papers, and concerning efavirenz-based regimens used as initial treatment for HIV infection. Thirty-four studies were included in the systematic review, while twenty-six trials were suitable for the meta-analysis. Efavirenz was compared with drugs from four different classes: NNRTIs other than efavirenz (nevirapine or rilpivirine), integrase strand transfer inhibitors (InSTIs), ritonavir-boosted protease inhibitors (bPI) and chemokine (C-C motif) receptor 5 (CCR5) antagonists (maraviroc), all of them were added to the background regimen. Results of the current meta-analysis showed that efavirenz-based regimens were equally effective as other recommended regimens based on NNRTI, ritonavir-boosted PI or CCR5 antagonist in terms of efficacy outcomes (disease progression and/or death, plasma viral HIV RNA <50 copies/ml) while statistically significant more patients treated with InSTI achieved plasma viral load <50 copies/ml at week 48. In comparison with both InSTI-based and CCR5-based therapy, efavirenz-based treatment was associated with a higher risk of therapy discontinuation due to adverse events. However, comparisons of efevirenz-based treatment with InSTI-based and CCR5-based therapy were based on a limited number of trials, therefore, conclusions from these two comparisons must be confirmed in further reliable randomized controlled studies. Results of our meta-analysis support the present clinical guidelines for antiretroviral-naive, HIV-infected patients, in which efavirenz is one of the most preferred regimens in the analyzed population. Beneficial safety profile of InSTI-based and CCR5-based therapy over efavirenz-based treatment needs further studies.	[Kawalec, Pawel] Jagiellonian Univ, Fac Hlth Sci, Inst Publ Hlth, Drug Management Dept, Krakow, Poland; [Pilc, Andrzej] Polish Acad Sci, Inst Pharmacol, Dept Neurobiol, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University; Polish Academy of Sciences	Kawalec, P (corresponding author), Jagiellonian Univ, Fac Hlth Sci, Inst Publ Hlth, Drug Management Dept, Krakow, Poland.	pawel.kawalec@uj.edu.pl	Pilc, Andrzej/A-3948-2008	Pilc, Andrzej/0000-0002-4045-0597; Kryst, Joanna/0000-0003-4516-8723				Albert JM, 1998, STAT MED, V17, P2435, DOI 10.1002/(SICI)1097-0258(19981115)17:21&lt;2435::AID-SIM994&gt;3.3.CO;2-7; Albini L, 2012, JAIDS-J ACQ IMM DEF, V59, P18, DOI 10.1097/QAI.0b013e31823a6124; Andersson LM, 2013, SCAND J INFECT DIS, V45, P543, DOI 10.3109/00365548.2012.756985; Ayala Gaytan JJ, 2004, MED INT MEX, V20, P29; Bartlett JA, 2006, JAIDS-J ACQ IMM DEF, V43, P284, DOI 10.1097/01.qai.0000243092.40490.26; Bartlett JA, 2007, HIV CLIN TRIALS, V8, P221, DOI 10.1310/hct0804-221; Cameron DW, 2008, J INFECT DIS, V198, P234, DOI 10.1086/589622; Chou R, 2006, LANCET, V368, P1503, DOI 10.1016/S0140-6736(06)69638-4; Clotet B, 2014, LANCET, V383, P2222, DOI 10.1016/S0140-6736(14)60084-2; Cohen C, 2011, AIDS, V25, pF7, DOI 10.1097/QAD.0b013e328345766f; Cohen CJ, 2011, LANCET, V378, P229, DOI 10.1016/S0140-6736(11)60983-5; Cooper DA, 2010, J INFECT DIS, V201, P803, DOI 10.1086/650697; Crabb C, 2006, AIDS, V20, P641, DOI 10.1097/01.aids.0000216362.59657.96; Currier J, 2008, ANTIVIR THER, V13, P297; Daar ES, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-7-201104050-00316; Decloedt EH, 2013, EXPERT OPIN DRUG SAF, V12, P841, DOI 10.1517/14740338.2013.823396; Echeverria P, 2010, ANTIVIR RES, V85, P403, DOI 10.1016/j.antiviral.2009.11.008; Eden A, 2010, AIDS RES HUM RETROV, V26, P533, DOI 10.1089/aid.2009.0177; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gazzard B, 2011, AIDS, V25, P2249, DOI 10.1097/QAD.0b013e32834c4c06; Gazzard B, 2010, AIDS REV, V12, P67; Gulick RM, 2004, NEW ENGL J MED, V350, P1850, DOI 10.1056/NEJMoa031772; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Honda M, 2011, INTERNAL MED, V50, P699, DOI 10.2169/internalmedicine.50.4572; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Josephson F, 2010, EUR J CLIN PHARMACOL, V66, P349, DOI 10.1007/s00228-009-0763-z; Kawalec P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076587; Kenedi CA, 2011, AIDS BEHAV, V15, P1803, DOI 10.1007/s10461-011-9939-5; Kumar P, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-269; Landovitz RJ, 2008, J INFECT DIS, V198, P1113, DOI 10.1086/592052; Lennox JL, 2010, JAIDS-J ACQ IMM DEF, V55, P39, DOI 10.1097/QAI.0b013e3181da1287; Lennox JL, 2009, LANCET, V374, P796, DOI 10.1016/S0140-6736(09)60918-1; MacArthur RD, 2006, LANCET, V368, P2125, DOI 10.1016/S0140-6736(06)69861-9; Mallolas J, 2008, AIDS, V22, P377, DOI 10.1097/QAD.0b013e3282f3db2c; Markowitz M, 2007, JAIDS-J ACQ IMM DEF, V46, P125, DOI 10.1097/QAI.0b013e318157131c; Markowitz M, 2009, JAIDS-J ACQ IMM DEF, V52, P350, DOI 10.1097/QAI.0b013e3181b064b0; Mbuagbaw LCE, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004246.pub3; Miro JM, 2010, AIDS RES HUM RETROV, V26, P747, DOI 10.1089/aid.2009.0105; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Molina JM, 2011, LANCET, V378, P238, DOI 10.1016/S0140-6736(11)60936-7; Mollan KR, 2014, ANN INTERN MED, V161, P1, DOI 10.7326/M14-0293; Murphy EL, 2001, ANN INTERN MED, V135, P17, DOI 10.7326/0003-4819-135-1-200107030-00005; Napoli AA, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19214; Nelson M, 2011, AIDS, V25, P335, DOI 10.1097/QAD.0b013e3283416873; Nunez Marina, 2002, HIV Clin Trials, V3, P186; Panel on Antiretroviral Guidelines for Adults and Adolescents, GUIDELINES FOR THE U; Pillay P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068995; Pozniak AL, 2010, AIDS, V24, P55, DOI 10.1097/QAD.0b013e32833032ed; Pulido F, 2012, AIDS REV, V14, P124; Puls RL, 2010, CLIN INFECT DIS, V51, P855, DOI 10.1086/656363; Raboud JM, 2000, J ACQ IMMUN DEF SYND, V24, P433, DOI 10.1097/00126334-200008150-00006; Raboud JM, 1998, AIDS, V12, P1619, DOI 10.1097/00002030-199813000-00008; Ratsela A, 2010, J INFECT DIS, V202, P1529, DOI 10.1086/656718; Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609; Sax PE, 2012, LANCET, V379, P2439, DOI 10.1016/S0140-6736(12)60917-9; Shubber Z, 2013, AIDS, V27, P1403, DOI 10.1097/QAD.0b013e32835f1db0; Siegfried NL, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004535; Sierra-Madero J, 2010, HIV CLIN TRIALS, V11, P127, DOI 10.1310/hct1103-125; Sierra-Madero J, 2010, JAIDS-J ACQ IMM DEF, V53, P582, DOI 10.1097/QAI.0b013e3181cae4a1; Smith C, 2014, J INT AIDS SOC, V17, P17, DOI 10.7448/IAS.17.4.19512; Stellbrink HJ, 2013, AIDS, V27, P1771, DOI 10.1097/QAD.0b013e3283612419; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Torti C, 2005, ANTIVIR THER, V10, P505; Torti C, 2008, CURR HIV RES, V6, P43, DOI 10.2174/157016208783571982; van den Berg-Wolf M, 2008, HIV CLIN TRIALS, V9, P324, DOI 10.1310/hct0905-324; van Leth F, 2004, LANCET, V363, P1253, DOI 10.1016/S0140-6736(04)15997-7; van Lunzen J, 2012, LANCET INFECT DIS, V12, P111, DOI 10.1016/S1473-3099(11)70290-0; Vernazza P, 2013, JAIDS-J ACQ IMM DEF, V62, P171, DOI [10.1097/QAI.0b013e31827a2ba2., 10.1097/QAI.0b013e31827a2ba2]; Vrouenraets SME, 2007, EXPERT OPIN PHARMACO, V8, P851, DOI 10.1517/14656566.8.6.851; Walmsley SL, 2013, NEW ENGL J MED, V369, P1807, DOI 10.1056/NEJMoa1215541; Wester CW, 2010, AIDS, V24, pS27, DOI 10.1097/01.aids.0000366080.91192.55; World Health Organization, 2013, CONSOLIDATED GUIDELI; Zolopa A, 2013, JAIDS-J ACQ IMM DEF, V63, P96, DOI 10.1097/QAI.0b013e318289545c	74	21	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124279	10.1371/journal.pone.0124279	http://dx.doi.org/10.1371/journal.pone.0124279			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933004	gold, Green Published, Green Submitted			2022-12-27	WOS:000353887100038
J	Sadiq, MW; Uchida, Y; Hoshi, Y; Tachikawa, M; Terasaki, T; Hammarlund-Udenaes, M				Sadiq, Muhammad Waqas; Uchida, Yasuo; Hoshi, Yutaro; Tachikawa, Masanori; Terasaki, Tetsuya; Hammarlund-Udenaes, Margareta			Validation of a P-Glycoprotein (P-gp) Humanized Mouse Model by Integrating Selective Absolute Quantification of Human MDR1, Mouse Mdr1a and Mdr1b Protein Expressions with In Vivo Functional Analysis for Blood-Brain Barrier Transport	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; CAPILLARY ENDOTHELIAL-CELLS; KNOCKOUT MICE; SPECIES-DIFFERENCES; ACTIVE UPTAKE; VITRO; PHARMACOKINETICS; OXYCODONE; PHARMACODYNAMICS; PROTEOMICS	It is essential to establish a useful validation method for newly generated humanized mouse models. The novel approach of combining our established species-specific protein quantification method combined with in vivo functional studies is evaluated to validate a humanized mouse model of P-gp/MDR1 efflux transporter. The P-gp substrates digoxin, verapamil and docetaxel were administered to male FVB Mdr1a/1b(+/+) (FVB WT), FVB Mdr1a/1b(-/-) (Mdr1a/1b(-/-)), C57BL/6 Mdr1a/1b(+/+) (C57BL/6 WT) and humanized C57BL (hMDR1) mice. Brain-to-plasma total concentration ratios (K-p) were measured. Quantitative targeted absolute proteomic (QTAP) analysis was used to selectively quantify the protein expression levels of hMDR1, Mdr1a and Mdr1b in the isolated brain capillaries. The protein expressions of other transporters, receptors and claudin-5 were also quantified. The K-p for digoxin, verapamil, and docetaxel were 20, 30 and 4 times higher in the Mdr1a/1b(-/-) mice than in the FVB WT controls, as expected. The K-p for digoxin, verapamil and docetaxel were 2, 16 and 2-times higher in the hMDR1 compared to the C57BL/6 WT mice. The hMDR1 mice had 63- and 9.1-fold lower expressions of the hMDR1 and Mdr1a proteins than the corresponding expression of Mdr1a in C57BL/6 WT mice, respectively. The protein expression levels of other molecules were almost consistent between C57BL/6 WT and hMDR1 mice. The P-gp function at the BBB in the hMDR1 mice was smaller than that in WT mice due to lower protein expression levels of hMDR1 and Mdr1a. The combination of QTAP and in vivo functional analyses was successfully applied to validate the humanized animal model and evaluates its suitability for further studies.	[Sadiq, Muhammad Waqas; Hammarlund-Udenaes, Margareta] Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden; [Uchida, Yasuo; Hoshi, Yutaro; Tachikawa, Masanori; Terasaki, Tetsuya] Tohoku Univ, Grad Sch Pharmaceut Sci, Div Membrane Transport & Drug Targeting, Aoba Ku, Sendai, Miyagi 980, Japan	Uppsala University; Tohoku University	Sadiq, MW (corresponding author), Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden.	waqas.sadiq@farmbio.uu.se	Sadiq, Waqas/ABC-3309-2021; Terasaki, Tetsuya/K-6730-2012	Sadiq, Waqas/0000-0002-6112-2971; Terasaki, Tetsuya/0000-0002-6332-7575	Higher Education Commission, Pakistan	Higher Education Commission, Pakistan(Higher Education Commission of Pakistan)	Britt Jansson and Jessica Dunhall are acknowledged for technical support during in vivo experiments. Karolina Nilsson and Thao Bui are also acknowledged for their contribution. Higher Education Commission, Pakistan is gratefully acknowledged for the scholarship of Muhammad Waqas Sadiq.	Agarwal S, 2012, DRUG METAB DISPOS, V40, P1164, DOI 10.1124/dmd.112.044719; Banker MJ, 2003, J PHARM SCI-US, V92, P967, DOI 10.1002/jps.10332; Bostrom E, 2005, J PHARM SCI-US, V94, P1060, DOI 10.1002/jps.20327; Bostrom E, 2006, DRUG METAB DISPOS, V34, P1624, DOI 10.1124/dmd.106.009746; Chen CP, 2003, CURR DRUG METAB, V4, P272, DOI 10.2174/1389200033489415; CHOKSAKULNIMITR S, 1995, J CONTROL RELEASE, V34, P233, DOI 10.1016/0168-3659(95)00007-U; Cutler L, 2006, J PHARM SCI-US, V95, P1944, DOI 10.1002/jps.20658; Friden M, 2007, DRUG METAB DISPOS, V35, P1711, DOI 10.1124/dmd.107.015222; Friden M, 2011, DRUG METAB DISPOS, V39, P353, DOI 10.1124/dmd.110.035998; Friden M, 2010, J CEREBR BLOOD F MET, V30, P150, DOI 10.1038/jcbfm.2009.200; Friden M, 2009, DRUG METAB DISPOS, V37, P1226, DOI 10.1124/dmd.108.026377; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; Hammarlund-Udenaes M, 2008, PHARM RES-DORDR, V25, P1737, DOI 10.1007/s11095-007-9502-2; Hendrikse NH, 1998, BRIT J PHARMACOL, V124, P1413, DOI 10.1038/sj.bjp.0701979; Hogan BLM, 1994, MANIPULATING MOUSE E, P253, DOI [10. 1007/ 978- 1- 60327- 019- 9_ 13 PMID: 19504073, DOI 10.1007/978-1-60327-019-9_]; HSU SIH, 1989, J BIOL CHEM, V264, P12053; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Kamiie J, 2008, PHARM RES-DORDR, V25, P1469, DOI 10.1007/s11095-008-9532-4; Katoh M, 2006, J PHARM SCI-US, V95, P2673, DOI 10.1002/jps.20686; KEILHOFF G, 1993, NEUROREPORT, V5, P129, DOI 10.1097/00001756-199311180-00008; Kemper EM, 2004, EUR J CANCER, V40, P1269, DOI 10.1016/j.ejca.2004.01.024; Lagas JS, 2009, MOL INTERV, V9, P136, DOI 10.1124/mi.9.3.7; Loryan I, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-6; Sadiq MW, 2013, J PHARM SCI-US, V102, P3320, DOI 10.1002/jps.23492; Sadiq MW, 2011, J PHARM SCI-US, V100, P3912, DOI 10.1002/jps.22567; Sasongko L, 2005, CLIN PHARMACOL THER, V77, P503, DOI 10.1016/j.clpt.2005.01.022; Scheer N, 2008, J CLIN INVEST, V118, P3228, DOI 10.1172/JCI35483; Schinkel AH, 1999, ADV DRUG DELIVER REV, V36, P179, DOI 10.1016/S0169-409X(98)00085-4; Schinkel AH, 1998, INT J CLIN PHARM TH, V36, P9; SCHINKEL AH, 1994, CELL, V77, P491, DOI 10.1016/0092-8674(94)90212-7; SCHINKEL AH, 1995, J CLIN INVEST, V96, P1698, DOI 10.1172/JCI118214; Syvanen S, 2009, DRUG METAB DISPOS, V37, P635, DOI 10.1124/dmd.108.024745; TSUJI A, 1992, LIFE SCI, V51, P1427, DOI 10.1016/0024-3205(92)90537-Y; Uchida Y, 2011, J NEUROCHEM, V117, P333, DOI 10.1111/j.1471-4159.2011.07208.x	34	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0118638	10.1371/journal.pone.0118638	http://dx.doi.org/10.1371/journal.pone.0118638			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932627	Green Published, gold, Green Submitted			2022-12-27	WOS:000353887100001
J	Schechtman, H; Souza, MO				Schechtman, Helio; Souza, Max O.			Costly Inheritance and the Persistence of Insecticide Resistance in Aedes aegypti Populations	PLOS ONE			English	Article							LIFE TABLE MODEL; GLOBAL DISTRIBUTION; ALBOPICTUS DIPTERA; CONTROL STRATEGIES; LUCILIA-CUPRINA; SODIUM-CHANNEL; VECTOR CONTROL; FITNESS COSTS; DENGUE; CULICIDAE	Global emergence of arboviruses is a growing public health concern, since most of these diseases have no vaccine or prevention treatment available. In this scenario, vector control through the use of chemical insecticides is one of the most important prevention tools. Nevertheless, their effectiveness has been increasingly compromised by the development of strong resistance observed in field populations, even in spite of fitness costs usually associated to resistance. Using a stage-structured deterministic model parametrised for the Aedes aegypti-the main vector for dengue-we investigated the persistence of resistance by studying the time for a population which displays resistance to insecticide to revert to a susceptible population. By means of a comprehensive series of in-silico experiments, we studied this reversal time as a function of fitness costs and the initial presence of the resistance allele in the population. The resulting map provides both a guiding and a surveillance tool for public health officers to address the resistance situation of field populations. Application to field data from Brazil indicates that reversal can take, in some cases, decades even if fitness costs are not small. As by-products of this investigation, we were able to fit very simple formulas to the reversal times as a function of either cost or initial presence of the resistance allele. In addition, the in-silico experiments also showed that density dependent regulation plays an important role in the dynamics, slowing down the reversal process.	[Schechtman, Helio] Fundacao Oswaldo Cruz, Programa Comp Cient, Rio De Janeiro, RJ, Brazil; [Souza, Max O.] Univ Fed Fluminense, Dept Matemat Aplicada, Niteroi, RJ, Brazil	Fundacao Oswaldo Cruz; Universidade Federal Fluminense	Schechtman, H (corresponding author), Fundacao Oswaldo Cruz, Programa Comp Cient, Rio De Janeiro, RJ, Brazil.	h.schechtman@fiocruz.br	Souza, Max/V-6908-2019; Souza, Max O/B-6399-2008; Schechtman, Helio/Q-5269-2019	Souza, Max/0000-0001-8200-1899; Souza, Max O/0000-0001-8200-1899; Schechtman, Helio/0000-0002-8753-4579	CNPq [308113/2012-8]; PRONEX Dengue, under CNPq [550030/2010-7]; CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PRONEX Dengue, under CNPq; CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	MOS was partially supported by CNPq under grant # 308113/2012-8. HS and MOS were partially supported by the PRONEX Dengue, under CNPq grant # 550030/2010-7. This work was supported by CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrera R, 2006, J MED ENTOMOL, V43, P484, DOI 10.1603/0022-2585(2006)43[484:EFIAAD]2.0.CO;2; Bedhomme S, 2003, J EVOLUTION BIOL, V16, P721, DOI 10.1046/j.1420-9101.2003.00576.x; Belinato TA, 2012, MEM I OSWALDO CRUZ, V107, P916, DOI 10.1590/S0074-02762012000700013; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Linss JGB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-25; Braks MAH, 2004, ANN ENTOMOL SOC AM, V97, P130, DOI 10.1603/0013-8746(2004)097[0130:ICBTIS]2.0.CO;2; Brito LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060878; Brogdon WG, 1998, EMERG INFECT DIS, V4, P605, DOI 10.3201/eid0404.980410; Burattini MN, 2008, EPIDEMIOL INFECT, V136, P309, DOI 10.1017/S0950268807008667; Caminade C, 2012, J R SOC INTERFACE, V9, P2708, DOI 10.1098/rsif.2012.0138; Castaneda LE, 2011, PHYSIOL ENTOMOL, V36, P253, DOI 10.1111/j.1365-3032.2011.00793.x; CDC, 2012, GEOGR DISTR CHIK VIR; Chan HH, 2013, J MED ENTOMOL, V50, P362, DOI 10.1603/ME12182; Charlesworth B., 1994, EVOLUTION AGE STRUCT, DOI [10.1017/CBO9780511525711, DOI 10.1017/CBO9780511525711]; Christophers, 1960, AEDES AEGYPTI L YELL; Churcher TS, 2006, J ANIM ECOL, V75, P1313, DOI 10.1111/j.1365-2656.2006.01154.x; David MR, 2012, THESIS FUNDACAO O CR; Du YZ, 2013, P NATL ACAD SCI USA, V110, P11785, DOI 10.1073/pnas.1305118110; Duerr HP, 2005, TRENDS PARASITOL, V21, P88, DOI 10.1016/j.pt.2004.11.011; Ewens WJ., 2004, MATH POPULATION GENE, V1, P1; FOCKS DA, 1993, J MED ENTOMOL, V30, P1003, DOI 10.1093/jmedent/30.6.1003; FOCKS DA, 1993, J MED ENTOMOL, V30, P1018, DOI 10.1093/jmedent/30.6.1018; Garcia GdA, 2012, THESIS FUNDACAO O CR; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Guillemaud T, 1998, EVOLUTION, V52, P443, DOI [10.2307/2411080, 10.1111/j.1558-5646.1998.tb01644.x]; Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Hoppensteadt F, 1975, REGIONAL C SERIES AP; IRAC, 2014, ARTHR PEST RES DAT; Jaramillo N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096379; Juliano SA, 2007, J AM MOSQUITO CONTR, V23, P265, DOI 10.2987/8756-971X(2007)23[265:PD]2.0.CO;2; Kliot A, 2012, PEST MANAG SCI, V68, P1431, DOI 10.1002/ps.3395; Labbe P, 2007, PLOS GENET, V3, P2190, DOI 10.1371/journal.pgen.0030205; Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646; Luz PM, 2009, EPIDEMIOL INFECT, V137, P1203, DOI 10.1017/S0950268808001799; Luz PM, 2011, LANCET, V377, P1673, DOI 10.1016/S0140-6736(11)60246-8; Martins AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031889; Martins AJ, 2009, AM J TROP MED HYG, V81, P108, DOI 10.4269/ajtmh.2009.81.108; MCKENZIE JA, 1980, AUST J BIOL SCI, V33, P85, DOI 10.1071/BI9800085; MCKENZIE JA, 1982, HEREDITY, V49, P1, DOI 10.1038/hdy.1982.60; Ministerio da Saude, 2006, REUN TECN DISC STAT; NEWTON EAC, 1992, AM J TROP MED HYG, V47, P709, DOI 10.4269/ajtmh.1992.47.709; Norrby R, 2014, CLIN MICROBIOL INFEC, V20, P92, DOI 10.1111/1469-0691.12442; Norton HTJ, 1928, P LOND MATH SOC, V28, P1, DOI 10.1112/plms/s2-28.1.1; Ocampo CB, 2011, ACTA TROP, V118, P37, DOI 10.1016/j.actatropica.2011.01.007; Oki M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001367; Otero M, 2006, B MATH BIOL, V68, P1945, DOI 10.1007/s11538-006-9067-y; Petersen LR, 2012, NEW ENGL J MED, V367, P1281, DOI 10.1056/NEJMp1210537; Poupardin R, 2008, INSECT BIOCHEM MOLEC, V38, P540, DOI 10.1016/j.ibmb.2008.01.004; Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471; Powers AM, 2010, CLIN LAB MED, V30, P209, DOI 10.1016/j.cll.2009.10.003; Rajapakse S, 2010, T ROY SOC TROP MED H, V104, P89, DOI 10.1016/j.trstmh.2009.07.031; Rivero A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001000; SOUTHWOOD T R E, 1972, Bulletin of the World Health Organization, V46, P211; Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008; Whalon ME, 2008, GLOBAL PESTICIDE RESISTANCE IN ARTHROPODS, P1, DOI 10.1079/9781845933531.0000; WHO, 2014, PEST EV SCHEM WHOPES; World Health Organization (WHO), 2014, DENG VACC RES; Yang HM, 2009, EPIDEMIOL INFECT, V137, P1188, DOI 10.1017/S0950268809002040	59	20	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0123961	10.1371/journal.pone.0123961	http://dx.doi.org/10.1371/journal.pone.0123961			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933383	Green Published, gold, Green Submitted			2022-12-27	WOS:000353887100027
J	Whitacre, DC; Espinosa, DA; Peters, CJ; Jones, JE; Tucker, AE; Peterson, DL; Zavala, FP; Milich, DR				Whitacre, David C.; Espinosa, Diego A.; Peters, Cory J.; Jones, Joyce E.; Tucker, Amy E.; Peterson, Darrell L.; Zavala, Fidel P.; Milich, David R.			P. falciparum and P. vivax Epitope-Focused VLPs Elicit Sterile Immunity to Blood Stage Infections	PLOS ONE			English	Article							HEPATITIS-B SURFACE; PREERYTHROCYTIC MALARIA VACCINES; PLASMODIUM-FALCIPARUM; CIRCUMSPOROZOITE-PROTEIN; CELL RECOGNITION; EFFICACY; PROTECTION; CANDIDATE; ANTIGEN; RODENT	In order to design P. falciparum preerythrocytic vaccine candidates, a library of circumsporozoite (CS) T and B cell epitopes displayed on the woodchuck hepatitis virus core antigen (WHcAg) VLP platform was produced. To test the protective efficacy of the WHcAg-CS VLPs, hybrid CS P. berghei/P. falciparum (Pb/Pf) sporozoites were used to challenge immunized mice. VLPs carrying 1 or 2 different CS repeat B cell epitopes and 3 VLPs carrying different CS non-repeat B cell epitopes elicited high levels of anti-insert antibodies (Abs). Whereas, VLPs carrying CS repeat B cell epitopes conferred 98% protection of the liver against a 10,000 Pb/Pf sporozoite challenge, VLPs carrying the CS non-repeat B cell eptiopes were minimally-to-non-protective. One-to-three CS-specific CD4/CD8 T cell sites were also fused to VLPs, which primed CS-specific as well as WHcAg-specific T cells. However, a VLP carrying only the 3 T cell domains failed to protect against a sporozoite challenge, indicating a requirement for anti-CS repeat Abs. A VLP carrying 2 CS repeat B cell epitopes and 3 CS T cell sites in alum adjuvant elicited high titer anti-CS Abs (endpoint dilution titer >1x10(6)) and provided 80-100% protection against blood stage malaria. Using a similar strategy, VLPs were constructed carrying P. vivax CS repeat B cell epitopes (WHc-Pv-78), which elicited high levels of anti-CS Abs and conferred 99% protection of the liver against a 10,000 Pb/Pv sporozoite challenge and elicited sterile immunity to blood stage infection. These results indicate that immunization with epitope-focused VLPs carrying selected B and T cell epitopes from the P. falciparum and P. vivax CS proteins can elicit sterile immunity against blood stage malaria. Hybrid WHcAg-CS VLPs could provide the basis for a bivalent P. falciparum/P. vivax malaria vaccine.	[Whitacre, David C.; Peters, Cory J.; Jones, Joyce E.; Milich, David R.] Vaccine Res Inst San Diego, San Diego, CA 92109 USA; [Whitacre, David C.; Peters, Cory J.; Jones, Joyce E.; Tucker, Amy E.; Milich, David R.] VLP Biotech Inc, San Diego, CA USA; [Espinosa, Diego A.; Zavala, Fidel P.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Malaria Res Inst, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Peterson, Darrell L.] Virginia Commonwealth Univ, Dept Biochem, Richmond, VA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Virginia Commonwealth University	Milich, DR (corresponding author), Vaccine Res Inst San Diego, San Diego, CA 92109 USA.	dmilich@vlp-biotech.com	milich, david/W-6493-2019; Espinosa, Diego/AAT-6950-2020	Espinosa, Diego A./0000-0002-4364-5031; Whitacre, David/0000-0003-3803-9157	Malaria Research Institute; NIH-NIAID [R01AI44375, RO1AI082740]; Bloomberg Family Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044375, R01AI082740] Funding Source: NIH RePORTER	Malaria Research Institute; NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bloomberg Family Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	DAE received a pre-doctoral fellowship from the Malaria Research Institute (http://malaria.jhsph.edu/). DAE and FPZ thank the Bloomberg Family Foundation (http://www.bloomberg.org/) for continued support. Research is funded in part by NIH-NIAID grants R01AI44375 to FPZ and RO1AI082740 to DRM DLP FPZ. VLP Biotech, Inc provided support in the form of salaries for authors DCW, JEJ, AET and DRM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; ALEY SB, 1986, J EXP MED, V164, P1915, DOI 10.1084/jem.164.6.1915; Alloueche A, 2003, AM J TROP MED HYG, V68, P97, DOI 10.4269/ajtmh.2003.68.97; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; ALPER CA, 1995, EXP CLIN IMMUNOGENET, V12, P171; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; Betancourt AA, 2007, INT J INFECT DIS, V11, P394, DOI 10.1016/j.ijid.2006.09.010; Billaud JN, 2007, VACCINE, V25, P1593, DOI 10.1016/j.vaccine.2006.11.013; Billaud JN, 2005, J VIROL, V79, P13656, DOI 10.1128/JVI.79.21.13656-13666.2005; Birkett A, 2002, INFECT IMMUN, V70, P6860, DOI 10.1128/IAI.70.12.6860-6870.2002; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Bruna-Romero O, 2001, INT J PARASITOL, V31, P1499, DOI 10.1016/S0020-7519(01)00265-X; CALLE JMC, 1992, J IMMUNOL, V149, P2695; CERAMI C, 1992, CELL, V70, P1021, DOI 10.1016/0092-8674(92)90251-7; Cockburn IA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001318; David Whitacre, 2015, VIRAL NANOTECHNOLOGY, P536; Duffy PE, 2012, EXPERT REV VACCINES, V11, P1261, DOI [10.1586/ERV.12.92, 10.1586/erv.12.92]; Espinosa DA, 2013, INFECT IMMUN, V81, P2882, DOI 10.1128/IAI.00461-13; GOOD MF, 1986, J EXP MED, V164, P655, DOI 10.1084/jem.164.2.655; GOOD MF, 1988, P NATL ACAD SCI USA, V85, P1199, DOI 10.1073/pnas.85.4.1199; GORDON DM, 1995, J INFECT DIS, V171, P1576, DOI 10.1093/infdis/171.6.1576; Guerra CA, 2006, TRENDS PARASITOL, V22, P353, DOI 10.1016/j.pt.2006.06.006; HOFFNAGLE JH, 1973, LANCET, V2, P869; Kaba SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048304; Kastenmuller K, 2013, INFECT IMMUN, V81, P789, DOI 10.1128/IAI.01108-12; Kumar KA, 2006, NATURE, V444, P937, DOI 10.1038/nature05361; Lee BO, 2009, J IMMUNOL, V182, P6670, DOI 10.4049/jimmunol.0803683; Liu SG, 1997, CLIN BIOCHEM, V30, P455, DOI 10.1016/S0009-9120(97)00049-0; Menard R, 1997, METHODS, V13, P148, DOI 10.1006/meth.1997.0507; MILICH DR, 1986, SCIENCE, V234, P1398, DOI 10.1126/science.3491425; Milich DR, 2001, VACCINE, V20, P771, DOI 10.1016/S0264-410X(01)00400-5; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Olotu A, 2013, NEW ENGL J MED, V368, P1111, DOI 10.1056/NEJMoa1207564; Persson C, 2002, J IMMUNOL, V169, P6681, DOI 10.4049/jimmunol.169.12.6681; Porter MD, 2013, CLIN VACCINE IMMUNOL, V20, P803, DOI 10.1128/CVI.00066-13; Przysiecki C, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00146; Rathore D, 2005, J BIOL CHEM, V280, P20524, DOI 10.1074/jbc.M414254200; SCHODEL F, 1994, J EXP MED, V180, P1037, DOI 10.1084/jem.180.3.1037; Schodel F, 1997, BEHRING I MITT, V98, P114; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Stoute JA, 1998, J INFECT DIS, V178, P1139, DOI 10.1086/515657; Tewari R, 2002, J BIOL CHEM, V277, P47613, DOI 10.1074/jbc.M208453200; Walther M, 2005, VACCINE, V23, P857, DOI 10.1016/j.vaccine.2004.08.020; Webster DP, 2005, P NATL ACAD SCI USA, V102, P4836, DOI 10.1073/pnas.0406381102; WHITE K, 1993, VACCINE, V11, P1341, DOI 10.1016/0264-410X(93)90105-7; White MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061395; ZAVALA F, 1983, J EXP MED, V157, P1947, DOI 10.1084/jem.157.6.1947; ZAVALA F, 1985, SCIENCE, V228, P1436, DOI 10.1126/science.2409595	48	22	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124856	10.1371/journal.pone.0124856	http://dx.doi.org/10.1371/journal.pone.0124856			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933001	Green Published, Green Submitted, gold			2022-12-27	WOS:000353887100059
J	Chen, Z; Yu, GR; Ge, JP; Wang, QF; Zhu, XJ; Xu, ZW				Chen, Zhi; Yu, Guirui; Ge, Jianping; Wang, Qiufeng; Zhu, Xianjin; Xu, Zhiwei			Roles of Climate, Vegetation and Soil in Regulating the Spatial Variations in Ecosystem Carbon Dioxide Fluxes in the Northern Hemisphere	PLOS ONE			English	Article							NET PRIMARY PRODUCTIVITY; TERRESTRIAL ECOSYSTEMS; LONG-TERM; INTERANNUAL VARIABILITY; FOREST ECOSYSTEMS; WATER-VAPOR; EXCHANGE; RESPIRATION; PATTERNS; ENERGY	Climate, vegetation, and soil characteristics play important roles in regulating the spatial variation in carbon dioxide fluxes, but their relative influence is still uncertain. In this study, we compiled data from 241 eddy covariance flux sites in the Northern Hemisphere and used Classification and Regression Trees and Redundancy Analysis to assess how climate, vegetation, and soil affect the spatial variations in three carbon dioxide fluxes (annual gross primary production (AGPP), annual ecosystem respiration (ARE), and annual net ecosystem production (ANEP)). Our results showed that the spatial variations in AGPP, ARE, and ANEP were significantly related to the climate and vegetation factors (correlation coefficients, R = 0.22 to 0.69, P < 0.01) while they were not related to the soil factors (R = -0.11 to 0.14, P > 0.05) in the Northern Hemisphere. The climate and vegetation together explained 60% and 58% of the spatial variations in AGPP and ARE, respectively. Climate factors (mean annual temperature and precipitation) could account for 45-47 % of the spatial variations in AGPP and ARE, but the climate constraint on the vegetation index explained approximately 75 %. Our findings suggest that climate factors affect the spatial variations in AGPP and ARE mainly by regulating vegetation properties, while soil factors exert a minor effect. To more accurately assess global carbon balance and predict ecosystem responses to climate change, these discrepant roles of climate, vegetation, and soil are required to be fully considered in the future land surface models. Moreover, our results showed that climate and vegetation factors failed to capture the spatial variation in ANEP and suggest that to reveal the underlying mechanism for variation in ANEP, taking into account the effects of other factors (such as climate change and disturbances) is necessary.	[Chen, Zhi; Yu, Guirui; Wang, Qiufeng; Zhu, Xianjin; Xu, Zhiwei] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observ & Modeling, Chinese Ecosyst Res Network,Synth Res Ctr, Beijing, Peoples R China; [Chen, Zhi; Xu, Zhiwei] Univ Chinese Acad Sci, Beijing, Peoples R China; [Ge, Jianping] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Beijing Normal University	Yu, GR (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observ & Modeling, Chinese Ecosyst Res Network,Synth Res Ctr, Beijing, Peoples R China.	yugr@igsnrr.ac.cn	Zhu, XianJin/B-2779-2009; wang, qiufeng/C-1654-2013; 于, 贵瑞/C-1768-2014	Zhu, XianJin/0000-0002-5662-3472; 于, 贵瑞/0000-0002-1859-8966	International Cooperation and Exchange Program of National Natural Science Foundation of China [31420103917]; Key Program of National Natural Science Foundation of China [31290221]; Chinese Academy of Sciences Strategic Priority Research Program [XDA05050602]	International Cooperation and Exchange Program of National Natural Science Foundation of China; Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences Strategic Priority Research Program	This research was funded by the International Cooperation and Exchange Program of National Natural Science Foundation of China (grant no. 31420103917), the Key Program of National Natural Science Foundation of China (grant no. 31290221), and the Chinese Academy of Sciences Strategic Priority Research Program (grant no. XDA05050602). The authors declare that no additional external funding was received in support of this study. The funders had no role in the study design, data collection and analysis, decision to publish, or manuscript preparation.	Arneth A, 2002, TELLUS B, V54, P514, DOI 10.1034/j.1600-0889.2002.01349.x; Aubinet M, 2005, BOUND-LAY METEOROL, V116, P63, DOI 10.1007/s10546-004-7091-8; Baldocchi D, 2001, B AM METEOROL SOC, V82, P2415, DOI 10.1175/1520-0477(2001)082<2415:FANTTS>2.3.CO;2; Baldocchi D, 2008, AUST J BOT, V56, P1, DOI 10.1071/BT07151; Baldocchi D, 2014, GLOBAL CHANGE BIOL, V20, P3600, DOI 10.1111/gcb.12649; Blewitt ME, 2008, NAT GENET, V40, P663, DOI 10.1038/ng.142; Chen Z, 2013, AGR FOREST METEOROL, V182, P266, DOI 10.1016/j.agrformet.2013.04.026; Churkina G, 2005, GLOBAL CHANGE BIOL, V11, P1777, DOI 10.1111/j.1365-2486.2005.001012.x; Cramer W, 1999, GLOBAL CHANGE BIOL, V5, P1, DOI 10.1046/j.1365-2486.1999.00009.x; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; Falge E, 2001, AGR FOREST METEOROL, V107, P43, DOI 10.1016/S0168-1923(00)00225-2; FAO/IIASA/ISRIC/ISSCAS/JRC, 2012, HARM WORLD SOIL DAT; Fernandez-Martinez M, 2014, NAT CLIM CHANGE, V4, P471, DOI [10.1038/nclimate2177, 10.1038/NCLIMATE2177]; Finnigan JJ, 2003, BOUND-LAY METEOROL, V107, P1, DOI 10.1023/A:1021554900225; Gilmanov TG, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB002023; Gough CM, 2004, FOREST ECOL MANAG, V191, P353, DOI 10.1016/j.foreco.2004.01.011; Hirata R, 2008, AGR FOREST METEOROL, V148, P761, DOI 10.1016/j.agrformet.2007.11.016; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Jung M, 2009, BIOGEOSCIENCES, V6, P2001, DOI 10.5194/bg-6-2001-2009; Jung M, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001566; Kato T, 2008, GLOBAL CHANGE BIOL, V14, P2333, DOI 10.1111/j.1365-2486.2008.01646.x; Lasslop G, 2010, GLOBAL CHANGE BIOL, V16, P187, DOI 10.1111/j.1365-2486.2009.02041.x; Law BE, 2002, AGR FOREST METEOROL, V113, P97, DOI 10.1016/S0168-1923(02)00104-1; Le Quere C, 2014, EARTH SYST SCI DATA, V6, P235, DOI 10.5194/essd-6-235-2014; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; LIETH H, 1973, HUM ECOL, V1, P303, DOI 10.1007/BF01536729; Magnani F, 2007, NATURE, V447, P848, DOI 10.1038/nature05847; Massman WJ, 2000, AGR FOREST METEOROL, V104, P185, DOI 10.1016/S0168-1923(00)00164-7; Massman WJ, 2002, AGR FOREST METEOROL, V113, P121, DOI 10.1016/S0168-1923(02)00105-3; Matsuura Y, 2007, P 7 INT C GLOB CHANG, V312, P258; Moffat AM, 2007, AGR FOREST METEOROL, V147, P209, DOI 10.1016/j.agrformet.2007.08.011; Oksanen J., 2015, MULTIVARIATE ANAL EC, P1, DOI DOI 10.1016/0169-5347(88)90124-3; Papale D, 2006, BIOGEOSCIENCES, V3, P571, DOI 10.5194/bg-3-571-2006; PASTOR J, 1993, CLIMATIC CHANGE, V23, P111, DOI 10.1007/BF01097332; Piao SL, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037381; POTTER CS, 1993, GLOBAL BIOGEOCHEM CY, V7, P811, DOI 10.1029/93GB02725; PRENTICE IC, 1992, J BIOGEOGR, V19, P117, DOI 10.2307/2845499; PRENTICE KC, 1990, J GEOPHYS RES-ATMOS, V95, P11811, DOI 10.1029/JD095iD08p11811; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; Reichstein M, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027880; Rodeghiero M, 2005, GLOBAL CHANGE BIOL, V11, P1024, DOI 10.1111/j.1365-2486.2005.00963.x; Schimel DS, 2001, NATURE, V414, P169, DOI 10.1038/35102500; Sun J, 2013, BIOGEOSCIENCES, V10, P1707, DOI 10.5194/bg-10-1707-2013; Thornton PE, 2002, AGR FOREST METEOROL, V113, P185, DOI 10.1016/S0168-1923(02)00108-9; Valentini R, 2000, NATURE, V404, P861, DOI 10.1038/35009084; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; WOFSY SC, 2002, N AM CARBON PROGRAM, P1; Xia JZ, 2014, REMOTE SENS-BASEL, V6, P1783, DOI 10.3390/rs6031783; Yi CX, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/3/034007; Yu GR, 2013, GLOBAL CHANGE BIOL, V19, P798, DOI 10.1111/gcb.12079; Yu GR, 2010, ENVIRON SCI TECHNOL, V44, P6074, DOI 10.1021/es100979s; Yuan WP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5270; Yuan WP, 2009, GLOBAL CHANGE BIOL, V15, P2905, DOI 10.1111/j.1365-2486.2009.01870.x; Zheng ZM, 2010, ENVIRON MANAGE, V46, P633, DOI 10.1007/s00267-010-9509-z; Zhou XH, 2009, ECOSYSTEMS, V12, P1369, DOI 10.1007/s10021-009-9296-7; 王兴昌, 2008, [中国科学. D辑, 地球科学, Science in China. Series D, Earth Sciences], V38, P1092	56	26	29	4	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125265	10.1371/journal.pone.0125265	http://dx.doi.org/10.1371/journal.pone.0125265			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928452	gold, Green Published, Green Submitted			2022-12-27	WOS:000353713100075
J	Sekiguchi, H; Shimamoto, K; Sekiguchi, N; Ozaki, Y; Shimizu, K; Takahashi, Y; Sakai, A; Tatsumi, F; Ishizuka, N; Kawana, M				Sekiguchi, Haruki; Shimamoto, Ken; Sekiguchi, Naoki; Ozaki, Yuri; Shimizu, Kaoru; Takahashi, Yufuko; Sakai, Akiko; Tatsumi, Fujio; Ishizuka, Naoko; Kawana, Masatoshi			Gender Differences in Predictors of Left Ventricular Myocardial Relaxation in Non-Obese, Healthy Individuals	PLOS ONE			English	Article							PRESERVED EJECTION FRACTION; METABOLIC RISK-FACTORS; HEART-FAILURE; DIASTOLIC FUNCTION; FILLING PRESSURES; DYSFUNCTION; COMMUNITY; OBESITY; AGE; ASSOCIATION	Background Previous studies indicate that individuals with metabolic syndrome (MetS) might be at risk for left ventricular (LV) diastolic dysfunction. However, little is known about which metabolic factors contribute to the development of LV dysfunction in individuals who are not obese or overweight and who do not have diabetes mellitus and/or cardiovascular disease. Methods Participants without diabetes mellitus, systolic dysfunction, or other heart diseases underwent a thorough physical examination, including tissue Doppler echocardiography. A peak early mitral annular velocity (e') of <5.0 was designated as indicating abnormal LV myocardial relaxation (LVMR). We performed single and multiple logistic regression analyses of e' and cardiovascular risk factors, including MetS factors and indicators of major organ dysfunction. Normal-weight subjects (body mass index <25 kg/m(2)) were also analyzed. Results A total of 1055 individuals (mean age, 63 +/- 13 years) participated, of which 307 (29.1%) had MetS and 199 (18.9%) had abnormal LVMR. Multiple logistic regression analysis revealed waist circumference (WC) (odds ratio [OR] 1.04, P < 0.05) and age (OR 1.10, P < 0.05) to be predictors of abnormal LVMR. In normal-weight subjects (n = 806), aging (OR 1.08, P < 0.01), abnormalWC (OR 3.80, P < 0.01), and renal dysfunction (OR 2.14, P < 0.01) were predictors of abnormal LVMR. Among MetS factors, abnormal WC in men (OR 3.70, P < 0.01) and high diastolic blood pressure (DBP) in women (OR 4.00, P = 0.01) were related to abnormal LVMR.	[Sekiguchi, Haruki; Shimamoto, Ken; Sekiguchi, Naoki; Ozaki, Yuri; Shimizu, Kaoru; Takahashi, Yufuko; Sakai, Akiko; Tatsumi, Fujio; Ishizuka, Naoko; Kawana, Masatoshi] Tokyo Womens Med Univ, Aoyama Hosp, Dept Cardiol, Tokyo, Japan; [Sekiguchi, Haruki; Shimamoto, Ken; Ozaki, Yuri; Shimizu, Kaoru; Takahashi, Yufuko; Sakai, Akiko; Tatsumi, Fujio; Ishizuka, Naoko; Kawana, Masatoshi] Tokyo Womens Med Univ, Dept Cardiol, Tokyo, Japan; [Sekiguchi, Haruki] Natl Hosp Org Yokohama Med Ctr, Dept Cardiol, Kanagawa, Japan	Tokyo Women's Medical University; Tokyo Women's Medical University	Kawana, M (corresponding author), Tokyo Womens Med Univ, Aoyama Hosp, Dept Cardiol, Tokyo, Japan.	kawana.masatoshi@twmu.ac.jp						Ammar KA, 2007, CIRCULATION, V115, P1563, DOI 10.1161/CIRCULATIONAHA.106.666818; [Anonymous], 2005, NIHON NAIKA GAKKAI Z, V94, P794; Bahrami H, 2008, J AM COLL CARDIOL, V51, P1775, DOI 10.1016/j.jacc.2007.12.048; Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530; Bonapace S, 2012, DIABETES CARE, V35, P389, DOI 10.2337/dc11-1820; Burchfiel CM, 2005, CIRCULATION, V112, P819, DOI 10.1161/CIRCULATIONAHA.104.518498; Canepa M, 2012, AM J CARDIOL, V109, P1171, DOI 10.1016/j.amjcard.2011.11.054; CaulinGlaser T, 1997, CIRC RES, V81, P885; Chinali M, 2004, AM J CARDIOL, V93, P40, DOI 10.1016/j.amjcard.2003.09.009; Davies MK, 2001, LANCET, V358, P439, DOI 10.1016/S0140-6736(01)05620-3; de las Fuentes L, 2007, EUR HEART J, V28, P553, DOI 10.1093/eurheartj/ehl526; de Simone G, 2002, J HYPERTENS, V20, P323, DOI 10.1097/00004872-200202000-00024; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Kaku K, 2011, J AM SOC ECHOCARDIOG, V24, P541, DOI 10.1016/j.echo.2011.01.011; Kane GC, 2011, JAMA-J AM MED ASSOC, V306, P856, DOI 10.1001/jama.2011.1201; Kramer CK, 2013, ANN INTERN MED, V159, P758, DOI 10.7326/0003-4819-159-11-201312030-00008; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Lam CSP, 2011, CIRCULATION, V124, P24, DOI 10.1161/CIRCULATIONAHA.110.979203; Lester SJ, 2008, J AM COLL CARDIOL, V51, P679, DOI 10.1016/j.jacc.2007.09.061; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; Nagueh SF, 1997, J AM COLL CARDIOL, V30, P1527, DOI 10.1016/S0735-1097(97)00344-6; Okura H, 2009, CIRC-CARDIOVASC IMAG, V2, P41, DOI 10.1161/CIRCIMAGING.108.809087; Ommen SR, 2000, CIRCULATION, V102, P1788; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Redfield MM, 2005, CIRCULATION, V112, P2254, DOI 10.1161/CIRCULATIONAHA.105.541078; REIS SE, 1994, CIRCULATION, V89, P52, DOI 10.1161/01.CIR.89.1.52; Russo C, 2011, J AM COLL CARDIOL, V57, P1368, DOI 10.1016/j.jacc.2010.10.042; Turkbey EB, 2010, JACC-CARDIOVASC IMAG, V3, P266, DOI 10.1016/j.jcmg.2009.10.012; Vasan RS, 1999, J AM COLL CARDIOL, V33, P1948, DOI 10.1016/S0735-1097(99)00118-7; Villari B, 1997, J AM COLL CARDIOL, V29, P181, DOI 10.1016/S0735-1097(96)00440-8; Zabalgoitia M, 1998, AM J CARDIOL, V82, P604, DOI 10.1016/S0002-9149(98)00404-4; Zimmet P., 2005, DIABETES VOICE, V50, P31	33	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125107	10.1371/journal.pone.0125107	http://dx.doi.org/10.1371/journal.pone.0125107			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927927	gold, Green Published, Green Submitted			2022-12-27	WOS:000353713100068
J	Ying, H; Qin, A; Cheng, TS; Pavlos, NJ; Rea, S; Dai, KR; Zheng, MH				Ying, Hua; Qin, An; Cheng, Tak S.; Pavlos, Nathan J.; Rea, Sarah; Dai, Kerong; Zheng, Ming H.			Disulfiram Attenuates Osteoclast Differentiation In Vitro: A Potential Antiresorptive Agent	PLOS ONE			English	Article							NF-KAPPA-B; BONE-RESORPTION; PYRROLIDINE DITHIOCARBAMATE; H+-ATPASE; MECHANISMS; PROTEASOME; INDUCTION; COMPLEX; FUSION; ACIDIFICATION	Disulfiram (DSF), a cysteine modifying compound, has long been clinically employed for the treatment of alcohol addiction. Mechanistically, DSF acts as a modulator of MAPK and NF-kappa B pathways signaling pathways. While these pathways are crucial for osteoclast (OC) differentiation, the potential influence of DSF on OC formation and function has not been directly assessed. Here, we explore the pharmacological effects of DSF on OC differentiation, activity and the modulation of osteoclastogenic signaling cascades. We first analyzed cytotoxicity of DSF on bone marrow monocytes isolated from C57BL/6J mice. Upon the establishment of optimal dosage, we conducted osteoclastogenesis and bone resorption assays in the presence or absence of DSF treatment. Luciferase assays in RAW264.7 cells were used to examine the effects of DSF on major transcription factors activation. Western blot, reverse transcription polymerase chain reaction, intracellular acidification and proton influx assays were employed to further dissect the underlying mechanism. DSF treatment dose-dependently inhibited both mouse and human osteoclastogenesis, especially at early stages of differentiation. This inhibition correlated with a decrease in the expression of key osteoclastic marker genes including CtsK, TRAP, DC-STAMP and Atp6v0d2 as well as a reduction in bone resorption in vitro. Suppression of OC differentiation was found to be due, at least in part, to the blockade of several key receptor activators of nuclear factor kappa-B ligand (RANKL)-signaling pathways including ERK, NF-kappa B and NFATc1. On the other hand, DSF failed to suppress intracellular acidification and proton influx in mouse and human osteoclasts using acridine orange quenching and microsome-based proton transport assays. Our findings indicate that DSF attenuates OC differentiation via the collective suppression of several key RANKL-mediated signaling cascades, thus making it an attractive agent for the treatment of OC-mediated disorders.	[Ying, Hua; Qin, An; Cheng, Tak S.; Pavlos, Nathan J.; Zheng, Ming H.] Univ Western Australia, Sch Surg, Ctr Orthopaed Res, Perth, WA 6009, Australia; [Qin, An; Dai, Kerong] Shanghai Jiao Tong Univ, Sch Med, Ninth Peoples Hosp, Dept Orthopaed, Shanghai 200030, Peoples R China; [Rea, Sarah] Harry Perkins Inst Med Res, Perth, WA, Australia; [Rea, Sarah] Sir Charles Gairdner Hosp, Dept Endocrinol & Diabet, Perth, WA, Australia	University of Western Australia; Shanghai Jiao Tong University; Harry Perkins Institute of Medical Research; University of Western Australia	Dai, KR (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ninth Peoples Hosp, Dept Orthopaed, Shanghai 200030, Peoples R China.	krdai@sibs.ac.cn; minghao.zheng@uwa.edu.au	YING, HUA/AAT-6663-2021; Rea, Sarah/GYJ-4753-2022	Zheng, Minghao/0000-0003-1185-4768; Pavlos, Nathan/0000-0001-7003-188X; Rea, Sarah Lyn/0000-0002-2181-9491; /0000-0002-2151-3433	National Health and Medical Research Council, Australia [APP572670]	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	The study is supported by grant APP572670 issued to MHZ from National Health and Medical Research Council, Australia. MHZ analyzed the data and contributed to the writing of the manuscript [http://www.nhmrc.gov.au/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amer Y, 2001, J BIOL CHEM, V276, P30499, DOI 10.1074/jbc.M104725200; Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; Ang ESM, 2007, J CELL PHYSIOL, V212, P787, DOI 10.1002/jcp.21076; BARON R, 1989, ANAT RECORD, V224, P317, DOI 10.1002/ar.1092240220; BLAIR HC, 1989, SCIENCE, V245, P855, DOI 10.1126/science.2528207; Blair HC, 2004, HISTOL HISTOPATHOL, V19, P189, DOI 10.14670/HH-19.189; Chen D, 2005, FRONT BIOSCI-LANDMRK, V10, P2932, DOI 10.2741/1749; Chen JS, 2012, NAT REV ENDOCRINOL, V8, P81, DOI 10.1038/nrendo.2011.146; Darnay BG, 1999, J BIOL CHEM, V274, P7724, DOI 10.1074/jbc.274.12.7724; DAVID P, 1994, J BIOL CHEM, V269, P30158; Feng SM, 2009, BIOCHEM J, V417, P195, DOI 10.1042/BJ20081073; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; FULLER RK, 1986, JAMA-J AM MED ASSOC, V256, P1449, DOI 10.1001/jama.256.11.1449; Gowen M, 1999, J BONE MINER RES, V14, P1654, DOI 10.1359/jbmr.1999.14.10.1654; Guo XX, 2010, CANCER LETT, V290, P104, DOI 10.1016/j.canlet.2009.09.002; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Johnson RM, 2010, ANAL BIOCHEM, V398, P203, DOI 10.1016/j.ab.2009.12.020; Jurdic P, 2006, EUR J CELL BIOL, V85, P195, DOI 10.1016/j.ejcb.2005.09.008; Kim I, 2004, EXP CELL RES, V298, P229, DOI 10.1016/j.yexcr.2004.04.017; KITSON TM, 1977, J STUD ALCOHOL, V38, P96, DOI 10.15288/jsa.1977.38.96; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Malich G, 1997, TOXICOLOGY, V124, P179, DOI 10.1016/S0300-483X(97)00151-0; Mittal M, 2014, TOXICOL SCI; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Ng PY, 2013, J BONE MINER RES, V28, P119, DOI 10.1002/jbmr.1725; PERIS P, 1994, J BONE MINER RES, V9, P1607; Qin A, 2012, INT J BIOCH CELL BIO; Qin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034132; Qin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027155; Rea SL, 2006, J BONE MINER RES, V21, P1136, DOI 10.1359/JBMR.060405; Seeman E, 2002, LANCET, V359, P1841, DOI 10.1016/S0140-6736(02)08706-8; Seeman E, 2003, OSTEOPOROSIS INT, V14, pS2, DOI 10.1007/s00198-002-1340-9; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Sorensen MG, 2007, J BONE MINER RES, V22, P1640, DOI 10.1359/JBMR.070613; Suh JJ, 2006, J CLIN PSYCHOPHARM, V26, P290, DOI 10.1097/01.jcp.0000222512.25649.08; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; UDAGAWA N, 1990, P NATL ACAD SCI USA, V87, P7260, DOI 10.1073/pnas.87.18.7260; Wang C, 2003, J BONE MINER RES, V18, P2159, DOI 10.1359/jbmr.2003.18.12.2159; Xu J, J BONE MINERAL, P2178; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yip NC, 2011, BRIT J CANCER, V104, P1564, DOI 10.1038/bjc.2011.126; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707	44	4	4	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125696	10.1371/journal.pone.0125696	http://dx.doi.org/10.1371/journal.pone.0125696			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928135	gold, Green Published, Green Submitted			2022-12-27	WOS:000353713100111
J	Chambers, JD; Naci, H; Wouters, OJ; Pyo, J; Gunjal, S; Kennedy, IR; Hoey, MG; Winn, A; Neumann, PJ				Chambers, James D.; Naci, Huseyin; Wouters, Olivier J.; Pyo, Junhee; Gunjal, Shalak; Kennedy, Ian R.; Hoey, Mark G.; Winn, Aaron; Neumann, Peter J.			An Assessment of the Methodological Quality of Published Network Meta-Analyses: A Systematic Review	PLOS ONE			English	Review							INDUSTRY-SUPPORTED METAANALYSES; MIXED TREATMENT COMPARISONS; CARE DECISION-MAKING; ISPOR TASK-FORCE; INTERVENTIONS; CONSISTENCY; TRIALS; BIAS	Objective To assess the methodological quality of published network meta-analysis. Design Systematic review. Methods We searched the medical literature for network meta-analyses of pharmaceuticals. We assessed general study characteristics, study transparency and reproducibility, methodological approach, and reporting of findings. We compared studies published in journals with lower impact factors with those published in journals with higher impact factors, studies published prior to January 1st, 2013 with those published after that date, and studies supported financially by industry with those supported by non-profit institutions or that received no support. Results The systematic literature search identified 854 citations. Three hundred and eighteen studies met our inclusion criteria. The number of network meta-analyses has grown rapidly, with 48% of studies published since January 2013. The majority of network meta-analyses were supported by a non-profit institution or received no support (68%). We found considerable inconsistencies among reviewed studies. Eighty percent reported search terms, 61% a network diagram, 65% sufficient data to replicate the analysis, and 90% the characteristics of included trials. Seventy percent performed a risk of bias assessment of included trials, 40% an assessment of model fit, and 56% a sensitivity analysis. Among studies with a closed loop, 69% examined the consistency of direct and indirect evidence. Sixty-four percent of studies presented the full matrix of head-to-head treatment comparisons. For Bayesian studies, 41% reported the probability that each treatment was best, 31% reported treatment ranking, and 16% included the model code or referenced publicly-available code. Network meta-analyses published in higher impact factors journals and those that did not receive industry support performed better across the assessment criteria. We found few differences between older and newer studies. Conclusions There is substantial variation in the network meta-analysis literature. Consensus among guidelines is needed improve the methodological quality, transparency, and consistency of study conduct and reporting.	[Chambers, James D.; Neumann, Peter J.] Tufts Med Ctr, Ctr Evaluat Value & Risk Hlth, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA; [Naci, Huseyin; Wouters, Olivier J.] Univ London London Sch Econ & Polit Sci, LSE Hlth & Social Care, London WC2A 2AE, England; [Pyo, Junhee] Univ Utrecht, Div Pharmacoepidemiol & Clin Pharmacol, WHO Collaborating Ctr Pharmaceut Sci & Regulat, NL-3508 TB Utrecht, Netherlands; [Gunjal, Shalak] Precis Hlth Econ, Austin, TX 78733 USA; [Kennedy, Ian R.] Royal Victoria Hosp, Belfast BT12 6BA, Antrim, North Ireland; [Hoey, Mark G.] Mater Hosp, Belfast BT14 6AB, Antrim, North Ireland; [Winn, Aaron] Univ N Carolina, Dept Hlth Policy & Management, Chapel Hill, NC 27599 USA	Tufts Medical Center; University of London; London School Economics & Political Science; Utrecht University; University of North Carolina; University of North Carolina Chapel Hill	Chambers, JD (corresponding author), Tufts Med Ctr, Ctr Evaluat Value & Risk Hlth, Inst Clin Res & Hlth Policy Studies, 800 Washington St,63, Boston, MA 02111 USA.	jchambers@tuftsmedicalcenter.org	Wouters, Olivier/AAA-6345-2021	Wouters, Olivier/0000-0002-2514-476X; Winn, Aaron/0000-0003-2906-3913				Ades AE, 2003, STAT MED, V22, P2995, DOI 10.1002/sim.1566; Bafeta Aida, 2013, BMJ, V347, pf3675, DOI 10.1136/bmj.f3675; Cipriani A, 2013, ANN INTERN MED, V159, P130, DOI 10.7326/0003-4819-159-2-201307160-00008; Coleman CI, AHRQ PUBLICATION; Cooper NJ, 2009, STAT MED, V28, P1861, DOI 10.1002/sim.3594; Dias S, 2010, J R STAT SOC A STAT, V173, P613, DOI 10.1111/j.1467-985X.2010.00639.x; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; Donegan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011054; Edwards SJ, 2009, INT J CLIN PRACT, V63, P841, DOI 10.1111/j.1742-1241.2009.02072.x; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hoaglin DC, 2011, VALUE HEALTH, V14, P429, DOI 10.1016/j.jval.2011.01.011; Hutton B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092508; Ioannidis JPA, 2006, LANCET, V368, P1470, DOI 10.1016/S0140-6736(06)69615-3; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jansen JP, 2014, VALUE HEALTH, V17, P157, DOI 10.1016/j.jval.2014.01.004; Jansen JP, 2011, VALUE HEALTH, V14, P417, DOI 10.1016/j.jval.2011.04.002; Jorgensen AW, 2006, BMJ-BRIT MED J, V333, P782, DOI 10.1136/bmj.38973.444699.0B; Jorgensen AW, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-60; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; National Institute for Health and Care Excellence, EV SYNTH TECHN SUPP; National Institute for Health and Care Excellence, GUID METH TECHN APPR; Piccini JP, 2011, EUROPACE, V13, P295, DOI 10.1093/europace/eur029; Reuters Thomson, 2013, 2013 J CITATION REPO; Salanti G, 2008, STAT METHODS MED RES, V17, P279, DOI 10.1177/0962280207080643; Salanti G, 2012, RES SYNTH METHODS, V3, P80, DOI 10.1002/jrsm.1037; Savovic J, 2012, ANN INTERN MED, V157, P429, DOI 10.7326/0003-4819-157-6-201209180-00537; Sobieraj DM, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003111; Song FJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1147; The Cochrane Collaboration, COMP MULT INT METH G; The Pharmaceutical Benefits Advisory Committee Australia, GUID PREP SUBM PHARM; Wells GA, INDIRECT EVIDENCE IN; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD	34	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0121715	10.1371/journal.pone.0121715	http://dx.doi.org/10.1371/journal.pone.0121715			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923737	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600006
J	Garai, E; Sensarn, S; Zavaleta, CL; Loewke, NO; Rogalla, S; Mandella, MJ; Felt, SA; Friedland, S; Liu, JTC; Gambhir, SS; Contag, CH				Garai, Ellis; Sensarn, Steven; Zavaleta, Cristina L.; Loewke, Nathan O.; Rogalla, Stephan; Mandella, Michael J.; Felt, Stephen A.; Friedland, Shai; Liu, Jonathan T. C.; Gambhir, Sanjiv S.; Contag, Christopher H.			A Real-Time Clinical Endoscopic System for Intraluminal, Multiplexed Imaging of Surface-Enhanced Raman Scattering Nanoparticles	PLOS ONE			English	Article							COLORECTAL NEOPLASMS; COLONOSCOPY; SPECTROSCOPY; CANCER; ADULTS; FLAT	The detection of biomarker-targeting surface-enhanced Raman scattering (SERS) nanoparticles (NPs) in the human gastrointestinal tract has the potential to improve early cancer detection; however, a clinically relevant device with rapid Raman-imaging capability has not been described. Here we report the design and in vivo demonstration of a miniature, non-contact, opto-electro-mechanical Raman device as an accessory to clinical endoscopes that can provide multiplexed molecular data via a panel of SERS NPs. This device enables rapid circumferential scanning of topologically complex luminal surfaces of hollow organs (e.g., colon and esophagus) and produces quantitative images of the relative concentrations of SERS NPs that are present. Human and swine studies have demonstrated the speed and simplicity of this technique. This approach also offers unparalleled multiplexing capabilities by simultaneously detecting the unique spectral fingerprints of multiple SERS NPs. Therefore, this new screening strategy has the potential to improve diagnosis and to guide therapy by enabling sensitive quantitative molecular detection of small and otherwise hard-to-detect lesions in the context of white-light endoscopy.	[Garai, Ellis] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Sensarn, Steven; Zavaleta, Cristina L.; Gambhir, Sanjiv S.; Contag, Christopher H.] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Sensarn, Steven; Rogalla, Stephan; Mandella, Michael J.; Contag, Christopher H.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Gambhir, Sanjiv S.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Gambhir, Sanjiv S.] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA; [Contag, Christopher H.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Friedland, Shai] Stanford Univ, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA; [Garai, Ellis; Sensarn, Steven; Zavaleta, Cristina L.; Loewke, Nathan O.; Rogalla, Stephan; Mandella, Michael J.; Gambhir, Sanjiv S.; Contag, Christopher H.] Stanford Univ, MIPS, Stanford, CA 94305 USA; [Felt, Stephen A.] Stanford Univ, Comparat Med, Stanford, CA 94305 USA; [Liu, Jonathan T. C.] Univ Washington, Dept Mech Engn, Seattle, WA 98195 USA; [Gambhir, Sanjiv S.] Stanford Univ, Canary Ctr Stanford Canc Early Detect, Stanford, CA 94305 USA; [Loewke, Nathan O.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; University of Washington; University of Washington Seattle; Stanford University; Stanford University	Gambhir, SS (corresponding author), Stanford Univ, Dept Radiol, Stanford, CA 94305 USA.	sgambhir@stanford.edu; ccontag@stanford.edu	Zavaleta, Cristina/AAC-2306-2020	Zavaleta, Cristina/0000-0001-7314-2446; Contag, Christopher/0000-0002-1011-8278; Felt, Stephen/0000-0001-7030-717X	Canary Foundation; Chambers Family Foundation; National Institute of Biomedical Imaging and Bioengineering [R21 EB015016]; National Cancer Institute [ICMIC P50 CA114747, CCNE U54 CA119367, NTR U54 CA136465]; NATIONAL CANCER INSTITUTE [P50CA114747, R01CA182043, U54CA119367, U54CA136465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB015016] Funding Source: NIH RePORTER	Canary Foundation; Chambers Family Foundation; National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was funded, in part, by The Canary Foundation (SSG), generous support from the Chambers Family Foundation (CHC), and grant support from the National Institute of Biomedical Imaging and Bioengineering: R21 EB015016 (JTCL), and the National Cancer Institute: ICMIC P50 CA114747 (SSG), CCNE U54 CA119367 (SSG), and NTR U54 CA136465 (CHC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter NN, 2009, ANN INTERN MED, V150, P1, DOI 10.7326/0003-4819-150-1-200901060-00306; Bohndiek SE, 2013, P NATL ACAD SCI USA, V110, P12408, DOI 10.1073/pnas.1301379110; Brenner H, 2010, J NATL CANCER I, V102, P89, DOI 10.1093/jnci/djp436; Conde J, 2014, J CONTROL RELEASE, V183, P87, DOI 10.1016/j.jconrel.2014.03.045; Coppola F, 2014, ABDOM IMAGING, V39, P25, DOI 10.1007/s00261-013-0052-2; Dinish US, 2014, SCI REP-UK, V4, DOI 10.1038/srep04075; Garai E, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.9.096008; Gregas MK, 2010, APPL SPECTROSC, V64, P858, DOI 10.1366/000370210792081037; Harris DC, 1989, SYMMETRY SPECTROSCOP, pxii; Heresbach D, 2008, ENDOSCOPY, V40, P284, DOI 10.1055/s-2007-995618; Jokerst JV, 2011, SMALL, V7, P625, DOI 10.1002/smll.201002291; Keren S, 2008, P NATL ACAD SCI USA, V105, P5844, DOI 10.1073/pnas.0710575105; Khashab MA, 2009, ENDOSCOPY, V41, P674, DOI 10.1055/s-0029-1214899; Kneipp K, 2006, SURFACE ENHANCED RAM, pxvii; Mamula P, 2011, GASTROINTEST ENDOSC, V73, P1092, DOI 10.1016/j.gie.2011.01.062; MARCHESINI R, 1994, LASER SURG MED, V15, P351, DOI 10.1002/lsm.1900150404; McVeigh PZ, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.4.046011; Qian XM, 2008, NAT BIOTECHNOL, V26, P83, DOI 10.1038/nbt1377; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; Simmonds PC, 2006, BRIT J CANCER, V94, P982, DOI 10.1038/sj.bjc.6603033; Soetikno RM, 2008, JAMA-J AM MED ASSOC, V299, P1027, DOI 10.1001/jama.299.9.1027; Wang YW, 2014, TECHNOLOGY, V2; Zavaleta C, 2008, NANO LETT, V8, P2800, DOI 10.1021/nl801362a; Zavaleta CL, 2013, P NATL ACAD SCI USA, V110, pE2288, DOI 10.1073/pnas.1211309110; Zavaleta CL, 2011, SMALL, V7, P2232, DOI 10.1002/smll.201002317	25	78	82	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123185	10.1371/journal.pone.0123185	http://dx.doi.org/10.1371/journal.pone.0123185			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923788	gold, Green Published, Green Submitted			2022-12-27	WOS:000353711600032
J	Hao, YX; Gao, JM; Zhang, XH; Liu, N; Li, JS; Zheng, LS; Duan, ZJ				Hao, Yexia; Gao, Jimin; Zhang, Xiaohong; Liu, Na; Li, Jinsong; Zheng, Lishu; Duan, Zhaojun			Seroepidemiology of Human Bocaviruses 1 and 2 in China	PLOS ONE			English	Article							REAL-TIME PCR; VIRUS-LIKE PARTICLES; HUMAN PARVOVIRUS; HIGH PREVALENCE; INFECTION; CHILDREN; ASSAYS; ANTIBODIES; DIAGNOSIS; B19	Seroepidemiology studies had been used to research the newly discovered human boca-viruses (HBoVs). Antibodies against the HBoV1-4 VP2 protein virus-like particles (VLPs) were found to be cross-reactive. The aim of the present study was to characterize the seroprevalence of HBoV1 and 2 among healthy populations in China. Recombinant HBoV1 and 2 VLPs were used to establish enzyme-linked immunosorbent assays (ELISAs) for detection of cross-reactivity between HBoV1 and HBoV2 in 1391 serum samples collected from healthy individuals in China. Of these, 884 samples were collected from Beijing and 507 were from Nanjing. Infection with HBoV1 and 2 was prevalent in healthy Chinese people, with the seroprevalence of HBoV1 and 2 in Beijing at 69.2 (612/884) and 64.4% (569/884), respectively. Highest seroprevalence was observed in 3-5-year-olds. The seroprevalence of HBoV1 was significantly decreased between 10-13-year-olds (80.3%) and 14-20-yearolds (62.3%, p<0.05). For individuals over 20 years, seroprevalence was relatively constant at about 60%. Similar trends were observed in children from Nanjing, with seroprevalence of HBoV1 and 2 for healthy children at 80.7% (409/507) and 81.3% (412/507), respectively. Moreover, both mouse and human antibodies against HBoV1 and HBoV2 VLPs were found to be cross-reactive and 58.4% (813/1391) serum samples were seropositive for both HBoV1 and HBoV2. This finding suggests HBoV is highly prevalent in China and the antibodies produced as a result of infection with either HBoV1 or HBoV 2 will offer future protection. The cross-reactivity between HBoVs is crucial for accurately determining HBoV seroepidemiology.	[Hao, Yexia; Liu, Na; Li, Jinsong; Zheng, Lishu; Duan, Zhaojun] China CDC, Natl Inst Viral Dis Control & Prevent, Key Lab Med Virol, Minist Hlth, Beijing, Peoples R China; [Hao, Yexia; Gao, Jimin] Wenzhou Med Univ, Wenzhou, Zhejiang, Peoples R China; [Zhang, Xiaohong] Natl Inst Sport Med, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Wenzhou Medical University	Zheng, LS (corresponding author), China CDC, Natl Inst Viral Dis Control & Prevent, Key Lab Med Virol, Minist Hlth, Beijing, Peoples R China.	zhenglishu2006@aliyun.com; zhaojund@126.com	Zhang, Hao/HHM-1940-2022		State Megaproject for Infectious Diseases Research of China [2013ZX10004-001]	State Megaproject for Infectious Diseases Research of China	This study was funded from the State Megaproject for Infectious Diseases Research of China (2013ZX10004-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Arthur JL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000391; Bastien N, 2006, EMERG INFECT DIS, V12, P848, DOI 10.3201/eid1205.051424; Bastien N, 2007, J CLIN MICROBIOL, V45, P610, DOI 10.1128/JCM.01044-06; BERNS KI, 1990, MICROBIOL REV, V54, P316, DOI 10.1128/MMBR.54.3.316-329.1990; Cecchini S, 2009, CLIN VACCINE IMMUNOL, V16, P597, DOI 10.1128/CVI.00470-08; Choi EH, 2006, CLIN INFECT DIS, V43, P585, DOI 10.1086/506350; Choi JH, 2008, J CLIN VIROL, V42, P249, DOI 10.1016/j.jcv.2008.02.010; Don M, 2010, PEDIATR PULM, V45, P120, DOI 10.1002/ppul.21151; Endo R, 2007, J CLIN MICROBIOL, V45, P3218, DOI 10.1128/JCM.02140-06; Guido M, 2012, CLIN MICROBIOL INFEC, V18, pE74, DOI 10.1111/j.1469-0691.2011.03756.x; Guo LN, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-636; Hedman L, 2010, J CLIN VIROL, V48, P44, DOI 10.1016/j.jcv.2010.02.003; Hustedt JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038206; Jin Y, 2011, J CLIN VIROL, V52, P251, DOI 10.1016/j.jcv.2011.07.012; Kahn JS, 2008, J INFECT DIS, V198, P41, DOI 10.1086/588674; Kantola K, 2008, CLIN INFECT DIS, V46, P540, DOI 10.1086/526532; Kantola K, 2011, J INFECT DIS, V204, P1403, DOI 10.1093/infdis/jir525; Kantola K, 2010, J CLIN MICROBIOL, V48, P4044, DOI 10.1128/JCM.00686-10; Kapoor A, 2009, J INFECT DIS, V199, P196, DOI 10.1086/595831; Kapoor A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021362; Kapoor A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011948; Kapoor A, 2010, J INFECT DIS, V201, P1633, DOI 10.1086/652416; Kelly HA, 2000, EPIDEMIOL INFECT, V124, P449, DOI 10.1017/S0950268899003817; Korppi M, 2010, PEDIATR INFECT DIS J, V29, P387, DOI 10.1097/INF.0b013e3181ce8e81; Lin F, 2008, J VIROL METHODS, V149, P110, DOI 10.1016/j.jviromet.2007.12.016; Lindner J, 2008, VIRAL IMMUNOL, V21, P443, DOI 10.1089/vim.2008.0045; Lindner J, 2008, J INFECT DIS, V198, P1677, DOI 10.1086/592985; Lu XY, 2006, J CLIN MICROBIOL, V44, P3231, DOI 10.1128/JCM.00889-06; Lusebrink J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019457; Ma XM, 2006, J CLIN MICROBIOL, V44, P1132, DOI 10.1128/JCM.44.3.1132-1134.2006; Manning A, 2006, J INFECT DIS, V194, P1283, DOI 10.1086/508219; Neske F, 2007, J CLIN MICROBIOL, V45, P2116, DOI 10.1128/JCM.00027-07; Neske F, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-215; Regamey N, 2007, PEDIATR INFECT DIS J, V26, P177, DOI 10.1097/01.inf.0000250623.43107.bc; Schildgen V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068020; Schnepp BC, 2005, J VIROL, V79, P14793, DOI 10.1128/JVI.79.23.14793-14803.2005; Sharp CP, 2010, J VIROL, V84, P10289, DOI 10.1128/JVI.01304-10; Smith-Whitley K, 2004, BLOOD, V103, P422, DOI 10.1182/blood-2003-01-0069; Soderlund-Venermo M, 2009, EMERG INFECT DIS, V15, P1423, DOI 10.3201/eid1509.090204; Zhao LQ, 2009, CHINESE MED J-PEKING, V122, P1289, DOI 10.3760/cma.j.issn.0366-6999.2009.11.010	41	5	5	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0122751	10.1371/journal.pone.0122751	http://dx.doi.org/10.1371/journal.pone.0122751			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923974	Green Published, gold, Green Submitted			2022-12-27	WOS:000353711600021
J	Vargas-Sanchez, GB; Romero-Valdovinos, M; Ramirez-Guerrero, C; Vargas-Hernandez, I; Ramirez-Miranda, ME; Martinez-Ocana, J; Valadez, A; Ximenez, C; Lopez-Escamilla, E; Hernandez-Campos, ME; Villalobos, G; Martinez-Hernandez, F; Maravilla, P				Vargas-Sanchez, Gie-Bele; Romero-Valdovinos, Mirza; Ramirez-Guerrero, Celedonio; Vargas-Hernandez, Ines; Elena Ramirez-Miranda, Maria; Martinez-Ocana, Joel; Valadez, Alicia; Ximenez, Cecilia; Lopez-Escamilla, Eduardo; Elena Hernandez-Campos, Maria; Villalobos, Guiehdani; Martinez-Hernandez, Fernando; Maravilla, Pablo			Blastocystis Isolates from Patients with Irritable Bowel Syndrome and from Asymptomatic Carriers Exhibit Similar Parasitological Loads, but Significantly Different Generation Times and Genetic Variability across Multiple Subtypes	PLOS ONE			English	Article							CLINICAL-SIGNIFICANCE; INTESTINAL PARASITES; SEQUENCE ALIGNMENT; PREVALENCE; EVOLUTION; HOMINIS; INDIVIDUALS; CULTIVATION; MICROBIOTA; PHYLOGENY	Blastocystis spp is a common intestinal parasite of humans and animals that has been associated to the etiology of irritable bowel syndrome (IBS); however, some studies have not found this association. Furthermore, many biological features of Blastocystis are little known. The objective of present study was to assess the generation times of Blastocystis cultures, from IBS patients and from asymptomatic carriers. A total of 100 isolates were obtained from 50 IBS patients and from 50 asymptomatic carriers. Up to 50 mg of feces from each participant were cultured in Barret's and in Pavlova's media during 48 h. Initial and final parasitological load were measured by microscopy and by quantitative PCR. Amplicons were purified, sequenced and submitted to GenBank; sequences were analysed for genetic diversity and a Bayesian inference allowed identifying genetic subtypes (ST). Generation times for Blastocystis isolates in both media, based on microscopic measures and molecular assays, were calculated. The clinical symptoms of IBS patients and distribution of Blastocystis ST 1, 2 and 3 in both groups was comparable to previous reports. Interestingly, the group of cases showed scarce mean nucleotide diversity (pi) as compared to the control group (0.011 +/- 0.016 and 0.118 +/- 0.177, respectively), whilst high gene flow and small genetic differentiation indexes between different ST were found. Besides, Tajima's D test showed negative values for ST1-ST3. No statistical differences regarding parasitological load between cases and controls in both media, as searched by microscopy and by qPCR, were detected except that parasites grew faster in Barret's than in Pavlova's medium. Interestingly, slow growth of isolates recovered from cases in comparison to those of controls was observed (p<0.05). We propose that generation times of Blastocystis might be easily affected by intestinal environmental changes due to IBS probably because virulent strains with slow growth may be selected, reducing their genetic variability.	[Vargas-Sanchez, Gie-Bele; Elena Hernandez-Campos, Maria] Inst Politecn Nacl, Escuela Super Med, Mexico City 11340, DF, Mexico; [Romero-Valdovinos, Mirza; Elena Ramirez-Miranda, Maria; Martinez-Ocana, Joel; Lopez-Escamilla, Eduardo; Martinez-Hernandez, Fernando; Maravilla, Pablo] Hosp Gen Dr Manuel Gea Gonzalez, Mexico City 14080, DF, Mexico; [Ramirez-Guerrero, Celedonio] Hosp Infantil Mexico Dr Federico Gomez, Mexico City 06720, DF, Mexico; [Valadez, Alicia; Ximenez, Cecilia] Univ Nacl Autonoma Mexico, Fac Med, Dept Expt Med, Mexico City 04510, DF, Mexico; [Villalobos, Guiehdani] Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolut, Mexico City 04510, DF, Mexico	Instituto Politecnico Nacional - Mexico; Hospital Infantil de Mexico Federico Gomez; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Maravilla, P (corresponding author), Hosp Gen Dr Manuel Gea Gonzalez, Calzada Tlalpan 4800,Secc XVI, Mexico City 14080, DF, Mexico.	maravillap@yahoo.com	Martínez-Ocaña, Joel/AGB-4819-2022; Hernandez-Campos, Maria Elena/R-3852-2018	Martínez-Ocaña, Joel/0000-0002-2189-749X; Hernandez-Campos, Maria Elena/0000-0002-1439-523X; Maravilla, Pablo/0000-0003-2534-9447; XIMENEZ, CECILIA/0000-0003-0574-4538	Consejo Nacional de Ciencia y Tecnologia (CONACYT) [182089, 168619]	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was sponsored by Consejo Nacional de Ciencia y Tecnologia (CONACYT) grant numbers 182089 and 168619.	Adam RD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-424; Alfellani MA, 2013, ACTA TROP, V126, P11, DOI 10.1016/j.actatropica.2012.12.011; BARRET Harvey P., 1921, Annals of Tropical Medicine and Parasitology, V15, P113; Bedi B, 2015, J EUKARYOT MICROBIOL, V62, P44, DOI 10.1111/jeu.12164; Boorom KF, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-40; Brandt LJ, 2002, AM J GASTROENTEROL, V97, pS7; Clark CG, 2002, CLIN MICROBIOL REV, V15, P329, DOI 10.1128/CMR.15.3.329-341.2002; Ramirez JD, 2014, INFECT GENET EVOL, V22, P223, DOI 10.1016/j.meegid.2013.07.020; Denoeud F, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r29; Doeschl-Wilson AB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007508; Dolezel J, 2003, CYTOM PART A, V51A, P127, DOI 10.1002/cyto.a.10013; DuPont HL, 2014, ALIMENT PHARM THER, V39, P1033, DOI 10.1111/apt.12728; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ramirez-Miranda ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-96; Jimenez-Gonzalez DE, 2012, PARASITOL RES, V110, P1269, DOI 10.1007/s00436-011-2626-7; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Giacometti A, 2003, J PARASITOL, V89, P490, DOI 10.1645/0022-3395(2003)089[0490:POIPAI]2.0.CO;2; Gomez C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/726045; Gonzalez-Bosquet J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014522; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Holder M, 2003, NAT REV GENET, V4, P275, DOI 10.1038/nrg1044; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Hyland NP, 2014, WORLD J GASTROENTERO, V20, P8859, DOI 10.3748/wjg.v20.i27.8859; Irikov OA, 2009, B EXP BIOL MED+, V148, P99, DOI 10.1007/s10517-009-0651-7; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Krogsgaard LR, 2015, CLIN GASTROENTEROL H, V13, P507, DOI 10.1016/j.cgh.2014.07.065; Leelayoova S, 2002, ANN TROP MED PARASIT, V96, P803, DOI 10.1179/000349802125002275; Little TJ, 2008, PARASITOLOGY, V135, P303, DOI 10.1017/S0031182007003939; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Mertz HR, 2003, NEW ENGL J MED, V349, P2136, DOI 10.1056/NEJMra035579; Olivo-Diaz A, 2012, PARASITOL RES, V111, P487, DOI 10.1007/s00436-012-2830-0; Pavlova E. A., 1938, Medical Parasitology and Parasitic Diseases Moscow, V7, P224; Poirier P, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002545; Poirier P, 2011, J CLIN MICROBIOL, V49, P975, DOI 10.1128/JCM.01392-10; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; QADRI SMH, 1989, J CLIN MICROBIOL, V27, P2407, DOI 10.1128/JCM.27.11.2407-2409.1989; Ragavan ND, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-404; Ramirez-Miranda M E, 2011, Rev Gastroenterol Mex, V76, P309; Read Andrew F., 1994, Trends in Microbiology, V2, P73, DOI 10.1016/0966-842X(94)90537-1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sambrook J., 2001, MOL CLONING LAB MANU; Sanchez-Aguillon F, 2013, J INFECT DEV COUNTR, V7, P763, DOI 10.3855/jidc.3512; Santos HJ, 2013, ASIAN PAC J TROP MED, V6, P780, DOI 10.1016/S1995-7645(13)60138-8; Scanlan PD, 2013, TRENDS PARASITOL, V29, P523, DOI 10.1016/j.pt.2013.08.006; Sistrom M, 2014, GENOME BIOL EVOL, V6, P2811, DOI 10.1093/gbe/evu222; Stensvold CR, 2009, EPIDEMIOL INFECT, V137, P1655, DOI 10.1017/S0950268809002672; Stensvold CR, 2012, INFECT GENET EVOL, V12, P263, DOI 10.1016/j.meegid.2011.11.002; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan TC, 2008, PARASITOL RES, V104, P85, DOI 10.1007/s00436-008-1163-5; Termmathurapoj S, 2004, PARASITOL RES, V93, P445, DOI 10.1007/s00436-004-1157-x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thompson WG, 2000, GUT, V46, P78, DOI 10.1136/gut.46.1.78; Tomasini N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103131; Tovy A, 2010, FUTURE MICROBIOL, V5, P1875, DOI 10.2217/FMB.10.140; Villalobos G, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0461-2; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; Yakoob J, 2004, AM J TROP MED HYG, V70, P383, DOI 10.4269/ajtmh.2004.70.383; Yakoob J, 2010, PARASITOL RES, V106, P1033, DOI 10.1007/s00436-010-1761-x; Zerpa LR, 2000, REV MEX PATOL CLIN, V47, P17; Zhang X, 2012, INT J INFECT DIS, V16, pE23, DOI 10.1016/j.ijid.2011.09.012	62	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124006	10.1371/journal.pone.0124006	http://dx.doi.org/10.1371/journal.pone.0124006			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923708	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600066
J	Feld, L; Hjelmso, MH; Nielsen, MS; Jacobsen, AD; Ronn, R; Ekelund, F; Krogh, PH; Strobel, BW; Jacobsen, CS				Feld, Louise; Hjelmso, Mathis Hjort; Nielsen, Morten Schostag; Jacobsen, Anne Dorthe; Ronn, Regin; Ekelund, Flemming; Krogh, Paul Henning; Strobel, Bjarne Westergaard; Jacobsen, Carsten Suhr			Pesticide Side Effects in an Agricultural Soil Ecosystem as Measured by amoA Expression Quantification and Bacterial Diversity Changes	PLOS ONE			English	Article							AMMONIA-OXIDIZING ARCHAEA; METHYL ISOTHIOCYANATE; NITROSOMONAS-EUROPAEA; COMMUNITIES; NITROGEN; NITRIFICATION; ABUNDANCE; FUMIGANTS; RNA; MONOOXYGENASE	Background and Methods Assessing the effects of pesticide hazards on microbiological processes in the soil is currently based on analyses that provide limited insight into the ongoing processes. This study proposes a more comprehensive approach. The side effects of pesticides may appear as changes in the expression of specific microbial genes or as changes in diversity. To assess the impact of pesticides on gene expression, we focused on the amoA gene, which is involved in ammonia oxidation. We prepared soil microcosms and exposed them to dazomet, mancozeb or no pesticide. We hypothesized that the amount of amoA transcript decreases upon pesticide application, and to test this hypothesis, we used reverse-transcription qPCR. We also hypothesized that bacterial diversity is affected by pesticides. This hypothesis was investigated via 454 sequencing and diversity analysis of the 16S ribosomal RNA and RNA genes, representing the active and total soil bacterial communities, respectively. Results and Conclusion Treatment with dazomet reduced both the bacterial and archaeal amoA transcript numbers by more than two log units and produced long-term effects for more than 28 days. Mancozeb also inhibited the numbers of amoA transcripts, but only transiently. The bacterial and archaeal amoA transcripts were both sensitive bioindicators of pesticide side effects. Additionally, the numbers of bacterial amoA transcripts correlated with nitrate production in Namended microcosms. Dazomet reduced the total bacterial numbers by one log unit, but the population size was restored after twelve days. The diversity of the active soil bacteria also seemed to be re-established after twelve days. However, the total bacterial diversity as reflected in the 16S ribosomal RNA gene sequences was largely dominated by Firmicutes and Proteobacteria at day twelve, likely reflecting a halt in the growth of early opportunists and the re-establishment of a more diverse population. We observed no effects of mancozeb on diversity.	[Feld, Louise; Hjelmso, Mathis Hjort; Nielsen, Morten Schostag; Jacobsen, Anne Dorthe; Jacobsen, Carsten Suhr] Geol Survey Denmark & Greenland GEUS, Dept Geochem, Copenhagen, Denmark; [Ronn, Regin; Ekelund, Flemming] Univ Copenhagen, Dept Biol, Sect Terr Ecol, Copenhagen, Denmark; [Krogh, Paul Henning] Univ Aarhus, Dept Biosci, Sect Soil Fauna Ecol & Ecotoxicol, Silkeborg, Denmark; [Strobel, Bjarne Westergaard] Univ Copenhagen, Dept Plant & Environm Sci, Sect Environm Chem & Phys, Frederiksberg, Denmark	Geological Survey Of Denmark & Greenland; University of Copenhagen; Aarhus University; University of Copenhagen	Feld, L (corresponding author), Geol Survey Denmark & Greenland GEUS, Dept Geochem, Copenhagen, Denmark.	lfe@geus.dk	Strobel, Bjarne W./AAG-9434-2021; Schostag, Morten Dencker/G-9653-2018; Krogh, Paul Henning/B-3566-2009; Rønn, Regin/K-4460-2014	Strobel, Bjarne W./0000-0001-9680-1715; Schostag, Morten Dencker/0000-0001-9221-1398; Krogh, Paul Henning/0000-0003-2033-553X; Rønn, Regin/0000-0002-7486-1191; Jacobsen, Carsten Suhr/0000-0003-1041-0823; Hjelmso, Mathis Hjort/0000-0001-9716-624X; Feld, Louise/0000-0002-5533-5604	Danish EPA [667-00082]	Danish EPA	The study was funded by a public grant 667-00082 from the Danish EPA.	Baelum J, 2008, ISME J, V2, P677, DOI 10.1038/ismej.2008.21; Bannert A, 2011, APPL ENVIRON MICROB, V77, P6109, DOI 10.1128/AEM.01751-10; BARTHA R, 1967, APPL MICROBIOL, V15, P67, DOI 10.1128/AEM.15.1.67-75.1967; Berg J, 2012, APPL ENVIRON MICROB, V78, P7438, DOI 10.1128/AEM.01071-12; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bock E, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P457, DOI 10.1007/0-387-30742-7_16; Bollmann A, 2005, APPL ENVIRON MICROB, V71, P1276, DOI 10.1128/AEM.71.3.1276-1282.2005; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cernohlavkova J, 2009, ECOTOX ENVIRON SAFE, V72, P80, DOI 10.1016/j.ecoenv.2008.07.001; Chang YJ, 2001, ENVIRON TOXICOL CHEM, V20, P2462, DOI [10.1897/1551-5028(2001)020&lt;2462:IOHOTA&gt;2.0.CO;2, 10.1002/etc.5620201110]; Di HJ, 2009, NAT GEOSCI, V2, P621, DOI 10.1038/NGEO613; Floch C, 2011, EUR J SOIL BIOL, V47, P256, DOI 10.1016/j.ejsobi.2011.05.007; Griffiths BS, 2000, OIKOS, V90, P279, DOI 10.1034/j.1600-0706.2000.900208.x; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hatzenpichler R, 2012, APPL ENVIRON MICROB, V78, P7501, DOI 10.1128/AEM.01960-12; He JZ, 2012, SOIL BIOL BIOCHEM, V55, P146, DOI 10.1016/j.soilbio.2012.06.006; Hernandez M, 2011, FEMS MICROBIOL ECOL, V78, P511, DOI 10.1111/j.1574-6941.2011.01180.x; Hjelmso MH, 2014, APPL ENVIRON MICROB, V80, P3568, DOI 10.1128/AEM.03923-13; Hood-Nowotny R, 2010, SOIL SCI SOC AM J, V74, P1018, DOI 10.2136/sssaj2009.0389; Ibekwe AM, 2001, APPL ENVIRON MICROB, V67, P3245, DOI 10.1128/AEM.67.7.3245-3257.2001; Iizumi T, 1998, APPL ENVIRON MICROB, V64, P3656; Jacobsen CS, 2014, CURR OPIN BIOTECH, V27, P15, DOI 10.1016/j.copbio.2013.09.003; Jia ZJ, 2009, ENVIRON MICROBIOL, V11, P1658, DOI 10.1111/j.1462-2920.2009.01891.x; KIM JH, 1994, J AGR FOOD CHEM, V42, P2019, DOI 10.1021/jf00045a035; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; LAM WW, 1993, J AGR FOOD CHEM, V41, P1497, DOI 10.1021/jf00033a027; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Liu MQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045306; Mao Y, 2011, PLOS ONE, V6, P1, DOI DOI 10.1371/J0URNALP0NE.0024750; Mertens J, 2006, ENVIRON MICROBIOL, V8, P2170, DOI 10.1111/j.1462-2920.2006.01100.x; Meyer A, 2014, MICROB ECOL, V67, P161, DOI 10.1007/s00248-013-0310-4; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; Nicol GW, 2008, ENVIRON MICROBIOL, V10, P2966, DOI 10.1111/j.1462-2920.2008.01701.x; Nyberg KA, 2012, MICROB ECOL, V63, P701, DOI 10.1007/s00248-011-9970-0; OECD, 2000, TEST NO 106 AD DES U, DOI [10.1787/9789264069602-en, DOI 10.1787/9789264069602-EN]; Ofek M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040117; Pell M, 1998, AMBIO, V27, P24; Prosser JI, 2012, TRENDS MICROBIOL, V20, P523, DOI 10.1016/j.tim.2012.08.001; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Ruzo LO, 2006, PEST MANAG SCI, V62, P99, DOI 10.1002/ps.1135; Schauss K, 2009, ENVIRON MICROBIOL, V11, P446, DOI 10.1111/j.1462-2920.2008.01783.x; Shrestha PM, 2007, ENVIRON MICROBIOL, V9, P2464, DOI 10.1111/j.1462-2920.2007.01364.x; Spyrou IM, 2009, MICROB ECOL, V58, P715, DOI 10.1007/s00248-009-9522-z; Stein LY, 1997, APPL ENVIRON MICROB, V63, P4588, DOI 10.1128/AEM.63.11.4588-4592.1997; Taylor AE, 2012, ISME J, V6, P2024, DOI 10.1038/ismej.2012.51; Tourna M, 2011, P NATL ACAD SCI USA, V108, P8420, DOI 10.1073/pnas.1013488108; Treusch AH, 2005, ENVIRON MICROBIOL, V7, P1985, DOI 10.1111/j.1462-2920.2005.00906.x; Ufer A., 1995, Acta Horticulturae, P110; US EPA, 2005, RER EL DEC MANC; van Elsas JD, 2012, P NATL ACAD SCI USA, V109, P1159, DOI 10.1073/pnas.1109326109; VONK JW, 1991, TOXICOL ENVIRON CHEM, V30, P241, DOI 10.1080/02772249109357662; Wertz S, 2006, ENVIRON MICROBIOL, V8, P2162, DOI 10.1111/j.1462-2920.2006.01098.x; Wessen E, 2011, ECOL INDIC, V11, P1696, DOI 10.1016/j.ecolind.2011.04.018; Yang WJ, 2014, SOIL BIOL BIOCHEM, V69, P197, DOI 10.1016/j.soilbio.2013.10.030; Yu BB, 2014, APPL MICROBIOL BIOT, V98, P263, DOI 10.1007/s00253-013-5311-1	57	58	62	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0126080	10.1371/journal.pone.0126080	http://dx.doi.org/10.1371/journal.pone.0126080			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938467	Green Published, gold, Green Submitted			2022-12-27	WOS:000353943000136
J	Roh, SS; Smith, LE; Lee, JS; Via, LE; Barry, CE; Alland, D; Chakravorty, S				Roh, Sandy S.; Smith, Laura E.; Lee, Jong Seok; Via, Laura E.; Barry, Clifton E., III; Alland, David; Chakravorty, Soumitesh			Comparative Evaluation of Sloppy Molecular Beacon and Dual-Labeled Probe Melting Temperature Assays to Identify Mutations in Mycobacterium tuberculosis Resulting in Rifampin, Fluoroquinolone and Aminoglycoside Resistance	PLOS ONE			English	Article							REAL-TIME PCR; DRUG-RESISTANCE; DIAGNOSTICS; GENES; SUSCEPTIBILITY; IDENTIFICATION; OFLOXACIN; SELECTION; REGIONS; CHINA	Several molecular assays to detect resistance to Rifampin, the Fluoroquinolones, and Aminoglycosides in Mycobacterium tuberculosis (M. tuberculosis) have been recently described. A systematic approach for comparing these assays in the laboratory is needed in order to determine the relative advantage of each assay and to decide which ones should be advanced to evaluation. We performed an analytic comparison of a Sloppy Molecular Beacon (SMB) melting temperature (Tm) assay and a Dual labeled probe (DLP) Tm assay. Both assays targeted the M. tuberculosis rpoB, gyrA, rrs genes and the eis promoter region. The sensitivity and specificity to detect mutations, analytic limit of detection (LOD) and the detection of heteroresistance were tested using a panel of 56 clinical DNA samples from drug resistant M. tuberculosis strains. Both SMB and DLP assays detected 29/29 (100%) samples with rpoB RRDR mutations and 3/3 (100%) samples with eis promoter mutations correctly. The SMB assay detected all 17/17 gyrA mutants and 22/22 rrs mutants, while the DLP assay detected 16/17 (94%) gyrA mutants and 12/22 (55%) rrs mutants. Both assays showed comparable LODs for detecting rpoB and eis mutations; however, the SMB assay LODs were at least two logs better for detecting wild type and mutants in gyrA and rrs targets. The SMB assay was also moderately better at detecting heteroresistance. In summary, both assays appeared to be promising methods to detect drug resistance associated mutations in M. tuberculosis; however, the relative advantage of each assay varied under each test condition.	[Roh, Sandy S.; Smith, Laura E.; Alland, David; Chakravorty, Soumitesh] Rutgers State Univ, Dept Med, New Jersey Med Sch, Newark, NJ 07102 USA; [Lee, Jong Seok] Int TB Res Ctr, Dept Microbiol, Chang Won, Gyeongsang, South Korea; [Via, Laura E.; Barry, Clifton E., III] NIAID, TB Res Sect, LCID, NIH, Bethesda, MD 20892 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Chakravorty, S (corresponding author), Rutgers State Univ, Dept Med, New Jersey Med Sch, Newark, NJ 07102 USA.	chakraso@njms.rutgers.edu	Barry, Clifton E/ABE-7992-2020; Via, Laura/AAD-3917-2021; Barry, III, Clifton/H-3839-2012	Barry, Clifton E/0000-0002-2927-270X; Via, Laura/0000-0001-6074-9521; Barry, III, Clifton/0000-0002-2927-270X	U.S. National Institutes of Health (NIH) grant [AI080653]; NIAID, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080653, ZIAAI001067] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the U.S. National Institutes of Health (NIH) grant AI080653 (DA, LES, SC and SSR). Partial funding for the clinical study in Masan, South Korea was provided by the intramural research program of NIAID, NIH (CEB and LEV).	Ajbani K, 2011, J CLIN MICROBIOL, V49, P2546, DOI 10.1128/JCM.02511-10; An DD, 2009, ANTIMICROB AGENTS CH, V53, P4835, DOI 10.1128/AAC.00541-09; Balasingham SV, 2009, MOL DIAGN THER, V13, P137, DOI 10.2165/01250444-200913030-00001; Blakemore R, 2010, J CLIN MICROBIOL, V48, P2495, DOI 10.1128/JCM.00128-10; Bonnet G, 1999, P NATL ACAD SCI USA, V96, P6171, DOI 10.1073/pnas.96.11.6171; Campbell PJ, 2011, ANTIMICROB AGENTS CH, V55, P2032, DOI 10.1128/AAC.01550-10; Chakravorty S, 2014, J CLIN MICROBIOL; Chakravorty S, 2012, J CLIN MICROBIOL, V50, P2194, DOI 10.1128/JCM.00143-12; Chakravorty S, 2011, J CLIN MICROBIOL, V49, P932, DOI 10.1128/JCM.02271-10; Chakravorty S, 2010, J CLIN MICROBIOL, V48, P258, DOI 10.1128/JCM.01725-09; Cui ZL, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-78; Dauendorffer JN, 2003, J CLIN MICROBIOL, V41, P1311, DOI 10.1128/JCM.41.3.1311-1315.2003; Farhat MR, 2013, NAT GENET, V45, P1183, DOI 10.1038/ng.2747; Feng Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055292; Feuerriegel S, 2009, ANTIMICROB AGENTS CH, V53, P3353, DOI 10.1128/AAC.00050-09; Grimaldo ER, 2001, INT J TUBERC LUNG D, V5, P546; Heifets L, 2000, J CLIN MICROBIOL, V38, P1227, DOI 10.1128/JCM.38.3.1227-1230.2000; Hillery N, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-434; Jamieson FB, 2014, J CLIN MICROBIOL, V52, P2157, DOI 10.1128/JCM.00691-14; Kalokhe AS, 2013, AM J MED SCI, V345, P143, DOI 10.1097/MAJ.0b013e31825d32c6; Khare R, 2014, J CLIN MICROBIOL, V52, P1711, DOI 10.1128/JCM.00358-14; Kim SJ, 2005, EUR RESPIR J, V25, P564, DOI 10.1183/09031936.05.00111304; Koser CU, 2013, NEW ENGL J MED, V369, P290, DOI 10.1056/NEJMc1215305; Liu QY, 2013, J ANTIMICROB CHEMOTH, V68, P1097, DOI 10.1093/jac/dks509; Luo T, 2011, J CLIN MICROBIOL, V49, P3132, DOI 10.1128/JCM.02046-10; Ma X, 2006, J CLIN MICROBIOL, V44, P3409, DOI 10.1128/JCM.00515-06; Marras Salvatore A. E., 2006, V335, P3; Nebenzahl-Guimaraes H, 2014, J ANTIMICROB CHEMOTH, V69, P331, DOI 10.1093/jac/dkt358; O'Grady J, 2011, CURR OPIN PULM MED, V17, P134, DOI 10.1097/MCP.0b013e3283452346; Rice JE, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks731; Rodwell TC, 2014, J CLIN MICROBIOL, V52, P781, DOI 10.1128/JCM.02701-13; WHO, 2014, GLOBAL TUBERCULOSIS; Xu P, 2009, ANTIMICROB AGENTS CH, V53, P3170, DOI 10.1128/AAC.00177-09; Yadav R, 2012, J APPL MICROBIOL, V113, P856, DOI 10.1111/j.1365-2672.2012.05379.x; Zhang HT, 2013, NAT GENET, V45, P1255, DOI 10.1038/ng.2735; Zimenkov DV, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-240	36	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0126257	10.1371/journal.pone.0126257	http://dx.doi.org/10.1371/journal.pone.0126257			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938476	Green Submitted, Green Published, gold			2022-12-27	WOS:000353943000156
J	Yan, XR; Marini, J; Mulligan, R; Deleault, A; Sharma, U; Brenner, MP; Rutledge, GC; Freyman, T; Pham, QP				Yan, Xuri; Marini, John; Mulligan, Robert; Deleault, Abby; Sharma, Upma; Brenner, Michael P.; Rutledge, Gregory C.; Freyman, Toby; Pham, Quynh P.			Slit-Surface Electrospinning: A Novel Process Developed for High-Throughput Fabrication of Core-Sheath Fibers	PLOS ONE			English	Article							NANOFIBERS; RELEASE; HOLLOW	In this work, we report on the development of slit-surface electrospinning - a process that co-localizes two solutions along a slit surface to spontaneously emit multiple core-sheath cone-jets at rates of up to 1 L/h. To the best of our knowledge, this is the first time that production of electrospun core-sheath fibers has been scaled to this magnitude. Fibers produced in this study were defect-free (i.e. non-beaded) and core-sheath geometry was visually confirmed under scanning electron microscopy. The versatility of our system was demonstrated by fabrication of (1) fibers encapsulating a drug, (2) bicomponent fibers, (3) hollow fibers, and (4) fibers from a polymer that is not normally electrospinnable. Additionally, we demonstrate control of the process by modulating parameters such as flow rate, solution viscosity, and fixture design. The technological achievements demonstrated in this work significantly advance core-sheath electrospinning towards commercial and manufacturing viability.	[Yan, Xuri; Marini, John; Mulligan, Robert; Deleault, Abby; Sharma, Upma; Freyman, Toby; Pham, Quynh P.] Arsenal Med Inc, Watertown, MA 02472 USA; [Brenner, Michael P.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Rutledge, Gregory C.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT)	Pham, QP (corresponding author), Arsenal Med Inc, Watertown, MA 02472 USA.	qpham@arsenalmedical.com			U.S. Department of Commerce, National Institute of Standards and Technology, Technology Innovation Program [70NANB11H004]; Arsenal Medical, Inc.	U.S. Department of Commerce, National Institute of Standards and Technology, Technology Innovation Program; Arsenal Medical, Inc.	This work was funded in part by the U.S. Department of Commerce, National Institute of Standards and Technology, Technology Innovation Program (http://www.nist.gov/tip), Cooperative Agreement #70NANB11H004. Additionally, coauthors Xuri Yan, John Marini, Robert Mulligan, Abby Deleault, Upma Sharma, Toby Freyman, and Quynh P. Pham received funding in the form of salaries from Arsenal Medical, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedford NM, 2010, ACS APPL MATER INTER, V2, P2448, DOI 10.1021/am1005089; Cohen I, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.026302; Cohen I, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.074501; Cohen I, 2001, SCIENCE, V292, P265, DOI 10.1126/science.1059175; Forward KM, 2013, CHEM ENG SCI, V104, P250, DOI 10.1016/j.ces.2013.09.002; Fuh YK, 2012, J MACROMOL SCI B, V51, P1742, DOI 10.1080/00222348.2012.659628; Han DW, 2009, LANGMUIR, V25, P9454, DOI 10.1021/la900660v; Huang HH, 2009, J BIOMED MATER RES A, V90A, P1243, DOI 10.1002/jbm.a.32543; Jiang GJ, 2013, MATER LETT, V106, P56, DOI 10.1016/j.matlet.2013.04.084; McCann JT, 2005, J MATER CHEM, V15, P735, DOI 10.1039/b415094e; Mickova A, 2012, BIOMACROMOLECULES, V13, P952, DOI 10.1021/bm2018118; Moghe AK, 2008, POLYM REV, V48, P353, DOI 10.1080/15583720802022257; Sohrabi A, 2013, POLYMER, V54, P2699, DOI 10.1016/j.polymer.2013.03.046; Su Y, 2011, J BIOMAT SCI-POLYM E, V22, P165, DOI 10.1163/092050609X12583785588757; Sun ZC, 2003, ADV MATER, V15, P1929, DOI 10.1002/adma.200305136; Theron SA, 2005, POLYMER, V46, P2889, DOI 10.1016/j.polymer.2005.01.054; Thoppey NM, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/34/345301; Varabhas JS, 2008, POLYMER, V49, P4226, DOI 10.1016/j.polymer.2008.07.043; Wei K, 2011, MACROMOL BIOSCI, V11, P1526, DOI 10.1002/mabi.201100141; Wu XF, 2013, J APPL POLYM SCI, V129, P1383, DOI 10.1002/app.38838; Yi F, 2008, MACROMOL BIOSCI, V8, P803, DOI 10.1002/mabi.200800041; Yu JH, 2004, ADV MATER, V16, P1562, DOI 10.1002/adma.200306644; Zander NE, 2013, POLYMERS-BASEL, V5, P19, DOI 10.3390/polym5010019; Zhou FL, 2010, J APPL POLYM SCI, V115, P2591, DOI 10.1002/app.31282	24	36	38	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125407	10.1371/journal.pone.0125407	http://dx.doi.org/10.1371/journal.pone.0125407			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938411	Green Published, gold, Green Submitted			2022-12-27	WOS:000353943000064
J	Conley, AC; Marquez, J; Parsons, MW; Fulham, WR; Heathcote, A; Karayanidis, F				Conley, Alexander C.; Marquez, Jodie; Parsons, Mark W.; Fulham, W. Ross; Heathcote, Andrew; Karayanidis, Frini			Anodal tDCS over the Motor Cortex on Prepared and Unprepared Responses in Young Adults	PLOS ONE			English	Article							DIRECT-CURRENT STIMULATION; NONINVASIVE BRAIN-STIMULATION; EXCITABILITY; TASK; POLARIZATION; INHIBITION; MODULATION; HANDEDNESS	Anodal transcranial direct current stimulation (tDCS) over the primary motor cortex (M1) has been proposed as a possible therapeutic rehabilitation technique for motor impairment. However, despite extensive investigation into the effects of anodal tDCS on motor output, there is little information on how anodal tDCS affects response processes. In this study, we used a cued go/nogo task with both directional and non-directional cues to assess the effects of anodal tDCS over the dominant (left) primary motor cortex on prepared and unprepared motor responses. Three experiments explored whether the effectiveness of tDCS varied with timing between stimulation and test. Healthy, right-handed young adults participated in a double-blind randomised controlled design with crossover of anodal tDCS and sham stimulation. In Experiment 1, twenty-four healthy young adults received anodal tDCS over dominant M1 at least 40 mins before task performance. In Experiment 2, eight participants received anodal tDCS directly before task performance. In Experiment 3, twenty participants received anodal tDCS during task performance. In all three experiments, participants responded faster to directional compared to non-directional cues and with their right hand. However, anodal tDCS had no effect on go/nogo task performance at any stimulation - test interval. Bayesian analysis confirmed that anodal stimulation had no effect on response speed. We conclude that anodal tDCS over M1 does not improve response speed of prepared or unprepared responses of young adults in a go/nogo task.	[Conley, Alexander C.; Fulham, W. Ross; Heathcote, Andrew; Karayanidis, Frini] Univ Newcastle, Sch Psychol, Funct Neuroimaging Lab, Newcastle, NSW 2300, Australia; [Conley, Alexander C.; Marquez, Jodie; Parsons, Mark W.; Fulham, W. Ross; Heathcote, Andrew; Karayanidis, Frini] Univ Newcastle, Prior Res Ctr Translat Neurosci & Mental Hlth, Newcastle, NSW 2300, Australia; [Conley, Alexander C.; Marquez, Jodie; Parsons, Mark W.; Fulham, W. Ross; Heathcote, Andrew; Karayanidis, Frini] Hunter Med Res Inst, Newcastle, NSW, Australia; [Marquez, Jodie] Univ Newcastle, Sch Hlth Sci, Newcastle, NSW 2300, Australia; [Parsons, Mark W.] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW 2300, Australia	University of Newcastle; University of Newcastle; Hunter Medical Research Institute; University of Newcastle; University of Newcastle; University of Newcastle	Karayanidis, F (corresponding author), Univ Newcastle, Sch Psychol, Funct Neuroimaging Lab, Newcastle, NSW 2300, Australia.	Frini.karayanidis@newcastle.edu.au	Karayanidis, Frini/I-9269-2012; Heathcote, Andrew/C-1856-2008; marquez, jodie L/G-8105-2013; Conley, Alexander Christian/O-1700-2019	Karayanidis, Frini/0000-0002-3317-9954; Heathcote, Andrew/0000-0003-4324-5537; marquez, jodie L/0000-0002-9845-5788; Conley, Alexander Christian/0000-0003-1159-5524	University of Newcastle Post-Graduate Research Scholarship [3092298]	University of Newcastle Post-Graduate Research Scholarship	This work was funded by a University of Newcastle Post-Graduate Research Scholarship for ACC (Reference No. 3092298).	Bachmann CG, 2010, CLIN NEUROPHYSIOL, V121, P2083, DOI 10.1016/j.clinph.2010.05.005; Boggio PS, 2006, NEUROSCI LETT, V404, P232, DOI 10.1016/j.neulet.2006.05.051; Bortoletto M, 2015, BRAIN STIMUL, V8, P269, DOI 10.1016/j.brs.2014.11.006; Miranda PC, 2013, NEUROIMAGE, V70, P48, DOI 10.1016/j.neuroimage.2012.12.034; Cogiamanian F, 2007, EUR J NEUROSCI, V26, P242, DOI 10.1111/j.1460-9568.2007.05633.x; Gomes-Osman J, 2013, J MOTOR BEHAV, V45, P361, DOI 10.1080/00222895.2013.808604; Hayduk-Costa G, 2013, BEHAV BRAIN RES, V257, P208, DOI 10.1016/j.bbr.2013.09.030; Hsu TY, 2011, NEUROIMAGE, V56, P2249, DOI 10.1016/j.neuroimage.2011.03.059; JEBSEN R H, 1969, Archives of Physical Medicine and Rehabilitation, V50, P311; Jeffery DT, 2007, EXP BRAIN RES, V182, P281, DOI 10.1007/s00221-007-1093-y; Jeffreys H, 1961, THE THEORY OF PROBAB; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kwon YH, 2013, J PHYS THER SCI, V25, P1083, DOI 10.1589/jpts.25.1083; Leite J., 2011, PLOS ONE, V6; Lindenberg R, 2013, J NEUROSCI, V33, P9176, DOI 10.1523/JNEUROSCI.0055-13.2013; Miniussi C, 2013, NEUROSCI BIOBEHAV R, V37, P1702, DOI 10.1016/j.neubiorev.2013.06.014; Miyaguchi S, 2013, BRAIN RES, V1529, P83, DOI 10.1016/j.brainres.2013.07.026; Morey R. D., 2013, BAYESFACTOR COMPUTAT; Morey RD, 2008, TUTOR QUANT METHODS, V4, P61, DOI 10.20982/tqmp.04.2.p061; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2003, J COGNITIVE NEUROSCI, V15, P619, DOI 10.1162/089892903321662994; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2003, CLIN NEUROPHYSIOL, V114, P600, DOI 10.1016/S1388-2457(02)00412-1; Nitsche MA, 2003, J PHYSIOL-LONDON, V553, P293, DOI 10.1113/jphysiol.2003.049916; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pellicciari MC, 2013, NEUROIMAGE, V83, P569, DOI 10.1016/j.neuroimage.2013.06.076; Rouder JN, 2012, J MATH PSYCHOL, V56, P356, DOI 10.1016/j.jmp.2012.08.001; Schmidt SL, 2000, BRAIN COGNITION, V44, P445, DOI 10.1006/brcg.1999.1204; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Utz KS, 2010, NEUROPSYCHOLOGIA, V48, P2789, DOI 10.1016/j.neuropsychologia.2010.06.002; Vines BW, 2008, EUR J NEUROSCI, V28, P1667, DOI 10.1111/j.1460-9568.2008.06459.x; Vines BW, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-103; Wechsler D., 1997, WECHSLER ADULT INTEL; Zimerman M, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00149	35	9	9	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124509	10.1371/journal.pone.0124509	http://dx.doi.org/10.1371/journal.pone.0124509			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933204	Green Published, gold			2022-12-27	WOS:000353887100047
J	Elhag, AAM; Mohamad, R; Aziz, MW; Zeshan, F				Elhag, Arafat Abdulgader Mohammed; Mohamad, Radziah; Aziz, Muhammad Waqar; Zeshan, Furkh			A Systematic Composite Service Design Modeling Method Using Graph-Based Theory	PLOS ONE			English	Article							ORIENTED SOFTWARE; IDENTIFICATION; IMPACT	The composite service design modeling is an essential process of the service-oriented software development life cycle, where the candidate services, composite services, operations and their dependencies are required to be identified and specified before their design. However, a systematic service-oriented design modeling method for composite services is still in its infancy as most of the existing approaches provide the modeling of atomic services only. For these reasons, a new method (ComSDM) is proposed in this work for modeling the concept of service-oriented design to increase the reusability and decrease the complexity of system while keeping the service composition considerations in mind. Furthermore, the ComSDM method provides the mathematical representation of the components of service-oriented design using the graph-based theory to facilitate the design quality measurement. To demonstrate that the ComSDM method is also suitable for composite service design modeling of distributed embedded real-time systems along with enterprise software development, it is implemented in the case study of a smart home. The results of the case study not only check the applicability of ComSDM, but can also be used to validate the complexity and reusability of ComSDM. This also guides the future research towards the design quality measurement such as using the ComSDM method to measure the quality of composite service design in service-oriented software system.	[Elhag, Arafat Abdulgader Mohammed] Int Univ Africa, Fac Comp Study, Dept Comp Sci, Khartoum, Sudan; [Elhag, Arafat Abdulgader Mohammed; Mohamad, Radziah; Zeshan, Furkh] Univ Teknol Malaysia, Fac Comp, Dept Software Engn, Skudai, Johor, Malaysia; [Aziz, Muhammad Waqar] Umm Al Qura Univ, Sci & Technol Unit, Mecca, Saudi Arabia	Universiti Teknologi Malaysia; Umm Al Qura University	Elhag, AAM (corresponding author), Int Univ Africa, Fac Comp Study, Dept Comp Sci, Khartoum, Sudan.	arofei@hotmail.com	Zeshan, Furkh/I-4818-2014; Zeshan, Furkh/U-5362-2019; Mohamad, Radziah/F-8422-2011	Zeshan, Furkh/0000-0003-2723-5670; Zeshan, Furkh/0000-0002-2960-9632; Mohamad, Radziah/0000-0003-4075-9604	International University of Africa, IUA	International University of Africa, IUA	We would like to thank Universiti Teknologi Malaysia (UTM) and member of Software Engineering Research Group (SERG). In addition, the authors would like to express their deepest gratitude to International University of Africa, IUA for continuous support.	Arsanjani A, 2008, IBM SYST J, V47, P377, DOI 10.1147/sj.473.0377; ARSANJANI A., 2004, IBM DEV WORKS; Bingu S, 2008, SOFTW ENG C 2008 APS; Briand LC, 1996, IEEE T SOFTWARE ENG, V22, P68, DOI 10.1109/32.481535; Bunke H, 2000, PATTERN RECOGN LETT, V21, P163, DOI 10.1016/S0167-8655(99)00143-9; Chaari S, 2007, ENTERPRISE INTEROPERABILITY II: NEW CHALLENGES AND APPROACHES, P495, DOI 10.1007/978-1-84628-858-6_54; Choi SW, 2008, E COMM TECHN 5 IEEE; Daghaghzadeh M., 2011, INT J COMPUTER SCI, V8; Dash RE, 2007, SERVICE ORIENTED ARC; Ding S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097762; Ding S, 2014, KNOWL-BASED SYST, V56, P216, DOI 10.1016/j.knosys.2013.11.014; Elhag A. A. M., 2013, COMP EL EL ENG ICCEE; Erl T., 2005, SERVICE ORIENTED ARC; Erl T., 2008, SOA PRINCIPLES SERVI, V1; Gao H., 2009, E BUS INF SYST SEC 2; Gebhart M., 2010, SOFTW ENG ADV ICSEA; Gu Q, 2010, LECT NOTES COMPUT SC, V6481, P37, DOI 10.1007/978-3-642-17694-4_4; Hirzalla M, 2009, LECT NOTES COMPUT SC, V5472, P41, DOI 10.1007/978-3-642-01247-1_5; Huergo RS, 2014, SERV ORIENTED COMPUT, V8, P199, DOI 10.1007/s11761-014-0161-y; Jordan Diane, 2007, 11 OASIS, V11, P11; Kim TH, 2010, IEEE T SERV COMPUT, V3, P236, DOI 10.1109/TSC.2010.2; Kim Y, 2013, INT J WEB GRID SERV, V9, P35, DOI 10.1504/IJWGS.2013.052847; Kohlborn T, 2009, SERVICE ANAL CRITICA; Kontogiannis K., 2007, SYST DEV SOA ENV 200; Krafzig Dirk, 2005, ENTERPRISE SOA SERVI; Lane S, 2011, INFORM SOFTWARE TECH, V53, P424, DOI 10.1016/j.infsof.2010.12.005; McHeick H, 2012, INN INF TECHN IIT 20; Micallef M, 2001, AUTOMATED SOFTWARE Q; Mohamad R, 2012, IET SOFTW, V6, P74, DOI 10.1049/iet-sen.2010.0159; Mohamad R., 2014, SOFTW ENG C MYSEC 20; Mohammed AA., 2010, STUDY SOFTWARE PROCE; Perepletchikov Mikhail, 2008, Journal of Software, V3, P1, DOI 10.4304/jsw.3.2.1-14; Perepletchikov M., 2007, SOFTW ENG C 2007 ASW; Perepletchikov M, 2011, IEEE T SOFTWARE ENG, V37, P449, DOI 10.1109/TSE.2010.61; Perepletchikov M, 2010, IEEE T SERV COMPUT, V3, P89, DOI 10.1109/TSC.2010.23; Qingqing Z, 2009, P 2009 2 INT S KNOWL, V03, P375; Rostampour A, 2011, ADV COMM TECHN ICACT; Sindhgatta R, 2009, LECT NOTES COMPUT SC, V5900, P485, DOI 10.1007/978-3-642-10383-4_36; Singh MP, 2006, SERVICE ORIENTED COM, P71; Tao Z, 2006, QUAL SOFTW 2006 QSIC; ZADEH AT, 2012, J APPL SCI, V12, P1232, DOI DOI 10.3923/jas.2012.1232.1244; Zhang QQ, 2009, 2009 2 INT S KNOWL A, V3; Zhang T, 2008, ENTERP INF SYST-UK, V2, P239, DOI 10.1080/17517570802285959	43	4	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0123086	10.1371/journal.pone.0123086	http://dx.doi.org/10.1371/journal.pone.0123086			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928358	gold, Green Published, Green Submitted			2022-12-27	WOS:000353713100014
J	Feeley, K				Feeley, Kenneth			Are We Filling the Data Void? An Assessment of the Amount and Extent of Plant Collection Records and Census Data Available for Tropical South America	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; FUTURE DISTRIBUTIONS; BIG DATA; CONSERVATION; BIODIVERSITY; DIVERSITY; LIMITATIONS; PATTERNS; ENDEMISM; ECOLOGY	Large-scale studies are needed to increase our understanding of how large-scale conservation threats, such as climate change and deforestation, are impacting diverse tropical ecosystems. These types of studies rely fundamentally on access to extensive and representative datasets (i.e., "big data"). In this study, I asses the availability of plant species occurrence records through the Global Biodiversity Information Facility (GBIF) and the distribution of networked vegetation census plots in tropical South America. I analyze how the amount of available data has changed through time and the consequent changes in taxonomic, spatial, habitat, and climatic representativeness. I show that there are large and growing amounts of data available for tropical South America. Specifically, there are almost 2,000,000 unique geo-referenced collection records representing more than 50,000 species of plants in tropical South America and over 1,500 census plots. However, there is still a gaping "data void" such that many species and many habitats remain so poorly represented in either of the databases as to be functionally invisible for most studies. It is important that we support efforts to increase the availability of data, and the representativeness of these data, so that we can better predict and mitigate the impacts of anthropogenic disturbances.	[Feeley, Kenneth] Florida Int Univ, Dept Biol Sci, Int Ctr Trop Bot, Miami, FL 33199 USA; [Feeley, Kenneth] Fairchild Trop Bot Garden, Coral Gables, FL USA	State University System of Florida; Florida International University	Feeley, K (corresponding author), Florida Int Univ, Dept Biol Sci, Int Ctr Trop Bot, Miami, FL 33199 USA.	kjfeeley@gmail.com	Feeley, Kenneth James/A-7631-2009	Feeley, Kenneth James/0000-0002-3618-1144	FIU Library's Open Access Publishing Fund; Direct For Biological Sciences [1257655] Funding Source: National Science Foundation	FIU Library's Open Access Publishing Fund; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	I gratefully acknowledge the thousands of hardworking scientists and workers who contribute to online databases and plot networks worldwide and thus help to make big ecology possible. I thank M. Silman for his contributions to the original "data void" assessment and A. Duque, W. Farfan, and all of the FIU Tropical Ecology and Conservation lab for their comments and suggestions on this manuscript. Publication of this article was funded in part by FIU Library's Open Access Publishing Fund. This is contribution #299 from the Tropical Biology Program of FIU.	Anderson-Teixeira K.J., 2014, GLOBAL CHANGE BIOL; Collen B, 2008, TROP CONSERV SCI, V1, P75, DOI 10.1177/194008290800100202; Feeley KJ, 2012, GLOBAL CHANGE BIOL, V18, P2636, DOI 10.1111/j.1365-2486.2012.02719.x; Feeley KJ, 2012, GLOBAL CHANGE BIOL, V18, P1335, DOI 10.1111/j.1365-2486.2011.02602.x; Feeley KJ, 2011, DIVERS DISTRIB, V17, P1132, DOI 10.1111/j.1472-4642.2011.00813.x; Feeley KJ, 2011, GLOBAL CHANGE BIOL, V17, P626, DOI 10.1111/j.1365-2486.2010.02239.x; Feeley KJ, 2010, J BIOGEOGR, V37, P733, DOI 10.1111/j.1365-2699.2009.02240.x; Feeley KJ, 2009, P NATL ACAD SCI USA, V106, P12382, DOI 10.1073/pnas.0900698106; Feeley KJ, 2015, AM J BOT, V102, P1, DOI [10.3732/ajb.102.1.1, DOI 10.3732/AJB.102.1.1]; Graham CH, 2008, J APPL ECOL, V45, P239, DOI 10.1111/j.1365-2664.2007.01408.x; Guitet S, 2014, FOREST ECOL MANAG, V328, P270, DOI 10.1016/j.foreco.2014.05.045; Hampton SE, 2013, FRONT ECOL ENVIRON, V11, P156, DOI 10.1890/120103; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hopkins MJG, 2007, J BIOGEOGR, V34, P1400, DOI 10.1111/j.1365-2699.2007.01737.x; Hortal J, 2007, CONSERV BIOL, V21, P853, DOI 10.1111/j.1523-1739.2007.00686.x; Joppa LN, 2011, P NATL ACAD SCI USA, V108, P13171, DOI 10.1073/pnas.1109389108; Joppa LN, 2011, P ROY SOC B-BIOL SCI, V278, P554, DOI 10.1098/rspb.2010.1004; Kadmon R, 2004, ECOL APPL, V14, P401, DOI 10.1890/02-5364; Klink CA, 2005, CONSERV BIOL, V19, P707, DOI 10.1111/j.1523-1739.2005.00702.x; Lewis SL, 2004, PHILOS T ROY SOC B, V359, P421, DOI 10.1098/rstb.2003.1431; Lewis SL, 2004, PHILOS T R SOC B, V359, P437, DOI 10.1098/rstb.2003.1432; Loiselle BA, 2008, J BIOGEOGR, V35, P105, DOI 10.1111/j.1365-2699.2007.01779.x; Lomolino MV, 2004, FRONTIERS OF BIOGEOGRAPHY: NEW DIRECTIONS IN THE GEOGRAPHY OF NATURE, P1; Moerman DE, 2006, J BIOGEOGR, V33, P1969, DOI 10.1111/j.1365-2699.2006.01549.x; NELSON BW, 1990, NATURE, V345, P714, DOI 10.1038/345714a0; Newbold T, 2010, PROG PHYS GEOG, V34, P3, DOI 10.1177/0309133309355630; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Pitman NCA, 2011, TROP CONSERV SCI, V4, P64, DOI 10.1177/194008291100400107; Ramirez-Villegas J, 2014, J NAT CONSERV, V22, P391, DOI 10.1016/j.jnc.2014.03.007; Soranno PA, 2014, FRONT ECOL ENVIRON, V12, P3, DOI 10.1890/1540-9295-12.1.3; Swenson JJ, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-1; ter Steege H, 2006, NATURE, V443, P444, DOI 10.1038/nature05134; ter Steege H, 2013, SCIENCE, V342, P325, DOI 10.1126/science.1243092; Tobler M, 2007, BIODIVERS CONSERV, V16, P659, DOI 10.1007/s10531-005-3373-9; Whittaker RJ, 2005, DIVERS DISTRIB, V11, P3, DOI 10.1111/j.1366-9516.2005.00143.x; Zhu K, 2012, GLOBAL CHANGE BIOL, V18, P1042, DOI 10.1111/j.1365-2486.2011.02571.x	37	29	30	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125629	10.1371/journal.pone.0125629	http://dx.doi.org/10.1371/journal.pone.0125629			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927831	Green Published, Green Submitted, gold			2022-12-27	WOS:000353713100107
J	Fernandez-Rosales, IY; Liebovitch, LS; Guzman-Vargas, L				Fernandez-Rosales, Ivan Y.; Liebovitch, Larry S.; Guzman-Vargas, Lev			The Dynamic Consequences of Cooperation and Competition in Small-World Networks	PLOS ONE			English	Article							CONFLICT	We present a study of the social dynamics among cooperative and competitive actors interacting on a complex network that has a small-world topology. In this model, the state of each actor depends on its previous state in time, its inertia to change, and the influence of its neighboring actors. Using numerical simulations, we determine how the distribution of final states of the actors and measures of the distances between the values of the actors at local and global levels, depend on the number of cooperative to competitive actors and the connectivity of the actors in the network. We find that similar numbers of cooperative and competitive actors yield the lowest values for the local and global measures of the distances between the values of the actors. On the other hand, when the number of either cooperative or competitive actors dominate the system, then the divergence is largest between the values of the actors. Our findings make new testable predictions on how the dynamics of a conflict depends on the strategies chosen by groups of actors and also have implications for the evolution of behaviors.	[Fernandez-Rosales, Ivan Y.] Inst Politecn Nacl, Escuela Super Fis & Matemat, Dept Fis, Mexico City, DF, Mexico; [Liebovitch, Larry S.] CUNY Queens Coll, Dept Phys, Flushing, NY USA; [Liebovitch, Larry S.] Columbia Univ, AC4, Earth Inst, New York, NY USA; [Guzman-Vargas, Lev] Inst Politecn Nacl, Unidad Profes Interdisciplinaria Ingn & Tecnol Av, Mexico City, DF, Mexico	Instituto Politecnico Nacional - Mexico; City University of New York (CUNY) System; Queens College NY (CUNY); Columbia University; Instituto Politecnico Nacional - Mexico	Fernandez-Rosales, IY (corresponding author), Inst Politecn Nacl, Escuela Super Fis & Matemat, Dept Fis, Mexico City, DF, Mexico.	ifdezr@gmail.com; lguzmanv@ipn.mx			program EDI from Instituto Politecnico Nacional; program COFAA from Instituto Politecnico Nacional; Consejo Nacional de Ciencia y Tenologia, Mexico	program EDI from Instituto Politecnico Nacional; program COFAA from Instituto Politecnico Nacional; Consejo Nacional de Ciencia y Tenologia, Mexico	This work was partially supported by programs EDI and COFAA from Instituto Politecnico Nacional and Consejo Nacional de Ciencia y Tenologia, Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barzel B, 2013, NAT PHYS, V9, P673, DOI [10.1038/nphys2741, 10.1038/NPHYS2741]; Christie, 2011, ENCY PEACE PSYCHOL; Coleman PT, 2007, AM BEHAV SCI, V50, P1454, DOI 10.1177/0002764207302463; Deutsch M, 2006, COOPERATION COMPETIT, P23; Deutsch M, 1949, HUM RELAT, V2, P129, DOI 10.1177/001872674900200204; Gottman J, 2002, PERS SOC PSYCHOL REV, V6, P326, DOI 10.1207/S15327957PSPR0604_07; Liebovitch LS, 2008, PHYSICA A, V387, P6360, DOI 10.1016/j.physa.2008.07.020; Newman M.E.J., 2010, NETWORKS INTRO; Nowak A, 2013, COMPLEX HUMAN DYNAMI; Nowak MA., 2012, EVOLUTION COOPERATIO, P33; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Peng W, 2012, COMPUT HUM BEHAV, V28, P2100, DOI 10.1016/j.chb.2012.06.014; Perc M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0997; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; PRUITT DG, 1969, J CONFLICT RESOLUT, V13, P18, DOI 10.1177/002200276901300102; Ranjbar-Sahraei B, 2014, AAMAS'14: PROCEEDINGS OF THE 2014 INTERNATIONAL CONFERENCE ON AUTONOMOUS AGENTS & MULTIAGENT SYSTEMS, P677; Requejo RJ, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.038701; Rojas-Pacheco A, 2013, PHYSICA A, V392, P458, DOI 10.1016/j.physa.2012.09.021; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Shigaki K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076942; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/50007; Szolnoki A, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/30007; Tauer JM, 2004, J PERS SOC PSYCHOL, V86, P849, DOI 10.1037/0022-3514.86.6.849; Wang Z, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.052813; Wang Z, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/3/033041; Wang Z, 2014, J THEOR BIOL, V349, P50, DOI 10.1016/j.jtbi.2014.01.037; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; West BJ, 2014, COMPUT SOC SCI, P1, DOI 10.1007/978-3-319-04879-6	32	8	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0126234	10.1371/journal.pone.0126234	http://dx.doi.org/10.1371/journal.pone.0126234			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0MA	25927995	Green Published, gold			2022-12-27	WOS:000353713100129
J	Hauck, T; Tanigawa, N; Probst, M; Wohlschlaeger, A; Ille, S; Sollmann, N; Maurer, S; Zimmer, C; Ringel, F; Meyer, B; Krieg, SM				Hauck, Theresa; Tanigawa, Noriko; Probst, Monika; Wohlschlaeger, Afra; Ille, Sebastian; Sollmann, Nico; Maurer, Stefanie; Zimmer, Claus; Ringel, Florian; Meyer, Bernhard; Krieg, Sandro M.			Task Type Affects Location of Language-Positive Cortical Regions by Repetitive Navigated Transcranial Magnetic Stimulation Mapping	PLOS ONE			English	Article							INFERIOR PREFRONTAL CORTEX; BRAIN-STIMULATION; SPOKEN LANGUAGE; VERB GENERATION; WORD PRODUCTION; NEURAL SYSTEMS; NAMING ERRORS; READING ALOUD; SPEECH; NOUNS	Objectives Recent repetitive TMS (rTMS) mapping protocols for language mapping revealed deficits of this method, mainly in posterior brain regions. Therefore this study analyzed the impact of different language tasks on the localization of language-positive brain regions and compared their effectiveness, especially with regard to posterior brain regions. Methods Nineteen healthy, right-handed subjects performed object naming, pseudoword reading, verb generation, and action naming during rTMS language mapping of the left hemisphere. Synchronically, 5 Hz/10 pulses were applied with a 0 ms delay Results The object naming task evoked the highest error rate (14%), followed by verb generation (13%) and action naming (11%). The latter revealed more errors in posterior than in anterior areas. Pseudoword reading barely generated errors, except for phonological paraphasias. Conclusions In general, among the evaluated language tasks, object naming is the most discriminative task to detect language-positive regions via rTMS. However, other tasks might be used for more specific questions.	[Hauck, Theresa; Ille, Sebastian; Sollmann, Nico; Maurer, Stefanie; Ringel, Florian; Meyer, Bernhard; Krieg, Sandro M.] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurosurg, D-80290 Munich, Germany; [Tanigawa, Noriko] Univ Oxford, Fac Linguist Philol & Phonet, Oxford, England; [Probst, Monika; Wohlschlaeger, Afra; Zimmer, Claus] Tech Univ Munich, Klinikum Rechts Isar, Dept Radiol, Neuroradiol Sect, D-80290 Munich, Germany	Technical University of Munich; University of Oxford; Technical University of Munich	Krieg, SM (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Neurosurg, D-80290 Munich, Germany.	Sandro.Krieg@lrz.tum.de	Ringel, Florian/E-4933-2014; Meyer, Bernhard/AAH-3329-2019; Meyer, Bernhard/Q-9413-2016; Krieg, Sandro M./L-8902-2016	Meyer, Bernhard/0000-0001-6486-7955; Krieg, Sandro M./0000-0003-4050-1531; Sollmann, Nico/0000-0002-8120-2223; Probst, Monika/0000-0003-1687-0409	BrainLab AG	BrainLab AG	BrainLab AG provided support in the form of salaries for authors [SK, FR], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Almairac F., 2014, BRAIN STRUCT FUNCT; Bonner MF, 2013, NEUROIMAGE, V71, P175, DOI 10.1016/j.neuroimage.2013.01.006; Brennan NMP, 2007, NEUROIMAGE, V37, pS100, DOI 10.1016/j.neuroimage.2007.04.052; BUCKNER RL, 1995, J NEUROPHYSIOL, V74, P2163, DOI 10.1152/jn.1995.74.5.2163; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; Corina DP, 2010, BRAIN LANG, V115, P101, DOI 10.1016/j.bandl.2010.04.001; Corina DP, 2005, HUM BRAIN MAPP, V24, P1, DOI 10.1002/hbm.20063; Corina I, 2005, J INFUS MURS, V28, P12, DOI 10.1097/00000446-200503001-00004; DAMASIO AR, 1993, P NATL ACAD SCI USA, V90, P4957, DOI 10.1073/pnas.90.11.4957; DANIELE A, 1994, NEUROPSYCHOLOGIA, V32, P1325, DOI 10.1016/0028-3932(94)00066-2; DeLeon J, 2007, BRAIN, V130, P1408, DOI 10.1093/brain/awm011; du Boisgueheneuc F, 2006, BRAIN, V129, P3315, DOI 10.1093/brain/awl244; Duffau H, 2013, BRAIN LANG; Epstein CM, 1996, NEUROLOGY, V47, P1590, DOI 10.1212/WNL.47.6.1590; Felty R. A, 2007, CONTEXT EFFECTS SPOK; Frings M, 2006, NEUROSCI LETT, V409, P19, DOI 10.1016/j.neulet.2006.08.058; Gathercole SE, 2006, APPL PSYCHOLINGUIST, V27, P599, DOI 10.1017/S014271640606053X; Gow DW, 2012, BRAIN LANG, V121, P273, DOI 10.1016/j.bandl.2012.03.005; Graves WW, 2008, J COGNITIVE NEUROSCI, V20, P1698, DOI 10.1162/jocn.2008.20113; Graves WW, 2010, CEREB CORTEX, V20, P1799, DOI 10.1093/cercor/bhp245; Henseler I, 2014, J COGNITIVE NEUROSCI, V26, P1403, DOI 10.1162/jocn_a_00572; Hermann BP, 1999, NEUROPSYCHOLOGY, V13, P3, DOI 10.1037/0894-4105.13.1.3; Indefrey P, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00255; Krieg SM, 2014, NEUROIMAGE, V100, P219, DOI 10.1016/j.neuroimage.2014.06.016; Krieg SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075403; Lioumis P, 2012, J NEUROSCI METH, V204, P349, DOI 10.1016/j.jneumeth.2011.11.003; Melby-Lervag M, 2012, PSYCHOL BULL, V138, P322, DOI 10.1037/a0026744; Moseley RL, 2014, BRAIN LANG, V132, P28, DOI 10.1016/j.bandl.2014.03.001; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Papagno C, 2011, NEUROIMAGE, V55, P1306, DOI 10.1016/j.neuroimage.2011.01.005; Papathanassiou D, 2000, NEUROIMAGE, V11, P347, DOI 10.1006/nimg.2000.0546; PASCUALLEONE A, 1991, NEUROLOGY, V41, P697, DOI 10.1212/WNL.41.5.697; Picht T, 2013, NEUROSURGERY, V72, P808, DOI 10.1227/NEU.0b013e3182889e01; Picht T, 2009, NEUROSURGERY, V65, P93, DOI 10.1227/01.NEU.0000348009.22750.59; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Price CJ, 2005, HUM BRAIN MAPP, V25, P70, DOI 10.1002/hbm.20132; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Roux FE, 2004, BRAIN, V127, P1796, DOI 10.1093/brain/awh204; Salmelin R, 2000, J CLIN NEUROPHYSIOL, V17, P163, DOI 10.1097/00004691-200003000-00005; Scott SK, 2003, NEUROIMAGE, V19, P870, DOI 10.1016/S1053-8119(03)00083-1; Simos PG, 2002, CEREB CORTEX, V12, P297, DOI 10.1093/cercor/12.3.297; Siri S, 2008, CEREB CORTEX, V18, P171, DOI 10.1093/cercor/bhm043; Sollmann N, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-150; Sollmann N, 2013, J NEUROSURG, V118, P175, DOI 10.3171/2012.9.JNS121053; Soros P, 2003, NEUROIMAGE, V19, P1787, DOI 10.1016/S1053-8119(03)00217-9; Tarapore PE, 2013, NEUROIMAGE, V82, P260, DOI 10.1016/j.neuroimage.2013.05.018; Taylor JSH, 2013, PSYCHOL BULL, V139, P766, DOI 10.1037/a0030266; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; Thurling M, 2011, NEUROIMAGE, V57, P1184, DOI 10.1016/j.neuroimage.2011.05.045; Vigliocco G, 2011, NEUROSCI BIOBEHAV R, V35, P407, DOI 10.1016/j.neubiorev.2010.04.007; Wassermann EM, 1999, NEUROPSYCHOLOGIA, V37, P537, DOI 10.1016/S0028-3932(98)00102-X	52	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125298	10.1371/journal.pone.0125298	http://dx.doi.org/10.1371/journal.pone.0125298			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928744	Green Published, gold, Green Submitted			2022-12-27	WOS:000353713100078
J	Jiang, X; Lim, CZH; Li, ZM; Lee, PL; Yatim, SMJM; Guan, PY; Li, JT; Zhou, JB; Pan, JX; Chng, WJ; Chai, CLL; Yu, Q				Jiang, Xia; Lim, Cheryl Zi Hui; Li, Zhimei; Lee, Puay Leng; Yatim, Siti Maryam J. M.; Guan, Peiyong; Li, Juntao; Zhou, Jianbiao; Pan, Jingxuan; Chng, Wee-Joo; Chai, Christina L. L.; Yu, Qiang			Functional Characterization of D9, a Novel Deazaneplanocin A (DZNep) Analog, in Targeting Acute Myeloid Leukemia (AML)	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; HISTONE METHYLTRANSFERASE EZH2; MEDIATED DRUG-RESISTANCE; SMALL-MOLECULE INHIBITOR; STEM-CELLS; PHARMACOLOGICAL DISRUPTION; EPIGENETIC THERAPY; TUMOR-CELLS; CANCER; 3-DEAZANEPLANOCIN	Aberrant epigenetic events contribute to tumorigenesis of all human cancers. Significant efforts are underway in developing new generation of epigenetic cancer therapeutics. Although clinical trials for agents targeting DNA hypermethylation and histone deacetylation have yielded promising results, developing agents that target histone methylation remains to be in the early stage. We and others have previously reported that 3-Deazaneplanocin A (DZNep) is a histone methylation inhibitor that has a wide range of anticancer effects in various human cancers. Here, focusing on acute myeloid leukemia (AML) as a model, we reported a less toxic analog of DZNep, named D9, which is shown to be efficacious in AML cell lines and patient-derived samples in vitro, as well as AML tumorigenesis in vivo. Gene expression analysis in a panel of AML cell lines treated with D9 identified a set of genes that is associated with D9 sensitivity and implicated in multiple oncogenic signaling pathways. Moreover, we show that D9 is able to deplete the leukemia stem cells (LSC) and abolish chemotherapy-induced LSC enrichment, leading to dramatic elimination of AML cell survival. Thus, D9 appears to be a robust epigenetic compound that may constitute a potential for AML therapy.	[Jiang, Xia; Lim, Cheryl Zi Hui; Li, Zhimei; Lee, Puay Leng; Yatim, Siti Maryam J. M.; Yu, Qiang] ASTAR, Genome Inst Singapore, Canc Therapeut & Stratified Oncol, Biopolis, Singapore 138672, Singapore; [Guan, Peiyong; Li, Juntao] ASTAR, Genome Inst Singapore, Computat & Syst Biol, Biopolis, Singapore 138672, Singapore; [Zhou, Jianbiao; Chng, Wee-Joo] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117599, Singapore; [Pan, Jingxuan] Sun Yat Sen Univ, Sch Med, Dept Pathophysiol, Guangzhou 510089, Guangdong, Peoples R China; [Chng, Wee-Joo] Natl Univ Hlth Syst, Natl Univ Canc Inst Singapore, Dept Haematol Oncol, Singapore, Singapore; [Chng, Wee-Joo] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore; [Chai, Christina L. L.] Inst Chem & Engn Sci, Singapore 138665, Singapore; [Chai, Christina L. L.] Natl Univ Singapore, Dept Pharm, Singapore 117543, Singapore; [Yu, Qiang] Jinan Univ, Inst Canc, Guangzhou 510632, Guangdong, Peoples R China; [Yu, Qiang] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117597, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; Sun Yat Sen University; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Sustainability for Chemicals, Energy & Environment (ISCE2); National University of Singapore; Jinan University; National University of Singapore	Yu, Q (corresponding author), ASTAR, Genome Inst Singapore, Canc Therapeut & Stratified Oncol, Biopolis, Singapore 138672, Singapore.	yuq@gis.a-star.edu.sg	Chai, Christina L/A-3133-2014; Guan, Peiyong/A-3715-2015	Guan, Peiyong/0000-0001-9958-0137; Yu, Qiang/0000-0003-2132-8278; Chai, Christina/0000-0002-9199-851X	Joint Council Office and Exploit Technology of Agency for Science, Technology, and Research (A*STAR); Singapore National Research Foundation; Ministry of Education; National Medical Research Council; A*STAR graduate fellowship	Joint Council Office and Exploit Technology of Agency for Science, Technology, and Research (A*STAR); Singapore National Research Foundation(National Research Foundation, Singapore); Ministry of Education; National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); A*STAR graduate fellowship	This work was supported by the Joint Council Office and Exploit Technology of Agency for Science, Technology, and Research (A*STAR) to Q.Y. and C.C.; by the Singapore National Research Foundation; and by the Ministry of Education under the Research Centre of Excellence Program to W.-J. C.W.-J.C. was supported by the National Medical Research Council Clinician Scientist Investigator Award. X.J. was supported by A*STAR graduate fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2010, CURR CANCER DRUG TAR, V10, P268, DOI 10.2174/156800910791190175; Asanuma H, 2005, CANCER RES, V65, P11018, DOI 10.1158/0008-5472.CAN-05-0491; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Bouillet P, 2001, MAMM GENOME, V12, P163, DOI 10.1007/s003350010242; Crea F, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-40; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Damiano JS, 2000, LEUKEMIA LYMPHOMA, V38, P71, DOI 10.3109/10428190009060320; Damiano JS, 1999, BLOOD, V93, P1658, DOI 10.1182/blood.V93.5.1658; Fiskus W, 2009, BLOOD, V114, P2733, DOI 10.1182/blood-2009-03-213496; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Hayden A, 2011, BREAST CANCER RES TR, V127, P109, DOI 10.1007/s10549-010-0982-0; Hu XT, 1998, LEUKEMIA RES, V22, P817, DOI 10.1016/S0145-2126(98)00073-3; Hubner A, 2008, MOL CELL, V30, P415, DOI 10.1016/j.molcel.2008.03.025; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Jiang X, 2008, CANCER CELL, V13, P529, DOI 10.1016/j.ccr.2008.04.019; Kikuchi J, 2012, LUNG CANCER, V78, P138, DOI 10.1016/j.lungcan.2012.08.003; Knutson SK, 2012, NAT CHEM BIOL, V8, P890, DOI [10.1038/NCHEMBIO.1084, 10.1038/nchembio.1084]; Kornblau SM, 2009, BLOOD, V113, P154, DOI 10.1182/blood-2007-10-119438; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Liu F, 2010, J MED CHEM, V53, P5844, DOI 10.1021/jm100478y; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Milella M, 2005, CURR PHARM DESIGN, V11, P2779, DOI 10.2174/1381612054546842; Ninomiya M, 2007, LEUKEMIA, V21, P136, DOI 10.1038/sj.leu.2404432; Piekarz RL, 2009, J CLIN ONCOL, V27, P5410, DOI 10.1200/JCO.2008.21.6150; Puppe J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2354; Qi W, 2012, P NATL ACAD SCI USA, V109, P21360, DOI 10.1073/pnas.1210371110; Roboz GJ, 2011, HEMATOL-AM SOC HEMAT, P43, DOI 10.1182/asheducation-2011.1.43; Roboz GJ, 2009, EXPERT REV HEMATOL, V2, P663, DOI [10.1586/ehm.09.53, 10.1586/EHM.09.53]; Stone RM, 2007, BEST PRACT RES CL HA, V20, P39, DOI 10.1016/j.beha.2006.11.006; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Stresemann C, 2008, INT J CANCER, V123, P8, DOI 10.1002/ijc.23607; Suva ML, 2013, SCIENCE, V339, P1567, DOI 10.1126/science.1230184; Suva ML, 2009, CANCER RES, V69, P9211, DOI 10.1158/0008-5472.CAN-09-1622; Tallman MS, 2005, BLOOD, V106, P1154, DOI 10.1182/blood-2005-01-0178; Tam EKW, 2015, CHEMMEDCHEM, V10, P173, DOI 10.1002/cmdc.201402315; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Tavor S, 2004, CANCER RES, V64, P2817, DOI 10.1158/0008-5472.CAN-03-3693; Trowbridge JJ, 2012, GENE DEV, V26, P344, DOI 10.1101/gad.184341.111; Vedadi M, 2011, NAT CHEM BIOL, V7, P566, DOI [10.1038/NCHEMBIO.599, 10.1038/nchembio.599]; Wang ZW, 2011, NAT REV GASTRO HEPAT, V8, P27, DOI 10.1038/nrgastro.2010.188; Wee ZN, 2014, CELL REP; YATES JW, 1973, CANCER CHEMOTH REP 1, V57, P485; Zhao P, 2010, BIOCHEM BIOPH RES CO, V395, P219, DOI 10.1016/j.bbrc.2010.03.165; Zhou JB, 2011, BLOOD, V118, P2830, DOI 10.1182/blood-2010-07-294827	46	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0122983	10.1371/journal.pone.0122983	http://dx.doi.org/10.1371/journal.pone.0122983			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928216	Green Published, gold, Green Submitted			2022-12-27	WOS:000353713100012
J	Lukowski, A; Giertych, MJ; Zadworny, M; Mucha, J; Karolewski, P				Lukowski, Adrian; Giertych, Marian J.; Zadworny, Marcin; Mucha, Joanna; Karolewski, Piotr			Preferential Feeding and Occupation of Sunlit Leaves Favors Defense Response and Development in the Flea Beetle, Altica brevicollis coryletorum - A Pest of Corylus avellana	PLOS ONE			English	Article							SPECIALIST HERBIVORES; LARVAL PERFORMANCE; INSECT HERBIVORE; QUERCUS-ROBUR; FOOD QUALITY; FOREST; TEMPERATURE; GROWTH; CHEMISTRY; SHADE	The monophagous beetle, Altica brevicollis coryletorum, is a major leaf pest of Corylus avellana (common hazel). In contrast to majority of the other studied species of shrubs, sunlit leaves are grazed to a much greater extent than shaded leaves. Since the observation of a link between leaf irradiance level and A. brevicollis feeding is unique, we hypothesized that feeding preference of this beetle species is related to the speed needed to escape threats i.e. faster jumping. We also hypothesized that sunlit leaves are more nutritious and easier to consume than the leaves of shaded shrubs. Results indicated that beetle mass was greater in beetles occupying sunlit leaves, which is consistent with our second hypothesis. The study also confirmed under laboratory conditions, that larvae, pupae and beetles that were fed full-light (100% of full light) leaves were significantly heavier than those fed with shaded leaves (15% of full light). In the high irradiance conditions (higher temperature) duration of larval development is also reduced. Further results indicated that neither the concentration of soluble phenols, leaf toughness, or the number of trichomes could explain the insect's preference for sunlit leaves. Notably, measurements of jump length of beetles of this species, both in the field and under laboratory conditions, indicated that the defense pattern related to jumping was associated with light conditions. The jump length of beetles in the sun was significantly higher than in the shade. Additionally, in laboratory tests, beetle defense (jumping) was more strongly affected by temperature (15, 25, or 35 degrees C for 24h) than by leaf type. The effect of sunlit, higher nutrient leaves (greater level of non-structural carbohydrates) on defense (jumping) appears to be indirect, having a positive effect on insect mass in all developmental stages.	[Lukowski, Adrian; Giertych, Marian J.; Zadworny, Marcin; Mucha, Joanna; Karolewski, Piotr] Polish Acad Sci, Inst Dendrol, PL-62035 Kornik, Poland; [Lukowski, Adrian] Poznan Univ Life Sci, Fac Forestry, Dept Forest Protect, Poznan, Poland; [Giertych, Marian J.] Univ Zielona Gora, Fac Biol Sci, Zielona Gora, Poland	Polish Academy of Sciences; Poznan University of Life Sciences; University of Zielona Gora	Lukowski, A (corresponding author), Polish Acad Sci, Inst Dendrol, PL-62035 Kornik, Poland.	adrian.lukowski@gmail.com	Łukowski, Adrian/K-2923-2019; Giertych, Marian J/A-1618-2008	Łukowski, Adrian/0000-0002-4860-4984; Giertych, Marian/0000-0001-5578-9545; Zadworny, Marcin/0000-0002-7352-5786; Karolewski, Piotr/0000-0003-3064-1274; Mucha, Joanna/0000-0002-1290-9639	Institute of Dendrology Polish Academy of Sciences in Kornik	Institute of Dendrology Polish Academy of Sciences in Kornik	The research was financially supported by the statutory activities of the Institute of Dendrology Polish Academy of Sciences in Kornik. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS MD, 1992, TREE PHYSIOL, V10, P343, DOI 10.1093/treephys/10.4.343; Alonso C, 2000, ACTA OECOL, V21, P257, DOI 10.1016/S1146-609X(00)01082-1; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; BARTKOWSKA J, 1975, Polskie Pismo Entomologiczne, V45, P633; Bauerfeind SS, 2013, ENTOMOL EXP APPL, V149, P148, DOI 10.1111/eea.12118; Bjorkman C, 1997, OIKOS, V79, P45, DOI 10.2307/3546088; Chaneton EJ, 2010, J ECOL, V98, P488, DOI 10.1111/j.1365-2745.2009.01631.x; Chen YG, 2008, ENTOMOL EXP APPL, V126, P244, DOI 10.1111/j.1570-7458.2007.00662.x; Crawley MJ, 1986, PLANT ECOLOGY; Crone EE, 1999, J CHEM ECOL, V25, P635, DOI 10.1023/A:1020966206840; DEACON J, 1974, NEW PHYTOL, V73, P1055, DOI 10.1111/j.1469-8137.1974.tb01331.x; Decocq G, 2004, J APPL ECOL, V41, P1065, DOI 10.1111/j.0021-8901.2004.00960.x; Dominy NJ, 2003, J EXP BOT, V54, P2007, DOI 10.1093/jxb/erg224; FEDER N, 1968, AM J BOT, V55, P123, DOI 10.2307/2440500; FURTH D G, 1980, Israel Journal of Entomology, V14, P55; Gantner M., 2002, Acta Scientiarum Polonorum - Hortorum Cultus, V1, P55; Gantner M., 2000, Annales Universitatis Mariae Curie-Sklodowska. Sectio EEE, Horticultura, V8, P155; Giertych MJ, 2007, FOREST ECOL MANAG, V242, P700, DOI 10.1016/j.foreco.2007.02.005; Giertych MJ, 2005, ENTOMOL EXP APPL, V117, P59, DOI 10.1111/j.1570-7458.2005.00332.x; Gokirmak T, 2009, GENET RESOUR CROP EV, V56, P147, DOI 10.1007/s10722-008-9352-8; Gromysz-Kalkowska Kazimiera, 2011, Annales Universitatis Mariae Curie-Sklodowska Sectio C Biologia, V66, P143; Gruev Blagoy, 1997, Scopolia, V37, P1; Hardin JW, 1997, J TORREY BOT SOC, V124, P124, DOI 10.2307/2996580; Hwang SY, 1997, OECOLOGIA, V111, P99, DOI 10.1007/s004420050213; Jansen MPT, 1997, ENTOMOL EXP APPL, V82, P319, DOI 10.1023/A:1002916325052; Jaworski Tomasz, 2013, Lesne Prace Badawcze, V74, P345; Kaitaniemi P, 1998, OECOLOGIA, V116, P182, DOI 10.1007/s004420050578; Kaplan I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093714; Karolewski P, 2007, DENDROBIOLOGY, V58, P43; Karolewski P, 2007, POL J ECOL, V55, P595; Karolewski P, 2013, ACTA OECOL, V53, P19, DOI 10.1016/j.actao.2013.08.004; Koksal AH, 2006, FOOD CHEM, V99, P509, DOI 10.1016/j.foodchem.2005.08.013; Koricheva J, 1998, ANNU REV ENTOMOL, V43, P195, DOI 10.1146/annurev.ento.43.1.195; Kral J., 1964, Entomologische Blaetter Krefeld, V60, P126; Lee KP, 2010, ENTOMOL EXP APPL, V136, P151, DOI 10.1111/j.1570-7458.2010.01018.x; Lee M.R., 2004, BRUSH MANAGEMENT PRE; Levesque KR, 2002, B ENTOMOL RES, V92, P127, DOI 10.1079/BER2002153; Mathur V, 2011, ENTOMOL EXP APPL, V139, P215, DOI 10.1111/j.1570-7458.2011.01122.x; McNeill S., 1978, BIOCH ASPECTS PLANT, P77; Molina-Montenegro MA, 2006, ACTA OECOL, V30, P147, DOI 10.1016/j.actao.2006.02.008; Mooney EH, 2009, OIKOS, V118, P1181, DOI 10.1111/j.1600-0706.2009.17228.x; Oliveira I, 2007, FOOD CHEM, V105, P1018, DOI 10.1016/j.foodchem.2007.04.059; Perez-Contreras T, 2014, ACTA OECOL, V55, P15, DOI 10.1016/j.actao.2013.10.006; Roberts MR, 2006, NEW PHYTOL, V170, P677, DOI 10.1111/j.1469-8137.2006.01707.x; Schmitt Michael, 2004, P161; Snedecor G W, 1976, STAT METHODS; SOUTHWOOD TRE, 1961, J ANIM ECOL, V30, P1, DOI 10.2307/2109; Tremmel M, 2013, BEHAV ECOL, V24, P386, DOI 10.1093/beheco/ars175; Waldbauer G. P., 1968, P229, DOI 10.1016/S0065-2806(08)60230-1; Wennstrom A, 2010, CHEMOECOLOGY, V20, P35, DOI 10.1007/s00049-010-0040-8	50	16	16	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0126072	10.1371/journal.pone.0126072	http://dx.doi.org/10.1371/journal.pone.0126072			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927706	Green Submitted, gold, Green Published			2022-12-27	WOS:000353713100126
J	Machado, DB; Rasella, D; dos Santos, DN				Machado, Daiane Borges; Rasella, Davide; dos Santos, Darci Neves			Impact of Income Inequality and Other Social Determinants on Suicide Rate in Brazil	PLOS ONE			English	Article							SOCIOECONOMIC-FACTORS; EUROPEAN COUNTRIES; MENTAL-HEALTH; MORTALITY; JAPAN; AREAS; PANEL	Studies about suicide worldwide have mainly focused on individual-level psychiatric risk factors. In Brazil, suicide is an important public health problem. Brazil has evidenced important socioeconomic changes over the last decades, leading to decreasing income inequality. However, the impact of income inequality on suicide rate has never been studied in the country. Purpose To analyze whether income inequality and other social determinants are associated with suicide rate in Brazil. Method This study used panel data from all 5,507 Brazilian municipalities from 2000 to 2011. Suicide rates were calculated by sex and standardized by age for each municipality and year. The independent variables of the regression model included the Gini Index, per capita income, percentage of individuals with up to eight years of education, urbanization, average number of residents per household, percentage of divorced people, of Catholics, Pentecostals, and Evangelicals. A multivariable negative binomial regression for panel data with fixed-effects specification was performed. Results The Gini index was positively associated with suicide rates; the rate ratio (RR) was 1.055 (95% CI: 1.011-1.101). Of the other social determinants, income had a significant negative association with suicide rates (RR: 0.968, 95% CI: 0.948-0.988), whereas a low-level education had a positive association (RR: 1.015, 95% CI: 1.010-1.021). Conclusions Income inequality represents a community-level risk factor for suicide rates in Brazil. The decrease in income inequality, increase in income per capita, and decrease in the percentage of individuals who did not complete basic studies may have counteracted the increase in suicides in the last decade. Other changes, such as the decrease in the mean residents per household, may have contributed to their increase. Therefore, the implementation of social policies that may improve the population's socioeconomic conditions and reduce income inequality in Brazil, and in other low and middle-income countries, can help to reduce suicide rates.	[Machado, Daiane Borges; dos Santos, Darci Neves] Univ Fed Bahia, Inst Collect Hlth, BR-40110040 Salvador, BA, Brazil; [Rasella, Davide] Univ Fed Bahia, Inst Saude Colet, BR-40110040 Salvador, BA, Brazil	Universidade Federal da Bahia; Universidade Federal da Bahia	Machado, DB (corresponding author), Univ Fed Bahia, Inst Collect Hlth, Rua Basilio da Gama S-N, BR-40110040 Salvador, BA, Brazil.	daianedbm@hotmail.com	Rasella, Davide/ABG-4182-2020	Rasella, Davide/0000-0002-7260-4386; B Machado, Daiane/0000-0003-2959-4650	NIMH NIH HHS [R01 MH128911] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Andres AR, 2005, APPL ECON, V37, P439, DOI 10.1080/0003684042000295304; [Anonymous], 2005, PREV SUIC MAN DIR PR; Bezerra JG, 2012, CAD SAUDE PUBLICA, V28, P833, DOI 10.1590/S0102-311X2012000500003; Chen J, 2009, JPN WORLD ECON, V21, P140, DOI 10.1016/j.japwor.2008.06.001; Mello-Santos Carolina de, 2005, Rev. Bras. Psiquiatr., V27, P131, DOI 10.1590/S1516-44462005000200011; Desaulniers J, 2008, SOC PSYCH PSYCH EPID, V43, P445, DOI 10.1007/s00127-008-0340-2; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Haynes R, 1999, EUR J PUBLIC HEALTH, V9, P218, DOI 10.1093/eurpub/9.3.218; Hilbe JM, 2007, NEGATIVE BINOMIAL RE; IBGE. Instituto Brasileiro de Geografia e Estatistica, PESQ NAC AM DOM; Inagaki K, 2010, J APPL ECON, V13, P113, DOI 10.1016/S1514-0326(10)60006-2; IPEA, 2012, DEC INCL 2001 2011 D; Klein SD, 2010, SWISS MED WKLY, V140, DOI 10.4414/smw.2010.13102; Kolves K, 2013, SOCIOL HEALTH ILL, V35, P956, DOI 10.1111/1467-9566.12011; Leigh A, 2007, J HEALTH ECON, V26, P1, DOI 10.1016/j.jhealeco.2006.07.003; Li ZY, 2011, SOC SCI MED, V72, P608, DOI 10.1016/j.socscimed.2010.11.008; Lynch J, 2001, LANCET, V358, P194, DOI 10.1016/S0140-6736(01)05407-1; Mann M, 2004, HEALTH EDUC RES, V19, P357, DOI 10.1093/her/cyg041; Ministerio da Saude, 2005, REF PSIQ POL SAUD ME; Minoiu C., 2008, J SOCIO-ECON, V37, P237, DOI DOI 10.1016/j.socec.2006.09.001; Nock MK, 2008, EPIDEMIOL REV, V30, P133, DOI 10.1093/epirev/mxn002; Otsu A, 2004, SOC SCI MED, V58, P1137, DOI 10.1016/S0277-9536(03)00285-5; Rasella D, 2013, J EPIDEMIOL COMMUN H, V67, P661, DOI 10.1136/jech-2012-201426; Rehkopf DH, 2006, PSYCHOL MED, V36, P145, DOI 10.1017/S003329170500588X; Reichenheim ME, 2011, LANCET, V377, P1962, DOI 10.1016/S0140-6736(11)60053-6; Robert SA, 1999, ANNU REV SOCIOL, V25, P489, DOI 10.1146/annurev.soc.25.1.489; Sarma K, 2010, PUBLIC HEALTH, V124, P278, DOI 10.1016/j.puhe.2010.02.018; Shah A, 2008, SUICIDE LIFE-THREAT, V38, P714, DOI 10.1521/suli.2008.38.6.714; Stack S, 2000, SUICIDE LIFE-THREAT, V30, P145; Stevovic LI, 2011, PSYCHIAT DANUB, V23, P45; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7; Subramanian SV, 2002, ANNU REV PUBL HEALTH, V23, P287, DOI 10.1146/annurev.publhealth.23.100901.140540; Szwarcwald CL, 2008, INT J EPIDEMIOL, V37, P738, DOI 10.1093/ije/dyn130; The World Bank, 2013, GDP RANK; Uutela A, 2010, CURR OPIN PSYCHIATR, V23, P127, DOI 10.1097/YCO.0b013e328336657d; Velez CE, 2004, INEQUALITY EC DEV BR; Wakefield J, 2008, ANNU REV PUBL HEALTH, V29, P75, DOI 10.1146/annurev.publhealth.29.020907.090821; *WHO, 1992, ICD10 WHO; WHO, SUIC PREV SPEC PROGR; Wooldridge J., 2005, INTRO ECONOMETRICS M, V3; World Bank, 2013, GINI IND; Ying YH, 2009, SUICIDE LIFE-THREAT, V39, P214, DOI 10.1521/suli.2009.39.2.214	42	35	39	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124934	10.1371/journal.pone.0124934	http://dx.doi.org/10.1371/journal.pone.0124934			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0MA	25928359	gold, Green Published			2022-12-27	WOS:000353713100054
J	MacIntyre, R; Stein, A; Harrison, C; Britt, H; Mahimbo, A; Cunningham, A				MacIntyre, Raina; Stein, Alicia; Harrison, Christopher; Britt, Helena; Mahimbo, Abela; Cunningham, Anthony			Increasing Trends of Herpes Zoster in Australia	PLOS ONE			English	Article							QUALITY-OF-LIFE; POSTHERPETIC NEURALGIA; VARICELLA VACCINATION; GENERAL-PRACTICE; IMPACT; EPIDEMIOLOGY; VIRUS; MANAGEMENT; RISK; PREVENTION	Background Increasing trends in incidence of herpes zoster (HZ) have been reported in Australia and internationally. This may reflect the impact of childhood VZV vaccination programs introduced universally in Australia in late 2005. The objective of this study was to evaluate changes in incidence of HZ and PHN in Australia over time, and associated healthcare resource utilisation. Methods Australian data on general practice (GP) encounters for HZ, specific antiviral prescribing data from the pharmaceutical benefits scheme, emergency department presentations from the states of NSWand Victoria and national hospitalisation data for HZ were analysed for time trends using regression models. Two time periods (2000-2006 and 2006-2013) were compared which correspond broadly with the pre- and post-universal VZV vaccination period. Results All data sources showed increasing rates of HZ with age and over time. The GP database showed a significant annual increase in encounters for HZ of 2.5 per 100,000 between 1998 and 2013, and the rates of prescriptions for HZ increased by 4.2% per year between 2002 and 2012. In the 60+ population HZ incidence was estimated to increase from 11.9 to 15.4 per 1,000 persons using GP data or from 12.8 to 14.2 per 1,000 persons using prescription data (p<0.05, between the two periods). Hospitalisation data did not show the same increasing trend over time, except for the age group >= 80 years. Most emergency visits for HZ were not admitted, and showed significant increases over time. Discussion The burden of HZ in Australia is substantial, and continues to increase over time. This increase is seen both pre-and post-universal VZV vaccination in 2005, and is most prominent in the older population. The substantial burden of HZ, along with ageing of the Australian population and the importance of healthy ageing, warrants consideration of HZ vaccination for the elderly.	[MacIntyre, Raina; Mahimbo, Abela] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [MacIntyre, Raina] Natl Ctr Immunisat Res NCIRS, Sydney, NSW, Australia; [Stein, Alicia] bioCSL, Melbourne, Vic, Australia; [Harrison, Christopher; Britt, Helena] Univ Sydney, Family Med Res Ctr, Sydney, NSW 2006, Australia; [Cunningham, Anthony] Univ Sydney, Westmead Millennium Inst, Sydney, NSW 2006, Australia	University of New South Wales Sydney; University of Sydney; University of Sydney; Westmead Institute for Medical Research	MacIntyre, R (corresponding author), Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia.	r.macintyre@unsw.edu.au	Mahimbo, Abela/AAR-6184-2020	Mahimbo, Abela/0000-0003-2058-6881; MacIntyre, C Raina/0000-0002-3060-0555; Harrison, Christopher/0000-0002-8769-6877	bioCSL	bioCSL	bioCSL provided support in the form of salaries for author Alicia Stein, who contributed to this publication as part of her employment role. bioCSL also funded all fees due for ethics review and data extraction to the various third parties involved as detailed below. The specific roles of this author are articulated in the 'author contributions' section. Merck and GSK did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, Aust Fam Physician, V32, P59; Australian Bureau of Statistics (ABS), 2013, 3101 0 AUSTRALIAN DE; Australian Bureau of Statistics (ABS), 2007, SERIES B PROJECTIONS; Australian Institute of Health and Welfare (AIHW), 2013, HOSPITAL DATA; Australian Institute of Health and Welfare (AIHW), 2007, INTERACTIVE NATIONAL; Australian Technical Advisory Group on Immunisation (ATAGI), 2008, SYSTEMATIC REVIEW OF; Brisson M., 2003, Journal of Medical Virology, V70, pS9, DOI 10.1002/jmv.10313; Brisson M., 2003, Journal of Medical Virology, V70, pS31, DOI 10.1002/jmv.10317; Brisson M, 2001, EPIDEMIOL INFECT, V127, P305, DOI 10.1017/S0950268801005921; Brisson M, 2010, VACCINE, V28, P3385, DOI 10.1016/j.vaccine.2010.02.079; Britt H, 2012, GENERAL PRACTICE ACT; Carville KS, 2010, VACCINE, V28, P2532, DOI 10.1016/j.vaccine.2010.01.036; Cunningham AL, 2008, MED J AUSTRALIA, V188, P171, DOI 10.5694/j.1326-5377.2008.tb01566.x; Drolet M, 2010, CAN MED ASSOC J, V182, P1731, DOI 10.1503/cmaj.091711; Fleming DM, 2004, EUR J EPIDEMIOL, V19, P1113, DOI 10.1007/s10654-004-2219-1; FMRC, 2014, ICPC 2 PLUS DEMONSTR, DOI 10.1186/s12998-015-0051-1; Gao Z, 2010, EPIDEMIOL INFECT, V138, P457, DOI 10.1017/S0950268809990860; GARNETT GP, 1992, EPIDEMIOL INFECT, V108, P513, DOI 10.1017/S0950268800050019; Grant KA, 2010, MED J AUSTRALIA, V193, P483, DOI 10.5694/j.1326-5377.2010.tb04009.x; Hales CM, 2013, ANN INTERN MED, V159, P739, DOI 10.7326/0003-4819-159-11-201312030-00006; Harpaz Rafael, 2007, Morbidity and Mortality Weekly Report, V57, P1; HOPESIMPSON RE, 1965, P ROY SOC MED, V58, P9, DOI 10.1177/003591576505800106; ICPC, 1998, ICPC 2 INTERNATIONAL; Jardine A, 2011, EPIDEMIOL INFECT, V139, P658, DOI 10.1017/S0950268810001949; Johnson RW, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-37; Johnson RW, 2008, DRUG AGING, V25, P991, DOI 10.2165/0002512-200825120-00002; Johnson RW, 2001, J ANTIMICROB CHEMOTH, V47, P1, DOI 10.1093/jac/47.suppl_1.1; Karhunen M, 2010, EPIDEMIOL INFECT, V138, P469, DOI 10.1017/S0950268809990768; Kost RG, 1996, NEW ENGL J MED, V335, P32, DOI 10.1056/NEJM199607043350107; Krzywinski M, 2013, NAT METHODS, V10, P921, DOI 10.1038/nmeth.2659; Langan SM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001420; Leung J, 2011, CLIN INFECT DIS, V52, P332, DOI 10.1093/cid/ciq077; MacIntyre C. R., 2013, Health, V5, P80; MacIntyre CR, 2003, EPIDEMIOL INFECT, V131, P675, DOI 10.1017/S0950268803008690; National Health and Medical Research Council, 2008, THE AUSTRALIAN IMMUN; Nelson MR, 2010, MED J AUSTRALIA, V193, P110, DOI 10.5694/j.1326-5377.2010.tb03818.x; NHMRC, 2008, AUSTRALIAN IMMUNIZAT; Ogunjimi B, 2014, CLIN VACCINE IMMUNOL, V21, P417, DOI 10.1128/CVI.00818-13; Ogunjimi B, 2011, VIRAL IMMUNOL, V24, P151, DOI 10.1089/vim.2010.0031; Opstelten W, 2002, FAM PRACT, V19, P471, DOI 10.1093/fampra/19.5.471; Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016; Perez-Farinos N, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-59; Pinchinat S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-170; Rimland D, 2010, CLIN INFECT DIS, V50, P1000, DOI 10.1086/651078; Schmader KE, 2012, CLIN INFECT DIS, V55, P1320, DOI 10.1093/cid/cis638; Schmader KE, 2002, CLIN J PAIN, V18, P350, DOI 10.1097/00002508-200211000-00002; Schuette MC, 1999, B MATH BIOL, V61, P1031, DOI 10.1006/bulm.1999.0126; Serpell M, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-92; Stein AN, 2009, VACCINE, V27, P520, DOI 10.1016/j.vaccine.2008.11.012; Tseng HF, 2011, JAMA-J AM MED ASSOC, V305, P160, DOI 10.1001/jama.2010.1983; van Hoek AJ, 2009, VACCINE, V27, P1454, DOI 10.1016/j.vaccine.2008.12.024; Wareham DW, 2007, BMJ-BRIT MED J, V334, P1211, DOI 10.1136/bmj.39206.571042.AE; Yawn BP, 2013, NEUROLOGY, V81, P928, DOI 10.1212/WNL.0b013e3182a3516e; Yih WK, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-68	54	33	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125025	10.1371/journal.pone.0125025	http://dx.doi.org/10.1371/journal.pone.0125025			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928713	gold, Green Published, Green Submitted			2022-12-27	WOS:000353713100058
J	Podder, MP; Banfield, SE; Keefe, GP; Whitney, HG; Tahlan, K				Podder, Milka P.; Banfield, Susan E.; Keefe, Greg P.; Whitney, Hugh G.; Tahlan, Kapil			Typing of Mycobacterium avium Subspecies paratuberculosis Isolates from Newfoundland Using Fragment Analysis	PLOS ONE			English	Article							CROHNS-DISEASE; JOHNES-DISEASE; VARIABLE-NUMBER; CATTLE HERDS; SEQUENCE; LOCI; INFECTION; COMBINATION; PREVALENCE; STABILITY	Short Sequence Repeat (SSR) typing of Mycobacterium avium subspecies paratuberculosis (Map) isolates is one of the most commonly used method for genotyping this pathogen. Currently used techniques have challenges in analyzing mononucleotide repeats >15 bp, which include some of the Map SSRs. Fragment analysis is a relatively simple technique, which can accurately measure the size of DNA fragments and can be used to calculate the repeat length of the target SSR loci. In the present study, fragment analysis was used to analyze 4 Map SSR loci known to provide sufficient discriminatory power to determine the relationship between Map isolates. Eighty-five Map isolates from 18 animals from the island of Newfoundland were successfully genotyped using fragment analysis. To the best of our knowledge, this is the first report on Map SSR diversity from Newfoundland dairy farms. Previously unreported Map SSR-types or combinations were also identified during the course of the described work. In addition, multiple Map SSR-types were isolated from a single animal in many cases, which is not a common finding.	[Podder, Milka P.; Banfield, Susan E.; Tahlan, Kapil] Mem Univ Newfoundland, Dept Biol, St John, NF, Canada; [Keefe, Greg P.] Univ Prince Edward Isl, Atlantic Vet Coll, Dept Hlth Management, Charlottetown, PE C1A 4P3, Canada; [Whitney, Hugh G.] Newfoundland & Labrador Dept Nat Resources, Div Anim Hlth, St John, NF, Canada	Memorial University Newfoundland; University of Prince Edward Island	Whitney, HG (corresponding author), Newfoundland & Labrador Dept Nat Resources, Div Anim Hlth, St John, NF, Canada.	hughwhitney@gov.nl.ca; ktahlan@mun.ca			Department of Natural Resources, Government of Newfoundland and Labrador (DNR-NL); Dairy Farmers of Newfoundland and Labrador; Natural Sciences and Engineering Research Council of Canada (NSERC); Research & Development Corporation of Newfoundland and Labrador (RDC-NL); Canada Foundation for Innovation (CFI); NSERC; Memorial University of Newfoundland (MUN)	Department of Natural Resources, Government of Newfoundland and Labrador (DNR-NL); Dairy Farmers of Newfoundland and Labrador; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Research & Development Corporation of Newfoundland and Labrador (RDC-NL); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Memorial University of Newfoundland (MUN)	The described work was funded by the Department of Natural Resources, Government of Newfoundland and Labrador (DNR-NL) and was supported by the Dairy Farmers of Newfoundland and Labrador. Equipment used in the study was purchased with funding from the Natural Sciences and Engineering Research Council of Canada (NSERC), Research & Development Corporation of Newfoundland and Labrador (RDC-NL), and the Canada Foundation for Innovation (CFI) to KT and from DNR-NL. We would also like to acknowledge NSERC and the Memorial University of Newfoundland (MUN) for additional financial assistance to MPP and SEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlstrom C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1387-6; Ahlstrom C, 2014, APPL ENVIRON MICROB, V80, P534, DOI 10.1128/AEM.03212-13; Amonsin A, 2004, J CLIN MICROBIOL, V42, P1694, DOI 10.1128/JCM.42.4.1694-1702.2004; Bannantine JP, 2013, LETT APPL MICROBIOL, V57, P165, DOI 10.1111/lam.12109; Bannantine JP, 2008, PROTEOMICS, V8, P463, DOI 10.1002/pmic.200700644; Castellanos E, 2009, APPL ENVIRON MICROB, V75, P676, DOI 10.1128/AEM.01683-08; El-Sayed A, 2009, J MICROBIOL, V47, P253, DOI 10.1007/s12275-008-0257-1; Ferrouillet C, 2009, PREV VET MED, V88, P128, DOI 10.1016/j.prevetmed.2008.08.001; Forde T, 2012, J WILDLIFE DIS, V48, P1, DOI 10.7589/0090-3558-48.1.1; Ghadiali AH, 2004, J CLIN MICROBIOL, V42, P5345, DOI 10.1128/JCM.42.11.5345-5348.2004; Harris NB, 2006, J CLIN MICROBIOL, V44, P2970, DOI 10.1128/JCM.00584-06; Hermon-Taylor J, 2002, DIGEST LIVER DIS, V34, P9, DOI 10.1016/S1590-8658(02)80052-4; Kalis CHJ, 2004, PREV VET MED, V65, P189, DOI 10.1016/j.prevetmed.2004.07.005; Kasnitz N, 2013, VET MICROBIOL, V167, P573, DOI 10.1016/j.vetmic.2013.09.008; Li LL, 2005, P NATL ACAD SCI USA, V102, P12344, DOI 10.1073/pnas.0505662102; Liu XF, 2001, FEMS MICROBIOL LETT, V202, P233, DOI 10.1111/j.1574-6968.2001.tb10809.x; Manning EJB, 2001, REV SCI TECH OIE, V20, P133, DOI 10.20506/rst.20.1.1275; Naser SA, 2000, AM J GASTROENTEROL, V95, P1094, DOI 10.1111/j.1572-0241.2000.01954.x; Oakey J, 2014, J VET DIAGN INVEST, V26, P651, DOI 10.1177/1040638714547257; Pradhan AK, 2011, J CLIN MICROBIOL, V49, P893, DOI 10.1128/JCM.01107-10; Prantera C, 1999, ITAL J GASTROENTEROL, V31, P244; Ricchi M, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-54; Settles M, 2009, ANIM GENET, V40, P655, DOI 10.1111/j.1365-2052.2009.01896.x; Sohal JS, 2014, J CLIN MICROBIOL, V52, P2764, DOI 10.1128/JCM.00386-14; Stabel JR, 2000, AM J VET RES, V61, P754, DOI 10.2460/ajvr.2000.61.754; Tiwari A, 2006, CAN VET J, V47, P874; Whittington RJ, 2011, J CLIN MICROBIOL, V49, P1822, DOI 10.1128/JCM.00210-11	27	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0126071	10.1371/journal.pone.0126071	http://dx.doi.org/10.1371/journal.pone.0126071			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927612	Green Submitted, Green Published, gold			2022-12-27	WOS:000353713100125
J	Rost, HL; Schmitt, U; Aebersold, R; Malmstrom, L				Roest, Hannes L.; Schmitt, Uwe; Aebersold, Ruedi; Malmstroem, Lars			Fast and Efficient XML Data Access for Next-Generation Mass Spectrometry	PLOS ONE			English	Article							OPEN-SOURCE SOFTWARE; PROTEOMICS; FRAMEWORK; TOOLS	Motivation In mass spectrometry-based proteomics, XML formats such as mzML and mzXML provide an open and standardized way to store and exchange the raw data (spectra and chromatograms) of mass spectrometric experiments. These file formats are being used by a multitude of open-source and cross-platform tools which allow the proteomics community to access algorithms in a vendor-independent fashion and perform transparent and reproducible data analysis. Recent improvements in mass spectrometry instrumentation have increased the data size produced in a single LC-MS/MS measurement and put substantial strain on open-source tools, particularly those that are not equipped to deal with XML data files that reach dozens of gigabytes in size. Results Here we present a fast and versatile parsing library for mass spectrometric XML formats available in C++ and Python, based on the mature OpenMS software framework. Our library implements an API for obtaining spectra and chromatograms under memory constraints using random access or sequential access functions, allowing users to process datasets that are much larger than system memory. For fast access to the raw data structures, small XML files can also be completely loaded into memory. In addition, we have improved the parsing speed of the core mzML module by over 4-fold (compared to OpenMS 1.11), making our library suitable for a wide variety of algorithms that need fast access to dozens of gigabytes of raw mass spectrometric data. Availability Our C++ and Python implementations are available for the Linux, Mac, and Windows operating systems. All proposed modifications to the OpenMS code have been merged into the OpenMS mainline codebase and are available to the community at https://github.com/OpenMS/OpenMS.	[Roest, Hannes L.; Aebersold, Ruedi; Malmstroem, Lars] ETH, Inst Mol Syst Biol, Dept Biol, CH-8093 Zurich, Switzerland; [Roest, Hannes L.] Univ Zurich, PhD Program Syst Biol, CH-8057 Zurich, Switzerland; [Roest, Hannes L.] ETH, CH-8057 Zurich, Switzerland; [Schmitt, Uwe] ETH, ID Sci IT Serv, CH-8092 Zurich, Switzerland; [Aebersold, Ruedi] Competence Ctr Syst Physiol & Metab Dis, CH-8093 Zurich, Switzerland; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland; [Malmstroem, Lars] Univ Zurich, S3IT, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Zurich	Malmstrom, L (corresponding author), ETH, Inst Mol Syst Biol, Dept Biol, CH-8093 Zurich, Switzerland.	lars.malmstroem@s3it.uzh.ch	Malmström, Lars/R-4991-2019; Röst, Hannes/L-2056-2019; Röst, Hannes L/E-9564-2013	Malmström, Lars/0000-0001-9885-9312; Röst, Hannes/0000-0003-0990-7488; Röst, Hannes L/0000-0003-0990-7488	Eidgenossische Technische Hochschule Zurich [ETH-30 11-2]	Eidgenossische Technische Hochschule Zurich	H.R. was funded by Eidgenossische Technische Hochschule Zurich (ETH-30 11-2) (https://www.ethz.ch/en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Aiche S, 2015, WORKFLOWS AUTOMATED; Bald T, 2012, BIOINFORMATICS, V28, P1052, DOI 10.1093/bioinformatics/bts066; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; Cote RG, 2012, MOL CELL PROTEOMICS, V11, P1682, DOI 10.1074/mcp.O112.021543; Cote RG, 2010, PROTEOMICS, V10, P1332, DOI 10.1002/pmic.200900719; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Domon B, 2010, NAT BIOTECHNOL, V28, P710, DOI 10.1038/nbt.1661; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Gillet LC, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.016717; Griss J, 2012, PROTEOMICS, V12, P795, DOI 10.1002/pmic.201100578; Han XM, 2008, CURR OPIN CHEM BIOL, V12, P483, DOI 10.1016/j.cbpa.2008.07.024; Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024; Kessner D, 2008, BIOINFORMATICS, V24, P2534, DOI 10.1093/bioinformatics/btn323; Kohlbacher O, 2007, BIOINFORMATICS, V23, pE191, DOI 10.1093/bioinformatics/btl299; Martens L, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.R110.000133; Mueller LN, 2007, PROTEOMICS, V7, P3470, DOI 10.1002/pmic.200700057; Pedrioli PGA, 2004, NAT BIOTECHNOL, V22, P1459, DOI 10.1038/nbt1031; Perez-Riverol Y, 2014, BBA-PROTEINS PROTEOM, V1844, P63, DOI 10.1016/j.bbapap.2013.02.032; Prince JT, 2008, BIOINFORMATICS, V24, P2796, DOI 10.1093/bioinformatics/btn513; Reiter L, 2011, NAT METHODS, V8, P430, DOI [10.1038/NMETH.1584, 10.1038/nmeth.1584]; Rost HL, 2014, NAT BIOTECHNOL, V32, P219, DOI 10.1038/nbt.2841; Rost HL, 2014, PROTEOMICS, V14, P74, DOI 10.1002/pmic.201300246; Sturm M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-163; Taylor CF, 2006, OMICS, V10, P145, DOI 10.1089/omi.2006.10.145	25	14	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125108	10.1371/journal.pone.0125108	http://dx.doi.org/10.1371/journal.pone.0125108			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927999	gold, Green Published, Green Submitted			2022-12-27	WOS:000353713100069
J	Zhou, M; Tan, S; Guo, MJ; Zhang, L				Zhou, Min; Tan, Shukui; Guo, Mingjing; Zhang, Lu			Locational Determinants of Emissions from Pollution-Intensive Firms in Urban Areas	PLOS ONE			English	Article							SPATIAL DETERMINANTS; QIANTANG RIVER; STREAM WATER; CHINA	Industrial pollution has remained as one of the most daunting challenges for many regions around the world. Characterizing the determinants of industrial pollution should provide important management implications. Unfortunately, due to the absence of high-quality data, rather few studies have systematically examined the locational determinants using a geographical approach. This paper aimed to fill the gap by accessing the pollution source census dataset, which recorded the quantity of discharged wastes (waste water and solid waste) from 717 pollution-intensive firms within Huzhou City, China. Spatial exploratory analysis was applied to analyze the spatial dependency and local clusters of waste emissions. Results demonstrated that waste emissions presented significantly positive autocorrelation in space. The high-high hotspots generally concentrated towards the city boundary, while the low-low clusters approached the Taihu Lake. Their locational determinants were identified by spatial regression. In particular, firms near the city boundary and county road were prone to discharge more wastes. Lower waste emissions were more likely to be observed from firms with high proximity to freight transfer stations or the Taihu Lake. Dense populous districts saw more likelihood of solid waste emissions. Firms in the neighborhood of rivers exhibited higher waste water emissions. Besides, the control variables (firm size, ownership, operation time and industrial type) also exerted significant influence. The present methodology can be applicable to other areas, and further inform the industrial pollution control practices. Our study advanced the knowledge of determinants of emissions from pollution-intensive firms in urban areas.	[Zhou, Min; Tan, Shukui; Zhang, Lu] Huazhong Univ Sci & Technol, Nontradit Secur Ctr, Wuhan 430074, Peoples R China; [Zhou, Min; Tan, Shukui; Zhang, Lu] Huazhong Univ Sci & Technol, Coll Publ Adm, Wuhan 430074, Peoples R China; [Guo, Mingjing] China Univ Geosci, Sch Econ & Management, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; China University of Geosciences	Tan, S (corresponding author), Huazhong Univ Sci & Technol, Nontradit Secur Ctr, Wuhan 430074, Peoples R China.	tansk@126.com	GUO, MINGJING/AAS-6028-2021	GUO, MINGJING/0000-0003-4398-3863	National 985 Project of Non-traditional Security at Huazhong University of Science and Technology; National Natural Science Foundation of China [41401631, 41401192]	National 985 Project of Non-traditional Security at Huazhong University of Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National 985 Project of Non-traditional Security at Huazhong University of Science and Technology and National Natural Science Foundation of China (No. 41401631 and No. 41401192). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen R. G., 1998, FAO Irrigation and Drainage Paper; Antoci A, 2014, J ECON DYN CONTROL, V47, P211, DOI 10.1016/j.jedc.2014.08.009; Apergis N, 2013, ECOL ECON, V88, P57, DOI 10.1016/j.ecolecon.2012.12.024; Ben Kheder S, 2012, ECOL ECON, V77, P48, DOI 10.1016/j.ecolecon.2011.10.005; Card D, 2010, J PUBLIC ECON, V94, P222, DOI 10.1016/j.jpubeco.2009.11.010; Chohaney ML, 2014, APPL GEOGR, V53, P32, DOI 10.1016/j.apgeog.2014.05.019; Cole MA, 2013, J ENVIRON ECON MANAG, V65, P290, DOI 10.1016/j.jeem.2012.07.002; Devos E, 2014, J CORP FINANC, V29, P20, DOI 10.1016/j.jcorpfin.2014.08.005; Dijkstra BR, 2006, EUR ECON REV, V50, P425, DOI 10.1016/j.euroecorev.2004.09.006; Duvivier C, 2011, ENVIRON DEV ECON, V18, P1; Geng Y, 2007, REG ENVIRON CHANGE, V7, P123, DOI 10.1007/s10113-007-0026-4; Geng Y, 2014, J CLEAN PROD, V76, P116, DOI 10.1016/j.jclepro.2014.04.047; He CF, 2003, PAP REG SCI, V82, P351, DOI 10.1007/s10110-003-0168-9; Hu YA, 2013, ENVIRON DEV, V8, P57, DOI 10.1016/j.envdev.2013.06.001; Jiang LL, 2014, J COMP ECON, V42, P118, DOI 10.1016/j.jce.2013.07.007; Kang JH, 2010, WATER RES, V44, P4143, DOI 10.1016/j.watres.2010.05.009; Kendy E, 2004, HYDROL PROCESS, V18, P2289, DOI 10.1002/hyp.5529; LeSage J, 2009, STAT TEXTB MONOGR, P1; Ma CB, 2010, ECOL ECON, V69, P1869, DOI 10.1016/j.ecolecon.2010.05.005; Meng QM, 2009, CAN J FOREST RES, V39, P2283, DOI 10.1139/X09-136; Ministry of Environmental Protection, 2009, 2008 CHIN STAT ENV; Ministry of Water Resources, 2012, 2010 CHIN WAT RES B; MORAN PAP, 1948, J ROY STAT SOC B, V10, P243; Petrakis E, 2003, RESOUR ENERGY ECON, V25, P197, DOI 10.1016/S0928-7655(02)00026-X; Su SL, 2013, REG ENVIRON CHANGE, V13, P77, DOI 10.1007/s10113-012-0313-6; Su SL, 2013, ECOL INDIC, V24, P375, DOI 10.1016/j.ecolind.2012.07.015; Su SL, 2011, APPL GEOGR, V31, P439, DOI 10.1016/j.apgeog.2010.10.008; Taguchi H, 2010, ENVIRON DEV ECON, V15, P363, DOI 10.1017/S1355770X10000033; Wang H, 2002, POLICY RES WORKING P, V2756; Warren KA, 1999, ENVIRON IMPACT ASSES, V19, P521, DOI 10.1016/S0195-9255(99)00030-X; Wei JC, 2012, J ENVIRON MANAGE, V113, P263, DOI 10.1016/j.jenvman.2012.08.040; World Bank, 2007, CHIN 2020 CLEAR WAT; Xue B, 2014, ECOL INDIC, V38, P272, DOI 10.1016/j.ecolind.2013.11.020; Ye XY, 2011, APPL GEOGR, V31, P800, DOI 10.1016/j.apgeog.2010.08.006; Yu S, 2014, SCI TOTAL ENVIRON, V488, P61, DOI [10.1016/j.scitotenv2014.04.061, 10.1016/j.scitotenv.2014.04.061]; Zhu SJ, 2014, GEOFORUM, V55, P53, DOI 10.1016/j.geoforum.2014.05.004	36	2	2	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125348	10.1371/journal.pone.0125348	http://dx.doi.org/10.1371/journal.pone.0125348			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927438	gold, Green Published, Green Submitted			2022-12-27	WOS:000353713100083
J	Gonzalez-Zalba, MF; Ciccarelli, C; Zarbo, LP; Irvine, AC; Campion, RC; Gallagher, BL; Jungwirth, T; Ferguson, AJ; Wunderlich, J				Gonzalez-Zalba, M. Fernando; Ciccarelli, Chiara; Zarbo, Liviu P.; Irvine, Andrew C.; Campion, Richard C.; Gallagher, Bryan L.; Jungwirth, Tomas; Ferguson, Andrew J.; Wunderlich, Joerg			Reconfigurable Boolean Logic Using Magnetic Single-Electron Transistors	PLOS ONE			English	Article							BLOCKADE ANISOTROPIC MAGNETORESISTANCE; OSCILLATIONS; CIRCUITS	We propose a novel hybrid single-electron device for reprogrammable low-power logic operations, the magnetic single-electron transistor (MSET). The device consists of an aluminium single-electron transistor with a GaMnAs magnetic back-gate. Changing between different logic gate functions is realized by reorienting the magnetic moments of the magnetic layer, which induces a voltage shift on the Coulomb blockade oscillations of the MSET. We show that we can arbitrarily reprogram the function of the device from an n-type SET for in-plane magnetization of the GaMnAs layer to p-type SET for out-of-plane magnetization orientation. Moreover, we demonstrate a set of reprogrammable Boolean gates and its logical complement at the single device level. Finally, we propose two sets of reconfigurable binary gates using combinations of two MSETs in a pull-down network.	[Gonzalez-Zalba, M. Fernando; Wunderlich, Joerg] Hitachi Cambridge Lab, Cambridge CB3 0HE, England; [Ciccarelli, Chiara; Irvine, Andrew C.; Ferguson, Andrew J.] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; [Zarbo, Liviu P.; Jungwirth, Tomas; Wunderlich, Joerg] Acad Sci Czech Republ, Inst Phys, Vvi, Prague 16253 6, Czech Republic; [Campion, Richard C.; Gallagher, Bryan L.; Jungwirth, Tomas] Univ Nottingham, Sch Phys & Astron, Nottingham NG7 2RD, England	University of Cambridge; University of Cambridge; Czech Academy of Sciences; Institute of Physics of the Czech Academy of Sciences; University of Nottingham	Gonzalez-Zalba, MF (corresponding author), Hitachi Cambridge Lab, Cambridge CB3 0HE, England.	mg507@cam.ac.uk	Zarbo, Liviu P/O-4960-2014; Jungwirth, Tomas/G-8952-2014; Ciccarelli, Chiara/AAF-9932-2019; Gallagher, Bryan/B-8116-2013	Zarbo, Liviu P/0000-0001-6019-2567; Jungwirth, Tomas/0000-0002-9910-1674; Ciccarelli, Chiara/0000-0003-2299-3704; Irvine, Andy/0000-0002-2097-3614; Gonzalez Zalba, Miguel Fernando/0000-0001-6964-3758; Gallagher, Bryan/0000-0001-8310-0899; Ferguson, Andrew/0000-0003-4868-7166	European Community [318397]; EU European Research Council (ERC) [268066]; Ministry of Education of the Czech Republic [LM2011026]; Grant Agency of the Czech Republic [14-37427G]; Hitachi Ltd.	European Community(European Commission); EU European Research Council (ERC)(European Research Council (ERC)); Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Hitachi Ltd.	European Community's Seventh Framework under the Grant Agreement No. 318397 (http://www.tolop.eu) supported MFGZ. EU European Research Council (ERC) advance grant no. 268066, the Ministry of Education of the Czech Republic grant no. LM2011026, and the Grant Agency of the Czech Republic grant no. 14-37427G were received by TW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Hitachi Ltd. provided support in the form of salaries for authors M. Fernando Gonzalez-Zalba and Joerg Wunderlich, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Barnas J, 2000, PHYS REV B, V62, P12363, DOI 10.1103/PhysRevB.62.12363; BEENAKKER CWJ, 1991, PHYS REV B, V44, P1646, DOI 10.1103/PhysRevB.44.1646; Betz AC, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4863538; Ciccarelli C, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4752013; Dery H, 2007, NATURE, V447, P573, DOI 10.1038/nature05833; Gonzalez-Zalba MF, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4750251; Hai PN, 2007, JPN J APPL PHYS 1, V46, P6579, DOI 10.1143/JJAP.46.6579; Heinzig A, 2012, NANO LETT, V12, P119, DOI 10.1021/nl203094h; Ishikuro H, 1998, INTERNATIONAL ELECTRON DEVICES MEETING 1998 - TECHNICAL DIGEST, P119, DOI 10.1109/IEDM.1998.746293; Jalil MBA, 2009, J APPL PHYS, V105, DOI 10.1063/1.3055271; Joo S, 2013, NATURE, V494, P72, DOI 10.1038/nature11817; KASTNER MA, 1992, REV MOD PHYS, V64, P849, DOI 10.1103/RevModPhys.64.849; Kirchner S, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.206401; Klein M, 2009, CHEMPHYSCHEM, V10, P162, DOI 10.1002/cphc.200800568; Mizuno Y, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2724771; Mol JA, 2011, P NATL ACAD SCI USA, V108, P13969, DOI 10.1073/pnas.1109935108; Ono K, 1997, J PHYS SOC JPN, V66, P1261, DOI 10.1143/JPSJ.66.1261; Shirakashi J., 2001, Journal of the Magnetics Society of Japan, V25, P783, DOI 10.3379/jmsjmag.25.783; Strukov DB, 2008, NATURE, V453, P80, DOI 10.1038/nature06932; Takiguchi M, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.043101; TUCKER JR, 1992, J APPL PHYS, V72, P4399, DOI 10.1063/1.352206; Uchida K., 2002, 2002 IEEE International Solid-State Circuits Conference. Digest of Technical Papers (Cat. No.02CH37315), P206, DOI 10.1109/ISSCC.2002.993008; Wang H, 2010, IEEE ELECTR DEVICE L, V31, P906, DOI 10.1109/LED.2010.2052017; Wunderlich J, 2007, J MAGN MAGN MATER, V310, P1883, DOI 10.1016/j.jmmm.2006.10.676; Wunderlich J, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.077201; Yu WJ, 2009, NANO LETT, V9, P1401, DOI 10.1021/nl803066v; Zhu C, 2007, DES AUT CON, P312, DOI 10.1109/DAC.2007.375178	27	3	3	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125142	10.1371/journal.pone.0125142	http://dx.doi.org/10.1371/journal.pone.0125142			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923789	Green Published, gold, Green Submitted			2022-12-27	WOS:000353711600128
J	Qu, X; Ding, LF; Qin, ZQ; Wu, JG; Pan, ZS				Qu, Xiao; Ding, Longfei; Qin, Zhenqiao; Wu, Jianguo; Pan, Zishu			Additional Evidence That the Polymerase Subunits Contribute to the Viral Replication and the Virulence of H5N1 Avian Influenza Virus Isolates in Mice	PLOS ONE			English	Article							A VIRUS; HOST-RANGE; PB2 PROTEIN; GENES CONTRIBUTE; MOLECULAR-BASIS; PANDEMIC H1N1; AMINO-ACID; TRANSMISSION; DETERMINANT; MOUSE	Genetically similar H5N1 viruses circulating in the avian reservoir exhibit different levels of pathogenicity in mice. In this study, we characterized two highly pathogenic H5N1 avian isolates-A/Hunan/316/2005 (HN05), which is highly pathogenic in mice, and A/Hubei/489/2004 (HB04), which is nonpathogenic. In mammalian cells, HN05 replicates more efficiently than HB04, although both viruses have similar growth kinetics in avian cells. We used reverse genetics to generate recombinant H5N1 strains containing genes from HN05 and HB04 and examined their virulence. HN05 genes encoding the polymerase complex determine pathogenicity and viral replication ability both in vitro and in vivo. The PB2 subunit plays an important role in enhancing viral replication, and the PB1 and PA subunits contribute mainly to pathogenicity in mice. These results can be used to elucidate host-range expansion and the molecular basis of the high virulence of H5N1 viruses in mammalian species.	[Qu, Xiao; Ding, Longfei; Qin, Zhenqiao; Wu, Jianguo; Pan, Zishu] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China	Wuhan University	Pan, ZS (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	zspan@whu.edu.cn		longfei, Ding/0000-0002-7660-0876; Wu, Jianguo/0000-0002-8326-2895	National Basic Research Program of China (973 Program) [2013CB911100, 2010CB534003]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the National Basic Research Program of China (973 Program) (2013CB911100 and 2010CB534003).	Bussey KA, 2010, J VIROL, V84, P4395, DOI 10.1128/JVI.02642-09; Chen H, 2004, P NATL ACAD SCI USA, V101, P10452, DOI 10.1073/pnas.0403212101; Chen LM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000072; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Conenello GM, 2007, PLOS PATHOG, V3, P1414, DOI 10.1371/journal.ppat.0030141; Conenello GM, 2011, J VIROL, V85, P652, DOI 10.1128/JVI.01987-10; Czudai- Matwich V, 2014, J VIROL; Davis JM, 2008, AM J PHYSIOL-REG I, V295, pR505, DOI 10.1152/ajpregu.90319.2008; Duan L, 2008, VIROLOGY, V380, P243, DOI 10.1016/j.virol.2008.07.038; Fan SF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6021; Fornek JL, 2009, J VIROL, V83, P11102, DOI 10.1128/JVI.00994-09; Gabriel G, 2007, J VIROL, V81, P9601, DOI 10.1128/JVI.00666-07; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; Gao P, 1999, J VIROL, V73, P3184, DOI 10.1128/JVI.73.4.3184-3189.1999; Govorkova EA, 2005, J VIROL, V79, P2191, DOI 10.1128/JVI.79.4.2191-2198.2005; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hu J, 2013, J VIROL, V87, P2660, DOI 10.1128/JVI.02891-12; Hulse-Post DJ, 2007, J VIROL, V81, P8515, DOI 10.1128/JVI.00435-07; Ilyushina NA, 2010, J VIROL, V84, P8607, DOI 10.1128/JVI.00159-10; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jin H, 2007, VACCINE, V25, P8664, DOI 10.1016/j.vaccine.2007.10.032; Jin SQ, 2014, SCI REP-UK, V4, DOI 10.1038/srep03799; Kashiwagi T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114502; Katz JM, 2000, J VIROL, V74, P10807, DOI 10.1128/JVI.74.22.10807-10810.2000; Kuiken T, 2004, SCIENCE, V306, P241, DOI 10.1126/science.1102287; Labadie K, 2007, VIROLOGY, V362, P271, DOI 10.1016/j.virol.2006.12.027; Leung BW, 2010, VIROLOGY, V401, P96, DOI 10.1016/j.virol.2010.01.036; Leymarie O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057894; Li CJ, 2010, P NATL ACAD SCI USA, V107, P4687, DOI 10.1073/pnas.0912807107; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Long JS, 2013, J VIROL, V87, P9983, DOI 10.1128/JVI.01399-13; Lu XH, 1999, J VIROL, V73, P5903, DOI 10.1128/JVI.73.7.5903-5911.1999; Manzoor R, 2009, J VIROL, V83, P1572, DOI 10.1128/JVI.01879-08; Massin P, 2001, J VIROL, V75, P5398, DOI 10.1128/JVI.75.11.5398-5404.2001; Mehle A, 2009, P NATL ACAD SCI USA, V106, P21312, DOI 10.1073/pnas.0911915106; Naffakh N, 2000, J GEN VIROL, V81, P1283, DOI 10.1099/0022-1317-81-5-1283; Neumann G, 2006, EMERG INFECT DIS, V12, P881, DOI 10.3201/eid1206.051336; OIE (World Organization for Animal Health), 2014, MAN DIAGN TESTS VACC; Ping JH, 2010, J VIROL, V84, P10606, DOI 10.1128/JVI.01187-10; REED L. J., 1938, AMER JOUR HYG, V27, P493; Salomon R, 2006, J EXP MED, V203, P689, DOI 10.1084/jem.20051938; Salzberg SL, 2007, EMERG INFECT DIS, V13, P713, DOI 10.3201/eid1305.070013; Schat KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030960; Shinya K, 2004, VIROLOGY, V320, P258, DOI 10.1016/j.virol.2003.11.030; Songserm T, 2006, EMERG INFECT DIS, V12, P1744, DOI 10.3201/eid1211.060542; Stech J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn646; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Sun W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093366; Sun YP, 2011, P NATL ACAD SCI USA, V108, P4164, DOI 10.1073/pnas.1019109108; Tao P, 2009, ANTIVIR RES, V81, P253, DOI 10.1016/j.antiviral.2008.12.009; Thanawongnuwech R, 2005, EMERG INFECT DIS, V11, P699, DOI 10.3201/eid1105.050007; Uchida Y, 2012, J VIROL, V86, P2686, DOI 10.1128/JVI.06374-11; Verhelst J, 2012, J VIROL, V86, P13445, DOI 10.1128/JVI.01682-12; Wasilenko JL, 2008, J VIROL, V82, P4544, DOI 10.1128/JVI.02642-07; Webster RG, 2006, NEW ENGL J MED, V355, P2174, DOI 10.1056/NEJMp068205; Wilker PR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3636; Xu C, 2012, J GEN VIROL, V93, P531, DOI 10.1099/vir.0.036434-0; Yao YX, 2001, J VIROL, V75, P5410, DOI 10.1128/JVI.75.11.5410-5415.2001; Zhou B, 2011, J VIROL, V85, P357, DOI 10.1128/JVI.01694-10; Zitzow LA, 2002, J VIROL, V76, P4420, DOI 10.1128/JVI.76.9.4420-4429.2002	65	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0124422	10.1371/journal.pone.0124422	http://dx.doi.org/10.1371/journal.pone.0124422			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938456	Green Published, Green Submitted, gold			2022-12-27	WOS:000353943000026
J	Li, XD; Yang, YJ; Wang, LY; Qiao, SB; Lu, XF; Wu, YJ; Xu, B; Li, HF; Gu, DF				Li, Xiangdong; Yang, Yuejin; Wang, Laiyuan; Qiao, Shubin; Lu, Xiangfeng; Wu, Yongjian; Xu, Bo; Li, Hongfan; Gu, Dongfeng			Plasma miR-122 and miR-3149 Potentially Novel Biomarkers for Acute Coronary Syndrome	PLOS ONE			English	Article							MICRORNAS; EXPRESSION; DIAGNOSIS; CANCER	Objective We evaluated the potentiality of plasma microRNAs (miRNAs, or miRs) that were considered as novel biomarkers for acute coronary syndrome (ACS), including acute myocardial infarction (AMI) and unstable angina (UA). Methods and Results We initially identified plasma miR-122, -140-3p, -144, -720, -1225-3p, -2861, and -3149 as candidate miRNAs associated with AMI (>= 2 fold and P < 0.05) by comparing expression differences of miRNAs among AMI, non-coronary heart disease (non-CHD) and stable angina (SA) groups, using miRNA microarrays (n = 8 independent arrays in each group). Those seven plasma miRNAs were further examined with qRT-PCR analyses in two replications including 111 and 428 patients separately, and the results demonstrated that plasma miR-122, -140-3p, -720, -2861, and -3149 were elevated in the ACS group vs. the non-ACS (non-CHD + SA) group (P < 0.01). The area under the receiver operating characteristic curve (AUC) of the five miRNAs for ACS classification was 0.838, 0.818, 0.865, 0.852, and 0.670, respectively (all P < 0.001), while the values reached 0.843 and 0.925 when simultaneously with miR-122 and -3149 or with miR-122, -2861, and -3149 together (all P < 0.001). In plasma of pigs after coronary ligation, miR-122 was increased from 180 min to 240 min and miR-3149 was augmented from 30 min to 240 min compared with the sham pigs (all P < 0.05). Conclusion Plasma miR-122, -140-3p, -720, -2861, and -3149 were associated with and potentially novel biomarkers for ACS.	[Li, Xiangdong; Wang, Laiyuan; Lu, Xiangfeng; Li, Hongfan; Gu, Dongfeng] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Dept Epidemiol,State Key Lab Cardiovasc Dis, Beijing 100037, Peoples R China; [Li, Xiangdong; Yang, Yuejin; Wang, Laiyuan; Qiao, Shubin; Lu, Xiangfeng; Wu, Yongjian; Xu, Bo; Li, Hongfan; Gu, Dongfeng] Peking Union Med Coll, Beijing 100037, Peoples R China; [Li, Xiangdong; Yang, Yuejin; Qiao, Shubin; Wu, Yongjian; Xu, Bo] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Dept Cardiol, Beijing 100037, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS	Gu, DF (corresponding author), Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Dept Epidemiol,State Key Lab Cardiovasc Dis, Beijing 100037, Peoples R China.	gudongfeng@vip.sina.com	Duarte, Graziela Biude Silva/Q-7728-2016	Wu, Yongjian/0000-0002-5590-8396	National Basic Research Program (973 Program) in China [2011CB503901, 2012CB518602]; China Postdoctoral Science Foundation [2012M510355]; National Science Foundation of China [81270334]	National Basic Research Program (973 Program) in China(National Basic Research Program of China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Basic Research Program (973 Program) in China (http://www.most.gov.cn/) (No. 2011CB503901 (Dr. Dong-Feng Gu) and 2012CB518602 (Dr. Yue-Jin Yang)), China Postdoctoral Science Foundation (http://res.chinapostdoctor.org.cn/) (Dr. Xiang-Dong Li, No. 2012M510355), and the National Science Foundation of China (http://www.nsfc.gov.cn/) (Dr. Lai-Yuan Wang, No. 81270334).	Agewall S, 2011, EUR HEART J, V32, P404, DOI 10.1093/eurheartj/ehq456; Arbab-Zadeh A, 2012, CIRCULATION, V125, P1147, DOI 10.1161/CIRCULATIONAHA.111.047431; Cardin S, 2012, CIRC-ARRHYTHMIA ELEC, V5, P1027, DOI 10.1161/CIRCEP.112.973214; Corsten MF, 2010, CIRC-CARDIOVASC GENE, V3, P499, DOI 10.1161/CIRCGENETICS.110.957415; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; Dangwal S, 2012, THROMB HAEMOSTASIS, V108, P599, DOI 10.1160/TH12-03-0211; Dawson K, 2013, CIRCULATION, V127, P1466, DOI 10.1161/CIRCULATIONAHA.112.001207; Edelstein LC, 2011, BLOOD, V117, P5289, DOI 10.1182/blood-2011-01-292011; Fernandez-Hernando C, 2011, CURR OPIN LIPIDOL, V22, P86, DOI 10.1097/MOL.0b013e3283428d9d; Gao W, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-55; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; Goch A, 2009, CLIN CARDIOL, V32, pE46, DOI DOI 10.1002/CLC.20354; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Haver VG, 2010, TRENDS CARDIOVAS MED, V20, P65, DOI 10.1016/j.tcm.2010.04.002; Hu R, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.176099; Huang Y, 2011, J PHYSIOL BIOCHEM, V67, P129, DOI 10.1007/s13105-010-0050-6; Kukreja RC, 2011, MOL PHARMACOL, V80, P558, DOI 10.1124/mol.111.073528; Li LZ, 2014, CARCINOGENESIS, V35, P469, DOI 10.1093/carcin/bgt330; Lu YJ, 2010, CIRCULATION, V122, P2378, DOI 10.1161/CIRCULATIONAHA.110.958967; Pagidipati NJ, 2013, CIRCULATION, V127, P749, DOI 10.1161/CIRCULATIONAHA.112.128413; Pleister A, 2013, BIOMARK MED, V7, P287, DOI [10.2217/bmm.13.8, 10.2217/BMM.13.8]; Raitoharju E, 2013, CLIN CHEM, V59, P1708, DOI 10.1373/clinchem.2013.204917; Sand M, 2012, BRIT J DERMATOL, V167, P847, DOI 10.1111/j.1365-2133.2012.11022.x; Taurino C, 2010, CLIN SCI, V119, P335, DOI 10.1042/CS20100043; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Wang Y, 2013, MOL MED REP, V7, P1506, DOI 10.3892/mmr.2013.1384; Wang Zhiguo, 2010, World J Biol Chem, V1, P41, DOI 10.4331/wjbc.v1.i4.41; Wang ZH, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0577-9; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Wu AHB, 1998, EUR HEART J, V19, pN25	30	37	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125430	10.1371/journal.pone.0125430	http://dx.doi.org/10.1371/journal.pone.0125430			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933289	Green Published, gold, Green Submitted			2022-12-27	WOS:000353887100111
J	Wu, P; Pan, L				Wu, Peng; Pan, Li			Multi-Objective Community Detection Based on Memetic Algorithm	PLOS ONE			English	Article							GENETIC ALGORITHM; MODULARITY; NETWORK; BALANCE	Community detection has drawn a lot of attention as it can provide invaluable help in understanding the function and visualizing the structure of networks. Since single objective optimization methods have intrinsic drawbacks to identifying multiple significant community structures, some methods formulate the community detection as multi-objective problems and adopt population-based evolutionary algorithms to obtain multiple community structures. Evolutionary algorithms have strong global search ability, but have difficulty in locating local optima efficiently. In this study, in order to identify multiple significant community structures more effectively, a multi-objective memetic algorithm for community detection is proposed by combining multi-objective evolutionary algorithm with a local search procedure. The local search procedure is designed by addressing three issues. Firstly, nondominated solutions generated by evolutionary operations and solutions in dominant population are set as initial individuals for local search procedure. Then, a new direction vector named as pseudonormal vector is proposed to integrate two objective functions together to form a fitness function. Finally, a network specific local search strategy based on label propagation rule is expanded to search the local optimal solutions efficiently. The extensive experiments on both artificial and real-world networks evaluate the proposed method from three aspects. Firstly, experiments on influence of local search procedure demonstrate that the local search procedure can speed up the convergence to better partitions and make the algorithm more stable. Secondly, comparisons with a set of classic community detection methods illustrate the proposed method can find single partitions effectively. Finally, the method is applied to identify hierarchical structures of networks which are beneficial for analyzing networks in multi-resolution levels.	[Wu, Peng; Pan, Li] Shanghai Jiao Tong Univ, Sch Elect Informat & Elect Engn, Shanghai 200030, Peoples R China; [Wu, Peng; Pan, Li] Shanghai Jiao Tong Univ, Natl Engn Lab Informat Content Anal Technol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Pan, L (corresponding author), Shanghai Jiao Tong Univ, Sch Elect Informat & Elect Engn, Shanghai 200030, Peoples R China.	panli@sjtu.edu.cn			National 973 Key Basic Research Program of China [2013CB329603]; National Key Technology Research and Development Program of China [2014BAG01B02]; Program of Shanghai Subject Chief Scientist [13XD1425100]	National 973 Key Basic Research Program of China(National Basic Research Program of China); National Key Technology Research and Development Program of China(National Key Technology R&D ProgramNational High Technology Research and Development Program of China); Program of Shanghai Subject Chief Scientist	This work is supported by National 973 Key Basic Research Program of China (2013CB329603) (http://www.973.gov.cn/English/Index.aspx) (LP), National Key Technology Research and Development Program of China (2014BAG01B02) (http://www.most.gov.cn/eng/index.htm) (LP), and Program of Shanghai Subject Chief Scientist (13XD1425100) (http://www.stcsm.gov.cn/) (LP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber MJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026129; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Clauset A, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.026132; Corne D. W., 2001, PROC 3 ANN C GENETIC, P283; Deb K, 2001, LECT NOTES COMPUT SC, V1993, P385; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Deb K., 2001, WIL INT S SYS OPT; Duch J, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.027104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gleiser PM, 2003, ADV COMPLEX SYST, V6, P565, DOI 10.1142/S0219525903001067; Gong MG, 2008, EVOL COMPUT, V16, P225, DOI 10.1162/evco.2008.16.2.225; Gong MG, 2013, APPL SOFT COMPUT, V13, P1705, DOI 10.1016/j.asoc.2013.01.018; Gong MG, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.056101; Guimera R, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.065103; Huang JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023829; Ishibuchi H, 2003, IEEE T EVOLUT COMPUT, V7, P204, DOI 10.1109/TEVC.2003.810752; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Knuth D. E., 1993, STANFORD GRAPHBASE P, V37; Lancichinetti A, 2009, PHYSICAL REVIEW E ST, V78, DOI [10.1103/PhysRevE.78.046110, DOI 10.1103/PHYSREVE.78.046110]; Lancichinetti A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033015; Lara A, 2010, IEEE T EVOLUT COMPUT, V14, P112, DOI 10.1109/TEVC.2009.2024143; Leon D, 2005, J STAT MECH-THEORY E; Li SH, 2015, NEUROCOMPUTING, V151, P1063, DOI 10.1016/j.neucom.2014.04.084; Li ZP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083739; Lusseau D, 2003, BEHAV ECOL SOCIOBIOL, V54, P396, DOI 10.1007/s00265-003-0651-y; Ma LJ, 2014, APPL SOFT COMPUT, V19, P121, DOI 10.1016/j.asoc.2014.02.003; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Pizzuti C, 2008, LECT NOTES COMPUT SC, V5199, P1081, DOI 10.1007/978-3-540-87700-4_107; Pizzuti C, 2012, IEEE T EVOLUT COMPUT, V16, P418, DOI 10.1109/TEVC.2011.2161090; Raghavan UN, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036106; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Rosvall M, 2007, P NATL ACAD SCI USA, V104, P7327, DOI 10.1073/pnas.0611034104; Shang RH, 2013, PHYSICA A, V392, P1215, DOI 10.1016/j.physa.2012.11.003; Shi C., 2011, INT C INF KNOWL MAN, P2301; Shi C, 2014, COMPUT INTELL-US, V30, P562, DOI 10.1111/coin.12007; Shi C, 2012, APPL SOFT COMPUT, V12, P850, DOI 10.1016/j.asoc.2011.10.005; Sun YX, 2014, PHYSICA A, V415, P261, DOI 10.1016/j.physa.2014.07.071; Tasgin M, 2007, ARXIV ARXIV07110491, P1; Vitali S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104655; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; YoungJa Park, 1998, Genetic Programming 1998. Proceedings of the Third Annual Conference, P568; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752	46	35	35	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0126845	10.1371/journal.pone.0126845	http://dx.doi.org/10.1371/journal.pone.0126845			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932646	Green Submitted, Green Published, gold			2022-12-27	WOS:000353887100155
J	Bijarnia, RK; Bachtler, M; Chandak, PG; van Goor, H; Pasch, A				Bijarnia, Rakesh K.; Bachtler, Matthias; Chandak, Prakash G.; van Goor, Harry; Pasch, Andreas			Sodium Thiosulfate Ameliorates Oxidative Stress and Preserves Renal Function in Hyperoxaluric Rats	PLOS ONE			English	Article							OXALATE CRYSTAL DEPOSITION; CALCIUM-OXALATE; VASCULAR CALCIFICATION; HEMODIALYSIS-PATIENTS; STONE FORMATION; CELL INJURY; VITAMIN-E; KIDNEY; DISEASE; CALCIPHYLAXIS	Background Hyperoxaluria causes crystal deposition in the kidney, which leads to oxidative stress and to injury and damage of the renal epithelium. Sodium thiosulfate (STS, Na2S2O3) is an antioxidant, which has been used in human medicine for decades. The effect of STS on hyperoxaluria-induced renal damage is not known. Methods Hyperoxaluria and renal injury were induced in healthy male Wistar rats by chronic exposure to ethylene glycol (EG, 0.75%) in the drinking water for 4 weeks. The treatment effects of STS, NaCl or Na2SO4 were compared. Furthermore, the effects of STS on oxalate-induced oxidative stress were investigated in vitro in renal LLC-PK1 cells. Results Chronic EG exposure led to hyperoxaluria, oxidative stress, calcium oxalate crystalluria and crystal deposition in the kidneys. Whereas all tested compounds significantly reduced crystal load, only STS-treatment maintained tissue superoxide dismutase activity and urine 8-isoprostaglandin levels in vivo and preserved renal function. In in vitro studies, STS showed the ability to scavenge oxalate-induced ROS accumulation dose dependently, reduced cell-released hydrogen peroxide and preserved superoxide dismutase activity. As a mechanism explaining this finding, STS was able to directly inactivate hydrogen peroxide in cell-free experiments. Conclusions STS is an antioxidant, which preserves renal function in a chronic EG rat model. Its therapeutic use in oxidative-stress induced renal-failure should be considered.	[Bijarnia, Rakesh K.; Bachtler, Matthias; Chandak, Prakash G.; Pasch, Andreas] Univ Hosp Bern, Dept Nephrol Hypertens & Clin Pharmacol, CH-3010 Bern, Switzerland; [Bijarnia, Rakesh K.; Bachtler, Matthias; Chandak, Prakash G.; Pasch, Andreas] Univ Bern, Inselspital, CH-3010 Bern, Switzerland; [Bijarnia, Rakesh K.; Bachtler, Matthias; Chandak, Prakash G.; Pasch, Andreas] Univ Hosp Bern, Dept Clin Res, CH-3010 Bern, Switzerland; [van Goor, Harry] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern; University of Groningen	Pasch, A (corresponding author), Univ Hosp Bern, Dept Nephrol Hypertens & Clin Pharmacol, CH-3010 Bern, Switzerland.	andreas.pasch@insel.ch	van+Goor, Harry/AAS-7712-2020	van Goor, Harry/0000-0002-6670-1577	Kohler Chemie, the provider of sodium thiosulfate	Kohler Chemie, the provider of sodium thiosulfate	AP has received an unrestricted research grant from Kohler Chemie, the provider of sodium thiosulfate. Kohler Chemie had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asplin JR, 2009, J AM SOC NEPHROL, V20, P1246, DOI 10.1681/ASN.2008070754; Bashir S, 2011, EUR J PHARMACOL, V651, P168, DOI 10.1016/j.ejphar.2010.10.076; Bijarnia RK, 2008, FOOD CHEM TOXICOL, V46, P2274, DOI 10.1016/j.fct.2008.03.007; Bodakhe KS, 2013, CHIN J NAT MEDICINES, V11, P466, DOI 10.1016/S1875-5364(13)60085-0; Byon CH, 2008, J BIOL CHEM, V283, P15319, DOI 10.1074/jbc.M800021200; Failli P, 2002, NITRIC OXIDE-BIOL CH, V7, P277, DOI 10.1016/S1089-8603(02)00120-9; Farese S, 2011, CLIN J AM SOC NEPHRO, V6, P1447, DOI 10.2215/CJN.10241110; Fridovich I, 1997, J BIOL CHEM, V272, P18515, DOI 10.1074/jbc.272.30.18515; Gaspar S, 2010, BIOSENS BIOELECTRON, V25, P1729, DOI 10.1016/j.bios.2009.12.013; Hayden MR, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-4; Hirose M, 2010, INT J UROL, V17, P83, DOI 10.1111/j.1442-2042.2009.02410.x; Holt C, 2014, J STRUCT BIOL, V185, P383, DOI 10.1016/j.jsb.2013.11.009; Huang S, 2009, AM J PHYSIOL-RENAL, V296, pF34, DOI 10.1152/ajprenal.90309.2008; Khan SR, 2013, J UROLOGY, V189, P803, DOI 10.1016/j.juro.2012.05.078; LaGrange CA, 2009, J ENDOUROL, V23, P529, DOI 10.1089/end.2008.0204; Lee HW, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-500; Li CY, 2009, UROL RES, V37, P211, DOI 10.1007/s00240-009-0197-1; Lorenzo V, 2014, NEFROLOGIA, V34, P398, DOI 10.3265/Nefrologia.pre2014.Jan.12335; Malbos S, 2014, RHEUMATOLOGY, V53, P547, DOI 10.1093/rheumatology/ket388; Mathews SJ, 2011, AM J NEPHROL, V33, P131, DOI 10.1159/000323550; Meimaridou E, 2005, FREE RADICAL BIO MED, V38, P1553, DOI 10.1016/j.freeradbiomed.2005.02.020; Meissner M, 2006, DERMATOLOGY, V212, P373, DOI 10.1159/000092290; Mulay SR, 2013, J CLIN INVEST, V123, P236, DOI 10.1172/JCI63679; Mulder GM, 2010, J PATHOL, V221, P183, DOI 10.1002/path.2698; Nath KA, 2000, AM J MED, V109, P665, DOI 10.1016/S0002-9343(00)00612-4; Park HK, 2008, J UROLOGY, V179, P1620, DOI 10.1016/j.juro.2007.11.039; Pasch A, 2008, KIDNEY INT, V74, P1444, DOI 10.1038/ki.2008.455; Samarneh Majed Mark, 2012, J Clin Med Res, V4, P56, DOI 10.4021/jocmr525w; Schepers MSJ, 2005, KIDNEY INT, V68, P1543, DOI 10.1111/j.1523-1755.2005.00566.x; Selvam R, 2000, INDIAN J MED RES, V111, P62; Selvam R, 2002, UROL RES, V30, P35, DOI 10.1007/s00240-001-0228-z; Smith VM, 2012, CLIN EXP DERMATOL, V37, P874, DOI 10.1111/j.1365-2230.2012.04350.x; Tanriverdi O, 2012, UROL RES, V40, P17, DOI 10.1007/s00240-011-0388-4; Thamilselvan S, 2005, BJU INT, V96, P117, DOI 10.1111/j.1464-410X.2005.05579.x; Thamilselvan V, 2014, BJU INT, V114, P140, DOI 10.1111/bju.12642; Thamilselvan V, 2009, AM J PHYSIOL-RENAL, V297, pF1399, DOI 10.1152/ajprenal.00051.2009; Tuan LQ, 2009, ENZYME MICROB TECH, V44, P101, DOI 10.1016/j.enzmictec.2008.10.012; ULLRICH KJ, 1980, PFLUG ARCH EUR J PHY, V387, P127, DOI 10.1007/BF00584263; van den Berg E, 2014, J AM SOC NEPHROL, V25, P1303, DOI 10.1681/ASN.2013050497; Xue KY, 2004, ACTA PHYS-CHIM SIN, V20, P772, DOI 10.3866/PKU.WHXB20040722; YATZIDIS H, 1985, CLIN NEPHROL, V23, P63; Yonova DH, 2014, INT J ARTIF ORGANS, V37, P308, DOI 10.5301/ijao.5000309; Zuo J, 2011, NEPHROL DIAL TRANSPL, V26, P1785, DOI 10.1093/ndt/gfr035	43	32	36	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124881	10.1371/journal.pone.0124881	http://dx.doi.org/10.1371/journal.pone.0124881			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928142	Green Submitted, Green Published, gold			2022-12-27	WOS:000353713100051
J	Lu, L; Yu, YY; Guo, YE; Wang, YW; Chang, EB; Claud, EC				Lu, Lei; Yu, Yueyue; Guo, Yuee; Wang, Yunwei; Chang, Eugene B.; Claud, Erika C.			Transcriptional Modulation of Intestinal Innate Defense/Inflammation Genes by Preterm Infant Microbiota in a Humanized Gnotobiotic Mouse Model	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; NECROTIZING ENTEROCOLITIS; BACTERIAL-COLONIZATION; GROWTH IMPAIRMENT; CROHNS-DISEASE; GUT MICROBIOTA; KAPPA-B; INFLAMMATION; INTERLEUKIN-6; MICROFLORA	Background and Aims It is known that postnatal functional maturation of the small intestine is facilitated by microbial colonization of the gut. Preterm infants exhibit defects in gut maturation, weak innate immunity against intestinal infection and increased susceptibility to inflammatory disorders, all of which may be related to the inappropriate microbial colonization of their immature intestines. The earliest microbes to colonize the preterm infant gut encounter a naive, immature intestine. Thus this earliest microbiota potentially has the greatest opportunity to fundamentally influence intestinal development and immune function. The aim of this study was to characterize the effect of early microbial colonization on global gene expression in the distal small intestine during postnatal gut development. Methods Gnotobiotic mouse models with experimental colonization by early (prior to two weeks of life) intestinal microbiota from preterm human infants were utilized. Microarray analysis was used to assess global gene expression in the intestinal epithelium. Results and Conclusion Multiple intestinal genes involved in metabolism, cell cycle regulation, cell-cell or cell-extracellular matrix communication, and immune function are developmental-and intestinal microbiota-regulated. Using a humanized gnotobiotic mouse model, we demonstrate that certain early preterm infant microbiota from prior to 2 weeks of life specifically induce increased NF-kappa B activation and a phenotype of increased inflammation whereas other preterm microbiota specifically induce decreased NF-kappa B activation. These fundamental differences correlate with altered clinical outcomes and suggest the existence of optimal early microbial communities to improve health outcomes.	[Lu, Lei; Yu, Yueyue; Guo, Yuee; Claud, Erika C.] Univ Chicago, Dept Pediat Neonatol, Chicago, IL 60637 USA; [Chang, Eugene B.; Claud, Erika C.] Univ Chicago, Dept Med Gastroenterol, Chicago, IL 60637 USA; [Wang, Yunwei] Univ Nevada, Sch Med, Internal Med Residency Program Reno, Reno, NV 89557 USA	University of Chicago; University of Chicago; Nevada System of Higher Education (NSHE); University of Nevada Reno	Claud, EC (corresponding author), Univ Chicago, Dept Pediat Neonatol, Chicago, IL 60637 USA.	eclaud@peds.bsd.uchicago.edu			R01 Human Development [059123]; P30 Digestive and Kidney [42086]; National Institute of Health Human Microbiome Demonstration Project UH3 Digestive and Kidney [083993]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097268] Funding Source: NIH RePORTER	R01 Human Development; P30 Digestive and Kidney; National Institute of Health Human Microbiome Demonstration Project UH3 Digestive and Kidney; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding Support: R01 Human Development 059123 (Erika Claud), P30 Digestive and Kidney 42086 (Digestive Disease Research Core Center), National Institute of Health Human Microbiome Demonstration Project UH3 Digestive and Kidney 083993 (Eugene Chang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azooz O, 2000, GASTROENTEROLOGY, V118, pA62, DOI 10.1016/S0016-5085(00)82322-7; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Ballinger A, 2002, HORM RES, V58, P7, DOI 10.1159/000064756; Barrett E, 2013, ARCH DIS CHILD-FETAL, V98, pF334, DOI 10.1136/archdischild-2012-303035; Burns RC, 2001, GASTROENTEROLOGY, V121, P1428, DOI 10.1053/gast.2001.29568; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cario E, 2007, GASTROENTEROLOGY, V132, P1359, DOI 10.1053/j.gastro.2007.02.056; Cilieborg MS, 2012, EARLY HUM DEV, V88, pS41, DOI 10.1016/j.earlhumdev.2011.12.027; Claud EC, 2004, P NATL ACAD SCI USA, V101, P7404, DOI 10.1073/pnas.0401710101; Claud EC, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-20; Claud Erika C., 2009, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V8, P248; Daly C, 2003, MICROCIRCULATION, V10, P247, DOI 10.1038/sj.mn.7800190; De Benedetti F, 2002, HORM RES, V58, P24, DOI 10.1159/000064757; De la Cochetiere MF, 2004, PEDIATR RES, V56, P366, DOI 10.1203/01.PDR.0000134251.45878.D5; DeBenedetti F, 1997, J CLIN INVEST, V99, P643, DOI 10.1172/JCI119207; DeSantis TZ, 2003, BIOINFORMATICS, V19, P1461, DOI 10.1093/bioinformatics/btg200; Ehrenkranz RA, 2006, PEDIATRICS, V117, P1253, DOI 10.1542/peds.2005-1368; Fell JME, 2005, EARLY HUM DEV, V81, P117, DOI 10.1016/j.earlhumdev.2004.10.001; Hallstrom M, 2004, EUR J CLIN MICROBIOL, V23, P463, DOI 10.1007/s10096-004-1146-0; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; HYDUK SJ, 2007, PROG INFLAM RES, P141; Kestler HA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-67; Macfarlane S, 2003, P NUTR SOC, V62, P67, DOI 10.1079/PNS2002207; Magne F, 2006, FEMS MICROBIOL ECOL, V57, P128, DOI 10.1111/j.1574-6941.2006.00097.x; Millar MR, 1996, J CLIN MICROBIOL, V34, P2506, DOI 10.1128/JCM.34.10.2506-2510.1996; Moal VLL, 2006, CLIN MICROBIOL REV, V19, P315, DOI 10.1128/CMR.19.2.315-337.2006; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Patsos G, 2009, BIOL CHEM, V390, P581, DOI 10.1515/BC.2009.052; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Schwiertz A, 2003, PEDIATR RES, V54, P393, DOI 10.1203/01.PDR.0000078274.74607.7A; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; Speer CP, 2001, BIOL NEONATE, V79, P205; Stoll BJ, 2004, JAMA-J AM MED ASSOC, V292, P2357, DOI 10.1001/jama.292.19.2357; The center for computational and integrative biology Massachusetts General Hospital School HM, 2011, PCR PRIM GEN EXPR DE; Viedt C, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000015609.31253.7F; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28	43	24	25	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124504	10.1371/journal.pone.0124504	http://dx.doi.org/10.1371/journal.pone.0124504			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928420	Green Published, gold, Green Submitted			2022-12-27	WOS:000353713100035
J	Qi, RL; Li, MH; Ma, YY; Chen, NH				Qi, Renli; Li, Minghong; Ma, Yuanye; Chen, Nanhui			State-Dependent Changes in Auditory Sensory Gating in Different Cortical Areas in Rats	PLOS ONE			English	Article							EVOKED-POTENTIALS; NEUROPHYSIOLOGICAL EVIDENCE; TEMPORAL VARIABILITY; P50 COMPONENT; HUMAN SLEEP; BRAIN-STEM; NREM SLEEP; K-COMPLEX; NON-REM; EEG	Sensory gating is a process in which the brain's response to a repetitive stimulus is attenuated; it is thought to contribute to information processing by enabling organisms to filter extraneous sensory inputs from the environment. To date, sensory gating has typically been used to determine whether brain function is impaired, such as in individuals with schizophrenia or addiction. In healthy subjects, sensory gating is sensitive to a subject's behavioral state, such as acute stress and attention. The cortical response to sensory stimulation significantly decreases during sleep; however, information processing continues throughout sleep, and an auditory evoked potential (AEP) can be elicited by sound. It is not known whether sensory gating changes during sleep. Sleep is a non-uniform process in the whole brain with regional differences in neural activities. Thus, another question arises concerning whether sensory gating changes are uniform in different brain areas from waking to sleep. To address these questions, we used the sound stimuli of a Conditioning-testing paradigm to examine sensory gating during waking, rapid eye movement (REM) sleep and Non-REM (NREM) sleep in different cortical areas in rats. We demonstrated the following: 1. Auditory sensory gating was affected by vigilant states in the frontal and parietal areas but not in the occipital areas. 2. Auditory sensory gating decreased in NREM sleep but not REM sleep from waking in the frontal and parietal areas. 3. The decreased sensory gating in the frontal and parietal areas during NREM sleep was the result of a significant increase in the test sound amplitude.	[Qi, Renli] Univ Sci & Technol China, Sch Life Sci, Hefei, Anhui, Peoples R China; [Qi, Renli; Li, Minghong; Ma, Yuanye; Chen, Nanhui] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Brain & Cognit Sci, Kunming, Yunnan, Peoples R China; [Li, Minghong] Yunnan Univ Tradit Chinese Med, Kunming, Peoples R China; [Ma, Yuanye] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China; [Ma, Yuanye; Chen, Nanhui] Yunnan Key Lab Primate Biomed Res, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Kunming Institute of Zoology; Yunnan University of Chinese Medicine; Chinese Academy of Sciences; Institute of Biophysics, CAS	Ma, YY (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Brain & Cognit Sci, Kunming, Yunnan, Peoples R China.	yuanma0716@vip.sina.com; nhchen@mail.kiz.ac.cn			Ministry of Science and Technology of the People's Republic of China [2011BAK04B04]; NSFC [61178051]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); NSFC(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from the Ministry of Science and Technology of the People's Republic of China (No. 2011BAK04B04) and a grant from NSFC (No. 61178051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER LE, 1982, BIOL PSYCHIAT, V17, P639; ADLER LE, 1986, BIOL PSYCHIAT, V21, P787, DOI 10.1016/0006-3223(86)90244-1; Anstrom KK, 2007, NEUROSCIENCE, V146, P515, DOI 10.1016/j.neuroscience.2007.01.060; BICKFORDWIMER PC, 1990, BIOL PSYCHIAT, V27, P183, DOI 10.1016/0006-3223(90)90648-L; BOUTROS NN, 1991, CLIN ELECTROENCEPHAL, V22, P40, DOI 10.1177/155005949102200109; Broyd SJ, 2013, INT J PSYCHOPHYSIOL, V89, P381, DOI 10.1016/j.ijpsycho.2013.04.015; Budd TW, 2013, BRAIN RES, V1498, P59, DOI 10.1016/j.brainres.2012.12.033; Cajochen C, 1999, Sleep Res Online, V2, P65; Colrain IM, 2007, SLEEP MED REV, V11, P277, DOI 10.1016/j.smrv.2007.05.001; Cote KA, 2002, INT J PSYCHOPHYSIOL, V46, P227, DOI 10.1016/S0167-8760(02)00114-9; CULLUM CM, 1993, SCHIZOPHR RES, V10, P131, DOI 10.1016/0920-9964(93)90048-N; de Bruin NMWJ, 2001, BIOL PSYCHOL, V55, P195, DOI 10.1016/S0301-0511(00)00084-3; De Bruin NMWJ, 2001, NEUROSCIENCE, V105, P169, DOI 10.1016/S0306-4522(01)00183-X; DI S, 1992, J NEUROPHYSIOL, V68, P425, DOI 10.1152/jn.1992.68.2.425; Dissanayake DWN, 2013, NEUROPHARMACOLOGY, V67, P66, DOI 10.1016/j.neuropharm.2012.10.011; Dissanayake DWN, 2009, BRAIN RES, V1298, P153, DOI 10.1016/j.brainres.2009.08.032; Feinberg I, 2011, SLEEP, V34, P325, DOI 10.1093/sleep/34.3.325; Finelli LA, 2001, EUR J NEUROSCI, V13, P2282, DOI 10.1046/j.0953-816x.2001.01597.x; FREEDMAN R, 1983, BIOL PSYCHIAT, V18, P537; FREEDMAN R, 1987, SCHIZOPHRENIA BULL, V13, P669, DOI 10.1093/schbul/13.4.669; GUTERMAN Y, 1992, INT J PSYCHOPHYSIOL, V12, P197, DOI 10.1016/0167-8760(92)90011-Y; Halasz P, 2005, SLEEP MED REV, V9, P391, DOI 10.1016/j.smrv.2005.04.003; Jellema T, 2004, NEUROSCIENCE, V129, P283, DOI 10.1016/j.neuroscience.2004.07.046; Jin Y, 1997, PSYCHIAT RES, V70, P71, DOI 10.1016/S0165-1781(97)03091-6; Jones BE, 2005, TRENDS PHARMACOL SCI, V26, P578, DOI 10.1016/j.tips.2005.09.009; JUDD LL, 1992, AM J PSYCHIAT, V149, P488; Kisley MA, 2001, CLIN NEUROPHYSIOL, V112, P1154, DOI 10.1016/S1388-2457(01)00578-8; Knott V, 2013, J PSYCHOPHARMACOL, V27, P790, DOI 10.1177/0269881113490449; Maquet P, 2000, J SLEEP RES, V9, P207; Massimini M, 2003, J NEUROPHYSIOL, V89, P1205, DOI 10.1152/jn.00373.2002; MIYAZATO H, 1995, BRAIN RES BULL, V37, P247, DOI 10.1016/0361-9230(95)00003-W; Miyazato H, 1996, NEUROSCIENCE, V75, P289, DOI 10.1016/0306-4522(96)00176-5; NAGAMOTO HT, 1991, SCHIZOPHR RES, V4, P31, DOI 10.1016/0920-9964(91)90007-E; Nicholas CL, 2006, NEUROSCI LETT, V404, P127, DOI 10.1016/j.neulet.2006.05.022; Nir Y, 2015, CEREB CORTEX, V25, P1362, DOI 10.1093/cercor/bht328; Patterson JV, 2000, ARCH GEN PSYCHIAT, V57, P57, DOI 10.1001/archpsyc.57.1.57; Phillips DJ, 2011, SLEEP, V34, P1527, DOI 10.5665/sleep.1392; Rector DM, 2009, NEUROSCIENCE, V159, P115, DOI 10.1016/j.neuroscience.2008.11.031; SHAW NA, 1995, PROG NEUROBIOL, V47, P95, DOI 10.1016/0301-0082(95)00021-M; Shinba T, 1997, EVOKED POTENTIAL, V104, P447, DOI 10.1016/S0168-5597(97)00047-6; STERIADE M, 1990, J NEUROSCI, V10, P2541; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; Steriade MM, 2007, BRAIN CONTROL WAKEFU; van Luijtelaar ELJM, 1998, ACTA NEUROBIOL EXP, V58, P263; Vuillier L, 2015, CLIN EEG NEUROSCI, V46, P81, DOI 10.1177/1550059414523417; Werth E, 1997, J SLEEP RES, V6, P102, DOI 10.1046/j.1365-2869.1997.d01-36.x; Werth E, 1996, NEUROREPORT, V8, P123, DOI 10.1097/00001756-199612200-00025; White PM, 1997, PSYCHOPHYSIOLOGY, V34, P703, DOI 10.1111/j.1469-8986.1997.tb02145.x; Witten L, 2014, BEHAV BRAIN RES, V266, P85, DOI 10.1016/j.bbr.2014.02.048; Yang CM, 2007, INT J PSYCHOPHYSIOL, V63, P87, DOI 10.1016/j.ijpsycho.2006.08.006; Zouridakis G, 1997, PSYCHIAT RES, V69, P169, DOI 10.1016/S0165-1781(96)02979-4	51	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0126684	10.1371/journal.pone.0126684	http://dx.doi.org/10.1371/journal.pone.0126684			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928147	Green Submitted, gold, Green Published			2022-12-27	WOS:000353713100131
J	Truppa, V; Carducci, P; Trapanese, C; Hanus, D				Truppa, Valentina; Carducci, Paola; Trapanese, Cinzia; Hanus, Daniel			Does Presentation Format Influence Visual Size Discrimination in Tufted Capuchin Monkeys (Sapajus spp.)?	PLOS ONE			English	Article							MATCHING-TO-SAMPLE; SAME-DIFFERENT CONCEPTUALIZATION; BABOONS PAPIO-PAPIO; LONG-TERM-MEMORY; QUANTITY DISCRIMINATION; PAN-TROGLODYTES; CEBUS-APELLA; COGNITIVE PERFORMANCE; GORILLA-GORILLA; GREAT APES	Most experimental paradigms to study visual cognition in humans and non-human species are based on discrimination tasks involving the choice between two or more visual stimuli. To this end, different types of stimuli and procedures for stimuli presentation are used, which highlights the necessity to compare data obtained with different methods. The present study assessed whether, and to what extent, capuchin monkeys' ability to solve a size discrimination problem is influenced by the type of procedure used to present the problem. Capuchins' ability to generalise knowledge across different tasks was also evaluated. We trained eight adult tufted capuchin monkeys to select the larger of two stimuli of the same shape and different sizes by using pairs of food items (Experiment 1), computer images (Experiment 1) and objects (Experiment 2). Our results indicated that monkeys achieved the learning criterion faster with food stimuli compared to both images and objects. They also required consistently fewer trials with objects than with images. Moreover, female capuchins had higher levels of acquisition accuracy with food stimuli than with images. Finally, capuchins did not immediately transfer the solution of the problem acquired in one task condition to the other conditions. Overall, these findings suggest that - even in relatively simple visual discrimination problems where a single perceptual dimension (i.e., size) has to be judged - learning speed strongly depends on the mode of presentation.	[Truppa, Valentina; Carducci, Paola; Trapanese, Cinzia] CNR, Inst Cognit Sci & Technol, Rome, Italy; [Carducci, Paola] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Hanus, Daniel] Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Leipzig, Germany	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); University of Rome Tor Vergata; Max Planck Society	Truppa, V (corresponding author), CNR, Inst Cognit Sci & Technol, Rome, Italy.	valentina.truppa@istc.cnr.it	Truppa, Valentina/AAK-4510-2021					Addessi E, 2008, ANIM COGN, V11, P275, DOI 10.1007/s10071-007-0111-6; Addessi E, 2011, P ROY SOC B-BIOL SCI, V278, P849, DOI 10.1098/rspb.2010.1602; Agrillo C, 2007, ANIM COGN, V10, P63, DOI 10.1007/s10071-006-0036-5; Alfaro JWL, 2012, AM J PRIMATOL, V74, P273, DOI 10.1002/ajp.22007; Alfaro JWL, 2012, J BIOGEOGR, V39, P272, DOI 10.1111/j.1365-2699.2011.02609.x; Barros RD, 2002, PSYCHOL REC, V52, P441; Bayer K, 2009, J VET BEHAV, V4, P51; Beran MJ, 2008, ANIM BEHAV, V75, P1793, DOI 10.1016/j.anbehav.2007.10.035; Beran MJ, 2008, ANIM COGN, V11, P109, DOI 10.1007/s10071-007-0094-3; Beran MJ, 1998, PSYCHOL REC, V48, P3, DOI 10.1007/BF03395255; Beran MJ, 2001, J COMP PSYCHOL, V115, P181, DOI 10.1037//0735-7036.115.2.181; Bovet D, 1998, LEARN MOTIV, V29, P309, DOI 10.1006/lmot.1998.1009; Bovet D, 2001, PSYCHON B REV, V8, P470, DOI 10.3758/BF03196181; Boysen ST, 2001, J COMP PSYCHOL, V115, P106, DOI 10.1037/0735-7036.115.1.106; Brannon EM, 2000, J EXP PSYCHOL ANIM B, V26, P31, DOI 10.1037/0097-7403.26.1.31; Brosnan SF, 2004, FOLIA PRIMATOL, V75, P317, DOI 10.1159/000080209; Cook RG, 1997, J EXP PSYCHOL ANIM B, V23, P417, DOI 10.1037/0097-7403.23.4.417; COOK RG, 1995, J EXP PSYCHOL ANIM B, V21, P253, DOI 10.1037/0097-7403.21.3.253; Cook RG, 2003, BEHAV PROCESS, V62, P125, DOI 10.1016/S0376-6357(03)00022-6; Cori M, 2012, NEUROPSYCHOLOGIA, V50, P1838, DOI 10.1016/j.neuropsychologia.2012.04.009; Cronin AL, 2014, ANIM COGN, V17, P1261, DOI 10.1007/s10071-014-0758-8; D'AMATO M R, 1972, Learning and Motivation, V3, P304, DOI 10.1016/0023-9690(72)90026-4; d'Amato M.R., 1984, P149; DAMATO MR, 1985, J EXP PSYCHOL ANIM B, V11, P35, DOI 10.1037/0097-7403.11.1.35; di Sorrentino EP, 2014, ANIM COGN, V17, P1081, DOI 10.1007/s10071-014-0740-5; Evans TA, 2008, BEHAV RES METHODS, V40, P590, DOI 10.3758/BRM.40.2.590; Fagot J, 2011, PSYCHOL SCI, V22, P1304, DOI 10.1177/0956797611422916; Fagot J, 2010, BEHAV RES METHODS, V42, P507, DOI 10.3758/BRM.42.2.507; Fagott J, 2006, P NATL ACAD SCI USA, V103, P17564, DOI 10.1073/pnas.0605184103; Fleagle JG, 2013, PRIMATE ADAPTATION AND EVOLUTION, 3RD EDITION, P1; Flemming TM, 2011, J EXP PSYCHOL ANIM B, V37, P353, DOI 10.1037/a0022142; Fobes J.L., 1982, P219; Fragaszy D, 2003, ANIM COGN, V6, P149, DOI 10.1007/s10071-002-0137-8; French R.M., 1995, SUBTLETY SAMENESS TH; Galvao ODF, 2005, PSYCHOL REC, V55, P219; Galvao OD, 2008, REV NEUROSCIENCE, V19, P149; Gilad Y, 2004, PLOS BIOL, V2, P120, DOI 10.1371/journal.pbio.0020005; Gori M, 2008, CURR BIOL, V18, P694, DOI 10.1016/j.cub.2008.04.036; Hanggi EB, 2009, ANIM COGN, V12, P451, DOI 10.1007/s10071-008-0205-9; Hanus D, 2007, J COMP PSYCHOL, V121, P241, DOI 10.1037/0735-7036.121.3.241; HERMAN LM, 1989, J EXP PSYCHOL ANIM B, V15, P124, DOI 10.1037/0097-7403.15.2.124; HERMAN LM, 1974, J EXP ANAL BEHAV, V21, P17; Hopkins WD, 2002, ANIM COGN, V5, P27, DOI 10.1007/s10071-001-0121-8; Howard AM, 2014, AM J PRIMATOL, V76, P828, DOI 10.1002/ajp.22271; KASTAK D, 1994, ANIM LEARN BEHAV, V22, P427, DOI 10.3758/BF03209162; Katz JS, 2006, J EXP PSYCHOL ANIM B, V32, P80, DOI 10.1037/0097-7403.32.1.80; Katz JS, 2002, J EXP PSYCHOL ANIM B, V28, P358, DOI 10.1037//0097-7403.28.4.358; Kennedy EH, 2008, J COMP PSYCHOL, V122, P167, DOI 10.1037/0735-7036.122.2.167; Manrique HM, 2011, ANIM COGN, V14, P775, DOI 10.1007/s10071-011-0410-9; Martin-Ordas G., 2009, INT J COMP PSYCHOL, V22, P43; Martin-Ordas G, 2011, BIOL LETTERS, V7, P829, DOI 10.1098/rsbl.2011.0437; MENZEL EW, 1960, SCIENCE, V131, P1527, DOI 10.1126/science.131.3412.1527; MENZEL EW, 1961, J COMP PHYSIOL PSYCH, V54, P588, DOI 10.1037/h0044421; Mercado E, 2000, BEHAV PROCESS, V50, P79, DOI 10.1016/S0376-6357(00)00100-5; MISHKIN M, 1975, J EXP PSYCHOL-ANIM B, V1, P326, DOI 10.1037/0097-7403.1.4.326; Moll FW, 2014, BEHAV PROCESS, V107, P142, DOI 10.1016/j.beproc.2014.08.009; Mueller-Paul J, 2014, BEHAV PROCESS, V106, P187, DOI 10.1016/j.beproc.2014.06.003; NISSEN HW, 1948, J COMP PHYSIOL PSYCH, V41, P62, DOI 10.1037/h0061040; ODEN DL, 1988, J EXP PSYCHOL ANIM B, V14, P140, DOI 10.1037/0097-7403.14.2.140; Ortony A., 1989, SIMILARITY ANALOGICA; Osman-Hill WC, 1960, PRIMATES COMP ANAT A; PACK AA, 1991, ANIM LEARN BEHAV, V19, P37, DOI 10.3758/BF03197858; Pena T, 2006, J EXP ANAL BEHAV, V85, P203, DOI 10.1901/jeab.2006.111-04; PEPPERBERG IM, 1987, ANIM LEARN BEHAV, V15, P423, DOI 10.3758/BF03205051; Premack D., 1978, COGNITIVE PROCESS, P423; Range F, 2008, ANIM COGN, V11, P339, DOI 10.1007/s10071-007-0123-2; Scarf D, 2011, SCIENCE, V334, P1664, DOI 10.1126/science.1213357; Schmitt V, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1262; Spinozzi G, 2003, J COMP PSYCHOL, V117, P15, DOI 10.1037/0735-7036.117.1.15; Thorndike EL, 1901, PSYCHOL REV, V8, P247, DOI 10.1037/h0071363; Truppa V, 2014, BEHAV BRAIN RES, V271, P240, DOI 10.1016/j.bbr.2014.05.023; Truppa V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023809; Truppa V, 2010, ANIM COGN, V13, P835, DOI 10.1007/s10071-010-0332-y; Truppa V, 2009, BEHAV PROCESS, V82, P140, DOI 10.1016/j.beproc.2009.05.004; Tudusciuc O, 2010, EXP BRAIN RES, V207, P221, DOI 10.1007/s00221-010-2452-7; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Veit L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3878; Vonk J, 2003, ANIM COGN, V6, P77, DOI 10.1007/s10071-003-0159-x; Vonk J, 2013, PEERJ, V1, DOI 10.7717/peerj.158; Walker Stephen, 1983, ANIMAL THOUGHT; WASSERMAN EA, 1992, PSYCHOL SCI, V3, P374, DOI 10.1111/j.1467-9280.1992.tb00050.x; WASSERMAN EA, 1995, J EXP PSYCHOL ANIM B, V21, P248, DOI 10.1037/0097-7403.21.3.248; Wasserman EA, 2001, J COMP PSYCHOL, V115, P42, DOI 10.1037/0735-7036.115.1.42; WASSERMAN EA, 1988, J EXP PSYCHOL ANIM B, V14, P235, DOI 10.1037/0097-7403.14.3.235; Weatherall D., 2006, USE NONHUMAN PRIMATE; WILSON B, 1985, Q J EXP PSYCHOL-B, V37, P313, DOI 10.1080/14640748508401173; Wright AA, 1997, PSYCHOL SCI, V8, P119, DOI 10.1111/j.1467-9280.1997.tb00693.x; WRIGHT AA, 1988, ANIM LEARN BEHAV, V16, P436, DOI 10.3758/BF03209384; Wright AA, 2003, J EXP PSYCHOL ANIM B, V29, P184, DOI 10.1037/0097-7403.29.3.184; Young ME, 1997, PSYCHON B REV, V4, P552, DOI 10.3758/BF03214348; ZENTALL TR, 1981, J EXP PSYCHOL ANIM B, V7, P70, DOI 10.1037/0097-7403.7.1.70	91	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0126001	10.1371/journal.pone.0126001	http://dx.doi.org/10.1371/journal.pone.0126001			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927363	Green Published, Green Submitted, gold			2022-12-27	WOS:000353713100122
J	Wang, JJ; Liu, HL; Liu, W; Zheng, DX; Zhao, YL; Li, Y; Wang, YL; Ge, SQ; Lv, Y; Zuo, YY; Yu, SM; Wang, ZL				Wang, Jingjing; Liu, Hualei; Liu, Wei; Zheng, Dongxia; Zhao, Yunling; Li, Yin; Wang, Yingli; Ge, Shengqiang; Lv, Yan; Zuo, Yuanyuan; Yu, Songmei; Wang, Zhiliang			Genomic Characterizations of Six Pigeon Paramyxovirus Type 1 Viruses Isolated from Live Bird Markets in China during 2011 to 2013	PLOS ONE			English	Article							NEWCASTLE-DISEASE VIRUS; PROTEIN CLEAVAGE SITE; HEMAGGLUTININ-NEURAMINIDASE; MONOCLONAL-ANTIBODIES; NUCLEOTIDE-SEQUENCE; GENE RECOMBINATION; RACING PIGEONS; GENOTYPE; DIVERSITY; EVOLUTION	The genomes of six pigeon paramyxovirus type 1 (PPMV-1) isolated from symptomless pigeons in live poultry markets during the national active surveillance from 2011 to 2013 were sequenced and analyzed in this study. The complete genome lengths of all isolates were 15,192 nucleotides with the gene order of 3'-NP-P-M-F-HN-L-5'. All isolates had the same motif of (112)RRQKRF(117) at the cleavage site of the fusion protein, which was typical of velogenic Newcastle disease virus (NDV). Several mutations were identified in the functional domains of F and HN proteins, including fusion peptide, heptad repeat region, transmembrane domains and neutralizing epitopes. Phylogenetic analysis based on sequences of complete genomes and six genes revealed that all isolates belonged to genotype VI in class II, but at least 2 sub-genotypes were identified. Most isolates were placed into sub-genotype VIb with the exception of pi/GX/1015/13, which was classified in sub-genotype VIa. The obvious antigenic difference between PPMV-1 isolates and La Sota strain was found based on the R-value calculated by cross hemagglutination inhibition (HI) assay. These results provided the evidence that PPMV-1 could be detected from healthy pigeons, and our study may be useful in designing vaccines used in pigeon, and developing molecular diagnostic tools to monitor and prevent future PPMV-1 outbreaks.	[Wang, Jingjing; Liu, Hualei; Zheng, Dongxia; Zhao, Yunling; Wang, Yingli; Ge, Shengqiang; Lv, Yan; Zuo, Yuanyuan; Yu, Songmei; Wang, Zhiliang] China Anim Hlth & Epidemiol Ctr, OIE Reference Lab Newcastle Dis, Qingdao 266032, Peoples R China; [Liu, Wei] China Anim Dis Control Ctr, Beijing 100125, Peoples R China; [Li, Yin] China Anim Hlth & Epidemiol Ctr, Div Epidemiol Survey, Qingdao 266032, Peoples R China	China Animal Health & Epidemiology Center; China Animal Health & Epidemiology Center	Wang, ZL (corresponding author), China Anim Hlth & Epidemiol Ctr, OIE Reference Lab Newcastle Dis, Qingdao 266032, Peoples R China.	zlwang111@163.com	Li, Yin/X-5635-2018; WANG, JINGYI/GSJ-1241-2022; Li, Yin/AAE-6546-2022; wang, jing/GRS-7509-2022	Li, Yin/0000-0002-7367-380X; Li, Yin/0000-0001-5720-5267; 	Chinese Special Fund for Agro-scientific Research in the Public Interest [201303033]	Chinese Special Fund for Agro-scientific Research in the Public Interest	This work was funded by the Chinese Special Fund for Agro-scientific Research in the Public Interest (201303033). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldous EW, 2010, AVIAN PATHOL, V39, P519, DOI 10.1080/03079457.2010.530938; Aldous EW, 2004, AVIAN PATHOL, V33, P258, DOI 10.1080/0307945042000195768; ALEXANDER DJ, 1987, AVIAN PATHOL, V16, P553, DOI 10.1080/03079458708436406; ALEXANDER DJ, 1984, VET REC, V114, P444, DOI 10.1136/vr.114.18.444; ALEXANDER DJ, 1984, VET REC, V115, P213, DOI 10.1136/vr.115.9.213; ARCHETTI I, 1950, J EXP MED, V92, P441, DOI 10.1084/jem.92.5.441; BallagiPordany A, 1996, ARCH VIROL, V141, P243, DOI 10.1007/BF01718397; Cai SX, 2011, VET MICROBIOL, V152, P46, DOI 10.1016/j.vetmic.2011.04.014; CHAMBERS P, 1986, J GEN VIROL, V67, P475, DOI 10.1099/0022-1317-67-3-475; Chen F, 2012, J VIROL, V86, P12461, DOI 10.1128/JVI.02314-12; Cho SH, 2008, J CLIN MICROBIOL, V46, P1541, DOI 10.1128/JCM.00187-08; Cho SH, 2007, VIRUS GENES, V35, P293, DOI 10.1007/s11262-007-0078-z; COLLINS MS, 1989, ARCH VIROL, V104, P53, DOI 10.1007/BF01313807; COLLINS MS, 1994, ARCH VIROL, V134, P403, DOI 10.1007/BF01310577; Courtney SC, 2013, J CLIN MICROBIOL, V51, P508, DOI 10.1128/JCM.02393-12; Czegledi A, 2006, VIRUS RES, V120, P36, DOI 10.1016/j.virusres.2005.11.009; de Leeuw OS, 2003, J GEN VIROL, V84, P475, DOI 10.1099/vir.0.18714-0; Diel DG, 2012, INFECT GENET EVOL, V12, P1770, DOI 10.1016/j.meegid.2012.07.012; Dortmans JCFM, 2010, VET MICROBIOL, V143, P139, DOI 10.1016/j.vetmic.2009.11.021; Guo HB, 2013, ARCH VIROL, V158, P1121, DOI 10.1007/s00705-012-1572-8; Han GZ, 2008, VIROLOGY, V371, P54, DOI 10.1016/j.virol.2007.09.038; Holmes E, 2003, J GEN VIROL, V84, P2691, DOI 10.1099/vir.0.19277-0; Hu SL, 2010, VET MICROBIOL, V140, P92, DOI 10.1016/j.vetmic.2009.07.029; KALETA EF, 1985, AVIAN PATHOL, V14, P553, DOI 10.1080/03079458508436258; Kim LM, 2007, J VIROL, V81, P12641, DOI 10.1128/JVI.00843-07; Kim LM, 2007, J CLIN MICROBIOL, V45, P1310, DOI 10.1128/JCM.02594-06; Liang R, 2002, VET MICROBIOL, V87, P193, DOI 10.1016/S0378-1135(02)00050-0; Liu HL, 2006, AVIAN DIS, V50, P636, DOI 10.1637/7618-042606R1.1; Liu XW, 2009, AVIAN PATHOL, V38, P377, DOI 10.1080/03079450903183637; Marlier D, 2006, VET J, V172, P40, DOI 10.1016/j.tvjl.2005.02.026; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Meulemans G, 2002, AVIAN PATHOL, V31, P515, DOI 10.1080/0307945021000005897; Miller PJ, 2010, INFECT GENET EVOL, V10, P26, DOI 10.1016/j.meegid.2009.09.012; Oberdorfer A, 1998, AVIAN PATHOL, V27, P237, DOI 10.1080/03079459808419330; Panda A, 2004, MICROB PATHOGENESIS, V36, P1, DOI 10.1016/j.micpath.2003.07.003; Qin ZM, 2008, J CLIN MICROBIOL, V46, P601, DOI 10.1128/JCM.01356-07; Qin ZM, 2008, VIRUS RES, V131, P299, DOI 10.1016/j.virusres.2007.10.001; Romer-Oberdorfer A, 2006, AVIAN DIS, V50, P259, DOI 10.1637/7471-111505R.1; Snoeck CJ, 2013, J CLIN MICROBIOL, V51, P2250, DOI 10.1128/JCM.00684-13; TANTAWI HH, 1979, AVIAN DIS, V23, P785, DOI 10.2307/1589594; TOYODA T, 1989, VIROLOGY, V169, P273, DOI 10.1016/0042-6822(89)90152-9; Ujvari D, 2006, VIRUS GENES, V32, P49, DOI 10.1007/s11262-005-5845-0; Ujvari D, 2003, VIRUS RES, V96, P63, DOI 10.1016/S0168-1702(03)00173-4; Umali DV, 2014, VIRUS GENES, V49, P89, DOI 10.1007/s11262-014-1075-7; Van Borm S, 2013, VIRUS RES, V171, P186, DOI 10.1016/j.virusres.2012.11.017; Wasik AM, 2013, SCI REP-UK, V3, DOI [10.1038/srep01400, 10.1038/srep02007]; Worobey M, 1999, J GEN VIROL, V80, P2535, DOI 10.1099/0022-1317-80-10-2535; Zhang R, 2010, VIRUS RES, V151, P45, DOI 10.1016/j.virusres.2010.03.015	48	22	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124261	10.1371/journal.pone.0124261	http://dx.doi.org/10.1371/journal.pone.0124261			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928057	Green Published, Green Submitted, gold			2022-12-27	WOS:000353713100030
J	Bertolini, F; Ghionda, MC; D'Alessandro, E; Geraci, C; Chiofalo, V; Fontanesi, L				Bertolini, Francesca; Ghionda, Marco Ciro; D'Alessandro, Enrico; Geraci, Claudia; Chiofalo, Vincenzo; Fontanesi, Luca			A Next Generation Semiconductor Based Sequencing Approach for the Identification of Meat Species in DNA Mixtures	PLOS ONE			English	Article							READ ALIGNMENT; GENOME; AUTHENTICATION; TECHNOLOGIES; TOOLS; SEQ	The identification of the species of origin of meat and meat products is an important issue to prevent and detect frauds that might have economic, ethical and health implications. In this paper we evaluated the potential of the next generation semiconductor based sequencing technology (Ion Torrent Personal Genome Machine) for the identification of DNA from meat species (pig, horse, cattle, sheep, rabbit, chicken, turkey, pheasant, duck, goose and pigeon) as well as from human and rat in DNA mixtures through the sequencing of PCR products obtained from different couples of universal primers that amplify 12S and 16S rRNA mitochondrial DNA genes. Six libraries were produced including PCR products obtained separately from 13 species or from DNA mixtures containing DNA from all species or only avian or only mammalian species at equimolar concentration or at 1: 10 or 1: 50 ratios for pig and horse DNA. Sequencing obtained a total of 33,294,511 called nucleotides of which 29,109,688 with Q20 (87.43%) in a total of 215,944 reads. Different alignment algorithms were used to assign the species based on sequence data. Error rate calculated after confirmation of the obtained sequences by Sanger sequencing ranged from 0.0003 to 0.02 for the different species. Correlation about the number of reads per species between different libraries was high for mammalian species (0.97) and lower for avian species (0.70). PCR competition limited the efficiency of amplification and sequencing for avian species for some primer pairs. Detection of low level of pig and horse DNA was possible with reads obtained from different primer pairs. The sequencing of the products obtained from different universal PCR primers could be a useful strategy to overcome potential problems of amplification. Based on these results, the Ion Torrent technology can be applied for the identification of meat species in DNA mixtures.	[Bertolini, Francesca; Ghionda, Marco Ciro; Geraci, Claudia; Fontanesi, Luca] Univ Bologna, Div Anim Sci, Dept Agr & Food Sci, I-40127 Bologna, Italy; [Ghionda, Marco Ciro; D'Alessandro, Enrico; Chiofalo, Vincenzo] Univ Messina, Polo Univ Annunziata, Dept Vet Sci, Anim Prod Unit, I-98168 Messina, Italy; [Chiofalo, Vincenzo] Polo Univ Annunziata, Meat Res Consortium, I-98168 Messina, Italy	University of Bologna; University of Messina	Fontanesi, L (corresponding author), Univ Bologna, Div Anim Sci, Dept Agr & Food Sci, Viale Fanin 46, I-40127 Bologna, Italy.	luca.fontanesi@unibo.it	D'ALESSANDRO, ENRICO/AAW-3539-2021; D'Alessandro, Enrico/ABB-9744-2021; bertolini, francesca/AAX-3836-2021; Fontanesi, Luca/L-1770-2014	D'ALESSANDRO, ENRICO/0000-0002-2282-0267; Fontanesi, Luca/0000-0001-7050-3760; Geraci, Claudia/0000-0002-4948-0725; Bertolini, Francesca/0000-0003-4181-3895	University of Bologna RFO funds; Italian MiPAAF Innovagen project; PAN lab European Project [PONa3 00166/F1]	University of Bologna RFO funds; Italian MiPAAF Innovagen project; PAN lab European Project	This work was supported by University of Bologna RFO funds, Italian MiPAAF Innovagen project, and PAN lab European Project PONa3 00166/F1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballin NZ, 2010, MEAT SCI, V86, P577, DOI 10.1016/j.meatsci.2010.06.001; Bertolini F, 2014, ANIM GENET, V45, P304, DOI 10.1111/age.12121; Chaves PB, 2012, MOL ECOL RESOUR, V12, P18, DOI 10.1111/j.1755-0998.2011.03056.x; Chen SY, 2012, ANIM BIOTECHNOL, V23, P213, DOI 10.1080/10495398.2012.696568; Cheng XW, 2014, SCI REP-UK, V4, DOI 10.1038/srep05147; Chisholm J, 2008, EUR FOOD RES TECHNOL, V228, P39, DOI 10.1007/s00217-008-0904-0; Coghlan Megan L, 2013, Investig Genet, V4, P27, DOI 10.1186/2041-2223-4-27; Coghlan ML, 2012, PLOS GENET, V8, P436, DOI 10.1371/journal.pgen.1002657; Dalton DL, 2011, FORENSIC SCI INT, V207, pE51, DOI 10.1016/j.forsciint.2010.12.017; Fajardo V, 2010, TRENDS FOOD SCI TECH, V21, P408, DOI 10.1016/j.tifs.2010.06.002; Flink LG, 2014, P NATL ACAD SCI USA, V111, P6184, DOI 10.1073/pnas.1308939110; Fonseca NA, 2012, BIOINFORMATICS, V28, P3169, DOI 10.1093/bioinformatics/bts605; Forde BM, 2013, BRIEF FUNCT GENOMICS, V12, P440, DOI 10.1093/bfgp/els062; Frey KG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-96; Galan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048374; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Horreo JL, 2013, J SCI FOOD AGR, V93, P354, DOI 10.1002/jsfa.5766; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Karlsson AO, 2007, FORENSIC SCI INT, V173, P16, DOI 10.1016/j.forsciint.2007.01.019; Kitano T, 2007, INT J LEGAL MED, V121, P423, DOI 10.1007/s00414-006-0113-y; Li H, 2013, ARXIV 1303 3997V2; Li H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/bib/bbq015; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lin CC, 2014, MEAT SCI, V96, P922, DOI 10.1016/j.meatsci.2013.09.001; Mafra I, 2008, EUR FOOD RES TECHNOL, V227, P649, DOI 10.1007/s00217-007-0782-x; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagarajan N, 2010, METHODS MOL BIOL, V673, P1, DOI 10.1007/978-1-60761-842-3_1; O'Mahony PJ, 2013, QJM-INT J MED, V106, P595, DOI 10.1093/qjmed/hct087; Pabinger S, 2014, BRIEF BIOINFORM, V15, P256, DOI 10.1093/bib/bbs086; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Ripp F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-639; Rodriguez-Ramirez R, 2011, ANAL CHIM ACTA, V685, P120, DOI 10.1016/j.aca.2010.11.021; Rogberg-Munoz Andres, 2013, Recent Pat Food Nutr Agric, V5, P3; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Shokralla S, 2012, MOL ECOL, V21, P1794, DOI 10.1111/j.1365-294X.2012.05538.x; Shokralla S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021252; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tillmar AO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083761; van Dijk EL, 2014, TRENDS GENET, V30, P418, DOI 10.1016/j.tig.2014.07.001; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484	44	51	58	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0121701	10.1371/journal.pone.0121701	http://dx.doi.org/10.1371/journal.pone.0121701			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923709	gold, Green Submitted, Green Published			2022-12-27	WOS:000353711600005
J	Frey, S; Gorlich, D				Frey, Steffen; Goerlich, Dirk			The Xenopus laevis Atg4B Protease: Insights into Substrate Recognition and Application for Tag Removal from Proteins Expressed in Pro- and Eukaryotic Hosts	PLOS ONE			English	Article							UBIQUITIN-LIKE PROTEINS; RECEPTOR-ASSOCIATED PROTEIN; ENGINEERED SUMO FUSIONS; SELECTIVE AUTOPHAGY; CRYSTAL-STRUCTURE; RECOMBINANT PROTEINS; STRUCTURAL BASIS; AFFINITY TAGS; CLEAVING PROTEASES; SOLUBILITY PARTNER	During autophagy, members of the ubiquitin-like Atg8 protein family get conjugated to phosphatidylethanolamine and act as protein-recruiting scaffolds on the autophagosomal membrane. The Atg4 protease produces mature Atg8 from C-terminally extended precursors and deconjugates lipid-bound Atg8. We now found that Xenopus laevis Atg4B (xAtg4B) is ideally suited for proteolytic removal of N-terminal tags from recombinant proteins. To implement this strategy, an Atg8 cleavage module is inserted in between tag and target protein. An optimized xAtg4B protease fragment includes the so far uncharacterized C-terminus, which crucially contributes to recognition of the Xenopus Atg8 homologs xLC3B and xGATE16. xAtg4B-mediated tag cleavage is very robust in solution or on-column, efficient at 4 degrees C and orthogonal to TEV protease and the recently introduced proteases bdSENP1, bdNEDP1 and xUsp2. Importantly, xLC3B fusions are stable in wheat germ extract or when expressed in Saccharomyces cerevisiae, but cleavable by xAtg4B during or following purification. We also found that fusions to the bdNEDP1 substrate bdNEDD8 are stable in S. cerevisiae. In combination, or findings now provide a system, where proteins and complexes fused to xLC3B or bdNEDD8 can be expressed in a eukaryotic host and purified by successive affinity capture and proteolytic release steps.	[Frey, Steffen; Goerlich, Dirk] Max Planck Inst Biophys Chem, Abt Zellulare Logist, D-37077 Gottingen, Germany	Max Planck Society	Frey, S (corresponding author), Max Planck Inst Biophys Chem, Abt Zellulare Logist, D-37077 Gottingen, Germany.	sfrey@mpibpc.mpg.de; goerlich@mpibpc.mpg.de	Görlich, Dirk/B-8296-2017	Görlich, Dirk/0000-0002-4343-5210; Steffen, Frey/0000-0002-5134-9961	Max-Planck-Geselleschaft; Deutsche Forschungsgemeinschaft [SFB860]	Max-Planck-Geselleschaft; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Max-Planck-Geselleschaft (www.mpg.de) and the Deutsche Forschungsgemeinschaft (SFB860). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemu EA, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.378109; Arnau J, 2006, PROTEIN EXPRES PURIF, V48, P1, DOI 10.1016/j.pep.2005.12.002; Bavro VN, 2002, EMBO REP, V3, P183, DOI 10.1093/embo-reports/kvf026; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Butt TR, 2005, PROTEIN EXPRES PURIF, V43, P1, DOI 10.1016/j.pep.2005.03.016; Colecchia D, 2012, AUTOPHAGY, V8, P1724, DOI 10.4161/auto.21857; CONZELMANN A, 1988, EMBO J, V7, P2233, DOI 10.1002/j.1460-2075.1988.tb03063.x; Cull MG, 2000, METHOD ENZYMOL, V326, P430; Frey S, 2014, J CHROMATOGR A, V1337, P106, DOI 10.1016/j.chroma.2014.02.030; Frey S, 2014, J CHROMATOGR A, V1337, P95, DOI 10.1016/j.chroma.2014.02.029; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Heikal AA, 2000, P NATL ACAD SCI USA, V97, P11996, DOI 10.1073/pnas.97.22.11996; Hemelaar J, 2003, J BIOL CHEM, V278, P51841, DOI 10.1074/jbc.M308762200; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Klionsky DJ, 2014, NAT STRUCT MOL BIOL, V21, P336, DOI 10.1038/nsmb.2787; Knight D, 2002, J BIOL CHEM, V277, P5556, DOI 10.1074/jbc.M109753200; Kouno T, 2005, J BIOL CHEM, V280, P24610, DOI 10.1074/jbc.M413565200; Kraft C, 2012, EMBO J, V31, P3691, DOI 10.1038/emboj.2012.225; Kumanomidou T, 2006, J MOL BIOL, V355, P612, DOI 10.1016/j.jmb.2005.11.018; Li M, 2011, J BIOL CHEM, V286, P7327, DOI 10.1074/jbc.M110.199059; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Liu L, 2008, PROTEIN EXPRES PURIF, V62, P21, DOI 10.1016/j.pep.2008.07.010; Malakhov Michael P., 2004, Journal of Structural and Functional Genomics, V5, P75, DOI 10.1023/B:JSFG.0000029237.70316.52; Marblestone JG, 2006, PROTEIN SCI, V15, P182, DOI 10.1110/ps.051812706; Marino G, 2003, J BIOL CHEM, V278, P3671, DOI 10.1074/jbc.M208247200; Michaelis L, 1913, BIOCHEM Z, V49, P333; Mijaljica D, 2012, AUTOPHAGY, V8, P1701, DOI 10.4161/auto.21332; Nair U, 2012, AUTOPHAGY, V8, P780, DOI 10.4161/auto.19385; Nair U, 2011, CELL, V146, P290, DOI 10.1016/j.cell.2011.06.022; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Nakatogawa H, 2012, J BIOL CHEM, V287, P28503, DOI 10.1074/jbc.C112.387514; Nilsson J, 1997, PROTEIN EXPRES PURIF, V11, P1, DOI 10.1006/prep.1997.0767; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Paz Y, 2000, J BIOL CHEM, V275, P25445, DOI 10.1074/jbc.C000307200; Peroutka RJ, 2008, PROTEIN SCI, V17, P1586, DOI 10.1110/ps.035576.108; Pimentel-Muinos FX, 2014, AUTOPHAGY, V10, P397, DOI 10.4161/auto.27244; Popovic D, 2012, MOL CELL BIOL, V32, P1733, DOI 10.1128/MCB.06717-11; Renicke C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067915; RIEZMAN H, 1983, EMBO J, V2, P2161, DOI 10.1002/j.1460-2075.1983.tb01717.x; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Rozenknop A, 2011, J MOL BIOL, V410, P477, DOI 10.1016/j.jmb.2011.05.003; Satoo K, 2009, EMBO J, V28, P1341, DOI 10.1038/emboj.2009.80; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; Sorensen HP, 2003, PROTEIN EXPRES PURIF, V32, P252, DOI 10.1016/j.pep.2003.07.001; Sugawara K, 2005, J BIOL CHEM, V280, P40058, DOI 10.1074/jbc.M509158200; Sugawara K, 2004, GENES CELLS, V9, P611, DOI 10.1111/j.1356-9597.2004.00750.x; Tanida I, 2004, J BIOL CHEM, V279, P36268, DOI 10.1074/jbc.M401461200; Taxis C, 2012, METHODS MOL BIOL, V832, P611, DOI 10.1007/978-1-61779-474-2_43; Taxis C, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.25; Urabe M, 1999, BIOCHEM BIOPH RES CO, V266, P92, DOI 10.1006/bbrc.1999.1788; van den Berg S, 2006, J BIOTECHNOL, V121, P291, DOI 10.1016/j.jbiotec.2005.08.006; van der Veen AG, 2012, ANNU REV BIOCHEM, V81, P323, DOI 10.1146/annurev-biochem-093010-153308; Waugh DS, 2005, TRENDS BIOTECHNOL, V23, P316, DOI 10.1016/j.tibtech.2005.03.012; Weidberg H, 2010, EMBO J, V29, P1792, DOI 10.1038/emboj.2010.74; Woo J, 2014, P NATL ACAD SCI USA, V111, P863, DOI 10.1073/pnas.1318207111; Wood DW, 2014, CURR OPIN STRUC BIOL, V26, P54, DOI 10.1016/j.sbi.2014.04.006; Yang WC, 2011, PROTEIN EXPRES PURIF, V80, P145, DOI 10.1016/j.pep.2011.06.017; Yeh ETH, 2000, GENE, V248, P1, DOI 10.1016/S0378-1119(00)00139-6; Young CL, 2012, BIOTECHNOL J, V7, P620, DOI 10.1002/biot.201100155	66	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125099	10.1371/journal.pone.0125099	http://dx.doi.org/10.1371/journal.pone.0125099			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923686	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600124
J	Li, G; Wang, JX; Ye, JP; Zhang, YM; Zhang, Y				Li, Ge; Wang, Jianxiong; Ye, Jianping; Zhang, Yimin; Zhang, Ying			PPAR alpha Protein Expression Was Increased by Four Weeks of Intermittent Hypoxic Training via AMPK alpha 2-Dependent Manner in Mouse Skeletal Muscle	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; FATTY-ACID OXIDATION; LIPID-METABOLISM; GENE-EXPRESSION; KINASE; EXERCISE; TRANSPORT; PATHWAY; HEALTH; ROLES	Peroxisome proliferator-activated receptor alpha (PPAR alpha) is critical for muscle endurance due to its role in the regulation of fatty acid oxidation. The 5'-AMP-activated protein kinase (AMPK) is an energy sensor in cells, but its role in PPARa regulation in vivo remains unknown. In this study, we examined PPAR alpha expression in the skeletal muscle of AMPK alpha 2 overexpression (OE), knockout (KO) and wild-type (WT) mice after four weeks of exercise under intermittent hypoxia. WT, OE and KO mice were used at 40 mice/strain and randomly subdivided into four subgroups: control (C), running (R), hypoxia (H), and running plus hypoxia (R+H) at 10 mice/group. The treadmill running was performed at the speed of 12 m/min, 60 min/day with a slope of 0 degree for four weeks. The hypoxia treatment was performed in daytime with normobaric hypoxia (11.20% oxygen, 8 hours/day). In the R+H group, the treadmill running was conducted in the hypoxic condition. AMPK alpha 2, phosphor-AMPK alpha (p-AMPK alpha) (Thr172), nuclear PPAR alpha proteins were measured by Western blot and the medium chain acyl coenzyme A dehydrogenase (MCAD) mRNA, the key enzyme for fatty acid oxidation and one of the PPAR alpha target genes, was also measured in skeletal muscles after the interventions. The results showed that nuclear PPAR alpha protein was significantly increased by R+H in WT muscles, the increase was enhanced by 41% (p<0.01) in OE mice, but was reduced by 33% (p<0.01) in KO mice. The MCAD mRNA expression was increased after four weeks of R+H intervention. The change in MCAD mRNA followed a similar trend as that of PPAR alpha protein in OE and KO mice. Our data suggest that the increase in nuclear PPAR alpha protein by four-week exercise training under the intermittent hypoxia was dependent on AMPK activation.	[Li, Ge; Zhang, Ying] Beijing Sport Univ, Inst Sports Sci, Div Exercise Biochem, Beijing, Peoples R China; [Wang, Jianxiong] Univ So Queensland, Fac Hlth Engn & Sci, Sch Hlth & Wellbeing, Toowoomba, Qld 4350, Australia; [Ye, Jianping] Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70803 USA; [Zhang, Yimin] Beijing Sport Univ, Key Lab Exercise & Phys Fitness, Minist Educ Peoples Republ China, Beijing, Peoples R China	Beijing Sport University; University of Southern Queensland; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Beijing Sport University; Ministry of Education, China	Zhang, Y (corresponding author), Beijing Sport Univ, Inst Sports Sci, Div Exercise Biochem, Beijing, Peoples R China.	zhyi9256@126.com	Ye, Jianping/N-1998-2017	Ye, Jianping/0000-0003-3875-365X	National Natural Science Foundation of China [31171140]; China Higher Education Research Fund for the Doctoral Program [20111112110005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Higher Education Research Fund for the Doctoral Program	This study was funded by grants from the National Natural Science Foundation of China (31171140) and China Higher Education Research Fund for the Doctoral Program (20111112110005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschenbach WG, 2004, SPORTS MED, V34, P91, DOI 10.2165/00007256-200434020-00003; Berger JP, 2005, TRENDS PHARMACOL SCI, V26, P244, DOI 10.1016/j.tips.2005.03.003; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Bronner M, 2004, BIOCHEM J, V384, P295, DOI 10.1042/BJ20040955; Chen YC, 2011, HIGH ALT MED BIOL, V12, P371, DOI 10.1089/ham.2010.1088; Chiu LL, 2004, J BIOMED SCI, V11, P838, DOI 10.1159/000081831; Cresci S, 1996, AM J PHYSIOL-CELL PH, V270, pC1413, DOI 10.1152/ajpcell.1996.270.5.C1413; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Dobrzyn P, 2004, P NATL ACAD SCI USA, V101, P6409, DOI 10.1073/pnas.0401627101; Everett L, 2000, LIVER, V20, P191, DOI 10.1034/j.1600-0676.2000.020003191.x; Faiss R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056522; Fan WW, 2013, J MOL ENDOCRINOL, V51, pT87, DOI 10.1530/JME-13-0258; FERNANDO P, 1993, CAN J PHYSIOL PHARM, V71, P854, DOI 10.1139/y93-128; Fluckey JD, 1999, ACTA PHYSIOL SCAND, V167, P77; Gong HJ, 2011, MED SCI SPORT EXER, V43, P1441, DOI 10.1249/MSS.0b013e31820f6093; GULICK T, 1994, P NATL ACAD SCI USA, V91, P11012, DOI 10.1073/pnas.91.23.11012; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Helge JW, 2007, EUR J APPL PHYSIOL, V101, P105, DOI 10.1007/s00421-007-0479-7; Horowitz JF, 2000, AM J PHYSIOL-ENDOC M, V279, pE348, DOI 10.1152/ajpendo.2000.279.2.E348; Iemitsu M, 2002, AM J PHYSIOL-HEART C, V283, pH1750, DOI 10.1152/ajpheart.01051.2001; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Jay MA, 2007, CURR DIABETES REV, V3, P33, DOI 10.2174/157339907779802067; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Lecoultre V, 2010, EXP PHYSIOL, V95, P315, DOI 10.1113/expphysiol.2009.050690; Lee WJ, 2006, BIOCHEM BIOPH RES CO, V340, P291, DOI 10.1016/j.bbrc.2005.12.011; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Leff T, 2003, BIOCHEM SOC T, V31, P224; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; Mor Vijay, 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P206; Morash AJ, 2013, AM J PHYSIOL-REG I, V305, pR534, DOI 10.1152/ajpregu.00510.2012; Muoio DM, 1999, BIOCHEM J, V338, P783, DOI 10.1042/0264-6021:3380783; Ponsot E, 2006, J APPL PHYSIOL, V100, P1249, DOI 10.1152/japplphysiol.00361.2005; Russell AP, 2003, DIABETES, V52, P2874, DOI 10.2337/diabetes.52.12.2874; Schmutz S, 2010, EXP PHYSIOL, V95, P723, DOI 10.1113/expphysiol.2009.051029; Sozio MS, 2011, AM J PHYSIOL, V301, P739; Staels B, 2007, THERAPIE, V62, P319, DOI 10.2515/therapie:2007051; Tunstall RJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE66, DOI 10.1152/ajpendo.00475.2001; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Watt MJ, 2004, J MOL ENDOCRINOL, V33, P533, DOI 10.1677/jme.1.01499; Winder WW, 2001, J APPL PHYSIOL, V91, P1017, DOI 10.1152/jappl.2001.91.3.1017; Yoon M, 2009, PHARMACOL RES, V60, P151, DOI 10.1016/j.phrs.2009.02.004; Zhong H, 1999, BIOCHEM BIOPH RES CO, V259, P523, DOI 10.1006/bbrc.1999.0815; Zhuang JG, 1999, BIOL SIGNAL RECEPT, V8, P316	44	12	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0122593	10.1371/journal.pone.0122593	http://dx.doi.org/10.1371/journal.pone.0122593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923694	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000353711600017
J	Loheswaran, G; Soklaridis, S; Selby, P; Le Foll, B				Loheswaran, Genane; Soklaridis, Sophie; Selby, Peter; Le Foll, Bernard			Screening and Treatment for Alcohol, Tobacco and Opioid Use Disorders: A Survey of Family Physicians across Ontario	PLOS ONE			English	Article							SUBSTANCE USE; PRIMARY-CARE; ADOLESCENT ALCOHOL; NONMEDICAL USE; GLOBAL BURDEN; UNITED-STATES; DRUG-ABUSE; TRENDS; INTERVENTIONS; INSTRUMENTS	Introduction As a primary point of contact within the health care system, family physicians are able to play a vital role in identifying individuals with substance use disorders and connecting them to the appropriate treatment. However, there is very little data available on whether family physicians are actively screening for and treating substance use disorders. The objective of the current survey was to assess whether family physicians in Ontario are screening for alcohol, opioid and tobacco use disorders, using validated tools and providing treatment. Methods An online survey consisting of a series of 38 primarily close-ended questions was circulated to family physicians in Ontario. Rates of screening for alcohol, opioid and tobacco dependence, use of validated tools for screening, providing treatment for dependent individuals and the current barriers to the prescription of pharmacotherapies for these drug dependences were assessed. Results The use of validated screening tools was limited for all three substances. Screening by family physicians for the substance use disorders among adolescents was much lower than screening among adults. Pharmacotherapy was more commonly used as an intervention for tobacco dependence than for alcohol and opioid dependence. This was explained by the lack of knowledge among family physicians on the pharmacotherapies for alcohol and opioid dependence. Conclusions Findings from the current study suggest there is a need for family physicians to integrate screening for substance use disorders using validated tools into their standard medical practice. Furthermore, there is a need for increased knowledge on pharmacotherapies for alcohol and opioid use disorders. It is important to note that the low response rate is a major limitation to this study. One possible reason for this low response rate may be a lack of interest and awareness among family physicians on the importance of screening and treatment of substance use disorders in Ontario.	[Loheswaran, Genane; Le Foll, Bernard] Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Res Inst, Translat Addict Res Lab, Toronto, ON, Canada; [Loheswaran, Genane; Le Foll, Bernard] Univ Toronto, Dept Pharmacol, Toronto, ON, Canada; [Soklaridis, Sophie] Ctr Addict & Mental Hlth, CAMH Educ, Toronto, ON, Canada; [Soklaridis, Sophie; Selby, Peter; Le Foll, Bernard] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Soklaridis, Sophie; Selby, Peter; Le Foll, Bernard] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada; [Selby, Peter; Le Foll, Bernard] Ctr Addict & Mental Hlth, Ambulatory Care & Struct Treatments, Toronto, ON, Canada; [Selby, Peter] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto	Le Foll, B (corresponding author), Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Res Inst, Translat Addict Res Lab, Toronto, ON, Canada.	bernard.lefoll@camh.ca	Soklaridis, Sophie/ABG-2223-2020; Le Foll, Bernard/K-2952-2014	Soklaridis, Sophie/0000-0001-5119-8473; Le Foll, Bernard/0000-0002-6406-4973	Development and Dissemination Funds	Development and Dissemination Funds	Financial support for this survey was provided by the Development and Dissemination Funds, which are internal Centre for Addiction and Mental Health funds awarded to Dr. Peter Selby and Dr. Bernard Le Foll. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarons GA, 1999, J ADOLESCENT HEALTH, V24, P412, DOI 10.1016/S1054-139X(99)00006-3; [Anonymous], 2007, REP INT NAR CONTR BO; [Anonymous], 1998, TOB FREE IN; [Anonymous], 2002, BEST PRACTICES CONCU; Borland T, 2010, DELIVERING TOBACCO P; Brands B, 2004, DRUG ALCOHOL DEPEN, V73, P199, DOI 10.1016/j.drugalcdep.2003.10.012; BREWSTER JM, 1990, CAN MED ASSOC J, V143, P1076; Bush Donna M, 2002, Occup Med, V17, P13; CBC, 2007, 5 EST; Compton WM, 2006, DRUG ALCOHOL DEPEN, V81, P103, DOI 10.1016/j.drugalcdep.2005.05.009; Couwenbergh C, 2009, SUBST USE MISUSE, V44, P823, DOI 10.1080/10826080802484264; Degenhardt L, 2008, PLOS MED, V5, P1053, DOI 10.1371/journal.pmed.0050141; Donovan DM, 2008, J STUD ALCOHOL DRUGS, V69, P5, DOI 10.15288/jsad.2008.69.5; DuRant RH, 1999, ARCH PEDIAT ADOL MED, V153, P286; Fischer B, 2006, EUR ADDICT RES, V12, P230, DOI 10.1159/000094425; Fischer B, 2006, CAN MED ASSOC J, V175, P1385, DOI 10.1503/cmaj.060729; Fischer B, 2006, CAN J PSYCHIAT, V51, P624, DOI 10.1177/070674370605101002; Fischer B, 2006, CAN J PSYCHIAT, V51, P621, DOI 10.1177/070674370605101001; FISHER JC, 1975, J STUD ALCOHOL, V36, P949, DOI 10.15288/jsa.1975.36.949; Fournier ME, 2006, CURR OPIN PEDIATR, V18, P352, DOI 10.1097/01.mop.0000236381.33907.9d; FRIEDMAN AS, 1989, J DRUG EDUC, V19, P285, DOI 10.2190/XBU5-9MAB-C2R5-0M96; FULLER PG, 1995, PEDIATR CLIN N AM, V42, P295; GELLER G, 1989, JAMA-J AM MED ASSOC, V261, P3115, DOI 10.1001/jama.261.21.3115; Gilson AM, 2004, J PAIN SYMPTOM MANAG, V28, P176, DOI 10.1016/j.jpainsymman.2004.01.003; Gruenewald PJ, 1990, RESULTS PRELIMINARY; Herie M, 2012, PATIENT EDUC COUNS, V86, P49, DOI 10.1016/j.pec.2011.04.018; Maheux B, 1999, CAN MED ASSOC J, V160, P1830; Martin TL, 2006, J ANAL TOXICOL, V30, P603, DOI 10.1093/jat/30.8.603; Mayer J, 1979, Curr Alcohol, V7, P169; McCabe SE, 2007, J ADOLESCENT HEALTH, V40, P76, DOI 10.1016/j.jadohealth.2006.07.016; McPherson TL, 2000, J SUBST ABUSE TREAT, V18, P193, DOI 10.1016/S0740-5472(99)00028-8; Merikangas KR, 2012, HUM GENET, V131, P779, DOI 10.1007/s00439-012-1168-0; MEYERS K, 1995, J SUBST ABUSE TREAT, V12, P181, DOI 10.1016/0740-5472(95)00009-T; MoHaL-T Care, 2013, ONT HLEP MOR SMOK QU; Pilowsky DJ, 2013, ADDICT BEHAV, V38, P2146, DOI 10.1016/j.addbeh.2013.01.015; Rahdert, 1991, PROBLEM ORIENTED SCR; Rawson RA, 2000, J PSYCHOACTIVE DRUGS, V32, P371, DOI 10.1080/02791072.2000.10400238; Rehm J., 2006, COST SUBSTANCE ABUSE; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Rehm J, 2006, DRUG ALCOHOL REV, V25, P503, DOI 10.1080/09595230600944453; RUSH B, 1994, CAN FAM PHYSICIAN, V40, P1557; RUSH BR, 1995, CAN MED ASSOC J, V152, P863; Rush BR, 2003, ADDICTION, V98, P895, DOI 10.1046/j.1360-0443.2003.00410.x; SCHWARTZ RH, 1990, CLIN PEDIATR, V29, P38, DOI 10.1177/000992289002900106; Sung HE, 2005, J ADOLESCENT HEALTH, V37, P44, DOI 10.1016/j.jadohealth.2005.02.013; Swahn MH, 2010, ADDICT BEHAV, V35, P452, DOI 10.1016/j.addbeh.2009.12.017; Volkow ND, 2014, NEW ENGL J MED, V370, P2219, DOI 10.1056/NEJMra1402309; WISNIEWSKI NM, 1985, ADDICT BEHAV, V10, P55, DOI 10.1016/0306-4603(85)90053-X; World Health Organization, 1992, INT STAT CLASS DIS R; Wu LT, 2011, ARCH GEN PSYCHIAT, V68, P1176, DOI 10.1001/archgenpsychiatry.2011.120; Xie XD, 1998, HEALTH ECON, V7, P81, DOI 10.1002/(SICI)1099-1050(199802)7:1<81::AID-HEC330>3.0.CO;2-I	51	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124402	10.1371/journal.pone.0124402	http://dx.doi.org/10.1371/journal.pone.0124402			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0LO	25923976	Green Submitted, Green Published, gold			2022-12-27	WOS:000353711600081
J	Mendes-Moreira, P; Alves, ML; Satovic, Z; dos Santos, JP; Santos, JN; Souza, JC; Pego, SE; Hallauer, AR; Patto, MCV				Mendes-Moreira, Pedro; Alves, Mara L.; Satovic, Zlatko; dos Santos, Joao Pacheco; Santos, Joao Nina; Souza, Joao Candido; Pego, Silas E.; Hallauer, Arnel R.; Vaz Patto, Maria Carlota			Genetic Architecture of Ear Fasciation in Maize (Zea mays) under QTL Scrutiny	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; MERISTEM CELL FATE; BARREN INFLORESCENCE2; HERITABLE CHARACTERS; GRAIN-YIELD; NONSTRESS ENVIRONMENTS; TRANSCRIPTION FACTOR; CO-ORTHOLOG; ENCODES; TASSEL	Maize ear fasciation Knowledge of the genes affecting maize ear inflorescence may lead to better grain yield modeling. Maize ear fasciation, defined as abnormal flattened ears with high kernel row number, is a quantitative trait widely present in Portuguese maize landraces. Material and Methods Using a segregating population derived from an ear fasciation contrasting cross (consisting of 149 F-2:3 families) we established a two location field trial using a complete randomized block design. Correlations and heritabilities for several ear fasciation-related traits and yield were determined. Quantitative Trait Loci (QTL) involved in the inheritance of those traits were identified and candidate genes for these QTL proposed. Results and Discussion Ear fasciation broad-sense heritability was 0.73. Highly significant correlations were found between ear fasciation and some ear and cob diameters and row number traits. For the 23 yield and ear fasciation-related traits, 65 QTL were identified, out of which 11 were detected in both environments, while for the three principal components, five to six QTL were detected per environment. Detected QTL were distributed across 17 genomic regions and explained individually, 8.7% to 22.4% of the individual traits or principal components phenotypic variance. Several candidate genes for these QTL regions were proposed, such as bearded-ear1, branched silkless1, compact plant1, ramosa2, ramosa3, tasselseed4 and terminal ear1. However, many QTL mapped to regions without known candidate genes, indicating potential chromosomal regions not yet targeted for maize ear traits selection. Conclusions Portuguese maize germplasm represents a valuable source of genes or allelic variants for yield improvement and elucidation of the genetic basis of ear fasciation traits. Future studies should focus on fine mapping of the identified genomic regions with the aim of mapbased cloning.	[Mendes-Moreira, Pedro; dos Santos, Joao Pacheco; Santos, Joao Nina] Inst Politecn Coimbra, Escola Super Agr Coimbra, Dept Ciencias Agron, Coimbra, Portugal; [Mendes-Moreira, Pedro; Alves, Mara L.; Vaz Patto, Maria Carlota] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, P-2780156 Oeiras, Portugal; [Satovic, Zlatko] Univ Zagreb, Fac Agr, Dept Seed Sci & Technol, Zagreb 41000, Croatia; [Souza, Joao Candido] Univ Fed Lavras, Dept Biol UFLA, Lavras, MG, Brazil; [Pego, Silas E.] Fundacao Bomfim, Braga, Portugal; [Hallauer, Arnel R.] Iowa State Univ, Dept Agron, Ames, IA USA	Instituto Politecnico de Coimbra (IPC); Universidade Nova de Lisboa; University of Zagreb; Universidade Federal de Lavras; Iowa State University	Mendes-Moreira, P (corresponding author), Inst Politecn Coimbra, Escola Super Agr Coimbra, Dept Ciencias Agron, Coimbra, Portugal.	pmm@esac.pt	Šatović, Zlatko/AAA-9626-2020; Patto, Maria Carlota Vaz/C-8775-2011; Mendes-Moreira, Pedro M R/D-4663-2009; Mendes-Moreira, Pedro/AAU-1693-2020	Šatović, Zlatko/0000-0002-9848-1601; Patto, Maria Carlota Vaz/0000-0002-8469-7508; Mendes-Moreira, Pedro M R/0000-0001-7809-1115; Mendes-Moreira, Pedro/0000-0001-7809-1115; Alves, Mara/0000-0003-3515-2082	VASO project; Fundacao para a Ciencia e a Tecnologia, Portugal [PEst-OE/EQB/LA0004/2011, PTDC/AGR-ALI/099285/2008, PTDC/AGR-AAM/70845/2006]; Ciencia Program;  [SFRH/BD/22188/2005];  [SFRH/PROTEC/50365/2009]	VASO project; Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Ciencia Program; ; 	This study was funded by the VASO project and by Fundacao para a Ciencia e a Tecnologia, Portugal (www.fct.pt), through the research projects PEst-OE/EQB/LA0004/2011, PTDC/AGR-ALI/099285/2008 and PTDC/AGR-AAM/70845/2006; research contract by the Ciencia 2008 Program (MCVP) and by the research grants SFRH/BD/22188/2005 and SFRH/PROTEC/50365/2009 (PMM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin DF, 1996, THEOR APPL GENET, V92, P817, DOI 10.1007/BF00221893; Bai F, 2012, P NATL ACAD SCI USA, V109, P12225, DOI 10.1073/pnas.1202439109; BEAVIS WD, 1991, THEOR APPL GENET, V83, P141, DOI 10.1007/BF00226242; Bommert P, 2005, DEVELOPMENT, V132, P1235, DOI 10.1242/dev.01671; Bommert P, 2013, NAT GENET, V45, P334, DOI 10.1038/ng.2534; Bortiri E, 2006, PLANT CELL, V18, P574, DOI 10.1105/tpc.105.039032; Brewbaker JL, 2009, MAIZE GENETICS COOPE, V1; Brown PJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002383; Carillo P, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-21; Chuck G, 2002, SCIENCE, V298, P1238, DOI 10.1126/science.1076920; Chuck G, 2008, DEVELOPMENT, V135, P3013, DOI 10.1242/dev.024273; Chuck G, 2007, NAT GENET, V39, P1517, DOI 10.1038/ng.2007.20; Chuck G, 2009, CURR OPIN PLANT BIOL, V12, P81, DOI 10.1016/j.pbi.2008.09.008; CHURCHILL GA, 1994, GENETICS, V138, P963; Collins NC, 2008, PLANT PHYSIOL, V147, P469, DOI 10.1104/pp.108.118117; Eckardt NA, 2007, PLANT CELL, V19, P3315, DOI 10.1105/tpc.107.057497; Emerson RA, 1912, AMER BREED ASS AN RE, V8, P385; Eveland AL, 2010, PLANT PHYSIOL, V154, P1024, DOI 10.1104/pp.110.159673; FERRAO JEM, 1992, AVENTURA PLANTAS DES; Gallavotti A, 2004, NATURE, V432, P630, DOI 10.1038/nature03148; Gallavotti A, 2010, DEVELOPMENT, V137, P2849, DOI 10.1242/dev.051748; Hayes HK, 1939, MAIZE GENET COOP NEW, V13, P1; IBPGR, 1991, DESCRIPTORS FOR MAIZ; IPGRI, 2000, DESCRITORES PARA O M; IRISH EE, 1994, DEV GENET, V15, P155, DOI 10.1002/dvg.1020150206; Jackson D, 2009, MNL, V2; Jackson Dave, 2009, P1, DOI 10.1007/978-0-387-79418-1_1; Jackson DP, 2009, NUCLEOTIDE SEQUENCES; JANSEN RC, 1994, GENETICS, V136, P1447; Jiao YP, 2012, NAT GENET, V44, P812, DOI 10.1038/ng.2312; Kempton JH, 1923, J HERED, V14, P243, DOI 10.1093/oxfordjournals.jhered.a102330; Kempton JH, 1934, J HERED, V25, P29, DOI 10.1093/oxfordjournals.jhered.a103835; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; LANDER ES, 1989, GENETICS, V121, P185; Lawrence Carolyn J, 2008, Int J Plant Genomics, V2008, P496957, DOI 10.1155/2008/496957; Liu RX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049836; Lu YL, 2009, THEOR APPL GENET, V120, P93, DOI 10.1007/s00122-009-1162-7; MATTHEWS DL, 1974, J AGR SCI-CAMBRIDGE, V82, P433, DOI 10.1017/S0021859600051327; McSteen P, 2000, TRENDS PLANT SCI, V5, P61, DOI 10.1016/S1360-1385(99)01541-1; McSteen P, 2001, DEVELOPMENT, V128, P2881; McSteen P, 2007, PLANT PHYSIOL, V144, P1000, DOI 10.1104/pp.107.098558; Mena M, 1995, PLANT J, V8, P845, DOI 10.1046/j.1365-313X.1995.8060845.x; Moreira PMRM, 2008, EUPHYTICA, V163, P481, DOI 10.1007/s10681-008-9683-8; Mendes-Moreira PMR, 2014, FIELD CROP RES, V161, P75, DOI 10.1016/j.fcr.2014.02.015; Modarres AM, 1998, MAYDICA, V43, P227; MONACO MK, 2013, PLANT GENOME, DOI DOI 10.3835/PLANTGENOME2009.01.0001; NELSON OE, 1957, SCIENCE, V125, P1200, DOI 10.1126/science.125.3259.1200; NELSON OLIVER E., 1961, AGRON JOUR, V53, P208; Neuffer MG, 1997, MUTANTS MAIZE; NICKERSON NORTON H., 1955, ANN MISSOURI BOT GARDEN, V42, P195, DOI 10.2307/2394655; Patto MCV, 2004, EUPHYTICA, V137, P63, DOI 10.1023/B:EUPH.0000040503.48448.97; Patto MCV, 2003, THEOR APPL GENET, V106, P1283, DOI 10.1007/s00122-003-1195-2; Pautler M, 2013, PLANT CELL PHYSIOL, V54, P302, DOI 10.1093/pcp/pct025; Pego S, 1982, THESIS; PEGO SE, 1984, MAYDICA, V29, P39; Phipps IF, 1928, J HERED, V19, P399, DOI 10.1093/oxfordjournals.jhered.a103030; Pressoir G, 2009, PLANT J, V58, P618, DOI 10.1111/j.1365-313X.2009.03802.x; Ribaut JM, 2007, MOL BREEDING, V20, P15, DOI 10.1007/s11032-006-9041-2; Ribaut JM, 1997, THEOR APPL GENET, V94, P887, DOI 10.1007/BF00221905; Ritchie SW, 1993, IOWA STATE UNIVERSIT, V48; Runge EC, 2004, CORN ORIGIN HISTORY; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Satoh-Nagasawa N, 2006, NATURE, V441, P227, DOI 10.1038/nature04725; Schnable JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017855; Schrag TA, 2006, THEOR APPL GENET, V113, P1037, DOI 10.1007/s00122-006-0363-6; Skirpan A, 2008, PLANT J, V55, P787, DOI 10.1111/j.1365-313X.2008.03546.x; Skirpan A, 2009, PLANT CELL PHYSIOL, V50, P652, DOI 10.1093/pcp/pcp006; Steinhoff J, 2012, THEOR APPL GENET, V125, P1539, DOI 10.1007/s00122-012-1933-4; STUBER CW, 1987, CROP SCI, V27, P639, DOI 10.2135/cropsci1987.0011183X002700040006x; Taguchi-Shiobara F, 2001, GENE DEV, V15, P2755, DOI 10.1101/gad.208501; Thompson BE, 2009, PLANT CELL, V21, P2578, DOI 10.1105/tpc.109.067751; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Upadyayula N, 2006, THEOR APPL GENET, V112, P592, DOI 10.1007/s00122-005-0133-x; USDA & ARS-GRIN, 2013, WF9 AMES 19293 ZEA M; Van Ooijen J, 2002, MAP QTL 4; Van Ooijen J. W, 2006, JOINMAP 4 SOFTWARE F; Patto MCV, 2007, GENET RESOUR CROP EV, V54, P1555, DOI 10.1007/s10722-006-9168-3; VEIT B, 1993, PLANT CELL, V5, P1205, DOI 10.1105/tpc.5.10.1205; Veit B, 1998, NATURE, V393, P166, DOI 10.1038/30239; VELDBOOM LR, 1994, THEOR APPL GENET, V88, P7, DOI 10.1007/BF00222387; VELDBOOM LR, 1994, THEOR APPL GENET, V89, P451, DOI 10.1007/BF00225380; Veldboom LR, 1996, CROP SCI, V36, P1320, DOI 10.2135/cropsci1996.0011183X003600050041x; Veldboom LR, 1996, CROP SCI, V36, P1310, DOI 10.2135/cropsci1996.0011183X003600050040x; Vollbrecht E, 2005, NATURE, V436, P1119, DOI 10.1038/nature03892; Vollbrecht Erik, 2009, P13, DOI 10.1007/978-0-387-79418-1_2; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Weber A, 2007, GENETICS, V177, P2349, DOI 10.1534/genetics.107.080424; Weber AL, 2008, GENETICS, V180, P1221, DOI 10.1534/genetics.108.090134; WHITE OE, 1948, BOT REV, V14, P319, DOI 10.1007/BF02861723; Wu XT, 2009, PLANT PHYSIOL, V149, P205, DOI 10.1104/pp.108.125005; Yamasaki M, 2005, PLANT CELL, V17, P2859, DOI 10.1105/tpc.105.037242; Young ND, 1996, ANNU REV PHYTOPATHOL, V34, P479, DOI 10.1146/annurev.phyto.34.1.479; Zhang GD, 2013, THEOR APPL GENET, V126, P1545, DOI 10.1007/s00122-013-2072-2; Zhang HM, 2010, AFR J AGR RES, V5, P626; Zhou ML, 2014, J PLANT GROWTH REGUL, V33, P256, DOI 10.1007/s00344-013-9368-y	96	17	21	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124543	10.1371/journal.pone.0124543	http://dx.doi.org/10.1371/journal.pone.0124543			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923975	gold, Green Published, Green Submitted			2022-12-27	WOS:000353711600092
J	Robert, S; Peppard, T; Hermann, D				Wallis, Robert S.; Peppard, Thomas; Hermann, David			Month 2 Culture Status and Treatment Duration as Predictors of Recurrence in Pulmonary Tuberculosis: Model Validation and Update	PLOS ONE			English	Article							PHASE-II; MOXIFLOXACIN; ETHAMBUTOL; GATIFLOXACIN; CONVERSION; REGIMENS; ADULTS	Background New regimens capable of shortening tuberculosis treatment without increasing the risk of recurrence are urgently needed. A 2013 meta-regression analysis, using data from trials published from 1973 to 1997 involving 7793 patients, identified 2-month sputum culture status and treatment duration as independent predictors of recurrence. The resulting model predicted that if a new 4-month regimen reduced the proportion of patients positive at month 2 to 1%, it would reduce to 10% the risk of a relapse rate >10% in a trial with 680 subjects per arm. The 1% target was far lower than anticipated. Methods Data from the 8 arms of 3 recent unsuccessful phase 3 treatment-shortening trials of fluoroquinolone-substituted regimens (REMox, OFLOTUB, and RIFAQUIN) were used to assess and refine the accuracy of the 2013 meta-regression model. The updated model was then tested using data from a treatment shortening trial reported in 2009 by Johnson et al. Findings The proportions of patients with recurrence as predicted by the 2013 model were highly correlated with observed proportions as reported in the literature (R2 = 0.86). Using the previously proposed threshold of 10% recurrences as the maximum likely considered acceptable by tuberculosis control programs, the original model correctly identified all 4 six-month regimens as satisfactory, and 3 of 4 four-month regimens as unsatisfactory (sensitivity = 100%, specificity = 75%, PPV = 80%, and NPV = 100%). A revision of the regression model based on the full dataset of 66 regimens and 11181 patients resulted in only minimal changes to its predictions. A test of the revised model using data from the treatment shortening trial of Johnson et al found the reported relapse rates in both arms to be consistent with predictions. Interpretation Meta-regression modeling of recurrence based on month 2 culture status and regimen duration can inform the design of future phase 3 tuberculosis clinical trials.	[Wallis, Robert S.] Aurum Inst, Johannesburg, South Africa; [Peppard, Thomas; Hermann, David] Certara LP, St Louis, MO USA		Robert, S (corresponding author), Aurum Inst, Johannesburg, South Africa.	rwallis@auruminstitute.org	Wallis, Robert S./A-8018-2009	Wallis, Robert S./0000-0001-6152-5183; Peppard, Thomas/0000-0003-2052-4007	Certara, LP	Certara, LP	The authors received no specific funding for this work. Co-authors Thomas Peppard and David Hermann are employed by Certara, LP. Certara, LP provided support in the form of salaries for authors TP and DH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 1990, CATEGORICAL DATA ANA, pXV; Barrett JS, 2008, J CLIN PHARMACOL, V48, P632, DOI 10.1177/0091270008315318; Burman WJ, 2006, AM J RESP CRIT CARE, V174, P331, DOI 10.1164/rccm.200603-360OC; Conde MB, 2009, LANCET, V373, P1183, DOI 10.1016/S0140-6736(09)60333-0; Dorman SE, 2009, AM J RESP CRIT CARE, V180, P273, DOI 10.1164/rccm.200901-0078OC; Gillespie SH, 2014, NEW ENGL J MED, V371, P1577, DOI 10.1056/NEJMoa1407426; Jindani A, 2014, NEW ENGL J MED, V371, P1599, DOI 10.1056/NEJMoa1314210; Johnson JL, 2009, AM J RESP CRIT CARE, V180, P558, DOI 10.1164/rccm.200904-0536OC; JONES BE, 1993, AM REV RESPIR DIS, V148, P1292, DOI 10.1164/ajrccm/148.5.1292; Merle CS, 2014, NEW ENGL J MED, V371, P1588, DOI 10.1056/NEJMoa1315817; MITCHISON DA, 1993, AM REV RESPIR DIS, V147, P1062, DOI 10.1164/ajrccm/147.4.1062; Okwera A, 2006, INT J TUBERC LUNG D, V10, P39; Phillips PPJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063840; Rustomjee R, 2008, INT J TUBERC LUNG D, V12, P128; SAS Institute, 2008, SAS STAT US GUID; Wallis RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071116; Wallis RS, 2010, LANCET INFECT DIS, V10, P68, DOI 10.1016/S1473-3099(10)70003-7; WHO, 2014, GLOB TUB REP 2014	19	38	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125403	10.1371/journal.pone.0125403	http://dx.doi.org/10.1371/journal.pone.0125403			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923700	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600149
J	Xeuatvongsa, A; Mirza, S; Winter, C; Feldon, K; Vongphrachanh, P; Phonekeo, D; Denny, J; Khanthamaly, V; Kounnavong, B; Lylianou, D; Phousavath, S; Norasingh, S; Boutta, N; Olsen, S; Bresee, J; Moen, A; Corwin, A				Xeuatvongsa, Anonh; Mirza, Sara; Winter, Christian; Feldon, Keith; Vongphrachanh, Phengta; Phonekeo, Darouny; Denny, Justin; Khanthamaly, Viengphone; Kounnavong, Bounheuang; Lylianou, Doualy; Phousavath, Sisouphane; Norasingh, Sisouveth; Boutta, Nao; Olsen, Sonja; Bresee, Joseph; Moen, Ann; Corwin, Andrew			The Lao Experience in Deploying Influenza A (H1N1)pdm09 Vaccine: Lessons Made Relevant in Preparing for Present Day Pandemic Threats	PLOS ONE			English	Article								The Lao PDR, as did most countries of the Mekong Region, embarked on a pandemic vaccine initiative to counter the threat posed by influenza A(H1N1)pdm09. Overall, estimated vaccine coverage of the Lao population was 14%, with uptake in targeted health care workers and pregnant women 99% and 41%, respectively. Adverse Events Following Immunization accounted for only 6% of survey driven, reported vaccination experiences, with no severe consequences or deaths. Public acceptability of the vaccine campaign was high (98%). Challenges to vaccine deployment included: 1) no previous experience in fielding a seasonal influenza vaccine, 2) safety and efficacy concerns, and 3) late arrival of vaccine 10 months into the pandemic. The Lao success in surmounting these hurdles was in large measure attributed to the oversight assigned the National Immunization Program, and national sensitivities in responding to the avian influenza A(H5N1) crisis in the years leading up to the pandemic. The Lao "lessons learned" from pandemic vaccine deployment are made even more relevant four years on, given the many avian influenza strains circulating in the region, all with pandemic potential.	[Xeuatvongsa, Anonh; Norasingh, Sisouveth] Minist Hlth, Natl Immunizat Program, Viangchan, Laos; [Mirza, Sara; Olsen, Sonja; Bresee, Joseph; Moen, Ann] US Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA; [Winter, Christian; Denny, Justin] World Hlth Org Western Pacific Reg, Emerging Dis Surveillance & Response Unit, Country Off, Viangchan, Laos; [Feldon, Keith] WHO, Country Off, Expanded Program Immunizat, Viangchan, Laos; [Vongphrachanh, Phengta; Phonekeo, Darouny] Minist Hlth, Natl Ctr Lab & Epidemiol, Viangchan, Laos; [Khanthamaly, Viengphone; Kounnavong, Bounheuang] US Ctr Dis Control & Prevent, Country Off, Viangchan, Laos; [Lylianou, Doualy; Phousavath, Sisouphane] Minist Hlth, Field Epidemiol Training Program, Natl Ctr Lab & Epidemiol, Viangchan, Laos; [Boutta, Nao] Minist Hlth, Cabinet, Viangchan, Laos	Centers for Disease Control & Prevention - USA; World Health Organization; World Health Organization	Corwin, A (corresponding author), US Ctr Dis Control & Prevent, Country Off, Viangchan, Laos.	Corwinal2e@yahoo.com	Winter, Christian/AAP-1643-2020	Denny, Justin/0000-0001-8311-3550	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		[Anonymous], REPORT WHO PANDEMIC; [Anonymous], 2012, REP REG WORKSH INFL; [Anonymous], 2012, REP WHO PAND INFL H1; Chan Paul K. S., 2014, SEASONAL FLU CONTROL; Girard MP, 2010, VACCINE, V28, P4895, DOI [10.1016/j.vaccine.2010.05.031, 10.1016/j.vaccine.2010.07.034]; Khamphaphongphane B, 2008, EPIDEMIOLOGICAL VIRO, DOI 10.111/j.1750-2659.2012.00394.x; Lao PDR National Immunization Program, 2011, LAO PDR NATL IMMUNIZ; Phengxay M, 2015, INFLUENZA OTHER RESP, DOI 10.1111/irv.12299; Ungchusak K, 2012, EMERG INFECT DIS, V18, P1058, DOI 10.3201/eid1807.110976; Weekly Epidemiological Record, 2014, PAND INFL H1N1 2009, V84, P505; World Health Organisation, 2009, GLOB AL RESP INFL IL; 2009, MMWR MORB MORTAL WKL, V58, P453	12	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0121717	10.1371/journal.pone.0121717	http://dx.doi.org/10.1371/journal.pone.0121717			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923779	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600007
J	de Winkel, KN; Katliar, M; Bulthoff, HH				de Winkel, Ksander N.; Katliar, Mikhail; Buelthoff, Heinrich H.			Forced Fusion in Multisensory Heading Estimation	PLOS ONE			English	Article							OPTIC FLOW STIMULI; VESTIBULAR CUE INTEGRATION; MST NEURONS; RESPONSE SELECTIVITY; INERTIAL CUES; PERCEPTION; SIGNALS; INFORMATION; SENSITIVITY	It has been shown that the Central Nervous System (CNS) integrates visual and inertial information in heading estimation for congruent multisensory stimuli and stimuli with small discrepancies. Multisensory information should, however, only be integrated when the cues are redundant. Here, we investigated how the CNS constructs an estimate of heading for combinations of visual and inertial heading stimuli with a wide range of discrepancies. Participants were presented with 2s visual-only and inertial-only motion stimuli, and combinations thereof. Discrepancies between visual and inertial heading ranging between 0-90 degrees were introduced for the combined stimuli. In the unisensory conditions, it was found that visual heading was generally biased towards the fore-aft axis, while inertial heading was biased away from the fore-aft axis. For multisensory stimuli, it was found that five out of nine participants integrated visual and inertial heading information regardless of the size of the discrepancy; for one participant, the data were best described by a model that explicitly performs causal inference. For the remaining three participants the evidence could not readily distinguish between these models. The finding that multisensory information is integrated is in line with earlier findings, but the finding that even large discrepancies are generally disregarded is surprising. Possibly, people are insensitive to discrepancies in visual-inertial heading angle because such discrepancies are only encountered in artificial environments, making a neural mechanism to account for them otiose. An alternative explanation is that detection of a discrepancy may depend on stimulus duration, where sensitivity to detect discrepancies differs between people.	[de Winkel, Ksander N.; Katliar, Mikhail; Buelthoff, Heinrich H.] Max Planck Inst Biol Cybernet, Dept Human Percept Cognit & Act, D-72076 Tubingen, Germany; [Buelthoff, Heinrich H.] Korea Univ, Dept Brain & Cognit Engn, Seoul 136713, South Korea	Max Planck Society; Korea University	Bulthoff, HH (corresponding author), Max Planck Inst Biol Cybernet, Dept Human Percept Cognit & Act, Spemannstr 38, D-72076 Tubingen, Germany.	heinrich.buelthoff@tuebingen.mpg.de	Bülthoff, Heinrich H/J-6579-2012; Bülthoff, Heinrich/AAC-8818-2019; de Winkel, Ksander/ABE-5608-2020	Bülthoff, Heinrich H/0000-0003-2568-0607; de Winkel, Ksander/0000-0003-0534-2723	Max Planck Society; Brain Korea 21 PLUS Program through the National Research Foundation of Korea - Ministry of Education	Max Planck Society(Max Planck Society); Brain Korea 21 PLUS Program through the National Research Foundation of Korea - Ministry of Education	Funding provided to KNdW: Max Planck Society; MK: Max Planck Society; and HHB: Max Planck Society and Brain Korea 21 PLUS Program through the National Research Foundation of Korea funded by the Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas SS, 2013, J MATH PSYCHOL, V57, P134, DOI 10.1016/j.jmp.2013.06.003; Angelaki DE, 2011, J PHYSIOL-LONDON, V589, P825, DOI 10.1113/jphysiol.2010.194720; Atanasiu V, 2011, KARNEL SMOOTHING DEN; Benson A, 1989, AVIATION SPACE ENV M; Bremmer F, 1999, ANN NY ACAD SCI, V871, P272, DOI 10.1111/j.1749-6632.1999.tb09191.x; Bremmer F, 2002, EUR J NEUROSCI, V16, P1554, DOI 10.1046/j.1460-9568.2002.02207.x; Bremmer F, 2010, EXP BRAIN RES, V200, P51, DOI 10.1007/s00221-009-1990-3; Butler JS, 2015, EXP BRAIN RES, V233, P587, DOI 10.1007/s00221-014-4136-1; Butler JS, 2011, SEEING PERCEIVING, V24, P453, DOI 10.1163/187847511X588070; Butler JS, 2010, J VISION, V10, DOI 10.1167/10.11.23; Crane BT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051383; Cuturi LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056862; DAvossa G, 1996, VISION RES, V36, P2915, DOI 10.1016/0042-6989(96)00010-7; de Winkel KN, 2013, EXP BRAIN RES, V231, P209, DOI 10.1007/s00221-013-3683-1; de Winkel KN, 2010, J VISION, V10, DOI 10.1167/10.12.1; Dewi K.C., 2010, 2010 INT C DISTR FRA, P1; Duffy CJ, 1998, J NEUROPHYSIOL, V80, P1816, DOI 10.1152/jn.1998.80.4.1816; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1346, DOI 10.1152/jn.1991.65.6.1346; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1329, DOI 10.1152/jn.1991.65.6.1329; DUFFY CJ, 1995, J NEUROSCI, V15, P5192; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; FERNANDEZ C, 1976, J NEUROPHYSIOL, V39, P985, DOI 10.1152/jn.1976.39.5.985; Fetsch CR, 2007, J NEUROSCI, V27, P700, DOI 10.1523/JNEUROSCI.3553-06.2007; Fetsch CR, 2010, EUR J NEUROSCI, V31, P1721, DOI 10.1111/j.1460-9568.2010.07207.x; Fetsch CR, 2009, J NEUROSCI, V29, P15601, DOI 10.1523/JNEUROSCI.2574-09.2009; FISHER R, 1953, PROC R SOC LON SER-A, V217, P295, DOI 10.1098/rspa.1953.0064; Gibson JJ, 1950, PERCEPTION VISUAL WO; Gu Y, 2006, J NEUROSCI, V26, P73, DOI 10.1523/JNEUROSCI.2356-05.2006; Gu Y, 2008, NAT NEUROSCI, V11, P1201, DOI 10.1038/nn.2191; Gu Y, 2007, NAT NEUROSCI, V10, P1038, DOI 10.1038/nn1935; Gu Y, 2010, NEURON, V66, P596, DOI 10.1016/j.neuron.2010.04.026; HENN V, 1974, BRAIN RES, V71, P144, DOI 10.1016/0006-8993(74)90198-X; JOHNSTON IR, 1973, AM J PSYCHOL, V86, P311, DOI 10.2307/1421439; Kaliuzhna M, 2015, J VISION, V15, DOI 10.1167/15.1.10; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Kording KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000943; Li L, 2002, OPTOMETRY VISION SCI, V79, P581, DOI 10.1097/00006324-200209000-00009; LLEWELLYN KR, 1971, J EXP PSYCHOL, V91, P245, DOI 10.1037/h0031788; Mittelstaedt H, 1996, BIOL PSYCHOL, V42, P53, DOI 10.1016/0301-0511(95)05146-5; Murray RF, 2010, J VISION, V10, DOI 10.1167/10.11.15; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nieuwenhuizen Frank M., 2013, Journal of Computing Science and Engineering, V7, P122, DOI 10.5626/JCSE.2013.7.2.122; PARZEN E, 1962, ANN MATH STAT, V33, P1065, DOI 10.1214/aoms/1177704472; Prsa M, 2012, J NEUROPHYSIOL, V108, P2282, DOI 10.1152/jn.00439.2012; ROSENBLATT M, 1956, ANN MATH STAT, V27, P832, DOI 10.1214/aoms/1177728190; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shams L, 2010, TRENDS COGN SCI, V14, P425, DOI 10.1016/j.tics.2010.07.001; TANAKA K, 1986, J NEUROSCI, V6, P134; Tanaka K, 1989, J NEUROPHYSIOLOGY, V62; Tschermak A., 1931, RECEPTIONSORGANE 2 H, V12, P834; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; Wozny DR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000871; Zaichik LE, 1999, AIAA MODELING AND SIMULATION TECHNOLOGIES CONFERENCE, P512; Zaidel A, 2011, J NEUROSCI, V31, P13949, DOI 10.1523/JNEUROSCI.2732-11.2011; Zemel RS, 1998, NEURAL COMPUT, V10, P403, DOI 10.1162/089976698300017818	56	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0127104	10.1371/journal.pone.0127104	http://dx.doi.org/10.1371/journal.pone.0127104			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938235	Green Published, gold, Green Submitted			2022-12-27	WOS:000353943000163
J	Osman, AEF; Hassan, AN; Ali, AE; Abdoel, TH; Smits, HL				Osman, Amira E. F.; Hassan, Abdullahi N.; Ali, Ali E.; Abdoel, Theresia H.; Smits, Henk L.			Brucella melitensis Biovar 1 and Brucella abortus S19 Vaccine Strain Infections in Milkers Working at Cattle Farms in the Khartoum Area, Sudan	PLOS ONE			English	Article							FLOW ASSAYS; DIAGNOSIS; SERODIAGNOSIS; CULTURE; SHEEP; KENYA	Background Human brucellosis is a preventable zoonoses that may become persistent, causing, if left untreated, severe localized disease. Occupational exposure to infected animals or animal products and consumption of fresh contaminated dairy are main risk factors. Methods One hundred farmworkers employed at two cattle farms one in Khartoum North and one in Omdurman were screened for the presence of specific antibodies and seropositive workers were invited to donate a blood sample for blood culture. Molecular typing was used to characterize Brucella isolates. Results Ten percent of farmworkers tested seropositive and while Brucella melitensis biovar 1 was isolated from the blood of three individuals, an isolate identical to the B. abortus S19 vaccine strain was isolated from a fourth person. All four bacteremic individuals were employed as milkers and did not have obvious disease. Conclusions The isolation of the highly infectious pathogen B. melitensis from seropositive workers is consistent with the notion that the pathogen may persist in the blood without causing overt disease. While vaccination with strain S19 is essential for the control of bovine brucellosis the vaccine strain may be transmitted to the human population and protective measures remain important to prevent exposure also in view of the presence of B. melitensis. To create awareness for this potentially severe disease more information on the prevalence of the pathogen in different risk groups and in livestock in the Sudan is needed.	[Osman, Amira E. F.; Hassan, Abdullahi N.; Ali, Ali E.] Univ Alzaiem Alazhari, Khartoum, Sudan; [Abdoel, Theresia H.; Smits, Henk L.] Royal Trop Inst, KIT Biomed Res, NL-1105 AZ Amsterdam, Netherlands		Smits, HL (corresponding author), Royal Trop Inst, KIT Biomed Res, NL-1105 AZ Amsterdam, Netherlands.	h.smits@kit.nl						Agab H, 1994, Rev Elev Med Vet Pays Trop, V47, P361; Al-Attas RA, 2000, ANN SAUDI MED, V20, P224, DOI 10.5144/0256-4947.2000.224; Alvarez J, 2011, RES VET SCI, V90, P208, DOI 10.1016/j.rvsc.2010.05.028; Berkelman RL, 2003, CLIN INFECT DIS, V37, P407, DOI 10.1086/375595; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Celebi G, 2007, SCAND J INFECT DIS, V39, P205, DOI 10.1080/00365540600978898; Cheesbrough M, 2006, DISTRICT LAB PRACTIC, V1st, DOI [10.1017/cbo9780511543470, DOI 10.1017/CBO9780511543470]; Corbel MJ, 1997, EMERG INFECT DIS, V3, P213, DOI 10.3201/eid0302.970219; CORBEL MJ, 1988, INT J SYST BACTERIOL, V38, P450, DOI 10.1099/00207713-38-4-450; Dean AS, 2012, PLOS NEGLECT TROP D, V6, DOI [10.1371/journal.pntd.0001929, 10.1371/journal.pntd.0001865]; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; El-Ansary EHH, 2001, SAUDI MED J, V22, P577; Espinosa BJ, 2009, AM J TROP MED HYG, V80, P625, DOI 10.4269/ajtmh.2009.80.625; Ferreira AC, 2003, VET RES, V34, P297, DOI 10.1051/vetres:2003005; Ficht TA, 2009, VACCINE, V27, pD40, DOI 10.1016/j.vaccine.2009.08.058; Franco MP, 2007, LANCET INFECT DIS, V7, P775, DOI 10.1016/S1473-3099(07)70286-4; del Pozo JSG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032090; Garin-Bastuji B, 1998, VET RES, V29, P255; Godfroid J, 2011, PREV VET MED, V102, P118, DOI 10.1016/j.prevetmed.2011.04.007; Godfroid J, 2013, COMP IMMUNOL MICROB, V36, P241, DOI 10.1016/j.cimid.2012.09.001; Gwida M, 2011, PREV VET MED, V102, P118, DOI [10.1016/j.prevetmed.2011.04.007, DOI 10.1016/J.PREVETMED.2011.04.007]; HELLMANN E, 1984, TROPENMED PARASITOL, V35, P123; Irmak H, 2004, AM J TROP MED HYG, V70, P688, DOI 10.4269/ajtmh.2004.70.688; Le Fleche P, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-9; Matope Gift, 2009, BMC Res Notes, V2, P261, DOI 10.1186/1756-0500-2-261; Mendoza-Nunez M, 2008, AM J TROP MED HYG, V78, P595, DOI 10.4269/ajtmh.2008.78.595; Muendo EN, 2012, TROP ANIM HEALTH PRO, V44, P17, DOI 10.1007/s11250-011-9899-9; MUSA MT, 1990, J COMP PATHOL, V103, P467, DOI 10.1016/S0021-9975(08)80034-5; Neta AVC, 2010, VET J, V184, P146, DOI 10.1016/j.tvjl.2009.04.010; Omer MM, 2010, REV SCI TECH OIE, V29, P663, DOI 10.20506/rst.29.3.2003; PALING RW, 1988, J WILDLIFE DIS, V24, P308, DOI 10.7589/0090-3558-24.2.308; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Smits HL, 2003, CLIN DIAGN LAB IMMUN, V10, P1141, DOI 10.1128/CDLI.10.6.1141-1146.2003; SPINK WW, 1950, J LAB CLIN MED, V35, P440; THOMAS EL, 1981, VET REC, V108, P90, DOI 10.1136/vr.108.5.90; Wallach JC, 2008, CLIN MICROBIOL INFEC, V14, P805, DOI 10.1111/j.1469-0691.2008.02029.x; Young E. J., 1990, Advances in brucellosis research., P465; Zhen Q, 2013, CLIN MICROBIOL INFEC, V19, pE395, DOI 10.1111/1469-0691.12250	38	37	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0123374	10.1371/journal.pone.0123374	http://dx.doi.org/10.1371/journal.pone.0123374			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938483	Green Published, gold, Green Submitted			2022-12-27	WOS:000353943000007
J	Yoon, SJ; Kwon, WS; Rahman, MS; Lee, JS; Pang, MG				Yoon, Sung-Jae; Kwon, Woo-Sung; Rahman, Md Saidur; Lee, June-Sub; Pang, Myung-Geol			A Novel Approach to Identifying Physical Markers of Cryo-Damage in Bull Spermatozoa	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; 2 DIFFERENT EXTENDERS; COLD SHOCK INJURY; SPERM CRYOPRESERVATION; BOVINE SPERM; POSTTHAW MOTILITY; OXIDATIVE STRESS; MALE-FERTILITY; PROTEINS; CAPACITATION	Cryopreservation is an efficient way to store spermatozoa and plays a critical role in the livestock industry as well as in clinical practice. During cryopreservation, cryo-stress causes substantial damage to spermatozoa. In present study, the effects of cryo-stress at various cryopreservation steps, such as dilution / cooling, adding cryoprtectant, and freezing were studied in spermatozoa collected from 9 individual bull testes. The motility (%), motion kinematics, capacitation status, mitochondrial activity, and viability of bovine spermatozoa at each step of the cryopreservation process were assessed using computer-assisted sperm analysis, Hoechst 33258/chlortetracycline fluorescence, rhodamine 123 staining, and hypo-osmotic swelling test, respectively. The results demonstrate that the cryopreservation steps reduced motility (%), rapid speed (%), and mitochondrial activity, whereas medium/slow speed (%), and the acrosome reaction were increased (P < 0.05). Differences (Delta) of the acrosome reaction were higher in dilution/cooling step (P < 0.05), whereas differences (Delta) of motility, rapid speed, and non-progressive motility were higher in cryoprotectant and freezing as compared to dilution/cooling (P < 0.05). On the other hand, differences (Delta) of mitochondrial activity, viability, and progressive motility were higher in freezing step ( P < 0.05) while the difference (Delta) of the acrosome reaction was higher in dilution/cooling ( P < 0.05). Based on these results, we propose that freezing / thawing steps are the most critical in cryopreservation and may provide a logical ground of understanding on the cryo-damage. Moreover, these sperm parameters might be used as physical markers of sperm cryo-damage.	[Yoon, Sung-Jae; Kwon, Woo-Sung; Rahman, Md Saidur; Lee, June-Sub; Pang, Myung-Geol] Chung Ang Univ, Dept Anim Sci & Technol, Anseong 456756, Gyeonggi Do, South Korea	Chung Ang University	Pang, MG (corresponding author), Chung Ang Univ, Dept Anim Sci & Technol, Anseong 456756, Gyeonggi Do, South Korea.	mgpang@cau.ac.kr	Kwon, Woo-Sung/J-6731-2019; Rahman, Mohammad Saifur/GZM-5483-2022; Pang, Myung-Geol/AAV-2014-2021; Rahman, Md Saidur/AAT-2972-2020; Rahman, Mohammad Sohelur/AAJ-7376-2020; Rahman, Saidur/J-7855-2012	Kwon, Woo-Sung/0000-0002-0848-7189; Rahman, Mohammad Saifur/0000-0002-9887-4456; Pang, Myung-Geol/0000-0003-2019-3789; Rahman, Mohammad Sohelur/0000-0002-4489-2202; Rahman, Saidur/0000-0003-4583-8731	National Research Foundation of Korea (NRF) - Korea government (MEST) [NRF-2014R1A2A2A01002706]	National Research Foundation of Korea (NRF) - Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government)	This study was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (no. NRF-2014R1A2A2A01002706).	Ahmad M, 2014, J S AFR VET ASSOC, V85, DOI 10.4102/jsava.v85i1.972; Alapati R, 2009, CRYOBIOLOGY, V59, P164, DOI 10.1016/j.cryobiol.2009.06.009; Ardon F, 2013, REPRODUCTION, V146, P111, DOI 10.1530/REP-12-0468; Awad MM, 2004, ANIM REPROD SCI, V84, P83, DOI 10.1016/j.anireprosci.2003.12.001; Ball B, 2001, TLS-TIMES LIT SUPPL, P22; Barbas JP, 2009, CELL TISSUE BANK, V10, P49, DOI 10.1007/s10561-008-9081-4; Brugnon F, 2013, HUM REPROD, V28, P2045, DOI 10.1093/humrep/det253; Celeghini ECC, 2008, ANIM REPROD SCI, V104, P119, DOI 10.1016/j.anireprosci.2007.02.001; D'Amours O, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100990; D'Amours O, 2010, REPRODUCTION, V139, P545, DOI 10.1530/REP-09-0375; DELAMIRANDE E, 1992, J ANDROL, V13, P368; DELEEUW FE, 1990, CRYOBIOLOGY, V27, P171, DOI 10.1016/0011-2240(90)90009-S; Dona G, 2013, MAR DRUGS, V11, P1909, DOI 10.3390/md11061909; DROBNIS EZ, 1993, J EXP ZOOL, V265, P432, DOI 10.1002/jez.1402650413; Ebertz SL, 2002, CRYOBIOLOGY, V45, P109, DOI 10.1016/S0011-2240(02)00116-5; Garcia-Herreros M, 2015, ANIMAL, V9, P1016, DOI 10.1017/S1751731115000129; Gilmore JA, 1996, J REPROD FERTIL, V107, P87, DOI 10.1530/jrf.0.1070087; HAMMERSTEDT RH, 1990, J ANDROL, V11, P73; HINTON BT, 1979, J REPROD FERTIL, V55, P167, DOI 10.1530/jrf.0.0550167; Jin JL, 2007, BIOL REPROD, V77, P37, DOI 10.1095/biolreprod.107.060186; Kutluyer F, 2014, CRYOBIOLOGY, V69, P462, DOI 10.1016/j.cryobiol.2014.10.005; Kwon WS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-897; Kwon WS, 2014, J PROTEOME RES, V13, P4505, DOI 10.1021/pr500524p; Kwon WS, 2013, FERTIL STERIL, V99, P354, DOI 10.1016/j.fertnstert.2012.09.021; Lessard C, 2000, J ANDROL, V21, P700; Li JJ, 2006, ACTA PHARMACOL SIN, V27, P1078, DOI 10.1111/j.1745-7254.2006.00345.x; Liu QH, 2015, FISH PHYSIOL BIOCHEM, V41, P413, DOI 10.1007/s10695-014-9993-9; Liu ZS, 1998, CRYOBIOLOGY, V37, P207, DOI 10.1006/cryo.1998.2116; Ludovico P, 2001, MICROBIOL-SGM, V147, P3335, DOI 10.1099/00221287-147-12-3335; Martins MIM, 2012, REPROD DOMEST ANIM, V47, P293, DOI 10.1111/rda.12042; Melville DF, 2012, CRYOBIOLOGY, V65, P224, DOI 10.1016/j.cryobiol.2012.06.007; Miller RR, 2004, CRYOBIOLOGY, V49, P137, DOI 10.1016/j.cryobiol.2004.06.002; Mostafapor Somayeh, 2014, Vet Res Forum, V5, P101; Mota AC, 2014, CRYOBIOLOGY, V69, P17, DOI 10.1016/j.cryobiol.2014.04.013; Olaciregui M, 2014, CRYOBIOLOGY, V68, P91, DOI 10.1016/j.cryobiol.2013.12.009; Peris SI, 2007, MOL REPROD DEV, V74, P878, DOI 10.1002/mrd.20686; PHOLPRAMOOL C, 1985, J REPROD FERTIL, V75, P413, DOI 10.1530/jrf.0.0750413; Pons-Rejraji H, 2009, REPROD FERT DEVELOP, V21, P511, DOI 10.1071/RD07169; Prathalingam NS, 2006, THERIOGENOLOGY, V66, P1894, DOI 10.1016/j.theriogenology.2006.04.041; Rahman MS, 2014, ANDROLOGY-US, V2, P899, DOI 10.1111/j.2047-2927.2014.00273.x; Rahman MS, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/360986; RAMON M, 2013, PLOS ONE, V0008; Sariozkan S, 2009, CRYOBIOLOGY, V58, P134, DOI 10.1016/j.cryobiol.2008.11.006; SHABANOWITZ RB, 1987, BIOL REPROD, V36, P753, DOI 10.1095/biolreprod36.3.753; Sorrenti G, 2014, CRYOBIOLOGY, V68, P43, DOI 10.1016/j.cryobiol.2013.11.005; SPUNGIN B, 1995, J CELL SCI, V108, P2525; Viveiros ATM, 2012, THERIOGENOLOGY, V78, P803, DOI 10.1016/j.theriogenology.2012.03.028; Wang AW, 1997, UROLOGY, V49, P921, DOI 10.1016/S0090-4295(97)00070-8; Wang SQ, 2014, PROTEOMICS, V14, P298, DOI 10.1002/pmic.201300225; Watson PF, 2000, ANIM REPROD SCI, V60, P481, DOI 10.1016/S0378-4320(00)00099-3; WHITE IG, 1993, REPROD FERT DEVELOP, V5, P639, DOI 10.1071/RD9930639; Xu X, 2012, J BIOTECHNOL, V162, P224, DOI 10.1016/j.jbiotec.2012.09.004; 김영희, 2010, Reproductive & Developmental biology, V34, P241; ZANEVELD LJD, 1991, HUM REPROD, V6, P1265, DOI 10.1093/oxfordjournals.humrep.a137524	54	31	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0126232	10.1371/journal.pone.0126232	http://dx.doi.org/10.1371/journal.pone.0126232			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938413	Green Submitted, gold, Green Published			2022-12-27	WOS:000353943000154
J	Zhao, YJ; Chen, X; Zhang, M; Su, P; Liu, YJ; Tong, YR; Wang, XJ; Huang, LQ; Gao, W				Zhao, Yu-Jun; Chen, Xin; Zhang, Meng; Su, Ping; Liu, Yu-Jia; Tong, Yu-Ru; Wang, Xiu-Juan; Huang, Lu-Qi; Gao, Wei			Molecular Cloning and Characterisation of Farnesyl Pyrophosphate Synthase from Tripterygium wilfordii	PLOS ONE			English	Article							DIPHOSPHATE SYNTHASE; ISOPRENOID BIOSYNTHESIS; SQUALENE SYNTHETASE; UP-REGULATION; GENE; EXPRESSION; INDUCTION; CULTURES; LOCALIZATION; TRIPTOLIDE	Farnesylpyrophosphate synthase (FPS) catalyzes the biosynthesis of farnesyl pyrophosphate (FPP), which is an important precursor of sesquiterpenoids such as artemisinin and wilfordine. In the present study, we report the molecular cloning and characterization of two full-length cDNAs encoding FPSs from Tripterygium wilfordii (TwFPSs). TwFPSs maintained their capability to synthesise FPP in vitro when purified as recombinant proteins from E. coli. Consistent with the endogenous role of FPS in FPP biosynthesis, TwFPSs were highly expressed in Tripterygium wilfordii roots, and were up-regulated upon methyl jasmonate (MeJA) treatment. The global gene expression profiles suggested that the TwFPSs might play an important regulatory role interpenoid biosynthesis in Tripterygium wilfordii, laying the groundwork for the future study of the synthetic biology of natural terpene products.	[Zhao, Yu-Jun; Chen, Xin; Zhang, Meng; Su, Ping; Liu, Yu-Jia; Tong, Yu-Ru; Wang, Xiu-Juan; Gao, Wei] Capital Med Univ, Sch Tradit Chinese Med, Beijing, Peoples R China; [Huang, Lu-Qi] China Acad Chinese Med Sci, Natl Resource Ctr Chinese Mat Med, Beijing, Peoples R China	Capital Medical University; China Academy of Chinese Medical Sciences; National Resource Center for Chinese Materia Medica, CACMS	Chen, X (corresponding author), Capital Med Univ, Sch Tradit Chinese Med, Beijing, Peoples R China.	chenxin4283@126.com; huangluqi01@126.com; weigao@ccmu.edu.cn	Zhao, Yujun/HGU-7295-2022	Zhao, Yujun/0000-0001-6687-6652	National Natural Science Foundation of China [81422053, 81373906, 81325023]; National Excellent Doctoral Dissertation of China [201188]; Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions [CITTCD201304174]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Excellent Doctoral Dissertation of China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions	This work was supported by the National Natural Science Foundation of China (81422053 and 81373906 to WG, and 81325023 to LH) and the Author of National Excellent Doctoral Dissertation of China (201188) and the Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions (CIT&TCD201304174) to WG.	Alcaino J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096626; Alexandrov NN, 2009, PLANT MOL BIOL, V69, P179, DOI 10.1007/s11103-008-9415-4; Banyai W, 2010, PLANT CELL TISS ORG, V103, P255, DOI 10.1007/s11240-010-9775-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brinker AM, 2007, PHYTOCHEMISTRY, V68, P732, DOI 10.1016/j.phytochem.2006.11.029; Cervantes-Cervantes M, 2006, PLANT PHYSIOL, V141, P220, DOI 10.1104/pp.106.077008; CHAPPELL J, 1995, ANNU REV PLANT PHYS, V46, P521, DOI 10.1146/annurev.pp.46.060195.002513; CHAPPELL J, 1987, PLANT PHYSIOL, V85, P469, DOI 10.1104/pp.85.2.469; CHEN AJ, 1994, PROTEIN SCI, V3, P600; Chen DH, 2000, PLANT SCI, V155, P179, DOI 10.1016/S0168-9452(00)00217-X; Chugh R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004334; Closa M, 2010, PLANT J, V63, P512, DOI 10.1111/j.1365-313X.2010.04253.x; CORNISH K, 1993, EUR J BIOCHEM, V218, P267, DOI 10.1111/j.1432-1033.1993.tb18374.x; Cunillera N, 2000, PLANT MOL BIOL, V44, P747, DOI 10.1023/A:1026588708849; Cunillera N, 1996, J BIOL CHEM, V271, P7774, DOI 10.1074/jbc.271.13.7774; DELSAL G, 1989, BIOTECHNIQUES, V7, P514; Devarenne TP, 1998, ARCH BIOCHEM BIOPHYS, V349, P205, DOI 10.1006/abbi.1997.0463; Gaffe J, 2000, PLANT PHYSIOL, V123, P1351, DOI 10.1104/pp.123.4.1351; Gupta P, 2011, PLANT GROWTH REGUL, V65, P93, DOI 10.1007/s10725-011-9578-x; Han JL, 2006, J INTEGR PLANT BIOL, V48, P482, DOI 10.1111/j.1744-7909.2006.00208.x; Jones CG, 2011, J BIOL CHEM, V286, P17445, DOI 10.1074/jbc.M111.231787; Kim OT, 2010, BIOL PLANTARUM, V54, P47, DOI 10.1007/s10535-010-0007-1; Kim OT, 2010, PLANT CELL REP, V29, P403, DOI 10.1007/s00299-010-0831-y; KUPCHAN SM, 1972, J AM CHEM SOC, V94, P7194, DOI 10.1021/ja00775a078; Lambert E, 2011, APPL BIOCHEM BIOTECH, V164, P220, DOI 10.1007/s12010-010-9129-3; Lange BM, 2000, P NATL ACAD SCI USA, V97, P13172, DOI 10.1073/pnas.240454797; Li CP, 1996, GENE, V171, P193, DOI 10.1016/0378-1119(95)00880-2; Liao ZH, 2006, J INTEGR PLANT BIOL, V48, P692, DOI 10.1111/j.1744-7909.2006.00243.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manzo SG, 2012, CANCER RES, V72, P5363, DOI 10.1158/0008-5472.CAN-12-1006; Matsushita Y, 1996, GENE, V172, P207, DOI 10.1016/0378-1119(96)00054-6; MCGARVEY DJ, 1995, PLANT CELL, V7, P1015, DOI 10.1105/tpc.7.7.1015; Moco S, 2007, J EXP BOT, V58, P4131, DOI 10.1093/jxb/erm271; Moses T, 2013, NEW PHYTOL, V200, P27, DOI 10.1111/nph.12325; Nkembo KM, 2005, CHEM PHARM BULL, V53, P780, DOI 10.1248/cpb.53.780; Ohnuma S, 1996, J BIOL CHEM, V271, P30748, DOI 10.1074/jbc.271.48.30748; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Sanmiya K, 1999, PLANT CELL PHYSIOL, V40, P348, DOI 10.1093/oxfordjournals.pcp.a029549; Szkopinska A, 2005, ACTA BIOCHIM POL, V52, P45; Thabet I, 2011, J PLANT PHYSIOL, V168, P2110, DOI 10.1016/j.jplph.2011.06.017; THRELFALL DR, 1988, PHYTOCHEMISTRY, V27, P2567, DOI 10.1016/0031-9422(88)87028-6; Titov DV, 2011, NAT CHEM BIOL, V7, P182, DOI [10.1038/nchembio.522, 10.1038/NCHEMBIO.522]; Vervacke JS, 2013, CURR MED CHEM, V20, P1585; VOGELI U, 1988, PLANT PHYSIOL, V88, P1291, DOI 10.1104/pp.88.4.1291; Wang JJ, 2014, MAR DRUGS, V12, P4274, DOI 10.3390/md12084274; Wang P, 2004, MOL CELLS, V18, P150; Wang Y, 2007, PLANT CELL REP, V26, P1073, DOI 10.1007/s00299-006-0295-2; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Yin T, 2011, ACTA PHYSIOL PLANT, V33, P137, DOI 10.1007/s11738-010-0529-3	49	27	36	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125415	10.1371/journal.pone.0125415	http://dx.doi.org/10.1371/journal.pone.0125415			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938487	Green Submitted, Green Published, gold			2022-12-27	WOS:000353943000067
J	Bozzi, M; Cassetta, A; Covaceuszach, S; Bigotti, MG; Bannister, S; Hubner, W; Sciandra, F; Lamba, D; Brancaccio, A				Bozzi, Manuela; Cassetta, Alberto; Covaceuszach, Sonia; Bigotti, Maria Giulia; Bannister, Saskia; Huebner, Wolfgang; Sciandra, Francesca; Lamba, Doriano; Brancaccio, Andrea			The Structure of the T190M Mutant of Murine alpha-Dystroglycan at High Resolution: Insight into the Molecular Basis of a Primary Dystroglycanopathy	PLOS ONE			English	Article							O-MANNOSYLATION PATHWAY; N-TERMINAL REGION; PROTEIN; WATER; GLYCOSYLATION; DYSTROPHIN; BINDING; HYPOGLYCOSYLATION; RECOGNITION; EXPRESSION	The severe dystroglycanopathy known as a form of limb-girdle muscular dystrophy (LGMD2P) is an autosomal recessive disease caused by the point mutation T192M in alpha-dystroglycan. Functional expression analysis in vitro and in vivo indicated that the mutation was responsible for a decrease in posttranslational glycosylation of dystroglycan, eventually interfering with its extracellular-matrix receptor function and laminin binding in skeletal muscle and brain. The X-ray crystal structure of the missense variant T190M of the murine N-terminal domain of alpha-dystroglycan (50-313) has been determined, and showed an overall topology (Ig-like domain followed by a basket-shaped domain reminiscent of the small subunit ribosomal protein S6) very similar to that of the wild-type structure. The crystallographic analysis revealed a change of the conformation assumed by the highly flexible loop encompassing residues 159-180. Moreover, a solvent shell reorganization around Met190 affects the interaction between the B1-B5 anti-parallel strands forming part of the floor of the basket-shaped domain, with likely repercussions on the folding stability of the protein domain (s) and on the overall molecular flexibility. Chemical denaturation and limited proteolysis experiments point to a decreased stability of the T190M variant with respect to its wild-type counterpart. This mutation may render the entire L-shaped protein architecture less flexible. The overall reduced flexibility and stability may affect the functional properties of alpha-dystroglycan via negatively influencing its binding behavior to factors needed for dystroglycan maturation, and may lay the molecular basis of the T190M-driven primary dystroglycanopathy.	[Bozzi, Manuela] Univ Cattolica Sacro Cuore, Ist Biochim & Biochim Clin, I-00168 Rome, Italy; [Cassetta, Alberto; Covaceuszach, Sonia; Lamba, Doriano] CNR, Ist Cristallog, I-34149 Trieste, Italy; [Bigotti, Maria Giulia; Brancaccio, Andrea] Univ Bristol, Sch Biochem, Bristol BS8 1TD, Avon, England; [Bannister, Saskia; Huebner, Wolfgang] Univ Bielefeld, Dept Phys, D-33615 Bielefeld, Germany; [Sciandra, Francesca; Brancaccio, Andrea] Univ Cattolica Sacro Cuore, CNR, Ist Chim Riconoscimento Mol, I-00168 Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Consiglio Nazionale delle Ricerche (CNR); Istituto Di Cristallografia (IC-CNR); University of Bristol; University of Bielefeld; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR)	Cassetta, A (corresponding author), CNR, Ist Cristallog, I-34149 Trieste, Italy.	alberto.cassetta@ts.ic.cnr.it; andrea.brancaccio@icrm.cnr.it	Brancaccio, Andrea/C-5876-2009; Cassetta, A./AAG-8712-2019; Lamba, Doriano/B-2961-2011; Sciandra, Francesca/AAY-4650-2020; Lamba, Doriano/L-9808-2018; Covaceuszach, Sonia/AAA-4116-2021; Hubner, Wolfgang/O-7907-2016	Brancaccio, Andrea/0000-0003-4690-8826; Cassetta, A./0000-0002-8600-4162; Lamba, Doriano/0000-0001-6859-7868; Sciandra, Francesca/0000-0002-2123-1516; Lamba, Doriano/0000-0001-6859-7868; Hubner, Wolfgang/0000-0002-1128-6468; Bigotti, Giulia/0000-0001-9595-3338	Wellcome Trust Career Re-entry fellowship	Wellcome Trust Career Re-entry fellowship(Wellcome Trust)	This work was supported by a Wellcome Trust Career Re-entry fellowship to MGB.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Bhattacharya S, 2014, GENE, V537, P108, DOI 10.1016/j.gene.2013.11.071; Bozic D, 2004, J BIOL CHEM, V279, P44812, DOI 10.1074/jbc.C400353200; Bozzi M, 2013, BMC BIOCHEM, V14, DOI 10.1186/1471-2091-14-15; BRANCACCIO A, 1995, FEBS LETT, V368, P139, DOI 10.1016/0014-5793(95)00628-M; Brancaccio A, 1997, EUR J BIOCHEM, V246, P166, DOI 10.1111/j.1432-1033.1997.00166.x; Brancaccio A, 2013, NEUROMUSCULAR DISORD, V23, P867, DOI 10.1016/j.nmd.2013.06.371; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Covalt JC, 2001, J MOL BIOL, V307, P657, DOI 10.1006/jmbi.2001.4482; De Rosa MC, 2011, J MOL GRAPH MODEL, V29, P1015, DOI 10.1016/j.jmgm.2011.04.008; Di Stasio E, 2004, BIOPHYS CHEM, V107, P197, DOI 10.1016/j.bpc.2003.09.005; Dong MR, 2015, NEUROLOGY, V84, P273, DOI 10.1212/WNL.0000000000001162; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Gesemann M, 1998, J BIOL CHEM, V273, P600, DOI 10.1074/jbc.273.1.600; Hara Y, 2011, P NATL ACAD SCI USA, V108, P17426, DOI 10.1073/pnas.1114836108; Hara Y, 2011, NEW ENGL J MED, V364, P939, DOI 10.1056/NEJMoa1006939; Harrison R, 2012, GLYCOBIOLOGY, V22, P662, DOI 10.1093/glycob/cws002; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Inamori K, 2012, SCIENCE, V335, P93, DOI 10.1126/science.1214115; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuroki K, 2014, P NATL ACAD SCI USA, V111, P8877, DOI 10.1073/pnas.1324105111; Ladbury JE, 1996, CHEM BIOL, V3, P973, DOI 10.1016/S1074-5521(96)90164-7; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Levy Y, 2006, ANNU REV BIOPH BIOM, V35, P389, DOI 10.1146/annurev.biophys.35.040405.102134; Liu MA, 2008, BIOPOLYMERS, V90, P358, DOI 10.1002/bip.20847; Live D, 2013, CHEMBIOCHEM, V14, P2392, DOI 10.1002/cbic.201300417; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Morlacchi S, 2012, BMC BIOCHEM, V13, DOI 10.1186/1471-2091-13-14; Praveen S, 2008, J APPL CRYSTALLOGR, V41, P952, DOI 10.1107/S0021889808022073; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schrodinger L., 2020, PYMOL; Sciandra F, 2013, CURR PROTEIN PEPT SC, V14, P626; Sciandra F, 2009, FEBS J, V276, P4933, DOI 10.1111/j.1742-4658.2009.07196.x; Stalnaker SH, 2010, J BIOL CHEM, V285, P24882, DOI 10.1074/jbc.M110.126474; Stanley P, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005199; Tran DT, 2012, J BIOL CHEM, V287, P20967, DOI 10.1074/jbc.M112.370387; Wells L, 2013, J BIOL CHEM, V288, P6930, DOI 10.1074/jbc.R112.438978; Yoshida-Moriguchi T, 2013, SCIENCE, V341, P896, DOI 10.1126/science.1239951	48	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124277	10.1371/journal.pone.0124277	http://dx.doi.org/10.1371/journal.pone.0124277			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932631	Green Published, gold, Green Submitted			2022-12-27	WOS:000353887100036
J	Ferreira, LJ; Azevedo, V; Maroco, J; Oliveira, MM; Santos, AP				Ferreira, Liliana J.; Azevedo, Vanessa; Maroco, Joao; Margarida Oliveira, M.; Santos, Ana Paula			Salt Tolerant and Sensitive Rice Varieties Display Differential Methylome Flexibility under Salt Stress	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; DNA METHYLATION; SALINITY STRESS; ABIOTIC STRESS; AMPLIFIED POLYMORPHISM; EPIGENETIC INHERITANCE; GENE-EXPRESSION; ARABIDOPSIS; CHROMATIN; GENOTYPES	DNA methylation has been referred as an important player in plant genomic responses to environmental stresses but correlations between the methylome plasticity and specific traits of interest are still far from being understood. In this study, we inspected global DNA methylation levels in salt tolerant and sensitive rice varieties upon salt stress imposition. Global DNA methylation was quantified using the 5-methylcytosine (5mC) antibody and an ELISA-based technique, which is an affordable and quite pioneer assay in plants, and in situ imaging of methylation sites in interphase nuclei of tissue sections. Variations of global DNA methylation levels in response to salt stress were tissue- and genotype-dependent. We show a connection between a higher ability of DNA methylation adjustment levels and salt stress tolerance. The salt-tolerant rice variety Pokkali was remarkable in its ability to quickly relax DNA methylation in response to salt stress. In spite of the same tendency for reduction of global methylation under salinity, in the salt-sensitive rice variety IR29 such reduction was not statistically supported. In 'Pokkali', the salt stress-induced demethylation may be linked to active demethylation due to increased expression of DNA demethylases under salt stress. In 'IR29', the induction of both DNA demethylases and methyltransferases may explain the lower plasticity of DNA methylation. We further show that mutations for epigenetic regulators affected specific phenotypic parameters related to salinity tolerance, such as the root length and biomass. This work emphasizes the role of differential methylome flexibility between salt tolerant and salt sensitive rice varieties as an important player in salt stress tolerance, reinforcing the need to better understand the connection between epigenetic networks and plant responses to environmental stresses.	[Ferreira, Liliana J.; Azevedo, Vanessa; Margarida Oliveira, M.; Santos, Ana Paula] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, Genom Plant Stress, P-2780157 Oeiras, Portugal; [Maroco, Joao] ISPA Inst Univ, UIPES, Lisbon, Portugal	Universidade Nova de Lisboa; Instituto Superior Psicologia Aplicada (ISPA)	Santos, AP (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, Genom Plant Stress, Av Republ, P-2780157 Oeiras, Portugal.	apsantos@itqb.unl.pt	Marôco, João P./A-5729-2010; Oliveira, M. Margarida/H-9318-2012; Marôco, João/H-3622-2019; Santos, Ana Paula/D-3154-2012	Marôco, João P./0000-0001-9214-5378; Oliveira, M. Margarida/0000-0002-0095-1952; Marôco, João/0000-0001-9214-5378; Saavedra Azevedo, Vanessa/0000-0003-0057-4381; Duarte Ferreira, Liliana de Jesus/0000-0003-0727-6678; Santos, Ana Paula/0000-0002-8108-1863	Portuguese Foundation for Science and Technology (FCT) [BIA/BCM/111645/2009]; FCT [BPD/74197/2010, BD/61428/2009]; Research unit GREEN-it "Bioresources for Sustainability" [UID/Multi/04551/2013]; Fundação para a Ciência e a Tecnologia [PTDC/BIA-BCM/111645/2009] Funding Source: FCT	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Research unit GREEN-it "Bioresources for Sustainability"; Fundação para a Ciência e a Tecnologia	The work was funded by Portuguese Foundation for Science and Technology (FCT) through the project "Epigenetic regulation of the rice genome under environmental stresses-BIA/BCM/111645/2009". APS and LF were financially supported by the following FCT grants: BPD/74197/2010 e BD/61428/2009, respectively. Research unit GREEN-it "Bioresources for Sustainability" (UID/Multi/04551/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceituno FF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-438; Bonilla P, 2002, PHILIPP AGRIC SCI, V85, P68; Cao XF, 2000, P NATL ACAD SCI USA, V97, P4979, DOI 10.1073/pnas.97.9.4979; Cerda S, 1997, MUTAT RES-REV MUTAT, V386, P141, DOI 10.1016/S1383-5742(96)00050-6; Chinnusamy V, 2005, CROP SCI, V45, P437, DOI 10.2135/cropsci2005.0437; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; Cotsaftis O, 2011, MOL PLANT, V4, P25, DOI 10.1093/mp/ssq056; Finnegan EJ, 2000, PLANT MOL BIOL, V43, P189, DOI 10.1023/A:1006427226972; Finnegan EJ, 1996, P NATL ACAD SCI USA, V93, P8449, DOI 10.1073/pnas.93.16.8449; Franco R, 2008, CANCER LETT, V266, P6, DOI 10.1016/j.canlet.2008.02.026; Fulnecek J, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-2; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Henikoff S, 1998, GENETICS, V149, P307; HERNANDEZ JA, 1995, PLANT SCI, V105, P151, DOI 10.1016/0168-9452(94)04047-8; HERNANDEZ JA, 1993, PHYSIOL PLANTARUM, V89, P103, DOI 10.1111/j.1399-3054.1993.tb01792.x; Hirochika H, 1996, P NATL ACAD SCI USA, V93, P7783, DOI 10.1073/pnas.93.15.7783; Jeon JS, 2000, PLANT J, V22, P561, DOI 10.1046/j.1365-313x.2000.00767.x; Jeong DH, 2006, PLANT J, V45, P123, DOI 10.1111/j.1365-313X.2005.02610.x; Jiang N, 2003, NATURE, V421, P163, DOI 10.1038/nature01214; Kankel MW, 2003, GENETICS, V163, P1109; Karan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040203; Kikuchi K, 2003, NATURE, V421, P167, DOI 10.1038/nature01218; Kim JM, 2010, PLANT CELL ENVIRON, V33, P604, DOI 10.1111/j.1365-3040.2009.02076.x; Kinnally EL, 2011, BRAIN BEHAV IMMUN, V25, P1548, DOI 10.1016/j.bbi.2011.05.001; Komatsu M, 2003, PLANT CELL, V15, P1934, DOI 10.1105/tpc.011809; Kouzminova E, 2001, EMBO J, V20, P4309, DOI 10.1093/emboj/20.15.4309; Kumar K, 2013, RICE, V6, DOI 10.1186/1939-8433-6-27; La HG, 2011, P NATL ACAD SCI USA, V108, P15498, DOI 10.1073/pnas.1112704108; Lafon-Placette C, 2013, NEW PHYTOL, V197, P416, DOI 10.1111/nph.12026; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lu YL, 2008, J GENET GENOMICS, V35, P41, DOI 10.1016/S1673-8527(08)60006-5; Madlung A, 2004, ANN BOT-LONDON, V94, P481, DOI 10.1093/aob/mch172; Marconi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075597; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Ortega-Galisteo AP, 2008, PLANT MOL BIOL, V67, P671, DOI 10.1007/s11103-008-9346-0; Penterman J, 2007, P NATL ACAD SCI USA, V104, P6752, DOI 10.1073/pnas.0701861104; Ramos M, 2013, TREE GENET GENOMES, V9, P1481, DOI 10.1007/s11295-013-0652-6; Santos AP, 2011, CYTOGENET GENOME RES, V132, P297, DOI 10.1159/000322287; Santos AP, 2011, OMICS, V15, P839, DOI 10.1089/omi.2011.0095; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Sharma R, 2009, FEBS J, V276, P6301, DOI 10.1111/j.1742-4658.2009.07338.x; Sohn YG, 2005, J PLANT BIOL, V48, P201, DOI 10.1007/BF03030409; Steward N, 2002, J BIOL CHEM, V277, P37741, DOI 10.1074/jbc.M204050200; Vaughn MW, 2007, PLOS BIOL, V5, P1617, DOI 10.1371/journal.pbio.0050174; Walia H, 2005, PLANT PHYSIOL, V139, P822, DOI 10.1104/pp.105.065961; Wang WS, 2011, J EXP BOT, V62, P1951, DOI 10.1093/jxb/erq391; Wang WS, 2011, J GENET GENOMICS, V38, P419, DOI 10.1016/j.jgg.2011.07.006; WEITZMAN SA, 1994, P NATL ACAD SCI USA, V91, P1261, DOI 10.1073/pnas.91.4.1261; Yoshida S., 1976, LAB MANUAL PHYSL STU; Zeng LH, 2005, PLANT SOIL, V268, P51, DOI 10.1007/s11104-004-0180-0; Zhu JH, 2007, CURR BIOL, V17, P54, DOI 10.1016/j.cub.2006.10.059; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2	58	58	65	8	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124060	10.1371/journal.pone.0124060	http://dx.doi.org/10.1371/journal.pone.0124060			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932633	Green Published, gold, Green Submitted			2022-12-27	WOS:000353887100029
J	Wang, HC; Hsu, SP; Lee, WS				Wang, Hui-Chen; Hsu, Sung-Po; Lee, Wen-Sen			Extra-Nuclear Signaling Pathway Involved in Progesterone-Induced Up-Regulations of p21(cip1) and p27(kip1) in Male Rat Aortic Smooth Muscle Cells	PLOS ONE			English	Article							ESTROGEN PLUS PROGESTIN; CORONARY-HEART-DISEASE; CYCLE PROGRESSION; MICE LACKING; INHIBITION; KINASE; PHOSPHORYLATION; PROLIFERATION; ATHEROSCLEROSIS; HYPERPLASIA	Previously, we demonstrated that progesterone (P4) at physiologic levels (5-500 nM) inhibited proliferation in cultured rat aortic smooth muscle cells (RASMCs) through a P4 receptor (PR)-dependent pathway. We also showed that P4-induced cell cycle arrest in RASMCs occurs when the cyclin-CDK2 system is inhibited just as p21(cip1) and p27(kip1) protein levels are augmented. In the present study, we further investigated the molecular mechanism underlying P4-induced up-regulations of p21(cip1) and p27(kip1) in RASMCs. We used pharmacological inhibitors as well as dominant negative constructs and conducted Western blot analyses to delineate the signaling pathway involved. Our data suggest that P4 up-regulated the expression of p21(cip1) and p27(kip1) in RASMCs through increasing the level of p53 protein mediated by activating the cSrc/Kras/Raf-1/AKT/ERK/p38/I kappa B alpha/NF kappa B pathway. The findings of the present study highlight the molecular mechanism underlying P4-induced up-regulations in p21(cip1) and p27(kip1) in RASMCs.	[Wang, Hui-Chen; Lee, Wen-Sen] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei 110, Taiwan; [Hsu, Sung-Po; Lee, Wen-Sen] Taipei Med Univ, Coll Med, Sch Med, Dept Physiol, Taipei 110, Taiwan; [Lee, Wen-Sen] Taipei Med Univ Hosp, Canc Res Ctr, Taipei 110, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital	Lee, WS (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei 110, Taiwan.	wslee@tmu.edu.tw	Hsu, Sung-Po/I-8383-2019	HSU, SUNG-PO/0000-0001-7527-9040	National Science Council [NSC 96-2320-B-038-023, NSC 97-2320-B-038-033-MY3, NSC 102-2320-B-038-023]; Taipei Medical University [TMU101-AE1-B45]	National Science Council(Ministry of Science and Technology, Taiwan); Taipei Medical University	This study was supported by the National Science Council grant (http://www.most.gov.tw) NSC 96-2320-B-038-023 and NSC 97-2320-B-038-033-MY3 to WSL and NSC 102-2320-B-038-023 to SPH and Taipei Medical University (http://www.tmu.edu.tw) TMU101-AE1-B45 to SPH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MR, 1990, ARTERIOSCLEROSIS, V10, P1051, DOI 10.1161/01.ATV.10.6.1051; Boonyaratanakornkit V, 2008, STEROIDS, V73, P922, DOI 10.1016/j.steroids.2008.01.010; Castellano E, 2002, NAT REV CANCER, V2, P489; Castellano E, 2014, GENES CANC, V2, P261; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; ELDEIRY WS, 1994, CANCER RES, V54, P1169; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; FOEGH ML, 1994, J VASC SURG, V19, P722, DOI 10.1016/S0741-5214(94)70047-8; FURMAN RH, 1968, ANN NY ACAD SCI, V149, P822, DOI 10.1111/j.1749-6632.1968.tb53838.x; Gellersen B, 2009, HUM REPROD UPDATE, V15, P119, DOI 10.1093/humupd/dmn044; GRODSTEIN F, 1995, PROG CARDIOVASC DIS, V38, P199, DOI 10.1016/S0033-0620(95)80012-3; HAARBO J, 1991, J CLIN INVEST, V87, P1274, DOI 10.1172/JCI115129; He GG, 2005, ONCOGENE, V24, P2929, DOI 10.1038/sj.onc.1208474; Ho PY, 2004, INT J CANCER, V111, P51, DOI 10.1002/ijc.20039; Hsu SP, 2015, ENDOCRINOLOGY, V156, P291, DOI 10.1210/en.2014-1629; Hsu SP, 2011, ATHEROSCLEROSIS, V217, P83, DOI 10.1016/j.atherosclerosis.2011.02.051; Hsu SP, 2011, MOL ENDOCRINOL, V25, P421, DOI 10.1210/me.2010-0424; Hsu YF, 2007, MOL CARCINOGEN, V46, P275, DOI 10.1002/mc.20274; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Igata M, 2005, CIRC RES, V97, P837, DOI 10.1161/01.RES.0000185823.73556.06; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; KUSHWAHA RS, 1991, ARTERIOSCLER THROMB, V11, P23, DOI 10.1161/01.ATV.11.1.23; Lam EWF, 2006, BIOCHEM SOC T, V34, P722, DOI 10.1042/BST0340722; Lee WS, 2003, ENDOCRINOLOGY, V144, P2785, DOI 10.1210/en.2003-0045; Lee WS, 1997, NAT MED, V3, P1005, DOI 10.1038/nm0997-1005; LIBBY P, 1991, LAB INVEST, V64, P5; Lin SY, 2012, ANGIOGENESIS, V15, P671, DOI 10.1007/s10456-012-9289-6; Liu PD, 2014, NATURE, V508, P541, DOI 10.1038/nature13079; Migliaccio A, 1998, EMBO J, V17, P2008, DOI 10.1093/emboj/17.7.2008; Miyagawa K, 1997, NAT MED, V3, P324, DOI 10.1038/nm0397-324; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; MUNRO JM, 1988, LAB INVEST, V58, P249; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Naumann U, 1999, BIOCHEM BIOPH RES CO, V261, P890, DOI 10.1006/bbrc.1999.1126; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Renault VM, 2011, ONCOGENE, V30, P3207, DOI 10.1038/onc.2011.35; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Sa G, 2004, EXP CELL RES, V300, P427, DOI 10.1016/j.yexcr.2004.07.032; SCHWARTZ SM, 1990, PHYSIOL REV, V70, P1177, DOI 10.1152/physrev.1990.70.4.1177; Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759; Shupnik MA, 2004, ONCOGENE, V23, P7979, DOI 10.1038/sj.onc.1208076; STAMLER J, 1953, CIRC RES, V1, P94, DOI 10.1161/01.RES.1.1.94; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P756, DOI 10.1056/NEJM199109123251102; SULLIVAN TR, 1995, J CLIN INVEST, V96, P2482, DOI 10.1172/JCI118307; Viglietto G, 2002, NAT MED, V8, P1136, DOI 10.1038/nm762; Wang HC, 2014, ENDOCRINOLOGY, V155, P4473, DOI 10.1210/en.2014-1344; Wang HC, 2014, ENDOCRINOLOGY, V155, P1428, DOI 10.1210/en.2013-1838; WEIGENSBERG BI, 1984, ATHEROSCLEROSIS, V52, P253, DOI 10.1016/0021-9150(84)90055-8; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	52	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125903	10.1371/journal.pone.0125903	http://dx.doi.org/10.1371/journal.pone.0125903			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932965	Green Submitted, Green Published, gold			2022-12-27	WOS:000353887100142
J	Yin, XY; Cheng, H; Lin, Y; Wineinger, NE; Zhou, FS; Sheng, YJ; Yang, C; Li, P; Li, F; Shen, CB; Yang, S; Schork, NJ; Zhang, XJ				Yin, Xianyong; Cheng, Hui; Lin, Yan; Wineinger, Nathan E.; Zhou, Fusheng; Sheng, Yujun; Yang, Chao; Li, Pan; Li, Feng; Shen, Changbing; Yang, Sen; Schork, Nicholas J.; Zhang, Xuejun			A Weighted Polygenic Risk Score Using 14 Known Susceptibility Variants to Estimate Risk and Age Onset of Psoriasis in Han Chinese	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ANALYSIS IDENTIFIES 3; COMMON VARIANTS; LOCI; GENES	With numbers of common variants identified mainly through genome-wide association studies (GWASs), there is great interest in incorporating the findings into screening individuals at high risk of psoriasis. The purpose of this study is to establish genetic prediction models and evaluate its discriminatory ability in psoriasis in Han Chinese population. We built the genetic prediction models through weighted polygenic risk score (PRS) using 14 susceptibility variants in 8,819 samples. We found the risk of psoriasis among individuals in the top quartile of PRS was significantly larger than those in the lowest quartile of PRS (OR = 28.20, P < 2.0x10(-16)). We also observed statistically significant associations between the PRS, family history and early age onset of psoriasis. We also built a predictive model with all 14 known susceptibility variants and alcohol consumption, which achieved an area under the curve statistic of similar to 0.88. Our study suggests that 14 psoriasis known susceptibility loci have the discriminating potential, as is also associated with family history and age of onset. This is the genetic predictive model in psoriasis with the largest accuracy to date.	[Yin, Xianyong; Cheng, Hui; Lin, Yan; Zhou, Fusheng; Sheng, Yujun; Yang, Chao; Li, Pan; Li, Feng; Shen, Changbing; Yang, Sen; Zhang, Xuejun] Anhui Med Univ, Affiliated Hosp 1, Inst Dermatol, Dept Dermatol, Hefei, Anhui, Peoples R China; [Yin, Xianyong; Cheng, Hui; Lin, Yan; Zhou, Fusheng; Sheng, Yujun; Yang, Chao; Li, Pan; Li, Feng; Shen, Changbing; Yang, Sen; Zhang, Xuejun] Anhui Med Univ, Incubat Ctr, State Key Lab Dermatol, Key Lab Dermatol,Minist Educ, Hefei, Anhui, Peoples R China; [Yin, Xianyong; Cheng, Hui; Lin, Yan; Zhou, Fusheng; Sheng, Yujun; Yang, Chao; Li, Pan; Li, Feng; Shen, Changbing; Yang, Sen; Zhang, Xuejun] Key Lab Gene Resource Utilizat Complex Dis, Hefei, Anhui, Peoples R China; [Yin, Xianyong; Cheng, Hui; Lin, Yan; Zhou, Fusheng; Sheng, Yujun; Yang, Chao; Li, Pan; Li, Feng; Shen, Changbing; Yang, Sen; Zhang, Xuejun] Anhui Med Univ, Collaborat Innovat Ctr Complex & Severe Dermatosi, Hefei, Anhui, Peoples R China; [Wineinger, Nathan E.] Scripps Hlth, La Jolla, CA USA; [Yin, Xianyong; Wineinger, Nathan E.] Scripps Translat Sci Inst, La Jolla, CA USA; [Yin, Xianyong] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Schork, Nicholas J.] J Craig Venter Inst, Human Biol, La Jolla, CA 92037 USA	Anhui Medical University; Anhui Medical University; Anhui Medical University; Scripps Research Institute; Scripps Research Institute; J. Craig Venter Institute	Schork, NJ (corresponding author), J Craig Venter Inst, Human Biol, La Jolla, CA 92037 USA.	nschork@jcvi.org; ayzxj@vip.sina.com	SHENG, Yu/GXZ-8269-2022	Schork, Nicholas/0000-0003-0920-5013	National Natural Science Foundation of China [81370044, 81130031, 81000692]; China Council of Scholarship [201208340003]; Anhui High Education Talent Fund and Anhui Medical University Ph.D. Fund [XJ201429]; NIGH [1UL1TR001114]; NIH [U19 AG023122-09, R01 DA030976-05, R01 MH094483-03, R01 AG035020-05, R01 MH100351-02, R21 AG045789-01A1]; Human Longeveity, Inc.; Johnson and Johnson; Tanner Foundation; Stand-Upto- Cancer organization; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100351, R01MH094483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U19AG023122, R01AG035020, R21AG045789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030976] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Council of Scholarship; Anhui High Education Talent Fund and Anhui Medical University Ph.D. Fund; NIGH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Longeveity, Inc.; Johnson and Johnson(Johnson & JohnsonJohnson & Johnson USA); Tanner Foundation; Stand-Upto- Cancer organization; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	XYY was supported by the National Natural Science Foundation of China (81370044 and 81000692), China Council of Scholarship (201208340003), Anhui High Education Talent Fund and Anhui Medical University Ph.D. Fund (XJ201429). XJZ was supported by the National Natural Science Foundation of China (81130031). NEW is supported by the NIGH grant 1UL1TR001114. NJS and his lab are supported by NIH grants U19 AG023122-09, R01 DA030976-05, R01 MH094483-03, R01 AG035020-05, R01 MH100351-02, R21 AG045789-01A1 as well as grants from Human Longeveity, Inc., Johnson and Johnson, the Tanner Foundation, and the Stand-Upto- Cancer organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao W, 2013, AM J EPIDEMIOL, V178, P1197, DOI 10.1093/aje/kwt123; Chatterjee N, 2011, CANCER EPIDEM BIOMAR, V20, P3, DOI 10.1158/1055-9965.EPI-10-1022; Chen HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019454; Cheng H, 2013, J INVEST DERMATOL; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; Ding XL, 2012, EUR J DERMATOL, V22, P663, DOI 10.1684/ejd.2012.1802; Ellinghaus E, 2010, NAT GENET, V42, P991, DOI 10.1038/ng.689; Enamandram M, 2013, J INVEST DERMATOL, V133, P287, DOI 10.1038/jid.2012.434; Feng BJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000606; HENSELER T, 1985, J AM ACAD DERMATOL, V13, P450, DOI 10.1016/S0190-9622(85)70188-0; Huffmeier U, 2010, NAT GENET, V42, P996, DOI 10.1038/ng.688; Knight J, 2012, HUM MOL GENET, V21, P5185, DOI 10.1093/hmg/dds344; Langley RGB, 2005, ANN RHEUM DIS, V64, P18, DOI 10.1136/ard.2004.033217; Li Y, 2013, J MED GENET; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Scott IC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003808; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Stuart PE, 2010, NAT GENET, V42, P1000, DOI 10.1038/ng.693; Sun LD, 2011, NAT GENET, V43, P690, DOI 10.1038/ng.851; Sun LD, 2010, NAT GENET, V42, P1005, DOI 10.1038/ng.690; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Wray NR, 2013, NAT REV GENET, V14, P507, DOI 10.1038/nrg3457; Yarwood A, 2013, ANN RHEUM DIS; Yin XY, 2013, J DERMATOL SCI, V70, P94, DOI 10.1016/j.jdermsci.2013.02.006; Yin XY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-87; Zhang XJ, 2009, NAT GENET, V41, P205, DOI 10.1038/ng.310; Zhu KJ, 2012, J DERMATOL, V39, P770, DOI 10.1111/j.1346-8138.2012.01577.x	28	27	30	1	629	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125369	10.1371/journal.pone.0125369	http://dx.doi.org/10.1371/journal.pone.0125369			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933357	gold, Green Published, Green Submitted			2022-12-27	WOS:000353887100104
J	Aninanya, GA; Debpuur, CY; Awine, T; Williams, JE; Hodgson, A; Howard, N				Aninanya, Gifty Apiung; Debpuur, Cornelius Y.; Awine, Timothy; Williams, John E.; Hodgson, Abraham; Howard, Natasha			Effects of an Adolescent Sexual and Reproductive Health Intervention on Health Service Usage by Young People in Northern Ghana: A Community-Randomised Trial	PLOS ONE			English	Article							BEHAVIOR-CHANGE; RURAL TANZANIA; IMPACT; EDUCATION; PROGRAM; DESIGN; RISK; KNOWLEDGE; SCHOOLS; PROJECT	Background While many Ghanaian adolescents encounter sexual and reproductive health problems, their usage of services remains low. A social learning intervention, incorporating environment, motivation, education, and self-efficacy to change behaviour, was implemented in a low-income district of northern Ghana to increase adolescent services usage. This study aimed to assess the impact of this intervention on usage of sexual and reproductive health services by young people. Methods Twenty-six communities were randomly allocated to (i) an intervention consisting of school-based curriculum, out-of-school outreach, community mobilisation, and health-worker training in youth-friendly health services, or (ii) comparison consisting of community mobilisation and youth-friendly health services training only. Outcome measures were usage of sexually-transmitted infections (STIs) management, HIV counselling and testing, antenatal care or perinatal services in the past year and reported service satisfaction. Data was collected, at baseline and three years after, from a cohort of 2,664 adolescents aged 15-17 at baseline. Results Exposure was associated with over twice the odds of using STI services (AOR 2.47; 95%CI 1.78-3.42), 89% greater odds of using perinatal services (AOR 1.89; 95%CI 1.37-2.60) and 56% greater odds of using antenatal services (AOR 1.56; 95%CI 1.10-2.20) among participants in intervention versus comparison communities, after adjustment for baseline differences. Conclusions The addition of targeted school-based and outreach activities increased service usage by young people more than community mobilisation and training providers in youth-friendly services provision alone.	[Aninanya, Gifty Apiung; Debpuur, Cornelius Y.; Awine, Timothy; Williams, John E.] Navrongo Hlth Res Ctr, Navrongo, Ghana; [Aninanya, Gifty Apiung] Kwame Nkrumah Univ Sci & Technol, Kumasi, Ghana; [Hodgson, Abraham] Ghana Hlth Serv, Div Res & Dev, Accra, Ghana; [Howard, Natasha] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England	Navrongo Health Research Center; Kwame Nkrumah University Science & Technology; Ghana Health Service; University of London; London School of Hygiene & Tropical Medicine	Aninanya, GA (corresponding author), Navrongo Hlth Res Ctr, Navrongo, Ghana.	Gifty.Apiung@navrongo-hrc.org		Awine, Timothy/0000-0002-7340-6111; Howard, Natasha/0000-0003-4174-7349; Debpuur, Cornelius/0000-0003-0968-5280	Rockefeller Foundation	Rockefeller Foundation	The work was supported by the Rockefeller Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adu-Mireku Samuel, 2003, Afr Health Sci, V3, P7; Ahmed F, 2005, HEALTHCARE SEEKING U; Ahmed N, 2009, SCAND J PUBLIC HEALT, V37, P48, DOI 10.1177/1403494808097190; Akpabio II, 2009, J ADOLESCENT HEALTH, V44, P118, DOI 10.1016/j.jadohealth.2008.05.005; Awusabo-Asare K, 2008, APPL HEALTH ECON HEA, V6, P27, DOI 10.2165/00148365-200806010-00003; Bandura Albert, 1977, SOCIAL LEARNING THEO; Bankole Akinrinola, 2007, Afr J Reprod Health, V11, P28, DOI 10.2307/25549730; Bayer AM, 2010, SOC SCI MED, V70, P2085, DOI 10.1016/j.socscimed.2010.03.001; Bersamin M, 2011, MATERN CHILD HLTH J, V15, P652, DOI 10.1007/s10995-010-0618-3; Biddlecom A, 2006, IUSSP SEM SEX REPR T; Biddlecom A, 2009, INT PERSPECT SEX R H, V35, P72, DOI 10.1363/ipsrh.35.072.09; Biddlecom Ann E, 2007, Afr J Reprod Health, V11, P99, DOI 10.2307/25549734; Bongaarts J, 1998, STUD FAMILY PLANN, V29, P99, DOI 10.2307/172152; Braungart M, 2011, HLTH PROFESSIONALS E; Brieger WR, 2001, J ADOLESCENT HEALTH, V29, P436, DOI 10.1016/S1054-139X(01)00264-6; Campbell MK, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5661; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Chavis AM, 2011, SOC WORK PUBLIC HLTH, V26, P471, DOI 10.1080/19371918.2011.591629; Debpuur C, 2002, STUD FAMILY PLANN, V33, P141, DOI 10.1111/j.1728-4465.2002.00141.x; Debpuur C., 2003, PROMOTING HLTH UNPUB; Doyle AM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000287; Erulkar Annabel S, 2005, Afr J Reprod Health, V9, P51; Erulkar AS, 2004, INT FAM PLAN PERSPEC, V30, P58, DOI 10.1363/3005804; Ford C, 2004, J ADOLESCENT HEALTH, V35, P160, DOI 10.1016/j.jadohealth.2004.03.002; Fullerton J, 2003, MIDWIFERY, V19, P17, DOI 10.1054/midw.2002.0334; Gloppen KM, 2010, J ADOLESCENT HEALTH, V46, pS42, DOI 10.1016/j.jadohealth.2009.11.216; Goicolea I, 2010, GLOBAL HEALTH ACTION, V3, DOI 10.3402/gha.v3i0.5280; Gray GE, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000227; GSS GHS ICF Macro, 2009, GHAN DEM HLTH SERV; Hayes RJ, 2005, CONTEMP CLIN TRIALS, V26, P430, DOI 10.1016/j.cct.2005.04.006; Hock-Long L, 2003, PERSPECT SEX REPRO H, V35, P144, DOI 10.1363/3514403; IPPF, 2010, FACTS AD WOM DEV WOR; Kalembo F. W., 2013, Californian Journal of Health Promotion, V11, P32; Karim AM, 2003, INT FAM PLAN PERSPEC, V29, P14, DOI 10.2307/3180997; KIRBY D, 1995, BRIT MED J, V311, P403, DOI 10.1136/bmj.311.7002.403; Koster A, 2001, AFR J REPROD HEALTH, V5, P40; Kumi-Kyereme Akwasi, 2007, Afr J Reprod Health, V11, P133, DOI 10.2307/25549736; Larke N, 2010, J ADOLESCENT HEALTH, V47, P512, DOI 10.1016/j.jadohealth.2010.03.020; Madise Nyovani, 2007, Afr J Reprod Health, V11, P83, DOI 10.2307/25549733; Marteleto L, 2008, STUD FAMILY PLANN, V39, P351, DOI 10.1111/j.1728-4465.2008.00180.x; Mbizvo MT, 2010, INT J GYNECOL OBSTET, V110, pS3, DOI 10.1016/j.ijgo.2010.04.001; Mbonye Anthony K, 2003, Int J Adolesc Med Health, V15, P105; Meekers D, 2002, STUD FAMILY PLANN, V33, P335, DOI 10.1111/j.1728-4465.2002.00335.x; Moore Ann M, 2007, Afr J Reprod Health, V11, P62, DOI 10.2307/25549732; NACP/GHS, 2009, HIV SENT SERV REP Q; National Population Council, 2000, AD REPR HLTH POL ARH; NHRC/ASRH, 2004, ANN PROJ PROGR REP; NHRC/ASRH, 2009, ANN PROJ PROGR REP; NHRC/ASRH, 2006, ANN PROJ PROGR REP; NHRC/NDSS, 2008, NAVR DEM SURV SYST A; Nyarko P, 2001, NAVRONGO DEMOGRAPHIC; Obasi AI, 2006, AIDS CARE, V18, P311, DOI 10.1080/09540120500161983; Oduro AR, 2012, INT J EPIDEMIOL, V41, P968, DOI 10.1093/ije/dys111; Okonofua Friday E., 2003, International Journal of Infectious Diseases, V7, P61, DOI 10.1016/S1201-9712(03)90044-0; Phillips JF, 2006, B WORLD HEALTH ORGAN, V84, P949, DOI 10.2471/BLT.06.030064; Plummer ML, 2007, HEALTH EDUC RES, V22, P500, DOI 10.1093/her/cyl103; Posner, 2007, EVALUATION AFRICAN Y; Rani M, 2004, INT FAM PLAN PERSPEC, V30, P110, DOI 10.1363/3011004; Renju J, 2010, HEALTH EDUC RES, V25, P903, DOI 10.1093/her/cyq041; Renju J, 2010, HEALTH RES POLICY SY, V8, DOI 10.1186/1478-4505-8-12; Rondini Simona, 2009, Afr J Reprod Health, V13, P51; Ross DA, 2010, AIDS, V24, pS4, DOI 10.1097/01.aids.0000390703.35642.89; Saaka S, 2005, HIV STIS HLTH SEEKIN; Secor-Turner Molly, 2009, Adolesc Med State Art Rev, V20, P1005; Simba Daudi O, 2009, Afr J Reprod Health, V13, P99; Speizer IS, 2003, J ADOLESCENT HEALTH, V33, P324, DOI 10.1016/S1054-139X(02)00535-9; Tu WZ, 2009, ARCH PEDIAT ADOL MED, V163, P1106, DOI 10.1001/archpediatrics.2009.203; UN Educational Scientific and Cultural Organization (UNESCO), 2009, INT GUID SEX ED EV I, P2; Van Belle SB, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-741; van Teijlingen E, 2012, SEXUAL REPROD HLTH S; Wight D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-788; Wolf RC, 2000, J HEALTH COMMUN, V5, P61, DOI 10.1080/10810730050019564; Wolf RC, 2002, AIDS CARE, V14, P361, DOI 10.1080/09540120220123748; Woodward A, 2014, INT J STD AIDS, V25, P817, DOI 10.1177/0956462414521163; World Bank, 2006, BACKGR PAP BRIDG N S; Zabin LS, 2009, STUD FAMILY PLANN, V40, P1, DOI 10.1111/j.1728-4465.2009.00182.x	76	35	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125267	10.1371/journal.pone.0125267	http://dx.doi.org/10.1371/journal.pone.0125267			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0MA	25928562	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000353713100076
J	Hill, JC; Thomas, E; Hill, S; Foster, NE; van der Windt, DA				Hill, Jonathan C.; Thomas, Elaine; Hill, Susan; Foster, Nadine E.; van der Windt, Danielle A.			Development and Validation of the Keele Musculoskeletal Patient Reported Outcome Measure (MSK-PROM)	PLOS ONE			English	Article							BACK-PAIN; CLINICAL-TRIALS; PRIMARY-CARE	Objective To develop and validate a patient report outcome measure (PROM) for clinical practice that can monitor health status of patients with a range of musculoskeletal (MSK) disorders. Methods Constructs for inclusion in the MSK-PROM were identified from a consensus process involving patients with musculoskeletal conditions, clinicians, purchasers of healthcare services, and primary care researchers. Psychometric properties of the brief tool, including face and construct validity, repeatability and responsiveness were assessed in a sample of patients with musculoskeletal pain consulting physiotherapy services in the United Kingdom (n=425). Results The consensus process identified 10 prioritised domains for monitoring musculoskeletal health status: pain intensity, quality of life, physical capacity, interference with social/leisure activities, emotional well-being, severity of most difficult thing, activities and roles, understanding independence, and overall impact. As the EuroQol (EQ-5D-5L) is a widely adopted PROMs tool and covers the first four domains listed, to reduce patient burden to a minimum the MSK-PROM was designed to capture the remaining six prioritised domains which are not measured by the EQ-5D-5L. The tool demonstrated excellent reliability, construct validity, responsiveness and acceptability to patients and clinicians for use in clinical practice. Conclusion We have validated a brief patient reported outcome measure (MSK-PROM) for use in clinical practice to measure musculoskeletal health status and monitor outcomes over time using domains that are meaningful to patients and sensitive to change. Further work will establish whether the MSK-PROM is useful in other musculoskeletal healthcare settings.	[Hill, Jonathan C.; Thomas, Elaine; Hill, Susan; Foster, Nadine E.; van der Windt, Danielle A.] Keele Univ, Inst Primary Care & Hlth Sci, Stoke On Trent, Staffs, England	Keele University	Hill, JC (corresponding author), Keele Univ, Inst Primary Care & Hlth Sci, Stoke On Trent, Staffs, England.	j.hill@keele.ac.uk	Hill, Jonathan/AAT-2744-2020	van der Windt, Danielle/0000-0002-7248-6703; Foster, Nadine/0000-0003-4429-9756	National Institute for Health Research (NIHR) [PB-PG-0909-20283]; NIHR [NIHR-RP-011-015]; National Institute for Health Research [PB-PG-0909-20283, NIHR-RP-011-015] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This abstract presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme (Grant Reference Number PB-PG-0909-20283) (http://www.nihr.ac.uk/funding/research-for-patient-benefit.htm). Nadine Foster is supported through a NIHR Research Professorship (NIHR-RP-011-015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyce MB, 2014, BMJ QUAL SAF, P6; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Darzi A., 2008, HIGH QUALITY CARE AL; Dawson J, 1998, J BONE JOINT SURG BR, V80B, P63, DOI 10.1302/0301-620X.80B1.7859; DELBECQ AL, 1971, J APPL BEHAV SCI, V7, P466, DOI 10.1177/002188637100700404; Devlin N., 2010, GETTING MOST OUT PRO; DONNER A, 1987, STAT MED, V6, P441, DOI 10.1002/sim.4780060404; Duncan EAS, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-96; Dunn KM, 2005, SPINE, V30, P1887, DOI 10.1097/01.brs.0000173900.46863.02; Dworkin RH, 2005, PAIN, V113, P9, DOI 10.1016/j.pain.2004.09.012; FDA, GUID IND PAT REP OUT; Greenhalgh J, 2009, QUAL LIFE RES, V18, P115, DOI 10.1007/s11136-008-9430-6; Hanley B, 2004, INVOLVING PUBLIC NHS; Harmon SC, 2007, PSYCHOTHER RES, V17, P379, DOI 10.1080/10503300600702331; Hartvigsen J, 2013, BEST PRACT RES CL RH, V27, P613, DOI 10.1016/j.berh.2013.09.008; Haywood KL, 2010, RHEUMATOLOGY EVIDENC; Health and Social Care Information Centre, 2013, HOSP EP STAT PROV MO; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Hill JC, 2008, ARTHRIT RHEUM-ARTHR, V59, P632, DOI 10.1002/art.23563; Imison C., 2011, TRANSFORMING OUR HLT; Janssen MF, 2013, QUAL LIFE RES, V22, P1717, DOI 10.1007/s11136-012-0322-4; Kamaleri Y, 2008, PAIN, V138, P41, DOI 10.1016/j.pain.2007.11.002; KAZIS LE, 1989, MED CARE, V27, pS178, DOI 10.1097/00005650-198903001-00015; LIANG MH, 1990, MED CARE, V28, P632, DOI 10.1097/00005650-199007000-00008; Mokkink L B, 2006, BMC Med Res Methodol, V6, P2, DOI 10.1186/1471-2288-6-2; Newnham EA, 2009, CLIN PSYCHOL REV, V10, P1016; Pham T, 2004, OSTEOARTHR CARTILAGE, V12, P389, DOI 10.1016/j.joca.2004.02.001; Resnik L, 2008, PHYS THER, V88, P1078, DOI 10.2522/ptj.20070327; Revicki D, 2008, J CLIN EPIDEMIOL, V61, P102, DOI 10.1016/j.jclinepi.2007.03.012; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; Shao J, 2003, STAT MED, V22, P2429, DOI 10.1002/sim.1519; Van der Wees PJ, INTEGRATING USE PATI; Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008	33	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124557	10.1371/journal.pone.0124557	http://dx.doi.org/10.1371/journal.pone.0124557			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0MA	25928807	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000353713100039
J	Kuk, H; Hutchenreuther, J; Murphy-Marshman, H; Carter, D; Leask, A				Kuk, Hanna; Hutchenreuther, James; Murphy-Marshman, Hannah; Carter, David; Leask, Andrew			5Z-7-Oxozeanol Inhibits the Effects of TGF beta 1 on Human Gingival Fibroblasts	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; GENE-EXPRESSION; TISSUE; MYOFIBROBLAST; SCLERODERMA; FIBROSIS; KINASE; CONTRACTION; INDUCTION; TAK1	Transforming growth factor (TGF)beta acts on fibroblasts to promote the production and remodeling of extracellular matrix (ECM). In adult humans, excessive action of TGF beta is associated with fibrotic disease and fibroproliferative conditions, including gingival hyperplasia. Understanding how the TGF beta 1 signals in fibroblasts is therefore likely to result in valuable insights into the fundamental mechanisms underlying fibroproliferative disorders. Previously, we used the TAK1 inhibitor (5Z)-7-Oxozeaenol to show that, in dermal fibroblasts, the non-canonical TAK1 pathway mediates the ability of TGF beta 1 to induce genes promoting tissue remodeling and repair. However, the extent to which TAK1 mediates fibroproliferative responses in fibroblasts in response to TGF beta 1 remains unclear. Herein, we show that, in gingival fibroblasts, (5Z)-7-Oxozeaenol blocks the ability of TGF beta 1 to induce expression of the pro-fibrotic mediator CCN2 (connective tissue growth factor, CTGF) and type I collagen protein. Moreover, genome-wide expression profiling revealed that, in gingival fibroblasts, (5Z)-7-Oxozeaenol reduces the ability of TGF beta 1 to induce mRNA expression of essentially all TGF beta 1-responsive genes (139/147), including those involved with a hyperproliferative response. Results from microarray analysis were confirmed using real time polymerase chain reaction analysis and a functional cell proliferation assay. Our results are consistent with the hypothesis that TAK1 inhibitors might be useful in treating fibroproliferative disorders, including that in the oral cavity.	[Kuk, Hanna; Hutchenreuther, James; Leask, Andrew] Univ Western Ontario, Dept Physiol & Pharmacol, Schulich Sch Med & Dent, London, ON N6A 5C1, Canada; [Murphy-Marshman, Hannah; Leask, Andrew] Univ Western Ontario, Dept Dent, Schulich Sch Med & Dent, London, ON N6A 5C1, Canada; [Carter, David] Robarts Res Inst, London Reg Genom Ctr, London, ON N6A 5B7, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Leask, A (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, Schulich Sch Med & Dent, London, ON N6A 5C1, Canada.	Andrew.Leask@schulich.uwo.ca	Leask, Andy/ABH-9433-2020; Leask, Andrew/G-5217-2015		Canadian Institutes for Health Research; Scleroderma Society of Ontario; JUMP program at the University of Western Ontario	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Scleroderma Society of Ontario; JUMP program at the University of Western Ontario	This work was supported by Canadian Institutes for Health Research (AL) and Scleroderma Society of Ontario (AL). HMM was funded by the JUMP program at the University of Western Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achterberg VF, 2014, J INVEST DERMATOL, V134, P1862, DOI 10.1038/jid.2014.90; Bitu CC, 2006, J CLIN PERIODONTOL, V33, P393, DOI 10.1111/j.1600-051X.2006.00928.x; Black SA, 2008, J BIOL CHEM, V283, P10835, DOI 10.1074/jbc.M710363200; Damasceno LS, 2012, BRAZ ORAL RES, V26, P373, DOI 10.1590/S1806-83242012005000012; EDDY RJ, 1988, AM J PATHOL, V130, P252; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; Grotendorst GR, 1996, CELL GROWTH DIFFER, V7, P469; Guo F, 2013, J INVEST DERMATOL, V133, P1646, DOI 10.1038/jid.2013.28; Guo F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027097; Guo F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019756; Holmes A, 2001, J BIOL CHEM, V276, P10594, DOI 10.1074/jbc.M010149200; Krieg T, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2188; Landstrom M, 2010, INT J BIOCHEM CELL B, V42, P585, DOI 10.1016/j.biocel.2009.12.023; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Leask A, 2001, J CLIN PATHOL-MOL PA, V54, P180, DOI 10.1136/mp.54.3.180; Leask A, 2011, J CELL COMMUN SIGNAL, V5, P125, DOI 10.1007/s12079-011-0122-6; Liu JQ, 2014, J CELL PHYSIOL, V229, P1121, DOI 10.1002/jcp.24630; Liu SX, 2009, ARTHRITIS RHEUM-US, V60, P2817, DOI 10.1002/art.24801; Mah W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090715; MAUVIEL A, 1993, CURR BIOL, V3, P822, DOI 10.1016/0960-9822(93)90216-B; Mauviel A, 1996, J BIOL CHEM, V271, P10917, DOI 10.1074/jbc.271.18.10917; Moodley YP, 2003, AM J RESP CELL MOL, V29, P490, DOI 10.1165/rcmb.2002-0262OC; Mu YB, 2012, CELL TISSUE RES, V347, P11, DOI 10.1007/s00441-011-1201-y; Nakerakanti SS, 2006, J BIOL CHEM, V281, P25259, DOI 10.1074/jbc.M600466200; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Piek E, 2001, J BIOL CHEM, V276, P19945, DOI 10.1074/jbc.M102382200; Safwat N, 2005, ENDOCRINOLOGY, V146, P4814, DOI 10.1210/en.2005-0457; Sampson N, 2013, ENDOCRINOLOGY, V154, P2586, DOI 10.1210/en.2012-2259; Shi-wen X, 2009, ARTHRITIS RHEUM-US, V60, P234, DOI 10.1002/art.24223; Thompson K, 2010, J DENT RES, V89, P1450, DOI 10.1177/0022034510379020; Thompson K, 2014, J CELL COMMUN SIGNAL, V8, P59, DOI 10.1007/s12079-014-0229-7; Uzel MI, 2001, J PERIODONTOL, V72, P921, DOI 10.1902/jop.2001.72.7.921; Van De Water L, 2013, ADV WOUND CARE, V2, P122, DOI 10.1089/wound.2012.0393; VANCHEESWARAN R, 1994, J RHEUMATOL, V21, P1268; Wong VW, 2012, NAT MED, V18, P148, DOI 10.1038/nm.2574; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Xu SW, 2004, J BIOL CHEM, V279, P23098, DOI 10.1074/jbc.M311430200	37	8	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0123689	10.1371/journal.pone.0123689	http://dx.doi.org/10.1371/journal.pone.0123689			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927238	gold, Green Submitted, Green Published			2022-12-27	WOS:000353713100021
J	Sarwar, A; Katas, H; Samsudin, SN; Zin, NM				Sarwar, Atif; Katas, Haliza; Samsudin, Siti Noradila; Zin, Noraziah Mohamad			Regioselective Sequential Modification of Chitosan via Azide-Alkyne Click Reaction: Synthesis, Characterization, and Antimicrobial Activity of Chitosan Derivatives and Nanoparticles	PLOS ONE			English	Article							ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; DELIVERY	Recently, the attention of researchers has been drawn toward the synthesis of chitosan derivatives and their nanoparticles with enhanced antimicrobial activities. In this study, chitosan derivatives with different azides and alkyne groups were synthesized using click chemistry, and these were further transformed into nanoparticles by using the ionotropic gelation method. A series of chitosan derivatives was successfully synthesized by regioselective modification of chitosan via an azide-alkyne click reaction. The amino moieties of chitosan were protected during derivatization by pthaloylation and subsequently unblocked at the end to restore their functionality. Nanoparticles of synthesized derivatives were fabricated by ionic gelation to form complexes of polyanionic penta-sodium tripolyphosphate (TPP) and cationic chitosan derivatives. Particle size analysis showed that nanoparticle size ranged from 181.03 +/- 12.73 nm to 236.50 +/- 14.32 nm and had narrow polydispersity index and positive surface charge. The derivatives and corresponding nanoparticles were evaluated in vitro for antibacterial and antifungal activities against three gram-positive and gram-negative bacteria and three fungal strains, respectively. The minimum inhibitory concentration (MIC) of all derivatives ranged from 31.3 to 250 mu g/mL for bacteria and 188 to1500 mu g/mL for fungi and was lower than that of native chitosan. The nanoparticles with MIC ranging from 1.56 to 25 mu g/mLfor bacteria and 94 to 750 mu g/mL for fungi exhibited higher activity than the chitosan derivatives. Chitosan O-(1-methylbenzene) triazolyl carbamateand chitosan O-(1-methyl phenyl sulfide) triazolyl carbamate were the most active against the tested bacterial and fungal strains. The hemolytic assay on erythrocytes and cell viability test on two different cell lines (Chinese hamster lung fibroblast cells V79 and Human hepatic cell line WRL68) demonstrated the safety; suggesting that these derivatives could be used in future medical applications. Chitosan derivatives with triazole functionality, synthesized by Huisgen 1,3-dipolar cycloaddition, and their nanoparticles showed significant enhancement in antibacterial and antifungal activities in comparison to those associated with native, non-altered chitosan.	[Sarwar, Atif; Katas, Haliza; Samsudin, Siti Noradila] Univ Kebangsaan Malaysia, Fac Pharm, Ctr Drug Delivery Res, Kuala Lumpur, Malaysia; [Zin, Noraziah Mohamad] Univ Kebangsaan Malaysia, Fac Hlth Sci, Novel Antibiot Res Grp, Kuala Lumpur, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Katas, H (corresponding author), Univ Kebangsaan Malaysia, Fac Pharm, Ctr Drug Delivery Res, Kuala Lumpur Campus,Jalan Raja Muda Abdul Aziz, Kuala Lumpur, Malaysia.	haliza.katas@gmail.com	Zin, Noraziah M/E-3326-2019; KATAS, HALIZA/I-6417-2016	KATAS, HALIZA/0000-0001-7249-1628; Zin, Noraziah/0000-0002-7839-1246	Ministry of Science, Technology and Innovation (MOSTI), Malaysia [02-01-02-SF0737]; Universiti Kebangsaan Malaysia	Ministry of Science, Technology and Innovation (MOSTI), Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); Universiti Kebangsaan Malaysia	The authors are thankful to the Universiti Kebangsaan Malaysia and Ministry of Science, Technology and Innovation (MOSTI), Malaysia for support and award of grant (02-01-02-SF0737).	Ahmad N, 2014, MOL PHARM; Anitha A, 2009, CARBOHYD POLYM, V78, P672, DOI 10.1016/j.carbpol.2009.05.028; Burkatovskaya M, 2006, BIOMATERIALS, V27, P4157, DOI 10.1016/j.biomaterials.2006.03.028; Calvo P, 1997, J APPL POLYM SCI, V63, P125, DOI 10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4; Choi CY, 2007, CARBOHYD POLYM, V68, P122, DOI 10.1016/j.carbpol.2006.07.018; Dash M, 2011, PROG POLYM SCI, V36, P981, DOI 10.1016/j.progpolymsci.2011.02.001; Araujo MGD, 2012, INT J MOL SCI, V13, P9260, DOI 10.3390/ijms13079260; Dedola S, 2007, ORG BIOMOL CHEM, V5, P1006, DOI 10.1039/b618048p; Demirbas N, 2004, EUR J MED CHEM, V39, P793, DOI 10.1016/j.ejmech.2004.06.007; Dhawade PP, 2012, ADV APPL SCI RES, V3, P1372; Dong YM, 2004, J APPL POLYM SCI, V93, P1553, DOI 10.1002/app.20630; El-Hefian EA, 2011, E-J CHEM, V8, P91, DOI 10.1155/2011/969062; Ezabadi RR, 2008, BIOORGAN MED CHEM, V16, P1150, DOI 10.1016/j.bmc.2007.10.082; Gao Y, 2009, BIOMACROMOLECULES, V10, P2175, DOI 10.1021/bm900341d; Holappa J, 2004, MACROMOLECULES, V37, P2784, DOI 10.1021/ma0358780; Ifuku S, 2011, CARBOHYD POLYM, V85, P653, DOI 10.1016/j.carbpol.2011.03.030; Ing LY, 2012, INT J BIOMATER, V2012, DOI 10.1155/2012/632698; Iqbal M, 2003, VACCINE, V21, P1478, DOI 10.1016/S0264-410X(02)00662-X; Jabbal-Gill I, 2012, EXPERT OPIN DRUG DEL, V9, P1051, DOI 10.1517/17425247.2012.697455; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X; Kong M, 2010, INT J FOOD MICROBIOL, V144, P51, DOI 10.1016/j.ijfoodmicro.2010.09.012; Kulbokaite R, 2009, REACT FUNCT POLYM, V69, P771, DOI 10.1016/j.reactfunctpolym.2009.06.010; Kurita K, 2002, BIOMACROMOLECULES, V3, P1, DOI 10.1021/bm0101163; Li XF, 2008, IRAN POLYM J, V17, P843; Liao SK, 2004, MACROMOL RES, V12, P466, DOI 10.1007/BF03218428; Liu N, 2006, CARBOHYD POLYM, V64, P60, DOI 10.1016/j.carbpol.2005.10.028; Moon MS, 2006, FASEB J, V20, pA1017; Mourya VK, 2008, REACT FUNCT POLYM, V68, P1013, DOI 10.1016/j.reactfunctpolym.2008.03.002; Munoz-Bonilla A, 2012, PROG POLYM SCI, V37, P281, DOI 10.1016/j.progpolymsci.2011.08.005; No HK, 2002, INT J FOOD MICROBIOL, V74, P65, DOI 10.1016/S0168-1605(01)00717-6; Oh JK, 2009, PROG POLYM SCI, V34, P1261, DOI 10.1016/j.progpolymsci.2009.08.001; Oliveira JR, 2012, CARBOHYD POLYM, V87, P240, DOI 10.1016/j.carbpol.2011.07.043; Petrikkou E, 2001, J CLIN MICROBIOL, V39, P1345, DOI 10.1128/JCM.39.4.1345-1347.2001; Qi LF, 2006, BIOORG MED CHEM LETT, V16, P4243, DOI 10.1016/j.bmcl.2006.05.078; Ramdas M, 1999, J BIOMATER APPL, V13, P290, DOI 10.1177/088532829901300402; Sajomsang W, 2009, INT J BIOL MACROMOL, V44, P419, DOI 10.1016/j.ijbiomac.2009.03.003; Sarwar A, 2014, J NANOPART RES, V16, DOI 10.1007/s11051-014-2517-9; Senel S, 2000, BIOMATERIALS, V21, P2067, DOI 10.1016/S0142-9612(00)00134-4; Shalini K, 2011, BEILSTEIN J ORG CHEM, V7, P668, DOI 10.3762/bjoc.7.79; Socrates G., 2004, INFRARED RAMAN CHARA; Sovadinova I, 2011, POLYMERS-BASEL, V3, P1512, DOI 10.3390/polym3031512; Tang H, 2010, ACTA BIOMATER, V6, P2562, DOI 10.1016/j.actbio.2010.01.002; Tillman J, 2006, BIOMATERIALS, V27, P5618, DOI 10.1016/j.biomaterials.2006.07.006; Wang JF, 2012, CHEM COMMUN, V48, P916, DOI 10.1039/c1cc16432e; Zampano G, 2010, REACT FUNCT POLYM, V70, P272, DOI 10.1016/j.reactfunctpolym.2010.01.004; Zhang C, 2006, J AGR FOOD CHEM, V54, P8409, DOI 10.1021/jf061541w; Zhong ZM, 2007, CARBOHYD RES, V342, P2390, DOI 10.1016/j.carres.2007.07.015	47	65	66	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0123084	10.1371/journal.pone.0123084	http://dx.doi.org/10.1371/journal.pone.0123084			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928293	Green Published, gold, Green Submitted			2022-12-27	WOS:000353713100013
J	Shaw, K; Baart, M; Depowski, N; Bortfeld, H				Shaw, Kathleen; Baart, Martijn; Depowski, Nicole; Bortfeld, Heather			Infants' Preference for Native Audiovisual Speech Dissociated from Congruency Preference	PLOS ONE			English	Article							PHONETIC INFORMATION; VISUAL SPEECH; INTERSENSORY PERCEPTION; 1ST YEAR; FACE; INTEGRATION; DISCRIMINATION; SYNCHRONY; ATTENTION; ADULTS	Although infant speech perception in often studied in isolated modalities, infants' experience with speech is largely multimodal (i.e., speech sounds they hear are accompanied by articulating faces). Across two experiments, we tested infants' sensitivity to the relationship between the auditory and visual components of audiovisual speech in their native (English) and non-native (Spanish) language. In Experiment 1, infants' looking times were measured during a preferential looking task in which they saw two simultaneous visual speech streams articulating a story, one in English and the other in Spanish, while they heard either the English or the Spanish version of the story. In Experiment 2, looking times from another group of infants were measured as they watched single displays of congruent and incongruent combinations of English and Spanish audio and visual speech streams. Findings demonstrated an age-related increase in looking towards the native relative to non-native visual speech stream when accompanied by the corresponding (native) auditory speech. This increase in native language preference did not appear to be driven by a difference in preference for native vs. non-native audiovisual congruence as we observed no difference in looking times at the audiovisual streams in Experiment 2.	[Shaw, Kathleen; Depowski, Nicole; Bortfeld, Heather] Univ Connecticut, Dept Psychol, Storrs, CT 06269 USA; [Baart, Martijn] BCBL, Basque Ctr Cognit Brain & Language, Donostia San Sebastian, Spain; [Bortfeld, Heather] Haskins Labs Inc, New Haven, CT USA	University of Connecticut; Yale University; Haskins Laboratories	Bortfeld, H (corresponding author), Univ Connecticut, Dept Psychol, Storrs, CT 06269 USA.	heather.bortfeld@uconn.edu	Baart, Martijn/L-2910-2013; Bortfeld, Heather/AAK-8553-2020	Baart, Martijn/0000-0002-5015-4265; Bortfeld, Heather/0000-0002-3545-5449; Basque Center on Cognition, Brain and Language, BCBL./0000-0002-8345-6892	National Institutes of Health [R01 DC010075]; National Science Foundation IGERT Grant [1144399]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010075] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation IGERT Grant; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by National Institutes of Health Grant R01 DC010075 (http://grants.nih.gov/grants/funding/r01.htm) to HB. KS was supported by a National Science Foundation IGERT Grant (1144399, http://www.igert.org/) to the University of Connecticut. The funders had no role in	Baart M, 2015, J EXP CHILD PSYCHOL, V129, P157, DOI 10.1016/j.jecp.2014.08.002; Baart M, 2014, COGNITION, V130, P31, DOI 10.1016/j.cognition.2013.09.006; BAHRICK LE, 1987, INFANT BEHAV DEV, V10, P387, DOI 10.1016/0163-6383(87)90039-7; Best CT, 2001, J ACOUST SOC AM, V109, P775, DOI 10.1121/1.1332378; Best CT, 2011, INT C AUD VIS SPEECH; Bristow D, 2009, J COGNITIVE NEUROSCI, V21, P905, DOI 10.1162/jocn.2009.21076; Desjardins RN, 2004, DEV PSYCHOBIOL, V45, P187, DOI 10.1002/dev.20033; Desjardins RN, 1997, J EXP CHILD PSYCHOL, V66, P85, DOI 10.1006/jecp.1997.2379; DODD B, 1979, COGNITIVE PSYCHOL, V11, P478, DOI 10.1016/0010-0285(79)90021-5; EIMAS PD, 1971, SCIENCE, V171, P303, DOI 10.1126/science.171.3968.303; Gogate LJ, 1998, J EXP CHILD PSYCHOL, V69, P133, DOI 10.1006/jecp.1998.2438; Kubicek C, 2014, INFANT BEHAV DEV, V37, P644, DOI 10.1016/j.infbeh.2014.08.010; Kubicek C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089275; Kubicek C, 2013, INT J BEHAV DEV, V37, P106, DOI 10.1177/0165025412473016; KUHL PK, 1982, SCIENCE, V218, P1138, DOI 10.1126/science.7146899; KUHL PK, 1992, SCIENCE, V255, P606, DOI 10.1126/science.1736364; Kushnerenko E, 2008, P NATL ACAD SCI USA, V105, P11442, DOI 10.1073/pnas.0804275105; Kushnerenko E, 2013, EUR J NEUROSCI, V38, P3363, DOI 10.1111/ejn.12317; LAWSON KR, 1980, DEV PSYCHOL, V16, P185, DOI 10.1037/0012-1649.16.3.185; Lewkowicz DJ, 2013, INT J BEHAV DEV, V37, P90, DOI 10.1177/0165025412467582; Lewkowicz DJ, 2012, P NATL ACAD SCI USA, V109, P1431, DOI 10.1073/pnas.1114783109; Lewkowicz DJ, 2010, DEV PSYCHOL, V46, P66, DOI 10.1037/a0015579; Lewkowicz DJ, 1996, J EXP PSYCHOL HUMAN, V22, P1094, DOI 10.1037/0096-1523.22.5.1094; Lewkowicz DJ, 2006, P NATL ACAD SCI USA, V103, P6771, DOI 10.1073/pnas.0602027103; Maidment DW, 2014, J SPEECH LANG HEAR R; Morein-Zamir S, 2003, COGNITIVE BRAIN RES, V17, P154, DOI 10.1016/S0926-6410(03)00089-2; Palmer SB, 2012, CHILD DEV, V83, P543, DOI 10.1111/j.1467-8624.2011.01715.x; Parise CV, 2012, CURR BIOL, V22, P46, DOI 10.1016/j.cub.2011.11.039; Patterson ML, 2003, DEVELOPMENTAL SCI, V6, P191, DOI 10.1111/1467-7687.00271; Patterson ML, 2002, J EXP CHILD PSYCHOL, V81, P93, DOI 10.1006/jecp.2001.2644; Patterson ML, 1999, INFANT BEHAV DEV, V22, P237, DOI 10.1016/S0163-6383(99)00003-X; Pons F, 2009, P NATL ACAD SCI USA, V106, P10598, DOI 10.1073/pnas.0904134106; Stein BE., 1993, MERGING SENSES; Teinonen T, 2008, COGNITION, V108, P850, DOI 10.1016/j.cognition.2008.05.009; Tomalski P, 2013, EUR J DEV PSYCHOL, V10, P611, DOI 10.1080/17405629.2012.728076; van Wassenhove V, 2007, NEUROPSYCHOLOGIA, V45, P598, DOI 10.1016/j.neuropsychologia.2006.01.001; Vouloumanos A, 2010, CHILD DEV, V81, P517, DOI 10.1111/j.1467-8624.2009.01412.x; Vroomen J, 2004, COGNITIVE BRAIN RES, V22, P32, DOI 10.1016/j.cogbrainres.2004.07.003; Weikum WM, 2007, SCIENCE, V316, P1159, DOI 10.1126/science.1137686; WERKER JF, 1984, INFANT BEHAV DEV, V7, P49, DOI 10.1016/S0163-6383(84)80022-3	40	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0126059	10.1371/journal.pone.0126059	http://dx.doi.org/10.1371/journal.pone.0126059			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0MA	25927529	gold, Green Published			2022-12-27	WOS:000353713100124
J	Subramaniam, KS; Skinner, J; Ivan, E; Mutimura, E; Kim, RS; Feintuch, CM; Portugal, S; Anastos, K; Crompton, PD; Daily, JP				Subramaniam, Krishanthi S.; Skinner, Jeff; Ivan, Emil; Mutimura, Eugene; Kim, Ryung S.; Feintuch, Catherine M.; Portugal, Silvia; Anastos, Kathryn; Crompton, Peter D.; Daily, Johanna P.			HIV Malaria Co-Infection Is Associated with Atypical Memory B Cell Expansion and a Reduced Antibody Response to a Broad Array of Plasmodium falciparum Antigens in Rwandan Adults	PLOS ONE			English	Article							COTRIMOXAZOLE PROPHYLAXIS; IMMUNE-RESPONSES; UNSTABLE MALARIA; PREGNANT-WOMEN; INFECTION; IMMUNOSUPPRESSION; INDIVIDUALS; PROTECTION; IMMUNODEFICIENCY; THROMBOCYTOPENIA	HIV infected individuals in malaria endemic areas experience more frequent and severe malaria episodes compared to non HIV infected. This clinical observation has been linked to a deficiency in antibody responses to Plasmodium falciparum antigens; however, prior studies have only focused on the antibody response to <0.5% of P. falciparum proteins. To obtain a broader and less-biased view of the effect of HIV on antibody responses to malaria we compared antibody profiles of HIV positive (HIV+) and negative (HIV-) Rwandan adults with symptomatic malaria using a microarray containing 824 P. falciparum proteins. We also investigated the cellular basis of the antibody response in the two groups by analyzing B and T cell subsets by flow cytometry. Although HIV malaria co-infected individuals generated antibodies to a large number of P. falciparum antigens, including potential vaccine candidates, the breadth and magnitude of their response was reduced compared to HIV-individuals. HIV malaria co-infection was also associated with a higher percentage of atypical memory B cells (MBC) (CD19+CD10-CD21-CD27-) compared to malaria infection alone. Among HIV+ individuals the CD4(+) T cell count and HIV viral load only partially explained variability in the breadth of P. falciparum-specific antibody responses. Taken together, these data indicate that HIV malaria co-infection is associated with an expansion of atypical MBCs and a diminished antibody response to a diverse array of P. falciparum antigens, thus offering mechanistic insight into the higher risk of malaria in HIV+ individuals.	[Subramaniam, Krishanthi S.] Univ Liverpool, Liverpool Sch Trop Med, Vector Biol Dept, Liverpool L3 5QA, Merseyside, England; [Skinner, Jeff; Portugal, Silvia; Crompton, Peter D.] NIAID, Malaria Infect Biol & Immun Unit, Immunogenet Lab, NIH, Bethesda, MD 20892 USA; [Ivan, Emil] Univ Rwanda, Dept Biomed Lab Sci, Coll Med & Hlth Sci, Kigali, Rwanda; [Mutimura, Eugene] Reg Alliance Sustainable Dev, Kigali, Rwanda; [Kim, Ryung S.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Feintuch, Catherine M.; Daily, Johanna P.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Anastos, Kathryn; Daily, Johanna P.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA	Liverpool School of Tropical Medicine; University of Liverpool; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Rwanda; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Daily, JP (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA.	jdaily@einstein.yu.edu	Crompton, Peter/N-1130-2016; Subramaniam, Krishanthi/AAW-8777-2021	Subramaniam, Krishanthi/0000-0002-1734-9351; Portugal, Silvia/0000-0003-4567-9101; Skinner, Jeff/0000-0001-5697-0442	Albert Einstein College of Medicine Global Health Pilot Grant; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health;  [NIAID: 1RC1AI086224]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI070117, RC1AI086224, ZIAAI001155] Funding Source: NIH RePORTER	Albert Einstein College of Medicine Global Health Pilot Grant; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by A. JPD supported by NIAID: 1RC1AI086224 and an Albert Einstein College of Medicine Global Health Pilot Grant. B. JS, SP and PDC are supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asito AS, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-238; Ataide R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022491; Beeson JG, 2008, TRENDS PARASITOL, V24, P578, DOI 10.1016/j.pt.2008.08.008; Brahimi K, 2001, INFECT IMMUN, V69, P3845, DOI 10.1128/IAI.69.6.3845-3952.2001; Campbell JD, 2012, CLIN INFECT DIS, V54, P1204, DOI 10.1093/cid/cis013; Cavanagh DR, 1998, J IMMUNOL, V161, P347; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Courtin D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007590; Crompton PD, 2010, P NATL ACAD SCI USA, V107, P6958, DOI 10.1073/pnas.1001323107; Denoeud-Ndam L, 2014, JAIDS-J ACQ IMM DEF, V65, P198, DOI 10.1097/QAI.0000000000000058; Doolan DL, 2008, PROTEOMICS, V8, P4680, DOI 10.1002/pmic.200800194; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; French N, 2001, AIDS, V15, P899, DOI 10.1097/00002030-200105040-00010; Gonzalez R, 2012, EXPERT REV ANTI-INFE, V10, P153, DOI [10.1586/ERI.11.167, 10.1586/eri.11.167]; GRAU GE, 1988, IMMUNOLOGY, V65, P501; Grimwade K, 2004, AIDS, V18, P547, DOI 10.1097/00002030-200402200-00023; Hasang W, 2014, J INFECT DIS, V210, P1407, DOI 10.1093/infdis/jiu262; Hendriksen ICE, 2012, CLIN INFECT DIS, V55, P1144, DOI 10.1093/cid/cis590; Hobbs CV, 2012, J INFECT DIS, V206, P1706, DOI 10.1093/infdis/jis602; Illingworth J, 2013, J IMMUNOL, V190, P1038, DOI 10.4049/jimmunol.1202438; Iroezindu Michael O, 2012, Niger J Med, V21, P209; Kamya MR, 2006, J INFECT DIS, V193, P9, DOI 10.1086/498577; Kardava L, 2014, J CLIN INVEST, V124, P3252, DOI 10.1172/JCI74351; Karema C, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-236; Khan Shiraz Jamal, 2012, Malar Res Treat, V2012, P405981, DOI 10.1155/2012/405981; Khosravi A, 2011, PARASITE IMMUNOL, V33, P145, DOI 10.1111/j.1365-3024.2010.01260.x; Klement E, 2014, CLIN INFECT DIS, V58, P651, DOI 10.1093/cid/cit806; Laufer MK, 2006, J INFECT DIS, V193, P872, DOI 10.1086/500245; LOOAREESUWAN S, 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P44; Malaspina A, 2006, P NATL ACAD SCI USA, V103, P2262, DOI 10.1073/pnas.0511094103; MIEDEMA F, 1988, J CLIN INVEST, V82, P1908, DOI 10.1172/JCI113809; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Moir S, 2013, IMMUNOL REV, V254, P207, DOI 10.1111/imr.12067; Mount AM, 2004, LANCET, V363, P1860, DOI 10.1016/S0140-6736(04)16354-X; Muellenbeck MF, 2013, J EXP MED, V210, P389, DOI 10.1084/jem.20121970; Muema DKM, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-55; Omoti CE, 2013, ASIAN PAC J TROP MED, V6, P126, DOI 10.1016/S1995-7645(13)60007-3; Osier FH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008705; Osier FHA, 2008, INFECT IMMUN, V76, P2240, DOI 10.1128/IAI.01585-07; Portugal S, 2013, J IMMUNOL, V190, P3039, DOI 10.4049/jimmunol.1203067; Puentes A, 2005, BIOCHIMIE, V87, P461, DOI 10.1016/j.biochi.2005.01.001; R Core Team, 2021, R LANGUAGE ENV STAT; Richards JS, 2010, CLIN INFECT DIS, V51, pE50, DOI 10.1086/656413; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; Sboner A, 2009, J PROTEOME RES, V8, P5451, DOI 10.1021/pr900412k; Sim BKL, 2001, MOL MED, V7, P247, DOI 10.1007/BF03401844; Subramaniam K, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu066; Tarlinton D, 2013, SCIENCE, V341, P1205, DOI 10.1126/science.1241146; Tatfeng Y. M., 2007, Journal of Vector Borne Diseases, V44, P111; Van Geertruyden JP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-258; Van Geertruyden JP, 2009, JAIDS-J ACQ IMM DEF, V50, P200, DOI 10.1097/QAI.0b013e3181900159; Weiss GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015983; Weiss GE, 2009, J IMMUNOL, V183, P2176, DOI 10.4049/jimmunol.0901297; Whitworth J, 2000, LANCET, V356, P1051, DOI 10.1016/S0140-6736(00)02727-6; WHO, 2010, GUID TREATM MAL, V2nd; Yamaguchi S, 1997, AM J HEMATOL, V56, P183, DOI 10.1002/(SICI)1096-8652(199711)56:3&lt;183::AID-AJH9&gt;3.0.CO;2-U	56	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124412	10.1371/journal.pone.0124412	http://dx.doi.org/10.1371/journal.pone.0124412			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928218	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000353713100032
J	Tedford, SE; Persons, AL; Napier, TC				Tedford, Stephanie E.; Persons, Amanda L.; Napier, T. Celeste			Dopaminergic Lesions of the Dorsolateral Striatum in Rats Increase Delay Discounting in an Impulsive Choice Task	PLOS ONE			English	Article							INTRACRANIAL SELF-STIMULATION; PARKINSONS-DISEASE; INTERNAL CLOCK; REINFORCEMENT; TIME; PERFORMANCE; REWARD; APATHY; MECHANISMS; ATTENTION	Dysregulated dopamine transmission in striatal circuitry is associated with impulsivity. The current study evaluated the influence of dopaminergic inputs to the dorsolateral striatum on impulsive choice, one aspect of impulsive behavior. We implemented an operant task that measures impulsive choice in rats via delay discounting wherein intracranial self-stimulation (ICSS) was used as the positive reinforcer. To do so, rats were anesthetized to allow implanting of a stimulating electrode within the lateral hypothalamus of one hemisphere and bilateral dorsal striatal injections of the dopaminergic toxin, 6-OHDA (lesioned) or its vehicle (sham). Following recovery, rats were trained in a delay discounting task wherein they selected between a small ICSS current presented immediately after lever pressing, and a large ICSS current presented following a 0 to 15s delay upon pressing the alternate lever. Task acquisition and reinforcer discrimination were similar for lesioned and sham rats. All rats exhibited an initial preference for the large reinforcer, and as the delay was increased, preference for the large reinforcer was decreased indicating that the subjective value of the large reinforcer was discounted as a function of delay time. However, this discounting effect was significantly enhanced in lesioned rats for the longer delays. These data reveal a contribution of dopaminergic inputs to the dorsolateral striatum on impulsive choice behavior, and provide new insights into neural substrates underlying discounting behaviors.	[Tedford, Stephanie E.; Persons, Amanda L.; Napier, T. Celeste] Rush Univ, Dept Pharmacol, Chicago, IL 60612 USA; [Napier, T. Celeste] Rush Univ, Dept Psychiat, Chicago, IL 60612 USA; [Tedford, Stephanie E.; Persons, Amanda L.; Napier, T. Celeste] Rush Univ, Ctr Compuls Behav & Addict, Chicago, IL 60612 USA	Rush University; Rush University; Rush University	Tedford, SE (corresponding author), Rush Univ, Dept Pharmacol, Chicago, IL 60612 USA.	Stephanie_E_Tedford@rush.edu			Michael J. Fox Foundation; United States Public Health Service Guidelines [NS074014, DA033121]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS074014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA033121] Funding Source: NIH RePORTER	Michael J. Fox Foundation; United States Public Health Service Guidelines; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Michael J. Fox Foundation (www.michaeljfox.org), and United States Public Health Service Guidelines #NS074014 and #DA033121. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi SM, 2003, BEHAV PROCESS, V64, P345, DOI 10.1016/S0376-6357(03)00150-5; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Barkley RA, 2001, J ABNORM CHILD PSYCH, V29, P541, DOI 10.1023/A:1012233310098; Beitz Janice M, 2014, Front Biosci (Schol Ed), V6, P65; Bickel WK, 2014, NEUROPHARMACOLOGY, V76, P518, DOI 10.1016/j.neuropharm.2013.06.013; Bickel WK, 2012, PHARMACOL THERAPEUT, V134, P287, DOI 10.1016/j.pharmthera.2012.02.004; Bickel WK, 1999, PSYCHOPHARMACOLOGY, V146, P447, DOI 10.1007/PL00005490; BLACK J, 1985, BRAIN RES, V359, P113, DOI 10.1016/0006-8993(85)91418-0; Buckholtz JW, 2010, SCIENCE, V329, P532, DOI 10.1126/science.1185778; Cardinal RN, 2000, PSYCHOPHARMACOLOGY, V152, P362, DOI 10.1007/s002130000536; Cardinal RN, 2006, NEURAL NETWORKS, V19, P1277, DOI 10.1016/j.neunet.2006.03.004; Decamp E, 2004, EUR J NEUROSCI, V20, P1371, DOI 10.1111/j.1460-9568.2004.03586.x; Drew MR, 2003, PHARMACOL BIOCHEM BE, V75, P9, DOI 10.1016/S0091-3057(03)00036-4; Dunnett SB, 2012, BRAIN RES BULL, V88, P251, DOI 10.1016/j.brainresbull.2011.04.002; FALK JL, 1961, J EXP ANAL BEHAV, V4, P213, DOI 10.1901/jeab.1961.4-213; Favier M, 2014, MOVEMENT DISORD, V29, P912, DOI 10.1002/mds.25837; Floresco SB, 2008, NEUROPSYCHOPHARMACOL, V33, P1966, DOI 10.1038/sj.npp.1301565; Fouriezos G, 1997, BEHAV BRAIN RES, V87, P111, DOI 10.1016/S0166-4328(97)02280-8; GIBSON WE, 1965, SCIENCE, V148, P1357, DOI 10.1126/science.148.3675.1357; Gregorios-Pippas L, 2009, J NEUROPHYSIOL, V101, P1507, DOI 10.1152/jn.90730.2008; Hariri AR, 2006, J NEUROSCI, V26, P13213, DOI 10.1523/JNEUROSCI.3446-06.2006; Harrington DL, 1998, J NEUROSCI, V18, P1085; Heilbronner SR, 2014, BEHAV PROCESS, V101, P123, DOI 10.1016/j.beproc.2013.09.013; Hong SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057831; Isella V, 2002, MOVEMENT DISORD, V17, P366, DOI 10.1002/mds.10041; Kayser AS, 2012, J NEUROSCI, V32, P9402, DOI 10.1523/JNEUROSCI.1180-12.2012; Koffarnus MN, 2011, BEHAV PHARMACOL, V22, P300, DOI 10.1097/FBP.0b013e3283473bcb; Lange KW, 1995, J NEURAL TRANSM-SUPP, P423; LINDHOLM EP, 1970, J COMP PHYSIOL PSYCH, V72, P318, DOI 10.1037/h0029462; MacDonald CJ, 2005, PSYCHOPHARMACOLOGY, V182, P232, DOI 10.1007/s00213-005-0074-8; Madden GJ, 2007, J GAMBL STUD, V23, P63, DOI 10.1007/s10899-006-9041-5; MALAPANI C, 1994, NEUROLOGY, V44, P319, DOI 10.1212/WNL.44.2.319; Mata R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039135; Matell MS, 2006, PSYCHOPHARMACOLOGY, V188, P201, DOI 10.1007/s00213-006-0489-x; Matell MS, 2004, BEHAV NEUROSCI, V118, P150, DOI 10.1037/0735-7044.118.1.150; McHugh MJ, 2013, AM J DRUG ALCOHOL AB, V39, P424, DOI 10.3109/00952990.2013.847446; Meck WH, 2006, BRAIN RES, V1109, P93, DOI 10.1016/j.brainres.2006.06.031; Meck WH, 2002, BRAIN COGNITION, V48, P195, DOI 10.1006/brcg.2001.1313; Minamimoto T, 2009, J NEUROPHYSIOL, V101, P437, DOI 10.1152/jn.90959.2008; Nenadic I, 2003, EXP BRAIN RES, V148, P238, DOI 10.1007/s00221-002-1188-4; OBoyle DJ, 1996, BRAIN, V119, P51, DOI 10.1093/brain/119.1.51; PASTOR MA, 1992, BRAIN, V115, P211, DOI 10.1093/brain/115.1.211; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Peters J, 2011, TRENDS COGN SCI, V15, P227, DOI 10.1016/j.tics.2011.03.002; Petry NM, 2001, J ABNORM PSYCHOL, V110, P482, DOI 10.1037/0021-843X.110.3.482; Raffard S, 2013, PSYCHIAT RES, V209, P393, DOI 10.1016/j.psychres.2013.04.016; Reynolds B, 2006, BEHAV PHARMACOL, V17, P651, DOI 10.1097/FBP.0b013e3280115f99; Rokosik SL, 2012, NEUROPSYCHOPHARMACOL, V37, P1397, DOI 10.1038/npp.2011.325; Rokosik SL, 2011, J NEUROSCI METH, V198, P260, DOI 10.1016/j.jneumeth.2011.04.025; Schuck-Paim C, 2004, PLOS BIOL, V2, P2305, DOI 10.1371/journal.pbio.0020402; Setlow B, 2009, BEHAV PHARMACOL, V20, P380, DOI 10.1097/FBP.0b013e3283305eb4; Sinha N, 2013, J NEUROPSYCHOL, V7, P255, DOI 10.1111/jnp.12013; SPIES G, 1965, J COMP PHYSIOL PSYCH, V60, P153, DOI 10.1037/h0022367; Tedford SE, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00215; Wearden JH, 2009, Q J EXP PSYCHOL, V62, P33, DOI 10.1080/17470210802229047; Wittmann M, 2007, EXP BRAIN RES, V179, P643, DOI 10.1007/s00221-006-0822-y; Yin HH, 2006, BEHAV BRAIN RES, V166, P189, DOI 10.1016/j.bbr.2005.07.012; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x	58	36	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0122063	10.1371/journal.pone.0122063	http://dx.doi.org/10.1371/journal.pone.0122063			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927685	Green Published, gold, Green Submitted			2022-12-27	WOS:000353713100006
J	Wang, TT; Zhao, L; Guo, YL; Zhang, MZ; Pei, HT				Wang, Tingting; Zhao, Li; Guo, Yunliang; Zhang, Meizeng; Pei, Haitao			Picroside II Inhibits Neuronal Apoptosis and Improves the Morphology and Structure of Brain Tissue following Cerebral Ischemic Injury in Rats	PLOS ONE			English	Article							ISCHEMIA/REPERFUSION INJURY; ARTERY OCCLUSION; CELL-DEATH; MODEL; ACTIVATION; EXPRESSION; PROTEIN	This paper aimed to explore the protective effects of picroside II against the neuronal apoptosis and changes in morphology and structure that follow cerebral ischemic injury in rats. A focal cerebral ischemic model was established by inserting a monofilament thread to achieve middle cerebral artery occlusion (MCAO) in 60 Wistar rats, and intraperitoneal injections of picroside II (20 mg/kg) were administered. The neurobehavioral functions were evaluated with the modified neurological severity score (mNSS) test. The cerebral infarct volumes were measured with tetrazolium chloride (TTC) staining. The morphology and ultrastructure of the cortical brain tissues were observed with hematoxylin-eosin staining and transmission electron microscopy, respectively. The apoptotic cells were counted with terminal deoxynucleotidyl transferase dUTP nick-end labeling and flow cytometry, and pERK1/2 expression was determined by immunohistochemical assay and Western blot. The results indicated that neurological behavioral malfunctions and cerebral infarcts were present in the MCAO rats. In the model group, the damage to the structures of the neurons and the blood brain barrier (BBB) in the cortex was more severe, and the numbers of apoptotic cells, the early apoptotic ratio (EAR) and pERK1/2 expression were significantly increased in this group compared to the control group (P<0.05). In the treatment group, the neurological behavioral function and the morphology and ultrastructure of the neurons and the BBB were improved including the number of Mi increased and relative area of condensed chromosome and basement (BM) thickness descreased, and the cerebral infarct volume, the number of apoptotic cells, the EAR and pERK1/2 expression were significantly decreased compared to the model group (P<0.05). These results suggest that picroside II reduced apoptosis and improved the morphology and ultrastructure of the neurons and the BBB and that these effects resulted in the recovery of the neurobehavioral function of rats with cerebral ischemia.	[Wang, Tingting; Zhao, Li; Guo, Yunliang; Zhang, Meizeng; Pei, Haitao] Qingdao Univ, Shandong Prov Collaborat Innovat Ctr Neurodegener, Taishan Scholars Construct Project Excellent Inno, Inst Cerebrovasc Dis,Affiliated Hosp, Qingdao 266003, Peoples R China	Qingdao University	Guo, YL (corresponding author), Qingdao Univ, Shandong Prov Collaborat Innovat Ctr Neurodegener, Taishan Scholars Construct Project Excellent Inno, Inst Cerebrovasc Dis,Affiliated Hosp, Qingdao 266003, Peoples R China.	guoqdsd@163.com	wang, tingting/AAK-2640-2020		 [81274116];  [81041092]	; 	This experiment was supported by grant-in-aids for the Natural Science Fund of China (81274116, 81041092). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], INT J MOL SCI; Bhat NR, 1999, J NEUROCHEM, V72, P112, DOI 10.1046/j.1471-4159.1999.0720112.x; Broughton BRS, 2009, STROKE, V40, pE331, DOI 10.1161/STROKEAHA.108.531632; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Deng XH, 2013, BRAIN RES BULL, V94, P56, DOI 10.1016/j.brainresbull.2013.02.007; Fadeel B, 2005, J INTERN MED, V258, P479, DOI 10.1111/j.1365-2796.2005.01570.x; Guo YL, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-43; Jin H, 2006, TOXICOL SCI, V90, P221, DOI 10.1093/toxsci/kfj066; Kim R, 2006, J PATHOL, V208, P319, DOI 10.1002/path.1885; Kovalska M, 2006, TOXICOL SCI, V90, P221; Li Q, 2012, CHINESE PHARMACOL B, V26, P342; Li Q, 2010, INT J MOL SCI, V11, P4580, DOI 10.3390/ijms11114580; Li XA, 2010, NEURAL REGEN RES, V5, P1403, DOI 10.3969/j.issn.1673-5374.2010.18.007; Li Zhen, 2010, Zhongguo Yaolixue Tongbao, V26, P52; Lobner D, 2004, NEUROCHEM RES, V29, P2303, DOI 10.1007/s11064-004-7040-4; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; NAGASAWA H, 1989, STROKE, V20, P1037, DOI 10.1161/01.STR.20.8.1037; Namura S, 2001, P NATL ACAD SCI USA, V98, P11569, DOI 10.1073/pnas.181213498; Subramaniam S, 2004, J CELL BIOL, V165, P357, DOI 10.1083/jcb.200403028; Sun L, 2011, NEURAL REGEN RES, V6, P1141, DOI 10.3969/j.issn.1673-5374.2011.15.004; Zhao Li, 2014, Chinese Pharmacological Bulletin, V30, P192, DOI 10.3969/j.issn.1001-1978.2014.02.011; Zhao L, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-25	22	9	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124099	10.1371/journal.pone.0124099	http://dx.doi.org/10.1371/journal.pone.0124099			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927985	Green Submitted, gold, Green Published			2022-12-27	WOS:000353713100029
J	Masood, M; Sheiham, A; Bernabe, E				Masood, Mohd; Sheiham, Aubrey; Bernabe, Eduardo			Household Expenditure for Dental Care in Low and Middle Income Countries	PLOS ONE			English	Article							CATASTROPHIC HEALTH EXPENDITURE; GLOBAL BURDEN; PERIODONTITIS; INEQUALITY	This study assessed the extent of household catastrophic expenditure in dental health care and its possible determinants in 41 low and middle income countries. Data from 182,007 respondents aged 18 years and over (69,315 in 18 low income countries, 59,645 in 15 lower middle income countries and 53,047 in 8 upper middle income countries) who participated in the WHO World Health Survey (WHS) were analyzed. Expenditure in dental health care was defined as catastrophic if it was equal to or higher than 40% of the household capacity to pay. A number of individual and country-level factors were assessed as potential determinants of catastrophic dental health expenditure (CDHE) in multilevel logistic regression with individuals nested within countries. Up to 7% of households in low and middle income countries faced CDHE in the last 4 weeks. This proportion rose up to 35% among households that incurred some dental health expenditure within the same period. The multilevel model showed that wealthier, urban and larger households and more economically developed countries had higher odds of facing CDHE. The results of this study show that payments for dental health care can be a considerable burden on households, to the extent of preventing expenditure on basic necessities. They also help characterize households more likely to incur catastrophic expenditure on dental health care. Alternative health care financing strategies and policies targeted to improve fairness in financial contribution are urgently required in low and middle income countries.	[Masood, Mohd] Univ Teknol MARA, Fac Dent, Ctr Populat Oral Hlth & Clin Prevent Studies, Shah Alam, Malaysia; [Sheiham, Aubrey] UCL, Dept Epidemiol & Publ Hlth, London, England; [Bernabe, Eduardo] Kings Coll London, Kings Coll London Dent Inst Guys, Div Populat & Patient Hlth, London WC2R 2LS, England; [Bernabe, Eduardo] St Thomas Hosp, London, England	Universiti Teknologi MARA; University of London; University College London; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	Sheiham, A (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London, England.	a.sheiham@ucl.ac.uk	Bernabe, Eduardo/R-3441-2017	Bernabe, Eduardo/0000-0002-1858-3713; Masood, Mohd/0000-0001-8902-0654				Baelum V, 2007, J ORAL REHABIL, V34, P872, DOI 10.1111/j.1365-2842.2007.01799.x; Bernabe E, 2015, J DENT RES; Bhandari B, 2015, J PUBLIC HEALTH DENT, V75, P58, DOI 10.1111/jphd.12071; Bredenkamp C, 2011, HEALTH POLICY PLANN, V26, P349, DOI 10.1093/heapol/czq070; Cai TJ, 2013, SOCIOL METHODOL, V43, P178, DOI 10.1177/0081175012460221; Carle AC, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-49; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Filmer D, 2012, DEMOGRAPHY, V49, P359, DOI 10.1007/s13524-011-0077-5; Kassebaum NJ, 2014, J DENT RES, V93, P1045, DOI 10.1177/0022034514552491; Kassebaum NJ, 2014, J DENT RES, V93, P20, DOI 10.1177/0022034514537828; Kavosi Z, 2012, HEALTH POLICY PLANN, V27, P613, DOI 10.1093/heapol/czs001; Kutzin J, 2013, B WORLD HEALTH ORGAN, V91, P602, DOI 10.2471/BLT.12.113985; Lavado RF, 2013, B WORLD HEALTH ORGAN, V91, P519, DOI 10.2471/BLT.12.115535; Lu CL, 2009, B WORLD HEALTH ORGAN, V87, P238, DOI 10.2471/BLT.08.054379; Knaul FM, 2011, SALUD PUBLICA MEXICO, V53, pS85; McIntyre D, 2006, SOC SCI MED, V62, P858, DOI 10.1016/j.socscimed.2005.07.001; Mills A, 2012, LANCET, V380, P126, DOI 10.1016/S0140-6736(12)60357-2; Perez-Nunez R, 2007, J PUBLIC HEALTH DENT, V67, P234, DOI 10.1111/j.1752-7325.2007.00035.x; Petersen PE, 2005, B WORLD HEALTH ORGAN, V83, P661; Raban MZ, 2013, B WORLD HEALTH ORGAN, V91, P726, DOI 10.2471/BLT.12.113100; Reisine Susan, 1995, P33; Rutstein SO, 2004, DHS COMPARATIVE REPO; US Department of Health and Human Services, 2000, ORAL HEALTH IN AMERI; Ustun TB, 2003, HEALTH SYSTEMS PERFO; Van Doorslaer E, 2007, HEALTH ECON, V16, P1159, DOI 10.1002/hec.1209; WHO, 2010, WOR HEALT REP, P1; WHO, 2005, DISTRIBUTION OF HEAL; World Bank, 2017, WORLD DEV IND 2014; World Bank, 2005, WORLD DEVELOPMENT IN; World Health Organization, 2000, THE WORLD HEALTH REP; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Xu K, 2009, HEALTH POLICY, V91, P297, DOI 10.1016/j.healthpol.2009.01.002; Yardim MS, 2010, HEALTH POLICY, V94, P26, DOI 10.1016/j.healthpol.2009.08.006; Yee R, 2002, INT DENT J, V52, P1	34	40	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123075	10.1371/journal.pone.0123075	http://dx.doi.org/10.1371/journal.pone.0123075			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0LO	25923691	Green Published, gold, Green Submitted			2022-12-27	WOS:000353711600029
J	Uematsu, H; Kunisawa, S; Yamashita, K; Imanaka, Y				Uematsu, Hironori; Kunisawa, Susumu; Yamashita, Kazuto; Imanaka, Yuichi			The Impact of Patient Profiles and Procedures on Hospitalization Costs through Length of Stay in Community-Acquired Pneumonia Patients Based on a Japanese Administrative Database	PLOS ONE			English	Article							HEALTH-CARE; PREDICTORS; QUALITY; RISK; MORTALITY; ADULTS; AGE	Background Community-acquired pneumonia is a common cause of patient hospitalization, and its burden on health care systems is increasing in aging societies. In this study, we aimed to investigate the factors that affect hospitalization costs in community-acquired pneumonia patients while considering the intermediate influence of patient length of stay. Methods Using a multi-institutional administrative claims database, we analyzed 30,041 patients hospitalized for community-acquired pneumonia who had been discharged between April 1, 2012 and September 30, 2013 from 289 acute care hospitals in Japan. Possible factors associated with hospitalization costs were investigated using structural equation modeling with length of stay as an intermediate variable. We calculated the direct, indirect (through length of stay), and total effects of the candidate factors on hospitalization costs in the model. Lastly, we calculated the ratio of indirect effects to direct effects for each factor. Results The structural equation model showed that higher disease severities (using A-DROP, Barthel Index, and Charlson Comorbidity Index scores), use of mechanical ventilation, and tube feeding were associated with higher hospitalization costs, regardless of the intermediate influence of length of stay. The severity factors were also associated with longer length of stay durations. The ratio of indirect effects to direct effects on total hospitalization costs showed that the former was greater than the latter in the factors, except in the use of mechanical ventilation. Conclusions Our structural equation modeling analysis indicated that patient profiles and procedures impacted on hospitalization costs both directly and indirectly. Furthermore, the profiles were generally shown to have greater indirect effects (through length of stay) on hospitalization costs than direct effects. These findings may be useful in supporting the more appropriate distribution of health care resources.	[Uematsu, Hironori; Kunisawa, Susumu; Yamashita, Kazuto; Imanaka, Yuichi] Kyoto Univ, Dept Healthcare Econ & Qual Management, Grad Sch Med, Kyoto, Kyoto, Japan; [Kunisawa, Susumu] Ritsumeikan Univ, Dept Biomed Sci, Kyoto, Kyoto, Japan	Kyoto University; Ritsumeikan University	Imanaka, Y (corresponding author), Kyoto Univ, Dept Healthcare Econ & Qual Management, Grad Sch Med, Kyoto, Kyoto, Japan.	imanaka-y@umin.net	KUNISAWA, Susumu/HCH-1094-2022	YAMASHITA, Kazuto/0000-0002-9684-5408	Japan Society for the Promotion of Science [25253033]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science ((A) 25253033).	Blough DK., 2000, HLTH SERV OUTCOMES R, V1, P185, DOI [DOI 10.1023/A:1012597123667, 10.1023/A%3A1012597123667, DOI 10.1023/A%3A1012597123667]; Bonafede MM, 2012, AM J MANAG CARE, V18, P380; Cohen-Mansfield J, 2003, J GERONTOL A-BIOL, V58, P271; Collin C, 1988, Int Disabil Stud, V10, P61; Cortoos PJ, 2013, SCAND J INFECT DIS, V45, P219, DOI 10.3109/00365548.2012.726737; DAVIS CK, 1988, HEALTH POLICY, V9, P117, DOI 10.1016/0168-8510(88)90029-2; Fox J., 2002, APPENDIX R S PLUS CO; Garau J, 2008, CLIN MICROBIOL INFEC, V14, P322, DOI 10.1111/j.1469-0691.2007.01915.x; Hamada H, 2012, HEALTH POLICY, V107, P194, DOI 10.1016/j.healthpol.2012.01.002; Kaysar M, 2008, GERIATR GERONTOL INT, V8, P227, DOI 10.1111/j.1447-0594.2008.00480.x; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Marrie TJ, 2000, CLIN INFECT DIS, V31, P1066, DOI 10.1086/318124; Menendez R, 2001, EUR RESPIR J, V18, P151, DOI 10.1183/09031936.01.00090001; Mitchell OS, 2004, AGED CARE SUPPORT JA; Park S, 2013, HEALTH POLICY, V111, P264, DOI 10.1016/j.healthpol.2013.05.015; Rothberg MB, 2014, ANN INTERN MED, V160, P380, DOI 10.7326/M13-1419; Sato R, 2013, APPL HEALTH ECON HEA, V11, P251, DOI 10.1007/s40258-013-0026-0; Sogaard M, 2014, RESP MED; Statistics And Information Department, 2012, PAT SURV 2011 DIS IN, P50; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Suter-Widmer I, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-21; Thomas CP, 2012, CHEST, V142, P973, DOI 10.1378/chest.11-1160; Torres OH, 2004, J AM GERIATR SOC, V52, P1603, DOI 10.1111/j.1532-5415.2004.52492.x; Uematsu H, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-203; Uematsu H, 2014, INT J QUAL HEALTH C, V26, P100, DOI 10.1093/intqhc/mzt078; Welte T, 2012, THORAX, V67, P71, DOI 10.1136/thx.2009.129502	26	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125284	10.1371/journal.pone.0125284	http://dx.doi.org/10.1371/journal.pone.0125284			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0LO	25923785	gold, Green Submitted, Green Published			2022-12-27	WOS:000353711600140
J	Weaver, SA; Ucar, Z; Bettinger, P; Merry, K				Weaver, Steven A.; Ucar, Zennure; Bettinger, Pete; Merry, Krista			How a GNSS Receiver Is Held May Affect Static Horizontal Position Accuracy	PLOS ONE			English	Article							REAL-TIME; GRADE GPS; FOREST; PERFORMANCE; RELIABILITY	The static horizontal position accuracy of a mapping-grade GNSS receiver was tested in two forest types over two seasons, and subsequently was tested in one forest type against open sky conditions in the winter season. The main objective was to determine whether the holding position during data collection would result in significantly different static horizontal position accuracy. Additionally, we wanted to determine whether the time of year (season), forest type, or environmental variables had an influence on accuracy. In general, the F4Devices Flint GNSS receiver was found to have mean static horizontal position accuracy levels within the ranges typically expected for this general type of receiver (3 to 5 m) when differential correction was not employed. When used under forest cover, in some cases the GNSS receiver provided a higher level of static horizontal position accuracy when held vertically, as opposed to held at an angle or horizontally (the more natural positions), perhaps due to the orientation of the antenna within the receiver, or in part due to multipath or the inability to use certain satellite signals. Therefore, due to the fact that numerous variables may affect static horizontal position accuracy, we only conclude that there is weak to moderate evidence that the results of holding position are significant. Statistical test results also suggest that the season of data collection had no significant effect on static horizontal position accuracy, and results suggest that atmospheric variables had weak correlation with horizontal position accuracy. Forest type was found to have a significant effect on static horizontal position accuracy in one aspect of one test, yet otherwise there was little evidence that forest type affected horizontal position accuracy. Since the holding position was found in some cases to be significant with regard to the static horizontal position accuracy of positions collected in forests, it may be beneficial to have an understanding of antenna positioning within the receiver to achieve the greatest accuracy during data collection.	[Weaver, Steven A.; Ucar, Zennure; Bettinger, Pete; Merry, Krista] Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Weaver, SA (corresponding author), Univ Georgia, Warnell Sch Forestry & Nat Resources, 180 E Green St, Athens, GA 30602 USA.	sw3av3r@uga.edu	Bettinger, Pete/H-2189-2018	Bettinger, Pete/0000-0002-5454-3970	Warnell School of Forestry and Natural Resources	Warnell School of Forestry and Natural Resources	This work was supported by the Warnell School of Forestry and Natural Resources. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen HE, 2009, WEST J APPL FOR, V24, P128, DOI 10.1093/wjaf/24.3.128; [Anonymous], 2014, LEA 6 NEO 6 MAX 6 U; Bettinger P, 2012, MATH COMPUT FOR NAT-, V4, P81; Bettinger P, 2012, CROAT J FOR ENG, V33, P149; Bettinger P, 2010, MATH COMPUT FOR NAT-, V2, P153; Bolstad P, 2005, NORTH J APPL FOR, V22, P5, DOI 10.1093/njaf/22.1.5; Cirocomm Technology Corp, 2014, INT ACT ANT GPS BAR; Cirocomm Technology Corp, 2012, CIROSTAR SER; Danskin S, 2009, FOREST SCI, V55, P109; Danskin SD, 2009, SOUTH J APPL FOR, V33, P9, DOI 10.1093/sjaf/33.1.9; F4Devices, 2014, FLINT; Hetet S., 2000, SIGNAL TO NOISE RATI; Langley R. B., 1997, GPS WORLD, V8, P40; Palisade Corporation, 1996, BESTFIT WIND VERS 2; Ransom M.D., 2010, RURALS REV UNDERGRAD, V5; Sigrist P, 1999, INT J REMOTE SENS, V20, P3595, DOI 10.1080/014311699211228; SPK Electronics Co. Ltd, 2004, SP03AE1800010 SPK EL; U. S. Federal Communications Commission, 2014, OET EXH LIST FCC ID; Ucar Z, 2014, FORESTRY, V87, P504, DOI 10.1093/forestry/cpu019; Veal MW, 2001, T ASAE, V44, P1903; Wing M. G., 2011, Research Journal of Forestry, V5, P78, DOI 10.3923/rjf.2011.78.88; Wing MG, 2005, J FOREST, V103, P169, DOI 10.1093/jof/103.4.169; Wing MG, 2008, J FOREST, V106, P185; Wing MG, 2008, WEST J APPL FOR, V23, P166, DOI 10.1093/wjaf/23.3.166; Wing MG, 2006, WEST J APPL FOR, V21, P222, DOI 10.1093/wjaf/21.4.222; Wing MG, 2009, J FOREST, V107, P307; Yuen MF, 2009, THESIS US NAVAL POST	27	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124696	10.1371/journal.pone.0124696	http://dx.doi.org/10.1371/journal.pone.0124696			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923667	gold, Green Submitted, Green Published			2022-12-27	WOS:000353711600100
J	Basu, S; Majumder, S; Bhowal, A; Ghosh, A; Naskar, S; Nandy, S; Mukherjee, S; Sinha, RK; Basu, K; Karmakar, D; Banerjee, S; Sengupta, S				Basu, Sanmitra; Majumder, Subhadipa; Bhowal, Ankur; Ghosh, Alip; Naskar, Sukla; Nandy, Sumit; Mukherjee, Subhabrata; Sinha, Rajan Kumar; Basu, Keya; Karmakar, Dilip; Banerjee, Soma; Sengupta, Sanghamitra			A Study of Molecular Signals Deregulating Mismatch Repair Genes in Prostate Cancer Compared to Benign Prostatic Hyperplasia	PLOS ONE			English	Article							DNA METHYLATION; CPG-ISLAND; RADICAL PROSTATECTOMY; ESTROGEN-RECEPTOR; RISK; HYPOXIA; EXPRESSION; AGE; VARIANTS; TRENDS	Prostate cancer is one of the leading causes of mortality among aging males. There is an unmet requirement of clinically useful biomarkers for early detection of prostate cancer to reduce the liabilities of overtreatment and accompanying morbidity. The present population-based study investigates the factors disrupting expression of multiple functionally related genes of DNA mismatch repair pathway in prostate cancer patients to identify molecular attributes distinguishing adenocarcinoma from benign hyperplasia of prostate. Gene expression was compared between tissue samples from prostate cancer and benign prostatic hyperplasia using real-time-PCR, western blot and immunohistochemistry. Assessment of genotypes of seven single-nucleotide-polymorphisms of three MMR genes was conducted using PCR-coupled RFLP and sequencing. Promoter methylation was interrogated by methylation-specific-PCR and bisulfite-sequencing. Interaction between microRNAs and MMR genes was verified by 3'UTR-based dual luciferase assays. Concurrent reduction of three MMR genes namely hMLH1, hMSH6 and hMSH2 (34-85%, P<0.05) was observed in prostate cancer tissues. hMSH6 polymorphism rs1800932(Pro92Pro) conferred a borderline protection in cancer patients (OR = 0.33, 95% CI = 0.15-0.75). Relative transcript level of hMLH1 was inversely related (r = -0.59, P<0.05) with methylation quotient of its promoter which showed a significantly higher methylation density (P = 0.008, Z = -2.649) in cancer patients. hsa-miR-155, hsa-miR-141 and hsa-miR-21 gene expressions were significantly elevated (66-85%, P<0.05) in tumor specimens and negatively correlated (r = -0.602 to -0.527, P<0.05) with that of MMR genes. hsa-miR-155 & hsa-miR-141 and hsa-miR-155 & hsa-miR-21 were demonstrated to bind to their putative seed sequences in hMLH1 and hMSH6 3'UTRs respectively. Relatively higher expression of DNA methyl-transferases (DNMT1 and DNMT3b) and HIF-1 alpha genes (34-50%, P<0.05) were also detected in tumor tissues. This study provides statistical evidence that MMR deficiency is correlated with hypermethylation of hMLH1 promoter and upregulation of hsa-miR-155, hsa-miR-141 and hsa-miR-21 in prostate cancer. This comparative study reflects that microRNA expression level, particularly hsa-miR-155, exhibits predictive signature of prostate adenocarcinoma.	[Basu, Sanmitra; Majumder, Subhadipa; Bhowal, Ankur; Sengupta, Sanghamitra] Univ Calcutta, Dept Biochem, Kolkata, W Bengal, India; [Naskar, Sukla; Nandy, Sumit; Basu, Keya] Calcutta Natl Med Coll & Hosp, Dept Pathol, Kolkata, W Bengal, India; [Mukherjee, Subhabrata; Sinha, Rajan Kumar; Karmakar, Dilip] Calcutta Natl Med Coll & Hosp, Dept Urol, Kolkata, W Bengal, India; [Ghosh, Alip; Banerjee, Soma] Postgrad Inst Med Educ & Res, Liver Res Ctr, Kolkata, W Bengal, India	University of Calcutta; Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata	Sengupta, S (corresponding author), Univ Calcutta, Dept Biochem, Kolkata, W Bengal, India.	sanghamitrasg@yahoo.com	Sengupta, Sanghamitra/AAW-4300-2021	Basu, Prof.(Dr.) Keya/0000-0001-5268-7551	Council of Scientific and Industrial Research, New Delhi, India [27/(0206)/09/EMR-II]	Council of Scientific and Industrial Research, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Council of Scientific and Industrial Research, New Delhi, India, Grant No. 27/(0206)/09/EMR-II (www.csirhrdg.res.in). SS received the funding.	Ahuja N, 1998, CANCER RES, V58, P5489; [Anonymous], IARC SCIENTIFIC PUBL, VVIII; Babar IA, 2011, CANCER BIOL THER, V12, P908, DOI 10.4161/cbt.12.10.17681; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bickers B, 2009, ANTICANCER RES, V29, P3289; BOSTWICK DG, 1992, CANCER, V70, P291, DOI 10.1002/1097-0142(19920701)70:1+<291::AID-CNCR2820701317>3.0.CO;2-4; Brase JC, 2011, INT J CANCER, V128, P608, DOI 10.1002/ijc.25376; Brion MJA, 2013, INT J EPIDEMIOL, V42, P1497, DOI 10.1093/ije/dyt179; Bruning U, 2011, MOL CELL BIOL, V31, P4087, DOI 10.1128/MCB.01276-10; Burmester JK, 2004, HUM HERED, V57, P172, DOI 10.1159/000081443; Calvanese V, 2009, AGEING RES REV, V8, P268, DOI 10.1016/j.arr.2009.03.004; Cecchin E, 2013, PHARMACOGENOMICS J, V13, P403, DOI 10.1038/tpj.2012.31; Chokkalingam AP, 2003, CANCER, V98, P1727, DOI 10.1002/cncr.11710; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Crosby ME, 2009, CANCER RES, V69, P1221, DOI 10.1158/0008-5472.CAN-08-2516; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; Dahiya R, 1997, INT J CANCER, V72, P762, DOI 10.1002/(SICI)1097-0215(19970904)72:5<762::AID-IJC10>3.0.CO;2-B; Dean M, 2013, ASIAN J ANDROL, V15, P309, DOI 10.1038/aja.2013.29; Deng GR, 1999, CANCER RES, V59, P2029; Dimmeler S, 2013, EMBO MOL MED, V5, P180, DOI 10.1002/emmm.201201986; Dluzniewski PJ, 2015, CANCER EPIDEM BIOMAR, V24, P88, DOI 10.1158/1055-9965.EPI-14-0863; Eifler JB, 2013, BJU INT, V111, P22, DOI 10.1111/j.1464-410X.2012.11324.x; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gao X, 1997, ADV EXP MED BIOL, V407, P41; Gerstenberger JP, 2015, PROSTATE, V75, P60, DOI 10.1002/pros.22892; Han Y, 2015, INT J CANCER, V136, P1210, DOI 10.1002/ijc.29066; Hsieh P, 2008, MECH AGEING DEV, V129, P391, DOI 10.1016/j.mad.2008.02.012; Hsing AW, 2001, EPIDEMIOL REV, V23, P3, DOI 10.1093/oxfordjournals.epirev.a000792; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Jain S, 2014, META GENE, V2, P596, DOI 10.1016/j.mgene.2014.07.007; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jeronimo C, 2004, CLIN CANCER RES, V10, P8472, DOI 10.1158/1078-0432.CCR-04-0894; Jing LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097522; Johnson KC, 2014, EPIGENETICS-US, V9, P268, DOI 10.4161/epi.27015; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Karan D, 2003, INT J CANCER, V103, P285, DOI 10.1002/ijc.10813; Karyadi DM, 2015, INT J CANCER, V136, P2166, DOI 10.1002/ijc.29241; Kattan MW, 1998, JNCI-J NATL CANCER I, V90, P766, DOI 10.1093/jnci/90.10.766; Kwabi-Addo B, 2007, CLIN CANCER RES, V13, P3796, DOI 10.1158/1078-0432.CCR-07-0085; Lalitha K, 2012, ASIAN PAC J CANCER P, V13, P6245, DOI 10.7314/APJCP.2012.13.12.6245; Langeberg WJ, 2010, CANCER EPIDEM BIOMAR, V19, P258, DOI 10.1158/1055-9965.EPI-09-0800; Lawrie CH, 2009, J CELL MOL MED, V13, P1248, DOI 10.1111/j.1582-4934.2008.00628.x; Li LC, 2000, CANCER RES, V60, P702; Liu JJ, 2013, CHINESE J CANCER RES, V25, P46, DOI 10.3978/j.issn.1000-9604.2012.11.04; Mace TA, 2013, J SURG RES, V184, P855, DOI 10.1016/j.jss.2013.04.061; McVary KT, 2006, AM J MANAG CARE, V12, pS122; Miah S, 2014, INDIAN J UROL, V30, P214, DOI 10.4103/0970-1591.126909; Mihaylova VT, 2003, MOL CELL BIOL, V23, P3265, DOI 10.1128/MCB.23.9.3265-3273.2003; Miller GJ, 2001, EPIDEMIOL REV, V23, P14, DOI 10.1093/oxfordjournals.epirev.a000780; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Momparler RL, 2000, J CELL PHYSIOL, V183, P145, DOI 10.1002/(SICI)1097-4652(200005)183:2<145::AID-JCP1>3.0.CO;2-V; Nakayama M, 2003, AM J PATHOL, V163, P923, DOI 10.1016/S0002-9440(10)63452-9; Nojima D, 2001, CANCER, V92, P2076, DOI 10.1002/1097-0142(20011015)92:8<2076::AID-CNCR1548>3.0.CO;2-A; Panagiotou OA, 2015, EUR UROL, V67, P649, DOI 10.1016/j.eururo.2014.09.020; Park HJ, 2013, WORLD J MENS HEALTH, V31, P193, DOI 10.5534/wjmh.2013.31.3.193; Patra SK, 2002, MOL CARCINOGEN, V33, P163, DOI 10.1002/mc.10033; Perry JRB, 2014, HUM MOL GENET, V23, P2490, DOI 10.1093/hmg/ddt620; Picelli S, 2010, EUR J CANCER, V46, P1041, DOI 10.1016/j.ejca.2010.01.013; Pinto M, 2000, LAB INVEST, V80, P1915, DOI 10.1038/labinvest.3780201; Quinn M, 2002, BJU INT, V90, P162, DOI 10.1046/j.1464-410X.2002.2822.x; Reyes-Hernandez OD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099974; Ruan K, 2009, J CELL BIOCHEM, V107, P1053, DOI 10.1002/jcb.22214; Ryan S, 2014, CANCER EPIDEM BIOMAR, V23, P437, DOI 10.1158/1055-9965.EPI-13-1165; Sanfiorenzo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054596; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Schofield MJ, 2003, ANNU REV MICROBIOL, V57, P579, DOI 10.1146/annurev.micro.57.030502.090847; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Sinha R, 2003, J Postgrad Med, V49, P222; Skowronski K, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12400; Smith TR, 2011, CARCINOGENESIS, V32, P1354, DOI 10.1093/carcin/bgr117; Soni A, 2011, OMICS, V15, P319, DOI 10.1089/omi.2010.0110; Srivastava K, 2010, CANCER-AM CANCER SOC, V116, P3160, DOI 10.1002/cncr.25063; Stangelberger Anton, 2008, Rev Urol, V10, P111; Titus S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004925; Valeri N, 2010, P NATL ACAD SCI USA, V107, P6982, DOI 10.1073/pnas.1002472107; Wang L, 2009, CANCER RES, V69, P9490, DOI 10.1158/0008-5472.CAN-09-2183; Watson CJ, 2014, HUM MOL GENET, V23, P2176, DOI 10.1093/hmg/ddt614; Yang XR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097460; Yeole BB, 2008, ASIAN PAC J CANCER P, V9, P141; Zhang D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.240; Zhong H, 2010, AM J HUM GENET, V86, P581, DOI 10.1016/j.ajhg.2010.02.020	81	22	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125560	10.1371/journal.pone.0125560	http://dx.doi.org/10.1371/journal.pone.0125560			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938433	Green Published, Green Submitted, gold			2022-12-27	WOS:000353943000075
J	Craig, D; Mazilu, M; Dholakia, K				Craig, Derek; Mazilu, Michael; Dholakia, Kishan			Quantitative Detection of Pharmaceuticals Using a Combination of Paper Microfluidics and Wavelength Modulated Raman Spectroscopy	PLOS ONE			English	Article							FLUORESCENCE SUPPRESSION; CELLS; INSTRUMENTATION; DIAGNOSTICS; EXCITATION; SCATTERING; ALGORITHM; PLATFORM; DEVICE; SPACE	Raman spectroscopy has proven to be an indispensable technique for the identification of various types of analytes due to the fingerprint vibration spectrum obtained. Paper microfluidics has also emerged as a low cost, easy to fabricate and portable approach for point of care testing. However, due to inherent background fluorescence, combining Raman spectroscopy with paper microfluidics is to date an unmet challenge in the absence of using surface enhanced mechanisms. We describe the first use of wavelength modulated Raman spectroscopy (WMRS) for analysis on a paper microfluidics platform. This study demonstrates the ability to suppress the background fluorescence of the paper using WMRS and the subsequent implementation of this technique for pharmaceutical analysis. The results of this study demonstrate that it is possible to discriminate between both paracetamol and ibuprofen, whilst, also being able to detect the presence of each analyte quantitatively at nanomolar concentrations.	[Craig, Derek; Mazilu, Michael; Dholakia, Kishan] Univ St Andrews, Dept Phys & Astron, St Andrews, Fife, Scotland	University of St Andrews	Dholakia, K (corresponding author), Univ St Andrews, Dept Phys & Astron, St Andrews, Fife, Scotland.	kd1@st-andrews.ac.uk	Mazilu, Michael/B-1852-2009	Mazilu, Michael/0000-0002-4758-3528; Dholakia, Kishan/0000-0001-6534-9009	UK Engineering and Physical Sciences Research Council [EP/J01771X/1, EP/M000869/1]; Engineering and Physical Sciences Research Council [EP/M000869/1, EP/J01771X/1] Funding Source: researchfish; EPSRC [EP/J01771X/1, EP/M000869/1] Funding Source: UKRI	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	All authors acknowledge the support of the UK Engineering and Physical Sciences Research Council through grant numbers EP/J01771X/1 and EP/M000869/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen J, 2010, DANCING TIMES, V100, P55; Betz JF, 2014, PHYS CHEM CHEM PHYS, V16, P2224, DOI 10.1039/c3cp53560f; Cai LF, 2013, J CHEM EDUC, V90, P232, DOI 10.1021/ed300385j; Carrilho E, 2009, ANAL CHEM, V81, P7091, DOI 10.1021/ac901071p; Chen YY, 2013, ANALYST, V138, P2624, DOI 10.1039/c3an36647b; Cialla D, 2012, ANAL BIOANAL CHEM, V403, P27, DOI 10.1007/s00216-011-5631-x; Clarke SJ, 2005, ANALYST, V130, P1019, DOI 10.1039/b502540k; Cooper JB, 2013, APPL SPECTROSC, V67, P973, DOI 10.1366/12-06852; De Luca AC, 2010, ANAL CHEM, V82, P738, DOI 10.1021/ac9026737; Dochow S, 2013, ANAL METHODS-UK, V5, P4608, DOI 10.1039/c3ay40193f; Dungchai W, 2009, ANAL CHEM, V81, P5821, DOI 10.1021/ac9007573; Hu J, 2014, BIOSENS BIOELECTRON, V54, P585, DOI 10.1016/j.bios.2013.10.075; Jarvis RM, 2006, FARADAY DISCUSS, V132, P281, DOI 10.1039/b506413a; Kneipp K, 1999, CHEM REV, V99, P2957, DOI 10.1021/cr980133r; Lee CH, 2011, ANAL CHEM, V83, P8953, DOI 10.1021/ac2016882; Li X, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.3687398; Liu Z, 2010, NANO RES, V3, P222, DOI 10.1007/s12274-010-1025-1; Martinez AW, 2007, ANGEW CHEM INT EDIT, V46, P1318, DOI 10.1002/anie.200603817; Mazilu M, 2010, OPT EXPRESS, V18, P11382, DOI 10.1364/OE.18.011382; McAughtrie S, 2013, CHEM SCI, V4, P3566, DOI 10.1039/c3sc51437d; Moore DS, 2004, REV SCI INSTRUM, V75, P2499, DOI 10.1063/1.1771493; Ni J, 1999, ANAL CHEM, V71, P4903, DOI 10.1021/ac990616a; Parolo C, 2013, CHEM SOC REV, V42, P450, DOI 10.1039/c2cs35255a; Praveen BB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067211; Praveen BB, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.7.077006; Sundarajoo S, 2013, J RAMAN SPECTROSC, V44, P949, DOI 10.1002/jrs.4313; Thom NK, 2014, RSC ADV, V4, P1334, DOI 10.1039/c3ra44717k; Tian LM, 2012, ANAL CHEM, V84, P9928, DOI 10.1021/ac302332g; Ying Hui N, 2013, J COLLOID INTERF SCI, V409, P59, DOI [10.1016/j.jcis.2013.07.051PMID:23978290, DOI 10.1016/J.JCIS.2013.07.051]; Yu WW, 2013, ANALYST, V138, P1020, DOI 10.1039/c2an36116g; Yu WW, 2010, ANAL CHEM, V82, P9626, DOI 10.1021/ac102475k; Zavaleta CL, 2013, P NATL ACAD SCI USA, V110, pE2288, DOI 10.1073/pnas.1211309110; Zhang R, 2012, CHEM COMMUN, V48, P5913, DOI 10.1039/c2cc31604h	33	12	12	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0123334	10.1371/journal.pone.0123334	http://dx.doi.org/10.1371/journal.pone.0123334			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938464	Green Submitted, Green Published, gold			2022-12-27	WOS:000353943000006
J	Angwenyi, V; Asante, KP; Traore, A; Febir, LG; Tawiah, C; Kwarteng, A; Ouedraogo, A; Sirima, SB; Owusu-Agyei, S; Imoukhuede, EB; Webster, J; Chandramohan, D; Molyneux, S; Jones, C				Angwenyi, Vibian; Asante, Kwaku-Poku; Traore, Abdoulaye; Febir, Lawrence Gyabaa; Tawiah, Charlotte; Kwarteng, Anthony; Ouedraogo, Alphonse; Sirima, Sodiomon Bienvenue; Owusu-Agyei, Seth; Imoukhuede, Egeruan Babatunde; Webster, Jayne; Chandramohan, Daniel; Molyneux, Sassy; Jones, Caroline			Health Providers' Perceptions of Clinical Trials: Lessons from Ghana, Kenya and Burkina Faso	PLOS ONE			English	Article							MALARIA VACCINE; ARTEMETHER-LUMEFANTRINE; COMMUNITY PERCEPTIONS; CHALLENGES; MANAGEMENT; CARE; GUIDELINES; QUALITY; AFRICA; SAFETY	Background Clinical trials conducted in Africa often require substantial investments to support trial centres and public health facilities. Trial resources could potentially generate benefits for routine health service delivery but may have unintended consequences. Strengthening ethical practice requires understanding the potential effects of trial inputs on the perceptions and practices of routine health care providers. This study explores the influence of malaria vaccine trials on health service delivery in Ghana, Kenya and Burkina Faso. Methods We conducted: audits of trial inputs in 10 trial facilities and among 144 health workers; individual interviews with frontline providers (n=99) and health managers (n=14); and group discussions with fieldworkers (n=9 discussions). Descriptive summaries were generated from audit data. Qualitative data were analysed using a framework approach. Results Facilities involved in trials benefited from infrastructure and equipment upgrades, support with essential drugs, access to trial vehicles, and placement of additional qualified trial staff. Qualified trial staff in facilities were often seen as role models by their colleagues; assisting with supportive supervision and reducing facility workload. Some facility staff in place before the trial also received formal training and salary top-ups from the trials. However, differential access to support caused dissatisfaction, and some interviewees expressed concerns about what would happen at the end of the trial once financial and supervisory support was removed. Conclusion Clinical trials function as short-term complex health service delivery interventions in the facilities in which they are based. They have the potential to both benefit facilities, staff and communities through providing the supportive environment required for improvements in routine care, but they can also generate dissatisfaction, relationship challenges and demoralisation among staff. Minimising trial related harm and maximising benefits requires careful planning and engagement of key actors at the outset of trials, throughout the trial and on its' completion.	[Angwenyi, Vibian; Molyneux, Sassy; Jones, Caroline] KEMRI Wellcome Trust Res Programme KWTRP, Dept Publ Hlth Res, Kilifi, Kenya; [Asante, Kwaku-Poku; Febir, Lawrence Gyabaa; Tawiah, Charlotte; Kwarteng, Anthony; Owusu-Agyei, Seth] KHRC, Kintampo, Ghana; [Traore, Abdoulaye; Ouedraogo, Alphonse; Sirima, Sodiomon Bienvenue] CNRFP, Ouagadougou 01, Burkina Faso; [Imoukhuede, Egeruan Babatunde] Univ Klinikum Heidelberg, European Vaccine Initiat EVI, D-69120 Heidelberg, Germany; [Webster, Jayne; Chandramohan, Daniel; Jones, Caroline] London Sch Hyg & Trop Med, Dis Control Dept, London WC1E 7HT, England; [Molyneux, Sassy] Univ Oxford, Ethox Ctr, Dept Publ Hlth, Oxford OX3 7LF, England; [Molyneux, Sassy; Jones, Caroline] Univ Oxford, Ctr Clin Vaccinol & Trop Med, Nuffield Dept Med, Oxford OX3 7LF, England	Kintampo Health Research Centre; Ruprecht Karls University Heidelberg; University of London; London School of Hygiene & Tropical Medicine; University of Oxford; University of Oxford	Angwenyi, V (corresponding author), KEMRI Wellcome Trust Res Programme KWTRP, Dept Publ Hlth Res, POB 230-80108, Kilifi, Kenya.	vangwenyi@kemri-wellcome.org	Molyneux, Catherine/HGB-8464-2022; OUEDRAOGO, Alphonse/F-7859-2019	Molyneux, Catherine/0000-0001-9522-416X; Angwenyi, Vibian/0000-0002-7554-6265; Webster, Jayne/0000-0002-0498-8883; Owusu-Agyei, Seth/0000-0002-0807-1781; Ouedraogo, Alphonse/0000-0002-3520-6637; SIRIMA, Sodiomon Bienvenu/0000-0002-0972-4211	European and Developing Countries Clinical Trials Partnership [JC.2010.10300.009]	European and Developing Countries Clinical Trials Partnership	European and Developing Countries Clinical Trials Partnership (grant number JC.2010.10300.009) supported our networking activities that has resulted in this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Angwenyi V, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-65; Asante KP, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-383; Asante KP, 2011, LANCET INFECT DIS, V11, P741, DOI 10.1016/S1473-3099(11)70100-1; Bejon P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000707; Chandler CIR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-53; Chandler CIR, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-113; Chandler CIR, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-13; Chilengi R, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-63; Chuma J, 2007, TROP MED INT HEALTH, V12, P673, DOI 10.1111/j.1365-3156.2007.01825.x; Chuma J, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-413; Chuma J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-144; Cutts FT, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010016; Dickson KE, 2014, LANCET, V384, P438, DOI 10.1016/S0140-6736(14)60582-1; Febir LG, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-156; Gabbay J, 2004, BRIT MED J, V329, P1013, DOI 10.1136/bmj.329.7473.1013; Gikonyo C, 2013, DEV WORLD BIOETH, V13, P48, DOI 10.1111/dewb.12010; Green J., 2018, QUALITATIVE METHODS, VFourth; Idoko OT, 2013, AM J TROP MED HYG, V88, P414, DOI 10.4269/ajtmh.12-0576; Jaffar S, 2008, TROP MED INT HEALTH, V13, P795, DOI 10.1111/j.1365-3156.2008.02068.x; Jehu-Appiah C, 2011, SOC SCI MED, V72, P157, DOI 10.1016/j.socscimed.2010.10.025; Kirkwood BR, 2010, LANCET, V375, P1640, DOI 10.1016/S0140-6736(10)60311-X; Kochhar S, 2013, HUM VACC IMMUNOTHER, V9, P924, DOI 10.4161/hv.23405; Lang TA, 2008, T ROY SOC TROP MED H, V102, P7, DOI 10.1016/j.trstmh.2007.08.008; Lang TD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001228; Liheluka EA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-157; Makanga M, 2006, AM J TROP MED HYG, V74, P991, DOI 10.4269/ajtmh.2006.74.991; Mathauer Inke, 2006, Hum Resour Health, V4, P24, DOI 10.1186/1478-4491-4-24; Mbindyo P, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-43; Mbuagbaw L, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-145; Mills A, 2012, HEALTH POLICY PLANN, V27, pi4, DOI 10.1093/heapol/czs002; Molyneux S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054894; Mwangoka G, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-86; Njue M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113112; Nyika A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-86; OforiAdjei D, 1996, SOC SCI MED, V42, P1169, DOI 10.1016/0277-9536(95)00389-4; Olotu A, 2011, LANCET INFECT DIS, V11, P102, DOI 10.1016/S1473-3099(10)70262-0; Owusu-Agyei S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007302; Owusu-Agyei S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002530; Pan African Clinical Trials Registry, PHAS 2 RAND CONTR DO; Pariyo GW, 2005, HEALTH POLICY PLANN, V20, pI58, DOI 10.1093/heapol/czi051; Philibert A, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-120; Rao VB, 2013, TRENDS PARASITOL, V29, P164, DOI 10.1016/j.pt.2013.01.005; Richie J., 1994, ANAL QUALITATIVE DAT; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Rowe AK, 2009, AM J PUBLIC HEALTH, V99, P837, DOI 10.2105/AJPH.2008.134411; Senkubuge F, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.23568; Sirima SB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007549; Sirima SB, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-48; The Institute of Clinical Research, 1996, INT C HARM TECHN REQ; Tinto H, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-113; Tinto H, 2013, AM J TROP MED HYG, V88, P608, DOI 10.4269/ajtmh.12-0330; Wakaba M, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-6; Wasunna B, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-261; Waweru E, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-404; Wenger E., 1998, COMMUNITIES PRACTICE, DOI [10.1016/j.nedt.2009.01.012, DOI 10.1016/J.NEDT.2009.01.012]; WHO, 2010, MONITORING BUILDING; Willis-Shattuck M, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-247; World Health Organization, 2011, AB DECL 10 YEARS; Zurovac D, 2008, TROP MED INT HEALTH, V13, P99, DOI 10.1111/j.1365-3156.2007.01980.x	60	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124554	10.1371/journal.pone.0124554	http://dx.doi.org/10.1371/journal.pone.0124554			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH2XA	25933429	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000353887100049
J	Bosscher, MRF; van Leeuwen, BL; Hoekstra, HJ				Bosscher, Marianne R. F.; van Leeuwen, Barbara L.; Hoekstra, Harald J.			Current Management of Surgical Oncologic Emergencies	PLOS ONE			English	Article							CANCER-PATIENTS; TERMINAL CANCER; OF-LIFE; SURVIVAL; CARE; PREDICTION; PHYSICIANS; MORTALITY; ADMISSION; DURATION	Objectives For some oncologic emergencies, surgical interventions are necessary for dissolution or temporary relieve. In the absence of guidelines, the most optimal method for decision making would be in a multidisciplinary cancer conference (MCC). In an acute setting, the opportunity for multidisciplinary discussion is often not available. In this study, the management and short term outcome of patients after surgical oncologic emergency consultation was analyzed. Method A prospective registration and follow up of adult patients with surgical oncologic emergencies between 01-11-2013 and 30-04-2014. The follow up period was 30 days. Results In total, 207 patients with surgical oncologic emergencies were included. Postoperative wound infections, malignant obstruction, and clinical deterioration due to progressive disease were the most frequent conditions for surgical oncologic emergency consultation. During the follow up period, 40% of patients underwent surgery. The median number of involved medical specialties was two. Only 30% of all patients were discussed in a MCC within 30 days after emergency consultation, and only 41% of the patients who underwent surgery were discussed in a MCC. For 79% of these patients, the surgical procedure was performed before the MCC. Mortality within 30 days was 13%. Conclusion In most cases, surgery occurred without discussing the patient in a MCC, regardless of the fact that multiple medical specialties were involved in the treatment process. There is a need for prognostic aids and acute oncology pathways with structural multidisciplinary management. These will provide in faster institution of the most appropriate personalized cancer care, and prevent unnecessary investigations or invasive therapy.	[Bosscher, Marianne R. F.; van Leeuwen, Barbara L.; Hoekstra, Harald J.] Univ Groningen, Univ Med Ctr Groningen, Dept Surg Oncol, Groningen, Netherlands	University of Groningen	Hoekstra, HJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Surg Oncol, Groningen, Netherlands.	h.j.hoekstra@umcg.nl	hoekstra, harald/AAR-3263-2021	van Leeuwen, Barbara/0000-0002-6745-4424	Groningen Melanoma and Sarcoma Foundation	Groningen Melanoma and Sarcoma Foundation	MRF Bosscher received a research grant from the Groningen Melanoma and Sarcoma Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2012, SUPPORT CARE CANCER, V20, P2205, DOI 10.1007/s00520-012-1478-8; Barbera L, 2010, CAN MED ASSOC J, V182, P563, DOI 10.1503/cmaj.091187; Borras JM, 2014, EUR J CANCER, V50, P475, DOI 10.1016/j.ejca.2013.11.012; Bosscher MRF, 2014, CANCER TREAT REV, V40, P1028, DOI 10.1016/j.ctrv.2014.05.005; Burge F, 2003, MED CARE, V41, P992, DOI 10.1097/00005650-200308000-00012; Cervantes A, 2004, ANN ONCOL, V15, P299, DOI 10.1093/annonc/mdh943; Dumont F, 2014, J SURG ONCOL, V109, P721, DOI 10.1002/jso.23557; Geraci JM, 2006, SUPPORT CARE CANCER, V14, P1038, DOI 10.1007/s00520-006-0053-6; Glare P, 2003, BRIT MED J, V327, P195, DOI 10.1136/bmj.327.7408.195; Glare P, 2008, EUR J CANCER, V44, P1146, DOI 10.1016/j.ejca.2008.02.030; Glare Paul, 2005, J Support Oncol, V3, P331; Grudzen CR, 2012, J PAIN SYMPTOM MANAG, V43, P1, DOI 10.1016/j.jpainsymman.2011.03.022; Katabathina VS, 2013, RADIOGRAPHICS, V33, P1533, DOI 10.1148/rg.336135508; King J, 2011, BMJ QUAL SAF, V20, P718, DOI 10.1136/bmjqs.2010.044313; Knops AM, 2013, ANN SURG, V257, P860, DOI 10.1097/SLA.0b013e3182864fd6; Lane H, 2014, SUPPORT CARE CANCER, V22, P1029, DOI 10.1007/s00520-013-2054-6; Llobera J, 2000, EUR J CANCER, V36, P2036, DOI 10.1016/S0959-8049(00)00291-4; Mallol M, 2013, PATIENT SAF SURG, V7, DOI 10.1186/1754-9493-7-29; McArdle CS, 2004, BRIT J SURG, V91, P605, DOI 10.1002/bjs.4456; Navani V, 2014, CURR ONCOL, V21, P147, DOI 10.3747/co.21.1904; Porta M, 1998, BRIT J CANCER, V77, P477, DOI 10.1038/bjc.1998.76; Ramchandran KJ, 2013, CANCER-AM CANCER SOC, V119, P2074, DOI 10.1002/cncr.27974; Roses RE, 2014, J PALLIAT MED, V17, P37, DOI 10.1089/jpm.2013.0235; Selby D, 2011, J PAIN SYMPTOM MANAG, V42, P578, DOI 10.1016/j.jpainsymman.2011.01.012; Shin SH, 2014, J PAIN SYMPTOM MANAG, V47, P1028, DOI 10.1016/j.jpainsymman.2013.07.015; Vandyk AD, 2012, SUPPORT CARE CANCER, V20, P1589, DOI 10.1007/s00520-012-1459-y; Vigano A, 2004, CANCER, V101, P1090, DOI 10.1002/cncr.20472; Wright FC, 2010, J SURG ONCOL, V101, P425, DOI 10.1002/jso.21492; Yates M, 2009, CLIN ONCOL-UK, V21, P226, DOI 10.1016/j.clon.2008.12.006	29	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124641	10.1371/journal.pone.0124641	http://dx.doi.org/10.1371/journal.pone.0124641			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933135	gold, Green Published, Green Submitted			2022-12-27	WOS:000353887100054
J	Carattoli, A; Seiffert, SN; Schwendener, S; Perreten, V; Endimiani, A				Carattoli, Alessandra; Seiffert, Salome N.; Schwendener, Sybille; Perreten, Vincent; Endimiani, Andrea			Differentiation of IncL and IncM Plasmids Associated with the Spread of Clinically Relevant Antimicrobial Resistance	PLOS ONE			English	Article							BETA-LACTAMASE GENE; NUCLEOTIDE-SEQUENCE; ESCHERICHIA-COLI; IDENTIFICATION; CLASSIFICATION; ACQUISITION; DIVERSITY; INSERTION; INTEGRON; ISOLATE	Introduction bla(OXA-48), bla(NDM-1) and bla(CTX-M-3) are clinically relevant resistance genes, frequently associated with the broad-host range plasmids of the IncL/M group. The L and M plasmids belong to two compatible groups, which were incorrectly classified together by molecular methods. In order to understand their evolution, we fully sequenced four IncL/M plasmids, including the reference plasmids R471 and R69, the recently described bla(OXA-48)-carrying plasmid pKPN-El.Nr7 from a Klebsiella pneumoniae isolated in Bern (Switzerland), and the bla(SHV-5) carrying plasmid p202c from a Salmonella enterica from Tirana (Albania). Methods Sequencing was performed using 454 Junior Genome Sequencer (Roche). Annotation was performed using Sequin and Artemis software. Plasmid sequences were compared with 13 fully sequenced plasmids belonging to the IncL/M group available in GenBank. Results Comparative analysis of plasmid genomes revealed two distinct genetic lineages, each containing one of the R471 (IncL) and R69 (IncM) reference plasmids. Conjugation experiments demonstrated that plasmids representative of the IncL and IncM groups were compatible with each other. The IncL group is constituted by the blaOXA-48-carrying plasmids and R471. The IncM group contains two sub-types of plasmids named IncM1 and IncM2 that are each incompatible. Conclusion This work re-defines the structure of the IncL and IncM families and ascribes a definitive designation to the fully sequenced IncL/M plasmids available in GenBank.	[Carattoli, Alessandra; Seiffert, Salome N.; Endimiani, Andrea] Univ Bern, Inst Infect Dis, Bern, Switzerland; [Carattoli, Alessandra] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, I-00161 Rome, Italy; [Carattoli, Alessandra; Seiffert, Salome N.; Schwendener, Sybille; Perreten, Vincent] Univ Bern, Vetsuisse Fac, Inst Vet Bacteriol, Bern, Switzerland; [Seiffert, Salome N.] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland	University of Bern; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Istituto Superiore di Sanita (ISS); University of Bern; University of Bern	Carattoli, A (corresponding author), Univ Bern, Inst Infect Dis, Bern, Switzerland.	alessandra.carattoli@iss.it	Perreten, Vincent/ABB-1144-2020; Seiffert, Salome Nadja/B-3777-2013; Carattoli, Alessandra/A-1324-2009; Endimiani, Andrea/H-4008-2019	Perreten, Vincent/0000-0001-5722-9445; Carattoli, Alessandra/0000-0002-6120-6526; Endimiani, Andrea/0000-0003-3186-5421	Institute of Infectious Diseases of Bern (IFIK); Institute of Veterinary Bacteriology (IVB); Hans Sigrist Foundation; Swiss Veterinary Federal Office (BVET) [1.12.06]	Institute of Infectious Diseases of Bern (IFIK); Institute of Veterinary Bacteriology (IVB); Hans Sigrist Foundation; Swiss Veterinary Federal Office (BVET)	Prof. Alessandra Carattoli received financial support from the Institute of Infectious Diseases of Bern (IFIK), the Institute of Veterinary Bacteriology (IVB), and the Hans Sigrist Foundation. This study was also partially financed by Grant 1.12.06 (2012-2014) from the Swiss Veterinary Federal Office (BVET).	Bonnin RA, 2013, ANTIMICROB AGENTS CH, V57, P674, DOI 10.1128/AAC.01086-12; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carattoli A, 2006, EMERG INFECT DIS, V12, P1145, DOI 10.3201/eid1207.051555; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Carrer A, 2008, ANTIMICROB AGENTS CH, V52, P2950, DOI 10.1128/AAC.01672-07; CHABBERT YA, 1972, J BACTERIOL, V112, P666, DOI 10.1128/JB.112.2.666-675.1972; COUTURIER M, 1988, MICROBIOL REV, V52, P375, DOI 10.1128/MMBR.52.3.375-395.1988; DATTA N, 1971, NATURE, V234, P222, DOI 10.1038/234222a0; Di Pilato V, 2014, J ANTIMICROB CHEMOTH, V69, P2620, DOI 10.1093/jac/dku216; Dolejska M, 2014, J ANTIMICROB CHEMOTH, V69, P2388, DOI 10.1093/jac/dku172; Foster GC, 2004, APPL ENVIRON MICROB, V70, P7539, DOI 10.1128/AEM.70.12.7539-7544.2004; Galimand A, 2005, ANTIMICROB AGENTS CH, V49, P2949, DOI 10.1128/AAC.49.7.2949-2953.2005; Garcia A, 2007, FEMS MICROBIOL LETT, V271, P71, DOI 10.1111/j.1574-6968.2007.00695.x; Garcia-Fernandez A, 2009, J ANTIMICROB CHEMOTH, V63, P274, DOI 10.1093/jac/dkn470; Garcia-Fernandez A, 2012, ANTIMICROB AGENTS CH, V56, P2143, DOI 10.1128/AAC.05308-11; Garcillan-Barcia MP, 2008, PLASMID, V60, P1, DOI 10.1016/j.plasmid.2008.03.002; Garcillan-Barcia MP, 2009, FEMS MICROBIOL REV, V33, P657, DOI 10.1111/j.1574-6976.2009.00168.x; Golebiewski M, 2007, ANTIMICROB AGENTS CH, V51, P3789, DOI 10.1128/AAC.00457-07; HEDGES RW, 1974, J BACTERIOL, V117, P56, DOI 10.1128/JB.117.1.56-62.1974; Ho PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017989; Johnson TJ, 2012, PLASMID, V68, P43, DOI 10.1016/j.plasmid.2012.03.001; JORGENSEN RA, 1979, J BACTERIOL, V138, P705, DOI 10.1128/JB.138.3.705-714.1979; Mierzejewska J, 2007, PLASMID, V57, P95, DOI 10.1016/j.plasmid.2006.09.001; Phan MD, 2008, J INFECT DEV COUNTR, V2, P272; Miriagou V, 2005, ANTIMICROB AGENTS CH, V49, P3541, DOI 10.1128/AAC.49.8.3541-3543.2005; Norman A, 2008, PLASMID, V60, P59, DOI 10.1016/j.plasmid.2008.03.003; Osborn AM, 2000, MICROBIOL-UK, V146, P2267, DOI 10.1099/00221287-146-9-2267; Partridge SR, 2012, ANTIMICROB AGENTS CH, V56, P6029, DOI 10.1128/AAC.01189-12; Poirel L, 2004, ANTIMICROB AGENTS CH, V48, P348, DOI 10.1128/AAC.48.1.348-351.2004; Potron A, 2014, ANTIMICROB AGENTS CH, V58, P467, DOI 10.1128/AAC.01344-13; Potron A, 2011, ANTIMICROB AGENTS CH, V55, P4405, DOI [10.1128/AAC.05289-11, 10.1128/AAC.00681-11]; RICHARDS H, 1979, PLASMID, V2, P293, DOI 10.1016/0147-619X(79)90048-9; Sakuma T, 2013, PLASMID, V69, P138, DOI 10.1016/j.plasmid.2012.11.004; Seiffert SN, 2014, INT J ANTIMICROB AG, V44, P260, DOI 10.1016/j.ijantimicag.2014.05.008; Seiffert SN, 2014, ANTIMICROB AGENTS CH, V58, P2446, DOI 10.1128/AAC.02417-13; SHAW WV, 1972, P NATL ACAD SCI USA, V69, P3049, DOI 10.1073/pnas.69.10.3049; Sherburne CK, 2000, NUCLEIC ACIDS RES, V28, P2177, DOI 10.1093/nar/28.10.2177; Smet A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011202; Tosini F, 1998, ANTIMICROB AGENTS CH, V42, P3053, DOI 10.1128/AAC.42.12.3053; Villa L, 2002, MICROB DRUG RESIST, V8, P1, DOI 10.1089/10766290252913692; Villa L, 2000, ANTIMICROB AGENTS CH, V44, P2911, DOI 10.1128/AAC.44.10.2911-2914.2000; Villa L, 2013, J ANTIMICROB CHEMOTH, V68, P2482, DOI 10.1093/jac/dkt235; Villa L, 2013, ANTIMICROB AGENTS CH, V57, P1965, DOI 10.1128/AAC.01297-12; Villa L, 2012, J ANTIMICROB CHEMOTH, V67, P1645, DOI 10.1093/jac/dks114; Zhu WH, 2009, ANTIMICROB AGENTS CH, V53, P5291, DOI 10.1128/AAC.00032-09	45	108	112	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0123063	10.1371/journal.pone.0123063	http://dx.doi.org/10.1371/journal.pone.0123063			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933288	Green Published, gold, Green Submitted			2022-12-27	WOS:000353887100013
J	Cluitmans, JCA; Tomelleri, C; Yapici, Z; Dinkla, S; Bovee-Geurts, P; Chokkalingam, V; De Franceschi, L; Brock, R; Bosman, GJGCM				Cluitmans, Judith C. A.; Tomelleri, Carlo; Yapici, Zuhal; Dinkla, Sip; Bovee-Geurts, Petra; Chokkalingam, Venkatachalam; De Franceschi, Lucia; Brock, Roland; Bosman, Giel J. G. C. M.			Abnormal Red Cell Structure and Function in Neuroacanthocytosis	PLOS ONE			English	Article							ERYTHROCYTE-MEMBRANE CHANGES; CHOREA-ACANTHOCYTOSIS; BLOOD-CELLS; EXPRESSION; CLEAVAGE; FEATURES	Background Panthothenate kinase-associated neurodegeneration (PKAN) belongs to a group of hereditary neurodegenerative disorders known as neuroacanthocytosis (NA). This genetically heterogeneous group of diseases is characterized by degeneration of neurons in the basal ganglia and by the presence of deformed red blood cells with thorny protrusions, acanthocytes, in the circulation. Objective The goal of our study is to elucidate the molecular mechanisms underlying this aberrant red cell morphology and the corresponding functional consequences. This could shed light on the etiology of the neurodegeneration. Methods We performed a qualitative and semi-quantitative morphological, immunofluorescent, biochemical and functional analysis of the red cells of several patients with PKAN and, for the first time, of the red cells of their family members. Results We show that the blood of patients with PKAN contains not only variable numbers of acanthocytes, but also a wide range of other misshapen red cells. Immunofluorescent and immunoblot analyses suggest an altered membrane organization, rather than quantitative changes in protein expression. Strikingly, these changes are not limited to the red blood cells of PKAN patients, but are also present in the red cells of heterozygous carriers without neurological problems. Furthermore, changes are not only present in acanthocytes, but also in other red cells, including discocytes. The patients' cells, however, are more fragile, as observed in a spleen-mimicking device. Conclusion These morphological, molecular and functional characteristics of red cells in patients with PKAN and their family members offer new tools for diagnosis and present a window into the pathophysiology of neuroacanthocytosis.	[Cluitmans, Judith C. A.; Dinkla, Sip; Bovee-Geurts, Petra; Brock, Roland; Bosman, Giel J. G. C. M.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Biochem, NL-6525 GA Nijmegen, Netherlands; [Tomelleri, Carlo; De Franceschi, Lucia] Univ Verona, Policlin GB Rossi, Dept Med, AOUI Verona, I-37134 Verona, Italy; [Yapici, Zuhal] Istanbul Univ, Istanbul Fac Med, Dept Neurol, Div Child Neurol, Istanbul, Turkey; [Chokkalingam, Venkatachalam] Radboud Univ Nijmegen, Inst Mol & Mat, Dept Phys Organ Chem, NL-6525 AJ Nijmegen, Netherlands	Radboud University Nijmegen; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; Istanbul University; Radboud University Nijmegen	Bosman, GJGCM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Biochem, Geert Grootepl 28, NL-6525 GA Nijmegen, Netherlands.	Giel.Bosman@radboudumc.nl	Brock, Roland/O-9411-2019; Brock, Roland/K-2590-2012; DE FRANCESCHI, Lucia/AAB-8652-2022	Brock, Roland/0000-0003-1395-6127; DE FRANCESCHI, Lucia/0000-0001-7093-777X	EMINA project - ERare [40-41905-98-9005]; Telethon [GP13005]	EMINA project - ERare; Telethon(Fondazione Telethon)	This paper was supported by the EMINA project, funded by ERare (40-41905-98-9005) to GB (http://www.erare.eu/) and the Telethon grant GP13005 to LdF (https://www.telethon.it/en/scientists/calls-application). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOSCH FH, 1992, BLOOD, V79, P254; Bosman G, 2008, NEUROACANTHOCYTOSIS, VII, P133; BOSMAN GJCGM, 1993, NEUROBIOL AGING, V14, P223, DOI 10.1016/0197-4580(93)90004-U; Cluitmans JCA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/764268; De Franceschi L, 2014, CURR OPIN HEMATOL, V21, P201, DOI 10.1097/MOH.0000000000000035; De Franceschi L, 2011, BLOOD, V118, P5652, DOI 10.1182/blood-2011-05-355339; Deplaine G, 2011, BLOOD, V117, pE88, DOI 10.1182/blood-2010-10-312801; Dinkla S, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.143; Dinkla S, 2013, NANOMEDICINE-UK, V8, P1657, DOI [10.2217/NNM.13.149, 10.2217/nnm.13.149]; Foller M, 2012, FASEB J, V26, P1526, DOI 10.1096/fj.11-198317; Gov N, 2009, ADV PLANAR LIP BILAY, V10, P95, DOI 10.1016/S1554-4516(09)10004-2; Hayflick SJ, 2003, NEW ENGL J MED, V348, P33, DOI 10.1056/NEJMoa020817; JENNINGS ML, 1986, J BIOL CHEM, V261, P9002; Jung HH, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-68; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Matte A, 2010, FREE RADICAL BIO MED, V49, P457, DOI 10.1016/j.freeradbiomed.2010.05.003; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; Mosca A, 2009, CLIN BIOCHEM, V42, P1797, DOI 10.1016/j.clinbiochem.2009.06.023; Neelam S, 2011, EXP BIOL MED, V236, P580, DOI 10.1258/ebm.2011.010394; Paulson RF, 2011, CURR OPIN HEMATOL, V18, P139, DOI 10.1097/MOH.0b013e32834521c8; Prohaska R, 2012, NEUROBIOL DIS, V46, P607, DOI 10.1016/j.nbd.2012.03.006; Rampoldi L, 2002, J MOL MED-JMM, V80, P475, DOI 10.1007/s00109-002-0349-z; ROCHETTE J, 1994, BLOOD REV, V8, P213, DOI 10.1016/0268-960X(94)90109-0; Schaeffer EK, 2014, BLOOD CELL MOL DIS, V52, P214, DOI 10.1016/j.bcmd.2013.10.007; Siegl C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076715; SKALAK R, 1969, SCIENCE, V164, P717, DOI 10.1126/science.164.3880.717; Willekens FLA, 1997, EUR J HAEMATOL, V58, P246	27	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125580	10.1371/journal.pone.0125580	http://dx.doi.org/10.1371/journal.pone.0125580			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933379	Green Submitted, gold, Green Published			2022-12-27	WOS:000353887100118
J	Mustiana, A; Toribio, JA; Abdurrahman, M; Suadnya, IW; Hernandez-Jover, M; Putra, AAG; Ward, MP				Mustiana, Ana; Toribio, Jenny-Ann; Abdurrahman, Muktasam; Suadnya, I. Wayan; Hernandez-Jover, Marta; Putra, Anak Agung Gde; Ward, Michael P.			Owned and Unowned Dog Population Estimation, Dog Management and Dog Bites to Inform Rabies Prevention and Response on Lombok Island, Indonesia	PLOS ONE			English	Article							EPIDEMIC; DISEASE; INDIA; BALI	Although Indonesia has been rabies-infected since at least the 1880s, some islands remain rabies-free, such as Lombok. However, due to its adjacency to rabies-infected islands such as Bali and Flores, there is considerable risk of a rabies incursion. As part of a rabies risk assessment project, surveys were conducted to estimate the size of the dog population and to describe dog management practices of households belonging to different ethnic groups. A photographic-recapture method was employed and the number of unowned dogs was estimated. A total of 400 dog owning households were interviewed, 300 at an urban site and 100 at a rural site. The majority of the interviewed households belonged to the Balinese ethnic group. Owned dogs were more likely male, and non-pedigree or local breed. These households kept their dogs either fully restricted, semi-free roaming or free-roaming but full restriction was reported only at the urban site. Dog bite cases were reported to be higher at the urban site, and commonly affected children/young adults to 20 years old and males. A higher number of unowned dogs was observed at the urban site than at the rural site. Data generated within these surveys can inform rabies risk assessment models to quantify the probability of rabies being released into Lombok and resulting in the infection of the local dog population. The information gained is critical for efforts to educate dog owners about rabies, as a component of preparedness to prevent the establishment of rabies should an incursion occur.	[Mustiana, Ana; Toribio, Jenny-Ann; Hernandez-Jover, Marta; Ward, Michael P.] Univ Sydney, Fac Vet Sci, Camden, NSW, Australia; [Abdurrahman, Muktasam; Suadnya, I. Wayan] Univ Mataram, Fac Agr, Res Ctr Rural Dev, Lombok, Indonesia; [Hernandez-Jover, Marta] NSW Dept Primary Ind, Graham Ctr Agr Innovat, Wagga Wagga, NSW, Australia; [Hernandez-Jover, Marta] Charles Sturt Univ, Sch Anim & Vet Sci, Wagga Wagga, NSW, Australia; [Putra, Anak Agung Gde] Dis Invest Ctr Denpasar, Minist Agr, Denpasar, Indonesia	University of Sydney; Universitas Mataram; NSW Department of Primary Industries; Charles Sturt University	Ward, MP (corresponding author), Univ Sydney, Fac Vet Sci, Camden, NSW, Australia.	michael.ward@sydney.edu.au	Ward, Michael Patrick/GRX-1851-2022; Toribio, Jenny-Ann LML/B-5032-2011; Ward, Michael Patrick/W-1897-2019; Abdurrahman, Muktasam/GQB-2748-2022; Hernandez-Jover, Marta/F-8688-2016; Ward, Michael/C-5758-2009	Ward, Michael Patrick/0000-0002-9921-4986; Ward, Michael/0000-0002-9921-4986; , Muktasam A/0000-0002-2074-9284; Hernandez-Jover, Marta/0000-0001-8803-9062	Australian Centre for International Agricultural Research via a Small Research Activity (SRA) [AH/2012/036]	Australian Centre for International Agricultural Research via a Small Research Activity (SRA)(Australian Ctr Intl Agr Res)	The study presented was funded by the Australian Centre for International Agricultural Research via a Small Research Activity (SRA) grant AH/2012/036 awarded to Professor Ward and a John Allwright Fellowship awarded to Ms. Ana Mustiana. The funders had no role in study design, data	Amaku M, 2010, MATH POPUL STUD, V17, P69, DOI 10.1080/08898481003689452; Amaral AC, 2014, PREV VET MED, V113, P608, DOI 10.1016/j.prevetmed.2013.11.012; Beck A.M., 1973, ECOLOGY STRAY DOGS S; Beck AM, 2000, HUMAN DOG RELATIONSH, P1; Belsare AV, 2013, PREV VET MED, V111, P139, DOI 10.1016/j.prevetmed.2013.04.003; BERAN GW, 1982, COMP IMMUNOL MICROB, V5, P265, DOI 10.1016/0147-9571(82)90047-9; Childs J.E., 2007, RABIES, P123; Cleaveland S, 2002, B WORLD HEALTH ORGAN, V80, P304; Constable SE, 2012, THESIS U SYDNEY SYDN; Dias RA, 2013, PREV VET MED, V110, P263, DOI 10.1016/j.prevetmed.2012.12.002; Direktorat Jenderal Kebudayaan Republik Indonesia, KEB IND SUK SAS; Downes M, 2009, PREV VET MED, V92, P140, DOI 10.1016/j.prevetmed.2009.07.005; Durr S, 2009, EPIDEMIOL INFECT, V137, P1558, DOI 10.1017/S0950268809002386; Elliott R, 2010, APPL ANIM BEHAV SCI, V124, P121, DOI 10.1016/j.applanim.2010.02.006; FEKADU M, 1982, AM J EPIDEMIOL, V115, P266, DOI 10.1093/oxfordjournals.aje.a113298; Hossain M, 2012, EPIDEMIOL INFECT, V140, P1964, DOI 10.1017/S095026881100272X; Indonesia Ministry of Agriculture, 2013, SIT PERK ZOON PAD HE; Kato M, 2003, ACTA MED OKAYAMA, V57, P261; Knobel DL, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-5; LAKHANPAL U, 1985, INT J EPIDEMIOL, V14, P614, DOI 10.1093/ije/14.4.614; Matter HC, 2000, ACTA TROP, V75, P95, DOI 10.1016/S0001-706X(99)00085-6; NTB Bureau Statistic, 2012, NUSA TENGG BAR FIG 2; Putra AAG, 2011, B VET BBVET DENPASAR, V78, P15; Putra AAG, 2011, 3 RAB AS C COL SRI L; Putra AAG, 2013, EMERG INFECT DIS, V19, P648, DOI 10.3201/eid1904.120380; Ratsitorahina M, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-21; Reece JF, 2007, VET REC, V161, P292, DOI 10.1136/vr.161.9.292; Scott-Orr H, 2009, MICROBIOL AUST, V30, P134; Serafini CAV, 2008, ZOONOSES PUBLIC HLTH, V55, P402, DOI 10.1111/j.1863-2378.2008.01171.x; Sparkes J, 2015, ZOONOSES PUBLIC HLTH, V62, P237, DOI 10.1111/zph.12142; Stavisky J, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-163; Susetya H, 2008, VIRUS RES, V135, P144, DOI 10.1016/j.virusres.2008.03.001; Tenzin, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001391; Totton SC, 2010, PREV VET MED, V97, P51, DOI 10.1016/j.prevetmed.2010.07.009; Townsend SE, 2013, PLOS NEGLECT TROP D, V7, P8; Utami S, 2008, J SAINS VET G MADA U, V26, P66; WALTNERTOEWS D, 1990, PREV VET MED, V8, P295, DOI 10.1016/0167-5877(90)90087-X; Ward MP, 2014, PREV VET MED, V114, P11, DOI 10.1016/j.prevetmed.2014.01.009; Westgarth C, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-102; Windiyaningsih Caecilia, 2004, Journal of the Medical Association of Thailand, V87, P1389; World Health Organisation, 2002, WHOCDSCSREPH20028	41	24	25	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124092	10.1371/journal.pone.0124092	http://dx.doi.org/10.1371/journal.pone.0124092			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932916	Green Published, Green Submitted, gold			2022-12-27	WOS:000353887100030
J	Simonetto, C; Schollnberger, H; Azizova, TV; Grigoryeva, ES; Pikulina, MV; Eidemuller, M				Simonetto, Cristoforo; Schoellnberger, Helmut; Azizova, Tamara V.; Grigoryeva, Evgenia S.; Pikulina, Maria V.; Eidemueller, Markus			Cerebrovascular Diseases in Workers at Mayak PA: The Difference in Radiation Risk between Incidence and Mortality	PLOS ONE			English	Article							ATOMIC-BOMB SURVIVORS; NUCLEAR WORKERS; CARDIOVASCULAR-DISEASE; CIRCULATORY DISEASE; IONIZING-RADIATION; CANCER-MORTALITY; APOE(-/-) MICE; EXPOSURE; COHORT; ATHEROSCLEROSIS	A detailed analysis of cerebrovascular diseases (CeVD) for the cohort of workers at Mayak Production Association (PA) is presented. This cohort is especially suitable for the analysis of radiation induced circulatory diseases, due to the detailed medical surveillance and information on several risk factors. The risk after external, typically protracted, gamma exposure is analysed, accounting for potential additional internal alpha exposure. Three different endpoints have been investigated: incidence and mortality from all cerebrovascular diseases and incidence of stroke. Particular emphasis was given to the form of the dose-response relationship and the time dependence of the radiation induced risk. Young attained age was observed to be an important, aggravating modifier of radiation risk for incidence of CeVD and stroke. For incidence of CeVD, our analysis supports a dose response sub-linear for low doses. Finally, the excess relative risk per dose was confirmed to be significantly higher for incidence of CeVD compared to CeVD mortality and incidence of stroke. Arguments are presented for this difference to be based on a true biological effect.	[Simonetto, Cristoforo; Schoellnberger, Helmut; Eidemueller, Markus] Helmholtz Zentrum Munchen, Dept Radiat Sci, Neuherberg, Germany; [Azizova, Tamara V.; Grigoryeva, Evgenia S.; Pikulina, Maria V.] SUBI, Ozyorsk, Chelyabinsk Reg, Russia	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Southern Urals Biophysics Institute	Simonetto, C (corresponding author), Helmholtz Zentrum Munchen, Dept Radiat Sci, Neuherberg, Germany.	Cristoforo.Simonetto@helmholtz-muenchen.de	Bannikova, Maria V./Z-1343-2019; Schöllnberger, Helmut/K-1446-2016; Grigoryeva, Evgeniya S./B-9142-2016; Simonetto, Cristoforo/AAE-7124-2020; Azizova, Tamara V./R-5295-2019	Bannikova, Maria V./0000-0002-2755-6282; Schöllnberger, Helmut/0000-0002-4398-6565; Grigoryeva, Evgeniya S./0000-0003-1806-9922; Simonetto, Cristoforo/0000-0003-4816-3514; Azizova, Tamara V./0000-0001-6954-2674	German Federal Office for Radiation Protection [3611S30022]; EU [295823]	German Federal Office for Radiation Protection; EU(European Commission)	This work was supported by a project of the German Federal Office for Radiation Protection (contract 3611S30022) and by the EU project ProCardio (contract number 295823). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2003, CRIT REV ONCOL HEMAT, V45, P55, DOI 10.1016/S1040-8428(01)00227-X; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Alwan A, 2011, GLOBAL STATUS REPORT ON NONCOMMUNICABLE DISEASES 2010, P9; Azizova TV, 2014, RADIAT RES, V182, P529, DOI 10.1667/RR13680.1; Azizova TV, 2013, RADIAT RES, V180, P610, DOI 10.1667/RR13228.1; Azizova TV, 2010, RADIAT RES, V174, P851, DOI 10.1667/RR1928.1; Azizova TV, 2010, RADIAT RES, V174, P155, DOI 10.1667/RR1789.1; Azizova TV, 2008, HEALTH PHYS, V94, P449, DOI 10.1097/01.HP.0000300757.00912.a2; Azizova TV, 2012, HEALTH PHYS, V103, P3, DOI 10.1097/HP.0b013e3182243a62; Azizova TV, 2011, RADIAT ENVIRON BIOPH, V50, P539, DOI 10.1007/s00411-011-0377-6; Bess JD, 2007, HEALTH PHYS, V93, P207, DOI 10.1097/01.HP.0000266741.42070.e8; Borghini A, 2013, ATHEROSCLEROSIS, V230, P40, DOI 10.1016/j.atherosclerosis.2013.06.010; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Eidemuller M, 2010, RADIAT ENVIRON BIOPH, V49, P477, DOI 10.1007/s00411-010-0289-x; Fokkema M, 2012, EUR J VASC ENDOVASC, V43, P643, DOI 10.1016/j.ejvs.2012.02.023; Gilbert ES, 2013, RADIAT RES, V179, P332, DOI 10.1667/RR3054.1; Hankey GJ, 2006, STROKE, V37, P2181, DOI 10.1161/01.STR.0000229883.72010.e4; Ivanov VK, 2006, HEALTH PHYS, V90, P199, DOI 10.1097/01.HP.0000175835.31663.ea; James F, 2004, MINUET USERS GUIDE; Khokhryakov VV, 2013, HEALTH PHYS, V104, P366, DOI 10.1097/HP.0b013e31827dbf60; Killander F, 2014, EUR J CANCER, V50, P2201, DOI 10.1016/j.ejca.2014.04.033; Koshurnikova NA, 1999, RADIAT RES, V152, P352, DOI 10.2307/3580220; Little MP, 2010, RADIAT ENVIRON BIOPH, V49, P139, DOI 10.1007/s00411-009-0250-z; Little MP, 2013, RADIAT ENVIRON BIOPH, V52, P435, DOI 10.1007/s00411-013-0484-7; Little MP, 2012, ENVIRON HEALTH PERSP, V120, P1503, DOI 10.1289/ehp.1204982; McGeoghegan D, 2008, INT J EPIDEMIOL, V37, P506, DOI 10.1093/ije/dyn018; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Metz-Flamant C, 2013, OCCUP ENVIRON MED, V70, P630, DOI 10.1136/oemed-2012-101149; Mitchel REJ, 2013, RADIAT RES, V179, P190, DOI 10.1667/RR3140.1; Mitchel REJ, 2011, RADIAT RES, V175, P665, DOI 10.1667/RR2176.1; Monceau V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057052; Moseeva MB, 2014, RADIAT ENVIRON BIOPH, V53, P469, DOI 10.1007/s00411-014-0517-x; Neylon A, 2013, PROG CARDIOVASC DIS, V55, P574, DOI 10.1016/j.pcad.2013.03.009; Preston DL, 2003, RADIAT RES, V160, P381, DOI 10.1667/RR3049; Santoro F, 2014, CLIN RES CARDIOL, V103, P955, DOI 10.1007/s00392-014-0718-y; Schollnberger H, 2012, RADIAT ENVIRON BIOPH, V51, P165, DOI 10.1007/s00411-012-0410-4; Scott AS, 2009, RADIOTHER ONCOL, V90, P163, DOI 10.1016/j.radonc.2008.12.019; Shilnikova NS, 2003, RADIAT RES, V159, P787, DOI 10.1667/0033-7587(2003)159[0787:CMRAWA]2.0.CO;2; Shimizu Y, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5349; Simonetto C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096309; Sokolnikov ME, 2008, INT J CANCER, V123, P905, DOI 10.1002/ijc.23581; Takahashi I, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000654; Tretyakov FD, 2012, RADIOACTIVE SOURCE 4, P4; United Nations Scientific Committee on the Effects of Atomic Radiation Sources, 1982, ION RAD SOURC BIOL E; van der Wal AC, 1999, CARDIOVASC RES, V41, P334, DOI 10.1016/S0008-6363(98)00276-4; Vasilenko EK, 2007, HEALTH PHYS, V93, P190, DOI 10.1097/01.HP.0000266071.43137.0e; Vyas MV, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4800; Walsh L, 2011, RADIAT ENVIRON BIOPH, V50, P21, DOI 10.1007/s00411-010-0337-6; Xu JP, 2013, INTERV NEUROL, V2, P183, DOI 10.1159/000363068; Yamada M, 2004, RADIAT RES, V161, P622, DOI 10.1667/RR3183; Yentrapalli R, 2013, PROTEOMICS, V13, P1096, DOI 10.1002/pmic.201200463; Zablotska Lydia B, 2013, BMJ Open, V3, DOI 10.1136/bmjopen-2012-002159	53	19	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125904	10.1371/journal.pone.0125904	http://dx.doi.org/10.1371/journal.pone.0125904			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933038	Green Published, Green Submitted, gold			2022-12-27	WOS:000353887100143
J	Song, G; Liu, J; Ren, WD; Qiao, W; Zhang, J; Zhan, Y; Bi, WJ				Song, Guang; Liu, Jing; Ren, Weidong; Qiao, Wei; Zhang, Jing; Zhan, Ying; Bi, Wenjing			Reversible Changes of Left Atrial Function during Pregnancy Assessed by Two-Dimensional Speckle Tracking Echocardiography	PLOS ONE			English	Article							VENTRICULAR DIASTOLIC FUNCTION; STRAIN; QUANTIFICATION; RESERVOIR; PRESSURE; SIZE	Background Left ventricular diastolic function is impaired during pregnancy. However, changes in left atrial (LA) function remain unclear. We aimed to evaluate changes in LA function during pregnancy using two-dimensional speckle tracking echocardiography (2DSTE). Methods and Results 50 pregnant and 50 healthy nulliparous (control group) women were enrolled in this study. All pregnant women were followed up postpartum in sixth-month. The LA maximum volume, LA minimal volume and LA preatrial contraction volume were obtained using biplane modified Simpson's method. LA filling volume, LA expansion index, LA ejection fraction, passive volume, passive emptying index, active volume, and active emptying index were calculated. LA longitudinal systolic strain (SS), systolic strain rate (s-SR), early diastolic strain rate (e-SR), and late diastolic strain rate (a-SR) were obtained by 2DSTE. Compared to the control group, the reservoir function was increased in pregnant patients (P<0.05); conduit function was decreased in pregnant patients (P<0.05); booster pump function was increased in pregnant patients (P<0.05). There was no statistically significant difference between the control group and postpartum group. Conclusions LA reservoir and booster pump function were increased, while conduit function was decreased during pregnancy using 2DSTE. The changes were reversible. 2DSTE can easily assess LA function during pregnancy with good repeatability.	[Song, Guang; Ren, Weidong; Qiao, Wei; Zhang, Jing; Zhan, Ying; Bi, Wenjing] China Med Univ, Shengjing Hosp, Dept Ultrasound, Shenyang 110001, Peoples R China; [Liu, Jing] China Med Univ, Affiliated Hosp 1, Dept Obstet, Shenyang 110001, Peoples R China	China Medical University; China Medical University	Ren, WD (corresponding author), China Med Univ, Shengjing Hosp, Dept Ultrasound, Shenyang 110001, Peoples R China.	renwd01@126.com		Liu, Jing/0000-0002-6730-9198; Song, Guang/0000-0002-5459-6247				Abhayaratna WP, 2006, J AM COLL CARDIOL, V47, P2357, DOI 10.1016/j.jacc.2006.02.048; Anwar AM, 2007, HEART, V93, P1393, DOI 10.1136/hrt.2006.099366; Bamfo JEAK, 2007, ULTRASOUND OBST GYN, V29, P414, DOI 10.1002/uog.3966; Barbier P, 1999, CIRCULATION, V100, P427, DOI 10.1161/01.CIR.100.4.427; Cameli M, 2012, CARDIOVASC ULTRASOUN, V10, DOI 10.1186/1476-7120-10-4; Fok WY, 2006, ULTRASOUND OBST GYN, V28, P789, DOI 10.1002/uog.3849; Cianciulli TF, 2010, WORLD J CARDIOL, V2, P163, DOI 10.4330/wjc.v2.i7.163; GREENBERG B, 1979, AM HEART J, V98, P742, DOI 10.1016/0002-8703(79)90473-3; Hibbard JU, 1999, OBSTET GYNECOL, V94, P311, DOI 10.1016/S0029-7844(99)00293-8; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Mesa A, 1999, CIRCULATION, V99, P511, DOI 10.1161/01.CIR.99.4.511; Nikitin N P, 2003, Eur J Echocardiogr, V4, P36, DOI 10.1053/euje.2002.0611; Okamatsu K, 2009, J AM SOC ECHOCARDIOG, V22, P70, DOI 10.1016/j.echo.2008.11.006; Qirko S, 1996, ARCH MAL COEUR VAISS, V89, P1003; Saraiva RM, 2010, J AM SOC ECHOCARDIOG, V23, P172, DOI 10.1016/j.echo.2009.11.003; Sirbu C, 2006, EUR J ECHOCARDIOGR, V7, P199, DOI 10.1016/j.euje.2005.06.001; Spencer KT, 2001, HEART, V85, P272, DOI 10.1136/heart.85.3.272; SUGA H, 1974, CIRC RES, V35, P39, DOI 10.1161/01.RES.35.1.39; Wakami K, 2009, J AM SOC ECHOCARDIOG, V22, P847, DOI 10.1016/j.echo.2009.04.026; Yosefy C, 2012, ECHOCARDIOGR-J CARD, V29, P1096, DOI 10.1111/j.1540-8175.2012.01745.x	20	16	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125347	10.1371/journal.pone.0125347	http://dx.doi.org/10.1371/journal.pone.0125347			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933100	Green Published, gold, Green Submitted			2022-12-27	WOS:000353887100102
J	Supindham, T; Chariyalertsak, S; Utaipat, U; Miura, T; Ruanpeng, D; Chotirosniramit, N; Kosashunhanan, N; Sugandhavesa, P; Saokhieo, P; Songsupa, R; Siriaunkgul, S; Wongthanee, A				Supindham, Taweewat; Chariyalertsak, Suwat; Utaipat, Utaiwan; Miura, Toshiyuki; Ruanpeng, Darin; Chotirosniramit, Nuntisa; Kosashunhanan, Natthapol; Sugandhavesa, Patcharaphan; Saokhieo, Pongpun; Songsupa, Radchanok; Siriaunkgul, Sumalee; Wongthanee, Antika			High Prevalence and Genotype Diversity of Anal HPV Infection among MSM in Northern Thailand	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; UNINFECTED MEN; RISK-FACTORS; SEX	Background HPV infection is common and may cause cancer among men who have sex with men (MSM). Anal HPV infection (HPV+) was found in 85% of HIV-positive (HIV+) and 59% of HIV-negative (HIV-) MSM in Bangkok, central Thailand. As little is known about HPV in this group in northern Thailand, we studied MSM subgroups comprised of gay men (GM), bisexual men (BM), and transgender women (TGW). Methods From July 2012 through January 2013, 85 (42.5% of 200) GM, 30 (15%) BM, and 85 (42.5%) TGW who practiced receptive anal intercourse were recruited after informed consent, followed by self-assisted computer interview, HIV testing, and anal swabs for HPV genotyping. Results Of 197 adequate specimens, the overall prevalence of any HPV was 157 (80%). Prevalence was 89% (76/85) in GM, 48% (14/29) in BM, and 81% (67/83) in TGW. The most common high-risk types were HPV16 (27% of 197), HPV58 (23%), and HPV51 (18%). Prevalence of high-risk types was 74% in 85 GM, 35% in 29 BM, and 71% in 83 TGW. Prevalence of any HPV type, or high-risk type, was 100% and 94%, respectively, among 48 HIV+ MSM, 70% and 54% among 120 HIV- MSM. Of the 197 specimens, 36% (70) had HPV types 16 and/or 18 in the bivalent vaccine, compared to 48% (95) with >= 1 of types 16/18/06/11 in the quadrivalent, 56% (111) for 16/18/31/33/45/52/58 in the 7-valent, and 64% (126) for 16/18/31/33/45/52/58/06/11 in the 9-valent. HIV+, GM, and TGW were independently associated with HPV infection. Conclusions We found higher rates of both any HPV and high-risk types than previous studies. Among the heretofore unstudied TGW, their equivalent HPV rates were comparable to GM. Current and investigational HPV vaccines could substantially protect GM, BM, and TGW from the serious consequences of HPV infection especially among HIV + MSM.	[Supindham, Taweewat; Chariyalertsak, Suwat; Utaipat, Utaiwan; Ruanpeng, Darin; Chotirosniramit, Nuntisa; Kosashunhanan, Natthapol; Sugandhavesa, Patcharaphan; Saokhieo, Pongpun; Songsupa, Radchanok; Wongthanee, Antika] Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50000, Thailand; [Miura, Toshiyuki] Nagasaki Univ, Inst Trop Med, Dept Clin Med, Nagasaki 852, Japan; [Siriaunkgul, Sumalee] Chiang Mai Univ, Fac Med, Dept Pathol, Chiang Mai 50000, Thailand	Chiang Mai University; Nagasaki University; Chiang Mai University	Chariyalertsak, S (corresponding author), Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50000, Thailand.	suwat@rihes.org			Ministry of Education, Culture, Sports, Science and Technology(MEXT) of Japan [23406032]; Thailand's Office of the Higher Education Commission	Ministry of Education, Culture, Sports, Science and Technology(MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Thailand's Office of the Higher Education Commission	This study was supported by a Grant-inAid for Scientific Research (B) (23406032) to Dr. Toshiyuki Miura from the Ministry of Education, Culture, Sports, Science and Technology(MEXT) of Japan. It was also supported in part by the National Research University Project under Thailand's Office of the Higher Education Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison MA, 2013, ACAD PEDIATR, V13, P466, DOI 10.1016/j.acap.2013.03.006; Chariyalertsak S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024295; Guimaraes MDC, 2011, JAIDS-J ACQ IMM DEF, V57, pS217, DOI 10.1097/QAI.0b013e31821e9994; Dona MG, 2012, J CLIN VIROL, V54, P185, DOI 10.1016/j.jcv.2012.02.014; Gaisa M, 2013, AIDS; Gao L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015256; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Guadamuz TE, 2011, AIDS BEHAV, V15, P650, DOI 10.1007/s10461-010-9850-5; Hu YF, 2013, JAIDS-J ACQ IMM DEF, V64, P103, DOI 10.1097/QAI.0b013e31829b6298; Lau JT, 2013, ARCH SEX BEHAV; MEHTA CR, 1995, STAT MED, V14, P2143, DOI 10.1002/sim.4780141908; Nyitray AG, 2011, SEX TRANSM DIS, V38, P932, DOI 10.1097/OLQ.0b013e31822154f9; Nyitray AG, 2011, J INFECT DIS, V203, P49, DOI 10.1093/infdis/jiq021; Palefsky JM, 1998, AIDS, V12, P495, DOI 10.1097/00002030-199805000-00011; Phanuphak N, 2011, 18 C RETR OPP INF CR; Phanuphak N, 2013, JAIDS-J ACQ IMM DEF, V63, P472, DOI 10.1097/QAI.0b013e3182918a5a; Rahman M, 2013, VACCINE; Schwartz LM, 2013, J INFECT DIS, V208, P1768, DOI 10.1093/infdis/jit374; Senba M, 2006, J MED VIROL, V78, P1341, DOI 10.1002/jmv.20703; Tong W, 2013, HIV MED; Wiley DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079492; Winitdhama G, 2006, ESTIMATES MEN HAVING; Yu CT, 2013, AIDS BEHAV, V17, P1211, DOI 10.1007/s10461-012-0173-6	23	29	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124499	10.1371/journal.pone.0124499	http://dx.doi.org/10.1371/journal.pone.0124499			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932915	gold, Green Published, Green Submitted			2022-12-27	WOS:000353887100044
J	Uddin, MJ; Khan, WA; Ismail, AIM				Uddin, Mohammed J.; Khan, Waqar A.; Ismail, Ahmad Izani Md.			G-Jitter Induced Magnetohydrodynamics Flow of Nanofluid with Constant Convective Thermal and Solutal Boundary Conditions	PLOS ONE			English	Article							POROUS-MEDIUM; MIXED CONVECTION; NATURAL-CONVECTION; FLAT-PLATE; LAYER-FLOW; TRANSPORT; SURFACE	Taking into account the effect of constant convective thermal and mass boundary conditions, we present numerical solution of the 2-D laminar g-jitter mixed convective boundary layer flow of water-based nanofluids. The governing transport equations are converted into non-similar equations using suitable transformations, before being solved numerically by an implicit finite difference method with quasi-linearization technique. The skin friction decreases with time, buoyancy ratio, and thermophoresis parameters while it increases with frequency, mixed convection and Brownian motion parameters. Heat transfer rate decreases with time, Brownian motion, thermophoresis and diffusion-convection parameters while it increases with the Reynolds number, frequency, mixed convection, buoyancy ratio and conduction-convection parameters. Mass transfer rate decreases with time, frequency, thermophoresis, conduction-convection parameters while it increases with mixed convection, buoyancy ratio, diffusion-convection and Brownian motion parameters. To the best of our knowledge, this is the first paper on this topic and hence the results are new. We believe that the results will be useful in designing and operating thermal fluids systems for space materials processing. Special cases of the results have been compared with published results and an excellent agreement is found.	[Uddin, Mohammed J.] Amer Int Univ Bangladesh, Dept Math, Dhaka, Bangladesh; [Khan, Waqar A.] Natl Univ Sci & Technol, PN Engn Coll, Dept Engn Sci, Karachi, Pakistan; [Ismail, Ahmad Izani Md.] Univ Sains Malaysia, Sch Math Sci, George Town, Malaysia	American International University Bangladesh (AIUB); National University of Sciences & Technology - Pakistan; Universiti Sains Malaysia	Khan, WA (corresponding author), Natl Univ Sci & Technol, PN Engn Coll, Dept Engn Sci, Karachi, Pakistan.	wkhan_2000@yahoo.com	Khan, Waqar/H-3886-2013	Khan, Waqar/0000-0002-8328-850X; Ahmad Izani, Ismail/0000-0003-1092-5579; Uddin, Dr. Md. Jashim/0000-0002-3243-3455	Universiti Sains Malaysia, RU Grant [1001/PMATHS/811252]	Universiti Sains Malaysia, RU Grant(Universiti Sains Malaysia)	The authors acknowledge financial support from Universiti Sains Malaysia, RU Grant 1001/PMATHS/811252. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PM, 1998, ANNU REV FLUID MECH, V20, P35; Aziz A, 2009, COMMUN NONLINEAR SCI, V14, P1064, DOI 10.1016/j.cnsns.2008.05.003; Beg OA, 2008, ACTA MECH, V200, P129, DOI 10.1007/s00707-008-0040-8; Bhadauria BS, 2013, TRANSPORT POROUS MED, V97, P185, DOI 10.1007/s11242-012-0117-7; Buongiorno J, 2006, J HEAT TRANS-T ASME, V128, P240, DOI 10.1115/1.2150834; CHEN H, 1994, J CRYST GROWTH, V142, P362, DOI 10.1016/0022-0248(94)90347-6; Chen WY, 1999, J FLUID MECH, V395, P327, DOI 10.1017/S0022112099006011; Choi S. U. S., 1995, 231MD ASME FED, V66, P99; Dey D, 2014, APPL MATH, V2014; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2011, CHEM ENG SCI, V66, P2660, DOI 10.1016/j.ces.2011.03.008; Gorla RSR, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-207; Hayat T, 2014, INT J NUMER METHOD H, V24, P342, DOI 10.1108/HFF-03-2012-0065; Kuznetsov AV, 2012, J POROUS MEDIA, V15, P233, DOI 10.1615/JPorMedia.v15.i3.30; LEE TS, 1982, INT J HEAT MASS TRAN, V25, P499, DOI 10.1016/0017-9310(82)90053-9; Magyari E, 2009, COMMUN NONLINEAR SCI, V14, P1064; Magyari E, 2009, COMMUN NONL SCI NUME, V6, P599; Makinde OD, 2010, INT J THERM SCI, V49, P1813, DOI 10.1016/j.ijthermalsci.2010.05.015; Mandi RA, 2015, RENEW SUST ENERG REV, V41, P715, DOI 10.1016/j.rser.2014.08.040; Merkin JH, 2013, TRANSPORT POROUS MED, V99, P413, DOI 10.1007/s11242-013-0193-3; Merkin JH, 2011, COMMUN NONLINEAR SCI, V16, P3602, DOI 10.1016/j.cnsns.2011.01.007; Mujeebu MA, 2010, PROG ENERG COMBUST, V36, P627, DOI 10.1016/j.pecs.2010.02.002; Murthy PVSN, 2013, INT COMMUN HEAT MASS, V47, P41, DOI 10.1016/j.icheatmasstransfer.2013.06.001; Nield DA, 2014, INT J HEAT MASS TRAN, V70, P430, DOI 10.1016/j.ijheatmasstransfer.2013.11.016; Nield DA, 2009, INT J HEAT MASS TRAN, V52, P5792, DOI 10.1016/j.ijheatmasstransfer.2009.07.024; Nield D.A., 2013, CONVECTION POROUS ME; Pantokratoras A, 2014, TRANSPORT POROUS MED, V104, P273, DOI 10.1007/s11242-014-0333-4; Pantokratoras A, 2014, INT J THERM SCI, V76, P221, DOI 10.1016/j.ijthermalsci.2013.09.006; Rees DAS, 2001, HEAT MASS TRANSFER, V37, P403, DOI 10.1007/s002310000178; Servati AA, 2014, ADV POWDER TECHNOL, V25, P666, DOI 10.1016/j.apt.2013.10.012; Shafie S, 2007, MECH RES COMMUN, V34, P115, DOI 10.1016/j.mechrescom.2006.05.004; Shu Y, 2001, NUMER HEAT TR A-APPL, V39, P245, DOI 10.1080/104077801300006571; Shu Y, 2002, NUMER HEAT TR A-APPL, V42, P345, DOI 10.1080/10407780290059594; Tiwari RK, 2007, INT J HEAT MASS TRAN, V50, P2002, DOI 10.1016/j.ijheatmasstransfer.2006.09.034; Uddin MJ, 2014, J MAGN MAGN MATER, V368, P252, DOI 10.1016/j.jmmm.2014.05.041; Uddin MJ, 2012, TRANSPORT POROUS MED, V92, P867, DOI 10.1007/s11242-011-9938-z; Uddin MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099384; Uddin MJ, 2014, MATH PROBL ENG, V2014, DOI 10.1155/2014/179172; Vafai K, 2013, POROUS MEDIA APPL BI; Wasu S, 2011, MATHEMATICS IN SCIENCE AND TECHNOLOGY: MATHEMATICAL METHODS, MODELS AND ALGORITHMS IN SCIENCE AND TECHNOLOGY, P510; Yasin MH, 2012, ADV SCI LETT, V13, P833, DOI DOI 10.1166/ASL.2012.3863; Zueco J, 2011, CHEM ENG COMMUN, V198, P172, DOI 10.1080/00986445.2010.499842	42	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0122663	10.1371/journal.pone.0122663	http://dx.doi.org/10.1371/journal.pone.0122663			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933066	gold, Green Published, Green Submitted			2022-12-27	WOS:000353887100011
J	van 't Sant, J; Fiolet, ATL; ter Horst, IAH; Cramer, MJ; Mastenbroek, MH; van Everdingen, WM; Mast, TP; Doevendans, PA; Versteeg, H; Meine, M				van 't Sant, Jetske; Fiolet, Aernoud T. L.; ter Horst, Iris A. H.; Cramer, Maarten J.; Mastenbroek, Mirjam H.; van Everdingen, Wouter M.; Mast, Thomas P.; Doevendans, Pieter A.; Versteeg, Henneke; Meine, Mathias			Volumetric Response beyond Six Months of Cardiac Resynchronization Therapy and Clinical Outcome	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; SEPTAL REBOUND STRETCH; HEART-FAILURE; HEALTH-STATUS; PREDICTOR; MORTALITY; SURVIVAL; INDEXES; DISEASE; MARKER	Aims Response to cardiac resynchronization therapy (CRT) is often assessed six months after implantation. Our objective was to assess the number of patients changing from responder to non-responder between six and 14 months, so-called late non-responders, and compare them to patients who were responder both at six and 14 months, so-called stable responders. Furthermore, we assessed predictive values of six and 14-month response concerning clinical outcome. Methods 105 patients eligible for CRT were enrolled. Clinical, laboratory, ECG, and echocardiographic parameters and patient-reported health status (Kansas City Cardiomyopathy Questionnaire [KCCQ]) were assessed before, and six and 14 months after implantation. Response was defined as >= 15% LVESV decrease as compared to baseline. Major adverse cardiac events (MACE) were registered until 24 months after implantation. Predictive values of six and 14-month response for MACE were examined. Results In total, 75 (71%) patients were six-month responders of which 12 (16%) patients became late non-responder. At baseline, late non-responders more often had ischemic cardiomyopathy and atrial fibrillation, higher BNP and less dyssynchrony compared to stable responders. At six months, late non-responders showed significantly less LVESV decrease, and higher creatinine levels. Mean KCCQ scores of late non-responders were lower than those of stable responders at every time point, with the difference being significant at 14 months. The 14 months response was a better predictor of MACE than six months response. Conclusions The assessment of treatment outcomes after six months of CRT could be premature and response rates beyond might better correlate to long-term clinical outcome.	[van 't Sant, Jetske; Fiolet, Aernoud T. L.; ter Horst, Iris A. H.; Cramer, Maarten J.; Mastenbroek, Mirjam H.; van Everdingen, Wouter M.; Mast, Thomas P.; Doevendans, Pieter A.; Versteeg, Henneke; Meine, Mathias] Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands; [Mastenbroek, Mirjam H.; Versteeg, Henneke] Tilburg Univ, CoRPS Ctr Res Psychol Somat Dis, Dept Med & Clin Psychol, NL-5000 LE Tilburg, Netherlands	Utrecht University; Utrecht University Medical Center; Tilburg University	van 't Sant, J (corresponding author), Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands.	j.vantsant@gmail.com	van Everdingen, Wouter M/Y-3603-2018; van Everdingen, Wouter/R-1666-2019	van Everdingen, Wouter M/0000-0003-3577-8923; van Everdingen, Wouter/0000-0003-3577-8923				Bongartz LG, 2005, EUR HEART J, V26, P11, DOI 10.1093/eurheartj/ehi020; Brignole M, 2013, EUROPACE, V15, P1070, DOI 10.1093/europace/eut206; Chan YH, 2013, J AM SOC ECHOCARDIOG, V26, P307, DOI 10.1016/j.echo.2012.11.012; Chung ES, 2008, CIRCULATION, V117, P2608, DOI 10.1161/CIRCULATIONAHA.107.743120; Cutlip DE, 2004, CIRCULATION, V110, P1226, DOI 10.1161/01.CIR.0000140721.27004.4B; De Boeck BWL, 2009, EUR J HEART FAIL, V11, P863, DOI 10.1093/eurjhf/hfp107; Foley PWX, 2011, EUR J HEART FAIL, V13, P43, DOI 10.1093/eurjhf/hfq182; Fung JWH, 2007, INT J CARDIOL, V122, P10, DOI 10.1016/j.ijcard.2006.11.015; Ghio S, 2009, EUR J HEART FAIL, V11, P480, DOI 10.1093/eurjhf/hfp034; Green CP, 2000, J AM COLL CARDIOL, V35, P1245, DOI 10.1016/S0735-1097(00)00531-3; Hayes DL, 2011, HEART RHYTHM, V8, P1469, DOI 10.1016/j.hrthm.2011.04.015; Henry RMA, 2002, KIDNEY INT, V62, P1402, DOI 10.1046/j.1523-1755.2002.00571.x; Leenders GE, 2012, J CARD FAIL, V18, P404, DOI 10.1016/j.cardfail.2012.02.001; Linde C, 2013, EUR HEART J, V34, P2592, DOI 10.1093/eurheartj/eht160; Linde C, 2010, J AM COLL CARDIOL, V56, P1826, DOI 10.1016/j.jacc.2010.05.055; Lumens J, 2012, CIRC-CARDIOVASC IMAG, V5, P491, DOI 10.1161/CIRCIMAGING.112.973446; Maeda K, 1998, AM HEART J, V135, P825, DOI 10.1016/S0002-8703(98)70041-9; Mastenbroek MH, 2014, EUR J HEART FAIL, V16, P384, DOI 10.1002/ejhf.55; McCullough PA, 2003, J AM COLL CARDIOL, V41, P725, DOI 10.1016/S0735-1097(02)02955-8; Mor-Avi V, 2011, EUR J ECHOCARDIOGR, V12, P167, DOI 10.1093/ejechocard/jer021; Omland T, 1996, CIRCULATION, V93, P1963, DOI 10.1161/01.CIR.93.11.1963; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Rickard J, 2014, HEART RHYTHM, V11, P412, DOI 10.1016/j.hrthm.2013.11.025; Schmidt S, 2014, EUR HEART J, V35, P1051, DOI 10.1093/eurheartj/eht514; Surawicz B, 2009, CIRCULATION, V119, pE235, DOI 10.1161/CIRCULATIONAHA.108.191095; Versteeg H, 2014, EUR J HEART FAIL, V16, P227, DOI 10.1002/ejhf.38; Vidal B, 2010, EUR J HEART FAIL, V12, P283, DOI 10.1093/eurjhf/hfq003; Wilton SB, 2011, HEART RHYTHM, V8, P1088, DOI 10.1016/j.hrthm.2011.02.014	28	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124323	10.1371/journal.pone.0124323	http://dx.doi.org/10.1371/journal.pone.0124323			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933068	Green Published, gold, Green Submitted			2022-12-27	WOS:000353887100039
J	Horne, MK; McGregor, S; Bergquist, F				Horne, Malcolm K.; McGregor, Sarah; Bergquist, Filip			An Objective Fluctuation Score for Parkinson's Disease	PLOS ONE			English	Article							MOTOR FLUCTUATIONS; LEVODOPA; EVOLUTION; PHARMACODYNAMICS; THERAPY	Introduction Establishing the presence and severity of fluctuations is important in managing Parkinson's Disease yet there is no reliable, objective means of doing this. In this study we have evaluated a Fluctuation Score derived from variations in dyskinesia and bradykinesia scores produced by an accelerometry based system. Methods The Fluctuation Score was produced by summing the interquartile range of bradykinesia scores and dyskinesia scores produced every 2 minutes between 0900-1800 for at least 6 days by the accelerometry based system and expressing it as an algorithm. Results This Score could distinguish between fluctuating and non-fluctuating patients with high sensitivity and selectivity and was significant lower following activation of deep brain stimulators. The scores following deep brain stimulation lay in a band just above the score separating fluctuators from non-fluctuators, suggesting a range representing adequate motor control. When compared with control subjects the score of newly diagnosed patients show a loss of fluctuation with onset of PD. The score was calculated in subjects whose duration of disease was known and this showed that newly diagnosed patients soon develop higher scores which either fall under or within the range representing adequate motor control or instead go on to develop more severe fluctuations. Conclusion The Fluctuation Score described here promises to be a useful tool for identifying patients whose fluctuations are progressing and may require therapeutic changes. It also shows promise as a useful research tool. Further studies are required to more accurately identify therapeutic targets and ranges.	[Horne, Malcolm K.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia; [Horne, Malcolm K.; McGregor, Sarah] St Vincents Hosp Melbourne, Ctr Clin Neurosci & Neurol Res, Fitzroy, Vic, Australia; [Bergquist, Filip] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Pharmacol, Gothenburg, Sweden	Florey Institute of Neuroscience & Mental Health; University of Melbourne; St Vincent's Hospital Melbourne; University of Gothenburg	Horne, MK (corresponding author), Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia.	malcolm.horne@florey.edu.au	Horne, Malcolm/AAL-5214-2020; Bergquist, Filip/G-1402-2010	Horne, Malcolm/0000-0001-9427-2100; Bergquist, Filip/0000-0002-3437-0267	Australian National Health and Medical research Council; Global Kinetics Corporationl	Australian National Health and Medical research Council(National Health and Medical Research Council (NHMRC) of Australia); Global Kinetics Corporationl	MH is a Practitioner Fellow funded by the Australian National Health and Medical research Council. An open grant was received from Global Kinetics Corporationl, the company that manufactures and supplies the PKG for SM's salary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Griffiths RI, 2012, J PARKINSON DIS, V2, P47, DOI 10.3233/JPD-2012-11071; HELY MA, 1994, J NEUROL NEUROSUR PS, V57, P903, DOI 10.1136/jnnp.57.8.903; HUGHES AJ, 1994, J NEUROL NEUROSUR PS, V57, P430, DOI 10.1136/jnnp.57.4.430; McColl CD, 2002, MOVEMENT DISORD, V17, P1227, DOI 10.1002/mds.10244; Nutt JG, 2002, ANN NEUROL, V51, P686, DOI 10.1002/ana.10189; Nutt JG, 1997, ANN NEUROL, V42, P349, DOI 10.1002/ana.410420311; NUTT JG, 1995, CLIN EXP PHARMACOL P, V22, P837, DOI 10.1111/j.1440-1681.1995.tb01946.x; Nutt JG, 2008, MOVEMENT DISORD, V23, pS580, DOI 10.1002/mds.22037; Papapetropoulos SS, 2011, CNS NEUROSCIENCE THE; Reardon KA, 1999, MOVEMENT DISORD, V14, P605, DOI 10.1002/1531-8257(199907)14:4<605::AID-MDS1009>3.0.CO;2-H	10	40	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124522	10.1371/journal.pone.0124522	http://dx.doi.org/10.1371/journal.pone.0124522			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928634	Green Published, gold			2022-12-27	WOS:000353713100037
J	Kapoor, S; Rodriguez, D; Riwanto, M; Edenhofer, I; Segerer, S; Mitchell, K; Wuthrich, RP				Kapoor, Sarika; Rodriguez, Daniel; Riwanto, Meliana; Edenhofer, Ilka; Segerer, Stephan; Mitchell, Katharyn; Wuthrich, Rudolf P.			Effect of Sodium-Glucose Cotransport Inhibition on Polycystic Kidney Disease Progression in PCK Rats	PLOS ONE			English	Article							V2 RECEPTOR ANTAGONIST; SGLT2 INHIBITOR; VASOPRESSIN; DAPAGLIFLOZIN; WATER; OSMOREGULATION; NEPHROPATHY; MANAGEMENT; POTENT; MODEL	The sodium-glucose-cotransporter-2 (SGLT2) inhibitor dapagliflozin (DAPA) induces glucosuria and osmotic diuresis via inhibition of renal glucose reabsorption. Since increased diuresis retards the progression of polycystic kidney disease (PKD), we investigated the effect of DAPA in the PCK rat model of PKD. DAPA (10 mg/kg/d) or vehicle was administered by gavage to 6 week old male PCK rats (n=9 per group). Renal function, albuminuria, kidney weight and cyst volume were assessed after 6 weeks of treatment. Treatment with DAPA markedly increased glucose excretion (23.6 +/- 4.3 vs 0.3 +/- 0.1 mmol/d) and urine output (57.3 +/- 6.8 vs 19.3 +/- 0.8 ml/d). DAPA-treated PCK rats had higher clearances for creatinine (3.1 +/- 0.1 vs 2.6 +/- 0.2 ml/min) and BUN (1.7 +/- 0.1 vs 1.2 +/- 0.1 ml/min) after 3 weeks, and developed a 4-fold increase in albuminuria. Ultrasound imaging and histological analysis revealed a higher cyst volume and a 23% higher total kidney weight after 6 weeks of DAPA treatment. At week 6 the renal cAMP content was similar between DAPA and vehicle, and staining for Ki67 did not reveal an increase in cell proliferation. In conclusion, the inhibition of glucose reabsorption with the SGLT2-specific inhibitor DAPA caused osmotic diuresis, hyperfiltration, albuminuria and an increase in cyst volume in PCK rats. The mechanisms which link glucosuria to hyperfiltration, albuminuria and enhanced cyst volume in PCK rats remain to be elucidated.	[Kapoor, Sarika; Rodriguez, Daniel; Riwanto, Meliana; Edenhofer, Ilka; Segerer, Stephan; Wuthrich, Rudolf P.] Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland; [Kapoor, Sarika; Rodriguez, Daniel; Riwanto, Meliana; Edenhofer, Ilka; Segerer, Stephan; Wuthrich, Rudolf P.] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Mitchell, Katharyn] Univ Zurich, Clin Equine Internal Med, Vetsuisse Fac, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich	Wuthrich, RP (corresponding author), Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland.	rudolf.wuethrich@usz.ch	Mitchell, Katharyn/G-7915-2016	Mitchell, Katharyn/0000-0002-5545-5630; Segerer, Stephan/0000-0002-1936-9719; Rodriguez Gutierrez, Daniel/0000-0002-2979-0769	Swiss National Science Foundation [320030_144093]; Hartmann Muller Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Hartmann Muller Foundation	Supported by the Swiss National Science Foundation (grant number 320030_144093 to RPW) and by the Hartmann Muller Foundation (to SK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown JH, 2005, J AM SOC NEPHROL, V16, P3517, DOI 10.1681/ASN.2005060601; CHAPMAN AB, 1994, J AM SOC NEPHROL, V5, P1349; Chevalier RL, 1998, SEMIN NEPHROL, V18, P585; De Nicola L, 2014, AM J KIDNEY DIS, V64, P16, DOI 10.1053/j.ajkd.2014.02.010; Devenny JJ, 2012, OBESITY, V20, P1645, DOI 10.1038/oby.2012.59; Devuyst O, 2013, CURR OPIN NEPHROL HY, V22, P459, DOI 10.1097/MNH.0b013e3283621510; Gattone VH, 2003, NAT MED, V9, P1323, DOI 10.1038/nm935; Han SP, 2008, DIABETES, V57, P1723, DOI 10.2337/db07-1472; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Hoff S, 2013, NAT GENET, V45, P951, DOI 10.1038/ng.2681; Hopp K, 2015, AM J PHYSIOL-RENAL, V308, pF261, DOI 10.1152/ajprenal.00345.2014; Mather A, 2010, NAT REV NEPHROL, V6, P307, DOI 10.1038/nrneph.2010.38; Meijer E, 2011, NEPHROL DIAL TRANSPL, V26, P2445, DOI 10.1093/ndt/gfr069; Meng W, 2008, J MED CHEM, V51, P1145, DOI 10.1021/jm701272q; Nagao S, 2006, J AM SOC NEPHROL, V17, P2220, DOI 10.1681/ASN.2006030251; Obermeier M, 2010, DRUG METAB DISPOS, V38, P405, DOI 10.1124/dmd.109.029165; Reed B, 2012, NEPHROL DIAL TRANSPL, V27, P2862, DOI 10.1093/ndt/gfr744; Schrier RW, 2003, KIDNEY INT, V63, P678, DOI 10.1046/j.1523-1755.2003.00776.x; Skrtic M, 2014, DIABETOLOGIA, V57, P2599, DOI 10.1007/s00125-014-3396-4; Ho TA, 2012, KIDNEY INT, V82, P1121, DOI 10.1038/ki.2012.225; Thomson SC, 2012, AM J PHYSIOL-REG I, V302, pR75, DOI 10.1152/ajpregu.00357.2011; Torres VE, 2004, NAT MED, V10, P363, DOI 10.1038/nm1004; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Torres VE, 2014, J AM SOC NEPHROL, V25, P18, DOI 10.1681/ASN.2013040398; Torres VE, 2012, NEW ENGL J MED, V367, P2407, DOI 10.1056/NEJMoa1205511; Torres VE, 2009, CLIN J AM SOC NEPHRO, V4, P1140, DOI 10.2215/CJN.00790209; Wang CJ, 2011, CLIN J AM SOC NEPHRO, V6, P192, DOI 10.2215/CJN.03950510; Wang XF, 2005, J AM SOC NEPHROL, V16, P846, DOI 10.1681/ASN.2004121090; Wang XF, 2008, J AM SOC NEPHROL, V19, P102, DOI 10.1681/ASN.2007060688; Wang XQ, 2013, KIDNEY INT, V84, P962, DOI 10.1038/ki.2013.199; Wuthrich RP, 2014, EXPERT OPIN PHARMACO, V15, P1085, DOI 10.1517/14656566.2014.903923	31	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125603	10.1371/journal.pone.0125603	http://dx.doi.org/10.1371/journal.pone.0125603			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927597	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000353713100105
J	Trnka, J; Elkalaf, M; Andel, M				Trnka, Jan; Elkalaf, Moustafa; Andel, Michal			Lipophilic Triphenylphosphonium Cations Inhibit Mitochondrial Electron Transport Chain and Induce Mitochondrial Proton Leak	PLOS ONE			English	Article							BIOMEMBRANE-PRODUCED ENERGY; RESPIRATORY-CHAIN; REACTIVE OXYGEN; ANTIOXIDANT; TRAP; UBIQUINONE; CONVERSION; KINETICS; EFFLUX; CELLS	Background The lipophilic positively charged moiety of triphenylphosphonium (TPP+) has been used to target a range of biologically active compounds including antioxidants, spin-traps and other probes into mitochondria. The moiety itself, while often considered biologically inert, appears to influence mitochondrial metabolism. Methodology/Principal Findings We used the Seahorse XF flux analyzer to measure the effect of a range of alkylTPP(+) on cellular respiration and further analyzed their effect on mitochondrial membrane potential and the activity of respiratory complexes. We found that the ability of alkylTPP(+) to inhibit the respiratory chain and decrease the mitochondrial membrane potential increases with the length of the alkyl chain suggesting that hydrophobicity is an important determinant of toxicity. Conclusions/Significance More hydrophobic TPP+ derivatives can be expected to have a negative impact on mitochondrial membrane potential and respiratory chain activity in addition to the effect of the biologically active moiety attached to them. Using shorter linker chains or adding hydrophilic functional groups may provide a means to decrease this negative effect.	[Trnka, Jan; Elkalaf, Moustafa] Charles Univ Prague, Fac Med 3, Lab Metab & Bioenerget, Prague, Czech Republic; [Trnka, Jan; Elkalaf, Moustafa; Andel, Michal] Charles Univ Prague, Fac Med 3, Ctr Res Diabet Metab & Nutr, Prague, Czech Republic	Charles University Prague; Charles University Prague	Trnka, J (corresponding author), Charles Univ Prague, Fac Med 3, Lab Metab & Bioenerget, Prague, Czech Republic.	jan.trnka@lf3.cuni.cz	Elkalaf, Moustafa/AAL-4938-2020; Anděl, Michal/E-4305-2012; Trnka, Jan/B-8951-2012	Elkalaf, Moustafa/0000-0002-0418-2732; Trnka, Jan/0000-0002-1786-7562	Charles University in Prague [PRVOUK P31, 260042/SVV/2014]	Charles University in Prague	This work was funded by grants from Charles University in Prague (www.cuni.cz) PRVOUK P31, and 260042/SVV/2014.	Antonenko YN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061902; BAKEEVA LE, 1970, BIOCHIM BIOPHYS ACTA, V216, P13, DOI 10.1016/0005-2728(70)90154-4; Brand M. D., 1995, BIOENERGETICS, V154, P62; Brown SE, 2007, FREE RADICAL BIO MED, V42, P1766, DOI 10.1016/j.freeradbiomed.2007.02.033; CERLETTI P, 1965, BIOCHEM BIOPH RES CO, V18, P259, DOI 10.1016/0006-291X(65)90750-3; Cocheme HM, 2011, CELL METAB, V13, P340, DOI 10.1016/j.cmet.2011.02.003; COOPERSTEIN SJ, 1951, J BIOL CHEM, V189, P665; Cunniff B, 2013, J CELL PHYSIOL, V228, P835, DOI 10.1002/jcp.24232; Filipovska A, 2005, J BIOL CHEM, V280, P24113, DOI 10.1074/jbc.M501148200; Floryk D, 1999, BIOSCIENCE REP, V19, P27, DOI 10.1023/A:1020193906974; FRY M, 1980, BIOCHEM BIOPH RES CO, V93, P1238, DOI 10.1016/0006-291X(80)90622-1; FRY M, 1981, J BIOL CHEM, V256, P1874; GRINIUS LL, 1970, BIOCHIM BIOPHYS ACTA, V216, P1, DOI 10.1016/0005-2728(70)90153-2; Hardy M, 2007, CHEM RES TOXICOL, V20, P1053, DOI 10.1021/tx700101d; James AM, 2005, J BIOL CHEM, V280, P21295, DOI 10.1074/jbc.M501527200; Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873; Kelso GF, 2012, CHEM BIOL, V19, P1237, DOI 10.1016/j.chembiol.2012.08.005; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; Leo S, 2008, ANN NY ACAD SCI, V1147, P264, DOI 10.1196/annals.1427.019; Luo C, 2008, CLIN CHIM ACTA, V395, P38, DOI 10.1016/j.cca.2008.04.025; Murphy MP, 2003, J BIOL CHEM, V278, P48534, DOI 10.1074/jbc.M308529200; Murphy MP, 1997, TRENDS BIOTECHNOL, V15, P326, DOI 10.1016/S0167-7799(97)01068-8; Nicholls DG, 2012, METHODS MOL BIOL, V810, P119, DOI 10.1007/978-1-61779-382-0_8; O'Malley Y, 2006, J BIOL CHEM, V281, P39766, DOI 10.1074/jbc.M608268200; Patkova J, 2014, CELL PHYSIOL BIOCHEM, V33, P1439, DOI 10.1159/000358709; Plecita-Hlavata L, 2009, INT J BIOCHEM CELL B, V41, P1697, DOI 10.1016/j.biocel.2009.02.015; Quin C, 2009, TETRAHEDRON, V65, P8154, DOI 10.1016/j.tet.2009.07.081; Reily C, 2013, REDOX BIOL, V1, P86, DOI 10.1016/j.redox.2012.11.009; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Ross MF, 2008, BIOCHEM J, V411, P633, DOI 10.1042/BJ20080063; Ross MF, 2005, BIOCHEMISTRY-MOSCOW+, V70, P222, DOI 10.1007/s10541-005-0104-5; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Severin FF, 2010, P NATL ACAD SCI USA, V107, P663, DOI 10.1073/pnas.0910216107; Smith RAJ, 1999, EUR J BIOCHEM, V263, P709, DOI 10.1046/j.1432-1327.1999.00543.x; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Trendeleva TA, 2012, BIOCHEMISTRY-MOSCOW+, V77, P1021, DOI 10.1134/S000629791209009X; Trnka J., 2008, THESIS U CAMBRIDGE; Trnka J, 2008, FREE RADICAL BIO MED, V44, P1406, DOI 10.1016/j.freeradbiomed.2007.12.036; Trnka J, 2009, FREE RADICAL RES, V43, P4, DOI 10.1080/10715760802582183; WINGROVE DE, 1986, J BIOL CHEM, V261, P5166; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Xu YK, 2007, FREE RADICAL RES, V41, P1, DOI 10.1080/10715760600911147	42	89	95	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0121837	10.1371/journal.pone.0121837	http://dx.doi.org/10.1371/journal.pone.0121837			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927600	Green Published, gold, Green Submitted			2022-12-27	WOS:000353713100005
J	Vemana, HP; Karim, ZA; Conlon, C; Khasawneh, FT				Vemana, Hari Priya; Karim, Zubair A.; Conlon, Christine; Khasawneh, Fadi T.			A Critical Role for the Transient Receptor Potential Channel Type 6 in Human Platelet Activation	PLOS ONE			English	Article							THROMBOXANE A(2) RECEPTORS; INTACT HUMAN-PLATELETS; OPERATED CA2+ ENTRY; G-PROTEINS; SHAPE CHANGE; FIBRINOGEN RECEPTOR; SIGNAL-TRANSDUCTION; MOUSE PLATELETS; G(I) PATHWAYS; A2 RECEPTOR	While calcium signaling is known to play vital roles in platelet function, the mechanisms underlying its receptor-operated calcium entry component (ROCE) remain poorly understood. It has been proposed, but never proven in platelets, that the canonical transient receptor potential channel-6 (TRPC6) mediates ROCE. Nonetheless, we have previously shown that the mouse TRPC6 regulates hemostasis, thrombogenesis by regulating platelet aggregation. In the present studies, we used a pharmacological approach to characterize the role of TRPC6 in human platelet biology. Thus, interestingly, we observed that a TRPC6 inhibitor exerted significant inhibitory effects on human platelet aggregation in a thromboxane receptor (TPR)-selective manner; no additional inhibition was observed in the presence of the calcium chelator BAPTA. This inhibitor also significantly inhibited human platelet secretion (dense and alpha granules), integrin IIb-IIIa, Akt and ERK phosphorylation, again, in a TPR-selective manner; no effects were observed in response to ADP receptor stimulation. Furthermore, there was a causal relationship between these inhibitory effects, and the capacity of the TRPC6 inhibitor to abrogate elevation in intracellular calcium, that was again found to be TPR-specific. This effect was not found to be due to antagonism of TPR, as the TRPC6 inhibitor did not displace the radiolabeled antagonist [H-3]SQ29,548 from its binding sites. Finally, our studies also revealed that TRPC6 regulates human clot retraction, as well as physiological hemostasis and thrombus formation, in mice. Taken together, our findings demonstrate, for the first time, that TRPC6 directly regulates TPR-dependent ROCE and platelet function. Moreover, these data highlight TRPC6 as a novel promising therapeutic strategy for managing thrombotic disorders.	[Vemana, Hari Priya; Karim, Zubair A.; Conlon, Christine; Khasawneh, Fadi T.] Western Univ Hlth Sci, Dept Pharmaceut Sci, Coll Pharm, Pomona, CA 91766 USA	Western University of Health Sciences	Khasawneh, FT (corresponding author), Western Univ Hlth Sci, Dept Pharmaceut Sci, Coll Pharm, Pomona, CA 91766 USA.	fkhasawneh@westernu.edu			American Heart Association [14GRNT20450127]	American Heart Association(American Heart Association)	This work was supported by the American Heart Association, Grant Number 14GRNT20450127 (to FTK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almirza WHM, 2012, CELL CALCIUM, V51, P12, DOI 10.1016/j.ceca.2011.10.001; Authi K. S., 2007, V179, P425; AUTHI KS, 1993, ADV EXP MED BIOL, V344, P83; Bauer M, 1999, BLOOD, V94, P1665, DOI 10.1182/blood.V94.5.1665.417k33_1665_1672; Behnke O, 1970, Int Rev Exp Pathol, V9, P1; Bhattacharya B, 2003, BRIT J PHARMACOL, V139, P156, DOI 10.1038/sj.bjp.0705208; Brass LF, 1997, THROMB HAEMOSTASIS, V78, P581; Carter RN, 2006, J PHYSIOL-LONDON, V576, P151, DOI 10.1113/jphysiol.2006.113886; CHARO IF, 1977, J CLIN INVEST, V60, P866, DOI 10.1172/JCI108841; Djellas Y, 1999, J BIOL CHEM, V274, P14325, DOI 10.1074/jbc.274.20.14325; Dorsam RT, 2004, J CLIN INVEST, V113, P340, DOI 10.1172/JCI200420986; Dorsam RT, 2002, J BIOL CHEM, V277, P47588, DOI 10.1074/jbc.M208778200; Du X, 1997, THROMB HAEMOSTASIS, V78, P96; Espinosa EVP, 2012, BIOCHEM BIOPH RES CO, V417, P853, DOI 10.1016/j.bbrc.2011.12.058; Gao YL, 2001, J PHARMACOL EXP THER, V296, P426; GHALI NI, 1984, PROSTAGLANDINS, V27, P865, DOI 10.1016/S0090-6980(84)80006-4; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HALUSHKA PV, 1989, ANNU REV PHARMACOL, V29, P213; HAMBERG M, 1975, P NATL ACAD SCI USA, V72, P2994, DOI 10.1073/pnas.72.8.2994; Hassock SR, 2002, BLOOD, V100, P2801, DOI 10.1182/blood-2002-03-0723; Huang JS, 2007, J BIOL CHEM, V282, P10210, DOI 10.1074/jbc.M605678200; Huang ZH, 2014, INTERNATIONAL CONFERENCE ON MECHANICAL DESIGN, MANUFACTURE AND AUTOMATION ENGINEERING (MDMAE 2014), P112; HUNG SC, 1983, BIOCHIM BIOPHYS ACTA, V728, P171, DOI 10.1016/0005-2736(83)90468-6; Karim ZA, 2013, BLOOD, V121, P4567, DOI 10.1182/blood-2012-11-470468; KATTELMAN EJ, 1986, THROMB RES, V41, P471, DOI 10.1016/0049-3848(86)91692-0; Kinsella BT, 1997, J PHARMACOL EXP THER, V281, P957; Klages B, 1999, J CELL BIOL, V144, P745, DOI 10.1083/jcb.144.4.745; KNEZEVIC I, 1993, J BIOL CHEM, V268, P26011; Krizaj D, 2005, EUR J NEUROSCI, V22, P3292, DOI 10.1111/j.1460-9568.2005.04469.x; Liao YY, 2009, P NATL ACAD SCI USA, V106, P3202, DOI 10.1073/pnas.0813346106; Lin OA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087026; Murad JP, 2012, BIOCHEM BIOPH RES CO, V421, P456, DOI 10.1016/j.bbrc.2012.04.011; Murad JP, 2012, BIOCHEM PHARMACOL, V83, P88, DOI 10.1016/j.bcp.2011.10.002; Murugappan S, 2006, FRONT BIOSCI-LANDMRK, V11, P1977, DOI 10.2741/1939; Nesbitt WS, 2003, J CELL BIOL, V160, P1151, DOI 10.1083/jcb.200207119; O'Brien KA, 2011, BLOOD, V118, P4215, DOI 10.1182/blood-2010-12-323204; OFFERMANNS S, 1994, P NATL ACAD SCI USA, V91, P504, DOI 10.1073/pnas.91.2.504; Offermanns S, 1997, NATURE, V389, P183, DOI 10.1038/38284; Offermanns S, 1996, J BIOL CHEM, V271, P26044, DOI 10.1074/jbc.271.42.26044; Osdoit S, 2001, J BIOL CHEM, V276, P6703, DOI 10.1074/jbc.M008945200; OWEN NE, 1981, AM J PHYSIOL, V241, pH613, DOI 10.1152/ajpheart.1981.241.4.H613; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; PARISE LV, 1984, J PHARMACOL EXP THER, V228, P240; Quinton TM, 2002, BIOCHEM J, V368, P535, DOI 10.1042/BJ20020226; Ramanathan G, 2012, J THROMB HAEMOST, V10, P419, DOI 10.1111/j.1538-7836.2011.04596.x; Roedding AS, 2006, LIFE SCI, V80, P89, DOI 10.1016/j.lfs.2006.08.021; SHATTIL SJ, 1987, J BIOL CHEM, V262, P992; SHENKER A, 1991, J BIOL CHEM, V266, P9309; Singh I, 2007, J BIOL CHEM, V282, P7833, DOI 10.1074/jbc.M608288200; USHIKUBI F, 1994, MOL PHARMACOL, V46, P808; Varga-Szabo D, 2008, PFLUG ARCH EUR J PHY, V457, P377, DOI 10.1007/s00424-008-0531-4; Yang J, 2000, P NATL ACAD SCI USA, V97, P9984, DOI 10.1073/pnas.180194597; Yang X, 1997, THROMB RES, V88, P317, DOI 10.1016/S0049-3848(97)00261-2	53	24	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125764	10.1371/journal.pone.0125764	http://dx.doi.org/10.1371/journal.pone.0125764			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928636	gold, Green Submitted, Green Published			2022-12-27	WOS:000353713100117
J	Mohamadi, H; Vandervalk, BP; Raymond, A; Jackman, SD; Chu, J; Breshears, CP; Birol, I				Mohamadi, Hamid; Vandervalk, Benjamin P.; Raymond, Anthony; Jackman, Shaun D.; Chu, Justin; Breshears, Clay P.; Birol, Inanc			DIDA: Distributed Indexing Dispatched Alignment	PLOS ONE			English	Article							DNA-SEQUENCES; BLOOM FILTERS; LOCAL ALIGNMENT; READ ALIGNMENT; LARGE GENOMES; EFFICIENT; MEMORY; SEARCH; TOOL; ULTRAFAST	One essential application in bioinformatics that is affected by the high-throughput sequencing data deluge is the sequence alignment problem, where nucleotide or amino acid sequences are queried against targets to find regions of close similarity. When queries are too many and/or targets are too large, the alignment process becomes computationally challenging. This is usually addressed by preprocessing techniques, where the queries and/or targets are indexed for easy access while searching for matches. When the target is static, such as in an established reference genome, the cost of indexing is amortized by reusing the generated index. However, when the targets are non-static, such as contigs in the intermediate steps of a de novo assembly process, a new index must be computed for each run. To address such scalability problems, we present DIDA, a novel framework that distributes the indexing and alignment tasks into smaller subtasks over a cluster of compute nodes. It provides a workflow beyond the common practice of embarrassingly parallel implementations. DIDA is a cost-effective, scalable and modular framework for the sequence alignment problem in terms of memory usage and runtime. It can be employed in large-scale alignments to draft genomes and intermediate stages of de novo assembly runs. The DIDA source code, sample files and user manual are available through http://www.bcgsc.ca/platform/bioinfo/software/dida. The software is released under the British Columbia Cancer Agency License (BCCA), and is free for academic use.	[Mohamadi, Hamid; Vandervalk, Benjamin P.; Raymond, Anthony; Jackman, Shaun D.; Chu, Justin; Birol, Inanc] British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; [Mohamadi, Hamid; Jackman, Shaun D.; Chu, Justin] Univ British Columbia, Dept Bioinformat, Vancouver, BC V5Z 1M9, Canada; [Birol, Inanc] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Birol, Inanc] Simon Fraser Univ, Sch Comp Sci, Burnaby, BC V5A 1S6, Canada; [Mohamadi, Hamid; Breshears, Clay P.] Intel Corp, Intel Hlth & Life Sci, Hillsboro, OR 97124 USA	British Columbia Cancer Agency; University of British Columbia; University of British Columbia; Simon Fraser University; Intel Corporation	Birol, I (corresponding author), British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada.	ibirol@bcgsc.ca	Birol, Inanc/G-5440-2011; Jackman, Shaun/G-9622-2013	Birol, Inanc/0000-0003-0950-7839; Vandervalk, Ben/0000-0002-3082-3476; Jackman, Shaun/0000-0002-9275-5966	British Columbia Cancer Foundation; Genome British Columbia; Genome Canada; Health and Life Sciences Group at Intel Corporation; National Institutes of Health [R01HG007182]; Intel Corporation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007182] Funding Source: NIH RePORTER	British Columbia Cancer Foundation; Genome British Columbia; Genome Canada(Genome Canada); Health and Life Sciences Group at Intel Corporation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intel Corporation(Intel Corporation); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors received funding from British Columbia Cancer Foundation (bccancerfoundation.com), Genome British Columbia (genomebc.ca), Genome Canada (genomecanada.ca), and Health and Life Sciences Group at Intel Corporation, (www.intel.com/healthcare/). The work is also partially funded by the National Institutes of Health under award number R01HG007182. The content of this work is solely the responsibility of the authors and does not necessarily represent the official views of any of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Intel Corporation provided support in the form of salaries for Clay P. Breshears and provided travel support for Hamid Mohamadi, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouelhoda MI, 2002, LECT NOTES COMPUT SC, V2452, P449; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Birol I, 2013, BIOINFORMATICS, V29, P1492, DOI 10.1093/bioinformatics/btt178; BLOOM BH, 1970, COMMUN ACM, V13, P422, DOI 10.1145/362686.362692; Broder A., 2004, INTERNET MATH, V1, P485, DOI [DOI 10.1080/15427951.2004.10129096, 10.1080/15427951.2004.10129096]; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Chen YH, 2009, BIOINFORMATICS, V25, P2514, DOI 10.1093/bioinformatics/btp486; Chikhi R, 2013, ALGORITHM MOL BIOL, V8, DOI 10.1186/1748-7188-8-22; Chu J, 2014, BIOINFORMATICS, V30, P3402, DOI 10.1093/bioinformatics/btu558; Ferragina P, 2000, ANN IEEE SYMP FOUND, P390, DOI 10.1109/SFCS.2000.892127; Hach F, 2010, NAT METHODS, V7, P576, DOI 10.1038/nmeth0810-576; Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Johnson D. S., 1985, Journal of Complexity, V1, P65, DOI 10.1016/0885-064X(85)90022-6; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lam TW, 2008, BIOINFORMATICS, V24, P791, DOI 10.1093/bioinformatics/btn032; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H., 2013, ARXIV E PRINTS; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Ma B, 2002, BIOINFORMATICS, V18, P440, DOI 10.1093/bioinformatics/18.3.440; MANBER U, 1993, SIAM J COMPUT, V22, P935, DOI 10.1137/0222058; Manber U, 1990, P 1 ANN ACM SIAM S D, P319; Marco-Sola S, 2012, NAT METHODS, V9, P1185, DOI [10.1038/NMETH.2221, 10.1038/nmeth.2221]; Meek C., 2003, VLDB, P910, DOI DOI 10.1016/B978-012722442-8/50085-9; Melsted P, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-333; Myers EW, 2005, BIOINFORMATICS, V21, P79, DOI 10.1093/bioinformatics/bti1114; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Publisi SJ, 2007, ACM COMPUT SURV, V39, DOI 10.1145/1242471.1242472; Salikhov K, 2014, ALGORITHM MOL BIOL, V9, DOI 10.1186/1748-7188-9-2; Schatz MC, 2009, BIOINFORMATICS, V25, P1363, DOI 10.1093/bioinformatics/btp236; Simpson JT, 2012, GENOME RES, V22, P549, DOI 10.1101/gr.126953.111; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Smith AD, 2009, BIOINFORMATICS, V25, P2841, DOI 10.1093/bioinformatics/btp533; Stranneheim H, 2010, BIOINFORMATICS, V26, P1595, DOI 10.1093/bioinformatics/btq230; Vazirani V., 2001, APPROXIMATION ALGORI; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	42	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0126409	10.1371/journal.pone.0126409	http://dx.doi.org/10.1371/journal.pone.0126409			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923767	Green Submitted, Green Published, gold			2022-12-27	WOS:000353711600175
J	Chan, SM; Lee, MS; Lu, CH; Cherng, CH; Huang, YS; Yeh, CC; Kuo, CY; Wu, ZF				Chan, Shun-Ming; Lee, Meei-Shyuan; Lu, Chueng-He; Cherng, Chen-Hwan; Huang, Yuan-Shiou; Yeh, Chun-Chang; Kuo, Chan-Yang; Wu, Zhi-Fu			Confounding Factors to Predict the Awakening Effect-Site Concentration of Propofol in Target-Controlled Infusion Based on Propofol and Fentanyl Anesthesia	PLOS ONE			English	Article							MANUALLY CONTROLLED INFUSION; GENERAL-ANESTHESIA; CONSCIOUSNESS; REMIFENTANIL; SUFENTANIL; PHARMACODYNAMICS; PHARMACOKINETICS; SURGERY; AGE; ALFENTANIL	We conducted a large retrospective study to investigate the confounding factors that predict Ce ROC under propofol-based TIVA with TCI. We recorded sex, age, height, weight, Ce LOC, Ce ROC, total propofol and fentanyl consumption dose, and anesthetic time. Simple linear regression models were used to identify potential predictors of Ce ROC, and multiple linear regression models were used to identify the confounding predictors of Ce ROC. We found that Ce ROC correlated with age, sex, Ce LOC, and both total fentanyl and propofol consumption dose. The prediction formula was: Ce ROC = 0.87 - 0.06 x age + 0.18 x Ce LOC + 0.04 (if fentanyl consumption > 150 mu g; if not, ignore this value) + 0.07 x (1 or 2, according to the total propofol consumption dose, 1 for a propofol amount 1000-2000 mg and 2 for a propofol amount > 2000 mg). We simplified the formula further as Ce ROC = 0.87 - 0.06 x age + 0.18 x Ce LOC. In conclusion, Ce ROC can be predicted under TCI with propofol- and fentanyl-based TIVA. The confounding factors that predicted propofol Ce ROC are age, sex, Ce LOC, and total consumption dose of propofol and fentanyl.	[Chan, Shun-Ming; Lu, Chueng-He; Cherng, Chen-Hwan; Huang, Yuan-Shiou; Yeh, Chun-Chang; Kuo, Chan-Yang; Wu, Zhi-Fu] Triserv Gen Hosp, Dept Anesthesiol, Taipei, Taiwan; [Chan, Shun-Ming; Lu, Chueng-He; Cherng, Chen-Hwan; Huang, Yuan-Shiou; Yeh, Chun-Chang; Kuo, Chan-Yang; Wu, Zhi-Fu] Natl Def Med Ctr, Taipei, Taiwan; [Lee, Meei-Shyuan] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chan, Shun-Ming; Wu, Zhi-Fu] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan	Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center	Wu, ZF (corresponding author), Triserv Gen Hosp, Dept Anesthesiol, Taipei, Taiwan.	aneswu@gmail.com	Yeh, Chun-Chang/AFS-9309-2022; Wu, Zhi-Fu/ABE-6379-2020					Aceto P, 2007, NEUROREPORT, V18, P823, DOI 10.1097/WNR.0b013e3280e129f5; [Anonymous], 1979, ASA Newsl, V43, P3; BRODY H, 1992, ACTA NEUROL SCAND, V85, P40, DOI 10.1111/j.1600-0404.1992.tb05037.x; Chan S.M., 2009, MED SCI, V29, P75; Chen J.L., 2013, MED SCI, V33, P205; Chiang MH, 2013, ENDOSCOPY, V45, P907, DOI 10.1055/s-0033-1344645; De Cosmo G, 2005, CURR DRUG TARGETS, V6, P741; De Cosmo G, 2005, NEUROL RES, V27, P433, DOI 10.1179/016164105X21724; Gan TJ, 1999, ANESTHESIOLOGY, V90, P1283, DOI 10.1097/00000542-199905000-00010; Glass PS, 2009, MILLERS ANESTHESIA, P997; Hentgen E, 2002, ANESTH ANALG, V95, P597, DOI 10.1097/00000539-200209000-00019; Horng Huei-Chi, 2007, Acta Anaesthesiol Taiwan, V45, P205; Hoymork SC, 2005, BRIT J ANAESTH, V95, P627, DOI 10.1093/bja/aei245; Iwakiri H, 2005, ANESTH ANALG, V100, P107, DOI 10.1213/01.ANE.0000139358.15909.EA; Jung SM, 2011, ACTA ANAESTH SCAND, V55, P110, DOI 10.1111/j.1399-6576.2010.02327.x; Kreuer S, 2005, EUR J ANAESTH, V22, P123, DOI 10.1017/S0265021505000232; Lentschener C, 2003, ACTA ANAESTH SCAND, V47, P84, DOI 10.1034/j.1399-6576.2003.470115.x; Lin BF, 2012, J NEUROSURG ANESTH, V24, P127, DOI 10.1097/ANA.0b013e31823c4a24; Lu Chueng-He, 2014, Acta Anaesthesiol Taiwan, V52, P6, DOI 10.1016/j.aat.2014.05.004; Lysakowski C, 2001, BRIT J ANAESTH, V86, P523, DOI 10.1093/bja/86.4.523; Nunes CS, 2009, J CLIN ANESTH, V21, P3, DOI 10.1016/j.jclinane.2008.06.011; Nunes CS, 2005, J NEUROSURG ANESTH, V17, P110, DOI 10.1097/01.ana.0000163198.02742.9d; Schnider TW, 1998, ANESTHESIOLOGY, V88, P1170, DOI 10.1097/00000542-199805000-00006; Schnider TW, 1999, ANESTHESIOLOGY, V90, P1502, DOI 10.1097/00000542-199906000-00003; Schuttler J, 1988, Anaesthesia, V43 Suppl, P2, DOI 10.1111/j.1365-2044.1988.tb09059.x; SHAFER A, 1988, ANESTHESIOLOGY, V69, P348, DOI 10.1097/00000542-198809000-00011; VUYK J, 1992, ANESTHESIOLOGY, V77, P3, DOI 10.1097/00000542-199207000-00002; Vuyk J, 1999, Minerva Anestesiol, V65, P215; Vuyk J, 2001, BRIT J ANAESTH, V86, P183, DOI 10.1093/bja/86.2.183; Wu ZF, 2014, ANESTH ANALG, V119, P1393, DOI 10.1213/ANE.0000000000000435; Yeganeh Naser, 2010, Middle East Journal of Anesthesiology, V20, P785	31	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0124343	10.1371/journal.pone.0124343	http://dx.doi.org/10.1371/journal.pone.0124343			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938415	Green Published, Green Submitted, gold			2022-12-27	WOS:000353943000024
J	Cui, FC; Yang, KC; Li, YQ				Cui, Fengchao; Yang, Kecheng; Li, Yunqi			Investigate the Binding of Catechins to Trypsin Using Docking and Molecular Dynamics Simulation	PLOS ONE			English	Article							DENSITY-FUNCTIONAL THERMOCHEMISTRY; GREEN TEA POLYPHENOLS; ALPHA-AMYLASE; LUNG-CANCER; INHIBITORS; PROTEIN; ENERGY; CELLS; (-)-EPIGALLOCATECHIN-3-GALLATE; CONSUMPTION	To explore the inhibitory mechanism of catechins for digestive enzymes, we investigated the binding mode of catechins to a typical digestive enzyme-trypsin and analyzed the structure- activity relationship of catechins, using an integration of molecular docking, molecular dynamics simulation and binding free energy calculation. We found that catechins with different structures bound to a conservative pocket S1 of trypsin, which is comprised of residues 189-195, 214-220 and 225-228. In the trypsin-catechin complexes, Asp189 by forming strong hydrogen bonding, and Gln192, Trp215 and Gly216 through hydrophobic interactions, all significantly contribute to the binding of catechins. The number and the position of hydroxyl and aromatic groups, the structure of stereoisomers, and the orientation of catechins in the binding pocket S1 of trypsin all affect the binding affinity. The binding affinity is in the order of Epigallocatechin gallate (EGCG) > Epicatechin gallate (ECG) > Epicatechin (EC) > Epigallocatechin (EGC), and 2R-3R EGCG shows the strongest binding affinity out of other stereoisomers. Meanwhile, the synergic conformational changes of residues and catechins were also analyzed. These findings will be helpful in understanding the knowledge of interactions between catechins and trypsin and referable for the design of novel polyphenol based functional food and nutriceutical formulas.	[Li, Yunqi] Chinese Acad Sci, Changchun Inst Appl Chem, Key Lab Synthet Rubber, Changchun 130022, Peoples R China; Chinese Acad Sci, Changchun Inst Appl Chem, Lab Adv Power Sources, Changchun 130022, Peoples R China	Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS	Li, YQ (corresponding author), Chinese Acad Sci, Changchun Inst Appl Chem, Key Lab Synthet Rubber, Changchun 130022, Peoples R China.	yunqi@ciac.ac.cn	Yang, kecheng/Y-8236-2018; Li, Yunqi/C-8372-2016	Li, Yunqi/0000-0002-5190-3037	National Natural Science Foundation of China [21374117]; 100 Talents Program of Chinese Academy of Sciences; China Postdoctoral Science Foundation [2014M561310]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 100 Talents Program of Chinese Academy of Sciences(Chinese Academy of Sciences); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study was supported by the National Natural Science Foundation of China (21374117) (http://www.nsfc.gov.cn/publish/portal1/) to YQL, the 100 Talents Program of Chinese Academy of Sciences to YQL, and the China Postdoctoral Science Foundation (2014M561310) to FCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe I, 2000, BIOCHEM BIOPH RES CO, V268, P767, DOI 10.1006/bbrc.2000.2217; Afaq F, 2003, ONCOGENE, V22, P9254, DOI 10.1038/sj.onc.1207035; BAXTER J, 1981, J OPER RES SOC, V32, P815, DOI 10.2307/2581397; BECKE AD, 1992, J CHEM PHYS, V96, P2155, DOI 10.1063/1.462066; BECKE AD, 1992, J CHEM PHYS, V97, P9173, DOI 10.1063/1.463343; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bertoldi M, 2001, BIOCHEM BIOPH RES CO, V284, P90, DOI 10.1006/bbrc.2001.4945; Blum C, 2008, STUD COMPUT INTELL, V114, P1, DOI 10.1007/978-3-540-78295-7; Case D.A., 2012, AMBER; Chen JZ, 2013, J COMPUT AID MOL DES, V27, P965, DOI 10.1007/s10822-013-9693-z; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Dupradeau FY, 2010, PHYS CHEM CHEM PHYS, V12, P7821, DOI 10.1039/c0cp00111b; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Ewald PP, 1921, ANN PHYS-BERLIN, V64, P253; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fisher SJ, 2012, ACTA CRYSTALLOGR D, V68, P800, DOI 10.1107/S0907444912012589; Frazier RA, 2006, J PHARMACEUT BIOMED, V41, P1602, DOI 10.1016/j.jpba.2006.02.004; Ghosh KS, 2004, BIOCHEM BIOPH RES CO, V325, P807, DOI 10.1016/j.bbrc.2004.10.116; GRAF L, 1988, P NATL ACAD SCI USA, V85, P4961, DOI 10.1073/pnas.85.14.4961; Grater F, 2005, J PHYS CHEM B, V109, P10474, DOI 10.1021/jp044185y; HARA Y, 1990, AGR BIOL CHEM TOKYO, V54, P1939, DOI 10.1080/00021369.1990.10870239; He Q, 2007, FOOD CHEM, V101, P1178, DOI 10.1016/j.foodchem.2006.03.020; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hou TJ, 2007, J MED CHEM, V50, P1177, DOI 10.1021/jm0609162; Hou TJ, 2011, BIOINFORMATICS, V27, P1814, DOI 10.1093/bioinformatics/btr294; Huang HH, 2004, J SCI FOOD AGR, V84, P121, DOI 10.1002/jsfa.1610; Huang HH, 2008, EUR FOOD RES TECHNOL, V227, P361, DOI 10.1007/s00217-007-0729-2; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ishii T, 2010, MOL NUTR FOOD RES, V54, P816, DOI 10.1002/mnfr.200900071; Jia XD, 2002, CANCER EPIDEM BIOMAR, V11, P1663; Ju J, 2005, CANCER RES, V65, P10623, DOI 10.1158/0008-5472.CAN-05-1949; Kao YH, 2006, MOL NUTR FOOD RES, V50, P188, DOI 10.1002/mnfr.200500109; Kato Y, 1998, EUR J CANCER, V34, P1117, DOI 10.1016/S0959-8049(98)00077-X; Koshikawa N, 1998, AM J PATHOL, V153, P937, DOI 10.1016/S0002-9440(10)65635-0; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Lee JY, 2011, B KOREAN CHEM SOC, V32, P2222, DOI 10.5012/bkcs.2011.32.7.2222; Li DF, 2014, APPL NUMER MATH, V82, P1, DOI 10.1016/j.apnum.2014.01.008; Li YQ, 2014, J PHYS CHEM B, V118, P10362, DOI 10.1021/jp5048503; Liebschner D, 2013, ACTA CRYSTALLOGR D, V69, P1447, DOI 10.1107/S0907444913009050; Ma WZ, 2005, BIOPHYS J, V89, P1183, DOI 10.1529/biophysj.104.057158; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Maurya PK, 2009, NAT PROD RES, V23, P1072, DOI 10.1080/14786410802267643; Mendilaharsu M, 1998, LUNG CANCER-J IASLC, V19, P101, DOI 10.1016/S0169-5002(97)00075-5; Meng FL, 2010, BIOCHEMISTRY-US, V49, P8127, DOI 10.1021/bi100939a; MIEHLICH B, 1989, CHEM PHYS LETT, V157, P200, DOI 10.1016/0009-2614(89)87234-3; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Nyberg P, 2006, EXP CELL RES, V312, P1219, DOI 10.1016/j.yexcr.2005.12.024; Okimoto N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000528; Pascal C, 2007, J AGR FOOD CHEM, V55, P4895, DOI 10.1021/jf0704108; Peters U, 2001, AM J EPIDEMIOL, V154, P495, DOI 10.1093/aje/154.6.495; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sahoo BR, 2014, MOL BIOSYST, V10, P1104, DOI 10.1039/c3mb70600a; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Scalmani G., 2016, GAUSSIAN 09; Sinha S, 2012, ACS CHEM NEUROSCI, V3, P451, DOI 10.1021/cn200133x; Soreide K, 2006, J PATHOL, V209, P147, DOI 10.1002/path.1999; Srinivasan J, 1998, J AM CHEM SOC, V120, P9401, DOI 10.1021/ja981844+; Sueoka N, 2001, ANN NY ACAD SCI, V928, P274; Suganuma M, 2001, J CANCER RES CLIN, V127, P69, DOI 10.1007/s004320000189; Tao Y, 2010, J BIOMOL STRUCT DYN, V28, P143, DOI 10.1080/073911010010524953; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Velayutham P, 2008, CURR MED CHEM, V15, P1840; Ruiz-Perez MV, 2012, J CHEM INF MODEL, V52, P113, DOI 10.1021/ci200221z; WALTER J, 1982, ACTA CRYSTALLOGR B, V38, P1462, DOI 10.1107/S0567740882006153; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang XW, 2014, MOL BIOSYST, V10, P1196, DOI 10.1039/c4mb00013g; Wang YP, 2012, LUNG CANCER, V78, P169, DOI 10.1016/j.lungcan.2012.08.009; Weinbach Y, 2005, J COMPUT PHYS, V209, P193, DOI 10.1016/j.jcp.2005.03.015; Wu XL, 2013, INT J FOOD SCI TECH, V48, P2340, DOI 10.1111/ijfs.12223; Xiao JB, 2011, MOL NUTR FOOD RES, V55, P310, DOI 10.1002/mnfr.201000208; Yen S G PYB, 1995, J KOREAN SOC FOOD NU, V24, P154; Zhang Y, 2004, J COMPUT CHEM, V25, P865, DOI 10.1002/jcc.20011; Zhu QZ, 2014, J PHARM INNOV, V9, P331, DOI 10.1007/s12247-014-9202-5	79	60	61	4	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125848	10.1371/journal.pone.0125848	http://dx.doi.org/10.1371/journal.pone.0125848			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938485	gold, Green Submitted, Green Published			2022-12-27	WOS:000353943000107
J	Gao, J; Munch, SB				Gao, Jin; Munch, Stephan B.			Does Reproductive Investment Decrease Telomere Length in Menidia menidia?	PLOS ONE			English	Article							NATURAL-SELECTION; QUANTITATIVE PCR; LIFE-HISTORIES; AGE; EVOLUTION; GROWTH; FISH; EXPRESSION; LONGEVITY; DYNAMICS	Given finite resources, intense investment in one life history trait is expected to reduce investment in others. Although telomere length appears to be strongly tied to age in many taxa, telomere maintenance requires energy. We therefore hypothesize that telomere maintenance may trade off against other life history characters. We used natural variation in laboratory populations of Atlantic silversides (Menidia menidia) to study the relationship between growth, fecundity, life expectancy, and relative telomere length. In keeping with several other studies on fishes, we found no clear dependence of telomere length on age. However, we did find that more fecund fish tended to have both reduced life expectancy and shorter telomeres. This result is consistent with the hypothesis that there is a trade-off between telomere maintenance and reproductive output.	[Gao, Jin] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; [Munch, Stephan B.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Gao, J (corresponding author), Natl Taiwan Univ, Inst Oceanog, Taipei 10617, Taiwan.	jingao84@gmail.com; Steve.Munch@noaa.gov						ALLSOPP RC, 1995, EXP CELL RES, V220, P194, DOI 10.1006/excr.1995.1306; Almroth BC, 2012, BIOL OPEN, V1, P922, DOI 10.1242/bio.20121446; Anchelin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016955; Au DWT, 2009, COMP BIOCHEM PHYS C, V149, P161, DOI 10.1016/j.cbpc.2008.08.005; Bidder. Senesence, 1932, BR MED J, V2, P583; Bize P, 2009, P R SOC B, V276, P1679, DOI 10.1098/rspb.2008.1817; Bronikowski AM, 2008, AGE, V30, P169, DOI 10.1007/s11357-008-9060-5; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chanov EL, 1973, INT J AVIAN SCI, V116, P217; CONOVER DO, 1982, ESTUARIES, V5, P275, DOI 10.2307/1351750; CONOVER DO, 1992, J FISH BIOL, V41, P161, DOI 10.1111/j.1095-8649.1992.tb03876.x; Downs KP, 2012, COMP BIOCHEM PHYS C, V155, P89, DOI 10.1016/j.cbpc.2011.05.005; Fleming IA, 1996, REV FISH BIOL FISHER, V6, P379, DOI 10.1007/BF00164323; Foote CG, 2011, J ZOOL, V283, P203, DOI 10.1111/j.1469-7998.2010.00774.x; GADGIL M, 1970, American Naturalist, V104, P1, DOI 10.1086/282637; Gopalakrishnan S, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-78; Hartmann N, 2009, MECH AGEING DEV, V130, P290, DOI 10.1016/j.mad.2009.01.003; Hatakeyama H, 2008, MECH AGEING DEV, V129, P550, DOI 10.1016/j.mad.2008.05.006; Hatase H, 2008, GENES GENET SYST, V83, P423, DOI 10.1266/ggs.83.423; Haussmann MF, 2008, MOL BIOL EVOL, V25, P220, DOI 10.1093/molbev/msm244; Haussmann MF, 2003, P ROY SOC B-BIOL SCI, V270, P1387, DOI 10.1098/rspb.2003.2385; Haussmann MF, 2002, OECOLOGIA, V130, P325, DOI 10.1007/s00442-001-0827-y; Henriques CM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003214; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; HIRSHFIELD MF, 1975, P NATL ACAD SCI USA, V72, P2227, DOI 10.1073/pnas.72.6.2227; Horn T, 2008, AUST J ZOOL, V56, P207, DOI 10.1071/ZO08046; HUTCHINGS JA, 1993, ECOLOGY, V74, P673, DOI 10.2307/1940795; Izzo C, 2014, COPEIA, P87, DOI 10.1643/CI-11-162; JOHNSON MS, 1974, EVOLUTION, V28, P607, DOI 10.1111/j.1558-5646.1974.tb00793.x; Kim YJ, 2011, ASIAN AUSTRAL J ANIM, V24, P603, DOI 10.5713/ajas.2011.10187; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Klapper W, 1998, FEBS LETT, V434, P409, DOI 10.1016/S0014-5793(98)01020-5; Klapper W, 2001, MECH AGEING DEV, V122, P695, DOI 10.1016/S0047-6374(01)00223-8; Lopez de Abechuco E, 2013, REV INVESTIG MAR, V20, P30; Lund TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007688; McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331; Munch SB, 2003, EVOLUTION, V57, P2119, DOI 10.1554/02-711; Nakagawa S, 2004, MOL ECOL, V13, P2523, DOI 10.1111/j.1365-294X.2004.02291.x; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Pauliny A, 2006, MOL ECOL, V15, P1681, DOI 10.1111/j.1365-294X.2006.02862.x; REZNICK D, 1985, OIKOS, V44, P257, DOI 10.2307/3544698; Reznick DN, 2004, NATURE, V431, P1095, DOI 10.1038/nature02936; Rollings N, 2014, NATURWISSENSCHAFTEN, V101, P241, DOI 10.1007/s00114-014-1142-x; Salomons HM, 2009, P ROY SOC B-BIOL SCI, V276, P3157, DOI 10.1098/rspb.2009.0517; SCHAFFER WM, 1974, ECOLOGY, V55, P291, DOI 10.2307/1935217; Scott NM, 2006, SOUTHEAST NAT, V5, P685, DOI 10.1656/1528-7092(2006)5[685:TLSWBL]2.0.CO;2; Selz Y, 2007, GENE, V401, P114, DOI 10.1016/j.gene.2007.07.005; Setiamarga DHE, 2008, MOL PHYLOGENET EVOL, V49, P598, DOI 10.1016/j.ympev.2008.08.008; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Zeichner SL, 1999, BLOOD, V93, P2824	50	18	18	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125674	10.1371/journal.pone.0125674	http://dx.doi.org/10.1371/journal.pone.0125674			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938489	Green Published, gold, Green Submitted			2022-12-27	WOS:000353943000088
J	Murthy, SRK; Sherrin, T; Jansen, C; Nijholt, I; Robles, M; Dolga, AM; Andreotti, N; Sabatier, JM; Knaus, HG; Penner, R; Todorovic, C; Blank, T				Murthy, Saravana R. K.; Sherrin, Tessi; Jansen, Chad; Nijholt, Ingrid; Robles, Michael; Dolga, Amalia M.; Andreotti, Nicolas; Sabatier, Jean-Marc; Knaus, Hans-Guenther; Penner, Reinhold; Todorovic, Cedomir; Blank, Thomas			Small-Conductance Ca2+-Activated Potassium Type 2 Channels Regulate the Formation of Contextual Fear Memory	PLOS ONE			English	Article							LONG-TERM POTENTIATION; K+ CHANNELS; SYNAPTIC PLASTICITY; CONJUNCTIVE REPRESENTATIONS; SK2 CHANNELS; C-TERMINUS; HIPPOCAMPUS; BRAIN; RECEPTORS; EXPRESSION	Small-conductance, Ca2+ activated K+ channels (SK channels) are expressed at high levels in brain regions responsible for learning and memory. In the current study we characterized the contribution of SK2 channels to synaptic plasticity and to different phases of hippocampal memory formation. Selective SK2 antisense-treatment facilitated basal synaptic transmission and theta-burst induced LTP in hippocampal brain slices. Using the selective SK2 antagonist Lei-Dab(7) or SK2 antisense probes, we found that hippocampal SK2 channels are critical during two different time windows: 1) blockade of SK2 channels before the training impaired fear memory, whereas, 2) blockade of SK2 channels immediately after the training enhanced contextual fear memory. We provided the evidence that the post-training cleavage of the SK2 channels was responsible for the observed bidirectional effect of SK2 channel blockade on memory consolidation. Thus, Lei-Dab(7)-injection before training impaired the C-terminal cleavage of SK2 channels, while Lei-Dab(7) given immediately after training facilitated the C-terminal cleavage. Application of the synthetic peptide comprising a leucine-zipper domain of the C-terminal fragment to Jurkat cells impaired SK2 channel-mediated currents, indicating that the endogenously cleaved fragment might exert its effects on memory formation by blocking SK2 channel-mediated currents. Our present findings suggest that SK2 channel proteins contribute to synaptic plasticity and memory not only as ion channels but also by additionally generating a SK2 C-terminal fragment, involved in both processes. The modulation of fear memory by down-regulating SK2 C-terminal cleavage might have applicability in the treatment of anxiety disorders in which fear conditioning is enhanced.	[Murthy, Saravana R. K.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cellular Neurobiol Sect, Program Dev Neurosci, Bethesda, MD USA; [Sherrin, Tessi; Jansen, Chad; Robles, Michael; Penner, Reinhold; Todorovic, Cedomir; Blank, Thomas] Univ Hawaii, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96822 USA; [Jansen, Chad; Penner, Reinhold] Queens Med Ctr, Lab Cell & Mol Signaling, Honolulu, HI USA; [Nijholt, Ingrid] Isala Acad, Isala Clin, Zwolle, Netherlands; [Dolga, Amalia M.] Univ Marburg, Dept Pharmacol & Toxicol, Marburg, Germany; [Andreotti, Nicolas; Sabatier, Jean-Marc] Lab INSERM UMR1097, Marseille 09, France; [Knaus, Hans-Guenther] Med Univ Innsbruck, Div Mol & Cellular Pharmacol, A-6020 Innsbruck, Austria; [Blank, Thomas] Univ Freiburg, Inst Neuropathol, D-79106 Freiburg, Germany	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Hawaii System; The Queen's Medical Center; Isala Clinics; Philipps University Marburg; Institut National de la Sante et de la Recherche Medicale (Inserm); Medical University of Innsbruck; University of Freiburg	Todorovic, C (corresponding author), Univ Hawaii, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96822 USA.	cedomir@hawaii.edu	Dolga, Amalia/C-9664-2018; Nijholt, Ingrid/AAB-8740-2021	Nijholt, Ingrid/0000-0003-4820-7505; Penner, Reinhold/0000-0002-5366-1537; Dolga, Amalia/0000-0001-5400-5614; Robles, Michael/0000-0002-5112-3882; SABATIER, Jean-Marc/0000-0002-9040-5647	National Institutes of Health [G12MD007601, U54MD008149, MH086733]; Angus Foundation [115054959]; Hawaiian Community Foundation [13ADVC-60319]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH086733] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD008149, G12MD007601] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Angus Foundation; Hawaiian Community Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by the National Institutes of Health grants G12MD007601, U54MD008149 and MH086733. Additional funding was provided by grants from the Angus Foundation (115054959) and the Hawaiian Community Foundation (13ADVC-60319).	Best PJ, 2001, ANNU REV NEUROSCI, V24, P459, DOI 10.1146/annurev.neuro.24.1.459; Blank T, 2003, NAT NEUROSCI, V6, P911, DOI 10.1038/nn1101; Blank T, 2002, J NEUROSCI, V22, P3788; Desai R, 2000, J BIOL CHEM, V275, P39954, DOI 10.1074/jbc.M001562200; Fakira AK, 2014, BIOL PSYCHIAT, V75, P105, DOI 10.1016/j.biopsych.2013.04.026; Fanselow MS, 2000, BEHAV BRAIN RES, V110, P73, DOI 10.1016/S0166-4328(99)00186-2; Garcia-Negredo G, 2014, J NEUROSCI, V34, P14793, DOI 10.1523/JNEUROSCI.2038-14.2014; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Hammond RS, 2006, J NEUROSCI, V26, P1844, DOI 10.1523/JNEUROSCI.4106-05.2006; Hulme JT, 2002, J BIOL CHEM, V277, P4079, DOI 10.1074/jbc.M109814200; Ishii TM, 1997, J BIOL CHEM, V272, P23195, DOI 10.1074/jbc.272.37.23195; Kim JY, 2008, PROTEINS, V70, P568, DOI 10.1002/prot.21634; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kramar EA, 2004, J NEUROSCI, V24, P5151, DOI 10.1523/JNEUROSCI.0800-04.2004; Lee AL, 2003, J NEUROCHEM, V86, P1079, DOI 10.1046/j.1471-4159.2003.01880.x; Lee WS, 2003, J BIOL CHEM, V278, P25940, DOI 10.1074/jbc.M302091200; Lin MT, 2008, NAT NEUROSCI, V11, P170, DOI 10.1038/nn2041; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McKay BM, 2012, J NEUROPHYSIOL, V108, P863, DOI 10.1152/jn.00025.2012; Mpari Bedel, 2005, Journal of Integrative Neuroscience, V4, P381, DOI 10.1142/S0219635205000884; Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449; Rudy JW, 2001, COGN AFFECT BEHAV NE, V1, P66, DOI 10.3758/CABN.1.1.66; Rudy JW, 1999, BEHAV NEUROSCI, V113, P867, DOI 10.1037/0735-7044.113.5.867; Sailer CA, 2004, MOL CELL NEUROSCI, V26, P458, DOI 10.1016/j.mcn.2004.03.002; Sailer CA, 2002, J NEUROSCI, V22, P9698; Shah M, 2000, BRIT J PHARMACOL, V129, P627, DOI 10.1038/sj.bjp.0703111; Shakkottai VG, 2001, J BIOL CHEM, V276, P43145, DOI 10.1074/jbc.M106981200; Sherrin T, 2010, J NEUROSCI, V30, P13348, DOI 10.1523/JNEUROSCI.3492-10.2010; Simmerman HKB, 1996, J BIOL CHEM, V271, P5941, DOI 10.1074/jbc.271.10.5941; Stackman RW, 2008, LEARN MEMORY, V15, P208, DOI 10.1101/lm.906808; Stackman RW, 2002, J NEUROSCI, V22, P10163; Stote DL, 2004, BEHAV NEUROSCI, V118, P253, DOI 10.1037/0735-7044.118.1.253; Vick KA, 2010, NEUROPHARMACOLOGY, V58, P650, DOI 10.1016/j.neuropharm.2009.11.008; Wiltgen BJ, 2001, BEHAV NEUROSCI, V115, P26, DOI 10.1037/0735-7044.115.1.26	34	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0127264	10.1371/journal.pone.0127264	http://dx.doi.org/10.1371/journal.pone.0127264			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938421	gold, Green Published, Green Submitted			2022-12-27	WOS:000353943000164
J	Balla, P; Maros, ME; Barna, G; Antal, I; Papp, G; Sapi, Z; Athanasou, NA; Benassi, MS; Picci, P; Krenacs, T				Balla, Peter; Maros, Mate Elod; Barna, Gabor; Antal, Imre; Papp, Gergo; Sapi, Zoltan; Athanasou, Nicholas Anthony; Benassi, Maria Serena; Picci, Pierro; Krenacs, Tibor			Prognostic Impact of Reduced Connexin43 Expression and Gap Junction Coupling of Neoplastic Stromal Cells in Giant Cell Tumor of Bone	PLOS ONE			English	Article							CORNEAL FIBROBLASTS; GENE-EXPRESSION; GROWTH-FACTOR; IN-VIVO; COMMUNICATION; MYOFIBROBLASTS; CX43; DIFFERENTIATION; MARROW; TISSUE	Missense mutations of the GJA1 gene encoding the gap junction channel protein connexin43 (Cx43) cause bone malformations resulting in oculodentodigital dysplasia (ODDD), while GJA1 null and ODDD mutant mice develop osteopenia. In this study we investigated Cx43 expression and channel functions in giant cell tumor of bone (GCTB), a locally aggressive osteolytic lesion with uncertain progression. Cx43 protein levels assessed by immunohistochemistry were correlated with GCTB cell types, clinico-radiological stages and progression free survival in tissue microarrays of 89 primary and 34 recurrent GCTB cases. Cx43 expression, phosphorylation, subcellular distribution and gap junction coupling was also investigated and compared between cultured neoplastic GCTB stromal cells and bone marow stromal cells or HDFa fibroblasts as a control. In GCTB tissues, most Cx43 was produced by CD163 negative neoplastic stromal cells and less by CD163 positive reactive monocytes/macrophages or by giant cells. Significantly less Cx43 was detected in alpha-smooth muscle actin positive than a-smooth muscle actin negative stromal cells and in osteoclast-rich tumor nests than in the adjacent reactive stroma. Progressively reduced Cx43 production in GCTB was significantly linked to advanced clinico-radiological stages and worse progression free survival. In neoplastic GCTB stromal cell cultures most Cx43 protein was localized in the paranuclear-Golgi region, while it was concentrated in the cell membranes both in bone marrow stromal cells and HDFa fibroblasts. In Western blots, alkaline phosphatase sensitive bands, linked to serine residues (Ser369, Ser372 or Ser373) detected in control cells, were missing in GCTB stromal cells. Defective cell membrane localization of Cx43 channels was in line with the significantly reduced transfer of the 622 Da fluorescing calcein dye between GCTB stromal cells. Our results show that significant downregulation of Cx43 expression and gap junction coupling in neoplastic stromal cells are associated with the clinical progression and worse prognosis in GCTB.	[Balla, Peter; Maros, Mate Elod; Barna, Gabor; Papp, Gergo; Sapi, Zoltan; Krenacs, Tibor] Semmelweis Univ, Dept Pathol & Expt Canc Res 1, H-1085 Budapest, Hungary; [Antal, Imre] Semmelweis Univ, Dept Orthopaed, H-1085 Budapest, Hungary; [Athanasou, Nicholas Anthony] Univ Oxford, Nuffield Orthopaed Ctr, Dept Pathol, Oxford, England; [Benassi, Maria Serena; Picci, Pierro] Inst Orthopaed Rizzoli, Expt Oncol Lab, Bologna, Italy; [Maros, Mate Elod] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Neuroradiol, Mannheim, Germany; [Krenacs, Tibor] Semmelweis Univ, Hunragian Acad Sci, MTA SE Tumor Progress Res Grp, H-1085 Budapest, Hungary	Semmelweis University; Semmelweis University; Nuffield Orthopaedic Centre; University of Oxford; Ruprecht Karls University Heidelberg; Semmelweis University	Krenacs, T (corresponding author), Semmelweis Univ, Dept Pathol & Expt Canc Res 1, H-1085 Budapest, Hungary.	krenacst@gmail.com	Maros, Máté E./ABB-3203-2021; Picci, Piero/J-5979-2016	Maros, Máté E./0000-0002-1589-8699; Picci, Piero/0000-0002-8519-4101	EuroBoNet an EU - Network of Excellence Programme [LSHC-CT-2006-018814]	EuroBoNet an EU - Network of Excellence Programme	This work was supported by EuroBoNet an EU FP6 funded Network of Excellence Programme (LSHC-CT-2006-018814). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberghini M, 2010, VIRCHOWS ARCH, V456, P97, DOI 10.1007/s00428-009-0863-2; Amanatullah DF, 2014, ORTHOPEDICS, V37, P112, DOI 10.3928/01477447-20140124-08; Antal I, 1999, INT ORTHOP, V23, P315, DOI 10.1007/s002640050381; Asazuma-Nakamura Y, 2009, EXP CELL RES, V315, P1190, DOI 10.1016/j.yexcr.2008.12.021; Asumda FZ, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-44; Axelsen LN, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00130; Balke M, 2008, J CANCER RES CLIN, V134, P969, DOI 10.1007/s00432-008-0370-x; Baum JR, 2012, AM J PHYSIOL-HEART C, V302, pH790, DOI 10.1152/ajpheart.00498.2011; Behjati S, 2013, NAT GENET, V45, P1479, DOI 10.1038/ng.2814; Bellido T, 2011, BONE, V49, P50, DOI 10.1016/j.bone.2010.08.008; Buo AM, 2014, FEBS LETT, V588, P1315, DOI 10.1016/j.febslet.2014.01.025; Burghardt RC, 1995, J MEMBRANE BIOL, V148, P243; CAMPANACCI M, 1987, J BONE JOINT SURG AM, V69A, P106, DOI 10.2106/00004623-198769010-00018; Chanson M, 2005, BBA-BIOMEMBRANES, V1711, P197, DOI 10.1016/j.bbamem.2004.10.005; Churko JM, 2011, HUM MUTAT, V32, P456, DOI 10.1002/humu.21472; Civitelli R, 2008, ARCH BIOCHEM BIOPHYS, V473, P188, DOI 10.1016/j.abb.2008.04.005; Dickson BC, 2008, MODERN PATHOL, V21, P369, DOI 10.1038/modpathol.2008.29; Dunn CA, 2012, J BIOL CHEM, V287, P2600, DOI 10.1074/jbc.M111.276261; ENNEKING WF, 1986, CLIN ORTHOP RELAT R, P9; Etzerodt A, 2013, ANTIOXID REDOX SIGN, V18, P2352, DOI 10.1089/ars.2012.4834; Forsyth R, 2008, J PATHOL, V214, P555, DOI 10.1002/path.2301; Gonzalez-Nieto D, 2012, BLOOD, V119, P5144, DOI 10.1182/blood-2011-07-368506; Gorunova L, 2009, GENE CHROMOSOME CANC, V48, P583, DOI 10.1002/gcc.20667; Hemingway F, 2012, VIRCHOWS ARCH, V460, P525, DOI 10.1007/s00428-012-1235-x; Horvai AE, 2008, MODERN PATHOL, V21, P423, DOI 10.1038/modpathol.3801015; Horvai AE, 2012, MODERN PATHOL, V25, P1452, DOI 10.1038/modpathol.2012.110; Knowles HJ, 2008, J PATHOL, V215, P56, DOI 10.1002/path.2319; Knowles HJ, 2009, HISTOL HISTOPATHOL, V24, P337, DOI 10.14670/HH-24.337; Krenacs T, 1998, AM J PATHOL, V152, P993; Kumta SM, 2003, LIFE SCI, V73, P1427, DOI 10.1016/S0024-3205(03)00434-X; Lau YS, 2005, HUM PATHOL, V36, P945, DOI 10.1016/j.humpath.2005.07.005; Lee CH, 2008, MODERN PATHOL, V21, P531, DOI 10.1038/modpathol.3801023; Lee MJ, 1998, CLIN RADIOL, V53, P481, DOI 10.1016/S0009-9260(98)80166-9; Lehner B, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-495; Li ZY, 2006, AM J PHYSIOL-CELL PH, V290, pC1248, DOI 10.1152/ajpcell.00428.2005; Lloyd SAJ, 2010, CLIN REV BONE MINER, V8, P189, DOI 10.1007/s12018-011-9084-8; Loiselle AE, 2013, BONE, V54, P205, DOI 10.1016/j.bone.2012.08.132; Moskovszky L, 2009, GENE CHROMOSOME CANC, V48, P468, DOI 10.1002/gcc.20656; Nielsen MS, 2012, COMPR PHYSIOL, V2, P1981, DOI 10.1002/cphy.c110051; Oviedo-Orta E, 2000, IMMUNOLOGY, V99, P578, DOI 10.1046/j.1365-2567.2000.00991.x; Park DJ, 2007, CELL COMMUN ADHES, V14, P211, DOI 10.1080/15419060701755958; Paznekas WA, 2009, HUM MUTAT, V30, P724, DOI 10.1002/humu.20958; Balla P, 2011, HISTOPATHOLOGY, V59, P376, DOI 10.1111/j.1365-2559.2011.03948.x; Petridou S, 1996, INVEST OPHTH VIS SCI, V37, P1740; Plotkin LI, 2013, BONE, V52, P157, DOI 10.1016/j.bone.2012.09.030; ROCK MG, 1986, J BONE JOINT SURG AM, V68A, P1073, DOI 10.2106/00004623-198668070-00016; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Saez JC, 2014, FEBS LETT, V588, P1205, DOI 10.1016/j.febslet.2014.03.004; Schajnovitz A, 2011, NAT IMMUNOL, V12, P391, DOI 10.1038/ni.2017; Schilling AF, 2008, J CELL MOL MED, V12, P2497, DOI 10.1111/j.1582-4934.2008.00275.x; Sohl G, 2004, CARDIOVASC RES, V62, P228, DOI 10.1016/j.cardiores.2003.11.013; Solan JL, 2014, FEBS LETT, V588, P1423, DOI 10.1016/j.febslet.2014.01.049; Spanakis SG, 1998, INVEST OPHTH VIS SCI, V39, P1320; Steensma MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069101; SUNG HW, 1982, J BONE JOINT SURG AM, V64, P755, DOI 10.2106/00004623-198264050-00015; Szendroi M, 2004, J BONE JOINT SURG BR, V86B, P5, DOI 10.1302/0301-620X.86B1.14053; van der Heijden L, 2014, ONCOLOGIST, V19, P550, DOI 10.1634/theoncologist.2013-0432; Watkins M, 2011, MOL BIOL CELL, V22, P1240, DOI 10.1091/mbc.E10-07-0571; Werner M, 2006, INT ORTHOP, V30, P484, DOI 10.1007/s00264-006-0215-7; Yogo K, 2002, FEBS LETT, V531, P132, DOI 10.1016/S0014-5793(02)03441-5; Zheng MH, 2000, HUM PATHOL, V31, P804, DOI 10.1053/hupa.2000.8441; Zhou JZ, 2014, FEBS LETT, V588, P1186, DOI 10.1016/j.febslet.2014.01.001	62	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125316	10.1371/journal.pone.0125316	http://dx.doi.org/10.1371/journal.pone.0125316			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933380	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000353887100097
J	Houben-van Herten, M; Bai, GN; Hafkamp, E; Landgraf, JM; Raat, H				Houben-van Herten, Marieke; Bai, Guannan; Hafkamp, Esther; Landgraf, Jeanne M.; Raat, Hein			Determinants of Health-Related Quality of Life in School-Aged Children: A General Population Study in the Netherlands	PLOS ONE			English	Article							REPORTED HEALTH; IMPORTANT DIFFERENCE; CHILDHOOD; QUESTIONNAIRE; RELIABILITY; ADOLESCENTS; OVERWEIGHT; VALIDITY; GENDER; IMPACT	Background Health related quality of life is the functional effect of a medical condition and/or its therapy upon a patient, and as such is particularly suitable for describing the general health of children. The objective of this study was to identify and confirm potential determinants of health-related quality of life in children aged 4-11 years in the general population in the Netherlands. Understanding such determinants may provide insights into more targeted public health policy. Methods As part of a population based cross sectional study, the Child Health Questionnaire (CHQ) Parental Form 28 was used to measure health-related quality of life in school-aged children in a general population sample. Parents of 10,651 children aged 4-11 years were interviewed from January 2001 to December 2009. Results Multivariate and regression analyses demonstrated a declined CHQ Physical Summary score for children who had >1 conditions, disorders or acute health complaints and who were greater consumers of healthcare; children with a non-western immigrant background; and children whose parents did not work. Lower CHQ Psychosocial Summary score was reported for children who had >1 conditions, disorders or acute health complaints, boys, children of single parents and obese children. Conclusion The best predictors of health-related quality of life are variables that describe use of health care and the number of disorders and health complaints. Nonetheless, a number of demographic, socio-economic and family/environmental determinants contribute to a child's health-related quality of life as well.	[Houben-van Herten, Marieke] Stat Netherlands, Socioecon & Spatial Stat, Heerlen, Netherlands; [Bai, Guannan; Hafkamp, Esther; Raat, Hein] Univ Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands; [Landgraf, Jeanne M.] HealthActCHQ, Boston, MA USA	Erasmus University Rotterdam; Erasmus MC	Houben-van Herten, M (corresponding author), Stat Netherlands, Socioecon & Spatial Stat, Heerlen, Netherlands.	m.vanherten@cbs.nl			HealthActCHQ	HealthActCHQ	The authors received no specific funding for this work. Co-author Jeanne M. Landgraf is employed by HealthActCHQ. HealthActCHQ provided support in the form of salary for author JML, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Banning R, 2012, SAMPLING THEORY SAMP; Beckung E, 2008, CHILD CARE HLTH DEV, V34, P806, DOI 10.1111/j.1365-2214.2008.00877.x; Bisegger C, 2005, SOZ PRAVENTIV MED, V50, P281, DOI 10.1007/s00038-005-4094-2; BJORKQVIST K, 1992, AGGRESSIVE BEHAV, V18, P117, DOI 10.1002/1098-2337(1992)18:2<117::AID-AB2480180205>3.0.CO;2-3; Botterweck A, 2003, FEASIBILITY RELIABIL; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P93; CELLA DF, 1995, SEMIN ONCOL, V22, P73; Cohen J, 1977, STAT POWER ANAL BEHA, V2 2 ed, DOI DOI 10.1016/B978-0-12-179060-8.50006-2; Cole JC, 2009, CEPHALALGIA, V29, P1180, DOI 10.1111/j.1468-2982.2009.01852.x; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Fagerland MW, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-78; Gerdtham U.-G., 2001, J SOC EC, V30, P553, DOI [10.1016/S1053-5357(01)00118-4, DOI 10.1016/S1053-5357(01)00118-4]; Hafkamp-de Groen E, 2013, EUR RESPIR J, V41, P952, DOI 10.1183/09031936.00015712; JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; Landgraf JM, 1999, CHILD HLTH QUESTIONN; Landgraf JM, 1998, MEASURING HLTH RELAT; Landgraf JM, 2005, PAEDIAT CLIN RES MAN; Landgraf JM, 2004, ASSESSING QUALITY LI; Mansour ME, 2003, PEDIATRICS, V111, P1372, DOI 10.1542/peds.111.6.1372; Masood M, 2014, J PUBLIC HEALTH DENT, V74, P13, DOI 10.1111/j.1752-7325.2012.00374.x; Michel G, 2009, QUAL LIFE RES, V18, P1147, DOI 10.1007/s11136-009-9538-3; Nichol MB, 2008, QUAL LIFE RES, V17, P955, DOI 10.1007/s11136-008-9369-7; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Ottova V, 2012, QUAL LIFE RES, V21, P59, DOI 10.1007/s11136-011-9922-7; Raat H, 2005, J EPIDEMIOL COMMUN H, V59, P75, DOI 10.1136/jech.2003.012914; Raat H, 2002, QUAL LIFE RES, V11, P575, DOI 10.1023/A:1016393311799; Ravens-Sieberer U, 2008, VALUE HEALTH, V11, P645, DOI 10.1111/j.1524-4733.2007.00291.x; Ruijsbroek A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-225; Schipper H., 1996, QUALITY LIFE PHARMAC, V2, P11; Schulpen TWJ, 1996, EUR J PEDIATR, V155, P351, DOI 10.1007/BF01955260; Simon AE, 2008, PEDIATRICS, V121, pE118, DOI 10.1542/peds.2007-0480; Spurrier NJ, 2003, AUST NZ J PUBL HEAL, V27, P27, DOI 10.1111/j.1467-842X.2003.tb00376.x; van Grieken A, 2013, QUAL LIFE RES, V22, P917, DOI 10.1007/s11136-012-0211-x; von Rueden U, 2006, J EPIDEMIOL COMMUN H, V60, P130, DOI 10.1136/jech.2005.039792; Wake M, 2002, INT J OBESITY, V26, P717, DOI 10.1038/sj.ijo.0801974; Waters E, 2008, CHILD CARE HLTH DEV, V34, P418, DOI 10.1111/j.1365-2214.2008.00825.x; Waters E, 2000, PEDIATRICS, V106, P1422, DOI 10.1542/peds.106.6.1422; Wilkins AJ, 2004, J PAEDIATR CHILD H, V40, P102, DOI 10.1111/j.1440-1754.2004.00309.x; Williams J, 2005, JAMA-J AM MED ASSOC, V293, P70, DOI 10.1001/jama.293.1.70; Wu XY, 2010, QUAL LIFE RES, V19, P969, DOI 10.1007/s11136-010-9663-z	40	27	28	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125083	10.1371/journal.pone.0125083	http://dx.doi.org/10.1371/journal.pone.0125083			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH2XA	25933361	Green Published, Green Submitted, gold			2022-12-27	WOS:000353887100076
J	Leodolter, J; Warweg, J; Weber-Ban, E				Leodolter, Julia; Warweg, Jannis; Weber-Ban, Eilika			The Mycobacterium tuberculosis ClpP1P2 Protease Interacts Asymmetrically with Its ATPase Partners ClpX and ClpC1	PLOS ONE			English	Article							COMPLEX-FORMATION; AAA+ PROTEINS; AXIAL CHANNEL; PEPTIDASE; ANTIBIOTICS; MODEL; DETERMINANTS; DEGRADATION; MUTAGENESIS; ACTIVATION	Clp chaperone-proteases are cylindrical complexes built from ATP-dependent chaper-one rings that stack onto a proteolytic ClpP double-ring core to carry out substrate pro tein degradation. Interaction of the ClpP particle with the chaperone is mediated by an N-terminal loop and a hydrophobic surface patch on the ClpP ring surface. In contrast to E. coli, Mycobacterium tuberculosis harbors not only one but two ClpP protease subunits, ClpP1 and ClpP2, and a homo-heptameric ring of each assembles to form the ClpP1P2 double-ring core. Consequently, this hetero double-ring presents two different potential binding surfaces for the interaction with the chaperones ClpX and ClpC1. To investigate whether ClpX or ClpC1 might preferentially interact with one or the other double-ring face, we mutated the hydrophobic chaperone-interaction patch on either ClpP1 or ClpP2, generating ClpP1P2 particles that are defective in one of the two binding patches and thereby in their ability to interact with their chaperone partners. Using chaperone-mediated degradation of ssrA-tagged model substrates, we show that both Mycobacterium tuberculosis Clp chaperones require the intact interaction face of ClpP2 to support degradation, resulting in an asymmetric complex where chaperones only bind to the ClpP2 side of the proteolytic core. This sets the Clp proteases of Mycobacterium tuberculosis, and probably other Actinobacteria, apart from the well-studied E. coli system, where chaperones bind to both sides of the protease core, and it frees the ClpP1 interaction interface for putative new binding partners.	[Leodolter, Julia; Warweg, Jannis; Weber-Ban, Eilika] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Weber-Ban, E (corresponding author), ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.	eilika@mol.biol.ethz.ch		Weber-Ban, Eilika/0000-0002-5773-9274; Leodolter, Julia/0000-0003-3632-056X	Swiss National Science Foundation [31003A_141236]; ETH (Eidgenossische Technische Hochschule Zurich) Research Grant [ETH-1311-2]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH (Eidgenossische Technische Hochschule Zurich) Research Grant	This work was supported by a Swiss National Science Foundation grant (31003A_141236) to EWB and an ETH (Eidgenossische Technische Hochschule Zurich) Research Grant (ETH-1311-2) to EWB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian T, 2012, EMBO J, V31, P1529, DOI 10.1038/emboj.2012.5; Alexopoulos J, 2013, MOL MICROBIOL, V90, P167, DOI 10.1111/mmi.12356; Alexopoulos JA, 2012, J STRUCT BIOL, V179, P202, DOI 10.1016/j.jsb.2012.05.003; Baker TA, 2012, BBA-MOL CELL RES, V1823, P15, DOI 10.1016/j.bbamcr.2011.06.007; BALDWIN RL, 1986, P NATL ACAD SCI USA, V83, P8069, DOI 10.1073/pnas.83.21.8069; Benaroudj N, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-61; Bottcher T, 2008, J AM CHEM SOC, V130, P14400, DOI 10.1021/ja8051365; Brotz-Oesterhelt H, 2005, NAT MED, V11, P1082, DOI 10.1038/nm1306; Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162; Compton CL, 2013, ACS CHEM BIOL, V8, P2669, DOI 10.1021/cb400577b; Effantin G, 2010, J BIOL CHEM, V285, P14834, DOI 10.1074/jbc.M109.090498; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Gavrish E, 2014, CHEM BIOL, V21, P509, DOI 10.1016/j.chembiol.2014.01.014; Geertsma ER, 2011, BIOCHEMISTRY-US, V50, P3272, DOI 10.1021/bi200178z; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Gribun A, 2005, J BIOL CHEM, V280, P16185, DOI 10.1074/jbc.M414124200; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Gur Eyal, 2013, Subcell Biochem, V66, P3, DOI 10.1007/978-94-007-5940-4_1; Ingvarsson H, 2007, ACTA CRYSTALLOGR D, V63, P249, DOI 10.1107/S0907444906050530; Jassal M, 2009, LANCET INFECT DIS, V9, P19, DOI 10.1016/S1473-3099(08)70260-3; Joshi SA, 2004, NAT STRUCT MOL BIOL, V11, P404, DOI 10.1038/nsmb752; Kang SG, 2004, J STRUCT BIOL, V148, P338, DOI 10.1016/j.jsb.2004.07.004; KESSEL M, 1995, J MOL BIOL, V250, P587, DOI 10.1006/jmbi.1995.0400; Kim YI, 2001, NAT STRUCT BIOL, V8, P230, DOI 10.1038/84967; Kirstein J, 2009, EMBO MOL MED, V1, P37, DOI 10.1002/emmm.200900002; Kress W, 2009, J BIOL CHEM, V284, P31441, DOI 10.1074/jbc.M109.022319; Laederach J., 2014, MOL CHAPERONES INTER, P419; Lee BG, 2010, NAT STRUCT MOL BIOL, V17, P471, DOI 10.1038/nsmb.1787; Li DHS, 2010, CHEM BIOL, V17, P959, DOI 10.1016/j.chembiol.2010.07.008; Maglica Z, 2009, STRUCTURE, V17, P508, DOI 10.1016/j.str.2009.02.014; Matthews B., 2001, HYDROPHOBIC INTERACT; Moore SD, 2007, ANNU REV BIOCHEM, V76, P101, DOI 10.1146/annurev.biochem.75.103004.142733; Ollinger J, 2012, J BACTERIOL, V194, P663, DOI 10.1128/JB.06142-11; Personne Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060228; Raju RM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002511; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Schmitt EK, 2011, ANGEW CHEM INT EDIT, V50, P5889, DOI 10.1002/anie.201101740; Schmitz KR, 2014, P NATL ACAD SCI USA, V111, pE4587, DOI 10.1073/pnas.1417120111; Schmitz KR, 2014, MOL MICROBIOL, V93, P617, DOI 10.1111/mmi.12694; Schubert OT, 2013, CELL HOST MICROBE, V13, P602, DOI 10.1016/j.chom.2013.04.008; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Snider J, 2008, BIOCHEM SOC T, V36, P72, DOI 10.1042/BST0360072; Vangone A, 2011, BIOINFORMATICS, V27, P2915, DOI 10.1093/bioinformatics/btr484; Viala J, 2002, MOL MICROBIOL, V44, P633, DOI 10.1046/j.1365-2958.2002.02907.x; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Zeiler E, 2011, ANGEW CHEM INT EDIT, V50, P11001, DOI 10.1002/anie.201104391	50	33	34	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125345	10.1371/journal.pone.0125345	http://dx.doi.org/10.1371/journal.pone.0125345			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933022	gold, Green Published, Green Submitted			2022-12-27	WOS:000353887100101
J	Liu, SD; Jing, F; Yu, CX; Gao, L; Qin, YJ; Zhao, JJ				Liu, Shudong; Jing, Fei; Yu, Chunxiao; Gao, Ling; Qin, Yejun; Zhao, Jiajun			AICAR-Induced Activation of AMPK Inhibits TSH/SREBP-2/HMGCR Pathway in Liver	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN-2; DENSITY-LIPOPROTEIN UPTAKE; FATTY LIVER; SUBCLINICAL HYPOTHYROIDISM; ADIPOSE-TISSUE; CHOLESTEROL-METABOLISM; CARDIOVASCULAR-DISEASE; GENE-EXPRESSION; LIPID PROFILE; KINASE	Our previous study found that thyroid-stimulating hormone promoted sterol regulatory element- binding protein-2 (SREBP-2) expression and suppressed AMP-activated protein kinase (AMPK) activity in the liver, but it was unclear whether there was a direct link between TSH, AMPK and SREBP-2. Here, we demonstrate that the 5-aminoimidazole-4-carboxyamide ribonucleoside (AICAR)-induced activation of AMPK directly inhibited the expression of SREBP-2 and its target genes HMGCR and HMGCS, which are key enzymes in cholesterol biosynthesis, and suppressed the TSH-stimulated up-regulation of SREBP-2 in HepG2 cells; similar results were obtained in TSH receptor knockout mice. Furthermore, AMPK, an evolutionally conserved serine/threonine kinase, phosphorylated threonine residues in the precursor and nuclear forms of SREBP-2, and TSH interacted with AMPK to influence SREBP-2 phosphorylation. These findings may represent a molecular mechanism by which AMPK ameliorates the hepatic steatosis and hypercholesterolemia associated with high TSH levels in patients with subclinical hypothyroidism (SCH).	[Liu, Shudong; Jing, Fei; Yu, Chunxiao; Zhao, Jiajun] Shandong Univ, Prov Hosp, Dept Endocrinol, Jinan 250100, Peoples R China; [Gao, Ling] Shandong Univ, Prov Hosp, Cent Lab, Jinan 250100, Peoples R China; [Gao, Ling; Zhao, Jiajun] Shandong Acad Clin Med, Inst Endocrinol, Jinan, Peoples R China; [Qin, Yejun] Shandong Univ, Prov Hosp, Dept Pathol, Jinan 250100, Peoples R China; [Liu, Shudong] Shandong Rongjun Gen Hosp, Dept Endocrinol, Jinan, Peoples R China	Shandong University; Shandong University; Shandong University	Gao, L (corresponding author), Shandong Univ, Prov Hosp, Cent Lab, Jinan 250100, Peoples R China.	gaoling1@medmail.com.cn; qinyejun@163.com; jjzhao@medmail.com.cn	Zhao, Jiajun/W-2963-2018; Liu, Shudong/L-1329-2018	Zhao, Jiajun/0000-0003-3267-9292; Liu, Shudong/0000-0002-8382-5328	National Basic Research Program [2012CB524900]; National Natural Science Foundation [81230018, 81430020, 81170794, 81270869, 81400828, 81471006]	National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Basic Research Program (2012CB524900), and the National Natural Science Foundation (81230018, 81430020, 81170794, 81270869, 81400828, 81471006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato S, 2011, SCIENCE, V332, P247, DOI 10.1126/science.1201678; Andrade BM, 2011, AM J PHYSIOL-CELL PH, V300, pC1291, DOI 10.1152/ajpcell.00136.2010; Arito M, 2008, J BIOL CHEM, V283, P15224, DOI 10.1074/jbc.M800910200; Asvold BO, 2007, EUR J ENDOCRINOL, V156, P181, DOI 10.1530/eje.1.02333; Bijland S, 2013, CLIN SCI, V124, P491, DOI 10.1042/CS20120536; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Chung GE, 2012, J HEPATOL, V57, P150, DOI 10.1016/j.jhep.2012.02.027; Garduno-Garcia JD, 2010, EUR J ENDOCRINOL, V163, P273, DOI 10.1530/EJE-10-0312; Erem C, 2006, CLIN ENDOCRINOL, V64, P323, DOI 10.1111/j.1365-2265.2006.02464.x; Foretz M, 2005, DIABETES, V54, P1331, DOI 10.2337/diabetes.54.5.1331; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Karthick N, 2013, J CLIN DIAGN RES, V7, P2122, DOI 10.7860/JCDR/2013/5777.3448; Kim SJ, 2011, NEOPLASIA, V13, P167, DOI 10.1593/neo.10806; Knowles C, 2011, BIOCHEM BIOPH RES CO, V412, P249, DOI 10.1016/j.bbrc.2011.07.078; Kotzka J, 2004, J BIOL CHEM, V279, P22404, DOI 10.1074/jbc.M401198200; Lee S, 2012, INT J MOL SCI, V13, P5729, DOI 10.3390/ijms13055729; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luboshitzky R, 2002, THYROID, V12, P421, DOI 10.1089/105072502760043512; Min HK, 2012, CELL METAB, V15, P665, DOI 10.1016/j.cmet.2012.04.004; Peppa M, 2011, J LIPIDS, V2011, DOI 10.1155/2011/575840; Rice LM, 2014, J BIOL CHEM, V289, P17268, DOI 10.1074/jbc.M114.570390; Santos-Palacios S, 2013, CLIN ENDOCRINOL, V79, P874, DOI 10.1111/cen.12216; Sert A, 2013, PEDIATR CARDIOL, V34, P1166, DOI 10.1007/s00246-013-0638-z; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Tian LM, 2010, HEPATOLOGY, V52, P1401, DOI 10.1002/hep.23800; Toth JI, 2004, MOL CELL BIOL, V24, P8288, DOI 10.1128/MCB.24.18.8288-8300.2004; Walker AK, 2010, GENE DEV, V24, P1403, DOI 10.1101/gad.1901210; Wang TT, 2013, ENDOCR J, V60, P941; Xu L, 2012, J HEPATOL, V57, P1153, DOI 10.1016/j.jhep.2012.05.025; Yang J, 2008, BIOCHEM BIOPH RES CO, V370, P248, DOI 10.1016/j.bbrc.2008.03.094; Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012	36	37	41	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124951	10.1371/journal.pone.0124951	http://dx.doi.org/10.1371/journal.pone.0124951			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933205	Green Published, Green Submitted, gold			2022-12-27	WOS:000353887100068
J	Matsuda, S; Aoki, K; Kawamata, T; Kimotsuki, T; Kobayashi, T; Kuriki, H; Nakayama, T; Okugawa, S; Sugimura, Y; Tomita, M; Takahashi, Y				Matsuda, Shinichi; Aoki, Kotonari; Kawamata, Takuya; Kimotsuki, Tetsuji; Kobayashi, Takumi; Kuriki, Hiroshi; Nakayama, Terumi; Okugawa, Seigo; Sugimura, Yoshihiko; Tomita, Minami; Takahashi, Yoichiro			Bias in Spontaneous Reporting of Adverse Drug Reactions in Japan	PLOS ONE			English	Article							PHARMACOVIGILANCE DATABASE; NOTORIETY BIAS; ATTITUDES; PHARMACISTS; PORTUGAL	Background Attitudes of healthcare professionals regarding spontaneous reporting of adverse drug reactions (ADRs) in Japan are not well known, and Japan's unique system of surveillance, called early post-marketing phase vigilance (EPPV), may affect these reporting attitudes. Our objectives were to describe potential effects of EPPV and to test whether ADR seriousness, prominence, and frequency are related to changes in reporting over time. Methods A manufacturer's database of spontaneous ADR reports was used to extract data from individual case safety reports for 5 drugs subject to EPPV. The trend of reporting and the time lag between ADR onset and reporting to the manufacturer were examined. The following indices for ADRs occurring with each drug were calculated and analyzed to assess reporting trends: Serious: Non-serious ratio, High prominence: Low prominence ratio, and High frequency: Low frequency ratio. Results For all 5 drugs, the time lag between ADR onset and reporting to the manufacturer was shorter in the EPPV period than in the post-EPPV period. All drugs showed higher Serious: Non-serious ratios in the post-EPPV period. No specific patterns were observed for the High prominence: Low prominence ratio. The High frequency: Low frequency ratio for peginterferon alpha-2a and sevelamer hydrochloride decreased steadily throughout the study period. Conclusions Healthcare professionals may be more likely to report serious ADRs than to report non-serious ADRs, but the effect of event prominence on reporting trends is still unclear. Factors associated with ADR reporting attitude in Japan might be different from those in other countries because of EPPV and the involvement of medical representatives in the spontaneous reporting process. Pharmacovigilance specialists should therefore be cautious when comparing data between different time periods or different countries. Further studies are needed to elucidate the underlying mechanism of spontaneous ADR reporting in Japan.	[Matsuda, Shinichi; Aoki, Kotonari; Kawamata, Takuya; Kimotsuki, Tetsuji; Kobayashi, Takumi; Nakayama, Terumi; Okugawa, Seigo; Sugimura, Yoshihiko; Tomita, Minami; Takahashi, Yoichiro] Chugai Pharmaceut Co Ltd, Drug Safety Div, Tokyo, Japan; [Kuriki, Hiroshi] Chugai Pharmaceut Co Ltd, Clin Dev Div, Tokyo, Japan	Chugai Pharmaceutical Co., Ltd.; Roche Holding; Chugai Pharmaceutical Co., Ltd.; Roche Holding	Matsuda, S (corresponding author), Chugai Pharmaceut Co Ltd, Drug Safety Div, Tokyo, Japan.	matsudasni@chugai-pharm.co.jp	Matsuda, Shinichi/U-2515-2019	Matsuda, Shinichi/0000-0003-1822-1090	Chugai Pharmaceutical Co. Ltd.	Chugai Pharmaceutical Co. Ltd.	Chugai Pharmaceutical Co. Ltd. provided support in the form of salaries for authors SM, KA, T. Kawamata, T. Kimotsuki, T. Kobayashi, HK, TN, SO, YS, MT, and YT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bate A, 1998, EUR J CLIN PHARMACOL, V54, P315, DOI 10.1007/s002280050466; Brown EG, 1999, DRUG SAFETY, V20, P109, DOI 10.2165/00002018-199920020-00002; Council for International Organizations of Medical Sciences (CIOMS), 2014, PRACT APPR RISK MIN, P11; de Boissieu P, 2014, PHARMACOEPIDEM DR S, V23, P989, DOI 10.1002/pds.3622; DuMouchel W, 1999, AM STAT, V53, P177, DOI 10.2307/2686093; Gavaza P, 2011, BRIT J CLIN PHARMACO, V72, P143, DOI 10.1111/j.1365-2125.2011.03944.x; Ghosh P, 2015, PHARM STAT, V14, P20, DOI 10.1002/pst.1657; Hazell L, 2006, DRUG SAFETY, V29, P385, DOI 10.2165/00002018-200629050-00003; Herdeiro MT, 2006, DRUG SAFETY, V29, P331, DOI 10.2165/00002018-200629040-00004; Herdeiro MT, 2005, DRUG SAFETY, V28, P825, DOI 10.2165/00002018-200528090-00007; Herdeiro MT, 2004, J EVAL CLIN PRACT, V10, P483, DOI 10.1111/j.1365-2753.2003.00456.x; Inman WHW, 1996, BRIT J CLIN PHARMACO, V41, P434; Irujo M, 2007, DRUG SAFETY, V30, P1073, DOI 10.2165/00002018-200730110-00006; Kimura T, 2011, PHARMACOEPIDEM DR S, V20, P1237, DOI 10.1002/pds.2244; Lopez-Gonzalez E, 2009, DRUG SAFETY, V32, P19, DOI 10.2165/00002018-200932010-00002; Maeda R., 2014, JPN J PHARMACOEPIDEM, V19, P51, DOI [DOI 10.3820/JJPE.19.51, 10.3820/jjpe.19.51]; Meyboom RHB, 1999, DRUG SAFETY, V21, P429, DOI 10.2165/00002018-199921060-00001; Moulis G, 2012, BRIT J CLIN PHARMACO, V74, P201, DOI 10.1111/j.1365-2125.2012.04185.x; Pariente A, 2007, DRUG SAFETY, V30, P891, DOI 10.2165/00002018-200730100-00007; PETRI H, 1991, STAT MED, V10, P577, DOI 10.1002/sim.4780100409; Weber J.C.P., 1984, ADV INFLAMMAT RES, V6, P1; Yamada T, 2013, PHARMACOEPIDEM DR S, V22, P468, DOI 10.1002/pds.3378	22	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0126413	10.1371/journal.pone.0126413	http://dx.doi.org/10.1371/journal.pone.0126413			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933226	Green Submitted, gold, Green Published			2022-12-27	WOS:000353887100153
J	Xie, MQ; Xu, YJ; Zhang, YG; Hwang, TH; Kuang, R				Xie, MaoQiang; Xu, YingJie; Zhang, YaoGong; Hwang, TaeHyun; Kuang, Rui			Network-based Phenome-Genome Association Prediction by Bi-Random Walk	PLOS ONE			English	Article							PROTEIN-INTERACTION NETWORKS; INFLAMMATORY-BOWEL-DISEASE; GLOBAL ALIGNMENT; GENES; INTERACTOME; PRIORITIZATION; BIOINFORMATICS; DATABASE; CANCER; IL-6	Motivation The availability of ontologies and systematic documentations of phenotypes and their genetic associations has enabled large-scale network-based global analyses of the association between the complete collection of phenotypes (phenome) and genes. To provide a fundamental understanding of how the network information is relevant to phenotype-gene associations, we analyze the circular bigraphs (CBGs) in OMIM human disease phenotype-gene association network and MGI mouse phentoype-gene association network, and introduce a bi-random walk (BiRW) algorithm to capture the CBG patterns in the networks for unveiling human and mouse phenome-genome association. BiRW performs separate random walk simultaneously on gene interaction network and phenotype similarity network to explore gene paths and phenotype paths in CBGs of different sizes to summarize their associations as predictions. Results The analysis of both OMIM and MGI associations revealed that majority of the phenotypegene associations are covered by CBG patterns of small path lengths, and there is a clear correlation between the CBG coverage and the predictability of the phenotype-gene associations. In the experiments on recovering known associations in cross-validations on human disease phenotypes and mouse phenotypes, BiRW effectively improved prediction performance over the compared methods. The constructed global human disease phenome-genome association map also revealed interesting new predictions and phenotype-gene modules by disease classes.	[Xie, MaoQiang; Xu, YingJie; Zhang, YaoGong] Nankai Univ, Coll Software, Tianjin 300071, Peoples R China; [Hwang, TaeHyun] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Kuang, Rui] Univ Minnesota Twin Cities, Dept Comp Sci & Engn, Minneapolis, MN 55455 USA	Nankai University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Minnesota System; University of Minnesota Twin Cities	Kuang, R (corresponding author), Univ Minnesota Twin Cities, Dept Comp Sci & Engn, Minneapolis, MN 55455 USA.	kuang@cs.umn.edu			National Science Foundation [III 1117153, III 1149697]; Direct For Computer & Info Scie & Enginr [1117153] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work is supported by grant III 1117153 and III 1149697 from National Science Foundation (www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baranzini SE, 2009, CURR OPIN IMMUNOL, V21, P596, DOI 10.1016/j.coi.2009.09.014; Barrenas F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008090; Bult C, 2010, NUCLEIC ACIDS RES; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Chen Y, 2011, BIOINFORMATICS, V27, pI167, DOI 10.1093/bioinformatics/btr213; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Dinan TG, 2008, AM J GASTROENTEROL, V103, P2570, DOI 10.1111/j.1572-0241.2008.01871.x; Edwards D, 2004, TRENDS BIOTECHNOL, V22, P232, DOI 10.1016/j.tibtech.2004.03.002; Espinosa O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019693; Franke L, 2006, AM J HUM GENET, V78, P1011, DOI 10.1086/504300; Freimer N, 2003, NAT GENET, V34, P15, DOI 10.1038/ng0503-15; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Goldin RD, 2009, HISTOPATHOLOGY, V55, P218, DOI 10.1111/j.1365-2559.2008.03192.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hwang T., 2010, P SIAM INT C DAT MIN, P583; Hwang TH, 2011, BIOINFORMATICS, V27, P2692, DOI 10.1093/bioinformatics/btr463; Kobayashi T, 2010, CELL, V142, P787, DOI 10.1016/j.cell.2010.07.039; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Krishnan K, 2011, INFLAMM BOWEL DIS, V17, P410, DOI 10.1002/ibd.21316; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Laurent C, 2011, INFLAMM BOWEL DIS, V17, P232, DOI 10.1002/ibd.21451; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Li YJ, 2010, BIOINFORMATICS, V26, P1219, DOI 10.1093/bioinformatics/btq108; Linghu B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r91; Maoqiang Xie, 2012, Advances in Knowledge Discovery and Data Mining. Proceedings 16th Pacific-Asia Conference (PAKDD 2012), P292, DOI 10.1007/978-3-642-30220-6_25; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Mehan MR, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S62; Menendez A, 2009, J INFECT DIS, V200, P1703, DOI 10.1086/646608; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Rooman I, 2012, GUT, V61, P449, DOI 10.1136/gut.2010.235804; Scriver CR, 2004, J INHERIT METAB DIS, V27, P305, DOI 10.1023/B:BOLI.0000031100.26546.6e; Singh R, 2008, P NATL ACAD SCI USA, V105, P12763, DOI 10.1073/pnas.0806627105; Singh R, 2007, LECT NOTES COMPUT SC, V4453, P16; Strazzabosco M, 2011, GASTROENTEROLOGY, V140, P1855, DOI 10.1053/j.gastro.2011.04.030; Tucker AS, 2007, SEMIN CELL DEV BIOL, V18, P237, DOI 10.1016/j.semcdb.2007.01.006; van Driel MA, 2006, EUR J HUM GENET, V14, P535, DOI 10.1038/sj.ejhg.5201585; Vanunu O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000641; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27; Wu XB, 2009, BIOINFORMATICS, V25, P98, DOI 10.1093/bioinformatics/btn593; Xu JZ, 2006, BIOINFORMATICS, V22, P2800, DOI 10.1093/bioinformatics/btl467; Xu LM, 2012, NUCLEIC ACIDS RES, V40, pD1016, DOI 10.1093/nar/gkr1145; Yang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021502; Zhou DY, 2004, ADV NEUR IN, V16, P321	44	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125138	10.1371/journal.pone.0125138	http://dx.doi.org/10.1371/journal.pone.0125138			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933025	Green Submitted, Green Published, gold			2022-12-27	WOS:000353887100080
J	Yuksel, A; Olmez, T				Yuksel, Ayhan; Olmez, Tamer			A Neural Network-Based Optimal Spatial Filter Design Method for Motor Imagery Classification	PLOS ONE			English	Article							EEG	In this study, a novel spatial filter design method is introduced. Spatial filtering is an important processing step for feature extraction in motor imagery-based brain-computer interfaces. This paper introduces a new motor imagery signal classification method combined with spatial filter optimization. We simultaneously train the spatial filter and the classifier using a neural network approach. The proposed spatial filter network (SFN) is composed of two layers: a spatial filtering layer and a classifier layer. These two layers are linked to each other with non-linear mapping functions. The proposed method addresses two shortcomings of the common spatial patterns (CSP) algorithm. First, CSP aims to maximize the between-classes variance while ignoring the minimization of within-classes variances. Consequently, the features obtained using the CSP method may have large within-classes variances. Second, the maximizing optimization function of CSP increases the classification accuracy indirectly because an independent classifier is used after the CSP method. With SFN, we aimed to maximize the between-classes variance while minimizing within-classes variances and simultaneously optimizing the spatial filter and the classifier. To classify motor imagery EEG signals, we modified the well-known feed-forward structure and derived forward and backward equations that correspond to the proposed structure. We tested our algorithm on simple toy data. Then, we compared the SFN with conventional CSP and its multi-class version, called one-versus-rest CSP, on two data sets from BCI competition III. The evaluation results demonstrate that SFN is a good alternative for classifying motor imagery EEG signals with increased classification accuracy.	[Yuksel, Ayhan; Olmez, Tamer] Istanbul Tech Univ, Dept Elect & Commun Engn, TR-80626 Istanbul, Turkey	Istanbul Technical University	Yuksel, A (corresponding author), Istanbul Tech Univ, Dept Elect & Commun Engn, TR-80626 Istanbul, Turkey.	yukselay@itu.edu.tr	Olmez, Tamer/ABE-7998-2020	Olmez, Tamer/0000-0001-6124-2394				[Anonymous], 2011, IND ELECT HDB; Barachant A, 2013, NEUROCOMPUTING, V112, P172, DOI 10.1016/j.neucom.2012.12.039; Blankertz B, 2004, IEEE T BIO-MED ENG, V51, P1044, DOI 10.1109/TBME.2004.826692; Blankertz B., 2007, ADV NEURAL INFORM PR, P113; Blankertz B, 2014, BCI COMPETITION 3 ON; Blankertz B, 2008, IEEE SIGNAL PROC MAG, V25, P41, DOI 10.1109/MSP.2008.4408441; Blankertz B, 2006, IEEE T NEUR SYS REH, V14, P153, DOI 10.1109/TNSRE.2006.875642; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dornhege G, 2004, IEEE T BIO-MED ENG, V51, P993, DOI 10.1109/TBME.2004.827088; Duda RO, 2001, PATTERN CLASSIFICATI, V2nd, P20; Falzon O, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/045009; Fattahi D, 2013, NEUROCOMPUTING, V119, P165, DOI 10.1016/j.neucom.2013.03.044; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; HAGAN MT, 1994, IEEE T NEURAL NETWOR, V5, P989, DOI 10.1109/72.329697; Levenberg K., 1944, Q APPL MATH, V2, P431; Lotte F, 2011, IEEE T BIO-MED ENG, V58, P355, DOI 10.1109/TBME.2010.2082539; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; More J. J., 1978, Proceedings of the Biennial Conference on numerical analysis, P105; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Ramoser H, 2000, IEEE T REHABIL ENG, V8, P441, DOI 10.1109/86.895946; Reuderink B, 2008, TRCTIT0852; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Samek W, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026013; The MathWorks Inc, 2013, MATLAB VERS 8 1 0; Wang HX, 2012, IEEE T BIO-MED ENG, V59, P653, DOI 10.1109/TBME.2011.2177523; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Yamashita N., 2001, TOPICS NUMERICAL ANA, P239	29	25	27	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125039	10.1371/journal.pone.0125039	http://dx.doi.org/10.1371/journal.pone.0125039			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933101	Green Published, gold			2022-12-27	WOS:000353887100074
J	Jordao, EMA; Onishi, BKA; Xavier, GF				Akagi Jordao, Elisa Mari; Amaral Onishi, Barbara Kazue; Xavier, Gilberto Fernando			Pre-Training Reversible Inactivation of the Basal Amygdala (BA) Disrupts Contextual, but Not Auditory, Fear Conditioning, in Rats	PLOS ONE			English	Article							HIPPOCAMPAL-FORMATION; MEMORY CONSOLIDATION; FUNCTIONAL INACTIVATION; BASOLATERAL AMYGDALA; RETROGRADE-AMNESIA; DORSAL HIPPOCAMPUS; PERIRHINAL CORTEX; LATERAL AMYGDALA; MUSCIMOL; NUCLEI	The basolateral amygdala complex (BLA), including the lateral (LA), basal (BA) and accessory basal (AB) nuclei, is involved in acquisition of contextual and auditory fear conditioning. The BA is one of the main targets for hippocampal information, a brain structure critical for contextual learning, which integrates several discrete stimuli into a single configural representation. Congruent with the hodology, selective neurotoxic damage to the BA results in impairments in contextual, but not auditory, fear conditioning, similarly to the behavioral impairments found after hippocampal damage. This study evaluated the effects of muscimol-induced reversible inactivation of the BA during a simultaneous contextual and auditory fear conditioning training on later fear responses to both the context and the tone, tested separately, without muscimol administration. As compared to control rats micro-infused with vehicle, subjects micro-infused with muscimol before training exhibited, during testing without muscimol, significant reduction of freezing responses to the conditioned context, but not to the conditioned tone. Therefore, reversible inactivation of the BA during training impaired contextual, but not auditory fear conditioning, thus confirming and extending similar behavioral observations following selective neurotoxic damage to the BA and, in addition, revealing that this effect is not related to the lack of a functional BA during testing.	[Akagi Jordao, Elisa Mari; Amaral Onishi, Barbara Kazue; Xavier, Gilberto Fernando] Univ Sao Paulo, Biosci Inst, Dept Physiol, Sao Paulo, SP, Brazil	Universidade de Sao Paulo	Jordao, EMA (corresponding author), Univ Sao Paulo, Biosci Inst, Dept Physiol, Sao Paulo, SP, Brazil.	elisajordao@yahoo.com.br	Xavier, Gilberto F/B-9464-2013	Xavier, Gilberto F/0000-0002-8567-7031	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/04820-7]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (2011/04820-7) http://www.fapesp.br/, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) http://www.capes.gov.br/ and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) http://www.cnpq.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almada RC, 2013, J PSYCHOPHARMACOL, V27, P1160, DOI 10.1177/0269881113482840; Amano T, 2011, J NEUROSCI, V31, P15481, DOI 10.1523/JNEUROSCI.3410-11.2011; Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; Anagnostaras SG, 1999, J NEUROSCI, V19, P1106; Bergstrom HC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015698; BLANCHARD DC, 1972, J COMP PHYSIOL PSYCH, V81, P281, DOI 10.1037/h0033521; Calandreau L, 2005, LEARN MEMORY, V12, P383, DOI 10.1101/lm.92305; CANTERAS NS, 1992, J COMP NEUROL, V324, P180, DOI 10.1002/cne.903240204; Dalzell L, 2011, SYNAPSE, V65, P513, DOI 10.1002/syn.20869; Coelho CAD, 2013, HIPPOCAMPUS, V23, P545, DOI 10.1002/hipo.22118; Edeline JM, 2002, NEUROBIOL LEARN MEM, V78, P100, DOI 10.1006/nlme.2001.4035; Flavell CR, 2012, LEARN MEMORY, V19, P256, DOI 10.1101/lm.025403.111; Goosens KA, 2001, LEARN MEMORY, V8, P148, DOI 10.1101/lm.37601; HELMSTETTER FJ, 1994, BEHAV NEUROSCI, V108, P1005, DOI 10.1037/0735-7044.108.5.1005; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEDOUX JE, 1990, J NEUROSCI, V10, P1062; Lorenzini CGA, 1999, NEUROBIOL LEARN MEM, V71, P1; Maren S, 1997, BEHAV BRAIN RES, V88, P261, DOI 10.1016/S0166-4328(97)00088-0; Maren S, 2007, LEARN MEMORY, V14, P318, DOI 10.1101/lm.477007; Martin JH, 1999, J NEUROSCI METH, V86, P145, DOI 10.1016/S0165-0270(98)00163-0; McDonald AJ, 1998, PROG NEUROBIOL, V55, P257, DOI 10.1016/S0301-0082(98)00003-3; Muller J, 1997, BEHAV NEUROSCI, V111, P683, DOI 10.1037/0735-7044.111.4.683; Nader K, 2001, LEARN MEMORY, V8, P156, DOI 10.1101/lm.38101; Onishi BKA, 2010, NEUROBIOL LEARN MEM, V93, P165, DOI 10.1016/j.nlm.2009.09.007; ONO T, 1995, PROG NEUROBIOL, V46, P401, DOI 10.1016/0301-0082(95)00008-J; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Pitkanen A, 2000, Folia Morphol (Warsz), V59, P1; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; ROMANSKI LM, 1993, BEHAV NEUROSCI, V107, P444, DOI 10.1037/0735-7044.107.3.444; Rudy JW, 1995, HIPPOCAMPUS, V5, P375, DOI 10.1002/hipo.450050502; RUDY JW, 1989, BEHAV BRAIN RES, V34, P97, DOI 10.1016/S0166-4328(89)80093-2; Rudy JW, 1999, BEHAV NEUROSCI, V113, P867, DOI 10.1037/0735-7044.113.5.867; Schafe GE, 2000, J NEUROSCI, V20, P8177; Swanson L. W., 1992, BRAIN MAPS STRUCTURE; Swanson LW, 1998, TRENDS NEUROSCI, V21, P323, DOI 10.1016/S0166-2236(98)01265-X; Swanson LW., 2004, BRAIN MAPS STRUCTURE, V3rd edition; Tehovnik EJ, 1997, J NEUROSCI METH, V74, P17, DOI 10.1016/S0165-0270(97)02229-2; Toyomitsu Y, 2002, EUR J NEUROSCI, V15, P753, DOI 10.1046/j.1460-9568.2002.01889.x; van Duuren E, 2007, J PHARMACOL EXP THER, V323, P61, DOI 10.1124/jpet.107.124784; Wilensky AE, 2000, J NEUROSCI, V20, P7059, DOI 10.1523/JNEUROSCI.20-18-07059.2000; Wilson YM, 2009, LEARN MEMORY, V16, P357, DOI 10.1101/lm.1361509; Yaniv D, 2004, BRAIN RES REV, V44, P179, DOI 10.1016/j.brainresrev.2003.08.008; Yaniv D, 2003, NEUROSCIENCE, V120, P1125, DOI 10.1016/S0306-4522(03)00386-5; Yaniv D, 2000, NEUROREPORT, V11, P525, DOI 10.1097/00001756-200002280-00020	46	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125489	10.1371/journal.pone.0125489	http://dx.doi.org/10.1371/journal.pone.0125489			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928357	gold, Green Published, Green Submitted			2022-12-27	WOS:000353713100094
J	Cornish, AJ; Green, R; Gartner, K; Mason, S; Hegg, EL				Cornish, Adam J.; Green, Robin; Gaertner, Katrin; Mason, Saundra; Hegg, Eric L.			Characterization of Hydrogen Metabolism in the Multicellular Green Alga Volvox carteri	PLOS ONE			English	Article							GERM-SOMA DIFFERENTIATION; CHLAMYDOMONAS-REINHARDTII; SHEWANELLA-ONEIDENSIS; IRON HYDROGENASES; GENE-EXPRESSION; FE HYDROGENASE; EVOLUTION; PHOTOPRODUCTION; CLASSIFICATION; IDENTIFICATION	Hydrogen gas functions as a key component in the metabolism of a wide variety of microorganisms, often acting as either a fermentative end-product or an energy source. The number of organisms reported to utilize hydrogen continues to grow, contributing to and expanding our knowledge of biological hydrogen processes. Here we demonstrate that Volvox carteri f. nagariensis, a multicellular green alga with differentiated cells, evolves H-2 both when supplied with an abiotic electron donor and under physiological conditions. The genome of Volvox carteri contains two genes encoding putative [FeFe]-hydrogenases (HYDA1 and HYDA2), and the transcripts for these genes accumulate under anaerobic conditions. The HYDA1 and HYDA2 gene products were cloned, expressed, and purified, and both are functional [FeFe]-hydrogenases. Additionally, within the genome the HYDA1 and HYDA2 genes cluster with two putative genes which encode hydrogenase maturation proteins. This gene cluster resembles operon-like structures found within bacterial genomes and may provide further insight into evolutionary relationships between bacterial and algal [FeFe]-hydrogenase genes.	[Cornish, Adam J.; Green, Robin; Gaertner, Katrin; Mason, Saundra; Hegg, Eric L.] Michigan State Univ, Great Lakes Bioenergy Res Ctr, E Lansing, MI 48824 USA; [Cornish, Adam J.; Green, Robin; Gaertner, Katrin; Mason, Saundra; Hegg, Eric L.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University; United States Department of Energy (DOE); Michigan State University	Hegg, EL (corresponding author), Michigan State Univ, Great Lakes Bioenergy Res Ctr, E Lansing, MI 48824 USA.	erichegg@msu.edu			United States Department of Energy, Great Lakes Bioenergy Research Center (DOE BER Office of Science) [DE-FC02-07ER64494]	United States Department of Energy, Great Lakes Bioenergy Research Center (DOE BER Office of Science)(United States Department of Energy (DOE))	This work was funded by the United States Department of Energy, Great Lakes Bioenergy Research Center (DOE BER Office of Science DE-FC02-07ER64494). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MWW, 1989, P NATL ACAD SCI USA, V86, P4932, DOI 10.1073/pnas.86.13.4932; Andersson JO, 2002, EUKARYOT CELL, V1, P304, DOI 10.1128/EC.1.2.304-310.2002; Antal TK, 2011, APPL MICROBIOL BIOT, V89, P3, DOI 10.1007/s00253-010-2879-6; Atteia A, 2006, J BIOL CHEM, V281, P9909, DOI 10.1074/jbc.M507862200; Bolhuis H, 2010, ISME J, V4, P121, DOI 10.1038/ismej.2009.99; Bothe H, 2010, MICROBIOL MOL BIOL R, V74, P529, DOI 10.1128/MMBR.00033-10; BRAND JJ, 1989, BIOTECHNOL BIOENG, V33, P1482, DOI 10.1002/bit.260331116; Catalanotti C, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00150; Chen M, 2010, J PROTEOME RES, V9, P3854, DOI 10.1021/pr100076c; Cornish AJ, 2011, J BIOL CHEM, V286, P38341, DOI 10.1074/jbc.M111.254664; D'Adamo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085812; Forestier M, 2003, EUR J BIOCHEM, V270, P2750, DOI 10.1046/j.1432-1033.2003.03656; Fournier M, 2004, J BIOL CHEM, V279, P1787, DOI 10.1074/jbc.M307965200; Ghirardi ML, 2007, ANNU REV PLANT BIOL, V58, P71, DOI 10.1146/annurev.arplant.58.032806.103848; Ghirardi ML, 2009, CHEM SOC REV, V38, P52, DOI 10.1039/b718939g; Godman JE, 2010, BIOCHEM J, V431, P345, DOI 10.1042/BJ20100932; Grossman AR, 2011, NEW PHYTOL, V190, P279, DOI 10.1111/j.1469-8137.2010.03534.x; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Hansen J, 2004, P NATL ACAD SCI USA, V101, P16109, DOI 10.1073/pnas.0406982101; Hemschemeier A, 2011, BBA-BIOENERGETICS, V1807, P919, DOI 10.1016/j.bbabio.2011.02.010; Hemschemeier A, 2009, PHOTOSYNTH RES, V102, P523, DOI 10.1007/s11120-009-9415-5; Homann PH, 2003, PHOTOSYNTH RES, V76, P93, DOI 10.1023/A:1024935223225; Horner DS, 2002, TRENDS BIOCHEM SCI, V27, P148, DOI 10.1016/S0968-0004(01)02053-9; Horner DS, 2000, MOL BIOL EVOL, V17, P1695, DOI 10.1093/oxfordjournals.molbev.a026268; Hwang JH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4234; Jinkerson RE, 2012, BIOENGINEERED, V4; King PW, 2006, J BACTERIOL, V188, P2163, DOI 10.1128/JB.188.6.2163-2172.2006; Kirk DL, 1999, CURR OPIN PLANT BIOL, V2, P496, DOI 10.1016/S1369-5266(99)00019-9; Kirk MM, 1999, DEVELOPMENT, V126, P639; KOCHERT G, 1968, J PROTOZOOL, V15, P438, DOI 10.1111/j.1550-7408.1968.tb02154.x; Kosourov S, 2002, BIOTECHNOL BIOENG, V78, P731, DOI 10.1002/bit.10254; Kruse O, 2010, CURR OPIN BIOTECH, V21, P238, DOI 10.1016/j.copbio.2010.03.012; Marshall MJ, 2008, ENVIRON MICROBIOL, V10, P125, DOI 10.1111/j.1462-2920.2007.01438.x; McKinlay JB, 2010, CURR OPIN BIOTECH, V21, P244, DOI 10.1016/j.copbio.2010.02.012; Meuser JE, 2012, BIOCHEM BIOPH RES CO, V417, P704, DOI 10.1016/j.bbrc.2011.12.002; Meuser JE, 2011, PLANTA, V234, P829, DOI 10.1007/s00425-011-1431-y; Muller M, 2012, MICROBIOL MOL BIOL R, V76, P444, DOI 10.1128/MMBR.05024-11; Mulder DW, 2011, STRUCTURE, V19, P1038, DOI 10.1016/j.str.2011.06.008; Nematollahi G, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-321; Nie W, 2012, CLIN SCI, V122, P575, DOI 10.1042/CS20110396; Nixon JEJ, 2003, BIOL BULL-US, V204, P1, DOI 10.2307/1543490; Noguchi K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010132; Ozawa K, 2001, BIOSCI BIOTECH BIOCH, V65, P185, DOI 10.1271/bbb.65.185; Posewitz MC, 2005, BIOCHEM SOC T, V33, P102, DOI 10.1042/BST0330102; Prochnik SE, 2010, SCIENCE, V329, P223, DOI 10.1126/science.1188800; Rupprecht J, 2009, J BIOTECHNOL, V142, P10, DOI 10.1016/j.jbiotec.2009.02.008; Schmitt R, 2003, CURR OPIN MICROBIOL, V6, P608, DOI 10.1016/j.mib.2003.10.007; Stark K, 2002, PROTIST, V153, P99, DOI 10.1078/1434-4610-00088; Sybirna K, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-73; TAM LW, 1991, DEV BIOL, V145, P51, DOI 10.1016/0012-1606(91)90212-L; Tamagnini P, 2002, MICROBIOL MOL BIOL R, V66, P1, DOI 10.1128/MMBR.66.1.1-20.2002; Tian F, 2005, SCIENCE, V308, P1014, DOI 10.1126/science.1106983; Tooming-Klunderud A, 2013, APPL ENVIRON MICROB, V79, P6803, DOI 10.1128/AEM.01455-13; Vieler A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003064; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Vignais PM, 2001, FEMS MICROBIOL REV, V25, P455, DOI 10.1111/j.1574-6976.2001.tb00587.x; Waller RF, 2006, MOL BIOL EVOL, V23, P1437, DOI 10.1093/molbev/msl008; Winkler M, 2010, EUR J CELL BIOL, V89, P998, DOI 10.1016/j.ejcb.2010.06.018; Yamano T, 2011, PHOTOSYNTH RES, V109, P151, DOI 10.1007/s11120-010-9614-0; Zhang LP, 2002, PLANTA, V214, P552, DOI 10.1007/s004250100660	60	6	6	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125324	10.1371/journal.pone.0125324	http://dx.doi.org/10.1371/journal.pone.0125324			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927230	Green Submitted, Green Published, gold			2022-12-27	WOS:000353713100081
J	Meland, K; Mees, J; Porter, M; Wittmann, KJ				Meland, Kenneth; Mees, Jan; Porter, Megan; Wittmann, Karl J.			Taxonomic Review of the Orders Mysida and Stygiomysida (Crustacea, Peracarida)	PLOS ONE			English	Review							BIOGEOGRAPHICAL DIVISION; STATOLITHS CRUSTACEA; LOPHOGASTRIDA; MALACOSTRACA; PHYLOGENY; DIVERSITY; RECORDS; SEA	The order Mysida (2 families, 178 genera, 1132 species) contains species across a broad range of habitats, such as subterranean, fresh, brackish, coastal, and surface to deep-sea habitats. The Stygiomysida (2 families, 2 genera, 16 species), however, are found primarily in subterranean waters, but always in waters with a marine influence. The Mysida and Stygiomysida body is divided into three main regions: cephalon, thorax, and abdomen. They are shrimp-like in appearance, containing morphological features earlier referred to as defining a "caridoid facies". The shrimp-like morphology was to some extent diagnostic for the historic Decapod taxon Schizopoda, containing the Nebalia, Mysida, Lophogastrida, and Euphausiacea. In 1904 the concept of Schizopoda was abandoned, and the Mysidacea (Mysida and Lophogastrida) along with Cumacea, Amphipoda, Isopoda, and Tanaidacea were placed in a new taxon, the Peracarida. Later discoveries of groundwater mysids led to the establishment of Stygiomysida, but placement to either Lophogastrida or Mysida remained unclear. The presence of oostegites and absence of podobranchiae, coupled with non-statocyst bearing uropods have been used to classify the Stygiomysida as a primitive Mysida family, comparable to Petalophthalmidae. On the other hand, equally suggestive characters, but for a Lophogastrida affiliation, was suggested for the archaic foregut characters and again, non-statocyst bearing uropods. With the inclusion of DNA sequence data of ribosomal genes, sister group relationships between Stygiomysida, Lophogastrida, and Mictacea within the Peracarida are observed, which supports a classification of the Stygiomysida as a separate order removed from the Mysida.	[Meland, Kenneth] Univ Bergen, Dept Biol, Bergen, Norway; [Mees, Jan] Flanders Marine Inst, Oostende, Belgium; [Mees, Jan] Univ Ghent, Oostende, Belgium; [Porter, Megan] Univ S Dakota, Dept Biol, Vermillion, SD 57069 USA; [Wittmann, Karl J.] Med Univ Wien, Inst Umwelthygiene, Abt Okotoxikol, Vienna, Austria	University of Bergen; Ghent University; University of South Dakota; Medical University of Vienna	Meland, K (corresponding author), Univ Bergen, Dept Biol, Bergen, Norway.	kenneth.meland@bio.uib.no	Porter, Megan L./X-1133-2019; Mees, Jan/HDN-5048-2022					Ariani AP, 2010, J CRUSTACEAN BIOL, V30, P384, DOI 10.1651/09-3150.1; ARIANI AP, 1993, BIOL BULL-US, V185, P393, DOI 10.2307/1542480; BACESCU M, 1986, Travaux du Museum d'Histoire Naturelle "Grigore Antipa", V28, P25; Bill PhC, 1914, MITTEILUNGEN GEOLOGI, V8, P289; BOAS J. E. V., 1883, MORPHOLOGISCHES JB, V8, P485; Bowman T.E., 1973, Bulletin Ass mex Cave Stud, VNo. 5,1973, P13; BOWMAN TE, 1984, P BIOL SOC WASH, V97, P637; Boxshall G. A., 2014, WORLD REGISTER MARIN; Brooks H. K., 1962, Bulletins of American Paleontology, V44, P163; Calman W. T., 1904, Annals of Natural History, V(7), P144; Calman WT, 1909, TREATISE ZOOLOGY A C, P171; Caroli E., 1937, Bollettino di Zoologia Torino, V8, P219; CASANOVA B, 1991, CR ACAD SCI III-VIE, V312, P461; CLARKE W. D., 1961, CRUSTACEANA, V2, P251, DOI 10.1163/156854061X00248; Czerniavsky V, 1882, PETERSBOURG, V13, P1; Czerniavsky V., 1882, T ST PETERBURGSKO OB, V13, P1; DAHL E, 1992, ACTA ZOOL-STOCKHOLM, V73, P339, DOI 10.1111/j.1463-6395.1992.tb01104.x; Dana JD, 1852, CRUSTACEA 1, VXIII, P635; Daneliya ME, 2011, RUSS J MAR BIOL+, V37, P85, DOI 10.1134/S1063074011020040; De Angeli Antonio, 2006, Societa Veneziana di Scienze Naturali Lavori, V31, P85; De Jong-Moreau L, 2001, ACTA ZOOL-STOCKHOLM, V82, P137, DOI 10.1046/j.1463-6395.2001.00077.x; Fabricius O, 1780, FAUNA GROENLANDICA S, p[i, 1]; Fage L., 1925, Archives de Zoologie Paris, V63, P525; Gordon I, 1960, ZOOLOGY, V6, P283, DOI DOI 10.5962/BHL.PART.26847; Hanamura Y, 2002, J NAT HIST, V36, P253, DOI 10.1080/00222930010004241; Hansen H. J., 1925, P1; Hansen H. J., 1893, Annals of Natural History, V(6), P417; Hansen H.J., 1910, SIBOGA EXPED, V37, P1; Hansen H.J., 1893, ZOOL ANZ, V16, P193; Hansen HJ, 1893, ZOOL ANZ, V16, P201; Haworth AH, 1825, PHILOS MAGAZINE J, V65, P183, DOI DOI 10.1080/14786442508628417; Hessler R.R., 1983, Crustacean Issues, V1, P145; Holt EWL, 1905, SCHIZOPODOUS CRUSTAC, P99; ICZN, 1999, INT COD ZOOL NOM, P1; Jarman SN, 2000, MOL PHYLOGENET EVOL, V17, P26, DOI 10.1006/mpev.2000.0823; Lamarck JBP, 1818, HIST NATURELLE ANIMA, V5, P109; Latreille P.A., 1802, HIST NATURELLE GEN P, V3; LATREILLE PA, 1825, FAMILLES NATURELLES, P1; Latreille PA, 1817, REGNE ANIMAL DISTRI, P5, DOI [10.1038/nature13704, DOI 10.1038/NATURE13704]; Leach W.E., 1814, EDINBURGH ENCY, P383, DOI DOI 10.5962/BHL.TITLE.30911; Leach W. E., 1814, T LINN SOC LOND, V11, P306, DOI DOI 10.1111/J.1096-3642.1813.TB00065.X; Martin J.W., 2001, UPDATED CLASSIFICATI, VVolume 39, P1; Mauchline J, 1977, Journal Tokyo Univ Fish, V64, P39; Mees J, 2012, WORLD LIS LOPHGASTRO; Meland K, 2004, ZOOTAXA, P1; Meland K, 2007, MOL PHYLOGENET EVOL, V44, P1083, DOI 10.1016/j.ympev.2007.02.009; Muller OF, 1776, ZOOLOGIAE DANICAE PR, p[I, 1], DOI DOI 10.5962/BHL.TITLE.13268; Murano Masaaki, 2008, National Museum of Nature and Science Monographs, P1; Neil D.M., 1975, Progress in Zoology, V23, P98; Norman A. M., 1892, ANN MAGAZINE NATURAL, V10, P143, DOI DOI 10.1080/00222939208677385; Nouvel H., 1999, MEMOIRES I OCEANOGRA, V19, P39; PANAMPUNNAYIL SU, 1991, HYDROBIOLOGIA, V209, P71, DOI 10.1007/BF00006720; Pesce GL, 2002, J NAT HIST, V36, P265, DOI 10.1080/00222930010005033; Petryashev V. V., 2005, Biologiya Morya (Vladivostok), V31, P233; Petryashev VV, 2007, RUSS J MAR BIOL+, V33, P1, DOI 10.1134/S1063074007010014; Petryashov VV, 2009, RUSS J MAR BIOL+, V35, P97, DOI 10.1134/S1063074009020011; Porter ML, 2008, HYDROBIOLOGIA, V595, P213, DOI 10.1007/s10750-007-9016-2; Remerie T, 2004, MOL PHYLOGENET EVOL, V32, P770, DOI 10.1016/j.ympev.2004.03.007; Richter S, 2001, J ZOOL SYST EVOL RES, V39, P113; Sars GO, 1870, CHRISTIANIA, P1; Sars GO, 1877, ARCH MATH NATURVIDEN, V2, P10; Sars GO, 1879, CARCINOLOGISKE BIDRA, p[i, 1]; Sars GO, 1872, CARCINOLOGISKE BIDRA, P1; Sars GO., 1885, SCI RESULTS VOYAGE H, V13, P1; SCHLACHER TA, 1992, ZOOMORPHOLOGY, V112, P67, DOI 10.1007/BF01673808; SCHRAM F R, 1984, Transactions of the San Diego Society of Natural History, V20, P301; Schram FR, 1998, ARTHROPOD FOSSILS AND PHYLOGENY, P233; Schram FR, 1986, CRUSTACEA, P107; SECRETAN S, 1986, Annales de Paleontologie, V72, P295; Sieg J, 1983, CRUSTACEORUM CATALOG, P1; Spears T, 2005, P BIOL SOC WASH, V118, P117, DOI 10.2988/0006-324X(2005)118[117:PMAIPI]2.0.CO;2; Stebbing TRR, 1893, INT SCI SERIES, V71, P256; Tattersall Walter M., 1909, Mitteilungen aus der Zoologischen Station zu Neapel Berlin, V19; Tattersall WM., 1911, FISH IRELAND SCI INV, V1910, P1; Tattersall WM, 1951, BRIT MYSIDACEA, V136, P460; Taylor RS, 2001, J PALEONTOL, V75, P310, DOI 10.1666/0022-3360(2001)075<0310:ANUMTS>2.0.CO;2; Tchindonova YG, 1981, P 14 PAC SCI C, V1, P24; Thompson JV, 1828, ZOOL RES ILL NAT HIS, V1, P13; Thompson JV, 1829, ZOOLOGICAL RES ILLUS, V2, P37; VOICU G, 1981, Micropaleontology (New York), V27, P227, DOI 10.2307/1485236; VOICU G, 1974, Geologicky Zbornik, V25, P231; von Willemoes-Suhm R, 1875, T LINN SOC LOND, VI, P23; Watling L., 1983, Crustacean Issues, V1, P213; WATLING L, 1981, Journal of Crustacean Biology, V1, P201, DOI 10.2307/1548159; WATLING L., 1999, P 4 INT CRUST C AMST, V1, P73; Wittmann K.J., 2014, TREATISE ZOOLOGY ANA, Vvol 4 Part B, ppp 189; Wittmann K J., 1999, CRUSTACEANS BIODIVER, V1, P511; Wittmann KJ, 2013, ZOOMORPHOLOGY, V132, P389, DOI 10.1007/s00435-013-0198-z; WITTMANN KJ, 1993, J MORPHOL, V215, P31, DOI 10.1002/jmor.1052150103; Wittmann KJ, 1996, MAR ECOL-P S Z N I, V17, P213, DOI 10.1111/j.1439-0485.1996.tb00502.x	90	30	31	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124656	10.1371/journal.pone.0124656	http://dx.doi.org/10.1371/journal.pone.0124656			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927358	gold, Green Published			2022-12-27	WOS:000353713100042
J	Summers, SK; Rainey, R; Kaur, M; Graham, JP				Summers, Sarah K.; Rainey, Rochelle; Kaur, Maneet; Graham, Jay P.			CO2 and H2O: Understanding Different Stakeholder Perspectives on the Use of Carbon Credits to Finance Household Water Treatment Projects	PLOS ONE			English	Article							MICROBIOLOGICAL EFFECTIVENESS; HYGIENE BEHAVIOR; DRINKING-WATER; QUESTIONNAIRES; REACTIVITY; SENSORS; COST	Background Carbon credits are an increasingly prevalent market-based mechanism used to subsidize household water treatment technologies (HWT). This involves generating credits through the reduction of carbon emissions from boiling water by providing a technology that reduces greenhouse gas emissions linked to climate change. Proponents claim this process delivers health and environmental benefits by providing clean drinking water and reducing greenhouse gases. Selling carbon credits associated with HWT projects requires rigorous monitoring to ensure households are using the HWT and achieving the desired benefits of the device. Critics have suggested that the technologies provide neither the benefits of clean water nor reduced emissions. This study explores the perspectives of carbon credit and water, sanitation and hygiene (WASH) experts on HWT carbon credit projects. Methods Thirteen semi-structured, in-depth interviews were conducted with key informants from the WASH and carbon credit development sectors. The interviews explored perceptions of the two groups with respect to the procedures applied in the Gold Standard methodology for trading Voluntary Emission Reduction (VER) credits. Results Agreement among the WASH and carbon credit experts existed for the concept of suppressed demand and parameters in the baseline water boiling test. Key differences, however, existed. WASH experts' responses highlighted a focus on objectively verifiable data for monitoring carbon projects while carbon credit experts called for contextualizing observed data with the need for flexibility and balancing financial viability with quality assurance. Conclusions Carbon credit projects have the potential to become an important financing mechanism for clean energy in low- and middle-income countries. Based on this research we recommend that more effort be placed on building consensus on the underlying assumptions for obtaining carbon credits from HWT projects, as well as the approved methods for monitoring correct and consistent use of the HWT technologies in order to support public health impacts.	[Summers, Sarah K.; Graham, Jay P.] George Washington Univ, Milken Inst Sch Publ Hlth, Dept Global Hlth, Washington, DC 20052 USA; [Rainey, Rochelle] US Agcy Int Dev, Washington, DC 20523 USA; [Kaur, Maneet] Berkeley Air Monitoring Grp, Berkeley, CA USA	George Washington University; United States Agency for International Development (USAID)	Graham, JP (corresponding author), George Washington Univ, Milken Inst Sch Publ Hlth, Dept Global Hlth, Washington, DC 20052 USA.	jgraham@gwu.edu		Kaur, Maneet/0000-0002-5231-1260				Arnold B, 2009, INT J EPIDEMIOL, V38, P1651, DOI 10.1093/ije/dyp241; Brown J, 2012, AM J TROP MED HYG, V87, P394, DOI 10.4269/ajtmh.2012.11-0715; CDM Methodology Booklet, 2014, UN FRAM CONV CLIM CH, V15; Centers for Disease Control and Prevention, 2013, FACT SHEET WHAT DO B; Clasen TF, 2008, ENVIRON SCI TECHNOL, V42, P4255, DOI 10.1021/es7024802; Cousens S, 1996, SOC SCI MED, V43, P1299, DOI 10.1016/0277-9536(95)00380-0; Hodge JM, 2014, ENVIRON SCI TECHNOL, V48, P12509, DOI 10.1021/es503155m; Jenner EA, 2006, J HOSP INFECT, V63, P418, DOI 10.1016/j.jhin.2006.03.012; ManunEbo M, 1997, TROP MED INT HEALTH, V2, P1015, DOI 10.1046/j.1365-3156.1997.d01-180.x; Markit, 2014, REGISTRY PUBLIC VIEW; McCutcheon S, 2012, GLOBAL HLTH INNOVATI; Mukerjee M, 2009, SCI AM, V300, P18, DOI 10.1038/scientificamerican0609-18; Psutka R, 2011, ENVIRON SCI TECHNOL, V45, P6095, DOI 10.1021/es2004045; Ram PK, 2010, AM J TROP MED HYG, V83, P1070, DOI 10.4269/ajtmh.2010.09-0763; Rosa G, 2010, AM J TROP MED HYG, V82, P473, DOI 10.4269/ajtmh.2010.09-0320; Schiermeier Q, 2011, NATURE, V477, P517, DOI 10.1038/477517a; STANTON BF, 1987, B WORLD HEALTH ORGAN, V65, P217; Starr K, 2012, ANOTHER LOOK CARBON; The Gold Standard Foundation, 2014, GUID CARR OUT US SUR; The Gold Standard Foundation, 2010, IND PROGR BAS MON ME; The Gold Standard Foundation, 2014, REQ QUAL STAND BE ME; The World Health Organization, 2014, HOUS POLL HLTH FACT; Thomas EA, 2012, GLOBAL WATER FORUM; Thomas EA, 2013, ENVIRON SCI TECHNOL, V47, P13602, DOI 10.1021/es403412x; United Nations Framework Convention on Climate Change, 2014, UN FRAM CONV CLIM CH; Williams M, 2013, ENVIRON LAW, V43, P517; Wilson K, 2011, ECOL LAW QUART, V38, P967; World Wildlife Foundation, 2008, MAK SENS VOL CARB MA; Yeo D, 2013, WATERLINES, V32, P308, DOI DOI 10.3362/1756-3488.2013.032	29	1	1	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0122894	10.1371/journal.pone.0122894	http://dx.doi.org/10.1371/journal.pone.0122894			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928139	Green Published, Green Submitted, gold			2022-12-27	WOS:000353713100011
J	Hagen, CM; Aidt, FH; Havndrup, O; Hedley, PL; Jensen, MK; Kanters, JK; Pham, TT; Bundgaard, H; Christiansen, M				Hagen, Christian M.; Aidt, Frederik H.; Havndrup, Ole; Hedley, Paula L.; Jensen, Morten K.; Kanters, Jorgen K.; Pham, Tam T.; Bundgaard, Henning; Christiansen, Michael			Private Mitochondrial DNA Variants in Danish Patients with Hypertrophic Cardiomyopathy	PLOS ONE			English	Article							MEDIAN-NETWORK ANALYSIS; TRANSFER-RNA MUTATIONS; POINT MUTATION; MTDNA MUTATIONS; RISK-FACTOR; DISEASE; PATHOGENICITY; PENETRANCE; GENES; HAPLOGROUPS	Hypertrophic cardiomyopathy (HCM) is a genetic cardiac disease primarily caused by mutations in genes coding for sarcomeric proteins. A molecular-genetic etiology can be established in similar to 60% of cases. Evolutionarily conserved mitochondrial DNA (mtDNA) haplogroups are susceptibility factors for HCM. Several polymorphic mtDNA variants are associated with a variety of late-onset degenerative diseases and affect mitochondrial function. We examined the role of private, non-haplogroup associated, mitochondrial variants in the etiology of HCM. In 87 Danish HCM patients, fullmtDNA sequencing revealed 446 variants. After elimination of 312 (69.9%) non-coding and synonymous variants, a further 109 (24.4%) with a global prevalence > 0.1%, three (0.7%) haplogroup associated and 19 (2.0%) variants with a low predicted in silico likelihood of pathogenicity, three variants: MT-TC: m.5772G>A, MT-TF: m.644A>G, and MT-CYB: m.15024G>A, p.C93Y remained. A detailed analysis of these variants indicated that none of them are likely to cause HCM. In conclusion, private mtDNA mutations are frequent, but they are rarely, if ever, associated with HCM.	[Hagen, Christian M.; Aidt, Frederik H.; Hedley, Paula L.; Pham, Tam T.; Christiansen, Michael] Statens Serum Inst, Dept Congenital Disorders, DK-2300 Copenhagen, Denmark; [Hagen, Christian M.; Kanters, Jorgen K.; Christiansen, Michael] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Havndrup, Ole] Roskilde Hosp, Dept Cardiol, Roskilde, Denmark; [Jensen, Morten K.; Bundgaard, Henning] Rigshosp, Ctr Heart, Dept Med B, DK-2100 Copenhagen, Denmark	Statens Serum Institut; University of Copenhagen; Rigshospitalet; University of Copenhagen	Christiansen, M (corresponding author), Statens Serum Inst, Dept Congenital Disorders, DK-2300 Copenhagen, Denmark.	mic@ssi.dk	Christiansen, Michael/B-4588-2009; Hedley, Paula L/E-6156-2011; Bundgaard, Henning/AAA-4381-2020	Christiansen, Michael/0000-0003-4713-755X; Hedley, Paula L/0000-0001-5801-960X; Bundgaard, Henning/0000-0002-0563-7049; Jensen, Morten Kvistholm/0000-0003-1144-4603; Kanters, Jorgen/0000-0002-3267-4910; Hagen, Christian/0000-0002-0513-7722	LUNDBECKFONDEN [R67-A6552]; Novo Nordisk Fonden [NNF14OC0012809] Funding Source: researchfish	LUNDBECKFONDEN(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	The work was supported by LUNDBECKFONDEN (grant no: R67-A6552), www.lundbeckfonden.com.	Andersen PS, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/685108; Andersen PS, 2009, HUM MUTAT, V30, P363, DOI 10.1002/humu.20862; Andersen PS, 2004, EUR J HUM GENET, V12, P673, DOI 10.1038/sj.ejhg.5201190; Andreu AL, 2000, PEDIATR RES, V48, P311, DOI 10.1203/00006450-200009000-00008; Arbustini E, 1998, HEART, V80, P548, DOI 10.1136/hrt.80.6.548; Bandelt HJ, 2008, INT J CARDIOL, V126, P439, DOI 10.1016/j.ijcard.2007.02.049; Bandelt HJ, 2009, J HUM GENET, V54, P174, DOI 10.1038/jhg.2009.9; Bandelt HJ, 2005, BIOCHEM BIOPH RES CO, V333, P122, DOI 10.1016/j.bbrc.2005.04.055; Bates MGD, 2012, EUR HEART J, V33, P3023, DOI 10.1093/eurheartj/ehs275; BINDOFF LA, 1993, J BIOL CHEM, V268, P19559; Bruno C, 1999, J PEDIATR-US, V135, P197, DOI 10.1016/S0022-3476(99)70022-3; Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720; Casali C, 1999, J AM COLL CARDIOL, V33, P1584, DOI 10.1016/S0735-1097(99)00079-0; CASALI C, 1995, BIOCHEM BIOPH RES CO, V213, P588, DOI 10.1006/bbrc.1995.2172; Castro MG, 2006, INT J CARDIOL, V112, P202, DOI 10.1016/j.ijcard.2005.09.008; Chan PA, 2007, HUM MUTAT, V28, P683, DOI 10.1002/humu.20492; Chinnery PF, 2010, LANCET NEUROL, V9, P498, DOI 10.1016/S1474-4422(10)70083-1; Christiansen M, 2015, MITOCHONDRION, V20, P105, DOI 10.1016/j.mito.2014.07.010; Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392; Drago I, 2011, EMBO J, V30, P4119, DOI 10.1038/emboj.2011.337; Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004; Elson JL, 2012, HUM MUTAT, V33, P1352, DOI 10.1002/humu.22118; Fernandez-Caggiano M, 2013, MITOCHONDRION, V13, P263, DOI 10.1016/j.mito.2013.03.005; Fernandez-Caggiano M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044128; Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1; Hagen CM, 2013, MOL GENET GENOM MED, V1, P54, DOI 10.1002/mgg3.5; Hagen CM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071904, 10.1371/currents.hd.d8917b4862929772c5a2f2a34ef1c201]; Havndrup O, 2010, EUR J HEART FAIL, V12, P535, DOI 10.1093/eurjhf/hfq073; Hedley PL, 2011, J NEGAT RESULTS BIOM, V10, DOI 10.1186/1477-5751-10-12; Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Hudson G, 2014, PLOS GENET, pe10; Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394; Jensen MK, 2013, CIRCULATION, V127, P48, DOI 10.1161/CIRCULATIONAHA.111.090514; Koga A, 2003, NEUROMUSCULAR DISORD, V13, P259, DOI 10.1016/S0960-8966(02)00267-5; Larsen S, 2014, BBA-BIOENERGETICS, V1837, P226, DOI 10.1016/j.bbabio.2013.10.009; Levinger L, 2004, J MOL BIOL, V337, P535, DOI 10.1016/j.jmb.2004.02.008; Marcuello A, 2009, MITOCHONDRION, V9, P27, DOI 10.1016/j.mito.2008.10.002; Maron BJ, 2013, LANCET, V381, P242, DOI 10.1016/S0140-6736(12)60397-3; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; Martinez-Redondo D, 2010, MITOCHONDRION, V10, P102, DOI 10.1016/j.mito.2009.11.005; McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014; McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819; MERANTE F, 1994, AM J HUM GENET, V55, P437; Merante F, 1996, HUM MUTAT, V8, P216, DOI 10.1002/(SICI)1098-1004(1996)8:3<216::AID-HUMU4>3.3.CO;2-Y; Mitchell AL, 2006, J MED GENET, V43, P175, DOI 10.1136/jmg.2005.032474; Montoya J, 2009, BBA-BIOENERGETICS, V1787, P476, DOI 10.1016/j.bbabio.2008.09.003; Oliva R, 2006, NUCLEIC ACIDS RES, V34, P865, DOI 10.1093/nar/gkj491; Perli E, 2012, HUM MOL GENET, V21, P85, DOI 10.1093/hmg/ddr440; Raule N, 2014, AGING CELL, V13, P401, DOI 10.1111/acel.12186; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; Rosca MG, 2013, J MOL CELL CARDIOL, V55, P31, DOI 10.1016/j.yjmcc.2012.09.002; Rossignol R, 2013, BIOCHEM J, V370, P751; Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217; Shin WS, 2000, AM J HUM GENET, V67, P1617, DOI 10.1086/316896; Sissler M, 2004, RNA, V10, P841, DOI 10.1261/rna.5267604; Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010; Strauss KA, 2013, P NATL ACAD SCI USA, V110, P3453, DOI 10.1073/pnas.1300690110; Tang S, 2010, BIOTECHNIQUES, V48, P287, DOI 10.2144/000113389; Tang XW, 2010, MOL GENET METAB, V100, P57, DOI 10.1016/j.ymgme.2010.01.008; Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0; Teekakirikul P, 2013, J MOL DIAGN, V15, P158, DOI 10.1016/j.jmoldx.2012.09.002; TENCATE FJ, 1979, AM J CARDIOL, V43, P731, DOI 10.1016/0002-9149(79)90071-7; Towbin JA, 2009, PACE, V32, pS23, DOI 10.1111/j.1540-8159.2009.02381.x; Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005; Ueki I, 2006, MITOCHONDRION, V6, P29, DOI 10.1016/j.mito.2005.10.003; Valnot I, 1999, HUM GENET, V104, P460, DOI 10.1007/s004390050988; Varani G, 2000, EMBO REP, V1, P18, DOI 10.1093/embo-reports/kvd001; Wallace DC, 2000, AM HEART J, V139, pS70, DOI 10.1067/mhj.2000.103934; Wang J, 2012, GENET MED, V14, P620, DOI 10.1038/gim.2012.4; Wang M, 2013, BIOCHEM J, V453, P455, DOI 10.1042/BJ20130294; Williams S, 2012, ANAL IN SILICO TOOLS; Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575; Yarham JW, 2010, WIRES RNA, V1, P304, DOI 10.1002/wrna.27; Zaragoza MV, 2011, EUR J HUM GENET, V19, P200, DOI 10.1038/ejhg.2010.169	75	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124540	10.1371/journal.pone.0124540	http://dx.doi.org/10.1371/journal.pone.0124540			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923817	gold, Green Published, Green Submitted			2022-12-27	WOS:000353711600091
J	Wang, JH; Zhao, YZ; Wang, C; Zhu, Q; Du, ZM; Hu, AG; Yang, Y				Wang, Jianhua; Zhao, Yuzheng; Wang, Chao; Zhu, Qian; Du, Zengmin; Hu, Aiguo; Yang, Yi			Organelle-Specific Nitric Oxide Detection in Living Cells via HaloTag Protein Labeling	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; IN-VIVO; LIVE CELLS; INDICATORS; PROBES; VISUALIZATION; SUPPRESSION; RECEPTOR; SENSORS; VITRO	Nitric oxide (NO) is a membrane-permeable signaling molecule that is constantly produced, transferred, and consumed in vivo. NO participates and plays important roles in multiple biological processes. However, spatiotemporal imaging of NO in living cells is challenging. To fill the gap in currently used techniques, we exploited the versatility of HaloTag technology and synthesized a novel organelle-targetable fluorescent probe called HTDAF-2DA. We demonstrate the utility of the probe by monitoring subcellular NO dynamics. The developed strategy enables precise determination of local NO function.	[Wang, Jianhua; Zhao, Yuzheng; Zhu, Qian; Du, Zengmin; Yang, Yi] E China Univ Sci & Technol, Synthet Biol & Biotechnol Lab, State Key Lab Bioreactor Engn, CAS Ctr Excellence Brain Sci, Shanghai 200237, Peoples R China; [Wang, Chao; Hu, Aiguo] E China Univ Sci & Technol, Shanghai Key Lab Adv Polymer Mat, Sch Mat Sci & Engn, Shanghai 200237, Peoples R China	East China University of Science & Technology; East China University of Science & Technology	Hu, AG (corresponding author), E China Univ Sci & Technol, Shanghai Key Lab Adv Polymer Mat, Sch Mat Sci & Engn, 130 Mei Long Rd, Shanghai 200237, Peoples R China.	hagmhsn@ecust.edu.cn; yiyang@ecust.edu.cn	, hagmhsn/D-7164-2012; Yang, Yi/C-1297-2013	, hagmhsn/0000-0003-0456-7269; Zhao, Yuzheng/0000-0001-5400-0135; Yang, Yi/0000-0001-7896-1184	National Special Fund for State Key Laboratory of Bioreactor Engineering of China [2060204]; 973 Program [2013CB531200]; NSFC [31225008, 91313301, 31071260, 31170815, 91013012]; Specialized Research Fund for the Doctoral Program of Higher Education [20100074110010]; Shanghai Science and Technology Commission [12JC1402900, 11DZ2260600]; Dawn Program of Shanghai Education Commission [11SG31]; State Key Laboratory of Bioreactor Engineering; 111 Project [B07023]; Fundamental Research Funds for the Central Universities	National Special Fund for State Key Laboratory of Bioreactor Engineering of China; 973 Program(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); Dawn Program of Shanghai Education Commission; State Key Laboratory of Bioreactor Engineering; 111 Project(Ministry of Education, China - 111 Project); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work is supported by the National Special Fund for State Key Laboratory of Bioreactor Engineering of China (2060204), 973 Program (2013CB531200), NSFC (31225008, 91313301, 31071260, 31170815, and 91013012), Specialized Research Fund for the Doctoral Program of Higher Education (20100074110010), Shanghai Science and Technology Commission (12JC1402900 and 11DZ2260600), Dawn Program of Shanghai Education Commission (11SG31), State Key Laboratory of Bioreactor Engineering, 111 Project (B07023), and Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwahab SI, 2012, EUR J PHARMACOL, V678, P61, DOI 10.1016/j.ejphar.2011.12.024; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Brien JF, 1996, METHOD ENZYMOL, V268, P83; Brown FO, 2005, ANAL BIOANAL CHEM, V381, P964, DOI 10.1007/s00216-004-2964-8; Burke AJ, 2013, CARCINOGENESIS, V34, P503, DOI 10.1093/carcin/bgt034; Chikuda H, 2004, GENE DEV, V18, P2418, DOI 10.1101/gad.1224204; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Frederiksen LJ, 2007, CLIN CANCER RES, V13, P2199, DOI 10.1158/1078-0432.CCR-06-1807; Fukumura D, 2006, NAT REV CANCER, V6, P521, DOI 10.1038/nrc1910; Gabe Y, 2004, J AM CHEM SOC, V126, P3357, DOI 10.1021/ja037944j; Garthwaite J, 2008, EUR J NEUROSCI, V27, P2783, DOI 10.1111/j.1460-9568.2008.06285.x; Heim N, 2004, J BIOL CHEM, V279, P14280, DOI 10.1074/jbc.M312751200; Jones JM, 2004, J CELL BIOL, V164, P57, DOI 10.1083/jcb.200304111; Kim YM, 1998, J IMMUNOL, V161, P4122; Kojima H, 2001, ANAL CHEM, V73, P1967, DOI 10.1021/ac001136i; Kojima H, 1999, ANGEW CHEM INT EDIT, V38, P3209, DOI 10.1002/(SICI)1521-3773(19991102)38:21<3209::AID-ANIE3209>3.0.CO;2-6; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Lee HLD, 2010, J AM CHEM SOC, V132, P15099, DOI 10.1021/ja1044192; Lee KS, 2012, BIOCHEM BIOPH RES CO, V418, P49, DOI 10.1016/j.bbrc.2011.12.123; Lim MH, 2006, NAT CHEM BIOL, V2, P375, DOI 10.1038/nchembio794; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Lowe G, 2008, NEUROSCIENCE, V153, P842, DOI 10.1016/j.neuroscience.2008.03.003; McQuade LE, 2010, P NATL ACAD SCI USA, V107, P8525, DOI 10.1073/pnas.0914794107; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Privett BJ, 2010, CHEM SOC REV, V39, P1925, DOI 10.1039/b701906h; Ridnour LA, 2006, ANTIOXID REDOX SIGN, V8, P1329, DOI 10.1089/ars.2006.8.1329; RIZZUTO R, 1995, CURR BIOL, V5, P635, DOI 10.1016/S0960-9822(95)00128-X; RIZZUTO R, 1989, J BIOL CHEM, V264, P10595; Sharma M, 2013, J BIOL CHEM, V288, P12554, DOI 10.1074/jbc.M112.443945; SKENE JHP, 1989, J CELL BIOL, V108, P613, DOI 10.1083/jcb.108.2.613; Srikun D, 2010, J AM CHEM SOC, V132, P4455, DOI 10.1021/ja100117u; Strauch RC, 2011, J AM CHEM SOC, V133, P16346, DOI 10.1021/ja206134b; Taniguchi Y, 2010, LANGMUIR, V26, P10433, DOI 10.1021/la101658a; Tantama M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3550; Tantama M, 2011, J AM CHEM SOC, V133, P10034, DOI 10.1021/ja202902d; Ueno Y, 2004, SYNTHESIS-STUTTGART, P2591, DOI 10.1055/s-2004-829194; Vinkenborg JL, 2009, NAT METHODS, V6, P737, DOI [10.1038/NMETH.1368, 10.1038/nmeth.1368]; von Bohlen und Halbach O, 2002, NEUROIMAGE, V15, P633, DOI 10.1006/nimg.2001.1045; Wang Y, 2012, CANCER LETT, V320, P111, DOI 10.1016/j.canlet.2012.01.037; Yang Y, 2005, P NATL ACAD SCI USA, V102, P117, DOI 10.1073/pnas.0405989102; Yoshimura T, 1996, NAT BIOTECHNOL, V14, P992, DOI 10.1038/nbt0896-992; Zhang Y, 2006, ANGEW CHEM INT EDIT, V45, P4936, DOI 10.1002/anie.200601197; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	44	10	10	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123986	10.1371/journal.pone.0123986	http://dx.doi.org/10.1371/journal.pone.0123986			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923693	gold, Green Published			2022-12-27	WOS:000353711600065
J	Jensen, LM; Wallis, IR; Foley, WJ				Jensen, Lora M.; Wallis, Ian R.; Foley, William J.			The Relative Concentrations of Nutrients and Toxins Dictate Feeding by a Vertebrate Browser, the Greater Glider Petauroides volans	PLOS ONE			English	Article							PLANT SECONDARY METABOLITES; FOOD SELECTION; FOLIVOROUS MARSUPIALS; BRUSHTAIL POSSUM; LEAF CHEMISTRY; TREE USE; EUCALYPTUS; PROTEIN; HERBIVORES; AVAILABILITY	Although ecologists believe that vertebrate herbivores must select a diet that allows them to meet their nutritional requirements, while avoiding intoxication by plant secondary metabolites, this is remarkably difficult to show. A long series of field and laboratory experiments means that we have a good understanding of the factors that affect feeding by leaf-eating marsupials. This knowledge and the natural intraspecific variation in Eucalyptus chemistry allowed us to test the hypothesis that the feeding decisions of greater gliders (Petauroides volans) depend on the concentrations of available nitrogen (incorporating total nitrogen, dry matter digestibility and tannins) and of formylated phloroglucinol compounds (FPCs), potent antifeedants unique to Eucalyptus. We offered captive greater gliders foliage from two species of Eucalyptus, E. viminalisand E. melliodora, which vary naturally in their concentrations of available nitrogen and FPCs. We then measured the amount of foliage eaten by each glider and compared this with our laboratory analyses of foliar total nitrogen, available nitrogen and FPCs for each tree offered. The concentration of FPCs was the main factor that determined how much gliders ate of E. viminalis and E. melliodora, but in gliders fed E. viminalis the concentration of available nitrogen was also a significant influence. In other words, greater gliders ate E. viminalis leaves with a particular combination of FPCs and available nitrogen that maximised the nutritional gain but minimised their ingestion of toxins. In contrast, the concentration of total nitrogen was not correlated with feeding. This study is among the first to empirically show that browsing herbivores select a diet that balances the potential gain (available nutrients) and the potential costs (plant secondary chemicals) of eating leaves. The major implication of the study is that it is essential to identify the limiting nutrients and relevant toxins in a system in order to understand feeding behaviour.	[Jensen, Lora M.; Wallis, Ian R.; Foley, William J.] Australian Natl Univ, Res Sch Biol, Evolut Ecol & Genet, Canberra, ACT 0200, Australia	Australian National University	Jensen, LM (corresponding author), Australian Natl Univ, Res Sch Biol, Evolut Ecol & Genet, Canberra, ACT 0200, Australia.	Lora.Jensen@anu.edu.au	Foley, William J/C-8069-2009	Foley, William J/0000-0001-8587-1814	Australian Research Council [DP0986142]	Australian Research Council(Australian Research Council)	The work was supported by an Australian Research Council Discovery Grant (DP0986142) to IRW and WJF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbehenn RV, 2011, PHYTOCHEMISTRY, V72, P1551, DOI 10.1016/j.phytochem.2011.01.040; Barthelmess EL, 2001, ETHOL ECOL EVOL, V13, P115; Chapman CA, 2002, INT J PRIMATOL, V23, P283, DOI 10.1023/A:1013831511405; Chapman CA, 2004, AM J PRIMATOL, V62, P55, DOI 10.1002/ajp.20006; Comport SS, 1996, WILDLIFE RES, V23, P401, DOI 10.1071/WR9960401; Cork SJ, 1996, FOREST ECOL MANAG, V85, P163, DOI 10.1016/S0378-1127(96)03757-7; CORK SJ, 1984, POSSUMS GLIDERS, P269; DeGabriel JL, 2008, OECOLOGIA, V156, P107, DOI 10.1007/s00442-008-0960-y; Degabriel JL, 2009, ECOLOGY, V90, P711, DOI 10.1890/08-0940.1; DEGABRIELE R, 1981, AUST J ECOL, V6, P139, DOI 10.1111/j.1442-9993.1981.tb01284.x; Eschler BM, 2000, BIOCHEM SYST ECOL, V28, P813, DOI 10.1016/S0305-1978(99)00123-4; Felton AM, 2009, BEHAV ECOL, V20, P685, DOI 10.1093/beheco/arp021; FOLEY WJ, 1990, AUST J ZOOL, V38, P1, DOI 10.1071/ZO9900001; FOLEY WJ, 1987, PHYSIOL ZOOL, V60, P103, DOI 10.1086/physzool.60.1.30158632; GANZHORN JU, 1992, OECOLOGIA, V91, P540, DOI 10.1007/BF00650329; Ganzhorn JU, 2002, OECOLOGIA, V131, P427, DOI 10.1007/s00442-002-0891-y; Gogarten JF, 2012, TROP CONSERV SCI, V5, P381, DOI 10.1177/194008291200500311; Harris Jamie M., 2010, Mammalian Species, P207, DOI 10.1644/866.1; Iason GR, 2006, J CHEM ECOL, V32, P1115, DOI 10.1007/s10886-006-9075-2; Jensen LM, 2014, OECOLOGIA, V176, P251, DOI 10.1007/s00442-014-2997-4; KAVANAGH RP, 1990, AUST WILDLIFE RES, V17, P285; KOOL KM, 1992, OECOLOGIA, V90, P527, DOI 10.1007/BF01875446; Lawler IR, 1998, OECOLOGIA, V116, P160, DOI 10.1007/s004420050575; Lawler IR, 2000, ECOLOGY, V81, P1327, DOI 10.1890/0012-9658(2000)081[1327:FCOAST]2.0.CO;2; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Mcart SH, 2009, ECOLOGY, V90, P1400, DOI 10.1890/08-1435.1; McLean S, 2006, J CHEM ECOL, V32, P1213, DOI 10.1007/s10886-006-9081-4; MILTON K, 1979, AM NAT, V114, P362, DOI 10.1086/283485; Moore BD, 2005, NATURE, V435, P488, DOI 10.1038/nature03551; Moore BD, 2005, BIOL LETT-UK, V1, P64, DOI 10.1098/rsbl.2004.0255; Moore BD, 2004, J CHEM ECOL, V30, P1743, DOI 10.1023/B:JOEC.0000042399.06553.c6; MOORE BD, 2004, CONSERVATION AUSTR F; OATES JF, 1990, ECOLOGY, V71, P328, DOI 10.2307/1940272; Pass DM, 1998, J CHEM ECOL, V24, P1513, DOI 10.1023/A:1020911800847; Pryor L. D., 1959, Monographiae Biologicae, V8, P461; ROBBINS CT, 1987, ECOLOGY, V68, P98, DOI 10.2307/1938809; Rothman JM, 2011, BIOL LETTERS, V7, P847, DOI 10.1098/rsbl.2011.0321; Wallis IR, 2012, OECOLOGIA, V169, P281, DOI 10.1007/s00442-011-2212-9; Wallis IR, 2010, FOREST ECOL MANAG, V260, P814, DOI 10.1016/j.foreco.2010.05.040; Wallis IR, 2005, PHYTOCHEM ANALYSIS, V16, P49, DOI 10.1002/pca.810; Wallis IR, 2002, AUST J ZOOL, V50, P507, DOI 10.1071/ZO02029; WATERMAN PG, 1988, BIOL J LINN SOC, V34, P1, DOI 10.1111/j.1095-8312.1988.tb01946.x; White T. C. R., 1993, INADEQUATE ENV NITRO; Youngentob KN, 2011, J CHEM ECOL, V37, P71, DOI 10.1007/s10886-010-9889-9; [No title captured]	45	15	15	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0121584	10.1371/journal.pone.0121584	http://dx.doi.org/10.1371/journal.pone.0121584			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938422	Green Published, gold, Green Submitted			2022-12-27	WOS:000353943000004
J	Palacin-Arce, A; Monteagudo, C; Beas-Jimenez, JD; Olea-Serrano, F; Mariscal-Arcas, M				Palacin-Arce, Alba; Monteagudo, Celia; de Dios Beas-Jimenez, Juan; Olea-Serrano, Fatima; Mariscal-Arcas, Miguel			Proposal of a Nutritional Quality Index (NQI) to Evaluate the Nutritional Supplementation of Sportspeople	PLOS ONE			English	Article							DIETARY-SUPPLEMENTS; MEDITERRANEAN DIET; QUESTIONNAIRES; VALIDATION; ADHERENCE; HABITS; PEOPLE	Background Numerous supplements are used by sportspeople. They are not always appropriate for the individual or the sports activity and may do more harm than good. Vitamin and mineral supplements are unnecessary if the energy intake is sufficient to maintain body weight and derives from a diet with an adequate variety of foods. The study objectives were to evaluate the main nutrients used as supplements in sports and to propose a nutritional quality index (NQI) that enables sportspeople to optimize their use of supplements and detect and remedy possible nutritional deficits. Material and Methods A nutritional study was performed in 485 sportspeople recruited from Centros Andaluces de Medicina del Deporte, (CAMD). All completed socio-demographic, food frequency, and lifestyle questionnaires. The nutritional quality of their diet and need for supplementation were evaluated by scoring their dietary intake with and without supplementation, yielding two NQI scores (scales of 0-21 points) for each participant. Results A superior mean NQI score was obtained when the supplements taken by participants were not included (16. 28 (SD of 3.52)) than when they were included (15.47 (SD: 3.08)), attributable to an excessive intake of some nutrients through supplementation. Conclusions These results indicate that sportspeople with a varied and balanced diet do not need supplements, which appear to offer no performance benefits and may pose a health risk.	[Palacin-Arce, Alba; Monteagudo, Celia; Olea-Serrano, Fatima; Mariscal-Arcas, Miguel] Univ Granada, Dept Nutr & Food Sci, Diet & Risk Assessment AGR255, Res Grp Nutr, Granada, Spain; [de Dios Beas-Jimenez, Juan; Mariscal-Arcas, Miguel] Andalusian Ctr Sport Med CAMD, Junta De Andalucia, Spain; [Mariscal-Arcas, Miguel] Univ Murcia, Dept Nutr & Food Sci, Food Technol, Murcia, Spain	University of Granada; University of Murcia	Olea-Serrano, F (corresponding author), Univ Granada, Dept Nutr & Food Sci, Diet & Risk Assessment AGR255, Res Grp Nutr, Granada, Spain.	folea@ugr.es	Olea-Serrano, Fatima/I-4584-2017; Mariscal, Miguel/N-6543-2019; Mariscal-Arcas, Miguel/K-4150-2017; Sánchez, Celia Monteagudo/M-1460-2014; Mariscal-Arcas, Miguel/R-3406-2019	Mariscal-Arcas, Miguel/0000-0001-9852-4950; Sánchez, Celia Monteagudo/0000-0003-0529-379X; Mariscal-Arcas, Miguel/0000-0001-9852-4950; Beas-Jimenez, Juan de Dios/0000-0001-9805-029X	Junta de Andalucia [FMD2010SC0071]	Junta de Andalucia(Junta de Andalucia)	The authors are grateful to the High Performance Centre of Sierra Nevada and the Sports Medicine Centres of Andalusia for their collaboration in this study and thank Richard Davies for his assistance with the English version. Furthermore, the authors are grateful to the Junta de Andalucia, Spain (Research Group AGR-255"Nutrition. Diet and Risk Assessment"), a collaboration agreement with the Andalusian Centres of Sports Medicine (Junta de Andalucia) and the FPU program of the Spanish Ministry of Education and Science. Study participants were recruited through the project "Nutritional and diet assessment methodologies applied to the Andalusian sportsperson in Andalusian Sports centres", Research project FMD2010SC0071 of the Junta de Andalucia.	[Anonymous], 2009, J AM DIET ASSOC, V109, P330, DOI 10.1016/j.jada.2008.11.041; [Anonymous], 2005, JOINT FAO OMS TECHN; [Anonymous], 2002, DIET REF INT EN CARB; Bountziouka V, 2010, CURR PHARM DESIGN, V16, P3770, DOI 10.2174/138161210794455102; Brennan B, 2014, BRIT J SPORT MED, V48, P343, DOI 10.1136/bjsports-2013-092956; EFSA, 2011, PUBL CONS DRAFT SCI; Gabarra AG, 2006, NUTR HOSP, V21, P437; Gabarra AG, 2006, NUTR HOSP, V21, P291; Gomez-Cabrera MC, 2008, AM J CLIN NUTR, V87, P142, DOI 10.1093/ajcn/87.1.142; Guallar E, 2013, ANN INTERN MED, V159, P850, DOI 10.7326/0003-4819-159-12-201312170-00011; Hamdan M, 2013, PUBLIC HEALTH NUTR, V16, P1; Hanekamp JC, 2007, CRIT REV FOOD SCI, V47, P267, DOI 10.1080/10408390600737748; Hansen BH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053044; Hawley JA, 2011, J APPL PHYSIOL, V110, P834, DOI 10.1152/japplphysiol.00949.2010; Huang SH, 2006, CLIN J SPORT MED, V16, P27, DOI 10.1097/01.jsm.0000194766.35443.9c; IoM United Kingdom Department of Health, 1991, DIET REF VAL FOOD EN; Jeukendrup AE, 2011, OBES REV, V12, P841, DOI 10.1111/j.1467-789X.2011.00908.x; Marisca-Arcas M, 2011, J NUTR HEALTH AGING, V15, P739, DOI 10.1007/s12603-011-0136-z; Mariscal-Arcas M, 2010, NUTR HOSP, V25, P1006, DOI 10.3305/nh.2010.25.6.4889; Maughan RJ, 2011, J SPORT SCI, V29, pS57, DOI 10.1080/02640414.2011.587446; Maughan RJ, 2007, J SPORT SCI, V25, pS103, DOI 10.1080/02640410701607395; Maughan RJ, 2012, P NUTR SOC, V71, P112, DOI 10.1017/S0029665111003211; Munro IC, 2006, J NUTR, V136, p490S, DOI 10.1093/jn/136.2.490S; National Statistic Office of Spain, NAT SURV SPORTS HAB; Nieper A, 2005, BRIT J SPORT MED, V39, P645, DOI 10.1136/bjsm.2004.015842; Nikolaidis MG, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/707941; Ortega Anta RM, 2008, DIAL V 1 19, V1.19; Panel on Dietetic Products Nutrition and Allergies (NDA), PUBL CONS DRAFT SCI; Papanikolaou G, 2005, TOXICOL APPL PHARM, V202, P199, DOI 10.1016/j.taap.2004.06.021; Richardson D. P., 2007, Food Science and Technology Bulletin: Functional Foods, V4, P51, DOI 10.1616/1476-2137.14996; Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106; Rivas A, 2009, NUTR HOSP, V24, P521, DOI 10.3305/nh.2009.24.5.4462; Rodek J, 2012, J INT SOC SPORT NUTR, V9, DOI 10.1186/1550-2783-9-51; Rodriguez NR, 2009, MED SCI SPORT EXER, V41, P709, DOI 10.1249/MSS.0b013e31890eb86; Suedekum Natalie A, 2005, Curr Sports Med Rep, V4, P199, DOI 10.1097/01.CSMR.0000306207.79809.7f; WHO, 2007, WHO TECH REP SER, V935, P1; WHO, 2000, OB PREV MAN GLOB EP; Willett W., 2012, NUTR EPIDEMIOLOGY	38	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125630	10.1371/journal.pone.0125630	http://dx.doi.org/10.1371/journal.pone.0125630			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938239	Green Published, gold, Green Submitted			2022-12-27	WOS:000353943000083
J	Poitou, C; Perret, C; Mathieu, F; Truong, V; Blum, Y; Durand, H; Alili, R; Chelghoum, N; Pelloux, V; Aron-Wisnewsky, J; Torcivia, A; Bouillot, JL; Parks, BW; Ninio, E; Clement, K; Tiret, L				Poitou, Christine; Perret, Claire; Mathieu, Francois; Truong, Vinh; Blum, Yuna; Durand, Herve; Alili, Rohia; Chelghoum, Nadjim; Pelloux, Veronique; Aron-Wisnewsky, Judith; Torcivia, Adriana; Bouillot, Jean-Luc; Parks, Brian W.; Ninio, Ewa; Clement, Karine; Tiret, Laurence			Bariatric Surgery Induces Disruption in Inflammatory Signaling Pathways Mediated by Immune Cells in Adipose Tissue: A RNA-Seq Study	PLOS ONE			English	Article							DIFFERENTIAL GENE-EXPRESSION; EXTRACELLULAR-MATRIX; PROTEINS; OBESITY; SIGNATURE; PACKAGE; MARKER; DIET	Background Bariatric surgery is associated to improvements in obesity-associated comorbidities thought to be mediated by a decrease of adipose inflammation. However, the molecular mechanisms behind these beneficial effects are poorly understood. Methodology/Principal Findings We analyzed RNA-seq expression profiles in adipose tissue from 22 obese women before and 3 months after surgery. Of 15,972 detected genes, 1214 were differentially expressed after surgery at a 5% false discovery rate. Upregulated genes were mostly involved in the basal cellular machinery. Downregulated genes were enriched in metabolic functions of adipose tissue. At baseline, 26 modules of coexpressed genes were identified. The four most stable modules reflected the innate and adaptive immune responses of adipose tissue. A first module reflecting a non-specific signature of innate immune cells, mainly macrophages, was highly conserved after surgery with the exception of DUSP2 and CD300C. A second module reflected the adaptive immune response elicited by T lymphocytes; after surgery, a disconnection was observed between genes involved in T-cell signaling and mediators of the signal transduction such as CXCR1, CXCR2, GPR97, CCR7 and IL7R. A third module reflected neutrophil-mediated inflammation; after surgery, several genes were dissociated from the module, including S100A8, S100A12, CD300E, VNN2, TUBB1 and FAM65B. We also identified a dense network of 19 genes involved in the interferon-signaling pathway which was strongly preserved after surgery, with the exception of DDX60, an antiviral factor involved in RIG-I-mediated interferon signaling. A similar loss of connection was observed in lean mice compared to their obese counterparts. Conclusions/Significance These results suggest that improvements of the inflammatory state following surgery might be explained by a disruption of immuno-inflammatory cascades involving a few crucial molecules which could serve as potential therapeutic targets.	[Poitou, Christine; Perret, Claire; Mathieu, Francois; Truong, Vinh; Durand, Herve; Alili, Rohia; Pelloux, Veronique; Aron-Wisnewsky, Judith; Ninio, Ewa; Clement, Karine; Tiret, Laurence] Hop La Pitie Salpetriere, AP HP, Inst Cardiometab & Nutr ICAN, Dept Nutr, F-75013 Paris, France; [Poitou, Christine; Alili, Rohia; Pelloux, Veronique; Aron-Wisnewsky, Judith; Clement, Karine] Univ Paris 06, Sorbonne Univ, INSERM, Nutri Team,UMR S 1166, F-75005 Paris, France; [Perret, Claire; Mathieu, Francois; Truong, Vinh; Durand, Herve; Ninio, Ewa; Tiret, Laurence] Univ Paris 06, Sorbonne Univ, INSERM, Genom & Pathophysiol Cardiovasc Dis Team,UMR S 11, F-75005 Paris, France; [Blum, Yuna; Parks, Brian W.] Univ Calif Los Angeles, Div Cardiol, Dept Med, Los Angeles, CA 90095 USA; [Chelghoum, Nadjim] Univ Paris 06, Sorbonne Univ, Post Genom Platform Pitie Salpetriere P3S, F-75013 Paris, France; [Torcivia, Adriana] Hop La Pitie Salpetriere, AP HP, Dept Visceral Surg, F-75013 Paris, France; [Bouillot, Jean-Luc] Ambroise Pare Hosp, AP HP, Dept Gen Digest & Metab Surg, F-92100 Boulogne, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of California System; University of California Los Angeles; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP	Tiret, L (corresponding author), Hop La Pitie Salpetriere, AP HP, Inst Cardiometab & Nutr ICAN, Dept Nutr, F-75013 Paris, France.	laurence.tiret@upmc.fr	Blum, Yuna/W-7343-2019; ARON-WISNEWSKY, judith/AAH-7608-2020; Clément, karine/R-1120-2017; Poitou, Christine/GVT-6117-2022	Poitou, Christine/0000-0001-7769-6331; Durand, Herve/0000-0002-8167-4693; Blum, Yuna/0000-0002-4716-8017	Fondation pour la Recherche Medicale (FRM) [ING20121226269]; Agence Nationale de la Recherche, France [ANR 09 GENO 106 01]; Assistance Publique-Hopitaux de Paris (APHP); Direction of Clinical Research (PHRC MICROBARIA)	Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche, France(French National Research Agency (ANR)); Assistance Publique-Hopitaux de Paris (APHP); Direction of Clinical Research (PHRC MICROBARIA)	The research was supported by the Fondation pour la Recherche Medicale (FRM ING20121226269) (F.M.), the Agence Nationale de la Recherche, France (ANR 09 GENO 106 01) (V.T.), the Assistance Publique-Hopitaux de Paris (APHP) and the Direction of Clinical Research (PHRC MICROBARIA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bass JIF, 2013, NAT METHODS, V10, P1169, DOI [10.1038/NMETH.2728, 10.1038/nmeth.2728]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett BJ, 2010, GENOME RES, V20, P281, DOI 10.1101/gr.099234.109; Borrego F, 2013, BLOOD, V121, P1951, DOI 10.1182/blood-2012-09-435057; Bouchard L, 2010, AM J CLIN NUTR, V91, P309, DOI 10.3945/ajcn.2009.28085; Chiellini C, 2008, BIOCHEM BIOPH RES CO, V374, P64, DOI 10.1016/j.bbrc.2008.06.121; Christis C, 2012, J CELL BIOL, V196, P327, DOI 10.1083/jcb.201107115; Cildir G, 2013, TRENDS MOL MED, V19, P487, DOI 10.1016/j.molmed.2013.05.001; Cimino D, 2008, INT J CANCER, V123, P1327, DOI 10.1002/ijc.23660; Curtis AM, 2014, IMMUNITY, V40, P178, DOI 10.1016/j.immuni.2014.02.002; Dahlman I, 2005, AM J CLIN NUTR, V81, P1275; Dorsett D, 2009, CHROMOSOME RES, V17, P185, DOI 10.1007/s10577-009-9022-5; el Bouazzaoui F, 2014, INT J OBESITY, V38, P746, DOI 10.1038/ijo.2013.175; Ferrante AW, 2013, DIABETES OBES METAB, V15, P34, DOI 10.1111/dom.12154; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; Heinig M, 2010, NATURE, V467, P460, DOI 10.1038/nature09386; Henegar C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r14; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hudson NJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-356; Jeon H, 2010, J BIOMOL SCREEN, V15, P949, DOI 10.1177/1087057110376090; Jing ZZ, 2010, J IMMUNOL, V185, P6719, DOI 10.4049/jimmunol.0903869; Johansson LE, 2012, AM J CLIN NUTR, V96, P196, DOI 10.3945/ajcn.111.020578; Kessel C, 2013, CLIN IMMUNOL, V147, P229, DOI 10.1016/j.clim.2012.11.008; Kirschner LS, 2000, BIOCHEM BIOPH RES CO, V270, P1106, DOI 10.1006/bbrc.2000.2568; Kolehmainen M, 2008, INT J OBESITY, V32, P292, DOI 10.1038/sj.ijo.0803718; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Longhese MP, 2012, FRONT BIOSCI-LANDMRK, V17, P1715, DOI 10.2741/4014; Menssen A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-461; Miyashita M, 2011, MOL CELL BIOL, V31, P3802, DOI 10.1128/MCB.01368-10; Mraz M, 2014, J ENDOCRINOL, V222, pR113, DOI 10.1530/JOE-14-0283; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Panopoulos AD, 2008, CYTOKINE, V42, P277, DOI 10.1016/j.cyto.2008.03.002; Parks BW, 2013, CELL METAB, V17, P141, DOI 10.1016/j.cmet.2012.12.007; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Poitou C, 2006, OBESITY, V14, P309, DOI 10.1038/oby.2006.40; Poitou C, 2011, ARTERIOSCL THROM VAS, V31, P2322, DOI 10.1161/ATVBAHA.111.230979; Roberts A, 2013, NAT METHODS, V10, P71, DOI [10.1038/NMETH.2251, 10.1038/nmeth.2251]; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Ronnegard L, 2010, R J, V2, P20; Rougerie P, 2013, J IMMUNOL, V190, P748, DOI 10.4049/jimmunol.1201174; Sanchez-Palencia A, 2011, INT J CANCER, V129, P355, DOI 10.1002/ijc.25704; Schauer PR, 2014, NEW ENGL J MED, V370, P2002, DOI [10.1056/NEJMoa1401329, 10.1056/NEJMc1407393]; Sobczak A, 2011, BBA-MOL CELL RES, V1813, P1025, DOI 10.1016/j.bbamcr.2010.12.023; Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wang IM, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.24; Wang XA, 2013, AM J PHYSIOL-ENDOC M, V305, pE485, DOI 10.1152/ajpendo.00505.2012; Wei SJ, 2013, CELL MOL LIFE SCI, V70, P4569, DOI 10.1007/s00018-013-1395-0; Wei W, 2013, GENES IMMUN, V14, P1, DOI 10.1038/gene.2012.54; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; Zhang HR, 2011, ARTERIOSCL THROM VAS, V31, P2063, DOI 10.1161/ATVBAHA.111.225870	57	38	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125718	10.1371/journal.pone.0125718	http://dx.doi.org/10.1371/journal.pone.0125718			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938420	Green Submitted, Green Published, gold			2022-12-27	WOS:000353943000094
J	Gulyas, G; Toth, JT; Toth, DJ; Kurucz, I; Hunyady, L; Balla, T; Varnai, P				Gulyas, Gergo; Toth, Jozsef T.; Toth, Daniel J.; Kurucz, Istvan; Hunyady, Laszlo; Balla, Tamas; Varnai, Peter			Measurement of Inositol 1,4,5-Trisphosphate in Living Cells Using an Improved Set of Resonance Energy Transfer-Based Biosensors	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE LEVELS; PROTEIN-COUPLED RECEPTOR; CALCIUM-ENTRY; FLUORESCENT PROTEIN; BINDING; DOMAINS; LIGAND; FRET; IDENTIFICATION; INDICATORS	Improved versions of inositol-1,4,5-trisphosphate (InsP(3)) sensors were created to follow intracellular InsP(3) changes in single living cells and in cell populations. Similar to previous InsP(3) sensors the new sensors are based on the ligand binding domain of the human type-I InsP(3) receptor (InsP(3)R-LBD), but contain a mutation of either R265K or R269K to lower their InsP(3) binding affinity. Tagging the InsP(3)R-LBD with N-terminal Cerulean and C-terminal Venus allowed measurement of InsP(3) in single-cell FRET experiments. Replacing Cerulean with a Luciferase enzyme allowed experiments in multi-cell format by measuring the change in the BRET signal upon stimulation. These sensors faithfully followed the agonist-induced increase in InsP(3) concentration in HEK 293T cells expressing the Gq-coupled AT1 angiotensin receptor detecting a response to agonist concentration as low as 10 pmol/L. Compared to the wild type InsP(3) sensor, the mutant sensors showed an improved off-rate, enabling a more rapid and complete return of the signal to the resting value of InsP(3) after termination of M3 muscarinic receptor stimulation by atropine. For parallel measurements of intracellular InsP(3) and Ca2+ levels in BRET experiments, the Cameleon D3 Ca2+ sensor was modified by replacing its CFP with luciferase. In these experiments depletion of plasma membrane Ptdlns(4,5)P-2 resulted in the fall of InsP(3) level, followed by the decrease of the Ca2+-signal evoked by the stimulation of the AT1 receptor. In contrast, when type-III PI 4-kinases were inhibited with a high concentration of wortmannin or a more specific inhibitor, A1, the decrease of the Ca2+-signal preceded the fall of InsP(3) level indicating an InsP(3)(-), independent, direct regulation of capacitative Ca2+ influx by plasma membrane inositol lipids. Taken together, our results indicate that the improved InsP(3) sensor can be used to monitor both the increase and decrease of InsP(3) levels in live cells suitable for high-throughput BRET applications.	[Gulyas, Gergo; Toth, Jozsef T.; Toth, Daniel J.; Hunyady, Laszlo; Varnai, Peter] Semmelweis Univ, Fac Med, Dept Physiol, H-1094 Budapest, Hungary; [Kurucz, Istvan; Balla, Tamas] NICHHD, Sect Mol Signal Transduct, Program Dev Neurosci, NIH, Bethesda, MD 20892 USA	Semmelweis University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Varnai, P (corresponding author), Semmelweis Univ, Fac Med, Dept Physiol, H-1094 Budapest, Hungary.	varnai.peter@med.semmelweis-univ.hu	Gulyás, Gergő/I-8923-2017; Tóth, Dániel/M-7105-2019	Gulyás, Gergő/0000-0002-5491-8699; Tóth, Dániel/0000-0001-6670-3348; Toth, Jozsef/0000-0002-4993-4926; Balla, Tamas/0000-0002-9077-3335	Hungarian Scientific Research Fund (OTKA) [K105006]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000196] Funding Source: NIH RePORTER	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding provided by Hungarian Scientific Research Fund (OTKA) K105006: PV, http://www.otka.hu/en.	Balla A, 2008, MOL BIOL CELL, V19, P711, DOI 10.1091/mbc.E07-07-0713; BALLA T, 1986, P NATL ACAD SCI USA, V83, P9323, DOI 10.1073/pnas.83.24.9323; Bojjireddy N, 2014, J BIOL CHEM, V289, P6120, DOI 10.1074/jbc.M113.531426; Bosanac I, 2002, NATURE, V420, P696, DOI 10.1038/nature01268; BREDT DS, 1989, BIOCHEM BIOPH RES CO, V159, P976, DOI 10.1016/0006-291X(89)92204-3; Broad LM, 2001, J BIOL CHEM, V276, P15945, DOI 10.1074/jbc.M011571200; Calloway N, 2011, J CELL SCI, V124, P2602, DOI 10.1242/jcs.084178; HUNYADY L, 1994, J BIOL CHEM, V269, P31378; Korzeniowski MK, 2009, J BIOL CHEM, V284, P21027, DOI 10.1074/jbc.M109.012252; Maleth J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6843; Matsu-ura T, 2006, J CELL BIOL, V173, P755, DOI 10.1083/jcb.200512141; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; NAKANISHI S, 1995, P NATL ACAD SCI USA, V92, P5317, DOI 10.1073/pnas.92.12.5317; Nezu A, 2006, BBA-GEN SUBJECTS, V1760, P1274, DOI 10.1016/j.bbagen.2006.04.004; Nezu A, 2010, J CELL SCI, V123, P2292, DOI 10.1242/jcs.064410; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; Remus TP, 2006, J BIOL CHEM, V281, P608, DOI 10.1074/jbc.M509645200; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rodgers W, 2002, BIOTECHNIQUES, V32, P1044, DOI 10.2144/02325st05; Sato M, 2005, ANAL CHEM, V77, P4751, DOI 10.1021/ac040195j; Tanimura A, 2004, J BIOL CHEM, V279, P38095, DOI 10.1074/jbc.C400312200; Tanimura A, 2009, J BIOL CHEM, V284, P8901, DOI 10.1074/jbc.M805865200; Torrecilla I, 2007, J CELL BIOL, V177, P127, DOI 10.1083/jcb.200610018; Toth DJ, 2012, J CELL SCI, V125, P2185, DOI 10.1242/jcs.097279; van der Krogt GNM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001916; Varnai P, 2005, P NATL ACAD SCI USA, V102, P7859, DOI 10.1073/pnas.0407535102; Varnai P, 2002, J BIOL CHEM, V277, P27412, DOI 10.1074/jbc.M109672200; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Varnai P, 2009, TRENDS PHARMACOL SCI, V30, P118, DOI 10.1016/j.tips.2008.11.005; Walsh CM, 2010, BIOCHEM J, V425, P159, DOI 10.1042/BJ20090884; Woo J, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-23; Yoshikawa F, 1999, J BIOL CHEM, V274, P328, DOI 10.1074/jbc.274.1.328	33	17	18	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125601	10.1371/journal.pone.0125601	http://dx.doi.org/10.1371/journal.pone.0125601			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932648	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000353887100120
J	Hong, ZF; Zhao, WX; Yin, ZY; Xie, CR; Xu, YP; Chi, XQ; Zhang, S; Wang, XM				Hong, Zai-Fa; Zhao, Wen-Xiu; Yin, Zhen-Yu; Xie, Cheng-Rong; Xu, Ya-Ping; Chi, Xiao-Qin; Zhang, Sheng; Wang, Xiao-Min			Capsaicin Enhances the Drug Sensitivity of Cholangiocarcinoma through the Inhibition of Chemotherapeutic-Induced Autophagy	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; CANCER-CELLS; INDUCED APOPTOSIS; PATHWAYS; THERAPY; DIFFERENTIATION; MODULATION; ANTITUMOR	Cholangiocarcinoma (CCA), a devastating cancer with a poor prognosis, is resistant to the currently available chemotherapeutic agents. Capsaicin, the major pungent ingredient found in hot red chili peppers of the genus Capsicum, suppresses the growth of several malignant cell lines. Our aims were to investigate the role and mechanism of capsaicin with respect to the sensitivity of CCA cells to chemotherapeutic agents. The effect of capsaicin on CCA tumor sensitivity to 5-fluorouracil (5-FU) was assessed in vitro in CCA cells and in vivo in a xenograft model. The drug sensitivity of QBC939 to 5-FU was significantly enhanced by capsaicin compared with either agent alone. In addition, the combination of capsaicin with 5-FU was synergistic, with a combination index (CI) < 1, and the combined treatment also suppressed tumor growth in the CCA xenograft to a greater extent than 5-FU alone. Further investigation revealed that the autophagy induced by 5-FU was inhibited by capsaicin. Moreover, the decrease in AKT and S6 phosphorylation induced by 5-FU was effectively reversed by capsaicin, indicating that capsaicin inhibits 5-FU-induced autophagy by activating the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) pathway in CCA cells. Taken together, these results demonstrate that capsaicin may be a useful adjunct therapy to improve chemosensitivity in CCA. This effect likely occurs via PI3K/AKT/mTOR pathway activation, suggesting a promising strategy for the development of combination drugs for CCA.	[Hong, Zai-Fa] Fujian Med Univ, Postgrad Coll, Fuzhou, Peoples R China; [Hong, Zai-Fa] Xiamen Tradit Hosp, Liver Dis Ctr, Dept Hepatobiliary Surg, Xiamen, Peoples R China; [Zhao, Wen-Xiu; Yin, Zhen-Yu; Xie, Cheng-Rong; Xu, Ya-Ping; Chi, Xiao-Qin; Zhang, Sheng; Wang, Xiao-Min] Xiamen Univ, Zhongshan Hosp, Dept Hepatobiliary Surg, Xiamen, Peoples R China; [Wang, Xiao-Min] Fujian Med Univ, Union Clin Med Coll, Fuzhou, Peoples R China	Fujian Medical University; Xiamen University; Fujian Medical University	Wang, XM (corresponding author), Xiamen Univ, Zhongshan Hosp, Dept Hepatobiliary Surg, Xiamen, Peoples R China.	wxm@xmzsh.com	Hong, zaifa/HGU-2883-2022; Yuhua, Xu/AFK-6705-2022	Yuhua, Xu/0000-0001-9285-3008	National Natural Science Foundation of China [81171976]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grant from the National Natural Science Foundation of China (Grant No. 81171976). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen KG, 2012, CLIN CANCER RES, V18, P1863, DOI 10.1158/1078-0432.CCR-11-1590; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Diaz-Laviada I, 2014, PROG DRUG RES, V68, P181, DOI 10.1007/978-3-0348-0828-6_8; Eskelinen EL, 2011, CURR OPIN PHARMACOL, V11, P294, DOI 10.1016/j.coph.2011.03.009; Fang YJ, 2012, CANCER SCI, V103, P1090, DOI 10.1111/j.1349-7006.2012.02272.x; Gil YG, 2008, LIFE SCI, V82, P997, DOI 10.1016/j.lfs.2008.02.020; Grunt TW, 2013, CURR CANCER DRUG TAR, V13, P188; Honscheid P, 2014, INT J RADIAT BIOL, V90, P628, DOI 10.3109/09553002.2014.907932; Hou YJ, 2011, LAB INVEST, V91, P1146, DOI 10.1038/labinvest.2011.97; Huang SP, 2009, ANTICANCER RES, V29, P165; Ip SW, 2012, ENVIRON TOXICOL, V27, P332, DOI 10.1002/tox.20646; Jin JZ, 2014, INT J BIOL SCI, V10, P285, DOI 10.7150/ijbs.7730; Kumar A, 2013, TOXICOL APPL PHARM, V273, P196, DOI 10.1016/j.taap.2013.09.005; Lang M, 2009, LIVER INT, V29, P670, DOI 10.1111/j.1478-3231.2009.01984.x; Lau JK, 2014, APOPTOSIS, V19, P1190, DOI 10.1007/s10495-014-1007-y; Lee JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083611; Li X, 2007, METHOD FIND EXP CLIN, V29, P607, DOI 10.1358/mf.2007.29.9.1139054; Liu H, 2014, J MOL MED; Liu ZH, 2011, MOL BIOL REP, V38, P1769, DOI 10.1007/s11033-010-0291-z; Mayer LD, 2006, MOL CANCER THER, V5, P1854, DOI 10.1158/1535-7163.MCT-06-0118; Naus PJ, 2007, J HEPATOL, V46, P222, DOI 10.1016/j.jhep.2006.08.012; Naveed Sidra, 2014, Oman Med J, V29, P391, DOI 10.5001/omj.2014.107; Rizvi S, 2014, DIGEST DIS, V32, P564, DOI 10.1159/000360502; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Shen DY, 2011, PHYTOTHER RES, V25, P1519, DOI 10.1002/ptr.3435; Sirica AE, 2005, HEPATOLOGY, V41, P5, DOI 10.1002/hep.20537; Soory Mena, 2009, Infectious Disorders - Drug Targets, V9, P400; Takara K, 2006, CURR PHARM DESIGN, V12, P273, DOI 10.2174/138161206775201965; Wojcik S, 2013, FOLIA HISTOCHEM CYTO, V51, P249, DOI 10.5603/FHC.2013.0036; Wu TTL, 2014, CELL CALCIUM, V56, P59, DOI 10.1016/j.ceca.2014.04.006	30	41	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0121538	10.1371/journal.pone.0121538	http://dx.doi.org/10.1371/journal.pone.0121538			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933112	Green Submitted, Green Published, gold			2022-12-27	WOS:000353887100004
J	Lee, S; Jia, B; Liu, JL; Pham, BP; Kwak, JM; Xuan, YH; Cheong, GW				Lee, Sangmin; Jia, Baolei; Liu, Jinliang; Bang Phuong Pham; Kwak, Jae Myeong; Xuan, Yuan Hu; Cheong, Gang-Won			A 1-Cys Peroxiredoxin from a Thermophilic Archaeon Moonlights as a Molecular Chaperone to Protect Protein and DNA against Stress-Induced Damage	PLOS ONE			English	Article							THIOL-SPECIFIC ANTIOXIDANT; THERMOCOCCUS-KODAKARAENSIS KOD1; OXIDATIVE STRESS; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; RING STRUCTURE; NADH OXIDASE; ENZYMES; PEROXIDASE	Peroxiredoxins (Prxs) act against hydrogen peroxide (H2O2), organic peroxides, and peroxynitrite. Thermococcus kodakaraensis KOD1, an anaerobic archaeon, contains many antioxidant proteins, including three Prxs (Tk0537, Tk0815, and Tk1055). Only Tk0537 has been found to be induced in response to heat, osmotic, and oxidative stress. Tk0537 was found to belong to a 1-Cys Prx6 subfamily based on sequence analysis and was named 1-Cys TkPrx. Using gel filtration chromatography, electron microscopy, and blue-native polyacrylamide gel electrophoresis, we observed that 1-Cys TkPrx exhibits oligomeric forms with reduced peroxide reductase activity as well as decameric and dodecameric forms that can act as molecular chaperones by protecting both proteins and DNA from oxidative stress. Mutational analysis showed that a cysteine residue at the N-terminus (Cys(46)) was responsible for the peroxide reductase activity, and cysteine residues at the C-terminus (Cys(205) and Cys(211)) were important for oligomerization. Based on our results, we propose that interconversion between different oligomers is important for regulating the different functions of 1-Cys TkPrx.	[Lee, Sangmin; Jia, Baolei; Bang Phuong Pham; Kwak, Jae Myeong; Cheong, Gang-Won] Gyeongsang Natl Univ, Div Appl Life Sci, Jinju, South Korea; [Lee, Sangmin; Jia, Baolei; Bang Phuong Pham; Kwak, Jae Myeong; Cheong, Gang-Won] Gyeongsang Natl Univ, Res Inst Nat Sci, Jinju, South Korea; [Lee, Sangmin] Korea Basic Sci Inst, Div Electron Microscop Res, Taejon, South Korea; [Jia, Baolei] Chung Ang Univ, Dept Life Sci, Seoul 156756, South Korea; [Liu, Jinliang] Jilin Univ, Coll Plant Sci, Changchun 130023, Peoples R China; [Xuan, Yuan Hu] Wenzhou Med Univ, Coll Pharmaceut Sci, Wenzhou, Peoples R China	Gyeongsang National University; Gyeongsang National University; Korea Basic Science Institute (KBSI); Chung Ang University; Jilin University; Wenzhou Medical University	Cheong, GW (corresponding author), Gyeongsang Natl Univ, Div Appl Life Sci, Jinju, South Korea.	gwcheong@gnu.ac.kr	Jia, Baolei/AIF-1053-2022	, Yuanhu/0000-0002-4704-8090; Jia, Baolei/0000-0001-6434-5604	Fund of Research Promotion Program (Gyeongsang National University); Natural Science Foundation of China [31201485]	Fund of Research Promotion Program (Gyeongsang National University); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Fund of Research Promotion Program (Gyeongsang National University, 2012) and Natural Science Foundation of China (31201485). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUMEISTER W, 1988, FEBS LETT, V241, P239, DOI 10.1016/0014-5793(88)81069-X; Blankenhorn D, 1999, J BACTERIOL, V181, P2209, DOI 10.1128/JB.181.7.2209-2216.1999; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7017, DOI 10.1073/pnas.91.15.7017; Choi MH, 2005, NATURE, V435, P347, DOI 10.1038/nature03587; Declercq JP, 2001, J MOL BIOL, V311, P751, DOI 10.1006/jmbi.2001.4853; Fukui T, 2005, GENOME RES, V15, P352, DOI 10.1101/gr.3003105; Guimaraes BG, 2005, J BIOL CHEM, V280, P25735, DOI 10.1074/jbc.M503076200; Hegerl R, 1996, J STRUCT BIOL, V116, P30, DOI 10.1006/jsbi.1996.0006; Hicks LD, 2010, J BACTERIOL, V192, P2077, DOI 10.1128/JB.01324-09; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Jara M, 2007, MOL BIOL CELL, V18, P2288, DOI 10.1091/mbc.E06-11-1039; Jenney FE, 1999, SCIENCE, V286, P306, DOI 10.1126/science.286.5438.306; Jeon SJ, 2003, J BIOL CHEM, V278, P24174, DOI 10.1074/jbc.M300618200; Jia B, 2008, FEBS J, V275, P5355, DOI 10.1111/j.1742-4658.2008.06665.x; Jia BL, 2013, EXTREMOPHILES, V17, P193, DOI 10.1007/s00792-012-0509-1; Jia BL, 2011, EXTREMOPHILES, V15, P337, DOI 10.1007/s00792-011-0365-4; Jia B, 2010, MOL CELLS, V29, P363, DOI 10.1007/s10059-010-0045-8; Kim KI, 2000, J MOL BIOL, V303, P655, DOI 10.1006/jmbi.2000.4165; Konig J, 2013, J EXP BOT, V64, P3483, DOI 10.1093/jxb/ert184; Kohda J, 2006, J BIOSCI BIOENG, V101, P131, DOI 10.1263/jbb.101.131; LIM YS, 1993, BIOCHEM BIOPH RES CO, V192, P273, DOI 10.1006/bbrc.1993.1410; Manevich Y, 2004, P NATL ACAD SCI USA, V101, P3780, DOI 10.1073/pnas.0400181101; Monteiro G, 2007, P NATL ACAD SCI USA, V104, P4886, DOI 10.1073/pnas.0700481104; Nelson KJ, 2011, CURR PROTOC TOXICOL, V7, DOI [10.1002/0471140856.tx0709s49, DOI 10.1002/0471140856.TX0709S49]; Noguera-Mazon V, 2006, PHOTOSYNTH RES, V89, P277, DOI 10.1007/s11120-006-9106-4; Park SC, 2008, BBA-PROTEINS PROTEOM, V1784, P783, DOI 10.1016/j.bbapap.2008.02.002; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rouhier N, 2001, PLANT PHYSIOL, V127, P1299, DOI 10.1104/pp.010586; Saccoccia F, 2012, STRUCTURE, V20, P429, DOI 10.1016/j.str.2012.01.004; SAURI H, 1995, BIOCHEM BIOPH RES CO, V208, P964, DOI 10.1006/bbrc.1995.1428; Seo JH, 2009, J BIOL CHEM, V284, P13455, DOI 10.1074/jbc.M900641200; VANHEEL M, 1981, ULTRAMICROSCOPY, V6, P187, DOI 10.1016/0304-3991(81)90059-0; Wang Q, 2008, COMP BIOCHEM PHYS B, V149, P176, DOI 10.1016/j.cbpb.2007.09.005; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; WOLFF SP, 1994, METHOD ENZYMOL, V233, P182; Woo HA, 2003, J BIOL CHEM, V278, P47361, DOI 10.1074/jbc.C300428200; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8	37	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125325	10.1371/journal.pone.0125325	http://dx.doi.org/10.1371/journal.pone.0125325			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933432	Green Published, gold, Green Submitted			2022-12-27	WOS:000353887100098
J	Nadendla, E; Teyssier, C; Delfosse, V; Vivat, V; Krishnasamy, G; Gronemeyer, H; Bourguet, W; Germain, P				Nadendla, Eswarkumar; Teyssier, Catherine; Delfosse, Vanessa; Vivat, Valerie; Krishnasamy, Gunasekaran; Gronemeyer, Hinrich; Bourguet, William; Germain, Pierre			An Unexpected Mode Of Binding Defines BMS948 as A Full Retinoic Acid Receptor beta (RAR beta, NR1B2) Selective Agonist	PLOS ONE			English	Article							STRUCTURAL BASIS; CRYSTAL-STRUCTURE; ANTAGONISTS; CANCER; GENE; IDENTIFICATION; MECHANISM	Retinoic acid is an important regulator of cell differentiation which plays major roles in embryonic development and tissue remodeling. The biological action of retinoic acid is mediated by three nuclear receptors denoted RAR alpha, beta and gamma. Multiple studies support that RAR beta possesses functional characteristics of a tumor suppressor and indeed, its expression is frequently lost in neoplastic tissues. However, it has been recently reported that RAR beta could also play a role in mammary gland tumorigenesis, thus demonstrating the important but yet incompletely understood function of this receptor in cancer development. As a consequence, there is a great need for RAR beta-selective agonists and antagonists as tools to facilitate the pharmacological analysis of this protein in vitro and in vivo as well as for potential therapeutic interventions. Here we provide experimental evidences that the novel synthetic retinoid BMS948 is an RAR beta-selective ligand exhibiting a full transcriptional agonistic activity and activating RAR beta as efficiently as the reference agonist TTNPB. In addition, we solved the crystal structures of the RAR beta ligand-binding domain in complex with BMS948 and two related compounds, BMS641 and BMS411. These structures provided a rationale to explain how a single retinoid can be at the same time an RAR alpha antagonist and an RAR beta full agonist, and revealed the structural basis of partial agonism. Finally, in addition to revealing that a flip by 180 degrees of the amide linker, that usually confers RAR alpha selectivity, accounts for the RAR beta selectivity of BMS948, the structural analysis uncovers guidelines for the rational design of RAR beta-selective antagonists.	[Nadendla, Eswarkumar; Teyssier, Catherine; Delfosse, Vanessa; Bourguet, William; Germain, Pierre] Ctr Biochim Struct, Inserm U1054, Montpellier, France; [Nadendla, Eswarkumar; Teyssier, Catherine; Delfosse, Vanessa; Bourguet, William; Germain, Pierre] Univ Montpellier I, CNRS UMR5048, Montpellier, France; [Nadendla, Eswarkumar; Teyssier, Catherine; Delfosse, Vanessa; Bourguet, William; Germain, Pierre] Univ Montpellier 2, Montpellier, France; [Nadendla, Eswarkumar; Krishnasamy, Gunasekaran] Univ Madras, CAS Crystallog & Biophys, Madras, Tamil Nadu, India; [Vivat, Valerie] Novalix, Illkirch Graffenstaden, CU De Strasbour, France; [Gronemeyer, Hinrich] IGBMC, CNRS INSERM UdS CERBM, Illkirch Graffenstaden, CU De Strasbour, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier; University of Madras; Institut National de la Sante et de la Recherche Medicale (Inserm)	Bourguet, W (corresponding author), Ctr Biochim Struct, Inserm U1054, Montpellier, France.	bourguet@cbs.cnrs.fr; germain@cbs.cnrs.fr	Bourguet, William/Y-6600-2019; Teyssier, Catherine/AAC-2395-2020; Bourguet, William/I-5569-2013; Nadendla, EswarKumar/AID-6966-2022; Gronemeyer, Hinrich/G-6240-2011; Gronemeyer, Hinrich/AAH-5575-2019; Gronemeyer, Hinrich/H-7002-2016	Bourguet, William/0000-0002-0643-7719; Teyssier, Catherine/0000-0003-4937-6503; Bourguet, William/0000-0002-0643-7719; Gronemeyer, Hinrich/0000-0001-9454-2449; Gronemeyer, Hinrich/0000-0001-9454-2449; Gronemeyer, Hinrich/0000-0001-9454-2449; Eswarkumar, Nadendla/0000-0001-7938-8033; Germain, Pierre/0000-0003-2962-9593; Delfosse, Vanessa/0000-0002-7436-7935	Agence Nationale pour la Recherche [ANR-13-BSV6-0003-01]; Association pour la Recherche sur le Cancer [ARC A08/4/1056]; Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique, Universite de Montpellier 1 2	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique, Universite de Montpellier 1 2	This work was supported by the Agence Nationale pour la Recherche (ANR-13-BSV6-0003-01), the Association pour la Recherche sur le Cancer (ARC A08/4/1056). It was also supported by funds from the Institut National de la Sante et de la Recherche Medicale, the Centre National de la Recherche Scientifique, Universite de Montpellier 1 & 2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Altucci L, 2001, NAT REV CANCER, V1, P181, DOI 10.1038/35106036; Alvarez R, 2014, CHEM REV, V114, P1, DOI 10.1021/cr400126u; Alvarez S, 2007, INT J BIOCHEM CELL B, V39, P1406, DOI 10.1016/j.biocel.2007.02.010; Alvarez S, 2009, CHEMMEDCHEM, V4, P1630, DOI 10.1002/cmdc.200900214; Bourguet W, 2000, MOL CELL, V5, P289, DOI 10.1016/S1097-2765(00)80424-4; Castillo L, 1997, CLIN CANCER RES, V3, P2137; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; CHEN JY, 1995, EMBO J, V14, P1187, DOI 10.1002/j.1460-2075.1995.tb07102.x; Dawson M. I., 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P199, DOI 10.2174/1568011043352975; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faria TN, 1999, J BIOL CHEM, V274, P26783, DOI 10.1074/jbc.274.38.26783; Gehin M, 1999, CHEM BIOL, V6, P519, DOI 10.1016/S1074-5521(99)80084-2; Germain P, 2004, EMBO REP, V5, P877, DOI 10.1038/sj.embor.7400235; Germain P, 2002, NATURE, V415, P187, DOI 10.1038/415187a; Germain P, 2006, PHARMACOL REV, V58, P685, DOI 10.1124/pr.58.4.2; Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; Germain P, 2009, CHEM BIOL, V16, P479, DOI 10.1016/j.chembiol.2009.03.008; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kagechika H, 2005, J MED CHEM, V48, P5875, DOI 10.1021/jm0581821; KAGECHIKA H, 1988, J MED CHEM, V31, P2182, DOI 10.1021/jm00119a021; Klaholz BP, 2000, J MOL BIOL, V302, P155, DOI 10.1006/jmbi.2000.4032; Klein ES, 1996, J BIOL CHEM, V271, P22692, DOI 10.1074/jbc.271.37.22692; le Maire A, 2012, CURR TOP MED CHEM, V12, P505, DOI 10.2174/156802612799436687; le Maire A, 2010, NAT STRUCT MOL BIOL, V17, P801, DOI 10.1038/nsmb.1855; Li Y, 1999, J BIOL CHEM, V274, P15360, DOI 10.1074/jbc.274.22.15360; Liu XX, 2011, P NATL ACAD SCI USA, V108, P774, DOI 10.1073/pnas.1011845108; LOTAN R, 1995, NEW ENGL J MED, V332, P1405, DOI 10.1056/NEJM199505253322103; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Martinez C, 2014, ACS MED CHEM LETT, V5, P533, DOI 10.1021/ml400521f; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ortiz MA, 2002, DRUG RESIST UPDATE, V5, P162, DOI 10.1016/S1368-7646(02)00050-X; Osz J, 2012, P NATL ACAD SCI USA, V109, pE588, DOI 10.1073/pnas.1118192109; Pogenberg V, 2005, J BIOL CHEM, V280, P1625, DOI 10.1074/jbc.M409302200; RENAUD JP, 1995, NATURE, V378, P681, DOI 10.1038/378681a0; Rochette-Egly Cecile, 2009, Nucl Recept Signal, V7, pe005, DOI 10.1621/nrs.07005; Shin DM, 1997, CLIN CANCER RES, V3, P875; Sirchia SM, 2002, CANCER RES, V62, P2455; Sun SY, 2002, CRIT REV ONCOL HEMAT, V41, P41, DOI 10.1016/S1040-8428(01)00144-5; Widschwendter M, 2001, J MAMMARY GLAND BIOL, V6, P193, DOI 10.1023/A:1011360724350; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	41	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0123195	10.1371/journal.pone.0123195	http://dx.doi.org/10.1371/journal.pone.0123195			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933005	Green Published, Green Submitted, gold			2022-12-27	WOS:000353887100017
J	Chitnis, CE; Mukherjee, P; Mehta, S; Yazdani, SS; Dhawan, S; Shakri, AR; Bharadwaj, R; Gupta, PK; Hans, D; Mazumdar, S; Singh, B; Kumar, S; Pandey, G; Parulekar, V; Imbault, N; Shivyogi, P; Godbole, G; Mohan, K; Leroy, O; Singh, K; Chauhan, VS				Chitnis, Chetan E.; Mukherjee, Paushali; Mehta, Shantanu; Yazdani, Syed Shams; Dhawan, Shikha; Shakri, Ahmad Rushdi; Bharadwaj, Rukmini; Gupta, Puneet Kumar; Hans, Dhiraj; Mazumdar, Suman; Singh, Bijender; Kumar, Sanjeev; Pandey, Gaurav; Parulekar, Varsha; Imbault, Nathalie; Shivyogi, Preethi; Godbole, Girish; Mohan, Krishna; Leroy, Odile; Singh, Kavita; Chauhan, Virander S.			Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-1; MONTANIDE ISA 720; RECEPTOR-BINDING DOMAIN; NEW-GUINEAN CHILDREN; C-TERMINAL FRAGMENT; PAPUA-NEW-GUINEA; INHIBITORY ANTIBODIES; IMMUNOGENICITY TRIAL; HEALTHY-ADULTS; SAFETY	Background A phase I randomised, controlled, single blind, dose escalation trial was conducted to evaluate safety and immunogenicity of JAIVAC-1, a recombinant blood stage vaccine candidate against Plasmodium falciparum malaria, composed of a physical mixture of two recombinant proteins, PfMSP-1(19), the 19 kD conserved, C-terminal region of PfMSP-1 and PfF2 the receptor-binding F2 domain of EBA175. Method Healthy malaria naive Indian male subjects aged 18-45 years were recruited from the volunteer database of study site. Fifteen subjects in each cohort, randomised in a ratio of 2: 1 and meeting the protocol specific eligibility criteria, were vaccinated either with three doses (10 mu g, 25 mu g and 50 mu g of each antigen) of JAIVAC-1 formulated with adjuvant Montanide ISA 720 or with standard dosage of Hepatitis B vaccine. Each subject received the assigned vaccine in the deltoid muscle of the upper arms on Day 0, Day 28 and Day 180. Results JAIVAC-1 was well tolerated and no serious adverse event was observed. All JAIVAC-1 subjects sero-converted for PfF2 but elicited poor immune response to PfMSP-1(19). Dose-response relationship was observed between vaccine dose of PfF2 and antibody response. The antibodies against PfF2 were predominantly of IgG1 and IgG3 isotype. Sera from JAIVAC-1 subjects reacted with late schizonts in a punctate pattern in immunofluorescence assays. Purified IgG from JAIVAC-1 sera displayed significant growth inhibitory activity against Plasmodium falciparum CAMP strain. Conclusion Antigen PfF2 should be retained as a component of a recombinant malaria vaccine but PfMSP-1(19) construct needs to be optimised to improve its immunogenicity.	[Chitnis, Chetan E.; Mukherjee, Paushali; Yazdani, Syed Shams; Dhawan, Shikha; Shakri, Ahmad Rushdi; Bharadwaj, Rukmini; Gupta, Puneet Kumar; Hans, Dhiraj; Mazumdar, Suman; Singh, Bijender; Kumar, Sanjeev; Chauhan, Virander S.] Int Ctr Genet Engn & Biotechnol, New Delhi, India; [Mehta, Shantanu; Pandey, Gaurav; Singh, Kavita] Malaria Vaccine Dev Program, New Delhi, India; [Imbault, Nathalie; Leroy, Odile] European Vaccine Initiat, Heidelberg, Germany; [Mohan, Krishna] Bharat Biotech Int Ltd, Hyderabad, Andhra Pradesh, India; [Shivyogi, Preethi; Godbole, Girish] Lotus Labs, Bangalore, Karnataka, India; [Parulekar, Varsha] Diagnosearch Lab Serv, Bombay, Maharashtra, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Chitnis, CE (corresponding author), Inst Pasteur, Dept Parasites & Insect Vectors, 25-28 Rue Dr Roux, F-75015 Paris, France.	cchitnis@gmail.com; viranderschauhan@gmail.com	Gupta, Puneet K/H-2841-2016; Pandey, Gaurav/Q-3777-2017; Chauhan, Virander S./K-5276-2019; Singh, Kavita/AAH-1126-2019	Gupta, Puneet K/0000-0003-1108-5903; Pandey, Gaurav/0000-0002-0115-3397; Kumar, Sanjeev/0000-0002-4454-9914; Singh, Bijender/0000-0002-2193-2910; Chitnis, Chetan/0000-0002-8773-9865	Department of Biotechnology, Government of India; European Vaccine Initiative (EVI)	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); European Vaccine Initiative (EVI)	This work was supported by grants from the Department of Biotechnology, Government of India and European Vaccine Initiative (EVI) to CEC and VSC. NI and OL from EVI were involved in study design, analysis, decision to publish and preparation of manuscript. They are co-authors on this manuscript.	AlYaman F, 1996, AM J TROP MED HYG, V54, P443, DOI 10.4269/ajtmh.1996.54.443; Arevalo-Herrera M, 2011, AM J TROP MED HYG, V84, P21, DOI 10.4269/ajtmh.2011.10-0110; Aucouturier Jerome, 2002, Expert Rev Vaccines, V1, P111, DOI 10.1586/14760584.1.1.111; Audran R, 2005, INFECT IMMUN, V73, P8017, DOI 10.1128/IAI.73.12.8017-8026.2005; Biswas S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107903; BLACKMAN MJ, 1992, MOL BIOCHEM PARASIT, V50, P307, DOI 10.1016/0166-6851(92)90228-C; DOLAN SA, 1990, J CLIN INVEST, V86, P618, DOI 10.1172/JCI114753; Egan AF, 1996, J INFECT DIS, V173, P765, DOI 10.1093/infdis/173.3.765; Egan AF, 1999, PARASITE IMMUNOL, V21, P133, DOI 10.1046/j.1365-3024.1999.00209.x; El Sahly HM, 2010, CLIN VACCINE IMMUNOL, V17, P1552, DOI 10.1128/CVI.00082-10; Elliott SL, 2008, J VIROL, V82, P1448, DOI 10.1128/JVI.01409-07; Ellis RD, 2010, HUM VACCINES, V6, P627, DOI 10.4161/hv.6.8.11446; Fox CB, 2008, COLLOID SURFACE B, V65, P98, DOI 10.1016/j.colsurfb.2008.03.003; Genton B, 2002, J INFECT DIS, V185, P820, DOI 10.1086/339342; Genton B, 2000, VACCINE, V18, P2504, DOI 10.1016/S0264-410X(00)00036-0; Genton B, 2003, VACCINE, V22, P30, DOI 10.1016/S0264-410X(03)00536-X; Hermsen CC, 2007, VACCINE, V25, P2930, DOI 10.1016/j.vaccine.2006.06.081; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; Hu JH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001952; Keitel WA, 1999, VACCINE, V18, P531, DOI 10.1016/S0264-410X(99)00221-2; Lawrence G, 2000, VACCINE, V18, P1925, DOI 10.1016/S0264-410X(99)00444-2; Lawrence GW, 1997, VACCINE, V15, P176, DOI 10.1016/S0264-410X(96)00150-8; MAKLER MT, 1993, AM J TROP MED HYG, V48, P739, DOI 10.4269/ajtmh.1993.48.739; malERA Consultative Group on Vaccines, 2011, PLoS Med, V8, pe1000398, DOI 10.1371/journal.pmed.1000398; Malkin E, 2008, VACCINE, V26, P6864, DOI 10.1016/j.vaccine.2008.09.081; McCallum FJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003571; Miles AP, 2005, VACCINE, V23, P2530, DOI 10.1016/j.vaccine.2004.08.049; Narum DL, 2000, INFECT IMMUN, V68, P1964, DOI 10.1128/IAI.68.4.1964-1966.2000; Nikodem DP, 2000, MOL BIOCHEM PARASIT, V108, P79, DOI 10.1016/S0166-6851(00)00206-1; Ockenhouse CF, 2006, VACCINE, V24, P3009, DOI 10.1016/j.vaccine.2005.11.028; Ogutu BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004708; Oliveira GA, 2005, INFECT IMMUN, V73, P3587, DOI 10.1128/IAI.73.6.3587-3597.2005; Pandey KC, 2002, MOL BIOCHEM PARASIT, V123, P23, DOI 10.1016/S0166-6851(02)00122-6; Pierce MA, 2010, VACCINE, V28, P2236, DOI 10.1016/j.vaccine.2009.12.049; RILEY EM, 1992, PARASITE IMMUNOL, V14, P321, DOI 10.1111/j.1365-3024.1992.tb00471.x; Roestenberg M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003960; Saul A, 1999, VACCINE, V17, P3145, DOI 10.1016/S0264-410X(99)00175-9; Sheehy SH, 2011, MOL THER, V19, P2269, DOI 10.1038/mt.2011.176; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; World Health Organization Media Centre, 2013, FACTSH WORLD MAL REP	40	27	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0117820	10.1371/journal.pone.0117820	http://dx.doi.org/10.1371/journal.pone.0117820			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927360	Green Published, gold, Green Submitted			2022-12-27	WOS:000353713100002
J	Corluka, A; Hyder, AA; Segura, E; Winch, P; McLean, RKD				Corluka, Adrijana; Hyder, Adnan A.; Segura, Elsa; Winch, Peter; McLean, Robert K. D.			Survey of Argentine Health Researchers on the Use of Evidence in Policymaking	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; PUBLIC-HEALTH; KNOWLEDGE TRANSLATION; DECISION-MAKERS; BARRIERS; ENVIRONMENT; INSTITUTES; IMPACT; CAREER; VIEWS	Objective In this study, Argentine health researchers were surveyed regarding their perceptions of facilitators and barriers to evidence-based policymaking in Argentina, as well as their publication activities, and research environment satisfaction. Methods A self-administered online survey was sent to health researchers in Argentina. The survey questions were based on a preceding qualitative study of Argentine health researchers, as well as the scientific literature. Results Of the 647 researchers that were reached, 226 accessed the survey, for a response rate of 34.9%. Over 80% of researchers surveyed had never been involved in or contributed to decision- making, while over 90% of researchers indicated they would like to be involved in the decision-making process. Decision-maker self-interest was perceived to be the driving factor in the development of health and healthcare policies. Research conducted by a research leader was seen to be the most influential factor in influencing health policy, followed by policy relevance of the research. With respect to their occupational environment, researchers rated highest and most favourably the opportunities available to present, discuss and publish research results and their ability to further their education and training. Argentine researchers surveyed demonstrated a strong interest and willingness to contribute their work and expertise to inform Argentine health policy development. Conclusion Despite Argentina's long scientific tradition, there are relatively few institutionalized linkages between health research results and health policymaking. Based on the results of this study, the disconnect between political decision-making and the health research system, coupled with fewer opportunities for formalized or informal researcher/decision-maker interaction, contribute to the challenges in evidence informing health policymaking in Argentina. Improving personal contact and the building of relationships between researchers and policymakers in Argentina will require taking into account researcher perceptions of policymakers, as highlighted in this study.	[Corluka, Adrijana; Hyder, Adnan A.; Winch, Peter] Johns Hopkins Bloomberg, Dept Int Hlth, Sch Publ Hlth, Baltimore, MD 21205 USA; [Segura, Elsa] Minist Hlth, Natl Inst Parasitol Dr M Fatala Chaben, Buenos Aires, DF, Argentina; [McLean, Robert K. D.] Int Dev Res Ctr, Policy Strategy & Evaluat Div, Ottawa, ON, Canada; [McLean, Robert K. D.] Canadian Inst Hlth Res, Evaluat Unit, Ottawa, ON, Canada	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Institute for Work & Health	Corluka, A (corresponding author), Johns Hopkins Bloomberg, Dept Int Hlth, Sch Publ Hlth, Baltimore, MD 21205 USA.	adrijana.corluka@gmail.com	Hyder, Adnan/AAT-9503-2021	Hyder, Adnan/0000-0002-7292-577X	Future Health Systems Research Consortium; UK Department for International Development (DFID) [H050474]	Future Health Systems Research Consortium; UK Department for International Development (DFID)	This work was supported by the Future Health Systems Research Consortium. The Future Health Systems Research consortium is funded by the UK Department for International Development (DFID) for the benefit of developing countries (grant number H050474). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaserud M, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-68; Albert Michael A, 2007, Health Res Policy Syst, V5, P2, DOI 10.1186/1478-4505-5-2; Almeida CM, 2001, HLTH SYSTEMS SERV RE; [Anonymous], 2005, STAT STAT SOFTW REL; Bennett S, 2012, HEALTH POLICY PLANN, V27, P194, DOI 10.1093/heapol/czr035; Canadian Institutes of Health Research, 2008, CIHRS PARTN HLTH SYS; Choi BCK, 2005, J EPIDEMIOL COMMUN H, V59, P632, DOI 10.1136/jech.2004.031765; Cook C, 2000, EDUC PSYCHOL MEAS, V60, P821, DOI 10.1177/00131640021970934; Corluka A, 2014, HLTH POLICY IN PRESS; Corluka A, 2014, HEALTH POLICY PLANN, V29, P40, DOI 10.1093/heapol/czu071; Couper MP, 2001, PUBLIC OPIN QUART, V65, P230, DOI 10.1086/322199; Davis P, 1996, SOC SCI MED, V43, P865, DOI 10.1016/0277-9536(96)00130-X; de Goede J, 2010, HEALTH RES POLICY SY, V8, DOI 10.1186/1478-4505-8-26; El-Jardali F, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-2; Gholami J, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-10; Goldberg-Freeman C, 2010, J EMPIR RES HUM RES, V5, P65, DOI 10.1525/jer.2010.5.4.65; Guindon GE, 2010, CAN MED ASSOC J, V182, pE362, DOI 10.1503/cmaj.081165; Hanney Stephen R, 2003, Health Res Policy Syst, V1, P2, DOI 10.1186/1478-4505-1-2; Haynes AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032665; Hennink M, 2005, J HEALTH COMMUN, V10, P163, DOI 10.1080/10810730590915128; Hyder AA, 2004, J MED ETHICS, V30, P68, DOI 10.1136/jme.2002.001933; Hyder AA, 2003, HEALTH POLICY PLANN, V18, P338, DOI 10.1093/heapol/czg040; Hyder AA, 2011, HEALTH POLICY PLANN, V26, P73, DOI 10.1093/heapol/czq020; Innvaer Simon, 2002, J Health Serv Res Policy, V7, P239, DOI 10.1258/135581902320432778; Kho ME, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-123; Lavis John, 2005, J Health Serv Res Policy, V10 Suppl 1, P35, DOI 10.1258/1355819054308549; Lavis JN, 2010, CAN MED ASSOC J, V182, pE350, DOI 10.1503/cmaj.081164; Lomas J, 2000, HEALTH AFFAIR, V19, P236, DOI 10.1377/hlthaff.19.3.236; Lomas J, 2007, BRIT MED J, V334, P129, DOI 10.1136/bmj.39038.593380.AE; Marincola E, 1998, MOL BIOL CELL, V9, P3003, DOI 10.1091/mbc.9.11.3003; McLean RKD, 2013, EVALUATION CANADIAN; McLean RKD, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-57; MOORMAN C, 1993, J MARKETING, V57, P81, DOI 10.2307/1252059; Oliver K, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-2; Ortiz Z, 2004, MEDICINA-BUENOS AIRE, V64, P84; Orton L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021704; Schneider H, 2006, Glob Public Health, V1, P49, DOI 10.1080/17441690500361083; Segura E, 2005, ARG FOR HLTH RES FOR, V9; Seifer Sarena D, 2004, J Interprof Care, V18, P416, DOI 10.1080/13561820400011719; SEMEOTICONS, 2014, SEMEIOTIC OR TECHN I; Shewan LG, 2005, MED J AUSTRALIA, V183, P606, DOI 10.5694/j.1326-5377.2005.tb00051.x; Stang A, 1999, EPIDEMIOLOGY, V10, P181, DOI 10.1097/00001648-199903000-00017; Tomson G, 2005, SOC SCI MED, V61, P1291, DOI 10.1016/j.socscimed.2005.01.014; Trostle J, 1999, HEALTH POLICY PLANN, V14, P103, DOI 10.1093/heapol/14.2.103; van Kammen J, 2006, B WORLD HEALTH ORGAN, V84, P608, DOI 10.2471/BLT.05.028308; VanDeusen LC, 2003, INFLUENCES VA RES SA; von Lengerke T, 2004, SOZ PRAVENTIV MED, V49, P185, DOI 10.1007/s00038-004-3110-2; WEISS CH, 1979, PUBLIC ADMIN REV, V39, P426, DOI 10.2307/3109916; World Health Organization, 2006, HLTH RES SYST ANAL I; Zardo P, 2014, IMPLEMENT SCI, V9, DOI 10.1186/s13012-014-0142-8; Zardo P, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-496; Zardo P, 2014, SOC SCI MED, V108, P120, DOI 10.1016/j.socscimed.2014.02.046	52	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125711	10.1371/journal.pone.0125711	http://dx.doi.org/10.1371/journal.pone.0125711			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0MA	25928292	Green Published, Green Submitted, gold			2022-12-27	WOS:000353713100113
J	Jin, YM; Raviv, N; Barnett, A; Bambakidis, NC; Filichia, E; Luo, Y				Jin, Yongmin; Raviv, Nataly; Barnett, Austin; Bambakidis, Nicholas C.; Filichia, Emily; Luo, Yu			The Shh Signaling Pathway Is Upregulated in Multiple Cell Types in Cortical Ischemia and Influences the Outcome of Stroke in an Animal Model	PLOS ONE			English	Article							ADULT SUBVENTRICULAR ZONE; SONIC-HEDGEHOG; STEM-CELLS; FUNCTIONAL RECOVERY; REACTIVE GLIA; PROLIFERATION; MAINTENANCE; MODULATION; PRECURSORS; SURVIVAL	Recently the sonic hedgehog (shh) signaling pathway has been shown to play an important role in regulating repair and regenerative responses after brain injury, including ischemia. However, the precise cellular components that express and upregulate the shh gene and the cellular components that respond to shh signaling remain to be identified. In this study, using a distal MCA occlusion model, our data show that the shh signal is upregulated both at the cortical area near the injury site and in the adjacent striatum. Multiple cell types upregulate shh signaling in ischemic brain, including neurons, reactive astrocytes and nestin-expressing cells. The shh signaling pathway genes are also expressed in the neural stem cells (NSCs) niche in the subventricular zone (SVZ). Conditional deletion of the shh gene in nestin-expressing cells both at the SVZ niche and at the ischemic site lead to significantly more severe behavioral deficits in these shh iKO mice after cortical stroke, measured using an automated open field locomotion apparatus (Student's t-test, p<0.05). In contrast, animals given post-stroke treatment with the shh signaling agonist (SAG) demonstrated less deficits in behavioral function, compared to vehicle-treated mice. At 7 days after stroke, SAG-treated mice showed higher values in multiple horizontal movement parameters compared to vehicle treated mice (Student's t-test, p<0.05) whereas there were no differences in pre-stroke measurements, (Student's t-test, p>0.05). In summary, our data demonstrate that shh signaling plays critical and ongoing roles in response to ischemic injury and modulation of shh signaling in vivo alters the functional outcome after cortical ischemic injury.	[Jin, Yongmin; Raviv, Nataly; Barnett, Austin; Bambakidis, Nicholas C.; Filichia, Emily; Luo, Yu] Case Western Reserve Univ, Dept Neurol Surg, Cleveland, OH 44106 USA	Case Western Reserve University	Luo, Y (corresponding author), Case Western Reserve Univ, Dept Neurol Surg, Cleveland, OH 44106 USA.	yxl710@case.edu		Luo, Yu/0000-0002-7939-5505	American Heart Association National Scientist Development Award [13SDG17200019]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS091213] Funding Source: NIH RePORTER	American Heart Association National Scientist Development Award(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Dr. Yu Luo is funded by the American Heart Association National Scientist Development Award (13SDG17200019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaba ARI, 2002, NAT REV NEUROSCI, V3, P24; Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Angot E, 2008, STEM CELLS, V26, P2311, DOI 10.1634/stemcells.2008-0297; Balordi F, 2007, J NEUROSCI, V27, P14248, DOI 10.1523/JNEUROSCI.4531-07.2007; Balordi F, 2007, J NEUROSCI, V27, P5936, DOI 10.1523/JNEUROSCI.1040-07.2007; Bambakidis NC, 2012, J NEUROSURG, V116, P1114, DOI 10.3171/2012.1.JNS111285; Bambakidis NC, 2010, NEUROSURGERY, V67, P1709, DOI 10.1227/NEU.0b013e3181f9b0a5; Belzung C, 2001, BEHAV BRAIN RES, V125, P141, DOI 10.1016/S0166-4328(01)00291-1; Cai C, 2008, STEM CELLS, V26, P1097, DOI 10.1634/stemcells.2007-0684; Ding XS, 2013, J CEREBR BLOOD F MET, V33, P1015, DOI 10.1038/jcbfm.2013.50; Ferent J, 2013, J NEUROSCI, V33, P1759, DOI 10.1523/JNEUROSCI.3334-12.2013; Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10; Gilman S, 2006, EXP NEUROL, V199, P28, DOI 10.1016/j.expneurol.2006.03.002; Goldstein LB, 2007, CIRCULATION, V116, P1504, DOI 10.1161/CIRCULATIONAHA.106.670885; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Lewis PM, 2001, CELL, V105, P599, DOI 10.1016/S0092-8674(01)00369-5; Li L, 2010, GLIA, V58, P1610, DOI 10.1002/glia.21033; Li NL, 2011, REJUV RES, V14, P261, DOI 10.1089/rej.2010.1115; Liu XS, 2013, J BIOL CHEM, V288, P12478, DOI 10.1074/jbc.M112.449025; Luo Y, 2011, J NEURAL TRANSM, V118, P61, DOI 10.1007/s00702-010-0478-4; Luo Y, 2009, ANN NEUROL, V65, P520, DOI 10.1002/ana.21592; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Magnusson JP, 2014, SCIENCE, V346, P237, DOI 10.1126/science.346.6206.237; Munro J, 2001, ONCOGENE, V20, P3541, DOI 10.1038/sj.onc.1204460; Oniscu A, 2004, J PATHOL, V203, P909, DOI 10.1002/path.1591; Palma V, 2005, DEVELOPMENT, V132, P335, DOI 10.1242/dev.01567; Pitter KL, 2014, GLIA, V62, P1595, DOI 10.1002/glia.22702; Reinert RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033529; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Rousselet E, 2012, JOVE-J VIS EXP, DOI 10.3791/4038; Shen H, 2008, NEUROSCI LETT, V442, P15, DOI 10.1016/j.neulet.2008.06.052; Shen H, 2010, J NEUROSCI METH, V186, P150, DOI 10.1016/j.jneumeth.2009.11.008; Sieber MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026288; Sims JR, 2009, STROKE, V40, P3618, DOI 10.1161/STROKEAHA.109.561951; Sirko S, 2013, CELL STEM CELL, V12, P426, DOI 10.1016/j.stem.2013.01.019; van den Brink GR, 2004, NAT GENET, V36, P277, DOI 10.1038/ng1304; van den Brink GR, 2001, GASTROENTEROLOGY, V121, P317, DOI 10.1053/gast.2001.26261; Wang Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085234, 10.1371/journal.pone.0110024, 10.1371/journal.pone.0096339, 10.1371/journal.pone.0108223]; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Wu MZ, 2012, J NEUROSCI, V32, P6651, DOI 10.1523/JNEUROSCI.4876-11.2012; Xia YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068891; Zhang L, 2005, STROKE, V36, P847, DOI 10.1161/01.STR.0000158923.19956.73	43	44	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124657	10.1371/journal.pone.0124657	http://dx.doi.org/10.1371/journal.pone.0124657			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927436	Green Submitted, gold, Green Published			2022-12-27	WOS:000353713100043
J	Shi, YG; Liu, YC; Wang, JR; Jie, D; Yun, T; Li, W; Yan, L; Wang, KM; Feng, JF				Shi, Yongguo; Liu, Yangchen; Wang, Jirong; Jie, Ding; Yun, Tian; Li, Wang; Yan, Lin; Wang, Keming; Feng, Jifeng			Downregulated Long Noncoding RNA BANCR Promotes the Proliferation of Colorectal Cancer Cells via Downregualtion of p21 Expression	PLOS ONE			English	Article							POOR-PROGNOSIS; LUNG-CANCER; INHIBITION; APOPTOSIS; GROWTH; GENES	BRAF activated non-coding RNA (BANCR), a long non-coding RNA (lncRNA), is crucial for cell migration in melanoma cells and non-small cell lung cancer (NSCLC) cells. However, little is known regarding the role of this gene in the proliferation of colorectal cancer. Therefore, we investigated the involvement of BANCR in the proliferation of colorectal cancer cells. In this study, we show that BANCR expression was significantly down-regulated in colorectal cancer tissues compared with normal tissues, and overexpression of BANCR suppressed colorectal cancer cell growth in vitro and in vivo. We also determined that pCDNA-BANCR-mediated colorectal cancer cell proliferation was associated with induction of G0/G1 cell-cycle arrest and apoptosis enhancement through regulation of p21, and its effects were most likely posttranscriptional. Taken together, our findings suggest that down-regulation of BANCR contributes to the proliferation of colorectal cancer cells, at least in part, through the regulation of p21 protein.	[Shi, Yongguo; Wang, Jirong; Jie, Ding; Yun, Tian; Li, Wang; Yan, Lin; Wang, Keming] Nanjing Med Univ, Affiliated Hosp 2, Dept Oncol, Nanjing, Jiangsu, Peoples R China; [Shi, Yongguo; Liu, Yangchen] Taixing Peoples Hosp, Taixing, Jiangsu, Peoples R China; [Feng, Jifeng] Canc Hosp Jiangsu Prov, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Wang, KM (corresponding author), Nanjing Med Univ, Affiliated Hosp 2, Dept Oncol, Nanjing, Jiangsu, Peoples R China.	kemingwang@njmu.edu.cn; fjif@medmail.com.cn			Outstanding Medical Academic Leader program of Jiangsu province [LG201126]; Six talents peak project of Jiangsu province [WSN-050]; Medical Science and Technology Development Fund Project of Nanjing [YKK13178]	Outstanding Medical Academic Leader program of Jiangsu province; Six talents peak project of Jiangsu province; Medical Science and Technology Development Fund Project of Nanjing	This work was supported by the Outstanding Medical Academic Leader program of Jiangsu province (LG201126), the Six talents peak project of Jiangsu province (WSN-050), and the Medical Science and Technology Development Fund Project of Nanjing (YKK13178).	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Chen G, 2013, NUCLEIC ACIDS RES, V41, pD983, DOI 10.1093/nar/gks1099; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Flockhart RJ, 2012, GENOME RES, V22, P1006, DOI 10.1101/gr.140061.112; Hu ZY, 2012, CARCINOGENESIS, V33, P1178, DOI 10.1093/carcin/bgs141; Huang J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.541; Ivanov I, 2007, ONCOGENE, V26, P2873, DOI 10.1038/sj.onc.1210098; Joshi US, 1998, CANCER GENE THER, V5, P183; Li DD, 2013, AM J PATHOL, V182, P64, DOI 10.1016/j.ajpath.2012.08.042; Liu ZL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077293; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Lu KH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-461; Mirzayans R, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/170325; Negishi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095216; Qi P, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-122; Qiu MT, 2013, TUMOR BIOL, V34, P613, DOI 10.1007/s13277-013-0658-6; Quo QH, 2014, ONCOL LETT, V8, P869, DOI 10.3892/ol.2014.2154; Rossi Marianna Nicoletta, 2014, Int J Cell Biol, V2014, P473857, DOI 10.1155/2014/473857; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Sostres Carlos, 2014, World J Gastrointest Pharmacol Ther, V5, P40, DOI 10.4292/wjgpt.v5.i1.40; Sun M, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-68; Wu MH, 2009, CURR GENOMICS, V10, P216, DOI 10.2174/138920209788488481; Wu QF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002803; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Zhang F, 2009, CANCER BIOL THER, V8, P823, DOI 10.4161/cbt.8.9.8143	28	94	104	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0122679	10.1371/journal.pone.0122679	http://dx.doi.org/10.1371/journal.pone.0122679			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928067	Green Published, Green Submitted, gold			2022-12-27	WOS:000353713100010
J	Jang, EK; Kim, WG; Kim, HC; Huh, JW; Kwon, H; Choi, YM; Jeon, MJ; Kim, TY; Shong, YK; Ryu, JS; Kim, WB				Jang, Eun Kyung; Kim, Won Gu; Kim, Ho-Cheol; Huh, Jin-Won; Kwon, Hyemi; Choi, Yun Mi; Jeon, Min Ji; Kim, Tae Yong; Shong, Young Kee; Ryu, Jin-Sook; Kim, Won Bae			Changes in the Pulmonary Function Test after Radioactive Iodine Treatment in Patients with Pulmonary Metastases of Differentiated Thyroid Cancer	PLOS ONE			English	Article							DISTANT METASTASES; RADIOIODINE THERAPY; PROGNOSTIC VARIABLES; RADIATION-THERAPY; CARCINOMA; LUNG; PAPILLARY; COMPLICATIONS; DIAGNOSIS; FIBROSIS	Objective Pulmonary function test (PFT) is a useful tool for an objective assessment of respiratory function. Impaired pulmonary function is critical for the survival and quality of life in patients with pulmonary metastases of solid cancers including thyroid cancer. This study aimed to evaluate clinical factors associated with severely impaired pulmonary function by serial assessment with PFT in patients with pulmonary metastasis of differentiated thyroid cancer (DTC) who received radioactive iodine treatment (RAIT). Patients This retrospective study enrolled 31 patients who underwent serial PFTs before and after RAIT for pulmonary metastasis of DTC. We evaluated the risk factors for severe impairment of pulmonary function. Results The median age of the patients was 44.1 years and 18 of them were female patients. Severe impairment of pulmonary function was observed in five patients (16%) after a median of three RAITs (cumulative I-131 activity = 20.4 GBq). These patients were older and more frequently had mild impairment of baseline pulmonary function, respiratory symptoms, or progressive disease compared with patients with stable pulmonary function. Neither cumulative dose nor number of RAIT was associated with decreased pulmonary function. Coexisting pulmonary diseases, presence of respiratory symptoms, and metastatic disease progression were significantly associated with severe decrease in forced vital capacity during follow-up (p =.047, p =. 011, and p =. 021, respectively). Conclusions Pulmonary function was severely impaired during follow-up in some patients with pulmonary metastasis of DTC after a high-dose RAITs. Neither the number of RAIT nor the cumulative I-131 activity was associated with decreased pulmonary function. Serial PFT might be considered for some high-risk patients during follow-up.	[Jang, Eun Kyung; Kim, Won Gu; Kwon, Hyemi; Choi, Yun Mi; Jeon, Min Ji; Kim, Tae Yong; Shong, Young Kee; Kim, Won Bae] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med,Div Endocrinol & Metab, Seoul 138736, South Korea; [Kim, Ho-Cheol; Huh, Jin-Won] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med,Div Pulmonol & Crit Care Med, Seoul 138736, South Korea; [Ryu, Jin-Sook] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Nucl Med, Seoul 138736, South Korea; [Jang, Eun Kyung] Dongnam Inst Radiol & Med Sci, Ctr Canc, Div Endocrinol, Busan, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Korea Institute of Radiological & Medical Sciences	Kim, WB (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med,Div Endocrinol & Metab, Seoul 138736, South Korea.	wongukim@amc.seoul.kr	Kim, Tae Yong/C-1272-2009; Kim, Won Gu/AAG-2096-2019	Kim, Tae Yong/0000-0003-4982-4441; Kim, Won Gu/0000-0002-8404-7759; Jeon, Min Ji/0000-0002-1297-107X; Kim, Won Bae/0000-0003-4544-1750; Choi, Yun Mi/0000-0001-8209-874X; Shong, Young Kee/0000-0002-7911-9471	Asan Institute for Life Sciences [2014-582]; Korean Foundation for Cancer Research, Seoul, South Korea [CB-2011-03-02]	Asan Institute for Life Sciences; Korean Foundation for Cancer Research, Seoul, South Korea	This study was supported by research grant (No. 2014-582) from the Asan Institute for Life Sciences and research grant (CB-2011-03-02) of the Korean Foundation for Cancer Research, Seoul, South Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P2185; BENUA RS, 1962, AMER J ROENTGENOL RA, V87, P171; BROWN AP, 1984, BRIT J RADIOL, V57, P323, DOI 10.1259/0007-1285-57-676-323; CASARA D, 1993, J NUCL MED, V34, P1626; Chen LB, 2010, THYROID, V20, P337, DOI 10.1089/thy.2009.0266; Cho SW, 2014, THYROID, V24, P277, DOI 10.1089/thy.2012.0654; Choi JK, 2005, TUBERC RESPIR DIS, V58, P230, DOI 10.4046/trd.2005.58.3.230; Choi YW, 2004, RADIOGRAPHICS, V24, P985, DOI 10.1148/rg.244035160; COGGLE JE, 1986, ENVIRON HEALTH PERSP, V70, P261, DOI 10.2307/3430363; CRAPO RO, 1994, NEW ENGL J MED, V331, P25, DOI 10.1056/NEJM199407073310107; DINNEEN SF, 1995, J CLIN ENDOCR METAB, V80, P2041, DOI 10.1210/jc.80.7.2041; Durante C, 2006, J CLIN ENDOCR METAB, V91, P2892, DOI 10.1210/jc.2005-2838; GROSS NJ, 1977, ANN INTERN MED, V86, P81, DOI 10.7326/0003-4819-86-1-81; Hebestreit H, 2011, EUR J NUCL MED MOL I, V38, P1683, DOI 10.1007/s00259-011-1841-x; Jeon MJ, 2014, EUR J ENDOCRINOL, V170, P23, DOI 10.1530/EJE-13-0524; Jones LW, 2012, J CLIN ONCOL, V30, P2530, DOI 10.1200/JCO.2011.39.9014; Kim TY, 2014, ENDOCRINOL METAB, V29, P217, DOI 10.3803/EnM.2014.29.3.217; Kloos RT, 2002, J CLIN ENDOCR METAB, V87, P5817, DOI 10.1210/jc.2002-020210; Lee SL, 2010, J NATL COMPR CANC NE, V8, P1277, DOI 10.6004/jnccn.2010.0094; Luster M, 2008, EUR J NUCL MED MOL I, V35, P1941, DOI 10.1007/s00259-008-0883-1; MASSIN JP, 1984, CANCER, V53, P982, DOI 10.1002/1097-0142(19840215)53:4<982::AID-CNCR2820530427>3.0.CO;2-E; Movsas B, 1997, CHEST, V111, P1061, DOI 10.1378/chest.111.4.1061; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; RALL JE, 1957, J CLIN ENDOCR METAB, V17, P1263; RUEGEMER JJ, 1988, J CLIN ENDOCR METAB, V67, P501, DOI 10.1210/jcem-67-3-501; Sabra MM, 2013, J CLIN ENDOCR METAB, V98, pE829, DOI 10.1210/jc.2012-3933; SAMAAN NA, 1985, J CLIN ENDOCR METAB, V60, P376, DOI 10.1210/jcem-60-2-376; Sampson E, 2007, CANCER, V110, P1451, DOI 10.1002/cncr.22956; SAMUEL AM, 1995, J NUCL MED, V36, P783; SCHLUMBERGER M, 1986, J CLIN ENDOCR METAB, V63, P960; Shoup M, 2003, J AM COLL SURGEONS, V197, P191, DOI 10.1016/S1072-7515(03)00332-6; ZIBRAK JD, 1990, ANN INTERN MED, V112, P763, DOI 10.7326/0003-4819-112-10-763	33	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125114	10.1371/journal.pone.0125114	http://dx.doi.org/10.1371/journal.pone.0125114			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923702	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600125
J	Van Steenberge, M; Pariselle, A; Huyse, T; Volckaert, FAM; Snoeks, J; Vanhove, MPM				Van Steenberge, Maarten; Pariselle, Antoine; Huyse, Tine; Volckaert, Filip A. M.; Snoeks, Jos; Vanhove, Maarten P. M.			Morphology, Molecules, and Monogenean Parasites: An Example of an Integrative Approach to Cichlid Biodiversity	PLOS ONE			English	Article							LAKE TANGANYIKA; ANCYROCEPHALIDAE MONOGENEA; GILL PARASITES; SPECIES PLATYHELMINTHES; SYSTEMATIC REVISION; TELEOSTEI; HOST; SPECIATION; PHYLOGENY; TAXONOMY	The unparalleled biodiversity of Lake Tanganyika (Africa) has fascinated biologists for over a century; its unique cichlid communities are a preferred model for evolutionary research. Although species delineation is, in most cases, relatively straightforward, higher-order classifications were shown not to agree with monophyletic groups. Here, traditional morphological methods meet their limitations. A typical example are the tropheine cichlids currently belonging to Simochromis and Pseudosimochromis. The affiliations of these widespread and abundant cichlids are poorly understood. Molecular work suggested that genus and species boundaries should be revised. Moreover, previous morphological results indicated that intraspecific variation should be considered to delineate species in Lake Tanganyika cichlids. We review the genera Simochromis and Pseudosimochromis using an integrative approach. Besides a morphometric study and a barcoding approach, monogenean Cichlidogyrus (Platyhelminthes: Ancyrocephalidae) gill parasites, often highly species-specific, are used as complementary markers. Six new species are described. Cichlidogyrus raeymaekersi sp. nov., C. muterezii sp. nov. and C. banyankimbonai sp. nov. infect S. diagramma. Cichlidogyrus georgesmertensi sp. nov. was found on S. babaulti and S. pleurospilus, C. franswittei sp. nov. on both S. marginatus and P. curvifrons and C. frankwillemsi sp. nov. only on P. curvifrons. As relatedness between Cichlidogyrus species usually reflects relatedness between hosts, we considered Simochromis monotypic because the three Cichlidogyrus species found on S. diagramma belonged to a different morphotype than those found on the other Simochromis. The transfer of S. babaulti, S. marginatus, S. pleurospilus and S. margaretae to Pseudosimochromis was justified by the similarity of their Cichlidogyrus fauna and the intermediate morphology of S. margaretae. Finally parasite data also supported the synonymy between S. pleurospilus and S. babaulti, a species that contains a large amount of geographical morphological variation.	[Van Steenberge, Maarten; Huyse, Tine; Snoeks, Jos; Vanhove, Maarten P. M.] Royal Museum Cent Africa, Dept Biol, Tervuren, Belgium; [Van Steenberge, Maarten; Huyse, Tine; Volckaert, Filip A. M.; Snoeks, Jos; Vanhove, Maarten P. M.] Univ Leuven, Dept Biol, Lab Biodivers & Evolutionary Genom, Leuven, Belgium; [Van Steenberge, Maarten] Graz Univ, Inst Zool, A-8010 Graz, Austria; [Pariselle, Antoine] Univ Montpellier, CNRS, IRD, Inst Sci Evolut, F-34059 Montpellier, France; [Vanhove, Maarten P. M.] Hellen Ctr Marine Res, Inst Marine Biol Resources & Inland Waters, Anavyssos, Greece	Royal Museum for Central Africa; KU Leuven; University of Graz; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Hellenic Centre for Marine Research	Van Steenberge, M (corresponding author), Royal Museum Cent Africa, Dept Biol, Tervuren, Belgium.	maarten.vansteenberge@bio.kuleuven.be	Van Steenberge, Maarten/E-4052-2017; Van Steenberge, Maarten/AAC-7132-2020; Volckaert, Filip/AAC-7691-2019; Pariselle, Antoine/L-5776-2016; Vanhove, Maarten/AAF-6446-2020	Pariselle, Antoine/0000-0002-1591-7423; Vanhove, Maarten/0000-0003-3100-7566; Van Steenberge, Maarten/0000-0002-6964-9014	Research Foundation Flanders; King Leopold III Fund for Nature Exploration and Conservation; Czech Science Foundation [P505/12/G112]	Research Foundation Flanders(FWO); King Leopold III Fund for Nature Exploration and Conservation; Czech Science Foundation(Grant Agency of the Czech Republic)	At the time of conducting this research, M.V. S. and M.P.M.V. were Ph.D. fellows, and T.H. a post-doctoral fellow of the Research Foundation - Flanders (FWO-Vlaanderen). Field work was funded by two travel grants from the Research Foundation Flanders to M.P.M.V. and two grants from the King Leopold III Fund for Nature Exploration and Conservation to M.V.S. and M.P.M.V. Currently, M.P.M.V. is supported by the Czech Science Foundation, Project no. P505/12/G112 (European Centre of Ichthyoparasitology (ECIP) - Centre of excellence). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta SJ, 2010, ZOOLOGIA-CURITIBA, V27, P151, DOI 10.1590/S1984-46702010000200001; Ahmadzadeh F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080563; Arthofer W, 2013, MOL ECOL, V22, P3850, DOI 10.1111/mec.12340; Axelrod G.S., 1978, SIMOCHROMIS MARGARET, V19, P1; BAREL CDN, 1977, NETH J ZOOL, V27, P333; Barson M, 2010, PARASITOLOGY, V137, P1585, DOI 10.1017/S0031182010000302; Boeger WA, 2003, ZOOL SCR, V32, P3, DOI 10.1046/j.1463-6409.2003.00109.x; Boulenger GA, 1898, P ZOOL SOC LOND, V1898, P494; Boulenger GA, 1898, T ZOOL SOC LONDON, V15, P1; Brichard P, 1989, P BRICHADS BOOK CICH; BROOKS DR, 1979, SYST ZOOL, V28, P299, DOI 10.2307/2412584; BROOKS DR, 1993, J PARASITOL, V79, P631, DOI 10.2307/3283396; Bukinga FM, 2012, PARASITOL RES, V111, P2049, DOI 10.1007/s00436-012-3052-1; Cohen AS, 1997, BASIN RES, V9, P107, DOI 10.1046/j.1365-2117.1997.00038.x; Combes Claude., 2001, PARASITISM ECOLOGY E; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; de Meeus T, 1998, PARASITOL TODAY, V14, P10, DOI 10.1016/S0169-4758(97)01163-0; Euzet L., 1981, Review of advances in parasitology. (Proc. 4th Internat. Congr. of Parasit. (ICOPA IV), Warsaw, 19-26 Aug. 1978)., P1003; FREY JK, 1992, J PARASITOL, V78, P930, DOI 10.2307/3283335; Gillardin C, 2012, PARASITOL RES, V110, P305, DOI 10.1007/s00436-011-2490-5; Gomez A, 2007, P ROY SOC B-BIOL SCI, V274, P199, DOI 10.1098/rspb.2006.3718; Gregoir AF, 2015, FRESHWATER BIOL, V60, P323, DOI 10.1111/fwb.12492; GUEGAN JF, 1990, SYST PARASITOL, V17, P153, DOI 10.1007/BF00009552; Gunther A, 1894, P ZOOL SOC LOND, V1893, P628; Gussev AV, 1962, KEY PARASITES FRESHW, P204; Haverty MI, 1996, SOCIOBIOLOGY, V28, P287; Hawlitschek O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016662; Huyse T, 2005, SYST BIOL, V54, P710, DOI 10.1080/10635150500221036; JOLICOEUR P, 1963, BIOMETRICS, V19, P497, DOI 10.2307/2527939; Justine JL, 2009, SYST PARASITOL, V72, P27, DOI 10.1007/s11230-008-9171-5; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Koblmuller S, 2008, MOL PHYLOGENET EVOL, V49, P153, DOI 10.1016/j.ympev.2008.05.045; Koblmuller S, 2008, HYDROBIOLOGIA, V615, P5, DOI 10.1007/s10750-008-9552-4; Koblmuller S, 2011, MOL ECOL, V20, P2272, DOI 10.1111/j.1365-294X.2011.05088.x; Koblmuller S, 2010, MOL PHYLOGENET EVOL, V55, P318, DOI 10.1016/j.ympev.2009.09.032; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Konings A, 2015, TANGANYIKA CICHLIDS; KRITSKY DC, 1989, J PARASITOL, V75, P207, DOI 10.2307/3282767; Krylova EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009957; Laurent P, 2006, MOL PHYLOGENET EVOL, V38, P241, DOI 10.1016/j.ympev.2005.08.013; Lavoue Sebastien, 2010, Zootaxa, V2600, P1; Malmberg G., 1956, SKR SOD SVER FISKFOR, V1957, P19; Muschick M, 2012, CURR BIOL, V22, P2362, DOI 10.1016/j.cub.2012.10.048; NELISSEN M H J, 1976, Annales de la Societe Royale Zoologique de Belgique, V106, P167; Nelissen MHJ, 1978, REV ZOOLOGIE AFRICAI, V92, P3; Nelissen MHJ, 1977, REV ZOOLOGIE AFRICAI, V91, P1; Nelissen MHJ, 1979, SCI ZOOLOGIQUES B, V229, P1; Nelissen MHJ, 1974, ACTA ZOOL PATHOL ANT, V61, P31; Nieberding C, 2004, P ROY SOC B-BIOL SCI, V271, P2559, DOI 10.1098/rspb.2004.2930; Padial JM, 2008, ZOOL J LINN SOC-LOND, V152, P353, DOI 10.1111/j.1096-3642.2007.00341.x; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; PAPERNA ILAN, 1960, BAMIDGEH, V12, P20; Pariselle A, 2003, SYST PARASITOL, V56, P201, DOI 10.1023/B:SYPA.0000003807.27452.bd; Pariselle A, 2003, FOLIA PARASIT, V50, P195, DOI 10.14411/fp.2003.035; PARISELLE A, 1995, SYST PARASITOL, V30, P187, DOI 10.1007/BF00010469; Pariselle A, 1996, THESIS U PERPIGNAN; Pariselle A, 2015, CONTRIB ZOOL, V84, P25, DOI 10.1163/18759866-08401003; Pariselle A, 2015, HYDROBIOLOGIA, V748, P99, DOI 10.1007/s10750-014-1975-5; Pariselle Antoine, 2011, International Journal of Evolutionary Biology, V2011, P1, DOI 10.4061/2011/471480; Pariselle Antoine, 2003, P147; Pariselle A, 2009, ZOOSYSTEMA, V31, P849, DOI 10.5252/z2009n4a6; PAUGY D, 1990, CAN J ZOOL, V68, P1124, DOI 10.1139/z90-167; Pellegrin J., 1927, B MUSEUM NATL HIST N, V33, P499; Plaisance L, 2005, ZOOL SCR, V34, P425, DOI 10.1111/j.1463-6409.2005.00191.x; Poll M., 1956, Exploration Hydrobiol Lac Tanganyika (1946-47), V3, P1; POLL M, 1986, Academie Royale de Belgique Memoires de la Classe des Sciences Collection in Octavo, V45, P1; Poll M., 1942, Revue de Zoologie et de Botanique Africaines, V36, P343; Raeymaekers JAM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-41; RAMIREZ W, 1977, ANN MO BOT GARD, V64, P296; Risch S, 2008, ZOOTAXA, P21, DOI 10.11646/zootaxa.1857.1.2; Salzburger W, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-17; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; Schliewen Ulrich K., 2004, Frontiers in Zoology, V1, P1; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Seehausen O, 2012, P ROY SOC LOND B BIO, V273, P1987; Simkova A, 2006, PARASITOLOGY, V133, P43, DOI 10.1017/S0031182006009942; Simkova A, 2003, SYST PARASITOL, V54, P1, DOI 10.1023/A:1022133608662; Smith AS, 2008, P NATL ACAD SCI USA, V105, P6906, DOI 10.1073/pnas.0801706105; Snoeks J, 2000, ADV ECOL RES, V31, P17, DOI 10.1016/S0065-2504(00)31005-4; Snoeks J., 2004, CICHLID DIVERSITY LA; Snoeks Jos, 2001, Journal of Aquariculture & Aquatic Sciences, V9, P150; Steindachner F, 1909, KAISERLICHE AKAD WIS, V26, P443; STURMBAUER C, 1992, NATURE, V358, P578, DOI 10.1038/358578a0; Sueur Jerome, 2007, Zootaxa, V1442, P55; Taborsky B, 2006, BIOL LETTERS, V2, P225, DOI 10.1098/rsbl.2005.0422; Takahashi T, 2003, ICHTHYOL RES, V50, P367, DOI 10.1007/s10228-003-0181-7; Takahashi T, 2014, ICHTHYOL RES, V61, P252, DOI 10.1007/s10228-014-0396-9; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Trewavas E, 1966, WORLD S WARM WAT PON; Trewavas E., 1983, TILAPIINE FISHES GEN, DOI [DOI 10.5962/BHL.TITLE.123198, 10.1016/j.foodcont.2016.07.004]; Tsigenopoulos CS, 2002, HEREDITY, V88, P466, DOI 10.1038/sj.hdy.6800080; Van Steenberge M, 2015, HYDROBIOLOGIA, V748, P39, DOI 10.1007/s10750-013-1692-5; Van Steenberge M, 2011, ACTA ICHTHYOL PISCAT, V41, P201, DOI 10.3750/AIP2011.41.3.08; Vanhove M. P. M., 2012, THESIS KU LEUVEN; Vanhove MPM, 2014, PARASITOL RES, V113, P653, DOI 10.1007/s00436-013-3693-8; Vanhove MPM, 2013, ZOOTAXA, V3608, P398, DOI 10.11646/zootaxa.3608.5.8; Vanhove MPM, 2011, ZOOLOGIA-CURITIBA, V28, P253, DOI 10.1590/S1984-46702011000200016; Vanhove MPM, 2011, PARASITOLOGY, V138, P364, DOI 10.1017/S0031182010001356; Vignon M, 2011, BIOL J LINN SOC, V102, P694, DOI 10.1111/j.1095-8312.2010.01607.x; Wagner CE, 2012, MOL ECOL, V21, P3283, DOI 10.1111/j.1365-294X.2012.05607.x; Whitfield JB, 2007, TRENDS ECOL EVOL, V22, P258, DOI 10.1016/j.tree.2007.01.012; Yamaoka Kosaku, 1997, P25	102	26	26	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124474	10.1371/journal.pone.0124474	http://dx.doi.org/10.1371/journal.pone.0124474			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923665	Green Submitted, Green Published, gold			2022-12-27	WOS:000353711600088
J	Chiu, CT; Liao, CK; Shen, CC; Tang, TK; Jow, GM; Wang, HS; Wu, JC				Chiu, Chi-Ting; Liao, Chih-Kai; Shen, Chien-Chang; Tang, Tswen-Kei; Jow, Guey-Mei; Wang, Hwai-Shi; Wu, Jiahn-Chun			HYS-32-Induced Microtubule Catastrophes in Rat Astrocytes Involves the PI3K-GSK3beta Signaling Pathway	PLOS ONE			English	Article							PLUS-END; CELL-MIGRATION; NEURONAL POLARITY; AXON GROWTH; EB1; DYNAMICS; EXPRESSION; PHOSPHORYLATION; GSK-3-BETA; ASSOCIATION	HYS-32 is a novel derivative of combretastatin-A4 (CA-4) previously shown to induce microtubule coiling in rat primary astrocytes. In this study, we further investigated the signaling mechanism and EB1, a microtubule-associated end binding protein, involved in HYS-32-induced microtubule catastrophes. Confocal microscopy with double immunofluorescence staining revealed that EB1 accumulates at the growing microtubule plus ends, where they exhibit a bright comet-like staining pattern in control astrocytes. HYS-32 induced microtubule catastrophes in both a dose-and time-dependent manner and dramatically increased the distances between microtubule tips and the cell border. Treatment of HYS-32 (5 mu M) eliminated EB1 localization at the microtubule plus ends and resulted in an extensive redistribution of EB1 to the microtubule lattice without affecting the beta-tubulin or EB1 protein expression. Time-lapse experiments with immunoprecipitation further displayed that the association between EB-1 and beta-tubulin was significantly decreased following a short-term treatment (2 h), but gradually increased in a prolonged treatment (6-24 h) with HYS-32. Further, HYS-32 treatment induced GSK3 beta phosphorylation at Y216 and S9, where the ratio of GSK3 beta-pY216 to GSK3 beta-pS9 was first elevated followed by a decrease over time. Co-treatment of astrocytes with HYS-32 and GSK3 beta inhibitor SB415286 attenuated the HYS-32-induced microtubule catastrophes and partially prevented EB1 dissociation from the plus end of microtubules. Furthermore, co-treatment with PI3K inhibitor LY294002 inhibited HYS-32-induced GSK3 beta-pS9 and partially restored EB1 distribution from the microtubule lattice to plus ends. Together these findings suggest that HYS-32 induces microtubule catastrophes by preventing EB1 from targeting to microtubule plus ends through the GSK3 beta signaling pathway.	[Chiu, Chi-Ting; Wang, Hwai-Shi; Wu, Jiahn-Chun] Natl Yang Ming Univ, Sch Med, Inst Anat & Cell Biol, Taipei 11221, Taiwan; [Liao, Chih-Kai] Natl Taiwan Univ, Coll Med, Dept Anat & Cell Biol, Taipei 10051, Taiwan; [Shen, Chien-Chang] Natl Res Inst Chinese Med, Div Med Chem, Taipei 11221, Taiwan; [Tang, Tswen-Kei] Natl Quemoy Univ, Dept Nursing, Coll Nursing & Hlth, Kinmen 89250, Taiwan; [Jow, Guey-Mei] Fu Jen Catholic Univ, Sch Med, New Taipei City 24205, Taiwan	National Yang Ming Chiao Tung University; National Taiwan University; National Research Institute of Chinese Medicine; Fu Jen Catholic University	Wu, JC (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Anat & Cell Biol, Taipei 11221, Taiwan.	jcwu2@ym.edu.tw			MOST grant [Ministry of Science and Technology, Taiwan] [MOST-103-2320-B010-013]	MOST grant [Ministry of Science and Technology, Taiwan]	JCW was supported by a MOST grant [Ministry of Science and Technology, Taiwan, grant number: MOST-103-2320-B010-013]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Askham JM, 2002, MOL BIOL CELL, V13, P3627, DOI 10.1091/mbc.E02-01-0061; Balzer EM, 2012, FASEB J, V26, P4045, DOI 10.1096/fj.12-211441; Behrens J, 2010, EUR J CELL BIOL, V89, P828, DOI 10.1016/j.ejcb.2010.06.003; Camand E, 2012, J CELL SCI, V125, P844, DOI 10.1242/jcs.087668; Cregg JM, 2014, EXP NEUROL, V253, P197, DOI 10.1016/j.expneurol.2013.12.024; Currie JD, 2011, MOL BIOL CELL, V22, P4343, DOI 10.1091/mbc.E11-06-0520; de Forges H, 2012, INT J BIOCHEM CELL B, V44, P266, DOI 10.1016/j.biocel.2011.11.009; Dixit R, 2009, P NATL ACAD SCI USA, V106, P492, DOI 10.1073/pnas.0807614106; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Etienne-Manneville S, 2010, CURR OPIN CELL BIOL, V22, P104, DOI 10.1016/j.ceb.2009.11.008; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Gardner MK, 2008, CURR OPIN CELL BIOL, V20, P64, DOI 10.1016/j.ceb.2007.12.003; Honore S, 2005, CELL MOL LIFE SCI, V62, P3039, DOI 10.1007/s00018-005-5330-x; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; Hur EM, 2011, GENE DEV, V25, P1968, DOI 10.1101/gad.17015911; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Komarova Y, 2009, J CELL BIOL, V184, P691, DOI 10.1083/jcb.200807179; Kumar P, 2009, J CELL BIOL, V184, P895, DOI 10.1083/jcb.200901042; Lansbergen G, 2006, TRAFFIC, V7, P499, DOI 10.1111/j.1600-0854.2006.00400.x; Li WJ, 2011, J CELL BIOL, V193, P973, DOI 10.1083/jcb.201101108; Liao CK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079350; Liao CK, 2010, INT J BIOCHEM CELL B, V42, P762, DOI 10.1016/j.biocel.2010.01.016; Lin PC, 2013, NEUROCHEM INT, V62, P881, DOI 10.1016/j.neuint.2013.02.027; Liu CM, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00003; Matsunaga W, 2002, NEUROSCIENCE, V111, P151, DOI 10.1016/S0306-4522(01)00607-8; Mimori-Kiyosue Y, 2003, J BIOCHEM, V134, P321, DOI 10.1093/jb/mvg148; Pagano A, 2012, BIOCHEM PHARMACOL, V84, P432, DOI 10.1016/j.bcp.2012.05.010; Renault-Mihara F, 2008, INT J BIOCHEM CELL B, V40, P1649, DOI 10.1016/j.biocel.2008.03.009; SANCHEZMARGALET V, 1994, ROLE PHOSPHATIDYLINO, V204, P446; Sandblad L, 2006, CELL, V127, P1415, DOI 10.1016/j.cell.2006.11.025; SHAIN W, 1992, GLIA, V5, P223, DOI 10.1002/glia.440050308; SHEN C-L, 1984, Proceedings of the National Science Council Republic of China Part B Life Sciences, V8, P324; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sun T, 2009, DEV GROWTH DIFFER, V51, P735, DOI 10.1111/j.1440-169X.2009.01141.x; van der Vaart B, 2009, BIOCHEM SOC T, V37, P1007, DOI 10.1042/BST0371007; Watanabe T, 2005, TRENDS CELL BIOL, V15, P76, DOI 10.1016/j.tcb.2004.12.006; Watanabe T, 2009, J CELL SCI, V122, P2969, DOI 10.1242/jcs.046649; Watson P, 2006, J CELL SCI, V119, P2758, DOI 10.1242/jcs.02999; Yang HL, 2010, J BIOL CHEM, V285, P32242, DOI 10.1074/jbc.M110.160820; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012	41	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0126217	10.1371/journal.pone.0126217	http://dx.doi.org/10.1371/journal.pone.0126217			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938237	Green Published, gold, Green Submitted			2022-12-27	WOS:000353943000153
J	Schneider, M; Schumacher, V; Lischke, T; Lucke, K; Meyer-Schwesinger, C; Velden, J; Koch-Nolte, F; Mittrucker, HW				Schneider, Michael; Schumacher, Valea; Lischke, Timo; Luecke, Karsten; Meyer-Schwesinger, Catherine; Velden, Joachim; Koch-Nolte, Friedrich; Mittruecker, Hans-Willi			CD38 Is Expressed on Inflammatory Cells of the Intestine and Promotes Intestinal Inflammation	PLOS ONE			English	Article							CYCLIC ADP-RIBOSE; INNATE IMMUNE-RESPONSE; T-CELLS; RETINOIC ACID; EXTRACELLULAR NAD(+); MICE; SURFACE; GLYCOHYDROLASE; CYCLASE; ENZYME	The enzyme CD38 is expressed on a variety of hematopoietic and non-hematopoietic cells and is involved in diverse processes such as generation of calcium-mobilizing metabolites, cell activation, and chemotaxis. Here, we show that under homeostatic conditions CD38 is highly expressed on immune cells of the colon mucosa of C57BL/6 mice. Myeloid cells recruited to this tissue upon inflammation also express enhanced levels of CD38. To determine the role of CD38 in intestinal inflammation, we applied the dextran sulfate sodium (DSS) colitis model. Whereas wild-type mice developed severe colitis, CD38(-/-) mice had only mild disease following DSS-treatment. Histologic examination of the colon mucosa revealed pronounced inflammatory damage with dense infiltrates containing numerous granulocytes and macrophages in wild-type animals, while these findings were significantly attenuated in CD38(-/-) mice. Despite attenuated histological findings, the mRNA expression of inflammatory cytokines and chemokines was only marginally lower in the colons of CD38(-/-) mice as compared to wild-type mice. In conclusion, our results identify a function for CD38 in the control of inflammatory processes in the colon.	[Schneider, Michael; Schumacher, Valea; Lischke, Timo; Luecke, Karsten; Koch-Nolte, Friedrich; Mittruecker, Hans-Willi] Univ Med Ctr Hamburg Eppendorf, Inst Immunol, Hamburg, Germany; [Meyer-Schwesinger, Catherine] Univ Med Ctr Hamburg Eppendorf, Dept Internal Med, Nephrol, Hamburg, Germany; [Velden, Joachim] Univ Med Ctr Hamburg Eppendorf, Inst Pathol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Mittrucker, HW (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Immunol, Hamburg, Germany.	h.mittruecker@uke.de		Lischke, Timo/0000-0003-0413-4252; Yan, Karsten/0000-0002-7343-2205; Koch-Nolte, Friedrich/0000-0003-1730-6674	Deutsche Forschungsgemeinschaft [MI476/3-1, SFB841, GRK841, PAK362, SFB877, KF228]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by the following: Deutsche Forschungsgemeinschaft MI476/3-1, SFB841, HWM; Deutsche Forschungsgemeinschaft GRK841, MS; Deutsche Forschungsgemeinschaft PAK362, SFB877, FKN; and Deutsche Forschungsgemeinschaft KF228, CMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriouch S, 2012, MICROBES INFECT, V14, P1284, DOI 10.1016/j.micinf.2012.05.011; Castaneda FE, 2005, GASTROENTEROLOGY, V129, P1991, DOI 10.1053/j.gastro.2005.09.017; Cervantes-Sandoval I, 2008, PARASITOL INT, V57, P307, DOI 10.1016/j.parint.2008.01.006; Chen J, 2006, J IMMUNOL, V176, P4590, DOI 10.4049/jimmunol.176.8.4590; Chen YG, 2006, J IMMUNOL, V177, P2939, DOI 10.4049/jimmunol.177.5.2939; Choe CU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019046; Cockayne DA, 1998, BLOOD, V92, P1324, DOI 10.1182/blood.V92.4.1324.416k26_1324_1333; COOPER HS, 1993, LAB INVEST, V69, P238; Deaglio S, 2001, FASEB J, V15, P580; DRACH J, 1993, BIOCHEM BIOPH RES CO, V195, P545, DOI 10.1006/bbrc.1993.2080; du Pre MF, 2011, AM J GASTROENTEROL, V106, P1147, DOI 10.1038/ajg.2011.24; Ernst IMA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00259; Estrada-Figueroa LA, 2011, PARASITE IMMUNOL, V33, P661, DOI 10.1111/j.1365-3024.2011.01333.x; Gally F, 2009, AM J RESP CELL MOL, V40, P433, DOI 10.1165/rcmb.2007-0392OC; Grahnert A, 2011, INNATE IMMUN-LONDON, V17, P212, DOI 10.1177/1753425910361989; Heiss K, 2008, J IMMUNOL, V181, P3861, DOI 10.4049/jimmunol.181.6.3861; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; Hubert S, 2010, J EXP MED, V207, P2561, DOI 10.1084/jem.20091154; Hussain AMM, 1998, PROTEIN EXPRES PURIF, V12, P133, DOI 10.1006/prep.1997.0811; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Kahl S, 2000, J IMMUNOL, V165, P4463, DOI 10.4049/jimmunol.165.8.4463; KONTANI K, 1993, J BIOL CHEM, V268, P16895; Lischke T, 2013, INFECT IMMUN, V81, P4091, DOI 10.1128/IAI.00340-13; Lischke T, 2013, EUR J IMMUNOL, V43, P1828, DOI 10.1002/eji.201243231; Lo Buono N, 2014, FRONT BIOSCI-LANDMRK, V19, P366, DOI 10.2741/4213; Longhi MS, 2013, J MOL MED, V91, P165, DOI 10.1007/s00109-012-0991-z; Lund FE, 2006, MOL MED, V12, P328, DOI 10.2119/2006-00099.Lund; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; MCNAGNY KM, 1988, J IMMUNOL, V141, P2551; Meyer-Schwesinger C, 2011, J IMMUNOL, V187, P3218, DOI 10.4049/jimmunol.1003451; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Partida-Sanchez S, 2001, NAT MED, V7, P1209, DOI 10.1038/nm1101-1209; Partida-Sanchez S, 2004, J IMMUNOL, V172, P1896, DOI 10.4049/jimmunol.172.3.1896; Partida-Sanchez S, 2004, IMMUNITY, V20, P279, DOI 10.1016/S1074-7613(04)00048-2; Partida-Sanchez S, 2003, MICROBES INFECT, V5, P49, DOI 10.1016/S1286-4579(02)00055-2; Postigo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033534; Schulz O, 2009, J EXP MED, V206, P3101, DOI 10.1084/jem.20091925; Seman M, 2003, IMMUNITY, V19, P571, DOI 10.1016/S1074-7613(03)00266-8; Viegas MS, 2007, MICROBES INFECT, V9, P847, DOI 10.1016/j.micinf.2007.03.003; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758; Yilmaz OH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163; Zhao YJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002700; ZOCCHI E, 1993, BIOCHEM BIOPH RES CO, V196, P1459, DOI 10.1006/bbrc.1993.2416	43	28	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0126007	10.1371/journal.pone.0126007	http://dx.doi.org/10.1371/journal.pone.0126007			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938500	Green Submitted, gold, Green Published			2022-12-27	WOS:000353943000128
J	Solaimanpour, S; Sarmiento, F; Mrazek, J				Solaimanpour, Sina; Sarmiento, Felipe; Mrazek, Jan			Tn-Seq Explorer: A Tool for Analysis of High-Throughput Sequencing Data of Transposon Mutant Libraries	PLOS ONE			English	Article							READ ALIGNMENT; INSERTION; GENOME; GENES; MICROORGANISMS; PREFERENCE; REVEALS; SYSTEMS	Tn-seq is a high throughput technique for analysis of transposon mutant libraries. Tn-seq Explorer was developed as a convenient and easy-to-use package of tools for exploration of the Tn-seq data. In a typical application, the user will have obtained a collection of sequence reads adjacent to transposon insertions in a reference genome. The reads are first aligned to the reference genome using one of the tools available for this task. Tn-seq Explorer reads the alignment and the gene annotation, and provides the user with a set of tools to investigate the data and identify possibly essential or advantageous genes as those that contain significantly low counts of transposon insertions. Emphasis is placed on providing flexibility in selecting parameters and methodology most appropriate for each particular dataset. Tn-seq Explorer is written in Java as a menu-driven, stand-alone application. It was tested on Windows, Mac OS, and Linux operating systems. The source code is distributed under the terms of GNU General Public License. The program and the source code are available for download at http://www.cmbl.uga.edu/downloads/programs/Tn_seq_ Explorer/ and https://github.com/sina-cb/Tn-seqExplorer.	[Solaimanpour, Sina] Univ Georgia, Dept Comp Sci, Athens, GA 30602 USA; [Sarmiento, Felipe] Swissaustral USA, Athens, GA 30602 USA; [Mrazek, Jan] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Mrazek, Jan] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Mrazek, J (corresponding author), Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.	mrazek@uga.edu			National Science Foundation [DBI-0950266]; Swissaustral USA; Direct For Biological Sciences [0950266] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Swissaustral USA; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation grant number DBI-0950266. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Swissaustral USA provided support in the form of salaries for author FS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Curtis PD, 2014, MOL MICROBIOL, V93, P713, DOI 10.1111/mmi.12686; Fu Y, 2013, CELL HOST MICROBE, V14, P652, DOI 10.1016/j.chom.2013.11.001; Gallagher LA, 2011, MBIO, V2, DOI 10.1128/mBio.00315-10; Gawronski JD, 2009, P NATL ACAD SCI USA, V106, P16422, DOI 10.1073/pnas.0906627106; Goryshin IY, 1998, P NATL ACAD SCI USA, V95, P10716, DOI 10.1073/pnas.95.18.10716; Green B, 2012, MOBILE DNA-UK, V3, DOI 10.1186/1759-8753-3-3; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Karlin S, 2000, J BACTERIOL, V182, P5238, DOI 10.1128/JB.182.18.5238-5250.2000; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Langridge GC, 2009, GENOME RES, V19, P2308, DOI 10.1101/gr.097097.109; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LODGE JK, 1988, GENETICS, V120, P645; Sarmiento F, 2013, P NATL ACAD SCI USA, V110, P4726, DOI 10.1073/pnas.1220225110; van Opijnen T, 2010, CURR PROTOC MICROBIO; van Opijnen T, 2013, NAT REV MICROBIOL, V11, DOI 10.1038/nrmicro3033; van Opijnen T, 2009, NAT METHODS, V6, P767, DOI [10.1038/NMETH.1377, 10.1038/nmeth.1377]; Zhang YJJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002946; Zomer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043012	19	42	42	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0126070	10.1371/journal.pone.0126070	http://dx.doi.org/10.1371/journal.pone.0126070			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938432	Green Published, Green Submitted, gold			2022-12-27	WOS:000353943000135
J	Chatwin, M; Tan, HL; Bush, A; Rosenthal, M; Simonds, AK				Chatwin, Michelle; Tan, Hui-Leng; Bush, Andrew; Rosenthal, Mark; Simonds, Anita Kay			Long Term Non-Invasive Ventilation in Children: Impact on Survival and Transition to Adult Care	PLOS ONE			English	Article							HOME MECHANICAL VENTILATION; SPINAL MUSCULAR-ATROPHY; POSITIVE-PRESSURE VENTILATION; NATURAL-HISTORY; DYSTROPHY; DISABILITY; LIFE	Background The number of children receiving domiciliary ventilatory support has grown over the last few decades driven largely by the introduction and widening applications of non-invasive ventilation. Ventilatory support may be used with the intention of increasing survival, or to facilitate discharge home and/or to palliate symptoms. However, the outcome of this intervention and the number of children transitioning to adult care as a consequence of longer survival is not yet clear. Methods In this retrospective cohort study, we analysed the outcome in children (< 17 years) started on home NIV at Royal Brompton Hospital over an 18 year period 1993-2011. The aim was to establish for different diagnostic groups: survival rate, likelihood of early death depending on diagnosis or discontinuation of ventilation, and the proportion transitioning to adult care. Results 496 children were commenced on home non invasive ventilation; follow-up data were available in 449 (91%). Fifty six per cent (n = 254) had neuromuscular disease. Ventilation was started at a median age (IQR) 10 (3-15) years. Thirteen percent (n = 59) were less than 1 year old. Forty percent (n = 181) have transitioned to adult care. Twenty four percent (n = 109) of patients have died, and nine percent (n = 42) were able to discontinue ventilatory support. Conclusion Long term ventilation is associated with an increase in survival in a range of conditions leading to ventilatory failure in children, resulting in increasing numbers surviving to adulthood. This has significant implications for planning transition and adult care facilities.	[Chatwin, Michelle; Simonds, Anita Kay] Royal Brompton & Harefield NHS Fdn Trust, Acad & Clin Dept Sleep & Breathing, London, England; [Tan, Hui-Leng; Bush, Andrew; Rosenthal, Mark] Royal Brompton & Harefield NHS Fdn Trust, Dept Paediat, London, England; [Chatwin, Michelle; Tan, Hui-Leng; Bush, Andrew; Rosenthal, Mark; Simonds, Anita Kay] Royal Brompton & Harefield NHS Fdn Trust, NIHR Resp Biomed Res Unit, London, England	Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton & Harefield NHS Foundation Trust	Chatwin, M (corresponding author), Royal Brompton & Harefield NHS Fdn Trust, Acad & Clin Dept Sleep & Breathing, Sydney St, London, England.	m.chatwin@rbht.nhs.uk			NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College London; National Institute for Health Research [NF-SI-0510-10192] Funding Source: researchfish	NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College London; National Institute for Health Research(National Institute for Health Research (NIHR))	The authors were supported by the NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin R, 2014, PEDIATR PULM, V49, P816, DOI 10.1002/ppul.22868; Bach JR, 2008, PAEDIATR RESPIR REV, V9, P45, DOI 10.1016/j.prrv.2007.11.003; Bach JR, 1997, CHEST, V112, P1024, DOI 10.1378/chest.112.4.1024; Bushby K, 2010, LANCET NEUROL, V9, P177, DOI 10.1016/S1474-4422(09)70272-8; Chatwin M, 2011, ARCH DIS CHILD, V96, P426, DOI 10.1136/adc.2009.177832; Chatwin M, 2010, EUR RESPIR J, V35, P310, DOI 10.1183/09031936.00073409; Chatwin M, 2008, RESP MED, V102, P1528, DOI 10.1016/j.rmed.2008.07.019; Chesson Jr A. L., 2007, THE AASM MANUAL FOR; DUBOWITZ V, 1995, NEUROMUSCULAR DISORD, V5, P3, DOI 10.1016/0960-8966(94)00075-K; Dubowitz V, 1999, Eur J Paediatr Neurol, V3, P49; Dubowitz V, 1995, MUSCLE DISORDERS CHI, P540; Eagle M, 2002, NEUROMUSCULAR DISORD, V12, P926, DOI 10.1016/S0960-8966(02)00140-2; Fauroux B, 2005, INTENS CARE MED, V31, P965, DOI 10.1007/s00134-005-2669-2; Foley AR, 2013, BRAIN, V136, P3625, DOI 10.1093/brain/awt284; Goodwin S, 2011, EUR J PEDIATR, V170, P1187, DOI 10.1007/s00431-011-1430-9; Hill ME, 2006, NEUROMUSCULAR DISORD, V16, P107, DOI 10.1016/j.nmd.2005.11.011; Hull J, 2012, THORAX, V67, P1, DOI 10.1136/thoraxjnl-2012-201964; Ishikawa Y, 2011, NEUROMUSCULAR DISORD, V21, P47, DOI 10.1016/j.nmd.2010.09.006; Jeppesen J, 2003, NEUROMUSCULAR DISORD, V13, P804, DOI 10.1016/S0960-8966(03)00162-7; Katz S, 2004, ARCH DIS CHILD, V89, P121, DOI 10.1136/adc.2002.018655; Kohler M, 2005, AM J RESP CRIT CARE, V172, P1032, DOI 10.1164/rccm.200503-322OC; Lloyd-Owen SJ, 2005, EUR RESPIR J, V25, P1025, DOI 10.1183/09031936.05.00066704; Matsumura Tsuyoshi, 2011, Rinsho Shinkeigaku, V51, P743; McDougall CM, 2013, ARCH DIS CHILD, V98, P660, DOI 10.1136/archdischild-2012-303062; Oskoui M, 2007, NEUROLOGY, V69, P1931, DOI 10.1212/01.wnl.0000290830.40544.b9; Paulides FM, 2012, INTENS CARE MED, V38, P847, DOI 10.1007/s00134-012-2545-9; Racca F, 2011, MINERVA ANESTESIOL, V77, P892; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Robb Stephanie A, 2010, Neuromuscul Disord, V20, P833, DOI 10.1016/j.nmd.2010.08.002; Shurayatcher Y, 2008, NEUROMUSCULAR DISORD, V18, P561, DOI 10.1016/j.nmd.2008.05.001; Toussaint M, 2006, EUR RESPIR J, V28, P549, DOI 10.1183/09031936.06.00004906; Vianello A, 2004, NEUROMUSCULAR DISORD, V14, P353, DOI 10.1061/j.nmd.2004.03.002; Wallis C, 2011, ARCH DIS CHILD, V96, P998, DOI 10.1136/adc.2010.192864; ZERRES K, 1995, ARCH NEUROL-CHICAGO, V52, P518, DOI 10.1001/archneur.1995.00540290108025	34	67	70	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125839	10.1371/journal.pone.0125839	http://dx.doi.org/10.1371/journal.pone.0125839			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933065	Green Published, gold, Green Submitted			2022-12-27	WOS:000353887100137
J	de Carvalho, AX; Maiato, H; Maia, AF; Ribeiro, SA; Pontes, P; Bickmore, W; Earnshaw, WC; Sambade, C				de Carvalho, Ana Xavier; Maiato, Helder; Maia, Andre F.; Ribeiro, Susana A.; Pontes, Patricia; Bickmore, Wendy; Earnshaw, William C.; Sambade, Clara			Reed-Sternberg Cells Form by Abscission Failure in the Presence of Functional Aurora B Kinase	PLOS ONE			English	Article							HODGKINS-DISEASE; KELCH PROTEIN; EXPRESSION; CCL5/RANTES; INVOLVEMENT; REPRESENT; FUSION; GROWTH; L-428; LINES	Large multinucleated Reed-Sternberg cells (RS) and large mononucleated Hodgkin cells (H) are traditionally considered to be the neoplastic population in classical Hodgkin lymphoma, (cHL) and postulated to promote the disease. However, the contribution of these larger cells to the progression of cHL remains debatable. We used established cHL cell lines and cHL cellular fractions composed of small mononucleated cells only or enriched in large RS/H cells to investigate RS/H cell origin and to characterize the cells which they derive from. We confirm that the small mononucleated cells give rise to RS/H cells, and we show that the latter proliferate significantly more slowly than the small cells. By using live-cell imaging, we demonstrate that binucleated RS cells are generated by failure of abscission when a few small cells attempt to divide. Finally, our results reveal that the small mononucleated cells are chromosomally unstable, but this is unlikely to be related to a malfunctioning chromosomal passenger protein complex. We propose that the small mononucleated cells, rather than the RS/H cells, are the main drivers of cHL.	[de Carvalho, Ana Xavier; Maiato, Helder; Maia, Andre F.] Univ Porto, Inst Invest & Inovacao Saude, P-4100 Oporto, Portugal; [Maiato, Helder] Univ Porto, Fac Med, Dept Expt Biol, Cell Div Unit, P-4100 Oporto, Portugal; [Ribeiro, Susana A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Ribeiro, Susana A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Pontes, Patricia; Sambade, Clara] Univ Porto, Inst Patol & Imunol Mol IPATIMUP, P-4100 Oporto, Portugal; [Bickmore, Wendy] Univ Edinburgh, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland; [Earnshaw, William C.] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland	Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Universidade do Porto; University of Edinburgh; University of Edinburgh	de Carvalho, AX (corresponding author), Univ Porto, IBMC, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	anacarvalho@ibmc.up.pt	Carvalho, Ana/J-4788-2013; Earnshaw, William/AAY-7438-2020; Maia, André/I-1565-2013; Maiato, Helder/J-9466-2013	Carvalho, Ana/0000-0002-2256-7134; Maia, André/0000-0001-5987-7016; Earnshaw, William/0000-0002-7191-0621; Maiato, Helder/0000-0002-6200-9997	project "Cell Homeostasis Tissue Organization and Organism Biology" [NORTE-07-0124-FEDER-000003]; Quadro de Referencia Estrategico Nacional (QREN), through the Fundo Europeu de Desenvolvimento Regional (FEDER); FCT (Fundacao para a Ciencia e Tecnologia); Portuguese Association Leukemia study (APCL); Praxis XXI, (FCT) [BD21811/99]; Welcome II Program - (FCT); Programa Operacional Potencial Humano (POPH); Promocao do Emprego Cientifico [4.2]; FCT [SFRH/BPD/11592/2002, SFRH/BPD/71364/2010]; Wellcome Trust [073915]; MRC; Marie Curie Action COFUND; European Research Council;  [077707];  [092076]; MRC [MC_PC_U127527202] Funding Source: UKRI; Medical Research Council [MC_PC_U127527202] Funding Source: researchfish	project "Cell Homeostasis Tissue Organization and Organism Biology"; Quadro de Referencia Estrategico Nacional (QREN), through the Fundo Europeu de Desenvolvimento Regional (FEDER); FCT (Fundacao para a Ciencia e Tecnologia)(Portuguese Foundation for Science and Technology); Portuguese Association Leukemia study (APCL); Praxis XXI, (FCT)(Portuguese Foundation for Science and Technology); Welcome II Program - (FCT); Programa Operacional Potencial Humano (POPH); Promocao do Emprego Cientifico; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Marie Curie Action COFUND; European Research Council(European Research Council (ERC)European Commission); ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the project "NORTE-07-0124-FEDER-000003-Cell Homeostasis Tissue Organization and Organism Biology" co-funded by Programa Operacional Regional do Norte (ON.2-O Novo Norte), under the Quadro de Referencia Estrategico Nacional (QREN), through the Fundo Europeu de Desenvolvimento Regional (FEDER) and by FCT (Fundacao para a Ciencia e Tecnologia) and by a grant from the Portuguese Association Leukemia study (APCL). A.X.C. was supported by Praxis XXI, BD21811/99 (FCT), the Welcome II Program (funded by FCT and the Marie Curie Action COFUND) and an IF position funded by FCT and co-financed by Programa Operacional Potencial Humano (POPH), 4.2 - Promocao do Emprego Cientifico. H.M. was supported by the postdoctoral research fellowship SFRH/BPD/11592/2002 from FCT and work in his lab is currently funded by a PRECISE grant from the European Research Council. A.F.M. was supported by the postdoctoral fellowship SFRH/BPD/71364/2010 from FCT. Work in the Earnshaw Lab was funded by The Wellcome Trust, of which W.C.E. is a Principal Research Fellow [grant number 073915]. The Wellcome Trust Centre for Cell Biology is supported by core grant numbers 077707 and 092076. W.B. is supported by the MRC.	Aldinucci D, 2008, INT J CANCER, V122, P769, DOI 10.1002/ijc.23119; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Cattaruzza L, 2009, INT J CANCER, V125, P1092, DOI 10.1002/ijc.24389; DREXLER HG, 1989, INT J CANCER, V43, P1083, DOI 10.1002/ijc.2910430622; Fischer M, 2003, INT J CANCER, V107, P197, DOI 10.1002/ijc.11370; Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001; HSU SM, 1988, BLOOD, V71, P1382; Ikeda JI, 2010, AM J PATHOL, V177, P3081, DOI 10.2353/ajpath.2010.100089; Ioannou M, 2013, J MOL HIST      1224; Kanzler H, 1996, BLOOD, V87, P3429, DOI 10.1182/blood.V87.8.3429.bloodjournal8783429; Kanzler H, 1996, J EXP MED, V184, P1495, DOI 10.1084/jem.184.4.1495; Krem MM, 2012, J BIOL CHEM, V287, P39083, DOI 10.1074/jbc.M112.390088; Kuppers R, 2009, NAT REV CANCER, V9, P15, DOI 10.1038/nrc2542; Kuppers R, 2003, J CLIN INVEST, V111, P529, DOI 10.1172/JC1200316624; KUPPERS R, 1994, P NATL ACAD SCI USA, V91, P10962, DOI 10.1073/pnas.91.23.10962; Kuppers R, 2001, BLOOD, V97, P818, DOI 10.1182/blood.V97.3.818; Marafioti T, 1997, NEW ENGL J MED, V337, P453, DOI 10.1056/NEJM199708143370703; Mori N, 2011, BIOCHEM PHARMACOL, V81, P1106, DOI 10.1016/j.bcp.2011.02.010; Muschen M, 2001, LAB INVEST, V81, P289, DOI 10.1038/labinvest.3780237; NEWCOM SR, 1988, INT J CELL CLONING, V6, P417, DOI 10.1002/stem.5530060606; Re D, 2001, AM J HEMATOL, V67, P6, DOI 10.1002/ajh.1068; Rengstl B, 2013, P NATL ACAD SCI USA, V110, P20729, DOI 10.1073/pnas.1312509110; Salipante SJ, 2009, P NATL ACAD SCI USA, V106, P14920, DOI 10.1073/pnas.0904231106; Skinnider BF, 2002, BLOOD, V99, P4283, DOI 10.1182/blood-2002-01-0099; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; Yasui Y, 2004, J BIOL CHEM, V279, P12997, DOI 10.1074/jbc.M311128200	27	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124629	10.1371/journal.pone.0124629	http://dx.doi.org/10.1371/journal.pone.0124629			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933052	gold, Green Published, Green Submitted			2022-12-27	WOS:000353887100053
J	Ogoina, D; Finomo, F; Harry, T; Inatimi, O; Ebuenyi, I; Tariladei, WW; Afolayan, AA				Ogoina, Dimie; Finomo, Finomo; Harry, Tubonye; Inatimi, Otonyo; Ebuenyi, Ikenna; Tariladei, Wolo-Wolo; Afolayan, Abimbola Anne			Factors Associated with Timing of Initiation of Antiretroviral Therapy among HIV-1 Infected Adults in the Niger Delta Region of Nigeria	PLOS ONE			English	Article							HIV-INFECTED ADULTS; SUB-SAHARAN AFRICA; PREVENTION	Introduction Based on growing evidence mainly from countries outside Sub-Saharan Africa, the World Health Organisation (WHO) now recommends initiation of antiretroviral therapy (ART) in HIV-infected individuals in developing countries when CD4 cell count (CD4+) is <= 500cells/ul. Nigeria accounts for about 14% of the estimated HIV/AIDS burden in Sub-Saharan Africa. We evaluated the factors associated with timing of initiation of ART among treatment-ineligible HIV-infected adults from Nigeria. Methods We retrospectively reviewed the hospital records of ART ineligible HIV-infected adults who enrolled into HIV care between January 2008 and December 2012 at two major tertiary hospitals in Bayelsa State, South-South Nigeria. Demographic, clinical and laboratories data were obtained at presentation, at each subsequent visit at 6 monthly intervals and at time of initiation of ART. Cox proportional regression and Kaplan-Meier survival analysis were used to evaluate independent predictors of time to initiation of ART. Results Amongst the 280 study participants, 70.6% were females, 62.6% had CD4+ >= 500cells/ul, 48.4% had WHO HIV Stage 1 disease and 34.3% were lost to follow up. In a cohort of 180 participants followed up for >= 3months, participants with CD4+ of 351-500cells/ul and stage 2 disease were more likely to start ART earlier than those with CD4+ >500cells/ul (Hazard ratio [HR]-1.7, 95% confidence interval [CI] of 1.0-2.9) and stage 1 disease (HR-2.3 (95% CI-1.3-4.2) respectively. HIV-infected adults with faster CD4+ decay required earlier ART initiation, especially in the first year of follow up. Conclusion ART-ineligible HIV-infected adults on follow up in South-South Nigeria are more likely to require earlier initiation of ART if they have stage 2 HIV disease or CD4+ <= 500cells/ul at presentation. Our findings suggest faster progression of HIV-disease in these groups of individuals and corroborate the growing evidence in support for earlier initiation of ART.	[Ogoina, Dimie; Harry, Tubonye; Inatimi, Otonyo; Ebuenyi, Ikenna] Niger Delta Univ, Teaching Hosp, Dept Internal Med, Okolobiri, Bayelsa State, Nigeria; [Finomo, Finomo; Tariladei, Wolo-Wolo; Afolayan, Abimbola Anne] Fed Med Ctr, Dept Med, Yenagoa, Bayelsa State, Nigeria		Ogoina, D (corresponding author), Niger Delta Univ, Teaching Hosp, Dept Internal Med, Okolobiri, Bayelsa State, Nigeria.	dimostic@yahoo.co.uk	Ogoina, Dimie/H-4091-2019; Harry, Tubonye/A-2107-2012	Ogoina, Dimie/0000-0002-2098-6300; Harry, Tubonye/0000-0003-3773-5230; Ebuenyi, Ikenna/0000-0002-3329-6296				Agu KA, 2012, WORLD J AIDS, V2, P330, DOI [10.4236/wja.2012.24044, DOI 10.4236/WJA.2012.24044]; Aliyu M H, 2010, Afr J Med Med Sci, V39, P233; Aliyu MH, 2014, JAIDS-J ACQ IMM DEF, V65, pE41, DOI 10.1097/QAI.0b013e31829ceaec; Anglaret X, 2013, ANTIVIR THER, V18, P45, DOI 10.3851/IMP2231; Anglemyer A, 2014, AIDS, V28, pS105, DOI 10.1097/QAD.0000000000000232; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; De Cock KM, 2013, NEW ENGL J MED, V368, P886, DOI 10.1056/NEJMp1300458; Easterbrook PJ, 1999, J ANTIMICROB CHEMOTH, V43, P379, DOI 10.1093/jac/43.3.379; Federal Ministry of Health Nigeria, 2010, NATIONAL HIV SEROPRE; Federal Ministry of Health Nigeria, 2010, NATIONAL GUIDELINES; Granich R, 2011, CURR HIV RES, V9, P446, DOI 10.2174/157016211798038597; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Kranzer K, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17383; Langford Simone E, 2007, AIDS Res Ther, V4, P11, DOI 10.1186/1742-6405-4-11; Le T, 2013, NEW ENGL J MED, V368, P218, DOI 10.1056/NEJMoa1110187; Lepri AC, 1998, EPIDEMIOL INFECT, V121, P369, DOI 10.1017/S095026889800140X; Mugglin C, 2012, TROP MED INT HEALTH, V17, P1509, DOI 10.1111/j.1365-3156.2012.03089.x; National Agency for Control of AIDS (NACA) Nigeria, 2011, FACT SHEET UPDATE ON, P1; Odafe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051254; Odafe S, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17424; Opravil M, 2002, AIDS, V16, P1371, DOI 10.1097/00002030-200207050-00009; Salamon R, 2002, J ACQ IMMUN DEF SYND, V29, P149, DOI 10.1097/00042560-200202010-00007; Siegfried N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008272.pub2; Suthar AB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001270; World Health Organization, 2013, COMPREHENSIVE CERVIC; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739	26	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125665	10.1371/journal.pone.0125665	http://dx.doi.org/10.1371/journal.pone.0125665			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933356	Green Published, Green Submitted, gold			2022-12-27	WOS:000353887100125
J	Ren, J; Huang, HR; Liu, Y; Zheng, X; Zou, QZ				Ren, Juan; Huang, Huarong; Liu, Yue; Zheng, Xi; Zou, Qingze			An Atomic Force Microscope Study Revealed Two Mechanisms in the Effect of Anticancer Drugs on Rate-Dependent Young's Modulus of Human Prostate Cancer Cells	PLOS ONE			English	Article							IN-VITRO; INHIBITION; DISULFIRAM; DIFFERENTIATION; MICRORHEOLOGY; CYTOSKELETON; FIBROBLASTS; MODULATION; ELASTICITY; MODEL	Mechanical properties of cells have been recognized as a biomarker for cellular cytoskeletal organization. As chemical treatments lead to cell cytoskeletal rearrangements, thereby, modifications of cellular mechanical properties, investigating cellular mechanical property variations provides insightful knowledge to effects of chemical treatments on cancer cells. In this study, the effects of eight different anticancer drugs on the mechanical properties of human prostate cancer cell (PC-3) are investigated using a recently developed control-based nanoindentation measurement (CNM) protocol on atomic force microscope (AFM). The CNM protocol overcomes the limits of other existing methods to in-liquid nanoindentation measurement of live cells on AFM, particularly for measuring mechanical properties of live cells. The Young's modulus of PC-3 cells treated by the eight drugs was measured by varying force loading rates over three orders of magnitude, and compared to the values of the control. The results showed that the Young's modulus of the PC-3 cells increased substantially by the eight drugs tested, and became much more pronounced as the force load rate increased. Moreover, two distinct trends were clearly expressed, where under the treatment of Disulfiram, paclitaxel, and MK-2206, the exponent coefficient of the frequency-modulus function remained almost unchanged, while with Celebrex, BAY, Totamine, TPA, and Vaproic acid, the exponential rate was significantly increased.	[Ren, Juan; Zou, Qingze] Rutgers State Univ, Dept Mech & Aerosp Engn, Piscataway, NJ 08855 USA; [Huang, Huarong; Zheng, Xi] Guangdong Univ Technol, Allan H Conney Lab Anticanc Res, Guangzhou 510006, Guangdong, Peoples R China; [Liu, Yue; Zheng, Xi] Rutgers State Univ, Dept Biol Chem, Ernest Mario Sch Pharm, Piscataway, NJ USA	Rutgers State University New Brunswick; Guangdong University of Technology; Rutgers State University New Brunswick	Zou, QZ (corresponding author), Rutgers State Univ, Dept Mech & Aerosp Engn, Piscataway, NJ 08855 USA.	qzzou@rci.rutgers.edu			NSF CAREER [CMMI-1066055]; IDBR [DBI-1353890]; Direct For Biological Sciences [1353890] Funding Source: National Science Foundation	NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); IDBR; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by NSF CAREER award grant CMMI-1066055 (http://www.nsf.gov/awardsearch/showAward?AWD_ID=1066055) and IDBR grant (DBI-1353890) (http://www.nsf.gov/awards/award_visualization_noscript.jsp?org=CMMI1@ion=US-NJ&instId= 0026294000).	Akunda JK, 2004, FASEB J, V18, P185, DOI 10.1096/fj.02-1192fje; Alcaraz J, 2003, BIOPHYS J, V84, P2071, DOI 10.1016/S0006-3495(03)75014-0; Alonso JL, 2003, LIFE SCI, V72, P2553, DOI 10.1016/S0024-3205(03)00165-6; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Butt HJ, 2005, SURF SCI REP, V59, P1, DOI 10.1016/j.surfrep.2005.08.003; Cen DZ, 2004, J MED CHEM, V47, P6914, DOI 10.1021/jm049568z; Chen D, 2006, CANCER RES, V66, P10425, DOI 10.1158/0008-5472.CAN-06-2126; Glass-Marmor L, 1999, EUR J PHARMACOL, V370, P195, DOI 10.1016/S0014-2999(99)00155-7; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Hoffman BD, 2009, ANNU REV BIOMED ENG, V11, P259, DOI 10.1146/annurev.bioeng.10.061807.160511; Huang HD, 2004, AM J PHYSIOL-CELL PH, V287, pC1, DOI 10.1152/ajpcell.00559.2003; Karcher H, 2003, BIOPHYS J, V85, P3336, DOI 10.1016/S0006-3495(03)74753-5; Kim KS, 2013, IEEE-ASME T MECH, V18, P1767, DOI 10.1109/TMECH.2012.2212912; Kim SH, 2007, ANN NY ACAD SCI, V1095, P82, DOI 10.1196/annals.1397.012; Kuznetsova TG, 2007, MICRON, V38, P824, DOI 10.1016/j.micron.2007.06.011; Lee GYH, 2007, TRENDS BIOTECHNOL, V25, P111, DOI 10.1016/j.tibtech.2007.01.005; Lee Juliet, 1993, Trends in Cell Biology, V3, P366, DOI 10.1016/0962-8924(93)90084-E; Lee ST, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018915; Lekka M, 1999, EUR BIOPHYS J BIOPHY, V28, P312, DOI 10.1007/s002490050213; Lekka M, 2009, NAT NANOTECHNOL, V4, P72, DOI 10.1038/nnano.2009.004; Li QS, 2008, BIOCHEM BIOPH RES CO, V374, P609, DOI 10.1016/j.bbrc.2008.07.078; Ma SH, 1997, GENE EXPRESSION, V6, P361; Mahaffy RE, 2004, BIOPHYS J, V86, P1777, DOI 10.1016/S0006-3495(04)74245-9; Mofrad M.R.K., 2006, CYTOSKELETAL MECH; POTCHOO Y, 1986, INT J CLIN PHARM TH, V24, P499; RADMACHER M, 1993, BIOPHYS J, V64, P735, DOI 10.1016/S0006-3495(93)81433-4; Rebelo LM, 2014, SOFT MATTER, V10, P2141, DOI 10.1039/c3sm52045e; Rebelo LM, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/5/055102; Ren J, 2014, IEEE T NANOTECHNOL, V13, P46, DOI 10.1109/TNANO.2013.2287505; Ren J, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.052711; Ren J, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4804381; Rotsch C, 2000, BIOPHYS J, V78, P520, DOI 10.1016/S0006-3495(00)76614-8; Schillers H, 2010, BIOPHYS J, V99, P3639, DOI 10.1016/j.bpj.2010.09.048; Smith BA, 2005, BIOPHYS J, V88, P2994, DOI 10.1529/biophysj.104.046649; STOSSEL TP, 1993, SCIENCE, V260, P1086, DOI 10.1126/science.8493552; Vaheri A, 1997, CURR OPIN CELL BIOL, V9, P659, DOI 10.1016/S0955-0674(97)80119-6; Venkatesan P, 2010, MICRON, V41, P247, DOI 10.1016/j.micron.2009.10.008; Werling U, 2001, MOL PHARMACOL, V59, P1269, DOI 10.1124/mol.59.5.1269; Xu ZH, 2010, J APPL PHYS, V107, DOI 10.1063/1.3327450; Xu ZH, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2990759; Zdunek A, 2013, SENSORS-BASEL, V13, P12175, DOI 10.3390/s130912175; Zhang HJ, 2010, CANCER RES, V70, P3996, DOI 10.1158/0008-5472.CAN-09-3752; Zheng X, 2006, CLIN CANCER RES, V12, P3444, DOI 10.1158/1078-0432.CCR-05-2823	44	35	36	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0126107	10.1371/journal.pone.0126107	http://dx.doi.org/10.1371/journal.pone.0126107			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932632	Green Published, gold, Green Submitted			2022-12-27	WOS:000353887100148
J	Yang, BR; Seong, JM; Choi, NK; Shin, JY; Lee, J; Kim, YJ; Kim, MS; Park, S; Song, HJ; Park, BJ				Yang, Bo Ram; Seong, Jong-Mi; Choi, Nam-Kyong; Shin, Ju-Young; Lee, Joongyub; Kim, Ye-Jee; Kim, Mi-Sook; Park, Soyoung; Song, Hong Ji; Park, Byung-Joo			Co-Medication of Statins with Contraindicated Drugs	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; AVERAGE CHOLESTEROL LEVELS; CYP3A4 INHIBITORS; ADMINISTRATIVE CLAIMS; MYOCARDIAL-INFARCTION; PLASMA-CONCENTRATIONS; PRIMARY PREVENTION; CORONARY EVENTS; ADVERSE EVENTS; RISK-FACTORS	Background The concomitant use of cytochrome P450 3A4 (CYP3A4) metabolized statins (simvastatin, lovastatin, and atorvastatin) with CYP3A4 inhibitors has been shown to increase the rate of adverse events. Objective This study was performed to describe the co-medication prevalence of CYP3A4-metabolized statins with contraindicated drugs. Methods The patients aged 40 or older receiving CYP3A4-metabolized statin prescriptions in 2009 were identified using the national patient sample from a Korea Health Insurance Review and Assessment Service database. Contraindicated co-medication was defined as prescription periods of statins and contraindicated drugs overlapping by at least one day. Co-medication patterns were classified into 3 categories as follows: co-medication in the same prescription, co-medication by the same medical institution, and co-medication by different medical institutions. The proportion of co-medication was analyzed by age, gender, co-morbidities, and the statin's generic name. Results A total of 2,119,401 patients received CYP3A4-metabolized statins and 60,254 (2.84%) patients were co-medicated with contraindicated drugs. The proportion of co-medication was 4.6%, 2.2%, and 1.8% in simvastatin, lovastatin, and atorvastatin users, respectively. The most frequent combination was atorvastatin-itraconazole, followed by simvastatin-clarithromycin and simvastatin-itraconazole. Among the co-medicated patients, 85.3% were prescribed two drugs by different medical institutions. Conclusion The proportion of co-medication of statins with contraindicated drugs was relatively lower than that of previous studies; however, the co-medication occurring by different medical institutions was not managed appropriately. There is a need to develop an effective system and to conduct outcomes research confirming the association between co-medication and the risk of unfavorable clinical outcomes.	[Yang, Bo Ram; Lee, Joongyub; Kim, Mi-Sook; Park, Soyoung; Park, Byung-Joo] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Yang, Bo Ram; Choi, Nam-Kyong; Lee, Joongyub] Seoul Natl Univ Hosp, Med Res Collaborating Ctr, Seoul 110744, South Korea; [Seong, Jong-Mi; Shin, Ju-Young; Kim, Ye-Jee] Korea Inst Drug Safety & Risk Management, Seoul, South Korea; [Song, Hong Ji] Hallym Univ, Coll Med, Dept Family Med, Chunchon, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Hallym University	Park, BJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea.	bjpark@snu.ac.kr		Choi, Nam-Kyong/0000-0003-1153-9928; Shin, Ju-Young/0000-0003-1010-7525				Backman JT, 2000, CLIN PHARMACOL THER, V68, P122, DOI 10.1067/mcp.2000.108507; Bakhai A, 2012, PHARMACOEPIDEM DR S, V21, P485, DOI 10.1002/pds.2308; Ballantyne CM, 2003, ARCH INTERN MED, V163, P553, DOI 10.1001/archinte.163.5.553; Brugts JJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2376; Buurma H, 2007, ANN PHARMACOTHER, V41, P2024, DOI 10.1345/aph.1K240; Cziraky MJ, 2006, AM J CARDIOL, V97, p61C, DOI 10.1016/j.amjcard.2005.12.011; Devold HM, 2009, BRIT J CLIN PHARMACO, V67, P234, DOI 10.1111/j.1365-2125.2008.03345.x; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Jacobson TA, 2004, AM J CARDIOL, V94, P1140, DOI 10.1016/j.amjcard.2004.07.080; Jones PH, 2005, AM J CARDIOL, V95, P120, DOI 10.1016/j.amjcard.2004.08.076; Kantola T, 1998, CLIN PHARMACOL THER, V64, P58, DOI 10.1016/S0009-9236(98)90023-6; Kim L, 2014, EPIDEMIOL HEALTH, V36, DOI 10.4178/epih/e2014008; Korea Health Insurance Review and Assessment Service, 2010, DRUG UTILIZATION REV; Korea Ministry of Health and Welfare, 2004, REV DET REG APPL STA; Korea Ministry of Health and Welfare, 2005, REVISION OF DETAILS; Kyrklund C, 2001, CLIN PHARMACOL THER, V69, P340, DOI 10.1067/mcp.2001.115542; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; Lewis SJ, 1998, J AM COLL CARDIOL, V32, P140, DOI 10.1016/S0735-1097(98)00202-2; Mills EJ, 2008, J AM COLL CARDIOL, V52, P1769, DOI 10.1016/j.jacc.2008.08.039; Ming EE, 2008, J CLIN LIPIDOL, V2, P453, DOI 10.1016/j.jacl.2008.10.007; Ministry Of Food And Drug Safety, 2007, CONTRAINDICATION DRU; Molden E, 2008, DRUG SAFETY, V31, P587, DOI 10.2165/00002018-200831070-00004; Neuvonen PJ, 2006, CLIN PHARMACOL THER, V80, P565, DOI 10.1016/j.clpt.2006.09.003; Omar MA, 2002, ANN PHARMACOTHER, V36, P288, DOI 10.1345/aph.1A289; Page SR, 2014, INTERN MED J, V44, P690, DOI 10.1111/imj.12464; Patel AM, 2013, ANN INTERN MED, V158, P869, DOI 10.7326/0003-4819-158-12-201306180-00004; Ronaldson KJ, 2006, DRUG SAFETY, V29, P1061, DOI 10.2165/00002018-200629110-00005; Roques Sebastien LM, 2011, DRUG METABOLISM AND, V26, P2; Rowan CG, 2008, PHARMACOEPIDEM DR S, V17, pS231; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Silva MA, 2006, CLIN THER, V28, P26, DOI 10.1016/j.clinthera.2006.01.005; Stang Paul, 2007, Am J Ther, V14, P30, DOI 10.1097/01.mjt.0000208875.61480.c8; Tobi H, 2007, PHARMACOEPIDEM DR S, V16, P405, DOI 10.1002/pds.1304; Whitfield LR, 2011, J CLIN PHARMACOL, V51, P378, DOI 10.1177/0091270010366446	34	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125180	10.1371/journal.pone.0125180	http://dx.doi.org/10.1371/journal.pone.0125180			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932626	Green Published, gold, Green Submitted			2022-12-27	WOS:000353887100085
J	Yoon, HS; Yang, JJ; Song, M; Lee, HW; Han, S; Lee, SA; Choi, JY; Lee, JK; Kang, D				Yoon, Hyung-Suk; Yang, Jae Jeong; Song, Minkyo; Lee, Hwi-Won; Han, Sohee; Lee, Sang-Ah; Choi, Ji-Yeob; Lee, Jong-koo; Kang, Daehee			Correlates of Self-Reported Sleep Duration in Middle-Aged and Elderly Koreans: from the Health Examinees Study	PLOS ONE			English	Article							METABOLIC CONSEQUENCES; LONG-SLEEP; SOCIOECONOMIC-STATUS; UNIVERSITY-STUDENTS; UNITED-STATES; WHITEHALL II; QUALITY; ASSOCIATION; HYPERTENSION; MORTALITY	Though various factors related to fluctuations in sleep duration have been identified, information remains limited regarding the correlates of short and long sleep duration among the Korean population. Thus, we investigated characteristics that could be associated with short and/or long sleep duration among middle-aged and elderly Koreans. A total of 84,094 subjects (27,717 men and 56,377 women) who participated in the Health Examinees Study were analyzed by using multinomial logistic regression models. To evaluate whether sociodemographic factors, lifestyle factors, psychological conditions, anthropometry results, and health conditions were associated with short and/or long sleep duration, odds ratios (ORs) and 95% confidence intervals (CIs) were estimated with sleep duration of 6-7 hours as the reference group, accounting for putative covariates. Regardless of sexual differences, we found that adverse behaviors and lifestyle factors including low educational attainment, unemployment, being unmarried, current smoking status, lack of exercise, having irregular meals, poor psychosocial well-being, frequent stress events, and poor self-rated health were significantly associated with abnormal sleep duration. Similarly, diabetes mellitus and depression showed positive associations with abnormal sleep duration in both men and women. Our findings suggest that low sociodemographic characteristics, adverse lifestyle factors, poor psychological conditions, and certain disease morbidities could be associated with abnormal sleep duration in middle-aged and elderly Koreans.	[Yoon, Hyung-Suk; Song, Minkyo; Lee, Hwi-Won; Choi, Ji-Yeob; Kang, Daehee] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea; [Yoon, Hyung-Suk; Yang, Jae Jeong; Song, Minkyo; Lee, Hwi-Won; Han, Sohee; Choi, Ji-Yeob; Kang, Daehee] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Yoon, Hyung-Suk; Yang, Jae Jeong; Song, Minkyo; Han, Sohee; Kang, Daehee] Seoul Natl Univ, Med Res Ctr, Inst Environm Med, Seoul, South Korea; [Lee, Sang-Ah] Kangwon Natl Univ, Dept Prevent Med, Kangwon Do, South Korea; [Choi, Ji-Yeob; Kang, Daehee] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea; [Lee, Jong-koo] Seoul Natl Univ, Coll Med, JW Lee Ctr Global Med, Seoul, South Korea; [Lee, Jong-koo] Seoul Natl Univ, Coll Med, Dept Family Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Kangwon National University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kang, D (corresponding author), Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea.	dhkang@snu.ac.kr	Yoon, Alex/ADQ-5328-2022; Song, Minkyo/AAE-9095-2020	Yoon, Alex/0000-0001-6368-2684; Song, Minkyo/0000-0002-9412-2871; Kang, Daehee/0000-0003-4031-5878	National Genome Research Institute, Korea Center for Disease Control and Prevention	National Genome Research Institute, Korea Center for Disease Control and Prevention	This study was supported by the National Genome Research Institute, Korea Center for Disease Control and Prevention. We would like to thank the participants and all members of the HEXA Study Group.	Akerstedt T, 2006, SCAND J WORK ENV HEA, V32, P493, DOI 10.5271/sjweh.1054; Arora T, 2011, DIABETES CARE, V34, P2317, DOI 10.2337/dc11-0647; Atkinson G, 2007, PHYSIOL BEHAV, V90, P229, DOI 10.1016/j.physbeh.2006.09.015; Ban DJ, 2001, J KOREAN MED SCI, V16, P475, DOI 10.3346/jkms.2001.16.4.475; Brand S, 2010, J ADOLESCENT HEALTH, V46, P133, DOI 10.1016/j.jadohealth.2009.06.018; Buxton OM, 2010, SOC SCI MED, V71, P1027, DOI 10.1016/j.socscimed.2010.05.041; Campbell SS, 2007, J SLEEP RES, V16, P24, DOI 10.1111/j.1365-2869.2007.00567.x; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Cappuccio FP, 2007, HYPERTENSION, V50, P693, DOI 10.1161/HYPERTENSIONAHA.107.095471; Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124; Chang S-J, 2000, DEVELOPING THE PSYCH, P92; Cohen S, 2004, AM PSYCHOL, V59, P676, DOI 10.1037/0003-066X.59.8.676; Dinas PC, 2011, IRISH J MED SCI, V180, P319, DOI 10.1007/s11845-010-0633-9; Espiritu JRD, 2008, CLIN GERIATR MED, V24, P1, DOI 10.1016/j.cger.2007.08.007; Fang J, 2012, AM J HYPERTENS, V25, P335, DOI 10.1038/ajh.2011.201; Franco OH, 2012, EUR J EPIDEMIOL, V27, P255, DOI 10.1007/s10654-012-9664-z; Geiger SD, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/518263; Goldfarb AH, 1997, SPORTS MED, V24, P8, DOI 10.2165/00007256-199724010-00002; Gu DN, 2010, SLEEP, V33, P601, DOI 10.1093/sleep/33.5.601; Haseli-Mashhadi N, 2009, BMC PUBLIC HEALTH, V9, DOI [10.1186/1471-2458-9-130, 10.1186/1471-2458-9-368]; Hayashino Y, 2010, SLEEP MED, V11, P366, DOI 10.1016/j.sleep.2009.05.021; Holt-Lunstad J, 2008, ANN BEHAV MED, V35, P239, DOI 10.1007/s12160-008-9018-y; Hori H, 2011, J PSYCHIATR RES, V45, P1257, DOI 10.1016/j.jpsychires.2011.04.001; Kalleinen Nea, 2008, Menopause Int, V14, P97, DOI 10.1258/mi.2008.008013; Kim Eui-Joong, 2007, Behav Sleep Med, V5, P256; Kim S, 2011, PUBLIC HEALTH NUTR, V14, P889, DOI 10.1017/S136898001000296X; Knutson KL, 2007, SLEEP MED REV, V11, P163, DOI 10.1016/j.smrv.2007.01.002; Knutson KL, 2006, ARCH INTERN MED, V166, P1768, DOI 10.1001/archinte.166.16.1768; Kravitz HM, 2003, MENOPAUSE, V10, P19, DOI 10.1097/01.GME.0000030707.35686.5A; Kripke DF, 2002, ARCH GEN PSYCHIAT, V59, P131, DOI 10.1001/archpsyc.59.2.131; Kronholm E, 2006, J SLEEP RES, V15, P276, DOI 10.1111/j.1365-2869.2006.00543.x; Krueger PM, 2009, AM J EPIDEMIOL, V169, P1052, DOI 10.1093/aje/kwp023; Lemma S, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-237; Leproult R, 1997, SLEEP, V20, P865; Magee CA, 2011, SLEEP MED, V12, P346, DOI 10.1016/j.sleep.2010.09.013; Moore PJ, 2002, PSYCHOSOM MED, V64, P337, DOI 10.1097/00006842-200203000-00018; Morin CM, 2003, PSYCHOSOM MED, V65, P259, DOI 10.1097/01.PSY.0000030391.09558.A3; Mullington JM, 2009, PROG CARDIOVASC DIS, V51, P294, DOI 10.1016/j.pcad.2008.10.003; Nakata A, 2008, INT J BEHAV MED, V15, P81, DOI 10.1080/10705500801929577; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Pampel FC, 2010, ANNU REV SOCIOL, V36, P349, DOI 10.1146/annurev.soc.012809.102529; Park SE, 2009, OBESITY, V17, P767, DOI 10.1038/oby.2008.586; Patel SR, 2007, SLEEP, V30, P1077, DOI 10.1093/sleep/30.9.1077; Patel SR, 2006, SLEEP, V29, P881, DOI 10.1093/sleep/29.7.881; Patel SR, 2012, SLEEP, V35, P641, DOI 10.5665/sleep.1822; Patel SR, 2004, SLEEP, V27, P440, DOI 10.1093/sleep/27.3.440; Peuhkuri K, 2012, NUTR RES, V32, P309, DOI 10.1016/j.nutres.2012.03.009; Polo-Kantola P, 2011, MATURITAS, V68, P224, DOI 10.1016/j.maturitas.2010.12.009; Roehrs T, 2008, SLEEP MED REV, V12, P153, DOI 10.1016/j.smrv.2007.07.004; Sabanayagam C, 2011, SLEEP MED, V12, P7, DOI 10.1016/j.sleep.2010.09.002; Stamatakis KA, 2007, ANN EPIDEMIOL, V17, P948, DOI 10.1016/j.annepidem.2007.07.096; Stefani KM, 2013, DIABETES RES CLIN PR, V102, P250, DOI 10.1016/j.diabres.2013.10.003; Stranges S, 2008, AM J EPIDEMIOL, V168, P1353, DOI 10.1093/aje/kwn337; Suarez EC, 2008, BRAIN BEHAV IMMUN, V22, P960, DOI 10.1016/j.bbi.2008.01.011; Tamakoshi A, 2004, SLEEP, V27, P51; Troxel WM, 2010, J PSYCHOSOM RES, V69, P459, DOI 10.1016/j.jpsychores.2010.04.003; Tu XD, 2012, SLEEP MED, V13, P1138, DOI 10.1016/j.sleep.2012.06.014; Van Cauter E, 1999, ANN NY ACAD SCI, V896, P254, DOI 10.1111/j.1749-6632.1999.tb08120.x; Van Cauter E, 2008, SLEEP MED, V9, pS23, DOI 10.1016/S1389-9457(08)70013-3; Yaggi HK, 2006, DIABETES CARE, V29, P657, DOI 10.2337/diacare.29.03.06.dc05-0879; Yeo Yohwan, 2013, J Prev Med Public Health, V46, P271, DOI 10.3961/jpmph.2013.46.5.271; Zhang L, 2006, AM J EPIDEMIOL, V164, P529, DOI 10.1093/aje/kwj231	62	24	25	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0123510	10.1371/journal.pone.0123510	http://dx.doi.org/10.1371/journal.pone.0123510			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH2XA	25933418	gold, Green Published, Green Submitted			2022-12-27	WOS:000353887100021
J	Chavan, V; Willis, J; Walker, SK; Clark, HR; Liu, XR; Fox, MA; Srivastava, S; Mukherjee, K				Chavan, Vrushali; Willis, Jeffery; Walker, Sidney K.; Clark, Helen R.; Liu, Xinran; Fox, Michael A.; Srivastava, Sarika; Mukherjee, Konark			Central Presynaptic Terminals Are Enriched in ATP but the Majority Lack Mitochondria	PLOS ONE			English	Article							TRICARBOXYLIC-ACID CYCLE; SYNAPTIC VESICLES; AXONAL-TRANSPORT; CENTRAL SYNAPSES; OXIDATIVE-PHOSPHORYLATION; NEUROMUSCULAR-JUNCTIONS; BRAIN; CA2+; PROTEINS; RELEASE	Synaptic neurotransmission is known to be an energy demanding process. At the presynapse, ATP is required for loading neurotransmitters into synaptic vesicles, for priming synaptic vesicles before release, and as a substrate for various kinases and ATPases. Although it is assumed that presynaptic sites usually harbor local mitochondria, which may serve as energy powerhouse to generate ATP as well as a presynaptic calcium depot, a clear role of presynaptic mitochondria in biochemical functioning of the presynapse is not well-defined. Besides a few synaptic subtypes like the mossy fibers and the Calyx of Held, most central presynaptic sites are either en passant or tiny axonal terminals that have little space to accommodate a large mitochondrion. Here, we have used imaging studies to demonstrate that mitochondrial antigens poorly co-localize with the synaptic vesicle clusters and active zone marker in the cerebral cortex, hippocampus and the cerebellum. Confocal imaging analysis on neuronal cultures revealed that most neuronal mitochondria are either somatic or distributed in the proximal part of major dendrites. A large number of synapses in culture are devoid of any mitochondria. Electron micrographs from neuronal cultures further confirm our finding that the majority of presynapses may not harbor resident mitochondria. We corroborated our ultrastructural findings using serial block face scanning electron microscopy (SBFSEM) and found that more than 60% of the presynaptic terminals lacked discernible mitochondria in the wild-type mice hippocampus. Biochemical fractionation of crude synaptosomes into mitochondria and pure synaptosomes also revealed a sparse presence of mitochondrial antigen at the presynaptic boutons. Despite a low abundance of mitochondria, the synaptosomal membranes were found to be highly enriched in ATP suggesting that the presynapse may possess alternative mechanism/s for concentrating ATP for its function. The potential mechanisms including local glycolysis and the possible roles of ATP-binding synaptic proteins such as synapsins, are discussed.	[Chavan, Vrushali; Willis, Jeffery; Walker, Sidney K.; Clark, Helen R.; Fox, Michael A.; Srivastava, Sarika; Mukherjee, Konark] Virginia Tech Caril Res Inst, Roanoke, VA 24016 USA; [Fox, Michael A.; Mukherjee, Konark] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24060 USA; [Liu, Xinran] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA	Virginia Polytechnic Institute & State University; Yale University	Srivastava, S (corresponding author), Virginia Tech Caril Res Inst, Roanoke, VA 24016 USA.	Sarika_Srivastava@vtc.vt.edu; konark@vtc.vt.edu		Fox, Michael/0000-0002-1649-7782; Srivastava, Sarika/0000-0001-9634-5510	NEI NIH HHS [R01 EY021222] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY021222] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; Bai Fengju, 2007, V43, P77, DOI 10.1007/978-1-4020-5943-8_6; Brown MR, 2006, J BIOL CHEM, V281, P11658, DOI 10.1074/jbc.M510303200; Buddhala C, 2009, NEUROCHEM INT, V55, P9, DOI 10.1016/j.neuint.2009.01.020; Calkins MJ, 2011, HUM MOL GENET, V20, P4515, DOI 10.1093/hmg/ddr381; Cardona A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038011; Chih CP, 2003, J CEREBR BLOOD F MET, V23, P1263, DOI 10.1097/01.WCB.0000081369.51727.6F; Chouhan AK, 2010, J NEUROSCI, V30, P1869, DOI 10.1523/JNEUROSCI.4701-09.2010; Dahlhaus M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005413; Gioio AE, 2001, J NEUROSCI RES, V64, P447, DOI 10.1002/jnr.1096; Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027; HAJOS F, 1971, J CELL BIOL, V51, P216, DOI 10.1083/jcb.51.1.216; Hall CN, 2012, J NEUROSCI, V32, P8940, DOI 10.1523/JNEUROSCI.0026-12.2012; Harris JJ, 2013, J CEREBR BLOOD F MET, V33, P33, DOI 10.1038/jcbfm.2012.148; HARRIS KM, 1995, NEUROPHARMACOLOGY, V34, P1387, DOI 10.1016/0028-3908(95)00142-S; Hosaka M, 1998, J BIOL CHEM, V273, P13371, DOI 10.1074/jbc.273.22.13371; Hosaka M, 1998, J BIOL CHEM, V273, P1425, DOI 10.1074/jbc.273.3.1425; Ikemoto A, 2003, J BIOL CHEM, V278, P5929, DOI 10.1074/jbc.M211617200; Juranek J, 2006, EUR J NEUROSCI, V24, P3043, DOI 10.1111/j.1460-9568.2006.05183.x; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; Kawai Y, 2013, AM J PHYSIOL-CELL PH, V305, pC1139, DOI 10.1152/ajpcell.00199.2013; Khatri N, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00199; Kirkinezos IG, 2005, J NEUROSCI, V25, P164, DOI 10.1523/JNEUROSCI.3829-04.2005; Lee D, 2007, J NEUROSCI, V27, P13603, DOI 10.1523/JNEUROSCI.3985-07.2007; LEONG SF, 1984, J NEUROCHEM, V42, P1306, DOI 10.1111/j.1471-4159.1984.tb02788.x; Li JL, 2003, J COMP NEUROL, V460, P394, DOI 10.1002/cne.10646; Liotta A, 2012, J CEREBR BLOOD F MET, V32, P2076, DOI 10.1038/jcbfm.2012.116; Marra V, 2012, NEURON, V76, P579, DOI 10.1016/j.neuron.2012.08.042; MINK JW, 1981, AM J PHYSIOL, V241, pR203, DOI 10.1152/ajpregu.1981.241.3.R203; Mukherjee K, 2010, P NATL ACAD SCI USA, V107, P6504, DOI 10.1073/pnas.1002307107; Novak P, 2013, NEURON, V79, P1067, DOI 10.1016/j.neuron.2013.07.012; PALAY SANFORD L., 1956, JOUR BIOPHYS AND BIOCHEM CYTOL, V2, P193, DOI 10.1083/jcb.2.4.193; Picard M, 2014, P NATL ACAD SCI USA, V111, P7, DOI 10.1073/pnas.1321881111; PINCHASI I, 1979, FEBS LETT, V108, P189, DOI 10.1016/0014-5793(79)81207-7; Ravera S, 2013, BIOCHIMIE, V95, P1991, DOI 10.1016/j.biochi.2013.07.003; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; Schikorski T, 1997, J NEUROSCI, V17, P5858; Serra-Pages C, 2005, BIOCHEMISTRY-US, V44, P15715, DOI 10.1021/bi051434f; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Shutov LP, 2013, J PHYSIOL-LONDON, V591, P2443, DOI 10.1113/jphysiol.2012.249219; Sims NR, 2008, NAT PROTOC, V3, P1228, DOI 10.1038/nprot.2008.105; SIMS NR, 1986, J NEUROCHEM, V47, P496; Spillane M, 2013, CELL REP, V5, P1564, DOI 10.1016/j.celrep.2013.11.022; Srivastava S, 2001, HUM MOL GENET, V10, P3093, DOI 10.1093/hmg/10.26.3093; STADLER H, 1984, EMBO J, V3, P3333, DOI 10.1002/j.1460-2075.1984.tb02300.x; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sun T, 2013, CELL REP, V4, P413, DOI 10.1016/j.celrep.2013.06.040; TIALOWSKA B, 1991, ACTA BIOCHIM POL, V38, P165; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Vivona S, 2013, J BIOL CHEM, V288, P24984, DOI 10.1074/jbc.M113.489807; Walmsley B, 1998, TRENDS NEUROSCI, V21, P81, DOI 10.1016/S0166-2236(97)01170-3; WALZ W, 1988, GLIA, V1, P366, DOI 10.1002/glia.440010603; Wang LY, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-36; Yao J, 2008, J BIOL CHEM, V283, P20628, DOI 10.1074/jbc.M800738200; Yao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005315	56	38	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125185	10.1371/journal.pone.0125185	http://dx.doi.org/10.1371/journal.pone.0125185			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928229	Green Published, Green Submitted, gold			2022-12-27	WOS:000353713100072
J	Pedersen, SK; Baker, RT; McEvoy, A; Murray, DH; Thomas, M; Molloy, PL; Mitchell, S; Lockett, T; Young, GP; LaPointe, LC				Pedersen, Susanne K.; Baker, Rohan T.; McEvoy, Aidan; Murray, David H.; Thomas, Melissa; Molloy, Peter L.; Mitchell, Sue; Lockett, Trevor; Young, Graeme P.; LaPointe, Lawrence C.			A Two-Gene Blood Test for Methylated DNA Sensitive for Colorectal Cancer	PLOS ONE			English	Article							PROGNOSTIC-SIGNIFICANCE; PROGENITOR CELLS; IKAROS; NOTCH; BIOMARKER; PLASMA; HOMEOSTASIS; MARKERS; SERUM; GENE	Background Specific genes are methylated with high frequency in colorectal neoplasia, and may leak into blood. Detection of multiple methylated DNA biomarkers in blood may improve assay sensitivity for colorectal cancer (CRC) relative to a single marker. We undertook a case-control study evaluating the presence of two methylation DNA markers, BCAT1 and IKZF1, in circulation to determine if they were complementary for detection of CRC. Methods Methylation-specific PCR assays were developed to measure the level of methylated BCAT1 and IKZF1 in DNA extracted from plasma obtained from colonoscopy-confirmed 144 healthy controls and 74 CRC cases. Results DNA yields ranged from 2 to 730 ng/mL plasma (mean 18.6ng/mL; 95% CI 11-26 ng/mL) and did not correlate with gender, age or CRC status. Methylated BCAT1 and IKZF1 DNA were detected in respectively 48 (65%) and 50 (68%) of the 74 cancers. In contrast, only 5 (4%) and 7 (5%) controls were positive for BCAT1 and IKZF1 DNA methylation, respectively. A two-gene classifier model ("either or" rule) improved segregation of CRC from controls, with 57 of 74 cancers (77%) compared to only 11 of 144 (7.6%) controls being positive for BCAT1 and/or IKZF1 DNA methylation. Increasing levels of methylated DNA were observed as CRC stage progressed. Conclusions Detection of methylated BCAT1 and/or IKZF1 DNA in plasma may have clinical application as a novel blood test for CRC. Combining the results from the two methylation-specific PCR assays improved CRC detection with minimal change in specificity. Further validation of this two-gene blood test with a view to application in screening is now indicated.	[Pedersen, Susanne K.; Baker, Rohan T.; McEvoy, Aidan; Murray, David H.; Thomas, Melissa; LaPointe, Lawrence C.] Clin Genom Proprietary Ltd, Sydney, NSW, Australia; [Molloy, Peter L.; Mitchell, Sue; Lockett, Trevor] CSIRO, Food & Nutr Flagship, Sydney, NSW, Australia; [Young, Graeme P.] Flinders Univ South Australia, Flinders Ctr Innovat Canc, Adelaide, SA, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Flinders University South Australia	Pedersen, SK (corresponding author), Clin Genom Proprietary Ltd, Sydney, NSW, Australia.	Susanne.pedersen@clinicalgenomics.com	Molloy, Peter L/H-7931-2013; Lockett, Trevor J/H-8970-2013; Murray, David Hugh/GPC-6570-2022	Molloy, Peter L/0000-0002-7788-3417; Lockett, Trevor J/0000-0002-8063-071X; Murray, David Hugh/0000-0002-3073-3593; , Susanne/0000-0002-5518-1959; Young, Graeme/0000-0001-9458-8383; LaPointe, Lawrence/0000-0002-8906-1867	Clinical Genomics Pty Ltd; Commonwealth Scientific and Industrial Research Organization (CSIRO)	Clinical Genomics Pty Ltd; Commonwealth Scientific and Industrial Research Organization (CSIRO)(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	This work was co-funded by Clinical Genomics Pty Ltd, and the Commonwealth Scientific and Industrial Research Organization (CSIRO). LCL, SKP, RTB, AM, DHM and MT are employed by Clinical Genomics Pty Ltd. PLM, SM and TL are employed by CSIRO. GPY is a paid consultant of Clinical Genomics Pty. Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betge J, 2012, CANCER-AM CANCER SOC, V118, P628, DOI 10.1002/cncr.26310; Church TR, 2014, GUT, V63, P317, DOI 10.1136/gutjnl-2012-304149; deVos T, 2009, CLIN CHEM, V55, P1337, DOI 10.1373/clinchem.2008.115808; Diaz B, 2013, J CELL BIOL, V201, P279, DOI 10.1083/jcb.201209151; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Gormally E, 2007, MUTAT RES-REV MUTAT, V635, P105, DOI 10.1016/j.mrrev.2006.11.002; Grutzmann R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003759; Hundt S, 2007, CANCER EPIDEM BIOMAR, V16, P1935, DOI 10.1158/1055-9965.EPI-06-0994; Iacobucci I, 2009, BLOOD, V114, P2159, DOI 10.1182/blood-2008-08-173963; Javierre BM, 2011, MOL CANCER RES, V9, P1139, DOI 10.1158/1541-7786.MCR-10-0515; Kibriya MG, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-50; Klemke RL, 2012, CURR OPIN CELL BIOL, V24, P662, DOI 10.1016/j.ceb.2012.08.005; Koukourakis MI, 2005, CLIN CANCER RES, V11, P8653, DOI 10.1158/1078-0432.CCR-05-1464; LaPointe LC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029059; Lofton-Day C, 2008, CLIN CHEM, V54, P414, DOI 10.1373/clinchem.2007.095992; Malinge S, 2013, BLOOD, V121, P2440, DOI 10.1182/blood-2012-08-450627; Mead R, 2011, BRIT J CANCER, V105, P239, DOI 10.1038/bjc.2011.230; Menendez P, 2013, J SURG ONCOL, V107, P217, DOI 10.1002/jso.23245; Mitchell SM, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-54; Mouliere F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023418; Noah TK, 2013, ANNU REV PHYSIOL, V75, P263, DOI 10.1146/annurev-physiol-030212-183741; Osborne J. M., 2012, Open Journal of Preventive Medicine, V2, P326; Quintero E, 2012, NEW ENGL J MED, V366, P697, DOI [10.1056/NEJMoa1108895, 10.1056/NEJMx150040]; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Radtke F, 2006, CURR MOL MED, V6, P275, DOI 10.2174/156652406776894527; Riccio O, 2008, EMBO REP, V9, P377, DOI 10.1038/embor.2008.7; Ross JP, 2013, EPIGENETICS-US, V8, P113, DOI 10.4161/epi.23330; Schjerven H, 2013, NAT IMMUNOL, V14, P1073, DOI 10.1038/ni.2707; Schwarzenbach H, 2008, ANN NY ACAD SCI, V1137, P190, DOI 10.1196/annals.1448.025; Shankar J, 2010, CANCER RES, V70, P3780, DOI 10.1158/0008-5472.CAN-09-4439; Sridharan R, 2007, J BIOL CHEM, V282, P30227, DOI 10.1074/jbc.M702541200; Staton CA, 2007, GUT, V56, P1426, DOI 10.1136/gut.2007.125286; Tonjes M, 2013, NAT MED, V19, P901, DOI 10.1038/nm.3217; Vincent A, 2011, CLIN CANCER RES, V17, P4341, DOI 10.1158/1078-0432.CCR-10-3431; Wang WG, 2005, TRENDS CELL BIOL, V15, P138, DOI 10.1016/j.tcb.2005.01.003; Warren JD, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-133; Yoshikawa R, 2006, WORLD J GASTROENTERO, V12, P5884, DOI 10.3748/wjg.v12.i36.5884; Zhang ZF, 2013, ANAT REC, V296, P907, DOI 10.1002/ar.22700	40	47	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125041	10.1371/journal.pone.0125041	http://dx.doi.org/10.1371/journal.pone.0125041			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928810	Green Published, Green Submitted, gold			2022-12-27	WOS:000353713100059
J	Tang, CQ; Yang, YC; Ohsawa, M; Momohara, A; Yi, SR; Robertson, K; Song, K; Zhang, SQ; He, LY				Tang, Cindy Q.; Yang, Yongchuan; Ohsawa, Masahiko; Momohara, Arata; Yi, Si-Rong; Robertson, Kevin; Song, Kun; Zhang, Shi-Qiang; He, Long-Yuan			Community Structure and Survival of Tertiary Relict Thuja sutchuenensis (Cupressaceae) in the Subtropical Daba Mountains, Southwestern China	PLOS ONE			English	Article							NIAGARA ESCARPMENT; CONSTRAINED GROWTH; PLANT-COMMUNITIES; NORTH-AMERICA; EASTERN ASIA; CLIFF FACES; OCCIDENTALIS; EVOLUTION; FORESTS; ENVIRONMENT	A rare coniferous Tertiary relict tree species, Thuja sutchuenensis Franch, has survived in the Daba Mountains of southwestern China. It was almost eliminated by logging during the past century. We measured size and age structures and interpreted regeneration dynamics of stands of the species in a variety of topographic contexts and community associations. Forest communities containing T. sutchuenensis were of three types: (1) the Thuja community dominated by T. sutchuenensis, growing on cliffs; (2) the Thuja-Quercus-Cyclobalanopsis community dominated by T. sutchuenensis, Quercus engleriana and Cyclobalanopsis oxyodon, along with Fagus engleriana and Carpinus fargesiana, on steep slopes; (3) the Thuja-Tsuga-Quercus community dominated by T. sutchuenensis, Tsuga chinensis, and Quercus spinosa, on crest ridges. The established seedlings/saplings were found in limestone crevices, on scarred cliff-faces, cliff-edges, fallen logs, canopy gaps and forest margins. The radial growth rate was 0.5-1.1 mm per year. Its growth forms were distorted. It had strong sprouting ability after disturbances. The T. sutchuenensis population thrives on cliffs where there is little competition from other species because of harsh conditions and rock-slide disturbances. It is shade-intolerant but stress-tolerant. Its regeneration has depended on natural disturbances.	[Tang, Cindy Q.; Ohsawa, Masahiko; He, Long-Yuan] Yunnan Univ, Inst Ecol & Geobot, Kunming 650091, Peoples R China; [Yang, Yongchuan] Chongqing Univ, Minist Educ, Key Lab Gorges Reservoir Reg Ecoenvironm 3, Chongqing 400045, Peoples R China; [Yang, Yongchuan] Chongqing Univ, Natl Ctr Int Res Low Carbon & Green Bldgs, Chongqing 400045, Peoples R China; [Momohara, Arata] Chiba Univ, Grad Sch Hort, Chiba 2718510, Japan; [Yi, Si-Rong] Inst Med Plant Cultivat Chongqing, Nanchuan 408435, Peoples R China; [Robertson, Kevin] Tall Timbers Res Stn & Land Conservancy, Tallahassee, FL 32312 USA; [Song, Kun] E China Normal Univ, Dept Environm Sci, Shanghai 200062, Peoples R China; [Zhang, Shi-Qiang] Dabashan Natl Nat Reserve, Chengkou 405900, Peoples R China	Yunnan University; Chongqing University; Chongqing University; Chiba University; East China Normal University	Tang, CQ (corresponding author), Yunnan Univ, Inst Ecol & Geobot, Kunming 650091, Peoples R China.	cindyqtang@aol.com; ycyang@cqu.edu.cn	Tang, Cindy/AAC-3343-2022; Robertson, Kevin/AAT-9357-2021; Yang, Yongchuan/N-4226-2014	Tang, Cindy/0000-0003-3789-6771; Yang, Yongchuan/0000-0001-7627-7776; Song, Kun/0000-0001-8019-9707	Education Department of Yunnan Province for Foreign Experts; Natural Science Foundation Project of CQ CSTC [cstc2012jjA00014]; Visiting Scholar Foundation of the Key Laboratory of the Three Gorges Reservoir Region's Eco-Environment (Ministry of Education) of Chongqing University [B13041]; JSPS (Japan) [24405023]	Education Department of Yunnan Province for Foreign Experts; Natural Science Foundation Project of CQ CSTC(Natural Science Foundation Project of CQ CSTC); Visiting Scholar Foundation of the Key Laboratory of the Three Gorges Reservoir Region's Eco-Environment (Ministry of Education) of Chongqing University; JSPS (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study is financially supported by Yunnan University's Special Research Program under the auspices of the Education Department of Yunnan Province for Foreign Experts, by the Natural Science Foundation Project of CQ CSTC (cstc2012jjA00014), by the Visiting Scholar Foundation of the Key Laboratory of the Three Gorges Reservoir Region's Eco-Environment (Ministry of Education) of Chongqing University, 111 Project No. B13041, and by a JSPS Grant-in-Aid for Scientific Research (No. 24405023, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmetiev MA, 1973, GEOL I T AKAD NAUK U, V247, P1; Axelrod D.I., 1998, FLORISTIC CHARACTERI, P43; Bennike O., 1990, Meddelelser om Gronland Geoscience, V23, P1; Chamber KL, 1993, FLORA N AM N MEXICO, V2; Christopher IE, 2015, GYMNOSPERM DATABASE; DANIELS LD, 1995, NORTHWEST SCI, V69, P175; DEBLOIS S, 1995, J VEG SCI, V6, P531, DOI 10.2307/3236352; Farjon A, 2001, WORLD CHECKLIST BIBL; Farjon A., 1999, STATUS SURVEY CONSER; Farjon A., 2008, NATURAL HIST CONIFER; Farjon A., 2013, IUCN 2013 IUCN RED L; Franchet A.R., 1899, J BOT, V13, P253; FRANKLIN JF, 1988, CAN J FOREST RES, V18, P633, DOI 10.1139/x88-093; Fu L.G., 1992, CHINA PLANT RED DATA, V1; GRIME JP, 1974, NATURE, V250, P26, DOI 10.1038/250026a0; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; GUAN Z-T, 1986, Acta Botanica Sinica, V28, P646; Hannah PR, 2004, NORTH J APPL FOR, V21, P173, DOI 10.1093/njaf/21.4.173; Havill N.P., 2011, IMPLEMENTATION STATU, P3; Hofmeyer PV, 2009, NORTH J APPL FOR, V26, P21, DOI 10.1093/njaf/26.1.21; HUZIOKA K, 1973, B NATL SCI MUSEUM TO, V18, P661; IUCN, 2013, IUCN RED LIST THREAT; Jin JQ, 2012, THESIS CHINESE ACAD; KELLY PE, 1992, INT J PLANT SCI, V153, P117, DOI 10.1086/297013; Kong W.-S., 1993, PLANT GEOGRAPHY KORE; Larouche C, 2010, NORTH J APPL FOR, V27, P5, DOI 10.1093/njaf/27.1.5; LARSON DW, 1991, CAN J BOT, V69, P1628, DOI 10.1139/b91-206; LePage BA, 2003, AM J BOT, V90, P167, DOI 10.3732/ajb.90.2.167; Li JH, 2005, J INTEGR PLANT BIOL, V47, P651, DOI 10.1111/j.1744-7909.2005.00087.x; Liu JF, 2013, INT J MOL SCI, V14, P14860, DOI 10.3390/ijms140714860; Liu JianFeng, 2004, Acta Agriculturae Universitatis Jiangxiensis, V26, P377; LIU KB, 1988, QUATERNARY SCI REV, V7, P1, DOI 10.1016/0277-3791(88)90089-3; Liu Z.Y., 2000, PLANT MAGAZINE, V3, P8; Lopez-Pujol J, 2011, J BIOGEOGR, V38, P1267, DOI 10.1111/j.1365-2699.2011.02504.x; Luo J, 1990, J SW TEACHERS U, V15, P266; Matthes-Sears U, 1999, INT J PLANT SCI, V160, P122, DOI 10.1086/314105; MATTHESSEARS U, 1995, INT J PLANT SCI, V156, P311, DOI 10.1086/297252; McCune B., 2011, PC ORD MULTIVARIATE; MCIVER EE, 1989, CAN J BOT, V67, P1903, DOI 10.1139/b89-242; MIKI SHIGERU, 1958, JOUR INST POLYTECH OSAKA CITY UNIV SER D BIOL, V9, P125; Milne RI, 2002, ADV BOT RES, V38, P281, DOI 10.1016/S0065-2296(02)38033-9; Minore D., 1983, PNWGTR150 USDA FOR S; Nakamura Y, 2005, CONIFEROUS FORESTS, P163; Nakane H, 1988, J FAC SCI SHINSHU U, V23, P33; Ohsawa M, 1984, PLANT ECOL, V57, P15; Peng D, 2008, MOL PHYLOGENET EVOL, V47, P1190, DOI 10.1016/j.ympev.2008.02.001; Qian H, 2000, NATURE, V407, P180, DOI 10.1038/35025052; Qiu YX, 2011, MOL PHYLOGENET EVOL, V59, P225, DOI 10.1016/j.ympev.2011.01.012; Sawada H, 1995, STUDY REGENERATION D, V93, P21; Schweitzer H. J., 1974, PALAEONTOGRAPHICA AB, V149, P1; [石玲 SHI Ling], 2009, [工程地质学报, Journal of Engineering Geology], V17, P212; SHI YF, 1986, QUATERNARY SCI REV, V5, P503; Tang CQ, 2013, AM J BOT, V100, P2112, DOI 10.3732/ajb.1300057; Tang CQ, 2012, AM J BOT, V99, P1408, DOI 10.3732/ajb.1200168; Tang CQ, 2011, BIOL CONSERV, V144, P279, DOI 10.1016/j.biocon.2010.09.003; Tang CQ, 2002, FOLIA GEOBOT, V37, P93, DOI 10.1007/BF02803193; THORNE RF, 1972, Q REV BIOL, V47, P365, DOI 10.1086/407399; TIFFNEY BH, 1985, J ARNOLD ARBORETUM, V66, P73, DOI 10.5962/bhl.part.13179; TIFFNEY BH, 1985, J ARNOLD ARBORETUM, V66, P243, DOI 10.5962/bhl.part.13183; Wang XiangFu, 2007, Forest Research, Beijing, V20, P673; Wen J, 1999, ANNU REV ECOL SYST, V30, P421, DOI 10.1146/annurev.ecolsys.30.1.421; Whittaker R. H., 1975, COMMUNITY ECOSYSTEM; WISHEU IC, 1992, J VEG SCI, V3, P147, DOI 10.2307/3235675; Xiang QP, 2002, BOT J LINN SOC, V140, P93	64	18	26	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125307	10.1371/journal.pone.0125307	http://dx.doi.org/10.1371/journal.pone.0125307			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928845	Green Submitted, Green Published, gold			2022-12-27	WOS:000353713100079
J	Wang, BQ; Gao, WJ; Yu, CQ; Cao, WH; Lv, J; Wang, SF; Pang, ZC; Cong, LM; Wang, H; Wu, XP; Li, LM				Wang, Biqi; Gao, Wenjing; Yu, Canqing; Cao, Weihua; Lv, Jun; Wang, Shengfeng; Pang, Zengchang; Cong, Liming; Wang, Hua; Wu, Xianping; Li, Liming			Determination of Zygosity in Adult Chinese Twins Using the 450K Methylation Array versus Questionnaire Data	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DNA METHYLATION; REGISTRY; DIAGNOSIS; UPDATE; BIRTH; YOUNG; PAIRS; AGE	Previous studies have shown that both single nucleotide polymorphisms (SNPs) and questionnaires-based method can be used for twin zygosity determination, but few validation studies have been conducted using Chinese populations. In the current study, we recruited 192 same sex Chinese adult twin pairs to evaluate the validity of using genetic markers-based method and questionnaire-based method in zygosity determination. We considered the relatedness analysis based on more than 0.6 million SNPs genotyping as the golden standards for zygosity determination. After quality control, qualified twins were left for relatedness analysis based on identical by descent calculation. Then those same sex twin pairs were included in the zygosity questionnaire validation analysis. Logistic regression model was applied to assess the discriminant ability of age, sex and the three questions in zygosity determination. Leave one out cross-validation was used as a measurement of internal validation. The results of zygosity determination based on 65 SNPs in 450k methylation array were all consistent with genotyping. Age, gender, questions of appearance confused by strangers and previously perceived zygosity consisted of the most predictable model with a consistency rate of 0.8698, cross validation predictive error of 0.1347. For twin studies with genotyping and\or 450k methylation array, there would be no need to conduct other zygosity testing for the sake of costs consideration.	[Wang, Biqi; Gao, Wenjing; Yu, Canqing; Cao, Weihua; Lv, Jun; Wang, Shengfeng; Li, Liming] Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100191, Peoples R China; [Pang, Zengchang] Qingdao Ctr Dis Control & Prevent, Qingdao 266033, Peoples R China; [Cong, Liming] Zhejiang Ctr Dis Control & Prevent, Hangzhou 310051, Zhejiang, Peoples R China; [Wang, Hua] Jiangsu Ctr Dis Control & Prevent, Nanjing 210009, Jiangsu, Peoples R China; [Wu, Xianping] Sichuan Ctr Dis Control & Prevent, Chengdu 610041, Peoples R China	Peking University; Jiangsu Provincial Center for Disease Control & Prevention	Li, LM (corresponding author), Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100191, Peoples R China.	lmlee@vip.163.com	Lv, Jun/O-4746-2019	Lv, Jun/0000-0001-7916-3870	National Natural Science Foundation of China [81202264]; Specific Research Project of Health Public Service, Ministry of Health, China [201002007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specific Research Project of Health Public Service, Ministry of Health, China	This work was supported by the National Natural Science Foundation of China (81202264) and the Specific Research Project of Health Public Service, Ministry of Health, China (201002007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell JT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3978; Butler John M, 2007, Forensic Sci Med Pathol, V3, P200, DOI 10.1007/s12024-007-0018-1; Chen J, 2010, TWIN RES HUM GENET, V13, P194, DOI 10.1375/twin.13.2.194; Chen WJ, 1999, BEHAV GENET, V29, P115, DOI 10.1023/A:1021660506222; Dedeurwaerder S, 2011, EPIGENOMICS-UK, V3, P771, DOI [10.2217/EPI.11.105, 10.2217/epi.11.105]; Derom C, 2013, TWIN RES HUM GENET, V16, P58, DOI 10.1017/thg.2012.75; Dick KJ, 2014, LANCET, V383, P1990, DOI 10.1016/S0140-6736(13)62674-4; Dixon LA, 2006, FORENSIC SCI INT, V164, P33, DOI 10.1016/j.forsciint.2005.11.011; Forsberg CW, 2010, TWIN RES HUM GENET, V13, P461, DOI 10.1375/twin.13.5.461; Gao WJ, 2006, TWIN RES HUM GENET, V9, P266, DOI 10.1375/twin.9.2.266; Gunn DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008021; Hannelius U, 2007, TWIN RES HUM GENET, V10, P604, DOI 10.1375/twin.10.4.604; Heath AC, 2003, TWIN RES, V6, P22, DOI 10.1375/twin.6.1.22; Hepler AB, 2005, PHESIS N CAROLINA ST; Heyn H, 2013, CARCINOGENESIS, V34, P102, DOI 10.1093/carcin/bgs321; HILL AVS, 1985, LANCET, V2, P1394; Hopper JL, 2013, TWIN RES HUM GENET, V16, P34, DOI 10.1017/thg.2012.121; Illumina, 2014, FREQ ASK QUEST; Jackson R W, 2001, Twin Res, V4, P12, DOI 10.1375/twin.4.1.12; JEFFREYS AJ, 1985, NATURE, V316, P76, DOI 10.1038/316076a0; Li LM, 2013, TWIN RES HUM GENET, V16, P86, DOI 10.1017/thg.2012.148; Lim CKP, 2012, J BIOCH MOL BIOL POS, V1; Magnusson PKE, 2013, TWIN RES HUM GENET, V16, P317, DOI 10.1017/thg.2012.104; Martino D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r42; Miller MB, 2012, TWIN RES HUM GENET, V15, P767, DOI 10.1017/thg.2012.62; Porcheron A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057985; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rexbye H, 2006, AGE AGEING, V35, P110, DOI 10.1093/ageing/afj031; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Schalkwyk L, 2012, NORMALIZING ILLUMINA; Skytthe A, 2011, SCAND J PUBLIC HEALT, V39, P75, DOI 10.1177/1403494810387966; Smits J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025239; Sobrino B, 2005, FORENSIC SCI INT, V154, P181, DOI 10.1016/j.forsciint.2004.10.020; Song YM, 2010, TWIN RES HUM GENET, V13, P223, DOI 10.1375/twin.13.3.223; Spitz E, 1996, BEHAV GENET, V26, P55, DOI 10.1007/BF02361159; Surakka I, 2012, TWIN RES HUM GENET, V15, P691, DOI 10.1017/thg.2012.63; Weir BS, 2006, NAT REV GENET, V7, P771, DOI 10.1038/nrg1960; Wolber LE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105729	38	13	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0123992	10.1371/journal.pone.0123992	http://dx.doi.org/10.1371/journal.pone.0123992			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927701	Green Published, Green Submitted, gold			2022-12-27	WOS:000353713100026
J	Wang, XM; Jiang, P; Wang, PQ; Yang, CS; Wang, XR; Feng, Q				Wang, Xuemin; Jiang, Pan; Wang, Pengqi; Yang, Chung S.; Wang, Xuerong; Feng, Qing			EGCG Enhances Cisplatin Sensitivity by Regulating Expression of the Copper and Cisplatin Influx Transporter CTR1 in Ovary Cancer	PLOS ONE			English	Article							ANTICANCER DRUG CISPLATIN; GREEN-TEA EGCG; CELLULAR ACCUMULATION; MOLECULAR-MECHANISMS; OXIDATIVE STRESS; NEPHROTOXICITY; CHEMOTHERAPY; POLYPHENOLS; CARCINOMA; CELLS	Cisplatin is one of the first-line platinum-based chemotherapeutic agents for treatment of many types of cancer, including ovary cancer. CTR1 (copper transporter 1), a transmembrane solute carrier transporter, has previously been shown to increase the cellular uptake and sensitivity of cisplatin. It is hypothesized that increased CTR1 expression would enhance the sensitivity of cancer cells to cisplatin (cDDP). The present study demonstrates for the first time that (-)-epigallocatechin-3-gallate (EGCG), a major polyphenol from green tea, can enhance CTR1 mRNA and protein expression in ovarian cancer cells and xenograft mice. EGCG inhibits the rapid degradation of CTR1 induced by cDDP. The combination of EGCG and cDDP increases the accumulation of cDDP and DNA-Pt adducts, and subsequently enhances the sensitivity of ovarian cancer SKOV3 and OVCAR3 cells to the chemotherapeutic agent. In the OVCAR3 ovarian cancer xenograft nude mice model, the combination of the lower concentration of cDDP and EGCG strongly repressed the tumor growth and exhibited protective effect on the nephrotoxicity induced by cisplatin. Overall, these findings uncover a novel chemotherapy mechanism of EGCG as an adjuvant for the treatment of ovarian cancer.	[Wang, Xuemin; Jiang, Pan; Wang, Pengqi; Feng, Qing] Nanjing Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Key Lab Toxicol, Nanjing, Jiangsu, Peoples R China; [Yang, Chung S.] Rutgers State Univ, Ctr Canc Prevent Res, Ernest Mario Sch Pharm, Dept Biol Chem, Piscataway, NJ USA; [Wang, Xuerong] Nanjing Med Univ, Sch Basic Med Sci, Dept Pharmacol, Nanjing, Jiangsu, Peoples R China; [Wang, Xuemin] Beijing Res Inst Nutr Resources, Beijing, Peoples R China	Nanjing Medical University; Rutgers State University New Brunswick; Nanjing Medical University	Feng, Q (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Key Lab Toxicol, Nanjing, Jiangsu, Peoples R China.	qingfeng@njmu.edu.cn			National Natural Science Foundation of China [81472977]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry [HG11-4302]; Foundation from Priority Academic Program Development of Jiangsu Higher Education Institutions; Foundation from Six Big Talent Peak of Jiangsu Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Foundation from Priority Academic Program Development of Jiangsu Higher Education Institutions; Foundation from Six Big Talent Peak of Jiangsu Province	This work was supported by National Natural Science Foundation of China (81472977), Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (HG11-4302), Foundation from Priority Academic Program Development of Jiangsu Higher Education Institutions, and Foundation from Six Big Talent Peak of Jiangsu Province.	Blair BG, 2011, MOL PHARMACOL, V79, P157, DOI 10.1124/mol.110.068411; Blair BG, 2010, MOL PHARMACOL, V77, P912, DOI 10.1124/mol.109.062836; Blair BG, 2009, CLIN CANCER RES, V15, P4312, DOI 10.1158/1078-0432.CCR-09-0311; Chan MM, 2006, J CELL PHYSIOL, V207, P389, DOI 10.1002/jcp.20569; Chen HHW, 2013, ANTICANCER RES, V33, P4157; Chen HP, 2013, J ONCOL, V2013, DOI 10.1155/2013/872957; Ciarimboli G, 2005, AM J PATHOL, V167, P1477, DOI 10.1016/S0002-9440(10)61234-5; Ciarimboli G, 2010, AM J PATHOL, V176, P1169, DOI 10.2353/ajpath.2010.090610; Deng PB, 2013, CHIN J NAT MEDICINES, V11, P245, DOI [10.3724/SP.J.1009.2013.00245, 10.1016/S1875-5364(13)60023-0]; El-Mowafy AM, 2011, NAT PROD RES, V25, P850, DOI 10.1080/14786419.2010.533669; El-Mowafy AM, 2010, PHYTOMEDICINE, V17, P1067, DOI 10.1016/j.phymed.2010.08.004; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Guo Y, 2004, J BIOL CHEM, V279, P17428, DOI 10.1074/jbc.M401493200; Hagen RM, 2013, INT J ONCOL, V43, P194, DOI 10.3892/ijo.2013.1920; Hall MD, 2008, ANNU REV PHARMACOL, V48, P495, DOI 10.1146/annurev.pharmtox.48.080907.180426; Holzer AK, 2004, CLIN CANCER RES, V10, P6744, DOI 10.1158/1078-0432.CCR-04-0748; Holzer AK, 2004, MOL PHARMACOL, V66, P817, DOI 10.1124/mol.104.001198; Holzer AK, 2006, CANCER RES, V66, P10944, DOI 10.1158/0008-5472.CAN-06-1710; Garces AHI, 2015, CANCER CHEMOTH PHARM, V75, P221, DOI 10.1007/s00280-014-2581-y; Ishida S, 2002, P NATL ACAD SCI USA, V99, P14298, DOI 10.1073/pnas.162491399; Ishida S, 2010, CANCER CELL, V17, P574, DOI 10.1016/j.ccr.2010.04.011; Jamieson ER, 1999, CHEM REV, V99, P2467, DOI 10.1021/cr980421n; Jandial DD, 2009, CLIN CANCER RES, V15, P553, DOI 10.1158/1078-0432.CCR-08-2081; Larson CA, 2009, MOL PHARMACOL, V75, P324, DOI 10.1124/mol.108.052381; Lecumberri E, 2013, CLIN NUTR, V32, P894, DOI 10.1016/j.clnu.2013.03.008; Lee J, 2002, J BIOL CHEM, V277, P40253, DOI 10.1074/jbc.M208002200; Lee SH, 2013, EUR J CANCER, V49, P3210, DOI 10.1016/j.ejca.2013.06.025; Liang ZD, 2012, MOL CANCER THER, V11, P2483, DOI 10.1158/1535-7163.MCT-12-0580; Liang ZD, 2012, MOL PHARMACOL, V81, P455, DOI 10.1124/mol.111.076422; Lin XJ, 2002, MOL PHARMACOL, V62, P1154, DOI 10.1124/mol.62.5.1154; Mei L, 2013, COCHRANE DB SYST REV, V6, pD7414; Molloy SA, 2009, J BIOL CHEM, V284, P29704, DOI 10.1074/jbc.M109.000166; Mortenson MM, 2004, CANCER CHEMOTH PHARM, V54, P343, DOI 10.1007/s00280-004-0811-4; Nakayama K, 2002, INT J CANCER, V101, P488, DOI 10.1002/ijc.10608; Nam S, 2001, J BIOL CHEM, V276, P13322, DOI 10.1074/jbc.M004209200; Noordhuis P, 2008, BIOCHEM PHARMACOL, V76, P53, DOI 10.1016/j.bcp.2008.04.007; Safaei R, 2006, CANCER LETT, V234, P34, DOI 10.1016/j.canlet.2005.07.046; Safaei R, 2009, J INORG BIOCHEM, V103, P333, DOI 10.1016/j.jinorgbio.2008.11.012; Sahin K, 2010, LIFE SCI, V87, P240, DOI 10.1016/j.lfs.2010.06.014; Samimi G, 2003, CLIN CANCER RES, V9, P5853; Shen M, 2012, ANTI-CANCER AGENT ME, V12, P891, DOI 10.2174/187152012802649978; Shervington A, 2009, MOL BIOL REP, V36, P1181, DOI 10.1007/s11033-008-9295-3; Song IS, 2008, MOL PHARMACOL, V74, P705, DOI 10.1124/mol.108.046771; Tsigelny IF, 2012, CELL BIOCHEM BIOPHYS, V63, P223, DOI 10.1007/s12013-012-9358-x; Yang CS, 2014, J BIOMED RES, V28, P447, DOI 10.7555/JBR.28.20140079; Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641; Yang H, 2011, CURR CANCER DRUG TAR, V11, P296, DOI 10.2174/156800911794519743; Yonezawa A, 2005, BIOCHEM PHARMACOL, V70, P1823, DOI 10.1016/j.bcp.2005.09.020; Zhou DH, 2014, NUTR CANCER, V66, P636, DOI 10.1080/01635581.2014.894101	49	38	40	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125402	10.1371/journal.pone.0125402	http://dx.doi.org/10.1371/journal.pone.0125402			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927922	gold, Green Published, Green Submitted			2022-12-27	WOS:000353713100088
J	Wojcik, M; Lewandowski, W; Krol, M; Pawlowski, K; Mieczkowski, J; Lechowski, R; Zabielska, K				Wojcik, Michal; Lewandowski, Wiktor; Krol, Magdalena; Pawlowski, Karol; Mieczkowski, Jozef; Lechowski, Roman; Zabielska, Katarzyna			Enhancing Anti-Tumor Efficacy of Doxorubicin by Non-Covalent Conjugation to Gold Nanoparticles - In Vitro Studies on Feline Fibrosarcoma Cell Lines	PLOS ONE			English	Article							TARGETED DRUG-DELIVERY; MULTIDRUG-RESISTANCE; CANCER-CELLS; TOXICITY; SYSTEMS; CYCLODEXTRINS; CHEMOTHERAPY; COMBINATION; SARCOMAS; RELEASE	Background Feline injection-site sarcomas are malignant skin tumors of mesenchymal origin, the treatment of which is a challenge for veterinary practitioners. Methods of treatment include radical surgery, radiotherapy and chemotherapy. The most commonly used cytostatic drugs are cyclophosphamide, doxorubicin and vincristine. However, the use of cytostatics as adjunctive treatment is limited due to their adverse side-effects, low biodistribution after intravenous administration and multidrug resistance. Colloid gold nanoparticles are promising drug delivery systems to overcome multidrug resistance, which is a main cause of ineffective chemotherapy treatment. The use of colloid gold nanoparticles as building blocks for drug delivery systems is preferred due to ease of surface functionalization with various molecules, chemical stability and their low toxicity. Methods Stability and structure of the glutathione-stabilized gold nanoparticles non-covalently modified with doxorubicin (Au-GSH-Dox) was confirmed using XPS, TEM, FT-IR, SAXRD and SAXS analyses. MTT assay, Annexin V and Propidium Iodide Apoptosis assay and Rhodamine 123 and Verapamil assay were performed on 4 feline fibrosarcoma cell lines (FFS1WAW, FFS1, FFS3, FFS5). Statistical analyses were performed using Graph Pad Prism 5.0 (USA). Results A novel approach, glutathione-stabilized gold nanoparticles (4.3 +/- 1.1 nm in diameter) non-covalently modified with doxorubicin (Au-GSH-Dox) was designed and synthesized. A higher cytotoxic effect (p<0.01) of Au-GSH-Dox than that of free doxorubicin has been observed in 3 (FFS1, FFS3, FFS1WAW) out of 4 feline fibrosarcoma cell lines. The effect has been correlated to the activity of glycoprotein P (main efflux pump responsible for multidrug resistance). Conclusions The results indicate that Au-GSH-Dox may be a potent new therapeutic agent to increase the efficacy of the drug by overcoming the resistance to doxorubicin in feline fibrosarcoma cell lines. Moreover, as doxorubicin is non-covalently attached to glutathione coated nanoparticles the synthesized system is potentially suitable to a wealth of different drug molecules.	[Wojcik, Michal; Lewandowski, Wiktor; Mieczkowski, Jozef] Univ Warsaw, Fac Chem, Warsaw, Poland; [Krol, Magdalena; Pawlowski, Karol; Lechowski, Roman; Zabielska, Katarzyna] Warsaw Univ Life Sci, Fac Vet Med, Warsaw, Poland	University of Warsaw; Warsaw University of Life Sciences	Wojcik, M (corresponding author), Univ Warsaw, Fac Chem, Warsaw, Poland.	mwojcik@chem.uw.edu.pl; katarzyna_zabielska@sggw.pl	Lewandowski, Wiktor/F-5639-2011; Zabielska-Koczywąs, Katarzyna/AFU-6510-2022; Zabielska-Koczywąs, Katarzyna Agnieszka/AAS-8153-2021; Krol, Magdalena/A-5554-2019	Lewandowski, Wiktor/0000-0002-3503-2120; Zabielska-Koczywąs, Katarzyna Agnieszka/0000-0003-1691-3982; Pawlowski, Karol/0000-0003-4565-2873; Krol, Magdalena/0000-0003-0421-5167; Lechowski, Roman/0000-0002-1121-4288	Polish National Science Centre [2013/09/D/ST5/03875, DEC-2012/07/N/NZ4/02413, 2011/01/N/ST5/0329]	Polish National Science Centre	The authors would like to acknowledge support by the Polish National Science Centre (Project 2013/09/D/ST5/03875 [WL], Project No. DEC-2012/07/N/NZ4/02413 [KZ], and Project 2011/01/N/ST5/0329[MW]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2013, ADV DRUG DELIVER REV, V65, P36, DOI 10.1016/j.addr.2012.09.037; Aryal S, 2009, J MATER CHEM, V19, P7879, DOI 10.1039/b914071a; Asadishad B, 2010, IND ENG CHEM RES, V49, P1958, DOI 10.1021/ie9011479; Barber LG, 2000, J AM ANIM HOSP ASSOC, V36, P416, DOI 10.5326/15473317-36-5-416; Boisselier E, 2009, CHEM SOC REV, V38, P1759, DOI 10.1039/b806051g; Bregazzi VS, 2001, J AM VET MED ASSOC, V218, P547, DOI 10.2460/javma.2001.218.547; Challa R, 2005, AAPS PHARMSCITECH, V6, DOI 10.1208/pt060243; Chang DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083239; Chen HY, 2012, BIOMATERIALS, V33, P8461, DOI 10.1016/j.biomaterials.2012.08.034; Chen L, 2014, SENSOR ACTUAT B-CHEM, V193, P857, DOI 10.1016/j.snb.2013.12.053; Cho KJ, 2008, CLIN CANCER RES, V14, P1310, DOI 10.1158/1078-0432.CCR-07-1441; Connor EE, 2005, SMALL, V1, P325, DOI 10.1002/smll.200400093; de Oliveira R, 2013, INT J PHARMACEUT, V454, P703, DOI 10.1016/j.ijpharm.2013.05.031; Ding Y, 2013, BIOMATERIALS, V34, P10217, DOI 10.1016/j.biomaterials.2013.09.008; Doane TL, 2012, CHEM SOC REV, V41, P2885, DOI 10.1039/c2cs15260f; Duncan B, 2010, J CONTROL RELEASE, V148, P122, DOI 10.1016/j.jconrel.2010.06.004; Farokhzad OC, 2009, ACS NANO, V3, P16, DOI 10.1021/nn900002m; Goodman CM, 2004, BIOCONJUGATE CHEM, V15, P897, DOI 10.1021/bc049951i; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Gu YJ, 2012, NANOMED-NANOTECHNOL, V8, P204, DOI 10.1016/j.nano.2011.06.005; Gulyaev AE, 1999, PHARM RES-DORDR, V16, P1564, DOI 10.1023/A:1018983904537; Hahn KA, 2007, JAVMA-J AM VET MED A, V231, P742, DOI 10.2460/javma.231.5.742; Janes KA, 2001, J CONTROL RELEASE, V73, P255, DOI 10.1016/S0168-3659(01)00294-2; Joshi P, 2011, J COLLOID INTERF SCI, V355, P402, DOI 10.1016/j.jcis.2010.12.032; Kayal S, 2010, J NANOSCI NANOTECHNO, V10, P5527, DOI 10.1166/jnn.2010.2461; LAMPIDIS TJ, 1985, CANCER RES, V45, P2626; Manju S, 2012, J COLLOID INTERF SCI, V368, P144, DOI 10.1016/j.jcis.2011.11.024; Martano M, 2011, VET J, V188, P136, DOI 10.1016/j.tvjl.2010.04.025; Meng HA, 2010, ACS NANO, V4, P4539, DOI 10.1021/nn100690m; Mimeault M, 2008, CLIN PHARMACOL THER, V83, P673, DOI 10.1038/sj.clpt.6100296; Minati L, 2012, INT J PHARMACEUT, V438, P45, DOI 10.1016/j.ijpharm.2012.08.057; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Murphy CJ, 2008, ACCOUNTS CHEM RES, V41, P1721, DOI 10.1021/ar800035u; Palmeira A, 2012, J PHARM PHARM SCI, V15, P31, DOI 10.18433/J3BG65; Pan Y, 2007, SMALL, V3, P1941, DOI 10.1002/smll.200700378; Pan Y, 2009, SMALL, V5, P2067, DOI 10.1002/smll.200900466; Pawlowski KM, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-119; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Poirier VJ, 2002, J VET INTERN MED, V16, P726, DOI 10.1111/j.1939-1676.2002.tb02415.x; Riss T.L., CELL VIABILITY ASSAY; Samad Abdus, 2007, Current Drug Delivery, V4, P297, DOI 10.2174/156720107782151269; Sapsford KE, 2013, CHEM REV, V113, P1904, DOI 10.1021/cr300143v; Schroeder A, 2012, NAT REV CANCER, V12, P39, DOI 10.1038/nrc3180; Simpson CA, 2013, NANOMED-NANOTECHNOL, V9, P257, DOI 10.1016/j.nano.2012.06.002; Tiwari G, 2010, J PHARM BIOALLIED SC, V2, P72, DOI 10.4103/0975-7406.67003; Tom RT, 2004, LANGMUIR, V20, P1909, DOI 10.1021/la0358567; von Erichsen J, 2012, VET PATHOL, V49, P648, DOI 10.1177/0300985811406887; Wang BY, 2014, BIOMATERIALS, V35, P5897, DOI 10.1016/j.biomaterials.2014.03.068; Wang F, 2011, ACS NANO, V5, P3679, DOI 10.1021/nn200007z; Williams LE, 2001, AM J VET RES, V62, P1354, DOI 10.2460/ajvr.2001.62.1354; Wu ZK, 2011, ADV FUNCT MATER, V21, P177, DOI 10.1002/adfm.201001120; Xie Y, 2014, BIOMATERIALS, V35, P7978, DOI 10.1016/j.biomaterials.2014.05.068; Zabielska K, 2012, VET RES COMMUN, V36, P227, DOI 10.1007/s11259-012-9535-9; Zhang XK, 2009, BIOMATERIALS, V30, P6041, DOI 10.1016/j.biomaterials.2009.07.025; Zhang XA, 2011, BIOCONJUGATE CHEM, V22, P235, DOI 10.1021/bc100374p; Zhou LJ, 2014, BIOMATERIALS, V35, P7666, DOI 10.1016/j.biomaterials.2014.05.051; Zhu D, 2014, RSC ADV, V4, P9372, DOI 10.1039/c3ra45491f	57	28	29	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124955	10.1371/journal.pone.0124955	http://dx.doi.org/10.1371/journal.pone.0124955			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928423	Green Published, Green Submitted, gold			2022-12-27	WOS:000353713100055
J	Mahmoud, SH; Alazba, AA				Mahmoud, Shereif H.; Alazba, A. A.			Hydrological Response to Land Cover Changes and Human Activities in Arid Regions Using a Geographic Information System and Remote Sensing	PLOS ONE			English	Article							MOISTURE ACCOUNTING PROCEDURE; BENIN WEST-AFRICA; CURVE-NUMBER; RUNOFF COEFFICIENT; RIVER-BASIN; GIS; MODELS; CATCHMENT; RAINFALL; CHINA	The hydrological response to land cover changes induced by human activities in arid regions has attracted increased research interest in recent decades. The study reported herein assessed the spatial and quantitative changes in surface runoff resulting from land cover change in the Al-Baha region of Saudi Arabia between 1990 and 2000 using an ArcGIS-surface runoff model and predicted land cover and surface runoff depth in 2030 using Markov chain analysis. Land cover maps for 1990 and 2000 were derived from satellite images using ArcGIS 10.1. The findings reveal a 26% decrease in forest and shrubland area, 28% increase in irrigated cropland, 1.5% increase in sparsely vegetated land and 0.5% increase in bare soil between 1990 and 2000. Overall, land cover changes resulted in a significant decrease in runoff depth values in most of the region. The decrease in surface runoff depth ranged from 25-106 mm/year in a 7020-km(2) area, whereas the increase in such depth reached only 10 mm/year in a 243-km(2) area. A maximum increase of 73 mm/year was seen in a limited area. The surface runoff depth decreased to the greatest extent in the central region of the study area due to the huge transition in land cover classes associated with the construction of 25 rainwater harvesting dams. The land cover prediction revealed a greater than twofold increase in irrigated cropland during the 2000-2030 period, whereas forest and shrubland are anticipated to occupy just 225 km(2) of land area by 2030, a significant decrease from the 747 km(2) they occupied in 2000. Overall, changes in land cover are predicted to result in an annual increase in irrigated cropland and dramatic decline in forest area in the study area over the next few decades. The increase in surface runoff depth is likely to have significant implications for irrigation activities.	[Mahmoud, Shereif H.; Alazba, A. A.] King Saud Univ, Alamoudi Water Res Chair, Riyadh 11451, Saudi Arabia	King Saud University	Mahmoud, SH (corresponding author), King Saud Univ, Alamoudi Water Res Chair, POB 2460, Riyadh 11451, Saudi Arabia.	shmahmoud@ksu.edu.sa	Mahmoud, Shereif/D-8810-2016	Mahmoud, Shereif/0000-0003-1798-3317	King Saud University, Deanship of Scientific Research, College of Food, and Agricultural Sciences Research Center	King Saud University, Deanship of Scientific Research, College of Food, and Agricultural Sciences Research Center	This project received financial support from King Saud University, Deanship of Scientific Research, College of Food, and Agricultural Sciences Research Center. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuelgasim AA, 1999, REMOTE SENS ENVIRON, V70, P208, DOI 10.1016/S0034-4257(99)00039-5; [Anonymous], 2004, NAT ENG HDB; Arsanjani JJ, 2011, INT J IMAGE DATA FUS, V2, P329, DOI 10.1080/19479832.2011.605397; Baldyga TJ, 2008, AFR J ECOL, V46, P46, DOI 10.1111/j.1365-2028.2007.00806.x; Bormann H, 2003, PHYS CHEM EARTH, V28, P1323, DOI 10.1016/j.pce.2003.09.008; Bormann H, 2007, ECOL MODEL, V209, P29, DOI 10.1016/j.ecolmodel.2007.07.004; Boughton W., 1989, SOIL RES, V27, P511; Brown DG, 2000, J ENVIRON MANAGE, V59, P247, DOI 10.1006/jema.2000.0369; Browne FX, 1990, STANDARD HDB ENV ENG, V7, P1; Campbell JB, 2002, INTRODUCTION TO REMO; Cermak RJ, 1979, TECHNICAL PAPER NO 6; Cheng QM, 2006, COMPUT GEOSCI-UK, V32, P1108, DOI 10.1016/j.cageo.2006.02.005; Costache R, 2014, CENT EUR J GEOSCI, V6, P363, DOI 10.2478/s13533-012-0181-0; de Winnaar G, 2007, PHYS CHEM EARTH, V32, P1058, DOI 10.1016/j.pce.2007.07.009; Dile YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079296; Durbude DG, 2011, HYDROL PROCESS, V25, P561, DOI 10.1002/hyp.7789; EASTMAN J. R, 2006, IDRISI ANDES GUIDE T; Edwards TC, 1996, CONSERV BIOL, V10, P263, DOI 10.1046/j.1523-1739.1996.10010263.x; Fan FL, 2008, ENVIRON MONIT ASSESS, V137, P127, DOI 10.1007/s10661-007-9734-y; Fetter CW, 2001, APPLIED HYDROGEOLOGY, V3; Giertz S, 2003, PHYS CHEM EARTH, V28, P1333, DOI 10.1016/j.pce.2003.09.009; Githui F.W., 2022, LAKE VICTORIA BASIN; Grimaldi S, 2013, HYDROL PROCESS, V27, P1253, DOI 10.1002/hyp.9303; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hathout S, 2002, J ENVIRON MANAGE, V66, P229, DOI 10.1006/jema.2002.0596; Helmschrot J, 2002, PHYS CHEM EARTH, V27, P711, DOI 10.1016/S1474-7065(02)00055-4; Hernandez M, 2000, ENVIRON MONIT ASSESS, V64, P285, DOI 10.1023/A:1006445811859; Hernandez-Guzman R, 2008, J ENVIRON SCI HEAL A, V43, P1471, DOI 10.1080/10934520802253465; Hormann G, 2005, ECOL MODEL, V187, P3, DOI 10.1016/j.ecolmodel.2005.01.022; Howat IM, 2014, CRYOSPHERE, V8, P1509, DOI 10.5194/tc-8-1509-2014; HUDSON WD, 1987, PHOTOGRAMM ENG REM S, V53, P421; Jensen J.R., 2005, PRENTICE HALL SERIES; JENSEN JR, 1996, INTRODUCTORY DIGITAL; Kepner WG, 2007, NATO SCI PEACE SECUR, P237, DOI 10.1007/978-1-4020-6594-1_16; Kiage LM, 2007, INT J REMOTE SENS, V28, P4285, DOI 10.1080/01431160701241753; Kirkby MJ, 1979, HYDROLOG SCI J, V24, P43; Lambin EF, 1997, PROG PHYS GEOG, V21, P375, DOI 10.1177/030913339702100303; Lan X, 1993, J APPL ECOL, V3, P272; Legesse D, 2003, J HYDROL, V275, P67, DOI 10.1016/S0022-1694(03)00019-2; Lillesand T., 2004, REMOTE SENSING AND I; Liu Y.B., 2004, WETSPA EXTENSION GIS, P1; Liu YB, 2004, DEVELOPMENT AND APPL, P315; Lopez E, 2001, LANDSCAPE URBAN PLAN, V55, P271, DOI 10.1016/S0169-2046(01)00160-8; Lu D, 2007, INT J REMOTE SENS, V28, P823, DOI 10.1080/01431160600746456; Ma X, 2009, HYDROL PROCESS, V23, P1179, DOI 10.1002/hyp.7233; Mahmoud SH, 2015, ARAB J GEOSCI, V8, P5167, DOI 10.1007/s12517-014-1535-3; Mahmoud SH, 2015, HYDROL RES, V46, P591, DOI 10.2166/nh.2014.054; Mahmoud SH, 2014, ENVIRON EARTH SCI, V72, P3429, DOI 10.1007/s12665-014-3249-y; Mahmoud SH, 2014, WATER RESOUR MANAG, V28, P3319, DOI 10.1007/s11269-014-0681-4; Mahmoud SH, 2014, CATENA, V120, P111, DOI 10.1016/j.catena.2014.04.011; Mahmoud SH, 2014, ARAB J GEOSCI, V7, P2041, DOI 10.1007/s12517-014-1303-4; McCoy RM, 2005, FIELD METHODS IN REM; Mengistu K. T., 2009, THESIS; Michel C, 2005, WATER RESOUR RES, V41, DOI 10.1029/2004WR003191; Miller SN, 2007, ENVIRON MODELL SOFTW, V22, P365, DOI 10.1016/j.envsoft.2005.12.004; MONTEITH JL, 1965, STATE MOVEMENT WATER, P205; MULLER MR, 1994, LANDSCAPE ECOL, V9, P151; Munoz-Villers LE, 2008, INT J REMOTE SENS, V29, P71, DOI 10.1080/01431160701280967; Myint SW, 2006, CAN J REMOTE SENS, V32, P390, DOI 10.5589/m06-032; Penman H. L., 1953, REP 13 INT HORT C, VII, P913; Penman HL, 1948, J MATH PHYS SCI SERI, V193, P120; Petit C, 2001, INT J REMOTE SENS, V22, P3435, DOI 10.1080/01431160010006881; Petrosillo I, 2008, NATO SECURITY THROUG; PILON PG, 1988, PHOTOGRAMM ENG REM S, V54, P1709; Ponce VM, 1996, J HYDROL ENG, V1, P11, DOI 10.1061/(ASCE)1084-0699(1996)1:1(11); Ravazzani G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109053; Reis S, 2008, SENSORS-BASEL, V8, P6188, DOI 10.3390/s8106188; Sahin V, 1996, J HYDROL, V178, P293, DOI 10.1016/0022-1694(95)02825-0; Savary S, 2009, J HYDROL ENG, V14, P575, DOI 10.1061/(ASCE)HE.1943-5584.0000024; SCOTT JM, 1993, WILDLIFE MONOGR, P1; Senay GB, 2004, APPL ENG AGRIC, V20, P789; Sharma T, 2001, INT J REMOTE SENS, V22, P2095, DOI 10.1080/014311601300190622; Sirikulchayanon P, 2008, INT J REMOTE SENS, V29, P3553, DOI 10.1080/01431160701646332; TURNER BL, 1994, AMBIO, V23, P91; Viglione A, 2009, HYDROL EARTH SYST SC, V13, P577, DOI 10.5194/hess-13-577-2009; Weng QH, 2002, J ENVIRON MANAGE, V64, P273, DOI 10.1006/jema.2001.0509; Wu Q, 2006, LANDSCAPE URBAN PLAN, V78, P322, DOI 10.1016/j.landurbplan.2005.10.002; Yang XL, 2014, J ARID LAND, V6, P678, DOI 10.1007/s40333-014-0026-4	79	32	33	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125805	10.1371/journal.pone.0125805	http://dx.doi.org/10.1371/journal.pone.0125805			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923712	gold, Green Submitted, Green Published			2022-12-27	WOS:000353711600162
J	Quan, C; Xie, BX; Wang, HY; Chen, S				Quan, Chao; Xie, Bingxian; Wang, Hong Yu; Chen, Shuai			PKB-Mediated Thr(649) Phosphorylation of AS160/TBC1D4 Regulates the R-Wave Amplitude in the Heart	PLOS ONE			English	Article							GLUT4 TRANSLOCATION; RAB GTPASE; MYOCARDIAL-INFARCTION; PLASMA-MEMBRANE; INSULIN; AS160; AKT; TRAFFICKING; SENSITIVITY; DEFICIENCY	The Rab GTPase activating protein (RabGAP), AS160/TBC1D4, is an important substrate of protein kinase B (PKB), and regulates insulin-stimulated trafficking of glucose transporter 4. Besides, AS160/TBC1D4 has also been shown to regulate trafficking of many other membrane proteins including FA translocase/CD36 in cardiomyocytes. However, it is not clear whether it plays any role in regulating heart functions in vivo. Here, we found that PKB-mediated phosphorylation of Thr(649) on AS160/TBC1D4 represented one of the major PASbinding signals in the heart in response to insulin. Mutation of Thr(649) to a non-phosphorylatable alanine increased the R-wave amplitude in the AS160(Thr649Ala) knockin mice. However, this knockin mutation did not affect the heart functions under both normal and infarct conditions. Interestingly, myocardial infarction induced the expression of a related RabGAP, TBC1D1, in the infarct zone as well as in the border zone. Together, these data show that the Thr(649) phosphorylation of AS160/TBC1D4 plays an important role in the heart's electrical conduction system through regulating the R-wave amplitude.	[Quan, Chao; Xie, Bingxian; Wang, Hong Yu; Chen, Shuai] Nanjing Univ, Nanjing Biomed Res Inst, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing 210061, Jiangsu, Peoples R China	Nanjing University	Wang, HY (corresponding author), Nanjing Univ, Nanjing Biomed Res Inst, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing 210061, Jiangsu, Peoples R China.	wanghy@nicemice.cn; schen6@163.com	Xie, Bingxian/Y-6487-2019		Ministry of Science and Technology of China [2014CB964704]; Ministry of Science and Technology of China (National Key Scientific Research Program of China); National Natural Science Foundation of China [31271498]; Ministry of Education of China [20120091120048, NCET-13-0270]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Science and Technology of China (National Key Scientific Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China)	This work was supported by the Ministry of Science and Technology of China (Grant No. 2014CB964704; the National Key Scientific Research Program of China to SC), the National Natural Science Foundation of China (Grant No. 31271498 to SC), and the Ministry of Education of China (Grant Nos. 20120091120048 and NCET-13-0270 to SC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belke DD, 2002, J CLIN INVEST, V109, P629, DOI 10.1172/JCI200213946; Chang Z, 2010, DEV BIOL, V347, P384, DOI 10.1016/j.ydbio.2010.08.033; Chen SA, 2008, BIOCHEM J, V409, P449, DOI 10.1042/BJ20071114; Chen SA, 2011, CELL METAB, V13, P68, DOI 10.1016/j.cmet.2010.12.005; Comellas AP, 2010, J CELL SCI, V123, P1343, DOI 10.1242/jcs.066464; DeBosch B, 2006, CIRCULATION, V113, P2097, DOI 10.1161/CIRCULATIONAHA.105.595231; DeBosch B, 2006, J BIOL CHEM, V281, P32841, DOI 10.1074/jbc.M513087200; Di RM, 2012, BIOCHEM J, V441, P199, DOI 10.1042/BJ20110033; Ducommun S, 2012, AM J PHYSIOL-ENDOC M, V302, pE1036, DOI 10.1152/ajpendo.00379.2011; Geraghty KM, 2007, BIOCHEM J, V407, P231, DOI 10.1042/BJ20070649; Kim HY, 2011, AM J PHYSIOL-RENAL, V301, pF151, DOI 10.1152/ajprenal.00519.2010; Laustsen PG, 2007, MOL CELL BIOL, V27, P1649, DOI 10.1128/MCB.01110-06; Liang XB, 2010, MOL BIOL CELL, V21, P2024, DOI 10.1091/mbc.E10-01-0042; Malmberg K, 1996, EUR HEART J, V17, P1337; Mazzaro Cdo L, 2008, ARQ BRAS CARDIOL, V90, P227; Mora A, 2003, EMBO J, V22, P4666, DOI 10.1093/emboj/cdg469; Muniyappa R, 2007, ENDOCR REV, V28, P463, DOI 10.1210/er.2007-0006; Ramm G, 2006, J BIOL CHEM, V281, P29174, DOI 10.1074/jbc.M603274200; Roach WG, 2007, BIOCHEM J, V403, P353, DOI 10.1042/BJ20061798; Samovski D, 2012, J LIPID RES, V53, P709, DOI 10.1194/jlr.M023424; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sena S, 2009, J MOL CELL CARDIOL, V46, P910, DOI 10.1016/j.yjmcc.2009.02.014; von Bibra Helene, 2011, Curr Heart Fail Rep, V8, P242, DOI 10.1007/s11897-011-0070-8; Wang HY, 2013, BIOCHEM J, V449, P479, DOI 10.1042/BJ20120702	24	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124491	10.1371/journal.pone.0124491	http://dx.doi.org/10.1371/journal.pone.0124491			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923736	gold, Green Published, Green Submitted			2022-12-27	WOS:000353711600089
J	Sorhus, E; Edvardsen, RB; Karlsen, O; Nordtug, T; van der Meeren, T; Thorsen, A; Harman, C; Jentoft, S; Meier, S				Sorhus, Elin; Edvardsen, Rolf B.; Karlsen, Orjan; Nordtug, Trond; van der Meeren, Terje; Thorsen, Anders; Harman, Christopher; Jentoft, Sissel; Meier, Sonnich			Unexpected Interaction with Dispersed Crude Oil Droplets Drives Severe Toxicity in Atlantic Haddock Embryos	PLOS ONE			English	Article							EARLY-LIFE STAGES; POLYCYCLIC AROMATIC-HYDROCARBONS; WATER-SOLUBLE FRACTION; FISH EMBRYOS; PINK SALMON; ONCORHYNCHUS-GORBUSCHA; EXXON-VALDEZ; AH RECEPTOR; LARVAE; CYTOCHROME-P4501A	The toxicity resulting from exposure to oil droplets in marine fish embryos and larvae is still subject for debate. The most detailed studies have investigated the effects of water-dissolved components of crude oil in water accommodated fractions (WAFs) that lack bulk oil droplets. Although exposure to dissolved petroleum compounds alone is sufficient to cause the characteristic developmental toxicity of crude oil, few studies have addressed whether physical interaction with oil micro-droplets are a relevant exposure pathway for open water marine speices. Here we used controlled delivery of mechanically dispersed crude oil to expose pelagic embryos and larvae of a marine teleost, the Atlantic haddock (Melanogrammus aeglefinus). Haddock embryos were exposed continuously to two different concentrations of dispersed crude oil, high and low, or in pulses. By 24 hours of exposure, micro-droplets of oil were observed adhering and accumulating on the chorion, accompanied by highly elevated levels of cyp1a, a biomarker for exposure to aromatic hydrocarbons. Embryos from all treatment groups showed abnormalities representative of crude oil cardiotoxicity at hatch (5 days of exposure), such as pericardial and yolk sac edema. Compared to other species, the frequency and severity of toxic effects was higher than expected for the waterborne PAH concentrations (e.g., 100% of larvae had edema at the low treatment). These findings suggest an enhanced tissue uptake of PAHs and/or other petroleum compounds from attached oil droplets. These studies highlight a novel property of haddock embryos that leads to greater than expected impact from dispersed crude oil. Given the very limited number of marine species tested in similar exposures, the likelihood of other species with similar properties could be high. This unanticipated result therefore has implications for assessing the ecological impacts of oil spills and the use of methods for dispersing oil in the open sea.	[Sorhus, Elin; Edvardsen, Rolf B.; Thorsen, Anders; Meier, Sonnich] Inst Marine Res, N-5024 Bergen, Norway; [Sorhus, Elin; Jentoft, Sissel] Univ Oslo, Ctr Ecol & Evolutionary Synth, Oslo, Norway; [Nordtug, Trond] SINTEF Mat & Chem, Trondheim, Norway; [Harman, Christopher] Norwegian Inst Water Res NIVA, Grimstad, Norway; [Karlsen, Orjan; van der Meeren, Terje] Inst Marine Res, Austevoll Res Stn, Storebo, Norway; [Karlsen, Orjan; van der Meeren, Terje] Hjort Ctr Marine Ecosyst Dynam, Storebo, Norway	Institute of Marine Research - Norway; University of Oslo; SINTEF; Norwegian Institute for Water Research (NIVA); Institute of Marine Research - Norway	Sorhus, E (corresponding author), Inst Marine Res, POB 1870, N-5024 Bergen, Norway.	elin.sorhus@imr.no	Karlsen, Ørjan/K-6137-2012; Thorsen, Anders/AAA-5911-2022; Nordtug, Trond/GZG-7597-2022	Karlsen, Ørjan/0000-0001-5801-4200; Nordtug, Trond/0000-0002-0269-2974; Edvardsen, Rolf/0000-0001-8430-8042; Sorhus, Elin/0000-0003-3542-4201; Jentoft, Sissel/0000-0001-8707-531X	VISTA foundation [6161]; Institute of Marine Research, Norway [14236]	VISTA foundation; Institute of Marine Research, Norway	This work was financed by the VISTA foundation (Project no. 6161, www.vista.no) and the Institute of Marine Research, Norway (Project no. 14236, www.imr.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2014, ENVIRON TOXICOL CHEM, V33, P107, DOI 10.1002/etc.2397; Agamy E, 2012, TOXICOL PATHOL, V40, P1128, DOI 10.1177/0192623312448936; Arukwe A, 2008, ENVIRON RES, V107, P362, DOI 10.1016/j.envres.2008.02.009; Barron MG, 2005, CHEMOSPHERE, V60, P105, DOI 10.1016/j.chemosphere.2004.12.006; Barron MG, 2003, ENVIRON TOXICOL CHEM, V22, P650, DOI 10.1002/etc.5620220326; Barron MG, 1999, AQUAT TOXICOL, V46, P253, DOI 10.1016/S0166-445X(98)00127-1; Bauder MB, 2005, ENVIRON TOXICOL CHEM, V24, P694, DOI 10.1897/04-23R.1; Blanchard A, 2014, MAR POLICY, V43, P313, DOI 10.1016/j.marpol.2013.07.001; Blazer VS, 2006, DIS AQUAT ORGAN, V72, P19, DOI 10.3354/dao072019; Bock KW, 2012, BIOCHEM PHARMACOL, V83, P833, DOI 10.1016/j.bcp.2011.12.006; Bogerd J, 2001, BIOL REPROD, V64, P1633, DOI 10.1095/biolreprod64.6.1633; Brette F, 2014, SCIENCE, V343, P772, DOI 10.1126/science.1242747; Carls MG, 2008, AQUAT TOXICOL, V88, P121, DOI 10.1016/j.aquatox.2008.03.014; Carls MG, 1999, ENVIRON TOXICOL CHEM, V18, P481, DOI 10.1002/etc.5620180317; Carls MG, 2000, ENVIRON TOXICOL CHEM, V19, P1649, DOI 10.1002/etc.5620190624; Carroll J, 2011, SOC PETROLEUM ENG, V18, P481; Dubansky B, 2013, ENVIRON SCI TECHNOL, V47, P5074, DOI 10.1021/es400458p; Fallahtafti S, 2012, AQUAT TOXICOL, V106, P56, DOI 10.1016/j.aquatox.2011.10.007; Frantzen M, 2012, AQUAT TOXICOL, V108, P42, DOI 10.1016/j.aquatox.2011.09.022; FRIDGEIRSSON E, 1978, Rit Fiskideildar, V5, P1; Goksoyr Anders, 1998, EXS, V86, P165; Gonzalez-Doncel M, 2008, AQUAT TOXICOL, V87, P280, DOI 10.1016/j.aquatox.2008.02.013; Hauge KH, 2014, MAR POLICY, V44, P82, DOI 10.1016/j.marpol.2013.07.008; Heintz RA, 1999, ENVIRON TOXICOL CHEM, V18, P494, DOI 10.1002/etc.5620180318; Hjermann DO, 2007, MAR ECOL PROG SER, V339, P283, DOI 10.3354/meps339283; Incardona JP, 2006, TOXICOL APPL PHARM, V217, P308, DOI 10.1016/j.taap.2006.09.018; Incardona JP, 2014, P NATL ACAD SCI USA, V111, pE1510, DOI 10.1073/pnas.1320950111; Incardona JP, 2013, AQUAT TOXICOL, V142, P303, DOI 10.1016/j.aquatox.2013.08.011; Incardona JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030116; Incardona JP, 2011, TOXICOL APPL PHARM, V257, P242, DOI 10.1016/j.taap.2011.09.010; Incardona JP, 2011, J EXPO SCI ENV EPID, V21, P3, DOI 10.1038/jes.2010.51; Incardona JP, 2009, ENVIRON SCI TECHNOL, V43, P201, DOI 10.1021/es802270t; Incardona JP, 2005, ENVIRON HEALTH PERSP, V113, P1755, DOI 10.1289/ehp.8230; Incardona JP, 2004, TOXICOL APPL PHARM, V196, P191, DOI 10.1016/j.taap.2003.11.026; Ingvarsdottir A, 2012, J MARINE SYST, V93, P69, DOI 10.1016/j.jmarsys.2011.10.014; Jung JH, 2013, CHEMOSPHERE, V91, P1146, DOI 10.1016/j.chemosphere.2013.01.019; Kushman ME, 2007, TOXICOL SCI, V99, P51, DOI 10.1093/toxsci/kfm133; Landrum P, 1987, OIL FRESHWATER CHEM, P304; Leirvik F, 2004, HEIDRUM OLJE EGENSKA; Liao WQ, 2006, J BIOCHEM MOL TOXIC, V20, P114, DOI 10.1002/jbt.20125; Marty GD, 1997, CAN J ZOOL, V75, P989, DOI 10.1139/z97-120; Mattingly CJ, 2001, DEV DYNAM, V222, P645, DOI 10.1002/dvdy.1215; McIntosh S, 2010, ENVIRON TOXICOL CHEM, V29, P1160, DOI 10.1002/etc.134; Meier S, 2010, MAR ENVIRON RES, V70, P383, DOI 10.1016/j.marenvres.2010.08.002; Melbye AG, 2009, ENVIRON TOXICOL CHEM, V28, P1815, DOI 10.1897/08-545.1; Misund OA, 2013, ICES J MAR SCI, V70, P722, DOI 10.1093/icesjms/fst086; Mohamed Fatma A.S., 2009, World Journal of Fish and Marine Sciences, V1, P29; Morrison C, 1999, CAN J ZOOL, V77, P890, DOI 10.1139/cjz-77-6-890; MORTENSEN DG, 1994, ALASKA SEA, P183; Naas K.E, 1997, REV FISH SCI, V5, P367, DOI 10.1080/10641269709388606; NAAS KE, 1992, AQUACULTURE, V105, P143, DOI 10.1016/0044-8486(92)90126-6; Neff JM, 2000, ENVIRON TOXICOL CHEM, V19, P1809; Nordtug T, 2011, SCI TOTAL ENVIRON, V412, P148, DOI 10.1016/j.scitotenv.2011.10.021; Nordtug T, 2011, MAR POLLUT BULL, V62, P2106, DOI 10.1016/j.marpolbul.2011.07.015; Olsen E, 2010, ICES J MAR SCI, V67, P87, DOI 10.1093/icesjms/fsp229; Olsen GH, 2013, MAR ENVIRON RES, V90, P9, DOI 10.1016/j.marenvres.2013.05.007; Olsvik PA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-702; Otte JC, 2010, AQUAT TOXICOL, V100, P38, DOI 10.1016/j.aquatox.2010.07.006; Patel S, 2008, FISH SHELLFISH IMMUN, V25, P570, DOI 10.1016/j.fsi.2008.08.007; Perquin M, 2001, J CANCER RES CLIN, V127, P368, DOI 10.1007/s004320000228; Petersen GI, 1998, ENVIRON TOXICOL CHEM, V17, P1385, DOI 10.1002/etc.5620170724; Pietrangelo Antonello, 1998, Journal of Hepatology, V28, P8, DOI 10.1016/S0168-8278(98)80368-1; Reinecke M, 1998, MAR ENVIRON RES, V46, P487, DOI 10.1016/S0141-1136(97)00120-7; Rhee JS, 2013, ENVIRON SCI TECHNOL, V47, P4804, DOI 10.1021/es400186r; RUSHMORE TH, 1993, J BIOL CHEM, V268, P11475; Sarasquete C, 1999, HISTOL HISTOPATHOL, V14, P407, DOI 10.14670/HH-14.407; Solberg T., 1982, International Council for the Exploration of the Sea C.M., V1982/E:60, P1; Solemdal P, 1997, MATURATION SPAWING E; STEGEMAN JJ, 1989, MOL PHARMACOL, V36, P723; STIVER W, 1984, ENVIRON SCI TECHNOL, V18, P834, DOI 10.1021/es00129a006; Sundarapian SM., 2013, FOREST RES, V3, P1; TILSETH S, 1984, MAR ENVIRON RES, V11, P1, DOI 10.1016/0141-1136(84)90007-2; van der Meeren T, 2014, AQUACULT ENG, V62, P17, DOI 10.1016/j.aquaeng.2014.07.003; Vikebo FB, 2014, ICES J MAR SCI, V71, P970, DOI 10.1093/icesjms/fst131; Wang IC, 2010, J ENVIRON SCI HEAL A, V45, P201, DOI 10.1080/10934520903429873; WANG SY, 1993, CAN J FISH AQUAT SCI, V50, P996, DOI 10.1139/f93-115; Wells PG, 1997, MUTAT RES-FUND MOL M, V396, P65, DOI 10.1016/S0027-5107(97)00175-9; Weltzien FA, 2003, COMP BIOCHEM PHYS A, V134, P315, DOI 10.1016/S1095-6433(02)00266-0; Whyte JJ, 2000, CRIT REV TOXICOL, V30, P347, DOI 10.1080/10408440091159239; Wu DM, 2012, ENVIRON TOXICOL CHEM, V31, P754, DOI 10.1002/etc.1739	80	61	61	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124376	10.1371/journal.pone.0124376	http://dx.doi.org/10.1371/journal.pone.0124376			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923774	Green Published, gold			2022-12-27	WOS:000353711600079
J	Mangels, J; Bluthgen, N; Frank, K; Grassein, F; Hilpert, A; Mody, K				Mangels, Jule; Bluethgen, Nico; Frank, Kevin; Grassein, Fabrice; Hilpert, Andrea; Mody, Karsten			Tree Species Composition and Harvest Intensity Affect Herbivore Density and Leaf Damage on Beech, Fagus sylvatica, in Different Landscape Contexts	PLOS ONE			English	Article							FOREST MANAGEMENT INTENSITY; ASSOCIATIONAL SUSCEPTIBILITY; VEGETATIONAL DIVERSITY; COMMUNITY STRUCTURE; INSECT HERBIVORY; PLANT DEFENSES; NORTH-AMERICA; GLOBAL CHANGE; BIODIVERSITY; RESISTANCE	Most forests are exposed to anthropogenic management activities that affect tree species composition and natural ecosystem processes. Changes in ecosystem processes such as herbivory depend on management intensity, and on regional environmental conditions and species pools. Whereas influences of specific forest management measures have already been addressed for different herbivore taxa on a local scale, studies considering effects of different aspects of forest management across different regions are rare. We assessed the influence of tree species composition and intensity of harvesting activities on arthropod herbivores and herbivore-related damage to beech trees, Fagus sylvatica, in 48 forest plots in three regions of Germany. We found that herbivore abundance and damage to beech trees differed between regions and that - despite the regional differences - density of tree-associated arthropod taxa and herbivore damage were consistently affected by tree species composition and harvest intensity. Specifically, overall herbivore damage to beech trees increased with increasing dominance of beech trees - suggesting the action of associational resistance processes - and decreased with harvest intensity. The density of leaf chewers and mines was positively related to leaf damage, and several arthropod groups responded to beech dominance and harvest intensity. The distribution of damage patterns was consistent with a vertical shift of herbivores to higher crown layers during the season and with higher beech dominance. By linking quantitative data on arthropod herbivore abundance and herbivory with tree species composition and harvesting activity in a wide variety of beech forests, our study helps to better understand the influence of forest management on interactions between a naturally dominant deciduous forest tree and arthropod herbivores.	[Mangels, Jule; Bluethgen, Nico; Frank, Kevin; Hilpert, Andrea; Mody, Karsten] Tech Univ Darmstadt, Dept Biol, Ecol Networks, Darmstadt, Germany; [Grassein, Fabrice] Univ Bern, Inst Plant Sci, Bern, Switzerland	Technical University of Darmstadt; University of Bern	Mody, K (corresponding author), Tech Univ Darmstadt, Dept Biol, Ecol Networks, Darmstadt, Germany.	mody@bio.tu-darmstadt.de	Blüthgen, Nico/F-5983-2010		DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories" [BL 960/2-1]	DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories"	The work has been funded by the DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories" (BL 960/2-1) to NB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2009, BIOL INVASIONS, V11, P1005, DOI 10.1007/s10530-008-9312-4; Agrawal AA, 2006, Q REV BIOL, V81, P349, DOI 10.1086/511529; Andersen AN, 1997, J BIOGEOGR, V24, P433, DOI 10.1111/j.1365-2699.1997.00137.x; ANDOW DA, 1991, ANNU REV ENTOMOL, V36, P561, DOI 10.1146/annurev.en.36.010191.003021; Ayres MP, 2000, SCI TOTAL ENVIRON, V262, P263, DOI 10.1016/S0048-9697(00)00528-3; Banfield-Zanin JA, 2015, AGR FOREST ENTOMOL, V17, P48, DOI 10.1111/afe.12079; Barbosa P, 2009, ANNU REV ECOL EVOL S, V40, P1, DOI 10.1146/annurev.ecolsys.110308.120242; Boch S, 2013, BASIC APPL ECOL, V14, P496, DOI 10.1016/j.baae.2013.06.001; Bouget C, 2012, CAN J FOREST RES, V42, P1421, DOI [10.1139/X2012-078, 10.1139/x2012-078]; Boyd IL, 2013, SCIENCE, V342, P823, DOI 10.1126/science.1235773; Brandle M, 2001, J ANIM ECOL, V70, P491, DOI 10.1046/j.1365-2656.2001.00506.x; BROWN BJ, 1987, ECOLOGY, V68, P108, DOI 10.2307/1938810; Castagneyrol B, 2014, J APPL ECOL, V51, P134, DOI 10.1111/1365-2664.12175; Castagneyrol B, 2013, J ECOL, V101, P418, DOI 10.1111/1365-2745.12055; Castagneyrol B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044247; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; Connor EF, 2000, ECOLOGY, V81, P734, DOI 10.2307/177373; Cornelissen T, 2008, OIKOS, V117, P1121, DOI 10.1111/j.0030-1299.2008.16588.x; Didham RK, 2003, ARTHROPODS OF TROPICAL FORESTS, P28; Dodd LE, 2012, FOREST ECOL MANAG, V267, P262, DOI 10.1016/j.foreco.2011.12.016; Elderd BD, 2013, P NATL ACAD SCI USA, V110, P14978, DOI 10.1073/pnas.1300759110; Ellenberg H., 2010, OKOLOGISCHER DYNAMIS; FAO, 2010, GLOBAL FOREST RESOUR; Finch S, 2000, ENTOMOL EXP APPL, V96, P91, DOI 10.1023/A:1004058518179; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Forkner RE, 2006, CONSERV BIOL, V20, P429, DOI 10.1111/j.1523-1739.2006.00346.x; Forkner RE, 2004, FOREST ECOL MANAG, V199, P21, DOI 10.1016/j.foreco.2004.03.044; Franklin AJ, 2003, ECOL ENTOMOL, V28, P278, DOI 10.1046/j.1365-2311.2003.00516.x; Gamfeldt L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2328; Gandhi KJK, 2008, FOREST ECOL MANAG, V256, P1104, DOI 10.1016/j.foreco.2008.06.011; GASTON KJ, 1994, PHILOS T R SOC B, V345, P335, DOI 10.1098/rstb.1994.0114; Gaylord ML, 2013, NEW PHYTOL, V198, P567, DOI 10.1111/nph.12174; Gering JC, 2003, CONSERV BIOL, V17, P488, DOI 10.1046/j.1523-1739.2003.01465.x; Gossner MM, 2014, BASIC APPL ECOL, V15, P347, DOI 10.1016/j.baae.2014.03.003; Gossner MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104876; Grove SJ, 2002, ANNU REV ECOL SYST, V33, P1, DOI 10.1146/annurev.ecolsys.33.010802.150507; Gutbrodt B, 2012, ARTHROPOD-PLANT INTE, V6, P171, DOI 10.1007/s11829-011-9173-0; Hartley MK, 2010, ARTHROPOD-PLANT INTE, V4, P237, DOI 10.1007/s11829-010-9105-4; Heiermann J, 2008, FOREST ECOL MANAG, V255, P1161, DOI 10.1016/j.foreco.2007.10.020; Hermy M, 2007, ECOL RES, V22, P361, DOI 10.1007/s11284-007-0354-3; Hochuli DF, 2001, AUSTRAL ECOL, V26, P563, DOI 10.1046/j.1442-9993.2001.01135.x; Hunter M.L., 1999, J WILDLIFE MANAGE; Jactel H, 2005, ECOL STUD-ANAL SYNTH, V176, P235; Jactel H, 2007, ECOL LETT, V10, P835, DOI 10.1111/j.1461-0248.2007.01073.x; Jactel H, 2012, GLOBAL CHANGE BIOL, V18, P267, DOI 10.1111/j.1365-2486.2011.02512.x; Jactel H, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2009054; Kahl T, 2014, NAT CONSERV-BULGARIA, P15, DOI 10.3897/natureconservation.7.7281; Kaplan I, 2007, ECOL LETT, V10, P977, DOI 10.1111/j.1461-0248.2007.01093.x; Kareiva P., 1983, P259; KEMP WP, 1979, ENVIRON ENTOMOL, V8, P993, DOI 10.1093/ee/8.6.993; KENNEDY CEJ, 1984, J ANIM ECOL, V53, P455, DOI 10.2307/4528; Koricheva J, 2006, CAN J FOREST RES, V36, P324, DOI 10.1139/x05-172; Lange M, 2014, FOREST ECOL MANAG, V329, P166, DOI 10.1016/j.foreco.2014.06.012; Lavandero B, 2009, BASIC APPL ECOL, V10, P10, DOI 10.1016/j.baae.2007.11.009; Leksono AS, 2005, ENTOMOL SCI, V8, P235, DOI 10.1111/j.1479-8298.2005.00122.x; Letourneau DK, 2011, ECOL APPL, V21, P9, DOI 10.1890/09-2026.1; Letourneau DK, 2009, ANNU REV ECOL EVOL S, V40, P573, DOI 10.1146/annurev.ecolsys.110308.120320; Levers C, 2014, FOREST ECOL MANAG, V315, P160, DOI 10.1016/j.foreco.2013.12.030; Lewinsohn TM, 2005, ANNU REV ECOL EVOL S, V36, P597, DOI 10.1146/annurev.ecolsys.36.091704.175520; Metcalfe DB, 2014, ECOL LETT, V17, P324, DOI 10.1111/ele.12233; Milad M, 2011, FOREST ECOL MANAG, V261, P829, DOI 10.1016/j.foreco.2010.10.038; Mody K, 2004, ECOL ENTOMOL, V29, P217, DOI 10.1111/j.1365-2311.2004.0588.x; Mody K, 2009, ECOL ENTOMOL, V34, P133, DOI 10.1111/j.1365-2311.2008.01053.x; Mody K, 2007, ECOLOGY, V88, P1012, DOI 10.1890/06-1338; Moreau G, 2006, J ANIM ECOL, V75, P853, DOI 10.1111/j.1365-2656.2006.01109.x; NIELSEN BO, 1978, ECOL ENTOMOL, V3, P193, DOI 10.1111/j.1365-2311.1978.tb00919.x; Nixon AE, 2012, ECOL ENTOMOL, V37, P13, DOI 10.1111/j.1365-2311.2011.01330.x; NUMMELIN M, 1992, AFR J ECOL, V30, P213, DOI 10.1111/j.1365-2028.1992.tb00496.x; Packham JR, 2012, J ECOL, V100, P1557, DOI 10.1111/j.1365-2745.2012.02017.x; Paillet Y, 2010, CONSERV BIOL, V24, P101, DOI 10.1111/j.1523-1739.2009.01399.x; Paquette A, 2006, ECOL APPL, V16, P1575, DOI 10.1890/1051-0761(2006)016[1575:SAGOUT]2.0.CO;2; Paquette A, 2010, FRONT ECOL ENVIRON, V8, P27, DOI 10.1890/080116; Pautasso M, 2010, BIOL REV, V85, P729, DOI 10.1111/j.1469-185X.2010.00123.x; Pere C, 2011, BIODIVERS CONSERV, V20, P3003, DOI 10.1007/s10531-011-0134-9; PERRIN RM, 1978, ENTOMOL EXP APPL, V24, P585, DOI 10.1007/BF02385112; Peter F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095551; Petersen C, 2000, PHYSIOL ENTOMOL, V25, P35, DOI 10.1046/j.1365-3032.2000.00163.x; PHILLIPSON J, 1983, ECOL ENTOMOL, V8, P315, DOI 10.1111/j.1365-2311.1983.tb00512.x; Pinheiro J., 2014, NLME LINEAR AND NONL; Plath M, 2012, OECOLOGIA, V169, P477, DOI 10.1007/s00442-011-2215-6; Poelman EH, 2009, ECOLOGY, V90, P1863, DOI 10.1890/08-0977.1; Poveda K, 2008, REV COLOMB ENTOMOL, V34, P131; Powers RF, 1999, NEW FOREST, V17, P263, DOI 10.1023/A:1006555219130; Pretzsch H, 2013, PLANT BIOLOGY, V15, P483, DOI 10.1111/j.1438-8677.2012.00670.x; Rasband W, 1997, IMAGEJ 1 46R; Rheinheimer J, 2010, RUSSELKAFER BADEN WU; Riedel J, 2013, FOREST ECOL MANAG, V297, P49, DOI 10.1016/j.foreco.2013.02.003; Riihimaki J, 2005, OECOLOGIA, V142, P90, DOI 10.1007/s00442-004-1696-y; ROOT RB, 1973, ECOL MONOGR, V43, P95, DOI 10.2307/1942161; Rosenvald R, 2008, FOREST ECOL MANAG, V255, P1, DOI 10.1016/j.foreco.2007.09.016; Ruhnke H, 2009, BASIC APPL ECOL, V10, P726, DOI 10.1016/j.baae.2009.06.006; Salazar D, 2012, P NATL ACAD SCI USA, V109, P12616, DOI 10.1073/pnas.1202907109; Savilaakso S, 2009, BIODIVERS CONSERV, V18, P3931, DOI 10.1007/s10531-009-9689-0; Schall P, 2013, EUR J FOREST RES, V132, P379, DOI 10.1007/s10342-013-0681-6; Schmitz OJ, 2014, BIOL CONTROL, V75, P87, DOI 10.1016/j.biocontrol.2013.10.001; Schowalter TD, 2012, ANNU REV ENTOMOL, V57, P1, DOI 10.1146/annurev-ento-120710-100610; Schowalter T. D., 1999, ECOSYSTEMS DISTURBED, V16, P253; Schowalter T.D, 2006, INSECT ECOLOGY ECOSY, P347, DOI [10.1016/B978-012088772-9/50038-8, DOI 10.1016/B978-012088772-9/50038-8]; SCHOWALTER TD, 1995, FOREST ECOL MANAG, V78, P115, DOI 10.1016/0378-1127(95)03592-4; SCHOWALTER TD, 1986, ANNU REV ENTOMOL, V31, P177, DOI 10.1146/annurev.en.31.010186.001141; Seidl R, 2011, ECOL MODEL, V222, P903, DOI 10.1016/j.ecolmodel.2010.09.040; SHEEHAN W, 1986, ENVIRON ENTOMOL, V15, P456, DOI 10.1093/ee/15.3.456; Sobek S, 2009, OECOLOGIA, V160, P279, DOI 10.1007/s00442-009-1304-2; Speight M. R., 1989, ECOLOGY MANAGEMENT F; Stoeckli S, 2008, TREE GENET GENOMES, V4, P833, DOI 10.1007/s11295-008-0156-y; Su JC, 2001, ENVIRON ENTOMOL, V30, P400, DOI 10.1603/0046-225X-30.2.400; Summerville KS, 2008, CAN ENTOMOL, V140, P475, DOI 10.4039/N07-Ls06; Summerville KS, 2011, ECOL APPL, V21, P806, DOI 10.1890/10-0715.1; TAHVANAINEN JO, 1972, OECOLOGIA, V10, P321, DOI 10.1007/BF00345736; Truxa C, 2012, INSECT CONSERV DIVER, V5, P389, DOI 10.1111/j.1752-4598.2011.00177.x; Ulyshen MD, 2011, FOREST ECOL MANAG, V261, P1479, DOI 10.1016/j.foreco.2011.01.033; Vandermeer J., 1989, The ecology of intercropping.; Vehvilainen H, 2006, BASIC APPL ECOL, V7, P1, DOI 10.1016/j.baae.2005.05.003; Vehvilainen H, 2007, OECOLOGIA, V152, P287, DOI 10.1007/s00442-007-0673-7; Watt A.D., 1992, Special Publication of the British Ecological Society, P267; Way MJ, 1977, ORIGINS PEST PARASIT, P127; White JA, 2000, ECOLOGY, V81, P1795, DOI 10.1890/0012-9658(2000)081[1795:ASOCTA]2.0.CO;2; WILSON E O, 1992; Yela JL, 1997, ENTOMOL EXP APPL, V85, P275, DOI 10.1023/A:1003125930772	119	6	7	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0126140	10.1371/journal.pone.0126140	http://dx.doi.org/10.1371/journal.pone.0126140			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938417	Green Published, gold, Green Submitted			2022-12-27	WOS:000353943000144
J	Hur, H; Ghaffarzadegan, N; Hawley, J				Hur, Hyungjo; Ghaffarzadegan, Navid; Hawley, Joshua			Effects of Government Spending on Research Workforce Development: Evidence from Biomedical Postdoctoral Researchers	PLOS ONE			English	Article							SCIENCE; PHDS	We examine effects of government spending on postdoctoral researchers' (postdocs) productivity in biomedical sciences, the largest population of postdocs in the US. We analyze changes in the productivity of postdocs before and after the US government's 1997 decision to increase NIH funding. In the first round of analysis, we find that more government spending has resulted in longer postdoc careers. We see no significant changes in researchers' productivity in terms of publication and conference presentations. However, when the population is segmented by citizenship, we find that the effects are heterogeneous; US citizens stay longer in postdoc positions with no change in publications and, in contrast, international permanent residents (green card holders) produce more conference papers and publications without significant changes in postdoc duration. Possible explanations and policy implications of the analysis are discussed.	[Hur, Hyungjo; Hawley, Joshua] Ohio State Univ, John Glenn Sch Publ Affairs, Columbus, OH 43210 USA; [Ghaffarzadegan, Navid] Virginia Tech, Dept Ind & Syst Engn, Blacksburg, VA 24061 USA	University System of Ohio; Ohio State University; Virginia Polytechnic Institute & State University	Ghaffarzadegan, N (corresponding author), Virginia Tech, Dept Ind & Syst Engn, Blacksburg, VA 24061 USA.	navidg@vt.edu	Hur, Hyungjo/V-2803-2019	Hur, Hyungjo/0000-0002-9481-9433; Ghaffarzadegan, Navid/0000-0003-3632-8588	National Institute of General Medical Sciences of the National Institutes of Health [5U01GM094141-02, 2U01GM094141-05]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM094141] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The National Institute of General Medical Sciences of the National Institutes of Health supported this work (grants 5U01GM094141-02 and 2U01GM094141-05). The grants were awarded to the Ohio State University, the Massachusetts Institute of Technology (MIT), and Virginia Tech. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2014, P NATL ACAD SCI USA, V111, P5773, DOI 10.1073/pnas.1404402111; Alberts B, 2013, SCIENCE, V339, P1252, DOI 10.1126/science.1237434; Bloch C, 2014, MINERVA, V52, P77, DOI 10.1007/s11024-014-9247-0; Blume-Kohout ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082759; Bonetta L, 2010, SCIENCE, V329, P1091, DOI 10.1126/science.opms.r1000093; Bound John, 2009, SCI ENG CAREERS US A, P59; Davis G., 2009, SCI ENG CAREERS US A; De Jesus M, 2012, OPINION POSTDOC CHAL; Diaz MG, 2012, THESIS MIT; Garrison HH, 2003, FASEB J, V17, P2169, DOI 10.1096/fj.03-0836life; Garrison HH, 2011, ED EMPLOYMENT BIOL M; Gentile NO, 1989, POSTDOCTORAL RES TRA; Ghaffarzadegan N, 2015, SYST RES BEHAV SCI, V32, P402, DOI 10.1002/sres.2324; Ghaffarzadegan N, 2014, SYST RES BEHAV SCI, V31, P301, DOI 10.1002/sres.2190; Hoots WK, 2015, BLOOD IN PRESS, DOI [10.1182/blood-2015-01-617811, DOI 10.1182/BLOOD-2015-01-617811]; Kim H, 2013, PUBLIC ADMIN REV, V73, P291, DOI 10.1111/j.1540-6210.2012.02656.x; Kolb D. A, 2014, EXPERIENTIAL LEARNIN; Lan XH, 2013, J POLICY ANAL MANAG, V32, P807, DOI 10.1002/pam.21713; Lan XH, 2012, J POLICY ANAL MANAG, V31, P623, DOI 10.1002/pam.21639; Larson RC, 2014, SYST RES BEHAV SCI, V31, P745, DOI 10.1002/sres.2210; Larson Richard C, 2012, Serv Sci, V4, P382; Laudel G., 2012, ERCS IMPACT GRANTEES; Lawler A, 1997, SCIENCE, V275, P916, DOI 10.1126/science.275.5302.916; LEVEY GS, 1988, ANN INTERN MED, V109, P414, DOI 10.7326/0003-4819-109-5-414; Mervis J, 1997, SCIENCE, V275, P608, DOI 10.1126/science.275.5300.608; Mervis J, 2014, SCI INSIDER; National Postdoctoral Association, 2014, WHAT IS POSTD; National Science Foundation, 2012, SCI ENG IND 2012; Office of Management and Budget, 2014, HIST TABL BUDG US GO; Root-Bernstein RS, 1992, DISCOVERING INVENTIN; Schillebeeckx M, 2013, NAT BIOTECHNOL, V31, P938, DOI 10.1038/nbt.2706; SCRIBNER S, 1993, APPL COGNITIVE PSYCH, V7, P185, DOI 10.1002/acp.2350070303; Smith PW, 2006, NATL I HLTH NIH ORG, DOI [10.1002/pam.21639, DOI 10.1002/PAM.21639]; Steiner JF, 2002, J GEN INTERN MED, V17, P854, DOI 10.1046/j.1525-1497.2002.10515.x; Stephan P., 2012, EC SHAPES SCI; Stephan P, 2013, BIOSCIENCE, V63, P245, DOI 10.1525/bio.2013.63.4.2; Su XH, 2013, J HIGH EDUC, V84, P239, DOI 10.1353/jhe.2013.0014; Teitelbaum MS, 2008, SCIENCE, V321, P644, DOI 10.1126/science.1160272; van Arensbergen P, 2014, RES EVALUAT, V23, P273, DOI 10.1093/reseval/rvu015; Weinberg BA, 2014, SCIENCE, V344, P41, DOI 10.1126/science.1250055; Zerhouni EA, 2006, SCIENCE, V314, P1088, DOI 10.1126/science.1136931; ZUMETA W, 1984, SCI TECHNOL HUM VAL, P23, DOI 10.1177/016224398400900203; Zumeta W., 1985, EXTENDING ED LADDER	43	11	11	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124928	10.1371/journal.pone.0124928	http://dx.doi.org/10.1371/journal.pone.0124928			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH2XA	25932942	Green Submitted, Green Published, gold			2022-12-27	WOS:000353887100065
J	Kang, M; He, JF; Song, T; Rutherford, S; Wu, J; Lin, JY; Huang, GF; Tan, XH; Zhong, HJ				Kang, Min; He, Jianfeng; Song, Tie; Rutherford, Shannon; Wu, Jie; Lin, Jinyan; Huang, Guofeng; Tan, Xiaohua; Zhong, Haojie			Environmental Sampling for Avian Influenza A( H7N9) in Live-Poultry Markets in Guangdong, China	PLOS ONE			English	Article							HUMAN INFECTIONS; VIRUS-INFECTION; HONG-KONG; RISK; SURVEILLANCE; CLOSURE; SPREAD	Background To provide an increased understanding of avian influenza A(H7N9) activity in live-poultry market in space and time and hence improve H7N9 epidemic control, an ongoing environmental sampling program in multiple live-poultry markets across Guangdong, China was conducted during March 2013-June 2014. Methods A total of 625 live-poultry markets throughout 21 prefecture areas took part in the study. A total of 10 environmental sites in markets for sampling were identified to represent 4 different poultry-related activity areas. At least 10 environmental samples were collected from each market every month. The real time RT-PCR was performed to detect the avian influenza A(H7N9) virus. Field survey was conducted to investigate the sanitation status of live-poultry markets. Results There were 109 human infections with H7N9 avian influenza in Guangdong, of which 37 (34%) died. A total of 18741 environmental swabs were collected and subjected to real-time RT-PCR test, of which 905(4.83%) were found positive for H7N9 virus. There were 201 (32.16%) markets affected by H7N9 in 16 prefecture areas. The detection of H7N9 virus in markets spiked in winter months. 63.33% markets (38/60) had no physical segregation for poultry holding, slaughter or sale zones. Closing live-poultry market significantly decreased the H7N9 detection rate from 14.83% (112/755) to 1.67% (5/300). Conclusions This study indicates the importance of live-poultry market surveillance based on environmental sampling for H7N9 Avian Influenza control. Improving live-poultry market management and sanitation and changing consumer practices are critical to reduce the risk of H7N9 infection.	[Kang, Min; He, Jianfeng; Song, Tie; Wu, Jie; Lin, Jinyan; Huang, Guofeng; Tan, Xiaohua; Zhong, Haojie] Ctr Dis Control & Prevent Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Rutherford, Shannon] Griffith Univ, Ctr Environm & Populat Hlth, Sch Environm, Brisbane, Qld 4111, Australia	Griffith University	Zhong, HJ (corresponding author), Ctr Dis Control & Prevent Guangdong Prov, Guangzhou, Guangdong, Peoples R China.	gdhaojie@126.com			Science and Technology Program of Guangdong, China [2013B020307007]; Medical Scientific Research Foundation of Guangdong, China [C2014002]; Chinese Center for Disease Control and Prevention and Guangdong Provincial Health and Family Planning Commission	Science and Technology Program of Guangdong, China; Medical Scientific Research Foundation of Guangdong, China; Chinese Center for Disease Control and Prevention and Guangdong Provincial Health and Family Planning Commission	This study is supported by Chinese Center for Disease Control and Prevention and Guangdong Provincial Health and Family Planning Commission. This study was supported by grants from Science and Technology Program of Guangdong, China (No. 2013B020307007) and the Medical Scientific Research Foundation of Guangdong, China (No. C2014002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai J, 2013, EUROSURVEILLANCE, V18, P4, DOI 10.2807/1560-7917.ES2013.18.26.20510; [Anonymous], WHO REAL TIM RT PCR; Bao CJ, 2013, NEW ENGL J MED, V368, P2337, DOI 10.1056/NEJMc1306100; Chen E, 2013, EURO SURVEILL, V18; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Cowling BJ, 2013, LANCET, V382, P129, DOI 10.1016/S0140-6736(13)61171-X; Fang LQ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02722; Fournie G, 2014, LANCET, V383, P496, DOI 10.1016/S0140-6736(13)62109-1; Fournie G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037986; Gilbert M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5116; Hong Kong Centre for Health Protection of the Department of Health, AV INFL REP; Horm SV, 2013, EMERG INFECT DIS, V19, P305, DOI 10.3201/eid1902.121201; Lau EHY, 2007, EMERG INFECT DIS, V13, P1340, DOI 10.3201/eid1309.061549; Leung YHC, 2007, EMERG INFECT DIS, V13, P1380, DOI 10.3201/eid1309.070517; Leung YHC, 2012, EMERG INFECT DIS, V18, P1339, DOI 10.3201/eid1808.111879; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Liao QY, 2009, EPIDEMICS-NETH, V1, P207, DOI 10.1016/j.epidem.2009.09.002; Lu J, 2014, J VIROL, V88, P8297, DOI 10.1128/JVI.00630-14; Magalhaes RJS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049712; Martin V, 2011, PREV VET MED, V102, P196, DOI 10.1016/j.prevetmed.2011.07.007; Martin V, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001308; National Health and Family Planning Commission of Guangdong Province, HUM INF AV INFL A H7; Wan XF, 2011, J VIROL, V85, P13432, DOI 10.1128/JVI.05266-11; Wang CM, 2014, J INFECT DIS, V209, P34, DOI 10.1093/infdis/jit478; Yu HJ, 2014, LANCET, V383, P541, DOI 10.1016/S0140-6736(13)61904-2; Yuan J, 2014, CLIN INFECT DIS; Zhang C, 2013, EURO SURVEILL, V18; Zhang QY, 2013, SCIENCE, V341, P410, DOI 10.1126/science.1240532	28	38	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0126335	10.1371/journal.pone.0126335	http://dx.doi.org/10.1371/journal.pone.0126335			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933138	Green Submitted, Green Published, gold			2022-12-27	WOS:000353887100152
J	Li, Y; Kang, GB; Duan, LJ; Lu, WX; Katze, MG; Lewis, MG; Haase, AT; Li, QS				Li, Yue; Kang, Guobin; Duan, Lijie; Lu, Wuxun; Katze, Michael G.; Lewis, Mark G.; Haase, Ashley T.; Li, Qingsheng			SIV Infection of Lung Macrophages	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; CD4(+) T-CELLS; BRONCHOALVEOLAR LAVAGE; REPLICATION; PATHOGENESIS; HIV; TISSUES	HIV-1 depletes CD4+ T cells in the blood, lymphatic tissues, gut and lungs. Here we investigated the relationship between depletion and infection of CD4+ T cells in the lung parenchyma. The lungs of 38 Indian rhesus macaques in early to later stages of SIVmac251 infection were examined, and the numbers of CD4+ T cells and macrophages plus the frequency of SIV RNA+ cells were quantified. We showed that SIV infected macrophages in the lung parenchyma, but only in small numbers except in the setting of interstitial inflammation where large numbers of SIV RNA+ macrophages were detected. However, even in this setting, the number of macrophages was not decreased. By contrast, there were few infected CD4+ T cells in lung parenchyma, but CD4+ T cells were nonetheless depleted by unknown mechanisms. The CD4+ T cells in lung parenchyma were depleted even though they were not productively infected, whereas SIV can infect large numbers of macrophages in the setting of interstitial inflammation without depleting them. These observations point to the need for future investigations into mechanisms of CD4+ T cell depletion at this mucosal site, and into mechanisms by which macrophage populations are maintained despite high levels of infection. The large numbers of SIV RNA+ macrophages in lungs in the setting of interstitial inflammation indicates that lung macrophages can be an important source for SIV persistent infection.	[Li, Yue; Kang, Guobin; Lu, Wuxun; Li, Qingsheng] Univ Nebraska, Sch Biol Sci, Nebraska Ctr Virol, Lincoln, NE 68588 USA; [Li, Yue] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Duan, Lijie; Haase, Ashley T.] Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA; [Katze, Michael G.] Washington Natl Primate Res Ctr, Seattle, WA USA; [Katze, Michael G.] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; [Lewis, Mark G.] BIOQUAL Inc, Rockville, MD USA	University of Nebraska System; University of Nebraska Lincoln; Nankai University; University of Minnesota System; University of Minnesota Twin Cities; University of Washington; University of Washington Seattle; BIOQUAL Inc.	Li, QS (corresponding author), Univ Nebraska, Sch Biol Sci, Nebraska Ctr Virol, Lincoln, NE 68588 USA.	qli@unl.edu			National Institutes of Health [DK087625]; Fogarty International Center grant at the University of Nebraska-Lincoln [D43 TW001429]; NIH (Washington National Primate Research Center Core Grant) [P51 OD010425]; FOGARTY INTERNATIONAL CENTER [D43TW001429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087625] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD010425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center grant at the University of Nebraska-Lincoln; NIH (Washington National Primate Research Center Core Grant)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grants DK087625 (to Q. Li). Y. Li was supported by the Fogarty International Center grant at the University of Nebraska-Lincoln (D43 TW001429). Funding for studies at the University of Washington was provided by NIH P51 OD010425 (Washington National Primate Research Center Core Grant) and the Simian Vaccine Evaluation Unit (Division of AIDS, NIH-NIAID). Dr. Mark Lewis played a role in the macaque design and data collection for publication through an NIH funding mechanism and a subcontract. BIOQUAL Inc. provided support in the form of salaries for author Dr. Mark Lewis, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all the authors are articulated in the author contributions' section.	Brenchley JM, 2008, MUCOSAL IMMUNOL, V1, P49, DOI 10.1038/mi.2007.5; Cai YH, 2014, J IMMUNOL, V192, P2821, DOI 10.4049/jimmunol.1302269; Cline AN, 2005, J MED PRIMATOL, V34, P303; Das S, 2003, SEX TRANSM INFECT, V79, P88, DOI 10.1136/sti.79.2.88; Fernandez E, 1996, Arch Bronconeumol, V32, P271; Fuller CL, 2002, AM J PATHOL, V161, P969, DOI 10.1016/S0002-9440(10)64257-5; HAASE AT, 1986, NATURE, V322, P130, DOI 10.1038/322130a0; HAASE AT, 1994, ANN NY ACAD SCI, V724, P75, DOI 10.1111/j.1749-6632.1994.tb38897.x; Jambo KC, 2011, THORAX, V66, P375, DOI 10.1136/thx.2010.153825; Knox KS, 2010, J VIROL, V84, P9010, DOI 10.1128/JVI.01138-10; Li QS, 2000, J INFECT DIS, V181, P867, DOI 10.1086/315304; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Mankowski JL, 1998, AM J PATHOL, V153, P1123, DOI 10.1016/S0002-9440(10)65656-8; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Orenstein JM, 1997, SCIENCE, V276, P1857, DOI 10.1126/science.276.5320.1857; Picker LJ, 2004, J EXP MED, V200, P1299, DOI 10.1084/jem.20041049; Sage PT, 2013, NAT IMMUNOL, V14, P152, DOI 10.1038/ni.2496; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Wang LX, 2014, P NATL ACAD SCI USA, V111, P3146, DOI 10.1073/pnas.1318175111; Zhang ZQ, 2004, P NATL ACAD SCI USA, V101, P5640, DOI 10.1073/pnas.0308425101	20	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125500	10.1371/journal.pone.0125500	http://dx.doi.org/10.1371/journal.pone.0125500			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933119	Green Published, gold			2022-12-27	WOS:000353887100116
J	Redaniel, MT; Martin, RM; Ridd, MJ; Wade, J; Jeffreys, M				Redaniel, Maria Theresa; Martin, Richard M.; Ridd, Matthew J.; Wade, Julia; Jeffreys, Mona			Diagnostic Intervals and Its Association with Breast, Prostate, Lung and Colorectal Cancer Survival in England: Historical Cohort Study Using the Clinical Practice Research Datalink	PLOS ONE			English	Article							PRACTICE RESEARCH DATABASE; PRIMARY-CARE; DELAYS; STAGE; RISK; TIME	Rapid diagnostic pathways for cancer have been implemented, but evidence whether shorter diagnostic intervals (time from primary care presentation to diagnosis) improves survival is lacking. Using the Clinical Practice Research Datalink, we identified patients diagnosed with female breast (8,639), colorectal (5,912), lung (5,737) and prostate (1,763) cancers between 1998 and 2009, and aged >15 years. Presenting symptoms were classified as alert or non-alert, according to National Institute for Health and Care Excellence guidance. We used relative survival and excess risk modeling to determine associations between diagnostic intervals and five-year survival. The survival of patients with colorectal, lung and prostate cancer was greater in those with alert, compared with non-alert, symptoms, but findings were opposite for breast cancer. Longer diagnostic intervals were associated with lower mortality for colorectal and lung cancer patients with non-alert symptoms, (colorectal cancer: Excess Hazards Ratio, EHR >6 months vs <1 month: 0.85; 95% CI: 0.72-1.00; Lung cancer: EHR 3-6 months vs <1 month: 0.87; 95% CI: 0.80-0.95; EHR >6 months vs <1 month: 0.81; 95% CI: 0.74-0.89). Prostate cancer mortality was lower in patients with longer diagnostic intervals, regardless of type of presenting symptom. The association between diagnostic intervals and cancer survival is complex, and should take into account cancer site, tumour biology and clinical practice. Nevertheless, unnecessary delay causes patient anxiety and general practitioners should continue to refer patients with alert symptoms via the cancer pathways, and actively follow-up patients with non-alert symptoms in the community.	[Redaniel, Maria Theresa] Univ Bristol, NIHR CLAHRC West, Bristol, Avon, England; [Redaniel, Maria Theresa; Martin, Richard M.; Ridd, Matthew J.; Wade, Julia; Jeffreys, Mona] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England	University of Bristol; University of Bristol	Redaniel, MT (corresponding author), Univ Bristol, NIHR CLAHRC West, Bristol, Avon, England.	theresa.redaniel@bristol.ac.uk	Jeffreys, Mona/W-3425-2019; Ridd, Matthew/E-5656-2016	Martin, Richard/0000-0002-7992-7719; Redaniel, Theresa/0000-0002-0668-0874; Jeffreys, Mona/0000-0002-2617-0361; Ridd, Matthew/0000-0002-7954-8823	Cancer Research UK [C41354/A13273]; National Institute for Health Research (NIHR); Care West at University Hospitals Bristol NHS Foundation Trust; Cancer Research UK [13273] Funding Source: researchfish; National Institute for Health Research [CTF-01-12-06] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Care West at University Hospitals Bristol NHS Foundation Trust; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	This study is funded by Cancer Research UK (Grant Ref: C41354/A13273). MTR was supported in part by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care West at University Hospitals Bristol NHS Foundation Trust. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funding agency had no role in the study design, in the collection, analysis and interpretation of the data, in the writing of the report and in the decision to submit the article for publication.	Ali F, 2007, GUT, V56, P1, DOI 10.1136/gut.2006.117598; Bosman FT, 2010, TUMOURS DIGESTIVE SY; Brenner H, 2004, EUR J CANCER, V40, P326, DOI 10.1016/j.ejca.2003.10.013; Cancer Research UK Cancer Survival Group, 2009, LIFE TABLES FOR ENGL; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Coleman MP, 2011, LANCET, V377, P127, DOI 10.1016/S0140-6736(10)62231-3; CPRD, 2012, CANCER REGISTRY DATA; De Angelis R, 2014, LANCET ONCOL, V15, P23, DOI 10.1016/S1470-2045(13)70546-1; Department of Health, 2005, PRACT GUID ETHN MON; Department of Health, 2000, THE NHS CANCER PLAN; Department of Health, 2007, CANCER REFORM STRATE; Department of Health Public Health England NHS England, 2013, IMPROVING OUTCOMES A; Dickman PW, 2004, STAT MED, V23, P51, DOI 10.1002/sim.1597; Dregan A, 2012, CANCER EPIDEMIOL; Dregan A, 2013, BRIT J GEN PRACT, V63, pE807, DOI 10.3399/bjgp13X675197; Droste JSTS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-332; Eble J, 2004, PATHOLOGY AND GENETI; EDERER FRED, 1961, NATL CANCER INST MONOGR, V6, P101; European Network of Cancer Registries, 1997, ENCR DEFINITIONS FOR; Hamilton W, 2009, BRIT J CANCER, V101, pS80, DOI 10.1038/sj.bjc.6605396; Hamilton W, 2010, BRIT J GEN PRACT, V60, P121, DOI 10.3399/bjgp10X483175; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Holmberg L, 2012, CANCER EPIDEMIOL, V36, pE7, DOI 10.1016/j.canep.2011.08.001; Hospital Episode Statistics, 2009, HOW GOOD IS HES ETHN; Gonzalez-Barcala FJ, 2010, CLIN TRANSL ONCOL, V12, P836, DOI 10.1007/s12094-010-0606-5; Kaye JA, 2000, BRIT J CANCER, V83, P1556, DOI 10.1054/bjoc.2000.1493; Khan NF, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483562; Korsgaard M, 2006, COLORECTAL DIS, V8, P688, DOI 10.1111/j.1463-1318.2006.01014.x; Murchie P, 2014, BRIT J CANCER, V111, P461, DOI 10.1038/bjc.2014.352; Myrdal G, 2004, THORAX, V59, P45; National Institute for Health and Clinical Excellence, 2014, REFERRAL GUIDELINES; National Institute for Health and Clinical Excellence, 2005, REFERRAL GUIDELINES; Neal RD, 2014, BRIT J CANCER, V110, P584, DOI 10.1038/bjc.2013.791; Neal RD, 2009, BRIT J CANCER, V101, pS9, DOI 10.1038/sj.bjc.6605384; Neal RD, 2005, BRIT J CANCER, V92, P1971, DOI 10.1038/sj.bjc.6602623; Neal RD, 2015, BR J CANCER; Noble M, 2008, THE ENGLISH INDICES; Nur U, 2010, INT J EPIDEMIOL, V39, P118, DOI 10.1093/ije/dyp309; Office of the Deputy Prime Minister, 2004, THE ENGLISH INDICES; OS M, 1985, THEORETICAL EPIDEMIO; PORTA M, 1991, J EPIDEMIOL COMMUN H, V45, P225, DOI 10.1136/jech.45.3.225; Pruitt SL, 2013, CANCER CAUSE CONTROL, V24, P961, DOI 10.1007/s10552-013-0172-6; Radzikowska E, 2013, ADV EXP MED BIOL, V788, P355, DOI 10.1007/978-94-007-6627-3_48; Rai S, 2007, COLORECTAL DIS, V9, P195, DOI 10.1111/j.1463-1318.2006.01107.x; Ramos M, 2007, EUR J CANCER, V43, P2467, DOI 10.1016/j.ejca.2007.08.023; Redaniel MT, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-642; Richards MA, 2009, BRIT J CANCER, V101, pS125, DOI 10.1038/sj.bjc.6605402; Richards MA, 1999, LANCET, V353, P1119, DOI 10.1016/S0140-6736(99)02143-1; Richards MA, 1999, BRIT J CANCER, V79, P858, DOI 10.1038/sj.bjc.6690137; Royston P, 2005, STATA J, V5, P527, DOI 10.1177/1536867X0500500404; Rupassara KS, 2006, COLORECTAL DIS, V8, P423, DOI 10.1111/j.1463-1318.2006.00958.x; Salisbury C, 2013, BRIT J GEN PRACT, V63, pE751, DOI 10.3399/bjgp13X674431; StataCorp, 2011, STATA STATISTICAL SO; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Tavassoli FA, 2003, PATHOLOGY AND GENETI; Torring ML, 2012, J CLIN EPIDEMIOL, V65, P669, DOI 10.1016/j.jclinepi.2011.12.006; Torring ML, 2013, EUR J CANCER; Travis WD, 2004, PATHOLOGY AND GENETI; Weller D, 2012, BRIT J CANCER, V106, P1262, DOI 10.1038/bjc.2012.68	59	47	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0126608	10.1371/journal.pone.0126608	http://dx.doi.org/10.1371/journal.pone.0126608			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933397	Green Submitted, Green Published, gold			2022-12-27	WOS:000353887100154
J	Sankaranarayanan, S; Barten, DM; Vana, L; Devidze, N; Yang, L; Cadelina, G; Hoque, N; DeCarr, L; Keenan, S; Lin, A; Cao, Y; Snyder, B; Zhang, B; Nitla, M; Hirschfeld, G; Barrezueta, N; Polson, C; Wes, P; Rangan, VS; Cacace, A; Albright, CF; Meredith, J; Trojanowski, JQ; Lee, VMY; Brunden, KR; Ahlijanian, M				Sankaranarayanan, Sethu; Barten, Donna M.; Vana, Laurel; Devidze, Nino; Yang, Ling; Cadelina, Gregory; Hoque, Nina; DeCarr, Lynn; Keenan, Stefanie; Lin, Alan; Cao, Yang; Snyder, Bradley; Zhang, Bin; Nitla, Magdalena; Hirschfeld, Gregg; Barrezueta, Nestor; Polson, Craig; Wes, Paul; Rangan, Vangipuram S.; Cacace, Angela; Albright, Charles F.; Meredith, Jere, Jr.; Trojanowski, John Q.; Lee, Virginia M-Y.; Brunden, Kurt R.; Ahlijanian, Michael			Passive Immunization with Phospho-Tau Antibodies Reduces Tau Pathology and Functional Deficits in Two Distinct Mouse Tauopathy Models	PLOS ONE			English	Article							NEUROFIBRILLARY TANGLES; ALZHEIMER-DISEASE; CEREBROSPINAL-FLUID; EXTRACELLULAR TAU; SYNTHETIC TAU; PROTEIN; IMMUNOTHERAPY; TRANSMISSION; PROPAGATION; SPREAD	In Alzheimer's disease (AD), an extensive accumulation of extracellular amyloid plaques and intraneuronal tau tangles, along with neuronal loss, is evident in distinct brain regions. Staging of tau pathology by postmortem analysis of AD subjects suggests a sequence of initiation and subsequent spread of neurofibrillary tau tangles along defined brain anatomical pathways. Further, the severity of cognitive deficits correlates with the degree and extent of tau pathology. In this study, we demonstrate that phospho-tau (p-tau) antibodies, PHF6 and PHF13, can prevent the induction of tau pathology in primary neuron cultures. The impact of passive immunotherapy on the formation and spread of tau pathology, as well as functional deficits, was subsequently evaluated with these antibodies in two distinct transgenic mouse tauopathy models. The rTg4510 transgenic mouse is characterized by inducible over-expression of P301L mutant tau, and exhibits robust age-dependent brain tau pathology. Systemic treatment with PHF6 and PHF13 from 3 to 6 months of age led to a significant decline in brain and CSF p-tau levels. In a second model, injection of preformed tau fibrils (PFFs) comprised of recombinant tau protein encompassing the microtubule-repeat domains into the cortex and hippocampus of young P301S mutant tau over-expressing mice (PS19) led to robust tau pathology on the ipsilateral side with evidence of spread to distant sites, including the contralateral hippocampus and bilateral entorhinal cortex 4 weeks post-injection. Systemic treatment with PHF13 led to a significant decline in the spread of tau pathology in this model. The reduction in tau species after p-tau antibody treatment was associated with an improvement in novel-object recognition memory test in both models. These studies provide evidence supporting the use of tau immunotherapy as a potential treatment option for AD and other tauopathies.	[Sankaranarayanan, Sethu; Barten, Donna M.; Devidze, Nino; Yang, Ling; Cadelina, Gregory; Hoque, Nina; DeCarr, Lynn; Keenan, Stefanie; Lin, Alan; Cao, Yang; Snyder, Bradley; Hirschfeld, Gregg; Barrezueta, Nestor; Polson, Craig; Wes, Paul; Cacace, Angela; Albright, Charles F.; Meredith, Jere, Jr.; Ahlijanian, Michael] Bristol Myers Squibb, Res & Dev, Wallingford, CT 06492 USA; [Vana, Laurel; Zhang, Bin; Nitla, Magdalena; Trojanowski, John Q.; Lee, Virginia M-Y.; Brunden, Kurt R.] Univ Penn, Perelman Sch Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA; [Rangan, Vangipuram S.] Bristol Myers Squibb, Res & Dev, Redwood City, CA USA	Bristol-Myers Squibb; University of Pennsylvania; Pennsylvania Medicine; Bristol-Myers Squibb	Sankaranarayanan, S (corresponding author), Bristol Myers Squibb, Res & Dev, Wallingford, CT 06492 USA.	sethus2008@gmail.com; kbrunden@upenn.edu; Michael.Ahlijanian@bms.com			Bristol-Myers Squibb; NIH grant [AG17586]; Marian S. Ware Alzheimer Program; CurePSP; Karen Cohen Segal and Christopher S. Segal Alzheimer Drug Discovery Initiative Fund; Paula C. Schmerler Fund for Alzheimer's Research; Barrist Neurodegenerative Disease Research Fund; Eleanor Margaret Kurtz Endowed Fund; Mary Rasmus Endowed Fund for Alzheimer's Research; Mrs. Gloria J. Miller and Arthur Peck, M.D.; NATIONAL INSTITUTE ON AGING [P01AG017586] Funding Source: NIH RePORTER	Bristol-Myers Squibb(Bristol-Myers Squibb); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marian S. Ware Alzheimer Program; CurePSP; Karen Cohen Segal and Christopher S. Segal Alzheimer Drug Discovery Initiative Fund; Paula C. Schmerler Fund for Alzheimer's Research; Barrist Neurodegenerative Disease Research Fund; Eleanor Margaret Kurtz Endowed Fund; Mary Rasmus Endowed Fund for Alzheimer's Research; Mrs. Gloria J. Miller and Arthur Peck, M.D.; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by funds from Bristol-Myers Squibb, and in part by NIH grant AG17586 and the Marian S. Ware Alzheimer Program, CurePSP, the Karen Cohen Segal and Christopher S. Segal Alzheimer Drug Discovery Initiative Fund, the Paula C. Schmerler Fund for Alzheimer's Research, the Barrist Neurodegenerative Disease Research Fund, the Eleanor Margaret Kurtz Endowed Fund, the Mary Rasmus Endowed Fund for Alzheimer's Research, Mrs. Gloria J. Miller and Arthur Peck, M.D. The funder provided support in the form of salaries for authors [SS, DB, ND, LY, GC, NH, LD, SK, AL, YC, BS, GH, NB, CP, PW, VR, AC, CA, JM, MA], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahmed Z, 2014, ACTA NEUROPATHOL, V127, P667, DOI 10.1007/s00401-014-1254-6; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Asuni AA, 2007, J NEUROSCI, V27, P9115, DOI 10.1523/JNEUROSCI.2361-07.2007; Bae EJ, 2012, J NEUROSCI, V32, P13454, DOI 10.1523/JNEUROSCI.1292-12.2012; Barten DM, 2011, J ALZHEIMERS DIS, V24, P127, DOI 10.3233/JAD-2011-110161; Bi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026860; Blennow K, 2012, ARCH NEUROL-CHICAGO, V69, P1002, DOI 10.1001/archneurol.2012.90; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Boimel M, 2010, EXP NEUROL, V224, P472, DOI 10.1016/j.expneurol.2010.05.010; Boutajangout A, 2011, J NEUROCHEM, V118, P658, DOI 10.1111/j.1471-4159.2011.07337.x; Boutajangout A, 2010, J NEUROSCI, V30, P16559, DOI 10.1523/JNEUROSCI.4363-10.2010; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Braak H, 2011, ACTA NEUROPATHOL, V121, P171, DOI 10.1007/s00401-010-0789-4; Bright J, 2015, NEUROBIOL AGING, V36, P693, DOI 10.1016/j.neurobiolaging.2014.09.007; Chai XY, 2011, J BIOL CHEM, V286, P34457, DOI 10.1074/jbc.M111.229633; Clavaguera F, 2013, P NATL ACAD SCI USA, V110, P9535, DOI 10.1073/pnas.1301175110; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Congdon EE, 2014, J ALZHEIMERS DIS, V40, pS113, DOI 10.3233/JAD-132435; d'Abramo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062402; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Guo JL, 2014, NAT MED, V20, P130, DOI 10.1038/nm.3457; Guo JL, 2013, FEBS LETT, V587, P717, DOI 10.1016/j.febslet.2013.01.051; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Hardy J, 2012, NEW ENGL J MED, V366, P2126, DOI 10.1056/NEJMcibr1202401; Hebert LE, 2001, ALZ DIS ASSOC DIS, V15, P169, DOI 10.1097/00002093-200110000-00002; Hebert LE, 2013, NEUROLOGY, V80, P1778, DOI 10.1212/WNL.0b013e31828726f5; Hoffmann R, 1997, BIOCHEMISTRY-US, V36, P8114, DOI 10.1021/bi970380+; Holmes BB, 2014, J BIOL CHEM, V289, P19855, DOI 10.1074/jbc.R114.549295; Hurtado DE, 2010, AM J PATHOL, V177, P1977, DOI 10.2353/ajpath.2010.100346; Iba M, 2013, J NEUROSCI, V33, P1024, DOI 10.1523/JNEUROSCI.2642-12.2013; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; MCKEE AC, 1991, ANN NEUROL, V30, P156, DOI 10.1002/ana.410300206; Meredith JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076523; Paxinos, 2012, MOUSE BRAIN STEREOTA; Peeraer E, 2015, NEUROBIOL DIS, V73, P83, DOI 10.1016/j.nbd.2014.08.032; Polydoro M, 2014, ACTA NEUROPATHOL, V127, P257, DOI 10.1007/s00401-013-1215-5; Polymenidou M, 2012, J EXP MED, V209, P889, DOI 10.1084/jem.20120741; Rosenmann H, 2008, EXP NEUROL, V212, P71, DOI 10.1016/j.expneurol.2008.03.007; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Troquier L, 2012, CURR ALZHEIMER RES, V9, P397, DOI 10.2174/156720512800492503; Vogelsberg-Ragaglia V, 2000, MOL BIOL CELL, V11, P4093, DOI 10.1091/mbc.11.12.4093; Walker LC, 2013, JAMA NEUROL, V70, P304, DOI 10.1001/jamaneurol.2013.1453; Witter MP, 2007, LEARN MEMORY, V14, P705, DOI 10.1101/lm.725207; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Wu JW, 2013, J BIOL CHEM, V288, P1856, DOI 10.1074/jbc.M112.394528; Yamada K, 2014, J EXP MED, V211, P387, DOI 10.1084/jem.20131685; Yamada K, 2011, J NEUROSCI, V31, P13110, DOI 10.1523/JNEUROSCI.2569-11.2011; Yanamandra K, 2013, NEURON, V80, P402, DOI 10.1016/j.neuron.2013.07.046; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010	52	99	106	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125614	10.1371/journal.pone.0125614	http://dx.doi.org/10.1371/journal.pone.0125614			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933020	Green Submitted, Green Published, gold			2022-12-27	WOS:000353887100122
J	Sun, HY; Kim, N; Hwang, CS; Yoo, JY				Sun, Hwa-Young; Kim, Nari; Hwang, Cheol-Sang; Yoo, Joo-Yeon			Protein Degradation of RNA Polymerase II-Association Factor 1(PAF1) Is Controlled by CNOT4 and 26S Proteasome	PLOS ONE			English	Article							PAF1 COMPLEX; CCR4-NOT COMPLEX; GENE-EXPRESSION; EUKARYOTIC CELLS; TRANSCRIPTION; CHROMATIN; METHYLATION; UBIQUITINATION; RECRUITMENT; ELONGATION	The PAF complex (PAFc) participates in various steps of the transcriptional process, from initiation to termination, by interacting with and recruiting various proteins to the proper locus for each step. PAFc is an evolutionarily conserved, multi-protein complex comprising PAF1, CDC73, CTR9, LEO1, yRTF1 and, in humans, hSKI8. These components of PAFc work together, and their protein levels are closely interrelated. In the present study, we investigated the mechanism of PAF1 protein degradation. We found that PAF1 protein levels are negatively regulated by the expression of CNOT4, an ortholog of yNOT4 and a member of the CCR4-NOT complex. CNOT4 specifically controls PAF1 but not other components of PAFc at the protein level by regulating the polyubiquitination of PAF1 and its subsequent degradation by the 26S proteasome. The degradation of PAF1 was found to require nuclear localization, as no PAF1 degradation by CNOT4 and the 26S proteasome was observed with NLS (nucleus localization signal)-deficient PAF1 mutants. However, chromatin binding by PAF1 was not necessary for 26S proteasome- or CNOT4-mediated degradation. Our results suggest that CNOT4 controls the degradation of chromatin-unbound PAF1 via the 26S proteasome.	[Sun, Hwa-Young; Kim, Nari; Hwang, Cheol-Sang; Yoo, Joo-Yeon] Pohang Univ Sci & Technol, Dept Life Sci, Pohang, South Korea	Pohang University of Science & Technology (POSTECH)	Yoo, JY (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, Pohang, South Korea.	jyoo@postech.ac.kr	Hwang, Cheol-Sang/Q-7391-2019	Hwang, Cheol-Sang/0000-0002-0105-5957; Kim, Nari/0000-0003-4837-9278	National Research Foundation of Korea (NRF) - Korea government (MSIP) [NRF-2012R1A2A2A01007525, NRF-2012R1A4 A1028200]	National Research Foundation of Korea (NRF) - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF; http://www.nrf.re.kr/) grant funded by the Korea government (MSIP) (NO. NRF-2012R1A2A2A01007525, NRF-2012R1A4 A1028200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrich CG, 2012, J BIOL CHEM, V287, P10863, DOI 10.1074/jbc.M111.325647; Carrera I, 2008, CURR OPIN GENET DEV, V18, P397, DOI 10.1016/j.gde.2008.07.007; Chaudhary K, 2007, ONCOGENE, V26, P7499, DOI 10.1038/sj.onc.1210582; Collart MA, 2013, CELL SIGNAL, V25, P743, DOI 10.1016/j.cellsig.2012.12.018; Collart MA, 2012, GENE, V492, P42, DOI 10.1016/j.gene.2011.09.033; Filtz TM, 2014, TRENDS PHARMACOL SCI, V35, P76, DOI 10.1016/j.tips.2013.11.005; Finkbeiner MG, 2008, CELL CYCLE, V7, P3908, DOI 10.4161/cc.7.24.7354; Harreman M, 2009, P NATL ACAD SCI USA, V106, P20705, DOI 10.1073/pnas.0907052106; Jaehning JA, 2010, BBA-GENE REGUL MECH, V1799, P379, DOI 10.1016/j.bbagrm.2010.01.001; Kim J, 2010, CELL, V140, P491, DOI 10.1016/j.cell.2009.12.050; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Kim N, 2013, NUCLEIC ACIDS RES, V41, P4495, DOI 10.1093/nar/gkt156; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Lin L, 2008, P NATL ACAD SCI USA, V105, P17420, DOI 10.1073/pnas.0710725105; Marazzi I, 2012, NATURE, V483, P428, DOI 10.1038/nature10892; Mersman DP, 2009, GENE DEV, V23, P951, DOI 10.1101/gad.1769209; Miller JE, 2012, CRIT REV BIOCHEM MOL, V47, P315, DOI 10.3109/10409238.2012.667214; Moniaux N, 2006, ONCOGENE, V25, P3247, DOI 10.1038/sj.onc.1209353; Mueller CL, 2004, MOL CELL, V14, P447, DOI 10.1016/S1097-2765(04)00257-6; Mulder KW, 2007, NUCLEIC ACIDS RES, V35, P2428, DOI 10.1093/nar/gkm175; Naar AM, 2001, ANNU REV BIOCHEM, V70, P475, DOI 10.1146/annurev.biochem.70.1.475; Nordick K, 2008, EUKARYOT CELL, V7, P1158, DOI 10.1128/EC.00434-07; Panasenko OO, 2011, MOL CELL BIOL, V31, P1610, DOI 10.1128/MCB.01210-10; Peng WM, 2008, GENETICS, V179, P277, DOI 10.1534/genetics.107.085068; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shema E, 2011, MOL CELL, V42, P477, DOI 10.1016/j.molcel.2011.03.011; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Tomson BN, 2013, BBA-GENE REGUL MECH, V1829, P116, DOI 10.1016/j.bbagrm.2012.08.011; Ulrich HD, 2014, NAT STRUCT MOL BIOL, V21, P317, DOI 10.1038/nsmb.2805; Voss TC, 2014, NAT REV GENET, V15, P69, DOI 10.1038/nrg3623; Woelk T, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-11; Youn MY, 2007, J BIOL CHEM, V282, P34727, DOI 10.1074/jbc.M705411200	32	21	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125599	10.1371/journal.pone.0125599	http://dx.doi.org/10.1371/journal.pone.0125599			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933433	Green Published, Green Submitted, gold			2022-12-27	WOS:000353887100119
J	Vitezova, A; Cartolano, NS; Heeringa, J; Zillikens, MC; Hofman, A; Franco, OH; Kiefte-de Jong, JC				Vitezova, Anna; Cartolano, Natasha S.; Heeringa, Jan; Zillikens, M. Carola; Hofman, Albert; Franco, Oscar H.; Kiefte-de Jong, Jessica C.			Vitamin D and the Risk of Atrial Fibrillation The Rotterdam Study	PLOS ONE			English	Article							CONGESTIVE-HEART-FAILURE; ANGIOTENSIN-II; D DEFICIENCY; PREVALENCE; POPULATION; EPIDEMIOLOGY; VALIDATION; GUIDELINES; MANAGEMENT; SUBSTRATE	Atrial fibrillation (AF) is the most common chronic arrhythmia and it increases the risk of cardiovascular morbidity and mortality. Still there is not a complete understanding of its etiology and underlying pathways. Vitamin D might regulate renin-angiotensin-aldosterone system and might be involved in inflammation, both implicated in the pathophysiology of AF. The objective of this work was to investigate the association between vitamin D status with the risk of AF in the elderly. This study was conducted within the Rotterdam Study, a community-based cohort of middle-aged and elderly participants in Rotterdam, The Netherlands. We had 3,395 participants who were free of AF diagnosis at the start of our study and who had vitamin D data available. We analyzed the association between serum 25-hydroxivitamin D (25(OH)D) and incidence of AF using Cox regression models. Vitamin D deficiency was defined as serum 25(OH)D concentrations <50nmol/l, insufficiency between 50nmol/l and 75nmol/l, while serum 25(OH)D concentrations equal to and above 75nmol/l were considered as adequate. After mean follow-up of 12.0 years 263 (7.7%) participants were diagnosed with incident AF. Vitamin D status was not associated with AF in any of the 3 multivariate models tested (model adjusted for socio-demographic factors and life-style factors: HR per 10 unit increment in serum 25(OH)D 0.96, 95% CI: 0.91-1.02; HR for insufficiency: 0.82, 95% CI: 0.60-1.11, and HR for adequate status: 0.76, 95% CI: 0.52-1.12 compared to deficiency). This prospective cohort study does not support the hypothesis that vitamin D status is associated with AF.	[Vitezova, Anna; Cartolano, Natasha S.; Heeringa, Jan; Hofman, Albert; Franco, Oscar H.; Kiefte-de Jong, Jessica C.] Erasmus MC, Univ Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Zillikens, M. Carola] Erasmus MC, Univ Med Ctr, Dept Internal Med, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Vitezova, A (corresponding author), Erasmus MC, Univ Med Ctr, Dept Epidemiol, Rotterdam, Netherlands.	a.vitezova@erasmusmc.nl	Franco, Óscar H/ABE-2305-2020; Kiefte-de Jong, Jessica/GLV-3216-2022	Franco, Óscar H/0000-0002-4606-4929; Kiefte-de Jong, Jessica/0000-0002-8136-0918	Erasmus MC and Erasmus University, Rotterdam, the Netherlands; Netherlands Organization for Scientific Research (NWO); Netherlands Organization for the Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; European Commission (DG XII); Municipality of Rotterdam; Nestle Nutrition (Nestec Ltd.); Metagenics Inc.; AXA; DSM Nutritional Products AG, Kaiseraugst, Switzerland; Erasmus Mundus Western Balkans (ERAWEB) - European Commission	Erasmus MC and Erasmus University, Rotterdam, the Netherlands(Netherlands Government); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for the Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; Nestle Nutrition (Nestec Ltd.)(Nestle SA); Metagenics Inc.; AXA; DSM Nutritional Products AG, Kaiseraugst, Switzerland; Erasmus Mundus Western Balkans (ERAWEB) - European Commission	The Rotterdam Study is funded by Erasmus MC and Erasmus University, Rotterdam, the Netherlands; the Netherlands Organization for Scientific Research (NWO); the Netherlands Organization for the Health Research and Development (ZonMw); the Research Institute for Diseases in the Elderly (RIDE); the Ministry of Education, Culture and Science; the Ministry for Health, Welfare and Sports; the European Commission (DG XII); and the Municipality of Rotterdam. NSC, AV, JCK and OHF work in ErasmusAGE, a center for aging research across the life course funded by Nestle Nutrition (Nestec Ltd.); Metagenics Inc.; and AXA. DSM Nutritional Products AG, Kaiseraugst, Switzerland provided funding for the assessment of vitamin D. AV has been supported by the Erasmus Mundus Western Balkans (ERAWEB), project funded by the European Commission. NSC is a Brazilian government sponsored student on the program Brazil Science Without Borders. These funding sources had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review or approval of the manuscript.	Afzal S, 2013, CLIN CHEM, V59, P771, DOI 10.1373/clinchem.2012.201939; Andrade J, 2014, CIRC RES, V114, P1453, DOI 10.1161/CIRCRESAHA.114.303211; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Boldt A, 2004, HEART, V90, P400, DOI 10.1136/hrt.2003.015347; Calvo MS, 2005, J NUTR, V135, P310, DOI 10.1093/jn/135.2.310; Canning MO, 2001, EUR J ENDOCRINOL, V145, P351, DOI 10.1530/eje.0.1450351; Cardin S, 2003, CARDIOVASC RES, V60, P315, DOI 10.1016/j.cardiores.2003.08.014; CASPERSEN CJ, 1991, AM J EPIDEMIOL, V133, P1078, DOI 10.1093/oxfordjournals.aje.a115821; Chen WR, 2013, ANN NONINVASIVE ELEC; Chowdhury R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1903; CORLESS D, 1979, GERONTOLOGY, V25, P350, DOI 10.1159/000212364; Dagres N, 2007, J AM COLL CARDIOL, V49, P572, DOI 10.1016/j.jacc.2006.10.047; DeLuca HF, 2004, AM J CLIN NUTR, V80, p1689S, DOI 10.1093/ajcn/80.6.1689S; Demir M, 2012, CLIN APPL THROMB HEM; Friberg J, 2004, AM J CARDIOL, V94, P889, DOI 10.1016/j.amjcard.2004.06.023; Friberg J, 2003, AM J CARDIOL, V92, P1419, DOI 10.1016/j.amjcard.2003.08.050; Frustaci A, 1997, CIRCULATION, V96, P1180, DOI 10.1161/01.CIR.96.4.1180; Gaborit N, 2010, J MOL CELL CARDIOL, V49, P639, DOI 10.1016/j.yjmcc.2010.06.005; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Goette A, 2000, CIRCULATION, V101, P2678, DOI 10.1161/01.CIR.101.23.2678; Goette A, 2008, EUROPACE, V10, P238, DOI 10.1093/europace/eum283; Grohe C, 1997, FEBS LETT, V416, P107, DOI 10.1016/S0014-5793(97)01179-4; Halligan SC, 2004, ANN INTERN MED, V140, P265, DOI 10.7326/0003-4819-140-4-200402170-00008; Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825; Heeringa J, 2008, AM HEART J, V156, P1163, DOI 10.1016/j.ahj.2008.08.003; Hofman A, 2013, EUR J EPIDEMIOL, V28, P889, DOI 10.1007/s10654-013-9866-z; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Klein I, 1998, ENDOCRIN METAB CLIN, V27, P51, DOI 10.1016/S0889-8529(05)70297-8; Klipstein-Grobusch K, 1998, EUR J CLIN NUTR, V52, P588, DOI 10.1038/sj.ejcn.1600611; Kors JA, 1996, J ELECTROCARDIOL, V29, P83, DOI 10.1016/S0022-0736(96)80025-2; Koura T, 2002, CIRCULATION, V105, P2092, DOI 10.1161/01.CIR.0000015506.36371.0D; Krijthe BP, 2013, EUR HEART J, V34, P2746, DOI 10.1093/eurheartj/eht280; Kunadian V, 2014, AM HEART J, V167, P283, DOI 10.1016/j.ahj.2013.11.012; Lappegard KT, 2013, SCAND J IMMUNOL, V78, P112, DOI 10.1111/sji.12061; Leening MJG, 2012, EUR J EPIDEMIOL, V27, P173, DOI 10.1007/s10654-012-9668-8; Lelorier P, 2004, AM J CARDIOL, V93, P647, DOI 10.1016/j.amjcard.2003.11.042; Li YC, 2003, J CELL BIOCHEM, V88, P327, DOI 10.1002/jcb.10343; MACLAUGHLIN J, 1985, J CLIN INVEST, V76, P1536, DOI 10.1172/JCI112134; Manjunath G, 2001, CURR OPIN NEPHROL HY, V10, P785, DOI 10.1097/00041552-200111000-00009; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Mithal A, 2009, OSTEOPOROSIS INT, V20, P1807, DOI 10.1007/s00198-009-0954-6; Mosterd A, 1999, EUR HEART J, V20, P447, DOI 10.1053/euhj.1998.1239; Nakashima H, 2000, CIRCULATION, V101, P2612, DOI 10.1161/01.CIR.101.22.2612; Nanchen D, 2013, CIRC-HEART FAIL, V6, P403, DOI 10.1161/CIRCHEARTFAILURE.112.000171; Norman PE, 2014, CIRC RES, V114, P379, DOI 10.1161/CIRCRESAHA.113.301241; Oldgren J, 2014, CIRCULATION, V129, P1568, DOI 10.1161/CIRCULATIONAHA.113.005451; Ott A, 1997, STROKE, V28, P316, DOI 10.1161/01.STR.28.2.316; Prentice A, 2008, NUTR REV, V66, pS153, DOI 10.1111/j.1753-4887.2008.00100.x; Qayyum F, 2012, DAN MED J, V59; Rienstra M, 2011, AM HEART J, V162, P538, DOI 10.1016/j.ahj.2011.06.013; Stewart S, 2002, AM J MED, V113, P359, DOI 10.1016/S0002-9343(02)01236-6; Swedberg K, 2005, EUR HEART J, V26, P1115, DOI 10.1093/eurheartj/ehi204; Vacek JL, 2012, AM J CARDIOL, V109, P359, DOI 10.1016/j.amjcard.2011.09.020; van Lee L, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-49; VANBEMMEL JH, 1990, METHOD INFORM MED, V29, P346; VANDERWIELEN RPJ, 1995, LANCET, V346, P207, DOI 10.1016/S0140-6736(95)91266-5; Wang TJ, 2003, CIRCULATION, V107, P2920, DOI 10.1161/01.CIR.0000072767.89944.6E; Woods CE, 2014, CIRC RES, V114, P1532, DOI 10.1161/CIRCRESAHA.114.302362; YU W, 1994, P ROY SOC B-BIOL SCI, V255, P125, DOI 10.1098/rspb.1994.0018; Zhou CL, 2008, KIDNEY INT, V74, P170, DOI 10.1038/ki.2008.101; Zoni-Berisso M, 2014, CLIN EPIDEMIOL, V6, P213, DOI 10.2147/CLEP.S47385	62	23	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125161	10.1371/journal.pone.0125161	http://dx.doi.org/10.1371/journal.pone.0125161			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933375	gold, Green Submitted, Green Published			2022-12-27	WOS:000353887100083
J	Akagi, T; Kato, K; Kobayashi, M; Kosaka, N; Ochiya, T; Ichiki, T				Akagi, Takanori; Kato, Kei; Kobayashi, Masashi; Kosaka, Nobuyoshi; Ochiya, Takahiro; Ichiki, Takanori			On-Chip Immunoelectrophoresis of Extracellular Vesicles Released from Human Breast Cancer Cells	PLOS ONE			English	Article							INTERCELLULAR COMMUNICATION; MEMBRANE-VESICLES; EXOSOMES; MICROVESICLES; MICROPARTICLES; BLOOD; DYSFUNCTION; ANTIBODIES; EXCHANGE; DELIVERY	Extracellular vesicles (EVs) including exosomes and microvesicles have attracted considerable attention in the fields of cell biology and medicine. For a better understanding of EVs and further exploration of their applications, the development of analytical methods for biological nanovesicles has been required. In particular, considering the heterogeneity of EVs, methods capable of measuring individual vesicles are desired. Here, we report that on-chip immunoelectrophoresis can provide a useful method for the differential protein expression profiling of individual EVs. Electrophoresis experiments were performed on EVs collected from the culture supernatant of MDA-MB-231 human breast cancer cells using a measurement platform comprising a microcapillary electrophoresis chip and a laser dark-field microimaging system. The zeta potential distribution of EVs that reacted with an anti-human CD63 (exosome and microvesicle marker) antibody showed a marked positive shift as compared with that for the normal immunoglobulin G (IgG) isotype control. Thus, on-chip immunoelectrophoresis could sensitively detect the over-expression of CD63 glycoproteins on EVs. Moreover, to explore the applicability of on-chip immunoelectrophoresis to cancer diagnosis, EVs collected from the blood of a mouse tumor model were analyzed by this method. By comparing the zeta potential distributions of EVs after their immunochemical reaction with normal IgG, and the anti-human CD63 and anti-human CD44 (cancer stem cell marker) antibodies, EVs of tumor origin circulating in blood were differentially detected in the real sample. The result indicates that the present method is potentially applicable to liquid biopsy, a promising approach to the low-invasive diagnosis of cancer.	[Akagi, Takanori; Kato, Kei; Kobayashi, Masashi; Ichiki, Takanori] Univ Tokyo, Sch Engn, Dept Bioengn, Bunkyo Ku, Tokyo, Japan; [Kosaka, Nobuyoshi; Ochiya, Takahiro] Natl Canc Ctr, Res Inst, Div Mol & Cellular Med, Chuo Ku, Tokyo 104, Japan	University of Tokyo; National Cancer Center - Japan	Ichiki, T (corresponding author), Univ Tokyo, Sch Engn, Dept Bioengn, Bunkyo Ku, 2-11-16 Yayoi, Tokyo, Japan.	ichiki@bioeng.t.tu-tokyo.ac.jp	Ichiki, Takanori/E-6430-2014; Shimogaki, Yukihiro/O-7414-2015; Ochiya, Takahiro/AAH-7585-2019	Ichiki, Takanori/0000-0002-3917-7140; 	Center of Innovation Program from Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science (JSPS) through its "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)"; Ministry of Education, Culture, Sports, Science and Technology, Japan [24710114]; Adaptable and Seamless Technology Transfer Program through Target-driven R&D (A-STEP) from the JST [AS2531063P]	Center of Innovation Program from Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science (JSPS) through its "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)"(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Adaptable and Seamless Technology Transfer Program through Target-driven R&D (A-STEP) from the JST	This research was supported by the Center of Innovation Program from Japan Science and Technology Agency (JST) and the Japan Society for the Promotion of Science (JSPS) through its "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)." In addition, this work was supported by a Grant-in-Aid for Young Scientists (B) (24710114 to TA) from the Ministry of Education, Culture, Sports, Science and Technology, Japan and a grant from the Adaptable and Seamless Technology Transfer Program through Target-driven R&D (A-STEP) (AS2531063P to TI) from the JST. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aatonen MT, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24692; Agouni A, 2008, AM J PATHOL, V173, P1210, DOI 10.2353/ajpath.2008.080228; Akagi T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.06JL01; Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Amabile N, 2005, J AM SOC NEPHROL, V16, P3381, DOI 10.1681/ASN.2005050535; Andre F, 2002, LANCET, V360, P295, DOI 10.1016/S0140-6736(02)09552-1; Bartolini E, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20181; Bobrie A, 2011, TRAFFIC, V12, P1659, DOI 10.1111/j.1600-0854.2011.01225.x; Boing AN, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.23430; Conde-Vancells J, 2008, J PROTEOME RES, V7, P5157, DOI 10.1021/pr8004887; Crescitelli R, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20677; Diehl P, 2011, J THROMB THROMBOLYS, V31, P173, DOI 10.1007/s11239-010-0507-z; Fanni D, 2013, RENAL FAILURE, V35, P967, DOI 10.3109/0886022X.2013.808955; Gardiner C, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.19671; Hamada Y, 2007, J PHOTOPOLYM SCI TEC, V20, P245, DOI 10.2494/photopolymer.20.245; Ichiki T, 2002, ELECTROPHORESIS, V23, P2029, DOI 10.1002/1522-2683(200207)23:13<2029::AID-ELPS2029>3.0.CO;2-R; ISHIHARA K, 1992, J BIOMED MATER RES, V26, P1543, DOI 10.1002/jbm.820261202; Jayachandran M, 2012, J IMMUNOL METHODS, V375, P207, DOI 10.1016/j.jim.2011.10.012; Kato K, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.06GK10; Kato K, 2013, ELECTROPHORESIS, V34, P1212, DOI 10.1002/elps.201200549; Kim DK, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20384; Kosaka N, 2013, J BIOL CHEM, V288, P10849, DOI 10.1074/jbc.M112.446831; Lai RC, 2010, STEM CELL RES, V4, P214, DOI 10.1016/j.scr.2009.12.003; Li JH, 2013, NAT IMMUNOL, V14, P793, DOI 10.1038/ni.2647; METZELAAR MJ, 1991, VIRCHOWS ARCH B, V61, P269; Mittelbrunn M, 2012, NAT REV MOL CELL BIO, V13, P328, DOI 10.1038/nrm3335; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Momen-Heravi F, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00162; Morse MA, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-9; Murohashi M, 2010, BRIT J CANCER, V102, P206, DOI 10.1038/sj.bjc.6605468; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Qin D, 2010, NAT PROTOC, V5, P491, DOI 10.1038/nprot.2009.234; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van der Pol E, 2010, J THROMB HAEMOST, V8, P2596, DOI 10.1111/j.1538-7836.2010.04074.x; van der Vlist EJ, 2012, NAT PROTOC, V7, P1311, DOI 10.1038/nprot.2012.065; van der Vos KE, 2011, CELL MOL NEUROBIOL, V31, P949, DOI 10.1007/s10571-011-9697-y; Vega VL, 2008, J IMMUNOL, V180, P4299, DOI 10.4049/jimmunol.180.6.4299; Verderio C, 2013, FRONT PHYSIOL, P4; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Witwer KW, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20360; Yoshioka Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4591; Yuana Y, 2011, THROMB HAEMOSTASIS, V105, P396, DOI 10.1160/TH10-09-0595	47	48	50	8	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0123603	10.1371/journal.pone.0123603	http://dx.doi.org/10.1371/journal.pone.0123603			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928805	Green Submitted, Green Published, gold			2022-12-27	WOS:000353713100019
J	Bakhtavar, MA; Afzal, I; Basra, SMA; Ahmad, AU; Noor, MA				Bakhtavar, Muhammad Amir; Afzal, Irfan; Basra, Shahzad Maqsood Ahmed; Ahmad, Azraf-ul-Haq; Noor, Mehmood Ali			Physiological Strategies to Improve the Performance of Spring Maize (Zea mays L.) Planted under Early and Optimum Sowing Conditions	PLOS ONE			English	Article							LEAF EXTRACT; TOLERANCE; ANTIOXIDANT; EXPRESSION; STRESS; LEAVES; WHEAT; SEED	Low temperature at stand establishment and high temperature at reproductive stage are involved in reduction of grain yield of spring maize. A field study was therefore conducted to evaluate different physiological strategies for improving performance of spring maize under temperature extremes. Seed priming and foliar spray with 3% moringa leaf extract (MLE) and 100 mg L-1 kinetin solution alone or in all possible combinations with each other at three growth stages (knee height, tasseling and grain filling stage) and hydropriming was compared with control. Seed priming plus foliar spray of MLE and kinetin significantly improved stand establishment especially under early sown crop as indicated by reduced mean emergence time (MET), improved emergence index (EI) and final emergence percentage (FEP). Similarly increased chlorophyll contents, crop growth rate, leaf area index, photosynthetic rate, transpiration rate, relative water content and decreased membrane permeability were recorded in both early and optimum sowing conditions in MLE priming plus foliar spray treatment. All these improvements were harvested in the form of increased yield and harvest index compared with control treatment. Overall crop sown at optimum time performed best but exogenous application of MLE through seed priming and foliar spray maximally improved the performance of early sown maize crop which is attributed more likely due to improved stand establishment, chlorophyll and phenolic contents, increased leaf area duration and grain filling period. It can be concluded that seed priming with MLE along with its foliar spray could increase production of maize under temperature extremes.	[Bakhtavar, Muhammad Amir; Afzal, Irfan; Basra, Shahzad Maqsood Ahmed] Univ Agr Faisalabad, Dept Crop Physiol, Faisalabad 38040, Pakistan; [Ahmad, Azraf-ul-Haq; Noor, Mehmood Ali] Univ Agr Faisalabad, Dept Agron, Faisalabad 38040, Pakistan; [Noor, Mehmood Ali] King Saud Univ, Coll Food & Agr Sci, Dept Agr Extens & Rural Soc, Riyadh, Saudi Arabia	University of Agriculture Faisalabad; University of Agriculture Faisalabad; King Saud University	Afzal, I (corresponding author), Univ Agr Faisalabad, Dept Crop Physiol, Faisalabad 38040, Pakistan.	iafzal@uaf.edu.pk	Afzal, Irfan/AAE-9266-2020; afzal, irfan/D-1495-2019; Bakhtavar, Muhammad Amir/ABG-1421-2021; Noor, Mehmood Ali/J-7419-2016; Noor, Mehmood Ali/P-7792-2018; Ahmad Basra, Shahzad Maqsood/G-7213-2015	afzal, irfan/0000-0001-5942-7672; Noor, Mehmood Ali/0000-0003-2459-2357; Noor, Mehmood Ali/0000-0003-2459-2357; Bakhtavar, Muhammad Amir/0000-0001-5246-7663	Higher Education Commission Pakistan	Higher Education Commission Pakistan(Higher Education Commission of Pakistan)	Higher Education Commission Pakistan.	Afzal I, 2008, SEED SCI TECHNOL, V36, P497, DOI 10.15258/sst.2008.36.2.26; Afzal I, 2012, SEED SCI TECHNOL, V40, P271, DOI 10.15258/sst.2012.40.2.13; Ajouri A, 2004, J PLANT NUTR SOIL SC, V167, P630, DOI 10.1002/jpln.200420425; Anjorin TS, 2010, INT J AGRIC BIOL, V12, P431; [Anonymous], 2001, MIRACLE TREE MORINGA; AOAC, 1990, OFFICIAL METHODS ANA, P770; AOSA, 1983, CONTRIBUTION HDB SEE, V32; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; Basra SMA, 2011, INT J AGRIC BIOL, V13, P1006; BLUM A, 1981, CROP SCI, V21, P43, DOI 10.2135/cropsci1981.0011183X002100010013x; COHN MA, 1978, AM J BOT, V65, P50, DOI 10.2307/2442553; Dezfuli P. M., 2008, Journal of Agricultural and Biological Science, V3, P22; Ding D, 2009, ANN BOT-LONDON, V103, P29, DOI 10.1093/aob/mcn205; ELLIS RH, 1981, SEED SCI TECHNOL, V9, P373; FAO, 2010, TRENDS CROP SECT; Farooq M, 2008, J AGRON CROP SCI, V194, P161, DOI 10.1111/j.1439-037X.2008.00300.x; FOIDL N., 2001, MIRACLE TREE MULTIPL, P45; Ghassemi-Golezani K, 2008, J FOOD AGRIC ENVIRON, V6, P196; Hunt, 1978, STUDIES BIOL, V96, P8; Irfan Afzal, 2005, [Журнал стресс-физиологии и биохимии, Zhurnal stress-fiziologii i biokhimii], V1, P6; Kaya C, 2010, TURK J AGRIC FOR, V34, P529, DOI 10.3906/tar-0906-173; Khan W, 2003, J PLANT PHYSIOL, V160, P485, DOI 10.1078/0176-1617-00865; Muhamman MA, 2013, INT J CHEM ENV BIOL, V1, P2320; Parida AK, 2004, AQUAT BOT, V80, P77, DOI 10.1016/j.aquabot.2004.07.005; Randhir R, 2004, ASIA PAC J CLIN NUTR, V13, P295; RiceEvans CA, 1997, TRENDS PLANT SCI, V2, P152, DOI 10.1016/S1360-1385(97)01018-2; Rizzardi M. A., 1994, Ciencia Rural, V24, P477, DOI 10.1590/S0103-84781994000300005; STIRLING CM, 1991, PLANT CELL ENVIRON, V14, P947, DOI 10.1111/j.1365-3040.1991.tb00964.x; Truong Q, 2013, J EXP BOT, V1, P1; Wahid A, 2007, J PLANT PHYSIOL, V164, P283, DOI 10.1016/j.jplph.2006.01.005; Waterhouse A. L., 2002, CURRENT PROTOCOLS FO, P1, DOI DOI 10.1002/0471142913.FAA0101S06; Yasmeen A, 2012, CHIL J AGR RES, V72, P92, DOI 10.4067/S0718-58392012000100015	32	37	39	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124441	10.1371/journal.pone.0124441	http://dx.doi.org/10.1371/journal.pone.0124441			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928295	gold, Green Published, Green Submitted			2022-12-27	WOS:000353713100033
J	Fauteux, L; Cottrell, MT; Kirchman, DL; Borrego, CM; Garcia-Chaves, MC; del Giorgio, PA				Fauteux, Lisa; Cottrell, Matthew T.; Kirchman, David L.; Borrego, Carles M.; Garcia-Chaves, Maria Carolina; del Giorgio, Paul A.			Patterns in Abundance, Cell Size and Pigment Content of Aerobic Anoxygenic Phototrophic Bacteria along Environmental Gradients in Northern Lakes	PLOS ONE			English	Article							PHOTOHETEROTROPHIC BACTERIA; PELAGIC BACTERIA; GROWTH-RATES; ARCTIC-OCEAN; DIVERSITY; BACTERIOCHLOROPHYLL; CARBON; SUMMER; WATERS; ATLANTIC	There is now evidence that aerobic anoxygenic phototrophic (AAP) bacteria are widespread across aquatic systems, yet the factors that determine their abundance and activity are still not well understood, particularly in freshwaters. Here we describe the patterns in AAP abundance, cell size and pigment content across wide environmental gradients in 43 temperate and boreal lakes of Quebec. AAP bacterial abundance varied from 1.51 to 5.49 x 10(5) cells mL(-1), representing <1 to 37% of total bacterial abundance. AAP bacteria were present year-round, including the ice-cover period, but their abundance relative to total bacterial abundance was significantly lower in winter than in summer (2.6% and 7.7%, respectively). AAP bacterial cells were on average two-fold larger than the average bacterial cell size, thus AAP cells made a greater relative contribution to biomass than to abundance. Bacteriochlorophyll a (BChla) concentration varied widely across lakes, and was not related to AAP bacterial abundance, suggesting a large intrinsic variability in the cellular pigment content. Absolute and relative AAP bacterial abundance increased with dissolved organic carbon (DOC), whereas cell-specific BChla content was negatively related to chlorophyll a (Chla). As a result, both the contribution of AAP bacteria to total prokaryotic abundance, and the cell-specific BChla pigment content were positively correlated with the DOC: Chla ratio, both peaking in highly colored, low-chlorophyll lakes. Our results suggest that photoheterotrophy might represent a significant ecological advantage in highly colored, low-chlorophyll lakes, where DOC pool is chemically and structurally more complex.	[Fauteux, Lisa; Garcia-Chaves, Maria Carolina; del Giorgio, Paul A.] Univ Quebec, Dept Sci Biol, Grp Rech Interuniv Limnol, Montreal, PQ H3C 3P8, Canada; [Cottrell, Matthew T.; Kirchman, David L.] Univ Delaware, Sch Marine Sci & Policy, Lewes, DE 19958 USA; [Borrego, Carles M.] Univ Girona, Inst Aquat Ecol, Grp Mol Microbial Ecol, E-17071 Girona, Spain	University of Quebec; University of Quebec Montreal; University of Delaware; Universitat de Girona	del Giorgio, PA (corresponding author), Univ Quebec, Dept Sci Biol, Grp Rech Interuniv Limnol, CP 8888, Montreal, PQ H3C 3P8, Canada.	del_giorgio.paul@uqam.ca	Cottrell, Matthew/C-3266-2009; Borrego, Carles M/M-8094-2014; del Giorgio, Paul/AAD-1315-2019; Borrego, Carles/GYV-0941-2022	Borrego, Carles M/0000-0002-2708-3753; del Giorgio, Paul/0000-0003-1866-8159; GARCIA CHAVES, MARIA CAROLINA/0000-0002-7600-533X; Cottrell, Matthew/0000-0003-0449-9999	National Science and Engineering Research Council of Canada; US National Science Foundation [DEB-0814918]	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); US National Science Foundation(National Science Foundation (NSF))	The research was supported by grants from the National Science and Engineering Research Council of Canada to Paul del Giorgio, and a US National Science Foundation grant DEB-0814918 to Matthew Cottrell. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beatty JT, 2002, PHOTOSYNTH RES, V73, P109, DOI 10.1023/A:1020493518379; Benner R., 2003, AQUATIC ECOSYSTEMS I, P121, DOI DOI 10.1016/B978-012256371-3/50006-8; Bertilsson S, 1999, AQUAT MICROB ECOL, V19, P47, DOI 10.3354/ame019047; BORREGO CM, 1994, PHOTOSYNTH RES, V41, P157, DOI 10.1007/BF02184156; Carignan R, 2000, LIMNOL OCEANOGR, V45, P189, DOI 10.4319/lo.2000.45.1.0189; Celussi M, 2015, AQUAT MICROB ECOL, V74, P235, DOI 10.3354/ame01738; Cottrell MT, 2010, ISME J, V4, P945, DOI 10.1038/ismej.2010.13; Cottrell MT, 2009, APPL ENVIRON MICROB, V75, P4958, DOI 10.1128/AEM.00117-09; Cottrell MT, 2006, APPL ENVIRON MICROB, V72, P557, DOI 10.1128/AEM.72.1.557-564.2006; Cuperova Z, 2013, APPL ENVIRON MICROB, V79, P6439, DOI 10.1128/AEM.01526-13; Docherty KM, 2006, MICROB ECOL, V52, P378, DOI 10.1007/s00248-006-9089-x; Eiler A, 2009, APPL ENVIRON MICROB, V75, P7221, DOI 10.1128/AEM.00960-09; Farjalla VF, 2009, ENVIRON SCI POLLUT R, V16, P531, DOI 10.1007/s11356-009-0165-x; Ferrera I, 2013, ENVIRON MICROBIOL, P1; Ferrera I, 2011, APPL ENVIRON MICROB, V77, P7451, DOI 10.1128/AEM.00208-11; Goericke R, 2002, LIMNOL OCEANOGR, V47, P290, DOI 10.4319/lo.2002.47.1.0290; GONZALEZ JM, 1990, APPL ENVIRON MICROB, V56, P583, DOI 10.1128/AEM.56.3.583-589.1990; Grimm B., 2006, CHLOROPHYLLS BACTERI; Guillemette F, 2013, J GEOPHYS RES-BIOGEO, V118, P963, DOI 10.1002/jgrg.20077; Hauruseu D, 2012, APPL ENVIRON MICROB, V78, P7414, DOI 10.1128/AEM.01747-12; Hojerova E, 2011, ENVIRON MICROBIOL, V13, P2717, DOI 10.1111/j.1462-2920.2011.02540.x; Hutalle-Schmelzer KML, 2010, FEMS MICROBIOL ECOL, V72, P58, DOI 10.1111/j.1574-6941.2009.00831.x; IDSO SB, 1973, LIMNOL OCEANOGR, V18, P681, DOI 10.4319/lo.1973.18.4.0681; Jiao NZ, 2007, ENVIRON MICROBIOL, V9, P3091, DOI 10.1111/j.1462-2920.2007.01419.x; Karl DM, 2002, NATURE, V415, P590, DOI 10.1038/415590b; Kirchman DL, 2014, AQUAT MICROB ECOL, V73, P41, DOI 10.3354/ame01709; Kirchman DL, 2013, ENV MICROBIOL REP, V5, P188, DOI 10.1111/j.1758-2229.2012.00367.x; Koblizek M, 2007, ENVIRON MICROBIOL, V9, P2401, DOI 10.1111/j.1462-2920.2007.01354.x; Kolber ZS, 2001, SCIENCE, V292, P2492, DOI 10.1126/science.1059707; Lami R, 2007, APPL ENVIRON MICROB, V73, P4198, DOI 10.1128/AEM.02652-06; Lamy D, 2011, BIOGEOSCIENCES, V8, P973, DOI 10.5194/bg-8-973-2011; Lehours AC, 2010, FEMS MICROBIOL ECOL, V74, P397, DOI 10.1111/j.1574-6941.2010.00954.x; Liu RL, 2010, AQUAT MICROB ECOL, V58, P303, DOI 10.3354/ame01371; Masin M, 2008, ENVIRON MICROBIOL, V10, P1988, DOI 10.1111/j.1462-2920.2008.01615.x; Masin M, 2006, AQUAT MICROB ECOL, V45, P247, DOI 10.3354/ame045247; Masin M, 2012, AQUAT MICROB ECOL, V66, P77, DOI 10.3354/ame01558; Medova H, 2011, FEMS MICROBIOL ECOL, V76, P393, DOI 10.1111/j.1574-6941.2011.01059.x; Nikrad MP, 2012, APPL ENVIRON MICROB, V78, P2402, DOI 10.1128/AEM.07130-11; Pace ML, 2002, LIMNOL OCEANOGR, V47, P333, DOI 10.4319/lo.2002.47.2.0333; Palovaara J, 2014, P NATL ACAD SCI USA, V111, pE3650, DOI 10.1073/pnas.1402617111; Ruiz-Gonzalez C., 2012, FEMS MICROBIOL ECOL, P1; Ruiz-Gonzalez C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00131; Salka I, 2014, GENOME ANNOUNC, V2, P1; Salka I, 2008, APPL ENVIRON MICROB, V74, P4398, DOI 10.1128/AEM.02447-07; Salka I, 2011, ENVIRON MICROBIOL, V13, P2865, DOI 10.1111/j.1462-2920.2011.02562.x; Sieracki ME, 2006, LIMNOL OCEANOGR, V51, P38, DOI 10.4319/lo.2006.51.1.0038; SIMEK K, 1992, APPL ENVIRON MICROB, V58, P3715; Stegman MR, 2014, ISME J, P1; Waidner LA, 2008, APPL ENVIRON MICROB, V74, P4012, DOI 10.1128/AEM.02324-07; Waidner LA, 2007, APPL ENVIRON MICROB, V73, P3936, DOI 10.1128/AEM.00592-07; Yurkov V, 2008, NEW LIGHT AEROBIC AN, P31; Yurkova N, 2002, FEMS MICROBIOL ECOL, V40, P191, DOI 10.1111/j.1574-6941.2002.tb00952.x; Yutin N, 2007, ENVIRON MICROBIOL, V9, P1464, DOI 10.1111/j.1462-2920.2007.01265.x	53	28	31	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124035	10.1371/journal.pone.0124035	http://dx.doi.org/10.1371/journal.pone.0124035			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927833	Green Submitted, Green Published, gold			2022-12-27	WOS:000353713100027
J	Ilangovan, K; Nagaraja, SB; Ananthakrishnan, R; Jacob, AG; Tripathy, JP; Tamang, D				Ilangovan, Kumaravel; Nagaraja, Sharath Burugina; Ananthakrishnan, Ramya; Jacob, Anil G.; Tripathy, Jaya Prasad; Tamang, Deepak			TB Treatment Delays in Odisha, India: Is It Expected Even after These Many Years of RNTCP Implementation?	PLOS ONE			English	Article							DIAGNOSIS	Background In India, the Revised National TB Control Programme (RNTCP) envisages initiation of TB treatment within seven days of diagnosis among smear-positive patients. After nearly two decades of RNTCP implementation, treatment delays are usually not expected. Objectives To determine the proportion of sputum smear-positive TB patients who were initiated on treatment after seven days and their associated risk factors. Methods The study was conducted in Cuttack and Rayagada districts of Odisha. It was a retrospective cohort study that involves review of TB treatment registers and laboratory registers for 2013. Results Among 1,800 pulmonary TB (PTB) patients, 1,074 (60%) had been initiated on treatment within seven days of diagnosis, 721 (40%) had been initiated on treatment more than seven days, and 354 (20%) had delays of more than 15 days. The mean duration between TB diagnosis and treatment initiation was 21 days with a range of 8-207 days (median = 14 days). Odds of treatment delay of more than seven days were 4.9 times (95% confidence interval [CI] 3.3-6.6) among those who had been previously treated, 6.2 times (95% CI 1.3-29.7) among those infected with HIV, and 1.8 times (95% CI 1.1-2.9) among those diagnosed outside district DMC. Conclusion Delay in initiation of TB treatment occurred in majority of the smear-positive patients. The RNTCP should focus on core areas of providing quality TB services with time-tested strategies. To have real-time monitoring mechanisms for diagnosed smear-positive TB patients is expected to be the way forward.	[Ilangovan, Kumaravel] Hlth Syst Res India Initiat, Thirvananthapuram, India; [Nagaraja, Sharath Burugina] ESIC Med Coll, Dept Community Med, Bangalore, Karnataka, India; [Nagaraja, Sharath Burugina] PGIMSR, Bangalore, Karnataka, India; [Ananthakrishnan, Ramya] Resource Grp Educ & Advocacy Community Hlth REACH, Madras, Tamil Nadu, India; [Jacob, Anil G.; Tamang, Deepak] Int Union TB & Lung Dis Union, South East Asia Off, New Delhi, India; [Tripathy, Jaya Prasad] PGIMER, Sch Publ Hlth, Dept Community Med, Chandigarh, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Ilangovan, K (corresponding author), Hlth Syst Res India Initiat, Thirvananthapuram, India.	kumaravelilangovan@gmail.com	Nagaraja, Sharath Burugina/ABD-7238-2021; , Kumaravel/AAJ-6200-2020; Nagaraja, Sharath Burugina/ABD-7748-2021	Nagaraja, Sharath Burugina/0000-0002-6599-5753; , Kumaravel/0000-0003-0111-511X; Nagaraja, Sharath Burugina/0000-0002-6599-5753; Tripathy, Jaya Prasad/0000-0002-2626-5977	American People through the United States Agency for International Development (USAID)	American People through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	Funding for the operational research course was made possible by the support of the American People through the United States Agency for International Development (USAID). The contents of this paper do not necessarily reflect the views of USAID, the United States Government, or International Union Against Tuberculosis and Lung Disease (The Union). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishnu B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055229; Central Tuberculosis Division, 2012, ANN REP REV NAT TUB; Central Tuberculosis Division, 2005, STRAT DOC SUP MON RE; Central Tuberculosis Division, 2010, ANN REP REV NAT TUB; Central Tuberculosis Division, 2011, ANN REP REV NAT TUB; Central Tuberculosis Division, 2013, ANN REP REV NAT TUB; Central Tuberculosis Division India, RNTCP ANN PERF REP 2; Central Tuberculosis Division India, DOTS IN IND; Central Tuberculosis Division. RNTCP, 2013, SOC ACT PLAN INCL TR, P41; Charles N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012379; Ministry of Finance Government of India, 2013, COMP DEV IND STAT, P49; Office of the Register General & Census Commissioner India. Ministry of Home Affairs Government of Inida, CENS 2011 DAT; Organisation W. H., 2013, GLOB TUB REP 2013, P306; Pathak Garima, 2011, SOCIAL ASSESSMENT ST, P134; Paul D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039040; Reach the Unreached|Central Tuberculosis Division, 2014, ANN REP REV NAT TUB, V2014, P204; Sreeramareddy CT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-91; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15	18	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125465	10.1371/journal.pone.0125465	http://dx.doi.org/10.1371/journal.pone.0125465			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928294	Green Published, Green Submitted, gold			2022-12-27	WOS:000353713100093
J	Chen, PC; Lip, GYH; Yeh, G; Lin, HJ; Chien, KL				Chen, Pei-Chun; Lip, Gregory Y. H.; Yeh, Grace; Lin, Hung-Ju; Chien, Kuo-Liong			Risk of Bleeding and Stroke with Oral Anticoagulation and Antiplatelet Therapy in Patients with Atrial Fibrillation in Taiwan: A Nationwide Cohort Study	PLOS ONE			English	Article							NET CLINICAL BENEFIT; ESC WORKING GROUP; ISCHEMIC-STROKE; ANTITHROMBOTIC THERAPY; CHA(2)DS(2)-VASC SCORE; PREDICTING STROKE; PREVENT STROKE; WARFARIN; STRATIFICATION; CHADS(2)	Background Data on the use of oral anticoagulation (OAC) and antiplatelet therapy and the risk of bleeding and stroke amongst Asian patients with atrial fibrillation (AF) are limited. We investigated the risks of bleeding and stroke with use of oral anticoagulation (OAC) and antiplatelet therapy as mono-or combination therapy, in patients with AF from a Chinese nationwide cohort study. Methods We studied a cohort of 10384 patients (57.2% men, age 67.8 +/- 13.2 yrs) between 1999 and 2010 from the National Health Insurance Research Database in Taiwan. Records of prescriptions were obtained during follow-up. The main outcome was a recurrent stroke during the follow-up period. Time-dependent Cox proportional hazards models were used for this analysis. Results We documented 1009 events for bleeding, as well as 224 hemorrhagic stroke and 1642 ischemic stroke events during a median 3.2 (interquartile range, 1.05-6.54) years' follow-up. Compared with warfarin users, patients with antiplatelet therapy had a lower risk of bleeding (adjusted relative risk [RR], 0.59, 95% confidence interval [CI], 0.49-0.71, p<0.001) whilst combination therapy had a non-statistically significant higher bleeding risk (RR, 1.33, 95%, 0.91-1.94, p = 0.20). Patients on antiplatelet monotherapy had a similar risk for ischemic stroke compared with OAC (RR 1.05, 95% CI, 0.89-1.25, p = 0.50), whilst those on combination therapy had a significantly higher risk (RR 1.90, 95% CI, 1.34-2.70, p<0.001). Conclusion In a national representative cohort, antiplatelet therapy had no significant difference in ischemic stroke risk to warfarin. For bleeding, aspirin had a lower risk compared to warfarin. This may reflect poor anticoagulation control, highlighting important missed opportunities for improved stroke prevention, especially in countries where anticoagulation management is suboptimal.	[Chen, Pei-Chun] Chang Gung Univ, Clin Informat & Med Stat Res Ctr, Taoyuan, Taiwan; [Lip, Gregory Y. H.] Univ Birmingham, City Hosp, Ctr Cardiovasc Sci, Birmingham, W Midlands, England; [Yeh, Grace] Natl Taiwan Univ, Hlth Data Res Ctr, Taipei 10764, Taiwan; [Lin, Hung-Ju; Chien, Kuo-Liong] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei 10764, Taiwan; [Lin, Hung-Ju; Chien, Kuo-Liong] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	Chang Gung University; University of Birmingham; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Chien, KL (corresponding author), Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei 10764, Taiwan.	klchien@ntu.edu.tw		Chen, Pei-Chun/0000-0002-8713-8816; CHIEN, KUO-LIONG/0000-0003-4979-8351	National Science Council, Taiwan [NSC 102-2314-B-002 -080 -MY2, NSC 102-2314-B-002 -075]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported from the National Science Council, Taiwan (NSC 102-2314-B-002 -080 -MY2 and NSC 102-2314-B-002 -075). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolakis S, 2013, THROMB HAEMOSTASIS, V110, P1074, DOI 10.1160/TH13-07-0552; Camm AJ, 2012, EUR HEART J, V33; Chao TF, 2012, STROKE, V43, P2551, DOI 10.1161/STROKEAHA.112.667865; Chien KL, 2010, STROKE, V41, P1858, DOI 10.1161/STROKEAHA.110.586222; Chien KL, 2010, INT J CARDIOL, V139, P173, DOI 10.1016/j.ijcard.2008.10.045; De Caterina R, 2012, J AM COLL CARDIOL, V59, P1413, DOI 10.1016/j.jacc.2012.02.008; Friberg L, 2012, EUR HEART J, V33, P1500, DOI 10.1093/eurheartj/ehr488; Friberg L, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3522; Friberg L, 2012, CIRCULATION, V125, P2298, DOI 10.1161/CIRCULATIONAHA.111.055079; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Gallagher AM, 2011, THROMB HAEMOSTASIS, V106, P968, DOI 10.1160/TH11-05-0353; Gomes T, 2013, CAN MED ASSOC J, V185, pE121, DOI 10.1503/cmaj.121218; Guo YT, 2013, INT J CARDIOL, V168, P515, DOI 10.1016/j.ijcard.2012.09.187; Hansen ML, 2010, ARCH INTERN MED, V170, P1433, DOI 10.1001/archinternmed.2010.271; Hart RG, 1999, ANN INTERN MED, V131, P492, DOI 10.7326/0003-4819-131-7-199910050-00003; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Hori M, 2013, STROKE, V44, P1891, DOI 10.1161/STROKEAHA.113.000990; Lee CH, 2007, AM J MED, V120, DOI 10.1016/j.amjmed.2006.10.014; Lin LY, 2011, ATHEROSCLEROSIS, V217, P292, DOI 10.1016/j.atherosclerosis.2011.03.033; Lip GYH, 2011, THROMB HAEMOSTASIS, V106, P997, DOI 10.1160/TH11-10-0690; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Lip GY, 2012, BMJ OPEN, P2; Morgan CL, 2009, THROMB RES, V124, P37, DOI 10.1016/j.thromres.2008.09.016; Ogawa S, 2013, J ARRYTHM, V29, P190, DOI 10.1016/j.joa.2013.03.002; Olesen JB, 2012, THROMB HAEMOSTASIS, V107, P1172, DOI 10.1160/TH12-03-0175; Olesen JB, 2011, THROMB HAEMOSTASIS, V106, P739, DOI 10.1160/TH11-05-0364; Potpara TS, 2011, CEREBROVASC DIS, V32, P461, DOI 10.1159/000332030; Rother J, 2010, CEREBROVASC DIS, V30, P314, DOI 10.1159/000319608; Roldan V, 2013, J AM COLL CARDIOL, V62, P2199, DOI 10.1016/j.jacc.2013.08.1623; Shen AYJ, 2007, J AM COLL CARDIOL, V50, P309, DOI 10.1016/j.jacc.2007.01.098; Singer DE, 2009, ANN INTERN MED, V151, P297, DOI 10.7326/0003-4819-151-5-200909010-00003; Tsai WC, 2013, INT J MED SCI, V10, P804, DOI 10.7150/ijms.5998; Wallentin L, 2011, THROMB HAEMOSTASIS, V105, P760, DOI 10.1160/TH11-03-0162; Wallentin L, 2010, LANCET, V376, P975, DOI 10.1016/S0140-6736(10)61194-4; Wan Y, 2008, CIRC-CARDIOVASC QUAL, V1, P84, DOI 10.1161/CIRCOUTCOMES.108.796185; Wong RSM, 2003, DRUG SAFETY, V26, P585, DOI 10.2165/00002018-200326080-00004	36	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125257	10.1371/journal.pone.0125257	http://dx.doi.org/10.1371/journal.pone.0125257			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923742	Green Published, gold, Green Submitted			2022-12-27	WOS:000353711600139
J	Landis, RC; Carmichael-Simmons, K; Hambleton, IR; Best, A				Landis, R. Clive; Carmichael-Simmons, Kelly; Hambleton, Ian R.; Best, Anton			HIV Viral Load Trends in Six Eastern Caribbean Countries Utilizing a Regional Laboratory Referral Service: Implications for Treatment as Prevention	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; TRANSMISSION; STRATEGIES; INFECTION	Objective Since 2009, seven countries in the Organization of Eastern Caribbean States (OECS), Antigua & Barbuda, Dominica, Grenada, Montserrat, St. Kitts & Nevis, Saint Lucia, and St. Vincent & the Grenadines, have been utilizing a laboratory referral service for HIV-1 viral load (VL) offered by The Ladymeade Reference Unit (LRU) Laboratory, Barbados. The objective of this study was to evaluate 5 year VL trends in the six larger OECS countries participating in this regional referral service. Methods Blood samples were collected in source countries and transported to Barbados as frozen plasma according to a standardized protocol. Plasma specimens were amplified by RT PCR on a Roche TaqMan 48 analyser (Roche Diagnostics, Panama City, Panama). VL was considered optimally suppressed below a threshold level of < 200 HIV-1 copies/mL of blood. The same threshold was used as a binary indicator in an analysis of the secular change in VL suppression. Montserrat was excluded due to insufficient number of samples. Results A steady rise in VL referrals from OECS countries was recorded, rising from 312 samples in 2009 to 1,060 samples in 2013. A total of 3,543 samples were tested, with a sample rejection rate (9.2%) mostly due to breaks in the cold chain. Aggregate VL data showed the odds of VL suppression in the Eastern Caribbean improved by 66% for each additional year after 2009 (Odds Ratio 1.66 [95% CI 1.46 to 1.88]; p<0.001). Conclusion We demonstrate the feasibility of establishing a regional laboratory referral service for HIV VL monitoring in the Eastern Caribbean. Aggregate VL trends showed a significant year-on-year improvement in VL suppression, implying public health benefits through treatment as prevention in the OECS. VL provides a powerful monitoring & evaluation tool for strengthening HIV programs at country level among the small island states participating in this regional referral network.	[Landis, R. Clive; Hambleton, Ian R.] Univ W Indies, Chron Dis Res Ctr, Cave Hill, Barbados; [Landis, R. Clive; Carmichael-Simmons, Kelly; Best, Anton] Minist Hlth, Ladymeade Reference Unit, St Michael, Barbados	University West Indies Mona Jamaica; University West Indies Cave Hill Campus	Landis, RC (corresponding author), Univ W Indies, Chron Dis Res Ctr, Cave Hill, Barbados.	clive.landis@cavehill.uwi.edu	Hambleton, Ian/AAP-3519-2020	Hambleton, Ian/0000-0002-5638-9794				Alemnji G, 2014, AIDS PATIENT CARE ST, V28, P268, DOI 10.1089/apc.2013.0356; [Anonymous], 2013, CONSOLIDATED GUIDELI; [Anonymous], 2012, MEASURE EVALUATION B; Buckley B, 2012, GLEANER NEWSPAP 0605; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cohen Stacy M., 2011, Morbidity and Mortality Weekly Report, V60, P1618; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Del Romero J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2205; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Gill J-A, 2009, HLTH MINISTRYS LRU L; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Henry D, 2013, CONSULTANCY IMPROVE; Landis RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058590; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Powers KA, 2011, LANCET, V378, P256, DOI 10.1016/S0140-6736(11)60842-8; Rodger A, HIV TRASNMISSION RIS; StJohn MA, 2013, HIV EPIDEMIC BARBADO; Vernazza P, 2008, LANCET, V372, P1806, DOI 10.1016/S0140-6736(08)61753-5	20	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125435	10.1371/journal.pone.0125435	http://dx.doi.org/10.1371/journal.pone.0125435			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923741	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600151
J	Ulrich, M; Kiefer, M; Bongartz, W; Gron, G; Hoenig, K				Ulrich, Martin; Kiefer, Markus; Bongartz, Walter; Groen, Georg; Hoenig, Klaus			Suggestion-Induced Modulation of Semantic Priming during Functional Magnetic Resonance Imaging	PLOS ONE			English	Article							UNCONSCIOUS COGNITION; HYPNOTIC SUGGESTION; ATTENTIONAL SENSITIZATION; SPREADING ACTIVATION; STROOP INTERFERENCE; TASK SETS; BRAIN; WORDS; MEMORY; INFORMATION	Using functional magnetic resonance imaging during a primed visual lexical decision task, we investigated the neural and functional mechanisms underlying modulations of semantic word processing through hypnotic suggestions aimed at altering lexical processing of primes. The priming task was to discriminate between target words and pseudowords presented 200 ms after the prime word which was semantically related or unrelated to the target. In a counterbalanced study design, each participant performed the task once at normal wakefulness and once after the administration of hypnotic suggestions to perceive the prime as a meaningless symbol of a foreign language. Neural correlates of priming were defined as significantly lower activations upon semantically related compared to unrelated trials. We found significant suggestive treatment-induced reductions in neural priming, albeit irrespective of the degree of suggestibility. Neural priming was attenuated upon suggestive treatment compared with normal wakefulness in brain regions supporting automatic (fusiform gyrus) and controlled semantic processing (superior and middle temporal gyri, pre- and postcentral gyri, and supplementary motor area). Hence, suggestions reduced semantic word processing by conjointly dampening both automatic and strategic semantic processes.	[Ulrich, Martin; Kiefer, Markus; Groen, Georg; Hoenig, Klaus] Univ Ulm, Dept Psychiat, D-89069 Ulm, Germany; [Bongartz, Walter] Klingenberg Inst Clin Hypnosis, Constance, Germany; [Hoenig, Klaus] Univ Ulm, Dept Psychosomat Med & Psychotherapy, D-89069 Ulm, Germany	Ulm University; Ulm University	Ulrich, M (corresponding author), Univ Ulm, Dept Psychiat, D-89069 Ulm, Germany.	martin.ulrich@uni-ulm.de		Ulrich, Martin/0000-0002-1237-0426; Gron, Georg/0000-0002-0282-3575	Landesgraduiertenforderung, Baden-Wurttemberg; German Research Foundation within the Research Network "Neuro-cognitive mechanisms of conscious and unconscious visual perception" [PAK 270/2, DFG Ki 804/3-2]	Landesgraduiertenforderung, Baden-Wurttemberg; German Research Foundation within the Research Network "Neuro-cognitive mechanisms of conscious and unconscious visual perception"	This work was supported by a fellowship from the Landesgraduiertenforderung, Baden-Wurttemberg, granted to Martin Ulrich, and by a grant from the German Research Foundation within the Research Network "Neuro-cognitive mechanisms of conscious and unconscious visual perception" (PAK 270/2) to Markus Kiefer (DFG Ki 804/3-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SC, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00241; Altarriba J, 2007, BEHAV RES METHODS, V39, P1, DOI 10.3758/BF03192839; Argyropoulos GP, 2013, CEREBELLUM, V12, P83, DOI 10.1007/s12311-012-0398-y; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Beauchamp MS, 2002, NEURON, V34, P149, DOI 10.1016/S0896-6273(02)00642-6; BENTIN S, 1995, J EXP PSYCHOL HUMAN, V21, P54, DOI 10.1037/0096-1523.21.1.54; BONGARTZ W, 1985, INT J CLIN EXP HYP, V33, P131, DOI 10.1080/00207148508406643; BROWN C, 1993, J COGNITIVE NEUROSCI, V5, P34, DOI 10.1162/jocn.1993.5.1.34; Chumbley JR, 2009, NEUROIMAGE, V44, P62, DOI 10.1016/j.neuroimage.2008.05.021; Cojan Y, 2009, NEURON, V62, P862, DOI 10.1016/j.neuron.2009.05.021; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Gold BT, 2006, J NEUROSCI, V26, P6523, DOI 10.1523/JNEUROSCI.0808-06.2006; Groussard M, 2010, NEUROIMAGE, V49, P2764, DOI 10.1016/j.neuroimage.2009.10.039; Heil M, 2004, PSYCHOL SCI, V15, P852, DOI 10.1111/j.0956-7976.2004.00766.x; Kiefer M, 2006, J COGNITIVE NEUROSCI, V18, P184, DOI 10.1162/089892906775783688; Kiefer M, 2002, COGNITIVE BRAIN RES, V13, P27, DOI 10.1016/S0926-6410(01)00085-4; Kiefer M, 2012, CORTEX, V48, P805, DOI 10.1016/j.cortex.2011.04.006; Kiefer M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00061; Kiefer M, 2010, J EXP PSYCHOL GEN, V139, P464, DOI 10.1037/a0019561; Koivisto M, 1998, NEUROPSYCHOLOGIA, V36, P661, DOI 10.1016/S0028-3932(97)00147-4; LUPKER SJ, 1984, J VERB LEARN VERB BE, V23, P709, DOI 10.1016/S0022-5371(84)90434-1; MacLeod CM, 2011, CONSCIOUS COGN, V20, P321, DOI 10.1016/j.concog.2009.10.007; Marien P, 2014, CEREBELLUM, V13, P386, DOI 10.1007/s12311-013-0540-5; Martens U, 2011, PSYCHOL SCI, V22, P282, DOI 10.1177/0956797610397056; Martin A, 2001, CURR OPIN NEUROBIOL, V11, P194, DOI 10.1016/S0959-4388(00)00196-3; MARTIN A, 1995, SCIENCE, V270, P102, DOI 10.1126/science.270.5233.102; Maxfield L, 1997, CONSCIOUS COGN, V6, P204, DOI 10.1006/ccog.1997.0311; Mendelsohn A, 2008, NEURON, V57, P159, DOI 10.1016/j.neuron.2007.11.022; MEYER DE, 1971, J EXP PSYCHOL, V90, P227, DOI 10.1037/h0031564; Neely J. H., 1991, BASIC PROCESSES READ, P264, DOI DOI 10.1016/J.BRAINRES.2007.05.058; NEELY JH, 1977, J EXP PSYCHOL GEN, V106, P226, DOI 10.1037/0096-3445.106.3.226; NEELY JH, 1989, J EXP PSYCHOL LEARN, V15, P1003, DOI 10.1037/0278-7393.15.6.1003; Neely JH, 2001, SCI CON SER, P69, DOI 10.1037/10394-005; Neumann O, 1984, COGNITION MOTOR PROC, P245; Oakley DA, 2013, NAT REV NEUROSCI, V14, P565, DOI 10.1038/nrn3538; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Plaut D.C., 1995, P 17 ANN C COGN SCI, P37; Posner M., 1975, INFORM PROCESSING CO; Raz A, 2006, PSYCHOL SCI, V17, P91, DOI 10.1111/j.1467-9280.2006.01669.x; Raz A, 2005, P NATL ACAD SCI USA, V102, P9978, DOI 10.1073/pnas.0503064102; Raz A, 2003, CONSCIOUS COGN, V12, P332, DOI 10.1016/S1053-8100(03)00024-2; Raz A, 2002, ARCH GEN PSYCHIAT, V59, P1155, DOI 10.1001/archpsyc.59.12.1155; Raz A, 2011, CONSCIOUS COGN, V20, P312, DOI 10.1016/j.concog.2009.09.013; Ruff I, 2008, BRAIN LANG, V105, P41, DOI 10.1016/j.bandl.2008.01.003; Ruoff A., 1990, HAUFIGKEITSWORTERBUC; SCHACTER DL, 1995, NATURE, V376, P587, DOI 10.1038/376587a0; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; Shor R. E., 1962, HARVARD GROUP SCALE; Sim EJ, 2015, CEREB CORTEX, V25, P2907, DOI 10.1093/cercor/bhu087; Stoodley CJ, 2012, NEUROIMAGE, V59, P1560, DOI 10.1016/j.neuroimage.2011.08.065; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Ulrich M, 2014, HUM BRAIN MAPP, V35, P5500, DOI 10.1002/hbm.22566; Ulrich M, 2013, J COGNITIVE NEUROSCI, V25, P2216, DOI 10.1162/jocn_a_00449; Vandenberghe R, 1996, NATURE, V383, P254, DOI 10.1038/383254a0; WARRINGTON EK, 1984, BRAIN, V107, P829, DOI 10.1093/brain/107.3.829; Weitzenhoffer AM, 1962, STANFORD HYPNOTIC SU, V27; Wheatley T, 2005, J COGNITIVE NEUROSCI, V17, P1871, DOI 10.1162/089892905775008689	57	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123686	10.1371/journal.pone.0123686	http://dx.doi.org/10.1371/journal.pone.0123686			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923740	Green Submitted, gold, Green Published			2022-12-27	WOS:000353711600055
J	Verinaud, L; Lopes, SCP; Prado, ICN; Zanucoli, F; da Costa, TA; Di Gangi, R; Issayama, LK; Carvalho, AC; Bonfanti, AP; Niederauer, GF; Duran, N; Costa, FTM; Oliveira, ALR; Hofling, MAD; Machado, DRS; Thome, R				Verinaud, Liana; Pinto Lopes, Stefanie Costa; Naranjo Prado, Isabel Cristina; Zanucoli, Fabio; da Costa, Thiago Alves; Di Gangi, Rosaria; Issayama, Luidy Kazuo; Carvalho, Ana Carolina; Bonfanti, Amanda Pires; Niederauer, Guilherme Francio; Duran, Nelson; Maranhao Costa, Fabio Trindade; Rodrigues Oliveira, Alexandre Leite; da Cruz Hoefling, Maria Alice; Stach Machado, Dagmar Ruth; Thome, Rodolfo			Violacein Treatment Modulates Acute and Chronic Inflammation through the Suppression of Cytokine Production and Induction of Regulatory T Cells	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; DENDRITIC CELLS; CHROMOBACTERIUM-VIOLACEUM; IN-VITRO; CHLOROQUINE; TOLERANCE; SECRETION; DISEASE; IL-17; TREG	Inflammation is a necessary process to control infection. However, exacerbated inflammation, acute or chronic, promotes deleterious effects in the organism. Violacein (viola), a quorum sensing metabolite from the Gram-negative bacterium Chromobacterium violaceum, has been shown to protect mice from malaria and to have beneficial effects on tumors. However, it is not known whether this drug possesses anti-inflammatory activity. In this study, we investigated whether viola administration is able to reduce acute and chronic autoimmune inflammation. For that purpose, C57BL/6 mice were intraperitoneally injected with 1 mu g of LPS and were treated with viola (3.5mg/kg) via i.p. at the same time-point. Three hours later, the levels of inflammatory cytokines in the sera and phenotypical characterization of leukocytes were determined. Mice treated with viola presented a significant reduction in the production of inflammatory cytokines compared with untreated mice. Interestingly, although viola is a compound derived from bacteria, it did not induce inflammation upon administration to naive mice. To test whether viola would protect mice from an autoimmune inflammation, Experimental Autoimmune Encephalomyelitis (EAE)-inflicted mice were given viola i.p. at disease onset, at the 10th day from immunization. Viola-treated mice developed mild EAE disease in contrast with placebo-treated mice. The frequencies of dendritic cells and macrophages were unaltered in EAE mice treated with viola. However, the sole administration of viola augmented the levels of splenic regulatory T cells (CD4+ Foxp3+). We also found that adoptive transfer of viola-elicited regulatory T cells significantly reduced EAE. Our study shows, for the first time, that violacein is able to modulate acute and chronic inflammation. Amelioration relied in suppression of cytokine production (in acute inflammation) and stimulation of regulatory T cells (in chronic inflammation). New studies must be conducted in order to assess the possible use of viola in therapeutic approaches in human autoimmune diseases.	[Verinaud, Liana; Zanucoli, Fabio; da Costa, Thiago Alves; Di Gangi, Rosaria; Issayama, Luidy Kazuo; Carvalho, Ana Carolina; Bonfanti, Amanda Pires; Niederauer, Guilherme Francio; Rodrigues Oliveira, Alexandre Leite; Stach Machado, Dagmar Ruth; Thome, Rodolfo] Univ Estadual Campinas, Inst Biol, Dept Struct & Funct Biol, Campinas, SP, Brazil; [Pinto Lopes, Stefanie Costa; Naranjo Prado, Isabel Cristina; Maranhao Costa, Fabio Trindade] Univ Estadual Campinas, Inst Biol, Dept Genet Evolut & Bioagents, Campinas, SP, Brazil; [Duran, Nelson] Univ Estadual Campinas, Inst Chem, Biol Chem Lab, Campinas, SP, Brazil; [Duran, Nelson] Univ Estadual Campinas, Inst Chem, Lab Nanostruct Synth & Biosyst Interact NanoBioss, Campinas, SP, Brazil; [da Cruz Hoefling, Maria Alice] Univ Estadual Campinas, Inst Biol, Dept Histol & Embryol, Campinas, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas	Thome, R (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Struct & Funct Biol, Campinas, SP, Brazil.	rodolfo.thome@gmail.com	Lopes, Stefanie/A-8314-2012; Oliveira, Alexandre L. R./C-4436-2012; da Costa, Thiago Alves/F-8187-2016; Oliveira, Alexandre/AAI-6815-2020; de Carvalho, Ana Carolina/B-1825-2019; Bonfanti, Amanda/AAS-4286-2021; Thome, Rodolfo/C-1564-2012; Costa, Fabio/E-1181-2012	Oliveira, Alexandre L. R./0000-0003-4224-4575; Oliveira, Alexandre/0000-0003-4224-4575; de Carvalho, Ana Carolina/0000-0001-7996-6497; Thome, Rodolfo/0000-0001-7627-4137; Costa, Fabio/0000-0001-9969-7300; Lopes, Stefanie/0000-0002-6981-2192; Issayama, Luidy/0000-0003-1701-0101; Alves da Costa, Thiago/0000-0001-9591-331X; Niederauer, Guilherme Francio/0000-0002-3032-778X; Duran, Nelson/0000-0001-8372-5143; Bonfanti, Amanda/0000-0003-0896-0105	Sao Paulo Research Foundation (FAPESP) [2011/17965-3]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [471066/2012-5]; FAPESP scholarship [2014/02631-0, 2011/23664-6, 2012/01892-0]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP scholarship(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Sao Paulo Research Foundation (FAPESP, grant #2011/17965-3) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq grant 471066/2012-5). FTMC and LV are CNPq researcher fellows. RT, SCPL and ICNP received FAPESP scholarships (#2014/02631-0, #2011/23664-6 and #2012/01892-0, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MH, 2003, J PHARMACOL EXP THER, V304, P156, DOI 10.1124/jpet.102.042523; Alarcon GS, 2007, ANN RHEUM DIS, V66, P1168, DOI 10.1136/ard.2006.068676; Apostolidis SA, 2011, LUPUS, V20, P120, DOI 10.1177/0961203310389100; Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Bromberg N, 2010, CHEM-BIOL INTERACT, V186, P43, DOI 10.1016/j.cbi.2010.04.016; Chauhan SK, 2009, J IMMUNOL, V182, P1247, DOI 10.4049/jimmunol.182.3.1247; Chu CQ, 2007, ARTHRITIS RHEUM, V56, P1145, DOI 10.1002/art.22453; de Carvalho DD, 2006, TOXICOL IN VITRO, V20, P1514, DOI 10.1016/j.tiv.2006.06.007; Domingues HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015531; Doodes PD, 2010, J IMMUNOL, V184, P1552, DOI 10.4049/jimmunol.0902907; Duran M, 2010, FOLIA MICROBIOL, V55, P535, DOI 10.1007/s12223-010-0088-4; Duran M, 2012, MED CHEM RES, V21, P1524, DOI 10.1007/s00044-011-9654-9; Duran N, 2007, BIOTECHNOL APPL BIOC, V48, P127, DOI 10.1042/BA20070115; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Zorzella-Pezavento SFG, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/519627; Grifka-Walk HM, 2013, EUR J IMMUNOL, V43, P2824, DOI 10.1002/eji.201343723; Hoshino T, 2011, APPL MICROBIOL BIOT, V91, P1463, DOI 10.1007/s00253-011-3468-z; Kang ZH, 2013, NAT NEUROSCI, V16, P1401, DOI 10.1038/nn.3505; Lee JH, 2006, IMMUNOLOGY, V117, P280, DOI 10.1111/j.1365-2567.2005.02306.x; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Lopes SCP, 2009, ANTIMICROB AGENTS CH, V53, P2149, DOI 10.1128/AAC.00693-08; Mangalam AK, 2014, J IMMUNOL, V193, P4859, DOI 10.4049/jimmunol.1302008; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Palafox D, 2010, TRANSPLANT REV-ORLAN, V24, P160, DOI 10.1016/j.trre.2010.04.003; Park MJ, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2361; Pena C, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/296031; Platt D, 2014, BIOCHEM BIOPH RES CO, V455, P107, DOI 10.1016/j.bbrc.2014.10.124; Queiroz KCS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045362; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Subramaniam S, 2014, PHARM BIOL, V52, P86, DOI 10.3109/13880209.2013.815634; Sun YP, 2009, J IMMUNOL, V182, P5899, DOI 10.4049/jimmunol.0804388; Thome R, 2014, PLOS ONE IN PRESS; Thome R, 2013, IMMUNOLOGY LETTERS; Thome R, 2014, IMMUNOLOGY, V143, P164, DOI 10.1111/imm.12298; Thome R, 2014, IMMUNOL CELL BIOL, V92, P124, DOI 10.1038/icb.2013.73; Thome R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065913; Thome R, 2012, CELL IMMUNOL, V280, P113, DOI 10.1016/j.cellimm.2012.11.017; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Unger WWJ, 2009, EUR J IMMUNOL, V39, P3147, DOI 10.1002/eji.200839103; Verinaud L, 2014, CELLULAR AND MOLECUL; Wakasa-Morimoto C, 2008, INT IMMUNOL, V20, P1331, DOI 10.1093/intimm/dxn091; Zanucoli F, 2014, CNS NEUROSCI THER, V20, P1061, DOI 10.1111/cns.12357; Zhao YG, 2012, J IMMUNOL, V189, P4417, DOI 10.4049/jimmunol.1200919; Zozulya AL, 2009, J NEUROSCI, V29, P140, DOI 10.1523/JNEUROSCI.2199-08.2009	45	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125409	10.1371/journal.pone.0125409	http://dx.doi.org/10.1371/journal.pone.0125409			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938431	Green Submitted, Green Published, gold			2022-12-27	WOS:000353943000065
J	Audusseau, H; Kolb, G; Janz, N				Audusseau, Helene; Kolb, Gundula; Janz, Niklas			Plant Fertilization Interacts with Life History: Variation in Stoichiometry and Performance in Nettle-Feeding Butterflies	PLOS ONE			English	Article							GROWTH-RATE; BIOLOGICAL STOICHIOMETRY; TRADE-OFFS; NITROGEN; PHOSPHORUS; SPECIALIZATION; LIMITATION; EVOLUTION; PREFERENCE; EFFICIENCY	Variation in food stoichiometry affects individual performance and population dynamics, but it is also likely that species with different life histories should differ in their sensitivity to food stoichiometry. To address this question, we investigated the ability of the three nettle-feeding butterflies (Aglais urticae, Polygonia c-album, and Aglais io) to respond adaptively to induced variation in plant stoichiometry in terms of larval performance. We hypothesized that variation in larval performance between plant fertilization treatments should be functionally linked to species differences in host plant specificity. We found species-specific differences in larval performance between plant fertilization treatments that could not be explained by nutrient limitation. We showed a clear evidence of a positive correlation between food stoichiometry and development time to pupal stage and pupal mass in Aglais urticae. The other two species showed a more complex response. Our results partly supported our prediction that host plant specificity affects larval sensitivity to food stoichiometry. However, we suggest that most of the differences observed may instead be explained by differences in voltinism (number of generations per year). We believe that the potential of some species to respond adaptively to variation in plant nutrient content needs further attention in the face of increased eutrophication due to nutrient leakage from human activities.	[Audusseau, Helene; Janz, Niklas] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden; [Kolb, Gundula] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden	Stockholm University; Stockholm University	Audusseau, H (corresponding author), Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden.	helene.audusseau@zoologi.su.se	Audusseau, Hélène/ABF-9178-2020; Janz, Niklas/B-1756-2010	Audusseau, Hélène/0000-0003-0312-4343; Janz, Niklas/0000-0002-6379-7905	Strategic Research Program Ekoklim at Stockholm University	Strategic Research Program Ekoklim at Stockholm University	Funding for this study was provided by the Strategic Research Program Ekoklim at Stockholm University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2000, ECOLOGY, V81, P500, DOI 10.1890/0012-9658(2000)081[0500:HREAAT]2.0.CO;2; Altermatt F, 2010, P ROY SOC B-BIOL SCI, V277, P1281, DOI 10.1098/rspb.2009.1910; Andersen T, 2004, ECOL LETT, V7, P884, DOI 10.1111/j.1461-0248.2004.00646.x; Apple JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007807; Arendt JD, 1997, Q REV BIOL, V72, P149, DOI 10.1086/419764; Audusseau H, 2013, ECOL EVOL, V3, P3021, DOI 10.1002/ece3.696; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bertram SM, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.2601; Betzholtz Per-Eric, 2013, Proc Biol Sci, V280, P20122305, DOI 10.1098/rspb.2012.2305; Bishop JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013598; Boersma M, 2006, ECOLOGY, V87, P1325, DOI 10.1890/0012-9658(2006)87[1325:TMOAGT]2.0.CO;2; Carrillo P, 2001, J PLANKTON RES, V23, P537, DOI 10.1093/plankt/23.5.537; Clesceri LS., 1998, TOTAL SUSPENDED SOLI; Crawley MJ, 2009, R BOOK, P569; Elser JJ, 1996, BIOSCIENCE, V46, P674, DOI 10.2307/1312897; Elser JJ, 2003, ECOL LETT, V6, P936, DOI 10.1046/j.1461-0248.2003.00518.x; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; Elser JJ, 2000, J EVOLUTION BIOL, V13, P845; Ergon T, 2001, NATURE, V411, P1043, DOI 10.1038/35082553; Faerovig PJ, 2003, FRESHWATER BIOL, V48, P1782, DOI 10.1046/j.1365-2427.2003.01128.x; Fagan WF, 2002, AM NAT, V160, P784, DOI 10.1086/343879; Feest A, 2014, ECOL INDIC, V39, P115, DOI 10.1016/j.ecolind.2013.12.008; Fischer K, 2000, OECOLOGIA, V124, P235, DOI 10.1007/s004420000365; Forister ML, 2007, J EVOLUTION BIOL, V20, P985, DOI 10.1111/j.1420-9101.2007.01310.x; FOX CW, 1994, OECOLOGIA, V97, P382, DOI 10.1007/BF00317329; Friberg M, 2009, OECOLOGIA, V159, P127, DOI 10.1007/s00442-008-1206-8; Frost PC, 2002, ECOL LETT, V5, P232, DOI 10.1046/j.1461-0248.2002.00307.x; FUTUYMA DJ, 1981, ENTOMOL EXP APPL, V30, P106, DOI 10.1007/BF00300873; Huberty AF, 2006, OECOLOGIA, V149, P444, DOI 10.1007/s00442-006-0462-8; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.es.21.110190.001331; Janz N, 1997, P ROY SOC B-BIOL SCI, V264, P701, DOI 10.1098/rspb.1997.0100; Janz N, 2011, ANNU REV ECOL EVOL S, V42, P71, DOI 10.1146/annurev-ecolsys-102710-145024; Joern A, 1997, OECOLOGIA, V112, P201, DOI 10.1007/s004420050301; KARLSSON B, 1989, FUNCT ECOL, V3, P399, DOI 10.2307/2389613; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; NYLIN S, 1988, OIKOS, V53, P381, DOI 10.2307/3565539; Pollard E, 1997, ECOL ENTOMOL, V22, P315, DOI 10.1046/j.1365-2311.1997.00064.x; Pullin AS, 1987, AGLAIS URTICAE OIKOS, P39, DOI [10.2307/3565552, DOI 10.2307/3565552]; R Core Team, 2021, R LANGUAGE ENV STAT; Sadeghi H, 1999, OECOLOGIA, V118, P405, DOI 10.1007/s004420050742; Schade JD, 2003, ECOL LETT, V6, P96, DOI 10.1046/j.1461-0248.2003.00409.x; Schoonhoven L. M., 2005, Insect-plant biology; Scriber J.M., 1992, P429; Singer MS, 2001, OIKOS, V93, P194, DOI 10.1034/j.1600-0706.2001.930203.x; SLANSKY F, 1977, ECOL MONOGR, V47, P209, DOI 10.2307/1942617; Sterner R.W., 2002, ECOLOGICAL STOICHIOM; SUTCLIFFE WH, 1970, J FISH RES BOARD CAN, V27, P606, DOI 10.1139/f70-065; Taylor K, 2009, J ECOL, V97, P1436, DOI 10.1111/j.1365-2745.2009.01575.x; Thompson JN, 1994, THE COEVOLUTIONARY P; VIA S, 1991, EVOLUTION, V45, P827, DOI 10.1111/j.1558-5646.1991.tb04353.x; Wahlberg N, 2003, CLADISTICS, V19, P213, DOI [10.1016/S0748-3007(03)00027-6, 10.1111/j.1096-0031.2003.tb00364.x]; Watts T, 2006, J INSECT PHYSIOL, V52, P187, DOI 10.1016/j.jinsphys.2005.09.012	53	11	11	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124616	10.1371/journal.pone.0124616	http://dx.doi.org/10.1371/journal.pone.0124616			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932628	gold, Green Published, Green Submitted			2022-12-27	WOS:000353887100050
J	Greaves, LM; Milojev, P; Huang, YS; Stronge, S; Osborne, D; Bulbulia, J; Grimshaw, M; Sibley, CG				Greaves, Lara M.; Milojev, Petar; Huang, Yanshu; Stronge, Samantha; Osborne, Danny; Bulbulia, Joseph; Grimshaw, Michael; Sibley, Chris G.			Regional Differences in the Psychological Recovery of Christchurch Residents Following the 2010/2011 Earthquakes: A Longitudinal Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; POSTTRAUMATIC STRESS SYMPTOMS; NATURAL DISASTER; MENTAL-HEALTH; SURVIVORS; DISORDER; IMPACTS	We examined changes in psychological distress experienced by residents of Christchurch following two catastrophic earthquakes in late 2010 and early 2011, using data from the New Zealand Attitudes and Values Study (NZAVS), a national probability panel study of New Zealand adults. Analyses focused on the 267 participants (172 women, 95 men) who were living in central Christchurch in 2009 (i.e., before the Christchurch earthquakes), and who also provided complete responses to our yearly panel questionnaire conducted in late 2010 (largely between the two major earthquakes), late 2011, and late 2012. Levels of psychological distress were similar across the different regions of central Christchurch immediately following the September 2010 earthquake, and remained comparable across regions in 2011. By late 2012, however, average levels of psychological distress in the regions had diverged as a function of the amount of property damage experienced within each given region. Specifically, participants in the least damaged region (i.e., the Fendalton-Waimairi and Riccarton-Wigram wards) experienced greater drops in psychological distress than did those in the moderately damaged region (i.e., across the Spreydon-Heathcote and Hagley-Ferrymead wards). However, the level of psychological distress reported by participants in the most damaged region (i.e., across Shirley-Papanui and Burwood-Pegasus) were not significantly different to those in the least damaged region of central Christchurch. These findings suggest that different patterns of psychological recovery emerged across the different regions of Christchurch, with the moderately damaged region faring the worst, but only after the initial shock of the destruction had passed.	[Greaves, Lara M.; Milojev, Petar; Huang, Yanshu; Stronge, Samantha; Osborne, Danny; Sibley, Chris G.] Univ Auckland, Auckland 1, New Zealand; [Bulbulia, Joseph] Victoria Univ Wellington, Wellington, New Zealand; [Grimshaw, Michael] Univ Canterbury, Christchurch 1, New Zealand	University of Auckland; Victoria University Wellington; University of Canterbury	Greaves, LM (corresponding author), Univ Auckland, Auckland 1, New Zealand.	lara.greaves@auckland.ac.nz	Sibley, Chris G/D-2974-2009; Stronge, Samantha/AAK-9955-2020	Sibley, Chris G/0000-0002-4064-8800; Huang, Yanshu/0000-0003-2120-6609; Osborne, Danny/0000-0002-8513-4125; Greaves, Lara/0000-0003-0537-7125; Bulbulia, Joseph/0000-0002-5861-2056	Templeton World Charity Foundation Grant [0077]	Templeton World Charity Foundation Grant(Templeton World Charity Foundation)	This research was supported by a Templeton World Charity Foundation Grant (ID: 0077)	Altindag A, 2005, COMPR PSYCHIAT, V46, P328, DOI 10.1016/j.comppsych.2005.01.005; Bannister S, 2012, NEW ZEAL J GEOL GEOP, V55, P295, DOI 10.1080/00288306.2012.680475; Chou FHC, 2004, QUAL LIFE RES, V13, P1089, DOI 10.1023/B:QURE.0000031337.73269.64; Dorahy MJ, 2012, J LOSS TRAUMA, V17, P203, DOI 10.1080/15325024.2011.616737; Duncan E, 2013, J TRAUMA DISSOCIATIO, V14, P501, DOI 10.1080/15299732.2013.769479; Earthquake Commission, CANT EARTHQ 2010 201; Gawith E, 2013, DISASTER PREV MANAG, V22, P395, DOI 10.1108/DPM-10-2013-0180; Gawith L, 2011, NEW ZEAL J PSYCHOL, V40, P121; Gluckman P., 2011, PSYCHOSOCIAL CONSEQU; Helton WS, 2011, CONSCIOUS COGN, V20, P1732, DOI 10.1016/j.concog.2011.02.011; Kaiser A, 2011, ROUT STUD ARCHAEOL, P67; Kemp S., 2011, AUSTRALAS J DISASTER, V2, P11; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Krynen A., 2013, NZ J PSYCHOL, V42, P69; Kuijer RG, 2012, PSYCHOL TRAUMA-US, P361; Lewin TJ, 1998, AUST NZ J PSYCHIAT, V32, P15, DOI 10.1046/j.1440-1614.1998.00380.x; McColl GJ, 2012, DISASTER MED PUBLIC, V6, P33, DOI 10.1001/dmp.2012.8; MCFARLANE AC, 1992, J NERV MENT DIS, V180, P498, DOI 10.1097/00005053-199208000-00004; MCFARLANE AC, 1988, BRIT J PSYCHIAT, V152, P116, DOI 10.1192/bjp.152.1.116; MCFARLANE AC, 1987, J AM ACAD CHILD PSY, V26, P764, DOI 10.1097/00004583-198709000-00025; Mental Health Commission, 2012, NAT IND 2012 MEAS ME; Milojev P, 2014, SOC PSYCHOL PERS SCI, V5, P760, DOI 10.1177/1948550614528545; NIWA, FLOOD MOD HEATHC RIV; NOLENHOEKSEMA S, 1991, J PERS SOC PSYCHOL, V61, P115, DOI 10.1037/0022-3514.61.1.115; Osborne D, 2013, DISASTER PREV MANAG, V22, P456, DOI 10.1108/DPM-09-2013-0161; Rogers N, 2014, EARTHQ SPECTRA, V30, P493, DOI 10.1193/021513EQS029M; Rowney C, 2010, NZJ PSYCHOL IN PRESS; Satherley N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121950; Sibley CG, NZAVS TECHNICAL DO E; Stevenson JR, 2011, BULL N Z SOC EARTHQ, V44, P65, DOI 10.5459/bnzsee.44.2.65-76; Wang XD, 2000, PSYCHIAT CLIN NEUROS, V54, P427, DOI 10.1046/j.1440-1819.2000.00732.x; Wu HC, 2006, AUST NZ J PSYCHIAT, V40, P355, DOI 10.1111/j.1440-1614.2006.01802.x; Zhang Z, 2011, PUBLIC HEALTH, V125, P293, DOI 10.1016/j.puhe.2010.12.008	33	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124278	10.1371/journal.pone.0124278	http://dx.doi.org/10.1371/journal.pone.0124278			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH2XA	25932919	Green Published, gold, Green Submitted			2022-12-27	WOS:000353887100037
J	Liu, RP; Zhang, LY; Yang, J; Zhang, XX; Mikkelsen, R; Song, SY; Zhou, HP				Liu, Runping; Zhang, Luyong; Yang, Jing; Zhang, Xiaoxuan; Mikkelsen, Ross; Song, Shiyu; Zhou, Huiping			HIV Protease Inhibitors Sensitize Human Head and Neck Squamous Carcinoma Cells to Radiation by Activating Endoplasmic Reticulum Stress	PLOS ONE			English	Article							DISRUPT BARRIER INTEGRITY; GROWTH ARREST; ER STRESS; SIGNALING PATHWAYS; LIPID-METABOLISM; MYELOMA CELLS; CANCER-CELL; IN-VITRO; NELFINAVIR; APOPTOSIS	Background Human head and neck squamous cell carcinoma (HNSCC) is the sixth most malignant cancer worldwide. Despite significant advances in the delivery of treatment and surgical reconstruction, there is no significant improvement of mortality rates for this disease in the past decades. Radiotherapy is the core component of the clinical combinational therapies for HNSCC. However, the tumor cells have a tendency to develop radiation resistance, which is a major barrier to effective treatment. HIV protease inhibitors (HIV PIs) have been reported with radiosensitizing activities in HNSCC cells, but the underlying cellular/molecular mechanisms remain unclear. Our previous study has shown that HIV PIs induce cell apoptosis via activation of endoplasmic reticulum (ER) stress. The aim of this study was to examine the role of ER stress in HIV PI-induced radiosensitivity in human HNSCC. Methodology and Principal Findings HNSCC cell lines, SQ20B and FaDu, and the most commonly used HIV PIs, lopinavir and ritonavir (L/R), were used in this study. Clonogenic assay was used to assess the radiosensitivity. Cell viability, apoptosis and cell cycle were analyzed using Cellometer Vision CBA. The mRNA and protein levels of ER stress-related genes (eIF2 alpha, CHOP, ATF-4, and XBP-1), as well as cell cycle related protein, cyclin D1, were detected by real time RT-PCR and Western blot analysis, respectively. The results demonstrated that L/R dose-dependently sensitized HNSCC cells to irradiation and inhibited cell growth. L/R-induced activation of ER stress was correlated to down-regulation of cyclin D1 expression and cell cycle arrest under G0/G1 phase. Conclusion and Significance HIV PIs sensitize HNSCC cells to radiotherapy by activation of ER stress and induction of cell cycle arrest. Our results provided evidence that HIV PIs can be potentially used in combination with radiation in the treatment of HNSCC.	[Liu, Runping; Zhang, Luyong; Yang, Jing; Zhang, Xiaoxuan] China Pharmaceut Univ, Jiangsu Ctr Drug Screening, Nanjing 210009, Jiangsu, Peoples R China; [Liu, Runping; Yang, Jing; Zhang, Xiaoxuan; Zhou, Huiping] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Mikkelsen, Ross; Song, Shiyu] Virginia Commonwealth Univ, Dept Radiat Oncol, Richmond, VA 23298 USA; [Zhou, Huiping] McGuire Vet Affairs Med Ctr, Richmond, VA 23298 USA	China Pharmaceutical University; Virginia Commonwealth University; Virginia Commonwealth University; Hunter Holmes McGuire Veterinary Affairs Medical Center	Zhang, LY (corresponding author), China Pharmaceut Univ, Jiangsu Ctr Drug Screening, Nanjing 210009, Jiangsu, Peoples R China.	lyzhang@cpu.edu.cn; hzhou@vcu.edu	Zhou, Huiping/J-3639-2015; Zhou, Huiping/H-6875-2019	Zhou, Huiping/0000-0002-0050-372X; yang, jing/0000-0003-3068-6595	NIH [R01 DK-057543, R01AT004148]; VA Merit Award [1I01BX001390]; National Science Foundation of China [81070245, 81270489]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT004148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057543] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Award(US Department of Veterans Affairs); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by NIH grants R01 DK-057543 and R01AT004148, VA Merit Award 1I01BX001390, and National Science Foundation of China Grants 81070245 and 81270489 to HZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein WB, 2008, CURR OPIN HIV AIDS, V3, P666, DOI 10.1097/COH.0b013e328313915d; Bose P, 2013, INT J CANCER, V133, P2013, DOI 10.1002/ijc.28112; Brewer JW, 2000, P NATL ACAD SCI USA, V97, P12625, DOI 10.1073/pnas.220247197; Bruning A, 2013, MOL ONCOL, V7, P1012, DOI 10.1016/j.molonc.2013.07.010; Cao RS, 2010, J PHARMACOL EXP THER, V334, P530, DOI 10.1124/jpet.110.168484; Chaturvedi AK, 2013, J CLIN ONCOL, V31, P4550, DOI 10.1200/JCO.2013.50.3870; Chen L, 2009, BIOCHEM PHARMACOL, V78, P70, DOI 10.1016/j.bcp.2009.03.022; Chen YF, 2014, CELL PHYSIOL BIOCHEM, V33, P1975, DOI 10.1159/000362974; Dionysopoulos D, 2013, STRAHLENTHER ONKOL, V189, P202, DOI 10.1007/s00066-012-0275-0; Fassbender JM, 2012, CURR NEUROVASC RES, V9, P274; Fokas E, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-48; George S, 2008, CLIN LUNG CANCER, V9, P160, DOI 10.3816/CLC.2008.n.024; Gills J, 2007, CLIN CANCER RES, V13, P5183, DOI 10.1158/1078-0432.CCR-07-0161; Gupta AK, 2001, CANCER RES, V61, P4278; Gupta AK, 2009, INT J RADIAT ONCOL, V74, P928, DOI 10.1016/j.ijrobp.2009.03.004; Hamanaka RB, 2005, MOL BIOL CELL, V16, P5493, DOI 10.1091/mbc.E05-03-0268; Hashibe M, 2009, CANCER EPIDEM BIOMAR, V18, P541, DOI 10.1158/1055-9965.EPI-08-0347; Hetz C, 2013, NAT REV DRUG DISCOV, V12, P703, DOI 10.1038/nrd3976; Ikezoe T, 2004, MOL CANCER THER, V3, P473; Jiang W, 2007, CANCER RES, V67, P1221, DOI 10.1158/0008-5472.CAN-06-3377; Kim YP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113442; Kraus M, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.2; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Liu RP, 2014, HEPATOLOGY, V60, P908, DOI 10.1002/hep.27085; Marron M, 2010, INT J EPIDEMIOL, V39, P182, DOI 10.1093/ije/dyp291; Masuda M, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000238; McKenna WG, 2003, ONCOGENE, V22, P5866, DOI 10.1038/sj.onc.1206699; Pang XL, 2013, WORLD J GASTROENTERO, V19, P1736, DOI 10.3748/wjg.v19.i11.1736; Parker RA, 2005, MOL PHARMACOL, V67, P1909, DOI 10.1124/mol.104.010165; Pore N, 2006, CANCER RES, V66, P9252, DOI 10.1158/0008-5472.CAN-06-1239; Pyrko P, 2007, CANCER RES, V67, P10920, DOI 10.1158/0008-5472.CAN-07-0796; Raven JF, 2008, J BIOL CHEM, V283, P3097, DOI 10.1074/jbc.M709677200; Safdari Y, 2014, CLIN BIOCHEM, V47, P1195, DOI 10.1016/j.clinbiochem.2014.05.066; Schonthal AH, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/857516; Steelman LS, 2011, CELL CYCLE, V10, P3003, DOI 10.4161/cc.10.17.17119; Su Nai-Wen, 2014, Onco Targets Ther, V7, P2197, DOI 10.2147/OTT.S70188; Suh Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.548; Taura M, 2013, FREE RADICAL BIO MED, V65, P778, DOI 10.1016/j.freeradbiomed.2013.08.161; Testa JR, 2001, P NATL ACAD SCI USA, V98, P10983, DOI 10.1073/pnas.211430998; Toulany M, 2012, MOL CANCER RES, V10, P945, DOI 10.1158/1541-7786.MCR-11-0592; Wang F, 2009, CURR OPIN PHARMACOL, V9, P389, DOI 10.1016/j.coph.2009.06.005; Wang Y, 2013, HEPATOLOGY, V57, P1005, DOI 10.1002/hep.26107; Wu XD, 2010, GASTROENTEROLOGY, V138, P197, DOI 10.1053/j.gastro.2009.08.054; Yang Y, 2005, CANCER SCI, V96, P425, DOI 10.1111/j.1349-7006.2005.00063.x; Yang Y, 2006, BRIT J CANCER, V95, P1653, DOI 10.1038/sj.bjc.6603435; Yin XY, 2010, INT J CANCER, V126, P1216, DOI 10.1002/ijc.24815; Zha BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059514; Zha WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054349; Zha WB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009069; Zhang XX, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0107072, 10.1371/journal.pone.0110243]; Zhang XX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090856; Zhou Huiping, 2007, Atherosclerosis, V195, pe134, DOI 10.1016/j.atherosclerosis.2007.04.008; Zhou HP, 2006, AM J PHYSIOL-GASTR L, V291, pG1071, DOI 10.1152/ajpgi.00182.2006; Zhou HP, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00112; Zhou HP, 2011, METHOD ENZYMOL, V490, P107, DOI 10.1016/B978-0-12-385114-7.00006-4	55	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125928	10.1371/journal.pone.0125928	http://dx.doi.org/10.1371/journal.pone.0125928			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933118	Green Published, gold, Green Submitted			2022-12-27	WOS:000353887100144
J	Lu, XW; Megchelenbrink, W; Notebaart, RA; Huynen, MA				Lu, Xiaowen; Megchelenbrink, Wout; Notebaart, Richard A.; Huynen, Martijn A.			Predicting Human Genetic Interactions from Cancer Genome Evolution	PLOS ONE			English	Article							FALSE DISCOVERY RATE; MISSING HERITABILITY; NETWORKS; HETEROGENEITY; TRANSCRIPTION; CELLS	Synthetic Lethal (SL) genetic interactions play a key role in various types of biological research, ranging from understanding genotype-phenotype relationships to identifying drug-targets against cancer. Despite recent advances in empirical measuring SL interactions in human cells, the human genetic interaction map is far from complete. Here, we present a novel approach to predict this map by exploiting patterns in cancer genome evolution. First, we show that empirically determined SL interactions are reflected in various gene presence, absence, and duplication patterns in hundreds of cancer genomes. The most evident pattern that we discovered is that when one member of an SL interaction gene pair is lost, the other gene tends not to be lost, i.e. the absence of co-loss. This observation is in line with expectation, because the loss of an SL interacting pair will be lethal to the cancer cell. SL interactions are also reflected in gene expression profiles, such as an under representation of cases where the genes in an SL pair are both under expressed, and an over representation of cases where one gene of an SL pair is under expressed, while the other one is over expressed. We integrated the various previously unknown cancer genome patterns and the gene expression patterns into a computational model to identify SL pairs. This simple, genome-wide model achieves a high prediction power (AUC = 0.75) for known genetic interactions. It allows us to present for the first time a comprehensive genome-wide list of SL interactions with a high estimated prediction precision, covering up to 591,000 gene pairs. This unique list can potentially be used in various application areas ranging from biotechnology to medical genetics.	[Lu, Xiaowen; Megchelenbrink, Wout; Notebaart, Richard A.; Huynen, Martijn A.] Radboud Univ Nijmegen, Med Ctr, Dept Bioinformat, Radboud Inst Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Megchelenbrink, Wout] Radboud Univ Nijmegen, Inst Comp & Informat Sci, NL-6525 ED Nijmegen, Netherlands; [Notebaart, Richard A.; Huynen, Martijn A.] Radboud Univ Nijmegen, Med Ctr, Ctr Syst Biol & Bioenerget, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Notebaart, RA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Bioinformat, Radboud Inst Mol Life Sci, NL-6525 ED Nijmegen, Netherlands.	Richard.Notebaart@radboudumc.nl; Martijn.Huijnen@radboudumc.nl	Huynen, Martijn A/A-1530-2014; Notebaart, Richard/A-1459-2014	Huynen, Martijn A/0000-0001-6189-5491; 	Netherlands Organisation for Scientific Research (NWO) [CSBR09/013V]; European Union [HEALTH-241995]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Union(European Commission)	This work was supported by Netherlands Organisation for Scientific Research (NWO), No: CSBR09/013V, (WM); and European Union's FP7 large scale integrated network Gencodys, http://www.gencodys.eu, HEALTH-241995, (XL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R J, V6, P82; Ashworth A, 2011, CELL, V145, P30, DOI 10.1016/j.cell.2011.03.020; Babu M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004120; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bloom JS, 2013, NATURE, V494, P234, DOI 10.1038/nature11867; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Broad Institute TCGA Genome Data Analysis Center, 2014, AN OV 16 MARCH 2014; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Cohen W W, 1995, P 12 INT C MACH LEAR, V95, P115, DOI DOI 10.1016/B978-1-55860-377-6.50023-2; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; DeLuna A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000347; Deshpande R, 2013, CANCER RES, V73, P6128, DOI 10.1158/0008-5472.CAN-12-3956; Dietterich TG, 2000, LECT NOTES COMPUT SC, V1857, P1, DOI 10.1007/3-540-45014-9_1; Dixon SJ, 2008, P NATL ACAD SCI USA, V105, P16653, DOI 10.1073/pnas.0806261105; Fedeles SV, 2011, NAT GENET, V43, P639, DOI 10.1038/ng.860; Frank E., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P144; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Harrison R, 2007, P NATL ACAD SCI USA, V104, P2307, DOI 10.1073/pnas.0607153104; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Hemani G, 2014, NATURE, V508, P249, DOI 10.1038/nature13005; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hermisson J, 2004, GENETICS, V168, P2271, DOI 10.1534/genetics.104.029173; Horn T, 2011, NAT METHODS, V8, P341, DOI 10.1038/NMETH.1581; Hornik K, 2009, COMPUTATION STAT, V24, P225, DOI 10.1007/s00180-008-0119-7; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jerby-Arnon L, 2014, CELL, V158, P1199, DOI 10.1016/j.cell.2014.07.027; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Kafri R, 2005, NAT GENET, V37, P295, DOI 10.1038/ng1523; Kapoor A, 2014, CELL, V158, P185, DOI 10.1016/j.cell.2014.06.003; Laufer C, 2013, NAT METHODS, V10, P427, DOI [10.1038/NMETH.2436, 10.1038/nmeth.2436]; LECESSIE S, 1992, APPL STAT-J ROY ST C, V41, P191; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lu J, 2012, GENOME RES, V22, P1243, DOI 10.1101/gr.132514.111; Lu XW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3124; McManus KJ, 2009, P NATL ACAD SCI USA, V106, P3276, DOI 10.1073/pnas.0813414106; Menardi G, 2014, DATA MIN KNOWL DISC, V28, P92, DOI 10.1007/s10618-012-0295-5; Nakatomi M, 2010, DEV BIOL, V340, P438, DOI 10.1016/j.ydbio.2010.01.031; Pandey G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000928; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; Roguev A, 2013, NAT METHODS, V10, P432, DOI [10.1038/nmeth.2398, 10.1038/NMETH.2398]; Rokach L, 2010, ARTIF INTELL REV, V33, P1, DOI 10.1007/s10462-009-9124-7; Vizeacoumar FJ, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.54; Wong SL, 2004, P NATL ACAD SCI USA, V101, P15682, DOI 10.1073/pnas.0406614101; Zhong WW, 2006, SCIENCE, V311, P1481, DOI 10.1126/science.1123287; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	50	12	12	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125795	10.1371/journal.pone.0125795	http://dx.doi.org/10.1371/journal.pone.0125795			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933428	gold, Green Published, Green Submitted			2022-12-27	WOS:000353887100133
J	Noutsos, C; Perera, AM; Nikolau, BJ; Seaver, SMD; Ware, DH				Noutsos, Christos; Perera, Ann M.; Nikolau, Basil J.; Seaver, Samuel M. D.; Ware, Doreen H.			Metabolomic Profiling of the Nectars of Aquilegia pubescens and A-Canadensis	PLOS ONE			English	Article							SUGAR COMPOSITION; AMINO-ACIDS; HUMMINGBIRDS; POLLINATION; ANNOTATION; PARENTS; HYBRIDS; SEED	To date, variation in nectar chemistry of flowering plants has not been studied in detail. Such variation exerts considerable influence on pollinator-plant interactions, as well as on flower traits that play important roles in the selection of a plant for visitation by specific pollinators. Over the past 60 years the Aquilegia genus has been used as a key model for speciation studies. In this study, we defined the metabolomic profiles of flower samples of two Aquilegia species, A. Canadensis and Aquilegia pubescens. We identified a total of 75 metabolites that were classified into six main categories: organic acids, fatty acids, amino acids, esters, sugars, and unknowns. The mean abundances of 25 of these metabolites were significantly different between the two species, providing insights into interspecies variation in floral chemistry. Using the PlantSEED biochemistry database, we found that the majority of these metabolites are involved in biosynthetic pathways. Finally, we explored the annotated genome of A. coerulea, using the PlantSEED pipeline and reconstructed the metabolic network of Aquilegia. This network, which contains the metabolic pathways involved in generating the observed chemical variation, is now publicly available from the DOE Systems Biology Knowledge Base (KBase; http://kbase.us).	[Noutsos, Christos; Ware, Doreen H.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Perera, Ann M.; Nikolau, Basil J.] Iowa State Univ, WM Keck Metabol Res Lab, Ames, IA USA; [Nikolau, Basil J.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA USA; [Seaver, Samuel M. D.] Argonne Natl Lab, Math & Comp Sci Div, Argonne, IL 60439 USA; [Seaver, Samuel M. D.] Univ Chicago, Computat Inst, Chicago, IL 60637 USA; [Ware, Doreen H.] USDA ARS, NAA, Robert W Holley Ctr, Ithaca, NY 14853 USA	Cold Spring Harbor Laboratory; Iowa State University; Iowa State University; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago; United States Department of Agriculture (USDA)	Noutsos, C (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	cnoutsos@cshl.edu	Noutsos, Christos/E-5601-2012; Seaver, Samuel M. D./C-2614-2008	Noutsos, Christos/0000-0003-1570-4724; Seaver, Samuel M. D./0000-0002-7674-5194	National Science Foundation of United States of America under Division of Biological Infrastructure [DBI-1265382]; Department of Energy [DE-AC02-98CH10886]; NSF [BDI-1265383]; iPlant Collaborative Project	National Science Foundation of United States of America under Division of Biological Infrastructure; Department of Energy(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); iPlant Collaborative Project	This work was funded by grants from the National Science Foundation of United States of America under the Division of Biological Infrastructure to Dr. Doreen Ware who is Co-Principal Investigator to the DBI-1265382. Financial support was provided by the Department of Energy (DE-AC02-98CH10886) for Seaver SMD and to Christos Noutsos from the NSF by the BDI-1265383, the iPlant Collaborative Project. Basil J. Nikolau and and Ann M. Perera received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER HG, 1977, BOT GAZ, V138, P183, DOI 10.1086/336914; Baker HG BI, 1983, FLORAL NECTAR SUGAR; BAKER I, 1976, NEW PHYTOL, V76, P87, DOI 10.1111/j.1469-8137.1976.tb01441.x; Baldwin MW, 2014, SCIENCE, V345, P929, DOI 10.1126/science.1255097; Bender R, 2012, FLORA, V207, P491, DOI 10.1016/j.flora.2012.06.005; Bernardello G, 1999, BIOCHEM SYST ECOL, V27, P779, DOI 10.1016/S0305-1978(99)00029-0; Bertazzini M, 2010, AMINO ACIDS, V39, P315, DOI 10.1007/s00726-010-0474-x; BIELESKI RL, 1980, AUST J PLANT PHYSIOL, V7, P15, DOI 10.1071/PP9800015; BRICE AT, 1991, PHYSIOL ZOOL, V64, P611, DOI 10.1086/physzool.64.2.30158193; Burke JM, 2000, J TORREY BOT SOC, V127, P200, DOI 10.2307/3088757; Canto A, 2007, ANN BOT-LONDON, V99, P653, DOI [10.1090/aob/mcl291, 10.1093/aob/mcl291]; Dupont YL, 2004, FUNCT ECOL, V18, P670, DOI 10.1111/j.0269-8463.2004.00891.x; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; Fenster CB, 2006, AM J BOT, V93, P1800, DOI 10.3732/ajb.93.12.1800; Gijbels P, 2014, J ECOL, V102, P136, DOI 10.1111/1365-2745.12183; Goff SA, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00034; GOTTSBERGER G, 1984, PLANT SYST EVOL, V145, P55, DOI 10.1007/BF00984031; GRANT VERNE, 1952, ALISO, V2, P341; HODGES SA, 1994, P NATL ACAD SCI USA, V91, P5129, DOI 10.1073/pnas.91.11.5129; HODGES SA, 1993, ECOLOGY, V74, P542, DOI 10.2307/1939314; Jones CE, 1983, LITTLE HDB EXPT POLL; Jurgens A, 2004, S AFR J BOT, V70, P191, DOI 10.1016/S0254-6299(15)30235-0; Kaczorowski RL, 2005, AM J BOT, V92, P1270, DOI 10.3732/ajb.92.8.1270; Kirk H, 2012, METABOLOMICS, V8, P211, DOI 10.1007/s11306-011-0301-8; Mato I, 2003, J FOOD PROTECT, V66, P2371, DOI 10.4315/0362-028X-66.12.2371; Nepi M, 2014, J ECOL, V102, P108, DOI 10.1111/1365-2745.12170; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Payan F, 2004, J BIOL CHEM, V279, P36029, DOI 10.1074/jbc.M404225200; Payson EB, 1918, N AM SPECIES AQUILEG; PYKE GH, 1981, BIOTROPICA, V13, P260, DOI 10.2307/2387804; Quanbeck SMM, 2012, FRONT PLANT SCI, P3; Roldan-Serrano AS, 2004, J HORTIC SCI BIOTECH, V79, P717, DOI 10.1080/14620316.2004.11511832; Schmidt MA, 2011, PLANT PHYSIOL, V156, P330, DOI 10.1104/pp.111.173807; Seaver SMD, 2014, P NATL ACAD SCI USA, V111, P9645, DOI 10.1073/pnas.1401329111; Shalit M, 2003, PLANT PHYSIOL, V131, P1868, DOI 10.1104/pp.102.018572; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Whittall JB, 2007, NATURE, V447, P706, DOI 10.1038/nature05857; Witt T, 1999, PLANT BIOLOGY, V1, P334; Wolff D, 2006, ANN BOT-LONDON, V97, P767, DOI 10.1093/aob/mcl033; WYATT R, 1992, AM J BOT, V79, P636, DOI 10.2307/2444879; Zajacz E, 2011, NECTAR PRODUCTION SO	41	17	18	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124501	10.1371/journal.pone.0124501	http://dx.doi.org/10.1371/journal.pone.0124501			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933103	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000353887100046
J	Seitz, F; Luderwald, S; Rosenfeldt, RR; Schulz, R; Bundschuh, M				Seitz, Frank; Luederwald, Simon; Rosenfeldt, Ricki R.; Schulz, Ralf; Bundschuh, Mirco			Aging of TiO2 Nanoparticles Transiently Increases Their Toxicity to the Pelagic Microcrustacean Daphnia magna	PLOS ONE			English	Article							TITANIUM-DIOXIDE NANOPARTICLES; HUMIC-ACID; AGGREGATION; SURFACE; ADSORPTION; FRESH; SIZE; PH	During their aquatic life cycle, nanoparticles are subject to environmentally driven surface modifications (e.g. agglomeration or coating) associated with aging. Although the ecotoxicological potential of nanoparticles might be affected by these processes, only limited information about the potential impact of aging is available. In this context, the present study investigated acute (96 h) and chronic (21 d) implications of systematically aged titanium dioxide nanoparticles (nTiO(2); similar to 90 nm) on the standard test species Daphnia magna by following the respective test guidelines. The nTiO(2) were aged for 0, 1, 3 and 6 d in media with varying ionic strengths (Milli-Q water: approx. 0.00 mmol/L and ASTM: 9.25 mmol/L) in the presence or absence of natural organic matter (NOM). Irrespective of the other parameters, aging in Milli-Q did not change the acute toxicity relative to an unaged control. In contrast, 6 d aged nTiO(2) in ASTM without NOM caused a fourfold decreased acute toxicity. Relative to the 0 d aged particles, nTiO(2) aged for 1 and 3 d in ASTM with NOM, which is the most environmentally-relevant setup used here, significantly increased acute toxicity (by approximately 30%), while a toxicity reduction (60%) was observed for 6 d aged nTiO(2). Comparable patterns were observed during the chronic experiments. A likely explanation for this phenomenon is that the aging of nTiO(2) increases the particle size at the start of the experiment or the time of the water exchange from <100 nm to approximately 500 nm, which is the optimal size range to be taken up by filter feeding D. magna. If subjected to further agglomeration, larger nTiO(2) particles, however, cannot be retained by the daphnids' filter apparatus ultimately reducing their ecotoxicological potential. This nonlinear pattern of increasing and decreasing nTiO(2) related toxicity over the aging duration, highlights the knowledge gap regarding the underlying mechanisms and processes. This understanding seems, however, fundamental to predict the risks of nanoparticles in the field.	[Seitz, Frank; Luederwald, Simon; Rosenfeldt, Ricki R.; Schulz, Ralf; Bundschuh, Mirco] Univ Koblenz Landau, Inst Environm Sci, Landau, Germany; [Bundschuh, Mirco] Swedish Univ Agr Sci, Dept Aquat Sci & Assessment, Uppsala, Sweden	University of Koblenz & Landau; Swedish University of Agricultural Sciences	Bundschuh, M (corresponding author), Univ Koblenz Landau, Inst Environm Sci, Landau, Germany.	mirco.bundschuh@slu.se	Schulz, Ralf/ABI-4526-2020; Schulz, Ralf/G-3674-2011; Bundschuh, Mirco/H-4559-2014	Schulz, Ralf/0000-0002-6348-6971; Schulz, Ralf/0000-0002-6348-6971; Bundschuh, Mirco/0000-0003-4876-220X; Seitz, Frank/0000-0002-3181-0140	DFG [SCHU2271/5-1]	DFG(German Research Foundation (DFG))	This work was supported by DFG grant#SCHU2271/5-1. (http://www.dfg.de/en/research funding/programmes/list/projectdetails/index.jsp? id=172114680) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2000, STATISTICS WITH CONF; [Anonymous], 2007, ASTM STANDARD E729; Bergman TU, 2011, ENVIRON SCI POLLUT R, V18, P655, DOI 10.1007/s11356-010-0413-0; Bouchnak R, 2010, LIMNOLOGICA, V40, P86, DOI 10.1016/j.limno.2009.11.010; Brame J, 2014, WATER RES, V60, P259, DOI 10.1016/j.watres.2014.05.005; Bundschuh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048956; Cupi D, 2015, ENVIRON TOXICOL CHEM, V34, P497, DOI 10.1002/etc.2855; D'Agata A, 2014, NANOTOXICOLOGY, V8, P549, DOI 10.3109/17435390.2013.807446; Dabrunz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020112; Dalai S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062970; Domingos RF, 2009, ENVIRON SCI TECHNOL, V43, P1282, DOI 10.1021/es8023594; Erhayem M, 2014, SCI TOTAL ENVIRON, V470, P92, DOI 10.1016/j.scitotenv.2013.09.063; Erhayem M, 2014, SCI TOTAL ENVIRON, V468, P249, DOI 10.1016/j.scitotenv.2013.08.038; European Comission, 2015, PAPER ASSESSES NANOT; Fouqueray M, 2012, ENVIRON POLLUT, V163, P55, DOI 10.1016/j.envpol.2011.11.035; French RA, 2009, ENVIRON SCI TECHNOL, V43, P1354, DOI 10.1021/es802628n; GELLER W, 1981, OECOLOGIA, V49, P316, DOI 10.1007/BF00347591; GLAZIER DS, 1992, OECOLOGIA, V90, P540, DOI 10.1007/BF01875448; Hall S, 2009, NANOTOXICOLOGY, V3, P91, DOI 10.1080/17435390902788078; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jiang JK, 2009, J NANOPART RES, V11, P77, DOI 10.1007/s11051-008-9446-4; Kim KT, 2010, SCI TOTAL ENVIRON, V408, P2268, DOI 10.1016/j.scitotenv.2010.01.041; Kwon D, 2015, J NANOSCI NANOTECHNO, V15, P4229, DOI 10.1166/jnn.2015.9695; Lemon J, 2010, R NEWS, V6, P8; Lin DH, 2012, WATER RES, V46, P4477, DOI 10.1016/j.watres.2012.05.035; Loosli F, 2015, J NANOPART RES, V17, DOI 10.1007/s11051-015-2863-2; Loureiro C, 2011, ECOTOXICOLOGY, V20, P139, DOI 10.1007/s10646-010-0565-1; Ma HB, 2012, ENVIRON TOXICOL CHEM, V31, P1621, DOI 10.1002/etc.1858; Noss C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080960; Phenrat T, 2009, ENVIRON SCI TECHNOL, V43, P195, DOI 10.1021/es801955n; R Development Core Team R, 2013, R A LANGUAGE AND ENV, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; Ritz C, 2005, J STATIST SOFTWARE, V12; Rosenfeldt RR, 2015, ENVIRON SCI TECHNOL, V49, P1815, DOI 10.1021/es506243d; Rosenfeldt RR, 2014, ENVIRON SCI TECHNOL, V48, P6965, DOI 10.1021/es405396a; Rosenkranz P, 2009, ENVIRON TOXICOL CHEM, V28, P2142, DOI 10.1897/08-559.1; Scheringer M, 2008, NAT NANOTECHNOL, V3, P322, DOI 10.1038/nnano.2008.145; Seitz F, 2015, ECOTOX ENVIRON SAFE, V111, P263, DOI 10.1016/j.ecoenv.2014.09.031; Seitz F, 2014, SCI TOTAL ENVIRON, V493, P891, DOI 10.1016/j.scitotenv.2014.06.092; Seitz F, 2013, AQUAT TOXICOL, V126, P163, DOI 10.1016/j.aquatox.2012.10.015; Seitz F, 2012, ENVIRON TOXICOL CHEM, V31, P518, DOI 10.1002/etc.1715; Sharma VK, 2009, J ENVIRON SCI HEAL A, V44, P1485, DOI 10.1080/10934520903263231; Westerhoff P, 2011, J ENVIRON MONITOR, V13, P1195, DOI 10.1039/c1em10017c; Wheeler MW, 2006, ENVIRON TOXICOL CHEM, V25, P1441, DOI 10.1897/05-320R.1; Zhao CM, 2012, ENVIRON SCI TECHNOL, V46, P11345, DOI 10.1021/es3014375; Zhu XS, 2010, CHEMOSPHERE, V78, P209, DOI 10.1016/j.chemosphere.2009.11.013	45	30	30	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0126021	10.1371/journal.pone.0126021	http://dx.doi.org/10.1371/journal.pone.0126021			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933435	Green Submitted, gold, Green Published			2022-12-27	WOS:000353887100147
J	Wilkinson-Ryan, I; Kim, J; Kim, SJ; Ak, F; Dodson, L; Colonna, M; Powell, M; Mutch, D; Spitzer, D; Hansen, T; Goedegebuure, SP; Curiel, D; Hawkins, W				Wilkinson-Ryan, Ivy; Kim, Julius; Kim, Sojung; Ak, Ferhat; Dodson, Lindzy; Colonna, Marco; Powell, Matthew; Mutch, David; Spitzer, Dirk; Hansen, Ted; Goedegebuure, Simon P.; Curiel, David; Hawkins, William			Incorporation of Porcine Adenovirus 4 Fiber Protein Enhances Infectivity of Adenovirus Vector on Dendritic Cells: Implications for Immune-Mediated Cancer Therapy	PLOS ONE			English	Article							GENE-TRANSFER EFFICIENCY; OVARIAN-CANCER; TARGETING ADENOVIRUS; PHASE-I; MESOTHELIN; RECEPTORS; COMPLEX; ANTIGEN; CD80; IMMUNOBIOLOGY	One strategy in cancer immunotherapy is to capitalize on the key immunoregulatory and antigen presenting capabilities of dendritic cells (DCs). This approach is dependent on efficient delivery of tumor specific antigens to DCs, which subsequently induce an anti-tumor T-cell mediated immune response. Human adenovirus serotype 5 (HAdV5) has been used in human studies for gene delivery, but has limited infection in DCs, which lack the proper receptors. Addition of the porcine fiber knob (PK) from porcine adenovirus type 4 to HAdV5 allows the virus to deliver genetic material via binding to glycosylated surface proteins and bypasses the coxsackie-and-adenovirus receptor required by wild-type HAdV5. In this study we explored the potential therapeutic applications of an adenovirus with PK-based tropism against cancers expressing mesothelin. Infectivity and gene transfer assays were used to compare Ad5-PK to wild-type HAdV5. Mouse models were used to demonstrate peptide specificity and T-cell responses. We show that the PK modification highly augmented infection of DCs, including the CD141+DC subset, a key subset for activation of naive CD8+T-cells. We also show that Ad5-PK increases DC infectivity and tumor specific antigen expression. Finally, vaccination of mice with the Ad5-PK vector resulted in enhanced T-cell-mediated interferon gamma (IFN-gamma) release in response to both mesothelin peptide and a tumor line expressing mesothelin. Ad5-PK is a promising tool for cancer immunotherapy as it improves infectivity, gene transfer, protein expression, and subsequent T-cell activation in DCs compared to wild-type HAdV5 viruses.	[Wilkinson-Ryan, Ivy; Powell, Matthew; Mutch, David] Washington Univ, Sch Med, Div Gynecol Oncol, St Louis, MO USA; [Kim, Julius] Univ Chicago, Dept Neurooncol, Chicago, IL 60637 USA; [Kim, Sojung; Colonna, Marco; Hansen, Ted] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Ak, Ferhat] St Jans Gathuis Hosp, Dept SJG Apotheek, Weert, Netherlands; [Dodson, Lindzy] St Louis Univ, Dept Biol, St Louis, MO 63103 USA; [Spitzer, Dirk; Goedegebuure, Simon P.; Hawkins, William] Washington Univ, Sch Med, Div Surg, St Louis, MO USA; [Curiel, David] Washington Univ, Sch Med, Div Canc Biol, St Louis, MO USA	Washington University (WUSTL); University of Chicago; Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); Washington University (WUSTL)	Hawkins, W (corresponding author), Washington Univ, Sch Med, Div Surg, St Louis, MO 63130 USA.	hawkinsw@wudosis.wustl.edu		Colonna, Marco/0000-0001-5222-4987	Eberle Ovarian Cancer Fund; Family Rock Ovarian Cancer Fund (FamiliesROC)	Eberle Ovarian Cancer Fund; Family Rock Ovarian Cancer Fund (FamiliesROC)	Eberle Ovarian Cancer Fund and The Family Rock Ovarian Cancer Fund (FamiliesROC): MP and DM received these funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnberg N, 2009, REV MED VIROL, V19, P165, DOI 10.1002/rmv.612; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bauer C, 2011, CANCER IMMUNOL IMMUN, V60, P1097, DOI 10.1007/s00262-011-1023-5; CHANG K, 1992, INT J CANCER, V50, P373, DOI 10.1002/ijc.2910500308; Chang MC, 2012, BIOCHEM J, V442, P293, DOI 10.1042/BJ20110282; Crozat K, 2010, J EXP MED, V207, P1283, DOI 10.1084/jem.20100223; Poulin LF, 2010, J EXP MED, V207, P1261, DOI 10.1084/jem.20092618; Gregori S, 2011, TISSUE ANTIGENS, V77, P89, DOI 10.1111/j.1399-0039.2010.01615.x; Hangalapura BN, 2011, CANCER RES, V71, P5827, DOI 10.1158/0008-5472.CAN-11-0804; Hassan R, 2005, APPL IMMUNOHISTO M M, V13, P243, DOI 10.1097/01.pai.00000141545.36485.d6; Hassan R, 2005, AM J CLIN PATHOL, V124, P838, DOI 10.1309/F1B64CL7H8VJKEAF; Hemmi M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/158128; Ho M, 2005, CLIN CANCER RES, V11, P3814, DOI 10.1158/1078-0432.CCR-04-2304; HOHLFELD R, 1994, IMMUNOL TODAY, V15, P269, DOI 10.1016/0167-5699(94)90006-X; Hung CF, 2007, VACCINE, V25, P127, DOI 10.1016/j.vaccine.2006.06.087; Kandalaft LE, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.22664; Kanerva A, 2002, CLIN CANCER RES, V8, P275; KIM J, 2013, NATL GEOGR, V224, P8; Kim KH, 2013, GYNECOL ONCOL, V130, P518, DOI 10.1016/j.ygyno.2013.06.003; Krasnykh V, 2001, J VIROL, V75, P4176, DOI 10.1128/JVI.75.9.4176-4183.2001; Le DT, 2012, CLIN CANCER RES, V18, P858, DOI 10.1158/1078-0432.CCR-11-2121; Leao IC, 2008, CTS-CLIN TRANSL SCI, V1, P228, DOI 10.1111/j.1752-8062.2008.00070.x; Li LJ, 2010, VACCINE, V28, P1911, DOI 10.1016/j.vaccine.2009.10.096; Lybarger L, 2003, J BIOL CHEM, V278, P27105, DOI 10.1074/jbc.M303716200; MAIZEL JV, 1968, VIROLOGY, V36, P115, DOI 10.1016/0042-6822(68)90121-9; McVey D, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-276; Murakami M, 2010, VIROLOGY, V407, P196, DOI 10.1016/j.virol.2010.08.010; Palucka K, 2011, J INTERN MED, V269, P64, DOI 10.1111/j.1365-2796.2010.02317.x; Pascolo S, 1997, J EXP MED, V185, P2043, DOI 10.1084/jem.185.12.2043; PEACH RJ, 1995, J BIOL CHEM, V270, P21181, DOI 10.1074/jbc.270.36.21181; Pereboev AV, 2004, MOL THER, V9, P712, DOI 10.1016/j.ymthe.2004.02.006; Primeau T, 2005, IMMUNOL RES, V32, P109, DOI 10.1385/IR:32:1-3:109; Rump A, 2004, J BIOL CHEM, V279, P9190, DOI 10.1074/jbc.M312372200; Russell WC, 2009, J GEN VIROL, V90, P1, DOI 10.1099/vir.0.003087-0; Santin AD, 2006, GYNECOL ONCOL, V100, P469, DOI 10.1016/j.ygyno.2005.09.040; Sharma A, 2009, VIRUS RES, V143, P184, DOI 10.1016/j.virusres.2009.02.010; Short JJ, 2004, VIROLOGY, V322, P349, DOI 10.1016/j.virol.2004.02.016; Shurin GV, 2012, CANCER IMMUNOL IMMUN, V61, P223, DOI 10.1007/s00262-011-1138-8; Stoff-Khalili MA, 2005, GENE THER, V12, P1696, DOI 10.1038/sj.gt.3302588; Thacker EE, 2009, VACCINE, V27, P7116, DOI 10.1016/j.vaccine.2009.09.055; Thomas AM, 2004, J EXP MED, V200, P297, DOI 10.1084/jem.20031435; Tillman BW, 2000, CANCER RES, V60, P5456; Ueno H, 2011, SEMIN IMMUNOL, V23, P21, DOI 10.1016/j.smim.2011.01.004; Ulasov IV, 2007, J NEUROSURG, V107, P617, DOI 10.3171/JNS-07/09/0617; van de Ven R, 2009, J IMMUNOTHER, V32, P895, DOI 10.1097/CJI.0b013e3181b56deb; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033214; Williams BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046981; Zajonc DM, 2003, NAT IMMUNOL, V4, P808, DOI 10.1038/ni948	49	7	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125851	10.1371/journal.pone.0125851	http://dx.doi.org/10.1371/journal.pone.0125851			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933160	Green Submitted, Green Published, gold			2022-12-27	WOS:000353887100138
J	Yamasaki, H; Funai, Y; Funao, T; Mori, T; Nishikawa, K				Yamasaki, Hiroyuki; Funai, Yusuke; Funao, Tomoharu; Mori, Takashi; Nishikawa, Kiyonobu			Effects of Tramadol on Substantia Gelatinosa Neurons in the Rat Spinal Cord: An In Vivo Patch-Clamp Analysis	PLOS ONE			English	Article							MU-OPIOID RECEPTOR; DORSAL-HORN; INHIBITORY TRANSMISSION; SYNAPTIC-TRANSMISSION; VENTROMEDIAL MEDULLA; XENOPUS OOCYTES; PAIN; METABOLITE; ACTIVATION; MECHANISMS	Tramadol is thought to modulate synaptic transmissions in the spinal dorsal horn mainly by activating mu-opioid receptors and by inhibiting the reuptake of monoamines in the CNS. However, the precise mode of modulation remains unclear. We used an in vivo patch clamp technique in urethane-anesthetized rats to determine the antinociceptive mechanism of tramadol. In vivo whole-cell recordings of spontaneous inhibitory postsynaptic currents (sIPSCs) and spontaneous excitatory postsynaptic currents (sEPSCs) were made from substantia gelatinosa (SG) neurons (lamina II) at holding potentials of 0 mV and -70 mV, respectively. The effects of intravenous administration (0.5, 5, 15 mg/kg) of tramadol were evaluated. The effects of superfusion of tramadol on the surface of the spinal cord and of a tramadol metabolite (M1) were further analyzed. Intravenous administration of tramadol at doses >5 mg/kg decreased the sEPSCs and increased the sIPSCs in SG neurons. These effects were not observed following naloxone pretreatment. Tramadol superfusion at a clinically relevant concentration (10 mu M) had no effect, but when administered at a very high concentration (100 mu M), tramadol decreased sEPSCs, produced outward currents, and enhanced sIPSCs. The effects of M1 (1, 5 mg/kg intravenously) on sEPSCs and sIPSCs were similar to those of tramadol at a corresponding dose (5, 15 mg/kg). The present study demonstrated that systemically administered tramadol indirectly inhibited glutamatergic transmission, and enhanced GABAergic and glycinergic transmissions in SG neurons. These effects were mediated primarily by the activation of mu-opioid receptors. M1 may play a key role in the antinociceptive mechanisms of tramadol.	[Yamasaki, Hiroyuki; Funai, Yusuke; Funao, Tomoharu; Mori, Takashi; Nishikawa, Kiyonobu] Osaka City Univ, Grad Sch Med, Dept Anesthesiol, Osaka 558, Japan	Osaka Metropolitan University	Mori, T (corresponding author), Osaka City Univ, Grad Sch Med, Dept Anesthesiol, Osaka 558, Japan.	m1377033@med.osaka-cu.ac.jp		Funai, Yusuke/0000-0002-8757-3738	Japan Society for the Promotion of Science, Tokyo, Japan [24592355]; Grants-in-Aid for Scientific Research [25462448] Funding Source: KAKEN	Japan Society for the Promotion of Science, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by a grant-in-aid for scientific research (24592355) from the Japan Society for the Promotion of Science, Tokyo, Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba H, 2000, ANESTHESIOLOGY, V92, P485, DOI 10.1097/00000542-200002000-00031; Baccei ML, 2004, J NEUROSCI, V24, P4749, DOI 10.1523/JNEUROSCI.5211-03.2004; CERVERO F, 1980, BRAIN, V103, P717, DOI 10.1093/brain/103.4.717; Codd EE, 2008, PAIN, V134, P254, DOI 10.1016/j.pain.2007.04.019; DRIESSEN B, 1992, BRIT J PHARMACOL, V105, P147, DOI 10.1111/j.1476-5381.1992.tb14226.x; Funai Y, 2014, PAIN, V155, P617, DOI 10.1016/j.pain.2013.12.018; Furue H, 2004, NEUROSCI RES, V48, P361, DOI 10.1016/j.neures.2003.12.005; Furue H, 1999, J PHYSIOL-LONDON, V521, P529, DOI 10.1111/j.1469-7793.1999.00529.x; Gillen C, 2000, N-S ARCH PHARMACOL, V362, P116, DOI 10.1007/s002100000266; Giusti P, 1997, BRIT J PHARMACOL, V122, P302, DOI 10.1038/sj.bjp.0701374; Grond S, 1999, BRIT J CLIN PHARMACO, V48, P254, DOI 10.1046/j.1365-2125.1999.00986.x; Hama A, 2007, EUR J PHARMACOL, V559, P32, DOI 10.1016/j.ejphar.2006.11.047; Hara K, 2005, ANESTH ANALG, V100, P1400, DOI 10.1213/01.ANE.0000150961.24747.98; HENNIES HH, 1988, ARZNEIMITTEL-FORSCH, V38-2, P877; Hurley RW, 2003, NEUROSCIENCE, V118, P789, DOI 10.1016/S0306-4522(03)00041-1; Ide S, 2006, NEUROPHARMACOLOGY, V51, P651, DOI 10.1016/j.neuropharm.2006.05.008; Kaneko K, 2014, NEUROSCI LETT, V562, P28, DOI 10.1016/j.neulet.2014.01.007; Kato G, 2006, J NEUROSCI, V26, P1787, DOI 10.1523/JNEUROSCI.4856-05.2006; Katsuki R, 2006, BRIT J PHARMACOL, V149, P319, DOI 10.1038/sj.bjp.0706868; Kawamata T, 2003, BRAIN RES, V978, P250, DOI 10.1016/S0006-8993(03)02952-4; Kimura M, 2012, ANESTH ANALG, V115, P443, DOI 10.1213/ANE.0b013e31825683c3; Klotz U, 2003, ARZNEIMITTELFORSCH, V53, P681; Koga A, 2005, BRIT J PHARMACOL, V145, P602, DOI 10.1038/sj.bjp.0706225; Kohno T, 1999, J PHYSIOL-LONDON, V518, P803, DOI 10.1111/j.1469-7793.1999.0803p.x; Narikawa K, 2000, J NEUROPHYSIOL, V84, P2171, DOI 10.1152/jn.2000.84.4.2171; Parasrampuria R, 2007, CHIRALITY, V19, P190, DOI 10.1002/chir.20360; Pinto M, 2008, J COMP NEUROL, V510, P175, DOI 10.1002/cne.21793; RAFFA RB, 1992, J PHARMACOL EXP THER, V260, P275; Shiraishi M, 2002, BRIT J PHARMACOL, V136, P207, DOI 10.1038/sj.bjp.0704703; Sonohata M, 2004, J PHYSIOL-LONDON, V555, P515, DOI 10.1113/jphysiol.2003.054932; Yoshimura M, 1996, PROG BRAIN RES, V113, P443, DOI 10.1016/S0079-6123(08)61103-6; Yoshimura M, 2006, J PHARMACOL SCI, V101, P107, DOI 10.1254/jphs.CRJ06008X	32	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125147	10.1371/journal.pone.0125147	http://dx.doi.org/10.1371/journal.pone.0125147			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933213	Green Published, gold, Green Submitted			2022-12-27	WOS:000353887100082
J	Davies, HR; Nazareth, I; Petersen, I				Davies, Hilary R.; Nazareth, Irwin; Petersen, Irene			Trends of People Using Drugs and Opioid Substitute Treatment Recorded in England and Wales General Practice (1994-2012)	PLOS ONE			English	Article							PRIMARY-CARE; PERIODS; UK	Background Illicit drug use is a multifaceted public-health problem with potentially serious impacts. The United Kingdom has one of the highest prevalence of illegal drug use in Europe. Reduction of overall illegal drug use in England and Wales has decreased from 11% to 8.2% (2012/13) over the past 10 years. People who use drugs often seek help from their family doctors. Aims To investigate General Practitioners (family doctors) first recording of drug use and opioid substitute treatment in primary care settings. Design A descriptive study design. Males and females (16-64 years old) were extracted from The Health Improvement Network (THIN) database. Setting England and Wales primary care. Method The first recording of drug use and opioid substitution treatment in primary care was estimated for the period (1994-2012). Poisson regressions were conducted to estimate incidence risk ratios (IRR). Results We identified 33,508 first recordings of drug use and 10,869 individuals with prescriptions for opioid substitute treatment. Overall, males (IRR 2.02, 95% CI:1.97-2.07), people in the age-group; 16-24 (IRR 6.7, 95% CI:6.4-6.9) compared to those over 25 years and the most deprived (IRR 4.2, 95% CI:3.9-4.4) were more likely to have a recording of drug use. Males (IRR 1.2 95% CI:1.2-1.3), in the age-group; 25-34 (IRR 1.8 95% CI:1.7-1.9) and the most deprived (IRR 3.9 95% CI:3.6-4.3) were the groups more likely to have a opioid substitute treatment prescription. Conclusion It is evident from this study that there is little recording of drug use and opioid substitute treatment in primary care. Most drug users do not receive treatment in primary care.	[Davies, Hilary R.; Nazareth, Irwin; Petersen, Irene] UCL, Dept Primary Care & Populat Hlth, London NW3 2PF, England	University of London; University College London	Davies, HR (corresponding author), UCL, Dept Primary Care & Populat Hlth, Rowland Hill St, London NW3 2PF, England.	h.davies.12@ucl.ac.uk	Petersen, Irene/C-5702-2009	Petersen, Irene/0000-0002-0037-7524	National Institute of Health Research English National School for Primary Care Research studentship	National Institute of Health Research English National School for Primary Care Research studentship	Hilary Davies is funded by the National Institute of Health Research English National School for Primary Care Research studentship (http://www.nspcr.ac.uk/). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. There were no conflicting interests.	[Anonymous], WORLD DRUG REP 2014; [Anonymous], DRUGM PSYCH INT PERS; Blak Betina T, 2011, Inform Prim Care, V19, P251; BMJ group, 2013, BRIT NAT FORM INT; Cornish R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5475; CSD Medical Research website, THIN STAT; Dave S, 2009, PHARMACOEPIDEM DR S, V18, P704, DOI 10.1002/pds.1770; de Lusignan S, 2003, METHOD INFORM MED, V42, P416; Degenhardt L, 2013, LANCET, V382, P1564, DOI 10.1016/S0140-6736(13)61530-5; European Monitoring Centre for Drugs and Drug Addiction, 2014, EUR DRUG REP; Ford C, 2013, GUIDANCE USE SUBSTIT; Frisher M, 2009, J PUBLIC HEALTH-UK, V31, P69, DOI 10.1093/pubmed/fdn081; Health Protection Agency, 2012, SHOOT INF PEOPL WHO; Horsfall L, 2013, PHARMACOEPIDEM DR S, V22, P64, DOI 10.1002/pds.3368; Huxley P, 1993, COMMON MENTAL DISORD; Leri F, 2003, ADDICTION, V98, P7, DOI 10.1046/j.1360-0443.2003.00236.x; LIS Y, 1995, J CLIN EPIDEMIOL, V48, P431, DOI 10.1016/0895-4356(94)00137-F; Madgula R.M., 2014, EXPERT REV OBSTET GY, V6, DOI [DOI 10.1586/EOG.10.54, 10.1586/eog.10.54]; Maguire A, 2009, PHARMACOEPIDEM DR S, V18, P76, DOI 10.1002/pds.1688; National Institute for Clinical Excellence, 2010, METH BUPR MAN OP DEP; National Treatment Agency for Substance Misuse, 2012, DRUG TREATM 2012 PRO; Office for National Statistics, 2013, CRIM SURV ENGL WAL; Pope C, 2014, J HEALTH SERV RES PO, V19, P67, DOI 10.1177/1355819614521181; Public Health England, OUR PRIOR 2013 14; Public Health England, NAT TREATM AG SUBST; Royal College of General Practitioners, 2013, SUBST MIS ASS HLTH; Royal College of General Practitioners, 2011, GUID US SUBST PRESCR; Social Exclusion Unit, 2002, RED RE OFF EXPR; Stewart, 2008, PROBL NEEDS NEWL SEN; TOWNSEND P, 1987, J SOC POLICY, V16, P125, DOI 10.1017/S0047279400020341; Townsend P, 1986, IN HLTH NO REG INT R; UK Drug Policy Commission, 2010, GETT SER STIGM PROBL; United Kingdom Drug Policy Commission, 2012, BRIEF PAP ILL DRUGS; Welsh Government, WELSH NAT DAT SUBST	35	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0122626	10.1371/journal.pone.0122626	http://dx.doi.org/10.1371/journal.pone.0122626			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923806	Green Published, gold			2022-12-27	WOS:000353711600020
J	Ong, HC; Alih, E				Ong, Hong Choon; Alih, Ekele			A Control Chart Based on Cluster-Regression Adjustment for Retrospective Monitoring of Individual Characteristics	PLOS ONE			English	Article							MULTIVARIATE CONTROL CHARTS; ESTIMATORS; ALGORITHM; LOCATION; MCD	The tendency for experimental and industrial variables to include a certain proportion of outliers has become a rule rather than an exception. These clusters of outliers, if left undetected, have the capability to distort the mean and the covariance matrix of the Hotelling's T-2 multivariate control charts constructed to monitor individual quality characteristics. The effect of this distortion is that the control chart constructed from it becomes unreliable as it exhibits masking and swamping, a phenomenon in which an out-of-control process is erroneously declared as an in-control process or an in-control process is erroneously declared as out-of-control process. To handle these problems, this article proposes a control chart that is based on cluster-regression adjustment for retrospective monitoring of individual quality characteristics in a multivariate setting. The performance of the proposed method is investigated through Monte Carlo simulation experiments and historical datasets. Results obtained indicate that the proposed method is an improvement over the state-of-art methods in terms of outlier detection as well as keeping masking and swamping rate under control.	[Ong, Hong Choon; Alih, Ekele] Univ Sains Malaysia, Sch Math Sci, Penang 11800, Malaysia	Universiti Sains Malaysia	Alih, E (corresponding author), Univ Sains Malaysia, Sch Math Sci, Penang 11800, Malaysia.	ekelson2002@yahoo.com	ALIH, EKELE/B-1116-2015	ALIH, EKELE/0000-0001-6840-5635	U.SM Fundamental Research Grant Scheme [FRGS/203/PMATHS/6711319]	U.SM Fundamental Research Grant Scheme	This work was supported by U.SM Fundamental Research Grant Scheme FRGS/203/PMATHS/6711319.	Alih E, 2014, COMMUNICATIONS IN ST; Alih E, 2015, J APPL STAT, V42, P1617, DOI 10.1080/02664763.2015.1004623; Alih E, 2015, J APPL STAT, V42, P938, DOI 10.1080/02664763.2014.993366; Billor N, 2000, COMPUT STAT DATA AN, V34, P279, DOI 10.1016/S0167-9473(99)00101-2; Cator EA, 2012, BERNOULLI, V18, P520, DOI 10.3150/11-BEJ353; Cator EA, 2010, J MULTIVARIATE ANAL, V101, P2372, DOI 10.1016/j.jmva.2010.06.009; Chenouri S, 2009, JOURNAL OF QUALITY T, V41; Chenouri S, 2011, QUAL RELIAB ENG INT, V27, P857, DOI 10.1002/qre.1169; Everitt BS, 2011, WILEY SERIES IN PROB; Fan SKS, 2013, QUAL RELIAB ENG INT, V29, P971, DOI 10.1002/qre.1448; Hampel FR, 1986, WILEY SERIES IN PROB; Hubert M, 2012, J COMPUT GRAPH STAT, V21, P618, DOI 10.1080/10618600.2012.672100; Jensen WA, 2007, QUAL RELIAB ENG INT, V23, P615, DOI 10.1002/qre.837; Jobe JM, 2009, J QUAL TECHNOL, V41, P323, DOI 10.1080/00224065.2009.11917789; Johnson R. A., 1992, APPLIED MULTIVARIATE; Jung KM, 2005, COMPUT STAT DATA AN, V48, P307, DOI 10.1016/j.csda.2004.01.008; Kaufman L, 2009, WILEY SERIES IN PROB; Kaufman L., 2005, WILEY SERIES IN PROB; Lawrence DE, 2014, QUAL RELIAB ENG INT, V30, P97, DOI 10.1002/qre.1480; Lee J.-S., 1992, THESIS; LOPUHAA HP, 1991, ANN STAT, V19, P229, DOI 10.1214/aos/1176347978; Maronna R. A., 2006, WILEY SERIES IN PROB; Mason RL, 2002, SOCIETY FOR INDUSTRI; Montgomery DC, 2001, WILEY SERIES IN PROB; Pison G, 2002, METRIKA, V55, P111, DOI 10.1007/s001840200191; Rousseeuw P., 1985, MATH STAT APPL, VB, P283; Rousseeuw PJ, 2004, TECHNOMETRICS, V46, P293, DOI 10.1198/004017004000000329; Rousseeuw PJ, 1999, TECHNOMETRICS, V41, P212, DOI 10.2307/1270566; Staudte RG, 1990, WILEY SERIES IN PROB; Vargas NJA, 2003, J QUAL TECHNOL, V35, P367, DOI 10.1080/00224065.2003.11980234; Variyath AM, 2013, RELIABILITY ENGINEER, V2013, DOI [10.1155/2013/542305, DOI 10.1155/2013/542305]; Variyath AM, 2014, QUAL RELIAB ENG INT, V30, P795, DOI 10.1002/qre.1559	32	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125835	10.1371/journal.pone.0125835	http://dx.doi.org/10.1371/journal.pone.0125835			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923739	Green Submitted, Green Published, gold			2022-12-27	WOS:000353711600163
J	Valentine, B; Kamenov, GD; Kenoyer, JM; Shinde, V; Mushrif-Tripathy, V; Otarola-Castillo, E; Krigbaum, J				Valentine, Benjamin; Kamenov, George D.; Kenoyer, Jonathan Mark; Shinde, Vasant; Mushrif-Tripathy, Veena; Otarola-Castillo, Erik; Krigbaum, John			Evidence for Patterns of Selective Urban Migration in the Greater Indus Valley (2600-1900 BC): A Lead and Strontium Isotope Mortuary Analysis	PLOS ONE			English	Article							ARCHAEOLOGY; FRONTIERS; IDENTITY; AGE	Just as modern nation-states struggle to manage the cultural and economic impacts of migration, ancient civilizations dealt with similar external pressures and set policies to regulate people's movements. In one of the earliest urban societies, the Indus Civilization, mechanisms linking city populations to hinterland groups remain enigmatic in the absence of written documents. However, isotopic data from human tooth enamel associated with Harappa Phase (2600-1900 BC) cemetery burials at Harappa (Pakistan) and Farmana (India) provide individual biogeochemical life histories of migration. Strontium and lead isotope ratios allow us to reinterpret the Indus tradition of cemetery inhumation as part of a specific and highly regulated institution of migration. Intra-individual isotopic shifts are consistent with immigration from resource-rich hinterlands during childhood. Furthermore, mortuary populations formed over hundreds of years and composed almost entirely of first-generation immigrants suggest that inhumation was the final step in a process linking certain urban Indus communities to diverse hinterland groups. Additional multi disciplinary analyses are warranted to confirm inferred patterns of Indus mobility, but the available isotopic data suggest that efforts to classify and regulate human movement in the ancient Indus region likely helped structure socioeconomic integration across an ethnically diverse landscape.	[Valentine, Benjamin] Dartmouth Coll, Dept Anthropol, Hanover, NH 03755 USA; [Kamenov, George D.] Univ Florida, Dept Geol Sci, Gainesville, FL USA; [Kenoyer, Jonathan Mark] Univ Wisconsin, Dept Anthropol, Madison, WI 53706 USA; [Shinde, Vasant; Mushrif-Tripathy, Veena] Deccan Coll Postgrad & Res Inst, Dept Archaeol, Pune, Maharashtra, India; [Otarola-Castillo, Erik] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Krigbaum, John] Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA	Dartmouth College; State University System of Florida; University of Florida; University of Wisconsin System; University of Wisconsin Madison; Harvard University; State University System of Florida; University of Florida	Valentine, B (corresponding author), Dartmouth Coll, Dept Anthropol, Hanover, NH 03755 USA.	benjamin.t.valentine@dartmouth.edu	Kamenov, George/AAE-6176-2020	Kamenov, George/0000-0002-6041-6687; Otarola-Castillo, Erik/0000-0002-7806-494X; Mushrif-Tripathy, Veena/0000-0002-4749-1316	American Institute of Indian Studies Junior Fellowship; Wenner-Gren Dissertation Fieldwork Grant [8383]	American Institute of Indian Studies Junior Fellowship; Wenner-Gren Dissertation Fieldwork Grant	Funding was provided by the American Institute of Indian Studies Junior Fellowship to BV, JK (www.indiastudies.org), and Wenner-Gren Dissertation Fieldwork Grant #8383 to BV, JK (www.wennergren.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal D.P, 2000, ANCIENT METAL TECHNO; Agrawala R.C., 1984, FRONTIERS INDUS CIVI, P157; Alizai A, 2011, GLOBAL PLANET CHANGE, V76, P33, DOI 10.1016/j.gloplacha.2010.11.008; AlQahtani SJ, 2010, AM J PHYS ANTHROPOL, V142, P481, DOI 10.1002/ajpa.21258; [Anonymous], REC J GEOL SURV INDI; [Anonymous], 2014, R LANG ENV STAT COMP; Beck L.A., 1995, REGIONAL APPROACHES; Begemann F, 2009, IRAN ANTIQ, V44, P1, DOI 10.2143/IA.44.0.2034374; Bentley RA, 2006, J ARCHAEOL METHOD TH, V13, P135, DOI 10.1007/s10816-006-9009-x; Bhutta AM, 1992, ACTA MINERALOGICA PA, V6, P21; Blakey M., 1998, TRANSFORM ANTHROPOL, V7, P53, DOI [10.1525/tran.1998.7.1.53, DOI 10.1525/tran.1998.7.1.53]; Bruck J, 2004, J SOC ARCHAEOL, V4, P307, DOI 10.1177/1469605304046417; Burmeister S, 2009, MORTUARY PRACTICES S, P46; Burton JH, 2013, ACS SYM SER, V1147, P309; CANNON A, 1989, CURR ANTHROPOL, V30, P437, DOI 10.1086/203764; Carr C., 1995, J ARCHAEOL METHOD TH, V2, P105, DOI 10.1007/BF02228990; Chapman R., 1981, ARCHAEOLOGY DEATH; Cook G., 2001, RITUAL SACRIFICE ANC, P1; Dales G., 1991, HARAPPA EXCAVATIONS, P185; Dales GF, 1989, PAKISTAN ARCHAEOLOGY, V24, P68; DEB M, 1989, PRECAMBRIAN RES, V43, P1, DOI 10.1016/0301-9268(89)90002-8; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Francis D., 2005, THE SECRET CEMETERY; Garcon M, 2013, GEOCHEM GEOPHY GEOSY, V14, P3324, DOI 10.1002/ggge.20219; Gillespie SD, 2001, J ANTHROPOL ARCHAEOL, V20, P73, DOI 10.1006/jaar.2000.0369; Goldstein LG, 1980, MISSISSIPIAN MORTUAR; Gulson B, 2008, SCI TOTAL ENVIRON, V400, P75, DOI 10.1016/j.scitotenv.2008.06.059; Hargrave E., 2000, SE ARCHAEOLOGY, V19, P1; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; HEMPHILL BE, 1991, HARAPPA EXCAVATIONS, P137; Hennig C., 2014, FPC FLEXIBLE PROCEDU; HILLSON S, 1996, DENT ANTHR; Hodder I., 1982, SYMBOLS ACTION ETHNO; Humphrey LT, 2008, P NATL ACAD SCI USA, V105, P6834, DOI 10.1073/pnas.0711513105; Jarrige C., 1995, MEHRGARH FIELD REPOR; Kamenov GD, 2004, J ANAL ATOM SPECTROM, V19, P1262, DOI 10.1039/b403222e; Kamenov GD, 2008, ENVIRON GEOL, V55, P669, DOI 10.1007/s00254-007-1017-y; Kamenov GD, 2014, SCI TOTAL ENVIRON, V490, P861, DOI 10.1016/j.scitotenv.2014.05.085; Kamp K.A., 1998, CROSS-CULT RES, V32, P79, DOI [10.1177/106939719803200103, DOI 10.1177/106939719803200103]; Karim A, 2000, CHEM GEOL, V170, P153, DOI 10.1016/S0009-2541(99)00246-6; Kennedy K. A. R., 2000, GOD APES FOSSIL MEN; KENNEDY KAR, 1984, AM J PHYS ANTHROPOL, V64, P105, DOI 10.1002/ajpa.1330640203; Kenoyer J.M, 1998, ANCIENT CITIES INDUS; Kenoyer JM, 2013, J ARCHAEOL SCI, V40, P2286, DOI 10.1016/j.jas.2012.12.040; KENOYER JM, 1991, J WORLD PREHIST, V5, P331, DOI 10.1007/BF00978474; Kenoyer JM, 2000, ORDER LEGITIMACY WEA, P88; Koch PL, 1997, J ARCHAEOL SCI, V24, P417, DOI 10.1006/jasc.1996.0126; Law RW, 2011, CURRENT STUDIES INDU, V8; LIGHTFOOT KG, 1995, ANNU REV ANTHROPOL, V24, P471, DOI 10.1146/annurev.an.24.100195.002351; Mant M, 2012, MORTALITY, V17, P18; Mengoni LE, 2010, J SOC ARCHAEOL, V10, P198, DOI 10.1177/1469605310365044; Miller HML, 2006, SPACE AND SPATIAL ANALYSIS IN ARCHAEOLOGY, P281; Montgomery J., 2002, THESIS U BRADFORD; Montgomery J, 2007, APPL GEOCHEM, V22, P1502, DOI 10.1016/j.apgeochem.2007.02.009; Mughal M. R., 1968, PAKISTAN ARCHAEOLOGY, V5, P63; Nath A, 1998, PURATATTVA, V28, P39; Nath A, 1999, PURATATTVA, V29, P46; Naum M, 2010, J ARCHAEOL METHOD TH, V17, P101, DOI 10.1007/s10816-010-9077-9; Parker Pearson M., 2000, ARCHAEOLOGY DEATH BU; Parker Pearson Michael, 1982, SYMBOLIC STRUCTURAL, P99, DOI DOI 10.1017/CBO9780511558252; Parkes P, 2001, COMP STUD SOC HIST, V43, P4, DOI 10.1017/S0010417501003565; Pollard AM, 2008, ROYAL SOC CHEM; Price TD, 2002, ARCHAEOMETRY, V44, P117, DOI 10.1111/1475-4754.00047; RAHA PK, 1978, J GEOL SOC INDIA, V19, P221; Rao S R, 1979, LOTHAL HARAPPAN PORT, V1; Rao S.R., 1985, LOTHAL HARAPPAN PORT, VII; Rao SR, 1973, LOTHAL INDUS VALLEY; Reid DJ, 2006, J HUM EVOL, V50, P329, DOI 10.1016/j.jhevol.2005.09.003; Rizvi U. Z., 2007, THESIS U PENNSYLVANI; Rugg J., 1998, MORTALITY, V3, P111; Rugg J., 2000, MORTALITY, V5, P259, DOI [10.1080/713686011, DOI 10.1080/713686011]; Sastri KN, 1965, NEW LIGHT INDUS CIVI, V2; Saxe A.A., 1970, THESIS U MICHIGAN; Schloen D., 2008, EXPLORING LONGUE DUR, P251; Sharma AK, 1999, DEPARTED HARAPPANS K; Shinde V, 2011, EXCAVATIONS FARMANA, P27; Shinde V, 2011, EXCAVATIONS FARMANA, P550; Stein GJ, 2002, AM ANTHROPOL, V104, P903, DOI 10.1525/aa.2002.104.3.903; Tripathi JK, 2013, CHEM GEOL, V344, P12, DOI 10.1016/j.chemgeo.2013.02.016; Trivedi PK, 2009, EXCAVATIONS TARKHANE; Vaishnav Ragini, 2001, Indian Journal of Pharmacology, V33, P46; Valentine B, 2008, J ARCHAEOL SCI, V35, P1463, DOI 10.1016/j.jas.2007.10.016; Wheeler Robert Eric Mortimer, 1946, ANCIENT INDIA, V2, P58; Wright RP, 2010, ANCIENT IDUS URBANIS	85	33	34	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123103	10.1371/journal.pone.0123103	http://dx.doi.org/10.1371/journal.pone.0123103			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CH0LO	25923705	Green Published, gold, Green Submitted			2022-12-27	WOS:000353711600030
J	Akbar, U; He, Y; Dai, Y; Hack, N; Malaty, I; McFarland, NR; Hess, C; Schmidt, P; Wu, S; Okun, MS				Akbar, Umer; He, Ying; Dai, Yunfeng; Hack, Nawaz; Malaty, Irene; McFarland, Nikolaus R.; Hess, Christopher; Schmidt, Peter; Wu, Samuel; Okun, Michael S.			Weight Loss and Impact on Quality of Life in Parkinson's Disease	PLOS ONE			English	Article							DAILY ENERGY-EXPENDITURE; MANAGEMENT; DIAGNOSIS; DOPAMINE	Introduction Weight loss is common in Parkinson's Disease (PD) and sometimes may precede the diagnosis. Weight loss is associated with multiple factors but its impact on health-related quality of life (HRQL) in PD remains unknown. We sought to investigate the factors associated with weight change and to quantify its effect on HRQL. Methods The National Parkinson Foundation Quality Improvement Initiative (NPF-QII) data was used to analyze PD patients longitudinally between two visits, separated by 12 +/- 6 months. Multiple linear regression analyses were used to assess the associations between baseline covariates and body weight change per month, and to evaluate whether, and to what degree, Parkinson's Disease Questionnaire (PDQ-39) scores were affected. Results A higher Hoehn & Yahr stage, higher number of comorbidities, older age, lower MOCA estimate, and higher rate of levodopa usage were observed in patients who lost weight. Multivariate regression analysis indicated that age and levodopa usage were significantly associated with weight loss. Furthermore, monthly body weight loss was significantly associated with HRQL decline in PD patients. Loss of 1 lb (0.45 kg) per month was associated with a decline in QOL: an increase of 0.5% in PDQ-39 Summary Index score (p=0.004), and 1.1% and 1.5% increases in the mobility and ADL dimensions, respectively. Conclusion Weight loss in PD is common and seems to correlate with worsened HRQL. Awareness of factors associated with weight loss and its relation to HRQL may help practitioners improve patient management and expectations.	[Akbar, Umer] Brown Univ, Dept Neurol, Providence, RI 02912 USA; [He, Ying] Clarkson Univ, Dept Math, Potsdam, NY USA; [Dai, Yunfeng; Wu, Samuel] Univ Florida, Dept Biostat, Gainesville, FL USA; [Hack, Nawaz; Malaty, Irene; McFarland, Nikolaus R.; Hess, Christopher; Okun, Michael S.] Univ Florida, Dept Neurol, Gainesville, FL USA; [Schmidt, Peter] Natl Parkinson Fdn, Miami, FL USA	Brown University; Clarkson University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Akbar, U (corresponding author), Brown Univ, Dept Neurol, Providence, RI 02912 USA.	umerakbar@yahoo.com	McFarland, Nikolaus R/I-4209-2017; Malaty, Irene/AAE-2553-2020; Hack, Nawaz/AAH-4509-2020	McFarland, Nikolaus R/0000-0002-8699-8857; Hess, Christopher/0000-0002-7317-8999; Okun, Michael/0000-0002-6247-9358	NIH; NPF; Michael J. Fox Foundation; Parkinson Alliance; Smallwood Foundation; Bachmann-Strauss Foundation; Tourette Syndrome Association; UF Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NPF; Michael J. Fox Foundation; Parkinson Alliance; Smallwood Foundation; Bachmann-Strauss Foundation; Tourette Syndrome Association; UF Foundation	Dr. Okun serves as a consultant for the National Parkinson Foundation, and has received research grants from NIH, NPF, the Michael J. Fox Foundation, the Parkinson Alliance, Smallwood Foundation, the Bachmann-Strauss Foundation, the Tourette Syndrome Association, and the UF Foundation. Dr. Okun has received royalties for publications with Demos, Manson, Amazon, Smashwords, and Cambridge (movement disorders books). This does not alter the authors' adherence to PLOS policy on sharing data and materials.	ABBOTT RA, 1992, EUR J CLIN NUTR, V46, P879; Bachmann CG, 2006, MOVEMENT DISORD, V21, P1824, DOI 10.1002/mds.21068; Barichella M, 2009, MOVEMENT DISORD, V24, P1881, DOI 10.1002/mds.22705; BEYER PL, 1995, J AM DIET ASSOC, V95, P979, DOI 10.1016/S0002-8223(95)00269-3; Cersosimo MG, 2008, MOVEMENT DISORD, V23, P1065, DOI 10.1002/mds.22051; Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7; Chen HL, 2003, ANN NEUROL, V53, P676, DOI 10.1002/ana.10577; Delikanaki-Skaribas E, 2009, MOVEMENT DISORD, V24, P667, DOI 10.1002/mds.22372; Keller HH, 2003, J AM GERIATR SOC, V51, P945, DOI 10.1046/j.1365-2389.2003.51307.x; LEVI S, 1990, BRIT MED J, V301, P1256, DOI 10.1136/bmj.301.6763.1256; Loewdalt B, 2006, GERONTOLOGY, V52, P160, DOI 10.1159/000091825; Lorefalt B, 2004, ACTA NEUROL SCAND, V110, P180, DOI 10.1111/j.1600-0404.2004.00307.x; MARKUS HS, 1993, J NEURAL TRANSM-PARK, V5, P117, DOI 10.1007/BF02251202; Meguid MM, 2000, NUTRITION, V16, P843, DOI 10.1016/S0899-9007(00)00449-4; Nirenberg MJ, 2006, MOVEMENT DISORD, V21, P524, DOI 10.1002/mds.20757; Nutt JG, 2005, NEW ENGL J MED, V353, P1021, DOI 10.1056/NEJMcp043908; PETO V, 1995, QUAL LIFE RES, V4, P241, DOI 10.1007/BF02260863; Ross GW, 2008, ANN NEUROL, V63, P167, DOI 10.1002/ana.21291; Suchowersky O, 2006, NEUROLOGY, V66, P968, DOI 10.1212/01.wnl.0000215437.80053.d0; Toth MJ, 1997, NEUROLOGY, V48, P88, DOI 10.1212/WNL.48.1.88; Uc EY, 2006, MOVEMENT DISORD, V21, P930, DOI 10.1002/mds.20837	21	45	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0124541	10.1371/journal.pone.0124541	http://dx.doi.org/10.1371/journal.pone.0124541			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938478	Green Published, Green Submitted, gold			2022-12-27	WOS:000353943000027
J	Brown, PM; Kennedy, DJ; Morton, RE; Febbraio, M				Brown, Paul M.; Kennedy, David J.; Morton, Richard E.; Febbraio, Maria			CD36/SR-B2-TLR2 Dependent Pathways Enhance Porphyromonas gingivalis Mediated Atherosclerosis in the Ldlr KO Mouse Model	PLOS ONE			English	Article							SCAVENGER RECEPTOR CD36; FOAM CELL-FORMATION; PERIODONTAL-DISEASE; LIPOPOLYSACCHARIDE PREPARATION; OXIDIZED PHOSPHOLIPIDS; LESION DEVELOPMENT; ORAL INFECTION; ACTIVATION; INFLAMMASOME; LIPOPROTEIN	There is strong epidemiological association between periodontal disease and cardiovascular disease but underlying mechanisms remain ill-defined. Because the human periodontal disease pathogen, Porphyromonas gingivalis (Pg), interacts with innate immune receptors Toll-like Receptor (TLR) 2 and CD36/scavenger receptor-B2 (SR-B2), we studied how CD36/SR-B2 and TLR pathways promote Pg-mediated atherosclerosis. Western diet fed low density lipoprotein receptor knockout (Ldlr degrees) mice infected orally with Pg had a significant increase in lesion burden compared with uninfected controls. This increase was entirely CD36/SR-B2-dependent, as there was no significant change in lesion burden between infected and uninfected Ldlr degrees mice. Western diet feeding promoted enhanced CD36/SR-B2-dependent IL1 beta generation and foam cell formation as a result of Pg lipopolysaccharide (PgLPS) exposure. CD36/SR-B2 and TLR2 were necessary for inflammasome activation and optimal IL1 beta generation, but also resulted in LPS induced lethality (pyroptosis). Modified forms of LDL inhibited Pg-mediated IL1 beta generation in a CD36/SR-B2-dependent manner and prevented pyroptosis, but promoted foam cell formation. Our data show that Pg infection in the oral cavity can lead to significant TLR2-CD36/SR-B2 dependent IL1 beta release. In the vessel wall, macrophages encountering systemic release of IL1 beta, PgLPS and modified LDL have increased lipid uptake, foam cell formation, and release of IL1 beta, but because pyroptosis is inhibited, this enables macrophage survival and promotes increased plaque development. These studies may explain increased lesion burden as a result of periodontal disease, and suggest strategies for development of therapeutics.	[Brown, Paul M.] Cleveland Clin, Lerner Res Inst, Pediat Res Ctr, Cleveland, OH 44106 USA; [Kennedy, David J.; Morton, Richard E.] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44106 USA; [Kennedy, David J.; Morton, Richard E.] Case Western Reserve Univ, Coll Med, Cleveland Clin Lerner, Dept Mol Med, Cleveland, OH 44106 USA; [Febbraio, Maria] Univ Alberta, Dept Dent, Edmonton, AB, Canada	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; University of Alberta	Febbraio, M (corresponding author), Univ Alberta, Dept Dent, Edmonton, AB, Canada.	febbraio@ualberta.ca			National Institutes of Health [HL094879, T32 HL7914]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL094879, T32HL007914] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding came from the National Institutes of Health, HL094879 (MF), National Institutes of Health, T32 HL7914 (PMB) and the American Heart Association Grant in Aid (MF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albandar JM, 2011, J PERIODONTOL, V82, P337, DOI 10.1902/jop.2011.100638; Andrukhov O, 2011, J PERIODONTOL, V82, P885, DOI 10.1902/jop.2010.100425; Aquino ARL, 2011, J PERIODONTAL RES, V46, P303, DOI 10.1111/j.1600-0765.2010.01343.x; Asai Y, 2005, INFECT IMMUN, V73, P2157, DOI 10.1128/IAI.73.4.2157-2163.2005; Ashimoto A, 1996, ORAL MICROBIOL IMMUN, V11, P266, DOI 10.1111/j.1399-302X.1996.tb00180.x; Azarpazhooh Amir, 2012, J Can Dent Assoc, V78, pc25; Bahekar AA, 2007, AM HEART J, V154, P830, DOI 10.1016/j.ahj.2007.06.037; Bamberger ME, 2003, J NEUROSCI, V23, P2665; Bodet C, 2006, CLIN EXP IMMUNOL, V143, P50, DOI 10.1111/j.1365-2249.2005.02956.x; Breyne K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105680; Burns E, 2006, J IMMUNOL, V177, P8296, DOI 10.4049/jimmunol.177.12.8296; Burns E, 2010, J IMMUNOL, V184, P1455, DOI 10.4049/jimmunol.0900378; Cai Y, 2014, ARCH ORAL BIOL, V59, P1183, DOI 10.1016/j.archoralbio.2014.07.012; Cassel SL, 2014, P NATL ACAD SCI USA, V111, P1072, DOI 10.1073/pnas.1318685111; Chaffee BW, 2010, J PERIODONTOL, V81, P1708, DOI 10.1902/jop.2010.100321; Chen G, 2010, SENSORS-BASEL, V10, P97, DOI 10.3390/s100100097; Coats SR, 2009, CELL MICROBIOL, V11, P1587, DOI 10.1111/j.1462-5822.2009.01349.x; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Dietrich Thomas, 2013, J Periodontol, V84, pS70, DOI [10.1111/jcpe.12062, 10.1902/jop.2013.134008]; Dinarello CA, 2011, EUR J IMMUNOL, V41, P1203, DOI 10.1002/eji.201141550; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; Eke PI, 2010, J DENT RES, V89, P1208, DOI 10.1177/0022034510377793; Febbraio M, 2004, ARTERIOSCL THROM VAS, V24, P2333, DOI 10.1161/01.ATV.0000148007.06370.68; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Garber DW, 2000, J LIPID RES, V41, P1020; Giacona MB, 2004, FEMS MICROBIOL LETT, V241, P95, DOI 10.1016/j.femsle.2004.10.009; Gibson FC, 2004, CIRCULATION, V109, P2801, DOI 10.1161/01.CIR.0000129769.17895.F0; Gotto Antonio M Jr, 2011, Trans Am Clin Climatol Assoc, V122, P256; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; Guy E, 2007, ATHEROSCLEROSIS, V192, P123, DOI 10.1016/j.atherosclerosis.2006.07.015; Hajishengallis G, 2008, P NATL ACAD SCI USA, V105, P13532, DOI 10.1073/pnas.0803852105; Hajishengallis G, 2006, CELL MICROBIOL, V8, P1557, DOI 10.1111/j.1462-5822.2006.00730.x; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Hashimoto M, 2004, INT IMMUNOL, V16, P1431, DOI 10.1093/intimm/dxh146; Hayashi Chie, 2010, J Innate Immun, V2, P334, DOI 10.1159/000314686; Hayashi C, 2012, J IMMUNOL, V189, P3681, DOI 10.4049/jimmunol.1201541; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Hou LT, 2003, J PERIODONTAL RES, V38, P247, DOI 10.1034/j.1600-0765.2003.02601.x; Huber J, 2006, J LIPID RES, V47, P1054, DOI 10.1194/jlr.M500555-JLR200; Jiang YG, 2012, BIOCHEM BIOPH RES CO, V425, P121, DOI 10.1016/j.bbrc.2012.07.011; Kennedy DJ, 2009, ARTERIOSCL THROM VAS, V29, P1481, DOI 10.1161/ATVBAHA.109.191940; Kuchibhotla S, 2008, CARDIOVASC RES, V78, P185, DOI 10.1093/cvr/cvm093; Lalla E, 2003, ARTERIOSCL THROM VAS, V23, P1405, DOI 10.1161/01.ATV.0000082462.26258.FE; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Leone CW, 2006, INFECT IMMUN, V74, P2286, DOI 10.1128/IAI.74.4.2286-2292.2006; Li CH, 2007, J PERIODONTOL, V78, P1120, DOI 10.1902/jop.2007.060320; Liu X, 2008, ATHEROSCLEROSIS, V196, P146, DOI 10.1016/j.atherosclerosis.2007.03.025; Lockhart PB, 2012, CIRCULATION, V125, P2520, DOI 10.1161/CIR.0b013e31825719f3; Lukens JR, 2014, P NATL ACAD SCI USA, V111, P1066, DOI 10.1073/pnas.1318688111; Madan M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003204; Maekawa T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020240; Marchesan JT, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4376; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Miller CS, 2006, J AM DENT ASSOC, V137, P322, DOI 10.14219/jada.archive.2006.0181; Miyakawa H, 2004, J PERIODONTAL RES, V39, P1, DOI 10.1111/j.1600-0765.2004.00697.x; Moresco EMY, 2011, CURR BIOL, V21, pR488, DOI 10.1016/j.cub.2011.05.039; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Pace CC, 2010, DYSPHAGIA, V25, P307, DOI 10.1007/s00455-010-9298-9; Papadopoulos G, 2013, J IMMUNOL, V190, P1148, DOI 10.4049/jimmunol.1202511; Podrez EA, 2000, J CLIN INVEST, V105, P1095, DOI 10.1172/JCI8574; Podrez EA, 2002, J BIOL CHEM, V277, P38517, DOI 10.1074/jbc.M205924200; Qi MS, 2003, MICROB PATHOGENESIS, V35, P259, DOI 10.1016/j.micpath.2003.07.002; Reed-Geaghan EG, 2009, J NEUROSCI, V29, P11982, DOI 10.1523/JNEUROSCI.3158-09.2009; Rivaldo EG, 2005, J PERIODONTOL, V76, P1966, DOI 10.1902/jop.2005.76.11.1966; Schenkein Harvey A, 2013, J Clin Periodontol, V40 Suppl 14, pS51, DOI [10.1902/jop.2013.134006, 10.1111/jcpe.12060]; Schillinger T, 2006, STROKE, V37, P2271, DOI 10.1161/01.STR.0000236495.82545.2e; Seimon TA, 2006, P NATL ACAD SCI USA, V103, P19794, DOI 10.1073/pnas.0609671104; Sheedy FJ, 2013, NAT IMMUNOL, V14, P812, DOI 10.1038/ni.2639; Skeggs JW, 2002, J LIPID RES, V43, P1264, DOI 10.1194/jlr.M100431-JLR200; Stashenko P, 2007, AM J PATHOL, V170, P203, DOI 10.2353/ajpath.2007.060597; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Suvan J, 2011, OBES REV, V12, pe381, DOI 10.1111/j.1467-789X.2010.00808.x; Toyofuku T, 2011, SURG TODAY, V41, P1395, DOI 10.1007/s00595-010-4496-5; Triantafilou M, 2007, CELL MICROBIOL, V9, P2030, DOI 10.1111/j.1462-5822.2007.00935.x; Turunen SP, 2015, INNATE IMMUN-LONDON, V21, P370, DOI 10.1177/1753425914542444; VANNIER E, 1993, J CLIN INVEST, V92, P281, DOI 10.1172/JCI116562; Velsko IM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097811; Walton KA, 2003, ARTERIOSCL THROM VAS, V23, P1197, DOI 10.1161/01.ATV.0000079340.80744.B8; Wang M, 2007, J IMMUNOL, V179, P2349, DOI 10.4049/jimmunol.179.4.2349; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm2; Zhou Q, 2005, INFECT IMMUN, V73, P935, DOI 10.1128/IAI.73.2.935-943.2005	84	32	34	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125126	10.1371/journal.pone.0125126	http://dx.doi.org/10.1371/journal.pone.0125126			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938460	gold, Green Published, Green Submitted			2022-12-27	WOS:000353943000046
J	Koffel, JB				Koffel, Jonathan B.			Use of Recommended Search Strategies in Systematic Reviews and the Impact of Librarian Involvement: A Cross-Sectional Survey of Recent Authors	PLOS ONE			English	Article							REPORTING CHARACTERISTICS; MEDICAL LIBRARIANS; METAANALYSES; METHODOLOGY; QUALITY; JOURNALS; APPARENT	Background Previous research looking at published systematic reviews has shown that their search strategies are often suboptimal and that librarian involvement, though recommended, is low. Confidence in the results, however, is limited due to poor reporting of search strategies the published articles. Objectives To more accurately measure the use of recommended search methods in systematic reviews, the levels of librarian involvement, and whether librarian involvement predicts the use of recommended methods. Methods A survey was sent to all authors of English-language systematic reviews indexed in the Database of Abstracts of Reviews of Effects (DARE) from January 2012 through January 2014. The survey asked about their use of search methods recommended by the Institute of Medicine, Cochrane Collaboration, and the Agency for Healthcare Research and Quality and if and how a librarian was involved in the systematic review. Rates of use of recommended methods and librarian involvement were summarized. The impact of librarian involvement on use of recommended methods was examined using a multivariate logistic regression. Results 1560 authors completed the survey. Use of recommended search methods ranged widely from 98% for use of keywords to 9% for registration in PROSPERO and were generally higher than in previous studies. 51% of studies involved a librarian, but only 64% acknowledge their assistance. Librarian involvement was significantly associated with the use of 65% of recommended search methods after controlling for other potential predictors. Odds ratios ranged from 1.36 (95% CI 1.06 to 1.75) for including multiple languages to 3.07 (95% CI 2.06 to 4.58) for using controlled vocabulary. Conclusions Use of recommended search strategies is higher than previously reported, but many methods are still under-utilized. Librarian involvement predicts the use of most methods, but their involvement is under-reported within the published article.	Univ Minnesota, Biomed Lib, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Koffel, JB (corresponding author), Univ Minnesota, Biomed Lib, Minneapolis, MN 55455 USA.	jbkoffel@umn.edu		Koffel, Jonathan/0000-0003-1723-5087				[Anonymous], 2014, DAT ABSTR REV EFF; [Anonymous], 2014, WEB SCI; [Anonymous], 2015, COCHR REV; Aziz T, 2013, J ORAL REHABIL, V40, P263, DOI 10.1111/joor.12028; Beller EM, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-36; Cornelius VR, 2009, PHARMACOEPIDEM DR S, V18, P1223, DOI 10.1002/pds.1844; Eden J, 2011, FINDING WHAT WORKS IN HEALTH CARE: STANDARDS FOR SYSTEMATIC REVIEWS, P1; Faggion CM, 2013, J CLIN PERIODONTOL, V40, P883, DOI 10.1111/jcpe.12132; Fehrmann P, 2011, RES SYNTH METHODS, V2, P15, DOI 10.1002/jrsm.31; Fleming PS, 2014, J CLIN EPIDEMIOL, V67, P754, DOI 10.1016/j.jclinepi.2014.01.002; Flores-Mir C, 2006, AM J ORTHOD DENTOFAC, V130, P214, DOI 10.1016/j.ajodo.2006.02.028; Ge L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085908; Gianola S, 2013, PHYS THER, V93, P1456, DOI 10.2522/ptj.20120382; Golder S, 2008, J CLIN EPIDEMIOL, V61, P440, DOI 10.1016/j.jclinepi.2007.06.005; Golder S, 2014, HEALTH INFO LIBR J, V31, P92, DOI 10.1111/hir.12041; Golder S, 2013, J CLIN EPIDEMIOL, V66, P253, DOI 10.1016/j.jclinepi.2012.09.013; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Klimo P, 2014, J NEUROSURG, V120, P796, DOI 10.3171/2013.11.JNS13195; Lawson ML, 2005, J CLIN EPIDEMIOL, V58, P777, DOI 10.1016/j.jclinepi.2004.08.022; Lee E, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-51; Li L, 2014, J CLIN EPIDEMIOL, V67, P1001, DOI 10.1016/j.jclinepi.2014.04.003; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lundh A, 2009, CANCER TREAT REV, V35, P645, DOI 10.1016/j.ctrv.2009.08.010; Maggio LA, 2011, ACAD MED, V86, P1049, DOI [10.1097/ACM.0b013e31822221e7, 10.1097/ACM.0b013e3182291716]; Major MP, 2006, J AM DENT ASSOC, V137, P1252, DOI 10.14219/jada.archive.2006.0382; Major MP, 2009, J DENT EDUC, V73, P471; Major Michael P, 2007, Evid Based Dent, V8, P66, DOI 10.1038/sj.ebd.6400504; Mallett S, 2006, BMJ-BRIT MED J, V333, P413, DOI 10.1136/bmj.38895.467130.55; McGowan J, 2005, J MED LIBR ASSOC, V93, P74; McKibbon KA, 2006, LIBR TRENDS, V55, P202, DOI 10.1353/lib.2006.0049; Moher D, 2007, PLOS MED, V4, P447, DOI 10.1371/journal.pmed.0040078; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Moseley AM, 2009, J CLIN EPIDEMIOL, V62, P1021, DOI 10.1016/j.jclinepi.2008.09.018; OCEBM Levels of Evidence Working Group, OXF LEV EV 2 WEBS; Panic N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083138; Papageorgiou SN, 2014, EUR J ORTHODONT, V36, P74, DOI 10.1093/ejo/cjt008; Relevo R, 2014, AHRQ PUBLICATION; Rethlefsen ML, 2014, JAMA-J AM MED ASSOC, V312, P999, DOI 10.1001/jama.2014.9263; Rethlefsen ML, 2015, J CLIN EPID IN PRESS; Sampson M, 2008, J CLIN EPIDEMIOL, V61, P748, DOI 10.1016/j.jclinepi.2007.10.009; Sampson M, 2006, J CLIN EPIDEMIOL, V59, P1057, DOI 10.1016/j.jclinepi.2006.01.007; Sampson M, 2009, J CLIN EPIDEMIOL, V62, P944, DOI 10.1016/j.jclinepi.2008.10.012; Scopus [website], 2014, SCOPUS; Seglen PO, 1997, BRIT MED J, V314, P498; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tannery NH, 2012, J MED LIBR ASSOC, V100, P142, DOI 10.3163/1536-5050.100.2.015; Tao KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027611; Thomson Reuters, 2014, J CITATION REPORTS; Turner L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053536; Weller AC, 2004, J MED LIBR ASSOC, V92, P163; Yoshii A, 2009, J MED LIBR ASSOC, V97, P21, DOI 10.3163/1536-5050.97.1.004; Zhang L, 2006, EVID BASED LIB INF P, V1, P3, DOI 10.18438/B85K52	52	71	74	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125931	10.1371/journal.pone.0125931	http://dx.doi.org/10.1371/journal.pone.0125931			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938454	Green Published, gold, Green Submitted			2022-12-27	WOS:000353943000116
J	Lu, X; Zhang, XX; Wang, Z; Huang, KL; Wang, Y; Liang, WG; Tan, YF; Liu, B; Tang, JY				Lu, Xin; Zhang, Xu-Xiang; Wang, Zhu; Huang, Kailong; Wang, Yuan; Liang, Weigang; Tan, Yunfei; Liu, Bo; Tang, Junying			Bacterial Pathogens and Community Composition in Advanced Sewage Treatment Systems Revealed by Metagenomics Analysis Based on High-Throughput Sequencing	PLOS ONE			English	Article							WATER TREATMENT PLANTS; ACTIVATED-SLUDGE; ANTIBIOTIC-RESISTANCE; AEROMONAS-HYDROPHILA; MICROBIAL PATHOGENS; VIRULENCE; INDICATORS; REMOVAL; RESIN; PCR	This study used 454 pyrosequencing, Illumina high-throughput sequencing and metagenomic analysis to investigate bacterial pathogens and their potential virulence in a sewage treatment plant (STP) applying both conventional and advanced treatment processes. Pyrosequencing and Illumina sequencing consistently demonstrated that Arcobacter genus occupied over 43.42% of total abundance of potential pathogens in the STP. At species level, potential pathogens Arcobacter butzleri, Aeromonas hydrophila and Klebsiella pneumonia dominated in raw sewage, which was also confirmed by quantitative real time PCR. Illumina sequencing also revealed prevalence of various types of pathogenicity islands and virulence proteins in the STP. Most of the potential pathogens and virulence factors were eliminated in the STP, and the removal efficiency mainly depended on oxidation ditch. Compared with sand filtration, magnetic resin seemed to have higher removals in most of the potential pathogens and virulence factors. However, presence of the residual Arcobacter butzleri in the final effluent still deserves more concerns. The findings indicate that sewage acts as an important source of environmental pathogens, but STPs can effectively control their spread in the environment. Joint use of the high-throughput sequencing technologies is considered a reliable method for deep and comprehensive overview of environmental bacterial virulence.	[Lu, Xin; Zhang, Xu-Xiang; Wang, Zhu; Huang, Kailong; Liu, Bo; Tang, Junying] Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse, Nanjing 210008, Jiangsu, Peoples R China; [Wang, Yuan] Environm Sci Res Inst Jiangsu, Nanjing, Jiangsu, Peoples R China; [Liang, Weigang; Tan, Yunfei] Zhengzhou Sewage Purificat Co, Zhengzhou, Peoples R China; [Liu, Bo] Nanjing Univ Lianyungang, Res Inst, Lianyungang, Peoples R China	Nanjing University	Zhang, XX (corresponding author), Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse, Nanjing 210008, Jiangsu, Peoples R China.	zhangxx@nju.edu.cn; yongboliu@163.com	zhang, xian/GYA-0290-2022; Zhu, Wang/AAT-1740-2021; 王, 铸/I-3824-2016; zhang, xu/GRX-9733-2022; Zhang, xiaoyu/GXA-3206-2022; zhang, xu/GYE-3558-2022	王, 铸/0000-0002-6763-8194; 	National Science and Technology Major Project of China [2012ZX07204-001, 2012ZX07101-002]; Environmental Protection Research Foundation of Jiangsu Province (China) [2012044, 2012045]	National Science and Technology Major Project of China; Environmental Protection Research Foundation of Jiangsu Province (China)	This study was financially supported by National Science and Technology Major Project of China (No. 2012ZX07204-001, PI: BL; No. 2012ZX07101-002, PI: XXZ; URL: http://www.nmp.gov.cn/) and Environmental Protection Research Foundation of Jiangsu Province (China) (No. 2012044 and 2012045; PI: XXZ; URL: http://www.jshb.gov.cn/jshbw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelbaqi K, 2007, J CLIN MICROBIOL, V45, P3015, DOI 10.1128/JCM.00256-07; Ahmed W, 2008, APPL ENVIRON MICROB, V74, P5490, DOI 10.1128/AEM.00331-08; [Anonymous], 2012, EMERGING ORGANIC CON; Atia AA, 2008, SEP PURIF TECHNOL, V61, P348, DOI 10.1016/j.seppur.2007.11.008; Bibby K, 2013, ENVIRON SCI TECHNOL, V47, P1945, DOI 10.1021/es305181x; Cai L, 2013, ENVIRON SCI TECHNOL, V47, P5433, DOI 10.1021/es400275r; Chen LH, 2005, NUCLEIC ACIDS RES, V33, pD325, DOI 10.1093/nar/gki008; Cheng HWA, 2012, J WATER HEALTH, V10, P380, DOI 10.2166/wh.2012.138; Collado L, 2008, ENVIRON MICROBIOL, V10, P1635, DOI 10.1111/j.1462-2920.2007.01555.x; Collado L, 2011, CLIN MICROBIOL REV, V24, P174, DOI 10.1128/CMR.00034-10; Elmund GK, 1999, WATER ENVIRON RES, V71, P332, DOI 10.2175/106143098X121752; Feazel LM, 2009, P NATL ACAD SCI USA, V106, P16393, DOI 10.1073/pnas.0908446106; Figueroa-Bossi N, 1999, MOL MICROBIOL, V33, P167, DOI 10.1046/j.1365-2958.1999.01461.x; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Fu CY, 2010, WATER SCI TECHNOL, V61, P1589, DOI 10.2166/wst.2010.757; George T, 2003, WASTEWATER ENG TREAT; Godfree A, 2005, J ENVIRON QUAL, V34, P105, DOI 10.2134/jeq2005.0105; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Huang JJ, 2011, WATER RES, V45, P2775, DOI 10.1016/j.watres.2011.02.026; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Lee DY, 2006, J MICROBIOL METH, V65, P453, DOI 10.1016/j.mimet.2005.09.008; Lucena F, 2004, J APPL MICROBIOL, V97, P1069, DOI 10.1111/j.1365-2672.2004.02397.x; Luo CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030087; Ma LP, 2013, J ENVIRON BIOL, V34, P391; Ma LP, 2011, ECOTOXICOLOGY, V20, P968, DOI 10.1007/s10646-011-0652-y; MONFORT P, 1990, APPL ENVIRON MICROB, V56, P1999, DOI 10.1128/AEM.56.7.1999-2006.1990; Neckers L, 2008, CELL HOST MICROBE, V4, P519, DOI 10.1016/j.chom.2008.10.011; Okoh AI, 2007, AFR J BIOTECHNOL, V6, P2932; Olsen JS, 2010, ENVIRON SCI TECHNOL, V44, P8712, DOI 10.1021/es1007774; Pillar CM, 2004, FRONT BIOSCI-LANDMRK, V9, P2335, DOI 10.2741/1400; POFFE R, 1991, J APPL BACTERIOL, V71, P366, DOI 10.1111/j.1365-2672.1991.tb03802.x; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Savichtcheva O, 2006, WATER RES, V40, P2463, DOI 10.1016/j.watres.2006.04.040; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Shi P, 2013, WATER RES, V47, P111, DOI 10.1016/j.watres.2012.09.046; Sonune A, 2004, DESALINATION, V167, P55, DOI 10.1016/j.desal.2004.06.113; Srinivasan S, 2011, WATER RES, V45, P2561, DOI 10.1016/j.watres.2011.02.010; Sun FL, 2010, FOOD CONTROL, V21, P487, DOI 10.1016/j.foodcont.2009.07.014; Toze S, 1999, WATER RES, V33, P3545, DOI 10.1016/S0043-1354(99)00071-8; Varela AR, 2013, ENVIRON SCI POLLUT R, V20, P3550, DOI 10.1007/s11356-013-1594-0; Vartoukian SR, 2010, FEMS MICROBIOL LETT, V309, P1, DOI 10.1111/j.1574-6968.2010.02000.x; Wang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076079; Wen QX, 2009, J ENVIRON MANAGE, V90, P1442, DOI 10.1016/j.jenvman.2008.09.002; Wert EC, 2005, OZONE-SCI ENG, V27, P371, DOI 10.1080/01919510500250754; Ye L, 2012, ENVIRON SCI TECHNOL, V46, P13244, DOI 10.1021/es303454k; Ye L, 2011, ENVIRON SCI TECHNOL, V45, P7173, DOI 10.1021/es201045e; Zhang R, 2006, DESALINATION, V192, P296, DOI 10.1016/j.desal.2005.07.040; Zhang T, 2012, ISME J, V6, P1137, DOI 10.1038/ismej.2011.188; Zhang T, 2009, ENVIRON SCI TECHNOL, V43, P3455, DOI 10.1021/es803309m; Zhang XX, 2011, ENVIRON SCI TECHNOL, V45, P2598, DOI 10.1021/es103672x; Zhou CE, 2007, NUCLEIC ACIDS RES, V35, pD391, DOI 10.1093/nar/gkl791	54	43	45	1	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125549	10.1371/journal.pone.0125549	http://dx.doi.org/10.1371/journal.pone.0125549			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938416	Green Submitted, gold, Green Published			2022-12-27	WOS:000353943000074
J	Toh, LS; Lai, PSM; Wu, DBC; Wong, KT; Low, BY; Anderson, C				Toh, Li Shean; Lai, Pauline Siew Mei; Wu, David Bin-Chia; Wong, Kok Thong; Low, Bee Yean; Anderson, Claire			The Development and Validation of the Osteoporosis Prevention and Awareness Tool (OPAAT) in Malaysia	PLOS ONE			English	Article							PSYCHOMETRIC PROPERTIES; WOMENS KNOWLEDGE; QUESTIONNAIRE; EDUCATION; VALIDITY	Objectives To develop and validate Osteoporosis Prevention and Awareness Tool (OPAAT) in Malaysia. Methods The OPAAT was modified from the Malaysian Osteoporosis Knowledge Tool and developed from an exploratory study on patients. Face and content validity was established by an expert panel. The OPAAT consists of 30 items, categorized into three domains. A higher score indicates higher knowledge level. English speaking non-osteoporotic postmenopausal women >= 50 years of age and pharmacists were included in the study. Results A total of 203 patients and 31 pharmacists were recruited. Factor analysis extracted three domains. Flesch reading ease was 59.2. The mean +/- SD accuracy rate was 0.60 +/- 0.22 (range: 0.26-0.94). The Cronbach's alpha for each domain ranged from 0.286-0.748. All items were highly correlated (Spearman's rho: 0.761-0.990, p<0.05), with no significant change in the overall test-retest scores, indicating that OPAAT has achieved stable reliability. Pharmacists had higher knowledge score than patients (80.9 +/- 8.7vs63.6 +/- 17.4, p<0.001), indicating that the OPAAT was able to discriminate between the knowledge levels of pharmacists and patients. Conclusion The OPAAT was found to be a valid and reliable instrument for assessing patient's knowledge about osteoporosis and its prevention in Malaysia. The OPAAT can be used to identify individuals in need of osteoporosis educational intervention.	[Toh, Li Shean; Wong, Kok Thong; Low, Bee Yean] Univ Nottingham, Fac Sci, Sch Pharm, Semenyih, Selangor, Malaysia; [Lai, Pauline Siew Mei] Univ Malaya, Fac Med, Dept Primary Care Med, Primary Care Res Grp, Kuala Lumpur, Wilayah Perseku, Malaysia; [Wu, David Bin-Chia] Monash Univ Malaysia, Sch Pharm, Subang Jaya, Selangor, Malaysia; [Anderson, Claire] Univ Nottingham, Sch Pharm, Div Social Res Med & Hlth, Nottingham NG7 2RD, England	University of Nottingham Malaysia; Universiti Malaya; Monash University; Monash University Sunway; University of Nottingham	Anderson, C (corresponding author), Univ Nottingham, Sch Pharm, Div Social Res Med & Hlth, Nottingham NG7 2RD, England.	claire.anderson@nottingham.ac.uk	Low, Bee Yean/L-9195-2017; Toh, Li Shean/F-2167-2016; Wu, David Bin-Chia/H-3267-2019; Lai, Pauline Siew Mei/B-1031-2012	Low, Bee Yean/0000-0002-1841-0169; Toh, Li Shean/0000-0002-9228-6266; Lai, Pauline Siew Mei/0000-0002-9940-9644; Anderson, Claire/0000-0002-5406-2296	Ministry of Science, Technology and Innovation (MOSTI), Malaysia [06-02-12 SF0183]	Ministry of Science, Technology and Innovation (MOSTI), Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia)	This project was funded by the 06-02-12 SF0183 Ministry of Science, Technology and Innovation (MOSTI), Malaysia. The URL: http://ernd.mosti.gov.my/eScience/frmLogin.aspx. The authors receiving the funding are LST, PSML, CA, KTW, LBY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulameer SA, 2013, J COMMUN HEALTH, V38, P95, DOI 10.1007/s10900-012-9586-4; Ailinger R L, 1998, Orthop Nurs, V17, P66; Ailinger RL, 2003, NURS RES, V52, P198, DOI 10.1097/00006199-200305000-00010; Ailinger RL, 1998, APPL NURS RES, V11, P111, DOI 10.1016/S0897-1897(98)80102-X; Alexandraki KI, 2008, MATURITAS, V59, P38, DOI 10.1016/j.maturitas.2007.10.008; Andersen RM, 1995, J HLTH SOCIAL BEHAV, P36; [Anonymous], 2001, HLTH SCI RES HDB QUA; Baheiraei A, 2005, MATURITAS, V50, P134, DOI 10.1016/j.maturitas.2004.05.001; Beaton DE, 2012, QUAL HEALTH RES, V22, P1647, DOI 10.1177/1049732312457467; Bruin J, 2006, NEWTEST COMMAND COMP; Burke-Doe Annie, 2008, J Geriatr Phys Ther, V31, P11; Cadarette SM, 2007, OSTEOPOROSIS INT, V18, P981, DOI 10.1007/s00198-007-0326-z; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cranney A, 2008, OSTEOPOROSIS INT, V19, P1733, DOI 10.1007/s00198-008-0669-0; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Curry LC, 2001, J WOMEN AGING, V13; Davis JC, 2007, J GERONTOL A-BIOL, V62, P888, DOI 10.1093/gerona/62.8.888; [Department of statistics Malaysia Malaysia Dos], 2013, SALARIES WAGES SURVE; DeVon HA, 2007, J NURS SCHOLARSHIP, V39, P155, DOI 10.1111/j.1547-5069.2007.00161.x; Etemadifar MR, 2013, WORLD J ORTHOP, V4, P139, DOI 10.5312/wjo.v4.i3.139; Field A., 2009, DISCOVERING STAT USI, V3, DOI DOI 10.1080/1057610X.2016.1157408; Flesch R, 1948, J APPL PSYCHOL, V32, P221, DOI 10.1037/h0057532; Gaines JM, 2011, MATURITAS, V68, P5, DOI 10.1016/j.maturitas.2010.08.013; Gemalmaz A, 2008, CLIN RHEUMATOL, V27, P723, DOI 10.1007/s10067-007-0777-9; George D, 2003, SPSS WINDOWS STEP ST, V4th, DOI DOI 10.1080/13803395.2011.614598; Gorsuch R.L., 1983, FACTOR ANAL, V2nd ed.; Hajcsar EE, 2000, CAN MED ASSOC J, V163, P819; Harman H.H., 1976, MODERN FACTOR ANAL; Harrington D., 2009, CONFIRMATORY FACTOR, DOI DOI 10.1093/ACPROF:OSO/9780195339888.001.0001; Jensen AL, 2014, OSTEOPOROSIS INT, V25, P1209, DOI 10.1007/s00198-013-2573-5; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kasper M J, 1994, Arch Fam Med, V3, P696, DOI 10.1001/archfami.3.8.696; Khan YH, 2014, TROP J PHARM RES, V13, P155, DOI 10.4314/tjpr.v13i1.22; Kim J, 1978, FACTOR ANAL STAT MET; Kim K., 1991, OSTEOPOROSIS KNOWLED; Lai PSM, 2008, MATURITAS, V60, P122, DOI 10.1016/j.maturitas.2008.04.006; Lai Psm, 2013, Malays Fam Physician, V8, P2; Liza H, 2009, MALAYS ORTHOP J, V3, P28; Lundy K. S., 2009, COMMUNITY HLTH NURSI; Magnus JH, 1996, OSTEOPOROSIS INT, V6, P31, DOI 10.1007/BF01626535; [Ministry of Health Malaysia Health Mo], 2012, CLIN GUIDELINE MANAG; Nielsen D, 2008, SCAND J PUBLIC HEALT, V36, P346, DOI 10.1177/1403494808089558; Pande KC, 2000, MATURITAS, V37, P75, DOI 10.1016/S0378-5122(00)00165-1; Richy F, 2004, J BONE MINER RES, V19, P1955, DOI 10.1359/JBMR.040903; Saw SM, 2003, OSTEOPOROSIS INT, V14, P595, DOI 10.1007/s00198-003-1403-6; Schutt, 2012, RES METHODS ED, P159; Smith F, 2002, RES METHODS PHARM PR; Terrio K, 2002, J COMMUN HEALTH, V27, P307, DOI 10.1023/A:1019840709367; Toh LS, 2012, OSTEOPOROSIS INT, V23, pS777; Ungan M, 2001, FAM PRACT, V18, P199, DOI 10.1093/fampra/18.2.199; University Testing Services ASU, GUID INT IT AN REP; Winzenberg TM, 2003, BMC MUSCULOSKEL DIS, V4, DOI 10.1186/1471-2474-4-17; Yeap SS, 2010, ASIA-PAC J PUBLIC HE, V22, P233, DOI 10.1177/1010539509343948; Yuksel N, 2010, OSTEOPOROSIS INT, V21, P391, DOI 10.1007/s00198-009-0977-z	54	13	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0124553	10.1371/journal.pone.0124553	http://dx.doi.org/10.1371/journal.pone.0124553			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH3PP	25938494	Green Published, gold, Green Submitted			2022-12-27	WOS:000353943000028
J	Yang, YQ; Chen, FY; Karasawa, T; Ma, KT; Guan, BC; Shi, XR; Li, HZ; Steyger, PS; Nuttall, AL; Jiang, ZG				Yang, Yuqin; Chen, Fangyi; Karasawa, Takatoshi; Ma, Ke-Tao; Guan, Bing-Cai; Shi, Xiao-Rui; Li, Hongzhe; Steyger, Peter S.; Nuttall, Alfred L.; Jiang, Zhi-Gen			Diverse Kir Expression Contributes to Distinct Bimodal Distribution of Resting Potentials and Vasotone Responses of Arterioles	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; RECTIFIER POTASSIUM CHANNEL; SPIRAL MODIOLAR ARTERY; COCHLEAR BLOOD-FLOW; AGE-RELATED-CHANGES; GUINEA-PIG; K+ CHANNELS; ENDOTHELIAL-CELLS; PATCH-CLAMP; FUNCTIONAL EXPRESSION	The resting membrane potential (RP) of vascular smooth muscle cells (VSMCs) is a major determinant of cytosolic calcium concentration and vascular tone. The heterogeneity of RPs and its underlying mechanism among different vascular beds remain poorly understood. We compared the RPs and vasomotion properties between the guinea pig spiral modiolar artery (SMA), brain arterioles (BA) and mesenteric arteries (MA). We found: 1) RPs showed a robust bimodal distribution peaked at -76 and -40 mV evenly in the SMA, unevenly at -77 and -51 mV in the BA and similar to-71 and -52 mV in the MA. Ba2+ 0.1 mM eliminated their high RP peaks similar to-75 mV. 2) Cells with low RP (similar to-45 mV) hyperpolarized in response to 10 mM extracellular K+, while cells with a high RP depolarized, and cells with intermediate RP (similar to-58 mV) displayed an initial hyperpolarization followed by prolonged depolarization. Moderate high K+ typically induced dilation, constriction and a dilation followed by constriction in the SMA, MA and BA, respectively. 3) Boltzmann-fit analysis of the Ba2+-sensitive inward rectifier K+ (Kir) whole-cell current showed that the maximum Kir conductance density significantly differed among the vessels, and the half-activation voltage was significantly more negative in the MA. 4) Corresponding to the whole-cell data, computational modeling simulated the three RP distribution patterns and the dynamics of RP changes obtained experimentally, including the regenerative swift shifts between the two RP levels after reaching a threshold. 5) Molecular works revealed strong Kir2.1 and Kir2.2 transcripts and Kir2.1 immunolabeling in all 3 vessels, while Kir2.3 and Kir2.4 transcript levels varied. We conclude that a dense expression of functional Kir2. X channels underlies the more negative RPs in endothelial cells and a subset of VSMC in these arterioles, and the heterogeneous Kir function is primarily responsible for the distinct bimodal RPs among these arterioles. The fast Kir-based regenerative shifts between two RP states could form a critical mechanism for conduction/spread of vasomotion along the arteriole axis.	[Yang, Yuqin; Chen, Fangyi; Karasawa, Takatoshi; Ma, Ke-Tao; Guan, Bing-Cai; Shi, Xiao-Rui; Li, Hongzhe; Steyger, Peter S.; Nuttall, Alfred L.; Jiang, Zhi-Gen] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97239 USA; [Chen, Fangyi] South Univ Sci & Technol China, Dept Biol, Shenzhen 518055, Peoples R China; [Ma, Ke-Tao] Shihezi Univ, Coll Med, Dept Physiol, Shihezi, Peoples R China; [Guan, Bing-Cai] Hebei Med Univ, Dept Pharmacol, Shijiazhuang, Peoples R China	Oregon Health & Science University; Southern University of Science & Technology; Shihezi University; Hebei Medical University	Jiang, ZG (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97239 USA.	Jiangz@ohsu.edu	Steyger, Peter S./B-9147-2011; Chen, Fangyi/I-3497-2018	Steyger, Peter S./0000-0002-6103-5237; Chen, Fangyi/0000-0002-5024-6215	Hearing Health Foundation; Oregon Medical Research Fund; NIH NIDCD [R01 DC004716, R03DC011622, DC010844, DC R21DC1239801, DC004555, DC00105]; NIH [P30 DC005983]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R56DC004555, P30DC005983, R01DC012588, R01DC004555, K23DC000105, R01DC010844, R21DC012398] Funding Source: NIH RePORTER	Hearing Health Foundation; Oregon Medical Research Fund; NIH NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from Hearing Health Foundation, Oregon Medical Research Fund, NIH NIDCD R01 DC004716 (ZGJ), and by NIH NIDCD R03DC011622 (HL), DC010844 (XS), DC R21DC1239801 (XS), DC004555 (PSS), DC00105 (ALN) and NIH P30 DC005983. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARONSON PI, 1988, J PHYSIOL-LONDON, V405, P57, DOI 10.1113/jphysiol.1988.sp017321; Albert AP, 2006, J PHYSIOL-LONDON, V570, P45, DOI 10.1113/jphysiol.2005.096875; ARMSTRONG CM, 1992, METHOD ENZYMOL, V207, P100; AXELSSON A, 1988, AM J OTOLARYNG, V9, P278, DOI 10.1016/S0196-0709(88)80036-X; Bae YM, 1999, J PHYSIOL-LONDON, V514, P747, DOI 10.1111/j.1469-7793.1999.747ad.x; BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; Bradley KK, 1999, J PHYSIOL-LONDON, V515, P639, DOI 10.1111/j.1469-7793.1999.639ab.x; BROWN JN, 1995, HEARING RES, V86, P189, DOI 10.1016/0378-5955(95)00070-K; Casella G., 2021, STAT INFERENCE; Crane GJ, 2003, J VASC RES, V40, P159, DOI 10.1159/000070713; DIETRICH HH, 1994, J NEUROSURG, V81, P437, DOI 10.3171/jns.1994.81.3.0437; DOUPNIK CA, 1995, CURR OPIN NEUROBIOL, V5, P268, DOI 10.1016/0959-4388(95)80038-7; EDWARDS FR, 1989, BRIT J PHARMACOL, V96, P785, DOI 10.1111/j.1476-5381.1989.tb11884.x; Emerson GG, 2000, CIRC RES, V87, P474; Emerson GG, 2001, AM J PHYSIOL-HEART C, V280, pH160; Emerson GG, 2000, CIRC RES, V86, P94, DOI 10.1161/01.RES.86.1.94; Fang Y, 2005, AM J PHYSIOL-CELL PH, V289, pC1134, DOI 10.1152/ajpcell.00077.2005; Faraci FM, 1998, J CEREBR BLOOD F MET, V18, P1047, DOI 10.1097/00004647-199810000-00001; Feletou M, 1999, J PHYSIOL PHARMACOL, V50, P525; Figueroa XF, 2004, PHYSIOLOGY, V19, P277, DOI 10.1152/physiol.00008.2004; Guan BC, 2007, BRIT J PHARMACOL, V151, P1049, DOI 10.1038/sj.bjp.0707244; Guo DL, 2003, J GEN PHYSIOL, V121, P261, DOI 10.1085/jgp.200208771; Hill CE, 2008, J PHYSIOL-LONDON, V586, P1465, DOI 10.1113/jphysiol.2008.151308; Hille B., 2001, IONIC CHANNELS EXCIT, P814; HIRST GDS, 1989, PHYSIOL REV, V69, P546, DOI 10.1152/physrev.1989.69.2.546; HULTCRANTZ E, 1988, AM J OTOLARYNG, V9, P317, DOI 10.1016/S0196-0709(88)80039-5; Jackson WF, 2005, MICROCIRCULATION, V12, P113, DOI 10.1080/10739680590896072; Jernigan NL, 2005, AM J PHYSIOL-RENAL, V289, pF891, DOI 10.1152/ajprenal.00019.2005; Jiang ZG, 2004, HEARING RES, V189, P92, DOI 10.1016/S0378-5955(03)00398-8; Jiang ZG, 2001, J PHYSIOL-LONDON, V537, P829; Jiang ZG, 1999, HEARING RES, V138, P171, DOI 10.1016/S0378-5955(99)00166-5; Jiang ZG, 2005, J PHYSIOL-LONDON, V564, P475, DOI 10.1113/jphysiol.2004.080960; Jiang ZG, 2007, J PHARMACOL EXP THER, V320, P544, DOI 10.1124/jpet.106.115212; Jiang ZG, 2010, FASEB J, V24; KIMURA RS, 1986, AM J OTOLARYNG, V7, P130, DOI 10.1016/S0196-0709(86)80042-4; KLIEBER HG, 1994, CARDIOVASC RES, V28, P823, DOI 10.1093/cvr/28.6.823; KNOT HJ, 1995, AM J PHYSIOL-HEART C, V269, pH348, DOI 10.1152/ajpheart.1995.269.1.H348; Knot HJ, 1998, J PHYSIOL-LONDON, V508, P199, DOI 10.1111/j.1469-7793.1998.199br.x; KONISHI T, 1961, J ACOUST SOC AM, V33, P349, DOI 10.1121/1.1908659; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Liu GX, 2001, J PHYSIOL-LONDON, V532, P115, DOI 10.1111/j.1469-7793.2001.0115g.x; Ma KT, 2011, AM J PHYSIOL-HEART C, V300, pH335, DOI 10.1152/ajpheart.00737.2010; Nakahata K, 2006, ANESTH ANALG, V102, P571, DOI 10.1213/01.ane.0000194303.00844.5e; NELSON MT, 1990, AM J PHYSIOL, V259, pC3; NELSON MT, 1995, AM J PHYSIOL-CELL PH, V268, pC799, DOI 10.1152/ajpcell.1995.268.4.C799; Nilius B, 2001, PHYSIOL REV, V81, P1415, DOI 10.1152/physrev.2001.81.4.1415; Quayle JM, 1997, PHYSIOL REV, V77, P1165, DOI 10.1152/physrev.1997.77.4.1165; Quinn K, 2000, AM J PHYSIOL-HEART C, V279, pH351, DOI 10.1152/ajpheart.2000.279.1.H351; Quinn K, 1998, PFLUG ARCH EUR J PHY, V435, P564, DOI 10.1007/s004240050553; QUIRK WS, 1991, HEARING RES, V52, P217, DOI 10.1016/0378-5955(91)90201-J; Ren TY, 1995, HEARING RES, V92, P30, DOI 10.1016/0378-5955(95)00192-1; SCHEIBE F, 1993, EUR ARCH OTO-RHINO-L, V250, P281; Schram G, 2003, CARDIOVASC RES, V59, P328, DOI 10.1016/S0008-6363(03)00366-3; Schram G, 2002, J PHYSIOL-LONDON, V544, P337, DOI 10.1113/jphysiol.2002.026047; SCHUKNECHT HF, 1993, ANN OTO RHINOL LARYN, V102, P1; SCHUKNECHT HF, 1982, AM J OTOLARYNG, V3, P349, DOI 10.1016/S0196-0709(82)80009-4; Si JQ, 2002, HEARING RES, V171, P167, DOI 10.1016/S0378-5955(02)00497-5; Suzuki T, 1998, ANN OTO RHINOL LARYN, V107, P648, DOI 10.1177/000348949810700803; Tang QY, 2010, CHANNELS, V4, P22, DOI 10.4161/chan.4.1.10481; Tennant BP, 2006, J MEMBRANE BIOL, V213, P19, DOI 10.1007/s00232-006-0037-y; THALMANN R, 1972, LARYNGOSCOPE, V82, P2249, DOI 10.1288/00005537-197212000-00013; Wangemann P, 1998, HEARING RES, V115, P113, DOI 10.1016/S0378-5955(97)00184-6; Welsh DG, 1998, AM J PHYSIOL-HEART C, V274, pH178, DOI 10.1152/ajpheart.1998.274.1.H178; Xu XP, 1999, PFLUG ARCH EUR J PHY, V438, P187, DOI 10.1007/s004240050897; Zaritsky JJ, 2000, CIRC RES, V87, P160, DOI 10.1161/01.RES.87.2.160	65	4	4	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125266	10.1371/journal.pone.0125266	http://dx.doi.org/10.1371/journal.pone.0125266			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938437	Green Published, gold, Green Submitted			2022-12-27	WOS:000353943000055
J	Yang, ZY; Zhang, YS; Dong, LM; Yang, C; Gou, SM; Yin, T; Wu, HS; Wang, CY				Yang, Zhiyong; Zhang, Yushun; Dong, Liming; Yang, Chong; Gou, Shanmiao; Yin, Tao; Wu, Heshui; Wang, Chunyou			The Reduction of Peripheral Blood CD4(+) T Cell Indicates Persistent Organ Failure in Acute Pancreatitis	PLOS ONE			English	Article							INFLAMMATORY RESPONSE; LYMPHOCYTE SUBSETS; DYSFUNCTION; SEVERITY; INTERLEUKIN-6; DEATH; RISK; MICE	Objective Few data are available on the potential role of inflammatory mediators and T lymphocytes in persistent organ failure (POF) in acute pancreatitis (AP). We conducted a retrospective study to characterize their role in the progression of POF in AP. Methods A total of 69 AP patients presented within 24 hours from symptom onset developing organ failure (OF) on admission were included in our study. There were 39 patients suffering from POF and 30 from transient OF (TOF). On the 1st, 3rd and 7th days after admission, blood samples were collected for biochemical concentration monitoring including serum IL-1 beta, IL-6, TNF-alpha and high-sensitivity C-reactive protein (hs-CRP). The proportions of peripheral CD4(+) and CD8(+) T lymphocytes were assessed based on flow cytometry simultaneously. Results Patients with POF showed a significantly higher value of IL-1 beta and hs-CRP on day 7 compared with the group of TOF (P < 0.05). Proportions of CD4(+) T cells on days 1, 3, 7 and CD4(+)/CD8(+) ratio on day 1 were statistically lower in the group of POF patients (P < 0.05). A CD4(+) T cell proportion of 30.34% on day 1 predicted POF with an area under the curve (AUC) of 0.798, a sensitivity with 61.54% and specificity with 90.00%, respectively. Conclusions The reduction of peripheral blood CD4(+) T lymphocytes is associated with POF in AP, and may act as a potential predictor.	[Yang, Zhiyong; Zhang, Yushun; Dong, Liming; Yang, Chong; Gou, Shanmiao; Yin, Tao; Wu, Heshui; Wang, Chunyou] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Pancreat Dis Inst, Wuhan, Hubei Province, Peoples R China	Huazhong University of Science & Technology	Wu, HS (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Pancreat Dis Inst, Wuhan, Hubei Province, Peoples R China.	heshuiwu@163.com; chunyouwang52@126.com			National Natural Science Foundation of China [81171840]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China (No. 81171840). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Mofleh IA, 2008, WORLD J GASTROENTERO, V14, P675, DOI 10.3748/wjg.14.675; Aoun E, 2009, PANCREATOLOGY, V9, P777, DOI 10.1159/000214191; Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779; Bhatia M, 2005, PANCREATOLOGY, V5, P132, DOI 10.1159/000085265; Buter A, 2002, BRIT J SURG, V89, P298, DOI 10.1046/j.0007-1323.2001.02025.x; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; CURLEY PJ, 1993, BRIT J SURG, V80, P1312, DOI 10.1002/bjs.1800801031; Demols A, 2000, GASTROENTEROLOGY, V118, P582, DOI 10.1016/S0016-5085(00)70265-4; Group of Pancreas Surgery Chinese Society of Surgery Chinese Medical Association, 2007, Zhonghua Wai Ke Za Zhi, V45, P727; Halonen KI, 2002, CRIT CARE MED, V30, P1274, DOI 10.1097/00003246-200206000-00019; Johnson CD, 2005, GUT, V54, P1, DOI 10.1136/gut.200A.057026; Johnson CD, 2004, GUT, V53, P1340, DOI 10.1136/gut.2004.039883; Johnson CD, 2001, GUT, V48, P62, DOI 10.1136/gut.48.1.62; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kylanpaa ML, 2010, WORLD J GASTROENTERO, V16, P2867, DOI 10.3748/wjg.v16.i23.2867; Lytras D, 2008, PANCREAS, V36, P249, DOI 10.1097/MPA.0b013e31815acb2c; Mayer J, 2000, GUT, V47, P546, DOI 10.1136/gut.47.4.546; Mofidi R, 2006, BRIT J SURG, V93, P738, DOI 10.1002/bjs.5290; Nakayama S, 2014, PANCREAS, V43, P28, DOI 10.1097/MPA.0b013e3182a7c76b; Nawaz H, 2013, AM J GASTROENTEROL, V108, P1911, DOI 10.1038/ajg.2013.348; Oiva J, 2010, CRIT CARE, V14, DOI 10.1186/cc9329; Papachristou GI, 2007, GASTROENTEROL CLIN N, V36, P277, DOI 10.1016/j.gtc.2007.03.003; PEZZILLI R, 1995, PANCREAS, V11, P95, DOI 10.1097/00006676-199507000-00010; Pietruczuk M, 2006, WORLD J GASTROENTERO, V12, P5344, DOI 10.3748/wjg.v12.i33.5344; Sendler M, 2013, GUT, V62, P430, DOI 10.1136/gutjnl-2011-300771; Sweeney KJ, 2003, BRIT J SURG, V90, P313, DOI 10.1002/bjs.4080; Takeyama Y, 2000, J GASTROINTEST SURG, V4, P379, DOI 10.1016/S1091-255X(00)80016-5; Tompkins RG, 1997, ANN SURG, V225, P243, DOI 10.1097/00000658-199703000-00001; Uehara S, 2003, J GASTROEN HEPATOL, V18, P363, DOI 10.1046/j.1440-1746.2003.02979.x; Wilson PG, 1998, J ANTIMICROB CHEMOTH, V41, P51, DOI 10.1093/jac/41.suppl_1.51	30	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125529	10.1371/journal.pone.0125529	http://dx.doi.org/10.1371/journal.pone.0125529			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938229	Green Published, Green Submitted, gold			2022-12-27	WOS:000353943000073
J	Zhao, WW; Wu, MH; Chen, F; Jiang, S; Su, H; Liang, JF; Deng, CH; Hu, CH; Yu, SH				Zhao, Wei-Wei; Wu, Menghua; Chen, Fan; Jiang, Shuai; Su, Hui; Liang, Jianfen; Deng, Chunhua; Hu, Chaohui; Yu, Shihui			Robertsonian Translocations: An Overview of 872 Robertsonian Translocations Identified in a Diagnostic Laboratory in China	PLOS ONE			English	Article							DOWN-SYNDROME; UNIPARENTAL DISOMY; CHROMOSOME REARRANGEMENTS; EPIDEMIOLOGIC FINDINGS; PRENATAL DETECTION; UNITED-STATES; SEX-RATIO; MOSAICISM; ABNORMALITIES; POPULATION	Robertsonian translocations (ROBs) have an estimated incidence rate of 1/1000 births, making this type of rearrangement the most common structural chromosomal abnormalities seen in the general population. In this study, we reports 872 cases of ROBs from 205,001 specimens karyotyped postnatally in a single accredited laboratory in China, including 583 balanced ROBs, 264 unbalanced ROBs, 9 mosaic ROBs, and 18 complex ROBs. Ninety-three percent of the balanced ROBs observed were adults with infertility, miscarriage, or offspring( s) with known chromosomal abnormalities. Significant excess of females were found to be carriers of balanced ROBs with an adjusted male/female ratio of 0.77. Ninety-eight percent of the unbalanced ROBs observed were children with variable referral reasons. Almost all of the unbalanced ROBs involved chromosome 21 except a single ROB with [46, XX, der(13; 14),+ 13] identified in a newborn girl with multiple congenital anomalies. Multiple novel ROB karyotypes were reported in this report. This study represents the largest collections of ROBs in Chinese population.	[Zhao, Wei-Wei; Wu, Menghua; Chen, Fan; Jiang, Shuai; Su, Hui; Liang, Jianfen; Deng, Chunhua; Hu, Chaohui; Yu, Shihui] KingMed Genome Diagnost Lab, Guangzhou, Guangdong, Peoples R China; [Yu, Shihui] Univ Washington, Sch Med, Dept Lab Med, Seattle, WA 98195 USA; [Yu, Shihui] Seattle Childrens Hosp, Seattle, WA USA	University of Washington; University of Washington Seattle; Seattle Children's Hospital	Yu, SH (corresponding author), KingMed Genome Diagnost Lab, Guangzhou, Guangdong, Peoples R China.	shihui.yu@seattlechildrens.org			KingMed Genome Diagnostic Laboratory	KingMed Genome Diagnostic Laboratory	KingMed Genome Diagnostic Laboratory provided support in the form of salaries for authors WWZ, MHW, FC, SJ, JFL, CHD, CHH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alfarawati S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003025; Bandyopadhyay R, 2003, AM J MED GENET A, V116A, P159, DOI 10.1002/ajmg.a.10113; Bandyopadhyay R, 2002, AM J HUM GENET, V71, P1456, DOI 10.1086/344662; Bandyopadhyay R, 2001, CHROMOSOME RES, V9, P235, DOI 10.1023/A:1016652621226; Benn P, 1998, AM J MED GENET, V79, P121, DOI 10.1002/(SICI)1096-8628(19980901)79:2<121::AID-AJMG8>3.0.CO;2-T; Berend SA, 1998, AM J MED GENET, V80, P252, DOI 10.1002/(SICI)1096-8628(19981116)80:3<252::AID-AJMG14>3.0.CO;2-Q; Berend SA, 2000, AM J HUM GENET, V66, P1787, DOI 10.1086/302916; Berend SA, 2002, AM J MED GENET, V111, P362, DOI 10.1002/ajmg.10566; Bishop J, 1997, AM J EPIDEMIOL, V145, P134; Carothers AD, 1999, J MED GENET, V36, P386; Choi Byung Ho, 2013, Ann Pediatr Endocrinol Metab, V18, P111, DOI 10.6065/apem.2013.18.3.111; CLARKE MJ, 1989, J MED GENET, V26, P198, DOI 10.1136/jmg.26.3.198; DANIEL A, 1989, AM J MED GENET, V33, P14, DOI 10.1002/ajmg.1320330105; Franssen MTM, 2006, BMJ-BRIT MED J, V332, P759, DOI 10.1136/bmj.38735.459144.2F; Gardner R, 2012, CHROMOSOME ABNORMALI, V4th; Griffin DK, 1996, AM J HUM GENET, V59, P1108; HAMERTON JL, 1975, CLIN GENET, V8, P223; Hook EB, 1999, AM J MED GENET, V84, P316, DOI 10.1002/(SICI)1096-8628(19990604)84:4<316::AID-AJMG2>3.3.CO;2-T; Huether CA, 1996, AM J MED GENET, V63, P492, DOI 10.1002/(SICI)1096-8628(19960614)63:3<492::AID-AJMG15>3.0.CO;2-H; Iwarsson E, 2009, AM J MED GENET A, V149A, P1706, DOI 10.1002/ajmg.a.32984; Jamal A, 2012, IRAN J PUBLIC HEALTH, V41, P91; Kim SR, 2002, GENET TEST, V6, P163, DOI 10.1089/109065702761403315; Kochhar PK, 2013, J OBSTET GYNAECOL RE, V39, P113, DOI 10.1111/j.1447-0756.2012.01905.x; Kovaleva NV, 2005, AM J MED GENET A, V136A, P401, DOI 10.1002/ajmg.a.30815; Lau TK, 1998, AM J MED GENET, V75, P386, DOI 10.1002/(SICI)1096-8628(19980203)75:4<386::AID-AJMG7>3.3.CO;2-D; Lesniewicz R, 2009, FOLIA HISTOCHEM CYTO, V47, pS137, DOI 10.2478/v10042-009-0053-8; LIEBER E, 1982, J MED GENET, V19, P229, DOI 10.1136/jmg.19.3.229; Mai CT, 2013, BIRTH DEFECTS RES A, V97, P709, DOI 10.1002/bdra.23198; Morris JK, 2012, AM J MED GENET A, V158A, P1151, DOI 10.1002/ajmg.a.35248; Mutton D, 1996, J MED GENET, V33, P387, DOI 10.1136/jmg.33.5.387; NIELSEN J, 1991, HUM GENET, V87, P81, DOI 10.1007/BF01213097; Qian Wei-Ping, 2005, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V30, P258; Qin Jing, 2009, Yichuan, V31, P142, DOI 10.3724/SP.J.1005.2009.00142; Ruggeri A, 2004, PRENATAL DIAG, V24, P997, DOI 10.1002/pd.961; Shaffer LG, 2006, PRENATAL DIAG, V26, P303, DOI 10.1002/pd.1384; Shin M, 2010, AM J MED GENET A, V152A, P800, DOI 10.1002/ajmg.a.33295; THERMAN E, 1989, ANN HUM GENET, V53, P49, DOI 10.1111/j.1469-1809.1989.tb01121.x; WARBURTON D, 1991, AM J HUM GENET, V49, P995; Zhu JL, 2013, GENET MED, V15, P64, DOI 10.1038/gim.2012.93	39	21	24	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0122647	10.1371/journal.pone.0122647	http://dx.doi.org/10.1371/journal.pone.0122647			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932913	Green Published, gold, Green Submitted			2022-12-27	WOS:000353887100009
J	Amaya, M; Keck, F; Lindquist, M; Voss, K; Scavone, L; Kehn-Hall, K; Roberts, B; Bailey, C; Schmaljohn, C; Narayanan, A				Amaya, Moushimi; Keck, Forrest; Lindquist, Michael; Voss, Kelsey; Scavone, Lauren; Kehn-Hall, Kylene; Roberts, Brian; Bailey, Charles; Schmaljohn, Connie; Narayanan, Aarthi			The Ubiquitin Proteasome System Plays a Role in Venezuelan Equine Encephalitis Virus Infection	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; ATTENUATED VACCINE; MULTIPLE-MYELOMA; CAPSID PROTEIN; OLD-WORLD; INHIBITION; REPLICATION; ALPHAVIRUSES; BORTEZOMIB; CELLS	Many viruses have been implicated in utilizing or modulating the Ubiquitin Proteasome System (UPS) to enhance viral multiplication and/or to sustain a persistent infection. The mosquito-borne Venezuelan equine encephalitis virus (VEEV) belongs to the Togaviridae family and is an important biodefense pathogen and select agent. There are currently no approved vaccines or therapies for VEEV infections; therefore, it is imperative to identify novel targets for therapeutic development. We hypothesized that a functional UPS is required for efficient VEEV multiplication. We have shown that at non-toxic concentrations Bortezomib, a FDA-approved inhibitor of the proteasome, proved to be a potent inhibitor of VEEV multiplication in the human astrocytoma cell line U87MG. Bortezomib inhibited the virulent Trinidad donkey (TrD) strain and the attenuated TC-83 strain of VEEV. Additional studies with virulent strains of Eastern equine encephalitis virus (EEEV) and Western equine encephalitis virus (WEEV) demonstrated that Bortezomib is a broad spectrum inhibitor of the New World alphaviruses. Time-of-addition assays showed that Bortezomib was an effective inhibitor of viral multiplication even when the drug was introduced many hours post exposure to the virus. Mass spectrometry analyses indicated that the VEEV capsid protein is ubiquitinated in infected cells, which was validated by confocal microscopy and immunoprecipitation assays. Subsequent studies revealed that capsid is ubiquitinated on K48 during early stages of infection which was affected by Bortezomib treatment. This study will aid future investigations in identifying host proteins as potential broad spectrum therapeutic targets for treating alphavirus infections.	[Amaya, Moushimi; Keck, Forrest; Voss, Kelsey; Scavone, Lauren; Kehn-Hall, Kylene; Bailey, Charles; Narayanan, Aarthi] George Mason Univ, Sch Syst Biol, Natl Ctr Biodefense & Infect Dis, Manassas, VA 20110 USA; [Lindquist, Michael; Schmaljohn, Connie] US Army, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA; [Roberts, Brian] Leidos Hlth Life Sci, Frederick, MD USA	George Mason University	Narayanan, A (corresponding author), George Mason Univ, Sch Syst Biol, Natl Ctr Biodefense & Infect Dis, Manassas, VA 20110 USA.	anaraya1@gmu.edu	Kehn-Hall, Kylene/I-5752-2013	Voss, Kelsey/0000-0003-1732-2682	George Mason University	George Mason University	This work was supported by George Mason University start up funds to AN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar PV, 2004, EMERG INFECT DIS, V10, P880, DOI 10.3201/eid1005.030634; Amaya M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086745; Atasheva S, 2010, J VIROL, V84, P10004, DOI 10.1128/JVI.01151-10; Atasheva S, 2010, J VIROL, V84, P4158, DOI 10.1128/JVI.02554-09; BARBER TL, 1978, AM J VET RES, V39, P621; Pisano MB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002551; Bhomia M, 2013, ANTIVIR RES, V100, P429, DOI 10.1016/j.antiviral.2013.08.010; Curran MP, 2009, DRUGS, V69, P859, DOI 10.2165/00003495-200969070-00006; Delboy MG, 2008, J VIROL, V82, P3381, DOI 10.1128/JVI.02296-07; Foy NJ, 2013, J VIROL, V87, P1997, DOI 10.1128/JVI.02853-12; Garmashova N, 2007, J VIROL, V81, P13552, DOI 10.1128/JVI.01576-07; Garmashova N, 2007, J VIROL, V81, P2472, DOI 10.1128/JVI.02073-06; Guo N, 2013, ASIA-PAC J CLIN ONCO, V9, P6, DOI 10.1111/j.1743-7563.2012.01535.x; Horan KA, 2013, J IMMUNOL, V190, P2311, DOI 10.4049/jimmunol.1202749; Jackson G, 2005, CANCER TREAT REV, V31, P591, DOI 10.1016/j.ctrv.2005.10.001; Jose J, 2009, FUTURE MICROBIOL, V4, P837, DOI [10.2217/fmb.09.59, 10.2217/FMB.09.59]; Julander JG, 2008, ANTIVIR RES, V78, P230, DOI 10.1016/j.antiviral.2008.01.007; Kehn-Hall K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034761; Khor R, 2003, TRAFFIC, V4, P857, DOI 10.1046/j.1398-9219.2003.0140.x; Kim DY, 2013, J VIROL, V87, P4202, DOI 10.1128/JVI.03142-12; KINNEY RM, 1989, VIROLOGY, V170, P19, DOI 10.1016/0042-6822(89)90347-4; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Lamb K, 2010, VIROLOGY, V406, P261, DOI 10.1016/j.virol.2010.07.009; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Ma XZ, 2010, J VIROL, V84, P12419, DOI 10.1128/JVI.01219-10; Mateos MV, 2008, EXPERT REV HEMATOL, V1, P17, DOI 10.1586/17474086.1.1.17; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Narayanan A, 2012, J BIOL CHEM, V287, P33198, DOI 10.1074/jbc.M112.356535; Raaben M, 2010, J VIROL, V84, P7869, DOI 10.1128/JVI.00485-10; Randow F, 2009, NAT CELL BIOL, V11, P527, DOI 10.1038/ncb0509-527; Satheshkumar PS, 2009, J VIROL, V83, P2469, DOI 10.1128/JVI.01986-08; Schneider M, 2012, J VIROL, V86, P10112, DOI 10.1128/JVI.01001-12; Schubert U, 2000, P NATL ACAD SCI USA, V97, P13057, DOI 10.1073/pnas.97.24.13057; Si XN, 2005, J VIROL, V79, P8014, DOI 10.1128/JVI.79.13.8014-8023.2005; Spurgers KB, 2013, J VIROL METHODS, V193, P226, DOI 10.1016/j.jviromet.2013.06.007; Steele KE, 2010, VET PATHOL, V47, P790, DOI 10.1177/0300985810372508; Taylor RT, 2011, METHODS, V55, P166, DOI 10.1016/j.ymeth.2011.08.003; Tretyakova I, 2013, VACCINE, V31, P1019, DOI 10.1016/j.vaccine.2012.12.050; Wang YE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001186; Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006; Weaver SC, 2004, ANNU REV ENTOMOL, V49, P141, DOI 10.1146/annurev.ento.49.061802.123422; Widjaja I, 2010, J VIROL, V84, P9625, DOI 10.1128/JVI.01048-10; Zacks MA, 2010, VET MICROBIOL, V140, P281, DOI 10.1016/j.vetmic.2009.08.023	43	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124792	10.1371/journal.pone.0124792	http://dx.doi.org/10.1371/journal.pone.0124792			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927990	Green Submitted, gold, Green Published			2022-12-27	WOS:000353713100049
J	Japaridze, N; Muthuraman, M; Reinicke, C; Moeller, F; Anwar, AR; Mideksa, KG; Pressler, R; Deuschl, G; Stephani, U; Siniatchkin, M				Japaridze, Natia; Muthuraman, Muthuraman; Reinicke, Christine; Moeller, Friederike; Anwar, Abdul Rauf; Mideksa, Kidist Gebremariam; Pressler, Ronit; Deuschl, Guenther; Stephani, Ulrich; Siniatchkin, Michael			Neuronal Networks during Burst Suppression as Revealed by Source Analysis	PLOS ONE			English	Article							CORRELATED CORTICAL ACTIVITY; PARTIAL DIRECTED COHERENCE; EEG-FMRI; PREFRONTAL CORTEX; DEFAULT MODE; BRAIN; TREMOR; ENCEPHALOPATHY; OSCILLATIONS; COMBINATION	Introduction Burst-suppression (BS) is an electroencephalography (EEG) pattern consisting of alternant periods of slow waves of high amplitude (burst) and periods of so called flat EEG (suppression). It is generally associated with coma of various etiologies (hypoxia, drug-related intoxication, hypothermia, and childhood encephalopathies, but also anesthesia). Animal studies suggest that both the cortex and the thalamus are involved in the generation of BS. However, very little is known about mechanisms of BS in humans. The aim of this study was to identify the neuronal network underlying both burst and suppression phases using source reconstruction and analysis of functional and effective connectivity in EEG. Material/Methods Dynamic imaging of coherent sources (DICS) was applied to EEG segments of 13 neonates and infants with burst and suppression EEG pattern. The brain area with the strongest power in the analyzed frequency (1-4 Hz) range was defined as the reference region. DICS was used to compute the coherence between this reference region and the entire brain. The renormalized partial directed coherence (RPDC) was used to describe the informational flow between the identified sources. Results/Conclusion Delta activity during the burst phases was associated with coherent sources in the thalamus and brainstem as well as bilateral sources in cortical regions mainly frontal and parietal, whereas suppression phases were associated with coherent sources only in cortical regions. Results of the RPDC analyses showed an upwards informational flow from the brainstem towards the thalamus and from the thalamus to cortical regions, which was absent during the suppression phases. These findings may support the theory that a "cortical deafferentiation" between the cortex and sub-cortical structures exists especially in suppression phases compared to burst phases in burst suppression EEGs. Such a deafferentiation may play a role in the poor neurological outcome of children with these encephalopathies.	[Japaridze, Natia; Reinicke, Christine; Stephani, Ulrich] Univ Kiel, Dept Neuropediat, Kiel, Germany; [Muthuraman, Muthuraman; Anwar, Abdul Rauf; Mideksa, Kidist Gebremariam] Univ Kiel, Dept Neurol, Kiel, Germany; [Moeller, Friederike; Pressler, Ronit; Deuschl, Guenther] Great Ormond St Hosp Sick Children, Dept Neurophysiol, London WC1N 3JH, England; [Siniatchkin, Michael] Univ Kiel, Inst Med Psychol & Med Sociol, Kiel, Germany	University of Kiel; University of Kiel; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Kiel	Japaridze, N (corresponding author), Univ Kiel, Dept Neuropediat, Kiel, Germany.	n.japaridze@pedneuro.uni-kiel.de	Deuschl, Gunther/A-7986-2010; Muthuraman, Muthuraman/ABD-2021-2020	Deuschl, Gunther/0000-0002-4176-9196; Muthuraman, Muthuraman/0000-0001-6158-2663; Pressler, Ronit/0000-0002-2905-6839; Moeller, Friederike/0000-0003-2434-2825	German Science Society (DFG) [D3, D2, Sonderforschungsbereich (SFB) 855]; EU FP7 project DESIRE "Development Epilepsy"; WP2 WP4	German Science Society (DFG)(German Research Foundation (DFG)); EU FP7 project DESIRE "Development Epilepsy"; WP2 WP4	Funding provided by D3 and D2 subproject of Sonderforschungsbereich (SFB) 855 of the German Science Society (DFG), Japaridze N., Muthuraman M., Anwar A. R.2, Mideksa K. G., Siniatchkin M. 4, http://www.sfb855.uni-kiel.de/ and EU FP7 project DESIRE "Development & Epilepsy", WP2 & WP4, Japaridze N., http://epilepsydesireproject.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Akrawi WP, 1996, J NEUROSURG ANESTH, V8, P40, DOI 10.1097/00008506-199601000-00010; Amjad AM, 1997, J NEUROSCI METH, V73, P69, DOI 10.1016/S0165-0270(96)02214-5; Amzica F, 2009, EPILEPSIA, V50, P38, DOI 10.1111/j.1528-1167.2009.02345.x; Astolfi L, 2007, HUM BRAIN MAPP, V28, P143, DOI 10.1002/hbm.20263; Baccala LA, 2001, BIOL CYBERN, V84, P463, DOI 10.1007/PL00007990; Brown EN, 2010, NEW ENGL J MED, V363, P2638, DOI 10.1056/NEJMra0808281; CASTAIGNE P, 1981, ANN NEUROL, V10, P127, DOI 10.1002/ana.410100204; Ching SN, 2012, P NATL ACAD SCI USA, V109, P3095, DOI 10.1073/pnas.1121461109; DEMUNCK JC, 1992, IEEE T BIO-MED ENG, V39, P986, DOI 10.1109/10.256433; Ding MZ, 2000, BIOL CYBERN, V83, P35, DOI 10.1007/s004229900137; Dubovik S, 2012, NEUROIMAGE, V61, P249, DOI 10.1016/j.neuroimage.2012.03.024; Elshoff L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078422; Groening K, 2009, NEUROIMAGE, V46, P827, DOI 10.1016/j.neuroimage.2009.02.026; Gross J, 2002, P NATL ACAD SCI USA, V99, P2299, DOI 10.1073/pnas.032682099; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Haufe S, 2013, NEUROIMAGE, V64, P120, DOI 10.1016/j.neuroimage.2012.09.036; Hellwig B, 2000, CLIN NEUROPHYSIOL, V111, P806, DOI 10.1016/S1388-2457(00)00248-0; Hellwig B, 2003, CLIN NEUROPHYSIOL, V114, P1462, DOI 10.1016/S1388-2457(03)00116-0; Hellwig B, 2001, LANCET, V357, P519, DOI 10.1016/S0140-6736(00)04044-7; Hesse W, 2003, J NEUROSCI METH, V124, P27, DOI 10.1016/S0165-0270(02)00366-7; Hirose M, 2010, EPILEPSIA, V51, P699, DOI 10.1111/j.1528-1167.2009.02399.x; Holmes MD, 2008, EPILEPSIA, V49, P3, DOI 10.1111/j.1528-1167.2008.01505.x; Holmes MD, 2010, NEUROIMAGE, V49, P80, DOI 10.1016/j.neuroimage.2009.08.004; Holmes MD, 2004, EPILEPSIA, V45, P1568, DOI 10.1111/j.0013-9580.2004.23204.x; Japaridze N, 2013, BRAIN TOPOGR, V26, P157, DOI 10.1007/s10548-012-0245-y; Kaminski M, 2001, BIOL CYBERN, V85, P145, DOI 10.1007/s004220000235; KINNEY HC, 1994, NEW ENGL J MED, V330, P1469, DOI 10.1056/NEJM199405263302101; Kroeger D, 2007, J NEUROSCI, V27, P10597, DOI 10.1523/JNEUROSCI.3440-07.2007; Lewis LD, 2013, BRAIN, V136, P2727, DOI 10.1093/brain/awt174; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; Middleton FA, 2002, CEREB CORTEX, V12, P926, DOI 10.1093/cercor/12.9.926; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; Moeller F, 2013, EPILEPSIA, V54, pE103, DOI 10.1111/epi.12243; Moeller F, 2013, HUM BRAIN MAPP, V34, P1896, DOI 10.1002/hbm.22026; Muthuraman M, 2012, NEUROIMAGE, V60, P1331, DOI 10.1016/j.neuroimage.2012.01.088; Muthuraman M, 2010, IEEE ENG MED BIO, P154, DOI 10.1109/IEMBS.2010.5627211; Muthuraman M, 2010, BIOMED SIGNAL PROCES, V5, P205, DOI 10.1016/j.bspc.2010.02.006; Muthuraman M, 2012, NEUROIMAGE; Muthuraman M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033928; Neumaier A, 2001, ACM T MATH SOFTWARE, V27, P27, DOI 10.1145/382043.382304; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Ohtahara S, 2003, J CLIN NEUROPHYSIOL, V20, P398, DOI 10.1097/00004691-200311000-00003; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; ROSENBERG JR, 1989, PROG BIOPHYS MOL BIO, V53, P1, DOI 10.1016/0079-6107(89)90004-7; Sameshima K, 1999, J NEUROSCI METH, V94, P93, DOI 10.1016/S0165-0270(99)00128-4; Schelter B, 2009, J NEUROSCI METH, V179, P121, DOI 10.1016/j.jneumeth.2009.01.006; Schiff ND, 2000, J CLIN NEUROPHYSIOL, V17, P438, DOI 10.1097/00004691-200009000-00002; Schiff ND, 2002, BRAIN, V125, P1210, DOI 10.1093/brain/awf131; Schiff Nicholas D, 2010, Cleve Clin J Med, V77 Suppl 3, pS27, DOI 10.3949/ccjm.77.s3.05; Schneider T, 2001, ACM T MATH SOFTWARE, V27, P58, DOI 10.1145/382043.382316; Schnitzler A, 2006, J PHYSIOLOGY-PARIS, V99, P3, DOI 10.1016/j.jphysparis.2005.06.010; Shi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018746; Siniatchkin M, 2007, EPILEPSIA, V48, P2312; Siniatchkin M, 2010, BRAIN, V133, P2798, DOI 10.1093/brain/awq183; SLEPIAN D, 1961, BELL SYST TECH J, V40, P43, DOI 10.1002/j.1538-7305.1961.tb03976.x; Stecker MM, 2001, ANN THORAC SURG, V71, P22, DOI 10.1016/S0003-4975(00)02021-X; STERIADE M, 1994, ELECTROEN CLIN NEURO, V90, P1, DOI 10.1016/0013-4694(94)90108-2; Sudmeyer M, 2006, MOVEMENT DISORD, V21, P2134, DOI 10.1002/mds.21136; Sudmeyer M, 2006, MOVEMENT DISORD, V21, P1935, DOI 10.1002/mds.21104; Tass P, 1998, PHYS REV LETT, V81, P3291, DOI 10.1103/PhysRevLett.81.3291; Timmermann L, 2003, BRAIN, V126, P199, DOI 10.1093/brain/awg022; Timmermann L, 2003, NEUROLOGY, V61, P689, DOI 10.1212/01.WNL.0000078816.05164.B1; van Uitert R, 2000, BIOMAGNETISM J, V1, P1; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Vogt BA, 2005, PROG BRAIN RES, V150, P205, DOI 10.1016/S0079-6123(05)50015-3; Volkmann J, 1996, NEUROLOGY, V46, P1359, DOI 10.1212/WNL.46.5.1359; Vulliemoz S, 2009, NEUROIMAGE, V46, P834, DOI 10.1016/j.neuroimage.2009.01.070; Young GB, 2000, J CLIN NEUROPHYSIOL, V17, P473, DOI 10.1097/00004691-200009000-00006	72	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0123807	10.1371/journal.pone.0123807	http://dx.doi.org/10.1371/journal.pone.0123807			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927439	gold, Green Published, Green Submitted			2022-12-27	WOS:000353713100023
J	Liu, W; Du, PJ; Wang, DC				Liu, Wei; Du, Peijun; Wang, Dongchen			Ensemble Learning for Spatial Interpolation of Soil Potassium Content Based on Environmental Information	PLOS ONE			English	Article							3-D OBJECT RETRIEVAL; PREDICTION; RECOGNITION	One important method to obtain the continuous surfaces of soil properties from point samples is spatial interpolation. In this paper, we propose a method that combines ensemble learning with ancillary environmental information for improved interpolation of soil properties (hereafter, EL-SP). First, we calculated the trend value for soil potassium contents at the Qinghai Lake region in China based on measured values. Then, based on soil types, geology types, land use types, and slope data, the remaining residual was simulated with the ensemble learning model. Next, the EL-SP method was applied to interpolate soil potassium contents at the study site. To evaluate the utility of the EL-SP method, we compared its performance with other interpolation methods including universal kriging, inverse distance weighting, ordinary kriging, and ordinary kriging combined geographic information. Results show that EL-SP had a lower mean absolute error and root mean square error than the data produced by the other models tested in this paper. Notably, the EL-SP maps can describe more locally detailed information and more accurate spatial patterns for soil potassium content than the other methods because of the combined use of different types of environmental information; these maps are capable of showing abrupt boundary information for soil potassium content. Furthermore, the EL-SP method not only reduces prediction errors, but it also compliments other environmental information, which makes the spatial interpolation of soil potassium content more reasonable and useful.	[Liu, Wei; Du, Peijun; Wang, Dongchen] Nanjing Univ, Jiangsu Prov Key Lab Geog Informat Sci & Technol, Nanjing 210008, Jiangsu, Peoples R China; [Liu, Wei] Jiangsu Normal Univ, Sch Geodesy & Geometr, Xuzhou, Jiangsu, Peoples R China	Nanjing University; Jiangsu Normal University	Du, PJ (corresponding author), Nanjing Univ, Jiangsu Prov Key Lab Geog Informat Sci & Technol, Nanjing 210008, Jiangsu, Peoples R China.	dupjrs@126.com		Du, Peijun/0000-0002-2488-2656	National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2012BAH31B00]; Natural Science Foundation of the Jiangsu Higher Education Institutions of China [14KJD170001]; Natural Science Foundation of the Jiangsu Provincial Bureau of Surveying and mapping geographic information of China [14KJD170001, JSCHKY201405]	National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); Natural Science Foundation of the Jiangsu Higher Education Institutions of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of the Jiangsu Provincial Bureau of Surveying and mapping geographic information of China	This study is supported by the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (Grant No. 2012BAH31B00), by the Natural Science Foundation of the Jiangsu Higher Education Institutions of China (Grant No. 14KJD170001), by the Natural Science Foundation of the Jiangsu Provincial Bureau of Surveying and mapping geographic information of China (Grant No. JSCHKY201405). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASLI M, 1995, MATH GEOL, V27, P641, DOI 10.1007/BF02093905; Bishop T, 2011, GEODERMA, V103, P149; Collins F. C., 1996, COMP SPATIAL INTERPO; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Drake JM, 2006, J APPL ECOL, V43, P424, DOI 10.1111/j.1365-2664.2006.01141.x; Florinsky IV, 2002, ENVIRON MODELL SOFTW, V17, P295, DOI 10.1016/S1364-8152(01)00067-6; Gao Y, 2014, IEEE T IND ELECTRON, V61, P2088, DOI 10.1109/TIE.2013.2262760; Gao Y, 2013, IEEE T IMAGE PROCESS, V22, P363, DOI 10.1109/TIP.2012.2202676; Gao Y, 2012, IEEE T IMAGE PROCESS, V21, P4290, DOI 10.1109/TIP.2012.2199502; Gilardi N, 2002, THESIS U LAUSANNE; Goovaerts P, 1999, GEODERMA, V89, P1, DOI 10.1016/S0016-7061(98)00078-0; Guan T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098806; Guan T, 2013, IEEE T MULTIMEDIA, V15, P1688, DOI 10.1109/TMM.2013.2265674; Hengl T, 2004, GEODERMA, V120, P75, DOI 10.1016/j.geoderma.2003.08.018; Ji RR, 2013, IEEE T MULTIMEDIA, V15, P153, DOI 10.1109/TMM.2012.2225035; Kravchenko A, 1999, AGRON J, V91, P393, DOI 10.2134/agronj1999.00021962009100030007x; Li J, 2011, ENVIRON MODELL SOFTW, V26, P1647, DOI 10.1016/j.envsoft.2011.07.004; Li J, 2011, ECOL INFORM, V6, P228, DOI 10.1016/j.ecoinf.2010.12.003; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Mosammam AM, 2013, J APPL STAT, V40, P923, DOI 10.1080/02664763.2012.750474; ODEH IOA, 1995, GEODERMA, V67, P215, DOI 10.1016/0016-7061(95)00007-B; Panagopoulos T, 2006, EUR J AGRON, V24, P1, DOI 10.1016/j.eja.2005.03.001; Shi WJ, 2012, J GEOGR SCI, V22, P752, DOI 10.1007/s11442-012-0960-z; Shi WJ, 2011, GEODERMA, V162, P347, DOI 10.1016/j.geoderma.2011.03.007; Triantafilis J, 2001, SOIL SCI, V166, P415, DOI 10.1097/00010694-200106000-00007; Wei BC, 2014, IEEE MULTIMEDIA, V21, P41, DOI 10.1109/MMUL.2013.65; Zhao N, 2014, THEOR APPL CLIMATOL, V116, P273, DOI 10.1007/s00704-013-0952-7	28	6	7	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124383	10.1371/journal.pone.0124383	http://dx.doi.org/10.1371/journal.pone.0124383			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928138	Green Submitted, gold, Green Published			2022-12-27	WOS:000353713100031
J	Maebe, K; Meeus, I; De Riek, J; Smagghe, G				Maebe, Kevin; Meeus, Ivan; De Riek, Jan; Smagghe, Guy			Quantitative Trait Loci for Light Sensitivity, Body Weight, Body Size, and Morphological Eye Parameters in the Bumblebee, Bombus terrestris	PLOS ONE			English	Article							APIS-MELLIFERA; LINKAGE MAP; GENETIC ARCHITECTURE; CONSTRUCTION; EVOLUTION; INSECT; BEE; MICROSATELLITES; HYMENOPTERA; POPULATIONS	Bumblebees such as Bombus terrestris are essential pollinators in natural and managed ecosystems. In addition, this species is intensively used in agriculture for its pollination services, for instance in tomato and pepper greenhouses. Here we performed a quantitative trait loci (QTL) analysis on B. terrestris using 136 microsatellite DNA markers to identify genes linked with 20 traits including light sensitivity, body size and mass, and eye and hind leg measures. By composite interval mapping (IM), we found 83 and 34 suggestive QTLs for 19 of the 20 traits at the linkage group wide significance levels of p = 0.05 and 0.01, respectively. Furthermore, we also found five significant QTLs at the genome wide significant level of p = 0.05. Individual QTLs accounted for 7.5-53.3% of the phenotypic variation. For 15 traits, at least one QTL was confirmed with multiple QTL model mapping. Multivariate principal components analysis confirmed 11 univariate suggestive QTLs but revealed three suggestive QTLs not identified by the individual traits. We also identified several candidate genes linked with light sensitivity, in particular the Phosrestin-1-like gene is a primary candidate for its phototransduction function. In conclusion, we believe that the suggestive and significant QTLs, and markers identified here, can be of use in marker-assisted breeding to improve selection towards light sensitive bumblebees, and thus also the pollination service of bumblebees.	[Maebe, Kevin; Meeus, Ivan; Smagghe, Guy] Univ Ghent, Fac Biosci Engn, Dept Crop Protect, B-9000 Ghent, Belgium; [De Riek, Jan] Inst Agr & Fisheries Res ILVO, Plant Sci Unit, B-9090 Melle, Belgium	Ghent University; Institute For Agricultural & Fisheries Research	Maebe, K (corresponding author), Univ Ghent, Fac Biosci Engn, Dept Crop Protect, Coupure Links 653, B-9000 Ghent, Belgium.	guy.smagghe@ugent.be; guy.smagghe@ugent.be	Smagghe, Guy/AAE-8914-2019	Smagghe, Guy/0000-0001-8334-3313; Maebe, Kevin/0000-0002-3741-2143				Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; [Anonymous], 2004, MAPQTL VERSION 5 0 S; Ayabe T, 2004, CHROMOSOME RES, V12, P215, DOI 10.1023/B:CHRO.0000021880.83639.4b; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blacquiere T., 2006, P NETH ENTOMOL SOC M, V17, P93; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Blacquiere Tjeerd, 2007, Proceedings of the Netherlands Entomological Society Meeting, V18, P71; Chittka L, 1999, NATURWISSENSCHAFTEN, V86, P361, DOI 10.1007/s001140050636; Choe E, 2012, EUPHYTICA, V183, P243, DOI 10.1007/s10681-011-0452-8; CHURCHILL GA, 1994, GENETICS, V138, P963; De Keyser E, 2013, EUPHYTICA, V189, P445, DOI 10.1007/s10681-012-0809-7; Dekkers J C M, 2004, J Anim Sci, V82 E-Suppl, pE313; ESTOUP A, 1995, MOL BIOL EVOL, V12, P1074; ESTOUP A, 1993, NUCLEIC ACIDS RES, V21, P1427, DOI 10.1093/nar/21.6.1427; Funk CR, 2006, MOL ECOL NOTES, V6, P83, DOI 10.1111/j.1471-8286.2005.01147.x; Gadau J, 2001, HEREDITY, V87, P234, DOI 10.1046/j.1365-2540.2001.00919.x; Gerloff CU, 2003, FUNCT ECOL, V17, P582, DOI 10.1046/j.1365-2435.2003.00769.x; Gorley C.K., 2006, GETTING STARTED PRIM; GOULSON D, 2003, BUMBLEBEES THEIR BEH; Heinrich B., 1979, BUMBLEBEE EC; Johansen NS, 2011, ANN APPL BIOL, V159, P1, DOI 10.1111/j.1744-7348.2011.00483.x; Kapustjanskij A, 2007, FUNCT ECOL, V21, P1130, DOI 10.1111/j.1365-2435.2007.01329.x; LANGE K, 1982, AM J HUM GENET, V34, P842; Maebe K, 2013, J INSECT PHYSIOL, V59, P913, DOI 10.1016/j.jinsphys.2013.06.012; Maebe K, 2013, APIDOLOGIE, V44, P188, DOI 10.1007/s13592-012-0170-9; Moghaddam HH, 2012, EUPHYTICA, V184, P413, DOI 10.1007/s10681-011-0616-6; Mommaerts V, 2010, ECOTOXICOLOGY, V19, P207, DOI 10.1007/s10646-009-0406-2; Morandin LA, 2001, CAN ENTOMOL, V133, P883, DOI 10.4039/Ent133883-6; Owen R. E., 2012, MORPHOMETRICS, P1, DOI DOI 10.5772/34745; Raine NE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000556; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Roman A, 2008, J APIC SCI, V52, P93; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Skorupski P, 2007, J COMP PHYSIOL A, V193, P485, DOI 10.1007/s00359-006-0206-6; Slate J, 2005, MOL ECOL, V14, P363, DOI 10.1111/j.1365-294X.2004.02378.x; Solignac M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r66; Stolle E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-48; Stolle E, 2009, MOL ECOL RESOUR, V9, P1345, DOI 10.1111/j.1755-0998.2009.02610.x; Van Oojen JW, 2006, SOFTWARE CALCULATION; Velthuis HHW, 2006, APIDOLOGIE, V37, P421, DOI 10.1051/apido:2006019; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang DL, 1999, THEOR APPL GENET, V99, P1255, DOI 10.1007/s001220051331; Warrant EJ, 2004, CURR BIOL, V14, P1309, DOI 10.1016/j.cub.2004.07.057; Wcislo WT, 2009, BIOL REV, V84, P19, DOI 10.1111/j.1469-185X.2008.00059.x; Wilfert L, 2007, MOL ECOL, V16, P1327, DOI 10.1111/j.1365-294X.2007.03234.x; Wilfert L, 2009, INSECT SOC, V56, P44, DOI 10.1007/s00040-008-1034-1; Wilfert L, 2007, EVOLUTION, V61, P804, DOI 10.1111/j.1558-5646.2007.00079.x; Wilfert L, 2006, GENOME, V49, P1215, DOI 10.1139/G06-075; Williams JL, 2005, REV SCI TECH OIE, V24, P379, DOI 10.20506/rst.24.1.1571; Xiong B, 2013, TRENDS NEUROSCI, V36, P652, DOI 10.1016/j.tins.2013.08.003; Xu SZ, 2003, GENETICS, V165, P2259	51	2	2	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125011	10.1371/journal.pone.0125011	http://dx.doi.org/10.1371/journal.pone.0125011			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928544	Green Published, Green Submitted, gold			2022-12-27	WOS:000353713100056
J	Naipal, KAT; Raams, A; Bruens, ST; Brandsma, I; Verkaik, NS; Jaspers, NGJ; Hoeijmakers, JHJ; van Leenders, GJLH; Pothof, J; Kanaar, R; Boormans, J; van Gent, DC				Naipal, Kishan A. T.; Raams, Anja; Bruens, Serena T.; Brandsma, Inger; Verkaik, Nicole S.; Jaspers, Nicolaas G. J.; Hoeijmakers, Jan H. J.; van Leenders, Geert J. L. H.; Pothof, Joris; Kanaar, Roland; Boormans, Joost; van Gent, Dik C.			Attenuated XPC Expression Is Not Associated with Impaired DNA Repair in Bladder Cancer	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; GROUP-C; POLYMORPHISMS; SUSCEPTIBILITY; DEFECT; RISK	Bladder cancer has a high incidence with significant morbidity and mortality. Attenuated expression of the DNA damage response protein Xeroderma Pigmentosum complementation group C (XPC) has been described in bladder cancer. XPC plays an essential role as the main initiator and damage-detector in global genome nucleotide excision repair (NER) of UV-induced lesions, bulky DNA adducts and intrastrand crosslinks, such as those made by the chemotherapeutic agent Cisplatin. Hence, XPC protein might be an informative biomarker to guide personalized therapy strategies in a subset of bladder cancer cases. Therefore, we measured the XPC protein expression level and functional NER activity of 36 bladder tumors in a standardized manner. We optimized conditions for dissociation and in vitro culture of primary bladder cancer cells and confirmed attenuated XPC expression in approximately 40% of the tumors. However, NER activity was similar to co-cultured wild type cells in all but one of 36 bladder tumors. We conclude, that (i) functional NER deficiency is a relatively rare phenomenon in bladder cancer and (ii) XPC protein levels are not useful as biomarker for NER activity in these tumors.	[Naipal, Kishan A. T.; Raams, Anja; Bruens, Serena T.; Brandsma, Inger; Verkaik, Nicole S.; Jaspers, Nicolaas G. J.; Hoeijmakers, Jan H. J.; Pothof, Joris; Kanaar, Roland; van Gent, Dik C.] Erasmus Univ, Med Ctr, Dept Genet, Rotterdam, Netherlands; [van Leenders, Geert J. L. H.] Erasmus Univ, Dept Pathol, Med Ctr, NL-3000 DR Rotterdam, Netherlands; [Kanaar, Roland] Erasmus Univ, Med Ctr, Dept Radiat Oncol, NL-3000 DR Rotterdam, Netherlands; [Boormans, Joost] Erasmus Univ, Dept Urol, Med Ctr, NL-3000 DR Rotterdam, Netherlands; [Kanaar, Roland] Erasmus Univ, Med Ctr, Canc Genom Netherlands, NL-3000 DR Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	van Gent, DC (corresponding author), Erasmus Univ, Med Ctr, Dept Genet, Rotterdam, Netherlands.	d.vangent@erasmusmc.nl	Hoeijmakers, Jan/AAX-6972-2021	Brandsma, Inger/0000-0003-3257-2540; Naipal, Kishan/0000-0001-8267-8218; van Gent, Dik C./0000-0003-1473-8148	European Community's Seventh Framework Programme [HEALTH-F2-2010-259893]; Dutch Cancer Society (KWF) [2011-5030]; Vereniging Trustfonds Erasmus University Rotterdam	European Community's Seventh Framework Programme; Dutch Cancer Society (KWF)(KWF Kankerbestrijding); Vereniging Trustfonds Erasmus University Rotterdam	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement No. HEALTH-F2-2010-259893 (DDResponse) to JH, RK and DvG, URL: http://cordis.europa.eu/fp7/home_en.html; Dutch Cancer Society (KWF) grant nr. 2011-5030 to JH, URL: http://www.kwf.nl/Pages/default.aspx; and Vereniging Trustfonds Erasmus University Rotterdam to JB, URL: http://www.eur.nl/eur/fondsen/trustfonds/. The funders had no role in study design, data	Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Chen ZW, 2007, CANCER RES, V67, P4578, DOI 10.1158/0008-5472.CAN-06-0877; Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399; Dai QS, 2013, GENE, V528, P335, DOI 10.1016/j.gene.2013.06.092; Dollfus H, 2003, SURV OPHTHALMOL, V48, P107, DOI 10.1016/S0039-6257(02)00400-9; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Jaspers NGJ, 2007, AM J HUM GENET, V80, P457, DOI 10.1086/512486; Kaemmerer D, 2012, INT J CLIN EXP PATHO, V5, P187; Kirkali Z, 2005, UROLOGY, V66, P4, DOI 10.1016/j.urology.2005.07.062; Li SH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0083037, 10.1371/journal.pone.0067928, 10.1371/journal.pone.0057604]; Limsirichaikul S, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp023; Marteijn JA, 2014, NAT REV MOL CELL BIO, V15, P465, DOI 10.1038/nrm3822; Ng JMY, 2003, GENE DEV, V17, P1630, DOI 10.1101/gad.260003; Stern MC, 2009, CANCER RES, V69, P6857, DOI 10.1158/0008-5472.CAN-09-1091; Sternberg CN, 2007, UROLOGY, V69, P62, DOI 10.1016/j.urology.2006.10.041; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; Theil AF, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003431; Wang YF, 2014, TUMOR BIOL, V35, P3155, DOI 10.1007/s13277-013-1412-9; Wen H, 2013, ACTAS UROL ESP, V37, P259, DOI 10.1016/j.acuro.2012.04.007; Yang J, 2010, J UROLOGY, V184, P336, DOI 10.1016/j.juro.2010.03.044	21	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0126029	10.1371/journal.pone.0126029	http://dx.doi.org/10.1371/journal.pone.0126029			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927440	gold, Green Published, Green Submitted			2022-12-27	WOS:000353713100123
J	Sa-nguanmoo, P; Posuwan, N; Vichaiwattana, P; Wutthiratkowit, N; Owatanapanich, S; Wasitthankasem, R; Thongmee, T; Poovorawan, K; Theamboonlers, A; Vongpunsawad, S; Poovorawan, Y				Sa-nguanmoo, Pattaratida; Posuwan, Nawarat; Vichaiwattana, Preeyaporn; Wutthiratkowit, Norra; Owatanapanich, Somchai; Wasitthankasem, Rujipat; Thongmee, Thanunrat; Poovorawan, Kittiyod; Theamboonlers, Apiradee; Vongpunsawad, Sompong; Poovorawan, Yong			Swine Is a Possible Source of Hepatitis E Virus Infection by Comparative Study of Hepatitis A and E Seroprevalence in Thailand	PLOS ONE			English	Article							GENOTYPE 3; MOLECULAR CHARACTERIZATION; CLINICAL-FEATURES; PREVALENCE; HEV; OUTBREAK; ANTIBODY; PIGS; CLASSIFICATION; IDENTIFICATION	Hepatitis A virus (HAV) and hepatitis E virus (HEV) infection in developing countries are associated with contaminated food or water. Although Thailand is non-endemic for HEV, sporadic infections may occur from zoonotic transmission. Individuals between 7 months to 69 years (mean age = 32.8) from predominantly Islamic Narathiwat (n = 305) and swine farmdense Lop Buri (n = 416) provinces were screened for anti-HEV and anti-HAV antibodies by commercial enzyme-linked immunosorbent assay and automated chemiluminescent microparticle immunoassay, respectively. Seroprevalence and relative antibody titers were analyzed according to age groups. HAV IgG antibody positive rates in Lop Buri and Narathiwat residents were 39.9% and 58%, respectively (p < 0.001). Greater than 90% of individuals > 50 years old in both provinces possessed anti-HAV IgG. In contrast, seroprevalence for anti-HEV IgG was much higher in Lop Buri (37.3%) than in Narathiwat (8.9%) (p < 0.001). Highest anti-HEV IgG prevalence was found among 21-30 year-olds (50%) in Lop Buri and 41-50 year-olds (14.1%) in Narathiwat. In summary, fewer individuals possessed anti-HEV IgG in Narathiwat where most residents abstained from pork and fewer swine farms are present. Therefore, an increased anti-HEV IgG seroprevalence was associated with the density of swine farm and possibly pork consumption. Adults were more likely than children to have antibodies to both HEV and HAV.	[Sa-nguanmoo, Pattaratida; Posuwan, Nawarat; Vichaiwattana, Preeyaporn; Wasitthankasem, Rujipat; Thongmee, Thanunrat; Theamboonlers, Apiradee; Vongpunsawad, Sompong; Poovorawan, Yong] Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Dept Pediat, Bangkok 10330, Thailand; [Wutthiratkowit, Norra] Narathiwat Ratchanakarin Hosp, Narathiwat, Thailand; [Owatanapanich, Somchai] King Narai Hosp, Lop Buri, Thailand; [Poovorawan, Kittiyod] Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Bangkok 10700, Thailand	Chulalongkorn University; Mahidol University	Poovorawan, Y (corresponding author), Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Dept Pediat, Bangkok 10330, Thailand.	Yong.P@chula.ac.th	ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022	Poovorawan, Kittiyod/0000-0001-7016-7605; Poovorawan, Yong/0000-0002-2337-6807; vongpunsawad, sompong/0000-0001-7520-8728	National Research University Project, Office of Higher Education Commission [WCU001-HR-57, WCU007-HR-57, WCU-58-006-HR]; Research Chair Grant from NSTDA, Chulalongkorn University Centenary Academic Development Project [CU56-HR01]; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University [RES560530093]; Outstanding Professor of the Thailand Research Fund [DPG5480002]; Center of Excellence in Clinical Virology, Chulalongkorn University; King Chulalongkorn Memorial Hospital; Siam Cement Group; MK Restaurant Company Limited; Rachadapisek Sompote Fund of Chulalongkorn University	National Research University Project, Office of Higher Education Commission; Research Chair Grant from NSTDA, Chulalongkorn University Centenary Academic Development Project; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University(Chulalongkorn University); Outstanding Professor of the Thailand Research Fund; Center of Excellence in Clinical Virology, Chulalongkorn University(Chulalongkorn University); King Chulalongkorn Memorial Hospital(Chulalongkorn University); Siam Cement Group; MK Restaurant Company Limited; Rachadapisek Sompote Fund of Chulalongkorn University	This work was supported by the National Research University Project, Office of Higher Education Commission (WCU001-HR-57, WCU007-HR-57, and WCU-58-006-HR), the Research Chair Grant from NSTDA, Chulalongkorn University Centenary Academic Development Project (CU56-HR01), the Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University (RES560530093), the Outstanding Professor of the Thailand Research Fund (DPG5480002), Center of Excellence in Clinical Virology, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Siam Cement Group, and MK Restaurant Company Limited. This research is also supported by the Rachadapisek Sompote Fund of Chulalongkorn University for postdoctoral fellowship to Pattaratida Sa-nguanmoo, Rujipat Wasitthankasem and Sompong Vongpunsawad. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2011, HEPATOLOGY, V54, P2218, DOI 10.1002/hep.24674; BURKE DS, 1981, AM J EPIDEMIOL, V113, P245, DOI 10.1093/oxfordjournals.aje.a113093; Charoensook R, 2013, MAEJO INT J SCI TECH, V7, P113; Chatproedprai S, 2007, ANN TROP MED PARASIT, V101, P61, DOI 10.1179/136485907X157040; Cooper K, 2005, J CLIN MICROBIOL, V43, P1684, DOI 10.1128/JCM.43.4.1684-1688.2005; Costa-Mattioli M, 2002, J VIROL, V76, P9516, DOI 10.1128/JVI.76.18.9516-9525.2002; Dalton HR, 2008, LANCET INFECT DIS, V8, P698, DOI 10.1016/S1473-3099(08)70255-X; Faber MS, 2012, EMERG INFECT DIS, V18, P1654, DOI 10.3201/eid1810.111756; Fukuda S, 2004, J MED VIROL, V73, P554, DOI 10.1002/jmv.20125; Goh KJ, 2000, NEW ENGL J MED, V342, P1229, DOI 10.1056/NEJM200004273421701; Gonwong S, 2014, EMERG INFECT DIS, V20, P1531, DOI 10.3201/eid2009.140418; Gossner CM, 2014, EURO SURVEILL, V19; Hewitt PE, 2014, LANCET, V384, P1766, DOI 10.1016/S0140-6736(14)61034-5; Hinjoy S, 2013, FOODBORNE PATHOG DIS, V10, P698, DOI 10.1089/fpd.2012.1369; Ijaz S, 2009, J CLIN VIROL, V44, P272, DOI 10.1016/j.jcv.2009.01.005; Kamar N, 2010, TRANSPLANTATION, V89, P353, DOI 10.1097/TP.0b013e3181c4096c; Kaufmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021150; Keawcharoen J, 2013, VIRUS GENES, V46, P369, DOI 10.1007/s11262-012-0853-3; Koff RS, 1998, LANCET, V351, P1643, DOI 10.1016/S0140-6736(98)01304-X; Labrique AB, 2012, EMERG INFECT DIS, V18, P1401, DOI 10.3201/eid1809.120241; LEE SD, 1994, HEPATOLOGY, V19, P866, DOI 10.1016/0270-9139(94)90284-4; Lop Buri Governor's Office, 2013, PREPRINT; Lopburi Provincial Livestock Office, 2013, PREPRINT; Louisirirotchanakul S., 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P837; Meng XJ, 1997, P NATL ACAD SCI USA, V94, P9860, DOI 10.1073/pnas.94.18.9860; Ministry of Agriculture and Cooperatives, 2013, PREPRINT; Narathiwat Provincial Livestock Office, 2013, PREPRINT; Palmeira P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/985646; Pavio N, 2014, EMERG INFECT DIS, V20, P1925, DOI 10.3201/eid2011.140891; Poovorawan K, 2013, PATHOG GLOB HEALTH, V107, P367, DOI 10.1179/2047773213Y.0000000116; Poovorawan Y, 2005, J CLIN VIROL, V32, P24, DOI 10.1016/j.jcv.2004.04.008; Poovorawan Y, 1996, VACCINE, V14, P1092, DOI 10.1016/0264-410X(96)00053-9; Poovorawan Y, 1996, ANN TROP MED PARASIT, V90, P189, DOI 10.1080/00034983.1996.11813043; Pourpongporn Pavin, 2009, J Med Assoc Thai, V92 Suppl 3, pS38; Purcell RH, 2008, J HEPATOL, V48, P494, DOI 10.1016/j.jhep.2007.12.008; Rianthavorn P, 2011, J HEALTH POPUL NUTR, V29, P174; Said B, 2014, EPIDEMIOL INFECT, V142, P1467, DOI 10.1017/S0950268813002318; Shata MT, 2007, J IMMUNOL METHODS, V328, P152, DOI 10.1016/j.jim.2007.08.014; Siripanyaphinyo U, 2009, J MED VIROL, V81, P657, DOI 10.1002/jmv.21428; Smith DB, 2014, J GEN VIROL, V95, P2223, DOI 10.1099/vir.0.068429-0; Suwannakarn K, 2010, ARCH VIROL, V155, P1697, DOI 10.1007/s00705-010-0751-8; Tanaka E, 2001, J GASTROENTEROL, V36, P317, DOI 10.1007/s005350170097; Teo CG, 2006, CURR OPIN INFECT DIS, V19, P460, DOI 10.1097/01.qco.0000244052.61629.49; Teppakdee Anchalee, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P118; Theamboonlers A, 2002, ANN TROP MED PARASIT, V96, P727, DOI 10.1179/000349802125001898; Thiry D, 2014, VET MICROBIOL, V172, P407, DOI 10.1016/j.vetmic.2014.06.004; Wattanasri N, 2005, J MED VIROL, V75, P1, DOI 10.1002/jmv.20234; Wheeler C, 2005, NEW ENGL J MED, V353, P890, DOI 10.1056/NEJMoa050855; Wiratsudakul A, 2012, J ZOO WILDLIFE MED, V43, P640, DOI 10.1638/2011-0217R1.1; World Health Organization, 2014, HEP E; World Health Organization, 2014, HEP A; Yoon Y, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-517; Zhang F, 2006, J MED VIROL, V78, P1441, DOI 10.1002/jmv.20717; Zhu FC, 2010, LANCET, V376, P895, DOI 10.1016/S0140-6736(10)61030-6	54	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0126184	10.1371/journal.pone.0126184	http://dx.doi.org/10.1371/journal.pone.0126184			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927925	gold, Green Submitted, Green Published			2022-12-27	WOS:000353713100128
J	Behringer, D; Zimmermann, H; Ziegenhagen, B; Liepelt, S				Behringer, David; Zimmermann, Heike; Ziegenhagen, Birgit; Liepelt, Sascha			Differential Gene Expression Reveals Candidate Genes for Drought Stress Response in Abies alba (Pinaceae)	PLOS ONE			English	Article							PINUS-PINASTER AIT.; REAL-TIME PCR; CLIMATE-CHANGE; WATER-STRESS; CA2+ CHANNEL; RNA-SEQ; IDENTIFICATION; SEQUENCE; TRANSCRIPTOME; ADAPTATION	Increasing drought periods as a result of global climate change pose a threat to many tree species by possibly outpacing their adaptive capabilities. Revealing the genetic basis of drought stress response is therefore implemental for future conservation strategies and risk assessment. Access to informative genomic regions is however challenging, especially for conifers, partially due to their large genomes, which puts constraints on the feasibility of whole genome scans. Candidate genes offer a valuable tool to reduce the complexity of the analysis and the amount of sequencing work and costs. For this study we combined an improved drought stress phenotyping of needles via a novel terahertz water monitoring technique with Massive Analysis of cDNA Ends to identify candidate genes for drought stress response in European silver fir (Abies alba Mill.). A pooled cDNA library was constructed from the cotyledons of six drought stressed and six well-watered silver fir seedlings, respectively. Differential expression analyses of these libraries revealed 296 candidate genes for drought stress response in silver fir (247 up-and 49 down-regulated) of which a subset was validated by RT-qPCR of the twelve individual cotyledons. A majority of these genes code for currently uncharacterized proteins and hint on new genomic resources to be explored in conifers. Furthermore, we could show that some traditional reference genes from model plant species (GAPDH and eIF4A2) are not suitable for differential analysis and we propose a new reference gene, TPC1, for drought stress expression profiling in needles of conifer seedlings.	[Behringer, David; Zimmermann, Heike; Ziegenhagen, Birgit; Liepelt, Sascha] Univ Marburg, Conservat Biol Grp, D-35032 Marburg, Germany	Philipps University Marburg	Behringer, D (corresponding author), Univ Marburg, Conservat Biol Grp, D-35032 Marburg, Germany.	david.behringer@biologie.uni-marburg.de	Liepelt, Sascha/H-1047-2011; Zimmermann, Heike H/Y-2973-2018; Zimmermann, Heike/AAC-8404-2022	Liepelt, Sascha/0000-0001-6529-2882; Zimmermann, Heike H/0000-0002-0225-5176; 	LinkTree: Linking genetic variability with ecological responses to environmental changes: forest trees as model systems [01LC0822A]	LinkTree: Linking genetic variability with ecological responses to environmental changes: forest trees as model systems	Support was provided by LinkTree: Linking genetic variability with ecological responses to environmental changes: forest trees as model systems (Grant number: 01LC0822A). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken SN, 2008, EVOL APPL, V1, P95, DOI 10.1111/j.1752-4571.2007.00013.x; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Bonardi V, 2011, P NATL ACAD SCI USA, V108, P16463, DOI 10.1073/pnas.1113726108; Born N, 2014, PLANT PHYSIOL, V164, P1571, DOI 10.1104/pp.113.233601; Brunner Amy M., 2004, BMC Plant Biology, V4, P14, DOI 10.1186/1471-2229-4-14; Bu QY, 2009, PLANT PHYSIOL, V150, P463, DOI 10.1104/pp.109.135269; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cailleret M, 2014, ANN FOREST SCI, V71, P643, DOI 10.1007/s13595-013-0265-0; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Desprez-Loustau ML, 2006, ANN FOREST SCI, V63, P597, DOI 10.1051/forest:2006040; Dubos C, 2003, PLANT MOL BIOL, V51, P249, DOI 10.1023/A:1021168811590; Durand-Gillmann M, 2014, ANN FOREST SCI, V71, P659, DOI 10.1007/s13595-012-0251-y; Eveno E, 2008, MOL BIOL EVOL, V25, P417, DOI 10.1093/molbev/msm272; Fossdal CG, 2007, PHYSIOL MOL PLANT P, V70, P161, DOI 10.1016/j.pmpp.2007.09.002; Fulton DC, 2008, PLANT CELL, V20, P1040, DOI 10.1105/tpc.107.056507; Furuichi T, 2001, PLANT CELL PHYSIOL, V42, P900, DOI 10.1093/pcp/pce145; Goncalves S, 2005, PLANTA, V222, P556, DOI 10.1007/s00425-005-1562-0; Gonzalez-Martinez SC, 2006, GENETICS, V172, P1915, DOI 10.1534/genetics.105.047126; Goyal K, 2005, BIOCHEM J, V388, P151, DOI 10.1042/BJ20041931; Guo Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S8-S2; Hamanishi ET, 2011, FORESTRY, V84, P273, DOI 10.1093/forestry/cpr012; Hansen OK, 2005, MOL ECOL NOTES, V5, P784, DOI 10.1111/j.1471-8286.2005.01062.x; IPCC, 2007, CLIMATE CHANGE 2007; Kahl G, 2012, J PLANT BIOCHEM BIOT, V21, pS119, DOI 10.1007/s13562-012-0129-y; Konczal M, 2014, MOL ECOL RESOUR, V14, P381, DOI 10.1111/1755-0998.12186; KONNERT M, 1995, PLANT SYST EVOL, V196, P19, DOI 10.1007/BF00985333; Kubista M, 2012, QUANTITATIVE REAL-TIME PCR IN APPLIED MICROBIOLOGY, P63; Kurusu T, 2005, PLANT J, V42, P798, DOI 10.1111/j.1365-313X.2005.02415.x; Lebourgeois F, 2007, ANN FOREST SCI, V64, P333, DOI 10.1051/forest:2007010; Lenz TL, 2013, MOL ECOL, V22, P774, DOI 10.1111/j.1365-294X.2012.05756.x; Linares J. C., 2012, FORESTRY, V2012, DOI [10.5402/2012/437690, DOI 10.5402/2012/437690]; Liu WH, 2002, ANAL BIOCHEM, V302, P52, DOI 10.1006/abio.2001.5530; Macias M, 2006, CLIMATIC CHANGE, V79, P289, DOI 10.1007/s10584-006-9071-0; MALEHORN DE, 1994, PLANT PHYSIOL, V106, P1471, DOI 10.1104/pp.106.4.1471; Maurel C, 2008, ANNU REV PLANT BIOL, V59, P595, DOI 10.1146/annurev.arplant.59.032607.092734; Muller T, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-014-0816-z; Murray BG, 1998, ANN BOT-LONDON, V82, P3, DOI 10.1006/anbo.1998.0764; Neale DB, 2011, NAT REV GENET, V12, P111, DOI 10.1038/nrg2931; Neale DB, 2004, TRENDS PLANT SCI, V9, P325, DOI 10.1016/j.tplants.2004.05.006; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Nourtier M, 2014, ANN FOREST SCI, V71, P683, DOI 10.1007/s13595-012-0229-9; Palovaara J, 2008, PLANT MOL BIOL, V66, P533, DOI 10.1007/s11103-008-9289-5; Pauletto M, 2014, FISH SHELLFISH IMMUN, V37, P154, DOI 10.1016/j.fsi.2014.01.017; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Peguero-Pina JJ, 2007, FLORA, V202, P226, DOI 10.1016/j.flora.2006.06.004; Perdiguero P, 2012, PLANT PHYSIOL BIOCH, V50, P44, DOI 10.1016/j.plaphy.2011.09.022; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2004, 3 2 MARKERS OF A SUC, P90; Pinosio S, 2014, MOL ECOL RESOUR, V14, P846, DOI 10.1111/1755-0998.12232; Piovani P, 2011, TREE PHYSIOL, V31, P500, DOI 10.1093/treephys/tpr029; Ralph SG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-484; Rivals I, 2007, BIOINFORMATICS, V23, P401, DOI 10.1093/bioinformatics/btl633; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Singh A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-435; Siqueira M, 2013, COMPREHENSIVE SURVEY, DOI [10.1016/j.yrtph.2010.06.017, DOI 10.1016/J.YRTPH.2010.06.017]; Sork VL, 2013, TREE GENET GENOMES, V9, P901, DOI 10.1007/s11295-013-0596-x; Taji T, 2002, PLANT J, V29, P417, DOI 10.1046/j.0960-7412.2001.01227.x; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Tenea Gabriela N, 2011, BMC Res Notes, V4, P373, DOI 10.1186/1756-0500-4-373; Todd J, 1999, PLANT J, V17, P119, DOI 10.1046/j.1365-313X.1999.00352.x; Tognetti VB, 2010, PLANT CELL, V22, P2660, DOI 10.1105/tpc.109.071316; Toromani E, 2011, CAN J FOREST RES, V41, P1795, DOI [10.1139/x11-096, 10.1139/X11-096]; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Velasco-Conde T, 2012, TREE GENET GENOMES, V8, P957, DOI 10.1007/s11295-012-0476-9; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang YJ, 2005, J EXP BOT, V56, P3051, DOI 10.1093/jxb/eri302; Witmer X, 2003, SEED SCI RES, V13, P167, DOI 10.1079/SSR2003134; WU SC, 1994, PLANT PHYSIOL, V106, P1709, DOI 10.1104/pp.106.4.1709; Yakovlev I, 2012, SEED SCI RES, V22, P63, DOI 10.1017/S0960258511000535; Yang YZ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-140; Zhao XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111915; Zheng XM, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S13-S7	76	34	35	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124564	10.1371/journal.pone.0124564	http://dx.doi.org/10.1371/journal.pone.0124564			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25924061	gold, Green Published, Green Submitted			2022-12-27	WOS:000353711600093
J	Deng, Q; Hui, DF; Wang, JM; Iwuozo, S; Yu, CL; Jima, T; Smart, D; Reddy, C; Dennis, S				Deng, Qi; Hui, Dafeng; Wang, Junming; Iwuozo, Stephen; Yu, Chih-Li; Jima, Tigist; Smart, David; Reddy, Chandra; Dennis, Sam			Corn Yield and Soil Nitrous Oxide Emission under Different Fertilizer and Soil Management: A Three-Year Field Experiment in Middle Tennessee	PLOS ONE			English	Article							GREENHOUSE-GAS FLUXES; N2O EMISSIONS; SLOW PYROLYSIS; BIOCHAR; TILLAGE; TEMPERATURE; DYNAMICS; SYSTEMS; CARBON	Background A three-year field experiment was conducted to examine the responses of corn yield and soil nitrous oxide (N2O) emission to various management practices in middle Tennessee. Methodology/Principal Findings The management practices include no-tillage + regular applications of urea ammonium nitrate (NT-URAN); no-tillage + regular applications of URAN + denitrification inhibitor (NT-inhibitor); no-tillage + regular applications of URAN + biochar (NT-biochar); no-tillage + 20% applications of URAN + chicken litter (NT-litter), no-tillage + split applications of URAN (NT-split); and conventional tillage + regular applications of URAN as a control (CT-URAN). Fertilizer equivalent to 217 kg N ha(-1) was applied to each of the experimental plots. Results showed that no-tillage (NT-URAN) significantly increased corn yield by 28% over the conventional tillage (CT-URAN) due to soil water conservation. The management practices significantly altered soil N2O emission, with the highest in the CT-URAN (0.48 mg N(2)Om(-2) h(-1)) and the lowest in the NT-inhibitor (0.20 mg N(2)Om(-2) h(-1)) and NT-biochar (0.16 mg N(2)Om(-2) h(-1)) treatments. Significant exponential relationships between soil N2O emission and water filled pore space were revealed in all treatments. However, variations in soil N2O emission among the treatments were positively correlated with the moisture sensitivity of soil N2O emission that likely reflects an interactive effect between soil properties and WFPS. Conclusion/Significance Our results indicated that improved fertilizer and soil management have the potential to maintain highly productive corn yield while reducing greenhouse gas emissions.	[Deng, Qi; Hui, Dafeng; Iwuozo, Stephen; Yu, Chih-Li; Jima, Tigist; Reddy, Chandra; Dennis, Sam] Tennessee State Univ, Coll Agr Human & Nat Sci, Nashville, TN 37209 USA; [Wang, Junming] Univ Illinois, Prairie Res Inst, Illinois State Water Survey, Climate Sci Sect, Champaign, IL 61802 USA; [Smart, David] Univ Calif Davis, Dept Viticulture & Enol, Davis, CA 95616 USA	Tennessee State University; Illinois State Water Survey; University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California Davis	Hui, DF (corresponding author), Tennessee State Univ, Coll Agr Human & Nat Sci, Nashville, TN 37209 USA.	dhui@tnstate.edu	Deng, Qi/M-3341-2019	Deng, Qi/0000-0001-8208-9763; Hui, Dafeng/0000-0002-5284-2897	USDA- Capacity Building Grants; Evans-Allen grants	USDA- Capacity Building Grants; Evans-Allen grants	This work was financially supported by USDA- Capacity Building Grants and Evans-Allen grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adviento-Borbe MAA, 2007, GLOBAL CHANGE BIOL, V13, P1972, DOI 10.1111/j.1365-2486.2007.01421.x; Asai H, 2009, FIELD CROP RES, V111, P81, DOI 10.1016/j.fcr.2008.10.008; AULAKH MS, 1984, J ENVIRON QUAL, V13, P130, DOI 10.2134/jeq1984.00472425001300010024x; Bhatia A, 2010, AGR ECOSYST ENVIRON, V136, P247, DOI 10.1016/j.agee.2010.01.004; Bouwman AF, 1996, NUTR CYCL AGROECOSYS, V46, P53, DOI 10.1007/BF00210224; Bouwman AF, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI [10.1029/2001GB001811, 10.1029/2001GB001812]; Cayuela ML, 2014, AGR ECOSYST ENVIRON, V191, P5, DOI 10.1016/j.agee.2013.10.009; Chen Y, 2011, SOIL TILL RES, V115, P56, DOI 10.1016/j.still.2011.06.007; Choudhary MA, 2002, AGR ECOSYST ENVIRON, V93, P33, DOI 10.1016/S0167-8809(02)00005-1; CRS, 2010, R40874 CRS; Cullum RF, 2012, SOIL TILL RES, V119, P1, DOI 10.1016/j.still.2011.11.011; Davidson E. A., 1991, Microbial production and consumption of greenhouse gases: methane, nitrogen oxides, and halomethanes., P219; DAVIDSON EA, 1986, APPL ENVIRON MICROB, V52, P1287, DOI 10.1128/AEM.52.6.1287-1292.1986; DeFelice MS, 2006, CROP MANAGEMENT, V5, DOI [10.1094/CM-2006-0626-01-RS, DOI 10.1094/CM-2006-0626-01-RS]; Dobbie KE, 2003, GLOBAL CHANGE BIOL, V9, P204, DOI 10.1046/j.1365-2486.2003.00563.x; Downie A., 2009, BIOCHAR ENV MANAGEME, V13, P32, DOI [10.4324/9781849770552, DOI 10.4324/9781849770552]; EPA, 2009, MAJ CROPS GROWN US A; Franzluebbers AJ, 2005, SOIL TILL RES, V83, P120, DOI 10.1016/j.still.2005.02.012; FRANZLUEBBERS AJ, 1995, SOIL SCI SOC AM J, V59, P1618, DOI 10.2136/sssaj1995.03615995005900060016x; Halvorson AD, 2005, AGRON J, V97, P1222, DOI 10.2134/agronj2004.0279; Huang H, 2014, ATMOS CHEM PHYS, V14, P12839, DOI 10.5194/acp-14-12839-2014; Kelliher FM, 2008, SOIL BIOL BIOCHEM, V40, P1878, DOI 10.1016/j.soilbio.2008.03.013; Kennedy TL, 2013, AGR ECOSYST ENVIRON, V170, P16, DOI 10.1016/j.agee.2013.02.002; Kim DG, 2013, AGR ECOSYST ENVIRON, V168, P53, DOI 10.1016/j.agee.2012.02.021; Kloss S, 2012, J ENVIRON QUAL, V41, P990, DOI 10.2134/jeq2011.0070; Lentz RD, 2014, J ENVIRON QUAL, V41, P1033; Linquist B, 2012, GLOBAL CHANGE BIOL, V18, P194, DOI 10.1111/j.1365-2486.2011.02502.x; Ma BL, 2010, GLOBAL CHANGE BIOL, V16, P156, DOI 10.1111/j.1365-2486.2009.01932.x; McSwiney CP, 2005, GLOBAL CHANGE BIOL, V11, P1712, DOI 10.1111/j.1365-2486.2005.01040.x; Menneer JC, 2008, AUST J SOIL RES, V46, P323, DOI 10.1071/SR06180; Molodovskaya M, 2011, SOIL SCI SOC AM J, V75, P1829, DOI 10.2136/sssaj2010.0415; Mosier A., 2000, CHEM GLOB CHANG SCI, V2, P465, DOI [10.1016/S1465-9972, DOI 10.1016/S1465-9972(00)00039-8, 10.1016/S1465-9972(00)00039-8]; Neftel A, 2007, TELLUS B, V59, P470, DOI 10.1111/j.1600-0889.2007.00273.x; Ogle S, 2008, LIFECYCLE CARBON FOO, P11; Parkin TB, 2006, J ENVIRON QUAL, V35, P1496, DOI 10.2134/jeq2005.0183; Phillips RL, 2009, J ENVIRON QUAL, V38, P1569, DOI 10.2134/jeq2008.0483; Rochette P, 2010, EUR J SOIL SCI, V61, P186, DOI 10.1111/j.1365-2389.2009.01222.x; Saarnio S, 2013, SOIL BIOL BIOCHEM, V58, P99, DOI 10.1016/j.soilbio.2012.10.035; Sainju UM, 2014, J ENVIRON QUAL, V43, P777, DOI 10.2134/jeq2013.10.0405; Schellenberg DL, 2012, AGR ECOSYST ENVIRON, V155, P7, DOI 10.1016/j.agee.2012.03.008; Singurindy O, 2009, AGR ECOSYST ENVIRON, V132, P74, DOI 10.1016/j.agee.2009.03.001; Smart DR, 2011, ACS SYM SER, V1072, P227; Ussiri DAN, 2009, SOIL TILL RES, V104, P247, DOI 10.1016/j.still.2009.03.001; Van Groenigen JW, 2010, EUR J SOIL SCI, V61, P903, DOI 10.1111/j.1365-2389.2009.01217.x; Van Zwieten L, 2010, PLANT SOIL, V327, P235, DOI 10.1007/s11104-009-0050-x; Venterea RT, 2011, J ENVIRON QUAL, V40, P1521, DOI 10.2134/jeq2011.0039; Verhoeven E, 2014, AGR ECOSYST ENVIRON, V191, P27, DOI 10.1016/j.agee.2014.03.008; Zheng JY, 2012, J ENVIRON QUAL, V41, P1361, DOI 10.2134/jeq2012.0019	48	25	25	5	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125406	10.1371/journal.pone.0125406	http://dx.doi.org/10.1371/journal.pone.0125406			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923716	Green Published, gold, Green Submitted			2022-12-27	WOS:000353711600150
J	Eren, MK; Kilincli, A; Eren, O				Eren, Mehtap Kilic; Kilincli, Ayten; Eren, Ozkan			Resveratrol Induced Premature Senescence Is Associated with DNA Damage Mediated SIRT1 and SIRT2 Down-Regulation	PLOS ONE			English	Article							CELLULAR SENESCENCE; LIFE-SPAN; IN-VIVO; CANCER; CELLS; PATHWAYS; SIRTUINS; HEALTHSPAN; INHIBITORS; STRESS	The natural polyphenolic compound resveratrol (3,4,5-trihydroxy-trans-stilbene) has broad spectrum health beneficial activities including antioxidant, anti-inflammatory, anti-aging, anti-cancer, cardioprotective, and neuroprotective effects. Remarkably, resveratrol also induces apoptosis and cellular senescence in primary and cancer cells. Resveratrol's anti-aging effects both in vitro and in vivo attributed to activation of a (NAD)-dependent histone deacetylase family member sirtuin-1 (SIRT1) protein. In mammals seven members (SIRT17) of sirtuin family have been identified. Among those, SIRT1 is the most extensively studied with perceptive effects on mammalian physiology and suppression of the diseases of aging. Yet no data has specified the role of sirtuins, under conditions where resveratrol treatment induces senescence. Current study was undertaken to investigate the effects of resveratrol in human primary dermal fibroblasts (BJ) and to clarify the role of sirtuin family members in particular SIRT1 and SIRT2 that are known to be involved in cellular stress responses and cell cycle, respectively. Here, we show that resveratrol decreases proliferation of BJ cells in a time and dose dependent manner. In addition the increase in senescence associated beta-galactosidase (SA-beta-gal) activity and methylated H3K9-me indicate the induction of premature senescence. A significant increase in phosphorylation of gamma-H2AX, a surrogate of DNA double strand breaks, as well as in levels of p53, p21(CIP1) and p16(INK4A) is also detected. Interestingly, at concentrations where resveratrol induced premature senescence we show a significant decrease in SIRT1 and SIRT2 levels by Western Blot and quantitative RT-PCR analysis. Conversely inhibition of SIRT1 and SIRT2 via siRNA or sirtinol treatment also induced senescence in BJ fibroblasts associated with increased SA-beta-gal activity, gamma-H2AX phosphorylation and p53, p21CIP1 and p16INK4A levels. Interestingly DNA damaging agent doxorubicin also induced senescence in BJ fibroblasts associated with decreased SIRT1/2 levels. In conclusion our data reveal that resveratrol induced premature senescence is associated with SIRT1 and SIRT2 down regulation in human dermal fibroblasts. Here we suggest that the concomitant decline in SIRT1/2 expression in response to resveratrol treatment may be a cause for induction of senescence, which is most likely mediated by a regulatory mechanism activated by DNA damage response.	[Eren, Mehtap Kilic] Adnan Menderes Univ, Sch Med, Dept Med Biol, Aydin, Turkey; [Eren, Mehtap Kilic] Adnan Menderes Univ, Sci & Technol Res & Applicat Ctr, ADU BILTEM, Aydin, Turkey; [Kilincli, Ayten; Eren, Ozkan] Adnan Menderes Univ, Dept Biol, Aydin, Turkey	Adnan Menderes University; Adnan Menderes University; Adnan Menderes University	Eren, MK (corresponding author), Adnan Menderes Univ, Sch Med, Dept Med Biol, Aydin, Turkey.	mkilic@adu.edu.tr	Kilincli, Ayten/ABI-3408-2020	Kilincli, Ayten/0000-0003-0907-0737	Adnan Menderes University Scientific Research Foundation [FEF-12036]; TUBITAK [108S3789, 108S3789 Cost-BM0703CANGENIN]	Adnan Menderes University Scientific Research Foundation(Adnan Menderes University); TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work is supported by Adnan Menderes University Scientific Research Foundation to OE (FEF-12036) and by TUBITAK (http://www.tubitak.gov.tr/en) grant to MKE (108S3789 Cost-BM0703CANGENIN). AK was financed by TUBITAK (108S3789 to MKE).	Agarwal B, 2011, ANN NY ACAD SCI, V1215, P138, DOI 10.1111/j.1749-6632.2010.05850.x; Allison SJ, 2007, CELL CYCLE, V6, P2669, DOI 10.4161/cc.6.21.4866; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bass TM, 2007, MECH AGEING DEV, V128, P546, DOI 10.1016/j.mad.2007.07.007; Baur JA, 2012, NAT REV DRUG DISCOV, V11, P443, DOI 10.1038/nrd3738; Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Binda O, 2008, ONCOGENE, V27, P3384, DOI 10.1038/sj.onc.1211014; Borriello A, 2014, CANCER TREAT RES, V159, P167, DOI 10.1007/978-3-642-38007-5_10; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Cao C, 2009, J CELL MOL MED, V13, P3632, DOI 10.1111/j.1582-4934.2008.00453.x; Carnero Amancio, 2013, Methods Mol Biol, V965, P63, DOI 10.1007/978-1-62703-239-1_4; Carter LG, 2014, ENDOCR-RELAT CANCER, V21, pR209, DOI 10.1530/ERC-13-0171; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; Dehennaut V, 2013, J BIOL CHEM, V288, P10254, DOI 10.1074/jbc.M112.421610; Demidenko ZN, 2009, CELL CYCLE, V8, P1901, DOI 10.4161/cc.8.12.8810; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Eren MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101064; Faragher RGA, 2011, AGE, V33, P555, DOI 10.1007/s11357-010-9201-5; Gao Z, 2011, BIOCHEM BIOPH RES CO, V407, P271, DOI 10.1016/j.bbrc.2011.02.008; Ghosh HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009199; Guarente L, 2007, COLD SH Q B, V72, P483, DOI 10.1101/sqb.2007.72.024; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Huang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001710; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; Kilic M, 2008, BEYOND APOPTOSIS CEL, P273; Kosar M, 2011, CELL CYCLE, V10, P457, DOI 10.4161/cc.10.3.14707; Lee James T, 2013, Genes Cancer, V4, P112, DOI 10.1177/1947601913484496; Luo HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060065; Marques FZ, 2009, INT J BIOCHEM CELL B, V41, P2125, DOI 10.1016/j.biocel.2009.06.003; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049; Peck B, 2010, MOL CANCER THER, V9, P844, DOI 10.1158/1535-7163.MCT-09-0971; Rood BR, 2013, EXPERT OPIN THER TAR, V17, P811, DOI 10.1517/14728222.2013.788152; Sasaki T, 2006, AGING CELL, V5, P413, DOI 10.1111/j.1474-9726.2006.00235.x; Stefani M, 2007, ANN NY ACAD SCI, V1114, P407, DOI 10.1196/annals.1396.001; Villalba JM, 2012, BIOFACTORS, V38, P349, DOI 10.1002/biof.1032; Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x; Wang F, 2007, AGING CELL, V6, P505, DOI 10.1111/j.1474-9726.2007.00304.x; Yamashita S, 2012, BIOCHEM BIOPH RES CO, V417, P630, DOI 10.1016/j.bbrc.2011.12.021; Yang Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070627	43	39	40	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124837	10.1371/journal.pone.0124837	http://dx.doi.org/10.1371/journal.pone.0124837			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25924011	gold, Green Published, Green Submitted			2022-12-27	WOS:000353711600105
J	Terranova, C; Narla, ST; Lee, YW; Bard, J; Parikh, A; Stachowiak, EK; Tzanakakis, ES; Buck, MJ; Birkaya, B; Stachowiak, MK				Terranova, Christopher; Narla, Sridhar T.; Lee, Yu-Wei; Bard, Jonathan; Parikh, Abhirath; Stachowiak, Ewa K.; Tzanakakis, Emmanuel S.; Buck, Michael J.; Birkaya, Barbara; Stachowiak, Michal K.			Global Developmental Gene Programing Involves a Nuclear Form of Fibroblast Growth Factor Receptor-1 (FGFR1)	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; PATHWAY MEDIATES ACTIVATION; GROUP PROTEIN SUZ12; RETINOIC-ACID; INTRACELLULAR TRAFFICKING; MORPHOGENETIC MOVEMENT; SIGNALING PATHWAY; ANGIOTENSIN-II; NITRIC-OXIDE; NEUROGENESIS	Genetic studies have placed the Fgfr1 gene at the top of major ontogenic pathways that enable gastrulation, tissue development and organogenesis. Using genome-wide sequencing and loss and gain of function experiments the present investigation reveals a mechanism that underlies global and direct gene regulation by the nuclear form of FGFR1, ensuring that pluripotent Embryonic Stem Cells differentiate into Neuronal Cells in response to Retinoic Acid. Nuclear FGFR1, both alone and with its partner nuclear receptors RXR and Nur77, targets thousands of active genes and controls the expression of pluripotency, homeobox, neuronal and mesodermal genes. Nuclear FGFR1 targets genes in developmental pathways represented by Wnt/beta-catenin, CREB, BMP, the cell cycle and cancer-related TP53 pathway, neuroectodermal and mesodermal programing networks, axonal growth and synaptic plasticity pathways. Nuclear FGFR1 targets the consensus sequences of transcription factors known to engage CREB-binding protein, a common coregulator of transcription and established binding partner of nuclear FGFR1. This investigation reveals the role of nuclear FGFR1 as a global genomic programmer of cell, neural and muscle development.	[Terranova, Christopher; Narla, Sridhar T.; Lee, Yu-Wei; Stachowiak, Ewa K.; Birkaya, Barbara; Stachowiak, Michal K.] SUNY Buffalo, Dept Pathol & Anat Sci, Western New York Stem Cell Culture & Anal Ctr, Buffalo, NY 14260 USA; [Bard, Jonathan] SUNY Buffalo, Next Generat Sequencing & Express Anal Core, Buffalo, NY 14260 USA; [Parikh, Abhirath; Tzanakakis, Emmanuel S.] SUNY Buffalo, Dept Chem & Biol Engn, Western New York Stem Cell Culture & Anal Ctr, Buffalo, NY 14260 USA; [Buck, Michael J.] SUNY Buffalo, Dept Biochem Genom & Bioinformat Core, Western New York Stem Cell Culture & Anal Ctr, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Stachowiak, MK (corresponding author), SUNY Buffalo, Dept Pathol & Anat Sci, Western New York Stem Cell Culture & Anal Ctr, Buffalo, NY 14260 USA.	mks4@buffalo.edu	Tzanakakis, Emmanuel S/F-6868-2015; Tzanakakis, Emmanuel/S-7617-2019	Tzanakakis, Emmanuel S/0000-0002-6677-352X; Tzanakakis, Emmanuel/0000-0002-6677-352X; Narla, Sridhar/0000-0001-9066-2072; Bard, Jonathan/0000-0001-7433-0086; Terranova, Christopher/0000-0002-3674-7013	Western New York Stem Cell Center [C026415, C026714]; Patrick Lee Foundation; National Institute of Heath [HL103709]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103709] Funding Source: NIH RePORTER	Western New York Stem Cell Center; Patrick Lee Foundation; National Institute of Heath; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by Western New York Stem Cell Center C026415, C026714 to MKS and EKS; Patrick Lee Foundation to MKS; National Institute of Heath HL103709 to EST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Abed S, 2001, GENE DEV, V15, P226, DOI 10.1101/gad.855001; Akanuma Hiromi, 2012, Frontiers in Genetics, V3, P141, DOI 10.3389/fgene.2012.00141; Bain G, 1996, BIOCHEM BIOPH RES CO, V223, P691, DOI 10.1006/bbrc.1996.0957; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Baron O, 2012, J BIOL CHEM, V287, P19827, DOI 10.1074/jbc.M112.347831; Bertrand S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-226; Bharali DJ, 2005, P NATL ACAD SCI USA, V102, P11539, DOI 10.1073/pnas.0504926102; Bobbs AS, 2012, J BIOL CHEM, V287, P38505, DOI 10.1074/jbc.M112.400598; BONCINELLI E, 1991, TRENDS GENET, V7, P329, DOI 10.1016/0168-9525(91)90423-N; Bryant DM, 2005, TRAFFIC, V6, P947, DOI 10.1111/j.1600-0854.2005.00332.x; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chioni AM, 2012, J CELL BIOL, V197, P801, DOI 10.1083/jcb.201108077; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; Ciruna BG, 1997, DEVELOPMENT, V124, P2829; Clarke WE, 2001, MOL CELL NEUROSCI, V17, P17, DOI 10.1006/mcne.2000.0920; Claus P, 2003, J BIOL CHEM, V278, P479, DOI 10.1074/jbc.M206056200; Coleman SJ, 2014, EMBO MOL MED, V6, P467, DOI 10.1002/emmm.201302698; Dequeant ML, 2008, NAT REV GENET, V9, P370, DOI 10.1038/nrg2320; Dottori M, 2001, DEVELOPMENT, V128, P4127; Dunham-Ems SM, 2009, MOL BIOL CELL, V20, P2401, DOI 10.1091/mbc.E08-06-0600; Fang XH, 2005, J BIOL CHEM, V280, P28451, DOI 10.1074/jbc.M504400200; Forget MA, 2007, BRIT J CANCER, V96, P646, DOI 10.1038/sj.bjc.6603579; Gillespie RF, 2007, J MOL BIOL, V372, P298, DOI 10.1016/j.jmb.2007.06.079; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; GONZALEZ AM, 1995, BRAIN RES, V701, P201, DOI 10.1016/0006-8993(95)01002-X; Guan KM, 2001, CELL TISSUE RES, V305, P171, DOI 10.1007/s004410100416; Horbinski C, 2002, J NEUROCHEM, V80, P54, DOI 10.1046/j.0022-3042.2001.00657.x; Hu YF, 2004, J BIOL CHEM, V279, P29325, DOI 10.1074/jbc.M311144200; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kehoe DE, 2008, BIOTECHNOL PROGR, V24, P1342, DOI 10.1002/btpr.57; Leadbeater WE, 2006, J NEUROCHEM, V96, P1189, DOI 10.1111/j.1471-4159.2005.03632.x; Lee YM, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/210604; Lee YW, 2012, J CELL BIOCHEM, V113, P2920, DOI 10.1002/jcb.24170; Lefebvre P, 2010, TRENDS ENDOCRIN MET, V21, P676, DOI 10.1016/j.tem.2010.06.009; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Maher PA, 1996, J CELL BIOL, V134, P529, DOI 10.1083/jcb.134.2.529; Maira M, 2003, MOL CELL BIOL, V23, P763, DOI 10.1128/MCB.23.3.763-776.2003; Maira M, 1999, MOL CELL BIOL, V19, P7549; Mansouri A, 1998, MECH DEVELOP, V78, P171, DOI 10.1016/S0925-4773(98)00168-3; Martinez-Ceballos E, 2005, J BIOL CHEM, V280, P16484, DOI 10.1074/jbc.M414397200; Montavon T, 2014, SEMIN CELL DEV BIOL, V34, P76, DOI 10.1016/j.semcdb.2014.06.005; MorrissKay GM, 1996, FASEB J, V10, P961, DOI 10.1096/fasebj.10.9.8801178; Myers JM, 2003, J CELL BIOCHEM, V88, P1273, DOI 10.1002/jcb.10476; Narla ST, 2013, STEM CELL TRANSL MED, V2, P776, DOI 10.5966/sctm.2012-0103; Nguyen PT, 2013, BRIT J CANCER, V109, P2248, DOI 10.1038/bjc.2013.550; Okada Y, 2004, DEV BIOL, V275, P124, DOI 10.1016/j.ydbio.2004.07.038; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Partanen J, 1998, GENE DEV, V12, P2332, DOI 10.1101/gad.12.15.2332; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pendaries V, 2003, ONCOGENE, V22, P8212, DOI 10.1038/sj.onc.1206913; Peng H, 2002, J NEUROCHEM, V81, P506, DOI 10.1046/j.1471-4159.2002.00833.x; Peng H, 2001, MOL BIOL CELL, V12, P449, DOI 10.1091/mbc.12.2.449; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Popovici C, 2006, EXP CELL RES, V312, P1484, DOI 10.1016/j.yexcr.2006.01.012; Qin LL, 2013, BLOOD, V121, P2154, DOI 10.1182/blood-2012-07-443903; Reilly JF, 2001, J CELL BIOL, V152, P1307, DOI 10.1083/jcb.152.6.1307; SHERMAN L, 1993, DEVELOPMENT, V118, P1313; Stachowiak EK, 2003, J NEUROCHEM, V84, P1296, DOI 10.1046/j.1471-4159.2003.01624.x; Stachowiak EK, 2011, STEM CELLS MECH TECH, P333; Stachowiak EK, 2009, INTEGR BIOL-UK, V1, P394, DOI 10.1039/b902617g; Stachowiak M. K., 2011, STEM CELLS MECH TECH, P87; Stachowiak MK, 2007, DNA CELL BIOL, V26, P811, DOI 10.1089/dna.2007.0664; Stachowiak MK, 1996, MOL BIOL CELL, V7, P1299, DOI 10.1091/mbc.7.8.1299; Stachowiak MK, 2003, J CELL BIOCHEM, V90, P662, DOI 10.1002/jcb.10606; Stachowiak MK, 1996, MOL BRAIN RES, V38, P161, DOI 10.1016/0169-328X(96)00010-1; Stuhlmiller TJ, 2012, DEVELOPMENT, V139, P289, DOI 10.1242/dev.070276; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Uchimura K, 2001, HEPATOLOGY, V33, P91, DOI 10.1053/jhep.2001.21145; Xiao Z, 2006, MOL CANCER THER, V5, P1935, DOI 10.1158/1535-7163.MCT-06-0077; Zhang W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4330; Zhao DZ, 2011, P NATL ACAD SCI USA, V108, P12066, DOI 10.1073/pnas.1018438108	71	31	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123380	10.1371/journal.pone.0123380	http://dx.doi.org/10.1371/journal.pone.0123380			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923916	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600045
J	Wu, JF; Peng, DH; Ma, JH; Zhao, L; Sun, C; Ling, HZ				Wu, Jianfa; Peng, Dahao; Ma, Jianhao; Zhao, Li; Sun, Ce; Ling, Huanzhang			Selection of Atmospheric Environmental Monitoring Sites based on Geographic Parameters Extraction of GIS and Fuzzy Matter-Element Analysis	PLOS ONE			English	Article							AIR-POLLUTION; WATER-QUALITY; OPTIMAL-DESIGN; MODEL; NETWORK; OPTIMIZATION; DISPERSION; SYSTEM; RIVER	To effectively monitor the atmospheric quality of small-scale areas, it is necessary to optimize the locations of the monitoring sites. This study combined geographic parameters extraction by GIS with fuzzy matter-element analysis. Geographic coordinates were extracted by GIS and transformed into rectangular coordinates. These coordinates were input into the Gaussian plume model to calculate the pollutant concentration at each site. Fuzzy matter-element analysis, which is used to solve incompatible problems, was used to select the locations of sites. The matter element matrices were established according to the concentration parameters. The comprehensive correlation functions K-A(x(j)) and K-B(x(j)), which reflect the degree of correlation among monitoring indices, were solved for each site, and a scatter diagram of the sites was drawn to determine the final positions of the sites based on the functions. The sites could be classified and ultimately selected by the scatter diagram. An actual case was tested, and the results showed that 5 positions can be used for monitoring, and the locations conformed to the technical standard. In the results of this paper, the hierarchical clustering method was used to improve the methods. The sites were classified into 5 types, and 7 locations were selected. Five of the 7 locations were completely identical to the sites determined by fuzzy matter-element analysis. The selections according to these two methods are similar, and these methods can be used in combination. In contrast to traditional methods, this study monitors the isolated point pollutant source within a small range, which can reduce the cost of monitoring.	[Wu, Jianfa; Ma, Jianhao] Harbin Engn Univ, Coll Automat, Harbin, Heilongjiang, Peoples R China; [Peng, Dahao] Harbin Engn Univ, Coll Comp Sci & Technol, Harbin, Heilongjiang, Peoples R China; [Zhao, Li] Harbin Engn Univ, Coll Natl Secrecy, Harbin, Heilongjiang, Peoples R China; [Sun, Ce] Harbin Engn Univ, Coll Mat Sci & Chem Engn, Harbin, Heilongjiang, Peoples R China; [Ling, Huanzhang] Harbin Engn Univ, Coll Sci, Harbin, Heilongjiang, Peoples R China	Harbin Engineering University; Harbin Engineering University; Harbin Engineering University; Harbin Engineering University; Harbin Engineering University	Ling, HZ (corresponding author), Harbin Engn Univ, Coll Sci, Harbin, Heilongjiang, Peoples R China.	linghuanzhang@hrbeu.edu.cn		Ling, Huanzhang/0000-0001-5825-6365				Borge R, 2007, ATMOS ENVIRON, V41, P4434, DOI 10.1016/j.atmosenv.2007.01.053; Briggs DJ, 1997, INT J GEOGR INF SCI, V11, P699, DOI 10.1080/136588197242158; Chen QW, 2012, J ENVIRON MANAGE, V110, P116, DOI 10.1016/j.jenvman.2012.05.024; Ebrahimi M, 2013, ENVIRON FLUID MECH, V13, P125, DOI 10.1007/s10652-012-9260-5; Elbir T, 2010, ATMOS ENVIRON, V44, P441, DOI 10.1016/j.atmosenv.2009.11.008; Gomez-Losada A, 2014, SCI TOTAL ENVIRON, V485, P292, DOI 10.1016/j.scitotenv.2014.03.091; He YX, 2011, INT J ELEC POWER, V33, P775, DOI 10.1016/j.ijepes.2010.12.037; Huq P, 2013, BOUND-LAY METEOROL, V147, P103, DOI 10.1007/s10546-012-9780-z; Ignaccolo R, 2008, ENVIRONMETRICS, V19, P672, DOI 10.1002/env.946; Jia CR, 2011, PROCEDIA ENVIRON SCI, V11, P631, DOI 10.1016/j.proenv.2011.12.098; Ketzel M, 2011, INT J ENVIRON POLLUT, V47, P226, DOI 10.1504/IJEP.2011.047337; Li H., 2012, TELKOMNIKA, V10, P586; Li ZY, 1996, RES ENV SCI CHINA, V6, P10; Liu DJ, 2012, J ENVIRON SCI, V24, P1210, DOI 10.1016/S1001-0742(11)60938-8; Lu WZ, 2011, BUILD ENVIRON, V46, P577, DOI 10.1016/j.buildenv.2010.09.004; Malley CS, 2014, ATMOS RES, V138, P30, DOI 10.1016/j.atmosres.2013.10.019; Mazzeo NA, 2014, AIR QUALITY     1014; Mazzoldi A, 2008, ATMOS ENVIRON, V42, P8046, DOI 10.1016/j.atmosenv.2008.06.038; Mofarrah A, 2010, ATMOS ENVIRON, V44, P432, DOI 10.1016/j.atmosenv.2009.07.045; Mohan R, 2009, J AIR WASTE MANAGE, V59, P490, DOI 10.3155/1047-3289.59.4.490; Pires JCM, 2009, ATMOS ENVIRON, V43, P3837, DOI 10.1016/j.atmosenv.2009.05.013; Pittau MG, 1999, ENVIRONMETRICS, V10, P351, DOI 10.1002/(SICI)1099-095X(199905/06)10:3<351::AID-ENV337>3.0.CO;2-6; Pope R, 2014, J AIR WASTE MANAGE, V64, P721, DOI 10.1080/10962247.2014.888378; Saunier O, 2009, ATMOS ENVIRON, V43, P4940, DOI 10.1016/j.atmosenv.2009.07.011; Silva C, 2003, ATMOS ENVIRON, V37, P2337, DOI 10.1016/S1352-2310(03)00152-3; Varma SAK, 2014, ENERGY ENV ENG, V2, P91; Wang JP, 2005, BIOMED ENVIRON SCI, V18, P233; Wang QL, 2010, ADV MATER RES-SWITZ, V108-111, P403, DOI 10.4028/www.scientific.net/AMR.108-111.403; Zhang J, 2011, INT J ENV RES PUB HE, V8, P1206, DOI 10.3390/ijerph8041206	29	4	4	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123766	10.1371/journal.pone.0123766	http://dx.doi.org/10.1371/journal.pone.0123766			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923911	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600057
J	Xu, YC; Chu, LL; Jin, QJ; Wang, YJ; Chen, X; Zhao, H; Xue, ZY				Xu, Yingchun; Chu, Lingling; Jin, Qijiang; Wang, Yanjie; Chen, Xian; Zhao, Hui; Xue, Zeyun			Transcriptome-Wide Identification of miRNAs and Their Targets from Typha angustifolia by RNA-Seq and Their Response to Cadmium Stress	PLOS ONE			English	Article							MEDICAGO-TRUNCATULA; GRAPEVINE MICRORNAS; NONCODING RNAS; ARABIDOPSIS; GENES; TOOL; MERCURY; ANNOTATION; BIOGENESIS; DISCOVERY	MicroRNAs (miRNAs) play important roles in plant responses to environmental stress. In this work, we used high-throughput sequencing to analyze transcriptome and small RNAs (sRNAs) in Typha angustifoliaunder cadmium (Cd) stress. 57,608,230 raw reads were obtained from deep sequencing of a pooled cDNA library. Sequence assembly and analysis yielded 102,473 unigenes. We subsequently sequenced two sRNA libraries from T. angustifolia with or without Cd exposure respectively. Based on transcriptome data of T. angustifolia, we catalogued and analyzed the sRNAs, resulting in the identification of 114 conserved miRNAs and 41 novel candidate miRNAs in both small RNA libraries. In silicoanalysis revealed 764 targets for 89 conserved miRNAs and 21 novel miRNAs. Statistical analysis on sequencing reads abundance and experimental validation revealed that 4 conserved and 6 novel miRNAs showed specific expression. Combined with function of target genes, these results suggested that miRNAs might play a role in plant Cd stress response. This study provided the first transcriptome-based analysis of miRNAs and their targets responsive to Cd stress in T. angustifolia, which provide a framework for further analysis of miRNAs and their role in regulating plant responses to Cd stress.	[Xu, Yingchun; Chu, Lingling; Jin, Qijiang; Wang, Yanjie; Chen, Xian; Zhao, Hui; Xue, Zeyun] Nanjing Agr Univ, Coll Hort, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University	Xu, YC (corresponding author), Nanjing Agr Univ, Coll Hort, Nanjing 210095, Jiangsu, Peoples R China.	xyc@njau.edu.cn			Natural Science Foundation of Jiangsu Province [BK2011640]	Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This research was supported by the Natural Science Foundation of Jiangsu Province (Grant No. BK2011640, YX received this funding).	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Axtell MJ, 2007, PLANT CELL, V19, P1750, DOI 10.1105/tpc.107.051706; Bah AM, 2011, BIOL TRACE ELEM RES, V142, P77, DOI 10.1007/s12011-010-8746-6; Montero-Palmero MB, 2014, NEW PHYTOL, V201, P116, DOI 10.1111/nph.12486; Black H, 1995, ENVIRON HEALTH PERSP, V103, P1106, DOI 10.2307/3432605; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Bressan R, 2009, MOL PLANT, V2, P1, DOI 10.1093/mp/ssn097; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Cameron M, 2004, IEEE ACM T COMPUT BI, V1, P116, DOI 10.1109/TCBB.2004.32; Chakraborty D., 2013, INT J ENV SCI, V3, P2291, DOI DOI 10.6088/IJES.2013030600045; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Ding YF, 2009, BIOCHEM BIOPH RES CO, V386, P6, DOI 10.1016/j.bbrc.2009.05.137; Fabian MR, 2012, NAT STRUCT MOL BIOL, V19, P586, DOI 10.1038/nsmb.2296; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Gielen H, 2012, INT J MOL SCI, V13, P15826, DOI 10.3390/ijms131215826; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kantar M, 2010, FUNCT INTEGR GENOMIC, V10, P493, DOI 10.1007/s10142-010-0181-4; Khraiwesh B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060774; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lindow M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-119; Macovei A, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-183; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Martin RC, 2010, SEED SCI RES, V20, P79, DOI 10.1017/S0960258510000085; Martinka M, 2014, PLANT CELL MONOGR, V22, P209, DOI 10.1007/978-3-642-41787-0_7; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Pantaleo V, 2010, PLANT J, V62, P960, DOI [10.1111/j.1365-313X.2010.04208.x, 10.1111/j.0960-7412.2010.04208.x]; Patra M, 2004, ENVIRON EXP BOT, V52, P199, DOI 10.1016/j.envexpbot.2004.02.009; Patra M, 2000, BOT REV, V66, P379, DOI 10.1007/BF02868923; Pelaez P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-83; Phillips JR, 2007, FEBS LETT, V581, P3592, DOI 10.1016/j.febslet.2007.04.007; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Rellan-Alvarez R, 2006, PLANT SOIL, V279, P41, DOI 10.1007/s11104-005-3900-1; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Unver T, 2009, PLANTA, V230, P659, DOI 10.1007/s00425-009-0974-7; Wang C, 2011, PHYSIOL PLANTARUM, V143, P64, DOI 10.1111/j.1399-3054.2011.01481.x; Wang TZ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-367; Xia ZH, 2011, PLANT MOL BIOL, V77, P299, DOI 10.1007/s11103-011-9811-z; Xu L, 2013, J EXP BOT, V64, P4271, DOI 10.1093/jxb/ert240; Xu W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069995; Yamasaki H, 2007, J BIOL CHEM, V282, P16369, DOI 10.1074/jbc.M700138200; Yang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072840; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yin ZJ, 2008, GENE, V414, P60, DOI 10.1016/j.gene.2008.02.007; Zeng QY, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-182; Zhou XF, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100143; Zhou ZS, 2012, PLANT CELL ENVIRON, V35, P86, DOI 10.1111/j.1365-3040.2011.02418.x; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	58	19	22	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125462	10.1371/journal.pone.0125462	http://dx.doi.org/10.1371/journal.pone.0125462			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923807	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600152
J	Hartin, SN; Hudson, ML; Yingling, C; Ackley, BD				Hartin, Samantha N.; Hudson, Martin L.; Yingling, Curtis; Ackley, Brian D.			A Synthetic Lethal Screen Identifies a Role for Lin-44/Wnt in C-elegans Embryogenesis	PLOS ONE			English	Article							VAB-1 EPH RECEPTOR; PROTEIN-TYROSINE-PHOSPHATASES; POSTERIOR NEUROBLAST MIGRATION; ASYMMETRIC CELL DIVISIONS; FIBROBLAST-GROWTH-FACTOR; CAENORHABDITIS-ELEGANS; AXON GUIDANCE; NERVOUS-SYSTEM; PTP-SIGMA; EMBRYONIC MORPHOGENESIS	Background The C. elegans proteins PTP-3/LAR-RPTP and SDN-1/Syndecan are conserved cell adhesion molecules. Loss-of-function (LOF) mutations in either ptp-3 or sdn-1 result in low penetrance embryonic developmental defects. Work from other systems has shown that syndecans can function as ligands for LAR receptors in vivo. We used double mutant analysis to test whether ptp-3 and sdn-1 function in a linear genetic pathway during C. elegans embryogenesis. Results We found animals with LOF in both sdn-1 and ptp-3 exhibited a highly penetrant synthetic lethality (SynLet), with only a small percentage of animals surviving to adulthood. Analysis of the survivors demonstrated that these animals had a synergistic increase in the penetrance of embryonic developmental defects. Together, these data strongly suggested PTP-3 and SDN-1 function in parallel during embryogenesis. We subsequently used RNAi to knockdown similar to 3,600 genes predicted to encode secreted and/or transmembrane molecules to identify genes that interacted with ptp-3 or sdn-1. We found that the Wnt ligand, lin-44, was SynLet with sdn-1, but not ptp-3. We used 4-dimensional time-lapse analysis to characterize the interaction between lin-44 and sdn-1. We found evidence that loss of lin-44 caused defects in the polarization and migration of endodermal precursors during gastrulation, a previously undescribed role for lin-44 that is strongly enhanced by the loss of sdn-1. Conclusions PTP-3 and SDN-1 function in compensatory pathways during C. elegans embryonic and larval development, as simultaneous loss of both genes has dire consequences for organismal survival. The Wnt ligand lin-44 contributes to the early stages of gastrulation in parallel to sdn-1, but in a genetic pathway with ptp-3. Overall, the SynLet phenotype provides a robust platform to identify ptp-3 and sdn-1 interacting genes, as well as other genes that function in development, yet might be missed in traditional forward genetic screens.	[Hartin, Samantha N.; Yingling, Curtis; Ackley, Brian D.] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; [Hudson, Martin L.] Kennesaw State Univ, Dept Biol & Phys, Kennesaw, GA USA	University of Kansas; University System of Georgia; Kennesaw State University	Ackley, BD (corresponding author), Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA.	bdackley@ku.edu		Hudson, Martin/0000-0002-2628-035X	National Institute of General Medical Sciences of the National Institutes of Health [P20GM103418]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103638, P20GM103418] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by a Major Starter Award (PI Brian D. Ackley) through the Kansas Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20GM103418, K-INBRE PI Dr. Douglas Wright. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackley BD, 2005, J NEUROSCI, V25, P7517, DOI 10.1523/JNEUROSCI.2010-05.2005; Alexander CM, 2000, NAT GENET, V25, P329, DOI 10.1038/77108; Aricescu AR, 2002, MOL CELL BIOL, V22, P1881, DOI 10.1128/MCB.22.6.1881-1892.2002; Baugh LR, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r45; Bernadskaya YY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002863; BRAUKER JH, 1991, DEV BIOL, V147, P285, DOI 10.1016/0012-1606(91)90286-C; BRENNER S, 1974, GENETICS, V77, P71; Carmona-Fontaine C, 2008, CELL ADHES MIGR, V2, P240, DOI 10.4161/cam.2.4.6747; Ceron J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-30; Chen LS, 2001, J CELL BIOL, V154, P841, DOI 10.1083/jcb.200009004; CHERNOUSOV MA, 1993, J BIOL CHEM, V268, P16810; Chin-Sang ID, 2002, DEVELOPMENT, V129, P5499, DOI 10.1242/dev.00122; Chin-Sang ID, 1999, CELL, V99, P781, DOI 10.1016/S0092-8674(00)81675-X; Coles CH, 2011, SCIENCE, V332, P484, DOI 10.1126/science.1200840; Coutts JC, 1995, IMMUNOL CELL BIOL, V73, P584, DOI 10.1038/icb.1995.92; Dani N, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003031; Davies AG, 1999, GENETICS, V153, P117; Dejima K, 2014, DEVELOPMENT, V141, P4354, DOI 10.1242/dev.113266; Escobedo N, 2013, DEVELOPMENT, V140, P3008, DOI 10.1242/dev.091173; Fox AN, 2005, CURR BIOL, V15, P1701, DOI 10.1016/j.cub.2005.08.035; George SE, 1998, CELL, V92, P633, DOI 10.1016/S0092-8674(00)81131-9; Ghenea S, 2005, DEVELOPMENT, V132, P3679, DOI 10.1242/dev.01947; Gleason JE, 2006, DEV BIOL, V298, P442, DOI 10.1016/j.ydbio.2006.06.050; Gonzalez-Brito MR, 2009, MOL CELL NEUROSCI, V42, P458, DOI 10.1016/j.mcn.2009.09.009; Gort EH, 2008, ONCOGENE, V27, P1501, DOI 10.1038/sj.onc.1210795; Hamamichi S, 2008, P NATL ACAD SCI USA, V105, P728, DOI 10.1073/pnas.0711018105; Harrington RJ, 2002, DEVELOPMENT, V129, P2141; HERMAN MA, 1995, CELL, V83, P101, DOI 10.1016/0092-8674(95)90238-4; Hilliard MA, 2006, DEV CELL, V10, P379, DOI 10.1016/j.devcel.2006.01.013; Hudson ML, 2006, DEV BIOL, V294, P352, DOI 10.1016/j.ydbio.2006.02.036; Johnson KG, 2003, PHYSIOL REV, V83, P1, DOI 10.1152/physrev.00016.2002; Johnson KG, 2006, NEURON, V49, P517, DOI 10.1016/j.neuron.2006.01.026; Kaksonen M, 2002, MOL CELL NEUROSCI, V21, P158, DOI 10.1006/mcne.2002.1167; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kirszenblat L, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001157; Klassen MP, 2007, CELL, V130, P704, DOI 10.1016/j.cell.2007.06.046; Kramer James M, 2005, WormBook, P1; Lee JY, 2006, CURR BIOL, V16, P1986, DOI 10.1016/j.cub.2006.08.090; Lee S, 2007, MOL CELL BIOL, V27, P1795, DOI 10.1128/MCB.00535-06; Li X, 2012, CELL DEATH DIFFER, V19, P1080, DOI 10.1038/cdd.2011.192; Linkert M, 2010, J CELL BIOL, V189, P777, DOI 10.1083/jcb.201004104; LUNDQUIST EA, 1994, GENETICS, V138, P83; Mani K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000510; McLellan J, 2009, MOL BIOL CELL, V20, P5306, DOI 10.1091/mbc.E09-08-0699; Minniti AN, 2004, J CELL SCI, V117, P5179, DOI 10.1242/jcs.01394; Mohamed AM, 2011, DEV BIOL, V354, P55, DOI 10.1016/j.ydbio.2011.03.019; Morck C, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-55; Morton DG, 2012, GENETICS, V192, P929, DOI 10.1534/genetics.112.143727; Munoz R, 2006, NAT CELL BIOL, V8, P492, DOI 10.1038/ncb1399; Nance J, 2002, DEVELOPMENT, V129, P387; O'Grady P, 1998, J CELL BIOL, V141, P1675, DOI 10.1083/jcb.141.7.1675; Park EC, 2012, EMBO J, V31, P1379, DOI 10.1038/emboj.2011.499; PULIDO R, 1995, P NATL ACAD SCI USA, V92, P11686, DOI 10.1073/pnas.92.25.11686; Rhiner C, 2005, DEVELOPMENT, V132, P4621, DOI 10.1242/dev.02042; Sajnani G, 2005, J NEUROBIOL, V65, P59, DOI 10.1002/neu.20175; SALMIVIRTA M, 1995, EXPERIENTIA, V51, P863, DOI 10.1007/BF01921737; Sawa H, 1996, GENE DEV, V10, P2189, DOI 10.1101/gad.10.17.2189; Schaapveld RQJ, 1997, DEV BIOL, V188, P134, DOI 10.1006/dbio.1997.8630; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwabiuk M, 2009, DEV BIOL, V334, P235, DOI 10.1016/j.ydbio.2009.07.020; Shao ZY, 2009, GENETICS, V183, P821, DOI 10.1534/genetics.109.107284; Shen P, 1999, BRAIN RES, V826, P157, DOI 10.1016/S0006-8993(99)01179-8; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; Sommer L, 1997, DEV DYNAM, V208, P48, DOI 10.1002/(SICI)1097-0177(199701)208:1<48::AID-AJA5>3.0.CO;2-1; Soto MC, 2002, GENE DEV, V16, P620, DOI 10.1101/gad.955702; Stoker AW, 2001, CURR OPIN NEUROBIOL, V11, P95, DOI 10.1016/S0959-4388(00)00179-3; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Sun Q, 2000, DEVELOPMENT, V127, P801; Sundararajan L, 2014, DEV BIOL, V392, P141, DOI 10.1016/j.ydbio.2014.06.009; Sundararajan L, 2012, GENETICS, V192, P1373, DOI 10.1534/genetics.112.145706; Takahashi H, 2013, TRENDS NEUROSCI, V36, P522, DOI 10.1016/j.tins.2013.06.002; Tucker M, 2008, DEV BIOL, V318, P215, DOI 10.1016/j.ydbio.2008.02.062; van Haaften G, 2004, P NATL ACAD SCI USA, V101, P12992, DOI 10.1073/pnas.0403131101; Wang F, 2012, CURR BIOL, V22, P373, DOI 10.1016/j.cub.2012.01.040; Wang ZH, 2004, SCIENCE, V304, P1164, DOI 10.1126/science.1096096; Wu MF, 2007, DEV BIOL, V303, P650, DOI 10.1016/j.ydbio.2006.12.002	77	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0121397	10.1371/journal.pone.0121397	http://dx.doi.org/10.1371/journal.pone.0121397			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938228	gold, Green Published, Green Submitted			2022-12-27	WOS:000353943000003
J	Olasz, EB; Seline, LN; Schock, AM; Duncan, NE; Lopez, A; Lazar, J; Flister, MJ; Lu, Y; Liu, PY; Sokumbi, O; Harwood, CA; Proby, CM; Neuburg, M; Lazarova, Z				Olasz, Edit B.; Seline, Lauren N.; Schock, Ashley M.; Duncan, Nathan E.; Lopez, Argelia; Lazar, Jozef; Flister, Michael J.; Lu, Yan; Liu, Pengyuan; Sokumbi, Olayemi; Harwood, Catherine A.; Proby, Charlotte M.; Neuburg, Marcy; Lazarova, Zelmira			MicroRNA-135b Regulates Leucine Zipper Tumor Suppressor 1 in Cutaneous Squamous Cell Carcinoma	PLOS ONE			English	Article							ORGAN TRANSPLANT RECIPIENTS; COLORECTAL-CANCER; FEZ1/LZTS1 GENE; DOWN-REGULATION; CHROMOSOME 8P22; EXPRESSION; SKIN; PROGRESSION; METASTASIS; INVASION	Cutaneous squamous cell carcinoma (cSCC) is the second most common skin malignancy and it presents a therapeutic challenge in organ transplant recipient patients. Despite the need, there are only a few targeted drug treatment options. Recent studies have revealed a pivotal role played by microRNAs (miRNAs) in multiple cancers, but only a few studies tested their function in cSCC. Here, we analyzed differential expression of 88 cancer related miRNAs in 43 study participants with cSCC; 32 immunocompetent, 11 OTR patients, and 15 non-lesional skin samples by microarray analysis. Of the examined miRNAs, miR-135b was the most upregulated (13.3-fold, 21.5-fold; p=0.0001) in both patient groups. Similarly, the miR-135b expression was also upregulated in three cSCC cell lines when evaluated by quantitative real-time PCR. In functional studies, inhibition of miR-135b by specific anti-miR oligonucleotides resulted in upregulation of its target gene LZTS1 mRNA and protein levels and led to decreased cell motility and invasion of both primary and metastatic cSCC cell lines. In contrast, miR-135b overexpression by synthetic miR-135b mimic induced further down-regulation of LZTS1 mRNA in vitro and increased cancer cell motility and invasiveness. Immunohistochemical evaluation of 67 cSCC tumor tissues demonstrated that miR-135b expression inversely correlated with LZTS1 staining intensity and the tumor grade. These results indicate that miR-135b functions as an oncogene in cSCC and provide new understanding into its pathological role in cSCC progression and invasiveness.	[Olasz, Edit B.; Seline, Lauren N.; Schock, Ashley M.; Duncan, Nathan E.; Lopez, Argelia; Lazar, Jozef; Sokumbi, Olayemi; Neuburg, Marcy; Lazarova, Zelmira] Med Coll Wisconsin, Dept Dermatol, Milwaukee, WI 53226 USA; [Flister, Michael J.; Lu, Yan; Liu, Pengyuan] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; [Harwood, Catherine A.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Ctr Cutaneous Res, London, England; [Proby, Charlotte M.] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Div Canc Res, Dundee DD1 9SY, Scotland	Medical College of Wisconsin; Medical College of Wisconsin; University of London; Queen Mary University London; University of Dundee	Lazarova, Z (corresponding author), Med Coll Wisconsin, Dept Dermatol, Milwaukee, WI 53226 USA.	zlazarov@mcw.edu		Harwood, Catherine/0000-0002-1375-0965; Sokumbi, Olayemi/0000-0001-8060-4311	Froedtert Hospital Foundation Skin Cancer Center grant; Medical College of Wisconsin, Milwaukee; Cancer Research UK [13044] Funding Source: researchfish	Froedtert Hospital Foundation Skin Cancer Center grant; Medical College of Wisconsin, Milwaukee; Cancer Research UK(Cancer Research UK)	This work was funded by Froedtert Hospital Foundation Skin Cancer Center grant (ZL and EO) through the generosity of the Szymanczyk Family, and Medical College of Wisconsin, Milwaukee.	Anglicheau D, 2010, TRANSPLANTATION, V90, P105, DOI 10.1097/TP.0b013e3181e913c2; Arigoni M, 2013, AM J PATHOL, V182, P2058, DOI 10.1016/j.ajpath.2013.02.046; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bruegger C, 2013, EXP DERMATOL, V22, P426, DOI 10.1111/exd.12153; Cabeza-Arvelaiz Y, 2001, ONCOGENE, V20, P4169, DOI 10.1038/sj.onc.1204539; Cooper JZ, 2006, ARCH DERMATOL, V142, P755, DOI 10.1001/archderm.142.6.755; EDINGTON KG, 1995, MOL CARCINOGEN, V13, P254, DOI 10.1002/mc.2940130408; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gastaldi C, 2014, CARCINOGENESIS; Hameetman L, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-58; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Housman TS, 2003, J AM ACAD DERMATOL, V48, P425, DOI 10.1067/mjd.2003.186; Ishii H, 1999, P NATL ACAD SCI USA, V96, P3928, DOI 10.1073/pnas.96.7.3928; Ishii H, 2001, P NATL ACAD SCI USA, V98, P10374, DOI 10.1073/pnas.181222898; Jourdan MM, 2011, RADIAT RES, V176, P636, DOI 10.1667/RR2422.1; Khatri R, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00268; Lin CW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2876; Liu Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102621; Nagel R, 2008, CANCER RES, V68, P5795, DOI 10.1158/0008-5472.CAN-08-0951; Ono K, 2003, INT J ONCOL, V23, P297; Petracco R, 2011, J CLIN ENDOCR METAB, V96, pE1925, DOI 10.1210/jc.2011-1231; Popp S, 2000, J INVEST DERMATOL, V115, P1095, DOI 10.1046/j.1523-1747.2000.00173.x; Proby CM, 2000, EXP DERMATOL, V9, P104, DOI 10.1034/j.1600-0625.2000.009002104.x; Rajabi H, 2012, PROSTATE, V72, P1659, DOI 10.1002/pros.22519; Ratushny V, 2012, J CLIN INVEST, V122, P464, DOI 10.1172/JCI57415; Sanchez-Diaz PC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061622; Sand M, 2012, J DERMATOL SCI, V68, P119, DOI 10.1016/j.jdermsci.2012.09.004; Sarma NJ, 2012, EXP MOL PATHOL, V93, P378, DOI 10.1016/j.yexmp.2012.09.020; Toyooka S, 2002, CLIN CANCER RES, V8, P2292; Vecchione A, 2002, AM J PATHOL, V160, P1345, DOI 10.1016/S0002-9440(10)62561-8; Vecchione A, 2001, CLIN CANCER RES, V7, P1546; Vecchione A, 2007, CANCER CELL, V11, P275, DOI 10.1016/j.ccr.2007.01.014; Vecchione Andrea, 2004, BMC Urol, V4, P11, DOI 10.1186/1471-2490-4-11; Vecchione A, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-24; Wang XX, 2011, HUM PATHOL, V42, P1410, DOI 10.1016/j.humpath.2010.12.007; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Wells JL, 2012, AM J CLIN ONCOL-CANC, V35, P498, DOI 10.1097/COC.0b013e318201a3ef; Wilson RC, 2013, ANNU REV BIOPHYS, V42, P217, DOI 10.1146/annurev-biophys-083012-130404; Wu WY, 2014, MOL CELL BIOCHEM, V388, P249, DOI 10.1007/s11010-013-1916-z; Xu N, 2012, J BIOL CHEM, V287, P29899, DOI 10.1074/jbc.M112.391243; Yamane K, 2013, J MOL MED, V91, P69, DOI 10.1007/s00109-012-0935-7; Zhang L, 2013, CANCER LETT, V331, P230, DOI 10.1016/j.canlet.2013.01.003	43	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125412	10.1371/journal.pone.0125412	http://dx.doi.org/10.1371/journal.pone.0125412			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938461	Green Published, Green Submitted, gold			2022-12-27	WOS:000353943000066
J	Zahl, PH; Maehlen, J				Zahl, Per-Henrik; Maehlen, Jan			Bias in Observational Studies of the Association between Menopausal Hormone Therapy and Breast Cancer	PLOS ONE			English	Article							ESTROGEN PLUS PROGESTIN; POSTMENOPAUSAL WOMEN; SCREENING MAMMOGRAPHY; REPLACEMENT THERAPY; NORWAY; SWEDEN; COHORT	Background During the period 1985-2000 the breast cancer incidence rates increased 50% in the age group invited to mammography screening in Norway and Sweden. Simultaneously, use of hormone replacement treatment therapy (HT) increased 5 times. Several influential observational studies showed that HT was associated with 50% to 100% increased risk of breast cancer and most for those using combined (estrogen plus progestin) hormone replacement therapy (CHT). In contrast, the randomized WHI trial reported that CHT increased the risk by 10% for those not having previously used hormones and 24% when including previous users in the analyses. In another randomized trial, estrogen use only was not associated with any increased risk at all. After the WHI trial was published in 2003, use of HT dropped 70% within 5 years in Norway and Sweden while breast cancer rates were essentially unchanged. After 2008, HT use has dropped further and breast cancer incidence rates have started increasing again. The study objective is to calculate and to explain potential bias in the observational study design. Methods and Findings Here we use data from the randomized WHI trial and analyze these data as done in the observational studies to calculate the magnitude of the potential biases in the observational study design. Time varying effect of hormones and categorization of the follow-up time may increase the hazard ratio for long-term users from 1.10 to 1.48. Selective retrospective reporting of hormone use may further increase the hazard ratio to 1.68. Conclusions We suggest that the mechanism causing higher hazard ratio of breast cancer (compared to the observational studies) is the time-varying effect of CHT on the breast cancer risk and selective retrospective reporting of hormone use. Other risk factors for the increase in breast cancer risk in the age group 50-69 years should be considered, for example, overdiagnosis.	[Zahl, Per-Henrik] Norwegian Inst Publ Hlth, Oslo, Norway; [Maehlen, Jan] Ullevaal Univ Hosp, Oslo, Norway	Norwegian Institute of Public Health (NIPH); University of Oslo	Zahl, PH (corresponding author), Norwegian Inst Publ Hlth, Oslo, Norway.	per-henrik.zahl@fhi.no						Bakken L, 2004, INT J CANCER, V112, P130, DOI 10.1002/ijc.20389; Banks E, 2004, BMJ-BRIT MED J, V329, P477, DOI 10.1136/bmj.329.7464.477; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Breen N, 2007, CANCER-AM CANCER SOC, V109, P2405, DOI 10.1002/cncr.22723; Cancer Registry of Norway, 2014, CANC NORW 2012; Chlebowski RT, 2009, NEW ENGL J MED, V360, P573, DOI 10.1056/NEJMoa0807684; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; Glass AG, 2007, JNCI-J NATL CANCER I, V99, P1152, DOI 10.1093/jnci/djm059; Hofvind S, 2006, INT J CANCER, V118, P3112, DOI 10.1002/ijc.21742; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Kerlikowske K, 2007, JNCI-J NATL CANCER I, V99, P1335, DOI 10.1093/jnci/djm111; National Board of Health and Welfare (Socialstyrelsen), 2013, CANC SWED 2011; Parkin DM, 2009, EUR J CANCER, V45, P1649, DOI 10.1016/j.ejca.2009.01.016; Prentice RL, 2008, AM J EPIDEMIOL, V167, P1207, DOI 10.1093/aje/kwn044; Ravdin PM, 2007, NEW ENGL J MED, V356, P1670, DOI 10.1056/NEJMsr070105; Rothmann KJ, 2008, MODERN EPIDEMIOLOGY; Stefanick ML, 2006, JAMA-J AM MED ASSOC, V295, P1647, DOI 10.1001/jama.295.14.1647; Suhrke P, 2012, BREAST J, V18, P549, DOI 10.1111/tbj.12001; Zahl Per-Henrik, 2012, Tidsskr Nor Laegeforen, V132, P414, DOI 10.4045/tidsskr.11.0195; Zahl PH, 2004, BMJ-BRIT MED J, V328, P921, DOI 10.1136/bmj.38044.666157.63	21	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0124076	10.1371/journal.pone.0124076	http://dx.doi.org/10.1371/journal.pone.0124076			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938446	gold, Green Submitted, Green Published			2022-12-27	WOS:000353943000016
J	Berent-Maoz, B; Montecino-Rodriguez, E; Fice, M; Casero, D; Seet, CS; Crooks, GM; Lowry, W; Dorshkind, K				Berent-Maoz, Beata; Montecino-Rodriguez, Encarnacion; Fice, Michael; Casero, David; Seet, Christopher S.; Crooks, Gay M.; Lowry, William; Dorshkind, Kenneth			The Expansion of Thymopoiesis in Neonatal Mice Is Dependent on Expression of High Mobility Group A 2 Protein (Hmga2)	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; FETAL; PROGENITORS; AXIS	Cell number in the mouse thymus increases steadily during the first two weeks after birth. It then plateaus and begins to decline by seven weeks after birth. The factors governing these dramatic changes in cell production are not well understood. The data herein correlate levels of High mobility group A 2 protein (Hmga2) expression with these temporal changes in thymopoiesis. Hmga2 is expressed at high levels in murine fetal and neonatal early T cell progenitors (ETP), which are the most immature intrathymic precursors, and becomes almost undetectable in these progenitors after 5 weeks of age. Hmga2 expression is critical for the initial, exponential expansion of thymopoiesis, as Hmga2 deficient mice have a deficit of ETPs within days after birth, and total thymocyte number is repressed compared to wild type littermates. Finally, our data raise the possibility that similar events occur in humans, because Hmga2 expression is high in human fetal thymic progenitors and falls in these cells during early infancy.	[Berent-Maoz, Beata; Montecino-Rodriguez, Encarnacion; Fice, Michael; Casero, David; Crooks, Gay M.; Dorshkind, Kenneth] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Berent-Maoz, Beata; Seet, Christopher S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; [Crooks, Gay M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Lowry, William] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Dorshkind, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.	kdorshki@mednet.ucla.edu	Casero, David/E-7365-2010	Casero, David/0000-0002-7347-3330; Seet, Christopher/0000-0002-4821-1400; Montecino Rodriguez, Encarnacion/0000-0002-2826-7503; Fice, Michael/0000-0002-6406-1211	National Institutes of Health [AG034875, P01 HL073104]; California Institute for Regenerative Medicine [RM1-01707]; Jonsson Comprehensive Cancer Center (NIH) [CA16042, AI28697]; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL073104, T32HL066992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034875] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Jonsson Comprehensive Cancer Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grant AG034875 from the National Institutes of Health (KD), P01 HL073104 from the National Institutes of Health (GMC), and RM1-01707 from the California Institute for Regenerative Medicine (GMC). Flow cytometry was performed in the cores operated by the Broad Stem Cell Research Center and the Jonsson Comprehensive Cancer Center (supported by NIH grants CA16042 and AI28697).	Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Berent-Maoz B, 2012, BLOOD, V119, P5715, DOI 10.1182/blood-2011-12-400002; Blom B, 2006, ANNU REV IMMUNOL, V24, P287, DOI 10.1146/annurev.immunol.24.021605.090612; Bowie MB, 2007, P NATL ACAD SCI USA, V104, P5878, DOI 10.1073/pnas.0700460104; Bowie MB, 2006, J CLIN INVEST, V116, P2808, DOI 10.1172/JCI28310; Copley MR, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.98; Copley MR, 2013, NAT CELL BIOL, V15, P916, DOI 10.1038/ncb2783; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Min H, 2004, J IMMUNOL, V173, P245, DOI 10.4049/jimmunol.173.1.245; MontecinoRodriguez E, 1997, J IMMUNOL, V159, P2712; PENIT C, 1989, J IMMUNOL, V142, P3369; Semposski GD, 2002, MOL IMMUNOL, V38, P841, DOI 10.1016/S0161-5890(01)00122-5; STEINMANN GG, 1985, SCAND J IMMUNOL, V22, P563, DOI 10.1111/j.1365-3083.1985.tb01916.x; Taub DD, 2005, IMMUNOL REV, V205, P72, DOI 10.1111/j.0105-2896.2005.00275.x; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Xiao SY, 2003, CELL RES, V13, P265, DOI 10.1038/sj.cr.7290171; Yuan J, 2012, SCIENCE, V335, P1195, DOI 10.1126/science.1216557; ZHOU XJ, 1995, NATURE, V376, P771, DOI 10.1038/376771a0	21	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125414	10.1371/journal.pone.0125414	http://dx.doi.org/10.1371/journal.pone.0125414			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933067	Green Published, gold, Green Submitted			2022-12-27	WOS:000353887100109
J	Bhandary, YP; Shetty, SK; Marudamuthu, AS; Midde, KK; Ji, HL; Shams, H; Subramaniam, R; Fu, J; Idell, S; Shetty, S				Bhandary, Yashodhar P.; Shetty, Shwetha K.; Marudamuthu, Amarnath S.; Midde, Krishna K.; Ji, Hong-Long; Shams, Homoyoun; Subramaniam, Renuka; Fu, Jian; Idell, Steven; Shetty, Sreerama			Plasminogen Activator Inhibitor-1 in Cigarette Smoke Exposure and Influenza A Virus Infection-Induced Lung Injury	PLOS ONE			English	Article							EPITHELIAL-CELL APOPTOSIS; MYELOPEROXIDASE ACTIVITY; FIBRINOLYTIC SYSTEM; PULMONARY-FIBROSIS; UP-REGULATION; PROTEIN P53; II CELLS; MICE; EXPRESSION; UROKINASE	Parenchymal lung inflammation and airway and alveolar epithelial cell apoptosis are associated with cigarette smoke exposure (CSE), which contributes to chronic obstructive pulmonary disease (COPD). Epidemiological studies indicate that people exposed to chronic cigarette smoke with or without COPD are more susceptible to influenza A virus (IAV) infection. We found increased p53, PAI-1 and apoptosis in AECs, with accumulation of macrophages and neutrophils in the lungs of patients with COPD. In Wild-type (WT) mice with passive CSE (PCSE), p53 and PAI-1 expression and apoptosis were increased in AECs as was lung inflammation, while those lacking p53 or PAI-1 resisted AEC apoptosis and lung inflammation. Further, inhibition of p53-mediated induction of PAI-1 by treatment of WT mice with caveolin-1 scaffolding domain peptide (CSP) reduced PCSE-induced lung inflammation and reversed PCSE-induced suppression of eosinophil-associated RNase1 (EAR1). Competitive inhibition of the p53-PAI-1 mRNA interaction by expressing p53-binding 3'UTR sequences of PAI-1 mRNA likewise suppressed CS-induced PAI-1 and AEC apoptosis and restored EAR1 expression. Consistent with PCSE-induced lung injury, IAV infection increased p53, PAI-1 and apoptosis in AECs in association with pulmonary inflammation. Lung inflammation induced by PCSE was worsened by subsequent exposure to IAV. Mice lacking PAI-1 that were exposed to IAV showed minimal viral burden based on M2 antigen and hemagglutination analyses, whereas transgenic mice that overexpress PAI-1 without PCSE showed increased M2 antigen and inflammation after IAV infection. These observations indicate that increased PAI-1 expression promotes AEC apoptosis and exacerbates lung inflammation induced by IAV following PCSE.	[Bhandary, Yashodhar P.; Shetty, Shwetha K.; Marudamuthu, Amarnath S.; Midde, Krishna K.; Ji, Hong-Long; Shams, Homoyoun; Subramaniam, Renuka; Idell, Steven; Shetty, Sreerama] Univ Texas Tyler, Hlth Sci Ctr, Texas Lung Injury Inst, Dept Med, Tyler, TX 75799 USA; [Fu, Jian] Univ Kentucky, Coll Med, Ctr Res Environm Dis & Toxicol, Lexington, KY USA	University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT); University of Kentucky	Shetty, S (corresponding author), Univ Texas Tyler, Hlth Sci Ctr, Texas Lung Injury Inst, Dept Med, Tyler, TX 75799 USA.	sreerama.shetty@uthct.edu	Bhandary, Yashodhar P/J-9078-2017; Midde, Krishna/AAM-2438-2020	Shetty, Shwetha Kumari/0000-0003-1762-8040	Flight Attendant Medical Research Institute Clinical Innovator Award [FAMRI-ID-123010]; American Heart Association [GRNT19020001]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R03HL095435, R01HL087017] Funding Source: NIH RePORTER	Flight Attendant Medical Research Institute Clinical Innovator Award; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported in part by a Flight Attendant Medical Research Institute Clinical Innovator Award (FAMRI-ID-123010) and an American Heart Association grant (GRNT19020001) to SS.	Abboud RT, 2008, INT J TUBERC LUNG D, V12, P361; Arcavi L, 2004, ARCH INTERN MED, V164, P2206, DOI 10.1001/archinte.164.20.2206; Balsara RD, 2008, THROMB HAEMOSTASIS, V100, P1029, DOI 10.1160/TH08-07-0427; Bhandary YP, 2013, AM J PATHOL, V183, P131, DOI 10.1016/j.ajpath.2013.03.022; Bhandary YP, 2012, AM J PHYSIOL-LUNG C, V302, pL463, DOI 10.1152/ajplung.00099.2011; CARP H, 1978, AM REV RESPIR DIS, V118, P617; Cho S, 2005, GENOMICS, V85, P208, DOI 10.1016/j.ygeno.2004.10.008; Cho SH, 2004, EXP BIOL MED, V229, P138, DOI 10.1177/153537020422900202; Cho SH, 2000, J IMMUNOL, V165, P3154, DOI 10.4049/jimmunol.165.6.3154; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; Dibbert B, 1999, P NATL ACAD SCI USA, V96, P13330, DOI 10.1073/pnas.96.23.13330; DOBBS LG, 1990, AM J PHYSIOL, V258, pL134, DOI 10.1152/ajplung.1990.258.4.L134; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Eitzman DT, 1996, J CLIN INVEST, V97, P232, DOI 10.1172/JCI118396; Feng Y, 2011, INFECT IMMUN, V79, P229, DOI 10.1128/IAI.00709-10; Foronjy RF, 2005, EXP LUNG RES, V31, P547, DOI 10.1080/019021490951522; Fujihara M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003119; Gelbman BD, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-10; Gualano RC, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-53; Heffner JE, 2010, CHEST, V137, P1181, DOI 10.1378/chest.09-2306; Hoshino Y, 2001, AM J PHYSIOL-LUNG C, V281, pL509, DOI 10.1152/ajplung.2001.281.2.L509; Huang FF, 2011, AM J RESP CRIT CARE, V184, P259, DOI 10.1164/rccm.201012-2036OC; Hurd S, 2000, CHEST, V117, P1; Idell S, 2003, CRIT CARE MED, V31, pS213, DOI 10.1097/01.CCM.0000057846.21303.AB; JINOT J, 1994, J CLIN EPIDEMIOL, V47, P339, DOI 10.1016/0895-4356(94)90154-6; JUHANVAGUE I, 1984, THROMB RES, V33, P523, DOI 10.1016/0049-3848(84)90018-5; Kosmider B, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-43; Kotani N, 2001, ANESTHESIOLOGY, V94, P999, DOI 10.1097/00000542-200106000-00013; KRUITHOF EKO, 1988, THROMB HAEMOSTASIS, V59, P7; Kucharewicz I, 2003, THROMB RES, V112, P1, DOI 10.1016/j.thromres.2003.10.011; Maestrelli P, AM J RESPIR CRIT CAR, V64, pS76; Marudamuthu AS, 2015, AM J PATHOL, V185, P55, DOI 10.1016/j.ajpath.2014.08.027; Masha AE, 2010, THE J OF INF DIS, V201, P794; Morrow SAM, 2011, AM J RESP CELL MOL B, V45, P610, DOI [10.1165/rcmb.2010-0259OC, DOI 10.1165/RCMB.2010-0259OC]; O'Reilly MA, 2012, AM J PATHOL, V181, P441, DOI 10.1016/j.ajpath.2012.05.005; Park YJ, 2008, P NATL ACAD SCI USA, V105, P11784, DOI 10.1073/pnas.0801394105; Pletz MWR, 2004, EUR RESPIR J, V23, P532, DOI 10.1183/09031936.04.00089004; Rana SN, 2005, J LEUKOCYTE BIOL, V77, P719, DOI 10.1189/jlb.0704396; Rangasamy T, 2009, AM J PHYSIOL-LUNG C, V296, pL888, DOI 10.1152/ajplung.90369.2008; Robbins CS, 2006, AM J RESP CRIT CARE, V174, P1342, DOI 10.1164/rccm.200604-561OC; Rosenberg HF, 2008, J LEUKOCYTE BIOL, V83, P1079, DOI 10.1189/jlb.1107725; Shetty SK, 2012, AM J RESP CELL MOL, V47, P474, DOI 10.1165/rcmb.2011-0390OC; Shetty S, 2010, AM J RESP CRIT CARE, V181, P1355, DOI 10.1164/rccm.200901-0015OC; Shetty S, 2008, J BIOL CHEM, V283, P19570, DOI 10.1074/jbc.M710268200; Simet SM, 2010, AM J RESP CELL MOL, V43, P635, DOI 10.1165/rcmb.2009-0297OC; Simpson AJ, 1997, BRIT J HAEMATOL, V97, P208, DOI 10.1046/j.1365-2141.1997.d01-2137.x; Sisson TH, 2007, CURR DRUG TARGETS, V8, P1016, DOI 10.2174/138945007781662319; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803; Technau-Ihling K, 2001, ARCH VIROL, V146, P1655, DOI 10.1007/s007050170054; Turpin E, 2005, J VIROL, V79, P8802, DOI 10.1128/JVI.79.14.8802-8811.2005; VASSALLI JD, 1991, J CLIN INVEST, V88, P1067, DOI 10.1172/JCI115405; Wu WX, 2010, VIROLOGY, V396, P178, DOI 10.1016/j.virol.2009.10.016; Yu HP, 2006, AM J PHYSIOL-LUNG C, V291, pL400, DOI 10.1152/ajplung.00537.2005; Zidovetzki R, 1999, STROKE, V30, P651, DOI 10.1161/01.STR.30.3.651	54	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0123187	10.1371/journal.pone.0123187	http://dx.doi.org/10.1371/journal.pone.0123187			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932922	Green Submitted, Green Published, gold			2022-12-27	WOS:000353887100016
J	El-Arab, KK; Pudasaini, A; Zoltowski, BD				El-Arab, Kaley K.; Pudasaini, Ashutosh; Zoltowski, Brian D.			Short LOV Proteins in Methylocystis Reveal Insight into LOV Domain Photocycle Mechanisms	PLOS ONE			English	Article							HYPOCREA-JECORINA; SIGNAL-TRANSDUCTION; INTEGRATING LIGHT; PHOTORECEPTOR; PHOTOTROPIN; OXYGEN; ENVOY; DIMERIZATION; NEUROSPORA; RESPONSES	Light Oxygen Voltage (LOV) proteins are widely used in optogenetic devices, however universal signal transduction pathways and photocycle mechanisms remain elusive. In particular, short-LOV (sLOV) proteins have been discovered in bacteria and fungi, containing only the photoresponsive LOV element without any obvious signal transduction domains. These sLOV proteins may be ideal models for LOV domain function due to their ease of study as full-length proteins. Unfortunately, characterization of such proteins remains limited to select systems. Herein, we identify a family of bacterial sLOV proteins present in Methylocystis. Sequence analysis of Methylocystis LOV proteins (McLOV) demonstrates conservation with sLOV proteins from fungal systems that employ competitive dimerization as a signaling mechanism. Cloning and characterization of McLOV proteins confirms functional dimer formation and reveal unexpected photocycle mechanisms. Specifically, some McLOV photocycles are insensitive to external bases such as imidazole, in contrast to previously characterized LOV proteins. Mutational analysis identifies a key residue that imparts insensitivity to imidazole in two McLOV homologs and affects adduct decay by two orders of magnitude. The resultant data identifies a new family of LOV proteins that indicate a universal photocycle mechanism may not be present in LOV proteins.	[El-Arab, Kaley K.; Pudasaini, Ashutosh; Zoltowski, Brian D.] So Methodist Univ, Dept Chem, Ctr Drug Discovery Design & Delivery, Dallas, TX 75275 USA	Southern Methodist University	Zoltowski, BD (corresponding author), So Methodist Univ, Dept Chem, Ctr Drug Discovery Design & Delivery, Dallas, TX 75275 USA.	bzoltowski@smu.edu		Pudasaini, Ashutosh/0000-0002-3566-1314	Herman Frasch Foundation [739-HF12]	Herman Frasch Foundation	This work was supported by a grant from Herman Frasch Foundation, 739-HF12 to BDZ. http://www.acs.org/content/acs/en/funding-and-awards/grants/frasch.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre MTA, 2007, BIOCHEMISTRY-US, V46, P3129, DOI 10.1021/bi062074e; Ballario P, 1996, EMBO J, V15, P1650, DOI 10.1002/j.1460-2075.1996.tb00510.x; Buttani V, 2007, PHOTOCHEM PHOTOBIOL, V6; Cao Z, 2008, BIOPHYS J, V94, P897, DOI 10.1529/biophysj.107.108977; Chan RH, 2013, PHOTOCHEM PHOTOBIOL, V89, P361, DOI 10.1111/php.12004; Chan RH, 2012, J PHYS CHEM B, V116, P10609, DOI 10.1021/jp304934t; Chen CH, 2010, P NATL ACAD SCI USA, V107, P16715, DOI 10.1073/pnas.1011190107; Christie JM, 2007, BIOCHEMISTRY-US, V46, P9310, DOI 10.1021/bi700852w; Corchnoy SB, 2003, J BIOL CHEM, V278, P724, DOI 10.1074/jbc.M209119200; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; Crosson S, 2003, BIOCHEMISTRY-US, V42, P2, DOI 10.1021/bi026978l; Domratcheva T, 2006, J CHEM THEORY COMPUT, V2, P1565, DOI 10.1021/ct0600114; Gin E, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.24; Halavaty AS, 2007, BIOCHEMISTRY-US, V46, P14001, DOI 10.1021/bi701543e; Hendrischk AK, 2009, PHOTOCHEM PHOTOBIOL, V85, P1254, DOI 10.1111/j.1751-1097.2009.00554.x; Jentzsch K, 2009, BIOCHEMISTRY-US, V48, P10321, DOI 10.1021/bi901115z; Kennis JTM, 2003, BIOCHEMISTRY-US, V42, P3385, DOI 10.1021/bi034022k; Kennis JTM, 2004, J AM CHEM SOC, V126, P4512, DOI 10.1021/ja031840r; Kraiselburd I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080930; Krauss U, 2005, PHYS CHEM CHEM PHYS, V7, P2804, DOI 10.1039/b504554a; Lamb JS, 2008, J AM CHEM SOC, V130, P12226, DOI 10.1021/ja804236f; Lamb JS, 2009, J MOL BIOL, V393, P909, DOI 10.1016/j.jmb.2009.08.045; Lokhandwala J, 2015, STRUCTURE, V23, P116, DOI 10.1016/j.str.2014.10.020; Loros JJ, 2001, ANNU REV PHYSIOL, V63, P757, DOI 10.1146/annurev.physiol.63.1.757; Moglich A, 2010, J MOL BIOL, V400, P477, DOI 10.1016/j.jmb.2010.05.019; Pudasaini A, 2013, BIOCHEMISTRY-US, V52, P7150, DOI 10.1021/bi401027n; Purcell EB, 2010, BIOCHEMISTRY-US, V49, P6761, DOI 10.1021/bi1006404; Raffelberg S, 2011, J AM CHEM SOC, V133, P5346, DOI 10.1021/ja1097379; Rambow-Larsen AA, 2009, TRENDS MICROBIOL, V17, P371, DOI 10.1016/j.tim.2009.05.006; Rani R, 2013, BIOCHEMISTRY-US, V52, P4460, DOI 10.1021/bi400311r; Schmoll M, 2005, EUKARYOT CELL, V4, P1998, DOI 10.1128/EC.4.12.1998-2007.2005; Schuster A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-449; Schwerdtfeger C, 2003, EMBO J, V22, P4846, DOI 10.1093/emboj/cdg451; Seibel C, 2012, EUKARYOT CELL, V11, P885, DOI 10.1128/EC.05321-11; Zoltowski BD, 2008, BIOCHEMISTRY-US, V47, P7012, DOI 10.1021/bi8007017; Zoltowski BD, 2007, SCIENCE, V316, P1054, DOI 10.1126/science.1137128; Zoltowski BD, 2013, BIOCHEMISTRY-US, V52, P6653, DOI 10.1021/bi401040m; Zoltowski BD, 2011, BIOCHEMISTRY-US, V50, P8771, DOI 10.1021/bi200976a; Zoltowski BD, 2011, BIOCHEMISTRY-US, V50, P4, DOI 10.1021/bi101665s; Zoltowski BD, 2009, NAT CHEM BIOL, V5, P827, DOI 10.1038/nchembio.210	40	11	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124874	10.1371/journal.pone.0124874	http://dx.doi.org/10.1371/journal.pone.0124874			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933162	Green Submitted, Green Published, gold			2022-12-27	WOS:000353887100061
J	Huang, WY; Dai, SP; Chang, YC; Sun, WH				Huang, Wei-Yu; Dai, Shih-Ping; Chang, Yan-Ching; Sun, Wei-Hsin			Acidosis Mediates the Switching of G(s)-PKA and G(i)-PKC epsilon Dependence in Prolonged Hyperalgesia Induced by Inflammation	PLOS ONE			English	Article							EXPERIMENTAL TISSUE ACIDOSIS; KINASE-C-EPSILON; EXTRACELLULAR ACIDIFICATION; MECHANICAL HYPERALGESIA; MOLECULAR-MECHANISMS; CYTOKINE PRODUCTION; SENSORY NEURONS; PKC-EPSILON; RAT SKIN; PROTEIN	Chronic inflammatory pain, when not effectively treated, is a costly health problem and has a harmful effect on all aspects of health-related quality of life. Previous studies suggested that in male Sprague Dawley rats, prostaglandin E-2 (PGE(2))-induced short-term hyperalgesia depends on protein kinase A (PKA) activity, whereas long-lasting hyperalgesia induced by PGE(2) with carrageenan pre-injection, requires protein kinase C-epsilon (PKC epsilon). However, the mechanism underlying the kinase switch with short-to long-term hyperalgesia remains unclear. In this study, we used the inflammatory agents carrageenan or complete Freund's adjuvant (CFA) to induce long-term hyperalgesia, and examined PKA and PKC epsilon dependence and switching time. Hyperalgesia induced by both agents depended on PKA/PKC epsilon and G(s)/Gi-proteins, and the switching time from PKA to PKC epsilon and from G(s) to G(i) was about 3 to 4 h after inflammation induction. Among the single inflammatory mediators tested, PGE(2) and 5-HT induced transient hyperalgesia, which depended on PKA and PKC epsilon, respectively. Only acidic solution-induced hyperalgesia required G(s)-PKA and G(i)-PKC epsilon, and the switch time for kinase dependency matched inflammatory hyperalgesia, in approximately 2 to 4 h. Thus, acidosis in inflamed tissues may be a decisive factor to regulate switching of PKA and PKC epsilon dependence via proton-sensing G-protein-coupled receptors.	[Huang, Wei-Yu; Dai, Shih-Ping; Chang, Yan-Ching; Sun, Wei-Hsin] Natl Cent Univ, Dept Life Sci, Jhongli, Taiwan; [Sun, Wei-Hsin] Natl Cent Univ, Inst Syst Biol & Bioinformat, Jhongli, Taiwan	National Central University; National Central University	Sun, WH (corresponding author), Natl Cent Univ, Dept Life Sci, Jhongli, Taiwan.	weihsin@cc.ncu.edu.tw	Sun, Wei-Hsin/AFR-0191-2022	Sun, Wei-Hsin/0000-0003-3009-520X	Ministry of Science and Technology, Taiwan [NSC 101-2321-B-008-001, NSC 102-2321-B-008-001]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Ministry of Science and Technology, Taiwan (grant no. NSC 101-2321-B-008-001 and NSC 102-2321-B-008-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aley KO, 1999, J NEUROSCI, V19, P2181; Aley KO, 2000, J NEUROSCI, V20, P4680, DOI 10.1523/JNEUROSCI.20-12-04680.2000; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; BECK PW, 1974, PFLUG ARCH EUR J PHY, V347, P209, DOI 10.1007/BF00592598; Belkouch M, 2011, J NEUROSCI, V31, P18381, DOI 10.1523/JNEUROSCI.3386-11.2011; Bolick DT, 2007, CIRC RES, V100, P572, DOI 10.1161/01.RES.0000258877.57836.d2; Chen WH, 2014, J CO2 UTIL, V5, P1, DOI 10.1016/j.jcou.2013.11.001; Chen YJ, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-39; Cui M, 2006, J NEUROSCI, V26, P9385, DOI 10.1523/JNEUROSCI.1246-06.2006; Decaris E, 1999, ARTHRITIS RHEUM-US, V42, P1951, DOI 10.1002/1529-0131(199909)42:9<1951::AID-ANR22>3.3.CO;2-4; Di Castro A, 2006, P NATL ACAD SCI USA, V103, P4699, DOI 10.1073/pnas.0508005103; Dina OA, 2009, NEUROSCIENCE, V160, P501, DOI 10.1016/j.neuroscience.2009.03.001; Fitzgerald EM, 1999, J PHYSIOL-LONDON, V516, P433, DOI 10.1111/j.1469-7793.1999.0433v.x; Frasch SC, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.181800; Gao YJ, 2010, PAIN, V148, P309, DOI 10.1016/j.pain.2009.11.017; Gavva NR, 2005, J PHARMACOL EXP THER, V313, P474, DOI 10.1124/jpet.104.079855; Hang LH, 2012, EUR J NEUROSCI, V36, P2107, DOI 10.1111/j.1460-9568.2012.08087.x; Honore P, 2005, J PHARMACOL EXP THER, V314, P410, DOI 10.1124/jpet.105.083915; Huang CW, 2007, MOL CELL NEUROSCI, V36, P195, DOI 10.1016/j.mcn.2007.06.010; Hucho TB, 2005, J NEUROSCI, V25, P6119, DOI 10.1523/JNEUROSCI.0285-05.2005; Ishii S, 2005, J BIOL CHEM, V280, P9083, DOI 10.1074/jbc.M407832200; Jin Y, 2014, J NEUROCHEM, V129, P683, DOI 10.1111/jnc.12661; Joseph EK, 2007, PAIN, V132, P67, DOI 10.1016/j.pain.2007.01.027; Joseph EK, 2010, PAIN, V150, P17, DOI 10.1016/j.pain.2010.02.011; Joseph EK, 2010, J NEUROSCI, V30, P4660, DOI 10.1523/JNEUROSCI.5530-09.2010; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; KESSLER W, 1992, EXP BRAIN RES, V91, P467; Khasar SG, 2008, J NEUROSCI, V28, P5721, DOI 10.1523/JNEUROSCI.0256-08.2008; Khasar SG, 1999, NEURON, V24, P253, DOI 10.1016/S0896-6273(00)80837-5; Khasar SG, 1999, J NEUROPHYSIOL, V81, P1104, DOI 10.1152/jn.1999.81.3.1104; Kim YH, 2012, NEURON, V74, P640, DOI 10.1016/j.neuron.2012.02.039; Kress M, 1997, NEUROSCI LETT, V224, P37, DOI 10.1016/S0304-3940(97)13450-4; Lin CR, 2006, J PHARMACOL EXP THER, V319, P1096, DOI 10.1124/jpet.106.105569; Lin SY, 2011, J NEUROSCI, V31, P1410, DOI 10.1523/JNEUROSCI.4682-10.2011; Mogi C, 2009, J IMMUNOL, V182, P3243, DOI 10.4049/jimmunol.0803466; Nagakura Y, 2003, J PHARMACOL EXP THER, V306, P490, DOI 10.1124/jpet.103.050781; Onozawa Y, 2012, EUR J PHARMACOL, V683, P325, DOI 10.1016/j.ejphar.2012.03.007; Parada CA, 2005, PAIN, V113, P185, DOI 10.1016/j.pain.2004.10.021; Parada CA, 2003, NEUROSCIENCE, V120, P219, DOI 10.1016/S0306-4522(03)00267-7; Peter C, 2008, J BIOL CHEM, V283, P5296, DOI 10.1074/jbc.M706586200; Reeh PW, 1996, PROG BRAIN RES, V113, P143, DOI 10.1016/S0079-6123(08)61085-7; SCHAIBLE HG, 1988, J PHYSIOL-LONDON, V403, P91, DOI 10.1113/jphysiol.1988.sp017240; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; STEEN KH, 1993, NEUROSCI LETT, V154, P113, DOI 10.1016/0304-3940(93)90184-M; Steen KH, 1996, PAIN, V66, P163, DOI 10.1016/0304-3959(96)03034-5; STEEN KH, 1995, PAIN, V62, P339, DOI 10.1016/0304-3959(95)00011-G; STEEN KH, 1995, NEUROSCI LETT, V199, P29, DOI 10.1016/0304-3940(95)12002-L; STEEN KH, 1992, J NEUROSCI, V12, P86; STEEN KH, 1995, J NEUROSCI, V15, P3982; Wang JQ, 2004, J BIOL CHEM, V279, P45626, DOI 10.1074/jbc.M406966200	50	27	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125022	10.1371/journal.pone.0125022	http://dx.doi.org/10.1371/journal.pone.0125022			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933021	gold, Green Submitted, Green Published			2022-12-27	WOS:000353887100073
J	Kristensen, K; Henriksen, JR; Andresen, TL				Kristensen, Kasper; Henriksen, Jonas R.; Andresen, Thomas L.			Adsorption of Cationic Peptides to Solid Surfaces of Glass and Plastic	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; PHOSPHOLIPID-VESICLES; QUANTITATIVE-ANALYSIS; BINDING; PERMEABILIZATION; CHROMATOGRAPHY; POLYPROPYLENE; MEMBRANES; LIPOSOMES; MECHANISM	Cationic membrane-active peptides have been studied for years in the hope of developing them into novel types of therapeutics. In this article, we investigate an effect that might have significant experimental implications for investigators who wish to study these peptides, namely, that the peptides adsorb to solid surfaces of glass and plastic. Specifically, we use analytical HPLC to systematically quantify the adsorption of the three cationic membrane-active peptides mastoparan X, melittin, and magainin 2 to the walls of commonly used glass and plastic sample containers. Our results show that, at typical experimental peptide concentrations, 90% or more of the peptides might be lost from solution due to rapid adsorption to the walls of the sample containers. Thus, our results emphasize that investigators should always keep these adsorption effects in mind when designing and interpreting experiments on cationic membrane-active peptides. We conclude the article by discussing different strategies for reducing the experimental impact of these adsorption effects.	[Kristensen, Kasper; Andresen, Thomas L.] Tech Univ Denmark, DTU Nanotech, Dept Micro & Nanotechnol, DK-2800 Lyngby, Denmark; [Henriksen, Jonas R.] Tech Univ Denmark, DTU Chem, Dept Chem, DK-2800 Lyngby, Denmark; [Kristensen, Kasper; Henriksen, Jonas R.; Andresen, Thomas L.] Tech Univ Denmark, Ctr Nanomed & Theranost, DK-2800 Lyngby, Denmark	Technical University of Denmark; Technical University of Denmark; Technical University of Denmark	Andresen, TL (corresponding author), Tech Univ Denmark, DTU Nanotech, Dept Micro & Nanotechnol, DK-2800 Lyngby, Denmark.	tlan@nanotech.dtu.dk	Kristensen, Kasper/M-9179-2013	Kristensen, Kasper/0000-0003-3596-4056; Henriksen, Jonas Rosager/0000-0001-9154-6639; Andresen, Thomas Lars/0000-0002-1048-127X	NanoMorph consortium; Danish Council for Technology and Innovation; Technical University of Denmark	NanoMorph consortium; Danish Council for Technology and Innovation; Technical University of Denmark	KK was partially funded by the NanoMorph consortium, funded by the Danish Council for Technology and Innovation, and partially funded by the Technical University of Denmark. JRH and TLA were funded by the Technical University of Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbuzova A, 1999, BBA-BIOMEMBRANES, V1420, P139, DOI 10.1016/S0005-2736(99)00098-X; Bark SJ, 2007, J PROTEOME RES, V6, P4511, DOI 10.1021/pr070294o; Bechara C, 2013, FEBS LETT, V587, P1693, DOI 10.1016/j.febslet.2013.04.031; BESCHIASCHVILI G, 1990, BIOCHEMISTRY-US, V29, P52, DOI 10.1021/bi00453a007; Chico DE, 2003, PEPTIDES, V24, P3, DOI 10.1016/S0196-9781(02)00270-X; DUNCAN M, 1994, J COLLOID INTERF SCI, V165, P341, DOI 10.1006/jcis.1994.1238; DUNCAN MR, 1995, INT J PHARMACEUT, V120, P179, DOI 10.1016/0378-5173(94)00402-Q; Etzerodt T, 2011, BIOPHYS J, V100, P399, DOI 10.1016/j.bpj.2010.11.040; Goebel-Stengel M, 2011, ANAL BIOCHEM, V414, P38, DOI 10.1016/j.ab.2011.02.009; GRANT E, 1992, BIOCHEMISTRY-US, V31, P9912, DOI 10.1021/bi00156a008; Gregory SM, 2009, BIOPHYS J, V96, P116, DOI 10.1016/j.bpj.2008.09.017; HELENIUS A, 1975, BIOCHIM BIOPHYS ACTA, V415, P29, DOI 10.1016/0304-4157(75)90016-7; JOOSTEN HMLJ, 1995, LETT APPL MICROBIOL, V21, P389, DOI 10.1111/j.1472-765X.1995.tb01089.x; Kraut A, 2009, J PROTEOME RES, V8, P3778, DOI 10.1021/pr900095u; Kristensen K, 2014, BBA-BIOMEMBRANES, V1838, P2994, DOI 10.1016/j.bbamem.2014.08.007; Milletti F, 2012, DRUG DISCOV TODAY, V17, P850, DOI 10.1016/j.drudis.2012.03.002; Pasupuleti M, 2012, CRIT REV BIOTECHNOL, V32, P143, DOI 10.3109/07388551.2011.594423; Persson D, 2003, BIOCHEMISTRY-US, V42, P421, DOI 10.1021/bi026453t; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; TOSTESON MT, 1985, J MEMBRANE BIOL, V87, P35, DOI 10.1007/BF01870697; van Midwoud PM, 2007, J PROTEOME RES, V6, P781, DOI 10.1021/pr0604099; Wimley WC, 2010, ACS CHEM BIOL, V5, P905, DOI 10.1021/cb1001558; Yeung ATY, 2011, CELL MOL LIFE SCI, V68, P2161, DOI 10.1007/s00018-011-0710-x; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	24	41	42	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0122419	10.1371/journal.pone.0122419	http://dx.doi.org/10.1371/journal.pone.0122419			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932639	Green Submitted, Green Published, gold			2022-12-27	WOS:000353887100008
J	An, F; Zou, Z; Cai, XQ; Wang, J; Rookes, J; Lin, WF; Cahill, D; Kong, LX				An, Feng; Zou, Zhi; Cai, Xiuqing; Wang, Jin; Rookes, James; Lin, Weifu; Cahill, David; Kong, Lingxue			Regulation of HbPIP2;3, a Latex-Abundant Water Transporter, Is Associated with Latex Dilution and Yield in the Rubber Tree (Hevea brasiliensis Muell. Arg.)	PLOS ONE			English	Article							PLANT AQUAPORINS; EXPRESSION; CHANNELS; GENE; ETHYLENE; STIMULATION; SEQUENCE; DROUGHT; CLONING; POPLAR	Rubber tree (Hevea brasiliensis) latex, the source of natural rubber, is synthesised in the cytoplasm of laticifers. Efficient water inflow into laticifers is crucial for latex flow and production since it is the determinant of the total solid content of latex and its fluidity after tapping. As the mature laticifer vessel rings are devoid of plasmodesmata, water exchange between laticifers and surrounding cells is believed to be governed by plasma membrane intrinsic proteins (PIPs). To identify the most important PIP aquaporin in the water balance of laticifers, the transcriptional profiles of ten-latex-expressed PIPs were analysed. One of the most abundant transcripts, designated HbPIP2; 3, was characterised in this study. When tested in Xenopus laevis oocytes HbPIP2; 3 showed a high efficiency in increasing plasmalemma water conductance. Expression analysis indicated that the HbPIP2; 3 gene was preferentially expressed in latex, and the transcripts were up-regulated by both wounding and exogenously applied Ethrel (a commonly-used ethylene releaser). Although regular tapping upregulated the expression of HbPIP2; 3 during the first few tappings of the virginal rubber trees, the transcriptional kinetics of HbPIP2; 3 to Ethrel stimulation in the regularly tapped tree exhibited a similar pattern to that of the previously reported HbPIP2; 1 in the virginal rubber trees. Furthermore, the mRNA level of HbPIP2; 3 was associated with clonal yield potential and the Ethrel stimulation response. Together, these results have revealed the central regulatory role of HbPIP2; 3 in laticifer water balance and ethylene stimulation of latex production in Hevea.	[An, Feng; Zou, Zhi; Wang, Jin; Lin, Weifu] Chinese Acad Trop Agr Sci, Rubber Res Inst, Danzhou Invest & Expt Stn Trop Crops, Minist Agr, Danzhou 571737, Peoples R China; [An, Feng; Kong, Lingxue] Deakin Univ, Inst Frontier Mat, Geelong, Vic 3216, Australia; [Cai, Xiuqing] Hainan Univ, Coll Agron, Haikou 570228, Peoples R China; [Rookes, James; Cahill, David] Deakin Univ, Sch Life & Environm Sci, Geelong, Vic 3216, Australia	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Deakin University; Hainan University; Deakin University	An, F (corresponding author), Chinese Acad Trop Agr Sci, Rubber Res Inst, Danzhou Invest & Expt Stn Trop Crops, Minist Agr, Danzhou 571737, Peoples R China.	an-f@163.com; lingxue.kong@deakin.edu.au	Zou, Zhi/F-1266-2018; Kong, Lingxue/D-8216-2011	Zou, Zhi/0000-0003-2881-1932; Kong, Lingxue/0000-0001-6219-3897; rookes, jim/0000-0003-1479-2339; Cahill, David/0000-0002-2556-0528	National Natural Science Foundation of China [31100460]; Earmarked Fund for China Agriculture Research System [CARS-34]; Natural Science Foundation of Hainan Province [312026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Earmarked Fund for China Agriculture Research System; Natural Science Foundation of Hainan Province	This work was supported by grants from the National Natural Science Foundation of China (31100460), the Earmarked Fund for China Agriculture Research System (CARS-34) and the Natural Science Foundation of Hainan Province (312026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRE P, 1987, J BIOL CHEM, V262, P17497; Almeida-Rodriguez AM, 2010, PHYSIOL PLANTARUM, V140, P321, DOI 10.1111/j.1399-3054.2010.01405.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Azad AK, 2013, PHYSIOL PLANTARUM, V148, P397, DOI 10.1111/j.1399-3054.2012.01717.x; Bae EK, 2011, GENE, V483, P43, DOI 10.1016/j.gene.2011.05.015; Chaumont F, 2005, BIOL CELL, V97, P749, DOI 10.1042/BC20040133; Chaumont F, 2000, PLANT PHYSIOL, V122, P1025, DOI 10.1104/pp.122.4.1025; Chaumont F, 2014, PLANT PHYSIOL, V164, P1600, DOI 10.1104/pp.113.233791; Chervin C, 2008, PHYSIOL PLANTARUM, V134, P534, DOI 10.1111/j.1399-3054.2008.01158.x; Chow Keng-See, 2014, BMC Res Notes, V7, P69, DOI 10.1186/1756-0500-7-69; D'Auzac J., 1997, Recent Research Developments in Plant Physiology, V1, P273; D'Auzac J., 1989, PHYSL RUBBER TREE LA; Daniels MJ, 1996, PLANT CELL, V8, P587, DOI 10.1105/tpc.8.4.587; Danielson JAH, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-45; DEFAY E, 1989, PROTOPLASMA, V149, P155, DOI 10.1007/BF01322987; Dusotoit-Coucaud A, 2010, TREE PHYSIOL, V30, P1586, DOI 10.1093/treephys/tpq088; Dusotoit-Coucaud A, 2010, PLANT CELL PHYSIOL, V51, P1878, DOI 10.1093/pcp/pcq151; Dusotoit-Coucaud A, 2009, ANN BOT-LONDON, V104, P635, DOI 10.1093/aob/mcp150; Fetter K, 2004, PLANT CELL, V16, P215, DOI 10.1105/tpc.017194; Froger A, 1998, PROTEIN SCI, V7, P1458, DOI 10.1002/pro.5560070623; Gao X, 2009, ZHONGGUO NONG TONG B, V3, P275; Gohet E, 2003, P IRRDB WORKSH EXPL, V203, P199; Gomes D, 2009, BBA-BIOMEMBRANES, V1788, P1213, DOI 10.1016/j.bbamem.2009.03.009; GOODING EGB, 1952, NEW PHYTOL, V51, P139, DOI 10.1111/j.1469-8137.1952.tb06122.x; Hachez C, 2010, ADV EXP MED BIOL, V679, P1; Hill AE, 2004, J MEMBRANE BIOL, V197, P1, DOI 10.1007/s00232-003-0639-6; Hua YW, 2010, PLANT BREEDING, V129, P202, DOI 10.1111/j.1439-0523.2009.01663.x; Huang DeBao, 2010, Journal of Tropical and Subtropical Botany, V18, P170; Johansson I, 2000, BBA-BIOMEMBRANES, V1465, P324, DOI 10.1016/S0005-2736(00)00147-4; JUNG JS, 1994, J BIOL CHEM, V269, P14648; Kaldenhoff R, 2006, ACTA PHYSIOL, V187, P169, DOI 10.1111/j.1748-1716.2006.01563.x; Kaldenhoff R, 2008, PLANT CELL ENVIRON, V31, P658, DOI 10.1111/j.1365-3040.2008.01792.x; KAMMERLOHER W, 1994, PLANT J, V6, P187, DOI 10.1046/j.1365-313X.1994.6020187.x; Katsuhara M, 2002, PLANT CELL PHYSIOL, V43, P885, DOI 10.1093/pcp/pcf102; Kelly G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087888; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li HP, 2011, PLANT SCI, V181, P132, DOI 10.1016/j.plantsci.2011.04.014; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; LINCOLN T, 2006, PLANT PHYSL; Lovisolo C, 2010, FUNCT PLANT BIOL, V37, P98, DOI 10.1071/FP09191; Marjanovic Z, 2005, PLANTA, V222, P258, DOI 10.1007/s00425-005-1539-z; Maurel C, 2008, ANNU REV PLANT BIOL, V59, P595, DOI 10.1146/annurev.arplant.59.032607.092734; Maurel C, 2007, FEBS LETT, V581, P2227, DOI 10.1016/j.febslet.2007.03.021; MONTGOMERY J, 1993, P NATL ACAD SCI USA, V90, P5939, DOI 10.1073/pnas.90.13.5939; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nair KPP, 2010, ELSEV INSIGHT, P237, DOI 10.1016/B978-0-12-384677-8.00008-4; Pakianathan SW, 1967, J RUBBER RES I MALAY, P23; PARANJOTHY K, 1979, J RUBBER RES I MALAY, V27, P159; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; Priyadarshan PM, 2011, BIOLOGY OF HEVEA RUBBER, P1, DOI 10.1079/9781845936662.0000; Rahman AYA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-75; Rawat R, 2005, PLANT MOL BIOL, V57, P629, DOI 10.1007/s11103-005-0954-7; Sabir F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102087; Secchi F, 2007, PLANTA, V225, P381, DOI 10.1007/s00425-006-0365-2; Sethuraj MR., 2012, CULTIVATION TECHNOLO; STEIN WD, 1956, DISCUSS FARADAY SOC, P238, DOI 10.1039/df9562100238; Suga S, 2004, PLANT CELL PHYSIOL, V45, P823, DOI 10.1093/pcp/pch120; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang CR, 2007, J BIOCHEM BIOPH METH, V70, P749, DOI 10.1016/j.jbbm.2007.04.002; Tang CR, 2010, PLANT CELL ENVIRON, V33, P1708, DOI 10.1111/j.1365-3040.2010.02175.x; Tapia G, 2005, PLANT PHYSIOL, V138, P2075, DOI 10.1104/pp.105.059766; Tungngoen K, 2011, J PLANT PHYSIOL, V168, P253, DOI 10.1016/j.jplph.2010.06.009; Tungngoen K, 2009, PLANT PHYSIOL, V151, P843, DOI 10.1104/pp.109.140228; Tupy J, 1985, MUEL ARG BIOL PLANT, V1, P51; Tyerman SD, 1999, J EXP BOT, V50, P1055, DOI 10.1093/jexbot/50.suppl_1.1055; Van Gils G. E., 1951, ARCH RUBBERCULTURE, V28, P61; Wang J, 2014, COMP BIOCHEM PHYS D, V11, P1, DOI 10.1016/j.cbd.2014.05.001; Xu CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079618; Xu W, 1990, RE DAI ZUO WU XUE BA, V11, P11; Zhou Y, 2007, PLANT CELL ENVIRON, V30, P1566, DOI 10.1111/j.1365-3040.2007.01732.x; Zhuang Hai-yan, 2010, Xibei Zhiwu Xuebao, V30, P861	72	17	21	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125595	10.1371/journal.pone.0125595	http://dx.doi.org/10.1371/journal.pone.0125595			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927524	Green Published, Green Submitted, gold			2022-12-27	WOS:000353713100104
J	Korol, SV; Jin, Z; Birnir, B				Korol, Sergiy V.; Jin, Zhe; Birnir, Bryndis			The GLP-1 Receptor Agonist Exendin-4 and Diazepam Differentially Regulate GABA(A) Receptor-Mediated Tonic Currents in Rat Hippocampal CA3 Pyramidal Neurons	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; AMINOBUTYRIC ACID(A) RECEPTORS; BENZODIAZEPINE BINDING-SITE; BRAIN; PHARMACOLOGY; CHANNELS; PHYSIOLOGY; SUBTYPES; INSULIN; CULTURE	Glucagon-like peptide-1 (GLP-1) is a metabolic hormone that is secreted in a glucose-dependent manner and enhances insulin secretion. GLP-1 receptors are also found in the brain where their signalling affects neuronal activity. We have previously shown that the GLP-1 receptor agonists, GLP-1 and exendin-4 enhanced GABA-activated synaptic and tonic currents in rat hippocampal CA3 pyramidal neurons. The hippocampus is the centre for memory and learning and is important for cognition. Here we examined if exendin-4 similarly enhanced the GABA-activated currents in the presence of the benzodiazepine diazepam. In whole-cell recordings in rat brain slices, diazepam (1 mu M), an allosteric positive modulator of GABA(A) receptors, alone enhanced the spontaneous inhibitory postsynaptic current (sIPSC) amplitude and frequency by a factor of 1.3 and 1.6, respectively, and doubled the tonic GABA(A) current normally recorded in the CA3 pyramidal cells. Importantly, in the presence of exendin-4 (10 nM) plus diazepam (1 mu M), only the tonic but not the sIPSC currents transiently increased as compared to currents recorded in the presence of diazepam alone. The results suggest that exendin-4 potentiates a subpopulation of extrasynaptic GABA(A) receptors in the CA3 pyramidal neurons.	[Korol, Sergiy V.; Jin, Zhe; Birnir, Bryndis] Uppsala Univ, Dept Neurosci, Uppsala, Sweden	Uppsala University	Birnir, B (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	bryndis.birnir@neuro.uu.se	Korol, Sergiy V./S-3442-2016; Jin, Zhe/C-5150-2008	Korol, Sergiy V./0000-0001-8279-2790; Jin, Zhe/0000-0002-4717-1558; Birnir, Bryndis/0000-0002-1763-0266	Swedish research council [2012-1789]; EXODIAB, a consortium - Swedish government; M.A.H. Landells Foundation; M. Sjostroms Foundation, Uppsala University	Swedish research council(Swedish Research CouncilEuropean Commission); EXODIAB, a consortium - Swedish government; M.A.H. Landells Foundation; M. Sjostroms Foundation, Uppsala University	This study was supported by the Swedish research council grant 2012-1789 to BB, http://vr.se/forskningvistodjer/projektdatabasen.4.14f1901d125640ed5ab80003173.html. SVK held a postdoctoral fellowship from EXODIAB, a consortium funded by the Swedish government. ZJ held a postdoctoral fellowship from M.A.H. Landells Foundation and M. Sjostroms Foundation, Uppsala University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai DL, 2001, MOL PHARMACOL, V59, P814, DOI 10.1124/mol.59.4.814; Benedict C, 2007, NEUROENDOCRINOLOGY, V86, P136, DOI 10.1159/000106378; Birnir B, 2000, BRIT J PHARMACOL, V131, P695, DOI 10.1038/sj.bjp.0703621; BIRNIR B, 1994, J MEMBRANE BIOL, V142, P93; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; Deuker L, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00064; Duarte AI, 2013, BBA-MOL BASIS DIS, V1832, P527, DOI 10.1016/j.bbadis.2013.01.008; Eghbali M, 1997, NATURE, V388, P71, DOI 10.1038/40404; Glykys J, 2007, NEURON, V56, P763, DOI 10.1016/j.neuron.2007.11.002; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Jin Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067228; Jin Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016188; Korol SV, 2015, DIABETES, V64, P79, DOI 10.2337/db14-0668; Lathe R, 2001, J ENDOCRINOL, V169, P205, DOI 10.1677/joe.0.1690205; Levi S, 2015, NEUROPHARMACOLOGY, V88, P199, DOI 10.1016/j.neuropharm.2014.06.002; Li P, 2013, ANESTHESIOLOGY, V118, P1417, DOI 10.1097/ALN.0b013e318289bcd3; Lindquist CEL, 2006, J NEUROCHEM, V97, P1349, DOI 10.1111/j.1471-4159.2006.03811.x; Marder TJ, 2014, DIABETES, V63, P3112, DOI 10.2337/db13-1783; McClean PL, 2010, EUR J PHARMACOL, V630, P158, DOI 10.1016/j.ejphar.2009.12.023; Middendorp SJ, 2014, ACS CHEM BIOL, V9, P1846, DOI 10.1021/cb500186a; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; Patrone C, 2014, LANCET DIABETES ENDO, V2, P256, DOI 10.1016/S2213-8587(13)70125-6; Pavlov I, 2009, J NEUROSCI, V29, P15341, DOI 10.1523/JNEUROSCI.2747-09.2009; Qiu CX, 2014, ANN NEUROL, V75, P138, DOI 10.1002/ana.24063; Richter L, 2012, NAT CHEM BIOL, V8, P455, DOI [10.1038/nchembio.917, 10.1038/NCHEMBIO.917]; Roberts RO, 2014, NEUROLOGY, V82, P1132, DOI 10.1212/WNL.0000000000000269; ROGERS CJ, 1994, J PHYSIOL-LONDON, V475, P69, DOI 10.1113/jphysiol.1994.sp020050; Schneeberger M, 2014, J ENDOCRINOL, V220, pT25, DOI 10.1530/JOE-13-0398; SEGAL M, 1984, J NEUROPHYSIOL, V52, P469, DOI 10.1152/jn.1984.52.3.469; Semyanov A, 2004, TRENDS NEUROSCI, V27, P262, DOI 10.1016/j.tins.2004.03.005; Semyanov A, 2003, NAT NEUROSCI, V6, P484, DOI 10.1038/nn1043; Sigel E, 1997, TRENDS PHARMACOL SCI, V18, P425, DOI 10.1016/S0165-6147(97)90675-1; Uusi-Oukari M, 2010, PHARMACOL REV, V62, P97, DOI 10.1124/pr.109.002063; Wan Q, 1997, NATURE, V388, P686, DOI 10.1038/41792	35	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124765	10.1371/journal.pone.0124765	http://dx.doi.org/10.1371/journal.pone.0124765			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927918	Green Published, Green Submitted, gold			2022-12-27	WOS:000353713100048
J	Chen, H; Ge, L; Sui, QL; Lin, M				Chen, Hong; Ge, Lin; Sui, Qiuli; Lin, Mei			Systematic Review and Meta-Analysis of the Relationship between EPHX1 Polymorphisms and the Risk of Head and Neck Cancer	PLOS ONE			English	Review							MICROSOMAL EPOXIDE HYDROLASE; SMOKING; ASSOCIATION; CARCINOMA; GENOTYPES; SUSCEPTIBILITY; GSTM1; GENE	Aim To evaluate the association between the EPHX1 Tyr113His and His139Arg polymorphisms in the EPHX1 gene and the risk of head and neck cancer. Materials and Methods Studies on the association of EPHX1 Tyr113His and His139Arg polymorphisms with HNC performed up until June 1st, 2014, were identified using a predefined search strategy. Summary odds ratios (ORs) and 95% confidence intervals (CIs) were used to evaluate the strength of these associations. Results In this meta-analysis, 10 case-control studies, which included 9 studies of Tyr113His (1890 cases and 1894 controls) and 10 studies of His139Arg polymorphisms (1982 cases and 2024 controls), were considered eligible for inclusion. Overall, the pooled results indicated that the EPHX1 Tyr113His polymorphism was significantly associated with increased HNC risk (Tyr/His vs. Tyr/Tyr, OR = 1.26, 95% 1.02-1.57; His/His+ Tyr/His vs. Tyr/Tyr, OR = 1.29, 95% I = 1.03-1.61). However, no significant association was found between the His139Arg polymorphism and HNC risk. In the subgroup analysis, a statistically significant association between the EPHX1 Tyr113His polymorphism and HNC was observed in population-based case-control studies (PCC), which involved less than 500 participants and genotype frequencies in HWE. This association showed minimal heterogeneity after excluding studies that were determined to contribute to heterogeneity. After categorizing the studies by publication time, a sensitivity analysis and cumulative meta-analysis of the two associations were conducted, and the results of the two analyses were consistent. Conclusion Our meta-analysis suggests that EPHX1 Tyr113His polymorphism may be a risk factor for HNC, while the EPHX1 His139Arg polymorphism has no association with HNC risk.	[Chen, Hong; Sui, Qiuli] Sichuan Univ, State Key Lab Oral Dis, Chengdu 610064, Sichuan, Peoples R China; [Ge, Lin] Sichuan Univ, West China Sch Stomatol, Dept Oral Med, Chengdu 610064, Sichuan, Peoples R China; [Lin, Mei] Sichuan Univ, West China Sch Stomatol, Dept Oral Med, Chengdu 610064, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Ge, L (corresponding author), Sichuan Univ, West China Sch Stomatol, Dept Oral Med, Chengdu 610064, Sichuan, Peoples R China.	v1i2c3@163.com; linmei2k@163.com			National Natural Science Foundation of China [81102059]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Natural Science Foundation of China (No. 81102059).	Amador AG, 2002, ORAL SURG ORAL MED O, V93, P440, DOI 10.1067/moe.2002.122586; Arand M, 2005, METHOD ENZYMOL, V400, P569, DOI 10.1016/S0076-6879(05)00032-7; Attia J, 2003, J CLIN EPIDEMIOL, V56, P297, DOI 10.1016/S0895-4356(03)00011-8; Balaji L, 2011, GENET TEST MOL BIOMA, V15, P595, DOI 10.1089/gtmb.2010.0260; BEETHAM JK, 1995, DNA CELL BIOL, V14, P61, DOI 10.1089/dna.1995.14.61; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Benhamou S, 2002, CARCINOGENESIS, V23, P1343, DOI 10.1093/carcin/23.8.1343; Bhaskar LV, 2012, AM J DRUG ALCOHOL AB; Boccia S, 2008, J CANCER RES CLIN, V134, P93, DOI 10.1007/s00432-007-0254-5; Buch SC, 2008, HEAD NECK-J SCI SPEC, V30, P1139, DOI 10.1002/hed.20867; Chen CZ, 2011, J FORMOS MED ASSOC, V110, P685, DOI 10.1016/j.jfma.2011.09.003; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dura P, 2012, ONCOL REP, V27, P1710, DOI 10.3892/or.2012.1734; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fretland AJ, 2000, CHEM-BIOL INTERACT, V129, P41, DOI 10.1016/S0009-2797(00)00197-6; Geisler SA, 2001, AM J EPIDEMIOL, V154, P95, DOI 10.1093/aje/154.2.95; Ghattas MH, 2012, ENDOCRINE; Hassett C, 1997, ARCH BIOCHEM BIOPHYS, V337, P275, DOI 10.1006/abbi.1996.9794; HASSETT C, 1994, HUM MOL GENET, V3, P421, DOI 10.1093/hmg/3.3.421; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HIYAMA T, 1992, JPN J CANCER RES, V83, P334, DOI 10.1111/j.1349-7006.1992.tb00111.x; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; JANOT F, 1993, CARCINOGENESIS, V14, P1279, DOI 10.1093/carcin/14.7.1279; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Jourenkova-Mironova N, 2000, CANCER RES, V60, P534; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Knechtel G, 2010, MOL CARCINOGEN, V49, P805, DOI 10.1002/mc.20655; Lacko M, 2008, HEAD NECK-J SCI SPEC, V30, P836, DOI 10.1002/hed.20781; Lacko M, 2013, HEAD NECK-J SCI SPEC, V35, P858, DOI 10.1002/hed.23054; Liu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043821; Liu L, 2011, J CANCER RES CLIN, V137, P1027, DOI 10.1007/s00432-010-0966-9; MANTEL N, 1959, J NATL CANCER I, V22, P719; Marcu LG, 2009, J CANCER RES CLIN, V135, P1303, DOI 10.1007/s00432-009-0648-7; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Nisa H, 2012, MOL CARCINOG; Park JY, 2003, ORAL ONCOL, V39, P483, DOI 10.1016/S1368-8375(03)00008-3; Parkin DM, 1999, CA-CANCER J CLIN, V49, P33, DOI 10.3322/canjclin.49.1.33; Pfeifer GP, 2002, ONCOGENE, V21, P7435, DOI 10.1038/sj.onc.1205803; To-Figueras J, 2002, CANCER LETT, V187, P95, DOI 10.1016/S0304-3835(02)00406-8; Varela-Lema L, 2008, J ONCOL, V2008, DOI 10.1155/2008/741310; Wenghoefer M, 2003, ARCH TOXICOL, V77, P37, DOI 10.1007/s00204-002-0414-y; Zhang JH, 2003, WORLD J GASTROENTERO, V9, P2654; Zhao ZQ, 2012, TUMOR BIOL, V33, P523, DOI 10.1007/s13277-011-0287-x; Zhong JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057064; Zhong Y, 2011, CHEM RES TOXICOL, V24, P246, DOI 10.1021/tx100345x	47	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123347	10.1371/journal.pone.0123347	http://dx.doi.org/10.1371/journal.pone.0123347			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923690	Green Submitted, Green Published, gold			2022-12-27	WOS:000353711600041
J	Pachnio, A; Begum, J; Fox, A; Moss, P				Pachnio, Annette; Begum, Jusnara; Fox, Ashini; Moss, Paul			Acyclovir Therapy Reduces the CD4+T Cell Response against the Immunodominant pp65 Protein from Cytomegalovirus in Immune Competent Individuals	PLOS ONE			English	Article							T-CELLS; PERIPHERAL-BLOOD; INFECTION; DISEASE; MORTALITY; CD8; SEROPOSITIVITY; PREVENTION; PHARMACOKINETICS; IMMUNOSENESCENCE	Cytomegalovirus (CMV) infects the majority of the global population and leads to the development of a strong virus-specific immune response. The CMV-specific CD4+ and CD8+ T cell immune response can comprise between 10 and 50% of the T cell pool within peripheral blood and there is concern that this may impair immunity to other pathogens. Elderly individuals with the highest magnitude of CMV-specific immune response have been demonstrated to be at increased risk of mortality and there is increasing interest in interventions that may serve to moderate this. Acyclovir is an anti-viral drug with activity against a range of herpes viruses and is used as long term treatment to suppress reactivation of herpes simplex virus. We studied the immune response to CMV in patients who were taking acyclovir to assess if therapy could be used to suppress the CMV-specific immune response. The T cell reactivity against the immunodominant late viral protein pp65 was reduced by 53% in people who were taking acyclovir. This effect was seen within one year of therapy and was observed primarily within the CD4+ response. Acyclovir treatment only modestly influenced the immune response to the IE-1 target protein. These data show that low dose acyclovir treatment has the potential to modulate components of the T cell response to CMV antigen proteins and indicate that anti-viral drugs should be further investigated as a means to reduce the magnitude of CMV-specific immune response and potentially improve overall immune function.	[Pachnio, Annette; Begum, Jusnara; Moss, Paul] Univ Birmingham, Sch Canc Sci, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Fox, Ashini] Nottingham Univ Hosp Trust, Dept Genito Urinary Med, Nottingham, England	University of Birmingham; Nottingham University Hospital NHS Trust; University of Nottingham	Moss, P (corresponding author), Univ Birmingham, Sch Canc Sci, Coll Med & Dent Sci, Birmingham, W Midlands, England.	p.moss@bham.ac.uk	Moss, Paul/D-1728-2009	Moss, Paul/0000-0002-6895-1967	Medical Research Council [G0901755]; Medical Research Council [G1000622] Funding Source: researchfish; MRC [G0901755, G1000622] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a program grant (G0901755) by the Medical Research Council. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; BALFOUR HH, 1991, TRANSPLANT P, V23, P17; Beswick M, 2013, J VIROL, V87, P779, DOI 10.1128/JVI.02427-12; Boeckh M, 2003, BLOOD, V101, P407, DOI 10.1182/blood-2002-03-0993; Bunce M, 1995, TISSUE ANTIGENS, V46, P355, DOI 10.1111/j.1399-0039.1995.tb03127.x; Casazza JP, 2001, J VIROL, V75, P6508, DOI 10.1128/JVI.75.14.6508-6516.2001; Chidrawar S, 2009, CLIN EXP IMMUNOL, V155, P423, DOI 10.1111/j.1365-2249.2008.03785.x; DEMIRANDA P, 1983, J ANTIMICROB CHEMOTH, V12, P29, DOI 10.1093/jac/12.suppl_B.29; ELION GB, 1977, P NATL ACAD SCI USA, V74, P5716, DOI 10.1073/pnas.74.12.5716; Fish KN, 1995, SCAND J INFECT DIS, P34; Gandhi MK, 2004, LANCET INFECT DIS, V4, P725, DOI 10.1016/S1473-3099(04)01202-2; Grahame-Clarke C, 2003, CIRCULATION, V108, P678, DOI 10.1161/01.CIR.0000084505.54603.C7; Grubeck-Loebenstein B, 2009, AGING CLIN EXP RES, V21, P201, DOI 10.1007/BF03324904; Hoshino Y, 2009, J VIROL, V83, P11857, DOI 10.1128/JVI.01005-09; Khan N, 2004, J IMMUNOL, V173, P7481, DOI 10.4049/jimmunol.173.12.7481; Kurz SK, 1999, J VIROL, V73, P482, DOI 10.1128/JVI.73.1.482-494.1999; Lang A, 2009, J IMMUNOL, V183, P8077, DOI 10.4049/jimmunol.0801117; Lowance D, 1999, NEW ENGL J MED, V340, P1462, DOI 10.1056/NEJM199905133401903; Morgan MD, 2011, ARTHRITIS RHEUM-US, V63, P2127, DOI 10.1002/art.30366; MYERSON D, 1984, HUM PATHOL, V15, P430, DOI 10.1016/S0046-8177(84)80076-3; Pawelec G, 2009, REV MED VIROL, V19, P47, DOI 10.1002/rmv.598; Polic B, 1998, J EXP MED, V188, P1047, DOI 10.1084/jem.188.6.1047; Roback JD, 2003, TRANSFUSION, V43, P314, DOI 10.1046/j.1537-2995.2003.00312.x; Roberts ET, 2010, AM J EPIDEMIOL, V172, P363, DOI 10.1093/aje/kwq177; Savva GM, 2013, AGING CELL, V12, P381, DOI 10.1111/acel.12059; Sia IG, 2000, CLIN MICROBIOL REV, V13, P83, DOI 10.1128/CMR.13.1.83-121.2000; Snyder CM, 2008, IMMUNITY, V29, P650, DOI 10.1016/j.immuni.2008.07.017; Snyder CM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002295; TAYLORWIEDEMAN J, 1991, J GEN VIROL, V72, P2059, DOI 10.1099/0022-1317-72-9-2059; Thewissen M, 2007, J IMMUNOL, V179, P6514, DOI 10.4049/jimmunol.179.10.6514; TYMS AS, 1981, J ANTIMICROB CHEMOTH, V8, P65, DOI 10.1093/jac/8.1.65; van de Berg PJEJ, 2008, J CLIN VIROL, V41, P213, DOI 10.1016/j.jcv.2007.10.016; Wallace DL, 2011, IMMUNOLOGY, V132, P27, DOI 10.1111/j.1365-2567.2010.03334.x; Wallace DL, 2004, J IMMUNOL, V173, P1787, DOI 10.4049/jimmunol.173.3.1787; Wang GC, 2010, AM J EPIDEMIOL, V171, P1144, DOI 10.1093/aje/kwq062; WELLER S, 1993, CLIN PHARMACOL THER, V54, P595, DOI 10.1038/clpt.1993.196; Wikby A, 2002, EXP GERONTOL, V37, P445, DOI 10.1016/S0531-5565(01)00212-1; Wikby A, 1998, MECH AGEING DEV, V102, P187, DOI 10.1016/S0047-6374(97)00151-6; WINGARD JR, 1983, ANTIMICROB AGENTS CH, V23, P593, DOI 10.1128/AAC.23.4.593; Yust I, 2004, EUR J CLIN MICROBIOL, V23, P550, DOI 10.1007/s10096-004-1160-2	40	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125287	10.1371/journal.pone.0125287	http://dx.doi.org/10.1371/journal.pone.0125287			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923913	gold, Green Published, Green Submitted			2022-12-27	WOS:000353711600141
J	Richardson, SP; Tinaz, S; Chen, R				Richardson, Sarah Pirio; Tinaz, Sule; Chen, Robert			Repetitive Transcranial Magnetic Stimulation in Cervical Dystonia: Effect of Site and Repetition in a Randomized Pilot Trial	PLOS ONE			English	Article							FOCAL HAND DYSTONIA; PREMOTOR CORTEX; WRITERS CRAMP; BOTULINUM TOXIN; RTMS; TMS	Dystonia is characterized by abnormal posturing due to sustained muscle contraction, which leads to pain and significant disability. New therapeutic targets are needed in this disorder. The objective of this randomized, sham-controlled, blinded exploratory study is to identify a specific motor system target for non-invasive neuromodulation and to evaluate this target in terms of safety and tolerability in the cervical dystonia (CD) population. Eight CD subjects were given 15-minute sessions of low-frequency (0.2 Hz) repetitive transcranial magnetic stimulation (rTMS) over the primary motor cortex (MC), dorsal premotor cortex (dPM), supplementary motor area (SMA), anterior cingulate cortex (ACC) and a sham condition with each session separated by at least two days. The Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) score was rated in a blinded fashion immediately pre- and post-intervention. Secondary outcomes included physiology and tolerability ratings. The mean change in TWSTRS severity score by site was 0.25 +/- 1.7 (ACC), -2.9 +/- 3.4 (dPM), -3.0 +/- 4.8 (MC), -0.5 +/- 1.1 (SHAM), and -1.5 +/- 3.2 (SMA) with negative numbers indicating improvement in symptom control. TWSTRS scores decreased from Session 1 (15.1 +/- 5.1) to Session 5 (11.0 +/- 7.6). The treatment was tolerable and safe. Physiology data were acquired on 6 of 8 subjects and showed no change over time. These results suggest rTMS can modulate CD symptoms. Both dPM and MC are areas to be targeted in further rTMS studies. The improvement in TWSTRS scores over time with multiple rTMS sessions deserves further evaluation.	[Richardson, Sarah Pirio] Univ New Mexico, Hlth Sci Ctr, Dept Neurol, Albuquerque, NM 87131 USA; [Tinaz, Sule] NINDS, Human Motor Control Sect, NIH, Bethesda, MD 20892 USA; [Chen, Robert] Univ Toronto, Toronto Western Res Inst, Toronto, ON, Canada	University of New Mexico; University of New Mexico's Health Sciences Center; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Toronto; University Toronto Affiliates; University Health Network Toronto	Richardson, SP (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Neurol, Albuquerque, NM 87131 USA.	spiriorichardson@salud.unm.edu			Dystonia Coalition part of the National Institutes of Health (NIH) Rare Disease Clinical Research Network (RDCRN); National Center for Research Resources and National Center for Advancing Translational Science (NCATS) [KL2TR000089, 8UL1TR000041]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001449] Funding Source: NIH RePORTER	Dystonia Coalition part of the National Institutes of Health (NIH) Rare Disease Clinical Research Network (RDCRN); National Center for Research Resources and National Center for Advancing Translational Science (NCATS); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The research was supported by the Dystonia Coalition (Grant Number U54NS065701) which is a part of the National Institutes of Health (NIH) Rare Disease Clinical Research Network (RDCRN), supported through a collaboration between the Office of Rare Diseases Research (ORDR), National Center for Advancing Translational Sciences (NCATS), and the National Institute of Neurological Diseases and Stroke (NINDS). This research was also supported (in part or in full) by the National Center for Research Resources and National Center for Advancing Translational Science (NCATS) through Grant Number KL2TR000089 and Grant Number 8UL1TR000041. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam N, 2007, ARQ NEURO-PSIQUIAT, V65, P697, DOI 10.1590/S0004-282X2007000400030; Batla A, 2012, CURR TREAT OPTION NE, V14, P213, DOI 10.1007/s11940-012-0169-6; Beck S, 2009, BRAIN STIMUL, V2, P208, DOI 10.1016/j.brs.2009.03.004; Borich M, 2009, RESTOR NEUROL NEUROS, V27, P55, DOI 10.3233/RNN-2009-0461; Breakefield XO, 2008, NAT REV NEUROSCI, V9, P222, DOI 10.1038/nrn2337; Comella CL, 2011, J NEUROL SCI, V308, P103, DOI 10.1016/j.jns.2011.05.041; Kimberley TJ, 2013, RESTOR NEUROL NEUROS, V31, P533, DOI 10.3233/RNN-120259; Lefaucheur JP, 2004, NEUROPHYSIOL CLIN, V34, P141, DOI 10.1016/j.neucli.2004.07.003; Murase N, 2005, BRAIN, V128, P104, DOI 10.1093/brain/awh315; Nijmeijer SWR, 2012, PARKINSONISM RELAT D, V18, P731, DOI 10.1016/j.parkreldis.2012.04.005; Pirio Richardson S, 2014, CLIN NEUROPHYSIOL, DOI [10.1016/jclinph.2014.10.140, DOI 10.1016/JCLINPH.2014.10.140]; Ramos VFML, 2014, J NEUROL NEUROSUR PS, V85, P987, DOI 10.1136/jnnp-2013-306971; Ricci R, 2014, BRAIN STIMUL, V7, P912, DOI 10.1016/j.brs.2014.07.038; Richardson SP, 2014, MOVEMENT DISORD, V29, P797, DOI 10.1002/mds.25878; Siebner HR, 2003, BRAIN, V126, P2710, DOI 10.1093/brain/awg282; Siebner HR, NEUROLOGY, V52, P529; Skogseid IM, 2005, MOVEMENT DISORD, V20, P1604, DOI 10.1002/mds.20670	17	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124937	10.1371/journal.pone.0124937	http://dx.doi.org/10.1371/journal.pone.0124937			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923718	gold, Green Published, Green Submitted			2022-12-27	WOS:000353711600114
J	Zhao, XG; Sun, RJ; Yang, XY; Liu, DY; Lei, DP; Jin, T; Pan, XL				Zhao, Xing-guo; Sun, Rui-jie; Yang, Xiao-yan; Liu, Da-yu; Lei, Da-peng; Jin, Tong; Pan, Xin-liang			Chloroquine-Enhanced Efficacy of Cisplatin in the Treatment of Hypopharyngeal Carcinoma in Xenograft Mice	PLOS ONE			English	Article							CELL LUNG-CANCER; CONCURRENT CHEMORADIOTHERAPY; HEPATOCELLULAR-CARCINOMA; BREAST-CANCER; AUTOPHAGY; RESISTANCE; INHIBITION; APOPTOSIS; TUMORIGENESIS; COMBINATION	Hypopharyngeal squamous cell carcinoma (HSCC) has the worst prognosis among head and neck cancers. Cisplatin (DDP)-based chemotherapy is an important part of multimodal treatments. However, resistance to DDP severely impairs the effectiveness of chemotherapy for HSCC. Chloroquine (CQ) has been reported to enhance the effectiveness of chemotherapy and radiotherapy in liver, pancreas, breast, prostate and colon tumors, but it is unclear whether CQ could increase the efficacy of DDP for treating HSCC. We inoculated BALB/c nude mice with a subcutaneous injection of human hypopharyngeal FaDu cells to generate our animal model. Mice were randomly divided into 4 groups and treated with vehicle control, CQ (60 mg/kg/day), DDP (5 mg/kg/6 days), or a combination of DDP and CQ. Tumor growth and survival of the mice were monitored. We found that CQ inhibited autophagy and increased DDP-induced apoptosis in the xenograft mouse model. CQ enhanced the efficacy of DDP, resulting in decreased tumor growth and prolonged survival of the mice. To test whether blocking autophagy enhanced the efficacy of DDP, FaDu cells were infected with lentiviral shRNA to Beclin-1 and inoculated into the flanks of nude mice. Inhibition of autophagy markedly enhanced the DDP-induced antitumor effect. Our study suggests that the addition of CQ to DDP-based chemotherapy could be a potential therapeutic strategy for treating HSCC, and the inhibition of autophagy may contribute to chemotherapy sensitization in HSCC.	[Zhao, Xing-guo; Sun, Rui-jie; Liu, Da-yu; Lei, Da-peng; Jin, Tong; Pan, Xin-liang] Shandong Univ, Qilu Hosp, Dept Otolaryngol, Jinan 250100, Shandong, Peoples R China; [Yang, Xiao-yan] Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University	Pan, XL (corresponding author), Shandong Univ, Qilu Hosp, Dept Otolaryngol, Jinan 250100, Shandong, Peoples R China.	pan_xinl@163.com			Independent Innovation Foundation of Shandong University (IIFSDU) [2012TS156]; Shandong Provincial Natural Science Foundation, China [ZR2013HM107]	Independent Innovation Foundation of Shandong University (IIFSDU); Shandong Provincial Natural Science Foundation, China(Natural Science Foundation of Shandong Province)	This work was supported by Independent Innovation Foundation of Shandong University (IIFSDU, #2012TS156 for DYL) and Shandong Provincial Natural Science Foundation, China (#ZR2013HM107 for XLP). XLP had a role in the study design. DYL had a role in data analysis.	Adelstein DJ, 2006, J CLIN ONCOL, V24, P1064, DOI 10.1200/JCO.2005.01.5867; Basanez G, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001399; Bristol ML, 2013, J PHARMACOL EXP THER, V344, P544, DOI 10.1124/jpet.112.199802; Chang MFT, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-91; Chatterjee T, 1998, MUTAGENESIS, V13, P619, DOI 10.1093/mutage/13.6.619; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; Cufi S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02469; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Del BB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057236, DOI 10.1371/JOURNAL.PONE.0057236]; Ding ZB, 2011, CLIN CANCER RES, V17, P6229, DOI 10.1158/1078-0432.CCR-11-0816; Fujii S, 2008, CANCER SCI, V99, P1813, DOI 10.1111/j.1349-7006.2008.00893.x; Ghadimi MP, 2012, MOL CANCER THER, V11, P1758, DOI 10.1158/1535-7163.MCT-12-0015; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Guo XL, 2012, CANCER LETT, V320, P171, DOI 10.1016/j.canlet.2012.03.002; Hall SF, 2008, LARYNGOSCOPE, V118, P1362, DOI 10.1097/MLG.0b013e318173dc4a; Han WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028491; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kogashiwa Y, 2009, ONCOL REP, V22, P1163, DOI 10.3892/or_00000550; Lee CM, 2006, BRIT J CANCER, V94, P863, DOI 10.1038/sj.bjc.6603010; Liu DL, 2011, MED ONCOL, V28, P105, DOI 10.1007/s12032-009-9397-3; Maes H, 2014, CANCER CELL, V26, P190, DOI 10.1016/j.ccr.2014.06.025; Martirosyan A, 2006, J PHARMACOL EXP THER, V317, P546, DOI 10.1124/jpet.105.096891; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Maycotte P, 2012, AUTOPHAGY, V8, P200, DOI 10.4161/auto.8.2.18554; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Peng YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074407; POOLE B, 1981, J CELL BIOL, V90, P665, DOI 10.1083/jcb.90.3.665; Ren JH, 2010, CANCER BIOTHER RADIO, V25, P75, DOI 10.1089/cbr.2009.0701; Sasaki K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-370; Shen DW, 2012, PHARMACOL REV, V64, P706, DOI 10.1124/pr.111.005637; Shi YH, 2011, AUTOPHAGY, V7, P1159, DOI 10.4161/auto.7.10.16818; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; Takes RP, 2012, HEAD NECK-J SCI SPEC, V34, P270, DOI 10.1002/hed.21613; Thome R, 2013, IMMUNOL LETT, V153, P50, DOI 10.1016/j.imlet.2013.07.004; Wang JR, 2013, NONLINEAR ANAL-HYBRI, V8, P1, DOI 10.1016/j.nahs.2012.08.003; Wu Zhaoju, 2010, Genes Cancer, V1, P40, DOI 10.1177/1947601909358324; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Yu L, 2014, CANCER LETT, V355, P34, DOI 10.1016/j.canlet.2014.09.020; Zinn RL, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-16; Zou YY, 2013, J THORAC ONCOL, V8, P693, DOI 10.1097/JTO.0b013e31828c7210	40	44	49	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0126147	10.1371/journal.pone.0126147	http://dx.doi.org/10.1371/journal.pone.0126147			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923669	gold, Green Submitted, Green Published			2022-12-27	WOS:000353711600172
J	Chadha, MS; Potdar, VA; Saha, S; Koul, PA; Broor, S; Dar, L; Chawla-Sarkar, M; Biswas, D; Gunasekaran, P; Abraham, AM; Shrikhande, S; Jain, A; Anukumar, B; Lal, RB; Mishra, AC				Chadha, Mandeep S.; Potdar, Varsha A.; Saha, Siddhartha; Koul, Parvaiz A.; Broor, Shobha; Dar, Lalit; Chawla-Sarkar, Mamta; Biswas, Dipankar; Gunasekaran, Palani; Abraham, Asha Mary; Shrikhande, Sunanda; Jain, Amita; Anukumar, Balakrishnan; Lal, Renu B.; Mishra, Akhilesh C.			Dynamics of Influenza Seasonality at Sub-Regional Levels in India and Implications for Vaccination Timing	PLOS ONE			English	Article							PATTERNS; TRANSMISSION	Background Influenza surveillance is an important tool to identify emerging/reemerging strains, and defining seasonality. We describe the distinct patterns of circulating strains of the virus in different areas in India from 2009 to 2013. Methods Patients in ten cities presenting with influenza like illness in out-patient departments of dispensaries/hospitals and hospitalized patients with severe acute respiratory infections were enrolled. Nasopharangeal swabs were tested for influenza viruses by real-time RT-PCR, and subtyping; antigenic and genetic analysis were carried out using standard assays. Results Of the 44,127 ILI/SARI cases, 6,193 (14.0%) were positive for influenza virus. Peaks of influenza were observed during July-September coinciding with monsoon in cities Delhi and Lucknow (north), Pune (west), Allaphuza (southwest), Nagpur (central), Kolkata (east) and Dibrugarh (northeast), whereas Chennai and Vellore (southeast) revealed peaks in October- November, coinciding with the monsoon months in these cities. In Srinagar (Northern most city at 34 degrees N latitude) influenza circulation peaked in January-March in winter months. The patterns of circulating strains varied over the years: whereas A/H1N1pdm09 and type B co-circulated in 2009 and 2010, H3N2 was the predominant circulating strain in 2011, followed by circulation of A/H1N1pdm09 and influenza B in 2012 and return of A/H3N2 in 2013. Antigenic analysis revealed that most circulating viruses were close to vaccine selected viral strains. Conclusions Our data shows that India, though physically located in northern hemisphere, has distinct seasonality that might be related to latitude and environmental factors. While cities with temperate seasonality will benefit from vaccination in September-October, cities with peaks in the monsoon season in July-September will benefit from vaccination in April-May. Continued surveillance is critical to understand regional differences in influenza seasonality at regional and sub-regional level, especially in countries with large latitude span.	[Chadha, Mandeep S.; Potdar, Varsha A.; Mishra, Akhilesh C.] Natl Inst Virol, Pune, Maharashtra, India; [Saha, Siddhartha; Lal, Renu B.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Koul, Parvaiz A.] Sheri Kashmir Inst Med Sci, Srinagar, Jammu & Kashmir, India; [Broor, Shobha; Dar, Lalit] All India Inst Med Sci, New Delhi, India; [Chawla-Sarkar, Mamta] Natl Inst Cholera & Enter Dis, Kolkata, India; [Biswas, Dipankar] Reg Med Res Ctr, Dibrugarh, Assam, India; [Gunasekaran, Palani] King Inst Prevent Med & Res, Madras, Tamil Nadu, India; [Abraham, Asha Mary] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India; [Shrikhande, Sunanda] Indira Gandhi Med Coll, Nagpur, Maharashtra, India; [Jain, Amita] King George Med Univ, Lucknow, Uttar Pradesh, India; [Anukumar, Balakrishnan] Natl Inst Virol, Alappuzha, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV); Centers for Disease Control & Prevention - USA; Sher-i-Kashmir Institute of Medical Sciences; All India Institute of Medical Sciences (AIIMS) New Delhi; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Christian Medical College & Hospital (CMCH) Vellore; King George's Medical University; Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV)	Chadha, MS (corresponding author), Natl Inst Virol, Pune, Maharashtra, India.	mscniv@gmail.com	jain, amita/ABA-9223-2020; Broor, Shobha/AAX-4163-2021; Koul, Parvaiz/B-1666-2017; Potdar, Varsha/ABA-3799-2021	Broor, Shobha/0000-0001-9679-4180; Koul, Parvaiz/0000-0002-1700-9285; Potdar, Varsha/0000-0002-7535-7878; Abraham, Asha/0000-0002-0736-1445; Saha, Siddhartha/0000-0002-7494-267X	Department of Health and Human Services-Centers for Disease Control and Prevention (DHHS-CDC) Cooperative [1U51000333]; Indian Council of Medical Research, New Delhi	Department of Health and Human Services-Centers for Disease Control and Prevention (DHHS-CDC) Cooperative(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Indian Council of Medical Research, New Delhi(Indian Council of Medical Research (ICMR))	This study was funded by Department of Health and Human Services-Centers for Disease Control and Prevention (DHHS-CDC) Cooperative agreement number 1U51000333 and Indian Council of Medical Research, New Delhi. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner EA, 2012, J INFECT DIS, V206, P838, DOI 10.1093/infdis/jis467; Broor S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029129; Centers for Disease Control and Prevention, 2009, CDC PROT REALT RTPCR; Chadha MS, 2012, INFLUENZA OTHER RESP, V6, P196, DOI 10.1111/j.1750-2659.2011.00293.x; Chittaganpitch M, 2012, INFLUENZA OTHER RESP, V6, P276, DOI 10.1111/j.1750-2659.2011.00302.x; Finkelman BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001296; Koul PA, 2014, EMERG INFECT DIS, V20, P1723, DOI 10.3201/eid2010.140431; Lofgren E, 2007, J VIROL, V81, P5429, DOI 10.1128/JVI.01680-06; Mathews JD, 2009, INFLUENZA OTHER RESP, V3, P143, DOI 10.1111/j.1750-2659.2009.00089.x; *MEMB W PAC REG GL, 2012, PLOS ONE, V0007; Mishra AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010540; Moura FEA, 2010, CURR OPIN INFECT DIS, V23, P415, DOI 10.1097/QCO.0b013e32833cc955; Park AW, 2007, LANCET INFECT DIS, V7, P543, DOI 10.1016/S1473-3099(07)70186-X; Potdar VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009693; Saha S, 2014, B WORLD HEALTH ORGAN, V92, P318, DOI 10.2471/BLT.13.124412; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Simonsen L, 1999, VACCINE, V17, pS3, DOI 10.1016/S0264-410X(99)00099-7; Tamerius J, 2011, ENVIRON HEALTH PERSP, V119, P439, DOI 10.1289/ehp.1002383; Tamerius JD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003194; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; WHO, REC COMP INFL VIR VA; World Health Organization, 2012, WHO GLOB DIS RESP AL; Yu HJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001552	23	72	73	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0124122	10.1371/journal.pone.0124122	http://dx.doi.org/10.1371/journal.pone.0124122			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938466	Green Submitted, gold, Green Published			2022-12-27	WOS:000353943000017
J	Lee, J; Kim, SK; Youm, HW; Kim, HJ; Lee, JR; Suh, CS; Kim, SH				Lee, Jaewang; Kim, Seul Ki; Youm, Hye Won; Kim, Hak Jun; Lee, Jung Ryeol; Suh, Chang Suk; Kim, Seok Hyun			Effects of Three Different Types of Antifreeze Proteins on Mouse Ovarian Tissue Cryopreservation and Transplantation	PLOS ONE			English	Article							ICE-BINDING PROTEIN; TRANSGENIC MICE; POLYPEPTIDE; INHIBITION; MECHANISMS; EXPRESSION; RESISTANCE; FOLLICLES; APOPTOSIS; PROMOTES	Background Ovarian tissue (OT) cryopreservation is effective in preserving fertility in cancer patients who have concerns about fertility loss due to cancer treatment. However, the damage incurred at different steps during the cryopreservation procedure may cause follicular depletion; hence, preventing chilling injury would help maintain ovarian function. Objective This study was designed to investigate the beneficial effects of different antifreeze proteins (AFPs) on mouse ovarian tissue cryopreservation and transplantation. Methodology Ovaries were obtained from 5-week-old B6D2F1 mice, and each ovary was cryopreserved using two-step vitrification and four-step warming procedures. In Experiment I, ovaries were randomly allocated into fresh, vitrification control, and nine experimental groups according to the AFP type (FfIBP, LeIBP, type III) and concentration (0.1, 1, 10 mg/mL) used. After vitrification and warming, 5,790 ovarian follicles were evaluated using histology and TUNEL assays, and immunofluorescence for tau H2AX and Rad51 was used to detect DNA double-strand breaks (DSBs) and repair (DDR), respectively. In Experiment II, 20 mice were randomly divided into two groups: one where the vitrification and warming media were supplemented with 10 mg/mL LeIBP, and the other where media alone were used (control). Ovaries were then autotransplanted under both kidney capsules 7 days after vitrification together with the addition of 10 mg/mL LeIBP in the vitrification-warming media. After transplantation, the ovarian follicles, the percentage of apoptotic follicles, the extent of the CD31-positive area, and the serum FSH levels of the transplanted groups were compared. Principal Findings In Experiment I, the percentage of total grade 1 follicles was significantly higher in the 10 mg/mL LeIBP group than in the vitrification control, while all AFP-treated groups had significantly improved grade 1 primordial follicle numbers compared with those of the vitrification control. The number of apoptotic (TUNEL-positive) follicles was significantly decreased in the groups treated with 1 and 10 mg/mL LeIBP. The proportion of tau H2AX-positive follicles was significantly reduced in all AFP-treated groups, while the proportion of Rad51-positive follicles was significantly decreased in only the FfIBP- and LeIBP-treated groups. In Experiment II, after autotransplantation of OT vitrified with 10 mg/mL of LeIBP, the percentage of total grade 1 and primordial grade 1 follicles, and the extent of the CD31-positive area, were increased significantly. Moreover, the levels of serum FSH and the percentage of TUNEL-positive follicles were significantly lower in the LeIBP-treated than in the control group. Conclusion A supplementation with high concentrations of AFPs had protective effects on follicle preservation during OT vitrification-warming procedures. The group treated with LeIBP was protected most effectively. The beneficial effects of LeIBP were also observed after autotransplantation of vitrified-warmed OT. Further studies are necessary to determine the exact mechanism of these protective effects.	[Lee, Jaewang; Kim, Seul Ki; Youm, Hye Won; Lee, Jung Ryeol; Suh, Chang Suk] Seoul Natl Univ, Bundang Hosp, Dept Obstet & Gynecol, Seongnam, Gyeonggi Do, South Korea; [Lee, Jaewang; Kim, Seul Ki; Lee, Jung Ryeol; Suh, Chang Suk; Kim, Seok Hyun] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Kim, Hak Jun] Korea Polar Res Inst, Div Polar Life Sci, Inchon, South Korea; [Kim, Hak Jun] Pukyong Natl Univ, Dept Chem, Busan, South Korea	Seoul National University (SNU); Seoul National University (SNU); Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI); Pukyong National University	Lee, JR (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Obstet & Gynecol, Seongnam, Gyeonggi Do, South Korea.	leejrmd@snu.ac.kr		Lee, Jung Ryeol/0000-0003-3743-2934; Kim, Seul Ki/0000-0002-1647-6711; Lee, Jaewang/0000-0001-6801-7149	Korea Healthcare technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI12C0055]	Korea Healthcare technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant of the Korea Healthcare technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI12C0055).	Arav A, 2012, REPROD DOMEST ANIM, V47, P193, DOI 10.1111/j.1439-0531.2012.02075.x; Bagis H, 2008, J EXP ZOOL PART A, V309A, P255, DOI 10.1002/jez.455; Bagis H, 2008, MOL REPROD DEV, V75, P608, DOI 10.1002/mrd.20799; Bagis H, 2006, MOL REPROD DEV, V73, P1404, DOI 10.1002/mrd.20601; Bos-Mikich A, 2012, J ASSIST REPROD GEN, V29, P1267, DOI 10.1007/s10815-012-9867-y; Brown ET, 2009, MOL CARCINOGEN, V48, P105, DOI 10.1002/mc.20463; Campbell BK, 2004, ENDOCRINOLOGY, V145, P1870, DOI 10.1210/en.2003-1138; DeLuca CI, 1998, BIOPHYS J, V74, P1502, DOI 10.1016/S0006-3495(98)77862-2; DEVRIES AL, 1969, SCIENCE, V163, P1073, DOI 10.1126/science.163.3871.1073; Do H, 2012, ACTA CRYSTALLOGR F, V68, P806, DOI 10.1107/S1744309112020465; Fletcher GL, 2001, ANNU REV PHYSIOL, V63, P359, DOI 10.1146/annurev.physiol.63.1.359; Gage AA, 1998, CRYOBIOLOGY, V37, P171, DOI 10.1006/cryo.1998.2115; Gandolfi F, 2006, FERTIL STERIL, V85, P1150, DOI 10.1016/j.fertnstert.2005.08.062; Garnham CP, 2008, BIOCHEM J, V411, P171, DOI 10.1042/BJ20071372; Hemadi M, 2009, EUR J PHARMACOL, V618, P84, DOI 10.1016/j.ejphar.2009.07.018; Huang YY, 1999, MOL CELL BIOL, V19, P2986; Jo JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037043; Jo JW, 2011, FERTIL STERIL, V96, P1239, DOI 10.1016/j.fertnstert.2011.08.023; Kamijima T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073643; Kawahara H, 2009, BIOCONTROL SCI, V14, P49, DOI 10.4265/bio.14.49; Kim GA, 2011, THERIOGENOLOGY, V75, P1045, DOI 10.1016/j.theriogenology.2010.11.012; KNIGHT CA, 1988, CRYOBIOLOGY, V25, P55, DOI 10.1016/0011-2240(88)90020-X; Kristiansen E, 2012, J INSECT PHYSIOL, V58, P1502, DOI 10.1016/j.jinsphys.2012.09.004; Kryeziu K, 2013, MOL CANCER THER, V12, P1073, DOI 10.1158/1535-7163.MCT-13-0065; Lee JH, 2012, J BIOL CHEM, V287, P11460, DOI 10.1074/jbc.M111.331835; Lee JR, 2015, YONSEI MED J, V56, P778, DOI 10.3349/ymj.2015.56.3.778; Lee SG, 2012, APPL BIOCHEM BIOTECH, V167, P824, DOI 10.1007/s12010-012-9739-z; Leinala EK, 2002, J BIOL CHEM, V277, P33349, DOI 10.1074/jbc.M205575200; Lundy T, 1999, J REPROD FERTIL, V115, P251, DOI 10.1530/jrf.0.1150251; Middleton AJ, 2012, J MOL BIOL, V416, P713, DOI 10.1016/j.jmb.2012.01.032; Newton H, 1996, HUM REPROD, V11, P1487; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Pfeifer S, 2013, FERTIL STERIL, V100, P1214, DOI 10.1016/j.fertnstert.2013.08.012; Prathalingam NS, 2006, THERIOGENOLOGY, V66, P1894, DOI 10.1016/j.theriogenology.2006.04.041; Raymond JA, 2008, EXTREMOPHILES, V12, P713, DOI 10.1007/s00792-008-0178-2; Raymond JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035968; Rubinsky L, 2010, NEUROSCI RES, V67, P256, DOI 10.1016/j.neures.2010.04.004; Sak A, 2005, BRIT J CANCER, V92, P1089, DOI 10.1038/sj.bjc.6602457; Salvay AG, 2010, BIOPHYS J, V99, P609, DOI 10.1016/j.bpj.2010.04.030; Shikanov A, 2011, TISSUE ENG PT A, V17, P3095, DOI [10.1089/ten.TEA.2011.0204, 10.1089/ten.tea.2011.0204]; Soleimani R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019475; WEN DY, 1992, BIOPHYS J, V63, P1659, DOI 10.1016/S0006-3495(92)81750-2; WEN DY, 1992, J BIOL CHEM, V267, P14102; Yang H, 2008, FERTIL STERIL, V90, P1550, DOI 10.1016/j.fertnstert.2007.08.086; Yeh Y, 1996, CHEM REV, V96, P601, DOI 10.1021/cr950260c; Youm HW, 2014, HUM REPROD, V29, P720, DOI 10.1093/humrep/det449; Yu SO, 2010, CRYOBIOLOGY, V61, P327, DOI 10.1016/j.cryobiol.2010.10.158	47	34	37	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0126252	10.1371/journal.pone.0126252	http://dx.doi.org/10.1371/journal.pone.0126252			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938445	Green Published, Green Submitted, gold			2022-12-27	WOS:000353943000155
J	Patil, KR; Mohapatra, P; Patel, HM; Goyal, SN; Ojha, S; Kundu, CN; Patil, CR				Patil, Kalpesh R.; Mohapatra, Purusottam; Patel, Harun M.; Goyal, Sameer N.; Ojha, Shreesh; Kundu, Chanakya N.; Patil, Chandragouda R.			Pentacyclic Triterpenoids Inhibit IKK beta Mediated Activation of NF-kappa B Pathway: In Silico and In Vitro Evidences	PLOS ONE			English	Article							INDUCED INFLAMMATORY RESPONSES; COMPUTER-AIDED PREDICTION; DRUG DISCOVERY; PHARMACOLOGICAL-ACTIVITIES; CRYSTAL-STRUCTURE; GENE-EXPRESSION; CANCER CELLS; KINASE IKK; ACID; IDENTIFICATION	Pentacyclic Triterpenoids (PTs) and their analogues as well as derivatives are emerging as important drug leads for various diseases. They act through a variety of mechanisms and a majority of them inhibit the nuclear factor kappa-beta (NF-kappa B) signaling pathway. In this study, we examined the effects of the naturally occurring PTs on I kappa B kinase-beta (IKK beta), which has great scientific relevance in the NF-kappa B signaling pathway. On virtual screening, 109 PTs were screened through the PASS (prediction of activity spectra of substances) software for prediction of NF-kappa B inhibitory activity followed by docking on the NEMO/IKK beta association complex (PDB: 3BRV) and testing for compliance with the softened Lipinski's Rule of Five using Schrodinger (LLC, New York, USA). Out of the projected 45 druggable PTs, Corosolic Acid (CA), Asiatic Acid (AA) and Ursolic Acid (UA) were assayed for IKK beta kinase activity in the cell free medium. The UA exhibited a potent IKK beta inhibitory effect on the hot-spot kinase assay with IC50 of 69 mu M. Whereas, CA at 50 mu M concentration markedly reduced the NF-kappa B luciferase activity and phospho-IKK beta protein expressions. The PTs tested, attenuated the expression of the NF-kappa B cascade proteins in the LPS-stimulated RAW 264.7 cells, prevented the phosphorylation of the IKK alpha/beta and blocked the activation of the Interferon-gamma (IFN-gamma). The results suggest that the IKK beta inhibition is the major mechanism of the PTs-induced NF-kappa B inhibition. PASS predictions along with in-silico docking against the NEMO/IKK beta can be successfully applied in the selection of the prospective NF-kappa B inhibitory downregulators of IKK beta phosphorylation.	[Patil, Kalpesh R.] HR Patel Inst Pharmaceut Educ & Res, Dept Pharmacol, Dist Dhule, Maharashtra, India; [Mohapatra, Purusottam; Kundu, Chanakya N.] KIIT Univ, KIIT Sch Biotechnol, Canc Biol Lab, Bhubaneswar, Orissa, India; [Patel, Harun M.] RC Patel Inst Pharmaceut Educ & Res, Dept Pharmaceut Chem, Dist Dhule, Maharashtra, India; [Goyal, Sameer N.; Patil, Chandragouda R.] RC Patel Inst Pharmaceut Educ & Res, Dept Pharmacol, Dist Dhule, Maharashtra, India; [Ojha, Shreesh] United Arab Emirates Univ, Dept Pharmacol & Therapeut, Coll Med & Hlth Sci, Al Ain, U Arab Emirates	Kalinga Institute of Industrial Technology (KIIT); United Arab Emirates University	Kundu, CN (corresponding author), KIIT Univ, KIIT Sch Biotechnol, Canc Biol Lab, Bhubaneswar, Orissa, India.	kalpeshpharma20@gmail.com; cnkundu@gmail.com; pchandragouda@yahoo.com	Patel, Harun/P-1434-2019; Patil, Kalpesh R./H-4173-2019; Patil, Chandragouda Raosaheb/E-3510-2019; Patel, Harun Miyalal/L-7942-2019	Patil, Chandragouda Raosaheb/0000-0001-7712-7227; Patel, Harun Miyalal/0000-0003-0920-1266; Goyal, sameer/0000-0002-5241-7049; Mohapatra, Purusottam/0000-0001-8059-4141; Kundu, Chanakya/0000-0003-0297-1030; Patil, Chandragouda/0000-0001-8401-1978; OJHA, SHREESH/0000-0001-7801-2966; Patil, Kalpesh/0000-0003-2397-4687				Aggarwal Bharat B., 2004, Indian Journal of Experimental Biology, V42, P341; Alqahtani A, 2013, CURR MED CHEM, V20, P908; An HJ, 2011, INT IMMUNOPHARMACOL, V11, P504, DOI 10.1016/j.intimp.2011.01.002; Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; [Anonymous], 2009, QIKPROP VERSION 9 0; [Anonymous], 2009, LIGPREP VERSION 2 3; [Anonymous], 2009, GLIDE VERSION 5 5; Bamborough P, 2009, CURR TOP MED CHEM, V9, P623, DOI 10.2174/156802609789007336; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Calixto JB, 2003, PLANTA MED, V69, P973, DOI [10.1055/s-2003-45141, 10.1055/s-2004-815483]; Cao W, 2010, INT IMMUNOPHARMACOL, V10, P723, DOI 10.1016/j.intimp.2010.03.015; Cha DS, 2011, J ETHNOPHARMACOL, V134, P305, DOI 10.1016/j.jep.2010.12.017; Chakraborty P, 2014, TOXICOL APPL PHARM, V277, P95, DOI 10.1016/j.taap.2014.03.011; Checker R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031318; Chen HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038261; Chen H, 2012, CIRC J, V76, P995, DOI 10.1253/circj.CJ-11-0344; Chen RJY, 2010, ACTA PHARMACOL SIN, V31, P696, DOI 10.1038/aps.2010.61; Choi RJ, 2014, INT IMMUNOPHARMACOL, V18, P182, DOI 10.1016/j.intimp.2013.11.022; Cuoi YH, 2011, BIOL PHARM BULL, V34, P959, DOI 10.1248/bpb.34.959; de las Heras B., 2009, Inflammation & Allergy Drug Targets, V8, P28; Dzubak P, 2006, NAT PROD REP, V23, P394, DOI 10.1039/b515312n; Filimonov DA, 2014, CHEM HETEROCYCL COM+, V50, P444, DOI 10.1007/s10593-014-1496-1; Gautam R, 2009, MED RES REV, V29, P767, DOI 10.1002/med.20156; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Goel RK, 2011, MED CHEM RES, V20, P1509, DOI 10.1007/s00044-010-9398-y; Grover A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S25; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Halgren TA, 1996, J COMPUT CHEM, V17, P520, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<520::AID-JCC2>3.0.CO;2-W; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Huang JJ, 2013, EUR J MED CHEM, V63, P269, DOI 10.1016/j.ejmech.2013.01.045; Jager S, 2009, MOLECULES, V14, P2016, DOI 10.3390/molecules14062016; Jung YS, 2014, TOXICOL APPL PHARM, V277, P67, DOI 10.1016/j.taap.2014.03.001; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Kim IT, 2012, J CELL BIOCHEM, V113, P1936, DOI 10.1002/jcb.24062; Kim JH, 2009, EUR J PHARMACOL, V602, P422, DOI 10.1016/j.ejphar.2008.10.062; Klimpel GR., 1996, MED MICROBIOLOGY; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Kryzhanovskii SA, 2012, PHARM CHEM J+, V45, P605; Kwon OK, 2010, J ETHNOPHARMACOL, V130, P28, DOI 10.1016/j.jep.2010.04.002; Lagunin A, 2010, CURR PHARM DESIGN, V16, P1703, DOI 10.2174/138161210791164063; Lagunin A, 2009, QSAR COMB SCI, V28, P806, DOI 10.1002/qsar.200860192; Lagunin AA, 2014, NAT PROD REP, V31, P1585, DOI 10.1039/c4np00068d; Laszczyk MN, 2009, PLANTA MED, V75, P1549, DOI 10.1055/s-0029-1186102; Lee JH, 2006, BIOCHEM PHARMACOL, V72, P1311, DOI 10.1016/j.bcp.2006.08.014; Lee SH, 2012, MBIO, V3, DOI 10.1128/mBio.00411-12; Leung CH, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-3; Li FY, 2012, INFLAMMATION, V35, P1669, DOI 10.1007/s10753-012-9483-0; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Liu J, 1995, J ETHNOPHARMACOL, V49, P57, DOI 10.1016/0378-8741(95)90032-2; Lu J, 2011, BRAIN BEHAV IMMUN, V25, P1658, DOI 10.1016/j.bbi.2011.06.009; Mbalaviele G, 2009, J PHARMACOL EXP THER, V329, P14, DOI 10.1124/jpet.108.143800; MOOLA ZB, 1994, BIOCHEM J, V302, P921, DOI 10.1042/bj3020921; Moura LIF, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/941764; Nagarajan S, 2010, BMC BIOINFORMATICS, V11, DOI [10.1186/1471-2105-11-S7-S15, 10.1186/1471-2105-11-S7-515]; Nam KY, 2011, B KOREAN CHEM SOC, V32, P4397, DOI 10.5012/bkcs.2011.32.12.4397; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; Novoselova EG, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/724838; Parasuraman S, 2011, J PHARMACOL PHARMACO, V2, P52, DOI 10.4103/0976-500X.77119; Petit J, 2012, BIOORGAN MED CHEM, V20, P5343, DOI 10.1016/j.bmc.2011.11.064; Piccagli L, 2010, BIOORGAN MED CHEM, V18, P8341, DOI 10.1016/j.bmc.2010.09.063; Pollier J, 2012, PHYTOCHEMISTRY, V77, P10, DOI 10.1016/j.phytochem.2011.12.022; Preet R, 2012, INT J CANCER, V130, P1660, DOI 10.1002/ijc.26158; Rios JL, 2010, J ETHNOPHARMACOL, V128, P1, DOI 10.1016/j.jep.2009.12.045; Rothgiesser KM, 2010, J CELL SCI, V123, P4251, DOI 10.1242/jcs.073783; Ruland J, 2003, IMMUNOL REV, V193, P93, DOI 10.1034/j.1600-065X.2003.00049.x; Safayhi H, 1997, PLANTA MED, V63, P487, DOI 10.1055/s-2006-957748; Salminen A, 2008, CELL MOL LIFE SCI, V65, P2979, DOI 10.1007/s00018-008-8103-5; Salminen A, 2010, BIOCHEM BIOPH RES CO, V394, P439, DOI 10.1016/j.bbrc.2010.03.050; Satapathy SR, 2013, NANOMEDICINE-UK, V8, P1307, DOI [10.2217/NNM.12.176, 10.2217/nnm.12.176]; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Shah BA, 2009, NAT PROD REP, V26, P72, DOI 10.1039/b809437n; Sporn MB, 2007, DRUG DEVELOP RES, V68, P174, DOI 10.1002/ddr.20179; Sun SC, 2013, TRENDS IMMUNOL, V34, P282, DOI 10.1016/j.it.2013.01.004; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tarasova OA, 2008, SAR QSAR ENVIRON RES, V19, P81, DOI 10.1080/10629360701844183; Tergaonkar V, 2006, INT J BIOCHEM CELL B, V38, P1647, DOI 10.1016/j.biocel.2006.03.023; Tolliday N, 2006, CANCER RES, V66, P8935, DOI 10.1158/0008-5472.CAN-06-2552; Tripathi P, 2006, CURR SCI INDIA, V90, P519; Verma IM, 2004, ANN RHEUM DIS, V63, P57, DOI 10.1136/ard.2004.028266; Wen DY, 2006, J PHARMACOL EXP THER, V317, P989, DOI 10.1124/jpet.105.097584; WEST MA, 1995, SURGERY, V118, P220, DOI 10.1016/S0039-6060(05)80327-7; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188; Wong ET, 2009, CLIN SCI, V116, P451, DOI 10.1042/CS20080502; Xu GZ, 2011, NATURE, V472, P325, DOI 10.1038/nature09853; Yadav VR, 2010, TOXINS, V2, P2428, DOI 10.3390/toxins2102428; Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914; Yore MM, 2006, MOL CANCER THER, V5, P3232, DOI 10.1158/1535-7163.MCT-06-0444; Zhang MQ, 2007, CURR OPIN BIOTECH, V18, P478, DOI 10.1016/j.copbio.2007.10.005	91	38	40	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125709	10.1371/journal.pone.0125709	http://dx.doi.org/10.1371/journal.pone.0125709			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938234	Green Published, Green Submitted, gold			2022-12-27	WOS:000353943000093
J	Zhang, GY; Liu, RR; Zhang, CQ; Tang, KX; Sun, MF; Yan, GH; Liu, QQ				Zhang, Gui-Yun; Liu, Ru-Ru; Zhang, Chang-Quan; Tang, Ke-Xuan; Sun, Ming-Fa; Yan, Guo-Hong; Liu, Qiao-Quan			Manipulation of the Rice L-Galactose Pathway: Evaluation of the Effects of Transgene Overexpression on Ascorbate Accumulation and Abiotic Stress Tolerance	PLOS ONE			English	Article							GALACTURONIC ACID REDUCTASE; VITAMIN-C; BIOSYNTHETIC-PATHWAY; CHILLING STRESS; PLANTS; GENE; ARABIDOPSIS; PHOSPHORYLASE; CHLOROPLASTS; LEAVES	Ascorbic acid (AsA) is the most abundant water-soluble antioxidant in plants, and it plays a crucial role in plant growth, development and abiotic stress tolerance. In the present study, six key Arabidopsis or rapeseed genes involved in AsA biosynthesis were constitutively overexpressed in an elite Japonica rice cultivar. These genes encoded the GDP-mannose pyrophosphorylase (GMP), GDP-mannose-3', 5'-epimerase (GME), GDP-L-galactose phosphorylase (GGP), L-galactose-1-phosphate phosphatase (GPP), L-galactose dehydrogenase (GDH), and L-galactono-1,4-lactone dehydrogenase (GalLDH). The effects of transgene expression on rice leaf AsA accumulation were carefully evaluated. In homozygous transgenic seedlings, AtGGP transgenic lines had the highest AsA contents (2.55-fold greater than the empty vector transgenic control), followed by the AtGME and AtGDH transgenic lines. Moreover, with the exception of the AtGPP lines, the increased AsA content also provoked an increase in the redox state (AsA/DHA ratio). To evaluate salt tolerance, AtGGP and AtGME transgenic seedlings were exposed to salt stress for one week. The relative plant height, root length and fresh weight growth rates were significantly higher for the transgenic lines compared with the control plants. Altogether, our results suggest that GGP may be a key rate-limiting step in rice AsA biosynthesis, and the plants with elevated AsA contents demonstrated enhanced tolerance for salt stress.	[Zhang, Gui-Yun; Liu, Ru-Ru; Zhang, Chang-Quan; Liu, Qiao-Quan] Yangzhou Univ, Coinnovat Ctr Modern Prod Technol Grain Crops, Key Lab Crop Genet & Physiol Jiangsu Prov, Yangzhou 225009, Jiangsu, Peoples R China; [Zhang, Gui-Yun; Sun, Ming-Fa; Yan, Guo-Hong] Agr Sci Inst Coastal Reg Jiangsu, Yancheng 224002, Jiangsu, Peoples R China; [Tang, Ke-Xuan] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200240, Peoples R China	Yangzhou University; Jiangsu Academy of Agricultural Sciences; Shanghai Jiao Tong University	Liu, QQ (corresponding author), Yangzhou Univ, Coinnovat Ctr Modern Prod Technol Grain Crops, Key Lab Crop Genet & Physiol Jiangsu Prov, Yangzhou 225009, Jiangsu, Peoples R China.	qqliu@yzu.edu.cn	Tang, Kexuan/E-3555-2013	Tang, Kexuan/0000-0002-8748-9624	National Key Basic Research Projects [2012CB944803]; National Major Special Project for the Development of Transgenic Organisms [2014ZX08001006-005]; National Science Foundation of China [31471459]; Independent Innovation Fund of Jiangsu Province, China [CX (13) 5084]	National Key Basic Research Projects(National Basic Research Program of China); National Major Special Project for the Development of Transgenic Organisms; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Independent Innovation Fund of Jiangsu Province, China	This study was supported by the National Key Basic Research Projects (2012CB944803), the National Major Special Project for the Development of Transgenic Organisms (2014ZX08001006-005), the National Science Foundation of China (31471459) to QQL, and the Independent Innovation Fund of Jiangsu Province (CX (13) 5084), China to GYZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agius F, 2003, NAT BIOTECHNOL, V21, P177, DOI 10.1038/nbt777; Badejo AA, 2008, PLANT CELL PHYSIOL, V49, P126, DOI 10.1093/pcp/pcm164; Barth C, 2004, PLANT PHYSIOL, V134, P1784, DOI 10.1104/pp.103.032185; Bulley S, 2012, PLANT BIOTECHNOL J, V10, P390, DOI 10.1111/j.1467-7652.2011.00668.x; Chao YY, 2010, PLANT PHYSIOL BIOCH, V48, P374, DOI 10.1016/j.plaphy.2010.01.009; Cronje C, 2012, PLANTA, V235, P553, DOI 10.1007/s00425-011-1525-6; De Tullio MC, 2004, CELL MOL LIFE SCI, V61, P209, DOI 10.1007/s00018-003-3203-8; Debolt S, 2007, ANN BOT-LONDON, V99, P3, DOI 10.1093/aob/mcl236; Eltayeb AE, 2011, BREEDING SCI, V61, P3, DOI 10.1270/jsbbs.61.3; Feng ZZ, 2010, ENVIRON POLLUT, V158, P3539, DOI 10.1016/j.envpol.2010.08.019; Frei M, 2012, PLANT PHYSIOL BIOCH, V59, P63, DOI 10.1016/j.plaphy.2012.02.015; Fukunaga K, 2010, BIOSCI BIOTECH BIOCH, V74, P888, DOI 10.1271/bbb.90929; Gatzek S, 2002, PLANT J, V30, P541, DOI 10.1046/j.1365-313X.2002.01315.x; Guo ZF, 2005, PLANT PHYSIOL BIOCH, V43, P955, DOI 10.1016/j.plaphy.2005.08.007; Hemavathi, 2011, MOL BREEDING, V28, P105, DOI 10.1007/s11032-010-9465-6; Hemavathi, 2009, PLANT SCI, V177, P659, DOI 10.1016/j.plantsci.2009.08.004; Holler S, 2014, PLANTA, V239, P367, DOI 10.1007/s00425-013-1978-x; Imai T, 2012, PLANT CELL TISS ORG, V111, P1, DOI 10.1007/s11240-012-0165-2; Jain AK, 2000, MOL BREEDING, V6, P73, DOI 10.1023/A:1009680818138; Kwon SY, 2003, J PLANT PHYSIOL, V160, P347, DOI 10.1078/0176-1617-00926; Laing WA, 2007, P NATL ACAD SCI USA, V104, P9534, DOI 10.1073/pnas.0701625104; Lim MY, 2012, IN VITRO CELL DEV-PL, V48, P453, DOI 10.1007/s11627-012-9461-0; Lisko KA, 2013, IN VITRO CELL DEV-PL, V49, P643, DOI 10.1007/s11627-013-9568-y; Liu W, 2013, ACTA PHYSIOL PLANT, V35, P1617, DOI 10.1007/s11738-012-1204-7; Liu YH, 2011, ACTA PHYSIOL PLANT, V33, P1353, DOI 10.1007/s11738-010-0669-5; Lopez-Carbonell M, 2006, J PLANT GROWTH REGUL, V25, P137, DOI 10.1007/s00344-005-0119-6; Lorence A, 2004, PLANT PHYSIOL, V134, P1200, DOI 10.1104/pp.103.033936; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Noctor G, 2006, PLANT CELL ENVIRON, V29, P409, DOI 10.1111/j.1365-3040.2005.01476.x; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Talla S, 2011, J BIOSCIENCES, V36, P163, DOI 10.1007/s12038-011-9000-x; Venkatesh J, 2012, HORTIC ENVIRON BIOTE, V53, P320, DOI 10.1007/s13580-012-0035-1; Wang HS, 2011, PLANT CELL REP, V30, P1029, DOI 10.1007/s00299-011-1009-y; Wang LY, 2013, J PLANT PHYSIOL, V170, P303, DOI 10.1016/j.jplph.2012.10.015; Wang LY, 2014, PLANT CELL REP, V33, P1441, DOI 10.1007/s00299-014-1627-2; Wang ZN, 2010, J INTEGR PLANT BIOL, V52, P400, DOI 10.1111/j.1744-7909.2010.00921.x; Watanabe K, 2006, PHYTOCHEMISTRY, V67, P338, DOI 10.1016/j.phytochem.2005.12.003; Wheeler GL, 1998, NATURE, V393, P365, DOI 10.1038/30728; Wolucka BA, 2003, J BIOL CHEM, V278, P47483, DOI 10.1074/jbc.M309135200; Yamane K, 2004, PLANT PROD SCI, V7, P292, DOI 10.1626/pps.7.292; Zhang CJ, 2011, PLANT CELL REP, V30, P389, DOI 10.1007/s00299-010-0939-0; Zhang GY, 2013, TRANSGENIC RES, V22, P89, DOI 10.1007/s11248-012-9630-2; Zhou Y, 2012, BIOL PLANTARUM, V56, P451, DOI 10.1007/s10535-012-0119-x	44	42	46	4	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125870	10.1371/journal.pone.0125870	http://dx.doi.org/10.1371/journal.pone.0125870			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938231	gold, Green Published, Green Submitted			2022-12-27	WOS:000353943000113
J	Cohan, CH; Neumann, JT; Dave, KR; Alekseyenko, A; Binkert, M; Stransky, K; Lin, HW; Barnes, CA; Wright, CB; Perez-Pinzon, MA				Cohan, Charles H.; Neumann, Jake T.; Dave, Kunjan R.; Alekseyenko, Aleksey; Binkert, Marc; Stransky, Kenneth; Lin, Hung Wen; Barnes, Carol A.; Wright, Clinton B.; Perez-Pinzon, Miguel A.			Effect of Cardiac Arrest on Cognitive Impairment and Hippocampal Plasticity in Middle-Aged Rats	PLOS ONE			English	Article							LONG-TERM POTENTIATION; MEMORY IMPAIRMENT; NEURONAL DAMAGE; FOREBRAIN ISCHEMIA; WORKING-MEMORY; BRAIN-DAMAGE; BARNES MAZE; WATER MAZE; CA1; DEFICITS	Cardiopulmonary arrest is a leading cause of death and disability in the United States that usually occurs in the aged population. Cardiac arrest (CA) induces global ischemia, disrupting global cerebral circulation that results in ischemic brain injury and leads to cognitive impairments in survivors. Ischemia-induced neuronal damage in the hippocampus following CA can result in the impairment of cognitive function including spatial memory. In the present study, we used a model of asphyxial CA (ACA) in nine month old male Fischer 344 rats to investigate cognitive and synaptic deficits following mild global cerebral ischemia. These experiments were performed with the goals of 1) establishing a model of CA in nine month old middle-aged rats; and 2) to test the hypothesis that learning and memory deficits develop following mild global cerebral ischemia in middle-aged rats. To test this hypothesis, spatial memory assays (Barnes circular platform maze and contextual fear conditioning) and field recordings (long-term potentiation and paired-pulse facilitation) were performed. We show that following ACA in nine month old middle-aged rats, there is significant impairment in spatial memory formation, paired-pulse facilitation n dysfunction, and a reduction in the number of non-compromised hippocampal Cornu Ammonis 1 and subiculum neurons. In conclusion, nine month old animals undergoing cardiac arrest have impaired survival, deficits in spatial memory formation, and synaptic dysfunction.	[Cohan, Charles H.; Neumann, Jake T.; Dave, Kunjan R.; Alekseyenko, Aleksey; Binkert, Marc; Stransky, Kenneth; Lin, Hung Wen; Perez-Pinzon, Miguel A.] Univ Miami, Leonard M Miller Sch Med, Cerebral Vasc Dis Res Labs, Miami, FL 33136 USA; [Cohan, Charles H.; Neumann, Jake T.; Dave, Kunjan R.; Alekseyenko, Aleksey; Lin, Hung Wen; Wright, Clinton B.; Perez-Pinzon, Miguel A.] Univ Miami, Leonard M Miller Sch Med, Evelyn F McKnight Brain Inst, Miami, FL USA; [Cohan, Charles H.; Neumann, Jake T.; Dave, Kunjan R.; Alekseyenko, Aleksey; Binkert, Marc; Stransky, Kenneth; Lin, Hung Wen; Wright, Clinton B.; Perez-Pinzon, Miguel A.] Univ Miami, Leonard M Miller Sch Med, Dept Neurol, Miami, FL USA; [Cohan, Charles H.; Dave, Kunjan R.; Wright, Clinton B.; Perez-Pinzon, Miguel A.] Univ Miami, Leonard M Miller Sch Med, Neurosci Program, Miami, FL USA; [Barnes, Carol A.] Univ Arizona, Evelyn F McKnight Brain Inst, Tucson, AZ USA; [Barnes, Carol A.] Univ Arizona, ARL Div Neural Syst Memory & Aging, Tucson, AZ USA; [Barnes, Carol A.] Univ Arizona, Dept Psychol, Tucson, AZ 85721 USA; [Barnes, Carol A.] Univ Arizona, Dept Neurol & Neurosci, Tucson, AZ 85721 USA	University of Miami; University of Miami; University of Miami; University of Miami; University of Arizona; University of Arizona; University of Arizona; University of Arizona	Perez-Pinzon, MA (corresponding author), Univ Miami, Leonard M Miller Sch Med, Cerebral Vasc Dis Res Labs, Miami, FL 33136 USA.	Perezpinzon@med.miami.edu			National Institutes of Health [NS45676, NS054147, NS34773, NS073779]; American Heart Association [13POST16720001]; Evelyn F. McKnight Brain Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS034773, R01NS073779, R55NS034773, R01NS045676, R01NS034773, R01NS054147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Evelyn F. McKnight Brain Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health, Grant Numbers: NS45676, NS054147, NS34773, and NS073779 (http://www.nih.gov); the American Heart Association, 13POST16720001 (http://www.heart.org); and the Evelyn F. McKnight Brain Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander MP, 2011, J INT NEUROPSYCH SOC, V17, P364, DOI 10.1017/S1355617710001633; AUER RN, 1989, J NEUROSCI, V9, P1641; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; BEACH ME, 1995, CELL, V81, P905, DOI 10.1016/0092-8674(95)90010-1; BECKER LB, 1993, NEW ENGL J MED, V329, P600, DOI 10.1056/NEJM199308263290902; Bizon JL, 2012, FRONT AGING NEUROSCI, V4, DOI 10.3389/fnagi.2012.00019; Block F, 1997, PHARMACOL BIOCHEM BE, V56, P755, DOI 10.1016/S0091-3057(96)00484-4; Brewer LD, 2006, CELL CALCIUM, V40, P277, DOI 10.1016/j.ceca.2006.04.001; Calabresi P, 2003, LANCET NEUROL, V2, P622, DOI 10.1016/S1474-4422(03)00532-5; CALLE PA, 1989, J PHARMACOL METHOD, V22, P185, DOI 10.1016/0160-5402(89)90013-2; Cipolotti L, 2006, CURR OPIN NEUROL, V19, P593, DOI 10.1097/01.wco.0000247608.42320.f9; Dai XN, 2007, NEUROPHARMACOLOGY, V52, P1124, DOI 10.1016/j.neuropharm.2006.11.012; Dave KR, 2004, BRAIN RES, V1024, P89, DOI 10.1016/j.brainres.2004.07.050; Dave KR, 2006, NEUROSCI LETT, V404, P170, DOI 10.1016/j.neulet.2006.05.037; DAVIS HP, 1986, PHYSIOL BEHAV, V37, P387, DOI 10.1016/0031-9384(86)90195-2; de la Tremblaye PB, 2011, BEHAV BRAIN RES, V219, P227, DOI 10.1016/j.bbr.2011.01.009; Della-Morte D, 2009, NEUROSCIENCE, V159, P993, DOI 10.1016/j.neuroscience.2009.01.017; Deo R, 2012, CIRCULATION, V125, P620, DOI 10.1161/CIRCULATIONAHA.111.023838; Ferguson GD, 2004, HIPPOCAMPUS, V14, P964, DOI 10.1002/hipo.20013; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; GINSBERG MD, 1989, STROKE, V20, P1627, DOI 10.1161/01.STR.20.12.1627; Ginsberg MD, 2008, NEUROPHARMACOLOGY, V55, P363, DOI 10.1016/j.neuropharm.2007.12.007; Ginsberg MD, 2009, STROKE, V40, pS111, DOI 10.1161/STROKEAHA.108.528877; GLOBUS MYT, 1992, STROKE, V23, P1595, DOI 10.1161/01.STR.23.11.1595; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Grubb NR, 2000, STROKE, V31, P1509, DOI 10.1161/01.STR.31.7.1509; Harrison FE, 2009, BEHAV BRAIN RES, V198, P247, DOI 10.1016/j.bbr.2008.10.015; Hickey RW, 1996, PEDIATR RES, V39, P77, DOI 10.1203/00006450-199601000-00011; Hicks SD, 2000, J CEREBR BLOOD F MET, V20, P520, DOI 10.1097/00004647-200003000-00011; HORI N, 1994, EXP NEUROL, V129, P279, DOI 10.1006/exnr.1994.1170; Horstmann A, 2010, NEUROLOGY, V74, P306, DOI 10.1212/WNL.0b013e3181cbcd6f; Jin KL, 2004, AGING CELL, V3, P373, DOI 10.1111/j.1474-9728.2004.00131.x; KATZ L, 1995, J CEREBR BLOOD F MET, V15, P1032, DOI 10.1038/jcbfm.1995.129; Kiprianova I, 1999, EXP NEUROL, V159, P511, DOI 10.1006/exnr.1999.7109; Kiryk A, 2011, BEHAV BRAIN RES, V219, P1, DOI 10.1016/j.bbr.2010.12.004; KIYOTA Y, 1991, BRAIN RES, V538, P295, DOI 10.1016/0006-8993(91)90443-Y; Kurinami H, 2014, STROKE, V45, P1131, DOI 10.1161/STROKEAHA.113.003577; Lebesgue D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008642; Lim C, 2004, NEUROLOGY, V63, P1774, DOI 10.1212/01.WNL.0000144189.83077.8E; Lin HW, 2014, J CEREBR BLOOD F MET, V34, P613, DOI 10.1038/jcbfm.2013.232; Lin HW, 2014, TRANSL STROKE RES, V5, P109, DOI 10.1007/s12975-013-0276-z; McNally B, 2011, MMWR SURVEILL SUMM, V60, P1; Moyer JR, VISUALLY GUIDED PATC, P169; Neigh GN, 2004, EUR J NEUROSCI, V20, P1865, DOI 10.1111/j.1460-9568.2004.03649.x; Neumann JT, 2013, CURR DRUG TARGETS, V14, P20; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; O'Leary TP, 2009, BEHAV BRAIN RES, V201, P120, DOI 10.1016/j.bbr.2009.01.039; ORDY JM, 1988, NEUROBIOL AGING, V9, P667, DOI 10.1016/S0197-4580(88)80131-3; PerezPinzon MA, 1997, J CEREBR BLOOD F MET, V17, P175, DOI 10.1097/00004647-199702000-00007; PETITO CK, 1987, NEUROLOGY, V37, P1281, DOI 10.1212/WNL.37.8.1281; Powell CM, 2004, NEURON, V42, P143, DOI 10.1016/S0896-6273(04)00146-1; Rea TD, 2010, CIRCULATION, V121, P1134, DOI 10.1161/CIRCULATIONAHA.109.899799; Roberge MC, 2008, BEHAV BRAIN RES, V187, P123, DOI 10.1016/j.bbr.2007.09.002; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; ROINE RO, 1993, JAMA-J AM MED ASSOC, V269, P237, DOI 10.1001/jama.269.2.237; Sacchetti B, 2002, EUR J NEUROSCI, V15, P143, DOI 10.1046/j.0953-816x.2001.01844.x; Sama DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038170; Sasson C, 2010, CIRC-CARDIOVASC QUAL, V3, P63, DOI 10.1161/CIRCOUTCOMES.109.889576; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; SMITH ML, 1984, ACTA NEUROPATHOL, V64, P319, DOI 10.1007/BF00690397; Verkhratsky A, 1998, TRENDS NEUROSCI, V21, P2, DOI 10.1016/S0166-2236(97)01156-9; VOLPE BT, 1992, BEHAV NEUROSCI, V106, P457, DOI 10.1037/0735-7044.106.3.457; VOLPE BT, 1989, STROKE, V20, P1700, DOI 10.1161/01.STR.20.12.1700; Wadowska M, 2014, NEUROPATHOLOGY APPL; Wang RM, 2013, HIPPOCAMPUS, V23, P634, DOI 10.1002/hipo.22126; Wang S, 2005, EXP BRAIN RES, V165, P250, DOI 10.1007/s00221-005-2296-8; WU LG, 1994, J NEUROSCI, V14, P645; Xu K, 2007, ADV EXP MED BIOL, V599, P199; Xu K, 2010, BRAIN RES, V1328, P181, DOI 10.1016/j.brainres.2010.02.080	69	42	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124918	10.1371/journal.pone.0124918	http://dx.doi.org/10.1371/journal.pone.0124918			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933411	Green Submitted, Green Published, gold			2022-12-27	WOS:000353887100063
J	Damiani, E; Adrario, E; Luchetti, MM; Scorcella, C; Carsetti, A; Mininno, N; Pierantozzi, S; Principi, T; Strovegli, D; Bencivenga, R; Gabrielli, A; Romano, R; Pelaia, P; Ince, C; Donati, A				Damiani, Elisa; Adrario, Erica; Luchetti, Michele Maria; Scorcella, Claudia; Carsetti, Andrea; Mininno, Nicoletta; Pierantozzi, Silvia; Principi, Tiziana; Strovegli, Daniele; Bencivenga, Rosella; Gabrielli, Armando; Romano, Rocco; Pelaia, Paolo; Ince, Can; Donati, Abele			Plasma Free Hemoglobin and Microcirculatory Response to Fresh or Old Blood Transfusions in Sepsis	PLOS ONE			English	Article							CELL-FREE HEMOGLOBIN; NITRIC-OXIDE BIOAVAILABILITY; NEAR-INFRARED SPECTROSCOPY; CRITICALLY-ILL; MICROVASCULAR RESPONSE; OXYGEN-SATURATION; SEPTIC PATIENTS; ORGAN FAILURE; STORAGE TIME; RED-CELLS	Background Free hemoglobin (fHb) may induce vasoconstriction by scavenging nitric oxide. It may increase in older blood units due to storage lesions. This study evaluated whether old red blood cell transfusion increases plasma fHb in sepsis and how the microvascular response may be affected. Methods This is a secondary analysis of a randomized study. Twenty adult septic patients received either fresh or old (<10 or >15 days storage, respectively) RBC transfusions. fHb was measured in RBC units and in the plasma before and 1 hour after transfusion. Simultaneously, the sublingual microcirculation was assessed with sidestream-dark field imaging. The perfused boundary region was calculated as an index of glycocalyx damage. Tissue oxygen saturation (StO(2)) and Hb index (THI) were measured with near-infrared spectroscopy and a vascular occlusion test was performed. Results Similar fHb levels were found in the supernatant of fresh and old RBC units. Despite this, plasma fHb increased in the old RBC group after transfusion (from 0.125 [0.098-0.219] mg/mL to 0.238 [0.163-0.369] mg/mL, p = 0.006). The sublingual microcirculation was unaltered in both groups, while THI increased. The change in plasma fHb was inversely correlated with the changes in total vessel density (r = -0.57 [95% confidence interval -0.82, -0.16], p = 0.008), De Backer score (r = -0.63 [95% confidence interval -0.84, -0.25], p = 0.003) and THI (r = -0.72 [95% confidence interval -0.88, -0.39], p = 0.0003). Conclusions Old RBC transfusion was associated with an increase in plasma fHb in septic patients. Increasing plasma fHb levels were associated with decreased microvascular density.	[Damiani, Elisa; Adrario, Erica; Scorcella, Claudia; Carsetti, Andrea; Mininno, Nicoletta; Pierantozzi, Silvia; Romano, Rocco; Pelaia, Paolo; Donati, Abele] Univ Politecn Marche, Dept Biomed Sci & Publ Hlth, Torrette Di Ancona, Italy; [Adrario, Erica; Principi, Tiziana; Strovegli, Daniele; Pelaia, Paolo; Donati, Abele] Azienda Osped Univ Osped Riuniti, Anesthesia & Intens Care Unit, Torrette Di Ancona, Italy; [Luchetti, Michele Maria; Gabrielli, Armando] Univ Politecn Marche, Dept Clin & Mol Sci, Med Clin, Torrette Di Ancona, Italy; [Bencivenga, Rosella] AOU Osped Riuniti, Immunohematol & Transfus Med, Torrette Di Ancona, Italy; [Ince, Can; Donati, Abele] Univ Amsterdam, Acad Med Ctr, Dept Translat Physiol, NL-1105 AZ Amsterdam, Netherlands	Marche Polytechnic University; Marche Polytechnic University; University of Amsterdam; Academic Medical Center Amsterdam	Donati, A (corresponding author), Univ Politecn Marche, Dept Biomed Sci & Publ Hlth, Torrette Di Ancona, Italy.	a.donati@univpm.it	Damiani, Elisa/AAA-8075-2019; Luchetti, Michele Maria/J-6955-2019; Gabrielli, Armando/AAC-3173-2019; Carsetti, Andrea/AAB-9305-2019	Luchetti, Michele Maria/0000-0001-9132-7401; Carsetti, Andrea/0000-0001-6096-6251; Donati, Abele/0000-0001-6792-8741; damiani, elisa/0000-0002-3166-1835				Adamzik M, 2012, CRIT CARE, V16, DOI 10.1186/cc11425; Aubron C, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-2; Ayhan B, 2013, TRANSFUS APHER SCI, V49, P212, DOI 10.1016/j.transci.2013.01.016; Bateman RM, 2003, CRIT CARE, V7, P359, DOI 10.1186/cc2353; Boerma EC, 2005, CRIT CARE, V9, pR601, DOI 10.1186/cc3809; Carter Rickey E, 2004, J Transl Med, V2, P37, DOI 10.1186/1479-5876-2-37; Creteur J, 2009, CRIT CARE, V13, DOI 10.1186/cc8009; De Backer D, 2007, CRIT CARE, V11, DOI 10.1186/cc6118; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Donadee C, 2011, CIRCULATION, V124, P465, DOI 10.1161/CIRCULATIONAHA.110.008698; Donati A, 2014, CRIT CARE, V18, DOI 10.1186/cc13730; Donati A, 2013, MICROVASC RES, V90, P86, DOI 10.1016/j.mvr.2013.08.007; Donati A, 2013, BMC ANESTHESIOL, V13, DOI 10.1186/1471-2253-13-25; Donati A, 2013, CRIT CARE, V17, DOI 10.1186/cc11503; Donati A, 2013, CRIT CARE RES PRACT, V2013, DOI 10.1155/2013/892710; Donati A, 2009, CRIT CARE, V13, DOI 10.1186/cc8010; Goedhart PT, 2007, OPT EXPRESS, V15, P15101, DOI 10.1364/OE.15.015101; Gomez H, 2009, CRIT CARE, V13, DOI 10.1186/cc8001; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Ince C, 2005, CRIT CARE, V9, pS13, DOI 10.1186/cc3753; Janz DR, 2013, CRIT CARE MED, V41, P784, DOI 10.1097/CCM.0b013e3182741a54; Edul VSK, 2012, CRIT CARE MED, V40, P1443, DOI 10.1097/CCM.0b013e31823dae59; Kim-Shapiro DB, 2011, TRANSFUSION, V51, P844, DOI 10.1111/j.1537-2995.2011.03100.x; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; Marik PE, 2008, CRIT CARE MED, V36, P2667, DOI 10.1097/CCM.0b013e3181844677; MARIK PE, 1993, JAMA-J AM MED ASSOC, V269, P3024, DOI 10.1001/jama.269.23.3024; Myers DE, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1925250; Myers D, 2009, CRIT CARE, V13, DOI 10.1186/cc8000; Napolitano LM, 2009, CRIT CARE MED, V37, P3124, DOI 10.1097/CCM.0b013e3181b39f1b; Phelan HA, 2012, AM J SURG, V203, P198, DOI 10.1016/j.amjsurg.2011.05.012; Raat NJH, 2007, VOX SANG, V93, P12, DOI 10.1111/j.1423-0410.2007.00909.x; Raat NJ, 2005, CRIT CARE MED, V33, P39, DOI 10.1097/01.CCM.0000150655.75519.02; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Reynolds JD, 2007, P NATL ACAD SCI USA, V104, P17058, DOI 10.1073/pnas.0707958104; Roback JD, 2011, TRANSFUSION, V51, P859, DOI 10.1111/j.1537-2995.2011.03094.x; Sadaka F, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-46; Sakr Y, 2004, CRIT CARE MED, V32, P1825, DOI 10.1097/01.CCM.0000138558.16257.3F; Sakr Y, 2007, CRIT CARE MED, V35, P1639, DOI 10.1097/01.CCM.0000269936.73788.32; Triulzi DJ, 2010, TRANSFUS APHER SCI, V43, P95, DOI 10.1016/j.transci.2010.05.013; van den Berg Bernard M, 2006, Pharmacol Rep, V58 Suppl, P75; Vincent JL, 2002, JAMA-J AM MED ASSOC, V288, P1499, DOI 10.1001/jama.288.12.1499; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Vlahu CA, 2012, J AM SOC NEPHROL, V23, P1900, DOI 10.1681/ASN.2011121181; Walsh TS, 2004, CRIT CARE MED, V32, P364, DOI 10.1097/01.CCM.0000108878.23703.E0; Weinberg JA, 2013, J TRAUMA ACUTE CARE, V75, P807, DOI 10.1097/TA.0b013e3182a74a9b; Windsant ICV, 2012, CRIT CARE, V16, DOI 10.1186/cc11359; Yalcin O, 2014, TRANSFUSION, V54, P1015, DOI 10.1111/trf.12361; Yuruk K, 2013, TRANSFUSION, V53, P1346, DOI 10.1111/j.1537-2995.2012.03905.x	48	36	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0122655	10.1371/journal.pone.0122655	http://dx.doi.org/10.1371/journal.pone.0122655			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932999	Green Submitted, Green Published, gold			2022-12-27	WOS:000353887100010
J	Farrow, DC; Burke, DS; Rosenfeld, R				Farrow, David C.; Burke, Donald S.; Rosenfeld, Roni			Computational Characterization of Transient Strain-Transcending Immunity against Influenza A	PLOS ONE			English	Article							PROTECTIVE IMMUNITY; SEASONAL INFLUENZA; LETHAL INFECTION; VIRUS-INFECTION; CROSS-IMMUNITY; EVOLUTION; RESPONSES; MICE; TRANSMISSION; FERRETS	The enigmatic observation that the rapidly evolving influenza A (H3N2) virus exhibits, at any given time, a limited standing genetic diversity has been an impetus for much research. One of the first generative computational models to successfully recapitulate this pattern of consistently constrained diversity posits the existence of a strong and short-lived strain-transcending immunity. Building on that model, we explored a much broader set of scenarios (parameterizations) of a transient strain-transcending immunity, ran long-term simulations of each such scenario, and assessed its plausibility with respect to a set of known or estimated influenza empirical measures. We evaluated simulated outcomes using a variety of measures, both epidemiological (annual attack rate, epidemic duration, reproductive number, and peak weekly incidence), and evolutionary (pairwise antigenic diversity, fixation rate, most recent common ancestor, and kappa, which quantifies the potential for antigenic evolution). Taking cumulative support from all these measures, we show which parameterizations of strain-transcending immunity are plausible with respect to the set of empirically derived target values. We conclude that strain-transcending immunity which is milder and longer lasting than previously suggested is more congruent with the observed short-and long-term behavior of influenza.	[Farrow, David C.; Rosenfeld, Roni] Carnegie Mellon Univ, Lane Ctr Computat Biol, Pittsburgh, PA 15213 USA; [Burke, Donald S.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA 15260 USA; [Farrow, David C.] Joint Carnegie Mellon Univ Univ Pittsburgh, Ph D Program Computat Biol, Pittsburgh, PA USA	Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University	Rosenfeld, R (corresponding author), Carnegie Mellon Univ, Lane Ctr Computat Biol, Pittsburgh, PA 15213 USA.	Roni.Rosenfeld@cs.cmu.edu		Rosenfeld, Ronald/0000-0002-3274-5862; Farrow, David/0000-0001-5798-1215; /0000-0002-5704-8094	National Institutes of Health T32 training grant , Howard Hughes Medical Institute-National Institute of Biomedical Imaging and Bioengineering Interfaces Initiative [T32 EB009403]; National Institute of General Medical Science of the National Institutes of Health [U54GM088491]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088491] Funding Source: NIH RePORTER	National Institutes of Health T32 training grant , Howard Hughes Medical Institute-National Institute of Biomedical Imaging and Bioengineering Interfaces Initiative; National Institute of General Medical Science of the National Institutes of Health; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	DF was a predoctoral trainee supported by National Institutes of Health T32 training grant T32 EB009403 as part of the Howard Hughes Medical Institute-National Institute of Biomedical Imaging and Bioengineering Interfaces Initiative. Research reported in this publication was supported by the National Institute of General Medical Science of the National Institutes of Health under award number U54GM088491. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2004, P ROY SOC B-BIOL SCI, V271, P2431, DOI 10.1098/rspb.2004.2877; Andreasen V, 2006, THEOR POPUL BIOL, V70, P164, DOI 10.1016/j.tpb.2006.04.004; Beaumont MA, 2002, GENETICS, V162, P2025; Bedford T, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-38; Bhatt S, 2011, MOL BIOL EVOL, V28, P2443, DOI 10.1093/molbev/msr044; Bodewes R, 2010, J VIROL, V84, P7943, DOI 10.1128/JVI.00549-10; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Cheng X, 2013, J INFECT DIS, V208, P594, DOI 10.1093/infdis/jit207; Chowell G, 2008, EPIDEMIOL INFECT, V136, P852, DOI 10.1017/S0950268807009144; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Flahault A, 1998, JAMA-J AM MED ASSOC, V280, P1330, DOI 10.1001/jama.280.15.1330; Fonville JM, 2014, SCIENCE, V346, P996, DOI 10.1126/science.1256427; GLEZEN WP, 1978, NEW ENGL J MED, V298, P587, DOI 10.1056/NEJM197803162981103; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Koelle K, 2011, P ROYAL SOC B; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Koelle K, 2009, EPIDEMICS-NETH, V1, P129, DOI 10.1016/j.epidem.2009.05.003; Kreijtz JHCM, 2007, VACCINE, V25, P612, DOI 10.1016/j.vaccine.2006.08.036; Kreijtz JHCM, 2009, VACCINE, V27, P4983, DOI 10.1016/j.vaccine.2009.05.079; Kucharski AJ, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002082; LAMBKIN R, 1994, J GEN VIROL, V75, P3493, DOI 10.1099/0022-1317-75-12-3493; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; Nelson MI, 2006, PLOS PATHOG, V2, P1144, DOI 10.1371/journal.ppat.0020125; Nukiwa-Souma N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033046; Omori R, 2010, J THEOR BIOL, V262, P48, DOI 10.1016/j.jtbi.2009.09.015; Recker M, 2007, P NATL ACAD SCI USA, V104, P7711, DOI 10.1073/pnas.0702154104; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Shaman J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000316; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; SPICER CC, 1984, J HYG-CAMBRIDGE, V93, P105, DOI 10.1017/S0022172400060988; Stohr K, 2002, LANCET INFECT DIS, V2, P517, DOI 10.1016/S1473-3099(02)00366-3; TANNOCK GA, 1987, ARCH VIROL, V92, P121, DOI 10.1007/BF01310067; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; Towers S, 2010, SHORT TERM HETEROLOG; Tria F, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/07/P07008; Truscott J, 2011, J ROYAL SOC INTERFAC; Wheaton William D, 2009, Methods Rep RTI Press, V2009, P905; Zinder D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003104	39	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125047	10.1371/journal.pone.0125047	http://dx.doi.org/10.1371/journal.pone.0125047			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933195	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000353887100075
J	Liu, Y; Mi, N; Zhou, YM; An, P; Bai, YY; Guo, YF; Hong, CM; Ji, ZX; Ye, P; Wu, CE				Liu, Yuan; Mi, Ning; Zhou, Yiming; An, Peng; Bai, Yongyi; Guo, Yifang; Hong, Changming; Ji, Zhixin; Ye, Ping; Wu, Caie			Transverse False Tendons in the Left Ventricular Cavity Are Associated with Early Repolarization	PLOS ONE			English	Article							PREVALENCE; SUBSTRATE; AUTOPSY; HEART; BAND	Background Left ventricular false tendons (LVFTs) are related to precordial murmurs, ventricular arrhythmias and some repolarization abnormalities. Early repolarization (ER) is a specific type of repolarization abnormality. Objective The aim of the present study was to investigate the relationship between LVFTs and ER. Methods This study retrospectively included 99 consecutive healthy subjects and 33 patients with ER. Early repolarization was defined as an elevation of the QRS-ST junction of >0.1 mV from baseline in at least 2 inferior or lateral leads, manifested as QRS slurring or notching. Each participant was examined using echocardiography with second harmonic imaging, and the attachments of the LVFTs were recorded. Results A total of 93 LVFTs were present in 82 (83%) of the 99 healthy subjects. Of these 93 LVFTs, the majority (79/93, or 84.9%) were longitudinal-type LVFTs, which originated from the basal interventricular septum (IVS) and progressed toward the apical segment of the left ventricular free wall. There were significant differences in the positioning of the LVFTs between the ER patients and control (P < 0.0001). LVFTs between mid-IVS to the middle of the LV free wall were found more common in patients with ER compared with control subjects (47.5% vs. 6.5%, P < 0.0001). In the ER group, LVFTs between the basal IVS to the apical segment of LV free wall were only identified in 21% of the LVFTs, compared to a value of 84.9% for the control group (P < 0.0001). The distribution of LVFT trends in the ER group was also significantly different from that in the control group (P < 0.05). Conclusions LVFTs are commonly visualized using echocardiography. An LVFT from the basal IVS to the apical segment of the left ventricular free wall may be a normal anatomical structure in the left ventricular cavity. On the contrary, transverse false tendons in the left ventricular cavity may be associated with ER.	[Liu, Yuan; Bai, Yongyi; Hong, Changming; Ye, Ping; Wu, Caie] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing 100853, Peoples R China; [Mi, Ning] Bethune Med Profess Sergeant Sch, Dept Clin Med, Shijiazhuang, Peoples R China; [Zhou, Yiming] Beijing Gen Hosp, Beijing Mil Command, Dept Liver Dis, Beijing, Peoples R China; [An, Peng] First Peoples Hosp Qujing, Dept Internal Med, Qujing, Peoples R China; [Guo, Yifang] Hebei Prov Peoples Hosp, Dept Geriatr Cardiol, Shijiazhuang, Hebei Province, Peoples R China; [Ji, Zhixin] Chinese Peoples Liberat Army Gen Hosp, Med Adm, Beijing 100853, Peoples R China	Chinese People's Liberation Army General Hospital; Seventh Medical Center of Chinese PLA General Hospital; Chinese People's Liberation Army General Hospital	Wu, CE (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing 100853, Peoples R China.	linyiling301@sina.com			Key National Basic Research Program of China [2012CB517503, 2013CB530804]; Nature Science Foundation of China [81270941, 81100878]; Beijing Nova Program [Z121107002513124]	Key National Basic Research Program of China(National Basic Research Program of China); Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Nova Program(Beijing Municipal Science & Technology Commission)	This work was supported by grants from the Key National Basic Research Program of China (2012CB517503, 2013CB530804) and Nature Science Foundation of China (81270941) to PY, and the Nature Science Foundation of China (81100878) and the Beijing Nova Program (Z121107002513124) to YB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDULLA AK, 1990, CHEST, V98, P129, DOI 10.1378/chest.98.1.129; Barnes AR, 1943, AM HEART J, V25, P528, DOI 10.1016/S0002-8703(43)90492-2; Boineau JP, 2007, J ELECTROCARDIOL, V40, P392, DOI 10.1016/j.jelectrocard.2007.07.012; BOYD MT, 1987, J AM COLL CARDIOL, V9, P323, DOI 10.1016/S0735-1097(87)80383-2; CASTA A, 1986, AM HEART J, V111, P321, DOI 10.1016/0002-8703(86)90147-X; Eckardt L, 2001, BASIC RES CARDIOL, V96, P369, DOI 10.1007/s003950170045; FORSGREN S, 1988, ANAT EMBRYOL, V177, P437, DOI 10.1007/BF00304741; Ho ML, 2009, J THORAC IMAG, V24, P119, DOI 10.1097/RTI.0b013e318192d4c1; Kenchaiah S, 2009, J AM SOC ECHOCARDIOG, V22, P739, DOI 10.1016/j.echo.2009.03.008; Kervancioglu M, 2003, CLIN ANAT, V16, P389, DOI 10.1002/ca.10152; LEPESCHKIN E, 1952, AM HEART J, V44, P80, DOI 10.1016/0002-8703(52)90174-9; Lin FC, 1996, CIRCULATION, V93, P525, DOI 10.1161/01.CIR.93.3.525; Lotkowski D, 1997, Folia Morphol (Warsz), V56, P31; Loukas M, 2007, CLIN ANAT, V20, P163, DOI 10.1002/ca.20347; LUETMER PH, 1986, J AM COLL CARDIOL, V8, P179, DOI 10.1016/S0735-1097(86)80110-3; MALOUF J, 1986, BRIT HEART J, V55, P587; Miyazaki S, 2010, CIRC J, V74, P2039, DOI 10.1253/circj.CJ-10-0753; Mobilia G, 1991, Minerva Cardioangiol, V39, P149; NISHIMURA T, 1981, AM J CARDIOL, V48, P177; Philip S, 2011, PEDIATR NEONATOL, V52, P279, DOI 10.1016/j.pedneo.2011.06.007; Pueyo E, 2009, PHILOS T R SOC A, V367, P213, DOI 10.1098/rsta.2008.0230; Salazar J, 1997, PEDIATR CARDIOL, V18, P434, DOI 10.1007/s002469900223; SUTTON MGS, 1994, BRIT HEART J, V71, P187; SUWA M, 1988, J AM COLL CARDIOL, V12, P910, DOI 10.1016/0735-1097(88)90453-6; Tereshchenko LG, 2012, HEART RHYTHM, V9, P1594, DOI 10.1016/j.hrthm.2012.06.036; Thakur RK, 1996, CIRCULATION, V93, P497, DOI 10.1161/01.CIR.93.3.497; Turner W., 1986, J ANAT PHYSL, V30, P568; van Noord C, 2010, EUR J EPIDEMIOL, V25, P21, DOI 10.1007/s10654-009-9406-z; VERED Z, 1984, AM J CARDIOL, V53, P330, DOI 10.1016/0002-9149(84)90450-8	29	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125173	10.1371/journal.pone.0125173	http://dx.doi.org/10.1371/journal.pone.0125173			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933440	gold, Green Published, Green Submitted			2022-12-27	WOS:000353887100084
J	Plieninger, T; Levers, C; Mantel, M; Costa, A; Schaich, H; Kuemmerle, T				Plieninger, Tobias; Levers, Christian; Mantel, Martin; Costa, Augusta; Schaich, Harald; Kuemmerle, Tobias			Patterns and Drivers of Scattered Tree Loss in Agricultural Landscapes: Orchard Meadows in Germany (1968-2009)	PLOS ONE			English	Article							EVERGREEN OAK WOODLANDS; LAND-USE; FUTURE; AGROFORESTRY; MANAGEMENT; EUROPE; FRAGMENTATION; MAINTENANCE; VEGETATION; PASTURES	Scattered trees support high levels of farmland biodiversity and ecosystem services in agricultural landscapes, but they are threatened by agricultural intensification, urbanization, and land abandonment. This study aimed to map and quantify the decline of orchard meadows (scattered fruit trees of high nature conservation value) for a region in Southwestern Germany for the 1968 2009 period and to identify the driving forces of this decline. We derived orchard meadow loss from 1968 and 2009 aerial images and used a boosted regression trees modelling framework to assess the relative importance of 18 environmental, demographic, and socio-economic variables to test five alternative hypothesis explaining orchard meadow loss. We found that orchard meadow loss occurred in flatter areas, in areas where smaller plot sizes and fragmented orchard meadows prevailed, and in areas near settlements and infrastructure. The analysis did not confirm that orchard meadow loss was higher in areas where agricultural intensification was stronger and in areas of lower implementation levels of conservation policies. Our results demonstrated that the influential drivers of orchard meadow loss were those that reduce economic profitability and increase opportunity costs for orchards, providing incentives for converting orchard meadows to other, more profitable land uses. These insights could be taken up by local-and regional-level conservation policies to identify the sites of persistent orchard meadows in agricultural landscapes that would be prioritized in conservation efforts.	[Plieninger, Tobias] Univ Copenhagen, Dept Geosci & Nat Resource Management, Frederiksberg C, Denmark; [Levers, Christian; Mantel, Martin; Kuemmerle, Tobias] Humboldt Univ, Dept Geog, D-10099 Berlin, Germany; [Costa, Augusta] Univ Nova Lisboa, Ctr Environm & Sustainabil Res CENSE, Caparica, Portugal; [Schaich, Harald] Univ Freiburg, Chair Landscape Management, D-79106 Freiburg, Germany; [Kuemmerle, Tobias] Humboldt Univ, Integrat Res Inst Transformat Human Environm Syst, D-10099 Berlin, Germany	University of Copenhagen; Humboldt University of Berlin; Universidade Nova de Lisboa; University of Freiburg; Humboldt University of Berlin	Plieninger, T (corresponding author), Univ Copenhagen, Dept Geosci & Nat Resource Management, Frederiksberg C, Denmark.	tobias.plieninger@ign.ku.dk	Schaich, Harald/B-1907-2010; Costa, Augusta/J-3644-2013; BITOUN, RACHEL Elisabeth/AAC-9538-2021; Kuemmerle, Tobias/B-4340-2008; Levers, Christian/L-9204-2013; Plieninger, Tobias/E-3861-2010	Schaich, Harald/0000-0003-4845-7678; Costa, Augusta/0000-0002-0400-8523; BITOUN, RACHEL Elisabeth/0000-0002-3614-9910; Kuemmerle, Tobias/0000-0002-9775-142X; Levers, Christian/0000-0003-4810-9024; Plieninger, Tobias/0000-0003-1478-2587	European Community [613520, 265104, 603447]; Einstein Foundation Berlin	European Community(European Commission); Einstein Foundation Berlin	This study has been funded through the European Community's 7th Framework Programme (http://ec.europa.eu/research/fp7/index_en.cfm) under Grant Agreements No. 613520 (Project AGFORWARD), No. 265104 (VOLANTE), and No. 603447 (Project HERCULES) and the Einstein Foundation Berlin (http://www.einsteinfoundation.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker MM, 2005, AGR ECOSYST ENVIRON, V105, P467, DOI 10.1016/j.agee.2004.07.009; Bergmeier E, 2010, BIODIVERS CONSERV, V19, P2995, DOI 10.1007/s10531-010-9872-3; Bernkopf S, 1994, ALTE OBSTSORTEN STRE, P41; Bieling C, 2013, LANDSCAPE RES, V38, P649, DOI 10.1080/01426397.2012.691469; Biro M, 2013, LANDSCAPE ECOL, V28, P789, DOI 10.1007/s10980-012-9818-0; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bunce R. G. H., 2009, V6, P321; Burgi M, 2004, LANDSCAPE ECOL, V19, P857, DOI 10.1007/s10980-004-0245-8; Campos P., 2013, MEDITERRANEAN OAK WO; Chetelat J, 2013, ECOL SOC, V18, DOI 10.5751/ES-05287-180139; Costa A, 2014, J ENVIRON MANAGE, V133, P18, DOI 10.1016/j.jenvman.2013.11.026; Costa A, 2011, LANDSCAPE URBAN PLAN, V102, P164, DOI 10.1016/j.landurbplan.2011.04.002; de Foresta H., 2013, ASSESSMENT TREES OUT; Deuschle J, 2008, B INSECTOL, V61, P73; Deutscher Wetterdienst, 2015, KLIM DEUTSCHL; Eichhorn MP, 2006, AGROFOREST SYST, V67, P29, DOI 10.1007/s10457-005-1111-7; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Fischer J, 2010, P NATL ACAD SCI USA, V107, P19597, DOI 10.1073/pnas.1008476107; Fischer J, 2010, BIOL CONSERV, V143, P1564, DOI 10.1016/j.biocon.2010.03.030; Fischer J, 2009, P NATL ACAD SCI USA, V106, P10386, DOI 10.1073/pnas.0900110106; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Gibbons P, 2008, CONSERV BIOL, V22, P1309, DOI 10.1111/j.1523-1739.2008.00997.x; Hartel T, 2013, BIOL CONSERV, V166, P267, DOI 10.1016/j.biocon.2013.06.020; Harvey CA, 2011, FOREST ECOL MANAG, V261, P1664, DOI 10.1016/j.foreco.2010.11.004; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Herrmann JD, 2010, LANDSCAPE ECOL, V25, P1375, DOI 10.1007/s10980-010-9518-6; Herzog F, 2005, AGR ECOSYST ENVIRON, V108, P189, DOI 10.1016/j.agee.2005.02.003; Herzog F., 2000, Unasylva (English ed.), V51, P42; Herzog F, 1998, AGROFOREST SYST, V42, P61, DOI 10.1023/A:1006152127824; Hijmans R.J., 2014, DISMO SPECIES DISTRI; Horak J, 2013, AGR ECOSYST ENVIRON, V178, P71, DOI 10.1016/j.agee.2013.06.020; Levers C, 2014, FOREST ECOL MANAG, V315, P160, DOI 10.1016/j.foreco.2013.12.030; Manning AD, 2006, BIOL CONSERV, V132, P311, DOI 10.1016/j.biocon.2006.04.023; MLR, 2009, STREUOBSTW BAD WURTT; Monteiro AT, 2011, LANDSCAPE URBAN PLAN, V100, P287, DOI 10.1016/j.landurbplan.2010.12.015; Muller D, 2013, AGR SYST, V117, P66, DOI 10.1016/j.agsy.2012.12.010; Muller J., 2005, LANDSCHAFTSELEMENTE; Nerlich K., 2012, AGROFOREST SYST, V87, P475, DOI [10.1007/s10457-012-9560-2, DOI 10.1007/S10457-012-9560-2]; Newton AC, 2009, PROG PHYS GEOG, V33, P528, DOI 10.1177/0309133309346882; Paprstein F, 2015, GENET RESOUR CROP EV, V62, P5, DOI 10.1007/s10722-014-0181-7; Plieninger T, 2006, LANDSCAPE ECOL, V21, P91, DOI 10.1007/s10980-005-8294-1; Plieninger T, 2012, APPL GEOGR, V32, P566, DOI 10.1016/j.apgeog.2011.06.015; Plieninger T, 2012, LAND USE POLICY, V29, P233, DOI 10.1016/j.landusepol.2011.06.011; Plieninger T, 2011, LANDSCAPE RES, V36, P435, DOI 10.1080/01426397.2011.582943; Pointereau P, 2008, REFLECTING ENV LAND; Puyravaud JP, 2003, FOREST ECOL MANAG, V177, P593, DOI 10.1016/S0378-1127(02)00335-3; R Developement Core Team, 2012, LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; Schleyer C, 2011, ENVIRON CONSERV, V38, P454, DOI 10.1017/S0376892911000361; Schmitzberger I, 2005, AGR ECOSYST ENVIRON, V108, P274, DOI 10.1016/j.agee.2005.02.009; Schonhart M, 2011, AGR SYST, V104, P122, DOI 10.1016/j.agsy.2010.03.014; Schonhart M, 2011, J ENVIRON PLANN MAN, V54, P115, DOI 10.1080/09640568.2010.502763; Schupbach B, 2008, J ENVIRON MANAGE, V89, P222, DOI 10.1016/j.jenvman.2007.01.060; Smith J, 2013, RENEW AGR FOOD SYST, V28, P80, DOI 10.1017/S1742170511000585; Steffan-Dewenter I, 2003, CONSERV BIOL, V17, P1036, DOI 10.1046/j.1523-1739.2003.01575.x; Steffan-Dewenter I, 2003, BIODIVERS CONSERV, V12, P1953, DOI 10.1023/A:1024199513365; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; Weller F, 1996, NATURLANDSCHAFT KULT, P137; Weller F., 2006, HDB NATURSCHUTZ LAND, P1; Zehnder M, 2011, STREUOBSTBAU	59	42	45	4	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0126178	10.1371/journal.pone.0126178	http://dx.doi.org/10.1371/journal.pone.0126178			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932914	Green Published, gold, Green Submitted			2022-12-27	WOS:000353887100149
J	Renner, DN; Jin, F; Litterman, AJ; Balgeman, AJ; Hanson, LM; Gamez, JD; Chae, M; Carlson, BL; Sarkaria, JN; Parney, IF; Ohlfest, JR; Pirko, I; Pavelko, KD; Johnson, AJ				Renner, Danielle N.; Jin, Fang; Litterman, Adam J.; Balgeman, Alexis J.; Hanson, Lisa M.; Gamez, Jeffrey D.; Chae, Michael; Carlson, Brett L.; Sarkaria, Jann N.; Parney, Ian F.; Ohlfest, John R.; Pirko, Istvan; Pavelko, Kevin D.; Johnson, Aaron J.			Effective Treatment of Established GL261 Murine Gliomas through Picornavirus Vaccination-Enhanced Tumor Antigen-Specific CD8+T Cell Responses	PLOS ONE			English	Article							EXPERIMENTAL BRAIN-TUMORS; SENECA VALLEY VIRUS; T-CELLS; GLIOBLASTOMA-MULTIFORME; IN-VIVO; SUPPRESSOR-CELLS; CANCER VACCINE; THEILERS VIRUS; MODEL; CHEMOTHERAPY	Glioblastoma (GBM) is among the most invasive and lethal of cancers, frequently infiltrating surrounding healthy tissue and giving rise to rapid recurrence. It is therefore critical to establish experimental model systems and develop therapeutic approaches that enhance antitumor immunity. In the current study, we have employed a newly developed murine glioma model to assess the efficacy of a novel picornavirus vaccination approach for the treatment of established tumors. The GL261-Quad system is a variation of the GL261 syngeneic glioma that has been engineered to expresses model T cell epitopes including OVA(257-264). MRI revealed that both GL261 and GL261-Quad tumors display characteristic features of human gliomas such as heterogeneous gadolinium leakage and larger T2 weighted volumes. Analysis of brain-infiltrating immune cells demonstrated that GL261-Quad gliomas generate detectable CD8+ T cell responses toward the tumor-specific K-b:OVA(257-264) antigen. Enhancing this response via a single intracranial or peripheral vaccination with picornavirus expressing the OVA(257-264) antigen increased anti-tumor CD8+ T cells infiltrating the brain, attenuated progression of established tumors, and extended survival of treated mice. Importantly, the efficacy of the picornavirus vaccination is dependent on functional cytotoxic activity of CD8+ T cells, as the beneficial response was completely abrogated in mice lacking perforin expression. Therefore, we have developed a novel system for evaluating mechanisms of anti-tumor immunity in vivo, incorporating the GL261-Quad model, 3D volumetric MRI, and picornavirus vaccination to enhance tumor-specific cytotoxic CD8+ T cell responses and track their effectiveness at eradicating established gliomas in vivo.	[Renner, Danielle N.] Mayo Clin, Neurobiol Dis Grad Program, Rochester, MN USA; [Renner, Danielle N.; Jin, Fang; Hanson, Lisa M.; Parney, Ian F.; Pavelko, Kevin D.; Johnson, Aaron J.] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA; [Litterman, Adam J.; Ohlfest, John R.] Univ Minnesota, Dept Neurosurg, Minneapolis, MN USA; [Balgeman, Alexis J.] Mayo Clin, Summer Undergrad Res Fellowship, Rochester, MN USA; [Gamez, Jeffrey D.; Pirko, Istvan] Mayo Clin, Dept Neurol, Rochester, MN USA; [Chae, Michael; Parney, Ian F.] Mayo Clin, Dept Neurosurg, Rochester, MN USA; [Carlson, Brett L.; Sarkaria, Jann N.] Mayo Clin, Dept Radiat Oncol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Pavelko, KD (corresponding author), Mayo Clin, Dept Immunol, Rochester, MN 55905 USA.	Pavelko.Kevin@mayo.edu; Johnson.Aaron2@mayo.edu	Ramos, Joe W./L-6189-2013; Pavelko, Kevin D/K-7072-2019	Ramos, Joe W./0000-0002-9708-2115; Pavelko, Kevin D/0000-0001-7555-1315; Parney, Ian/0000-0002-9702-8047	Lefkofsky Family Foundation; Mayo Clinic Brain Tumor SPORE Development Research Project Award [CA108961]; National Institutes of Health [R01 CA154345, R01 CA160782, RSG-09-189-01-LIB, R01 NS060881, R21 CA186976, F31 CA180299]; NATIONAL CANCER INSTITUTE [R01CA154345, R21CA186976, R01CA160782, P50CA108961, F31CA180299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060881] Funding Source: NIH RePORTER	Lefkofsky Family Foundation; Mayo Clinic Brain Tumor SPORE Development Research Project Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by the generous gift from the Lefkofsky Family Foundation to the Mayo Clinic Cancer Center and a Mayo Clinic Brain Tumor SPORE Development Research Project Award (CA108961) (AJJ). Additional support was provided by the National Institutes of Health: R01 CA154345, R01 CA160782, RSG-09-189-01-LIB to JRO; R01 NS060881, R21 CA186976 to AJJ; F31 CA180299 to DNR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; AUSMAN JI, 1970, CANCER RES, V30, P2394; Barcia C, 2009, AM J PATHOL, V175, P786, DOI 10.2353/ajpath.2009.081034; Boissonnas A, 2007, J EXP MED, V204, P345, DOI 10.1084/jem.20061890; Breart B, 2008, J CLIN INVEST, V118, P1390, DOI 10.1172/JCI34388; Cantini G, 2011, CANCER IMMUNOL IMMUN, V60, P1739, DOI 10.1007/s00262-011-1069-4; Chen XZ, 2012, AM J NEURORADIOL, V33, P1907, DOI 10.3174/ajnr.A3106; Dethlefs S, 1997, J VIROL, V71, P5361, DOI 10.1128/JVI.71.7.5361-5365.1997; Dziurzynski K, 2011, CLIN CANCER RES, V17, P4642, DOI 10.1158/1078-0432.CCR-11-0414; El Andaloussi A, 2006, J NEUROSURG, V105, P430, DOI 10.3171/jns.2006.105.3.430; Eyupoglu IY, 2005, J NEUROSURG, V102, P738, DOI 10.3171/jns.2005.102.4.0738; Fadul CE, 2011, J IMMUNOTHER, V34, P382, DOI 10.1097/CJI.0b013e318215e300; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Grauer OM, 2008, J IMMUNOL, V181, P6720, DOI 10.4049/jimmunol.181.10.6720; Hammoud MA, 1996, J NEUROONCOL, V27; Hatano Manabu, 2004, J Transl Med, V2, P40, DOI 10.1186/1479-5876-2-40; Iizuka Y, 2006, INT J CANCER, V118, P942, DOI 10.1002/ijc.21432; IWAMA T, 1991, Neurological Research, V13, P48; Johnson AJ, 1999, J VIROL, V73, P3702, DOI 10.1128/JVI.73.5.3702-3708.1999; Johnson AJ, 2001, FASEB J, V15, P2760, DOI 10.1096/fj.01-0373fje; Johnson HL, 2012, J IMMUNOL, V189, P1937, DOI 10.4049/jimmunol.1200658; KELLY PJ, 1987, J NEUROSURG, V66, P865, DOI 10.3171/jns.1987.66.6.0865; Learn CA, 2006, CLIN CANCER RES, V12, P7306, DOI 10.1158/1078-0432.CCR-06-1727; Litterman AJ, 2013, J IMMUNOL, V190, P6259, DOI 10.4049/jimmunol.1203539; Maes W, 2011, CANCER IMMUNOL IMMUN, V60, P153, DOI 10.1007/s00262-010-0946-6; Maes W, 2009, NEURO-ONCOLOGY, V11, P529, DOI 10.1215/15228517-2009-004; Morton CL, 2010, PEDIATR BLOOD CANCER, V55, P295, DOI 10.1002/pbc.22535; Muldoon LL, 2007, J CLIN ONCOL, V25, P2295, DOI 10.1200/JCO.2006.09.9861; Nieder C, 2000, CANCER TREAT REV, V26, P397, DOI 10.1053/ctrv.2000.0191; Ohlfest JR, 2013, J IMMUNOL, V190, P613, DOI 10.4049/jimmunol.1201557; Pafundi DH, 2013, NEURO-ONCOLOGY, V15, P1058, DOI 10.1093/neuonc/not002; Parney IF, 2009, J NEUROSURG, V110, P572, DOI 10.3171/2008.7.JNS08475; Pavelko KD, 2013, MOL THER, V21, P1087, DOI 10.1038/mt.2013.52; Pavelko KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020217; Pirko I, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-31; Prins RM, 2003, CANCER RES, V63, P8487; Prins RM, 2011, CLIN CANCER RES, V17, P1603, DOI 10.1158/1078-0432.CCR-10-2563; Reddy PS, 2007, J NATL CANCER I, V99, P1623, DOI 10.1093/jnci/djm198; Rodrigues JC, 2010, NEURO-ONCOLOGY, V12, P351, DOI 10.1093/neuonc/nop023; Rudin CM, 2011, CLIN CANCER RES, V17, P888, DOI 10.1158/1078-0432.CCR-10-1706; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Ueda R, 2009, CLIN CANCER RES, V15, P6551, DOI 10.1158/1078-0432.CCR-09-1067; Umemura N, 2008, J LEUKOCYTE BIOL, V83, P1136, DOI 10.1189/jlb.0907611; Wheeler CJ, 2008, CANCER RES, V68, P5955, DOI 10.1158/0008-5472.CAN-07-5973; Wu A, 2010, NEURO-ONCOLOGY, V12, P1113, DOI 10.1093/neuonc/noq082; Wu A, 2007, J IMMUNOTHER, V30, P789, DOI 10.1097/CJI.0b013e318155a0f6; Xiong ZM, 2011, J IMMUNOTHER, V34, P264, DOI 10.1097/CJI.0b013e318209eed4; Yang J, 2010, P NATL ACAD SCI USA, V107, P4716, DOI 10.1073/pnas.0911587107; Zagzag D, 2000, LAB INVEST, V80, P837, DOI 10.1038/labinvest.3780088; Zoll J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000416	51	18	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125565	10.1371/journal.pone.0125565	http://dx.doi.org/10.1371/journal.pone.0125565			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933216	Green Published, gold, Green Submitted			2022-12-27	WOS:000353887100117
J	Akama, H; Miyake, M; Jung, JY; Murphy, B				Akama, Hiroyuki; Miyake, Maki; Jung, Jaeyoung; Murphy, Brian			Using Graph Components Derived from an Associative Concept Dictionary to Predict fMRI Neural Activation Patterns that Represent the Meaning of Nouns	PLOS ONE			English	Article							BRAIN ACTIVITY; GRAMMATICAL CONSTRUCTIONS; COMPLEX NETWORKS; LANGUAGE; CLASSIFICATION; CATEGORIES; SIMULATION; WORDS; FLOW	In this study, we introduce an original distance definition for graphs, called the Markov-inverse-F measure (MiF). This measure enables the integration of classical graph theory indices with new knowledge pertaining to structural feature extraction from semantic networks. MiF improves the conventional Jaccard and/or Simpson indices, and reconciles both the geodesic information (random walk) and co-occurrence adjustment (degree balance and distribution). We measure the effectiveness of graph-based coefficients through the application of linguistic graph information for a neural activity recorded during conceptual processing in the human brain. Specifically, the MiF distance is computed between each of the nouns used in a previous neural experiment and each of the in-between words in a subgraph derived from the Edinburgh Word Association Thesaurus of English. From the MiF-based information matrix, a machine learning model can accurately obtain a scalar parameter that specifies the degree to which each voxel in (the MRI image of) the brain is activated by each word or each principal component of the intermediate semantic features. Furthermore, correlating the voxel information with the MiF-based principal components, a new computational neurolinguistics model with a network connectivity paradigm is created. This allows two dimensions of context space to be incorporated with both semantic and neural distributional representations.	[Akama, Hiroyuki; Jung, Jaeyoung] Tokyo Inst Technol, Grad Sch Decis Sci & Technol, Tokyo 152, Japan; [Miyake, Maki] Osaka Univ, Grad Sch Language & Culture, Osaka, Japan; [Murphy, Brian] Carnegie Mellon Univ, Machine Learning Dept, Pittsburgh, PA 15213 USA	Tokyo Institute of Technology; Osaka University; Carnegie Mellon University	Akama, H (corresponding author), Tokyo Inst Technol, Grad Sch Decis Sci & Technol, Tokyo 152, Japan.	akama.h.aa@m.titech.ac.jp		AKAMA, HIROYUKI/0000-0003-1777-497X	Japan Society for the Promotion of Science (JSPS) [26330246]; Research Administration Center, Tokyo Institute of Technology	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research Administration Center, Tokyo Institute of Technology	This work was supported by 1) Grants-in-Aid for Scientific Research ("KAKENHI", http://www.jsps.go.jp/english/e-grants/index.html), Japan Society for the Promotion of Science (JSPS) (http://kaken.nii.ac.jp/en/), and Kiban (C)-26330246 for data analysis and preparation of the manuscript; and 2) Research Administration Center, Tokyo Institute of Technology (http://www. rac.titech.ac.jp/english/)for English proofreading (1-129). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akama H, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00024; Allen K, 2012, BRAIN LANG, V123, P174, DOI 10.1016/j.bandl.2012.08.005; Anderson AJ, 2012, P 3 WORKSH COGN ASP, V2012, P21; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Baroni M, 2010, COMPUT LINGUIST, V36, P673, DOI 10.1162/coli_a_00016; Baroni Marco, 2010, P 2010 C EMP METH NA, P1183; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Barsalou LW, 2003, LANG COGNITIVE PROC, V18, P513, DOI 10.1080/01690960344000026; Barsalou LW, 1999, AMST STUD THEORY HIS, V152, P209; Bass JIF, 2013, NAT METHODS, V10, P1169, DOI [10.1038/NMETH.2728, 10.1038/nmeth.2728]; Bergen B., 2005, LITERAL NONLITERAL L, P255; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Boguna M, 2003, LECT NOTES PHYS, V625, P127; Bullinaria JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057191; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cancho RFI, 2001, P ROY SOC B-BIOL SCI, V268, P2261, DOI 10.1098/rspb.2001.1800; Cox DD, 2003, NEUROIMAGE, V19, P261, DOI 10.1016/S1053-8119(03)00049-1; Davatzikos C, 2005, NEUROIMAGE, V28, P663, DOI 10.1016/j.neuroimage.2005.08.009; Devereux Barry, 2010, P NAACL WORKSH COMP, P70; Dorow Beate, 2005, P MEAN 2005 WORKSH T; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Feldman J, 2004, BRAIN LANG, V89, P385, DOI 10.1016/S0093-934X(03)00355-9; Feldman J, 2010, PHYS LIFE REV, V7, P385, DOI 10.1016/j.plrev.2010.06.006; Feldman J, 2010, PHYS LIFE REV, V7, P421, DOI 10.1016/j.plrev.2010.11.004; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Hayward PJ, 1994, INT S SERIES, V9; HUBBELL CH, 1965, SOCIOMETRY, V28, P377, DOI 10.2307/2785990; Huth AG, 2012, NEURON, V76, P1210, DOI 10.1016/j.neuron.2012.10.014; Joyce T, 2005, GLOTTOMETRICS, V10, P82; Jung J, 2010, P NAACL HLT 2010 1 W, P27; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kaschak MP, 2000, J MEM LANG, V43, P508, DOI 10.1006/jmla.2000.2705; KATZ E, 1957, PUBLIC OPIN QUART, V21, P61, DOI 10.1086/266687; KISS GR, 1968, J VERB LEARN VERB BE, V7, P707, DOI 10.1016/S0022-5371(68)80130-6; LaConte S, 2005, NEUROIMAGE, V26, P317, DOI 10.1016/j.neuroimage.2005.01.048; Leicht EA, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.026120; Lenci A, 2008, ITAL J LINGUIST, V20, P1; Malin B., 2005, Computational & Mathematical Organization Theory, V11, P119, DOI 10.1007/s10588-005-3940-3; MCEVOY CL, 1982, AM J PSYCHOL, V95, P581, DOI 10.2307/1422189; McRae K, 2005, BEHAV RES METHODS, V37, P547, DOI 10.3758/BF03192726; Meara P., 1992, VOCABULARY APPL LING, P62; MIRON MS, 1964, J VERB LEARN VERB BE, V3, P376, DOI 10.1016/S0022-5371(64)80006-2; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Miyake M, 2007, PACLIC 21: THE 21ST PACIFIC ASIA CONFERENCE ON LANGUAGE, INFORMATION AND COMPUTATION, PROCEEDINGS, P321; Moss Helen, 1996, BIRKBECK WORD ASS NO; Mourao-Miranda J, 2005, NEUROIMAGE, V28, P980, DOI 10.1016/j.neuroimage.2005.06.070; Murphy B., 2009, P 2009 C EMP METH NA, P619, DOI [10.3115/1699571.1699594, DOI 10.3115/1699571.1699594]; Murphy B, 2012, COLING; NELSON DL, 1974, J EXP PSYCHOL, V102, P503, DOI 10.1037/h0035896; Nelson DL, 2000, MEM COGNITION, V28, P887, DOI 10.3758/BF03209337; Nelson DL, 2008, U S FLORIDA WORD ASS; Nikoloski Z, 2005, DISCR MATH THEOR COM, V2005, P239; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; O'Toole AJ, 2007, J COGNITIVE NEUROSCI, V19, P1735, DOI 10.1162/jocn.2007.19.11.1735; Okamoto J, 2001, P C PAC ASS COMP LIN, P214; Pereira F, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00072; Pereira Francisco, 2009, Neuroimage, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Pulvermuller F, 2001, TRENDS COGN SCI, V5, P517, DOI 10.1016/S1364-6613(00)01803-9; Pulvermuller F, 2005, NAT REV NEUROSCI, V6, P576, DOI 10.1038/nrn1706; ROSENZWEIG MR, 1959, AM PSYCHOL, V14, P363; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Russell W.A, 1954, COMPLETE MINNESOTA N; Saygin AP, 2010, J COGNITIVE NEUROSCI, V22, P2480, DOI 10.1162/jocn.2009.21388; Shimizu Y, 2008, J ENV INF STUD MUSAS, P73; Spivey M. J., 2007, METHODS COGNITIVE LI, P277, DOI [DOI 10.1075/HCP.18.19BER, 10.1075/hcp.18.19ber.in]; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Steyvers M, 2005, COGNITIVE SCI, V29, P41, DOI 10.1207/s15516709cog2901_3; Steyvers M., 2004, EXPT COGNITIVE PSYCH, P237, DOI DOI 10.1037/10895-018; Telesford Qawi K, 2010, Front Neuroinform, V4, P117, DOI 10.3389/fninf.2010.00117; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Volchenkov D, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.026104; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weil RS, 2010, CURR OPIN NEUROL, V23, P649, DOI 10.1097/WCO.0b013e32834028c7; Willems RM, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00116; Wu LL, 2009, ACTA PSYCHOL, V132, P173, DOI 10.1016/j.actpsy.2009.02.002; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752; Zhitomirsky-Geffet M, 2009, COMPUT LINGUIST, V35, P435, DOI 10.1162/coli.08-032-R1-06-96; Zock Michael, 2004, P WORKSH ENH US EL D; Zwaan RA, 2008, LANG LEARN, V58, P13, DOI 10.1111/j.1467-9922.2008.00458.x	88	1	2	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125725	10.1371/journal.pone.0125725	http://dx.doi.org/10.1371/journal.pone.0125725			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928363	gold, Green Published, Green Submitted			2022-12-27	WOS:000353713100114
J	Fand, BB; Sul, NT; Bal, SK; Minhas, PS				Fand, Babasaheb B.; Sul, Nitin T.; Bal, Santanu K.; Minhas, P. S.			Temperature Impacts the Development and Survival of Common Cutworm (Spodoptera litura): Simulation and Visualization of Potential Population Growth in India under Warmer Temperatures through Life Cycle Modelling and Spatial Mapping	PLOS ONE			English	Article							CLIMATE-CHANGE; FUTURE DISTRIBUTION; PHENOLOGY MODEL; LEPIDOPTERA; FECUNDITY; FERTILITY; ABUNDANCE; MEALYBUG; PEST	The common cutworm, Spodoptera litura, has become a major pest of soybean (Glycine max) throughout its Indian range. With a changing climate, there is the potential for this insect to become an increasingly severe pest in certain regions due to increased habitat suitability. To examine this possibility, we developed temperature-based phenology model for S. litura, by constructing thermal reaction norms for cohorts of single life stages, at both constant and fluctuating temperatures within the ecologically relevant range (15-38 degrees C) for its development. Life table parameters were estimated stochastically using cohort updating and rate summation approach. The model was implemented in the geographic information system to examine the potential future pest status of S. litura using temperature change projections from SRES A(1)B climate change scenario for the year 2050. The changes were visualized by means of three spatial indices demonstrating the risks for establishment, number of generations per year and pest abundance according to the temperature conditions. The results revealed that the development rate as a function of temperature increased linearly for all the immature stages of S. litura until approximately 34-36 degrees C, after which it became non-linear. The extreme temperature of 38 degrees C was found lethal to larval and pupal stages of S. litura wherein no development to the next stage occurred. Females could lay no eggs at the extreme low (15 degrees C) and high (>35 degrees C) test temperatures, demonstrating the importance of optimum temperature in determining the suitability of climate for the mating and reproduction in S. litura. The risk mapping predicts that due to temperature increase under future climate change, much of the soybean areas in Indian states like Madhya Pradesh, Maharashtra and Rajasthan, will become suitable for S. litura establishment and increased pest activity, indicating the expansion of the suitable and favourable areas over time. This has serious implication in terms of soybean production since these areas produce approximately 95% of the total soybeans in India. As the present model results are based on temperature only, and the effects of other abiotic and biotic factors determining the pest population dynamics were excluded, it presents only the potential population growth parameters for S. litura. However, if combined with the field observations, the model results could certainly contribute to gaining insight into the field dynamics of S. litura.	[Fand, Babasaheb B.; Sul, Nitin T.; Bal, Santanu K.; Minhas, P. S.] ICAR Natl Inst Abiot Stress Management NIASM, Pune, Maharashtra, India	Indian Council of Agricultural Research (ICAR); ICAR - National Institute of Abiotic Stress Management	Fand, BB (corresponding author), ICAR Natl Inst Abiot Stress Management NIASM, Pune, Maharashtra, India.	babasahebfand@gmail.com	Fand, Babasaheb/AAF-9417-2020	Fand, Babasaheb/0000-0002-4957-1002; Minhas, Paramjit Singh/0000-0002-2108-6048	Science and Engineering Research Board (SERB) (Department of Science and Technology), Ministry of Science and Technology, Government of India [SB/YS/LS-06/2013]	Science and Engineering Research Board (SERB) (Department of Science and Technology), Ministry of Science and Technology, Government of India	This research was supported by grants from the Science and Engineering Research Board (SERB) (Department of Science and Technology), Ministry of Science and Technology, Government of India, under the "Fast Track Scheme for Young Scientists" program (Grant No. SB/YS/LS-06/2013).	Ahire M. C., 2013, Indian Research Journal of Extension Education, V13, P108; Ahmed AM, 1979, J AUSTR ENTOMOL SOC, Vl, P363; Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; ALLEN JC, 1995, ENVIRON ENTOMOL, V24, P996, DOI 10.1093/ee/24.5.996; [Anonymous], 2012, CROP PEST SURV ADV P; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Berzitis EA, 2014, GLOBAL CHANGE BIOL, V20, P2778, DOI 10.1111/gcb.12557; Bharathi JL, 2007, TOBACCO RES, V33, P36; BOARDMAN L A, 1977, New Zealand Entomologist, V6, P316; Briere JF, 1999, ENVIRON ENTOMOL, V28, P22, DOI 10.1093/ee/28.1.22; *CABI, 2014, INV SPEC COMP DAT MA; Chelliah S., 1985, P139; Choudhary A. K., 2007, International Journal of Agricultural Sciences, V3, P15; CURRY GL, 1978, THEOR POPUL BIOL, V13, P197, DOI 10.1016/0040-5809(78)90042-4; Dhaliwal GS, 2010, QUEST PESTS MANAGEME; Dhir BC, 1992, INDIAN J PLANT PROTE, V20, P215; EPPO, 2013, PQR DAT EUR MED PLAN; Fand BB, 2014, ECOL MODEL, V288, P62, DOI 10.1016/j.ecolmodel.2014.05.018; Fand BB, 2014, CROP PROT, V55, P98, DOI 10.1016/j.cropro.2013.10.020; GARAD GP, 1984, P INDIAN AS-ANIM SCI, V93, P29, DOI 10.1007/BF03186223; Gedia M. V., 2008, Annals of Plant Protection Sciences, V16, P62; HASHMAT M, 1978, Z ANGEW ENTOMOL, V85, P215; HASHMAT M, 1977, J ANIM MORPHOL PHYSL, V24, P203; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; *IIE, 1993, DISTR MAPS PLANT PES; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Jarvis Claire H., 2001, Diversity and Distributions, V7, P237, DOI 10.1046/j.1366-9516.2001.00114.x; Jarvis Claire H., 2001, Diversity and Distributions, V7, P223, DOI 10.1046/j.1366-9516.2001.00113.x; Khadioli N, 2014, B ENTOMOL RES, V104, P809, DOI 10.1017/S0007485314000601; Kim DS, 2003, ECOL MODEL, V162, P145, DOI 10.1016/S0304-3800(02)00402-7; Kocmankova E, 2011, J AGR SCI, V149, P185, DOI 10.1017/S0021859610001140; Kroschel J, 2013, AGR FOREST METEOROL, V170, P228, DOI 10.1016/j.agrformet.2012.06.017; Lee Geung-Joo, 2007, V2, P1; MACK TP, 1987, ECOL MODEL, V39, P269, DOI 10.1016/0304-3800(87)90004-4; Manimanjari D, 2014, J INSECT SCI, V14, DOI 10.1093/jisesa/ieu159; Mason PG, 2011, CAN ENTOMOL, V143, P185, DOI 10.4039/n10-058; MIYASHITA K, 1971, Applied Entomology and Zoology, V6, P105; Moussa AM, 1960, B SEC ENT EGPT, V44, P241; Parry M. L., 2007, CONTRIBUTION WORKING, P976; Patil R. K., 1996, Journal of Oilseeds Research, V13, P18; Patil RA, 2014, ENTOMOLOGY ORNITHOLO, V3, P2161, DOI DOI 10.4172/2161-0983.1000118; Patil RH, 2002, THESIS U AGR SCI DHA; Prasad JV, 2004, TOBACCO RES, V30, P42; Punithavalli M, 2014, PHYTOPARASITICA, V42, P213, DOI 10.1007/s12600-013-0354-5; Ramirez J, 2010, 1 INT CTR TROP AGT; RAO GVR, 1989, ENVIRON ENTOMOL, V18, P548, DOI 10.1093/ee/18.4.548; SCHOOLFIELD RM, 1981, J THEOR BIOL, V88, P719, DOI 10.1016/0022-5193(81)90246-0; Shahout H. A., 2011, Asian Journal of Agricultural Sciences, V3, P291; Sharma AN, 2014, DIRECYTORTE PLANT PR, P41; SHARPE PJH, 1977, J THEOR BIOL, V64, P649, DOI 10.1016/0022-5193(77)90265-X; Smith IM, 1997, QUARANTINE PESTS EUR, V2, P518; Sporleder M, 2004, ENVIRON ENTOMOL, V33, P477, DOI 10.1603/0046-225X-33.3.477; Sporleder M, 2008, ADV CROP RES, V10, P15; Sporleder M., 2013, ILCYM INSECT LIFE CY, P193; Sridhar V, 2014, CLIMAX SIMULATIONS T, P4; STINNER RE, 1974, CAN ENTOMOL, V106, P519, DOI 10.4039/Ent106519-5; WAGNER TL, 1984, ANN ENTOMOL SOC AM, V77, P475, DOI 10.1093/aesa/77.5.475; Wang R.S., 1982, ACTA ECOLOGICA SINIC, V2, P47; Xue M, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.2201; You L., 2000, SPATIAL PRODUCTION A	60	41	46	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124682	10.1371/journal.pone.0124682	http://dx.doi.org/10.1371/journal.pone.0124682			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927609	Green Published, Green Submitted, gold			2022-12-27	WOS:000353713100045
J	Wilcox, KC; Marunde, MR; Das, A; Velasco, PT; Kuhns, BD; Marty, MT; Jiang, HM; Luan, CH; Sligar, SG; Klein, WL				Wilcox, Kyle C.; Marunde, Matthew R.; Das, Aditi; Velasco, Pauline T.; Kuhns, Benjamin D.; Marty, Michael T.; Jiang, Haoming; Luan, Chi-Hao; Sligar, Stephen G.; Klein, William L.			Nanoscale Synaptic Membrane Mimetic Allows Unbiased High Throughput Screen That Targets Binding Sites for Alzheimer's-Associated A beta Oligomers	PLOS ONE			English	Article							PRION PROTEIN; MOLECULAR-BASIS; MOUSE MODEL; RECEPTOR; DISEASE; TOXICITY; BRAIN; NEURODEGENERATION; PERMEABILIZATION; PHOSPHORYLATION	Despite their value as sources of therapeutic drug targets, membrane proteomes are largely inaccessible to high-throughput screening (HTS) tools designed for soluble proteins. An important example comprises the membrane proteins that bind amyloid beta oligomers (A beta Os). A beta Os are neurotoxic ligands thought to instigate the synapse damage that leads to Alzheimer's dementia. At present, the identities of initial A beta O binding sites are highly uncertain, largely because of extensive protein-protein interactions that occur following attachment of A beta Os to surface membranes. Here, we show that A beta O binding sites can be obtained in a state suitable for unbiased HTS by encapsulating the solubilized synaptic membrane proteome into nanoscale lipid bilayers (Nanodiscs). This method gives a soluble membrane protein library (SMPL)-a collection of individualized synaptic proteins in a soluble state. Proteins within SMPL Nanodiscs showed enzymatic and ligand binding activity consistent with conformational integrity. A beta Os were found to bind SMPL Nanodiscs with high affinity and specificity, with binding dependent on intact synaptic membrane proteins, and selective for the higher molecular weight oligomers known to accumulate at synapses. Combining SMPL Nanodiscs with a mix-incubate-read chemiluminescence assay provided a solution-based HTS platform to discover antagonists of A beta O binding. Screening a library of 2700 drug-like compounds and natural products yielded one compound that potently reduced A beta O binding to SMPL Nanodiscs, synaptosomes, and synapses in nerve cell cultures. Although not a therapeutic candidate, this small molecule inhibitor of synaptic A beta O binding will provide a useful experimental antagonist for future mechanistic studies of A beta Os in Alzheimer's model systems. Overall, results provide proof of concept for using SMPLs in high throughput screening for A beta O binding antagonists, and illustrate in general how a SMPL Nanodisc system can facilitate drug discovery for membrane protein targets.	[Wilcox, Kyle C.; Marunde, Matthew R.; Velasco, Pauline T.; Kuhns, Benjamin D.; Jiang, Haoming; Klein, William L.] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA; [Das, Aditi] Univ Illinois, Dept Comparat Biosci, Urbana, IL 61801 USA; [Das, Aditi; Sligar, Stephen G.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Marty, Michael T.; Sligar, Stephen G.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Luan, Chi-Hao] Northwestern Univ, High Throughput Anal Lab, Evanston, IL USA; [Luan, Chi-Hao] Northwestern Univ, Dept Mol Biosci, Evanston, IL USA	Northwestern University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Northwestern University; Northwestern University	Klein, WL (corresponding author), Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA.	wklein@northwestern.edu	Marty, Michael T/C-5897-2013	Marty, Michael T/0000-0001-8115-1772; Kuhns, Benjamin/0000-0002-0593-481X	National Institutes of Health [AG029460, AG022547, AG041953, GM33775, AG020506, AG039171]; National Science Foundation [EEC-0647560]; Alzheimer's Association Zenith Award [ZEN-09-133875]; Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118145, R01GM033775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG020506, R21AG041953, R01AG022547, R01AG029460, F32AG039171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Alzheimer's Association Zenith Award(Alzheimer's Association); Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants AG029460, AG022547, AG041953, GM33775, AG020506, AG039171; National Science Foundation grant EEC-0647560, and The Alzheimer's Association Zenith Award ZEN-09-133875. Additional funding was provided by the Chicago Biomedical Consortium with support from The Searle Funds at The Chicago Community Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baas BJ, 2004, ARCH BIOCHEM BIOPHYS, V430, P218, DOI 10.1016/j.abb.2004.07.003; Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Bayburt TH, 2002, P NATL ACAD SCI USA, V99, P6725, DOI 10.1073/pnas.062565599; Bayburt TH, 2011, J BIOL CHEM, V286, P1420, DOI 10.1074/jbc.M110.151043; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; BRECKENRIDGE WC, 1972, BIOCHIM BIOPHYS ACTA, V266, P695, DOI 10.1016/0005-2736(72)90365-3; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Butz S, 1999, J BIOL CHEM, V274, P18290, DOI 10.1074/jbc.274.26.18290; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Cooper MA, 2004, J MOL RECOGNIT, V17, P286, DOI 10.1002/jmr.675; CUATRECASAS P, 1973, BIOCHEMISTRY-US, V12, P3547, DOI 10.1021/bi00742a031; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; DODD PR, 1981, BRAIN RES, V226, P107, DOI 10.1016/0006-8993(81)91086-6; Dodgson K, 2009, J RECEPT SIG TRANSD, V29, P163, DOI 10.1080/10799890903079844; Drew D, 2005, PROTEIN SCI, V14, P2011, DOI 10.1110/ps.051466205; Eglen Richard M, 2008, Curr Chem Genomics, V1, P2, DOI 10.2174/1875397300801010002; Gotz J, 2011, CELL MOL LIFE SCI, V68, P3359, DOI 10.1007/s00018-011-0750-2; Gonzalez R, 2010, P NATL ACAD SCI USA, V107, P3552, DOI 10.1073/pnas.0914019107; Johnson EN, 2008, ASSAY DRUG DEV TECHN, V6, P327, DOI 10.1089/adt.2007.113; Kagan BL, 2002, PEPTIDES, V23, P1311, DOI 10.1016/S0196-9781(02)00067-0; Kakio A, 2002, BIOCHEMISTRY-US, V41, P7385, DOI 10.1021/bi0255874; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217; Khoury K, 2012, CURR PHARM DESIGN, V18, P4668, DOI 10.2174/138161212802651580; Kim T, 2013, SCIENCE, V341, P1399, DOI 10.1126/science.1242077; Klein WL, 2013, J ALZHEIMERS DIS, V33, pS49, DOI 10.3233/JAD-2012-129039; Klein WL, 2002, NEUROCHEM INT, V41, P345, DOI 10.1016/S0197-0186(02)00050-5; Knowles JK, 2009, J NEUROSCI, V29, P10627, DOI 10.1523/JNEUROSCI.0620-09.2009; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lambert MP, 2001, J NEUROCHEM, V79, P595, DOI 10.1046/j.1471-4159.2001.00592.x; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lee M, 2012, NEUROBIOL AGING, V33, P2237, DOI 10.1016/j.neurobiolaging.2011.12.005; Leitz AJ, 2006, BIOTECHNIQUES, V40, P601, DOI 10.2144/000112169; Malchiodi-Albedi Fiorella, 2011, Int J Alzheimers Dis, V2011, P906964, DOI 10.4061/2011/906964; MARKWELL MAK, 1981, P NATL ACAD SCI-BIOL, V78, P5406, DOI 10.1073/pnas.78.9.5406; Marty MT, 2013, ANAL BIOANAL CHEM, V405, P4009, DOI 10.1007/s00216-013-6790-8; Mustata GM, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3697682; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Pitt J, 2013, FASEB J, V27, P199, DOI 10.1096/fj.12-211896; Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460; Simakova O, 2007, J NEUROSCI, V27, P13719, DOI 10.1523/JNEUROSCI.3006-07.2007; Takeda S, 2013, FASEB J, V27, P3239, DOI 10.1096/fj.13-229666; Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Viola KL, 2015, NAT NANOTECHNOL, V10, P91, DOI [10.1038/NNANO.2014.254, 10.1038/nnano.2014.254]; Wang DY, 2010, FASEB J, V24, P3511, DOI 10.1096/fj.10-156661; Wang HY, 2000, J BIOL CHEM, V275, P5626, DOI 10.1074/jbc.275.8.5626; Wong PT, 2009, J MOL BIOL, V386, P81, DOI 10.1016/j.jmb.2008.11.060; Xiao C, 2013, J ALZHEIMERS DIS, V35, P777, DOI 10.3233/JAD-122419; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhao WQ, 2010, J BIOL CHEM, V285, P7619, DOI 10.1074/jbc.M109.057182; Zhao WQ, 2009, J BIOL CHEM, V284, P18742, DOI 10.1074/jbc.M109.011015	67	29	29	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125263	10.1371/journal.pone.0125263	http://dx.doi.org/10.1371/journal.pone.0125263			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928376	Green Published, Green Submitted, gold			2022-12-27	WOS:000353713100074
J	Yoshihama, N; Yamaguchi, K; Chigita, S; Mine, M; Abe, M; Ishii, K; Kobayashi, Y; Akimoto, N; Mori, Y; Sugiura, T				Yoshihama, Naoya; Yamaguchi, Koujiro; Chigita, Satomi; Mine, Mariko; Abe, Masakazu; Ishii, Kotaro; Kobayashi, Yosuke; Akimoto, Naonari; Mori, Yoshihide; Sugiura, Tsuyoshi			A Novel Function of CD82/KAI1 in Sialyl Lewis Antigen-Mediated Adhesion of Cancer Cells: Evidence for an Anti-Metastasis Effect by Down-Regulation of Sialyl Lewis Antigens	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; COLORECTAL-CANCER; CARCINOMA-CELLS; KAI1 GENE; GLYCOSYLTRANSFERASES; COMPLEXES; PROTEIN; IV	We have recently elucidated a novel function for CD82 in E-cadherin-mediated homocellular adhesion; due to this function, it can inhibit cancer cell dissociation from the primary cancer nest and limit metastasis. However, the effect of CD82 on selectin ligand-mediated heterocellular adhesion has not yet been elucidated. In this study, we focused on the effects of the metastasis suppressor CD82/KAI1 on heterocellular adhesion of cancer cells to the endothelium of blood vessels in order to further elucidate the function of tetraspanins. The over-expression of CD82 in cancer cells led to the inhibition of experimentally induced lung metastases in mice and significantly inhibited the adhesion of these cells to human umbilical vein epithelial cells (HUVECs) in vitro. Pre-treatment of the cells with function-perturbing antibodies against sLe(a/x) significantly inhibited the adhesion of CD82-negative cells to HUVECs. In addition, cells over-expressing CD82 exhibited reduced expression of sLe(a/x) compared to CD82-negative wild-type cells. Significant down-regulation of ST3 beta-galactoside alpha-2, 3-sialyltransferase 4 (ST3GAL4) was detected by cDNA microarray, real-time PCR, and western blotting analyses. Knockdown of ST3GAL4 on CD82-negative wild-type cells inhibited expression of sLe(x) and reduced cell adhesion to HUVECs. We concluded that CD82 decreases sLe(a/x) expression via the down-regulation of ST3GAL4 expression and thereby reduces the adhesion of cancer cells to blood vessels, which results in inhibition of metastasis.	[Yoshihama, Naoya; Chigita, Satomi; Mine, Mariko; Abe, Masakazu; Ishii, Kotaro; Kobayashi, Yosuke; Akimoto, Naonari; Mori, Yoshihide] Kyushu Univ, Fac Dent Sci, Div Maxillofacial Diagnost & Surg Sci, Sect Oral & Maxillofacial Surg,Higashi Ku, Fukuoka 8128582, Japan; [Yamaguchi, Koujiro; Sugiura, Tsuyoshi] Kagoshima Univ, Grad Sch Med & Dent Sci, Field Oral & Maxillofacial Rehabil, Dept Maxillofacial Diagnost & Surg Sci, Kagoshima 8908544, Japan	Kyushu University; Kagoshima University	Sugiura, T (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Field Oral & Maxillofacial Rehabil, Dept Maxillofacial Diagnost & Surg Sci, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	sugiura@dent.kagoshima-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [23390465]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research (KAKEN No. 23390465) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T. Sugiura). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2008, CANCER LETT, V266, P163, DOI 10.1016/j.canlet.2008.02.058; Adachi M, 1998, J CLIN ONCOL, V16, P1397, DOI 10.1200/JCO.1998.16.4.1397; Berditchevski F, 1999, J CELL BIOL, V146, P477, DOI 10.1083/jcb.146.2.477; CHANDRASEKARAN EV, 1992, J BIOL CHEM, V267, P23806; Chigita S, 2012, INT J ONCOL, V41, P2021, DOI 10.3892/ijo.2012.1671; DONG JT, 1995, SCIENCE, V268, P884, DOI 10.1126/science.7754374; Guo XZ, 1996, CANCER RES, V56, P4876; Ito H, 1997, INT J CANCER, V71, P556, DOI 10.1002/(SICI)1097-0215(19970516)71:4<556::AID-IJC9>3.3.CO;2-J; Kannagi R, 2004, CANCER SCI, V95, P377, DOI 10.1111/j.1349-7006.2004.tb03219.x; Koike T, 2004, P NATL ACAD SCI USA, V101, P8132, DOI 10.1073/pnas.0402088101; Laubli H, 2010, SEMIN CANCER BIOL, V20, P169, DOI 10.1016/j.semcancer.2010.04.005; LEBELBINAY S, 1994, CELL IMMUNOL, V154, P468, DOI 10.1006/cimm.1994.1092; Muneyuki T, 2001, ANTICANCER RES, V21, P3581; Ogawa J, 1996, CANCER RES, V56, P325; Petretti T, 2000, GUT, V46, P359, DOI 10.1136/gut.46.3.359; Petretti T, 1999, BBA-GEN SUBJECTS, V1428, P209, DOI 10.1016/S0304-4165(99)00080-X; Recchi MA, 1998, CANCER RES, V58, P4066; Renkonen R, 1997, GLYCOCONJUGATE J, V14, P593, DOI 10.1023/A:1018536509950; Saito S, 2002, ONCOL REP, V9, P1251; SASAKI K, 1993, J BIOL CHEM, V268, P22782; Seki K, 2005, ORAL SCI INT, V2, P36, DOI 10.1016/S1348-8643(05)80005-9; Sugiura T, 1999, J CELL BIOL, V146, P1375, DOI 10.1083/jcb.146.6.1375; Tagawa K, 1999, JPN J CANCER RES, V90, P970, DOI 10.1111/j.1349-7006.1999.tb00843.x; TAKADA A, 1991, BIOCHEM BIOPH RES CO, V179, P713, DOI 10.1016/0006-291X(91)91875-D; Takahashi M, 2007, INT J CANCER, V121, P1919, DOI 10.1002/ijc.22887; Takaoka A, 1998, ONCOGENE, V16, P1443, DOI 10.1038/sj.onc.1201648; Yu Y, 1997, CLIN CANCER RES, V3, P1045	27	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124743	10.1371/journal.pone.0124743	http://dx.doi.org/10.1371/journal.pone.0124743			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923697	Green Published, gold, Green Submitted			2022-12-27	WOS:000353711600101
J	Houlden, A; Hayes, KS; Bancroft, AJ; Worthington, JJ; Wang, P; Grencis, RK; Roberts, IS				Houlden, Ashley; Hayes, Kelly S.; Bancroft, Allison J.; Worthington, John J.; Wang, Ping; Grencis, Richard K.; Roberts, Ian S.			Chronic Trichuris muris Infection in C57BL/6 Mice Causes Significant Changes in Host Microbiota and Metabolome: Effects Reversed by Pathogen Clearance	PLOS ONE			English	Article							COMMENSAL BACTERIA; GUT MICROBIOTA; MICROFLORA; RESISTANCE; IMMUNITY; MODEL; TIME; DIET	Trichuris species are a globally important and prevalent group of intestinal helminth parasites, in which Trichuris muris (mouse whipworm) is an ideal model for this disease. This paper describes the first ever highly controlled and comprehensive investigation into the effects of T. muris infection on the faecal microbiota of mice and the effects on the microbiota following successful clearance of the infection. Communities were profiled using DGGE, 454 pyrosequencing, and metabolomics. Changes in microbial composition occurred between 14 and 28 days post infection, resulting in significant changes in a and beta-diversity. This impact was dominated by a reduction in the diversity and abundance of Bacteroidetes, specifically Prevotella and Parabacteroides. Metabolomic analysis of stool samples of infected mice at day 41 showed significant differences to uninfected controls with a significant increase in the levels of a number of essential amino acids and a reduction in breakdown of dietary plant derived carbohydrates. The significant reduction in weight gain by infected mice probably reflects these metabolic changes and the incomplete digestion of dietary polysaccharides. Following clearance of infection the intestinal microbiota underwent additional changes gradually transitioning by day 91 towards a microbiota of an uninfected animal. These data indicate that the changes in microbiota as a consequence of infection were transitory requiring the presence of the pathogen for maintenance. Interestingly this was not observed for all of the key immune cell populations associated with chronic T. muris infection. This reflects the highly regulated chronic response and potential lasting immunological consequences of dysbiosis in the microbiota. Thus infection of T. muris causes a significant and substantial impact on intestinal microbiota and digestive function of mice with affects in long term immune regulation.	[Houlden, Ashley; Hayes, Kelly S.; Bancroft, Allison J.; Worthington, John J.; Wang, Ping; Grencis, Richard K.; Roberts, Ian S.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Grencis, RK (corresponding author), Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England.	Richard.k.grencis@manchester.ac.uk; i.s.roberts@manchester.ac.uk	hayes, kelly/GVT-8455-2022	Houlden, Ashley/0000-0002-1526-5963; Worthington, John Joseph/0000-0002-1429-5669	Medical Research Council [G1100076]; Welcome Trust [WT 100290MA]; MRC [G1100076] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Welcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Medical Research Council Grant G1100076 (http://www.mrc.ac.uk) Awarded to ISR and RKG. The Welcome Trust grant WT 100290MA (http://www.wellcome.ac.uk) awarded to RKG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Artis D, 1999, EXP PARASITOL, V92, P144, DOI 10.1006/expr.1999.4407; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Bancroft AJ, 2012, TRENDS PARASITOL, V28, P93, DOI 10.1016/j.pt.2011.12.001; BEER RJS, 1973, PARASITOLOGY, V67, P263, DOI 10.1017/S0031182000046503; Begley P, 2009, ANAL CHEM, V81, P7038, DOI 10.1021/ac9011599; Broadhurst MJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003000; Brown M, 2011, BIOINFORMATICS, V27, P1108, DOI 10.1093/bioinformatics/btr079; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cantacessi C, 2014, J INFECT DIS, V210, P1431, DOI 10.1093/infdis/jiu256; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chu FF, 2004, CANCER RES, V64, P962, DOI 10.1158/0008-5472.CAN-03-2272; Cliffe LJ, 2004, ADV PARASIT, V57, P255, DOI 10.1016/S0065-308X(04)57004-5; Cooper P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076573; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Grencis RK, 2014, IMMUNOL REV, V260, P183, DOI 10.1111/imr.12188; Gu SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074957; Hasnain SZ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001856; Hayes KS, 2010, SCIENCE, V328, P1391, DOI 10.1126/science.1187703; Hepworth MR, 2010, EUR J IMMUNOL, V40, P406, DOI 10.1002/eji.200939589; Kang DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068322; Klementowicz JE, 2012, SEMIN IMMUNOPATHOL, V34, P815, DOI 10.1007/s00281-012-0348-2; Lee SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002880; Li RW, 2012, INFECT IMMUN, V80, P2150, DOI 10.1128/IAI.00141-12; Littman DR, 2011, CELL HOST MICROBE, V10, P311, DOI 10.1016/j.chom.2011.10.004; McCafferty J, 2013, ISME J, V7, P2116, DOI 10.1038/ismej.2013.106; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Ooi M, 2011, INFLAMM RES, V60, P831, DOI 10.1007/s00011-011-0340-7; PANESAR TS, 1980, INT J PARASITOL, V10, P261, DOI 10.1016/0020-7519(80)90006-5; Perez-Vilar J, 1999, J BIOL CHEM, V274, P31751, DOI 10.1074/jbc.274.45.31751; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Prindiville T, 2004, INFLAMM BOWEL DIS, V10, P824, DOI 10.1097/00054725-200411000-00017; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Robertson BR, 2005, INT J SYST EVOL MICR, V55, P1199, DOI 10.1099/ijs.0.63472-0; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schopf LR, 2002, J IMMUNOL, V168, P2383, DOI 10.4049/jimmunol.168.5.2383; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shiomi Y, 2011, INFLAMM BOWEL DIS, V17, P2261, DOI 10.1002/ibd.21616; Summers RW, 2005, GUT, V54, P87, DOI 10.1136/gut.2004.041749; Thomas F, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00093; Thompson JR, 2002, NUCLEIC ACIDS RES, V30, P2083, DOI 10.1093/nar/30.9.2083; WAKELIN D, 1967, PARASITOLOGY, V57, P515, DOI 10.1017/S0031182000072395; Weigmann B, 2007, NAT PROTOC, V2, P2307, DOI 10.1038/nprot.2007.315; WHO, 2011, HELMINTH CONTROL IN SCHOOL-AGE CHILDREN: A GUIDE FOR MANAGERS OF CONTROL PROGRAMMES, SECOND EDITION, P1; Wlodarska M, 2014, CELL, V156, P1045, DOI 10.1016/j.cell.2014.01.026; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Wu ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035470; Yau YK, 2013, J GASTROEN HEPATOL, V28, P1076, DOI 10.1111/jgh.12193	55	122	124	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125945	10.1371/journal.pone.0125945	http://dx.doi.org/10.1371/journal.pone.0125945			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938477	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000353943000117
J	Hung, CL; Chien, JY; Ou, CY				Hung, Chung-Lin; Chien, Jung-Yien; Ou, Chih-Ying			Associated Factors for Tuberculosis Recurrence in Taiwan: A Nationwide Nested Case-Control Study from 1998 to 2010	PLOS ONE			English	Article							RISK-FACTORS; PULMONARY TUBERCULOSIS; RELAPSE; REINFECTION; POPULATION	Background The contribution of human immunodeficiency virus (HIV) co-infection to tuberculosis (TB) recurrence is well established worldwide. We conducted this study to investigate associated factors for recurrent TB in Taiwan, which has a relatively low prevalence of HIV. Methods A case-control study nested within a nationwide population-based cohort was performed using the Taiwan National Health Insurance (NHI) database from 1998 to 2010. Patients with notified TB were identified according to diagnosis codes and prescriptions of anti-TB drugs for more than 60 days. Recurrent TB was defined as cases being retreated for more than 60 days and 6 months after the end of previous TB episode. Four controls were randomly selected from cohort and matched to each case by observational period within a calendar year. Socio-demographic variables and comorbidities were evaluated as factors associated with TB recurrence. Results There were totally 760 patients being investigated (608 controls and 152 cases). During an average 5.12 years of follow-up, 3.76% of all developed recurrent TB and the incidence of TB recurrence was 734 per 100,000 person-years. About half of recurrence (55%) was notified within three years of follow-up, and most (86%) recurrences were intrapulmonary. Independent associated factors for TB recurrence included: male (odds ratio, OR: 2.23, 95% confidence interval, CI: 1.40-3.53), diabetes mellitus (DM) (OR: 1.51, 95% CI: 1.02-2.13), chronic obstructive pulmonary disease (COPD) (OR: 1.59, 95% CI: 1.08-2.36) and lower socio-economic status (p=0.001 between groups). Conclusions Despite low prevalence of HIV in the Taiwanese population, the incidence of recurrent TB among Taiwanese was not less than that of other countries. Identification of subgroups such as male gender, low economic status, DM and COPD should be a high priority in TB control programs.	[Hung, Chung-Lin] Dalin Tzu Chi Hosp, Tzu Chi Med Fdn, Dept Internal Med, Div Hematol Oncol, Chiayi, Taiwan; [Chien, Jung-Yien] Natl Taiwan Univ Hosp, Dept Internal Med, Div Chest Med, Taipei 100, Taiwan; [Chien, Jung-Yien] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Ou, Chih-Ying] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Internal Med,Div Chest Med, Tainan 70101, Taiwan	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Cheng Kung University; National Cheng Kung University Hospital	Chien, JY (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Div Chest Med, Taipei 100, Taiwan.	jychien@ntu.edu.tw; budda0714@gmail.com		CHIEN, JUNG-YIEN/0000-0002-7718-0594	Clinical Research Fund of National Cheng Kung University Medical Center, Tainan, Taiwan [NCKUH-10406032]	Clinical Research Fund of National Cheng Kung University Medical Center, Tainan, Taiwan	This study was funded by NCKUH-10406032 grant from the Clinical Research Fund of National Cheng Kung University Medical Center, Tainan, Taiwan.	Aber V R, 1978, Bull Int Union Tuberc, V53, P276; Bang D, 2010, INT J TUBERC LUNG D, V14, P447; Centers for Disease Control, 2013, CDC ANN REP; Cox HS, 2008, BMJ-BRIT MED J, V336, P484, DOI 10.1136/bmj.39463.640787.BE; Crofts JP, 2010, THORAX, V65, P310, DOI 10.1136/thx.2009.124677; Driver CR, 2001, CLIN INFECT DIS, V33, P1762, DOI 10.1086/323784; Huang SH, 2012, TAIWAN EPIDEMIOL B, V28, P269; Jasmer RM, 2004, AM J RESP CRIT CARE, V170, P1360, DOI 10.1164/rccm.200408-1081OC; Lambert ML, 2003, LANCET INFECT DIS, V3, P282, DOI 10.1016/S1473-3099(03)00607-8; Lee CH, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-194; Lee PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092623; Liao CM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-29; Millet JP, 2009, J EPIDEMIOL COMMUN H, V63, P799, DOI 10.1136/jech.2008.077560; Millet JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064898; Panjabi R, 2007, INT J TUBERC LUNG D, V11, P828; Pascopella L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026541; Pasipanodya JG, 2013, CLIN INFECT DIS, V57, P21, DOI 10.1093/cid/cit167; Selassie AW, 2005, ANN EPIDEMIOL, V15, P519, DOI 10.1016/j.annepidem.2005.03.002; Wang JY, 2007, J INFECT DIS, V196, P281, DOI 10.1086/518898; World Health Organization, 1995, WHOTB95183; Yang SL, 2012, TUBERCULOSIS CONTROL	21	19	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124822	10.1371/journal.pone.0124822	http://dx.doi.org/10.1371/journal.pone.0124822			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932917	Green Published, gold, Green Submitted			2022-12-27	WOS:000353887100058
J	Ruchi, R; Genovese, G; Lee, J; Charoonratana, VT; Bernhardy, AJ; Alper, SL; Kopp, JB; Thadhani, R; Friedman, DJ; Pollak, MR				Ruchi, Rupam; Genovese, Giulio; Lee, Jessica; Charoonratana, Victoria T.; Bernhardy, Andrea J.; Alper, Seth L.; Kopp, Jeffrey B.; Thadhani, Ravi; Friedman, David J.; Pollak, Martin R.			Copy Number Variation at the APOL1 Locus	PLOS ONE			English	Article							APOLIPOPROTEIN-L GENE; SEGMENTAL DUPLICATIONS; HUMAN GENOME; KIDNEY-DISEASE; EVOLUTION; VARIANTS; AFRICAN; REARRANGEMENTS; ARCHITECTURE; INITIATION	Two coding variants in the APOL1 gene (G1 and G2) explain most of the high rate of kidney disease in African Americans. APOL1-associated kidney disease risk inheritance follows an autosomal recessive pattern: The relative risk of kidney disease associated with inheritance of two high-risk variants is 7-30 fold, depending on the specific kidney phenotype. We wished to determine if the variability in phenotype might in part reflect structural differences in APOL1 gene. We analyzed sequence coverage from 1000 Genomes Project Phase 3 samples as well as exome sequencing data from African American kidney disease cases for copy number variation. 8 samples sequenced in the 1000 Genomes Project showed increased coverage over a similar to 100kb region that includes APOL2, APOL1 and part of MYH9, suggesting the presence of APOL1 copy number greater than 2. We reasoned that such duplications should be enriched in apparent G1 heterozygotes with kidney disease. Using a PCR-based assay, we observed the presence of this duplication in additional samples from apparent G0G1 or G0G2 individuals. The frequency of this APOL1 duplication was compared among cases (n = 123) and controls (n = 255) with apparent G0G1 heterozygosity. The presence of APOL1 duplication was observed in 4.06% of cases and 0.78% controls, preliminary evidence that this APOL1 duplication may alter susceptibility to kidney disease (p = 0.03). Taqman-based copy number assays confirmed the presence of 3 APOL1 copies in individuals positive for this specific duplication by PCR assay, but also identified a small number of individuals with additional APOL1 copies of presumably different structure. These observations motivate further studies to better assess the contribution of APOL1 copy number on kidney disease risk and on APOL1 function. Investigators and clinicians genotyping APOL1 should also consider whether the particular genotyping platform used is subject to technical errors when more than two copies of APOL1 are present.	[Ruchi, Rupam; Lee, Jessica; Charoonratana, Victoria T.; Bernhardy, Andrea J.; Alper, Seth L.; Friedman, David J.; Pollak, Martin R.] Beth Israel Deaconess Med Ctr, Dept Med, Div Nephrol, Boston, MA 02215 USA; [Ruchi, Rupam] Univ Florida, Dept Med, Div Nephrol, Gainesville, FL USA; [Ruchi, Rupam; Alper, Seth L.; Friedman, David J.; Pollak, Martin R.] Harvard Univ, Sch Med, Boston, MA USA; [Genovese, Giulio; Alper, Seth L.] Broad Inst Harvard & MIT, Stanley Ctr, Cambridge, MA USA; [Genovese, Giulio; Pollak, Martin R.] Broad Inst Harvard & MIT, Cambridge, MA USA; [Kopp, Jeffrey B.] NIH, Kidney Dis Branch, Bethesda, MD 20892 USA; [Thadhani, Ravi] Massachusetts Gen Hosp, Dept Med, Renal Unit, Boston, MA 02114 USA; [Friedman, David J.] Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; State University System of Florida; University of Florida; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; National Institutes of Health (NIH) - USA; Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center	Pollak, MR (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Nephrol, Boston, MA 02215 USA.	mpollak@bidmc.harvard.edu	Kopp, Jeffrey B/O-2681-2015	Kopp, Jeffrey B/0000-0001-9052-186X; Ruchi, Rupam/0000-0001-7973-6050; Friedman, David/0000-0002-0301-9298	NIH [MD007092]; NephCure Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054931, ZIADK043308] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007092] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NephCure Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The work was supported by NIH MD007092 and NephCure Foundation.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Cheng Z, 2005, NATURE, V437, P88, DOI 10.1038/nature04000; Duchateau PN, 2001, J LIPID RES, V42, P620; Friedman DJ, 2011, J AM SOC NEPHROL, V22, P2098, DOI 10.1681/ASN.2011050519; Genovese G, 2013, NAT REV NEPHROL, V9, P240, DOI 10.1038/nrneph.2013.34; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Kanji Z, 2011, J AM SOC NEPHROL, V22, P2091, DOI 10.1681/ASN.2010121234; Kopp JB, 2011, J AM SOC NEPHROL, V22, P2129, DOI 10.1681/ASN.2011040388; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Monajemi H, 2002, GENOMICS, V79, P539, DOI 10.1006/geno.2002.6729; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Sahoo T, 2015, EUR J HUM GENET, V23, P61, DOI 10.1038/ejhg.2014.53; Shaikh TH, 2009, GENOME RES, V19, P1682, DOI 10.1101/gr.083501.108; Shastry BS, 2009, MOL MED REP, V2, P143, DOI 10.3892/mmr_00000074; Stankiewicz P, 2004, GENOME RES, V14, P2209, DOI 10.1101/gr.2746604; Stankiewicz P, 2003, AM J HUM GENET, V72, P1101, DOI 10.1086/374385; Thomson R, 2014, P NATL ACAD SCI USA, V111, pE2130, DOI 10.1073/pnas.1400699111; Tzur S, 2012, NEPHROL DIAL TRANSPL, V27, P1498, DOI 10.1093/ndt/gfr796; Tzur S, 2010, HUM GENET, V128, P345, DOI 10.1007/s00439-010-0861-0; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Whitley E, 2002, CRIT CARE, V6, P335; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217; 2005, NATURE, V437, P69, DOI DOI 10.1038/NATURE04072	26	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125410	10.1371/journal.pone.0125410	http://dx.doi.org/10.1371/journal.pone.0125410			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933006	gold, Green Published, Green Submitted			2022-12-27	WOS:000353887100108
J	Wang, H; Sun, RT; Li, Y; Yang, YF; Xiao, FJ; Zhang, YK; Wang, SX; Sun, HY; Zhang, QW; Wu, CT; Wang, LS				Wang, Hua; Sun, Rui-Ting; Li, Yang; Yang, Yue-Feng; Xiao, Feng-Jun; Zhang, Yi-Kun; Wang, Shao-Xia; Sun, Hui-Yan; Zhang, Qun-Wei; Wu, Chu-Tse; Wang, Li-Sheng			HGF Gene Modification in Mesenchymal Stem Cells Reduces Radiation-Induced Intestinal Injury by Modulating Immunity	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; STROMAL CELLS; THERAPY; TISSUE; IRRADIATION; REPAIR; TRIAL; TH1	Background Effective therapeutic strategies to address intestinal complications after radiation exposure are currently lacking. Mesenchymal stem cells (MSCs), which display the ability to repair the injured intestine, have been considered as delivery vehicles for repair genes. In this study, we evaluated the therapeutic effect of hepatocyte growth factor (HGF)-gene-modified MSCs on radiation-induced intestinal injury (RIII). Methods Female 6- to 8-week-old mice were radiated locally at the abdomen with a single 13-Gy dose of radiation and then treated with saline control, Ad-HGF or Ad-Null-modified MSCs therapy. The transient engraftment of human MSCs was detected via real-time PCR and immunostaining. The therapeutic effects of non-and HGF-modified MSCs were evaluated via FACS to determine the lymphocyte immunophenotypes; via ELISA to measure cytokine expression; via immunostaining to determine tight junction protein expression; via PCNA staining to examine intestinal epithelial cell proliferation; and via TUNEL staining to detect intestinal epithelial cell apoptosis. Results The histopathological recovery of the radiation-injured intestine was significantly enhanced following non-or HGF-modified MSCs treatment. Importantly, the radiation-induced immunophenotypic disorders of the mesenteric lymph nodes and Peyer's patches were attenuated in both MSCs-treated groups. Treatment with HGF-modified MSCs reduced the expression and secretion of inflammatory cytokines, including tumor necrosis factor alpha (TNF-alpha) and interferon-gamma (IFN-gamma), increased the expression of the anti-inflammatory cytokine IL-10 and the tight junction protein ZO-1, and promoted the proliferation and reduced the apoptosis of intestinal epithelial cells. Conclusions Treatment of RIII with HGF-gene-modified MSCs reduces local inflammation and promotes the recovery of small intestinal histopathology in a mouse model. These findings might provide an effective therapeutic strategy for RIII.	[Wang, Hua; Sun, Rui-Ting; Yang, Yue-Feng; Xiao, Feng-Jun; Zhang, Yi-Kun; Sun, Hui-Yan; Zhang, Qun-Wei; Wu, Chu-Tse; Wang, Li-Sheng] Beijing Inst Radiat Med, Dept Expt Hematol, Beijing 100850, Peoples R China; [Sun, Rui-Ting] Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing 100022, Peoples R China; [Li, Yang; Wang, Shao-Xia] Beijing Inst Radiat Med, Dept Expt Pathol, Beijing 100850, Peoples R China; [Wu, Chu-Tse] Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, Chengdu 610041, Peoples R China	Academy of Military Medical Sciences - China; Beijing University of Technology; Academy of Military Medical Sciences - China; Sichuan University	Wu, CT (corresponding author), Beijing Inst Radiat Med, Dept Expt Hematol, Beijing 100850, Peoples R China.	wuct@bmi.ac.cn; wangls@bmi.ac.cn		Wu, Chu-tse/0000-0003-0417-8925	Chinese High-Tech '863' Program [2012AA020807]; Chinese National Basic Research and Development '973' [2012CB518205]; National Natural Science Foundation of China [81072240, 81342927]	Chinese High-Tech '863' Program(National High Technology Research and Development Program of China); Chinese National Basic Research and Development '973'(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Chinese High-Tech '863' Program (No. 2012AA020807), the Chinese National Basic Research and Development '973' Grants (No. 2012CB518205) and the National Natural Science Foundation of China (No. 81072240 and No. 81342927). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bian L, 2009, IN VIVO, V23, P21; Billiard F, 2011, INT J RADIAT ONCOL, V80, P869, DOI 10.1016/j.ijrobp.2010.12.041; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Galipeau J, 2013, CYTOTHERAPY, V15, P2, DOI 10.1016/j.jcyt.2012.10.002; Garcia-Olmo D, 2005, DIS COLON RECTUM, V48, P1416, DOI 10.1007/s10350-005-0052-6; Hamada K, 2010, CANCER CHEMOTH PHARM, V66, P1031, DOI 10.1007/s00280-010-1253-9; Hernigou P, 2014, INT ORTHOP, V38, P1913, DOI 10.1007/s00264-014-2285-2; Hu ZB, 2008, CANCER GENE THER, V15, P173, DOI 10.1038/sj.cgt.7701105; Ido A, 2005, J GASTROENTEROL, V40, P925, DOI 10.1007/s00535-005-1705-x; Kanayama M, 2007, AM J PHYSIOL-GASTR L, V293, pG230, DOI 10.1152/ajpgi.00068.2007; Kudo K, 2010, J RADIAT RES, V51, P73, DOI 10.1269/jrr.09091; Lange C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014486; Linard C, 2012, INT J RADIAT ONCOL, V84, P266, DOI 10.1016/j.ijrobp.2011.11.027; Lu LL, 2006, HAEMATOLOGICA, V91, P1017; Luz-Crawford P, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt216; Madrigal M, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0260-8; Matsumoto K, 1997, BIOCHEM BIOPH RES CO, V239, P639, DOI 10.1006/bbrc.1997.7517; Monti P., 2005, BRIT J RADIOL, P89, DOI DOI 10.1259/BJR/53186341; Onal C, 2011, DIGEST DIS SCI, V56, P359, DOI 10.1007/s10620-010-1322-2; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Reagan MR, 2012, J BREAST CANCER, V15, P273, DOI 10.4048/jbc.2012.15.3.273; Rodrigo SF, 2013, J CARDIOVASC TRANSL, V6, P816, DOI 10.1007/s12265-013-9507-7; Selleri S, 2013, STEM CELLS DEV, V22, P1063, DOI 10.1089/scd.2012.0315; Semont A, 2010, CELL DEATH DIFFER, V17, P952, DOI 10.1038/cdd.2009.187; Setoyama H, 2011, LIFE SCI, V89, P269, DOI 10.1016/j.lfs.2011.06.019; Tanaka F, 2008, LIFE SCI, V83, P771, DOI 10.1016/j.lfs.2008.09.016; Turner JD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001269; Wang H, 2013, HUM GENE THER, V24, P343, DOI 10.1089/hum.2012.177; Xu LF, 2011, ARCH PHARM RES, V34, P245, DOI 10.1007/s12272-011-0210-4; Yang C, 2013, CURR GENE THER, V13, P305, DOI 10.2174/15665232113136660027; Zhang J, 2008, J BIOMED SCI, V15, P585, DOI 10.1007/s11373-008-9256-9	31	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124420	10.1371/journal.pone.0124420	http://dx.doi.org/10.1371/journal.pone.0124420			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933295	Green Published, gold, Green Submitted			2022-12-27	WOS:000353887100041
J	Wang, SY; Li, W; Lian, BF; Liu, XY; Zhang, Y; Dai, EY; Yu, XX; Meng, FL; Jiang, W; Li, X				Wang, Shuyuan; Li, Wei; Lian, Baofeng; Liu, Xinyi; Zhang, Yan; Dai, Enyu; Yu, Xuexin; Meng, Fanlin; Jiang, Wei; Li, Xia			(TM) REC: A Database of Transcription Factor and MiRNA Regulatory Cascades in Human Diseases	PLOS ONE			English	Article							GENE-REGULATION; HUMAN MICRORNA; MIR-181C; TARGET; CELLS; PROLIFERATION; INVASION	Over the past decades, studies have reported that the combinatorial regulation of transcription factors (TFs) and microRNAs (miRNAs) is essential for the appropriate execution of biological events and developmental processes. Dysregulations of these regulators often cause diseases. However, there are no available resources on the regulatory cascades of TFs and miRNAs in the context of human diseases. To fulfill this vacancy, we established the (TM) REC database in this study. First, we integrated curated transcriptional and post-transcriptional regulations to construct the TFs and miRNA regulatory network. Next, we identified all linear paths using the Breadth First Search traversal method. Finally, we used known disease-related genes and miRNAs to measure the strength of association between cascades and diseases. Currently, (TM) REC consists of 74,248 cascades and 25,194 cascade clusters, involving in 412 TFs, 266 miRNAs and 545 diseases. With the expanding of experimental support regulation data, we will regularly update the database. (TM) REC aims to help experimental biologists to comprehensively analyse gene expression regulation, to understand the aetiology and to predict novel therapeutic targets. (TM) REC is freely available at http://bioinfo.hrbmu.edu.cn/TMREC/.	[Wang, Shuyuan; Li, Wei; Lian, Baofeng; Liu, Xinyi; Zhang, Yan; Dai, Enyu; Yu, Xuexin; Meng, Fanlin; Jiang, Wei; Li, Xia] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin 150081, Peoples R China; [Li, Wei] Fudan Univ, Inst Biomed Sci, EpiRNA Lab, Shanghai 200032, Peoples R China; [Lian, Baofeng] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200240, Peoples R China; [Lian, Baofeng] Shanghai Ctr Bioinformat Technol, Shanghai 201203, Peoples R China	Harbin Medical University; Fudan University; Shanghai Jiao Tong University; Chinese Academy of Sciences	Jiang, W (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin 150081, Peoples R China.	jiangwei@hrbmu.edu.cn; lixia@hrbmu.edu.cn	li, xia/HHZ-7468-2022; liu, xinyi/GWZ-8739-2022	Zhang, Yan/0000-0002-1011-6184	Funds for the Graduate Innovation Fund of Heilongjiang Province [YJSCX2012-250HLJ]; Creative Research Groups of The National Natural Science Foundation of China [81121003]; National Natural Science Foundation of China [30900837, 61170154, 81202074]; Program for Young Talents of Science and Technology in Harbin [2013RFQXJ057]; Heilong Jiang Postdoctoral Funds for Scientific Research Initiation [LBH-Q11042]	Funds for the Graduate Innovation Fund of Heilongjiang Province; Creative Research Groups of The National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Young Talents of Science and Technology in Harbin; Heilong Jiang Postdoctoral Funds for Scientific Research Initiation	This work was supported by the Funds for the Graduate Innovation Fund of Heilongjiang Province (YJSCX2012-250HLJ), the Creative Research Groups of The National Natural Science Foundation of China (81121003), the National Natural Science Foundation of China (30900837, 61170154 and 81202074), the Program for Young Talents of Science and Technology in Harbin (2013RFQXJ057), the Heilong Jiang Postdoctoral Funds for Scientific Research Initiation (LBH-Q11042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora S, 2013, MOL GENET GENOMICS, V288, P77, DOI 10.1007/s00438-013-0734-z; Becker KG, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-61; Cui QH, 2007, BIOCHEM BIOPH RES CO, V352, P733, DOI 10.1016/j.bbrc.2006.11.080; Davies AH, 2014, STEM CELLS, V32, P1437, DOI 10.1002/stem.1707; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Green CD, 2007, MOL CANCER RES, V5, P1191, DOI 10.1158/1541-7786.MCR-07-0123; Hobert O, 2004, TRENDS BIOCHEM SCI, V29, P462, DOI 10.1016/j.tibs.2004.07.001; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Jiang W, 2013, BIOINFORMATICS, V29, P2596, DOI 10.1093/bioinformatics/btt423; Kornfeld JW, 2013, NATURE, V494, P111, DOI 10.1038/nature11793; Li Y, 2014, ACTA BIOCH BIOPH SIN, V46, P48, DOI 10.1093/abbs/gmt124; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Nazarov PV, 2013, NUCLEIC ACIDS RES, V41, P2817, DOI 10.1093/nar/gks1471; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Ruan J, 2015, NEUROREPORT, V26, P66, DOI 10.1097/WNR.0000000000000302; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sun JC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002488; Wang YQ, 2011, GENOMICS, V98, P73, DOI 10.1016/j.ygeno.2011.04.011; Wu JH, 2013, GENE, V518, P139, DOI 10.1016/j.gene.2012.11.056; Wu L, 2008, MOL CELL, V29, P1, DOI 10.1016/j.molcel.2007.12.010; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Zhang Y, 2015, TOXICOL LETT, V232, P481, DOI 10.1016/j.toxlet.2014.11.028; Zitman-Gal T, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-8	25	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125222	10.1371/journal.pone.0125222	http://dx.doi.org/10.1371/journal.pone.0125222			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932650	gold, Green Published, Green Submitted			2022-12-27	WOS:000353887100092
J	Wu, XJ; Conlin, VS; Morampudi, V; Ryz, NR; Nasser, Y; Bhinder, G; Bergstrom, KS; Yu, HB; Waterhouse, CCM; Buchan, AMJ; Popescu, OE; Gibson, WT; Waschek, JA; Vallance, BA; Jacobson, K				Wu, Xiujuan; Conlin, Victoria S.; Morampudi, Vijay; Ryz, Natasha R.; Nasser, Yasmin; Bhinder, Ganive; Bergstrom, Kirk S.; Yu, Hong B.; Waterhouse, Chris C. M.; Buchan, Allison M. J.; Popescu, Oana E.; Gibson, William T.; Waschek, James A.; Vallance, Bruce A.; Jacobson, Kevan			Vasoactive Intestinal Polypeptide Promotes Intestinal Barrier Homeostasis and Protection Against Colitis in Mice	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; RODENTIUM-INDUCED COLITIS; CROHNS-DISEASE; ULCERATIVE-COLITIS; CITROBACTER-RODENTIUM; TREFOIL FACTOR; GENE-EXPRESSION; MURINE MODEL; STEM-CELLS; RAT COLON	Inflammatory bowel disease is a chronic gastrointestinal inflammatory disorder associated with changes in neuropeptide expression and function, including vasoactive intestinal peptide (VIP). VIP regulates intestinal vasomotor and secretomotor function and motility; however, VIP's role in development and maintenance of colonic epithelial barrier homeostasis is unclear. Using VIP deficient (VIPKO) mice, we investigated VIP's role in epithelial barrier homeostasis, and susceptibility to colitis. Colonic crypt morphology and epithelial barrier homeostasis were assessed in wildtype (WT) and VIPKO mice, at baseline. Colitic responses were evaluated following dinitrobenzene sulfonic acid (DNBS) or dextran-sodium sulfate (DSS) exposure. Mice were also treated with exogenous VIP. At baseline, VIPKO mice exhibited distorted colonic crypts, defects in epithelial cell proliferation and migration, increased apoptosis, and altered permeability. VIPKO mice also displayed reduced goblet cell numbers, and reduced expression of secreted goblet cell factors mucin 2 and trefoil factor 3. These changes were associated with reduced expression of caudal type homeobox 2 (Cdx2), a master regulator of intestinal function and homeostasis. DNBS and DSS-induced colitis were more severe in VIPKO than WT mice. VIP treatment rescued the phenotype, protecting VIPKO mice against DSS colitis, with results comparable to WT mice. In conclusion, VIP plays a crucial role in the development and maintenance of colonic epithelial barrier integrity under physiological conditions and promotes epithelial repair and homeostasis during colitis.	[Wu, Xiujuan; Conlin, Victoria S.; Morampudi, Vijay; Ryz, Natasha R.; Nasser, Yasmin; Bhinder, Ganive; Bergstrom, Kirk S.; Yu, Hong B.; Vallance, Bruce A.; Jacobson, Kevan] BC Childrens Hosp, Dept Pediat, Div Gastroenterol, Vancouver, BC, Canada; [Wu, Xiujuan; Conlin, Victoria S.; Morampudi, Vijay; Ryz, Natasha R.; Nasser, Yasmin; Bhinder, Ganive; Bergstrom, Kirk S.; Yu, Hong B.; Popescu, Oana E.; Gibson, William T.; Vallance, Bruce A.; Jacobson, Kevan] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Wu, Xiujuan; Conlin, Victoria S.; Morampudi, Vijay; Ryz, Natasha R.; Nasser, Yasmin; Bhinder, Ganive; Bergstrom, Kirk S.; Yu, Hong B.; Gibson, William T.; Vallance, Bruce A.; Jacobson, Kevan] BC Childrens Hosp, Child & Family Res Inst, Vancouver, BC, Canada; [Bergstrom, Kirk S.] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; [Waterhouse, Chris C. M.] Univ Calgary, Dept Pediat, Calgary, AB T2N 1N4, Canada; [Buchan, Allison M. J.] Univ Toronto, Fac Med, Toronto, ON M5S 1A1, Canada; [Popescu, Oana E.] BC Childrens Hosp, Dept Pathol, Vancouver, BC, Canada; [Gibson, William T.] Univ British Columbia, Dept Med Genet, Vancouver, BC V5Z 1M9, Canada; [Waschek, James A.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA	BC Childrens Hospital; University of British Columbia; University of British Columbia; BC Childrens Hospital; Child & Family Research Institute; University of British Columbia; Oklahoma Medical Research Foundation; University of Calgary; University of Toronto; BC Childrens Hospital; University of British Columbia; University of British Columbia; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Jacobson, K (corresponding author), BC Childrens Hosp, Dept Pediat, Div Gastroenterol, Vancouver, BC, Canada.	kjacobson@cw.bc.ca	, Kevan/AAD-4896-2021; Gibson, William/AFL-3634-2022; Nasser, Yasmin/AAR-4334-2021; Bergstrom, Kirk/AAZ-8856-2021	Gibson, William/0000-0002-6552-402X; Vallance, Bruce/0000-0003-1345-6747; Buchan, Alison/0000-0003-3642-1328; Popescu, Oana-Eugenia/0000-0002-2033-883X; Jacobson, Kevan/0000-0001-7269-8557	Crohn's and Colitis Foundation of Canada; joint Michael Smith Foundation for Health Research/Crohn's and Colitis Foundation of Canada postdoctoral fellowship; Child and Family Research Institute (CFRI) Clinician Scientists Award Program, University of British Columbia; CHILD Foundation	Crohn's and Colitis Foundation of Canada; joint Michael Smith Foundation for Health Research/Crohn's and Colitis Foundation of Canada postdoctoral fellowship; Child and Family Research Institute (CFRI) Clinician Scientists Award Program, University of British Columbia; CHILD Foundation	This work was supported by Crohn's and Colitis Foundation of Canada (www.crohnsandcolitis.ca) to BV and KJ. VM holds a joint Michael Smith Foundation for Health Research/Crohn's and Colitis Foundation of Canada postdoctoral fellowship (http://www.msfhr.org and www.crohnsandcolitis.ca). BAV is the Children with Intestinal and Liver Disorders (CHILD) Foundation Chair in Pediatric Gastroenterology and the Canada Research Chair in Pediatric Gastroenterology (http://www.child.ca/). KJ and WG are Senior Clinician Scientists supported by the Child and Family Research Institute (CFRI) Clinician Scientists Award Program, University of British Columbia (www.cfri.ca). KJ is supported by the CHILD Foundation, (http://www.child.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad C, 2003, GASTROENTEROLOGY, V124, P961, DOI 10.1053/gast.2003.50141; Abad C, 2015, NEUROIMMUNOMODULAT, V22, P203, DOI 10.1159/000364912; An GY, 2007, J EXP MED, V204, P1417, DOI 10.1084/jem.20061929; Arranz A, 2008, NEUROIMMUNOMODULAT, V15, P46, DOI 10.1159/000135623; Bergstrom KSB, 2008, INFECT IMMUN, V76, P796, DOI 10.1128/IAI.00093-07; Bergstrom KSB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000902; Boyd M, 2010, J BIOL CHEM, V285, P25115, DOI 10.1074/jbc.M109.089516; Boyer L, 2007, AUTON NEUROSCI-BASIC, V134, P106, DOI 10.1016/j.autneu.2007.03.001; Calon A, 2007, GUT, V56, P1688, DOI 10.1136/gut.2007.125542; Conlin VS, 2009, AM J PHYSIOL-GASTR L, V297, pG735, DOI 10.1152/ajpgi.90551.2008; Coskun M, 2011, BBA-MOL BASIS DIS, V1812, P283, DOI 10.1016/j.bbadis.2010.11.008; Coskun M, 2010, J CELL BIOCHEM, V109, P1118, DOI 10.1002/jcb.22490; Crissey MAS, 2011, GASTROENTEROLOGY, V140, P517, DOI 10.1053/j.gastro.2010.11.033; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Gao N, 2009, DEV CELL, V16, P588, DOI 10.1016/j.devcel.2009.02.010; Gersemann M, 2009, DIFFERENTIATION, V77, P84, DOI 10.1016/j.diff.2008.09.008; Gibson DL, 2008, CELL MICROBIOL, V10, P618, DOI 10.1111/j.1462-5822.2007.01071.x; Hinoi T, 2002, GASTROENTEROLOGY, V123, P1565, DOI 10.1053/gast.2002.36598; Hokari R, 2005, AM J PHYSIOL-GASTR L, V289, pG949, DOI 10.1152/ajpgi.00142.2005; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Jonsson M, 2012, DIGEST DIS SCI, V57, P303, DOI 10.1007/s10620-011-1985-3; Keller MS, 2004, AM J PHYSIOL-GASTR L, V287, pG104, DOI 10.1152/ajpgi.00484.2003; KIMURA M, 1994, PATHOL INT, V44, P624, DOI 10.1111/j.1440-1827.1994.tb01723.x; Lakhan SE, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-37; Lelievre V, 2007, PEPTIDES, V28, P1688, DOI 10.1016/j.peptides.2007.05.006; Liu Z, 2005, ACTA PAEDIATR, V94, P386, DOI 10.1080/08035250410023304; Martinez C, 1999, J NEUROIMMUNOL, V93, P126, DOI 10.1016/S0165-5728(98)00216-1; Mashimo H, 1996, SCIENCE, V274, P262, DOI 10.1126/science.274.5285.262; MCROBERTS JA, 1985, J BIOL CHEM, V260, P4163; Mennigen R, 2009, AM J PHYSIOL-GASTR L, V296, pG1140, DOI 10.1152/ajpgi.90534.2008; Mesquita P, 2003, J BIOL CHEM, V278, P51549, DOI 10.1074/jbc.M309019200; Morampudi V, 2014, JOVE-J VIS EXP, DOI 10.3791/51297; Moro F, 2001, REGUL PEPTIDES, V101, P35, DOI 10.1016/S0167-0115(01)00257-9; Nasser Y, 2006, J COMP NEUROL, V495, P529, DOI 10.1002/cne.20898; Ogata H, 1997, AM J PHYSIOL-GASTR L, V273, pG348, DOI 10.1152/ajpgi.1997.273.2.G348; Ooi JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086366; Plaisancie P, 1998, AM J PHYSIOL-GASTR L, V275, pG1073, DOI 10.1152/ajpgi.1998.275.5.G1073; Podolsky DK, 2009, GASTROENTEROLOGY, V137, P209, DOI 10.1053/j.gastro.2009.03.007; Ryz NR, 2012, AM J PHYSIOL-GASTR L, V303, pG1299, DOI 10.1152/ajpgi.00320.2012; SHERR CJ, 1995, TRENDS BIOCHEM SCI, V20, P187, DOI 10.1016/S0968-0004(00)89005-2; Sipos F, 2010, SCAND J GASTROENTERO, V45, P440, DOI 10.3109/00365521003624144; Snoek SA, 2010, CURR PHARM DESIGN, V16, P1091, DOI 10.2174/138161210790963814; Stillie R, 2009, INFLAMM BOWEL DIS, V15, P1515, DOI 10.1002/ibd.20951; Strugala V, 2008, INT J CLIN PRACT, V62, P762, DOI 10.1111/j.1742-1241.2007.01665.x; Taupin DR, 2000, P NATL ACAD SCI USA, V97, P799, DOI 10.1073/pnas.97.2.799; Urbanska A, 2012, J MOL NEUROSCI, V46, P10, DOI 10.1007/s12031-011-9526-2; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Vu JP, 2014, J MOL NEUROSCI, V52, P37, DOI 10.1007/s12031-013-0205-3; Yadav M, 2011, CELL IMMUNOL, V267, P124, DOI 10.1016/j.cellimm.2011.01.001; Yamamoto H, 2003, BIOCHEM BIOPH RES CO, V300, P813, DOI 10.1016/S0006-291X(02)02935-2; Yang K, 2008, CANCER RES, V68, P7313, DOI 10.1158/0008-5472.CAN-08-0598; Yusta B, 2012, ENDOCRINOLOGY, V153, P2623, DOI 10.1210/en.2012-1069	53	37	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125225	10.1371/journal.pone.0125225	http://dx.doi.org/10.1371/journal.pone.0125225			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932952	Green Published, Green Submitted, gold			2022-12-27	WOS:000353887100093
J	Kuo, B; Bhasin, M; Jacquart, J; Scult, MA; Slipp, L; Riklin, EIK; Lepoutre, V; Comosa, N; Norton, BA; Dassatti, A; Rosenblum, J; Thurler, AH; Surjanhata, BC; Hasheminejad, NN; Kagan, L; Slawsby, E; Rao, SR; Macklin, EA; Fricchione, GL; Benson, H; Libermann, TA; Korzenik, J; Denninger, JW				Kuo, Braden; Bhasin, Manoj; Jacquart, Jolene; Scult, Matthew A.; Slipp, Lauren; Riklin, Eric Isaac Kagan; Lepoutre, Veronique; Comosa, Nicole; Norton, Beth-Ann; Dassatti, Allison; Rosenblum, Jessica; Thurler, Andrea H.; Surjanhata, Brian C.; Hasheminejad, Nicole N.; Kagan, Leslee; Slawsby, Ellen; Rao, Sowmya R.; Macklin, Eric A.; Fricchione, Gregory L.; Benson, Herbert; Libermann, Towia A.; Korzenik, Joshua; Denninger, John W.			Genomic and Clinical Effects Associated with a Relaxation Response Mind-Body Intervention in Patients with Irritable Bowel Syndrome and Inflammatory Bowel Disease	PLOS ONE			English	Article							QUALITY-OF-LIFE; FOLLOW-UP; CONTROLLED-TRIAL; BEHAVIORAL TREATMENT; STRESS-MANAGEMENT; OXIDATIVE STRESS; CROHNS-DISEASE; T-CELLS; EXPRESSION; THERAPY	Introduction Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD) can profoundly affect quality of life and are influenced by stress and resiliency. The impact of mind-body interventions (MBIs) on IBS and IBD patients has not previously been examined. Methods Nineteen IBS and 29 IBD patients were enrolled in a 9-week relaxation response based mind-body group intervention (RR-MBI), focusing on elicitation of the RR and cognitive skill building. Symptom questionnaires and inflammatory markers were assessed pre- and post-intervention, and at short-term follow-up. Peripheral blood transcriptome analysis was performed to identify genomic correlates of the RR-MBI. Results Pain Catastrophizing Scale scores improved significantly post-intervention for IBD and at short-term follow-up for IBS and IBD. Trait Anxiety scores, IBS Quality of Life, IBS Symptom Severity Index, and IBD Questionnaire scores improved significantly post-intervention and at short-term follow-up for IBS and IBD, respectively. RR-MBI altered expression of more genes in IBD (1059 genes) than in IBS (119 genes). In IBD, reduced expression of RR-MBI response genes was most significantly linked to inflammatory response, cell growth, proliferation, and oxidative stress-related pathways. In IBS, cell cycle regulation and DNA damage related gene sets were significantly upregulated after RR-MBI. Interactive network analysis of RR-affected pathways identified TNF, AKT and NF-kappa B as top focus molecules in IBS, while in IBD kinases (e.g. MAPK, P38 MAPK), inflammation (e.g. VEGF-C, NF-kappa B) and cell cycle and proliferation (e.g. UBC, APP) related genes emerged as top focus molecules. Conclusions In this uncontrolled pilot study, participation in an RR-MBI was associated with improvements in disease-specific measures, trait anxiety, and pain catastrophizing in IBS and IBD patients. Moreover, observed gene expression changes suggest that NF-kappa B is a target focus molecule in both IBS and IBD- and that its regulation may contribute to counteracting the harmful effects of stress in both diseases. Larger, controlled studies are needed to confirm this preliminary finding.	[Kuo, Braden; Comosa, Nicole; Norton, Beth-Ann; Dassatti, Allison; Rosenblum, Jessica; Thurler, Andrea H.; Surjanhata, Brian C.; Korzenik, Joshua] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Bhasin, Manoj; Libermann, Towia A.] Beth Israel Deaconess Med Ctr, Dept Med, Div Interdisciplinary Med & Biotechnol, Boston, MA 02215 USA; [Bhasin, Manoj; Libermann, Towia A.] Beth Israel Deaconess Med Ctr, Dept Med, Genom Prote Bioinformat & Syst Biol Ctr, Boston, MA 02215 USA; [Bhasin, Manoj; Jacquart, Jolene; Scult, Matthew A.; Slipp, Lauren; Riklin, Eric Isaac Kagan; Hasheminejad, Nicole N.; Kagan, Leslee; Slawsby, Ellen; Fricchione, Gregory L.; Benson, Herbert; Libermann, Towia A.; Denninger, John W.] Massachusetts Gen Hosp, Benson Henry Inst Mind Body Med, Boston, MA 02114 USA; [Lepoutre, Veronique; Benson, Herbert; Korzenik, Joshua] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Fricchione, Gregory L.; Denninger, John W.] Massachusetts Gen Hosp, Psychiat, Boston, MA 02114 USA; [Macklin, Eric A.] Harvard Univ, Sch Med, Boston, MA USA; [Rao, Sowmya R.] Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Worcester, MA USA; [Rao, Sowmya R.] Bedford VA Med Ctr, Ctr Healthcare Org & Implementat Res, Bedford, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester	Denninger, JW (corresponding author), Massachusetts Gen Hosp, Benson Henry Inst Mind Body Med, Boston, MA 02114 USA.	jdenninger@mgh.harvard.edu	Macklin, Eric A/E-2955-2013	Macklin, Eric A/0000-0003-1618-3502; Libermann, Towia/0000-0002-4006-8179; Scult, Matthew/0000-0001-5554-8186; Bhasin, Manoj/0000-0001-5172-420X	Center for Disease Control and Prevention [R01DP000339]; International Foundation for Functional Gastrointestinal Diseases (Neuroenteric Research Program Grant); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [R01DP000339] Funding Source: NIH RePORTER	Center for Disease Control and Prevention; International Foundation for Functional Gastrointestinal Diseases (Neuroenteric Research Program Grant); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was supported by the Center for Disease Control and Prevention (Grant R01DP000339) and the International Foundation for Functional Gastrointestinal Diseases (Neuroenteric Research Program Grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almenier Hazem A, 2012, Front Biosci (Elite Ed), V4, P1335; Ananthakrishnan AN, 2013, CLIN GASTROENTEROL H, V11, P57, DOI 10.1016/j.cgh.2012.08.032; Antoni MH, 2012, BIOL PSYCHIAT, V71, P366, DOI 10.1016/j.biopsych.2011.10.007; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhasin MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062817; BLANCHARD EB, 1988, BEHAV THER, V19, P67, DOI 10.1016/S0005-7894(88)80056-X; Blanchard EB, 2007, BEHAV RES THER, V45, P633, DOI 10.1016/j.brat.2006.07.003; Broom OJ, 2009, CLIN EXP IMMUNOL, V158, P272, DOI 10.1111/j.1365-2249.2009.04033.x; Cannon W. B., 1932, THE WISDOM OF THE BO; Casey A, 2009, J CARDIOPULM REHABIL, V29, P230, DOI 10.1097/HCR.0b013e3181a33352; Cleeland C., 2009, THE BRIEF PAIN INVEN; Creswell JD, 2012, BRAIN BEHAV IMMUN, V26, P1095, DOI 10.1016/j.bbi.2012.07.006; Drossman DA, 2006, GASTROENTEROLOGY, V130, P1377, DOI 10.1053/j.gastro.2006.03.008; Dusek JA, 2008, J ALTERN COMPLEM MED, V14, P129, DOI 10.1089/acm.2007.0623; Dusek Jeffery A, 2009, Minn Med, V92, P47; Dusek JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002576; Elsenbruch S, 2005, PSYCHOTHER PSYCHOSOM, V74, P277, DOI 10.1159/000086318; Feng XM, 2010, BLOOD, V115, P510, DOI 10.1182/blood-2009-07-232694; Flik CE, 2013, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-137; Francis CY, 1997, ALIMENT PHARM THERAP, V11, P395, DOI 10.1046/j.1365-2036.1997.142318000.x; Fukuhara S, 2005, MOL CELL BIOL, V25, P136, DOI 10.1128/MCB.25.1.136-146.2005; GUTHRIE E, 1991, GASTROENTEROLOGY, V100, P450, DOI 10.1016/0016-5085(91)90215-7; GUYATT G, 1989, GASTROENTEROLOGY, V96, P804, DOI 10.1016/0016-5085(89)90905-0; Han XN, 2006, AM J PATHOL, V169, P1999, DOI 10.2353/ajpath.2006.060186; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Husebye H, 2010, IMMUNITY, V33, P583, DOI 10.1016/j.immuni.2010.09.010; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Karp SM, 2006, DM-DIS MON, V52, P199, DOI 10.1016/j.disamonth.2006.05.005; Kearney DJ, 2008, NAT CLIN PRACT GASTR, V5, P624, DOI 10.1038/ncpgasthep1257; Keefer L, 2002, BEHAV RES THER, V40, P541, DOI 10.1016/S0005-7967(01)00065-1; Kohane IS, 2012, BIOINFORMATICS, V28, P538, DOI 10.1093/bioinformatics/btr713; Kokkotou E, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2009.01440.x; Kruidenier L, 2003, J PATHOL, V201, P28, DOI 10.1002/path.1409; Labus J, 2013, ALIMENT PHARM THER, V37, P304, DOI 10.1111/apt.12171; Lackner JM, 2007, GASTROENTEROLOGY, V133, P433, DOI 10.1053/j.gastro.2007.05.014; Lackner JM, 2012, CONTEMP CLIN TRIALS, V33, P1293, DOI 10.1016/j.cct.2012.07.013; Litvak V, 2012, NATURE, V490, P421, DOI 10.1038/nature11428; Lowen MBO, 2013, ALIMENT PHARM THER, V37, P1184, DOI 10.1111/apt.12319; Mahvi-Shirazi M, 2012, ARCH MED SCI, V8, P123, DOI 10.5114/aoms.2012.27292; McGuckin MA, 2010, AM J PHYSIOL-GASTR L, V298, pG820, DOI 10.1152/ajpgi.00063.2010; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Mittermaier C, 2004, PSYCHOSOM MED, V66, P79, DOI 10.1097/01.PSY.0000106907.24881.F2; Mizrahi MC, 2012, PSYCHOL HEALTH, V27, P1463, DOI 10.1080/08870446.2012.691169; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Moser G, 2013, AM J GASTROENTEROL, V108, P602, DOI 10.1038/ajg.2013.19; NEFF DF, 1987, BEHAV THER, V18, P70, DOI 10.1016/S0005-7894(87)80052-7; Patrick DL, 1998, DIGEST DIS SCI, V43, P400, DOI 10.1023/A:1018831127942; Rezaie A, 2007, DIGEST DIS SCI, V52, P2015, DOI 10.1007/s10620-006-9622-2; Rollins B, 2010, AM J MED GENET B, V153B, P919, DOI 10.1002/ajmg.b.31062; Samuelson M, 2010, J ALTERN COMPLEM MED, V16, P187, DOI 10.1089/acm.2009.0142; SCHWARZ SP, 1986, BIOFEEDBACK SELF-REG, V11, P189, DOI 10.1007/BF01003478; SCHWARZ SP, 1990, BEHAV RES THER, V28, P331, DOI 10.1016/0005-7967(90)90085-W; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Song MS, 2013, AM J PATHOL, V182, P1308, DOI 10.1016/j.ajpath.2012.12.022; Spielberger C. D., 1983, MIND GARDEN; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Timmer A, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006913.pub2; Vogtenhuber C, 2010, BLOOD, V116, P466, DOI 10.1182/blood-2009-11-252825; Woelk CH, 2011, INT REV NEUROBIOL, V101, P41, DOI 10.1016/B978-0-12-387718-5.00003-1; Zijdenbos IL, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006442.pub2	62	49	51	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0123861	10.1371/journal.pone.0123861	http://dx.doi.org/10.1371/journal.pone.0123861			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927528	Green Published, Green Submitted, gold			2022-12-27	WOS:000353713100024
J	Stark, K; Scott, DE; Tsyusko, O; Coughlin, DP; Hinton, TG				Stark, Karolina; Scott, David E.; Tsyusko, Olga; Coughlin, Daniel P.; Hinton, Thomas G.			Multi-Level Effects of Low Dose Rate Ionizing Radiation on Southern Toad, Anaxyrus [Bufo] terrestris	PLOS ONE			English	Article							ADAPTIVE RESPONSE; COMET ASSAY; DNA-DAMAGE; METAMORPHOSIS; IRRADIATION; EXPOSURE; SIZE; FROG; REDISTRIBUTION; CONTAMINANTS	Despite their potential vulnerability to contaminants from exposure at multiple life stages, amphibians are one of the least studied groups of vertebrates in ecotoxicology, and research on radiation effects in amphibians is scarce. We used multiple endpoints to assess the radiosensitivity of the southern toad (Anaxyrus [Bufo] terrestris) during its pre-terrestrial stages of development -embryonic, larval, and metamorphic. Toads were exposed, from several hours after oviposition through metamorphosis (up to 77 days later), to four low dose rates of Cs-137 at 0.13, 2.4, 21, and 222 mGy d(-1), resulting in total doses up to 15.8 Gy. Radiation treatments did not affect hatching success of embryos, larval survival, or the length of the larval period. The individual family variation in hatching success of embryos was larger than the radiation response. In contrast, newly metamorphosed individuals from the higher dose-rate treatments had higher mass and mass/length body indices, a measure which may relate to higher post-metamorphic survival. The increased mass and index at higher dose rates may indicate that the chronic, low dose rate radiation exposures triggered secondary responses. Additionally, the increases in growth were linked to a decrease in DNA damage (as measured by the Comet Assay) in red blood cells at a dose rate of 21 mGy d(-1) and a total dose of 1.1 Gy. In conclusion, the complex effects of low dose rates of ionizing radiation may trigger growth and cellular repair mechanisms in amphibian larvae.	[Stark, Karolina] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden; [Stark, Karolina; Scott, David E.; Tsyusko, Olga; Coughlin, Daniel P.; Hinton, Thomas G.] Univ Georgia, Savannah River Ecol Lab, Aiken, SC USA; [Tsyusko, Olga] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY USA; [Hinton, Thomas G.] Inst Radiat Protect & Nucl Safety, Dept Radioecol Environm Modeling & Ecotoxicol, Cadarache, France	Stockholm University; United States Department of Energy (DOE); Savannah River Ecology Laboratory; University System of Georgia; University of Georgia; University of Kentucky	Stark, K (corresponding author), Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden.	karolina.stark@su.se	Scott, David/V-7683-2019	Scott, David/0000-0003-2937-0593; Tsyusko, Olga/0000-0001-8196-1062	Savannah River Ecology Laboratory's Education Program; L. Namowitsky's foundation; Swedish Radiation Protection Authority (SSI); U.S. Department of Energy [DE-FC09-96SR18546, FC09-07SR22506]	Savannah River Ecology Laboratory's Education Program; L. Namowitsky's foundation; Swedish Radiation Protection Authority (SSI); U.S. Department of Energy(United States Department of Energy (DOE))	This study was financed by the Savannah River Ecology Laboratory's Education Program, the L. Namowitsky's foundation, the Swedish Radiation Protection Authority (SSI), and the U.S. Department of Energy under Award Number DE-FC09-96SR18546 and FC09-07SR22506 to the University of Georgia Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amburgey S, 2012, HERPETOLOGICA, V68, P456, DOI 10.1655/HERPETOLOGICA-D-11-00093; [Anonymous], 2008, ICRP PUBL; Audette-Stuart M, 2011, J ENVIRON RADIOACTIV, V102, P566, DOI 10.1016/j.jenvrad.2011.03.001; Baker LA, 1992, ECOL ENG, V1, P1, DOI [10.1016/0925-8574(92)90023-U, DOI 10.1016/0925-8574(92)90023-U]; Beard KH, 2002, OECOLOGIA, V133, P583, DOI 10.1007/s00442-002-1071-9; Beck CW, 1999, CAN J ZOOL, V77, P944, DOI 10.1139/cjz-77-6-944; Beresford Nicholas A., 2011, Integrated Environmental Assessment and Management, V7, P371, DOI 10.1002/ieam.238; Blaustein AR, 2011, ANN NY ACAD SCI, V1223, P108, DOI 10.1111/j.1749-6632.2010.05909.x; BRIDGES C. M., 2003, AMPHIBIAN DECLINE IN; Calabrese EJ, 2008, ENVIRON TOXICOL CHEM, V27, P1451, DOI 10.1897/07-541; Duellman W. E., 1986, BIOL AMPHIBIANS; Eggen RIL, 2004, ENVIRON SCI TECHNOL, V38, p58A, DOI 10.1021/es040349c; Gibbons JW, 2006, CONSERV BIOL, V20, P1457, DOI 10.1111/j.1523-1739.2006.00443.x; Gosner K. L., 1960, Herpetologica, V16, P183; Hinton TG, 2013, J ENVIRON RADIOACTIV, V115, P73, DOI 10.1016/j.jenvrad.2012.07.011; Hinton T G, 2005, SCI TRENDS RADIOLOGI; Hinton TG, 2004, J ENVIRON RADIOACTIV, V74, P43, DOI 10.1016/j.jenvrad.2004.01.014; Howard BJ, 2010, J RADIOL PROT, V30, P195, DOI 10.1088/0952-4746/30/2/S01; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; IAEA, 1992, IAEA TECHN REP SER, V332; Jagoe C. H., 2002, P INT C RAD EC CONT, P873; Jarvis RB, 2003, MUTAT RES-GEN TOX EN, V541, P63, DOI 10.1016/S1383-5718(03)00182-7; Kerby JL, 2010, ECOL LETT, V13, P60, DOI 10.1111/j.1461-0248.2009.01399.x; Lance SL, 2013, ENVIRON POLLUT, V177, P135, DOI 10.1016/j.envpol.2013.02.009; LANDRETH HF, 1974, RADIAT RES, V58, P432, DOI 10.2307/3573912; Larsson C-M, 2011, ANN ICRP, P208; Larsson C-M, 2004, DEL 6 FRAM ASS ENV I; Loat's Associates, 2000, IM AN SOFTW; MACKLIS RM, 1991, J NUCL MED, V32, P350; McNamee JP, 2000, MUTAT RES-GEN TOX EN, V466, P63, DOI 10.1016/S1383-5718(00)00004-8; Metts BS, 2013, ENVIRON SCI TECHNOL, V47, P2846, DOI 10.1021/es303989u; Metts BS, 2012, ENVIRON POLLUT, V164, P211, DOI 10.1016/j.envpol.2012.01.042; PANTER HC, 1986, J EXP ZOOL, V238, P193, DOI 10.1002/jez.1402380209; Ryan TJ, 2001, AM MIDL NAT, V145, P46, DOI 10.1674/0003-0031(2001)145[0046:EOHOMI]2.0.CO;2; Sazykina T, 2006, J ENVIRON RADIOACTIV, V88, P11, DOI 10.1016/j.jenvrad.2005.12.009; SCOTT DE, 1994, ECOLOGY, V75, P1383, DOI 10.2307/1937462; SEALE DB, 1980, ECOLOGY, V61, P1531, DOI 10.2307/1939059; SEMLITSCH RD, 1988, ECOLOGY, V69, P184, DOI 10.2307/1943173; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Sparling D. W., 2000, ECOTOXICOLOGY AMPHIB, V904, P1124; Stark K, 2006, J ENVIRON RADIOACTIV, V87, P175, DOI 10.1016/j.jenvrad.2005.11.008; Stark K, 2012, ECOTOX ENVIRON SAFE, V79, P283, DOI 10.1016/j.ecoenv.2012.01.014; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Tsyusko O, 2011, MUTAT RES-GEN TOX EN, V718, P18, DOI 10.1016/j.mrgentox.2010.11.001; Ulsh B, 2003, J ENVIRON RADIOACTIV, V66, P121, DOI 10.1016/S0265-931X(02)00119-4; Ulsh BA, 2004, J ENVIRON RADIOACTIV, V74, P73, DOI 10.1016/j.jenvrad.2004.01.005; *UNSCEAR, 1996, SOURC EFF ION RAD; WALLING DE, 1988, ENVIRON GEOCHEM HLTH, V10, P35, DOI 10.1007/BF01758590	48	13	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125327	10.1371/journal.pone.0125327	http://dx.doi.org/10.1371/journal.pone.0125327			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927361	Green Published, Green Submitted, gold			2022-12-27	WOS:000353713100082
J	Bueno, PD; Yochite, JNU; Derigge-Pisani, GF; de Farias, KCRM; de Avo, LRD; Voltarelli, JC; Leal, AMD				Bueno, Patricia de Godoy; Ueda Yochite, Juliana Navarro; Derigge-Pisani, Graziela Fernanda; Ribeiro Malmegrim de Farias, Kelen Cristina; da Silva de Avo, Lucimar Retto; Voltarelli, Julio Cesar; de Oliveira Leal, Angela Merice			Metabolic and Pancreatic Effects of Bone Marrow Mesenchymal Stem Cells Transplantation in Mice Fed High-Fat Diet	PLOS ONE			English	Article							IN-VIVO DISTRIBUTION; GLUCOSE-HOMEOSTASIS; INSULIN-RESISTANCE; STROMAL CELLS; ALPHA-CELLS; MOUSE MODEL; HYPERGLYCEMIA; SECRETION; THERAPY; MASS	The purpose of this study was to investigate the effects of multiple infusions of allogeneic MSCs on glucose homeostasis and morphometry of pancreatic islets in high-fat diet (HFD) fed mice. Swiss mice were fed standard diet (C group) or HFD (HFD group). After 8 weeks, animals of HFD group received sterile phosphate-buffered saline infusions (HFD-PBS) or four infusions of MSCs one week apart (HFD-MSCs). Fasting glycemia (FG) was determined weekly and glucose (GTT) and insulin (ITT) tolerance tests were performed 4, 8, 12, and 16 weeks after the infusions of MSCs. The MSCs transplanted mice were classified as responder (FG < 180 mg/dL, 72.2% of transplanted mice) or non-responder (FG > 180mg/dL, 28.8%) Seven weeks after MSCs infusions, FG decreased in HFD-MSCs responder mice compared with the HFD-PBS group. Sixteen weeks post MSCs infusions, GTT and ITT areas under the curve (AUC) decreased in HFD-MSCs responder mice compared to HFD-PBS group. Serum insulin concentration was higher in HFD-PBS group than in control animals and was not different compared with the other groups. The relative volume of alpha-cells was significantly smaller in HFD-PBS group than in C group and significantly higher in HFD-MSCs-NR than in HFD-PBS and HFD-MSCs-R groups. Cell apoptosis in the islets was higher in HFD-PBS group than in C group, and lower in HFD-MSCs responder mice than in HFD-PBS group and non-responder animals. The results demonstrate the ability of multiple infusions of MSCs to promote prolonged decrease in hyperglycemia and apoptosis in pancreatic islets and increase in insulin sensitivity in HFD fed mice.	[Bueno, Patricia de Godoy; Derigge-Pisani, Graziela Fernanda] Univ Fed Sao Carlos, Dept Physiol Sci, Ctr Biol Sci & Hlth, Sao Paulo, Brazil; [Ueda Yochite, Juliana Navarro] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Biochem & Immunol, Sao Paulo, Brazil; [Ribeiro Malmegrim de Farias, Kelen Cristina] Univ Sao Paulo, Fac Pharmaceut Sci Ribeirao Preto, Dept Clin Toxicol & Bromatol Anal, Sao Paulo, Brazil; [da Silva de Avo, Lucimar Retto; de Oliveira Leal, Angela Merice] Univ Fed Sao Carlos, Dept Med, Sao Paulo, Brazil	Universidade Federal de Sao Carlos; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Carlos	Leal, AMD (corresponding author), Univ Fed Sao Carlos, Dept Med, Sao Paulo, Brazil.	angelaleal@ufscar.br	Leal, Angela M O/O-7535-2016; Malmegrim, Kelen/H-1016-2015	Malmegrim, Kelen/0000-0002-9303-0086	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). PGB, AMOL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Asghar Z, 2006, DIABETOLOGIA, V49, P90, DOI 10.1007/s00125-005-0045-y; Bhansali A, 2009, STEM CELLS DEV, V18, P1407, DOI 10.1089/scd.2009.0164; Boumaza I, 2009, J AUTOIMMUN, V32, P33, DOI 10.1016/j.jaut.2008.10.004; Burdon TJ, 2011, BONE MARROW RES, DOI 10.1155/2011/207326; Butler AE, 2003, DIABETES, V52, P2304, DOI 10.2337/diabetes.52.9.2304; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cheng CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036085; Choi JB, 2003, DIABETOLOGIA, V46, P1366, DOI 10.1007/s00125-003-1182-9; Chung Cheng-Ho, 2010, Rev Diabet Stud, V7, P124, DOI 10.1900/RDS.2010.7.124; De Souza CT, 2007, FASEB J, V21, P1153, DOI 10.1096/fj.06-7148com; Dinarvand P, 2010, BIOL PHARM BULL, V33, P1212, DOI 10.1248/bpb.33.1212; Ezquer F, 2012, STEM CELLS, V30, P1664, DOI 10.1002/stem.1132; Ezquer F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016566; Ezquer FE, 2008, BIOL BLOOD MARROW TR, V14, P631, DOI 10.1016/j.bbmt.2008.01.006; Fiorina P, 2011, ENDOCR REV, V32, P725, DOI 10.1210/er.2011-0008; Fiorina P, 2009, J IMMUNOL, V183, P993, DOI 10.4049/jimmunol.0900803; Francese R, 2010, CLIN IMMUNOL, V136, P309, DOI 10.1016/j.clim.2010.04.010; Fraulob JC, 2010, J CLIN BIOCHEM NUTR, V46, P212, DOI 10.3164/jcbn.09-83; Gao JZ, 2001, CELLS TISSUES ORGANS, V169, P12, DOI 10.1159/000047856; Gao XD, 2008, BIOCHEM BIOPH RES CO, V371, P132, DOI 10.1016/j.bbrc.2008.04.033; Gosmain Y, 2013, J DIABETES, V5, P102, DOI 10.1111/1753-0407.12022; Habener JF, 2012, ISLETS, V4, P188, DOI 10.4161/isl.20500; Hao HJ, 2013, BIOCHEM BIOPH RES CO, V436, P418, DOI 10.1016/j.bbrc.2013.05.117; Hasegawa Y, 2007, ENDOCRINOLOGY, V148, P2006, DOI 10.1210/en.2006-1351; HELLMAN B., 1959, ACTA PATHOL ET MICROBIOL SCAND, V47, P35; Henquin JC, 2011, DIABETOLOGIA, V54, P1720, DOI 10.1007/s00125-011-2118-4; Hess D, 2003, NAT BIOTECHNOL, V21, P763, DOI 10.1038/nbt841; Ho JH, 2012, CELL TRANSPLANT, V21, P997, DOI 10.3727/096368911X603611; Hu JX, 2014, ENDOCRINE, V45, P279, DOI 10.1007/s12020-013-9984-0; Hughey CC, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-128; Jiang Ranhua, 2011, Front Med, V5, P94, DOI 10.1007/s11684-011-0116-z; Jurewicz M, 2010, DIABETES, V59, P3139, DOI 10.2337/db10-0542; Kerkis I, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-35; Kilimnik G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027445; Laschke MW, 2014, ACTA BIOMATER; Le Blanc K, 2005, CYTOTHERAPY, V7, P36, DOI 10.1080/14653240510018118; Lee RH, 2006, P NATL ACAD SCI USA, V103, P17438, DOI 10.1073/pnas.0608249103; Levesque J. -P., 2007, V180, P3; Li Z, 2000, J ENDOCRINOL, V165, P93, DOI 10.1677/joe.0.1650093; Lin P, 2009, TRANSPL P, V41, P1891, DOI 10.1016/j.transproceed.2009.02.078; Meier JJ, 2011, AM J PHYSIOL-ENDOC M, V300, pE717, DOI 10.1152/ajpendo.00315.2010; Meyerrose TE, 2007, STEM CELLS, V25, P220, DOI 10.1634/stemcells.2006-0243; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Park KS, 2010, TRANSPLANTATION, V89, P509, DOI 10.1097/TP.0b013e3181c7dc99; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Quesada I, 2008, J ENDOCRINOL, V199, P5, DOI 10.1677/JOE-08-0290; Schwasinger-Schmidt T, 2013, PHARMACOL RES, V76, P58, DOI 10.1016/j.phrs.2013.07.005; Scuteri A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084309; Si YL, 2011, AGEING RES REV, V10, P93, DOI 10.1016/j.arr.2010.08.005; Si YL, 2012, DIABETES, V61, P1616, DOI 10.2337/db11-1141; Sohni A, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/130763; Sone H, 2005, DIABETOLOGIA, V48, P58, DOI 10.1007/s00125-004-1605-2; Sordi V, 2005, BLOOD, V106, P419, DOI 10.1182/blood-2004-09-3507; Stagg J, 2007, TISSUE ANTIGENS, V69, P1, DOI 10.1111/j.1399-0039.2006.00739.x; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Thorel F, 2010, M S-MED SCI, V26, P906, DOI 10.1051/medsci/20102611906; Urban VS, 2008, STEM CELLS, V26, P244, DOI 10.1634/stemcells.2007-0267; Voltarelli JC, 2007, JAMA-J AM MED ASSOC, V297, P1568, DOI 10.1001/jama.297.14.1568; Voltarelli JC, 2009, DIABETOL METAB SYNDR, V1, DOI [10.1186/1758-5996-1-19, 10.1186/1758-5996-1-4]; Wilson T, 2010, J TISSUE ENG, V1, DOI 10.4061/2010/345806; Xu YX, 2008, MED HYPOTHESES, V71, P390, DOI 10.1016/j.mehy.2008.03.046; Yanai G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064499; Yeung TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038189; Zenari L, 2013, DIABETES OBES METAB, V15, P17, DOI 10.1111/dom.12143; Zhang J, 2005, EXP NEUROL, V195, P16, DOI 10.1016/j.expneurol.2005.03.018; Zhou H, 2009, CHINESE MED J-PEKING, V122, P2573, DOI 10.3760/cma.j.issn.0366-6999.2009.21.009	67	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124369	10.1371/journal.pone.0124369	http://dx.doi.org/10.1371/journal.pone.0124369			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923733	gold, Green Published, Green Submitted			2022-12-27	WOS:000353711600078
J	Ma, YH; Zhang, XL; Xu, XX; Shen, L; Yao, Y; Yang, ZY; Liu, PS				Ma, Yanhui; Zhang, Xiaolei; Xu, Xiaoxuan; Shen, Liang; Yao, Yao; Yang, Ziyan; Liu, Peishu			STAT3 Decoy Oligodeoxynucleotides-Loaded Solid Lipid Nanoparticles Induce Cell Death and Inhibit Invasion in Ovarian Cancer Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; SUPPRESSES GROWTH; GENE-THERAPY; ACTIVATION; DELIVERY; PATHWAY; CYTOTOXICITY; SLN	Recent advances in the synthesis of multi-functional nanoparticles have opened up tremendous opportunities for the targeted delivery of genes of interest. Cationic solid lipid nanoparticles (SLN) can efficiently bind nucleic acid molecules and transfect genes in vitro. Few reports have combined SLN with therapy using decoy oligodeoxynucleotides (ODN). In the present study, we prepared SLN to encapsulate STAT3 decoy ODN; then, the properties and in vitro behavior of SLN-STAT3 decoy ODN complexes were investigated. SLN-STAT3 decoy ODN complexes were efficiently taken up by human ovarian cancer cells and significantly suppressed cell growth. Blockage of the STAT3 pathway by SLN-STAT3 decoy ODN complexes resulted in an evident induction of cell death, including apoptotic and autophagic death. The mechanism involved the increased expression of cleaved caspase 3, Bax, Beclin-1 and LC3-II and reduced expression of Bcl-2, pro-caspase 3, Survivin, p-Akt and p-mTOR. In addition, SLN-STAT3 decoy ODN complexes inhibited cell invasion by up-regulating E-cadherin expression and down-regulating Snail and MMP-9 expression. These findings confirmed that SLN as STAT3 decoy ODN carriers can induce cell death and inhibit invasion of ovarian cancer cells. We propose that SLN represent a potential approach for targeted gene delivery in cancer therapy.	[Ma, Yanhui; Zhang, Xiaolei; Xu, Xiaoxuan; Yang, Ziyan; Liu, Peishu] Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, Jinan 250100, Shandong, Peoples R China; [Shen, Liang] Shandong Univ, Prov Hosp, Dept Obstet & Gynecol, Jinan 250100, Shandong, Peoples R China; [Yao, Yao] Shandong Univ, Sch Pharmaceut Sci, Dept Pharmaceut, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University	Liu, PS (corresponding author), Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, Jinan 250100, Shandong, Peoples R China.	peishuliu@126.com			National Natural Science Foundation of China [81101984, 81101982]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The project was supported by National Natural Science Foundation of China (No. 81101984 and No. 81101982). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson WF, 1998, NATURE, V392, P25; Assi H, 2012, NEUROSCI LETT, V527, P71, DOI 10.1016/j.neulet.2012.08.003; Basarkar A, 2007, INT J PHARM, V343, P247, DOI 10.1016/j.ijpharm.2007.05.023; Brenner Malcolm K, 2009, Hematology Am Soc Hematol Educ Program, P675, DOI 10.1182/asheducation-2009.1.675; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Burke WM, 2001, ONCOGENE, V20, P7925, DOI 10.1038/sj.onc.1204990; Caldera V, 2008, J ONCOL, V2008, DOI 10.1155/2008/219241; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chobanian N, 2008, SURG CLIN N AM, V88, P285, DOI 10.1016/j.suc.2007.12.002; Cortesi R, 2014, NEW BIOTECHNOL, V31, P44, DOI 10.1016/j.nbt.2013.10.001; de Lima MCP, 2001, ADV DRUG DELIVER REV, V47, P277, DOI 10.1016/S0169-409X(01)00110-7; del Pozo-Rodriguez A, 2007, INT J PHARMACEUT, V339, P261, DOI 10.1016/j.ijpharm.2007.03.015; Deng JH, 2012, CANCER CELL, V21, P642, DOI 10.1016/j.ccr.2012.03.039; Duan ZF, 2006, CLIN CANCER RES, V12, P5055, DOI 10.1158/1078-0432.CCR-06-0861; Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3; Garg Minal, 2013, World J Stem Cells, V5, P188, DOI 10.4252/wjsc.v5.i4.188; Ghobrial IM, 2005, CA-CANCER J CLIN, V55, P178, DOI 10.3322/canjclin.55.3.178; Ginn SL, 2013, J GENE MED, V15, P65, DOI 10.1002/jgm.2698; Giraud AS, 2012, EXPERT OPIN THER TAR, V16, P889, DOI 10.1517/14728222.2012.709238; Gu JH, 2008, J NEURO-ONCOL, V89, P9, DOI 10.1007/s11060-008-9590-9; Han S, 2000, MOL THER, V2, P302, DOI 10.1006/mthe.2000.0142; Heydenreich AV, 2003, INT J PHARM, V254, P83, DOI 10.1016/S0378-5173(02)00688-9; Huang M, 2000, GYNECOL ONCOL, V79, P67, DOI 10.1006/gyno.2000.5931; Jonchere Barbara, 2013, JAKSTAT, V2, pe24353, DOI 10.4161/jkst.24353; Kamada S, 2005, J BIOL CHEM, V280, P857, DOI 10.1074/jbc.C400538200; Keeler AM, 2012, HUM GENE THER, V23, P548, DOI 10.1089/hum.2012.087; Kim MJ, 2014, CANCER LETT, V354, P33, DOI 10.1016/j.canlet.2014.06.023; Klein JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081819; Lee MY, 2012, AM J TRANSL RES, V4, P1; Merdan T, 2002, ADV DRUG DELIVER REV, V54, P715, DOI 10.1016/S0169-409X(02)00046-7; Muller RH, 2000, EUR J PHARM BIOPHARM, V50, P161, DOI 10.1016/S0939-6411(00)00087-4; Nefedova Y, 2007, CURR CANCER DRUG TAR, V7, P71, DOI 10.2174/156800907780006887; Olbrich C, 2001, J CONTROL RELEASE, V77, P345, DOI 10.1016/S0168-3659(01)00506-5; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Savarese TM, 2002, CYTOKINE, V17, P324, DOI 10.1006/cyto.2002.1022; Schubert MA, 2005, EUR J PHARM BIOPHARM, V61, P77, DOI 10.1016/j.ejpb.2005.03.006; Shi SJ, 2012, PHARM RES-DORDR, V29, P97, DOI 10.1007/s11095-011-0514-6; Shi SJ, 2013, ANGEW CHEM INT EDIT, V52, P3901, DOI 10.1002/anie.201208077; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Silver DL, 2004, CANCER RES, V64, P3550, DOI 10.1158/0008-5472.CAN-03-3959; Souissi I, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-14; Sun XX, 2008, CANCER LETT, V262, P201, DOI 10.1016/j.canlet.2007.12.009; Tabatt K, 2004, EUR J PHARM BIOPHARM, V57, P155, DOI 10.1016/j.ejpb.2003.10.015; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Ye JS, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/28/285708; Yu WY, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/21/215102; Yuan Q, 2014, INT J NANOMED, V9, P4829, DOI 10.2147/IJN.S70919; Zhang XL, 2013, INT J MOL MED, V32, P623, DOI 10.3892/ijmm.2013.1431; Zhang XL, 2010, CANCER GENET CYTOGEN, V197, P46, DOI 10.1016/j.cancergencyto.2009.10.004	49	28	29	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124924	10.1371/journal.pone.0124924	http://dx.doi.org/10.1371/journal.pone.0124924			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923701	Green Published, gold, Green Submitted			2022-12-27	WOS:000353711600113
J	Thibault, R; Makhlouf, AM; Kossovsky, MP; Iavindrasana, J; Chikhi, M; Meyer, R; Pittet, D; Zingg, W; Pichard, C				Thibault, Ronan; Makhlouf, Anne-Marie; Kossovsky, Michel P.; Iavindrasana, Jimison; Chikhi, Marinette; Meyer, Rodolphe; Pittet, Didier; Zingg, Walter; Pichard, Claude			Healthcare-Associated Infections Are Associated with Insufficient Dietary Intake: An Observational Cross-Sectional Study	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; HOSPITAL STAY; FOOD-INTAKE; ENTERAL NUTRITION; ESPEN GUIDELINES; RISK-FACTORS; IMPACT; MORTALITY; MALNUTRITION; SURGERY	Background Indicators to predict healthcare-associated infections (HCAI) are scarce. Malnutrition is known to be associated with adverse outcomes in healthcare but its identification is time-consuming and rarely done in daily practice. This cross-sectional study assessed the association between dietary intake, nutritional risk, and the prevalence of HCAI, in a general hospital population. Methods and findings Dietary intake was assessed by dedicated dieticians on one day for all hospitalized patients receiving three meals per day. Nutritional risk was assessed using Nutritional Risk Screening (NRS)-2002, and defined as a NRS score >= 3. Energy needs were calculated using 110% of Harris-Benedict formula. HCAIs were diagnosed based on the Center for Disease Control criteria and their association with nutritional risk and measured energy intake was done using a multivariate logistic regression analysis. From 1689 hospitalised patients, 1024 and 1091 were eligible for the measurement of energy intake and nutritional risk, respectively. The prevalence of HCAI was 6.8%, and 30.1% of patients were at nutritional risk. Patients with HCAI were more likely identified with decreased energy intake (i.e. <= 70% of predicted energy needs) (30.3% vs. 14.5%, P = 0.002). The proportion of patients at nutritional risk was not significantly different between patients with and without HCAI (35.6% vs. 29.7%, P = 0.28), respectively. Measured energy intake <= 70% of predicted energy needs (odds ratio: 2.26; 95% CI: 1.24 to 4.11, P = 0.008) and moderate severity of the disease (odds ratio: 3.38; 95% CI: 1.49 to 7.68, P = 0.004) were associated with HCAI in the multivariate analysis. Conclusion Measured energy intake <= 70% of predicted energy needs is associated with HCAI in hospitalised patients. This suggests that insufficient dietary intake could be a risk factor of HCAI, without excluding reverse causality. Randomized trials are needed to assess whether improving energy intake in patients identified with decreased dietary intake could be a novel strategy for HCAI prevention.	[Thibault, Ronan; Makhlouf, Anne-Marie; Chikhi, Marinette; Pichard, Claude] Univ Hosp Geneva, Nutr Unit, Geneva, Switzerland; [Kossovsky, Michel P.] Univ Hosp Geneva, Rehabil & Geriatr, Geneva, Switzerland; [Iavindrasana, Jimison] Univ Hosp Geneva, Business Intelligence Div, Geneva, Switzerland; [Meyer, Rodolphe] Univ Hosp Geneva, Dept Informat, Geneva, Switzerland; [Pittet, Didier; Zingg, Walter] Univ Hosp Geneva, Infect Control Programme, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva	Pichard, C (corresponding author), Univ Hosp Geneva, Nutr Unit, Geneva, Switzerland.	claude.pichard@unige.ch		Thibault, Ronan/0000-0002-6038-5649; Pittet, Didier/0000-0002-3667-7131; Meyer, Rodolphe/0000-0002-5712-0607	BBraun; Fresenius-Kabi; Nutricia; Nestle; Baxter; Swiss National Science Foundation; Public Foundation Nutrition 2000plus; Nestle Nutrition; Abbott; B. Braun; Danone-Nutricia; Cosmed	BBraun; Fresenius-Kabi; Nutricia(Danone Nutricia); Nestle(Nestle SA); Baxter; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Public Foundation Nutrition 2000plus; Nestle Nutrition(Nestle SA); Abbott(Abbott Laboratories); B. Braun; Danone-Nutricia(Danone Nutricia); Cosmed	Dr. Thibault reports grants from BBraun, Fresenius-Kabi, Nutricia, Nestle, Baxter, In addition, Dr. Pichard reports grants from Swiss National Science Foundation, grants from Public Foundation Nutrition 2000plus, Nestle Nutrition, Abbott, B. Braun, Fresenius-Kabi, Danone-Nutricia, Cosmed, Baxter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal E, 2013, CLIN NUTR, V32, P737, DOI 10.1016/j.clnu.2012.11.021; Benkovic V, 2014, CLIN NUTR, V33, P689, DOI 10.1016/j.clnu.2013.09.006; Bouadma L, 2010, CLIN INFECT DIS, V51, P1115, DOI 10.1086/656737; Braga M, 1999, ARCH SURG-CHICAGO, V134, P428, DOI 10.1001/archsurg.134.4.428; Chambrier C, 2012, J VISC SURG, V149, pE325, DOI 10.1016/j.jviscsurg.2012.06.006; Chima CS, 1997, J AM DIET ASSOC, V97, P975, DOI 10.1016/S0002-8223(97)00235-6; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Correia MITD, 2003, CLIN NUTR, V22, P235, DOI 10.1016/S0261-5614(02)00215-7; Dupertuis YM, 2003, CLIN NUTR, V22, P115, DOI 10.1054/clnu.2002.0623; Gianotti L, 2002, GASTROENTEROLOGY, V122, P1763, DOI 10.1053/gast.2002.33587; Heidegger CP, 2013, LANCET, V381, P385, DOI 10.1016/S0140-6736(12)61351-8; Hiesmayr M, 2009, CLIN NUTR, V28, P484, DOI 10.1016/j.clnu.2009.05.013; Johansen N, 2004, CLIN NUTR, V23, P539, DOI 10.1016/j.clnu.2003.10.008; Kondrup J, 2003, CLIN NUTR, V22, P415, DOI 10.1016/S0261-5614(03)00098-0; Kreymann KG, 2006, CLIN NUTR, V25, P210, DOI 10.1016/j.clnu.2006.01.021; Lean M, 2008, BRIT MED J, V336, P290, DOI 10.1136/bmj.39449.723090.80; Leandro-Merhi VA, 2011, JPEN-PARENTER ENTER, V35, P241, DOI 10.1177/0148607110374477; National Institute for Health and Care Excellence (NICE), 2006, NUTR SUPP AD OR NUTR; Norman K, 2008, CLIN NUTR, V27, P5, DOI 10.1016/j.clnu.2007.10.007; Olmsted R. N., 1996, APIC INFECT CONTROL, pA1; Pittet D, 1999, INFECT CONT HOSP EP, V20, P37, DOI 10.1086/501554; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Pronovost PJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c309; Saint S, 2013, JAMA INTERN MED, V173, P874, DOI 10.1001/jamainternmed.2013.101; Schneider SM, 2004, BRIT J NUTR, V92, P105, DOI 10.1079/BJN20041152; Scott RD, 2009, DIRECT MED COSTS HEA; Senesse P, 2012, NUTR CLIN METAB, V26, P151, DOI 10.1016/j.nupar.2012.10.002; Singer P, 2009, CLIN NUTR, V28, P387, DOI 10.1016/j.clnu.2009.04.024; Tangvik RJ, 2014, CLIN NUTR, V33, P634, DOI 10.1016/j.clnu.2013.09.008; Thibault R, 2011, CLIN NUTR, V30, P289, DOI 10.1016/j.clnu.2010.10.002; Thibault R, 2009, CLIN NUTR, V28, P134, DOI 10.1016/j.clnu.2009.01.003; Umscheid CA, 2011, INFECT CONT HOSP EP, V32, P101, DOI 10.1086/657912; Villet S, 2005, CLIN NUTR, V24, P502, DOI 10.1016/j.clnu.2005.03.006; Weimann A, 2006, CLIN NUTR, V25, P224, DOI 10.1016/j.clnu.2006.01.015; Zingg W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093898; Zingg W, 2014, INFECT CONT HOSP EP, V35, P674, DOI 10.1086/676424; Zingg W, 2009, CRIT CARE MED, V37, P2167, DOI 10.1097/CCM.0b013e3181a02d8f	37	29	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123695	10.1371/journal.pone.0123695	http://dx.doi.org/10.1371/journal.pone.0123695			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923783	gold, Green Published, Green Submitted			2022-12-27	WOS:000353711600056
J	Ferrao, PM; d'Avila-Levy, CM; Araujo-Jorge, TC; Degrave, WM; Goncalves, AD; Garzoni, LR; Lima, AP; Feige, JJ; Bailly, S; Mendonca-Lima, L; Waghabi, MC				Ferrao, Patricia Mello; d'Avila-Levy, Claudia Masini; Araujo-Jorge, Tania Cremonini; Degrave, Wim Maurits; Goncalves, Antonio da Silva; Garzoni, Luciana Ribeiro; Lima, Ana Paula; Feige, Jean Jacques; Bailly, Sabine; Mendonca-Lima, Leila; Waghabi, Mariana Caldas			Cruzipain Activates Latent TGF-beta from Host Cells during T-cruzi Invasion	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; MAJOR CYSTEINE PROTEINASE; PARASITE CYCLE COMPLETION; PROTEASE INHIBITORS; CHAGAS-DISEASE; MURINE MACROPHAGES; MAMMALIAN-CELLS; CATHEPSIN-B; MOUSE MODEL; INFECTION	Several studies indicate that the activity of cruzipain, the main lysosomal cysteine peptidase of Trypanosoma cruzi, contributes to parasite infectivity. In addition, the parasitic invasion process of mammalian host cells is described to be dependent on the activation of the host TGF-beta signaling pathway by T. cruzi. Here, we tested the hypothesis that cruzipain could be an important activator of latent TGF-beta and thereby trigger TGF-beta-mediated events crucial for the development of Chagas disease. We found that live epimastigotes of T. cruzi, parasite lysates and purified cruzipain were able to activate latent TGF-beta in vitro. This activation could be inhibited by the cysteine peptidase inhibitor Z-Phe-Ala-FMK. Moreover, transfected parasites overexpressing chagasin, a potent endogenous cruzipain inhibitor, prevented latent TGF-beta activation. We also observed that T. cruzi invasion, as well as parasite intracellular growth, were inhibited by the administration of Z-Phe-Ala-FMK or anti-TGF-beta neutralizing antibody to Vero cell cultures. We further demonstrated that addition of purified cruzipain enhanced the invasive activity of trypomastigotes and that this effect could be completely inhibited by addition of a neutralizing anti-TGF-beta antibody. Taken together, these results demonstrate that the activities of cruzipain and TGF-beta in the process of cell invasion are functionally linked. Our data suggest that cruzipain inhibition is an interesting chemotherapeutic approach for Chagas disease not only because of its trypanocidal activity, but also due to the inhibitory effect on TGF-beta activation.	[Ferrao, Patricia Mello; Degrave, Wim Maurits; Mendonca-Lima, Leila; Waghabi, Mariana Caldas] Fiocruz MS, Inst Oswaldo Cruz, Lab Genom Func & Bioinformat, BR-21045900 Rio De Janeiro, Brazil; [Ferrao, Patricia Mello; Garzoni, Luciana Ribeiro] Fiocruz MS, Inst Oswaldo Cruz, Lab Invest Cardiovasc, BR-21045900 Rio De Janeiro, Brazil; [d'Avila-Levy, Claudia Masini] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol & Doencas Endem, BR-21045900 Rio De Janeiro, Brazil; [Araujo-Jorge, Tania Cremonini] Fiocruz MS, Inst Oswaldo Cruz, Lab Inovacoes Terapias Ensino & Bioprod, BR-21045900 Rio De Janeiro, Brazil; [Goncalves, Antonio da Silva] Fiocruz MS, Inst Oswaldo Cruz, Lab Biotecnol & Fisiol Infeccoes Virais, BR-21045900 Rio De Janeiro, Brazil; [Lima, Ana Paula] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Bioquim & Biol Mol Peptidases, BR-21941 Rio De Janeiro, Brazil; [Feige, Jean Jacques; Bailly, Sabine] INSERM, Unite 1036, F-38054 Grenoble, France; [Feige, Jean Jacques; Bailly, Sabine] Univ Grenoble Alpes, F-38041 Grenoble, France; [Feige, Jean Jacques; Bailly, Sabine] CEA, DSV, iRTSV, Lab Biol Canc & Infect, F-38054 Grenoble, France; [Garzoni, Luciana Ribeiro; Waghabi, Mariana Caldas] Fiocruz MS, Programa Integrado Doenca Chagas, BR-21045900 Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Institut National de la Sante et de la Recherche Medicale (Inserm); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Fundacao Oswaldo Cruz	Waghabi, MC (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Genom Func & Bioinformat, BR-21045900 Rio De Janeiro, Brazil.	mariana@ioc.fiocruz.br	Mendonça-Lima, Leila/J-3390-2014; Feige, Jean-Jacques/M-8905-2017; Lima, Ana Paula CA/G-4122-2012; bailly, sabine/G-3540-2013; d'Avila-Levy, Claudia M/O-7192-2014	Mendonça-Lima, Leila/0000-0003-4388-5083; Feige, Jean-Jacques/0000-0002-1354-7692; bailly, sabine/0000-0003-1043-7030; d'Avila-Levy, Claudia M/0000-0001-8042-4695; LIMA, ANA PAULA C. A./0000-0003-4631-2694	INSERM-FIOCRUZ collaborative research program; Instituto Oswaldo Cruz; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); INSERM; CEA	INSERM-FIOCRUZ collaborative research program; Instituto Oswaldo Cruz; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CEA(French Atomic Energy Commission)	This work was supported by the INSERM-FIOCRUZ collaborative research program, by grants from Instituto Oswaldo Cruz, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) to the Brazilian laboratories, and by recurrent funding from INSERM and CEA to the French laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliberti JCS, 1996, INFECT IMMUN, V64, P1961, DOI 10.1128/IAI.64.6.1961-1967.1996; [Anonymous], 2010, 1 WHO; Araujo-Jorge TC, 2012, CLIN PHARMACOL THER, V92, P613, DOI 10.1038/clpt.2012.102; ASLUND L, 1991, MOL BIOCHEM PARASIT, V45, P345, DOI 10.1016/0166-6851(91)90103-D; BOGDAN C, 1993, ANN NY ACAD SCI, V685, P713, DOI 10.1111/j.1749-6632.1993.tb35934.x; BOUTARD V, 1995, J IMMUNOL, V155, P2077; CAMPETELLA O, 1992, MOL BIOCHEM PARASIT, V50, P225, DOI 10.1016/0166-6851(92)90219-A; CAVALLESCO R, 1988, J IMMUNOL, V140, P617; Cazorla SI, 2010, J INFECT DIS, V202, P136, DOI 10.1086/652872; Cazzulo JJ, 2001, CURR PHARM DESIGN, V7, P1143, DOI 10.2174/1381612013397528; Cazzulo Juan Jose, 2002, Current Topics in Medicinal Chemistry, V2, P1261, DOI 10.2174/1568026023392995; Cunha-e-Silva NL, 2002, FEMS MICROBIOL LETT, V214, P7; dos Reis FCG, 2006, FEMS MICROBIOL LETT, V259, P215, DOI 10.1111/j.1574-6968.2006.00267.x; Doyle PS, 2007, ANTIMICROB AGENTS CH, V51, P3932, DOI 10.1128/AAC.00436-07; EAKIN AE, 1992, J BIOL CHEM, V267, P7411; Engel JC, 1998, J CELL SCI, V111, P597; Engel JC, 2000, J CELL SCI, V113, P1345; Engel JC, 1998, J EXP MED, V188, P725, DOI 10.1084/jem.188.4.725; Ferrao PM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038736; Freire-de-Lima CG, 2000, NATURE, V403, P199, DOI 10.1038/35003208; Gantt KR, 2003, J IMMUNOL, V170, P2613, DOI 10.4049/jimmunol.170.5.2613; Guo M, 2002, J BIOL CHEM, V277, P14829, DOI 10.1074/jbc.M108180200; HARTH G, 1993, MOL BIOCHEM PARASIT, V58, P17, DOI 10.1016/0166-6851(93)90086-D; Klemba M, 2002, ANNU REV BIOCHEM, V71, P275, DOI 10.1146/annurev.biochem.71.090501.145453; LIMA APCA, 1992, MOL BIOCHEM PARASIT, V56, P335, DOI 10.1016/0166-6851(92)90183-K; LIMA APCD, 1994, MOL BIOCHEM PARASIT, V67, P333, DOI 10.1016/0166-6851(94)00144-8; McKerrow JH, 2008, CURR OPIN INFECT DIS, V21, P668, DOI 10.1097/QCO.0b013e328315cca9; MEIRELLES MNL, 1992, MOL BIOCHEM PARASIT, V52, P175, DOI 10.1016/0166-6851(92)90050-T; MING M, 1995, CELL, V82, P287, DOI 10.1016/0092-8674(95)90316-X; Monteiro AC, 2006, J IMMUNOL, V177, P6325, DOI 10.4049/jimmunol.177.9.6325; Monteiro AC, 2007, PLOS PATHOG, V3, P1730, DOI 10.1371/journal.ppat.0030185; Munger JS, 1997, KIDNEY INT, V51, P1376, DOI 10.1038/ki.1997.188; Ndao M, 2014, ANTIMICROB AGENTS CH, V58, P1167, DOI 10.1128/AAC.01855-13; Oliveira FL, 2012, PLOS NEGLECT TROP D, V6, pe1696, DOI [10.1371/journal.pntd.0001696, DOI 10.1371/JOURNAL.PNTD.0001696]; Omer FM, 2003, J EXP MED, V198, P1817, DOI 10.1084/jem.20030713; Santos ALS, 2006, AN ACAD BRAS CIENC, V78, P687, DOI 10.1590/S0001-37652006000400006; Santos CC, 2005, J CELL SCI, V118, P901, DOI 10.1242/jcs.01677; Scharfstein J, 2000, J EXP MED, V192, P1289, DOI 10.1084/jem.192.9.1289; Scharfstein J, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00396; Scharfstein Julio, 2008, V47, P140; Schnapp AR, 2002, INFECT IMMUN, V70, P5065, DOI 10.1128/IAI.70.9.5065-5074.2002; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; SOARES MJ, 1992, J CELL SCI, V102, P157; Somanna A, 2002, J BIOL CHEM, V277, P25305, DOI 10.1074/jbc.M203034200; Stempin C, 2002, J LEUKOCYTE BIOL, V72, P727; Tomas AM, 1997, EUR J BIOCHEM, V244, P596, DOI 10.1111/j.1432-1033.1997.t01-1-00596.x; Uehara LA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001958; Venturini G, 2000, BIOCHEM BIOPH RES CO, V270, P437, DOI 10.1006/bbrc.2000.2447; Waghabi MC, 2007, ANTIMICROB AGENTS CH, V51, P2905, DOI 10.1128/AAC.00022-07; Waghabi MC, 2009, ANTIMICROB AGENTS CH, V53, P4694, DOI 10.1128/AAC.00580-09; Waghabi MC, 2005, AM J PATHOL, V167, P993, DOI 10.1016/S0002-9440(10)61189-3; Waghabi MC, 2005, CELL MICROBIOL, V7, P511, DOI 10.1111/j.1462-5822.2004.00481.x; Zech B, 1999, J BIOL CHEM, V274, P20931, DOI 10.1074/jbc.274.30.20931	53	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0124832	10.1371/journal.pone.0124832	http://dx.doi.org/10.1371/journal.pone.0124832			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938232	Green Submitted, Green Published, gold			2022-12-27	WOS:000353943000033
J	Li, YL; Wang, XL; Chen, TT; Yao, FW; Li, CP; Tang, QL; Sun, M; Sun, GY; Hu, SN; Yu, J; Song, SH				Li, Yuli; Wang, Xiliang; Chen, Tingting; Yao, Fuwen; Li, Cuiping; Tang, Qingli; Sun, Min; Sun, Gaoyuan; Hu, Songnian; Yu, Jun; Song, Shuhui			RNA-Seq Based De Novo Transcriptome Assembly and Gene Discovery of Cistanche deserticola Fleshy Stem	PLOS ONE			English	Article							PHENYLALANINE AMMONIA-LYASE; GENOME-WIDE CHARACTERIZATION; PHENYLETHANOID GLYCOSIDES; ROOT TRANSCRIPTOME; MOLECULAR-CLONING; BIOSYNTHESIS; LIGNIN; 2-PHENYLETHANOL; RECONSTRUCTION; ANNOTATION	Backgrounds Cistanche deserticola is a completely non-photosynthetic parasitic plant with great medicinal value and mainly distributed in desert of Northwest China. Its dried fleshy stem is a crucial tonic in traditional Chinese medicine with roles of mainly improving male sexual function and strengthening immunity, but few mechanistic studies have been conducted partly due to the lack of genomic and transcriptomic resources. Results In this study, we performed deep transcriptome sequencing in fleshy stem of C. deserticola, and about 80 million reads were generated using Illumina pair-end sequencing on HiSeq2000 platform. Using trinity assembler, we obtained 95,787 transcript sequences with transcript lengths ranging from 200bp to 15,698bp, having an average length of 950 bases and the N50 length of 1,519 bases. 63,957 transcripts were identified actively expressed with FPKM >= 0.5, in which 30,098 transcripts were annotated with gene descriptions or gene ontology terms by sequence similarity analyses against several public databases (Uniprot, NR and Nt at NCBI, and KEGG). Furthermore, we identified key enzyme genes involved in biosynthesis of lignin and phenylethanoid glycosides (PhGs) which are known to be the primary active ingredients. Four phenylalanine ammonia-lyase (PAL) genes, the first key enzyme in lignin and PhG biosynthesis, were identified based on sequences comparison and phylogenetic analysis. Two biosynthesis pathways of PhGs were also proposed for the first time. Conclusions In all, we completed a global analysis of the C. deserticola fleshy stem transcriptome using RNA-seq technology. A collection of enzyme genes related to biosynthesis of lignin and phenylethanoid glysides were identified from the assembled and annotated transcripts, and the gene family of PAL was also predicted. The sequence data from this study will provide a valuable resource for conducting future phenylethanoid glysides biosynthesis researches and functional genomic studies in this important medicinal plant.	[Li, Yuli; Wang, Xiliang; Hu, Songnian; Yu, Jun; Song, Shuhui] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Chen, Tingting; Yao, Fuwen; Li, Cuiping; Sun, Min; Sun, Gaoyuan; Song, Shuhui] Chinese Acad Sci, Beijing Inst Genom, Core Genom Facil, Beijing, Peoples R China; [Li, Yuli; Wang, Xiliang; Yao, Fuwen] Univ Chinese Acad Sci, Beijing, Peoples R China; [Tang, Qingli] HongKui CongRong Grp, Alashan, Inner Mongolia, Peoples R China	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Song, SH (corresponding author), Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China.	songshh@big.ac.cn			HongKui CongRong Group	HongKui CongRong Group	HongKui CongRong Group provided support in the form of salaries for author QT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Alagna F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-399; Bagal UR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S3-S1; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Cao Rui, 2004, Zhongguo Zhong Yao Za Zhi, V29, P35; Chen S, 2011, PLANT CELL REP, V30, P1593, DOI 10.1007/s00299-011-1070-6; Chen Shilin, 2011, Front Med, V5, P178, DOI 10.1007/s11684-011-0131-0; Cheng XY, 2006, J BIOTECHNOL, V121, P253, DOI 10.1016/j.jbiotec.2005.07.012; Clark MS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-362; College JNM and Press SSaT, 1977, DICTIONARY OF CHINES, P895; Collins LJ, 2008, GENOME INFORM SER, V21, P3; Dassanayake M, 2009, NEW PHYTOL, V183, P764, DOI 10.1111/j.1469-8137.2009.02913.x; Dong Q, 2007, CARBOHYD RES, V342, P1343, DOI 10.1016/j.carres.2007.03.017; Gayral P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003457; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gu L, 2013, ASIAN J ANDROL, V15, P838, DOI 10.1038/aja.2013.73; Guo DJ, 2001, PLANT CELL, V13, P73, DOI 10.1105/tpc.13.1.73; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Halls C, 2008, TRENDS BIOTECHNOL, V26, P77, DOI 10.1016/j.tibtech.2007.11.002; Hao DC, 2012, SCI CHINA LIFE SCI, V55, P452, DOI 10.1007/s11427-012-4319-6; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Hou XM, 2013, MOL BIOL REP, V40, P4301, DOI 10.1007/s11033-013-2517-3; Jiang Y, 2009, J CHROMATOGR A, V1216, P1970, DOI 10.1016/j.chroma.2008.07.031; JIMENEZ C, 1994, NAT PROD REP, V11, P591, DOI 10.1039/np9941100591; Lacombe E, 1997, PLANT J, V11, P429, DOI 10.1046/j.1365-313X.1997.11030429.x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li LG, 2001, PLANT CELL, V13, P1567, DOI 10.1105/tpc.13.7.1567; Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Li X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058747; LI Y, 2010, BMC BIOINFORMATICS, V11, P1, DOI DOI 10.1186/1471-2164-11-1; Li YL, 2014, RNA BIOL, V11, P1180, DOI 10.4161/rna.36281; Lin XH, 2011, PHYSIOL PLANTARUM, V143, P207, DOI 10.1111/j.1399-3054.2011.01500.x; Lu MC, 1998, J ETHNOPHARMACOL, V59, P161, DOI 10.1016/S0378-8741(97)00108-6; Lu TT, 2010, GENOME RES, V20, P1238, DOI 10.1101/gr.106120.110; Luo HM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-209; Maher CA, 2009, P NATL ACAD SCI USA, V106, P12353, DOI 10.1073/pnas.0904720106; Marita JM, 2001, J CHEM SOC PERK T 1, P2939, DOI 10.1039/b107219f; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Naoumkina MA, 2010, MOL PLANT PATHOL, V11, P829, DOI 10.1111/j.1364-3703.2010.00648.x; Negre F, 2003, PLANT CELL, V15, P2992, DOI 10.1105/tpc.016766; Pouteau C, 2003, POLYM DEGRAD STABIL, V81, P9, DOI 10.1016/S0141-3910(03)00057-0; Raes J, 2003, PLANT PHYSIOL, V133, P1051, DOI 10.1104/pp.103.026484; Ralph J, 2001, PHYTOCHEMISTRY, V57, P993, DOI 10.1016/S0031-9422(01)00109-1; Rogers LA, 2005, J EXP BOT, V56, P1651, DOI 10.1093/jxb/eri162; Sakai M, 2007, BIOSCI BIOTECH BIOCH, V71, P2408, DOI 10.1271/bbb.70090; Sarsenbayev K. N., 2013, World Applied Sciences Journal, V25, P1478; Shang QM, 2012, PLANTA, V236, P1093, DOI 10.1007/s00425-012-1659-1; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Shi R, 2010, PLANTA, V232, P1281, DOI 10.1007/s00425-010-1253-3; Shi R, 2010, PLANT CELL PHYSIOL, V51, P144, DOI 10.1093/pcp/pcp175; Song J, 2005, ANN BOT-LONDON, V96, P399, DOI 10.1093/aob/mci196; Stalman M, 2003, J PLANT PHYSIOL, V160, P607, DOI 10.1078/0176-1617-00773; Stefanova NA, 2011, J ETHNOPHARMACOL, V138, P624, DOI 10.1016/j.jep.2011.10.017; Tieman D, 2006, P NATL ACAD SCI USA, V103, P8287, DOI 10.1073/pnas.0602469103; Trick M, 2009, PLANT BIOTECHNOL J, V7, P334, DOI 10.1111/j.1467-7652.2008.00396.x; Tu P.-F., 1994, CHIN TRADIT HERB DRU, V24, P205; Tu PF, 1997, NAT PROD RES DEV, V9, P452; Tu PF, 1994, CHINA ACADEMIC JOURN, V19, P1; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; Verdonk JC, 2003, PHYTOCHEMISTRY, V62, P997, DOI 10.1016/S0031-9422(02)00707-0; Vinardell MP, 2008, IND CROP PROD, V27, P220, DOI 10.1016/j.indcrop.2007.07.011; Wang T, 2012, AM J CHINESE MED, V40, P1123, DOI 10.1142/S0192415X12500838; Wang XW, 2001, CHIN PHARM J, V36, P29; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; WANNER LA, 1995, PLANT MOL BIOL, V27, P327, DOI 10.1007/BF00020187; Watanabe S, 2002, BIOSCI BIOTECH BIOCH, V66, P943, DOI 10.1271/bbb.66.943; Xu H, 2010, BIORESOURCE TECHNOL, V101, P9715, DOI 10.1016/j.biortech.2010.07.083; Zhai LL, 2014, MOL BREEDING, V33, P611, DOI 10.1007/s11032-013-9978-x; Zhang JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-90; Zhu Liucun, 2014, Biomed Res Int, V2014, P750961, DOI 10.1155/2014/750961	74	13	16	5	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125722	10.1371/journal.pone.0125722	http://dx.doi.org/10.1371/journal.pone.0125722			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938435	Green Published, gold, Green Submitted			2022-12-27	WOS:000353943000095
J	Tamura, K; Minami, K; Kudo, M; Iemoto, K; Takahashi, H; Seino, S				Tamura, Kanako; Minami, Kohtaro; Kudo, Maya; Iemoto, Keisuke; Takahashi, Harumi; Seino, Susumu			Liraglutide Improves Pancreatic Beta Cell Mass and Function in Alloxan-Induced Diabetic Mice	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; OXIDATIVE STRESS; INSULIN-SECRETION; GLUCOSE; ISLET; HYPERGLYCEMIA; MECHANISMS; NEOGENESIS; GLP-1; REPLICATION	Glucagon-like peptide-1 (GLP-1) receptor agonists potentiate glucose-induced insulin secretion. In addition, they have been reported to increase pancreatic beta cell mass in diabetic rodents. However, the precise mode of action of GLP-1 receptor agonists still needs to be elucidated. Here we clarify the effects of the human GLP-1 analog liraglutide on beta cell fate and function by using an inducible Cre/loxP-based pancreatic beta cell tracing system and alloxan-induced diabetic mice. Liraglutide was subcutaneously administered once daily for 30 days. The changes in beta cell mass were examined as well as glucose tolerance and insulin secretion. We found that chronic liraglutide treatment improved glucose tolerance and insulin response to oral glucose load. Thirty-day treatment with liraglutide resulted in a 2-fold higher mass of pancreatic beta cells than that in vehicle group. Liraglutide increased proliferation rate of pancreatic beta cells and prevented beta cells from apoptotic cells death. However, the relative abundance of YFP-labeled beta cells to total beta cells was no different before and after liraglutide treatment, suggesting no or little contribution of neogenesis to the increase in beta cell mass. Liraglutide reduced oxidative stress in pancreatic islet cells of alloxan-induced diabetic mice. Furthermore, the beneficial effects of liraglutide in these mice were maintained two weeks after drug withdrawal. In conclusion, chronic liraglutide treatment improves hyperglycemia by ameliorating beta cell mass and function in alloxan-induced diabetic mice.	[Tamura, Kanako; Minami, Kohtaro; Kudo, Maya; Iemoto, Keisuke; Takahashi, Harumi; Seino, Susumu] Kobe Univ, Grad Sch Med, Div Cellular & Mol Med, Kobe, Hyogo 657, Japan	Kobe University	Minami, K (corresponding author), Kobe Univ, Grad Sch Med, Div Cellular & Mol Med, Kobe, Hyogo 657, Japan.	kminami@harbor.kobe-u.ac.jp; seino@med.kobe-u.ac.jp		Minami, Kohtaro/0000-0003-4698-6250	Japan Science and Technology Agency; Ministry of Education, Culture, Sport, Science and Technology, Japan; Novo Nordisk Pharma, Tokyo, Japan	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sport, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Novo Nordisk Pharma, Tokyo, Japan	This study was supported by a CREST grant from the Japan Science and Technology Agency, Grants-in-Aids for Scientific Research from the Ministry of Education, Culture, Sport, Science and Technology, Japan, and a grant by Novo Nordisk Pharma, Tokyo, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bensellam M, 2012, MOL CELL ENDOCRINOL, V364, P1, DOI 10.1016/j.mce.2012.08.003; Blonde L, 2009, DIABETES OBES METAB, V11, P26, DOI 10.1111/j.1463-1326.2009.01075.x; Bonner-Weir S, 2010, DIABETES, V59, P2340, DOI 10.2337/db10-0084; Bunck MC, 2009, DIABETES CARE, V32, P762, DOI 10.2337/dc08-1797; Cho JM, 2011, DIABETES RES CLIN PR, V91, P72, DOI 10.1016/j.diabres.2010.10.012; Dandona P, 1996, LANCET, V347, P444, DOI 10.1016/S0140-6736(96)90013-6; Davidson MB, 2005, NAT REV DRUG DISCOV, V4, P713, DOI 10.1038/nrd1828; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Doyle ME, 2007, PHARMACOL THERAPEUT, V113, P546, DOI 10.1016/j.pharmthera.2006.11.007; Drucker DJ, 2013, DIABETES, V62, P3316, DOI 10.2337/db13-0822; Edlund H, 2002, NAT REV GENET, V3, P524, DOI 10.1038/nrg841; Fehse F, 2005, J CLIN ENDOCR METAB, V90, P5991, DOI 10.1210/jc.2005-1093; Flint A, 1998, J CLIN INVEST, V101, P515, DOI 10.1172/JCI990; Guo SL, 2013, J CLIN INVEST, V123, P3305, DOI 10.1172/JCI65390; GUTNIAK MK, 1994, DIABETES CARE, V17, P1039, DOI 10.2337/diacare.17.9.1039; Hanley NA, 2008, MOL CELL ENDOCRINOL, V288, P79, DOI 10.1016/j.mce.2008.03.001; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Ihara Y, 1999, DIABETES, V48, P927, DOI 10.2337/diabetes.48.4.927; Kaneto H, 1996, BIOCHEM J, V320, P855, DOI 10.1042/bj3200855; Kitamura T, 2013, NAT REV ENDOCRINOL, V9, P615, DOI 10.1038/nrendo.2013.157; Knudsen LB, 2000, J MED CHEM, V43, P1664, DOI 10.1021/jm9909645; Kwon DY, 2009, J PHARMACOL SCI, V111, P361, DOI 10.1254/jphs.09178FP; Lenzen S, 2008, DIABETOLOGIA, V51, P216, DOI 10.1007/s00125-007-0886-7; Madsbad S, 2009, BEST PRACT RES CL EN, V23, P463, DOI 10.1016/j.beem.2009.03.008; Minami K, 2011, DIABETOLOGIA, V54, pS26; Mukai E, 2011, DIABETES, V60, P218, DOI 10.2337/db10-0021; Nakamura K, 2011, BIOMED RES-TOKYO, V32, P167, DOI 10.2220/biomedres.32.167; Nauck MA, 1997, AM J PHYSIOL-ENDOC M, V273, pE981, DOI 10.1152/ajpendo.1997.273.5.E981; Perfetti R, 2000, ENDOCRINOLOGY, V141, P4600, DOI 10.1210/en.141.12.4600; Pospisilik JA, 2003, DIABETES, V52, P741, DOI 10.2337/diabetes.52.3.741; Retnakaran R, 2014, DIABETES CARE, V37, P3270, DOI 10.2337/dc14-0893; Robertson RP, 2004, J BIOL CHEM, V279, P42351, DOI 10.1074/jbc.R400019200; ROSSETTI L, 1990, DIABETES CARE, V13, P610, DOI 10.2337/diacare.13.6.610; Sakuraba H, 2002, DIABETOLOGIA, V45, P85, DOI 10.1007/s125-002-8248-z; Shimoda M, 2011, DIABETOLOGIA, V54, P1098, DOI 10.1007/s00125-011-2069-9; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stoffers DA, 2000, DIABETES, V49, P741, DOI 10.2337/diabetes.49.5.741; Sturis J, 2003, BRIT J PHARMACOL, V140, P123, DOI 10.1038/sj.bjp.0705397; UNGER RH, 1985, DIABETOLOGIA, V28, P119; Vilsboll T, 2008, DIABETIC MED, V25, P152, DOI 10.1111/j.1464-5491.2007.02333.x; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270; Yabe D, 2011, PROG BIOPHYS MOL BIO, V107, P248, DOI 10.1016/j.pbiomolbio.2011.07.010; YKIJARVINEN H, 1990, DIABETOLOGIA, V33, P579, DOI 10.1007/BF00400200; Zhang J, 2007, DIABETOLOGIA, V50, P1900, DOI 10.1007/s00125-007-0737-6	44	40	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0126003	10.1371/journal.pone.0126003	http://dx.doi.org/10.1371/journal.pone.0126003			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938469	gold, Green Submitted, Green Published			2022-12-27	WOS:000353943000127
J	Tobler, M; Ballen, C; Healey, M; Wilson, M; Olsson, M				Tobler, Michael; Ballen, Cissy; Healey, Mo; Wilson, Mark; Olsson, Mats			Oxidant Trade-Offs in Immunity: An Experimental Test in a Lizard	PLOS ONE			English	Article							OXIDATIVE STRESS; SEXUAL-DIMORPHISM; INNATE IMMUNITY; BIRDS; RED; SUSCEPTIBILITY; MITOCHONDRIA; INFLAMMATION; SUPEROXIDE; RESPONSES	Immune system functioning and maintenance entails costs which may limit investment into other processes such as reproduction. Yet, the proximate mechanisms and 'currencies' mediating the costs of immune responses remain elusive. In vertebrates, up-regulation of the innate immune system is associated with rapid phagocytic production of pro-oxidant molecules (so-called 'oxidative burst' responses). Oxidative burst responses are intended to eliminate pathogens but may also constitute an immunopathological risk as they may induce oxidative damage to self cells. To minimize the risk of infection and, at the same time, damage to self, oxidative burst activity must be carefully balanced. The current levels of pro-and antioxidants (i.e. the individual oxidative state) is likely to be a critical factor affecting this balance, but this has not yet been evaluated. Here, we perform an experiment on wild-caught painted dragon lizards (Ctenophorus pictus) to examine how the strength of immune-stimulated oxidative burst responses of phagocytes in whole blood relates to individual oxidative status under control conditions and during an in vivo immune challenge with Escherichia coli lipopolysaccharide (LPS). Under control conditions, oxidative burst responses were not predicted by the oxidative status of the lizards. LPS-injected individuals showed a strong increase in pro-oxidant levels and a strong decrease in antioxidant levels compared to control individuals demonstrating a shift in the pro-/antioxidant balance. Oxidative burst responses in LPS-injected lizards were positively related to post-challenge extracellular pro-oxidants (reflecting the level of cell activation) and negatively related to pre-challenge levels of mitochondrial superoxide (suggesting an immunoregulatory effect of this pro-oxidant). LPS-challenged males had higher oxidative burst responses than females, and in females oxidative burst responses seemed to depend more strongly on antioxidant status than in males. Our results confirm the idea that oxidative state may constrain the activity of the innate immune system. These constraints may have important consequences for the way selection acts on pro-oxidant generating processes.	[Tobler, Michael; Ballen, Cissy; Healey, Mo; Olsson, Mats] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Tobler, Michael] Lund Univ, Dept Biol, SE-22362 Lund, Sweden; [Wilson, Mark] Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia	University of Sydney; Lund University; University of Wollongong	Tobler, M (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	michael.tobler@biol.lu.se	Tobler, Michael/B-2754-2013; Olsson, Mats/AAK-5565-2021; Wilson, Mark R/B-3254-2018	Tobler, Michael/0000-0001-5895-6302; Olsson, Mats/0000-0002-4130-1323; Wilson, Mark R/0000-0002-9551-7445; Ballen, Cissy/0000-0002-4693-6117	European Commission [PIOF-GA-2009-252635]; Australian Research Council	European Commission(European CommissionEuropean Commission Joint Research Centre); Australian Research Council(Australian Research Council)	This study was funded by the European Commission (Marie Curie International Outgoing Fellowship PIOF-GA-2009-252635 to MT) and the Australian Research Council (to MO).	Ashley NT, 2012, ANNU REV ECOL EVOL S, V43, P385, DOI 10.1146/annurev-ecolsys-040212-092530; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Ballen C, 2012, J EXP BIOL, V215, P731, DOI 10.1242/jeb.062257; Bertrand S, 2006, FUNCT ECOL, V20, P1022, DOI 10.1111/j.1365-2435.2006.01191.x; Casagrande S, 2012, COMP BIOCHEM PHYS A, V163, P296, DOI 10.1016/j.cbpa.2012.07.018; Case AJ, 2011, FREE RADICAL BIO MED, V50, P448, DOI 10.1016/j.freeradbiomed.2010.11.025; Cohen J., 1988, STATISTICAL POWER AN, DOI DOI 10.1234/12345678; Costantini D, 2009, COMP BIOCHEM PHYS A, V153, P339, DOI 10.1016/j.cbpa.2009.03.010; Dowling DK, 2009, P ROY SOC B-BIOL SCI, V276, P1737, DOI 10.1098/rspb.2008.1791; Forstmeier W, 2011, BEHAV ECOL SOCIOBIOL, V65, P47, DOI 10.1007/s00265-010-1038-5; French SS, 2008, J COMP PHYSIOL B, V178, P997, DOI 10.1007/s00360-008-0290-8; French SS, 2008, GEN COMP ENDOCR, V155, P148, DOI 10.1016/j.ygcen.2007.04.007; Galeotti P, 2010, COMP BIOCHEM PHYS A, V157, P354, DOI [10.1016/J.cbpa.2010.08.005, 10.1016/j.cbpa.2010.08.005]; Graham AL, 2010, SCIENCE, V330, P662, DOI 10.1126/science.1194878; Halliwell B, 2007, FREE RADICALS IN BIO; Hasselquist D, 2007, J ORNITHOL, V148, pS571, DOI 10.1007/s10336-007-0201-x; Hasselquist D, 2012, ANIM BEHAV, V83, P1303, DOI 10.1016/j.anbehav.2012.03.025; Huff GR, 2011, BRIT POULTRY SCI, V52, P446, DOI 10.1080/00071668.2011.600753; Janeway CA, 2005, IMMUNOBIOLOGY THE IM; Klasing Kirk C., 2004, Acta Zoologica Sinica, V50, P961; Klein, 2012, ECOIMMUNOLOGY, P497; Kurtz J, 2004, P ROY SOC B-BIOL SCI, V271, P197, DOI 10.1098/rspb.2003.2567; Levine TR, 2002, HUM COMMUN RES, V28, P612, DOI 10.1093/hcr/28.4.612; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Marriott I, 2006, IMMUNOL RES, V34, P177, DOI 10.1385/IR:34:3:177; Martin LB, 2006, FUNCT ECOL, V20, P290, DOI 10.1111/j.1365-2435.2006.01094.x; Massot M, 2011, FUNCT ECOL, V25, P848, DOI 10.1111/j.1365-2435.2011.01837.x; McKean KA, 2011, MECHANISMS OF LIFE H; Meylan S, 2010, GEN COMP ENDOCR, V169, P158, DOI 10.1016/j.ygcen.2010.08.002; Nappi AJ, 2000, BIOESSAYS, V22, P469, DOI 10.1002/(SICI)1521-1878(200005)22:5<469::AID-BIES9>3.3.CO;2-W; Nathan C, 2013, NAT REV IMMUNOL, V13, P349, DOI 10.1038/nri3423; Nunn CL, 2009, PHILOS T R SOC B, V364, P61, DOI 10.1098/rstb.2008.0148; Olsson M, 2008, J EXP BIOL, V211, P1257, DOI 10.1242/jeb.015065; Olsson M, 2008, BIOL LETTERS, V4, P186, DOI 10.1098/rsbl.2007.0611; Olsson M, 2007, MOL ECOL, V16, P5307, DOI 10.1111/j.1365-294X.2007.03578.x; Olsson M, 2007, PHYSIOL BEHAV, V91, P531, DOI 10.1016/j.physbeh.2007.04.025; Olsson M, 2012, OECOLOGIA, V170, P917, DOI 10.1007/s00442-012-2383-z; Olsson M, 2012, J EXP BIOL, V215, P575, DOI 10.1242/jeb.059352; Olsson M, 2009, NATURWISSENSCHAFTEN, V96, P25, DOI 10.1007/s00114-008-0444-2; Raberg L, 1998, P ROY SOC B-BIOL SCI, V265, P1637, DOI 10.1098/rspb.1998.0482; Rainio MJ, 2015, COMP BIOCHEM PHYS C, V167, P24, DOI 10.1016/j.cbpc.2014.08.004; Rolff J, 2002, P ROY SOC B-BIOL SCI, V269, P867, DOI 10.1098/rspb.2002.1959; Roth O, 2009, J EVOLUTION BIOL, V24, P1410; Schneeberger K, 2013, J EXP BIOL, V216, P4514, DOI 10.1242/jeb.090837; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Sheridan LAD, 2000, OIKOS, V88, P327, DOI 10.1034/j.1600-0706.2000.880211.x; Sild E, 2010, BEHAV ECOL SOCIOBIOL, V64, P2065, DOI 10.1007/s00265-010-1076-z; Sorci G, 2009, PHILOS T R SOC B, V364, P71, DOI 10.1098/rstb.2008.0151; Stoehr AM, 2006, BEHAV ECOL, V17, P751, DOI 10.1093/beheco/ark018; Tobler M, 2011, BIOL LETTERS, V7, P906, DOI 10.1098/rsbl.2011.0350; Uller T, 2006, FUNCT ECOL, V20, P873, DOI 10.1111/j.1365-2435.2006.01163.x; Vinkler M, 2010, FUNCT ECOL, V24, P1081, DOI 10.1111/j.1365-2435.2010.01711.x; Wang DT, 2010, J IMMUNOL, V184, P582, DOI 10.4049/jimmunol.0902352; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; Zimmerman LM, 2013, J EXP BIOL, V216, P633, DOI 10.1242/jeb.078832; Zimmerman LM, 2010, J EXP BIOL, V213, P1477, DOI 10.1242/jeb.037770; Zuk M, 2010, SEX HORMONES AND IMMUNITY TO INFECTION, P1, DOI 10.1007/978-3-642-02155-8_1	57	12	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0126155	10.1371/journal.pone.0126155	http://dx.doi.org/10.1371/journal.pone.0126155			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938441	Green Published, Green Submitted, gold			2022-12-27	WOS:000353943000145
J	Zhang, J; Chen, M; Dong, XY; Lin, RZ; Fan, JH; Chen, ZD				Zhang, Jian; Chen, Min; Dong, Xiaoyu; Lin, Ruozhu; Fan, Jianhua; Chen, Zhiduan			Evaluation of Four Commonly Used DNA Barcoding Loci for Chinese Medicinal Plants of the Family Schisandraceae	PLOS ONE			English	Article							MOLECULAR PHYLOGENETICS; CHEMICAL-CONSTITUENTS; COMMUNITY PHYLOGENY; MAXIMUM-LIKELIHOOD; TRNH-PSBA; IDENTIFICATION; RBCL; BIODIVERSITY; SEQUENCES; CHINENSIS	Many species of Schisandraceae are used in traditional Chinese medicine and are faced with contamination and substitution risks due to inaccurate identification. Here, we investigated the discriminatory power of four commonly used DNA barcoding loci (ITS, trnH-psbA, matK, and rbcL) and corresponding multi-locus combinations for 135 individuals from 33 species of Schisandraceae, using distance-, tree-, similarity-, and character-based methods, at both the family level and the genus level. Our results showed that the two spacer regions (ITS and trnH-psbA) possess higher species-resolving power than the two coding regions (matK and rbcL). The degree of species resolution increased with most of the multilocus combinations. Furthermore, our results implied that the best DNA barcode for the species discrimination at the family level might not always be the most suitable one at the genus level. Here we propose the combination of ITS+trnH-psbA+matK+rbcL as the most ideal DNA barcode for discriminating the medicinal plants of Schisandra and Kadsura, and the combination of ITS+trnH-psbA as the most suitable barcode for Illicium species. In addition, the closely related species Schisandra rubriflora Rehder & E. H. Wilson and Schisandra grandifloraHook.f. & Thomson, were paraphyletic with each other on phylogenetic trees, suggesting that they should not be distinct species. Furthermore, the samples of these two species from the southern Hengduan Mountains region formed a distinct cluster that was separated from the samples of other regions, implying the presence of cryptic diversity. The feasibility of DNA barcodes for identification of geographical authenticity was also verified here. The database and paradigm that we provide in this study could be used as reference for the authentication of traditional Chinese medicinal plants utilizing DNA barcoding.	[Zhang, Jian; Chen, Min; Fan, Jianhua; Chen, Zhiduan] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Chen, Min] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Dong, Xiaoyu] Jiangsu Prov & Chinese Acad Sci, Nanjing Bot Garden Mem Sun Yat Sen, Inst Bot, Nanjing, Jiangsu, Peoples R China; [Lin, Ruozhu] Chinese Acad Forestry, Res Inst Forest Ecol Environm & Protect, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF	Chen, ZD (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China.	zhiduan@ibcas.ac.cn			National Natural Science Foundation of China [31100171, 31270268]; Major Innovation Program of Chinese Academy of Sciences [KSCX2-EW-Z-2]; National Basic Research Program of China [2014CB954101]; CAS International Research & Education Development Program [SAJC201315]; CAS External Cooperation Program of BIC [GJ II Z201321]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Innovation Program of Chinese Academy of Sciences; National Basic Research Program of China(National Basic Research Program of China); CAS International Research & Education Development Program; CAS External Cooperation Program of BIC	This research was supported by National Natural Science Foundation of China grant No. 31100171 and 31270268, Major Innovation Program of Chinese Academy of Sciences (KSCX2-EW-Z-2), and National Basic Research Program of China grant No. 2014CB954101. Field work was partially supported by CAS International Research & Education Development Program (grant No. SAJC201315) and CAS External Cooperation Program of BIC (grant No. GJ II Z201321). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Barthelson RA, 2006, AM J BOT, V93, P566, DOI 10.3732/ajb.93.4.566; Beheregaray Luciano B, 2007, J Biol, V6, P9, DOI 10.1186/jbiol60; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bremer K, 1998, ANN MO BOT GARD, V85, P531, DOI 10.2307/2992015; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Chen SL, 2014, BIOTECHNOL ADV, V32, P1237, DOI 10.1016/j.biotechadv.2014.07.004; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Chen Z.-D., 1998, ACTA PHYTOTAXONOMICA, V36, P1; Christina VLP, 2014, MOL ECOL RESOUR, V14, P60, DOI 10.1111/1755-0998.12167; Collins RA, 2013, MOL ECOL RESOUR, V13, P969, DOI 10.1111/1755-0998.12046; Collins RA, 2012, METHODS ECOL EVOL, V3, P457, DOI 10.1111/j.2041-210X.2011.00176.x; Collins RA, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0028381, 10.1371/journal.pone.0030581]; Cronquist A, 1981, INTEGRATED SYSTEM CL; Cuenoud P, 2002, AM J BOT, V89, P132, DOI 10.3732/ajb.89.1.132; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fan JH, 2011, J SYST EVOL, V49, P330, DOI 10.1111/j.1759-6831.2011.00125.x; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; Feliner GN, 2007, MOL PHYLOGENET EVOL, V44, P911, DOI 10.1016/j.ympev.2007.01.013; Funk WC, 2012, P ROY SOC B-BIOL SCI, V279, P1806, DOI 10.1098/rspb.2011.1653; [高建平 Gao Jianping], 2003, [中国中药杂志, China Journal of Chinese Materia Medica], V28, P706; Hao G, 2000, PLANT SYST EVOL, V223, P81, DOI 10.1007/BF00985328; Hao G, 2001, BOT J LINN SOC, V135, P401, DOI 10.1006/bojl.2000.0420; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth PM, 2011, P NATL ACAD SCI USA, V108, P19451, DOI 10.1073/pnas.1116812108; Ize-Ludlow D, 2004, PEDIATRICS, V114, pE653, DOI 10.1542/peds.2004-0058; Kiebala M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011875, 10.1371/journal.pone.0013102]; Kim JS, 2012, GENES GENOM, V34, P283, DOI 10.1007/s13258-011-0201-3; Kool A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039459; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Law Y, 1996, FLORA REIPUBLICAE PO, V30, P231; Law Y, 2002, ACTA SCI NATURALIUM, V41, P67; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; [李庭古 LI Tinggu], 2006, [海洋湖沼通报, Transactions of Oceanology and Limnology], P58; Li XK, 2013, ACTA SOC BOT POL, V82, P283, DOI 10.5586/asbp.2013.032; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lim GS, 2012, SYST BIOL, V61, P165, DOI 10.1093/sysbio/syr030; Lin Q., 2001, B BOT RES, V21, P161; Lin Q, 2001, B BOT RES, V21, P322; Lin Qi, 2007, Bulletin of Botanical Research, V27, P6; [林祁 Lin Qi], 2002, [中草药, Chinese Traditional and Herbal Drugs], V33, P654; Liu Haitao, 2012, Zhongguo Zhong Yao Za Zhi, V37, P1353; Liu J, 2013, NEW PHYTOL, V199, P1093, DOI 10.1111/nph.12336; Liu J, 2012, INT J MOL SCI, V13, P8740, DOI 10.3390/ijms13078740; Liu J, 2011, MOL ECOL RESOUR, V11, P89, DOI 10.1111/j.1755-0998.2010.02907.x; Liu JS, 2014, PHYTOMEDICINE, V21, P1092, DOI 10.1016/j.phymed.2014.01.015; Liu M, 2012, J MED PLANTS RES, V6, P3156; [刘玉壶 Liu Yuhu], 2002, [中山大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Sunyatseni], V41, P77; Liu YN, 2009, CHEM BIODIVERS, V6, P963, DOI 10.1002/cbdv.200700433; Liu Z, 2000, ACTA BOT SIN, V42, P758; Liu Z, 2006, INT J PLANT SCI, V167, P539, DOI 10.1086/501476; Lledo MD, 1998, SYST BOT, V23, P21, DOI 10.2307/2419571; Lohne C, 2007, BOT J LINN SOC, V154, P141, DOI 10.1111/j.1095-8339.2007.00659.x; Maddison WP, 2009, MESQUITE MODULAR SYS; Mahadani P, 2014, MOL BIOL REP, V41, P7217, DOI 10.1007/s11033-014-3606-7; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Morris AB, 2007, SYST BOT, V32, P236, DOI 10.1600/036364407781179734; Muller KF, 2006, MOL PHYLOGENET EVOL, V41, P99, DOI 10.1016/j.ympev.2006.06.017; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; National Pharmacopoeia Committee, 2010, CHIN PHARM 2010, p[4, 61, 227]; Newmaster SG, 2008, MOL ECOL RESOUR, V8, P480, DOI 10.1111/j.1471-8286.2007.02002.x; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Pang XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048833; Panossian A, 2008, J ETHNOPHARMACOL, V118, P183, DOI 10.1016/j.jep.2008.04.020; Parkinson CL, 1999, CURR BIOL, V9, P1485, DOI 10.1016/S0960-9822(00)80119-0; Pei Nan-Cai, 2012, Plant Diversity and Resources, V34, P263, DOI 10.3724/SP.J.1143.2012.11173; Perret C, 2011, ARCH PEDIATRIE, V18, P750, DOI 10.1016/j.arcped.2011.03.024; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Purushothaman N, 2014, GENET MOL RES, V13, P2959, DOI 10.4238/2014.April.16.4; QIU YL, 1993, ANN MO BOT GARD, V80, P587, DOI 10.2307/2399848; Qiu YL, 1999, NATURE, V402, P404, DOI 10.1038/46536; Rach J, 2008, P ROY SOC B-BIOL SCI, V275, P237, DOI 10.1098/rspb.2007.1290; Ren BQ, 2010, MOL ECOL RESOUR, V10, P594, DOI 10.1111/j.1755-0998.2009.02815.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Sarkar IN, 2008, MOL ECOL RESOUR, V8, P1256, DOI 10.1111/j.1755-0998.2008.02235.x; Saunders R. M. K., 2000, SYSTEMATIC BOT MONOG, V58, P1, DOI DOI 10.2307/25027879; Saunders RMK, 1998, SYST BOT MONOGR, V54, P1, DOI DOI 10.2307/25096646; Saunders RMK, 1997, FL MALES 1, V13, P169; Smith A. C., 1947, SARGENTIA, V7, P1; Srirama R, 2010, J ETHNOPHARMACOL, V130, P208, DOI 10.1016/j.jep.2010.04.042; Srivathsan A, 2012, CLADISTICS, V28, P190, DOI 10.1111/j.1096-0031.2011.00370.x; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steven F, 1989, HERBS SPICES MED PLA, V4, P135; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tate JA, 2003, SYST BOT, V28, P723; Techen N, 2014, CURR OPIN BIOTECH, V25, P103, DOI 10.1016/j.copbio.2013.09.010; Theodoridis S, 2012, MOL ECOL RESOUR, V12, P620, DOI 10.1111/j.1755-0998.2012.03129.x; Tripathi AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057934; USA The Angiosperm Phylogeny Group, 2003, Botanical Journal of the Linnean Society, V141, P399, DOI 10.1046/j.1095-8339.2003.t01-1-00158.x; van Velzen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030490; Wang GW, 2011, J ETHNOPHARMACOL, V136, P10, DOI 10.1016/j.jep.2011.04.051; Wang VH, 2006, CHEM BIODIVERS, V3, P359, DOI 10.1002/cbdv.200690039; [王彦涵 Wang Yanhan], 2003, [复旦学报. 自然科学版, Journal of Fudan University.Natural Sciences], V42, P550; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Xia N, 2008, FLORA CHINA, V7, P39; Xia N, 2008, FLORA CHINA, V7, P32; Xia YG, 2015, PHYTOCHEM REV, V14, P155, DOI 10.1007/s11101-014-9343-7; Xu LJ, 2008, J SYST EVOL, V46, P692, DOI 10.3724/SP.J.1002.2008.07112; Yang HQ, 2012, ANN BOT FENN, V49, P319, DOI 10.5735/085.049.0603; Yang JB, 2012, MOL ECOL RESOUR, V12, P267, DOI 10.1111/j.1755-0998.2011.03095.x; Yao H, 2009, PLANTA MED, V75, P667, DOI 10.1055/s-0029-1185385; Yuan QJ, 2015, MOL ECOL RESOUR, V15, P358, DOI 10.1111/1755-0998.12296; Zou SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047276; Zuo YJ, 2011, PLANTA MED, V77, P182, DOI 10.1055/s-0030-1250166	112	23	28	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125574	10.1371/journal.pone.0125574	http://dx.doi.org/10.1371/journal.pone.0125574			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938480	Green Submitted, gold, Green Published			2022-12-27	WOS:000353943000077
J	Clark, LN; Chan, R; Cheng, R; Liu, XM; Park, N; Parmalee, N; Kisselev, S; Cortes, E; Torres, PA; Pastores, GM; Vonsattel, JP; Alcalay, R; Marder, K; Honig, LL; Fahn, S; Mayeux, R; Shelanski, M; Di Paolo, G; Lee, JH				Clark, Lorraine N.; Chan, Robin; Cheng, Rong; Liu, Xinmin; Park, Naeun; Parmalee, Nancy; Kisselev, Sergey; Cortes, Etty; Torres, Paola A.; Pastores, Gregory M.; Vonsattel, Jean P.; Alcalay, Roy; Marder, Karen; Honig, Lawrence L.; Fahn, Stanley; Mayeux, Richard; Shelanski, Michael; Di Paolo, Gilbert; Lee, Joseph H.			Gene-Wise Association of Variants in Four Lysosomal Storage Disorder Genes in Neuropathologically Confirmed Lewy Body Disease	PLOS ONE			English	Article							SPORADIC PARKINSONS-DISEASE; GLUCOCEREBROSIDASE MUTATIONS; ALZHEIMERS-DISEASE; GAUCHER-DISEASE; ALPHA-SYNUCLEIN; DEMENTIA; PATHOLOGY; BRAIN; BETA-GLUCOSIDASE-2; IDENTIFICATION	Objective Variants in GBA are associated with Lewy Body (LB) pathology. We investigated whether variants in other lysosomal storage disorder (LSD) genes also contribute to disease pathogenesis. Methods We performed a genetic analysis of four LSD genes including GBA, HEXA, SMPD1, and MCOLN1 in 231 brain autopsies. Brain autopsies included neuropathologically defined LBD without Alzheimer Disease (AD) changes (n = 59), AD without significant LB pathology (n = 71), Alzheimer disease and lewy body variant (ADLBV) (n = 68), and control brains without LB or AD neuropathology (n = 33). Sequencing of HEXA, SMPD1, MCOLN1 and GBA followed by 'gene wise' genetic association analysis was performed. To determine the functional effect, a biochemical analysis of GBA in a subset of brains was also performed. GCase activity was measured in a subset of brain samples (n = 64) that included LBD brains, with or without GBA mutations, and control brains. A lipidomic analysis was also performed in brain autopsies (n = 67) which included LBD (n = 34), ADLBV (n = 3), AD (n = 4), PD (n = 9) and control brains (n = 17), comparing GBA mutation carriers to non-carriers. Results In a 'gene-wise' analysis, variants in GBA, SMPD1 and MCOLN1 were significantly associated with LB pathology (p range: 0.03-4.14 x 10(-5)). Overall, the mean levels of GCase activity were significantly lower in GBA mutation carriers compared to non-carriers (p<0.001). A significant increase and accumulation of several species for the lipid classes, ceramides and sphingolipids, was observed in LBD brains carrying GBA mutations compared to controls (p range: p<0.05-p<0.01). Interpretation Our study indicates that variants in GBA, SMPD1 and MCOLN1 are associated with LB pathology. Biochemical data comparing GBA mutation carrier to non-carriers support these findings, which have important implications for biomarker development and therapeutic strategies.	[Clark, Lorraine N.; Chan, Robin; Cortes, Etty; Vonsattel, Jean P.; Alcalay, Roy; Marder, Karen; Honig, Lawrence L.; Mayeux, Richard; Shelanski, Michael; Di Paolo, Gilbert; Lee, Joseph H.] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA; [Clark, Lorraine N.; Chan, Robin; Liu, Xinmin; Parmalee, Nancy; Kisselev, Sergey; Vonsattel, Jean P.; Mayeux, Richard; Shelanski, Michael; Di Paolo, Gilbert] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Cheng, Rong; Park, Naeun; Alcalay, Roy; Marder, Karen; Honig, Lawrence L.; Lee, Joseph H.] Columbia Univ, Gertrude H Sergievsky Ctr, New York, NY 10027 USA; [Torres, Paola A.; Pastores, Gregory M.; Mayeux, Richard] NYU, Dept Neurol, Sch Med, New York, NY 10016 USA; [Torres, Paola A.; Pastores, Gregory M.] NYU, Dept Pediat, Sch Med, New York, NY 10016 USA; [Alcalay, Roy; Marder, Karen; Honig, Lawrence L.; Fahn, Stanley; Mayeux, Richard] Columbia Univ, Dept Neurol, New York, NY USA; [Mayeux, Richard] Columbia Univ, Dept Psychiat, New York, NY USA; [Mayeux, Richard] Columbia Univ, Dept Stat, New York, NY USA; [Mayeux, Richard; Lee, Joseph H.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Clark, Lorraine N.; Mayeux, Richard; Lee, Joseph H.] Columbia Univ, Ctr Human Genet, New York, NY USA	Columbia University; Columbia University; Columbia University; New York University; New York University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Clark, LN (corresponding author), Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA.	LC654@cumc.columbia.edu	Pastores, Gregory M./AAE-8647-2020; Lee, Joseph H/D-2441-2012	Lee, Joseph H/0000-0002-2000-4821	National Institutes of Health [NS050487, NS060113, P50AG08702]; Parkinson's Disease Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS050487, R01NS056049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG008702] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parkinson's Disease Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institutes of Health NS050487 (LNC) NS060113 (LNC), P50AG08702 (MS), www.nih.gov; The Parkinson's Disease Foundation (www.pdf.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, NACC NEUR NP DIAGN C; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Boot RG, 2007, J BIOL CHEM, V282, P1305, DOI 10.1074/jbc.M610544200; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Chan R, 2008, J VIROL, V82, P11228, DOI 10.1128/JVI.00981-08; Chan RB, 2012, J BIOL CHEM, V287, P2678, DOI 10.1074/jbc.M111.274142; Choi JH, 2011, MOL GENET METAB, V104, P185, DOI 10.1016/j.ymgme.2011.06.008; Clark LN, 2007, NEUROLOGY, V69, P1270, DOI 10.1212/01.wnl.0000276989.17578.02; Clark LN, 2009, ARCH NEUROL-CHICAGO, V66, P578, DOI 10.1001/archneurol.2009.54; Cox TM, 2012, J PATHOL, V226, P241, DOI 10.1002/path.3021; Di Fonzo A, 2007, NEUROLOGY, V68, P1557, DOI 10.1212/01.wnl.0000260963.08711.08; Do CB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002141; Gan-Or Z, 2013, NEUROLOGY, V80, P1606, DOI 10.1212/WNL.0b013e31828f180e; Gegg ME, 2012, ANN NEUROL, V72, P455, DOI 10.1002/ana.23614; Hawkes CH, 2008, MOVEMENT DISORD, V23, P1799, DOI 10.1002/mds.22242; Hruska KS, 2008, HUM MUTAT, V29, P567, DOI 10.1002/humu.20676; Irun P, 2013, CLIN GENET, V84, P356, DOI 10.1111/cge.12076; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; KOLLER WC, 1992, NEUROLOGY, V42, P27; Koller WC., 1992, NEUROLOGY, V42, P41; McKeith IG, 2000, NEUROL CLIN, V18, P865, DOI 10.1016/S0733-8619(05)70230-9; McKeith IG, 2000, ANN NY ACAD SCI, V920, P1; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; McKeith IG, 1999, NEUROLOGY, V53, P902, DOI 10.1212/WNL.53.5.902; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Murphy KE, 2014, BRAIN, V137, P834, DOI 10.1093/brain/awt367; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Simonaro CM, 2002, AM J HUM GENET, V71, P1413, DOI 10.1086/345074; Suzuki K, 2007, ACTA NEUROPATHOL, V114, P481, DOI 10.1007/s00401-007-0264-z; Tayebi N, 2003, MOL GENET METAB, V79, P104, DOI 10.1016/S1096-7192(03)00071-4; TRIGGSRAINE B, 1995, AM J HUM GENET, V56, P870; Tsuang D, 2012, NEUROLOGY, V79, P1944, DOI 10.1212/WNL.0b013e3182735e9a; Vilarino-Guell C, 2011, AM J HUM GENET, V89, P162, DOI 10.1016/j.ajhg.2011.06.001; Winder-Rhodes SE, 2012, MOVEMENT DISORD, V27, P312, DOI 10.1002/mds.24029; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yildiz Y, 2006, J CLIN INVEST, V116, P2985, DOI 10.1172/JCI29224	38	39	39	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125204	10.1371/journal.pone.0125204	http://dx.doi.org/10.1371/journal.pone.0125204			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933391	gold, Green Published, Green Submitted			2022-12-27	WOS:000353887100091
J	Dobson, KL; Jackson, C; Balakrishnan, S; Bellamy, TC				Dobson, Katharine L.; Jackson, Claire; Balakrishnan, Saju; Bellamy, Tomas C.			Caffeine Modulates Vesicle Release and Recovery at Cerebellar Parallel Fibre Terminals, Independently of Calcium and Cyclic AMP Signalling	PLOS ONE			English	Article							LONG-TERM DEPRESSION; DEPENDENT PROTEIN-KINASE; PURKINJE-CELL SYNAPSES; BERGMANN GLIAL-CELLS; CLIMBING FIBER; MULTIVESICULAR RELEASE; RYANODINE RECEPTORS; ECTOPIC RELEASE; GRANULE CELL; PLASTICITY	Background Cerebellar parallel fibres release glutamate at both the synaptic active zone and at extrasynaptic sites-a process known as ectopic release. These sites exhibit different short-term and long-term plasticity, the basis of which is incompletely understood but depends on the efficiency of vesicle release and recycling. To investigate whether release of calcium from internal stores contributes to these differences in plasticity, we tested the effects of the ryanodine receptor agonist caffeine on both synaptic and ectopic transmission. Methods Whole cell patch clamp recordings from Purkinje neurons and Bergmann glia were carried out in transverse cerebellar slices from juvenile (P16-20) Wistar rats. Key Results Caffeine caused complex changes in transmission at both synaptic and ectopic sites. The amplitude of postsynaptic currents in Purkinje neurons and extrasynaptic currents in Bergmann glia were increased 2-fold and 4-fold respectively, but paired pulse ratio was substantially reduced, reversing the short-term facilitation observed under control conditions. Caffeine treatment also caused synaptic sites to depress during 1 Hz stimulation, consistent with inhibition of the usual mechanisms for replenishing vesicles at the active zone. Unexpectedly, pharmacological intervention at known targets for caffeine-intracellular calcium release, and cAMP signalling-had no impact on these effects. Conclusions We conclude that caffeine increases release probability and inhibits vesicle recovery at parallel fibre synapses, independently of known pharmacological targets. This complex effect would lead to potentiation of transmission at fibres firing at low frequencies, but depression of transmission at high frequency connections.	[Dobson, Katharine L.; Bellamy, Tomas C.] Univ Nottingham, Sch Life Sci, Sch Med, Queens Med Ctr, Nottingham NG7 2RD, England; [Jackson, Claire; Balakrishnan, Saju; Bellamy, Tomas C.] Babraham Inst, Mol Signalling Lab, Cambridge, England; [Balakrishnan, Saju] Inst Neuro & Sensory Physiol, Gottingen, Germany	University of Nottingham; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Dobson, KL (corresponding author), Univ Nottingham, Sch Life Sci, Sch Med, Queens Med Ctr, Nottingham NG7 2RD, England.	katharine.dobson@nottingham.ac.uk	Dobson, Katharine/AAG-8618-2020; Dobson, Katharine/D-5344-2015	Dobson, Katharine/0000-0003-4117-8684; Dobson, Katharine/0000-0003-4117-8684; Bellamy, Tomas/0000-0003-0204-7366	Biotechnology and Biological Sciences Research Council, UK [BB/D018501/1, BB/J015660/1]; Biotechnology and Biological Sciences Research Council [BB/D018501/1, BB/J015660/1] Funding Source: researchfish; BBSRC [BB/D018501/1, BB/J015660/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council, UK (www.bbsrc.ac.uk, grant numbers: BB/D018501/1 and BB/J015660/1). Both grants were awards made to TCB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso MT, 2003, CELL CALCIUM, V33, P27, DOI 10.1016/S0143-4160(02)00179-3; Balakrishnan S, 2011, GLIA, V59, P82, DOI 10.1002/glia.21078; Balakrishnan S, 2009, GLIA, V57, P393, DOI 10.1002/glia.20768; Balezina OP, 2001, NEUROPHYSIOLOGY+, V33, P79, DOI 10.1023/A:1012324008410; BATCHELOR AM, 1992, EUR J NEUROSCI, V4, P1059, DOI 10.1111/j.1460-9568.1992.tb00132.x; Bellamy TC, 2006, EUR J NEUROSCI, V23, P581, DOI 10.1111/j.1460-9568.2005.04588.x; Bellamy TC, 2005, GLIA, V52, P325, DOI 10.1002/glia.20248; Bellamy TC, 2007, NEUROPHARMACOLOGY, V52, P368, DOI 10.1016/j.neuropharm.2006.08.009; Bender VA, 2009, J NEUROSCI, V29, P10974, DOI 10.1523/JNEUROSCI.2123-09.2009; Bergles DE, 1997, P NATL ACAD SCI USA, V94, P14821, DOI 10.1073/pnas.94.26.14821; BEZPROZVANNY I, 1994, MOL BIOL CELL, V5, P97, DOI 10.1091/mbc.5.1.97; Boswell-Smith V, 2006, BRIT J PHARMACOL, V147, pS252, DOI 10.1038/sj.bjp.0706495; Bouchard R, 2003, PROG NEUROBIOL, V69, P391, DOI 10.1016/S0301-0082(03)00053-4; Brown SP, 2003, NAT NEUROSCI, V6, P1048, DOI 10.1038/nn1126; Carter AG, 2002, J NEUROSCI, V22, P21, DOI 10.1523/JNEUROSCI.22-01-00021.2002; Chen CF, 1997, J NEUROSCI, V17, P8687; Clark BA, 1997, J PHYSIOL-LONDON, V502, P335, DOI 10.1111/j.1469-7793.1997.335bk.x; Coesmans M, 2004, NEURON, V44, P691, DOI 10.1016/j.neuron.2004.10.031; Cousin MA, 2011, J PHYSIOL-LONDON, V589, P1943, DOI 10.1113/jphysiol.2010.200477; Crowley JJ, 2007, J NEUROSCI, V27, P5448, DOI 10.1523/JNEUROSCI.1186-07.2007; Dittman JS, 1996, J NEUROSCI, V16, P1623; Dittman JS, 1997, J NEUROSCI, V17, P9048; Foster KA, 2005, J NEUROSCI, V25, P11655, DOI 10.1523/JNEUROSCI.4029-05.2005; Hagenston AM, 2009, CELL CALCIUM, V45, P310, DOI 10.1016/j.ceca.2008.11.003; Hegg CC, 2009, GLIA, V57, P634, DOI 10.1002/glia.20792; Isope P, 2002, J NEUROSCI, V22, P9668; Jacoby S, 2001, J PHYSIOL-LONDON, V535, P825, DOI 10.1111/j.1469-7793.2001.t01-1-00825.x; Kaeser PS, 2008, P NATL ACAD SCI USA, V105, P14680, DOI 10.1073/pnas.0806679105; Kaneko M, 2004, J NEUROSCI, V24, P5202, DOI 10.1523/JNEUROSCI.0999-04.2004; Kimura T, 2005, P NATL ACAD SCI USA, V102, P17160, DOI 10.1073/pnas.0508190102; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; Linden DJ, 1999, J NEUROSCI, V19, P10221; Matsui K, 2005, J NEUROSCI, V25, P7538, DOI 10.1523/JNEUROSCI.1927-05.2005; Matsui K, 2004, J NEUROSCI, V24, P8932, DOI 10.1523/JNEUROSCI.2650-04.2004; Matsui K, 2003, NEURON, V40, P1173, DOI 10.1016/S0896-6273(03)00788-8; MCPHERSON PS, 1991, NEURON, V7, P17, DOI 10.1016/0896-6273(91)90070-G; Montero M, 2000, NAT CELL BIOL, V2, P57, DOI 10.1038/35000001; Morton-Jones RT, 2008, CELL CALCIUM, V43, P356, DOI 10.1016/j.ceca.2007.07.003; Neale SA, 2001, NEUROPHARMACOLOGY, V41, P42, DOI 10.1016/S0028-3908(01)00046-6; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; ONEILL SC, 1990, J PHYSIOL-LONDON, V425, P55, DOI 10.1113/jphysiol.1990.sp018092; Peppiatt CM, 2003, CELL CALCIUM, V34, P97, DOI 10.1016/S0143-4160(03)00026-5; Ribeiro JA, 2010, J ALZHEIMERS DIS, V20, pS3, DOI 10.3233/JAD-2010-1379; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; SABATINI BL, 1995, NEUROPHARMACOLOGY, V34, P1453, DOI 10.1016/0028-3908(95)00129-T; Saleem H, 2014, BRIT J PHARMACOL, V171, P3298, DOI 10.1111/bph.12685; Salin PA, 1996, NEURON, V16, P797, DOI 10.1016/S0896-6273(00)80099-9; Simpson PB, 1996, J NEUROCHEM, V67, P364; TAKAHASHI M, 1995, J NEUROSCI, V15, P5693; Tazzeo T, 2012, AM J PHYSIOL-LUNG C, V303, pL334, DOI 10.1152/ajplung.00103.2012; Valera AM, 2012, J NEUROSCI, V32, P3267, DOI 10.1523/JNEUROSCI.3175-11.2012; Wu LG, 2007, J NEUROSCI, V27, P11793, DOI 10.1523/JNEUROSCI.3471-07.2007; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	54	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125974	10.1371/journal.pone.0125974	http://dx.doi.org/10.1371/journal.pone.0125974			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933382	Green Submitted, Green Published, gold			2022-12-27	WOS:000353887100146
J	Huang, HY; Shen, HH; Tien, CH; Li, CJ; Fan, SK; Liu, CH; Hsu, WS; Yao, DJ				Huang, Hong-Yuan; Shen, Hsien-Hua; Tien, Chang-Hung; Li, Chin-Jung; Fan, Shih-Kang; Liu, Cheng-Hsien; Hsu, Wen-Syang; Yao, Da-Jeng			Digital Microfluidic Dynamic Culture of Mammalian Embryos on an Electrowetting on Dielectric (EWOD) Chip	PLOS ONE			English	Article							DEVELOPMENT IN-VITRO; PREIMPLANTATION EMBRYOS; LIQUID DROPLETS; SYSTEM; MOUSE; ACTUATION; GROWTH; EXTRACTION; TRANSPORT; CELLS	Current human fertilization in vitro (IVF) bypasses the female oviduct and manually inseminates, fertilizes and cultivates embryos in a static microdrop containing appropriate chemical compounds. A microfluidic microchannel system for IVF is considered to provide an improved in-vivo-mimicking environment to enhance the development in a culture system for an embryo before implantation. We demonstrate a novel digitalized microfluidic device powered with electrowetting on a dielectric (EWOD) to culture an embryo in vitro in a single droplet in a microfluidic environment to mimic the environment in vivo for development of the embryo and to culture the embryos with good development and live births. Our results show that the dynamic culture powered with EWOD can manipulate a single droplet containing one mouse embryo and culture to the blastocyst stage. The rate of embryo cleavage to a hatching blastocyst with a dynamic culture is significantly greater than that with a traditional static culture (p<0.05). The EWOD chip enhances the culture of mouse embryos in a dynamic environment. To test the reproductive outcome of the embryos collected from an EWOD chip as a culture system, we transferred embryos to pseudo-pregnant female mice and produced live births. These results demonstrate that an EWOD-based microfluidic device is capable of culturing mammalian embryos in a microfluidic biological manner, presaging future clinical application.	[Huang, Hong-Yuan; Li, Chin-Jung] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Obstet & Gynecol, Taoyuan, Taiwan; [Huang, Hong-Yuan] Chang Gung Univ, Dept Obstet & Gynecol, Taoyuan, Taiwan; [Huang, Hong-Yuan] Coll Med, Taoyuan, Taiwan; [Shen, Hsien-Hua; Yao, Da-Jeng] Natl Tsing Hua Univ, Inst Nanoengn & Microsyst, Hsinchu, Taiwan; [Tien, Chang-Hung; Fan, Shih-Kang] Natl Taiwan Univ, Dept Mech Engn, Taipei 10764, Taiwan; [Liu, Cheng-Hsien; Yao, Da-Jeng] Natl Tsing Hua Univ, Dept Power Mech Engn, Hsinchu, Taiwan; [Hsu, Wen-Syang] Natl Chiao Tung Univ, Dept Mech Engn, Hsinchu, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; National Tsing Hua University; National Taiwan University; National Tsing Hua University; National Yang Ming Chiao Tung University	Yao, DJ (corresponding author), Natl Tsing Hua Univ, Inst Nanoengn & Microsyst, Hsinchu, Taiwan.	djyao@mx.nthu.edu.tw		Liu, Cheng-Hsien/0000-0003-1882-3892; Hsu, Wensyang/0000-0002-0189-9578; FAN, SHIH-KANG/0000-0002-1740-2992	National Science Council grant, Taiwan [NSC 982314-B-182A-106, 101-2314-B-182A-133, 101-2120-M-002-017]; Chang Gung Memorial Hospital/National Tsing Hua University Collaboration grant (CMRPG) [300211/371332]	National Science Council grant, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital/National Tsing Hua University Collaboration grant (CMRPG)	Part of the research was supported in part by National Science Council grant, Taiwan (NSC 982314-B-182A-106, 101-2314-B-182A-133, 101-2120-M-002-017) and Chang Gung Memorial Hospital/National Tsing Hua University Collaboration grant (CMRPG 300211/371332), both to H.Y.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry S, 2006, J COLLOID INTERF SCI, V303, P517, DOI 10.1016/j.jcis.2006.08.004; Biggers JD, 2005, HUM REPROD, V20, P3376, DOI 10.1093/humrep/dei228; Bogojevic D, 2012, LAB CHIP, V12, P627, DOI 10.1039/c2lc20893h; Brody JP, 1997, SENSOR ACTUAT A-PHYS, V58, P13, DOI 10.1016/S0924-4247(97)80219-1; BYATTSMITH JG, 1991, HUM REPROD, V6, P52, DOI 10.1093/oxfordjournals.humrep.a137258; Cho BS, 2003, ANAL CHEM, V75, P1671, DOI 10.1021/ac020579e; Cho SK, 2003, J MICROELECTROMECH S, V12, P70, DOI 10.1109/JMEMS.2002.807467; Clark SG, 2005, LAB CHIP, V5, P1229, DOI 10.1039/b504397m; Eydelnant IA, 2012, LAB CHIP, V12, P750, DOI 10.1039/c2lc21004e; Fan SK, 2009, LAB CHIP, V9, P1236, DOI 10.1039/b816535a; Fauci LJ, 2006, ANNU REV FLUID MECH, V38, P371, DOI 10.1146/annurev.fluid.37.061903.175725; Han C, 2010, LAB CHIP, V10, P2848, DOI 10.1039/c005296e; Heo YS, 2012, LAB CHIP, V12, P2240, DOI 10.1039/c2lc21050a; Hickman DL, 2002, COMPARATIVE MED, V52, P122; HINKLE L, 1981, J PHYSIOL-LONDON, V314, P121, DOI 10.1113/jphysiol.1981.sp013695; Huang H.-Y., 2014, J NANOMED NANOTECHNO, V5, P199, DOI [10.4172/2157-7439.1000199., DOI 10.4172/2157-7439.1000199, 10.4172/2157-7439.1000199]; Huang HY, 2014, JALA-J LAB AUTOM, V19, P91, DOI 10.1177/2211068213486650; Huang WH, 2004, ANAL CHEM, V76, P483, DOI 10.1021/ac035026y; Hunter HC, 2009, PHYS CHEM CHEM PHYS, V11, P6156, DOI 10.1039/b820457h; JAFFE LF, 1979, J EXP ZOOL, V209, P115, DOI 10.1002/jez.1402090114; Kenis PJA, 1999, SCIENCE, V285, P83, DOI 10.1126/science.285.5424.83; Kim MS, 2009, ELECTROPHORESIS, V30, P3276, DOI 10.1002/elps.200900157; Kolle S, 2009, BIOL REPROD, V81, P267, DOI 10.1095/biolreprod.108.073874; Krivokharchenko A, 2003, BIOL REPROD, V68, P829, DOI 10.1095/biolreprod.102.006494; Lane M, 2007, BEST PRACT RES CL OB, V21, P83, DOI 10.1016/j.bpobgyn.2006.09.009; Lee J, 2002, SENSOR ACTUAT A-PHYS, V95, P259, DOI 10.1016/S0924-4247(01)00734-8; Lin HC, 2010, JALA-J LAB AUTOM, V15, P210, DOI 10.1016/j.jala.2010.01.010; Lin YY, 2012, SENSOR ACTUAT B-CHEM, V173, P338, DOI 10.1016/j.snb.2012.07.022; Lin YY, 2010, SENSOR ACTUAT B-CHEM, V150, P465, DOI 10.1016/j.snb.2010.06.059; Liu YJ, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/4/045017; Luk VN, 2008, LANGMUIR, V24, P6382, DOI 10.1021/la7039509; Malic L, 2010, LAB CHIP, V10, P418, DOI 10.1039/b917668c; Melin J, 2009, DEV DYNAM, V238, P950, DOI 10.1002/dvdy.21918; Nagy A, 2002, MANIPULATING THE MOU, P251; PARIA BC, 1990, P NATL ACAD SCI USA, V87, P4756, DOI 10.1073/pnas.87.12.4756; PATEL N, 1982, J NEUROSCI, V2, P483; Pollack MG, 2002, LAB CHIP, V2, P96, DOI 10.1039/b110474h; Pollack MG, 2000, APPL PHYS LETT, V77, P1725, DOI 10.1063/1.1308534; Popova E, 2011, HUM REPROD, V26, P662, DOI 10.1093/humrep/deq379; Pyne DG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108128; Raty S, 2004, LAB CHIP, V4, P186, DOI 10.1039/b316437c; RICKORDS LF, 1992, MOL REPROD DEV, V32, P259, DOI 10.1002/mrd.1080320311; ROBINSON KR, 1985, J CELL BIOL, V101, P2023, DOI 10.1083/jcb.101.6.2023; Sano H, 2010, THERIOGENOLOGY, V74, P863, DOI 10.1016/j.theriogenology.2010.04.011; Seo DB, 2007, MICROFLUID NANOFLUID, V3, P561, DOI 10.1007/s10404-006-0142-3; Sharma Sanjiv, 2013, Methods Mol Biol, V949, P207, DOI 10.1007/978-1-62703-134-9_15; Smith GD, 2011, SEMIN REPROD MED, V29, P5, DOI 10.1055/s-0030-1268699; Smith GS, 2012, NEUROPSYCHOPHARMACOL, V37, P1, DOI 10.1038/npp.2011.233; Srigunapalan S, 2012, LAB CHIP, V12, P369, DOI 10.1039/c1lc20844f; STEPTOE PC, 1978, LANCET, V2, P366; Sugimura S, 2010, BIOL REPROD, V83, P970, DOI 10.1095/biolreprod.110.085522; Suh RS, 2006, HUM REPROD, V21, P477, DOI 10.1093/humrep/dei323; Suzuki Hiroyuki, 2001, Journal of Reproduction and Development, V47, P227, DOI 10.1262/jrd.47.227; Swain JE, 2011, HUM REPROD UPDATE, V17, P541, DOI 10.1093/humupd/dmr006; Swain JE, 2008, J CLIN EMBRYOL, V11, P3; Takayama S, 2001, NATURE, V411, P1016, DOI 10.1038/35082637; Tomlinson AJ, 1995, J CAPILLARY ELECTROP, V2, P247; Verpoorte E, 2002, ELECTROPHORESIS, V23, P677, DOI 10.1002/1522-2683(200203)23:5<677::AID-ELPS677>3.0.CO;2-8; Wang XQ, 2009, REPRODUCTION, V138, P527, DOI 10.1530/REP-09-0148; Welters WJJ, 1998, LANGMUIR, V14, P1535, DOI 10.1021/la971153b; WESTROM L, 1977, FERTIL STERIL, V28, P955; Wheeler MB, 2007, THERIOGENOLOGY, V68, pS178, DOI 10.1016/j.theriogenology.2007.04.042; Xie Y, 2007, MOL REPROD DEV, V74, P1287, DOI 10.1002/mrd.20563; Zhang J, 1999, FERTIL STERIL, V72, P509, DOI 10.1016/S0015-0282(99)00264-2	64	34	41	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124196	10.1371/journal.pone.0124196	http://dx.doi.org/10.1371/journal.pone.0124196			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933003	Green Published, Green Submitted, gold			2022-12-27	WOS:000353887100031
J	Hussein, NR; Basharat, Z; Muhammed, AH; Al-Dabbagh, SA				Hussein, Nawfal R.; Basharat, Zarrin; Muhammed, Ary H.; Al-Dabbagh, Samim A.			Comparative Evaluation of MRSA Nasal Colonization Epidemiology in the Urban and Rural Secondary School Community of Kurdistan, Iraq	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; PREVALENCE; RISK	Background To study the nasal carriage rate of Staphylococcus aureus (Staphylococcus aureus) (including methicillin-resistant strains) in secondary school community of the urban and rural districts of the Kurdistan region of Iraq, a cross-sectional population based survey was carried out in the city Duhok and rural areas of Amedya, Akre and Zakho. Methods Nasal swabs were obtained from nostrils of 509 students aged 14-23 years. Resistance to methicillin was assessed by Kirby-Bauer disk diffusion and agar dilution assay. Vancomycin sensitivity was also tested on Muller-Hinton agar. Results It was found that the frequency of overall Staphylococcus aureus nasal carriage (SANC) was 17.75% (90/509, CI95, 14.58-21.42%). In urban areas, the carriage rate was 20.59% (49/239, CI95, 15.64-26.29%), whereas it was 15.24% (41/270, CI95, 11.17-20.10%) in rural districts. The frequency of methicillin-resistant Staphylococcus aureus (MRSA) among the isolated strains was found to be 2.04% (1/49) and 21.95% (9/41) in urban and rural areas respectively. It was found that in urban residents, the odd ratio (OR) of acquiring SANC was 1.44 (CI95, 0.91-2.27%) and risk ratio (RR) was at least 1.35 (CI95, 0.92-1.96%) while OR decreased to 0.12 (CI95, 0.01-0.96%) for MRSA carriage. Hence, the Staphylococcus aureus carriage rate was higher in urban districts compared to rural areas while more MRSA were found in rural areas compared to urban districts. All studied strains were sensitive to vancomycin. Conclusion This study provided baseline information for Staphylococcus aureus nasal colonization in the region. Also, it showed that living in rural areas increased the odds of MRSA colonization. More attention should be paid to control MRSA colonization in rural communities.	[Hussein, Nawfal R.] Univ Duhok, Fac Med Sci, Sch Med, Dept Internal Med, Duhok, Kurdistan Regio, Iraq; [Basharat, Zarrin] Fatima Jinnah Women Univ, Dept Environm Sci, Microbiol & Biotechnol Res Lab, Rawalpindi, Pakistan; [Muhammed, Ary H.] Univ Duhok, Fac Med Sci, Sch Med, Dept Community Med, Duhok, Kurdistan Regio, Iraq; [Al-Dabbagh, Samim A.] Univ Duhok, Fac Med Sci, Sch Med, Dept Family & Community Med, Duhok, Kurdistan Regio, Iraq	University of Duhok; University of Duhok; University of Duhok	Basharat, Z (corresponding author), Fatima Jinnah Women Univ, Dept Environm Sci, Microbiol & Biotechnol Res Lab, Rawalpindi, Pakistan.	zarrin.iiui@gmail.com	Basharat, Zarrin/U-3274-2019	Basharat, Zarrin/0000-0003-1785-3803; Hussein, Nawfal/0000-0002-7813-9198				Askari E., 2012, J MED BACTERIOL, V1, P53; Balslev U, 2005, MICROB DRUG RESIST, V11, P78, DOI 10.1089/mdr.2005.11.78; Bartoloni A, 2013, INT J INFECT DIS, V17, pE339, DOI 10.1016/j.ijid.2012.11.017; Bonesso MF, 2012, CA MRSA EPIDEMIOLOGY; Champion AE, 2014, ANN CLIN MICROB ANTI, V13, DOI 10.1186/s12941-014-0033-5; Chen CJ, 2011, J CLIN MICROBIOL, V49, P131, DOI 10.1128/JCM.01774-10; Datta R, 2014, J CLIN MICROBIOL, V52, P312, DOI 10.1128/JCM.01606-13; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Egyir B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096119; Feingold BJ, 2012, EMERG INFECT DIS, V18, P1841, DOI 10.3201/eid1811.111850; Ghebremedhin B, 2009, J CLIN MICROBIOL, V47, P2975, DOI 10.1128/JCM.00648-09; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Habeeb A, 2014, J MICROBIOL INFECT D, V4, P59, DOI DOI 10.5799/ahinjs.02.2014.02.0128; Huang YC, 2007, J CLIN MICROBIOL, V45, P3992, DOI 10.1128/JCM.01202-07; Hussein NR, 2014, INT J PURE APPL SCI, V21, P8; Ito Teruyo, 2014, Methods Mol Biol, V1085, P131, DOI 10.1007/978-1-62703-664-1_8; Kamiya K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113562; Kejela T, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-11; Kock R, 2011, DTSCH ARZTEBL INT, V108, P761, DOI 10.3238/arztebl.2011.0761; Moussa IM, 2009, SAUDI MED J, V30, P611; MURAKAMI K, 1991, J CLIN MICROBIOL, V29, P2240, DOI 10.1128/JCM.29.10.2240-2244.1991; Roisin S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096310; Sener AG, 2013, WORLD J TRANSLATION, V2, P27; Struelens MJ, 2009, CLIN MICROBIOL INFEC, V15, P112, DOI 10.1111/j.1469-0691.2009.02698.x; Tavares DA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-110; Tenover FC, 2007, CLIN INFECT DIS, V44, P1208, DOI 10.1086/513203; Uhlemann AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022407; van Belkum A, 2009, INFECT GENET EVOL, V9, P32, DOI 10.1016/j.meegid.2008.09.012; Van Nguyen Kinh, 2014, Trans R Soc Trop Med Hyg, V108, P783, DOI 10.1093/trstmh/tru132; van Rijen MML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065594; Wielders CLC, 2002, J CLIN MICROBIOL, V40, P3970, DOI 10.1128/JCM.40.11.3970-3975.2002; Yan ML, 2013, CELL HOST MICROBE, V14, P631, DOI 10.1016/j.chom.2013.11.005	32	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124920	10.1371/journal.pone.0124920	http://dx.doi.org/10.1371/journal.pone.0124920			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932644	Green Published, Green Submitted, gold			2022-12-27	WOS:000353887100064
J	Barbosa, IAJ; Boon, MY; Khuu, SK				Jimenez Barbosa, Ingrid Astrid; Boon, Mei Ying; Khuu, Sieu K.			Exposure to Organic Solvents Used in Dry Cleaning Reduces Low and High Level Visual Function	PLOS ONE			English	Article							COLOR-VISION LOSS; OCCUPATIONAL-EXPOSURE; CONTRAST-SENSITIVITY; NEUROTOXIC SYMPTOMS; Q16 QUESTIONNAIRE; MOTION PERCEPTION; PATTERN DETECTION; GLASS PATTERNS; WORKERS; STYRENE	Purpose To investigate whether exposure to occupational levels of organic solvents in the dry cleaning industry is associated with neurotoxic symptoms and visual deficits in the perception of basic visual features such as luminance contrast and colour, higher level processing of global motion and form (Experiment 1), and cognitive function as measured in a visual search task (Experiment 2). Methods The Q16 neurotoxic questionnaire, a commonly used measure of neurotoxicity (by the World Health Organization), was administered to assess the neurotoxic status of a group of 33 dry cleaners exposed to occupational levels of organic solvents (OS) and 35 age-matched non dry-cleaners who had never worked in the dry cleaning industry. In Experiment 1, to assess visual function, contrast sensitivity, colour/hue discrimination (Munsell Hue 100 test), global motion and form thresholds were assessed using computerised psychophysical tests. Sensitivity to global motion or form structure was quantified by varying the pattern coherence of global dot motion (GDM) and Glass pattern (oriented dot pairs) respectively (i.e., the percentage of dots/dot pairs that contribute to the perception of global structure). In Experiment 2, a letter visual-search task was used to measure reaction times (as a function of the number of elements: 4, 8, 16, 32, 64 and 100) in both parallel and serial search conditions. Results Dry cleaners exposed to organic solvents had significantly higher scores on the Q16 compared to non dry-cleaners indicating that dry cleaners experienced more neurotoxic symptoms on average. The contrast sensitivity function for dry cleaners was significantly lower at all spatial frequencies relative to non dry-cleaners, which is consistent with previous studies. Poorer colour discrimination performance was also noted in dry cleaners than non dry-cleaners, particularly along the blue/yellow axis. In a new finding, we report that global form and motion thresholds for dry cleaners were also significantly higher and almost double than that obtained from non dry-cleaners. However, reaction time performance on both parallel and serial visual search was not different between dry cleaners and non dry-cleaners. Conclusions Exposure to occupational levels of organic solvents is associated with neurotoxicity which is in turn associated with both low level deficits (such as the perception of contrast and discrimination of colour) and high level visual deficits such as the perception of global form and motion, but not visual search performance. The latter finding indicates that the deficits in visual function are unlikely to be due to changes in general cognitive performance.	[Jimenez Barbosa, Ingrid Astrid; Boon, Mei Ying; Khuu, Sieu K.] Univ New S Wales, Sch Optometry & Vis Sci, Sydney, NSW, Australia; [Jimenez Barbosa, Ingrid Astrid] Univ La Salle, Hlth & Sci Fac, Bogota, Bogota DC, Colombia	University of New South Wales Sydney; Universidad de La Salle	Barbosa, IAJ (corresponding author), Univ New S Wales, Sch Optometry & Vis Sci, Sydney, NSW, Australia.	injimenez@unisalle.edu.co	Khuu, Sieu/N-7957-2019; Boon, Mei Ying/F-2194-2016; Jimenez-Barbosa, Ingrid Astrid/AIC-7372-2022	Khuu, Sieu/0000-0003-1850-0225; Boon, Mei Ying/0000-0002-9759-8402; Jimenez-Barbosa, Ingrid Astrid/0000-0001-7874-2598	Administrative Department of Science, Technology and Innovation from Colombia (Colciencias); Laspau the Academic and Professional Programs for the Americas; Universidad de La Salle Colombia; Australian Research Council [DP110104713]	Administrative Department of Science, Technology and Innovation from Colombia (Colciencias)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Laspau the Academic and Professional Programs for the Americas; Universidad de La Salle Colombia; Australian Research Council(Australian Research Council)	IAJB is funded by the Administrative Department of Science, Technology and Innovation from Colombia (Colciencias) and Laspau the Academic and Professional Programs for the Americas, as well as by the Universidad de La Salle Colombia. SK is funded by Australian Research Council Discovery Project Grant: Number: DP110104713. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGGAZZOTTI G, 1994, SCI TOTAL ENVIRON, V156, P133, DOI 10.1016/0048-9697(94)90349-2; ALTMANN L, 1990, INT ARCH OCC ENV HEA, V62, P493, DOI 10.1007/BF00381179; Anger W, 1999, CURRENT PROTOCOLS TO, P17; ANGER WK, 1990, NEUROTOXICOLOGY, V11, P629; AXELSON O, 1976, Scandinavian Journal of Work Environment and Health, V2, P14; Axelson O, 1988, HLTH EFFECTS SOLVENT; Badcock DR, 2005, VISION RES, V45, P881, DOI 10.1016/j.visres.2004.09.042; Badcock DR, 2001, PSYCHOL RES-PSYCH FO, V65, P50, DOI 10.1007/s004260000020; BAKER EL, 1994, J OCCUP ENVIRON MED, V36, P1079, DOI 10.1097/00043764-199410000-00010; Bast-Pettersen R, 2006, SCAND J WORK ENV HEA, P41; Bockelmann I, 2003, OPHTHALMOLOGE, V100, P133, DOI 10.1007/s00347-002-0712-z; Boeckelmann I, 2003, J OCCUP ENVIRON MED, V45, P25, DOI 10.1097/00043764-200301000-00009; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; Braddick OJ, 2001, PERCEPTION, V30, P61, DOI 10.1068/p3048; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Broadbent D. E., 1958, NATURE, V182, P1572; BROADWELL DK, 1995, AM J IND MED, V27, P677, DOI 10.1002/ajim.4700270505; CAMPAGNA D, 1995, SCAND J WORK ENV HEA, V21, P382, DOI 10.5271/sjweh.53; CAMPBELL FW, 1964, J OPT SOC AM, V54, P581; Candura S M, 1991, G Ital Med Lav, V13, P17; Cardinal KS, 2003, J VISION, V3, P199, DOI 10.1167/3.3.2; CARRICABURU P, 1980, ANN PHARM FR, V38, P155; CARRICABURU P, 1979, ANN PHARM FR, V37, P531; Castillo L, 2001, AM J IND MED, V39, P351, DOI 10.1002/ajim.1025; Cavalleri A, 2000, ARCH ENVIRON HEALTH, V55, P399, DOI 10.1080/00039890009604037; CAVALLERI A, 1994, NEUROSCI LETT, V179, P162, DOI 10.1016/0304-3940(94)90959-8; Chen CC, 2004, VISION RES, V44, P915, DOI 10.1016/j.visres.2003.11.017; CHERRY N, 1980, BRIT J IND MED, V37, P234; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; Costa T, 2012, PLOS ONE, V7; CULLEN MR, 1995, CLIN CHEM, V41, P1809; Lacerda EMDB, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/784390; Dain SJ, 1998, VISION RES, V38, P3473, DOI 10.1016/S0042-6989(98)00099-6; Dakin SC, 1997, PERCEPTION, V26, P253, DOI 10.1068/p260253; Dick FD, 2006, OCCUP ENVIRON MED, V63, P221, DOI 10.1136/oem.2005.022400; Donoghue AM, 1995, J OCCUP ENVIRON MED, V37, P1357, DOI 10.1097/00043764-199512000-00005; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1329, DOI 10.1152/jn.1991.65.6.1329; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; ECHEVERRIA D, 1995, J OCCUP ENVIRON MED, V37, P667, DOI 10.1097/00043764-199506000-00008; EDLING C, 1993, BRIT J IND MED, V50, P843; EDWARDS M, 1994, VISION RES, V34, P2849, DOI 10.1016/0042-6989(94)90054-X; Ehrenberg R, 1989, AM J PUBLIC HLTH, V79; Farnsworth D, 1957, FRANSWORTH MUNSELL 1; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FRENETTE B, 1991, OPTOMETRY VISION SCI, V68, P556, DOI 10.1097/00006324-199107000-00009; Gallant JL, 1996, J NEUROPHYSIOL, V76, P2718, DOI 10.1152/jn.1996.76.4.2718; Gamberale F, 1989, ARBETE HALSA, V6, P1; Glass L, 1969, NATURE, P223; GOBBA F, 1991, J OCCUP ENVIRON MED, V33, P761, DOI 10.1097/00043764-199107000-00006; Hogstedt C, 1984, BIOL MONITORING SURV; HSIA, 1999, PERCHL WHIT PAP; Hyejin Y, 2009, VISION RES, V49, P2095, DOI [10.1016/j.visres.2009.05.017, DOI 10.1016/J.VISRES.2009.05.017]; Ihrig A, 2003, IND HEALTH, V41, P39, DOI 10.2486/indhealth.41.39; Ihrig A, 2001, OCCUP ENVIRON MED, V58, P19, DOI 10.1136/oem.58.1.19; Iregren A, 2002, NEUROTOXICOLOGY, V23, P719, DOI 10.1016/S0161-813X(02)00088-8; Iyaniwura T, 2004, RESPONSE TOXIC CHEM; Jimenez I, 2011, CIENCIA TECHNOLOGIA, V9, P19; Khuu S, 2011, J VISION, V11; Khuu S, 2003, PERCEPTION, V32; Khuu S, 2006, VISION RES; Khuu SK, 2012, J VISION, V12, DOI 10.1167/12.6.19; Khuu SK, 2005, VISION RES, V45, P2461, DOI 10.1016/j.visres.2005.02.019; Khuu SK, 2002, VISION RES, V42, P3031, DOI 10.1016/S0042-6989(02)00384-X; Kinnear PR, 2002, BRIT J OPHTHALMOL, V86, P1408, DOI 10.1136/bjo.86.12.1408; Kulig BM, 1996, ENVIRON HEALTH PERSP, V104, P317, DOI 10.2307/3432651; Legge G, 2007, PSYCHOHYSICS READING; Lennie P, 1998, PERCEPTION, V27, P889, DOI 10.1068/p270889; Li WO, 2008, VISION RES, V48, P167, DOI 10.1016/j.visres.2007.10.019; Likert R., 1932, ACTA PSYCHOL, V140, P44; LIVINGSTONE MS, 1987, J NEUROSCI, V7, P3416; Lundberg I, 1997, OCCUP ENVIRON MED, V54, P343, DOI 10.1136/oem.54.5.343; McGraw PV, 2004, PERCEPTION, V33, P121, DOI 10.1068/p5210; MERGLER D, 1990, NEUROTOXICOL TERATOL, V12, P669, DOI 10.1016/0892-0362(90)90084-P; MERGLER D, 1988, TOXICOLOGY, V49, P341, DOI 10.1016/0300-483X(88)90017-0; MERGLER D, 1987, INT ARCH OCC ENV HEA, V59, P313, DOI 10.1007/BF00405275; MERGLER D, 1991, ARCH ENVIRON HEALTH, V46, P326, DOI 10.1080/00039896.1991.9934398; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Muttray A, 1997, INT ARCH OCC ENV HEA, V70, P407, DOI 10.1007/s004200050237; NAKATSUKA H, 1992, INT ARCH OCC ENV HEA, V64, P113, DOI 10.1007/BF00381478; Nasanen R, 2005, ENVIRON TOXICOL PHAR, V19, P497, DOI 10.1016/j.etap.2004.12.013; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; Nguyen-Tri D, 2003, INVEST OPHTH VIS SCI, V44, P3698, DOI 10.1167/iovs.02-1191; PALMER J, 1994, VISION RES, V34, P1703, DOI 10.1016/0042-6989(94)90128-7; Paramei GV, 2004, NEUROTOXICOLOGY, V25, P803, DOI 10.1016/j.neuro.2004.01.006; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pirsaraei SRA, 2009, IND HEALTH, V47, P155, DOI 10.2486/indhealth.47.155; RAITTA C, 1981, J OCCUP ENVIRON MED, V23, P189; RODEZNO RA, 1995, AM J IND MED, V28, P505, DOI 10.1002/ajim.4700280407; Rutchik J, 2009, ORGANIC SOLVENTS; SAITO H, 1986, J NEUROSCI, V6, P145; Schaper M, 2004, TOXICOL LETT, V151, P193, DOI 10.1016/j.toxlet.2004.01.020; Schreiber JS, 2002, ENVIRON HEALTH PERSP, V110, P655, DOI 10.1289/ehp.02110655; SEEBER A, 1989, NEUROTOXICOL TERATOL, V11, P579, DOI 10.1016/0892-0362(89)90041-X; Smith A, 1994, J OPT SOC AM A, V11, P1; Smith MA, 2002, J NEUROSCI, V22, P8334, DOI 10.1523/jneurosci.22-18-08334.2002; Smith MA, 2007, J VISION, V7, DOI 10.1167/7.3.5; Snowden RJ, 1994, VISUAL DETECTION MOT, P51; Soderkvist P, 1996, SCAND J WORK ENV HEA, V5, P360; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Trick LM, 1998, COGNITIVE DEV, V13, P369, DOI 10.1016/S0885-2014(98)90016-8; VANESSEN DC, 1992, SCIENCE, V255, P419, DOI 10.1126/science.1734518; White R, 1997, SOLVENTS NEUROTOXICI, P349; WHO WHO, 1985, CHRON EFF ORG SOLV C; WHO WHO, 1986, 60 WHO ENV HLTH CRIT; Wilkinson F, 2000, CURR BIOL, V10, P1455, DOI 10.1016/S0960-9822(00)00800-9; WILLIAMS DW, 1984, VISION RES, V24, P55, DOI 10.1016/0042-6989(84)90144-5; Wilson HR, 1998, VISION RES, V38, P2933, DOI 10.1016/S0042-6989(98)00109-6; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774; Wolfreys Julian, 2002, VICTORIAN HAUNTINGS, P1; Xintaras C, 1984, BEHAV TOXICOLOGY, P126; Zahiruddin Kowser, 2010, Korean J Ophthalmol, V24, P159, DOI 10.3341/kjo.2010.24.3.159; Zavalic M, 1998, INT ARCH OCC ENV HEA, V71, P194, DOI 10.1007/s004200050270; ZEKI S, 1983, NEUROSCIENCE, V9, P741, DOI 10.1016/0306-4522(83)90265-8	113	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0121422	10.1371/journal.pone.0121422	http://dx.doi.org/10.1371/journal.pone.0121422			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933026	Green Published, gold, Green Submitted			2022-12-27	WOS:000353887100003
J	Kmiecik, AM; Pula, B; Suchanski, J; Olbromski, M; Gomulkiewicz, A; Owczarek, T; Kruczak, A; Ambicka, A; Rys, J; Ugorski, M; Podhorska-Okolow, M; Dziegiel, P				Kmiecik, Alicja M.; Pula, Bartosz; Suchanski, Jaroslaw; Olbromski, Mateusz; Gomulkiewicz, Agnieszka; Owczarek, Tomasz; Kruczak, Anna; Ambicka, Aleksandra; Rys, Janusz; Ugorski, Maciej; Podhorska-Okolow, Marzena; Dziegiel, Piotr			Metallothionein-3 Increases Triple-Negative Breast Cancer Cell Invasiveness via Induction of Metalloproteinase Expression	PLOS ONE			English	Article							ALZHEIMERS-DISEASE BRAIN; GROWTH-INHIBITORY FACTOR; MT EXPRESSION; MESSENGER-RNA; HUMAN KIDNEY; ISOFORM 3; CARCINOMA; PROSTATE; INVASION; PROTEIN	It has been recently found that metallothionein-3 (MT3) enhances the invasiveness and tumorigenesis of prostate cancer cells. This finding is in contrast to those of earlier studies, which indicated that overexpression of MT3 in breast cancer and prostate cancer cell lines inhibits their growth in vitro. Therefore, to clarify the role of MT3 in breast cancer progression, we analyzed the effect of MT3-overexpression on proliferation, invasiveness, migration, and tumorigenesis of breast cancer MDA-MB-231/BO2 cells. It was found that MDA-MB-231/BO2 cells overexpressing MT3 were characterized by increased invasiveness in vitro, compared to the control cells. Interestingly, this increased invasiveness correlated with a highly increased concentration of MMP3 in the culture supernatants (p<0.0001). Our data suggest that MT3 may regulate breast cancer cell invasiveness by modulating the expression of MMP3. These experimental results, obtained using triple-negative MDA-MB-231/BO2 cells, were further supported by clinical data. It was found that, in triple-negative breast cancer (TNBC), nuclear MT3 immunoreactivity in cancer cells tended to be associated with patients' shorter disease-specific survival, suggesting that nuclear MT3 expression may be a potential marker of poor prognosis of triple-negative TNBC cases.	[Kmiecik, Alicja M.; Owczarek, Tomasz; Ugorski, Maciej] Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Lab Glycobiol & Cell Interact, Wroclaw, Poland; [Pula, Bartosz; Olbromski, Mateusz; Gomulkiewicz, Agnieszka; Podhorska-Okolow, Marzena; Dziegiel, Piotr] Med Univ, Dept Histol & Embryol, Wroclaw, Poland; [Suchanski, Jaroslaw; Ugorski, Maciej] Univ Environm & Life Sci, Fac Vet Med, Dept Biochem Pharmacol & Toxicol, Wroclaw, Poland; [Kruczak, Anna; Ambicka, Aleksandra; Rys, Janusz] Maria Sklodowska Curie Mem Canc Ctr, Dept Tumor Pathol, Krakow, Poland; [Kruczak, Anna; Ambicka, Aleksandra; Rys, Janusz] Inst Oncol, Krakow, Poland; [Dziegiel, Piotr] Univ Wroclaw, Sch Phys Educ, Dept Physiotherapy, PL-50138 Wroclaw, Poland	Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Wroclaw Medical University; Wroclaw University of Environmental & Life Sciences; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; University of Wroclaw	Dziegiel, P (corresponding author), Med Univ, Dept Histol & Embryol, Wroclaw, Poland.	piotr.dziegiel@umed.wroc.pl	Kmiecik, Alicja/AAY-1543-2020; Ugorsku, Maciej/AAJ-1050-2020; Puła, Bartosz/AAO-3209-2020	Kmiecik, Alicja/0000-0002-6498-717X; Puła, Bartosz/0000-0003-0116-5002; Ugorski, Maciej/0000-0003-0299-8372; Suchanski, Jaroslaw/0000-0002-2672-1020; Podhorska-Okolow, Marzenna/0000-0003-2215-5997; Olbromski, Mateusz/0000-0002-1972-1524; Kruczak, Anna/0000-0001-6298-6950; Dziegiel, Piotr/0000-0002-8292-1385; Owczarek, Tomasz/0000-0002-5095-8642; Gomulkiewicz, Agnieszka/0000-0003-2256-1055	Polish Ministry of Science and Higher Education [N N401 048038]; Foundation for Polish Science; START	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); START(Austrian Science Fund (FWF))	This study was supported by a grant from the Polish Ministry of Science and Higher Education, no. N N401 048038. Bartosz Pula is supported by the "START" stipend awarded by the Foundation for Polish Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMOUREUX MC, 1995, BIOCHEM BIOPH RES CO, V214, P639, DOI 10.1006/bbrc.1995.2334; Asai M, 1999, JPN J CANCER RES, V90, P86, DOI 10.1111/j.1349-7006.1999.tb00670.x; Coyle P, 2002, CELL MOL LIFE SCI, V59, P627, DOI 10.1007/s00018-002-8454-2; Deng DJ, 2003, CARCINOGENESIS, V24, P25, DOI 10.1093/carcin/24.1.25; Dutta R, 2002, PROSTATE, V52, P89, DOI 10.1002/pros.10097; Dziegiel P, 2005, HISTOL HISTOPATHOL, V20, P83, DOI 10.14670/HH-20.83; Dziegiel Piotr, 2004, Polish Journal of Pathology, V55, P3; ELSTON CW, 1987, DIAGNOSTIC HISTOPATH, P300; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Garrett SH, 1999, TOXICOL LETT, V105, P207, DOI 10.1016/S0378-4274(99)00003-X; Garrett SH, 1999, PROSTATE, V41, P196, DOI 10.1002/(SICI)1097-0045(19991101)41:3<196::AID-PROS7>3.0.CO;2-U; Gobel H, 2000, VIRCHOWS ARCH, V437, P528, DOI 10.1007/s004280000260; Gurel V, 2003, BREAST CANCER RES TR, V80, P181, DOI 10.1023/A:1024520801262; Hoey JG, 1997, TOXICOL LETT, V92, P149, DOI 10.1016/S0378-4274(97)00049-0; Juang HH, 2013, PROSTATE, V73, P1495, DOI 10.1002/pros.22697; Kim HG, 2011, FEBS LETT, V585, P421, DOI 10.1016/j.febslet.2010.12.030; Kobierzycki C, 2012, ANTICANCER RES, V32, P773; Krizkova S, 2012, DRUG METAB REV, V44, P287, DOI 10.3109/03602532.2012.725414; Lee SJ, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-30; Nielsen AE, 2006, BIOMARK INSIGHTS, V1, P99; Pedersen MO, 2009, PROG HISTOCHEM CYTO, V44, P29, DOI 10.1016/j.proghi.2008.10.001; Peng D, 2011, PLOS ONE, DOI 10.1371/journal.pone.0022009; Person RJ, 2013, TOXICOL APPL PHARM, V273, P281, DOI 10.1016/j.taap.2013.06.013; Peyruchaud O, 2001, J BONE MINER RES, V16, P2027, DOI 10.1359/jbmr.2001.16.11.2027; Pula B, 2012, THYROID RES, V5, DOI 10.1186/1756-6614-5-26; Ryu HH, 2012, INT J ONCOL, V41, P1305, DOI 10.3892/ijo.2012.1570; Sens MA, 2001, AM J PATHOL, V159, P21, DOI 10.1016/S0002-9440(10)61668-9; Sens MA, 2000, ENVIRON HEALTH PERSP, V108, P413; Smith E, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-42; Somji Seema, 2010, Toxicol Environ Chem, V92, P1673; Surowiak P, 2005, HISTOL HISTOPATHOL, V20, P1037, DOI 10.14670/HH-20.1037; Thirumoorthy N, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-54; TSUJI S, 1992, EMBO J, V11, P4843, DOI 10.1002/j.1460-2075.1992.tb05590.x; UCHIDA Y, 1989, BRAIN RES, V481, P190, DOI 10.1016/0006-8993(89)90503-9; UCHIDA Y, 1991, NEURON, V7, P337, DOI 10.1016/0896-6273(91)90272-2; Werynska B, 2013, ANTICANCER RES, V33, P965; Wojnar A, 2011, ANTICANCER RES, V31, P3027; Zitka O, 2011, ELECTROPHORESIS, V32, P857, DOI 10.1002/elps.201000526	38	24	26	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124865	10.1371/journal.pone.0124865	http://dx.doi.org/10.1371/journal.pone.0124865			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933064	Green Submitted, gold, Green Published			2022-12-27	WOS:000353887100060
J	Li, ML; Deng, QY; Jin, XA				Li, Meilian; Deng, Qingying; Jin, Xian'an			A General Method for Computing the Homfly Polynomial of DNA Double Crossover 3-Regular Links	PLOS ONE			English	Article							POLYHEDRAL LINKS; KNOTS; INVARIANT; GRAPHS	In the last 20 years or so, chemists and molecular biologists have synthesized some novel DNA polyhedra. Polyhedral links were introduced to model DNA polyhedra and study topological properties of DNA polyhedra. As a very powerful invariant of oriented links, the Homfly polynomial of some of such polyhedral links with small number of crossings has been obtained. However, it is a challenge to compute Homfly polynomials of polyhedral links with large number of crossings such as double crossover 3-regular links considered here. In this paper, a general method is given for computing the chain polynomial of the truncated cubic graph with two different labels from the chain polynomial of the original labeled cubic graph by substitutions. As a result, we can obtain the Homfly polynomial of the double crossover 3-regular link which has relatively large number of crossings.	[Li, Meilian; Deng, Qingying; Jin, Xian'an] Xiamen Univ, Sch Math Sci, Xiamen, Fujian, Peoples R China; [Li, Meilian] Longyan Univ, Sch Math & Comp Sci, Longyan, Fujian, Peoples R China	Xiamen University; Longyan University	Jin, XA (corresponding author), Xiamen Univ, Sch Math Sci, Xiamen, Fujian, Peoples R China.	xajin@xmu.edu.cn			National Natural Science Foundation of China [J 11271307]; Natural Science Foundation of Fujian Province of China [J 2012J01019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province)	This work was supported by J 11271307 National Natural Science Foundation of China and J 2012J01019 Natural Science Foundation of Fujian Province of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams C., 2004, KNOT BOOK; Alexander JW, 1928, T AM MATH SOC, V30, P275, DOI 10.2307/1989123; [Anonymous], KOBE J MATH; CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0; Cheng XS, 2014, J MATH CHEM, V52, P23, DOI 10.1007/s10910-013-0241-9; Cheng XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048968; Cheng XS, 2012, J MATH CHEM, V50, P1386, DOI 10.1007/s10910-012-9976-y; Cheng XS, 2009, MATCH-COMMUN MATH CO, V62, P115; Cheng XS, 2010, MATCH COMMUN MATH CO, V63, P115; Comoglio F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018693; Conway J., 1970, COMPUTATIONAL PROBLE, P329; Cromwell P., 2004, KNOTS LINKS; Duan JW, 2014, MATCH-COMMUN MATH CO, V72, P475; Erben CM, 2007, J AM CHEM SOC, V129, P6992, DOI 10.1021/ja071493b; FRANKS J, 1987, T AM MATH SOC, V303, P97, DOI 10.2307/2000780; FREYD P, 1985, B AM MATH SOC, V12, P239, DOI 10.1090/S0273-0979-1985-15361-3; FU TJ, 1993, BIOCHEMISTRY-US, V32, P3211, DOI 10.1021/bi00064a003; Goodman RP, 2004, CHEM COMMUN, P1372, DOI 10.1039/b402293a; He Y, 2008, NATURE, V452, P198, DOI 10.1038/nature06597; He Y, 2010, ANGEW CHEM INT EDIT, V49, P748, DOI 10.1002/anie.200904513; Helgstrand Charlotte, 2003, Journal of Molecular Biology, V334, P885, DOI 10.1016/j.jmb.2003.09.035; Hosokawa F., 1958, OSAKA MATH J, V10, P273; HOSTE J, 1985, P AM MATH SOC, V95, P299, DOI 10.2307/2044531; Hu G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026308; Jin XA, 2012, P AM MATH SOC, V140, P1459, DOI 10.1090/S0002-9939-2011-11050-5; Jin XA, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/07/P07011; Jin XA, 2011, MATCH-COMMUN MATH CO, V65, P501; Jin XA, 2010, ELECTRON J COMB, V17; Jin XA, 2010, MATCH-COMMUN MATH CO, V63, P657; JONES VFR, 1985, B AM MATH SOC, V12, P103, DOI 10.1090/S0273-0979-1985-15304-2; Kuzuya A, 2010, NANOSCALE, V2, P310, DOI 10.1039/b9nr00246d; Lin C, 2009, BIOCHEMISTRY-US, V48, P1663, DOI 10.1021/bi802324w; MORTON HR, 1986, MATH PROC CAMBRIDGE, V99, P107, DOI 10.1017/S0305004100063982; Murasugi K., 1996, KNOT THEORY ITS APPL; OHYAMA Y, 1993, CAN J MATH, V45, P117, DOI 10.4153/CJM-1993-007-x; Read RC, 2003, DISCRETE MATH, V265, P213, DOI 10.1016/S0012-365X(02)00581-2; Read RC, 1999, DISCRETE MATH, V204, P337, DOI 10.1016/S0012-365X(98)00378-1; Shahmohamad H, 2002, UTILITAS MATHEMATICA, V62, P13; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307; Sun XB, 2014, MATCH-COMMUN MATH CO, V72, P489; Wikoff WR, 2000, SCIENCE, V289, P2129, DOI 10.1126/science.289.5487.2129; Zhang C, 2008, P NATL ACAD SCI USA, V105, P10665, DOI 10.1073/pnas.0803841105; Zhang C, 2009, J AM CHEM SOC, V131, P1413, DOI 10.1021/ja809666h; Zhang HP, 2015, MATCH-COMMUN MATH CO, V73, P473; Zhang HP, 2015, MATCH-COMMUN MATH CO, V73, P457; Zimmermann J, 2008, ANGEW CHEM INT EDIT, V47, P3626, DOI 10.1002/anie.200702682	46	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125184	10.1371/journal.pone.0125184	http://dx.doi.org/10.1371/journal.pone.0125184			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932998	gold, Green Published, Green Submitted			2022-12-27	WOS:000353887100087
J	Shui, RH; Yu, BH; Bi, R; Yang, F; Yang, WT				Shui, Ruohong; Yu, Baohua; Bi, Rui; Yang, Fei; Yang, Wentao			An Interobserver Reproducibility Analysis of Ki67 Visual Assessment in Breast Cancer	PLOS ONE			English	Article							LABELING INDEX; INTERNATIONAL KI67; PROLIFERATION; KI-67; METAANALYSIS; PROGNOSIS; ACCURACY; MARKER	Background Ki67 labeling index (LI) is used as a predictive marker and is associated with prognosis in breast cancer. However, standardised methodologies for measurement are lacking which has limited its application in clinical practice. In this study, we evaluated the interobserver concordance of visual assessment of Ki67 LI in breast cancer. Methods Ki67-immunostained slides of 160 cases of primary invasive breast cancer were visual assessed by five breast pathologists with two different methods to choose the scoring fields: (1) hot-spot score, (2) average score. Proportions of positive invasive tumor cells at 10 % intervals were scored. The intra-class correlation coefficient (ICC) was used to assess the interobserver reproducibility. Results (1) A perfect concordance of Ki67 LI was demonstrated according to both score methods (P<0.0001). Average score method (ICC, 0.904) demonstrated a better correlation than hotspot score method (ICC, 0.894). (2) By respective means according to two score methods, all cases were classified into three groups (<= 10%, 11%-30% and >30% Ki-67 LI). The concordance was relatively low in intermediate Ki67 LI group compared with low and high Ki67 LI groups. (3) All cases were classified into three groups by paired-difference (d) between means of hot-spot score and average score (d<5, 5 <= d<10, d >= 10). The consistency was observed to decrease with increasing paired-difference according to both methods. Conclusions Visual assessment of Ki67 LI at 10% intervals is a candidate for a standard method in breast cancer clinical practice. Average score and hot-spot score of visual assessment both demonstrated a perfect concordance, and an overall average assessment across the whole section including hot spots may be a better method. Interobserver concordance of intermediate Ki67 LI in which most cutoffs are located for making clinical decisions was relatively low.	[Shui, Ruohong; Yu, Baohua; Bi, Rui; Yang, Fei; Yang, Wentao] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200032, Peoples R China; [Shui, Ruohong; Yu, Baohua; Bi, Rui; Yang, Fei; Yang, Wentao] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China	Fudan University; Fudan University	Yang, WT (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200032, Peoples R China.	yangwt2000@163.com			Priority of Shanghai Key Discipline of Medicine [ZZZZ1302-3]	Priority of Shanghai Key Discipline of Medicine	This work was supported by Priority of Shanghai Key Discipline of Medicine (ZZZZ1302-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Cserni G, 2014, BREAST, V23, P259, DOI 10.1016/j.breast.2014.02.003; Cuzick J, 2011, J CLIN ONCOL, V29, P4273, DOI 10.1200/JCO.2010.31.2835; de Azambuja E, 2007, BRIT J CANCER, V96, P1504, DOI 10.1038/sj.bjc.6603756; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; FLEISS JL, 1973, EDUC PSYCHOL MEAS, V33, P613, DOI 10.1177/001316447303300309; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Gudlaugsson E, 2012, HISTOPATHOLOGY, V61, P1134, DOI 10.1111/j.1365-2559.2012.04329.x; Hida AI, 2015, BREAST CANCER-TOKYO, V22, P129, DOI 10.1007/s12282-013-0460-8; Jonat W, 2011, ANN ONCOL, V22, P500, DOI 10.1093/annonc/mdq732; Laurinavicius A, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3639; Mikami Y, 2013, CANCER SCI, V104, P1539, DOI 10.1111/cas.12245; Niikura N, 2012, CANCER SCI, V103, P1508, DOI 10.1111/j.1349-7006.2012.02319.x; Ohno S, 2013, BREAST CANCER RES TR, V142, P69, DOI 10.1007/s10549-013-2691-y; Polley MYC, 2013, JNCI-J NATL CANCER I, V105, P1897, DOI 10.1093/jnci/djt306; Stuart-Harris R, 2008, BREAST, V17, P323, DOI 10.1016/j.breast.2008.02.002; Varga Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037379; Voros A, 2013, PATHOBIOLOGY, V80, P111, DOI 10.1159/000343795; von Minckwitz G, 2013, CLIN CANCER RES, V19, P4521, DOI 10.1158/1078-0432.CCR-12-3628; Yerushalmi R, 2010, LANCET ONCOL, V11, P174, DOI 10.1016/S1470-2045(09)70262-1	20	33	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125131	10.1371/journal.pone.0125131	http://dx.doi.org/10.1371/journal.pone.0125131			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932921	gold, Green Published			2022-12-27	WOS:000353887100079
J	Tung, HC; Lee, FY; Wang, SS; Tsai, MH; Lee, JY; Huo, TI; Huang, HC; Chuang, CL; Lin, HC; Lee, SD				Tung, Hung-Chun; Lee, Fa-Yauh; Wang, Sun-Sang; Tsai, Ming-Hung; Lee, Jing-Yi; Huo, Teh-Ia; Huang, Hui-Chun; Chuang, Chiao-Lin; Lin, Han-Chieh; Lee, Shou-Dong			The Beneficial Effects of P2X(7) Antagonism in Rats with Bile Duct Ligation-induced Cirrhosis	PLOS ONE			English	Article							PORTAL HYPERTENSIVE-RATS; NITRIC-OXIDE SYNTHASE; TUMOR-NECROSIS-FACTOR; GROWTH-FACTOR-BETA; EXTRACELLULAR ATP; INTERLEUKIN-1-BETA RELEASE; INCREASED ANGIOGENESIS; PURINERGIC MODULATION; ENDOTHELIAL-CELLS; LIVER FIBROSIS	Splanchnic angiogenesis in liver cirrhosis often leads to complications as gastroesophageal variceal hemorrhage and the treatment efficacy is adversely affected by poor portal-systemic collateral vasoresponsiveness related to nitric oxide (NO). Purinergic receptor subtype P2X(7) participates in the modulation of inflammation, angiogenesis, fibrogenesis and vasoresponsiveness, but the relevant influence in cirrhosis is unknown. Common bile duct-ligated (CBDL) or sham-operated Spraque-Dawley rats received brilliant blue G (BBG, a P2X(7) antagonist and food additive) or vehicle from the 15th to 28th day after operations, then hemodynamics, mesenteric angiogenesis, portal-systemic shunting, liver fibrosis, and protein expressions of angiogenic and fibrogenic factors were evaluated. The influence of oxidized ATP (oATP, another P2X(7) receptor antagonist) on the collateral vasoresponsiveness to arginine vasopressin (AVP) was also surveyed. BBG decreased superior mesenteric artery (SMA) flow, portal-systemic shunting, mesenteric vascular density, and mesenteric protein expressions of vascular endothelial growth factor (VEGF), VEGF receptor 2 (VEGFR2), phospho (p)-VEGFR2, platelet-derived growth factor (PDGF), PDGF receptor beta (PDGFR beta), cyclooxygenase (COX)-1, COX-2, and endothelial NO synthase (eNOS) in CBDL rats. BBG also ameliorated liver fibrosis and down-regulated hepatic interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), PDGF, IL-1 beta, transforming growth factor-beta (TGF-beta), p-extracellular-signal-regulated kinases (ERK), and alpha-smooth muscle actin (alpha-SMA) expressions in CBDL rats. The collateral vasocontractility to AVP was enhanced by oATP. oATP down-regulated eNOS, inducible NOS (iNOS), VEGF, Akt, p-Akt, and nuclear factor-kappa B (NF-kappa B) expressions in splenorenal shunt, the most prominent intra-abdominal collateral vessel in rodents. P2X(7) antagonism alleviates splanchnic hyperemia, severity of portal-systemic shunting, mesenteric angiogenesis, liver fibrosis, and enhances portal-systemic collateral vasoresponsiveness in cirrhotic rats. P2X(7) blockade may be a feasible strategy to control cirrhosis and complications.	[Tung, Hung-Chun; Lee, Jing-Yi; Huo, Teh-Ia] Natl Yang Ming Univ, Sch Med, Inst Pharmacol, Taipei 112, Taiwan; [Lee, Fa-Yauh; Wang, Sun-Sang; Huang, Hui-Chun; Chuang, Chiao-Lin; Lin, Han-Chieh; Lee, Shou-Dong] Natl Yang Ming Univ, Fac Med, Sch Med, Taipei 112, Taiwan; [Lee, Fa-Yauh; Lee, Jing-Yi; Huo, Teh-Ia; Huang, Hui-Chun; Lin, Han-Chieh] Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol, Taipei, Taiwan; [Chuang, Chiao-Lin] Taipei Vet Gen Hosp, Dept Med, Div Gen Med, Taipei, Taiwan; [Wang, Sun-Sang] Taipei Vet Gen Hosp, Dept Med Affair & Planning, Taipei, Taiwan; [Tsai, Ming-Hung] Chang Gung Mem Hosp, Div Digest Therapeut Endoscopy, Taipei 10591, Taiwan; [Tsai, Ming-Hung] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Lee, Shou-Dong] Cheng Hsin Gen Hosp, Dept Med, Div Gastroenterol, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Chang Gung Memorial Hospital; Chang Gung University; Cheng Hsin General Hospital	Huang, HC (corresponding author), Natl Yang Ming Univ, Fac Med, Sch Med, Taipei 112, Taiwan.	hchuang2@vghtpe.gov.tw			Ministry of Science and Technology, Taipei, Taiwan [99-2314-B-075-021-MY3]	Ministry of Science and Technology, Taipei, Taiwan	This work was supported by the Ministry of Science and Technology, Taipei, Taiwan (grant number 99-2314-B-075-021-MY3).	Adinolfi E, 2012, CANCER RES, V72, P2957, DOI 10.1158/0008-5472.CAN-11-1947; Balboa MA, 1999, J BIOL CHEM, V274, P36764, DOI 10.1074/jbc.274.51.36764; BISSELL DM, 1995, J CLIN INVEST, V96, P447, DOI 10.1172/JCI118055; BORZELLECA JF, 1990, FOOD CHEM TOXICOL, V28, P221, DOI 10.1016/0278-6915(90)90034-K; Bosch J, 2008, J HEPATOL, V48, pS68, DOI 10.1016/j.jhep.2008.01.021; Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033; CAMERON GR, 1958, J PATHOL BACTERIOL, V75, P333, DOI 10.1002/path.1700750212; Chan CC, 1999, HEPATOLOGY, V30, P630, DOI 10.1002/hep.510300317; Chiao CW, 2008, J PHARMACOL EXP THER, V326, P864, DOI 10.1124/jpet.107.135350; Chiao CW, 2013, CLIN SCI, V125, P131, DOI 10.1042/CS20120479; CHOJKIER M, 1981, AM J PHYSIOL, V240, pG371, DOI 10.1152/ajpgi.1981.240.5.G371; Chuang CL, 2015, J GASTROEN HEPATOL, V30, P199, DOI 10.1111/jgh.12670; COLOMBATO LA, 1991, AM J PHYSIOL, V260, pG1, DOI 10.1152/ajpgi.1991.260.1.G1; Cooke CLM, 2002, AM J PHYSIOL-CELL PH, V282, pC395, DOI 10.1152/ajpcell.00295.2001; Dong A, 2014, ANGIOGENESIS, V17, P553, DOI 10.1007/s10456-013-9402-5; Feliers D, 2005, KIDNEY INT, V68, P1648, DOI 10.1111/j.1523-1755.2005.00575.x; Fernandez M, 2005, J HEPATOL, V43, P98, DOI 10.1016/j.jhep.2005.02.022; Fernandez M, 2004, GASTROENTEROLOGY, V126, P886, DOI 10.1053/j.gastro.2003.12.012; Ferrari D, 1997, J EXP MED, V185, P579, DOI 10.1084/jem.185.3.579; Franco F, 1979, ARCH SURG-CHICAGO, V114, P1064; Garcia-Pagan JC, 2012, J HEPATOL, V57, P458, DOI 10.1016/j.jhep.2012.03.007; Geerts AM, 2006, LIVER INT, V26, P889, DOI 10.1111/j.1478-3231.2006.01308.x; Goncalves RG, 2006, KIDNEY INT, V70, P1599, DOI 10.1038/sj.ki.5001804; Gupta RA, 2003, CANCER RES, V63, P906; HAMILTON RL, 1974, J LIPID RES, V15, P182; Hide I, 2000, J NEUROCHEM, V75, P965, DOI 10.1046/j.1471-4159.2000.0750965.x; Hu Y, 1998, J BIOL CHEM, V273, P27170, DOI 10.1074/jbc.273.42.27170; Huang CS, 2014, MOL MED REP, V9, P57, DOI 10.3892/mmr.2013.1807; Huang HC, 2000, SCAND J GASTROENTERO, V35, P1308; Huang HC, 2012, HEPATOLOGY, V56, P248, DOI 10.1002/hep.25625; Inoue K, 2002, GLIA, V40, P156, DOI 10.1002/glia.10150; KOUNTOURAS J, 1984, BRIT J EXP PATHOL, V65, P305; Laleman W, 2005, LIVER INT, V25, P1079, DOI 10.1111/j.1478-3231.2005.01163.x; Lee FY, 1997, J HEPATOL, V26, P687, DOI 10.1016/S0168-8278(97)80436-9; Martins JP, 2012, BRIT J PHARMACOL, V165, P183, DOI 10.1111/j.1476-5381.2011.01535.x; Mehta VB, 2001, J BIOL CHEM, V276, P3820, DOI 10.1074/jbc.M006814200; Moncao-Ribeiro LC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110185; MURGIA M, 1993, J BIOL CHEM, V268, P8199; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Pellicoro A, 2014, NAT REV IMMUNOL, V14, P181, DOI 10.1038/nri3623; Riteau N, 2010, AM J RESP CRIT CARE, V182, P774, DOI 10.1164/rccm.201003-0359OC; Seki S, 2012, PHARM ANAL ACTA, V3, P9; Shigeki TA, 2006, CLIN CHIM ACTA, V364, P33, DOI 10.1016/j.cca.2005.06.014; Shun CT, 2003, HEPATO-GASTROENTEROL, V50, P988; Solini A, 2005, KIDNEY INT, V67, P875, DOI 10.1111/j.1523-1755.2005.00152.x; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Sumanovski LT, 1999, HEPATOLOGY, V29, P1044, DOI 10.1002/hep.510290436; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Suzuki S, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-224; Suzuki T, 2004, J NEUROSCI, V24, P1, DOI 10.1523/JNEUROSCI.3792-03.2004; Svegliati-Baroni G, 2003, J HEPATOL, V39, P528, DOI 10.1016/S0168-8278(03)00291-5; Tamodiunas AE, 2003, SEMIN CARDIOL, V9, P53; Vesey DA, 2002, J LAB CLIN MED, V140, P342, DOI 10.1067/mlc.2002.128468; Vidal O, 2008, J GASTROINTEST SURG, V12, P1005, DOI 10.1007/s11605-007-0336-3; Wang CM, 2003, CELL SIGNAL, V15, P1129, DOI 10.1016/S0898-6568(03)00112-8	55	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124654	10.1371/journal.pone.0124654	http://dx.doi.org/10.1371/journal.pone.0124654			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933224	Green Published, Green Submitted, gold			2022-12-27	WOS:000353887100055
J	Oberhelman, RA; Soto-Castellares, G; Gilman, RH; Castillo, ME; Kolevic, L; Delpino, T; Saito, M; Salazar-Lindo, E; Negron, E; Montenegro, S; Laguna-Torres, VA; Maurtua-Neumann, P; Datta, S; Evans, CA				Oberhelman, Richard A.; Soto-Castellares, Giselle; Gilman, Robert H.; Castillo, Maria E.; Kolevic, Lenka; Delpino, Trinidad; Saito, Mayuko; Salazar-Lindo, Eduardo; Negron, Eduardo; Montenegro, Sonia; Alberto Laguna-Torres, V.; Maurtua-Neumann, Paola; Datta, Sumona; Evans, Carlton A.			A Controlled Study of Tuberculosis Diagnosis in HIV-Infected and Uninfected Children in Peru	PLOS ONE			English	Article							CHILDHOOD PULMONARY TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; INTRATHORACIC TUBERCULOSIS; MICROSCOPIC-OBSERVATION; GASTRIC LAVAGE; ENDEMIC AREA; SPUTUM; ASSAY; CHALLENGES; ERA	Background Diagnosing tuberculosis in children is challenging because specimens are difficult to obtain and contain low tuberculosis concentrations, especially with HIV-coinfection. Few studies included well-controls so test specificities are poorly defined. We studied tuberculosis diagnosis in 525 children with and without HIV-infection. Methods and Findings 'Cases' were children with suspected pulmonary tuberculosis (n = 209 HIV-negative; n = 81 HIV-positive) and asymptomatic 'well-control' children (n = 200 HIV-negative; n = 35 HIV-positive). Specimens (n = 2422) were gastric aspirates, nasopharyngeal aspirates and stools analyzed by a total of 9688 tests. All specimens were tested with an in-house hemi-nested IS6110 PCR that took <24 hours. False-positive PCR in well-controls were more frequent in HIV-infection (P <= 0.01): 17% (6/35) HIV-positive well-controls versus 5.5% (11/200) HIV-negative well-controls; caused by 6.7% (7/104) versus 1.8% (11/599) of their specimens, respectively. 6.7% (116/1719) specimens from 25% (72/290) cases were PCR-positive, similar (P>0.2) for HIV-positive versus HIV-negative cases. All specimens were also tested with auramine acid-fast microscopy, microscopic-observation drug-susceptibility (MODS) liquid culture, and Lowenstein-Jensen solid culture that took <= 6 weeks and had 100% specificity (all 2112 tests on 704 specimens from 235 well-controls were negative). Microscopy-positivity was rare (0.21%, 5/2422 specimens) and all microscopy-positive specimens were culture-positive. Culture-positivity was less frequent (P <= 0.01) in HIV-infection: 1.2% (1/81) HIV-positive cases versus 11% (22/209) HIV-negative cases; caused by 0.42% (2/481) versus 4.7% (58/1235) of their specimens, respectively. Conclusions In HIV-positive children with suspected tuberculosis, diagnostic yield was so low that 1458 microscopy and culture tests were done per case confirmed and even in children with culture-proven tuberculosis most tests and specimens were false-negative; whereas PCR was so prone to false-positives that PCR-positivity was as likely in specimens from well-controls as suspected-tuberculosis cases. This demonstrates the importance of control participants in diagnostic test evaluation and that even extensive laboratory testing only rarely contributed to the care of children with suspected TB.	[Oberhelman, Richard A.] Tulane Sch Publ Hlth & Trop Med, New Orleans, LA 70112 USA; [Soto-Castellares, Giselle; Gilman, Robert H.; Saito, Mayuko] Asociac Benef Proyectos Informat Salud Med & Agr, Lima, Peru; [Soto-Castellares, Giselle; Alberto Laguna-Torres, V.] US Naval Med Res Unit Six, Lima, Peru; [Gilman, Robert H.; Datta, Sumona; Evans, Carlton A.] Univ Peruana Cayetano Heredia, Fac Sci & Philosophy, Dept Microbiol, Lima, Peru; [Gilman, Robert H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Castillo, Maria E.; Kolevic, Lenka; Delpino, Trinidad] Inst Nacl Salud Nino, Infect Dis Serv, Lima, Peru; [Castillo, Maria E.] Univ Peruana Cayetano Heredia, Dept Pediat, Fac Med, Lima, Peru; [Salazar-Lindo, Eduardo; Negron, Eduardo] Hosp Nacl Cayetano Heredia, Dept Pediat, Lima, Peru; [Montenegro, Sonia] Univ Concepcion, Concepcion, Chile; [Maurtua-Neumann, Paola] Tulane Univ, Sch Med, Dept Pediat, New Orleans, LA 70112 USA; [Datta, Sumona; Evans, Carlton A.] Univ London Imperial Coll Sci Technol & Med, Infect Dis & Immun, London, England; [Datta, Sumona; Evans, Carlton A.] Univ London Imperial Coll Sci Technol & Med, Wellcome Trust, Ctr Global Hlth Res, London, England; [Datta, Sumona; Evans, Carlton A.] IFHAD Innovat Hlth & Dev, London, England	Tulane University; Universidad Peruana Cayetano Heredia; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universidad Peruana Cayetano Heredia; Universidad de Concepcion; Tulane University; Imperial College London; Imperial College London; University of London; University College London	Oberhelman, RA (corresponding author), Tulane Sch Publ Hlth & Trop Med, New Orleans, LA 70112 USA.	oberhel@tulane.edu	Evans, Carlton/AAI-1653-2020; Saito, Mayuko/J-4508-2018	Evans, Carlton/0000-0002-6873-5447; Saito, Mayuko/0000-0003-4622-7027; Datta, Sumona/0000-0002-3476-9753; LAGUNA-TORRES, VICTOR ALBERTO/0000-0002-9507-6301	National Institutes of Health [1 RO1 AI-49139]; USAID TB [HRN-5986-A-00-6006-00]; NIH ITREID [5D43-TW00910]; Fogarty-NIH AIDS training program [3T22-TW00016-05S3]; NIAID [5T35-AI07646-02]; IFHAD: Innovation For Health And Development; Joint Global Health Trials consortium (Wellcome Trust/MRC/DFID); Wellcome Trust; Imperial College Biomedical Research Centre;  [62787 S17 H B0002]; Bill & Melinda Gates Foundation � Grand Challenges Explorations Initiative [OPP1118545] Funding Source: researchfish; FOGARTY INTERNATIONAL CENTER [D43TW000910, T22TW000016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049139, T35AI007646] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USAID TB(United States Agency for International Development (USAID)); NIH ITREID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty-NIH AIDS training program; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); IFHAD: Innovation For Health And Development; Joint Global Health Trials consortium (Wellcome Trust/MRC/DFID); Wellcome Trust(Wellcome TrustEuropean Commission); Imperial College Biomedical Research Centre; ; Bill & Melinda Gates Foundation � Grand Challenges Explorations Initiative; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research study was supported entirely by National Institutes of Health grant 1 RO1 AI-49139. Collaborators and the diagnostic laboratory for this research were also funded by: USAID TB Award HRN-5986-A-00-6006-00; NIH ITREID grant 5D43-TW00910; Fogarty-NIH AIDS training program 3T22-TW00016-05S3; NIAID tutorial training grant 5T35-AI07646-02; IFHAD: Innovation For Health And Development; Joint Global Health Trials consortium (Wellcome Trust/MRC/DFID); The Wellcome Trust; and Imperial College Biomedical Research Centre. NAMRU-6 work was supported by Work Unit Number 62787 S17 H B0002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABADCO DL, 1992, PEDIATR INFECT DIS J, V11, P735, DOI 10.1097/00006454-199209000-00013; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Caviedes L, 2000, J CLIN MICROBIOL, V38, P1203, DOI 10.1128/JCM.38.3.1203-1208.2000; Demers AM, 2010, INT J TUBERC LUNG D, V14, P1016; Evans CA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001064; Graham SM, 2012, J INFECT DIS, V205, pS199, DOI 10.1093/infdis/jis008; Harries A, 2004, TB HIV CLIN MANUAL S; Hesseling AC, 2002, INT J TUBERC LUNG D, V6, P1038; Joint United Nations Programme on HIV/AIDS, 2008, COUNTR RESP PER; Kelynack TN, 1908, TUBERCULOSIS INFANCY, P80; Kiwanuka J, 2001, ANN TROP PAEDIATR, V21, P5, DOI 10.1080/02724930020028849; Marais BJ, 2007, J INFECT DIS, V196, pS76, DOI 10.1086/518659; Marais BJ, 2006, INT J TUBERC LUNG D, V10, P732; Marais BJ, 2006, AM J RESP CRIT CARE, V173, P1078, DOI 10.1164/rccm.200511-1809SO; Marais BJ, 2006, CLIN INFECT DIS, V42, pE69, DOI 10.1086/502652; Mayta H, 2003, J CLIN MICROBIOL, V41, P5774, DOI 10.1128/JCM.41.12.5774-5777.2003; Montenegro SH, 2003, CLIN INFECT DIS, V36, P16, DOI 10.1086/344900; Moore DAJ, 2006, NEW ENGL J MED, V355, P1539, DOI 10.1056/NEJMoa055524; Moore DAJ, 2006, DIAGN MICR INFEC DIS, V56, P35, DOI 10.1016/j.diagmicrobio.2006.03.009; Oberhelman RA, 2010, LANCET INFECT DIS, V10, P612, DOI 10.1016/S1473-3099(10)70141-9; Palme IB, 2004, ACTA PAEDIATR, V93, P311, DOI 10.1080/08035250410023566; Perkins MD, 2007, J INFECT DIS, V196, pS15, DOI 10.1086/518656; Salazar GE, 2001, PEDIATRICS, V108, P448, DOI 10.1542/peds.108.2.448; Schaaf HS, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-140; Starke JR, 2003, TUBERCULOSIS, V83, P208, DOI 10.1016/S1472-9792(02)00088-4; STEGEN G, 1969, PEDIATRICS, V43, P260; Toledo A, 1979, REV MEX PEDIAT, V46, P239; Zar HJ, 2005, LANCET, V365, P130, DOI 10.1016/S0140-6736(05)17702-2; Zar HJ, 2012, CLIN INFECT DIS	29	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0120915	10.1371/journal.pone.0120915	http://dx.doi.org/10.1371/journal.pone.0120915			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927526	gold, Green Published, Green Submitted			2022-12-27	WOS:000353713100004
J	Park, JH; Chae, J; Roh, K; Kil, EJ; Lee, M; Auh, CK; Lee, MA; Yeom, CH; Lee, S				Park, Jin-Hee; Chae, Jisook; Roh, Kangsan; Kil, Eui-Joon; Lee, Minji; Auh, Chung-Kyun; Lee, Myung-Ah; Yeom, Chang-Hwan; Lee, Sukchan			Oxaliplatin-Induced Peripheral Neuropathy via TRPA1 Stimulation in Mice Dorsal Root Ganglion Is Correlated with Aluminum Accumulation	PLOS ONE			English	Article							NERVOUS-SYSTEM; CHANNELS; NEURONS; COLD; CHEMOTHERAPY; CANCER; PAIN; RAT; ADENOCARCINOMA; ENCEPHALOPATHY	Oxaliplatin is a platinum-based anticancer drug used to treat metastatic colorectal, breast, and lung cancers. While oxaliplatin kills cancer cells effectively, it exhibits several side effects of varying severity. Neuropathic pain is commonly experienced during treatment with oxaliplatin. Patients describe symptoms of paresthesias or dysesthesias that are triggered by cold (acute neuropathy), or as abnormal sensory or motor function (chronic neuropathy). In particular, we found that aluminum levels were relatively high in some cancer patients suffering from neuropathic pain based on clinical observations. Based on these findings, we hypothesized that aluminum accumulation in the dorsal root ganglion (DRG) in the course of oxaliplatin treatment exacerbates neuropathic pain. In mice injected with oxaliplatin (three cycles of 3 mg/kg i.p. daily for 5 days, followed by 5 days of rest), we detected cold allodynia using the acetone test, but not heat hyperalgesia using a hot plate. However, co-treatment with aluminum chloride (AlCl(3 center dot)6H(2)O; 7 mg/kg i.p. for 14 days: equivalent 0.78 mg/kg of elemental Al) and oxaliplatin (1 cycle of 3 mg/kg i.p. daily for 5 days, followed by 5 days of rest) synergistically induced cold allodynia as well as increased TRPAl mRNA and protein expression. Inductively Coupled Plasma Mass Spectrometry (ICP-MS) analysis showed a significant increase in aluminum concentrations in the DRG of mice treated with aluminum chloride and oxaliplatin compared to aluminum chloride alone. Similarly, in a mouse induced-tumor model, aluminum concentrations were increased in DRG tissue and tumor cells after oxaliplatin treatment. Taken together, these findings suggest that aluminum accumulation in the DRG may exacerbate neuropathic pain in oxaliplatin-treated mice.	[Park, Jin-Hee] Catholic Univ Korea, Coll Med, Inst Canc Res, Seoul, South Korea; [Chae, Jisook; Roh, Kangsan; Kil, Eui-Joon; Lee, Minji; Lee, Sukchan] Sungkyunkwan Univ, Dept Genet Engn, Suwon, South Korea; [Kil, Eui-Joon] Sungkyunkwan Univ, Inst Life Sci & Technol, Suwon, South Korea; [Auh, Chung-Kyun] Mokpo Natl Univ, Dept Biol Sci, Muan, South Korea; [Lee, Myung-Ah] Catholica Univ Korea, Seoul St Marys Hosp, Dept Med Oncol, Seoul, South Korea; [Yeom, Chang-Hwan] Yeoms Family Med Clin, Seoul, South Korea	Catholic University of Korea; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Mokpo National University; Catholic University of Korea; Seoul St. Mary's Hospital	Yeom, CH (corresponding author), Yeoms Family Med Clin, Seoul, South Korea.	lymphych@hanmail.net; cell4u@skku.edu	Kil, Eui-Joon/AAZ-9823-2020		Korean Association for Vitamin Research; National Research Foundation of Korea [2013R1A2A2A04014661]	Korean Association for Vitamin Research; National Research Foundation of Korea(National Research Foundation of Korea)	This work is supported by grants from the Korean Association for Vitamin Research and the National Research Foundation of Korea (2013R1A2A2A04014661, CKA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram SE, 2006, ANESTHESIOLOGY, V105, P146, DOI 10.1097/00000542-200607000-00024; ALFREY AC, 1976, NEW ENGL J MED, V294, P184, DOI 10.1056/NEJM197601222940402; Anand U, 2008, NEUROSCI LETT, V438, P221, DOI 10.1016/j.neulet.2008.04.007; Anand U, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-82; Argyriou AA, 2007, ACTA ONCOL, V46, P1131, DOI 10.1080/02841860701355055; Bardin L, 2009, BEHAV BRAIN RES, V205, P360, DOI 10.1016/j.bbr.2009.07.005; Becaria A, 2002, TOXICOL IND HEALTH, V18, P309, DOI 10.1191/0748233702th157oa; Bessac BF, 2008, PHYSIOLOGY, V23, P360, DOI 10.1152/physiol.00026.2008; Bondy SC, 2010, NEUROTOXICOLOGY, V31, P575, DOI 10.1016/j.neuro.2010.05.009; Caspani O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007383; Cassidy J, 2002, SEMIN ONCOL; Cavaletti G, 2001, EUR J CANCER, V37, P2457, DOI 10.1016/S0959-8049(01)00300-8; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Descoeur J, 2011, EMBO MOL MED, V3, P266, DOI 10.1002/emmm.201100134; Farah Ibrahim O, 2010, Biomed Sci Instrum, V46, P404; Flatters SJL, 2004, PAIN, V109, P150, DOI 10.1016/j.pain.2004.01.029; Galaris D, 2002, CRIT REV ONCOL HEMAT, V42, P93, DOI 10.1016/S1040-8428(01)00212-8; Gauchan P, 2009, NEUROSCI LETT, V458, P93, DOI 10.1016/j.neulet.2009.04.029; Gu CW, 2009, NEUROCHEM RES, V34, P1150, DOI 10.1007/s11064-008-9891-6; Guindon J, 2013, PHARMACOL RES, V67, P94, DOI 10.1016/j.phrs.2012.10.013; Gunn A, 2011, J PAIN, V12, P222, DOI 10.1016/j.jpain.2010.06.011; Guo CH, 2009, ENVIRON TOXICOL PHAR, V27, P176, DOI 10.1016/j.etap.2008.10.001; Holzer P, 2011, CURR PHARM BIOTECHNO, V12, P24, DOI 10.2174/138920111793937862; Kawahara M, 2001, BRAIN RES BULL, V55, P211, DOI 10.1016/S0361-9230(01)00475-0; Kerstein PC, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-19; Kumar V, 2009, ARCH TOXICOL, V83, P965, DOI 10.1007/s00204-009-0455-6; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Labat-Moleur F, 1998, J HISTOCHEM CYTOCHEM, V46, P327, DOI 10.1177/002215549804600306; Lehky RJ, 2004, MUSCLE NERVE, V29, P387, DOI 10.1002/mus.10559; Lorgis V, 2012, ANTICANCER RES, V32, P4125; Mailloux RJ, 2011, EXP CELL RES, V317, P2231, DOI 10.1016/j.yexcr.2011.07.009; Mantyh PW, 2006, NAT REV NEUROSCI, V7, P797, DOI 10.1038/nrn1914; Materazzi S, 2012, PFLUG ARCH EUR J PHY, V463, P561, DOI 10.1007/s00424-011-1071-x; McKeage MJ, 2001, BRIT J CANCER, V85, P1219, DOI 10.1054/bjoc.2001.2024; Morgan M, 2008, TRANSL ONCOL, V1, P44, DOI 10.1593/tlo.07118; Nassini R, 2011, PAIN, V152, P1621, DOI 10.1016/j.pain.2011.02.051; Nayak P, 2002, ENVIRON RES, V89, P101, DOI 10.1006/enrs.2002.4352; Peto MV, 2010, REJUV RES, V13, P589, DOI 10.1089/rej.2009.0995; PLATTS MM, 1977, BRIT MED J, V2, P657, DOI 10.1136/bmj.2.6088.657; Raymond E, 1998, ANN ONCOL, V9, P1053, DOI 10.1023/A:1008213732429; Renn CL, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-29; Saijilafu, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1568; Sakurai M, 2009, PAIN, V147, P165, DOI 10.1016/j.pain.2009.09.003; Sapunar Damir, 2012, J Pain Res, V5, P31, DOI 10.2147/JPR.S26603; Sato S, 2009, CANCER SCI, V100, P546, DOI 10.1111/j.1349-7006.2008.01065.x; Shati AA, 2011, NEUROSCIENCE, V175, P66, DOI 10.1016/j.neuroscience.2010.11.043; Sorich Joan, 2004, Clin J Oncol Nurs, V8, P251, DOI 10.1188/04.CJON.251-256; Staaf S, 2009, PAIN, V144, P187, DOI 10.1016/j.pain.2009.04.013; Stein A, 2012, EXPERT OPIN PHARMACO, V13, P125, DOI 10.1517/14656566.2012.643870; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Ta LE, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-15; Ta LE, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-9; United States Department of Health and Human Services, 1999, TOX PROF AL; Vasudevaraju BP, 2008, INDIAN J MED RES, V128, P545; Wang BA, 2010, ENVIRON TOXICOL PHAR, V29, P308, DOI 10.1016/j.etap.2010.03.007; WANG MK, 1983, CLAY CLAY MINER, V31, P65, DOI 10.1346/CCMN.1983.0310111; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0; Yokel RA, 2002, COORDIN CHEM REV, V228, P97, DOI 10.1016/S0010-8545(02)00078-4; Zhang ZW, 1997, SCI TOTAL ENVIRON, V205, P179, DOI 10.1016/S0048-9697(97)00197-6; Zhao M, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-55	60	22	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124875	10.1371/journal.pone.0124875	http://dx.doi.org/10.1371/journal.pone.0124875			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928068	Green Published, gold, Green Submitted			2022-12-27	WOS:000353713100050
J	Xiao, WW; Liu, S; Tian, YM; Guan, Y; Huang, SM; Lin, CG; Zhao, C; Lu, TX; Han, F				Xiao, WeiWei; Liu, Shuai; Tian, YunMing; Guan, Ying; Huang, ShaoMin; Lin, ChengGuang; Zhao, Chong; Lu, TaiXiang; Han, Fei			Prognostic Significance of Tumor Volume in Locally Recurrent Nasopharyngeal Carcinoma Treated with Salvage Intensity-Modulated Radiotherapy	PLOS ONE			English	Article							T-STAGE; SURVIVAL	Introduction To evaluate the prognostic value of gross tumor volume (TV) in patients with locally recurrent, nonmetastatic nasopharyngeal carcinoma. Methods Between 2001 and 2012, 291 consecutive patients with locally recurrent, nonmetastatic nasopharyngeal carcinoma underwent salvage IMRT were retrospectively reviewed. The correlations between TV and recurrent T classification were analyzed. Survival analyses were performed. Receiver operating characteristic (ROC) curves were calculated to identify cutoff point of TV. The Akaike information criterion and Harrell's concordance index (c-index) were utilized to test the prognostic value. Results The median TV significantly increased with advancing recurrent T classification (P<0.001). The 5-year overall survival rate was 33.2% for the entire cohort. On multivariate analysis, TV was an independent negative prognostic factor for distant metastasis-free survival (hazard ratio = 1.013, P = 0.003), overall survival (hazard ratio = 1.015, P<0.001) and toxicityrelated death (hazard ratio = 1.014, P<0.001). The 5-year overall survival rates were 63.1% and 20.8% for patients with a TV < 22 cm(3) and TV >= 22 cm(3), respectively (P < 0.001). In patient with TV < 22 cm(3), locoregional failure is the leading cause of death. In patients with TV >= 22 cm(3), distant metastasis rate is higher and occurred within short term after local recurrence; meanwhile, radiation-induced injuries became more common and led to half of deaths in this group. The Akaike information criterion and c-index analyses indicated that the predictive ability of recurrent T classification improved when combined with TV. Conclusions Our data suggests TV is a significant prognostic factor for predicting the distant metastasis, overall survival and toxicity-related death of patients with locally recurrent, nonmetastatic nasopharyngeal carcinoma after salvage IMRT. TV should be considered when designing personalized salvage treatments for these patients. For patients with bulky local recurrent tumor, radiation may need to be de-emphasized in favor of systemic treatment or best supportive care.	[Xiao, WeiWei; Liu, Shuai; Guan, Ying; Huang, ShaoMin; Lin, ChengGuang; Zhao, Chong; Lu, TaiXiang; Han, Fei] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, Dept Radiotherapy,State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Tian, YunMing] Hui Zhou Municipal Cent Hosp, Dept Radiat Oncol, Huizhou, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University	Han, F (corresponding author), Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, Dept Radiotherapy,State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China.	hanfei@sysucc.org.cn	Han, Fei/AAD-7348-2021	Han, Fei/0000-0002-1598-9048; Xiao, WeiWei/0000-0002-9922-640X	Science and Technology Planning Project of Guangdong Province, China [2012B061700089]; Sun Yat-sen University, China [12ykpy57]	Science and Technology Planning Project of Guangdong Province, China; Sun Yat-sen University, China	This work was supported by Grant: Science and Technology Planning Project of Guangdong Province, China (No. 2012B061700089) and Young scientists fund of Sun Yat-sen University, China (No 12ykpy57). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Chang CC, 2003, J OTOLARYNGOL, V32, P87, DOI 10.2310/7070.2003.37253; Chen CB, 2011, JPN J CLIN ONCOL, V41, P537, DOI 10.1093/jjco/hyq242; Chen HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073918; Chen MK, 2004, CANCER-AM CANCER SOC, V100, P2160, DOI 10.1002/cncr.20210; Chua DTT, 2006, INT J RADIAT ONCOL, V66, P1415, DOI 10.1016/j.ijrobp.2006.07.1364; De Jaeger K, 1998, INT J RADIAT ONCOL, V42, P717, DOI 10.1016/S0360-3016(98)00323-X; Edge SB, 2009, AJCC CANC STAGING MA, V7; Evans SM, 2003, CANCER LETT, V195, P1, DOI 10.1016/S0304-3835(03)00012-0; Guo R, 2012, RADIOTHER ONCOL, V104, P294, DOI 10.1016/j.radonc.2012.09.001; Han F, 2012, CLIN ONCOL-UK, V24, P569, DOI 10.1016/j.clon.2011.11.010; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hua YJ, 2012, EUR J CANCER, V48, P3422, DOI 10.1016/j.ejca.2012.06.016; Lee CC, 2008, ACTA OTO-LARYNGOL, V128, P93, DOI 10.1080/00016480701361921; Sarisahin M, 2011, AURIS NASUS LARYNX, V38, P250, DOI 10.1016/j.anl.2010.09.002; Suarez C, 2010, EUR ARCH OTO-RHINO-L, V267, P1811, DOI 10.1007/s00405-010-1385-x; Sze WM, 2004, INT J RADIAT ONCOL, V59, P21, DOI 10.1016/j.ijrobp.2003.10.027; Tian YM, 2014, BRIT J CANCER, V110, P297, DOI 10.1038/bjc.2013.715; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Wu Z, 2013, HEAD NECK-J SCI SPEC, V35, P689, DOI 10.1002/hed.23010; Yu KJ, 2011, CLIN CANCER RES, V17, P1906, DOI 10.1158/1078-0432.CCR-10-1681; ZWEIG MH, 1993, CLIN CHEM, V39, P561	22	23	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125351	10.1371/journal.pone.0125351	http://dx.doi.org/10.1371/journal.pone.0125351			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927527	Green Published, Green Submitted, gold			2022-12-27	WOS:000353713100084
J	Li, Z; Zhang, HR; Li, XW; Yang, Y; Xin, HN; Li, MF; Feng, BX; Gao, L				Li, Zhen; Zhang, Haoran; Li, Xiangwei; Yang, Yu; Xin, Henan; Li, Mufei; Feng, Boxuan; Gao, Lei			Anal Human Papillomavirus Genotyping among HIV-Positive Men Who Have Sex with Men in Xi'an, China	PLOS ONE			English	Article							RISK-FACTORS; INTRAEPITHELIAL NEOPLASIA; HPV INFECTION; PREVALENCE; VACCINE; QUADRIVALENT; CANCER; LESIONS; COHORT; CELLS	Background Anal human papillomavirus (HPV) infection and its related diseases are relatively common in men who have sex with men (MSM), especially in those HIV positive. In China, molecular epidemiology of anal HPV infection among HIV-positive MSM has been sparsely studied. Methods A cross-sectional study was conducted among HIV-positive MSM in Xi'an, China between April and July 2014. Anal swabs were collected for HPV genotyping. Results A total of 195 HIV-positive MSM were included in this study. HPV genotyping showed that 99.0% (191/193) of participants were positive for at least one of the targeted 37 HPV genotypes. 183 (94.8%) of them were infected with multiple high-risk types and 154 (79.8%) of them with low-risk HPV types. HPV 18 was the most frequently identified high-risk type, followed by HPV 16 and HPV 51. As for low-risk types, HPV11, HPV 6 and HPV 81 were most commonly observe. High-risk HPV infection was found to be associated with the status of antiretroviral therapy (ART), the distribution of low-risk types was observed to be varied by CD4(+)T cell level. Conclusion Almost all HIV-positive MSM were anal HPV infected in our study. It is highly recommended to consider regular active screening and preventive intervention of HPV infection among this high risk population.	[Li, Zhen; Zhang, Haoran; Li, Xiangwei; Xin, Henan; Li, Mufei; Feng, Boxuan; Gao, Lei] Chinese Acad Med Sci, Inst Pathogen Biol, Beijing 100730, Peoples R China; [Li, Zhen; Zhang, Haoran; Li, Xiangwei; Xin, Henan; Li, Mufei; Feng, Boxuan; Gao, Lei] Peking Union Med Coll, Beijing 100730, Peoples R China; [Yang, Yu] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100191, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking University	Gao, L (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, Dong Dan San Tiao 9, Beijing 100730, Peoples R China.	gaolei@ipbcams.ac.cn		Yang, Yu/0000-0002-5611-8951	Beijing Nova program [Z121107002512073]	Beijing Nova program(Beijing Municipal Science & Technology Commission)	This work was supported by The Beijing Nova program (Z121107002512073) (to LG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz L, 2001, INT J CANCER, V129, P433; Alemany L, 2015, INT J CANCER, V136, P98, DOI 10.1002/ijc.28963; Bertisch B, 2013, AM J EPIDEMIOL, V178, P877, DOI 10.1093/aje/kwt153; Brown B, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005687; Brown B, 2012, VIRUSES-BASEL, V4, P3851, DOI 10.3390/v4123851; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; Chaturvedi AK, 2009, JNCI-J NATL CANCER I, V101, P1120, DOI 10.1093/jnci/djp205; Chow EPF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089959; Cingolani A, 2014, J INT AIDS SOC, V17, P106, DOI 10.7448/IAS.17.4.19653; de Pokomandy A, 2011, CLIN INFECT DIS, V52, P1174, DOI 10.1093/cid/cir064; de Pokomandy A, 2009, J INFECT DIS, V199, P965, DOI 10.1086/597207; De Vuyst H, 2009, INT J CANCER, V124, P1626, DOI 10.1002/ijc.24116; Gage JR, 2000, OBSTET GYNECOL, V96, P879, DOI 10.1016/S0029-7844(00)01057-7; Gao L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015256; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Goldstone S, 2011, J INFECT DIS, V203, P66, DOI 10.1093/infdis/jiq016; Gonzalez C, 2013, INT J CANCER, V133, P1164, DOI 10.1002/ijc.28102; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Hu YF, 2013, JAIDS-J ACQ IMM DEF, V64, P103, DOI 10.1097/QAI.0b013e31829b6298; Latini A, 2014, J INT AIDS SOC, V17, P113, DOI 10.7448/IAS.17.4.19662; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Machalek DA, 2012, SEX HEALTH, V9, P527, DOI 10.1071/SH12043; Machalek DA, 2012, LANCET ONCOL, V13, P487, DOI 10.1016/S1470-2045(12)70080-3; Meites E, 2014, VACCINE, V32, P6356, DOI 10.1016/j.vaccine.2014.09.033; Mendez-Martinez R, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0671-4; Nadarzynski T, 2014, SEX TRANSM INFECT, V90, P515, DOI 10.1136/sextrans-2013-051357; Nicol AF, 2005, DIAGN MOL PATHOL, V14, P39, DOI 10.1097/01.pas.0000143309.81183.6c; NOFFSINGER A, 1992, CANCER-AM CANCER SOC, V70, P1276, DOI 10.1002/1097-0142(19920901)70:3+<1276::AID-CNCR2820701514>3.0.CO;2-B; Nyitray AG, 2011, J INFECT DIS, V203, P49, DOI 10.1093/infdis/jiq021; Parisi SG, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-150; Pieriangeli A, 2008, AIDS, V22, P1929, DOI 10.1097/QAD.0b013e32830fbd7a; Piketty C, 2008, AIDS, V22, P1203, DOI 10.1097/QAD.0b013e3283023f78; Sadlier C, 2014, HIV MED, V15, P499, DOI 10.1111/hiv.12150; Silverberg MJ, 2012, CLIN INFECT DIS, V54, P1026, DOI 10.1093/cid/cir1012; Vajdic CM, 2009, SEX TRANSM INFECT, V85, P330, DOI 10.1136/sti.2008.034744; Van de Velde N, 2012, JNCI-J NATL CANCER I, V104, P1712, DOI 10.1093/jnci/djs395; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Wilkin T, 2010, J INFECT DIS, V202, P1246, DOI 10.1086/656320; Yang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035983; Zhang DY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096364; Zhang Hailan, 2014, Zhonghua Liu Xing Bing Xue Za Zhi, V35, P421; Zhang XJ, 2013, AIDS BEHAV, V17, P1129, DOI 10.1007/s10461-011-0085-x; Zou HC, 2014, VACCINE, V32, P3936, DOI 10.1016/j.vaccine.2014.05.043	43	9	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125120	10.1371/journal.pone.0125120	http://dx.doi.org/10.1371/journal.pone.0125120			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923768	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600127
J	Lamp, O; Derno, M; Otten, W; Mielenz, M; Nurnberg, G; Kuhla, B				Lamp, Ole; Derno, Michael; Otten, Winfried; Mielenz, Manfred; Nuernberg, Gerd; Kuhla, Bjoern			Metabolic Heat Stress Adaption in Transition Cows: Differences in Macronutrient Oxidation between Late-Gestating and Early-Lactating German Holstein Dairy Cows	PLOS ONE			English	Article							HIGH AMBIENT-TEMPERATURE; FEED-INTAKE; PLASMA 3-METHYLHISTIDINE; TECHNICAL-NOTE; DRY PERIOD; PROTEIN; CATTLE; SUPPLEMENTATION; NUTRIENTS; ADAPTATIONS	High ambient temperatures have severe adverse effects on biological functions of high-yielding dairy cows. The metabolic adaption to heat stress was examined in 14 German Holsteins transition cows assigned to two groups, one heat-stressed (HS) and one pair-fed (PF) at the level of HS. After 6 days of thermoneutrality and ad libitum feeding (P1), cows were challenged for 6 days (P2) by heat stress (temperature humidity index (THI) = 76) or thermoneutral pair-feeding in climatic chambers 3 weeks ante partum and again 3 weeks post-partum. On the sixth day of each period P1 or P2, oxidative metabolism was analyzed for 24 hours in open circuit respiration chambers. Water and feed intake, vital parameters and milk yield were recorded. Daily blood samples were analyzed for glucose, beta-hydroxybutyric acid, non-esterified fatty acids, urea, creatinine, methyl histidine, adrenaline and noradrenaline. In general, heat stress caused marked effects on water homeorhesis with impairments of renal function and a strong adrenergic response accompanied with a prevalence of carbohydrate oxidation over fat catabolism. Heat-stressed cows extensively degraded tissue protein as reflected by the increase of plasma urea, creatinine and methyl histidine concentrations. However, the acute metabolic heat stress response in dry cows differed from early-lactating cows as the prepartal adipose tissue was not refractory to lipolytic, adrenergic stimuli, and the rate of amino acid oxidation was lower than in the postpartal stage. Together with the lower endogenous metabolic heat load, metabolic adaption in dry cows is indicative for a higher heat tolerance and the prioritization of the nutritional requirements of the fast-growing near-term fetus. These findings indicate that the development of future nutritional strategies for attenuating impairments of health and performance due to ambient heat requires the consideration of the physiological stage of dairy cows.	[Lamp, Ole; Derno, Michael; Mielenz, Manfred; Kuhla, Bjoern] Leibniz Inst Farm Anim Biol FBN, Inst Nutr Physiol Oskar Kellner, Dummerstorf, Germany; [Otten, Winfried] Leibniz Inst Farm Anim Biol FBN, Inst Behav Physiol, Dummerstorf, Germany; [Nuernberg, Gerd] Leibniz Inst Farm Anim Biol FBN, Inst Genet & Biometry, Dummerstorf, Germany	Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN)	Kuhla, B (corresponding author), Leibniz Inst Farm Anim Biol FBN, Inst Nutr Physiol Oskar Kellner, Dummerstorf, Germany.	b.kuhla@fbn-dummerstorf.de	Otten, Winfried/V-8376-2019; Mielenz, Manfred/ABB-2293-2021	Otten, Winfried/0000-0002-5613-5356; 	Leibniz Institute for Farm Animal Biology (FBN), Germany	Leibniz Institute for Farm Animal Biology (FBN), Germany	This study was supported by the core budget of the Leibniz Institute for Farm Animal Biology (FBN), Germany.	ALBIN RC, 1966, J ANIM SCI, V25, P107, DOI 10.2527/jas1966.251107x; ALVAREZ MB, 1973, J DAIRY SCI, V56, P189, DOI 10.3168/jds.S0022-0302(73)85145-8; Asai Hideki, 2005, Animal Science Journal, V76, P51, DOI 10.1111/j.1740-0929.2005.00237.x; BAIRD GD, 1972, BIOCHEM J, V128, P1311, DOI 10.1042/bj1281311; Basirico L, 2011, CELL STRESS CHAPERON, V16, P441, DOI 10.1007/s12192-011-0257-7; BAUMAN DE, 1980, J DAIRY SCI, V63, P1514, DOI 10.3168/jds.S0022-0302(80)83111-0; Baumgard LH, 2011, J DAIRY SCI, V94, P5620, DOI 10.3168/jds.2011-4462; Baumgard LH, 2013, ANNU REV ANIM BIOSCI, V1, P311, DOI 10.1146/annurev-animal-031412-103644; Baumgard LH, 2002, J ANIM SCI, V80, P1285; BEEDE DK, 1986, J ANIM SCI, V62, P543, DOI 10.2527/jas1986.622543x; Bernabucci U, 2010, ANIMAL, V4, P1167, DOI 10.1017/S175173111000090X; Bernabucci U, 2002, J DAIRY SCI, V85, P2173, DOI 10.3168/jds.S0022-0302(02)74296-3; BLUMENKRANTZ MJ, 1980, AM J CLIN NUTR, V33, P1567, DOI 10.1093/ajcn/33.7.1567; Blummel M, 1999, J ANIM PHYSIOL AN N, V81, P157, DOI 10.1046/j.1439-0396.1999.813205.x; Brouwer E., 1965, ENERGY METABOLISM FA, V11, P441, DOI DOI 10.1017/S1751731118001489; Chwalibog A, 1996, ARCH ANIM NUTR, V49, P255, DOI 10.1080/17450399609381888; COLLIER RJ, 1982, J DAIRY SCI, V65, P2213, DOI 10.3168/jds.S0022-0302(82)82484-3; Dale H, 1954, MISSOURI AGR EXP STA, P562; Derno M, 2005, J ANIM SCI, V83, P2590; Derno M, 2013, J DAIRY SCI, V96, P971, DOI 10.3168/jds.2012-5727; Derno M, 2009, J DAIRY SCI, V92, P2804, DOI 10.3168/jds.2008-1839; do Amaral BC, 2011, J DAIRY SCI, V94, P86, DOI 10.3168/jds.2009-3004; do Amaral BC, 2009, J DAIRY SCI, V92, P5988, DOI 10.3168/jds.2009-2343; Dunn RJH, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/6/064006; FUQUAY JW, 1981, J ANIM SCI, V52, P164, DOI 10.2527/jas1981.521164x; GfE, 2001, EMPFEHLUNGEN ZUR ENE; Greenwood PL, 2007, ANIMAL, V1, P1283, DOI 10.1017/S175173110700050X; Hahn GL, 1999, J ANIM SCI, V77, P10; IPCC (Intergovernmental Panel on Climate Change), 2007, CONTRIBUTION WORKING, P793; Kamiya M, 2006, ANIM SCI J, V77, P201, DOI 10.1111/j.1740-0929.2006.00338.x; Kamiya M, 2006, ASIAN AUSTRAL J ANIM, V19, P1159, DOI 10.5713/ajas.2006.1159; Khelil-Arfa H, 2014, J DAIRY SCI, V97, P2305, DOI 10.3168/jds.2013-7079; Klaus S, 2005, PHYSIOL GENOMICS, V21, P193, DOI 10.1152/physiolgenomics.00299.2004; Kuhla B, 2010, PROTEOMICS, V10, P2573, DOI 10.1002/pmic.200900789; Ma Y, 2011, PLACENTA, V32, P255, DOI 10.1016/j.placenta.2011.01.007; Marini JC, 2005, J DAIRY SCI, V88, P1778, DOI 10.3168/jds.S0022-0302(05)72852-6; Nardone A, 2010, LIVEST SCI, V130, P57, DOI 10.1016/j.livsci.2010.02.011; NRC, 1971, GUIDE ENV RES ANIMAL; Obitsu T, 2011, ANIM SCI J, V82, P531, DOI 10.1111/j.1740-0929.2011.00880.x; Pere MC, 2003, REPROD NUTR DEV, V43, P1, DOI 10.1051/rnd:2003002; Rhoads ML, 2009, J DAIRY SCI, V92, P1986, DOI 10.3168/jds.2008-1641; Rhoads RP, 2013, J ANIM SCI, V91, P2492, DOI 10.2527/jas.2012-6120; Rungruang S, 2014, J DAIRY SCI, V97, P5023, DOI 10.3168/jds.2013-6970; Sawka MN, 2000, MED SCI SPORT EXER, V32, P332, DOI 10.1097/00005768-200002000-00012; SCHNEIDER PL, 1988, J ANIM SCI, V66, P112, DOI 10.2527/jas1988.661112x; Shwartz G, 2009, J DAIRY SCI, V92, P935, DOI 10.3168/jds.2008-1496; SILANIKOVE N, 1992, LIVEST PROD SCI, V30, P175, DOI 10.1016/S0301-6226(06)80009-6; SILANIKOVE N, 1994, EXP PHYSIOL, V79, P281, DOI 10.1113/expphysiol.1994.sp003764; SIMONSON DC, 1990, AM J PHYSIOL, V258, pE399, DOI 10.1152/ajpendo.1990.258.3.E399; Smith BP, 2014, LARGE ANIMAL INTERNA; St-Pierre NR, 2003, J DAIRY SCI, V86, pE52, DOI 10.3168/jds.S0022-0302(03)74040-5; Tao S, 2013, J DAIRY SCI, V96, P4079, DOI 10.3168/jds.2012-6278; Urdaz JH, 2006, J DAIRY SCI, V89, P2000, DOI 10.3168/jds.S0022-0302(06)72267-6; Walter K, 2010, LANDBAUFORSCHUNG APP, V60; WAYMAN O, 1962, J DAIRY SCI, V45, P1472, DOI 10.3168/jds.S0022-0302(62)89658-1; Weber C, 2013, J DAIRY SCI, V96, P165, DOI 10.3168/jds.2012-5574; West JW, 2003, J DAIRY SCI, V86, P2131, DOI 10.3168/jds.S0022-0302(03)73803-X; Wheelock JB, 2010, J DAIRY SCI, V93, P644, DOI 10.3168/jds.2009-2295; Windisch W, 1995, J ANIM PHYSIOL AN N, V74, P274, DOI 10.1111/j.1439-0396.1995.tb00461.x; Zhang FJ, 2014, J ANIM SCI, V92, P3026, DOI 10.2527/jas.2013-6932; Zimbelman RB, 2010, J DAIRY SCI, V93, P2387, DOI 10.3168/jds.2009-2557	61	50	51	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125264	10.1371/journal.pone.0125264	http://dx.doi.org/10.1371/journal.pone.0125264			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938406	gold, Green Submitted, Green Published			2022-12-27	WOS:000353943000054
J	Sun, HY; Hsueh, PR; Liu, WC; Su, YC; Chang, SY; Hung, CC; Chang, SC				Sun, Hsin-Yun; Hsueh, Po-Ren; Liu, Wen-Chun; Su, Yi-Ching; Chang, Sui-Yuan; Hung, Chien-Ching; Chang, Shan-Chwen			Risk of Active Tuberculosis in HIV-Infected Patients in Taiwan with Free Access to HIV Care and a Positive T-Spot. TB Test	PLOS ONE			English	Article							GAMMA RELEASE ASSAY; INTERFERON-GAMMA; ANTIRETROVIRAL THERAPY; PREDICTIVE-VALUE; DOUBLE-BLIND; DIAGNOSIS; ADULTS; ERA	Background Interferon-gamma release assays (IGRAs) have been used to identify individuals at risk for developing active tuberculosis (TB). However, data regarding the risk of TB development in HIV-infected patients testing positive for IGRAs remain sparse in the era of combination antiretroviral therapy. Methods Between 2011 and 2013, 608 HIV-infected patients without active TB undergoing T-Spot. TB testing were enrolled in this prospective observational study at a university hospital designated for HIV care in Taiwan with a declining TB incidence from 72 per 100,000 population in 2005 to 53 per 100,000 population in 2012. All of the subjects were followed until September 30, 2014. The national TB registry was accessed to identify any TB cases among those lost to follow-up. Results T-Spot. TB tested negative in 534 patients (87.8%), positive in 64 patients (10.5%), and indeterminate in 10 patients (1.6%). In multivariate analysis, positive T-Spot. TB was significantly associated with older age (adjusted odds ratio [AOR], 1.172 per 10-year increase; 95% confidence interval [CI], 1.022-1.344, P=0.023), past history of TB (AOR, 13.412; 95% CI, 6.106-29.460, P<0.001), and higher CD4 counts at enrollment (AOR, per 50-cell/mu l increase, 1.062; 95% CI, 1.017-1.109, P=0.007). Of the 64 patients testing positive for T-Spot. TB, none received isoniazid preventive therapy and all but 5 received combination antiretroviral therapy at the end of follow-up with the latest CD4 count and plasma HIV RNA load being 592.8 cells/mu L and 1.85 log(10) copies/mL, respectively. One patient (1.6%) developed active TB after 167 person-years of follow-up (PYFU), resulting in an incidence rate of 0.599 per 100 PFYU. None of the 534 patients testing negative for T-Spot. TB developed TB after 1380 PYFU, nor did the 24 patients with old TB and positive T-Spot. TB tests develop TB after 62.33 PYFU. Conclusions The risk of developing active TB in HIV-infected patients with positive T-Spot. TB receiving combination antiretroviral therapy is low in Taiwan where the national TB program has led to a sustained decrease in TB incidence.	[Sun, Hsin-Yun; Hsueh, Po-Ren; Liu, Wen-Chun; Su, Yi-Ching; Hung, Chien-Ching; Chang, Shan-Chwen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Sun, Hsin-Yun; Hsueh, Po-Ren; Liu, Wen-Chun; Su, Yi-Ching; Chang, Sui-Yuan; Hung, Chien-Ching; Chang, Shan-Chwen] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Hsueh, Po-Ren; Chang, Sui-Yuan] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei 100, Taiwan; [Chang, Sui-Yuan] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Hung, Chien-Ching] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Hung, Chien-Ching] China Med Univ, Taichung, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Hung, CC (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	hcc0401@ntu.edu.tw	Hsueh, Po-Ren/ABE-1594-2021	HSUEH, PO-REN/0000-0002-7502-9225; Hung, Chien-Ching/0000-0001-7345-0836; CHANG, SHAN-CHWEN/0000-0001-6505-4139; CHANG, SUI-YUAN/0000-0002-6009-6724; SUN, HSIN-YUN/0000-0003-0074-7721	Research Center for Biotechnologyy and Medicine Policy, Taiwan [DOH100-DC-1022]	Research Center for Biotechnologyy and Medicine Policy, Taiwan	This study was supported by grants from the Research Center for Biotechnologyy and Medicine Policy (grant number, DOH100-DC-1022), Taiwan. The funding source had no role in study design and conduct, data collection, analysis, or interpretation, or in the writing of the manuscript or the decision to submit it for publication.	Aichelburg MC, 2009, CLIN INFECT DIS, V48, P954, DOI 10.1086/597351; Cattamanchi A, 2011, JAIDS-J ACQ IMM DEF, V56, P230, DOI 10.1097/QAI.0b013e31820b07ab; Chan PC, 2014, J FORMOS MED ASSOC, V113, P775, DOI 10.1016/j.jfma.2014.03.003; Collins SE, 2015, INT J TUBERC LUNG D, V19, P50, DOI 10.5588/ijtld.14.0217; COMSTOCK GW, 1974, AM J EPIDEMIOL, V99, P131, DOI 10.1093/oxfordjournals.aje.a121593; Converse PJ, 1997, J INFECT DIS, V176, P144, DOI 10.1086/514016; Diel R, 2012, CHEST, V142, P63, DOI 10.1378/chest.11-3157; Golub JE, 2014, CLIN INFECT DIS OFFI; Grinsztejn B, 2014, LANCET INFECT DIS, V14, P281, DOI 10.1016/S1473-3099(13)70692-3; Hall HI, 2013, JAMA INTERN MED, V173, P1337, DOI 10.1001/jamainternmed.2013.6841; Hung CC, 2006, JPN J INFECT DIS, V59, P222; Jonnalagadda S, 2010, J INFECT DIS, V202, P1826, DOI 10.1086/657411; Kim YJ, 2012, AIDS RES HUM RETROV, V28, P838, DOI [10.1089/aid.2011.0360, 10.1089/AID.2011.0360]; Lo YC, 2011, J FORMOS MED ASSOC, V110, P306, DOI 10.1016/S0929-6646(11)60046-6; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Rangaka MX, 2014, LANCET, V384, P682, DOI 10.1016/S0140-6736(14)60162-8; Rangaka MX, 2012, LANCET INFECT DIS, V12, P45, DOI 10.1016/S1473-3099(11)70210-9; ROTHEL JS, 1990, AUST VET J, V67, P134, DOI 10.1111/j.1751-0813.1990.tb07730.x; Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3; Santin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032482; Small PM, 2001, NEW ENGL J MED, V345, P189, DOI 10.1056/NEJM200107193450307; Streeton JA, 1998, INT J TUBERC LUNG D, V2, P443; Suthar AB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001270; Ukwaja KN, 2014, NEW ENGL J MED, V370, P1661, DOI 10.1056/NEJMc1402073; van Asten L, 2003, AIDS, V17, P1201, DOI 10.1097/00002030-200305230-00012; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wu PY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104945; Yang CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073069; Zhang LF, 2010, CHINESE MED J-PEKING, V123, P1117, DOI 10.3760/cma.j.issn.0366-6999.2010.09.003	30	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125260	10.1371/journal.pone.0125260	http://dx.doi.org/10.1371/journal.pone.0125260			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938227	Green Published, Green Submitted, gold			2022-12-27	WOS:000353943000053
J	Thong, VD; Wasitthankasem, R; Tangkijvanich, P; Vongpunsawad, S; Poovorawan, Y				Vo Duy Thong; Wasitthankasem, Rujipat; Tangkijvanich, Pisit; Vongpunsawad, Sompong; Poovorawan, Yong			Prevalence of Thymine-Adenine Dinucleotide Repeat, IL28B and IFNL4 in Thai Population and Correlation with Spontaneous Clearance and Treatment Outcome of Hepatitis C Infection	PLOS ONE			English	Article							GENETIC-VARIATION; PEGINTERFERON ALPHA-2B; TREATMENT RESPONSE; RIBAVIRIN THERAPY; PLUS RIBAVIRIN; INTERFERON; POLYMORPHISMS; LAMBDA; LIVER	Background The interleukin-28B (IL28B) gene polymorphism is a strong baseline predictor of sustained virological response (SVR) in hepatitis C virus (HCV) treatment. The length of thymine-adenine dinucleotide repeats, or (TA)(n), in the regulatory region of IL28B can affect interferon transcription. In order to determine predictive values in HCV infection, we explored the correlation among factors including (TA)(n) genotypes, clinical features, interferon-lambda-3 (IFNL3) and interferon-lambda-4 (IFNL4) polymorphisms, and HCV treatment outcome. Methods Sera from 492 patients with chronic HCV infection, 101 individuals with spontaneous HCV clearance and 123 healthy blood donors (control group) were analyzed. Genotyping of the (TA)(n) was performed by direct sequencing. The rs12979860 (IFNL3) was identified using nested PCR and sequencing, while ss469415590 (IFNL4) was identified by real-time PCR. Results The distribution of (TA)(n) was similar between individuals with spontaneous HCV clearance and chronic HCV infection, but differed significantly from healthy controls. Individuals with both (TA)(n) alleles >= 12 had significantly higher SVR rate compared to individuals with at least one (TA)(n) <12 allele. This strong correlation was seen for patients infected with HCV-1, HCV-3, and HCV-6. The (TA)(n) genotypes were not associated with HCV viral load, ALT levels and liver stiffness, but were correlated with platelet counts (p<0.001). In contrast, rs12979860 (CC) and ss469415590 (TT/TT) genotypes were associated with higher SVR rated only in patients with HCV-1. Conclusions The (TA)(n) genotypes were not associated with spontaneous clearance of HCV infection but associated with treatment response in patients infected with HCV-1, HCV-3 and HCV-6. In contrast, IFNL3 and IFNL4 polymorphisms were predictive of treatment outcome only for patients infected with HCV-1.	[Vo Duy Thong; Wasitthankasem, Rujipat; Vongpunsawad, Sompong; Poovorawan, Yong] Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Bangkok 10330, Thailand; [Tangkijvanich, Pisit] Chulalongkorn Univ, Fac Med, Dept Biochem, Res Unit Hepatitis & Liver Canc, Bangkok 10330, Thailand; [Vo Duy Thong] Univ Med & Pharm, Fac Med, Dept Internal Med, Div Gastroenterol & Hepatol, Ho Chi Minh, Vietnam	Chulalongkorn University; Chulalongkorn University; Hochiminh City University of Medicine & Pharmacy	Poovorawan, Y (corresponding author), Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Bangkok 10330, Thailand.	Yong.P@chula.ac.th	Thong, Vo Duy/E-7951-2015; ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022	vongpunsawad, sompong/0000-0001-7520-8728; Duy Thong, Vo/0000-0002-4151-7861; Poovorawan, Yong/0000-0002-2337-6807	National Research University Project, Office of Higher Education Commission [WCU007-HR-57, WCU001-HR-57]; NSTDA; Chulalongkorn University Centenary Academic Development Project [CU56-HR01]; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University [RES560530093, RES560530155]; Outstanding Professor of the Thailand Research Fund [DPG5480002]; Graduate Scholarship for Neighboring Countries of Chulalongkorn University; SCG; MK Restaurant Company Limited; Ratchadaphiseksomphot Endowment Fund, Chulalongkorn University	National Research University Project, Office of Higher Education Commission; NSTDA; Chulalongkorn University Centenary Academic Development Project; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University(Chulalongkorn University); Outstanding Professor of the Thailand Research Fund; Graduate Scholarship for Neighboring Countries of Chulalongkorn University; SCG; MK Restaurant Company Limited; Ratchadaphiseksomphot Endowment Fund, Chulalongkorn University(Chulalongkorn University)	This work was supported by grants WCU007-HR-57 and WCU001-HR-57 from the National Research University Project, Office of Higher Education Commission, the Research Chair Grant from NSTDA, CU56-HR01 from Chulalongkorn University Centenary Academic Development Project, RES560530093 and RES560530155 from the Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University, DPG5480002 from the Outstanding Professor of the Thailand Research Fund, The Graduate Scholarship for Neighboring Countries of Chulalongkorn University, SCG and MK Restaurant Company Limited. This research was also supported by Ratchadaphiseksomphot Endowment Fund for a postdoctoral fellowship, Chulalongkorn University, to Rujipat Wasitthankasem. The authors also received funding from SCG and MK Restaurant Company Limited. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkarathamrongsin S, 2014, J MED VIROL, V86, P1482, DOI 10.1002/jmv.23957; Akkarathamrongsin S, 2010, HEPATOL RES, V40, P956, DOI 10.1111/j.1872-034X.2010.00702.x; Akkarathamrongsin S, 2010, J MED VIROL, V82, P257, DOI 10.1002/jmv.21680; Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Ank N, 2008, J IMMUNOL, V180, P2474, DOI 10.4049/jimmunol.180.4.2474; Antaki N, 2012, GUT, V61, P1640, DOI 10.1136/gutjnl-2012-302019; Aoki Y, 2014, J GASTROENTEROLOGY; Asselah T, 2012, J HEPATOL, V56, P527, DOI 10.1016/j.jhep.2011.09.008; Berg CL, 2009, AM J TRANSPLANT, V9, P907, DOI 10.1111/j.1600-6143.2009.02567.x; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Fukuhara T, 2010, GASTROENTEROLOGY, V139, P1577, DOI 10.1053/j.gastro.2010.07.058; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hiramine S, 2015, J GASTROENTEROLOGY; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Langhans B, 2011, J HEPATOL, V54, P859, DOI 10.1016/j.jhep.2010.08.020; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Matsuura K, 2014, J GASTROEN HEPATOL, V29, P241, DOI 10.1111/jgh.12475; MCHUTCHISON JG, 2009, NEW ENGL J MED, V361, P580, DOI DOI 10.1056/NEJM0A0808010; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Seto WK, 2013, J VIRAL HEPATITIS, V20, P470, DOI 10.1111/jvh.12047; Sugiyama M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026620; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463	27	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125400	10.1371/journal.pone.0125400	http://dx.doi.org/10.1371/journal.pone.0125400			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938236	Green Published, Green Submitted, gold			2022-12-27	WOS:000353943000063
J	Foumani, M; Vuong, TV; MacCormick, B; Master, ER				Foumani, Maryam; Vuong, Thu V.; MacCormick, Benjamin; Master, Emma R.			Enhanced Polysaccharide Binding and Activity on Linear beta-Glucans through Addition of Carbohydrate-Binding Modules to Either Terminus of a Glucooligosaccharide Oxidase	PLOS ONE			English	Article							OLIGOSACCHARIDE OXIDASE; TRICHODERMA-REESEI; SUBSTRATE-SPECIFICITY; ACREMONIUM-STRICTUM; CATALYTIC-ACTIVITY; DOMAINS; THERMOSTABILITY; DETERMINANTS; CONSTRUCTION; HYDROLYSIS	The gluco-oligosaccharide oxidase from Sarocladium strictum CBS 346.70 (GOOX) is a single domain flavoenzyme that favourably oxidizes gluco- and xylo-oligosaccharides. In the present study, GOOX was shown to also oxidize plant polysaccharides, including cellulose, glucomannan, beta-(1 -> 3,1 -> 4)-glucan, and xyloglucan, albeit to a lesser extent than oligomeric substrates. To improve GOOX activity on polymeric substrates, three carbohydrate binding modules (CBMs) from Clostridium thermocellum, namely CtCBM3 (type A), CtCBM11 (type B), and CtCBM44 (type B), were separately appended to the amino and carboxy termini of the enzyme, generating six fusion proteins. With the exception of GOOX-CtCBM3 and GOOX-CtCBM44, fusion of the selected CBMs increased the catalytic activity of the enzyme (kcat) on cellotetraose by up to 50%. All CBM fusions selectively enhanced GOOX binding to soluble and insoluble polysaccharides, and the immobilized enzyme on a solid cellulose surface remained stable and active. In addition, the CBM fusions increased the activity of GOOX on soluble glucomannan by up to 30% and on insoluble crystalline as well as amorphous cellulose by over 50 %.	[Foumani, Maryam; Vuong, Thu V.; MacCormick, Benjamin; Master, Emma R.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E5, Canada	University of Toronto	Master, ER (corresponding author), Univ Toronto, Dept Chem Engn & Appl Chem, 200 Coll St, Toronto, ON M5S 3E5, Canada.	emma.master@utoronto.ca	Master, Emma/O-3554-2014		Government of Ontario for the project "Forest FAB: Applied Genomics for Functionalized Fibre and Biochemicals" [ORF-RE-05-005]; Natural Sciences and Engineering Research Council of Canada through the "NSERC Bioconversion Network"	Government of Ontario for the project "Forest FAB: Applied Genomics for Functionalized Fibre and Biochemicals"; Natural Sciences and Engineering Research Council of Canada through the "NSERC Bioconversion Network"(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this research was provided by the Government of Ontario for the project "Forest FAB: Applied Genomics for Functionalized Fibre and Biochemicals" (ORF-RE-05-005), and by the Natural Sciences and Engineering Research Council of Canada through the "NSERC Bioconversion Network". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Carvalho AL, 2004, J BIOL CHEM, V279, P34785, DOI 10.1074/jbc.M405867200; Charnock SJ, 2000, BIOCHEMISTRY-US, V39, P5013, DOI 10.1021/bi992821q; Cumpstey Ian, 2013, ISRN Org Chem, V2013, P417672, DOI 10.1155/2013/417672; Dias FMV, 2004, FEMS MICROBIOL LETT, V238, P71, DOI 10.1016/j.femsle.2004.07.019; Fan ZL, 2000, BIOTECHNOL BIOENG, V68, P231, DOI 10.1002/(SICI)1097-0290(20000420)68:2<231::AID-BIT12>3.3.CO;2-4; Foumani M., 2012, Glucooligosaccharide oxidases from Acremonium strictum and uses thereof, Patent No. [WO 2012/116431, 2012116431, WO/2012/116431]; Foumani M, 2011, BIOTECHNOL BIOENG, V108, P2261, DOI 10.1002/bit.23149; Freelove ACJ, 2001, J BIOL CHEM, V276, P43010, DOI 10.1074/jbc.M107143200; Furtado GP, 2015, APPL MICROBIOL BIOT, V99, P5095, DOI 10.1007/s00253-014-6324-0; Giffhorn F, 2000, APPL MICROBIOL BIOT, V54, P727, DOI 10.1007/s002530000446; Gilbert HJ, 2013, CURR OPIN STRUC BIOL, V23, P669, DOI 10.1016/j.sbi.2013.05.005; Hagglund P, 2003, J BIOTECHNOL, V101, P37, DOI 10.1016/S0168-1656(02)00290-0; He J, 2009, NEW BIOTECHNOL, V26, P53, DOI 10.1016/j.nbt.2009.04.002; Henriksson G, 2000, J BIOTECHNOL, V78, P93, DOI 10.1016/S0168-1656(00)00206-6; Heuts DPHM, 2007, FEBS LETT, V581, P4905, DOI 10.1016/j.febslet.2007.09.019; Huang CH, 2005, J BIOL CHEM, V280, P38831, DOI 10.1074/jbc.M506078200; Kataeva IA, 2001, PROTEIN ENG, V14, P167, DOI 10.1093/protein/14.3.167; Koseki T, 2010, APPL MICROBIOL BIOT, V86, P155, DOI 10.1007/s00253-009-2224-0; Kurokawa T, 2002, J CHEM ENG JPN, V35, P1277, DOI 10.1252/jcej.35.1277; Le Costaouec T, 2013, BIORESOURCE TECHNOL, V143, P196, DOI 10.1016/j.biortech.2013.05.079; Lee MH, 2005, APPL ENVIRON MICROB, V71, P8881, DOI 10.1128/AEM.71.12.8881-8887.2005; Lehtio J, 2003, P NATL ACAD SCI USA, V100, P484, DOI 10.1073/pnas.212651999; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; LIN SF, 1991, BIOCHIM BIOPHYS ACTA, V1118, P41, DOI 10.1016/0167-4838(91)90439-7; LIN SF, 1993, BIOTECHNOL ADV, V11, P417, DOI 10.1016/0734-9750(93)90011-B; Mamo G, 2007, EXTREMOPHILES, V11, P169, DOI 10.1007/s00792-006-0023-4; Mangala SL, 2003, J MOL CATAL B-ENZYM, V21, P221, DOI 10.1016/S1381-1177(02)00226-6; Meng DD, 2015, APPL ENVIRON MICROB, V81, P2006, DOI 10.1128/AEM.03677-14; Najmudin S, 2006, J BIOL CHEM, V281, P8815, DOI 10.1074/jbc.M510559200; Palonen H, 2004, J BIOTECHNOL, V107, P65, DOI 10.1016/j.jbiotec.2003.09.011; Parikka K, 2010, J AGR FOOD CHEM, V58, P262, DOI 10.1021/jf902930t; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shi XZ, 2003, PROTEIN EXPRES PURIF, V28, P321, DOI 10.1016/S1046-5928(02)00706-4; Telke AA, 2012, BIORESOURCE TECHNOL, V112, P10, DOI 10.1016/j.biortech.2012.02.066; Varela O, 2003, ADV CARBOHYD CHEM BI, V58, P307, DOI 10.1016/S0065-2318(03)58006-4; Varnai A, 2014, ADV APPL MICROBIOL, V88, P103, DOI 10.1016/B978-0-12-800260-5.00004-8; Varnai A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-30; Viegas A, 2008, FEBS J, V275, P2524, DOI 10.1111/j.1742-4658.2008.06401.x; Voutilainen SP, 2014, APPL MICROBIOL BIOT, V98, P2991, DOI 10.1007/s00253-013-5177-2; Vuong TV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095170; Vuong TV, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-148; Whittaker JW, 2005, ARCH BIOCHEM BIOPHYS, V433, P227, DOI 10.1016/j.abb.2004.08.034; Xu F, 2001, EUR J BIOCHEM, V268, P1136, DOI 10.1046/j.1432-1327.2001.01982.x; Yaniv O, 2011, ACTA CRYSTALLOGR D, V67, P506, DOI 10.1107/S0907444911011322; Ye XH, 2011, APPL MICROBIOL BIOT, V92, P551, DOI 10.1007/s00253-011-3346-8; Zhang YHP, 2006, BIOMACROMOLECULES, V7, P644, DOI 10.1021/bm050799c; Zou G, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-21	48	12	12	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125398	10.1371/journal.pone.0125398	http://dx.doi.org/10.1371/journal.pone.0125398			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932926	Green Published, Green Submitted, gold			2022-12-27	WOS:000353887100107
J	Gits-Muselli, M; Peraldi, MN; de Castro, N; Delcey, V; Menotti, J; Guigue, N; Hamane, S; Raffoux, E; Bergeron, A; Valade, S; Molina, JM; Bretagne, S; Alanio, A				Gits-Muselli, Maud; Peraldi, Marie-Noelle; de Castro, Nathalie; Delcey, Veronique; Menotti, Jean; Guigue, Nicolas; Hamane, Samia; Raffoux, Emmanuel; Bergeron, Anne; Valade, Sandrine; Molina, Jean-Michel; Bretagne, Stephane; Alanio, Alexandre			New Short Tandem Repeat-Based Molecular Typing Method for Pneumocystis jirovecii Reveals Intrahospital Transmission between Patients from Different Wards	PLOS ONE			English	Article							RENAL-TRANSPLANT RECIPIENTS; HIV-INFECTED PATIENTS; F-SP HOMINIS; ASPERGILLUS-FUMIGATUS; CARINII-PNEUMONIA; CANDIDA-ALBICANS; INTERHUMAN TRANSMISSION; MICROSATELLITE MARKERS; PCR-SSCP; OUTBREAK	Pneumocystis pneumonia is a severe opportunistic infection in immunocompromised patients caused by the unusual fungus Pneumocystis jirovecii. Transmission is airborne, with both immunocompromised and immunocompetent individuals acting as a reservoir for the fungus. Numerous reports of outbreaks in renal transplant units demonstrate the need for valid genotyping methods to detect transmission of a given genotype. Here, we developed a short tandem repeat (STR)-based molecular typing method for P. jirovecii. We analyzed the P. jirovecii genome and selected six genomic STR markers located on different contigs of the genome. We then tested these markers in 106 P. jirovecii PCR-positive respiratory samples collected between October 2010 and November 2013 from 91 patients with various underlying medical conditions. Unique (one allele per marker) and multiple (more than one allele per marker) genotypes were observed in 34 (32%) and 72 (68%) samples, respectively. A genotype could be assigned to 55 samples (54 patients) and 61 different genotypes were identified in total with a discriminatory power of 0.992. Analysis of the allelic distribution of the six markers and minimum spanning tree analysis of the 61 genotypes identified a specific genotype (Gt21) in our hospital, which may have been transmitted between 10 patients including six renal transplant recipients. Our STR-based molecular typing method is a quick, cheap and reliable approach to genotype Pneumocystis jirovecii in hospital settings and is sensitive enough to detect minor genotypes, thus enabling the study of the transmission and pathophysiology of Pneumocystis pneumonia.	[Gits-Muselli, Maud; Menotti, Jean; Guigue, Nicolas; Hamane, Samia; Bretagne, Stephane; Alanio, Alexandre] Grp Hosp St Louis Lariboisiere Femand Widal, AP HP, Lab Parasitol Mycol, Paris, France; [Peraldi, Marie-Noelle] Grp Hosp St Louis Lariboisiere Femand Widal, AP HP, Serv Transplantat Renale, Paris, France; [Peraldi, Marie-Noelle; Menotti, Jean; Guigue, Nicolas; Bergeron, Anne; Molina, Jean-Michel; Bretagne, Stephane; Alanio, Alexandre] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [de Castro, Nathalie; Molina, Jean-Michel] Grp Hosp St Louis Lariboisiere Femand Widal, AP HP, Serv Malad Infect & Trop, Paris, France; [Delcey, Veronique] Grp Hosp St Louis Lariboisiere Femand Widal, AP HP, Serv Med Interne, Paris, France; [Menotti, Jean; Bretagne, Stephane; Alanio, Alexandre] Ctr Natl Reference Mycoses Invas & Antifong, Inst Pasteur, Unite Mycol Mol, Paris, France; [Menotti, Jean; Bretagne, Stephane; Alanio, Alexandre] CNRS, URA3012, Paris, France; [Raffoux, Emmanuel] Grp Hosp St Louis Lariboisiere Femand Widal, AP HP, Serv Hematol Adulte, Paris, France; [Bergeron, Anne] Grp Hosp St Louis Lariboisiere Femand Widal, AP HP, Serv Pneumol, Paris, France; [Valade, Sandrine] Grp Hosp St Louis Lariboisiere Femand Widal, AP HP, Serv Reanimat, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Alanio, A (corresponding author), Grp Hosp St Louis Lariboisiere Femand Widal, AP HP, Lab Parasitol Mycol, Paris, France.	alexandre.alanio@aphp.fr	BRETAGNE, Stephane/H-6655-2019; BRETAGNE, Stephane/GLT-8879-2022; Menotti, Jean/AFV-1886-2022; De Castro, Nathalie/AFQ-4610-2022; Alanio, Alexandre/N-8472-2016	BRETAGNE, Stephane/0000-0001-6870-3800; Alanio, Alexandre/0000-0001-9726-3082; Menotti, Jean/0000-0001-5703-8403; GITS-MUSELLI, Maud/0000-0002-0470-6866; Bergeron, Anne/0000-0003-2156-254X				Alanio A, 2011, CLIN MICROBIOL INFEC, V17, P1531, DOI 10.1111/j.1469-0691.2010.03400.x; Angulo B, 2010, J MOL DIAGN, V12, P292, DOI 10.2353/jmoldx.2010.090139; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Botterel F, 2001, J CLIN MICROBIOL, V39, P4076, DOI 10.1128/JCM.39.11.4076-4081.2001; Catherinot E, 2010, INFECT DIS CLIN N AM, V24, P107, DOI 10.1016/j.idc.2009.10.010; Chabe M, 2004, EUR J CLIN MICROBIOL, V23, P89, DOI 10.1007/s10096-003-1092-2; Choukri F, 2010, CLIN INFECT DIS, V51, P259, DOI 10.1086/653933; Cisse OH, 2013, MBIO, V4, DOI 10.1128/mBio.00428-12; Cushion MT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001009; Davidson S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-614; de Boer MGJ, 2007, CLIN INFECT DIS, V44, P1143, DOI 10.1086/513198; De Castro N, 2005, BONE MARROW TRANSPL, V36, P879, DOI 10.1038/sj.bmt.1705149; De Castro N, 2012, REV MAL RESPIR, V29, P793, DOI 10.1016/j.rmr.2011.10.975; De Castro N, 2010, CLIN MICROBIOL INFEC, V16, P1375, DOI [10.1111/j.1469-0691.2009.03143.x, 10.1111/j.1469-0691.2010.03143.x]; de Valk HA, 2009, CLIN MICROBIOL INFEC, V15, P180, DOI 10.1111/j.1469-0691.2008.02656.x; de Valk HA, 2005, J CLIN MICROBIOL, V43, P4112, DOI 10.1128/JCM.43.8.4112-4120.2005; de Valk HA, 2007, J MICROBIOL METH, V69, P268, DOI 10.1016/j.mimet.2007.01.009; Enache-Angoulvant A, 2010, J CLIN MICROBIOL, V48, P4028, DOI 10.1128/JCM.02140-09; Esteves F, 2011, J CLIN MICROBIOL, V49, P1810, DOI 10.1128/JCM.02303-10; Esteves F, 2010, INFECT GENET EVOL, V10, P192, DOI 10.1016/j.meegid.2009.12.007; Feil EJ, 2004, NAT REV MICROBIOL, V2, P483, DOI 10.1038/nrmicro904; Garcia-Hermoso D, 1999, J CLIN MICROBIOL, V37, P3204, DOI 10.1128/JCM.37.10.3204-3209.1999; Garcia-Hermoso D, 2007, J CLIN MICROBIOL, V45, P3958, DOI 10.1128/JCM.01261-07; Garcia-Hermoso D, 2010, J CLIN MICROBIOL, V48, P2578, DOI 10.1128/JCM.00040-10; Gianella S, 2010, TRANSPL INFECT DIS, V12, P1, DOI 10.1111/j.1399-3062.2009.00447.x; Gigliotti F, 2003, INFECT IMMUN, V71, P3852, DOI 10.1128/IAI.71.7.3852-3856.2003; Gigliotti F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003025; Hauser P, 2009, EMERG INFECT DIS, V15, P506, DOI 10.3201/eid1503.081350; Hauser PM, 2004, INFECT GENET EVOL, V4, P199, DOI 10.1016/j.meegid.2004.01.011; Hauser PM, 1997, J CLIN MICROBIOL, V35, P3086, DOI 10.1128/JCM.35.12.3086-3091.1997; Hauser PM, 1996, J EUKARYOT MICROBIOL, V43, pS34, DOI 10.1111/j.1550-7408.1996.tb04970.x; Hauser PM, 2001, AIDS, V15, P461, DOI 10.1097/00002030-200103090-00004; Helweg-Larsen J, 2001, J CLIN MICROBIOL, V39, P3789, DOI 10.1128/JCM.39.10.3789-3792.2001; Hocker B, 2005, EMERG INFECT DIS, V11, P330; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Illnait-Zaragozi MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009124; Le Gal S, 2012, CLIN INFECT DIS, V54, pE62, DOI 10.1093/cid/cir996; Maitte C, 2013, J CLIN MICROBIOL, V51, P2843, DOI 10.1128/JCM.01073-13; Mori S, 2012, RHEUMATOLOGY, V51, P2120, DOI 10.1093/rheumatology/kes244; Nahimana A, 2000, J MED MICROBIOL, V49, P753, DOI 10.1099/0022-1317-49-8-753; Olsson M, 2001, SCAND J INFECT DIS, V33, P285, DOI 10.1080/003655401300077324; Pagano L, 2002, BRIT J HAEMATOL, V117, P379, DOI 10.1046/j.1365-2141.2002.03419.x; Parobek CM, 2014, J CLIN MICROBIOL, V52, P1391, DOI 10.1128/JCM.02531-13; Phipps LM, 2011, TRANSPLANTATION, V92, P1327, DOI 10.1097/TP.0b013e3182384b57; Pliquett RU, 2012, EUR J CLIN MICROBIOL, V31, P2429, DOI 10.1007/s10096-012-1586-x; Rabodonirina L, 2004, EMERG INFECT DIS, V10, P1766; Reid AB, 2011, CURR OPIN INFECT DIS, V24, P534, DOI 10.1097/QCO.0b013e32834cac17; Roblot F, 2003, J INFECTION, V47, P19, DOI 10.1016/S0163-4453(03)00038-0; Schildgen V, 2014, MBIO, V5, DOI 10.1128/mBio.01186-14; Tasaka S, 2012, J INFECT CHEMOTHER, V18, P793, DOI 10.1007/s10156-012-0453-0; Vargas SL, 2001, CLIN INFECT DIS, V32, P855, DOI 10.1086/319340; Wissmann G, 2011, EUR J CLIN INVEST, V41, P343, DOI 10.1111/j.1365-2362.2010.02415.x; Yazaki H, 2009, TRANSPLANTATION, V88, P380, DOI 10.1097/TP.0b013e3181aed389	53	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125763	10.1371/journal.pone.0125763	http://dx.doi.org/10.1371/journal.pone.0125763			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933203	Green Published, Green Submitted, gold			2022-12-27	WOS:000353887100131
J	Jaiswal, AS; Panda, H; Law, BK; Sharma, J; Jani, J; Hromas, R; Narayan, S				Jaiswal, Aruna S.; Panda, Harekrushna; Law, Brian K.; Sharma, Jay; Jani, Jitesh; Hromas, Robert; Narayan, Satya			NSC666715 and Its Analogs Inhibit Strand-Displacement Activity of DNA Polymerase beta and Potentiate Temozolomide-Induced DNA Damage, Senescence and Apoptosis in Colorectal Cancer Cells	PLOS ONE			English	Article							BASE EXCISION-REPAIR; ADENOMATOUS POLYPOSIS-COLI; LONG-PATCH; CELLULAR SENESCENCE; MISMATCH REPAIR; POLY(ADP-RIBOSE) POLYMERASE-1; ALKYLATING-AGENTS; GROWTH ARREST; GLIOMA-CELLS; G(2) ARREST	Recently approved chemotherapeutic agents to treat colorectal cancer (CRC) have made some impact; however, there is an urgent need for newer targeted agents and strategies to circumvent CRC growth and metastasis. CRC frequently exhibits natural resistance to chemotherapy and those who do respond initially later acquire drug resistance. A mechanism to potentially sensitize CRC cells is by blocking the DNA polymerase beta (Pol-beta) activity. Temozolomide (TMZ), an alkylating agent, and other DNA-interacting agents exert DNA damage primarily repaired by a Pol-beta-directed base excision repair (BER) pathway. In previous studies, we used structure-based molecular docking of Pol-beta and identified a potent small molecule inhibitor (NSC666715). In the present study, we have determined the mechanism by which NSC666715 and its analogs block Fen1-induced strand-displacement activity of Pol-beta-directed LP-BER, cause apurinic/apyrimidinic (AP) site accumulation and induce S-phase cell cycle arrest. Induction of S-phase cell cycle arrest leads to senescence and apoptosis of CRC cells through the p53/p21 pathway. Our initial findings also show a 10-fold reduction of the IC50 of TMZ when combined with NSC666715. These results provide a guide for the development of a target-defined strategy for CRC chemotherapy that will be based on the mechanisms of action of NSC666715 and TMZ. This combination strategy can be used as a framework to further reduce the TMZ dosages and resistance in CRC patients.	[Jaiswal, Aruna S.; Hromas, Robert] Univ Florida, Dept Med, Div Hematol & Oncol, Gainesville, FL 32610 USA; [Panda, Harekrushna; Narayan, Satya] Univ Florida, Dept Anat & Cell Biol, Gainesville, FL 32610 USA; [Law, Brian K.] Univ Florida, Dept Pharmacol & Expt Therapeut, Gainesville, FL 32610 USA; [Sharma, Jay; Jani, Jitesh] Celprogen Inc, Torrance, CA 90503 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Narayan, S (corresponding author), Univ Florida, Dept Anat & Cell Biol, Gainesville, FL 32610 USA.	snarayan@ufl.edu	Law, Brian/L-6043-2019		National Institutes of Health (NIH) [R01-CA097031]; Celprogen Inc.; NATIONAL CANCER INSTITUTE [R01CA097031] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Celprogen Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The financial support for these studies was provided by the National Institutes of Health (NIH) grant R01-CA097031. Celprogen Inc. provided support in the form of salaries for authors Jay Sharma and Jitesh Jani, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Balusu R, 2007, BIOCHEMISTRY-US, V46, P13961, DOI 10.1021/bi701632e; BRANCH P, 1993, NATURE, V362, P652, DOI 10.1038/362652a0; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cohen MH, 2005, CLIN CANCER RES, V11, P6767, DOI 10.1158/1078-0432.CCR-05-0722; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Das A, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-36; DENNY BJ, 1994, BIOCHEMISTRY-US, V33, P9045, DOI 10.1021/bi00197a003; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Fishel ML, 2007, CLIN CANCER RES, V13, P260, DOI 10.1158/1078-0432.CCR-06-1920; Fu D, 2012, NAT REV CANCER, V12, P104, DOI 10.1038/nrc3185; Gewirtz DA, 2008, BIOCHEM PHARMACOL, V76, P947, DOI 10.1016/j.bcp.2008.06.024; Gunther W, 2003, BRIT J CANCER, V88, P463, DOI 10.1038/sj.bjc.6600711; Gupte M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074071; Hayashi T, 2013, J NEURO-ONCOL, V115, P169, DOI 10.1007/s11060-013-1220-5; Hirose Y, 2005, CANCER RES, V65, P4861, DOI 10.1158/0008-5472.CAN-04-2633; Itahana Koji, 2013, Methods Mol Biol, V965, P143, DOI 10.1007/978-1-62703-239-1_8; Jaiswal AS, 2006, BIOCHEMISTRY-US, V45, P15903, DOI 10.1021/bi0607958; Jaiswal AS, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-3; Jaiswal AS, 2013, NEOPLASIA, V15, P454, DOI 10.1593/neo.13176; Jaiswal AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016691; Jaiswal AS, 2009, MOL CANCER RES, V7, P1973, DOI 10.1158/1541-7786.MCR-09-0309; Jaiswal AS, 2002, ONCOGENE, V21, P8414, DOI 10.1038/sj.onc.1205947; Jekimovs C, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00086; Kaina B, 2002, INT J CLIN PHARM TH, V40, P354; Kaina B, 2007, DNA REPAIR, V6, P1079, DOI 10.1016/j.dnarep.2007.03.008; KARRAN P, 1994, BIOESSAYS, V16, P833, DOI 10.1002/bies.950161110; Kawate H, 1998, P NATL ACAD SCI USA, V95, P5116, DOI 10.1073/pnas.95.9.5116; Khan OA, 2008, BRIT J CANCER, V98, P1614, DOI 10.1038/sj.bjc.6604366; Knizhnik AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055665; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Kumar M, ACTA BIOMED, V83, P220; Liu L, 1999, CLIN CANCER RES, V5, P2908; Liu Lili, 2004, Curr Opin Investig Drugs, V5, P623; Liu LL, 1996, CANCER RES, V56, P5375; Longley DB, 2006, BBA-REV CANCER, V1766, P184, DOI 10.1016/j.bbcan.2006.08.001; Ma WJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002059; Marin JJG, 2012, DRUG METAB REV, V44, P148, DOI 10.3109/03602532.2011.638303; Martinkova E, 2010, INT J CANCER, V127, P1240, DOI 10.1002/ijc.25187; McWhirter D, 2013, CRIT REV ONCOL HEMAT, V88, P404, DOI 10.1016/j.critrevonc.2013.05.011; Muller M, 2009, ANTIOXID REDOX SIGN, V11, P59, DOI 10.1089/ars.2008.2104; Nakamura J, 1998, CANCER RES, V58, P222; Narayan S, 2005, J BIOL CHEM, V280, P6942, DOI 10.1074/jbc.M409200200; Narayan S, 2001, BRIT J CANCER, V85, P898, DOI 10.1054/bjoc.2001.2002; O'Connell MJ, 2000, TRENDS CELL BIOL, V10, P296, DOI 10.1016/S0962-8924(00)01773-6; Prasad R, 2001, J BIOL CHEM, V276, P32411, DOI 10.1074/jbc.C100292200; Prasad R, 2000, J BIOL CHEM, V275, P4460, DOI 10.1074/jbc.275.6.4460; Savonarola A, 2012, PHARMACOGENOMICS J, V12, P277, DOI 10.1038/tpj.2012.28; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Schmitt CA, 2003, NAT REV CANCER, V3, P286, DOI 10.1038/nrc1044; Sevrioukova IF, 2011, ANTIOXID REDOX SIGN, V14, P2545, DOI 10.1089/ars.2010.3445; Spiro TP, 2001, CLIN CANCER RES, V7, P2309; Sur S, 2009, P NATL ACAD SCI USA, V106, P3964, DOI 10.1073/pnas.0813333106; Tentori L, 1998, J PHARMACOL EXP THER, V285, P884; Trivedi RN, 2005, CANCER RES, V65, P6394, DOI 10.1158/0008-5472.CAN-05-0715; TSANG LLH, 1991, CANCER CHEMOTH PHARM, V27, P342, DOI 10.1007/BF00688855; Venturelli S, 2013, MOL CANCER THER, V12, P2226, DOI 10.1158/1535-7163.MCT-13-0137; Veuger SJ, 2004, ONCOGENE, V23, P7322, DOI 10.1038/sj.onc.1207984; von Zglinicki T, 2005, MECH AGEING DEV, V126, P111, DOI 10.1016/j.mad.2004.09.034; Weizman N, 2003, J BIOL CHEM, V278, P6741, DOI 10.1074/jbc.M211168200	61	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0123808	10.1371/journal.pone.0123808	http://dx.doi.org/10.1371/journal.pone.0123808			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933036	Green Submitted, Green Published, gold			2022-12-27	WOS:000353887100024
J	Motl, RW; Putzki, N; Pilutti, LA; Cadavid, D				Motl, Robert W.; Putzki, Norman; Pilutti, Lara A.; Cadavid, Diego			Longitudinal Changes in Self-Reported Walking Ability in Multiple Sclerosis	PLOS ONE			English	Article							TIMED 25-FOOT WALK; IMPACT SCALE MSIS-29; FUNCTIONAL COMPOSITE; CLINICALLY MEANINGFUL; DISEASE PROGRESSION; CONTROLLED-TRIAL; OUTCOME MEASURE; MS; VALIDITY; PERFORMANCE	Background Patient-reported outcomes are increasingly used to understand the clinical meaningfulness of multiple sclerosis disability and its treatments. For example, the 12-item Multiple Sclerosis Walking Scale (MSWS-12) measures the patient-reported impact of the disease on walking ability. Objective We studied longitudinal changes in walking ability using the MSWS-12 in a cohort of 108 patients with relapsing-remitting multiple sclerosis and moderate-to-severe disability from a single US center cohort study investigating multiple sclerosis symptoms and physical activity. Methods The MSWS-12 was completed every 6 months over 2 years together with self-reported measures of disease impact on daily life (Multiple Sclerosis Impact Scale) and walking disability (Patient Determined Disease Steps scale). Results The results revealed a high frequency of self-reported changes in walking ability at the individual level, affecting approximately 80% of patients for all four time periods. MSWS-12 scores remained stable at the group level for all four time periods. The magnitude of observed changes at the individual level was higher than the proposed minimal clinically important differences of 4 or 6 points and correlated better with Multiple Sclerosis Impact Scale physical scores than psychological scores, but little with self-reported Patient Determined Disease Steps Scale scores. Conclusions This novel finding of frequent fluctuations in self-reported walking ability is new and requires further investigation.	[Motl, Robert W.; Pilutti, Lara A.] Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL USA; [Putzki, Norman; Cadavid, Diego] Biogen, Clin Dev Grp, Cambridge, MA 02142 USA	University of Illinois System; University of Illinois Urbana-Champaign; Biogen	Cadavid, D (corresponding author), Biogen, Clin Dev Grp, Cambridge, MA 02142 USA.	diego.cadavid@biogen.com			Biogen; National Multiple Sclerosis Society [RG 3926A2/1]	Biogen(Biogen); National Multiple Sclerosis Society(National Multiple Sclerosis Society)	This study was funded by Biogen and by a grant from the National Multiple Sclerosis Society (RG 3926A2/1). Biogen also provided support in the form of salaries for authors (NP, DC) and funding for editorial assistance, and they reviewed an early draft of the manuscript, but the funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Benedict RHB, 2006, J NEUROL SCI, V245, P67, DOI 10.1016/j.jns.2005.05.020; Bosma LVAE, 2010, MULT SCLER J, V16, P862, DOI 10.1177/1352458510370464; Cadavid D, 2009, NEUROLOGY, V72, P1976, DOI 10.1212/01.wnl.0000345970.73354.17; Cadavid D, 2011, MULT SCLER J, V17, P1113, DOI 10.1177/1352458511405375; Cadavid D, 2010, REV NEUROLOGIA, V51, P321, DOI 10.33588/rn.5106.2010390; Coleman CI, 2012, CURR MED RES OPIN, V28, P49, DOI 10.1185/03007995.2011.639752; Cutter GR, 1999, BRAIN, V122, P871, DOI 10.1093/brain/122.5.871; Fischer JS, 1999, MULT SCLER J, V5, P244, DOI 10.1177/135245859900500409; Goldman MD, 2013, NEUROLOGY, V81, P1856, DOI 10.1212/01.wnl.0000436065.97642.d2; Goodman AD, 2009, LANCET, V373, P732, DOI 10.1016/S0140-6736(09)60442-6; Hobart J, 2000, BRAIN, V123, P1027, DOI 10.1093/brain/123.5.1027; Hobart J, 2001, BRAIN, V124, P962, DOI 10.1093/brain/124.5.962; Hobart JC, 2005, J NEUROL NEUROSUR PS, V76, P1539, DOI 10.1136/jnnp.2005.064584; Hobart JC, 2003, NEUROLOGY, V60, P31, DOI 10.1212/WNL.60.1.31; Hobart J, 2013, NEUROLOGY, V80, P1509, DOI 10.1212/WNL.0b013e31828cf7f3; HOHOL MJ, 1995, NEUROLOGY, V45, P251, DOI 10.1212/WNL.45.2.251; Holland A, 2006, J NEUROL, V253, P1594, DOI 10.1007/s00415-006-0272-2; Kragt JJ, 2006, MULT SCLER J, V12, P594, DOI 10.1177/1352458506070768; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; LaRocca NG, 2011, PATIENT, V4, P189, DOI 10.2165/11591150-000000000-00000; Learmonth YC, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-37; Lincoln JA, 2009, ARCH NEUROL-CHICAGO, V66, P412, DOI 10.1001/archneurol.2009.26; Liu C, 2000, J NEUROL NEUROSUR PS, V68, P450, DOI 10.1136/jnnp.68.4.450; Meier DS, 2010, NEUROLOGY, V75, P799, DOI 10.1212/WNL.0b013e3181f0734c; Motl RW, 2014, EUR NEUROL, V71, P196, DOI 10.1159/000356116; Motl RW, 2013, J NEUROL SCI, V335, P169, DOI 10.1016/j.jns.2013.09.024; Motl RW, 2010, J NERV MENT DIS, V198, P213, DOI 10.1097/NMD.0b013e3181d14131; Orbach R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045409; Paltamaa J, 2007, ARCH PHYS MED REHAB, V88, P1649, DOI 10.1016/j.apmr.2007.07.032; Paltamaa J, 2005, PHYSIOTHER RES INT, V10, P93, DOI 10.1002/pri.30; Riazi A, 2004, MULT SCLER J, V10, P61, DOI 10.1191/1352458504ms986oa; Riazi A, 2002, J NEUROL NEUROSUR PS, V73, P701, DOI 10.1136/jnnp.73.6.701; Schwid SR, 2002, NEUROLOGY, V58, P1294, DOI 10.1212/WNL.58.8.1294; Sutliff MH, 2010, CURR MED RES OPIN, V26, P109, DOI 10.1185/03007990903433528	34	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125002	10.1371/journal.pone.0125002	http://dx.doi.org/10.1371/journal.pone.0125002			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932911	Green Submitted, gold, Green Published			2022-12-27	WOS:000353887100072
J	Ahmed, M; Fayyaz-ul-Hassan				Ahmed, Mukhtar; Fayyaz-ul-Hassan			Response of Spring Wheat (Triticum aestivum L.) Quality Traits and Yield to Sowing Date	PLOS ONE			English	Article							GRAIN QUALITY; HEAT-SHOCK; NITROGEN MANAGEMENT; HIGH-TEMPERATURE; PROTEIN-CONTENT; WATER-DEFICIT; BREAD WHEAT; STRESS; DURUM; DROUGHT	The unpredictability and large fluctuation of the climatic conditions in rainfed regions do affect spring wheat yield and grain quality. These variations offer the opportunity for the production of better quality wheat. The effect of variable years, locations and sowing managements on wheat grain yield and quality was studied through field experiments using three genotypes, three locations for two years under rainfed conditions. The two studied years as contrasting years at three locations and sowing dates depicted variability in temperature and water stress during grain filling which resulted considerable change in grain yield and quality. Delayed sowing, years (2009-10) and location (Talagang) with high temperature and water stress resulted increased proline, and grain quality traits i.e. grain protein (GP) and grain ash (GA) than optimum conditions (during 2008-09, at Islamabad and early sowing). However, opposite trend was observed for dry gluten (DG), sodium dodecyl sulphate (SDS), SPAD content and grain yield irrespective of genotypes. The influence of variable climatic conditions was dominant in determining the quality traits and inverse relationship was observed among some quality traits and grain yield. It may be concluded that by selecting suitable locations and different sowing managements for subjecting the crop to desirable environmental conditions (temperature and water) quality traits of wheat crop could be modified.	[Ahmed, Mukhtar] Pir Mehr Ali Shah Arid Agr Univ, Dept Agron, Rawalpindi, Punjab, Pakistan; [Ahmed, Mukhtar] Washington State Univ, Dept Biol Syst Engn, Pullman, WA 99164 USA; [Fayyaz-ul-Hassan] CIIT Ctr Hlth Res, COMSATS, Dept Biosci, Islamabad, Pakistan	Arid Agriculture University; Washington State University; COMSATS University Islamabad (CUI)	Ahmed, M (corresponding author), Pir Mehr Ali Shah Arid Agr Univ, Dept Agron, Rawalpindi, Punjab, Pakistan.	mukhtar.ahmed@wsu.edu	Ahmad, Mukhtar/G-7346-2012; Ahmed, Mukhtar/HIR-3483-2022	Ahmad, Mukhtar/0000-0002-7223-5541; 	Higher Education Commison Pakistan	Higher Education Commison Pakistan	Mukhtar Ahmed received funding from Higher Education Commison Pakistan for PhD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[AACC] American Association of Cereal Chemists, 2010, INT APPR METH, P55; AACC International, 1999, 080101 AACC INT; Akhkha A, 2011, INT J AGRIC BIOL, V13, P215; Allen R. G., 1998, FAO Irrigation and Drainage Paper; BLUMENTHAL CS, 1993, J CEREAL SCI, V18, P3, DOI 10.1006/jcrs.1993.1030; BORGHI B, 1995, AUST J AGR RES, V46, P1365, DOI 10.1071/AR9951365; Carter TR, 2007, CLIMATE CHANGE 2007, P131; Ciaffi M, 1996, J CEREAL SCI, V24, P91, DOI 10.1006/jcrs.1996.0042; Coventry DR, 2011, FIELD CROP RES, V123, P214, DOI 10.1016/j.fcr.2011.05.017; [邓志英 DENG ZhiYing], 2006, [生态学报, Acta Ecologica Sinica], V26, P2757; Dhyani K, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24564; Erbs M, 2010, AGR ECOSYST ENVIRON, V136, P59, DOI 10.1016/j.agee.2009.11.009; Fernando N, 2014, AGR ECOSYST ENVIRON, V185, P24, DOI 10.1016/j.agee.2013.11.023; Fischer G, 2002, GLOBAL AGROECOLOGICA; Flagella Z, 2010, EUR J AGRON, V33, P197, DOI 10.1016/j.eja.2010.05.006; Gil DH, 2011, FIELD CROP RES, V123, P1, DOI 10.1016/j.fcr.2011.04.001; Vendruscolo ECG, 2007, J PLANT PHYSIOL, V164, P1367, DOI 10.1016/j.jplph.2007.05.001; Gutierrez M, 2010, J EXP BOT, V61, P3291, DOI 10.1093/jxb/erq156; Gutierrez M, 2010, CROP SCI, V50, P197, DOI 10.2135/cropsci2009.07.0381; Gutierrez-Rodriguez M, 2004, AUST J AGR RES, V55, P1139, DOI 10.1071/AR04214; Guttieri MJ, 2001, CROP SCI, V41, P327, DOI 10.2135/cropsci2001.412327x; Hamblin J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092529; Hayat S, 2014, J PLANT INTERACT, V9, P35, DOI 10.1080/17429145.2012.751635; Hurkman WJ, 2009, J CEREAL SCI, V49, P12, DOI 10.1016/j.jcs.2008.06.014; Jiang D, 2009, J AGRON CROP SCI, V195, P89, DOI 10.1111/j.1439-037X.2008.00353.x; Labuschagne MT, 2009, CEREAL CHEM, V86, P61, DOI 10.1094/CCHEM-86-1-0061; Larsson H, 1997, J TEXTURE STUD, V28, P487, DOI 10.1111/j.1745-4603.1997.tb00132.x; Li YF, 2013, J CEREAL SCI, V57, P398, DOI 10.1016/j.jcs.2013.01.005; Miller RO, 1999, P 4 INT C PREC AGR A; Minocha R, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00175; Moinuddin, 2005, AGRON J, V97, P1062, DOI 10.2134/agronj2004.0152; Moldestad A, 2014, J CEREAL SCI, V60, P406, DOI 10.1016/j.jcs.2014.05.003; Motzo R, 2007, J SCI FOOD AGR, V87, P1480, DOI 10.1002/jsfa.2855; Noorka IR, 2009, PAK J BOT, V41, P2917; Otteson BN, 2008, CROP SCI, V48, P749, DOI 10.2135/cropsci2007.08.0473; R Core Team, 2018, R LANG ENV STAT COMP; Shewry PR, 2009, J EXP BOT, V60, P1537, DOI 10.1093/jxb/erp058; Singh S, 2010, FOOD CHEM, V122, P559, DOI 10.1016/j.foodchem.2010.03.010; Souza EJ, 2004, CROP SCI, V44, P425, DOI 10.2135/cropsci2004.0425; Sun M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075191; Tausz M, 2013, ENVIRON EXP BOT, V88, P71, DOI 10.1016/j.envexpbot.2011.12.005; Thornton PK, 2014, GLOBAL CHANGE BIOL, V20, P3313, DOI 10.1111/gcb.12581; Toscano P, 2014, EUR J AGRON, V61, P1, DOI 10.1016/j.eja.2014.08.003; van Ogtrop F, 2014, METEOROL APPL, V21, P431, DOI 10.1002/met.1429; Verslues Paul E, 2010, Arabidopsis Book, V8, pe0140, DOI 10.1199/tab.0140; Wang YX, 2011, AGR ECOSYST ENVIRON, V141, P271, DOI 10.1016/j.agee.2011.03.017; Wardlaw IF, 2002, FUNCT PLANT BIOL, V29, P25, DOI 10.1071/PP00147; WARDLAW IF, 1995, AUST J PLANT PHYSIOL, V22, P391, DOI 10.1071/PP9950391; Zhao Hui, 2007, Acta Agronomica Sinica, V33, P2021	49	24	27	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0126097	10.1371/journal.pone.0126097	http://dx.doi.org/10.1371/journal.pone.0126097			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927839	Green Published, Green Submitted, gold			2022-12-27	WOS:000353713100127
J	Colazzo, F; Castiglioni, L; Sironi, L; Fontana, L; Nobili, E; Franzosi, M; Guerrini, U				Colazzo, Francesca; Castiglioni, Laura; Sironi, Luigi; Fontana, Lucia; Nobili, Elena; Franzosi, Matteo; Guerrini, Uliano			Murine Left Atrium and Left Atrial Appendage Structure and Function: Echocardiographic and Morphologic Evaluation	PLOS ONE			English	Article							VENTRICULAR-FUNCTION; SYSTOLIC FUNCTION; CARDIAC-FUNCTION; HEART; MICE; MOUSE; DETERMINANTS; HYPERTROPHY; ULTRASOUND; FLOW	Aim of this study was to provide an echocardiographic protocol for the description of the normal murine venous reservoir (atrium, appendage and pulmonary veins) and to investigate the possibility to use this approach to discriminate changes on left atrium (LA) and left atrial appendage (LAA) in a stress-induced model such us myocardial infarction. Global left ventricular function and the venous reservoir were assessed by a Vevo2100 in 20 female C57BL/6N. LA and LAA were also studied in 10 CD-1 and 10 FVB mice, whereas modifications investigated in 15 C57BL/6N subjected to coronary artery ligation. Left ventricle function was evaluated as well as pulsed Doppler mitral valve, pulmonary vein, and LAA velocities. From 2D view monoplane LA volumes were obtained and LAA long axis measured. Macroscopic inspection with casts and immunohistochemistry were performed. Results show that compared to humans, in C57BL/6N mice left atrium was disproportionately smaller (5.2 +/- 1.4 mu L) than the left ventricle (53 +/- 8 mu L) and connected through a duct by a large LAA and posteriorly to three pulmonary veins. The LA volume increased 2-fold during reservoir with two distinct phases, early and late divided by a short pause. LAA long axis (4.1 +/- 0.5mm) was almost 2 times longer than the LA. LAA flow volume together with LA volume reservoir account for about 36% of stroke volume and the rest was provided by conduit flow. Linear regressions showed that stroke volume was strongly influenced by LAA flow, LA early filling volume and left ventricle base descent. Moreover, we also report the ability to assess LA and LAA in other mice strains and discriminate size increase following myocardial infarction. In conclusion, we performed a complete characterization of murine left venous reservoir establishing an optimized protocol that can be used in both investigative and pharmacological studies requiring rapid and serial determination of cardiac structure and function.	[Colazzo, Francesca; Sironi, Luigi; Nobili, Elena] IRCCS, Ctr Cardiol Monzino, Milan, Italy; [Castiglioni, Laura; Sironi, Luigi; Fontana, Lucia; Franzosi, Matteo; Guerrini, Uliano] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy	IRCCS Centro Cardiologico Monzino; University of Milan	Guerrini, U (corresponding author), Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy.	labtremoli@gmail.com	Sironi, Luigi/S-8174-2016; Fontana, Lucia/J-8778-2015	COLAZZO, FRANCESCA/0000-0002-5782-1606; castiglioni, laura/0000-0002-0772-3231; Fontana, Lucia/0000-0001-9564-2310; SIRONI, LUIGI/0000-0002-4738-3454	Region Lombardy (Italy) [1137]; Institutional Funding (Ricerca Corrente) at Centro Cardiologico Monzino	Region Lombardy (Italy); Institutional Funding (Ricerca Corrente) at Centro Cardiologico Monzino	This study was partially granted by Region Lombardy (Italy) (deliberation no 1137 - 10/12/2010) in support to innovative research and by Institutional Funding (Ricerca Corrente) at Centro Cardiologico Monzino.	Abhayaratna WP, 2006, J AM COLL CARDIOL, V47, P2357, DOI 10.1016/j.jacc.2006.02.048; Barbier P, 1999, CIRCULATION, V100, P427, DOI 10.1161/01.CIR.100.4.427; Barbier P, 2000, J AM COLL CARDIOL, V35, P1947, DOI 10.1016/S0735-1097(00)00642-2; Baumann PQ, 2008, ECHOCARDIOGR-J CARD, V25, P739, DOI 10.1111/j.1540-8175.2008.00680.x; Bose AK, 2007, ECHOCARDIOGR-J CARD, V24, P412, DOI 10.1111/j.1540-8175.2007.00402.x; Collins KA, 2003, PHYSIOL GENOMICS, V13, P227, DOI 10.1152/physiolgenomics.00005.2003; Dewald O, 2003, P NATL ACAD SCI USA, V100, P2700, DOI 10.1073/pnas.0438035100; Fayssoil A, 2013, HEART FAIL REV, V18, P511, DOI 10.1007/s10741-012-9345-8; Franzosi M, 2011, COMPUT BIOL MED, V41, P829, DOI 10.1016/j.compbiomed.2011.06.021; GARDIN JM, 1995, CIRC RES, V76, P907, DOI 10.1161/01.RES.76.5.907; Gottlieb S, 1995, J Am Soc Echocardiogr, V8, P149, DOI 10.1016/S0894-7317(05)80404-3; Hinton RB, 2008, AM J PHYSIOL-HEART C, V294, pH2480, DOI 10.1152/ajpheart.91431.2007; Hoit BD, 2006, TOXICOL PATHOL, V34, P105, DOI 10.1080/01926230500369535; HOIT BD, 1993, CIRC RES, V72, P167, DOI 10.1161/01.RES.72.1.167; Holmes DR, 2009, LANCET, V374, P534, DOI 10.1016/S0140-6736(09)61343-X; KALMANSON D, 1971, CARDIOVASC RES, V5, P293, DOI 10.1093/cvr/5.3.293; Khouri SJ, 2004, J AM SOC ECHOCARDIOG, V17, P290, DOI 10.1016/j.echo.2003.08.012; Kruithof BPT, 2003, DEV DYNAM, V227, P1, DOI 10.1002/dvdy.10269; Liao YL, 2002, AM J PHYSIOL-HEART C, V282, pH1703, DOI 10.1152/ajpheart.00238.2001; Ponten A, 2003, AM J PATHOL, V163, P673, DOI 10.1016/S0002-9440(10)63694-2; RAJAGOPALAN B, 1979, CARDIOVASC RES, V13, P677, DOI 10.1093/cvr/13.12.677; Rottman JN, 2007, ECHOCARDIOGR-J CARD, V24, P83, DOI 10.1111/j.1540-8175.2006.00356.x; SUGA H, 1974, CIRC RES, V35, P39, DOI 10.1161/01.RES.35.1.39; Triposkiadis F, 2007, J AM SOC ECHOCARDIOG, V20, P177, DOI 10.1016/j.echo.2006.08.013; Wessels A, 2003, PHYSIOL GENOMICS, V15, P165, DOI 10.1152/physiolgenomics.00033.2003; Wu JA, 2010, J ULTRAS MED, V29, P1771, DOI 10.7863/jum.2010.29.12.1771; Yang XP, 1999, AM J PHYSIOL-HEART C, V277, pH1967, DOI 10.1152/ajpheart.1999.277.5.H1967; Zhang Y, 2007, AM J PHYSIOL-HEART C, V292, pH1187, DOI 10.1152/ajpheart.00895.2006; Zhou YQ, 2004, PHYSIOL GENOMICS, V18, P232, DOI 10.1152/physiolgenomics.00026.2004; Zhou YQ, 2003, AM J PHYSIOL-HEART C, V285, pH1563, DOI 10.1152/ajpheart.00384.2003	30	7	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125541	10.1371/journal.pone.0125541	http://dx.doi.org/10.1371/journal.pone.0125541			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928887	Green Published, gold			2022-12-27	WOS:000353713100100
J	Li, R; Xiao, J; Qing, XT; Xing, JH; Xia, YF; Qi, J; Liu, XJ; Zhang, S; Sheng, X; Zhang, XY; Ji, XP				Li, Rui; Xiao, Jie; Qing, Xiaoteng; Xing, Junhui; Xia, Yanfei; Qi, Jia; Liu, Xiaojun; Zhang, Sen; Sheng, Xi; Zhang, Xinyu; Ji, Xiaoping			Sp1 Mediates a Therapeutic Role of MiR-7a/b in Angiotensin II-Induced Cardiac Fibrosis via Mechanism Involving the TGF-beta and MAPKs Pathways in Cardiac Fibroblasts	PLOS ONE			English	Article							MATRIX GENE-EXPRESSION; NECROSIS-FACTOR-ALPHA; DNA-BINDING ACTIVITY; NF-KAPPA-B; COLLAGEN GENE; DOWN-REGULATION; TRANSCRIPTION; PROLIFERATION; MICRORNAS; CELLS	MicroRNA-7a/b (miR-7a/b) protects cardiac myocytes from apoptosis during ischemia/reperfusion injury; however, its role in angiotensin II (ANG II)-stimulated cardiac fibroblasts (CFs) remains unknown. Therefore, the present study investigated the anti-fibrotic mechanism of miR-7a/b in ANG II-treated CFs. ANG II stimulated the expression of specific protein 1 (Sp1) and collagen I in a dose-and time-dependent manner, and the overexpression of miR-7a/b significantly down-regulated the expression of Sp1 and collagen I stimulated by ANG II (100 nM) for 24 h. miR-7a/b overexpression effectively inhibited MMP-2 expression/activity and MMP-9 expression, as well as CF proliferation and migration. In addition, miR7a/b also repressed the activation of TGF-beta, ERK, JNK and p38 by ANG II. The inhibition of Sp1 binding activity by mithramycin prevented collagen I overproduction; however, miR-7a/b down-regulation reversed this effect. Further studies revealed that Sp1 also mediated miR-7a/b-regulated MMP expression and CF migration, as well as TGF-beta and ERK activation. In conclusion, miR-7a/b has an anti-fibrotic role in ANG II-treated CFs that is mediated by Sp1 mechanism involving the TGF-beta and MAPKs pathways.	[Li, Rui; Xiao, Jie; Qing, Xiaoteng; Xing, Junhui; Xia, Yanfei; Sheng, Xi; Zhang, Xinyu; Ji, Xiaoping] Shandong Univ, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250100, Shandong, Peoples R China; [Li, Rui; Xiao, Jie; Qing, Xiaoteng; Xing, Junhui; Xia, Yanfei; Sheng, Xi; Zhang, Xinyu; Ji, Xiaoping] Shandong Univ, Qilu Hosp, Chinese Minist Publ Hlth, Jinan 250100, Shandong, Peoples R China; [Xing, Junhui] Shandong Univ, Qilu Hosp, Dept Emergency, Jinan 250100, Shandong, Peoples R China; [Qi, Jia; Liu, Xiaojun] Cent Hosp Zibo, Dept Cardiol, Zibo, Shandong, Peoples R China; [Zhang, Sen] Shandong Univ, Qilu Hosp, Dept Cardiol, Qingdao, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University	Ji, XP (corresponding author), Shandong Univ, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250100, Shandong, Peoples R China.	jxp1964@hotmail.com			National Natural Science Foundation of China [81070087]; National 973 Basic Research Program of China [2012CB722406]; Natural Science Foundation of Shandong Province [ZR2010HM063]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This work was supported by the the National Natural Science Foundation of China [81070087], and the National 973 Basic Research Program of China [2012CB722406], The Natural Science Foundation of Shandong Province [ZR2010HM063]. The URL of the funder's website: http://isisn.nsfc.gov.cn/egrantweb/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bracey NA, 2014, J BIOL CHEM, V289, P19571, DOI 10.1074/jbc.M114.550624; Chae YM, 2006, GENE THER, V13, P430, DOI 10.1038/sj.gt.3302696; Cui Y, 2014, STEM CELLS DEV, V23, P393, DOI 10.1089/scd.2013.0342; Cutroneo KR, 2000, MOL BIOL REP, V27, P191, DOI 10.1023/A:1007206014638; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Etoh M, 2013, ARCH DERMATOL RES, V305, P9, DOI 10.1007/s00403-012-1287-4; Feng HJ, 2014, BRAZ J MED BIOL RES, V47, P361, DOI 10.1590/1414-431X20142937; FERREIRA J, 1988, FEBS LETT, V234, P485, DOI 10.1016/0014-5793(88)80143-1; Gonzalez GE, 2015, J HYPERTENS, V33, P144, DOI 10.1097/HJH.0000000000000358; Haase M, 2000, INT J RADIAT BIOL, V76, P487, DOI 10.1080/095530000138484; Hitraya EG, 1998, ARTHRITIS RHEUM-US, V41, P2048, DOI 10.1002/1529-0131(199811)41:11<2048::AID-ART21>3.0.CO;2-X; Hori Y, 2012, AM J PHYSIOL-CELL PH, V303, pC947, DOI 10.1152/ajpcell.00401.2011; Huang XR, 2010, HYPERTENSION, V55, P1165, DOI 10.1161/HYPERTENSIONAHA.109.147611; Ihn H, 1996, J BIOL CHEM, V271, P26717, DOI 10.1074/jbc.271.43.26717; Ihn H, 2000, J INVEST DERMATOL, V114, P1011, DOI 10.1046/j.1523-1747.2000.00956.x; INAGAKI Y, 1995, J BIOL CHEM, V270, P3353, DOI 10.1074/jbc.270.7.3353; Iwata M, 2011, J MOL CELL CARDIOL, V51, P542, DOI 10.1016/j.yjmcc.2010.12.003; Jia LF, 2014, ORAL ONCOL, V50, P1062, DOI 10.1016/j.oraloncology.2014.07.010; Jiang BH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059621; Jiang L, 2013, EXP CELL RES, V319, P2254, DOI 10.1016/j.yexcr.2013.06.007; Jiang XY, 2013, J PHYSIOL SCI, V63, P31, DOI 10.1007/s12576-012-0230-y; Ju HS, 1996, MOL CELL BIOCHEM, V164, P231, DOI 10.1007/BF00408663; Kajihara I, 2012, AM J PATHOL, V180, P703, DOI 10.1016/j.ajpath.2011.10.030; Kum YS, 2007, BIOCHEM BIOPH RES CO, V363, P368, DOI 10.1016/j.bbrc.2007.08.176; Li B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090096; Li LP, 2014, HYPERTENSION, V64, P94, DOI 10.1161/HYPERTENSIONAHA.113.03021; Li YY, 2000, P NATL ACAD SCI USA, V97, P12746, DOI 10.1073/pnas.97.23.12746; Lijnen PJ, 2012, CARDIOVASC THER, V30, pe1, DOI 10.1111/j.1755-5922.2010.00205.x; Marzioni M, 2014, HEPATOLOGY, V60, P1324, DOI 10.1002/hep.27262; Okada M, 2010, J VET MED SCI, V72, P735, DOI 10.1292/jvms.09-0582; Olson ER, 2005, AM J PHYSIOL-HEART C, V288, pH1131, DOI 10.1152/ajpheart.00763.2004; Olson ER, 2008, HYPERTENSION, V51, P704, DOI 10.1161/HYPERTENSIONAHA.107.098459; Papakrivopoulou J, 2004, CARDIOVASC RES, V61, P736, DOI 10.1016/j.cardiores.2003.12.018; Park JH, 2009, J GENE MED, V11, P824, DOI 10.1002/jgm.1355; Parthasarathy A, 2013, MOL CELL BIOCHEM, V378, P217, DOI 10.1007/s11010-013-1612-z; Pires PW, 2011, AM J PHYSIOL-HEART C, V301, pH87, DOI 10.1152/ajpheart.01206.2010; Reddy VS, 2010, AM J PHYSIOL-HEART C, V299, pH1242, DOI 10.1152/ajpheart.00451.2010; RIPPE RA, 1995, HEPATOLOGY, V22, P241, DOI 10.1016/0270-9139(95)90378-X; Roy S, 2009, CARDIOVASC RES, V82, P21, DOI 10.1093/cvr/cvp015; Sano M, 2001, CIRC RES, V89, P661, DOI 10.1161/hh2001.098873; Siddesha JM, 2014, CELL SIGNAL, V26, P933, DOI 10.1016/j.cellsig.2014.01.005; Siddesha JM, 2013, J MOL CELL CARDIOL, V65, P9, DOI 10.1016/j.yjmcc.2013.09.015; Subramanian SV, 2004, MOL BIOL CELL, V15, P4532, DOI 10.1091/mbc.E04-04-0348; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Verrecchia F, 2001, J INVEST DERMATOL, V116, P755, DOI 10.1046/j.1523-1747.2001.01326.x; Wang WK, 2014, INT J CARDIOL, V172, P202, DOI 10.1016/j.ijcard.2014.01.011; Wang YT, 2008, J MOL BIOL, V380, P869, DOI 10.1016/j.jmb.2008.05.043; Wang YT, 2011, J MOL BIOL, V414, P1, DOI 10.1016/j.jmb.2011.09.027; Wei LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070195; Wei LH, 2013, CARDIOVASC RES, V99, P665, DOI 10.1093/cvr/cvt151; Yang HC, 2014, NUCLEIC ACIDS RES, V42, P13573, DOI 10.1093/nar/gku1145; Zhang W, 2000, J BIOL CHEM, V275, P39237, DOI 10.1074/jbc.M003339200; Zhang Y, 2014, MOL THER, V22, P974, DOI 10.1038/mt.2014.25; Zhao XH, 2012, MOL BIOL CELL, V23, P2867, DOI 10.1091/mbc.E12-04-0270	55	29	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125513	10.1371/journal.pone.0125513	http://dx.doi.org/10.1371/journal.pone.0125513			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923922	Green Submitted, Green Published, gold			2022-12-27	WOS:000353711600153
J	Beaudouin, R; Goussen, B; Piccini, B; Augustine, S; Devillers, J; Brion, F; Pery, ARR				Beaudouin, Remy; Goussen, Benoit; Piccini, Benjamin; Augustine, Starrlight; Devillers, James; Brion, Francois; Pery, Alexandre R. R.			An Individual-Based Model of Zebrafish Population Dynamics Accounting for Energy Dynamics	PLOS ONE			English	Article							DANIO-RERIO; LARVAL ZEBRAFISH; FEMALE ZEBRAFISH; RISK-ASSESSMENT; WILD ZEBRAFISH; SEX-RATIO; GROWTH; FISH; TEMPERATURE; ENERGETICS	Developing population dynamics models for zebrafish is crucial in order to extrapolate from toxicity data measured at the organism level to biological levels relevant to support and enhance ecological risk assessment. To achieve this, a dynamic energy budget for individual zebrafish (DEB model) was coupled to an individual based model of zebrafish population dynamics (IBM model). Next, we fitted the DEB model to new experimental data on zebrafish growth and reproduction thus improving existing models. We further analysed the DEB-model and DEB-IBM using a sensitivity analysis. Finally, the predictions of the DEB-IBM were compared to existing observations on natural zebrafish populations and the predicted population dynamics are realistic. While our zebrafish DEB-IBM model can still be improved by acquiring new experimental data on the most uncertain processes (e.g. survival or feeding), it can already serve to predict the impact of compounds at the population level.	[Beaudouin, Remy; Goussen, Benoit; Pery, Alexandre R. R.] Inst Natl Environm Ind & Risques INERIS, Unite Modeles Ecotoxicol & Toxicol METO, Verneuil En Halatte, France; [Piccini, Benjamin; Brion, Francois] Inst Natl Environm Ind & Risques INERIS, Unite Ecotoxicol In Vitro & In Vivo ECOT, Verneuil En Halatte, France; [Augustine, Starrlight] Tech Univ Denmark, Natl Inst Aquat Resources, Ctr Ocean Life, Charlottenlund, Denmark; [Devillers, James] CTIS, Rillieux La Pape, France; [Pery, Alexandre R. R.] AgroParisTech, Paris, France	Institut National de l'Environnement Industriel et des Risques (INERIS); Universite de Reims Champagne-Ardenne; Institut National de l'Environnement Industriel et des Risques (INERIS); Technical University of Denmark; AgroParisTech	Beaudouin, R (corresponding author), Inst Natl Environm Ind & Risques INERIS, Unite Modeles Ecotoxicol & Toxicol METO, Verneuil En Halatte, France.	remy.beaudouin@ineris.fr	GOUSSEN, Benoit/E-7687-2012; Beaudouin, Rémy/H-1491-2012; BRION, Francois/Q-8713-2018	GOUSSEN, Benoit/0000-0001-7204-7981; Beaudouin, Rémy/0000-0002-2855-1571; BRION, Francois/0000-0003-2341-4196	French Ministry in charge of Ecology and Sustainable Development, within the frameworks of the National Research Programme on Endocrine Disruption (PNRPE) [190]; Villum Fonden [00007178] Funding Source: researchfish	French Ministry in charge of Ecology and Sustainable Development, within the frameworks of the National Research Programme on Endocrine Disruption (PNRPE); Villum Fonden(Villum Fonden)	This study was funded by the French Ministry in charge of Ecology and Sustainable Development, within the frameworks of the National Research Programme on Endocrine Disruption (PNRPE) and of the Programme 190.	Affan Abu, 2005, Algae, V20, P43; [Anonymous], 2010, REFERENCE GROWTH CUR, P1199; [Anonymous], 2007, ESTIMATING THE APPRO, P957; [Anonymous], 2009, DEVELOPMENT AND VALI, P310; [Anonymous], 2008, RAPID GROWTH AND OUT, P239; Ashauer R, 2011, ENVIRON TOXICOL CHEM, V30, P2519, DOI 10.1002/etc.639; Augustine S, 2011, COMP BIOCHEM PHYS A, V159, P275, DOI 10.1016/j.cbpa.2011.03.016; Bagatto B, 2001, J EXP BIOL, V204, P4335; Bala N, 1999, ICLARM CONF PROC; Balasubramani A, 2008, CURRENT SCIENCE, V94, P10; Beaudouin R, 2008, J FISH BIOL, V73, P2468, DOI 10.1111/j.1095-8649.2008.02101.x; Beaudouin R, 2012, ECOTOXICOLOGY, V21, P1225, DOI 10.1007/s10646-012-0877-4; Beaudouin R, 2012, ECOTOXICOLOGY, V21, P155, DOI 10.1007/s10646-011-0775-1; Best J, 2010, ZEBRAFISH, V7, P289, DOI 10.1089/zeb.2010.0667; Billoir E, 2008, J THEOR BIOL, V254, P55, DOI 10.1016/j.jtbi.2008.05.006; Bodiguel X, 2009, J SEA RES, V62, P124, DOI 10.1016/j.seares.2009.02.006; Bois FY, 1997, JOURNAL OF STATISTIC, V2; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Brion F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036069; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Cosnefroy A, 2012, TOXICOL SCI, V125, P439, DOI 10.1093/toxsci/kfr297; de Kermoysan G, 2013, AQUAT TOXICOL, V144, P186, DOI 10.1016/j.aquatox.2013.09.034; Devillers J, 2014, IN SILICO BEES, P179; Drew RE, 2008, PHYSIOL GENOMICS, V35, P283, DOI 10.1152/physiolgenomics.90213.2008; EATON RC, 1974, COPEIA, P204; Engeszer RE, 2007, ZEBRAFISH, V4, P21, DOI 10.1089/zeb.2006.9997; Forbes VE, 2008, ENVIRON TOXICOL CHEM, V27, P1987, DOI 10.1897/08-029.1; Forbes VE, 2011, HUM ECOL RISK ASSESS, V17, P287, DOI 10.1080/10807039.2011.552391; Freitas V, 2010, PHILOS T R SOC B, V365, P3553, DOI 10.1098/rstb.2010.0049; Gabsi F, 2014, ECOL MODEL, V280, P18, DOI 10.1016/j.ecolmodel.2013.06.018; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gerhard GS, 2002, EXP GERONTOL, V37, P1055, DOI 10.1016/S0531-5565(02)00088-8; Godin J- G, 1997, BEHAVIOURAL ECOLOGY; Goussen B, 2015, CHEMOSPHERE, V120, P507, DOI 10.1016/j.chemosphere.2014.09.006; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Hazlerigg CRE, 2014, ECOL MODEL, V280, P76, DOI 10.1016/j.ecolmodel.2013.12.016; Hisaoka KK, 1962, COPEIA, P302; Iwasaki Y, 2011, ENVIRON TOXICOL CHEM, V30, P2237, DOI 10.1002/etc.612; Jager T, 2005, FUNCT ECOL, V19, P136, DOI 10.1111/j.0269-8463.2005.00941.x; Kidd KA, 2007, P NATL ACAD SCI USA, V104, P8897, DOI 10.1073/pnas.0609568104; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kooijman SALM, 2014, J SEA RES, V94, P128, DOI 10.1016/j.seares.2014.06.005; Kooijman SALM, 1996, WATER RES, V30, P1711, DOI 10.1016/0043-1354(96)00054-1; Kooijman SALM, 2010, DYNAMIC ENERGY BUDGE, DOI [10.1111/j.1469-185X.2008.00053.x, DOI 10.1111/J.1469-185X.2008.00053.X]; Lenth R., 2019, Journal of Statistical Software, V60, P1; Li L, 2003, AQUACULT ENG, V27, P9, DOI 10.1016/S0144-8609(02)00037-7; Liew WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034397; Markovich ML, 2007, ZEBRAFISH, V4, P69, DOI 10.1089/zeb.2006.9993; Martin BT, 2013, ECOTOXICOLOGY, V22, P574, DOI 10.1007/s10646-013-1049-x; Menuet A, 2002, BIOL REPROD, V66, P1881, DOI 10.1095/biolreprod66.6.1881; MORRIS MD, 1991, TECHNOMETRICS, V33, P161, DOI 10.2307/1269043; Pery ARR, 2014, ENVIRON SCI TECHNOL, V48, P781, DOI 10.1021/es404301q; R Core Team, 2013, R A LANGUAGE AND ENV; Rasband WS, 1997, IMAGEJ; Rice PJ, 2013, SCI TOTAL ENVIRON, V456, P61, DOI 10.1016/j.scitotenv.2013.02.051; Saltelli A, 2010, COMPUT PHYS COMMUN, V181, P259, DOI 10.1016/j.cpc.2009.09.018; Schilling Thomas F., 2002, P59; Sfakianakis DG, 2012, J BIOL RES-THESSALON, V17, P68; Spence R, 2007, J FISH BIOL, V71, P304, DOI 10.1111/j.1095-8649.2007.01492.x; Spence R, 2005, ANIM BEHAV, V69, P1317, DOI 10.1016/j.anbehav.2004.10.010; Spence R, 2008, BIOL REV, V83, P13, DOI 10.1111/j.1469-185X.2007.00030.x; Spence R, 2006, BEHAV ECOL, V17, P779, DOI 10.1093/beheco/arl016; Stonedahl F, 2010, PROCEEDINGS OF THE M; Uusi-Heikkila S, 2010, J FISH BIOL, V77, P552, DOI 10.1111/j.1095-8649.2010.02698.x; Vosges M, 2010, AQUAT TOXICOL, V99, P479, DOI 10.1016/j.aquatox.2010.06.009; Wilensky U., 1999, NETLOGO; Wootton RJ, 1998, ECOLOGY OF TELEOST F; Wootton RJ, 1994, THE EVOLUTIONARY BIO, P571; Zimmer EI, 2012, ECOTOXICOLOGY, V21, P2195, DOI 10.1007/s10646-012-0973-5	69	27	27	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125841	10.1371/journal.pone.0125841	http://dx.doi.org/10.1371/journal.pone.0125841			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938409	gold, Green Published, Green Submitted			2022-12-27	WOS:000353943000104
J	Origer, A; Le Bihan, E; Baumann, M				Origer, Alain; Le Bihan, Etienne; Baumann, Michele			A Social Gradient in Fatal Opioids and Cocaine Related Overdoses?	PLOS ONE			English	Article							NEW-YORK-CITY; DRUG OVERDOSE; INCOME-DISTRIBUTION; HARM-REDUCTION; MORTALITY; HEALTH; RISK; INEQUALITIES; BARCELONA; POVERTY	Background To determine the existence of a social gradient in fatal overdose cases related to nonprescribed opioids and cocaine use, recorded in Luxembourg between 1994 and 2011. Methods Overdose cases were individually matched with four controls in a nested case-control study design, according to sex, year of birth, drug administration route and duration of drug use. The study sample, composed of 272 cases and 1,056 controls, was stratified according to a Social Inequality Accumulation Score (SIAS), based on educational attainment, employment, income, financial situation of subjects and the professional status of their father or legal guardian. Least squares linear regression analysis on overdose mortality rates and ridit scores were applied to determine the Relative Index of Inequality (RII) of the study sample. Results A negative linear relationship between the overdose mortality rate and the relative socioeconomic position was observed. We found a difference in mortality of 29.22 overdose deaths per 100 drug users in the lowest socioeconomic group compared to the most advantaged group. In terms of the Relative Inequality Index, the overdose mortality rate of opioid and cocaine users with lowest socioeconomic profiles was 9.88 times as high as that of their peers from the highest socioeconomic group (95% CI 6.49-13.26). Conclusions Our findings suggest the existence of a marked social gradient in opioids and cocaine related overdose fatalities. Harm reduction services should integrate socially supportive offers, not only because of their general aim of social (re) integration but crucially in order to meet their most important objective, that is to reduce drug-related mortality.	[Origer, Alain] Minist Hlth, Drug Coordinat Off, Luxembourg, Luxembourg; [Origer, Alain; Le Bihan, Etienne; Baumann, Michele] Univ Luxembourg, Res Unit INSIDE, Inst Hlth & Behav, Walferdange, Luxembourg	University of Luxembourg	Origer, A (corresponding author), Minist Hlth, Drug Coordinat Off, Luxembourg, Luxembourg.	alain.origer@ms.etat.lu						Arias LC, 1998, MED CLIN-BARCELONA, V110, P161; Bergenstrom A, 2008, SUBST USE MISUSE, V43, P73, DOI 10.1080/10826080701205109; Borrell C, 2002, INJURY PREV, V8, P297, DOI 10.1136/ip.8.4.297; BROSS IDJ, 1958, BIOMETRICS, V14, P18, DOI 10.2307/2527727; Cai TX, 2012, BIOSTATISTICS, V13, P89, DOI 10.1093/biostatistics/kxr021; Darke S, 1996, ADDICTION, V91, P1765, DOI 10.1111/j.1360-0443.1996.tb03800.x; DAVOLI M, 1993, INT J EPIDEMIOL, V22, P273, DOI 10.1093/ije/22.2.273; EMCDDA, 2011, MORTALITY RELATED TO; Farrell M, 1996, ADDICTION, V91, P321, DOI 10.1111/j.1360-0443.1996.tb02282.x; Galea S, 2002, PUBLIC HEALTH REP, V117, pS135; Galea S, 2003, DRUG ALCOHOL DEPEN, V70, P139, DOI 10.1016/S0376-8716(02)00342-3; HARLOW KC, 1990, PUBLIC HEALTH REP, V105, P455; ILLSLEY R, 1990, SOC SCI MED, V31, P229, DOI 10.1016/0277-9536(90)90269-X; Jones R, 2002, ADDICTION, V97, P1517, DOI 10.1046/j.1360-0443.2002.00244.x; Langendam MW, 2001, AM J PUBLIC HEALTH, V91, P774, DOI 10.2105/AJPH.91.5.774; Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1; MARMOT MG, 1987, ANNU REV PUBL HEALTH, V8, P111, DOI 10.1146/annurev.pu.08.050187.000551; MARMOT MG, 1986, LANCET, V2, P274; Marzuk PM, 1997, AM J DRUG ALCOHOL AB, V23, P221, DOI 10.3109/00952999709040943; O'Driscoll PT, 2001, AM J PUBLIC HEALTH, V91, P984, DOI 10.2105/AJPH.91.6.984; Origer A, 2014, INT J DRUG POLICY; Origer A, 2014, EUR ADDICT RES, V20, P87, DOI 10.1159/000355170; Pasarin M, 1999, Gac Sanit, V13, P431; Pauly B, 2008, INT J DRUG POLICY, V19, P4, DOI 10.1016/j.drugpo.2007.11.005; Rubin DB, 1987, MULTIPLE IMPUTATION, DOI [10.1002/sim.6008, DOI 10.1002/SIM.6008]; Sporer KA, 2003, BMJ-BRIT MED J, V326, P442, DOI 10.1136/bmj.326.7386.442; Torralba L, 1996, ADDICTION, V91, P419, DOI 10.1111/j.1360-0443.1996.tb02291.x; United Nations Office on Drugs and Crime, 2013, WORLD DRUG REPORT 20; URY HK, 1975, BIOMETRICS, V31, P643, DOI 10.2307/2529548; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; WILKINSON RG, 1989, J SOC POLICY, V18, P307, DOI 10.1017/S0047279400017591; World Health Organization, 2009, GLOBAL HEALTH RISKS	32	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125568	10.1371/journal.pone.0125568	http://dx.doi.org/10.1371/journal.pone.0125568			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH3PP	25938451	Green Published, Green Submitted, gold			2022-12-27	WOS:000353943000076
J	Shafi, T; Meyer, TW; Hostetter, TH; Melamed, ML; Parekh, RS; Hwang, S; Banerjee, T; Coresh, J; Powe, NR				Shafi, Tariq; Meyer, Timothy W.; Hostetter, Thomas H.; Melamed, Michal L.; Parekh, Rulan S.; Hwang, Seungyoung; Banerjee, Tanushree; Coresh, Josef; Powe, Neil R.			Free Levels of Selected Organic Solutes and Cardiovascular Morbidity and Mortality in Hemodialysis Patients: Results from the Retained Organic Solutes and Clinical Outcomes (ROSCO) Investigators	PLOS ONE			English	Article							P-CRESYL SULFATE; INDOXYL SULFATE; UREMIC TOXINS; MICROBIAL FERMENTATION; DIETARY POLYPHENOLS; DIALYSIS PATIENTS; ALL-CAUSE; METABOLISM; ACID; GUT	Background and Objectives Numerous substances accumulate in the body in uremia but those contributing to cardiovascular morbidity and mortality in dialysis patients are still undefined. We examined the association of baseline free levels of four organic solutes that are secreted in the native kidney - p-cresol sulfate, indoxyl sulfate, hippurate and phenylacetylglutamine - with outcomes in hemodialysis patients. Design, Setting, Participants and Measurements We measured these solutes in stored specimens from 394 participants of a US national prospective cohort study of incident dialysis patients. We examined the relation of each solute and a combined solute index to cardiovascular mortality and morbidity (first cardiovascular event) using Cox proportional hazards regression adjusted for demographics, comorbidities, clinical factors and laboratory tests including Kt/V-UREA. Results Mean age of the patients was 57 years, 65% were white and 55% were male. In fully adjusted models, a higher p-cresol sulfate level was associated with a greater risk (HR per SD increase; 95% CI) of cardiovascular mortality (1.62; 1.17-2.25; p=0.004) and first cardiovascular event (1.60; 1.23-2.08; p<0.001). A higher phenylacetylglutamine level was associated with a greater risk of first cardiovascular event (1.37; 1.18-1.58; p<0.001). Patients in the highest quintile of the combined solute index had a 96% greater risk of cardiovascular mortality (1.96; 1.05-3.68; p=0.04) and 62% greater risk of first cardiovascular event (1.62; 1.12-2.35; p=0.01) compared with patients in the lowest quintile. Results were robust in sensitivity analyses. Conclusions Free levels of uremic solutes that are secreted by the native kidney are associated with a higher risk of cardiovascular morbidity and mortality in incident hemodialysis patients.	[Shafi, Tariq; Hwang, Seungyoung; Coresh, Josef] Johns Hopkins Univ, Dept Med, Div Nephrol, Baltimore, MD 21218 USA; [Shafi, Tariq; Coresh, Josef] Johns Hopkins Univ, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA; [Meyer, Timothy W.] Vet Adm Palo Alto Hlth Care Syst, Dept Med, Div Nephrol, Palo Alto, CA USA; [Meyer, Timothy W.] Stanford Univ, Palo Alto, CA 94304 USA; [Hostetter, Thomas H.] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA; [Melamed, Michal L.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Melamed, Michal L.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Parekh, Rulan S.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Parekh, Rulan S.] Univ Toronto, Dept Pediat, Toronto, ON, Canada; [Banerjee, Tanushree; Powe, Neil R.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Coresh, Josef] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Coresh, Josef] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Stat, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Stanford University; Case Western Reserve University; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Toronto; University of Toronto; University of California System; University of California San Francisco; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Shafi, T (corresponding author), Johns Hopkins Univ, Dept Med, Div Nephrol, Baltimore, MD 21218 USA.	tshafi@jhmi.edu	Parekh, Rulan/AAQ-4411-2020	Parekh, Rulan/0000-0001-6313-5752; Shafi, Tariq/0000-0002-7222-4666	Agency for Healthcare Quality and Research AHRQ [R01-HS008365]; National Heart, Lung, and Blood Institute (NHLBI) [RO1-HL-62985]; National Institute of Diabetes & Digestive & Kidney Diseases NIDDK [R01-DK-059616, R01-DK-080123]; National Kidney Foundation of Maryland Professional Development Award [K23-DK-083514]; American Heart Association [01-4019-7N]; National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health;  [R01-DK-072367];  [K24-DK- 02643]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS008365] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001073] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059616, K24DK002643, R01DK080123] Funding Source: NIH RePORTER	Agency for Healthcare Quality and Research AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes & Digestive & Kidney Diseases NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Kidney Foundation of Maryland Professional Development Award; American Heart Association(American Heart Association); National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); ; ; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	CHOICE was supported by R01-HS008365 (Agency for Healthcare Quality and Research AHRQ) from 7/1994 to 6/1999, by RO1-HL-62985 (National Heart, Lung, and Blood Institute (NHLBI) from 9/00 to 6/06, R01-DK-059616 (National Institute of Diabetes & Digestive & Kidney Diseases NIDDK) from 9/2000 to 6/2005 and by R01-DK-080123 from 8/2008 to 6/2015 (National Institute of Diabetes & Digestive & Kidney Diseases NIDDK). Dr. Shafi is supported by K23-DK-083514 and National Kidney Foundation of Maryland Professional Development Award. Dr. Parekh was supported by R01-DK-072367. Dr. Coresh is supported in part as an American Heart Association established investigator (01-4019-7N). Dr. Powe is supported in part by K24-DK-02643 and R01-DK-080123. Research reported in this publication was supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The reagents for low molecular weight solutes beta-Trace Protein, beta 2 microglobulin and cystatin C were provided by Siemens to the University of Minnesota, where the measurements were performed. Siemens had no role in the design, analysis, and interpretation of data or the preparation of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronov PA, 2011, J AM SOC NEPHROL, V22, P1769, DOI 10.1681/ASN.2010121220; Athienites NV, 2000, SEMIN DIALYSIS, V13, P320, DOI 10.1046/j.1525-139x.2000.00095.x; Bammens B, 2006, KIDNEY INT, V69, P1081, DOI 10.1038/sj.ki.5000115; Barreto FC, 2009, CLIN J AM SOC NEPHRO, V4, P1551, DOI 10.2215/CJN.03980609; Depner TA, 2001, SEMIN DIALYSIS, V14, P9, DOI 10.1046/j.1525-139x.2001.00003-2.x; Depner TA, 2001, SEMIN DIALYSIS, V14, P246, DOI 10.1046/j.1525-139X.2001.00072.x; Dobre M, 2013, CLIN J AM SOC NEPHRO, V8, P322, DOI 10.2215/CJN.04260412; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Duranton F, 2012, J AM SOC NEPHROL, V23, P1258, DOI 10.1681/ASN.2011121175; Eloot S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076838; Eloot S, 2012, NEPHROL DIAL TRANSPL, V27, P4021, DOI 10.1093/ndt/gfs367; Eloot S, 2012, NEPHROL DIAL TRANSPL, V27, P3975, DOI 10.1093/ndt/gfs435; Eloot S, 2012, SEMIN DIALYSIS, V25, P505, DOI 10.1111/j.1525-139X.2012.01107.x; Evenepoel P, 2009, KIDNEY INT, V76, pS12, DOI 10.1038/ki.2009.402; Foley RN, 1998, J AM SOC NEPHROL, V9, P267; Fujii H, 2011, THER APHER DIAL, V15, P125, DOI 10.1111/j.1744-9987.2010.00883.x; Gonthier MP, 2006, BIOMED PHARMACOTHER, V60, P536, DOI 10.1016/j.biopha.2006.07.084; Liabeuf S, 2010, NEPHROL DIAL TRANSPL, V25, P1183, DOI 10.1093/ndt/gfp592; Lin CJ, 2013, ARCH MED RES, V44, P535, DOI 10.1016/j.arcmed.2013.09.007; Lin CJ, 2013, ARCH MED SCI, V9, P662, DOI 10.5114/aoms.2013.36901; Lin CJ, 2010, NEPHROL DIAL TRANSPL, V25, P3693, DOI 10.1093/ndt/gfq251; Liu YM, 2004, JAMA-J AM MED ASSOC, V291, P451, DOI 10.1001/jama.291.4.451; Longenecker JC, 2005, J AM SOC NEPHROL, V16, P1794, DOI 10.1681/ASN.2004110922; Marquez IO, 2011, CLIN J AM SOC NEPHRO, V6, P290, DOI 10.2215/CJN.06100710; Meijers BKI, 2011, NEPHROL DIAL TRANSPL, V26, P759, DOI 10.1093/ndt/gfq818; Meijers BKI, 2010, CLIN J AM SOC NEPHRO, V5, P1182, DOI 10.2215/CJN.07971109; Meijers BKI, 2009, AM J KIDNEY DIS, V54, P891, DOI 10.1053/j.ajkd.2009.04.022; Melamed ML, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-134; Meyer TW, 2007, NEW ENGL J MED, V357, P1316, DOI 10.1056/NEJMra071313; Meyer TW, 2011, SEMIN DIALYSIS, V24, P471, DOI 10.1111/j.1525-139X.2011.00979.x; Miskulin DC, 2002, AM J KIDNEY DIS, V39, P324, DOI 10.1053/ajkd.2002.30552; Mulder TP, 2005, AM J CLIN NUTR, V81, p256S, DOI 10.1093/ajcn/81.1.256S; Niwa T, 2010, J RENAL NUTR, V20, pS2, DOI 10.1053/j.jrn.2010.05.002; OWEN WF, 1993, NEW ENGL J MED, V329, P1001, DOI 10.1056/NEJM199309303291404; Patel KP, 2012, CLIN J AM SOC NEPHRO, V7, P982, DOI 10.2215/CJN.12491211; Pereira-Caro G, 2014, AM J CLIN NUTR, V100, P1378, DOI 10.3945/ajcn.114.090282; Poesen R, 2013, SEMIN DIALYSIS, V26, P323, DOI 10.1111/sdi.12082; Powe NR, 1996, SEMIN DIALYSIS, V9, P9, DOI 10.1111/j.1525-139X.1996.tb00890.x; Rechner AR, 2004, FREE RADICAL BIO MED, V36, P212, DOI 10.1016/j.freeradbiomed.2003.09.022; Rechner AR, 2002, FREE RADICAL RES, V36, P1229, DOI 10.1080/246-1071576021000016472; Rhee EP, 2010, J AM SOC NEPHROL, V21, P1041, DOI 10.1681/ASN.2009111132; Russell WR, 2013, MOL NUTR FOOD RES, V57, P523, DOI 10.1002/mnfr.201200594; Schepers E, 2010, BLOOD PURIFICAT, V29, P130, DOI 10.1159/000245639; SEAKINS JWT, 1971, CLIN CHIM ACTA, V35, P121, DOI 10.1016/0009-8981(71)90302-0; Singer JD., 2003, APPL LONGITUDINAL AN; Sirich TL, 2014, J AM SOC NEPHROL, V25, P615, DOI 10.1681/ASN.2013060597; Sirich TL, 2012, NEPHROL DIAL TRANSPL, V27, P1574, DOI 10.1093/ndt/gfr691; U S Renal Data System, 2015, USRDS 2013 ANN DAT R, V4, P2; Vanholder R, 2012, NAT REV NEPHROL, V8, P579, DOI 10.1038/nrneph.2012.189; Wu IW, 2012, NEPHROL DIAL TRANSPL, V27, P1169, DOI 10.1093/ndt/gfr453; Yu L, 2006, BIOCHEMISTRY-US, V45, P9584, DOI 10.1021/bi060840b	51	63	64	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0126048	10.1371/journal.pone.0126048	http://dx.doi.org/10.1371/journal.pone.0126048			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938230	Green Published, gold, Green Submitted			2022-12-27	WOS:000353943000133
J	Tulbure, BT; Szentagotai, A; David, O; Stefan, S; Mansson, KNT; David, D; Andersson, G				Tulbure, Bogdan Tudor; Szentagotai, Aurora; David, Oana; Stefan, Simona; Mansson, Kristoffer N. T.; David, Daniel; Andersson, Gerhard			Internet-Delivered Cognitive-Behavioral Therapy for Social Anxiety Disorder in Romania: A Randomized Controlled Trial	PLOS ONE			English	Article							PSYCHOMETRIC PROPERTIES; PHOBIA INVENTORY; SELF-HELP; PSYCHOTHERAPY; PREVALENCE; DEPRESSION	Background and Aims Internet-based cognitive-behavioral therapy (iCBT) for social anxiety disorder has been found effective, as attested by independently conducted randomized controlled trials in four languages. The study aim is to test the efficacy of an iCBT program in a culture where it was not tested before (i.e. Romania). Methods Participants (n = 76) were recruited, screened and randomized to either a nine-week guided iCBT or a wait-list control group in April and May 2012. Self-report measures were collected before (April 2012) and after the intervention (July 2012), as well as six months later (January 2013). Although social anxiety was assessed with multiple measures, the Liebowitz Social Anxiety Scale - Self Report version (LSAS-SR) and Social Phobia Inventory (SPIN) were used as the primary outcome measures. Results A significant difference with a large between-group effect size in favor of iCBT was found (Cohen's d = 1.19 for LSAS-SR and d = 1.27 for SPIN). Recovery rates show that 36.8% (n = 14) in the treatment group score below the SPIN clinical cut-off compared to only 2.6% (n = 1) in the wait-list control group. Post-intervention clinical interviews also revealed that 34.2% (n = 13) of the treatment group was completely recovered (full remission) while additionally 36.8%(n = 14) retained some social anxiety symptoms (partial remission). However, an important study limitation is that post-intervention interviewers were not blinded to the study conditions. The program also effectively reduced depression and dysfunctional thinking (between-group Cohen's d = 0.84 for depression and d = 0.63 for dysfunctional thinking). Moreover, the iCBT intervention appears to have a long-term impact for participants' functioning, as the treatment gains were maintained six months later. Conclusions Internet-delivered interventions display a high potential to quickly and widely disseminate effective evidence-based programs around the world. This study provides support for guided iCBT as a promising treatment approach in Romania.	[Tulbure, Bogdan Tudor] West Univ Timiosara, Dept Psychol, Timisoara 300223, Romania; [Szentagotai, Aurora; David, Oana; Stefan, Simona; David, Daniel] Univ Babes Bolyai, Dept Clin Psychol & Psychotherapy, Cluj Napoca 400015, Romania; [Mansson, Kristoffer N. T.; Andersson, Gerhard] Linkoping Univ, Dept Behav Sci & Learning, SE-58183 Linkoping, Sweden; [Andersson, Gerhard] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Andersson, Gerhard] Karolinska Univ Hosp Huddinge, SE-14186 Stockholm, Sweden	West University of Timisoara; Babes Bolyai University from Cluj; Linkoping University; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Tulbure, BT (corresponding author), West Univ Timiosara, Dept Psychol, Bd V Parvan 4, Timisoara 300223, Romania.	bogdan.tulbure@e-uvt.ro	Andersson, Gerhard/J-8529-2012; Tulbure, Bogdan Tudor/AAF-4896-2021; Tatar, Aurora Szentagotai/C-4045-2012; Tulbure, Bogdan Tudor/H-4226-2015; Stefan, Simona/AAY-5271-2021; David, Oana/I-4479-2013	Andersson, Gerhard/0000-0003-4753-6745; Tulbure, Bogdan Tudor/0000-0001-8101-1753; Tulbure, Bogdan Tudor/0000-0001-8101-1753; David, Oana/0000-0001-8706-1778; Stefan, Simona/0000-0003-1073-1993	Sectoral Operational Program for Human Resources Development; European Social Fund [POSDRU 89/1.5/S/60189]; Postdoctoral Programs for Sustainable Development in a Knowledge Based Society; Linkoping University, Sweden	Sectoral Operational Program for Human Resources Development; European Social Fund(European Social Fund (ESF)); Postdoctoral Programs for Sustainable Development in a Knowledge Based Society; Linkoping University, Sweden	This work was possible with the financial support of the Sectoral Operational Program for Human Resources Development 2007-2013, cofinanced by the European Social Fund, under the project number POSDRU 89/1.5/S/60189 with the title "Postdoctoral Programs for Sustainable Development in a Knowledge Based Society" (Postdoctoral researcher: Dr. Bogdan Tudor Tulbure; Director of the Postdoctoral program: Dr. Daniel David), and grants awarded to the last author from Linkoping University, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acarturk C, 2009, PSYCHOL MED, V39, P241, DOI 10.1017/S0033291708003590; Andersson G, 2006, J CONSULT CLIN PSYCH, V74, P677, DOI 10.1037/0022-006X.74.4.677; Andersson G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037411; Andersson G, 2011, STEPPED CARE AND E-HEALTH: PRACTICAL APPLICATIONS TO BEHAVIORAL DISORDERS, P99, DOI 10.1007/978-1-4419-6510-3_6; Antony MM, 2006, BEHAV RES THER, V44, P1177, DOI 10.1016/j.brat.2005.08.013; Association AP, 1994, DIAGN STAT MAN MENT, V4th; Baker SL, 2002, BEHAV RES THER, V40, P701, DOI 10.1016/S0005-7967(01)00060-2; Beck AT, 1996, PSYCHOL ASSESS; Berger T, 2011, BEHAV RES THER, V49, P158, DOI 10.1016/j.brat.2010.12.007; Carlbring P, 2007, BRIT J PSYCHIAT, V190, P123, DOI 10.1192/bjp.bp.105.020107; Carlbring Per, 2011, Cognitive Behaviour Therapy, V40, P79, DOI 10.1080/16506073.2011.575591; Clark D. M., 1995, SOCIALPHOBIA DIAGNOS, P69, DOI DOI 10.1017/S1352465808004487; Connor KM, 2000, BRIT J PSYCHIAT, V176, P379, DOI 10.1192/bjp.176.4.379; Dagoo J, 2014, J ANXIETY DISORD, V28, P410, DOI 10.1016/j.janxdis.2014.02.003; Davidson JRT, 2004, ARCH GEN PSYCHIAT, V61, P1005, DOI 10.1001/archpsyc.61.10.1005; DiGiuseppe R., 1988, WORLD C BEH THER ED; DiGiuseppe R, 1990, J RATION-EMOT COGN-B, V8, P129, DOI DOI 10.1007/BF01066280; Ellis A., 1994, REASON EMOTION PSYCH; Eng W, 2007, HDB EVIDENCE BASED P, P367; Fehm L, 2005, EUR NEUROPSYCHOPHARM, V15, P453, DOI 10.1016/j.euroneuro.2005.04.002; First M. B., 1997, STRUCTURED CLIN INTE; Fresco DM, 2001, PSYCHOL MED, V31, P1025, DOI 10.1017/S0033291701004056; Furmark T, 1999, SOC PSYCH PSYCH EPID, V34, P416, DOI 10.1007/s001270050163; Furmark T, 2002, ACTA PSYCHIAT SCAND, V105, P84, DOI 10.1034/j.1600-0447.2002.1r103.x; FURMARK T, 2006, SOCIAL FOBI EFFEKTIV; Furmark T, 2009, BRIT J PSYCHIAT, V195, P440, DOI 10.1192/bjp.bp.108.060996; Hedman E, 2011, BEHAV RES THER, V49, P729, DOI 10.1016/j.brat.2011.07.009; Heimberg RG, 2002, BIOL PSYCHIAT, V51, P101, DOI 10.1016/S0006-3223(01)01183-0; Heimberg RG, 2000, EUR PSYCHIAT, V15, P29, DOI 10.1016/S0924-9338(00)00213-3; Heimberg RG, 2010, SOCIAL ANXIETY: CLINICAL, DEVELOPMENTAL, AND SOCIAL PERSPECTIVES, 2ND EDITION, P395, DOI 10.1016/B978-0-12-375096-9.00015-8; Hofmann Stefan G., 2007, Cognitive Behaviour Therapy, V36, P193, DOI 10.1080/16506070701421313; HOLLON SD, 1980, COGNITIVE THER RES, V4, P383, DOI 10.1007/BF01178214; HOLT CS, 1992, J ANXIETY DISORD, V6, P63, DOI 10.1016/0887-6185(92)90027-5; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Keller MB, 2003, ACTA PSYCHIAT SCAND, V108, P85, DOI 10.1034/j.1600-0447.108.s417.6.x; Ledley DR, 2009, BEHAV THER, V40, P414, DOI 10.1016/j.beth.2008.12.001; Liebowitz M R, 1987, Mod Probl Pharmacopsychiatry, V22, P141; Liebowitz MR, 2000, ARCH GEN PSYCHIAT, V57, P191, DOI 10.1001/archpsyc.57.2.191-a; Macavei B., 2002, ROMANIAN J COGNITIVE, V2, P105; Magee WJ, 1996, ARCH GEN PSYCHIAT, V53, P159; Mansson KNT, 2013, PSYCHIAT RES-NEUROIM, V214, P229, DOI 10.1016/j.pscychresns.2013.08.012; Martins RK, 2009, CLIN PSYCHOL REV, V29, P283, DOI 10.1016/j.cpr.2009.02.001; Mattick RP, 1998, BEHAV RES THER, V36, P455, DOI 10.1016/S0005-7967(97)10031-6; Mortberg E, 2007, ACTA PSYCHIAT SCAND, V115, P142, DOI 10.1111/j.1600-0447.2006.00839.x; Olfson M, 2000, AM J PSYCHIAT, V157, P521, DOI 10.1176/appi.ajp.157.4.521; Person JB, 2008, GUIDE ASSESSMENTS WO, P96; Rowa K., 2008, GUIDE ASSESSMENTS WO, P207; Schneier FR, 1989, J ANXIETY DIORD, V3, P15, DOI DOI 10.1016/0887-6185(89)90025-X; Spek V, 2008, PSYCHOL MED, V38, P635, DOI 10.1017/S0033291707002590; Stangier U, 2003, BEHAV RES THER, V41, P991, DOI 10.1016/S0005-7967(02)00176-6; Stein MB, 2000, AM J PSYCHIAT, V157, P1606, DOI 10.1176/appi.ajp.157.10.1606; Titov N, 2009, AUST NZ J PSYCHIAT, V43, P754, DOI 10.1080/00048670903001992; Tulbure BT, 2012, CHILD PSYCHIAT HUM D, V43, P795, DOI 10.1007/s10578-012-0297-y; Tulbure BT, 2011, PROCD SOC BEHV, V30, DOI 10.1016/j.sbspro.2011.10.108; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123; Wayman JC, 2003, ANNU M AM EDUC RES, P16	56	30	30	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0123997	10.1371/journal.pone.0123997	http://dx.doi.org/10.1371/journal.pone.0123997			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH3PP	25938241	Green Submitted, gold, Green Published			2022-12-27	WOS:000353943000013
J	Xu, Z; Shen, MX; Hu, L; Zhuang, XR; Peng, M; Hu, D; Liu, J; Wang, JH; Qu, J; Lu, F				Xu, Zhe; Shen, Meixiao; Hu, Liang; Zhuang, Xiran; Peng, Mei; Hu, Di; Liu, Jing; Wang, Jianhua; Qu, Jia; Lu, Fan			The Impact of Flap Creation Methods for Sub-Bowman's Keratomileusis (SBK) on the Central Thickness of Bowman's Layer	PLOS ONE			English	Article							IN-SITU KERATOMILEUSIS; OPTICAL COHERENCE TOMOGRAPHY; FREQUENCY DIGITAL ULTRASOUND; 3-DIMENSIONAL DISPLAY; CONFOCAL MICROSCOPY; STROMAL THICKNESS; FEMTOSECOND LASER; PHOTOTHERAPEUTIC KERATECTOMY; PHOTOREFRACTIVE KERATECTOMY; EPITHELIAL THICKNESS	Purpose To determine the impact of flap creation methods for sub-Bowman's keratomileusis (SBK) on central Bowman's layer thickness. Methods SBK flaps were made by Moria microkeratome for 20 subjects and by femtosecond (FEMTO) laser for 21 subjects. Corneal sublayer thicknesses were measured by ultra-high resolution optical coherence tomography before SBK and at 1 day, 1 week, 2 weeks, and 1 month afterwards. Each subject was imaged twice on each visit. Thicknesses of central epithelium, Bowman's layer, flap, and total cornea were calculated using a custom-made automated image processing algorithm. The repeatability of sublayer thickness measurements was tested by the intraclass correlation coefficient (ICC) and by the coefficient of repeatability (CoR) at 1 week post-SBK. Results ICCs of the Moria and FEMTO groups were >= 0.959 and >= 0.961 respectively for all sublayer measurements. The segmentation CoRs were less than 6.78% and 5.63% respectively. For both groups, microdistortions were present in the epithelium and Bowman's layer after SKB. The flap thickness of the Moria group was 9.8 mu m (95% confidence interval: 4.8-14.8 mu m) thinner than the FEMTO group one day after SBK (independent samples t-test, P < 0.05). Bowman's layer became thicker by 1.6 +/- 1.1 mu m and 1.7 +/- 1.6 mu m one day post-SBK for the Moria and FEMTO groups (repeated ANOVA, P < 0.05) and then remained stable. Corneal and sublayer thickness were similar between the two groups. Conclusions Central Bowman's layer thickness increased 1 day post-SBK. Flap creation by Moria microkeratome and femtosecond laser did not have significantly different impacts on Bowman's layer thickness following SBK.	[Xu, Zhe; Shen, Meixiao; Hu, Liang; Zhuang, Xiran; Peng, Mei; Hu, Di; Liu, Jing; Qu, Jia; Lu, Fan] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China; [Wang, Jianhua] Univ Miami, Bascom Palmer Eye Inst, Dept Ophthalmol, Miami, FL USA	Wenzhou Medical University; Bascom Palmer Eye Institute; University of Miami	Lu, F (corresponding author), Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China.	lufan62@mail.eye.ac.cn			Zhejiang Provincial Natural Science Foundation of China [LY13H180014]; Zhejiang Medical Technology and Education of China [2013KYA132]; National Nature Science Foundation of China [81170869, 81400441]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Zhejiang Medical Technology and Education of China; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by research grants from Zhejiang Provincial Natural Science Foundation of China (LY13H180014 to Shen), Zhejiang Medical Technology and Education of China (2013KYA132 to Shen), and the National Nature Science Foundation of China (Grant No. 81170869 to Lu and Grant No. 81400441 to Shen). The authors have no proprietary interest in any materials or methods described within this article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck TW, 2013, J STRENGTH COND RES, V27, P2323, DOI 10.1519/JSC.0b013e318278eea0; BETTMAN JW, 1970, NEW ENGL J MED, V282, P344; Binder PS, 2007, J CATARACT REFR SURG, V33, P1530, DOI 10.1016/j.jcrs.2007.04.043; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Charman WN, 2002, J CATARACT REFR SURG, V28, P2146, DOI 10.1016/S0886-3350(02)01636-X; Dupps WJ, 2006, EXP EYE RES, V83, P709, DOI 10.1016/j.exer.2006.03.015; Durairaj VD, 2000, OPHTHALMOLOGY, V107, P2140, DOI 10.1016/S0161-6420(00)00407-3; Durrie DS, 2008, J REFRACT SURG, V24, P77, DOI 10.3928/1081597X-20080101-14; Fagerholm P, 2003, ACTA OPHTHALMOL SCAN, V81, P19, DOI 10.1034/j.1600-0420.2003.00015.x; Ge LL, 2013, INVEST OPHTH VIS SCI, V54, P746, DOI 10.1167/iovs.11-9308; Ge LL, 2012, EYE CONTACT LENS, V38, P150, DOI 10.1097/ICL.0b013e3182499b64; Germundsson J, 2012, INVEST OPHTH VIS SCI, V53, P2354, DOI 10.1167/iovs.11-8565; Hamilton C, 2010, J CLIN MONIT COMPUT, V24, P173, DOI 10.1007/s10877-010-9230-8; Ivarsen A, 2009, INVEST OPHTH VIS SCI, V50, P2061, DOI 10.1167/iovs.08-2853; KAASHANSEN M, 1993, ACTA OPHTHALMOL, V71, P411; Kobayashi A, 2007, OPHTHALMOLOGY, V114, P69, DOI 10.1016/j.ophtha.2006.05.076; KOMAI Y, 1991, INVEST OPHTH VIS SCI, V32, P2244; KREMER I, 1995, AM J OPHTHALMOL, V119, P511, DOI 10.1016/S0002-9394(14)71239-5; Krueger RR, 2008, OPHTHALMOLOGY, V115, P1187, DOI 10.1016/j.ophtha.2007.10.007; Krueger RR, 2010, J REFRACT SURG, V26, P749, DOI 10.3928/1081597X-20100921-01; KUCHLE M, 1995, CORNEA, V14, P333; Lagali N, 2009, INVEST OPHTH VIS SCI, V50, P4192, DOI 10.1167/iovs.09-3781; Li Y, 2007, OPHTHALMOLOGY, V114, P1124, DOI 10.1016/j.ophtha.2006.09.031; Maldonado MJ, 2000, OPHTHALMOLOGY, V107, P81, DOI 10.1016/S0161-6420(99)00022-6; Muller LJ, 2001, BRIT J OPHTHALMOL, V85, P437, DOI 10.1136/bjo.85.4.437; Nagy ZZ, 2004, J REFRACT SURG, V20, P279; Netto MV, 2007, J REFRACT SURG, V23, P667; Ortiz D, 2008, J CATARACT REFR SURG, V34, P238, DOI 10.1016/j.jcrs.2007.09.023; Patel SV, 2007, J REFRACT SURG, V23, P385; Ramos-Esteban JC, 2008, J REFRACT SURG, V24, P953, DOI 10.3928/1081597X-20081101-16; Randleman JB, 2008, J REFRACT SURG, V24, P85; Reinstein DZ, 2008, J REFRACT SURG, V24, P571, DOI 10.3928/1081597X-20080601-05; Reinstein DZ, 2012, J REFRACT SURG, V28, P195, DOI 10.3928/1081597X-20120127-02; Reinstein DZ, 2011, J REFRACT SURG, V27, P417, DOI 10.3928/1081597X-20101110-01; Rocha KM, 2009, AM J OPHTHALMOL, V147, P966, DOI 10.1016/j.ajo.2009.01.010; Schmoll T, 2012, OPTOMETRY VISION SCI, V89, pE795, DOI 10.1097/OPX.0b013e3182504346; Slade SG, 2008, CURR OPIN OPHTHALMOL, V19, P325, DOI 10.1097/ICU.0b013e328302cc77; Stahl JE, 2007, J REFRACT SURG, V23, P555; Sykakis E, 2012, PATHOLOGY, V44, P234, DOI 10.1097/PAT.0b013e3283511b42; Tao AZ, 2011, INVEST OPHTH VIS SCI, V52, P3901, DOI 10.1167/iovs.09-4748; Wang JH, 2004, INVEST OPHTH VIS SCI, V45, P1812, DOI 10.1167/iovs.03-1088; Wang Jianhua, 2011, Ophthalmic Surg Lasers Imaging, V42 Suppl, pS15, DOI 10.3928/15428877-20110627-02; Wilson SE, 1998, INVEST OPHTH VIS SCI, V39, P220; Yao PJ, 2013, J REFRACT SURG, V29, P669, DOI 10.3928/1081597X-20130806-01	44	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0124996	10.1371/journal.pone.0124996	http://dx.doi.org/10.1371/journal.pone.0124996			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938492	Green Submitted, gold, Green Published			2022-12-27	WOS:000353943000037
J	Hao, Y; Armbruster, D; Hutt, MT				Hao, Yan; Armbruster, Dieter; Huett, Marc-Thorsten			Node Survival in Networks under Correlated Attacks	PLOS ONE			English	Article							COMPLEX NETWORKS	We study the interplay between correlations, dynamics, and networks for repeated attacks on a socio-economic network. As a model system we consider an insurance scheme against disasters that randomly hit nodes, where a node in need receives support from its network neighbors. The model is motivated by gift giving among the Maasai called Osotua. Survival of nodes under different disaster scenarios (uncorrelated, spatially, temporally and spatio-temporally correlated) and for different network architectures are studied with agent-based numerical simulations. We find that the survival rate of a node depends dramatically on the type of correlation of the disasters: Spatially and spatio-temporally correlated disasters increase the survival rate; purely temporally correlated disasters decrease it. The type of correlation also leads to strong inequality among the surviving nodes. We introduce the concept of disaster masking to explain some of the results of our simulations. We also analyze the subsets of the networks that were activated to provide support after fifty years of random disasters. They show qualitative differences for the different disaster scenarios measured by path length, degree, clustering coefficient, and number of cycles.	[Hao, Yan] Hobart & William Smith Coll, Dept Math & Comp Sci, Geneva, NY 14456 USA; [Armbruster, Dieter] Arizona State Univ, Sch Math & Stat Sci, Tempe, AZ 85287 USA; [Huett, Marc-Thorsten] Jacobs Univ Bremen, Sch Sci & Engn, D-28759 Bremen, Germany	Arizona State University; Arizona State University-Tempe; Jacobs University	Armbruster, D (corresponding author), Arizona State Univ, Sch Math & Stat Sci, Tempe, AZ 85287 USA.	armbruster@asu.edu			Volkswagen Foundation under the program on Complex Networks; National Science Foundation [DMS-1313312]	Volkswagen Foundation under the program on Complex Networks; National Science Foundation(National Science Foundation (NSF))	This work was partially supported by the Volkswagen Foundation under the program on Complex Networks (to Y.H and D.A.) and by the National Science Foundation under grant DMS-1313312 (DA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktipis CA, 2011, HUM ECOL, V39, P131, DOI 10.1007/s10745-010-9364-9; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Bollig M, 2006, STUDIES HUMAN ECOLOG, V2, P1; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Crucitti P, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.045104; Dorogovtsev SN, 2008, REV MOD PHYS, V80, P1275, DOI 10.1103/RevModPhys.80.1275; Hanski I., 1999, METAPOPULATION ECOLO; Hao Y, 2015, EVOLUTION HUMAN BEHA; Motter AE, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.065102; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	11	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125467	10.1371/journal.pone.0125467	http://dx.doi.org/10.1371/journal.pone.0125467			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932635	Green Published, Green Submitted, gold			2022-12-27	WOS:000353887100113
J	Hou, HF; Yuan, N; Guo, Q; Sun, T; Li, C; Liu, JB; Li, QW; Jiang, BF				Hou, Hai-Feng; Yuan, Na; Guo, Qing; Sun, Tao; Li, Cheng; Liu, Jian-Bao; Li, Qun-Wei; Jiang, Bao-Fa			Citreoviridin Enhances Atherogenesis in Hypercholesterolemic ApoE-Deficient Mice via Upregulating Inflammation and Endothelial Dysfunction	PLOS ONE			English	Article							GROWTH-FACTOR; ATHEROSCLEROSIS; ADHESION; ACTIVATION; MECHANISMS; EXPRESSION	Vascular endothelial dysfunction and inflammatory response are early events during initiation and progression of atherosclerosis. In vitro studies have described that CIT markedly upregulates expressions of ICAM-1 and VCAM-1 of endothelial cells, which result from NF-kappa B activation induced by CIT. In order to determine whether it plays a role in atherogenesis in vivo, we conducted the study to investigate the effects of CIT on atherosclerotic plaque development and inflammatory response in apolipoprotein E deficient (apoE(-/-)) mice. Five-week-old apoE(-/-) mice were fed high-fat diets and treated with CIT for 15 weeks, followed by assay of atherosclerotic lesions. Nitric oxide (NO), vascular endothelial growth factor (VEGF) and endothelin-1 (ET-1) were detected in serum. Levels of intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesionmolecule-1 (VCAM-1), VEGF, and ET-1 in plaque areas of artery walls were examined. NF-kappa B p65 expression and NF-kappa B activation in aorta also were assessed. CIT treatment significantly augmented atherosclerotic plaques and increased expressions of ICAM-1, VCAM-1, VEGF and ET-1 in aorta. Mechanistic studies showed that activation of NF-kappa B was significantly elevated by CIT treatment, indicating the effect of CIT on atherosclerosismay be regulated by activation of NF-kappa B.	[Hou, Hai-Feng; Yuan, Na; Sun, Tao; Liu, Jian-Bao; Li, Qun-Wei] Taishan Med Univ, Sch Publ Hlth, Tai An 271000, Shandong, Peoples R China; [Hou, Hai-Feng; Jiang, Bao-Fa] Shandong Univ, Sch Publ Hlth, Jinan 250012, Peoples R China; [Guo, Qing] Taian City Cent Hosp, Tai An 271000, Shandong, Peoples R China; [Li, Cheng] Shanghai Jiao Tong Univ, Coll Med, Ruijin Hosp, Shanghai 200025, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shanghai Jiao Tong University	Hou, HF (corresponding author), Taishan Med Univ, Sch Publ Hlth, Tai An 271000, Shandong, Peoples R China.	hfhou@163.com		Hou, Haifeng/0000-0002-1131-1619	National Natural Science Foundation of China (NSFC) [81202170]; Shandong Provincial Natural Science Foundation, China [ZR20010HQ006]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation, China(Natural Science Foundation of Shandong Province)	This study was supported by the National Natural Science Foundation of China (Grants: NSFC, No. 81202170), Shandong Provincial Natural Science Foundation, China (No. ZR20010HQ006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham D, 2008, RHEUMATOLOGY, V47, pV23, DOI 10.1093/rheumatology/ken282; Addabbo F, 2011, AM J PHYSIOL-ENDOC M, V301, pE1143, DOI 10.1152/ajpendo.00208.2011; Almeida MI, 2012, FOOD ADDIT CONTAM A, V29, P694, DOI 10.1080/19440049.2011.651750; Lima HCAV, 2010, TROP DOCT, V40, P95, DOI 10.1258/td.2009.090439; Blann AD, 2001, AM J CARDIOL, V87, P1160, DOI 10.1016/S0002-9149(01)01486-2; Branen L, 2004, ARTERIOSCL THROM VAS, V24, P2137, DOI 10.1161/01.ATV.0000143933.20616.1b; Cao CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064930; Cavieres V, 2014, AM J CARDIOVASC DIS, V4, P114; Fang YQ, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-123; Giannotti G, 2007, HERZ, V32, P568, DOI 10.1007/s00059-007-3073-1; Hirase T, 2012, AM J PHYSIOL-HEART C, V302, pH499, DOI 10.1152/ajpheart.00325.2011; Hou HF, 2015, TOXICOL IND HEALTH, V31, P193, DOI 10.1177/0748233713483194; Iglarz M, 2007, J CARDIOVASC PHARM, V50, P621, DOI 10.1097/FJC.0b013e31813c6cc3; Ishibashi M, 2004, ARTERIOSCL THROM VAS, V24, pE174, DOI 10.1161/01.ATV.0000143384.69170.2d; Jin N, 2014, TOXICON, V90, P226, DOI 10.1016/j.toxicon.2014.08.057; Kim I, 2001, J BIOL CHEM, V276, P7614, DOI 10.1074/jbc.M009705200; Kong BS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113242; Krieglstein CF, 2001, AM J HYPERTENS, V14, p44S, DOI 10.1016/S0895-7061(01)02069-6; Li D, 2009, CHIN J CTRL ENDEM DI, V24, P226; Maier W, 2005, CIRCULATION, V111, P1355, DOI 10.1161/01.CIR.0000158479.58589.0A; Nespereira B, 2003, ATHEROSCLEROSIS, V171, P67, DOI 10.1016/j.atherosclerosis.2003.08.009; NISHIE K, 1988, RES COMMUN CHEM PATH, V59, P31; Pateras I, 2014, EXPERT OPIN THER TAR, V18, P1089, DOI 10.1517/14728222.2014.938051; Rajesh M, 2007, AM J PHYSIOL-HEART C, V293, pH2210, DOI 10.1152/ajpheart.00688.2007; Sessa R, 2014, WORLD J CLIN CASES, V2, P240, DOI 10.12998/wjcc.v2.i7.240; Sun SQ, 2010, MED HYPOTHESES, V74, P841, DOI 10.1016/j.mehy.2009.11.043; Traub O, 1998, ARTERIOSCL THROM VAS, V18, P677, DOI 10.1161/01.ATV.18.5.677; [万悦竹 WAN Yuezhu], 2011, [中国地方病学杂志, Chinese Journal of Endemiology], V30, P379; Wang HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098070; Yu JiaNan, 2012, Chinese Journal of Endemiology, V31, P385	30	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125956	10.1371/journal.pone.0125956	http://dx.doi.org/10.1371/journal.pone.0125956			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933220	gold, Green Submitted, Green Published			2022-12-27	WOS:000353887100145
J	Hu, TT; Weng, SQ; Tang, WQ; Xue, RY; Chen, S; Cai, GX; Cai, Y; Shen, XZ; Zhang, S; Dong, L				Hu, Tingting; Weng, Shuqiang; Tang, Wenqing; Xue, Ruyi; Chen, She; Cai, Guoxiang; Cai, Yu; Shen, Xizhong; Zhang, Si; Dong, Ling			Overexpression of BIRC6 Is a Predictor of Prognosis for Colorectal Cancer	PLOS ONE			English	Article							S-PHASE ARREST; 1ST-LINE TREATMENT; APOPTOSIS PROTEIN; POOR-PROGNOSIS; CELL-GROWTH; IAP; APOLLON; BRUCE; GENE; EXPRESSION	Background and Objective Inhibitors of apoptosis proteins (IAPs) have been well investigated in human cancers, where they are frequently overexpressed and associated with poor prognosis. Here we explored the role of baculoviral IAP repeat containing 6 (BIRC6), a member of IAPs, in human colorectal cancer (CRC). Methods We used Western blotting and immunohistochemistry to examine BIRC6 expression in 7 CRC cell lines and 126 CRC clinical samples. We determined the biological significance of BIRC6 in CRC cell lines by a lentivirus-mediated silencing method. Results We reported that BIRC6 was overexpressed in CRC cell lines and clinical CRC tissues. BIRC6 overexpression was correlated with tumor size and invasion depth of CRC. BIRC6 overexpression is associated with worse overall survival (OS) (P = 0.001) and shorter disease- free survival (DFS) (P = 0.010). BIRC6 knockdown inhibited cell proliferation, arrested cell cycle at S phase, downregulated cyclin A2, B1, D1 and E1 levels, and sensitized CRC cells to chemotherapy in vitro and in vivo. Conclusions Taken together, these data suggests that BIRC6 overexpression is a predictor of poor prognosis in colorectal cancer and BIRC6 could be a potential target of CRC therapy.	[Hu, Tingting; Weng, Shuqiang; Tang, Wenqing; Xue, Ruyi; Cai, Yu; Shen, Xizhong; Dong, Ling] Fudan Univ, Zhongshan Hosp, Shanghai Inst Liver Dis, Dept Gastroenterol & Hepatol, Shanghai 200433, Peoples R China; [Hu, Tingting] Wenzhou Med Univ, Affiliated Hosp 1, Dept Gastroenterol & Hepatol, Wenzhou, Peoples R China; [Chen, She; Zhang, Si] Fudan Univ, Shanghai Med Coll, Dept Biochem & Mol Biol, Shanghai 200433, Peoples R China; [Cai, Guoxiang] Fudan Univ, Shanghai Canc Ctr, Dept Colorectal Surg, Shanghai 200433, Peoples R China; [Cai, Guoxiang] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China	Fudan University; Wenzhou Medical University; Fudan University; Fudan University; Fudan University	Zhang, S (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Biochem & Mol Biol, Shanghai 200433, Peoples R China.	zhangsi@fudan.edu.cn; dong.ling@zs-hospital.sh.cn	zhang, si/AAG-9094-2021	Xue, Ruyi/0000-0002-5710-0091; zhang, Si/0000-0002-5682-4995	Shanghai Science and Technology Commission [10411950100, 12ZR1405300]; National Natural Science Foundation of China [81100344, 81173078, 81371268, 81172273, 81272388, 81472673, 81400628]; National Clinical Key Special Subject of China [371]; Shanghai Pujiang Program [13PJD008]	Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Clinical Key Special Subject of China; Shanghai Pujiang Program(Shanghai Pujiang Program)	This work was supported by Shanghai Science and Technology Commission (grant numbers: 10411950100 to XS, 12ZR1405300 to YC), National Natural Science Foundation of China (grant numbers: 81100344, 81173078 to SZ, 81371268 to SC, 81172273, 81272388 to LD, 81472673 to YC, 81272388, 81400628 to XS), the National Clinical Key Special Subject of China (grant number: 371 to XS), and Shanghai Pujiang Program(grant number: No. 13PJD008 to GC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akin O, 2012, CA-CANCER J CLIN, V62, P364, DOI 10.3322/caac.21156; Akiyoshi T, 2008, GASTROENTEROLOGY, V134, P131, DOI 10.1053/j.gastro.2007.10.008; Athanasoula KC, 2014, CANCER LETT, V347, P175, DOI 10.1016/j.canlet.2014.02.014; Bartke T, 2004, MOL CELL, V14, P801, DOI 10.1016/j.molcel.2004.05.018; Bianchini M, 2006, INT J ONCOL, V29, P83; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Chen ZH, 1999, BIOCHEM BIOPH RES CO, V264, P847, DOI 10.1006/bbrc.1999.1585; Chu L, 2008, GENE THER, V15, P484, DOI 10.1038/gt.2008.6; Dong X, 2013, J THORAC ONCOL, V8, P161, DOI 10.1097/JTO.0b013e31827d5237; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; Findeisen P, 2005, CANCER RES, V65, P8072, DOI 10.1158/0008-5472.CAN-04-4146; Fuchs CS, 2008, J CLIN ONCOL, V26, P689, DOI 10.1200/JCO.2007.15.5390; Fulda S, 2014, LEUKEMIA, V28, P1414, DOI 10.1038/leu.2014.56; Grothey A, 2004, J CLIN ONCOL, V22, P1209, DOI 10.1200/JCO.2004.11.037; Guicciardi ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092124; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hauser HP, 1998, J CELL BIOL, V141, P1415, DOI 10.1083/jcb.141.6.1415; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Joe AK, 2002, CLIN CANCER RES, V8, P893; Kikuchi R, 2014, J BIOL CHEM, V289, P3457, DOI 10.1074/jbc.M113.514430; LaCasse EC, 2008, ONCOGENE, V27, P6252, DOI 10.1038/onc.2008.302; LaCasse EC, 1998, ONCOGENE, V17, P3247, DOI 10.1038/sj.onc.1202569; Lamers F, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-285; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee YS, 2013, J NAT PROD, V76, P2195, DOI 10.1021/np4005135; Lopergolo A, 2009, BRIT J CANCER, V100, P739, DOI 10.1038/sj.bjc.6604927; Lotz K, 2004, MOL CELL BIOL, V24, P9339, DOI 10.1128/MCB.24.21.9339-9350.2004; Low CG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055837; Morikawa T, 2012, INT J CANCER, V131, P1169, DOI 10.1002/ijc.26495; Qiu XB, 2004, EMBO J, V23, P800, DOI 10.1038/sj.emboj.7600075; Qiu XB, 2005, J BIOL CHEM, V280, P174, DOI 10.1074/jbc.M411430200; Ren JY, 2005, P NATL ACAD SCI USA, V102, P565, DOI 10.1073/pnas.0408744102; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Sung KW, 2007, CLIN CANCER RES, V13, P5109, DOI 10.1158/1078-0432.CCR-07-0693; Suzuki K, 2010, CANCER SCI, V101, P1163, DOI 10.1111/j.1349-7006.2010.01504.x; Van Houdt WJ, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.011353-1, 10.1074/mcp.M111.011353]; Vernooy SY, 2002, CURR BIOL, V12, P1164, DOI 10.1016/S0960-9822(02)00935-1; Yang XR, 2009, CLIN CANCER RES, V15, P5518, DOI 10.1158/1078-0432.CCR-09-0151; Zaanan A, 2011, CELL ONCOL, V34, P155, DOI 10.1007/s13402-011-0024-x; Zhao N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073461	40	21	22	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125281	10.1371/journal.pone.0125281	http://dx.doi.org/10.1371/journal.pone.0125281			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933218	gold, Green Published, Green Submitted			2022-12-27	WOS:000353887100096
J	Loprinzi, PD; Swenor, BK; Ramulu, PY				Loprinzi, Paul D.; Swenor, Bonnielin K.; Ramulu, Pradeep Y.			Age-Related Macular Degeneration Is Associated with Less Physical Activity among US Adults: Cross-Sectional Study	PLOS ONE			English	Article							UNCORRECTED REFRACTIVE ERROR; VISUAL IMPAIRMENT; CARDIOVASCULAR-DISEASE; SEDENTARY BEHAVIOR; UNITED-STATES; RISK-FACTORS; PREVALENCE; POPULATION; VISION; MACULOPATHY	Background We have a limited understanding of the effects of age-related macular degeneration (AMD) on physical activity (PA), and we have no prevalence estimates of the daily movement patterns among Americans with AMD. Therefore, we examined the association between AMD and PA and provided estimates of the daily movement patterns of Americans with AMD. Methods Data from the 2005-2006 National Health and Nutrition Examination Survey were used, including 1,656 adults (40-85 yrs). Retinal imaging was performed to classify individuals as no AMD, early AMD, or late AMD. Participants wore an ActiGraph 7164 accelerometer for 7 days to measure PA behavior. Results 93.2% of participants with late AMD were in the least desirable group (not sufficiently active and having a negative light intensity-sedentary behavior balance). After adjustments (including age), participants with late AMD, as compared to those with no AMD, engaged in 50% less moderate-to-vigorous physical activity (MVPA) (RR = 0.50; 95% CI: 0.28-0.90). When visual acuity was entered into the model along with the other covariates, the association between late AMD and MVPA was no longer significant (RR = 0.54; 95% CI: 0.29-1.01), suggesting that visual acuity may partially mediate this relationship. Conclusions Individuals with late AMD engage in very little moderate-to-vigorous physical activity. Visually acuity, in part, explains the relationship between late AMD and PA.	[Loprinzi, Paul D.] Univ Mississippi, Ctr Hlth Behav Res, Dept Hlth Exercise Sci & Recreat Management, University, MS 38677 USA; [Swenor, Bonnielin K.; Ramulu, Pradeep Y.] Johns Hopkins Sch Med, Wilmer Eye Inst, Baltimore, MD USA	University of Mississippi; Johns Hopkins University; Johns Hopkins Medicine	Loprinzi, PD (corresponding author), Univ Mississippi, Ctr Hlth Behav Res, Dept Hlth Exercise Sci & Recreat Management, University, MS 38677 USA.	pdloprin@olemiss.edu	Swenor, Bonnie/ABH-1542-2021	Swenor, Bonnie/0000-0002-6044-0951	Research to Prevent Blindness; National Institutes of Health [EY015025, EY022976]; NATIONAL EYE INSTITUTE [K12EY015025, R01EY022976] Funding Source: NIH RePORTER	Research to Prevent Blindness(Research to Prevent Blindness (RPB)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by Research to Prevent Blindness (http://www.rpbusa.org/rpb/) and National Institutes of Health grants EY015025 and EY022976 (PYR; http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquilante K, 2001, OPTOMETRY VISION SCI, V78, P290, DOI 10.1097/00006324-200105000-00012; Bandello F, 2007, INVEST OPHTH VIS SCI, V48, P96, DOI 10.1167/iovs.06-0283; BULLIMORE MA, 1991, INVEST OPHTH VIS SCI, V32, P2020; Cackett P, 2008, BRIT J OPHTHALMOL, V92, P1564, DOI 10.1136/bjo.2008.143875; Casten Robin J, 2004, Curr Opin Ophthalmol, V15, P181, DOI 10.1097/01.icu.0000120710.35941.3f; Chomistek AK, 2013, J AM COLL CARDIOL, V61, P2346, DOI 10.1016/j.jacc.2013.03.031; Ford ES, 2012, INT J EPIDEMIOL, V41, P1338, DOI 10.1093/ije/dys078; Hassan SE, 2002, OPTOMETRY VISION SCI, V79, P697, DOI 10.1097/00006324-200211000-00007; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Hochberg C, 2012, INVEST OPHTH VIS SCI, V53, P3201, DOI 10.1167/iovs.12-9469; Klein R, 2010, ARCH OPHTHALMOL-CHIC, V128, P750, DOI 10.1001/archophthalmol.2010.92; Knudtson MD, 2006, BRIT J OPHTHALMOL, V90, P1461, DOI 10.1136/bjo.2006.103796; Ko F, 2012, JAMA-J AM MED ASSOC, V308, P2361, DOI 10.1001/jama.2012.85685; LAATIKAINEN L, 1995, ACTA OPHTHALMOL SCAN, V73, P105; Loprinzi PD, 2013, MAYO CLIN PROC, V88, P942, DOI 10.1016/j.mayocp.2013.05.015; Loprinzi PD, 2013, OBESITY FACTS, V6, P380, DOI 10.1159/000354752; Loprinzi PD, 2013, J PHYS ACT HEALTH; Mares JA, 2011, ARCH OPHTHALMOL-CHIC, V129, P470, DOI 10.1001/archophthalmol.2010.314; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; MCPHILLIPS JB, 1989, AM J PREV MED, V5, P65, DOI 10.1016/S0749-3797(18)31107-3; Munch IC, 2013, INVEST OPHTH VIS SCI, V54, P3932, DOI 10.1167/iovs.12-10785; Rani PK, 2012, MIDDLE EAST AFR J OP, V19, P129, DOI 10.4103/0974-9233.92129; Richman J, 2010, ARCH OPHTHALMOL-CHIC, V128, P1576, DOI 10.1001/archophthalmol.2010.275; Rosenberg T, 1996, ACTA OPHTHALMOL SCAN, V74, P399; Rovner BW, 2009, ALZHEIMERS DEMENT, V5, P12, DOI 10.1016/j.jalz.2008.06.001; Scilley K, 2002, OPHTHALMOLOGY, V109, P1235, DOI 10.1016/S0161-6420(02)01060-6; Seddon Johanna M., 2004, International Ophthalmology Clinics, V44, P17, DOI 10.1097/00004397-200404440-00004; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Subhi Y, 2014, CLIN OPHTHALMOL, V8, P15, DOI 10.2147/OPTH.S55080; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; van Poppel MNM, 2010, SPORTS MED, V40, P565, DOI 10.2165/11531930-000000000-00000; Warburton DER, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-39; West SK, 1997, INVEST OPHTH VIS SCI, V38, P72; Westerterp KR, 2009, EUR J APPL PHYSIOL, V105, P823, DOI 10.1007/s00421-009-1000-2; Wiliams RA, 1998, ARCH OPHTHALMOL-CHIC, V116, P514; Williams PT, 2009, INVEST OPHTH VIS SCI, V50, P101, DOI 10.1167/iovs.08-2165; Willis JR, 2013, JAMA OPHTHALMOL, V131, P1049, DOI 10.1001/jamaophthalmol.2013.316; Willis JR, 2012, ARCH OPHTHALMOL-CHIC, V130, P329, DOI 10.1001/archopthalmol.2011.1773; YANNUZZI LA, 1992, ARCH OPHTHALMOL-CHIC, V110, P1701	39	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125394	10.1371/journal.pone.0125394	http://dx.doi.org/10.1371/journal.pone.0125394			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933421	Green Published, gold, Green Submitted			2022-12-27	WOS:000353887100105
J	Martinez-Hernandez, A; Cordova, EJ; Rosillo-Salazar, O; Garcia-Ortiz, H; Contreras-Cubas, C; Islas-Andrade, S; Revilla-Monsalve, C; Salas-Labadia, C; Orozco, L				Martinez-Hernandez, Angelica; Cordova, Emilio J.; Rosillo-Salazar, Oscar; Garcia-Ortiz, Humberto; Contreras-Cubas, Cecilia; Islas-Andrade, Sergio; Revilla-Monsalve, Cristina; Salas-Labadia, Consuelo; Orozco, Lorena			Association of HMOX1 and NQO1 Polymorphisms with Metabolic Syndrome Components	PLOS ONE			English	Article							HEME OXYGENASE-1 GENE; OXIDATIVE STRESS; CARBON-MONOXIDE; NAD(P)H-QUINONE OXIDOREDUCTASE-1; ENDOTHELIAL DYSFUNCTION; MICROSATELLITE REPEATS; C609T POLYMORPHISM; NATIONAL-HEALTH; IRON STATUS; PROMOTER	Metabolic syndrome (MetS) is among the most important public health problems worldwide, and is recognized as a major risk factor for various illnesses, including type 2 diabetes mellitus, obesity, and cardiovascular diseases. Recently, oxidative stress has been suggested as part of MetS aetiology. The heme oxygenase 1 (HMOX1) and NADH: quinone oxidoreductase 1 (NQO1) genes are crucial mediators of cellular defence against oxidative stress. In the present study, we analysed the associations of HMOX1 (GT)n and NQO1 C609T polymorphisms with MetS and its components. Our study population comprised 735 Mexican Mestizos unrelated volunteers recruited from different tertiary health institutions from Mexico City. In order to know the HMOX1 (GT) n and NQO1 C609T allele frequencies in Amerindians, we included a population of 241 Amerindian native speakers. Their clinical and demographic data were recorded. The HMOX1 (GT) n polymorphism was genotyped using PCR and fluorescence technology. NQO1 C609T polymorphism genotyping was performed using TaqMan probes. Short allele (<25 GT repeats) of the HMOX1 polymorphism was associated with high systolic and diastolic blood pressure, and the T allele of the NQO1 C609T polymorphism was associated with increased triglyceride levels and decreased HDL-c levels, but only in individuals with MetS. This is the first study to analyse the association between MetS and genes involved in oxidative stress among Mexican Mestizos. Our data suggest that polymorphisms of HMOX1 and NQO1 genes are associated with a high risk of metabolic disorders, including high systolic and diastolic blood pressure, hypertriglyceridemia, and low HDL-c levels in Mexican Mestizo individuals.	[Martinez-Hernandez, Angelica; Cordova, Emilio J.; Rosillo-Salazar, Oscar; Garcia-Ortiz, Humberto; Contreras-Cubas, Cecilia; Orozco, Lorena] Inst Nacl Med Genom, SS, Immunogen & Metab Dis Lab, Mexico City, DF, Mexico; [Islas-Andrade, Sergio; Revilla-Monsalve, Cristina] IMSS, Ctr Med Nacl Siglo 21, Med Res Unit Metab Dis, Mexico City, DF, Mexico; [Salas-Labadia, Consuelo] Inst Nacl Pediat, SS, Dept Human Genet, Tissue Culture Lab, Mexico City, DF, Mexico	Instituto Nacional de Medicina Genomica; Instituto Mexicano del Seguro Social	Orozco, L (corresponding author), Inst Nacl Med Genom, SS, Immunogen & Metab Dis Lab, Mexico City, DF, Mexico.	lorozco@inmegen.gob.mx	/ABI-8453-2020; Revilla-Monsalve, Cristina/ABG-6663-2021	/0000-0002-9402-4219; Orozco, Lorena/0000-0002-5801-9180; Rosillo Salazar, Oscar Daniel/0000-0002-6393-2409; Garcia-Ortiz, Humberto/0000-0002-0453-980X; salas, consuelo/0000-0002-3301-7357; Revilla Monsalve, Maria Cristina/0000-0002-6202-1160				Abraham NG, 2005, FREE RADICAL BIO MED, V39, P1, DOI 10.1016/j.freeradbiomed.2005.03.010; Arredondo M, 2007, AM J CLIN NUTR, V86, P1347, DOI 10.1093/ajcn/86.5.1347; Arredondo M, 2011, BIOL TRACE ELEM RES, V143, P625, DOI 10.1007/s12011-010-8895-7; Bagul PK, 2012, PHARMACOL RES, V66, P260, DOI 10.1016/j.phrs.2012.05.003; Cordova EJ, 2012, CLIN EXP RHEUMATOL, V30, P297; Cordova EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088069; Ford ES, 2003, DIABETES, V52, P2346, DOI 10.2337/diabetes.52.9.2346; Funke C, 2009, J NEURAL TRANSM, V116, P853, DOI 10.1007/s00702-009-0237-6; Gaikwad A, 2001, J BIOL CHEM, V276, P22559, DOI 10.1074/jbc.M101053200; Gregorek AC, 2013, BIOCHEM GENET, V51, P482, DOI 10.1007/s10528-013-9579-8; Han SJ, 2009, MOL GENET METAB, V97, P85, DOI 10.1016/j.ymgme.2009.01.012; Hassan N, 2013, N-S ARCH PHARMACOL, V386, P217, DOI 10.1007/s00210-012-0822-3; Hong CC, 2007, CANCER EPIDEM BIOMAR, V16, P1784, DOI 10.1158/1055-9965.EPI-07-0247; Hwang JH, 2009, DIABETES, V58, P965, DOI 10.2337/db08-1183; Idriss NK, 2008, J AM COLL CARDIOL, V52, P971, DOI 10.1016/j.jacc.2008.06.019; Ilkun O, 2013, CURR PHARM DESIGN, V19, P4806, DOI 10.2174/1381612811319270003; Islam T, 2008, AM J RESP CRIT CARE, V177, P388, DOI 10.1164/rccm.200706-863OC; Javanmard SH, 2012, MOL BIOL REP, V39, P3355, DOI 10.1007/s11033-011-1105-7; Johnson FK, 2006, AM J PHYSIOL-REG I, V290, pR601, DOI 10.1152/ajpregu.00308.2005; Katana EP, 2011, CHINESE MED J-PEKING, V124, P3408, DOI 10.3760/cma.j.issn.0366-6999.2011.20.036; Kim DH, 2008, J PHARMACOL EXP THER, V325, P833, DOI 10.1124/jpet.107.135285; Kral A, 2011, FOLIA BIOL-PRAGUE, V57, P182; Leffler CW, 1999, AM J PHYSIOL-HEART C, V276, pH1641, DOI 10.1152/ajpheart.1999.276.5.H1641; Leiva E, 2013, BIOL TRACE ELEM RES, V151, P1, DOI 10.1007/s12011-012-9525-3; Martin NJ, 2009, MUTAT RES-GEN TOX EN, V674, P93, DOI 10.1016/j.mrgentox.2008.09.009; Mustafa S, 2008, J VASC SURG, V47, P566, DOI 10.1016/j.jvs.2007.09.060; Ono K, 2003, J HYPERTENS, V21, P1497, DOI 10.1097/00004872-200308000-00013; Palmieri VO, 2006, J NUTR, V136, P3022, DOI 10.1093/jn/136.12.3022; Palming J, 2007, J CLIN ENDOCR METAB, V92, P2346, DOI 10.1210/jc.2006-2476; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramprasath T, 2012, MOL CELL BIOCHEM, V361, P143, DOI 10.1007/s11010-011-1098-5; Rojas R, 2010, SALUD PUBLICA MEXICO, V52, pS11, DOI 10.1590/s0036-36342010000700004; Rojas-Martinez R, 2012, SALUD PUBLICA MEXICO, V54, P13; Rueda B, 2007, ARTHRITIS RHEUM-US, V56, P3953, DOI 10.1002/art.23048; Saraiva RM, 2007, NITRIC OXIDE-BIOL CH, V16, P331, DOI 10.1016/j.niox.2006.12.001; Sarbia M, 2003, INT J CANCER, V107, P381, DOI 10.1002/ijc.11430; Sheu CC, 2009, INTENS CARE MED, V35, P1343, DOI 10.1007/s00134-009-1504-6; Teran FJ, 2005, AM J PHYSIOL-REG I, V288, pR615, DOI 10.1152/ajpregu.00123.2004; Vazquez-Armenta G, 2013, TOHOKU J EXP MED, V231, P201, DOI 10.1620/tjem.231.201; Wan Hua-ying, 2005, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V27, P285; Wang GY, 2006, BIOCHEM BIOPH RES CO, V341, P310, DOI 10.1016/j.bbrc.2005.12.195; Wu MM, 2011, ATHEROSCLEROSIS, V219, P704, DOI 10.1016/j.atherosclerosis.2011.08.047; Zhang JH, 2003, CARCINOGENESIS, V24, P905, DOI 10.1093/carcin/bgg019; Zierold KM, 2004, AM J PUBLIC HEALTH, V94, P1936, DOI 10.2105/AJPH.94.11.1936	44	18	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0123313	10.1371/journal.pone.0123313	http://dx.doi.org/10.1371/journal.pone.0123313			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933176	Green Published, gold, Green Submitted			2022-12-27	WOS:000353887100019
J	Obure, CD; Sweeney, S; Darsamo, V; Michaels-Igbokwe, C; Guinness, L; Terris-Prestholt, F; Muketo, E; Nhlabatsi, Z; Warren, CE; Mayhew, S; Watts, C; Vassall, A				Obure, Carol Dayo; Sweeney, Sedona; Darsamo, Vanessa; Michaels-Igbokwe, Christine; Guinness, Lorna; Terris-Prestholt, Fern; Muketo, Esther; Nhlabatsi, Zelda; Warren, Charlotte E.; Mayhew, Susannah; Watts, Charlotte; Vassall, Anna		Integra Initiative	The Costs of Delivering Integrated HIV and Sexual Reproductive Health Services in Limited Resource Settings	PLOS ONE			English	Article							HIV/AIDS	Objective To present evidence on the total costs and unit costs of delivering six integrated sexual reproductive health and HIV services in a high and medium HIV prevalence setting, in order to support policy makers and planners scaling up these essential services. Design A retrospective facility based costing study conducted in 40 non-government organization and public health facilities in Kenya and Swaziland. Methods Economic and financial costs were collected retrospectively for the year 2010/11, from each study site with an aim to estimate the cost per visit of six integrated HIV and SRH services. A full cost analysis using a combination of bottom-up and step-down costing methods was conducted from the health provider's perspective. The main unit of analysis is the economic unit cost per visit for each service. Costs are converted to 2013 International dollars. Results The mean cost per visit for the HIV/SRH services ranged from $Int 14.23 (PNC visit) to $Int 74.21 (HIV treatment visit). We found considerable variation in the unit costs per visit across settings with family planning services exhibiting the least variation ($Int 6.71-52.24) and STI treatment and HIV treatment visits exhibiting the highest variation in unit cost ranging from ($Int 5.44-281.85) and ($Int 0.83-314.95), respectively. Unit costs of visits were driven by fixed costs while variability in visit costs across facilities was explained mainly by technology used and service maturity. Conclusion For all services, variability in unit costs and cost components suggest that potential exists to reduce costs through better use of both human and capital resources, despite the high proportion of expenditure on drugs and medical supplies. Further work is required to explore the key drivers of efficiency and interventions that may facilitate efficiency improvements.	[Obure, Carol Dayo; Sweeney, Sedona; Darsamo, Vanessa; Michaels-Igbokwe, Christine; Guinness, Lorna; Terris-Prestholt, Fern; Mayhew, Susannah; Watts, Charlotte; Vassall, Anna] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England; [Warren, Charlotte E.] Populat Council, Nairobi, Kenya; [Muketo, Esther] Family Hlth Opt Kenya, Nairobi, Kenya; [Nhlabatsi, Zelda] Family Life Assoc Swaziland, Manzini, Swaziland	University of London; London School of Hygiene & Tropical Medicine	Obure, CD (corresponding author), London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England.	dayoobure@gmail.com	Guinness, Lorna/AAN-3875-2020	Guinness, Lorna/0000-0002-1013-4200; Vassall, Anna/0000-0002-2911-1375; Michaels-Igbokwe, Christine/0000-0003-0469-7055; Mayhew, Susannah/0000-0002-2433-3809; Terris-Prestholt, Fern/0000-0003-1693-5196	Bill and Melinda Gates Foundation [48733]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Funding for this study was provided by the Bill and Melinda Gates Foundation (Grant No: 48733). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askew I, 2003, REPROD HEALTH MATTER, V11, P51, DOI 10.1016/S0968-8080(03)22101-7; Bikilla AD, 2009, COST EFF RESOUR ALLO, V7, P6, DOI DOI 10.1186/1478-7547-7-6; Bratt JH, 2011, TROP MED INT HEALTH, V16, P110, DOI 10.1111/j.1365-3156.2010.02640.x; Central Statistics Office, 2007, SWAZ DEM HLTH SURV 2, DOI [10.1371/journal.pone.0117219, DOI 10.1371/JOURNAL.PONE.0117219]; Church K, 2009, STUD FAMILY PLANN, V40, P171, DOI 10.1111/j.1728-4465.2009.00201.x; Cleary Susan M, 2006, Cost Eff Resour Alloc, V4, P20, DOI 10.1186/1478-7547-4-20; Conteh L, 2004, HEALTH POLICY PLANN, V19, P127, DOI 10.1093/heapol/czh015; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Gleneagles G, 2005, GLENEAGLES COMMINIQU; Government of Kenya, 2009, NAT REPR HLTH HIV AI; Government of Swaziland, 2009, NAT STRAT FRAM NSF H; Government of Swaziland, 2013, SWAZ HIV INC MEAS SU; Homan R., 2007, STRENGTHENING FINANC; Homan R, 2006, LINKING REPROD HLTH; Johns Benjamin, 2003, Cost Eff Resour Alloc, V1, P1, DOI 10.1186/1478-7547-1-1; Kanavos P, 1999, J Health Serv Res Policy, V4, P122; Liambila W, 2008, FEASIBILITY ACCEPTAB; Lush L, 2002, INT FAM PLAN PERSPEC, V28, P71, DOI 10.2307/3088238; Martinson N, 2009, JAIDS J ACQUIRED IMM, V50; Menzies NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048726; National AIDS and STI Control Programme, 2013, KEN AIDS IND SURV 20; National AIDS/STI Control Program, 2009, 2007 KEN AIDS IND SU; Rosen S, 2008, TROP MED INT HEALTH, V13, P1005, DOI 10.1111/j.1365-3156.2008.02114.x; Shade SB, 2013, AIDS, V27, pS87, DOI 10.1097/QAD.0000000000000038; Sweeney S, 2011, SEX TRANSM INFECT; UNFPA, 2004, NEW YORK CALL COMM L; UNFPA, 2004, GLION CALL ACT FAM P; UNGASS, 2001, UN GEN ASS SPEC SESS; Warren CE, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-973; World Bank, PPP CONV FACT GDP LC	30	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124476	10.1371/journal.pone.0124476	http://dx.doi.org/10.1371/journal.pone.0124476			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH2XA	25933414	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000353887100042
J	Popken, J; Graf, A; Krebs, S; Blum, H; Schmid, VJ; Strauss, A; Guengoer, T; Zakhartchenko, V; Wolf, E; Cremer, T				Popken, Jens; Graf, Alexander; Krebs, Stefan; Blum, Helmut; Schmid, Volker J.; Strauss, Axel; Guengoer, Tuna; Zakhartchenko, Valeri; Wolf, Eckhard; Cremer, Thomas			Remodeling of the Nuclear Envelope and Lamina during Bovine Preimplantation Development and Its Functional Implications	PLOS ONE			English	Article							PORE COMPLEX; GENOME ACTIVATION; FIBROBLAST NUCLEI; MICROSCOPY; DYNAMICS; ORGANIZATION; ARCHITECTURE; PERIPHERY; REVEALS; PROTEIN	The present study demonstrates a major remodeling of the nuclear envelope and its underlying lamina during bovine preimplantation development. Up to the onset of major embryonic genome activation (MGA) at the 8-cell stage nuclei showed a non-uniform distribution of nuclear pore complexes (NPCs). NPCs were exclusively present at sites where DNA contacted the nuclear lamina. Extended regions of the lamina, which were not contacted by DNA, lacked NPCs. In post-MGA nuclei the whole lamina was contacted rather uniformly by DNA. Accordingly, NPCs became uniformly distributed throughout the entire nuclear envelope. These findings shed new light on the conditions which control the integration of NPCs into the nuclear envelope. The switch from maternal to embryonic production of mRNAs was accompanied by multiple invaginations covered with NPCs, which may serve the increased demands of mRNA export and protein import. Other invaginations, as well as interior nuclear segments and vesicles without contact to the nuclear envelope, were exclusively positive for lamin B. Since the abundance of these invaginations and vesicles increased in concert with a massive nuclear volume reduction, we suggest that they reflect a mechanism for fitting the nuclear envelope and its lamina to a shrinking nuclear size during bovine preimplantation development. In addition, a deposit of extranuclear clusters of NUP153 (a marker for NPCs) without associated lamin B was frequently observed from the zygote stage up to MGA. Corresponding RNA-Seq data revealed deposits of spliced, maternally provided NUP153 mRNA and little unspliced, newly synthesized RNA prior to MGA, which increased strongly at the initiation of embryonic expression of NUP153at MGA.	[Popken, Jens; Cremer, Thomas] Ludwig Maximilians Univ Munchen, Bioctr, Div Anthropol & Human Genet, Planegg Martinsried, Germany; [Popken, Jens; Guengoer, Tuna; Zakhartchenko, Valeri; Wolf, Eckhard] Ludwig Maximilians Univ Munchen, Gene Ctr, Chair Mol Anim Breeding & Biotechnol, Munich, Germany; [Graf, Alexander; Krebs, Stefan; Blum, Helmut; Wolf, Eckhard] Ludwig Maximilians Univ Munchen, Gene Ctr, Lab Funct Genome Anal LAFUGA, Munich, Germany; [Schmid, Volker J.] Ludwig Maximilians Univ Munchen, Inst Stat, Munich, Germany; [Strauss, Axel] Ludwig Maximilians Univ Munchen, Bioctr, Div Genet, Planegg Martinsried, Germany	University of Munich; University of Munich; University of Munich; University of Munich; University of Munich	Popken, J (corresponding author), Ludwig Maximilians Univ Munchen, Bioctr, Div Anthropol & Human Genet, Planegg Martinsried, Germany.	Jens.Popken@campus.lmu.de; ewolf@lmb.uni-muenchen.de; Thomas.Cremer@lrz.uni-muenchen.de	Schmid, Volker/F-3251-2010; Strauß, Axel/G-8473-2013; Cremer, Thomas/D-7979-2011	Schmid, Volker/0000-0003-2195-8130; Cremer, Thomas/0000-0002-1830-9589; Cremer, Thomas/0000-0001-7135-7216; Zakhartchenko, Valeri/0000-0002-5974-9759; Wolf, Eckhard/0000-0002-0430-9510	Deutsche Forschungsgemeinschaft [CR 59/26, FOR 1041, ZA 425/1-3]; EU grant Plurisys, FP7 Health 534 project [HEALTH-F4-2009-223485]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EU grant Plurisys, FP7 Health 534 project	This study was supported by grants from the Deutsche Forschungsgemeinschaft to T.C, E.W. and V.Z. (CR 59/26, FOR 1041, ZA 425/1-3), In addition, research of E.W. and V.Z. was supported by the EU grant Plurisys, HEALTH-F4-2009-223485 FP7 Health 534 project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam SA, 2001, GENOME BIOL, V2; Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Amendola M, 2014, CURR OPIN CELL BIOL, V28, P61, DOI 10.1016/j.ceb.2014.03.003; Arlucea J, 1998, J STRUCT BIOL, V124, P51, DOI 10.1006/jsbi.1998.4054; Bacher CP, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-45; Ball JR, 2005, CHROMOSOMA, V114, P319, DOI 10.1007/s00412-005-0019-3; Bauersachs S, 2009, P NATL ACAD SCI USA, V106, P5681, DOI 10.1073/pnas.0811841106; Baum M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5494; Beaudouin J, 2002, CELL, V108, P83, DOI 10.1016/S0092-8674(01)00627-4; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Chen BC, 2014, SCIENCE, V346, P439, DOI 10.1126/science.1257998; Cremer C, 2013, EUR PHYS J H, V38, P281, DOI 10.1140/epjh/e2012-20060-1; Cremer T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003889; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Daddysman MK, 2013, J PHYS CHEM B, V117, P1241, DOI 10.1021/jp310348s; Doucet CM, 2010, CHROMOSOMA, V119, P469, DOI 10.1007/s00412-010-0289-2; EVERINGH.JW, 1968, J CELL BIOL, V37, P540, DOI 10.1083/jcb.37.2.540; FAKAN S, 1980, BIOL CELLULAIRE, V37, P211; Fricker M, 1997, J CELL BIOL, V136, P531, DOI 10.1083/jcb.136.3.531; Graf A, 2014, P NATL ACAD SCI USA, V111, P4139, DOI 10.1073/pnas.1321569111; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Hase ME, 2003, MOL BIOL CELL, V14, P1923, DOI 10.1091/mbc.E02-09-0620; Hiendleder S, 2006, BIOL REPROD, V75, P17, DOI 10.1095/biolreprod.105.043919; HINSHAW JE, 1992, CELL, V69, P1133, DOI 10.1016/0092-8674(92)90635-P; Holm P, 2002, REPRODUCTION, V123, P553, DOI 10.1530/rep.0.1230553; HSU WS, 1963, Z ZELLFORSCH MIK ANA, V58, P660; Kanka J, 2009, THERIOGENOLOGY, V72, P572, DOI 10.1016/j.theriogenology.2009.04.014; Kind J, 2013, CELL, V153, P178, DOI 10.1016/j.cell.2013.02.028; Maimon T, 2012, STRUCTURE, V20, P998, DOI 10.1016/j.str.2012.03.025; Malhas A, 2011, TRENDS CELL BIOL, V21, P362, DOI 10.1016/j.tcb.2011.03.008; Markaki Y, 2010, COLD SH Q B, V75, P475, DOI 10.1101/sqb.2010.75.042; Markaki Y, 2012, BIOESSAYS, V34, P412, DOI 10.1002/bies.201100176; MAUL GG, 1972, J CELL BIOL, V55, P433, DOI 10.1083/jcb.55.2.433; Meuleman W, 2013, GENOME RES, V23, P270, DOI 10.1101/gr.141028.112; Mor A, 2010, NAT CELL BIOL, V12, P543, DOI 10.1038/ncb2056; Naumova N, 2013, SCIENCE, V342, P948, DOI 10.1126/science.1236083; Popken J, 2014, NUCLEUS-PHILA, V5, P555, DOI 10.4161/19491034.2014.979712; Popken J, 2014, NUCLEUS-PHILA, V5, P542, DOI 10.4161/19491034.2014.970107; Rothballer A, 2013, TRENDS BIOCHEM SCI, V38, P292, DOI 10.1016/j.tibs.2013.04.001; Rouquette J, 2010, INT REV CEL MOL BIO, V282, P1, DOI 10.1016/S1937-6448(10)82001-5; Rouquette J, 2009, CHROMOSOME RES, V17, P801, DOI 10.1007/s10577-009-9070-x; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; Shimi T, 2012, CURR OPIN CELL BIOL, V24, P71, DOI 10.1016/j.ceb.2011.11.007; Smeets D, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-8; Speese SD, 2012, CELL, V149, P832, DOI 10.1016/j.cell.2012.03.032; SUKEGAWA J, 1993, CELL, V72, P29, DOI 10.1016/0092-8674(93)90047-T; Wandke C, 2013, CELL, V152, P1222, DOI 10.1016/j.cell.2013.02.046; Zuela N, 2012, EMBO REP, V13, P1070, DOI 10.1038/embor.2012.167	49	21	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124619	10.1371/journal.pone.0124619	http://dx.doi.org/10.1371/journal.pone.0124619			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932910	Green Published, gold, Green Submitted			2022-12-27	WOS:000353887100051
J	Torso, M; Serra, L; Giulietti, G; Spano, B; Tuzzi, E; Koch, G; Caltagirone, C; Cercignani, M; Bozzali, M				Torso, Mario; Serra, Laura; Giulietti, Giovanni; Spano, Barbara; Tuzzi, Elisa; Koch, Giacomo; Caltagirone, Carlo; Cercignani, Mara; Bozzali, Marco			Strategic Lesions in the Anterior Thalamic Radiation and Apathy in Early Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; WHITE-MATTER HYPERINTENSITIES; VOXEL-BASED MORPHOMETRY; NEUROPSYCHIATRIC SYMPTOMS; DEMENTIA; RISK; DISCONNECTION; ASSOCIATION; DYSFUNCTION; DEPRESSION	Background Behavioural disorders and psychological symptoms of Dementia (BPSD) are commonly observed in Alzheimer's disease (AD), and strongly contribute to increasing patients' disability. Using voxel-lesion-symptom mapping (VLSM), we investigated the impact of white matter lesions (WMLs) on the severity of BPSD in patients with amnestic mild cognitive impairment (a-MCI). Methods Thirty-one a-MCI patients (with a conversion rate to AD of 32% at 2 year follow-up) and 26 healthy controls underwent magnetic resonance imaging (MRI) examination at 3T, including T2-weighted and fluid-attenuated-inversion-recovery images, and T1-weighted volumes. In the patient group, BPSD was assessed using the Neuropsychiatric Inventory-12. After quantitative definition of WMLs, their distribution was investigated, without an a priori anatomical hypothesis, against patients' behavioural symptoms. Unbiased regional grey matter volumetrics was also used to assess the contribution of grey matter atrophy to BPSD. Results Apathy, irritability, depression/dysphoria, anxiety and agitation were shown to be the most common symptoms in the patient sample. Despite a more widespread anatomical distribution, a-MCI patients did not differ from controls in WML volumes. VLSM revealed a strict association between the presence of lesions in the anterior thalamic radiations (ATRs) and the severity of apathy. Regional grey matter atrophy did not account for any BPSD. Conclusions This study indicates that damage to the ATRs is strategic for the occurrence of apathy in patients with a-MCI. Disconnection between the prefrontal cortex and the mediodorsal and anterior thalamic nuclei might represent the pathophysiological substrate for apathy, which is one of the most common psychopathological symptoms observed in dementia.	[Torso, Mario; Serra, Laura; Giulietti, Giovanni; Spano, Barbara; Tuzzi, Elisa; Cercignani, Mara; Bozzali, Marco] IRCCS, Santa Lucia Fdn, Neuroimaging Lab, Rome, Italy; [Koch, Giacomo; Caltagirone, Carlo] IRCCS, Santa Lucia Fdn, Dept Clin & Behav Neurol, Rome, Italy; [Koch, Giacomo; Caltagirone, Carlo] Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy; [Cercignani, Mara] Brighton & Sussex Med Sch, CISC, Brighton, E Sussex, England	IRCCS Santa Lucia; IRCCS Santa Lucia; University of Rome Tor Vergata; University of Brighton; University of Sussex	Bozzali, M (corresponding author), IRCCS, Santa Lucia Fdn, Neuroimaging Lab, Rome, Italy.	m.bozzali@hsantalucia.it	Koch, Giacomo/G-3155-2012; Giulietti, Giovanni/D-2771-2009; Serra, Laura/K-5637-2016; Spano', Barbara/K-9535-2016; Torso, Mario/ADO-3442-2022; Bozzali, Marco/AAC-1031-2022; Spano', Barbara/AAG-1671-2021	Serra, Laura/0000-0002-2717-1286; Spano', Barbara/0000-0002-5291-0984; Spano', Barbara/0000-0002-5291-0984; Torso, Mario/0000-0002-5284-9167; Cercignani, Mara/0000-0002-4550-2456; Bozzali, Marco/0000-0002-0568-2026; KOch, Giacomo/0000-0001-6155-9439	Italian Ministry of Health [150/RF-2009-1491699]	Italian Ministry of Health(Ministry of Health, Italy)	The current study was performed with the financial support of the Italian Ministry of Health (http://www.salute.gov.it/) (Grant number: 150/RF-2009-1491699, given to Marco Bozzali). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman JM, 2001, ANN NY ACAD SCI, V935, P107, DOI 10.1111/j.1749-6632.2001.tb03476.x; [Anonymous], 2000, DSM 4 TR DIAGN STAT; Apostolova LG, 2007, NEUROLOGY, V13, P165; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2001, NEUROIMAGE, V14, P1238, DOI 10.1006/nimg.2001.0961; Bates E, 2003, NAT NEUROSCI, V6, P448, DOI 10.1038/nn1050; Benedictus MR, 2013, NEUROBIOL AGING, V34, P2488, DOI 10.1016/j.neurobiolaging.2013.04.023; Benoit M, 2002, PSYCHIAT RES-NEUROIM, V114, P103, DOI 10.1016/S0925-4927(02)00003-3; Birdsill AC, 2014, NEUROBIOL AGING, V35, P769, DOI 10.1016/j.neurobiolaging.2013.10.072; Bozzali M, 2011, CURR MED CHEM, V18, P2452, DOI 10.2174/092986711795843263; Bruen PD, 2008, BRAIN, V131, P2455, DOI 10.1093/brain/awn151; Busch D, 2010, LATERALITY, V15, P610, DOI 10.1080/13576500903081806; Carlesimo GA, 2011, NEUROPSYCHOLOGIA, V49, P2199, DOI 10.1016/j.neuropsychologia.2010.11.013; Cummings JL, 1997, NEUROLOGY, V48, pS10, DOI 10.1212/WNL.48.5_Suppl_6.10S; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; DeCarli C, 2005, STROKE, V36, P50, DOI 10.1161/01.STR.0000150668.58689.f2; Drijgers RL, 2011, INT PSYCHOGERIATR, V23, P1327, DOI 10.1017/S1041610211001037; Erten-Lyons D, 2013, NEUROLOGY, V81, P977, DOI 10.1212/WNL.0b013e3182a43e45; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Geda YE, 2013, ALZHEIMERS DEMENT, V9, P602, DOI 10.1016/j.jalz.2012.12.001; Ghika-Schmid F, 2000, ANN NEUROL, V48, P220, DOI 10.1002/1531-8249(200008)48:2<220::AID-ANA12>3.0.CO;2-M; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; HACHINSKI VC, 1975, ARCH NEUROL-CHICAGO, V32, P632, DOI 10.1001/archneur.1975.00490510088009; Heo JH, 2009, J GERIATR PSYCH NEUR, V22, P207, DOI 10.1177/0891988709335800; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Iadecola C, 2013, NEURON, V80, P844, DOI 10.1016/j.neuron.2013.10.008; Kimberg DY, 2007, J COGNITIVE NEUROSCI, V19, P1067, DOI 10.1162/jocn.2007.19.7.1067; Knutson KM, 2013, HUM BRAIN MAPP, V35, P1; Kraft A, 2014, CORTEX, V56, P38, DOI 10.1016/j.cortex.2012.10.004; Lawlor BA, 2004, J CLIN PSYCHIAT, V65, P5; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; Marin, 1996, Semin Clin Neuropsychiatry, V1, P304; Marshall GA, 2007, ARCH NEUROL-CHICAGO, V64, P1015, DOI 10.1001/archneur.64.7.1015; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mori S., 2005, MRI ATLAS HUMAN WHIT; Mufson EJ, 2012, ACTA NEUROPATHOL, V123, P13, DOI 10.1007/s00401-011-0884-1; O'Dwyer L, 2011, J ALZHEIMERS DIS, V26, P667, DOI 10.3233/JAD-2011-110137; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Petersen RC, 2013, ANN NEUROL, V74, P199, DOI 10.1002/ana.23931; Quaranta Davide, 2012, Curr Gerontol Geriatr Res, V2012, P719250, DOI 10.1155/2012/719250; Serra L, 2013, J ALZHEIMERS DIS, V33, P1157, DOI 10.3233/JAD-2012-121663; Serra L, 2010, J ALZHEIMERS DIS, V21, P627, DOI 10.3233/JAD-2010-100048; Serra L, 2010, J ALZHEIMERS DIS, V19, P147, DOI 10.3233/JAD-2010-1223; Snow AL, 2012, AGING MENT HEALTH, V16, P592, DOI 10.1080/13607863.2011.644518; Starkstein SE, 2009, J NEUROPSYCH CLIN N, V21, P259, DOI 10.1176/appi.neuropsych.21.3.259; Stoub TR, 2006, P NATL ACAD SCI USA, V103, P10041, DOI 10.1073/pnas.0603414103; Stuss DT, 2000, NEUROPSYCHOLOGY EMOT, P340; Teng E, 2007, DEMENT GERIATR COGN, V24, P253, DOI 10.1159/000107100; Vallet GT, 2013, CORTEX, V49, P2402, DOI 10.1016/j.cortex.2012.10.010; Yoshita M, 2006, NEUROLOGY, V67, P2192, DOI 10.1212/01.wnl.0000249119.95747.1f; Zahodne LB, 2013, INT J GERIATR PSYCH, V28, P50, DOI 10.1002/gps.3789	55	35	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124998	10.1371/journal.pone.0124998	http://dx.doi.org/10.1371/journal.pone.0124998			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932637	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000353887100071
J	Chen, Z; Chen, X; Yan, HW; Li, WW; Li, Y; Cai, RH; Xiang, Y				Chen, Zhu; Chen, Xue; Yan, Hanwei; Li, Weiwei; Li, Yuan; Cai, Ronghao; Xiang, Yan			The Lipoxygenase Gene Family in Poplar: Identification, Classification, and Expression in Response to MeJA Treatment	PLOS ONE			English	Article							COMPREHENSIVE ANALYSIS; SEX DETERMINATION; ARABIDOPSIS; DEFENSE; GENOME; OXYLIPINS; INSECT; CONSEQUENCES; ADAPTATION; DIVERSITY	Background Lipoxygenases (LOXs) are important dioxygenases in cellular organisms. LOXs contribute to plant developmental processes and environmental responses. However, a systematic and comprehensive analysis has not been focused on the LOX gene family in poplar. Therefore, in the present study, we performed a comprehensive analysis of the LOX gene family in poplar. Results Using bioinformatics methods, we identified a total of 20 LOX genes. These LOX genes were clustered into two subfamilies. The gene structure and motif composition of each subfamily were relatively conserved. These genes are distributed unevenly across nine chromosomes. The PtLOX gene family appears to have expanded due to high tandem and low segmental duplication events. Microarray analysis showed that a number of PtLOX genes have different expression pattern across disparate tissues and under various stress treatments. Quantitative real-time PCR (qRT-PCR) analysis was further performed to confirm the responses to MeJA treatment of the 20 poplar LOX genes. The results show that the PtLOX genes are regulated by MeJA (Methyl jasmonate) treatment. Conclusions This study provides a systematic analysis of LOX genes in poplar. The gene family analysis reported here will be useful for conducting future functional genomics studies to uncover the roles of LOX genes in poplar growth and development.	[Chen, Zhu; Chen, Xue; Yan, Hanwei; Li, Weiwei; Li, Yuan; Xiang, Yan] Anhui Agr Univ, Lab Modern Biotechnol, Hefei, Peoples R China; [Cai, Ronghao; Xiang, Yan] Anhui Agr Univ, Key Lab Biomass Improvement & Convers, Hefei, Peoples R China	Anhui Agricultural University; Anhui Agricultural University	Xiang, Y (corresponding author), Anhui Agr Univ, Lab Modern Biotechnol, Hefei, Peoples R China.	xiangyanahau@sina.com			National Natural Science Foundation [31370561]; Specialized Research Fund for the Doctoral Program of Higher Education [20133418110005]; Anhui Provincial Natural Science Foundation [1308085MC36]; Anhui Agricultural University disciplinary construction Foundation [XKTS2013001]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province); Anhui Agricultural University disciplinary construction Foundation	This work was supported by fundings from National Natural Science Foundation (31370561), Specialized Research Fund for the Doctoral Program of Higher Education (20133418110005), Anhui Provincial Natural Science Foundation (1308085MC36), Anhui Agricultural University disciplinary construction Foundation (XKTS2013001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta IF, 2010, METHODS FOR CONTROLL; Acosta IF, 2009, SCIENCE, V323, P262, DOI 10.1126/science.1164645; Allmann S, 2010, SCIENCE, V329, P1075, DOI 10.1126/science.1191634; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bailly C, 2002, SEED SCI RES, V12, P47, DOI 10.1079/SSR200197; Bannenberg G, 2009, LIPIDS, V44, P85, DOI 10.1007/s11745-008-3245-7; Barry CS, 2007, J PLANT GROWTH REGUL, V26, P143, DOI 10.1007/s00344-007-9002-y; Basso B, 1995, PLANT BIOSYST, V129, P935; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bateman A, 1999, CURRENT BIOLOGY, V9; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Blee E, 2002, TRENDS PLANT SCI, V7, P315, DOI 10.1016/S1360-1385(02)02290-2; BOYINGTON JC, 1993, SCIENCE, V260, P1482, DOI 10.1126/science.8502991; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; Bryfczynski SP, 2009, GRAPHPAD A GRAPH CRE; Caldelari D, 2011, PLANT MOL BIOL, V75, P25, DOI 10.1007/s11103-010-9701-9; Cao J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-465; Chai GH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-253; Chen X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087156; Cheng Q, 2006, PLANT SCI, V170, P1027, DOI 10.1016/j.plantsci.2005.12.012; Chuck G, 2010, ADV BOT RES, V54, P53, DOI 10.1016/S0065-2296(10)54002-3; Dai LM, 2009, ENVIRON MANAGE, V43, P1162, DOI 10.1007/s00267-008-9229-9; Feng L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110896; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Fortier J, 2012, FOREST CHRON, V88, P391, DOI 10.5558/tfc2012-075; GASEN JB, 1990, J EDUC COMPUT RES, V6, P17, DOI 10.2190/N7C0-8KLA-REY8-F1K2; Gobel C., 2001, UNTERSUCHUNGEN ZUR F; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Hall T., 2011, GERF B BIOSCI, V2, P60; Heidel AJ, 2010, CHEMOECOLOGY, V20, P149, DOI 10.1007/s00049-009-0031-9; HILDEBRAND DF, 1989, PHYSIOL PLANTARUM, V76, P249, DOI 10.1111/j.1399-3054.1989.tb05641.x; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Howe GA, 2002, CURR OPIN PLANT BIOL, V5, P230, DOI 10.1016/S1369-5266(02)00250-9; Hu RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031149; Hu RB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-145; Hurst LD, 2002, TRENDS GENET, V18, P486, DOI 10.1016/S0168-9525(02)02722-1; Itoh A, 2001, J BIOL CHEM, V276, P3620, DOI 10.1074/jbc.M008964200; Kolomiets MV, 2001, PLANT CELL, V13, P613, DOI 10.1105/tpc.13.3.613; Kondrashov FA, 2012, P ROY SOC B-BIOL SCI, V279, P5048, DOI 10.1098/rspb.2012.1108; Kreuzwieser J, 2009, PLANT PHYSIOL, V149, P461, DOI 10.1104/pp.108.125989; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee DS, 2008, NATURE, V455, P363, DOI 10.1038/nature07307; Liu SQ, 2011, GENET MOL RES, V10, P2613, DOI 10.4238/2011.October.25.9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Matsui K, 2006, CURR OPIN PLANT BIOL, V9, P274, DOI 10.1016/j.pbi.2006.03.002; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Moran PJ, 2001, PLANT PHYSIOL, V125, P1074, DOI 10.1104/pp.125.2.1074; Nekrutenko A, 2002, GENOME RES, V12, P198, DOI 10.1101/gr.200901; Philippe RN, 2007, CAN J BOT, V85, P1111, DOI 10.1139/B07-109; Podolyan A., 2010, STUDY GREEN LEAF VOL; Ponting CP, 1999, CURR BIOL, V9, pR585, DOI 10.1016/S0960-9822(99)80379-0; Porta H, 2002, PLANT PHYSIOL, V130, P15, DOI 10.1104/pp.010787; Prost I, 2005, PLANT PHYSIOL, V139, P1902, DOI 10.1104/pp.105.066274; Richardson J J., 2001, POPLAR CULTURE N AM, P43; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rosahl S, 1995, JOURNAL OF BIOSCIENC, V51, P123; Shah J, 2009, CURR OPIN PLANT BIOL, V12, P459, DOI 10.1016/j.pbi.2009.05.011; SHIBATA D, 1987, J BIOL CHEM, V262, P10080; Sjodin A, 2009, NEW PHYTOL, V182, P1013, DOI 10.1111/j.1469-8137.2009.02807.x; STECZKO J, 1992, BIOCHEMISTRY-US, V31, P4053, DOI 10.1021/bi00131a022; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Takashima Y, 2011, P NATL ACAD SCI USA, V108, P3300, DOI 10.1073/pnas.1014418108; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tattersall EAR, 2007, FUNCT INTEGR GENOMIC, V7, P317, DOI 10.1007/s10142-007-0051-x; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Umate P, 2011, PLANT SIGNAL BEHAV, V6, P335, DOI 10.4161/psb.6.3.13546; VanDoorn A, 2010, PLANT SIGNAL BEHAV, V5, P1674, DOI 10.4161/psb.5.12.14036; Vellosillo T, 2007, PLANT CELL, V19, P831, DOI 10.1105/tpc.106.046052; Vogt J, 2013, TREE GENET GENOMES, V9, P1493, DOI 10.1007/s11295-013-0653-5; Yang XY, 2012, INT J MOL SCI, V13, P2481, DOI 10.3390/ijms13022481; Yu HY, 2004, GENOME RES, V14, P1107, DOI 10.1101/gr.1774904; Zarate SI, 2007, PLANT PHYSIOL, V143, P866, DOI 10.1104/pp.106.090035; Zhang B, 2006, J EXP BOT, V57, P3825, DOI 10.1093/jxb/erl151; Zheng SJ, 2007, MOL PLANT MICROBE IN, V20, P1332, DOI 10.1094/MPMI-20-11-1332; Zuo R, 2013, MOL BIOL REP, V40, P2645, DOI 10.1007/s11033-012-2351-z	78	39	42	6	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125526	10.1371/journal.pone.0125526	http://dx.doi.org/10.1371/journal.pone.0125526			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928711	Green Submitted, Green Published, gold			2022-12-27	WOS:000353713100098
J	Lehrberg, J; Gardiner, DM				Lehrberg, Jeffrey; Gardiner, David M.			Regulation of Axolotl (Ambystoma mexicanum) Limb Blastema Cell Proliferation by Nerves and BMP2 in Organotypic Slice Culture	PLOS ONE			English	Article							DORSAL-ROOT-GANGLIA; ADULT NEWT; IN-VITRO; FORELIMB REGENERATION; CYCLE; INVITRO; GROWTH; VIRIDESCENS; INDUCTION; IDENTIFICATION	We have modified and optimized the technique of organotypic slice culture in order to study the mechanisms regulating growth and pattern formation in regenerating axolotl limb blastemas. Blastema cells maintain many of the behaviors that are characteristic of blastemas in vivo when cultured as slices in vitro, including rates of proliferation that are comparable to what has been reported in vivo. Because the blastema slices can be cultured in basal medium without fetal bovine serum, it was possible to test the response of blastema cells to signaling molecules present in serum, as well as those produced by nerves. We also were able to investigate the response of blastema cells to experimentally regulated changes in BMP signaling. Blastema cells responded to all of these signals by increasing the rate of proliferation and the level of expression of the blastema marker gene, Prrx-1. The organotypic slice culture model provides the opportunity to identify and characterize the spatial and temporal co-regulation of pathways in order to induce and enhance a regenerative response.	[Lehrberg, Jeffrey; Gardiner, David M.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA	University of California System; University of California Irvine	Gardiner, DM (corresponding author), Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA.	dmgardin@uci.edu			United States Army Multidisciplinary University Research Initiative (MURI) subcontract from Tulane University [TUL 589-09/10]; National Science Foundation through the Ambystoma Genetic Stock Center at the University of Kentucky, Lexington; Grass Foundation	United States Army Multidisciplinary University Research Initiative (MURI) subcontract from Tulane University; National Science Foundation through the Ambystoma Genetic Stock Center at the University of Kentucky, Lexington; Grass Foundation	Research funded by a United States Army Multidisciplinary University Research Initiative (MURI) subcontract from Tulane University (TUL 589-09/10), and the National Science Foundation through its support of the Ambystoma Genetic Stock Center at the University of Kentucky, Lexington. JL was funded in part by a research fellowship from the Grass Foundation (www.grassfoundation.org) for a summer research internship at the Marine Biological Laboratory, Woods Hole, Massachusetts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athippozhy A, 2014, REGENERATION, V1, P1, DOI 10.1002/reg2.14; Boergermann JH, 2010, INT J BIOCHEM CELL B, V42, P1802, DOI 10.1016/j.biocel.2010.07.018; Boilly B, 1988, Monogr Dev Biol, V21, P1; BRYANT SV, 1976, DEV BIOL, V50, P212, DOI 10.1016/0012-1606(76)90079-8; CARLONE RL, 1979, J EXP ZOOL, V210, P245, DOI 10.1002/jez.1402100207; CHOO AF, 1978, J EXP ZOOL, V206, P347, DOI 10.1002/jez.1402060306; CONN ME, 1979, IN VITRO CELL DEV B, V15, P409, DOI 10.1007/BF02618408; DALTON HC, 1950, J EXP ZOOL, V115, P17; Endo T, 2004, DEV BIOL, V270, P135, DOI 10.1016/j.ydbio.2004.02.016; FERRETTI P, 1988, J EXP ZOOL, V247, P77, DOI 10.1002/jez.1402470111; FIMIAN WJ, 1959, J EXP ZOOL, V140, P125, DOI 10.1002/jez.1401400107; FRENCH V, 1976, SCIENCE, V193, P969, DOI 10.1126/science.948762; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; GLOBUS M, 1975, J EMBRYOL EXP MORPH, V33, P813; GLOBUS M, 1977, DEV BIOL, V56, P316, DOI 10.1016/0012-1606(77)90273-1; GOLDHAMER DJ, 1992, J EXP ZOOL, V262, P71, DOI 10.1002/jez.1402620110; GOLDHAMER DJ, 1987, DEVELOPMENT, V100, P619; GROELL AL, 1993, ROUX ARCH DEV BIOL, V202, P170, DOI 10.1007/BF00365307; Guimond JC, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-15; HAY ED, 1961, DEV BIOL, V3, P26, DOI 10.1016/0012-1606(61)90009-4; Herrera B, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-20; HINTERBERGER TJ, 1983, J EXP ZOOL, V226, P399, DOI 10.1002/jez.1402260310; Holtfreter J, 1943, J EXP ZOOL, V93, P251, DOI 10.1002/jez.1400930205; Holtfreter J, 1929, UBER HISTOLOGISCHE D; Honda Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep03420; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; JABAILY JA, 1982, J EXP ZOOL, V219, P67, DOI 10.1002/jez.1402190108; KAMRIN ANNE A., 1959, JOUR MORPHOL, V104, P415, DOI 10.1002/jmor.1051040303; Knapp D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061352; Kodaira K, 2006, BIOCHEM BIOPH RES CO, V345, P1224, DOI 10.1016/j.bbrc.2006.05.045; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Kumar A, 2007, SCIENCE, V318, P772, DOI 10.1126/science.1147710; Kumar Anoop, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5367; Lossi L, 2009, PROG NEUROBIOL, V88, P221, DOI 10.1016/j.pneurobio.2009.01.002; MADEN M, 1978, J EMBRYOL EXP MORPH, V48, P169; Makanae A, 2013, DEV BIOL, V381, P213, DOI 10.1016/j.ydbio.2013.05.010; Mayer H, 1996, CALCIFIED TISSUE INT, V58, P249; McCusker C, 2014, REGENERATION, V1, P27, DOI 10.1002/reg2.10; McCusker CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077064; MESCHER AL, 1981, J EXP ZOOL, V216, P235, DOI 10.1002/jez.1402160204; Mescher AL, 1997, DEV GROWTH DIFFER, V39, P677; MONNICKE.MA, 1973, EXPERIENTIA, V29, P1, DOI 10.1007/BF01913222; MONNICKENDAM MA, 1970, J MORPHOL, V132, P453, DOI 10.1002/jmor.1051320406; Mullen LM, 1996, DEVELOPMENT, V122, P3487; Muller TL, 1999, SEMIN CELL DEV BIOL, V10, P405, DOI 10.1006/scdb.1999.0327; MUNEOKA K, 1986, DEV BIOL, V116, P256, DOI 10.1016/0012-1606(86)90062-X; OUDKHIR M, 1986, EXPERIENTIA, V42, P189, DOI 10.1007/BF01952461; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reddien PW, 2007, DEVELOPMENT, V134, P4043, DOI 10.1242/dev.007138; Salley-Guydon JD, 2006, WOUND REPAIR REGEN, V14, P479, DOI 10.1111/j.1743-6109.2006.00154.x; Satoh A, 2008, DEV BIOL, V319, P321, DOI 10.1016/j.ydbio.2008.04.030; Satoh A, 2007, DEV BIOL, V312, P231, DOI 10.1016/j.ydbio.2007.09.021; Satoh A, 2012, DEV BIOL, V366, P374, DOI 10.1016/j.ydbio.2012.03.022; Satoh A, 2011, DEV BIOL, V355, P263, DOI 10.1016/j.ydbio.2011.04.017; Sidman R. L., 1951, American Journal of Physiology, V165, P257; SINGER M, 1947, J EXP ZOOL, V104, P223, DOI 10.1002/jez.1401040204; SINGER M, 1946, J EXP ZOOL, V101, P299, DOI 10.1002/jez.1401010303; SINGER M, 1948, J EXP ZOOL, V108, P279, DOI 10.1002/jez.1401080207; SINGER M, 1949, J EXP ZOOL, V111, P295, DOI 10.1002/jez.1401110208; SINGER MARCUS, 1952, QUART REV BIOL, V27, P169, DOI 10.1086/398873; TASSAVA RA, 1987, BIOCHEM CELL BIOL, V65, P739, DOI 10.1139/o87-097; Todd T. J., 1823, Q J SCI LIT ARTS, V16, P84; TOMLINSON BL, 1984, J EXP ZOOL, V232, P249, DOI 10.1002/jez.1402320212; Wallace, 1981, VERTEBRATE LIMB REGE; WALLACE H, 1976, J CELL SCI, V20, P539; Wang Q, 2011, MOL VIS, V17, P647; Whited JL, 2011, DEV DYNAM, V240, P1249, DOI 10.1002/dvdy.22548; WILDE CE, 1950, J MORPHOL, V86, P73, DOI 10.1002/jmor.1050860106; Wong GA, 2003, AM J PHYSIOL-ENDOC M, V284, pE972, DOI 10.1152/ajpendo.00385.2002; Wrighton KH, 2009, J BIOL CHEM, V284, P9755, DOI 10.1074/jbc.M809223200; Yokoyama H, 2011, J INVEST DERMATOL, V131, P2477, DOI 10.1038/jid.2011.223; Yu L, 2010, DEVELOPMENT, V137, P551, DOI 10.1242/dev.042424; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54	74	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123186	10.1371/journal.pone.0123186	http://dx.doi.org/10.1371/journal.pone.0123186			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923915	Green Published, gold			2022-12-27	WOS:000353711600033
J	Mousavi, SJ; Doweidar, MH				Jamaleddin Mousavi, Seyed; Doweidar, Mohamed H.			Role of Mechanical Cues in Cell Differentiation and Proliferation: A 3D Numerical Model	PLOS ONE			English	Article							TISSUE DIFFERENTIATION; MATRIX ELASTICITY; STIFFNESS; MIGRATION; STRESS; REGENERATION; RIGIDITY; STIMULI; STRAIN	Cell differentiation, proliferation and migration are essential processes in tissue regeneration. Experimental evidence confirms that cell differentiation or proliferation can be regulated according to the extracellular matrix stiffness. For instance, mesenchymal stem cells (MSCs) can differentiate to neuroblast, chondrocyte or osteoblast within matrices mimicking the stiffness of their native substrate. However, the precise mechanisms by which the substrate stiffness governs cell differentiation or proliferation are not well known. Therefore, a mechano-sensing computational model is here developed to elucidate how substrate stiffness regulates cell differentiation and/or proliferation during cell migration. In agreement with experimental observations, it is assumed that internal deformation of the cell (a mechanical signal) together with the cell maturation state directly coordinates cell differentiation and/or proliferation. Our findings indicate that MSC differentiation to neurogenic, chondrogenic or osteogenic lineage specifications occurs within soft (0.1-1 kPa), intermediate (20-25 kPa) or hard (30-45 kPa) substrates, respectively. These results are consistent with well-known experimental observations. Remarkably, when a MSC differentiate to a compatible phenotype, the average net traction force depends on the substrate stiffness in such a way that it might increase in intermediate and hard substrates but it would reduce in a soft matrix. However, in all cases the average net traction force considerably increases at the instant of cell proliferation because of cell-cell interaction. Moreover cell differentiation and proliferation accelerate with increasing substrate stiffness due to the decrease in the cell maturation time. Thus, the model provides insights to explain the hypothesis that substrate stiffness plays a key role in regulating cell fate during mechanotaxis.	[Jamaleddin Mousavi, Seyed; Doweidar, Mohamed H.] Univ Zaragoza, Aragon Inst Engn Res I3A, Grp Struct Mech & Mat Modeling GEMM, Zaragoza, Spain; [Jamaleddin Mousavi, Seyed; Doweidar, Mohamed H.] Univ Zaragoza, Sch Engn & Architecture EINA, Dept Mech Engn, Zaragoza, Spain; [Jamaleddin Mousavi, Seyed; Doweidar, Mohamed H.] CIBER BBN, Zaragoza, Spain	University of Zaragoza; University of Zaragoza; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN	Doweidar, MH (corresponding author), Univ Zaragoza, Aragon Inst Engn Res I3A, Grp Struct Mech & Mat Modeling GEMM, Zaragoza, Spain.	mohamed@unizar.es	Doweidar, Mohamed H./F-2140-2016; Doweidar, Mohamed H./HGF-0661-2022	Doweidar, Mohamed H./0000-0003-0088-7222; 	Spanish Ministry of Economy and Competitiveness (MINECO) [MAT2013-46467-C4-3-R]; Centro de Investigacion Biomedica en Red en Bioingenieria, Biomateriales y Nanomedicina (CIBER-BBN)	Spanish Ministry of Economy and Competitiveness (MINECO); Centro de Investigacion Biomedica en Red en Bioingenieria, Biomateriales y Nanomedicina (CIBER-BBN)	This work was supported by The Spanish Ministry of Economy and Competitiveness (MINECO), https://sede.micinn.gob.es/, MAT2013-46467-C4-3-R, MHD; and Centro de Investigacion Biomedica en Red en Bioingenieria, Biomateriales y Nanomedicina (CIBER-BBN), http://www.ciber-bbn.es/es/quienes-somos, MHD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA SK, 1985, J BIOL CHEM, V260, P4492; Allena R, 2013, B MATH BIOL, V75, P288, DOI 10.1007/s11538-012-9806-1; Allena R, 2012, J THEOR BIOL, V306, P15, DOI 10.1016/j.jtbi.2012.03.041; BEAUPRE GS, 1988, J ORTHOP RES, V6, P39, DOI 10.1002/jor.1100060106; Brodland G. Wayne, 2004, Computer Methods in Biomechanics and Biomedical Engineering, V7, P91; Brown G, 2003, EXP CELL RES, V291, P282, DOI 10.1016/S0014-4827(03)00393-8; Burke DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040737; Buxboim A, 2010, J CELL SCI, V123, P297, DOI 10.1242/jcs.041186; Claes LE, 1999, J BIOMECH, V32, P255, DOI 10.1016/S0021-9290(98)00153-5; Cullinane DM, 2003, J EXP BIOL, V206, P2459, DOI 10.1242/jeb.00453; Delaine-Smith Robin M, 2012, Muscles Ligaments Tendons J, V2, P169; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Evans ND, 2009, EUR CELLS MATER, V18, P1; Fouliard S, 2009, MATH COMPUT MODEL, V49, P2104, DOI 10.1016/j.mcm.2008.07.003; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487; Georges PC, 2005, J APPL PHYSIOL, V98, P1547, DOI 10.1152/japplphysiol.01121.2004; Geris L., 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P277, DOI 10.1080/10255840310001634412; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Gladman SJ, 2010, NEUROSCIENCE, V171, P577, DOI 10.1016/j.neuroscience.2010.07.009; Harrison NC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022700; Her GJ, 2013, ACTA BIOMATER, V9, P5170, DOI 10.1016/j.actbio.2012.10.012; Hibbit, 2011, ABAQUS THEORY MANUAL; Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]; Isaksson H, 2006, J BIOMECH, V39, P1507, DOI 10.1016/j.jbiomech.2005.01.037; Mousavi SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122094; Mousavi SJ, 2013, J THEOR BIOL, V329, P64, DOI 10.1016/j.jtbi.2013.03.021; JAMES DW, 1969, EXP CELL RES, V54, P107, DOI 10.1016/0014-4827(69)90299-7; Kang KT, 2011, TISSUE ENG REGEN MED, V8, P359; Kearney EM, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2979870; Kelly DJ, 2005, J BIOMECH, V38, P1413, DOI 10.1016/j.jbiomech.2004.06.026; Kurpinski K, 2006, P NATL ACAD SCI USA, V103, P16095, DOI 10.1073/pnas.0604182103; Lacroix D, 2002, J BIOMECH, V35, P1163, DOI 10.1016/S0021-9290(02)00086-6; Lacroix D, 2002, MED BIOL ENG COMPUT, V40, P14, DOI 10.1007/BF02347690; Lee DA, 2011, J CELL BIOCHEM, V112, P1, DOI 10.1002/jcb.22758; Lee YH, 2013, INTEGR BIOL-UK, V5, P1447, DOI 10.1039/c3ib40161h; Li D, 2011, REGEN MED, V6, P229, DOI 10.2217/RME.11.2; Maul TM, 2011, BIOMECH MODEL MECHAN, V10, P939, DOI 10.1007/s10237-010-0285-8; Mousavi SJ, 2014, COMPUT METHOD BIOMEC, V17, P678, DOI 10.1080/10255842.2012.710841; Mousavi SJ, 2013, MOL CELL BIOMECH, V10, P1; Mousavi SJ, 2014, PHYS BIOL, V11, DOI 10.1088/1478-3975/11/2/026002; Mousavi SJ, 2014, J PHYS BIOL, V11; OSTER GF, 1983, J EMBRYOL EXP MORPH, V78, P83; Palomares KTS, 2009, J ORTHOP RES, V27, P1123, DOI 10.1002/jor.20863; Palsson E, 2001, FUTURE GENER COMP SY, V17, P835, DOI 10.1016/S0167-739X(00)00062-5; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pauwels F., 1980, BIOMECHANICS LOCOMOT, P375; PIERCE JH, 1990, P NATL ACAD SCI USA, V87, P5613, DOI 10.1073/pnas.87.15.5613; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prokharau PA, 2014, COMPUT METHOD BIOMEC, V17, P1051, DOI 10.1080/10255842.2012.736503; Ramtani S, 2004, J BIOMECH, V37, P1709, DOI 10.1016/j.jbiomech.2004.01.028; Schafer A, 2005, ACTA BIOMATER, V1, P273, DOI 10.1016/j.actbio.2005.02.004; Shi N, 2014, J BIOMED RES, V28, P40, DOI 10.7555/JBR.28.20130130; Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386; Stops AJF, 2010, J BIOMECH, V43, P618, DOI 10.1016/j.jbiomech.2009.10.037; Subramony SD, 2013, BIOMATERIALS, V34, P1942, DOI 10.1016/j.biomaterials.2012.11.012; Taylor D L, 1982, Cold Spring Harb Symp Quant Biol, V46 Pt 1, P101; Thery M, 2006, CURR OPIN CELL BIOL, V18, P648, DOI 10.1016/j.ceb.2006.10.001; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; Wehrle-Haller B, 2003, INT J BIOCHEM CELL B, V35, P39, DOI 10.1016/S1357-2725(02)00071-7; Wozniak MA, 2009, NAT REV MOL CELL BIO, V10, P34, DOI 10.1038/nrm2592; Wu QQ, 2000, EXP CELL RES, V256, P383, DOI 10.1006/excr.2000.4847; Zaman MH, 2005, BIOPHYS J, V89, P1389, DOI 10.1529/biophysj.105.060723; Zemel A, 2010, NAT PHYS, V6, P468, DOI 10.1038/NPHYS1613	65	44	46	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124529	10.1371/journal.pone.0124529	http://dx.doi.org/10.1371/journal.pone.0124529			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933372	gold, Green Submitted, Green Published			2022-12-27	WOS:000353887100048
J	Kader, R; Govender, R; Seedat, S; Koch, JR; Parry, C				Kader, Rehana; Govender, Rajen; Seedat, Soraya; Koch, John Randy; Parry, Charles			Understanding the Impact of Hazardous and Harmful Use of Alcohol and/or Other Drugs on ARV Adherence and Disease Progression	PLOS ONE			English	Article							HIV-INFECTED ADULTS; ANTIRETROVIRAL THERAPY; MEDICATION ADHERENCE; MENTAL-DISORDERS; PROBLEM DRINKING; SOUTH-AFRICA; PREDICTORS; NONADHERENCE; PREVALENCE; HIV/AIDS	The objective of this study was to understand the impact of hazardous and harmful use of alcohol and/or other drugs on ARV adherence and disease progression among HIV patients. A cross-sectional study design was used. A total of 1503 patients attending HIV clinics in Cape Town, South Africa were screened for problematic substance use. A sub-sample of 607 patients (303 patients who screened positive for problematic substance use and 304 who did not) participated in this study. Hazardous or harmful alcohol use and problematic drug use predicted missing and stopping ARVs which, in turn, was associated with a decrease in CD4 counts and more rapid HIV-disease progression and poorer health outcomes in people living with HIV/AIDS (PLWHA). The findings of this study underscore the need for an integrated approach to managing substance-use disorders in PLWHA.	[Kader, Rehana; Parry, Charles] MRC, Alcohol Tobacco & Other Drug Res Unit, Cape Town, South Africa; [Govender, Rajen] Univ Cape Town, Ctr Social Sci Res, ZA-7925 Cape Town, South Africa; [Govender, Rajen] Univ Cape Town, Dept Sociol, ZA-7925 Cape Town, South Africa; [Seedat, Soraya; Parry, Charles] Univ Stellenbosch, Dept Psychiat, ZA-7600 Stellenbosch, South Africa; [Koch, John Randy] Virginia Commonwealth Univ, Inst Drug & Alcohol Studies, Richmond, VA USA	University of Cape Town; University of Cape Town; Stellenbosch University; Virginia Commonwealth University	Kader, R (corresponding author), MRC, Alcohol Tobacco & Other Drug Res Unit, Cape Town, South Africa.	kaderrehana@gmail.com	Parry, Charles/A-2906-2009; Govender, Rajen/Y-4477-2019	Parry, Charles/0000-0001-9787-2785; Govender, Rajen/0000-0003-2720-7653; Seedat, Soraya/0000-0002-5118-786X	US President's Emergency Fund for AIDS Relief (PEPFAR) through the US Centers for Disease Control and Prevention (CDC) [5U2GPS001137]	US President's Emergency Fund for AIDS Relief (PEPFAR) through the US Centers for Disease Control and Prevention (CDC)	This research has been supported by the US President's Emergency Fund for AIDS Relief (PEPFAR) through the US Centers for Disease Control and Prevention (CDC), under the terms of Co-operative agreement grant number 5U2GPS001137. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the CDC or PEPFAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman A., 2005, DUDIT MANUAL DRUG US; Chander G, 2006, JAIDS-J ACQ IMM DEF, V43, P411, DOI 10.1097/01.qai.0000243121.44659.a4; Cook RL, 2001, J GEN INTERN MED, V16, P83, DOI 10.1111/j.1525-1497.2001.00122.x; Dada S, 2013, MONITORING ALCOHOL T, V34; Do NT, 2010, AIDS RES HUM RETROV, V26, P685, DOI 10.1089/aid.2009.0222; Farley John, 2010, J Int Assoc Physicians AIDS Care (Chic), V9, P218, DOI 10.1177/1545109710371133; Freeman M, 2007, AIDS CARE, V19, P1201, DOI 10.1080/09540120701426482; Hendershot CS, 2009, JAIDS-J ACQ IMM DEF, V52, P180, DOI 10.1097/QAI.0b013e3181b18b6e; Higgins-Biddle J., 2010, ALCOHOL USE DISORDER; Kader R, 2012, AFR J PSYCHIATRY, V15, P346, DOI [10.4314/ajpsy.v15i5.43, http://dx.doi.org/10.4314/ajpsy.v15i5.43]; Lucas GM, 2001, J ACQ IMMUN DEF SYND, V27, P251, DOI 10.1097/00126334-200107010-00006; Mellins CA, 2003, AIDS PATIENT CARE ST, V17, P407, DOI 10.1089/108729103322277420; Mellins CA, 2009, AIDS CARE, V21, P168, DOI 10.1080/09540120802001705; Mohammed H, 2004, AIDS PATIENT CARE ST, V18, P289, DOI 10.1089/108729104323076025; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Myer L, 2008, AIDS PATIENT CARE ST, V22, P147, DOI 10.1089/apc.2007.0102; Nachega JB, 2004, AIDS RES HUM RETROV, V20, P1053, DOI 10.1089/aid.2004.20.1053; Olley BO, 2003, SAMJ S AFR MED J, V93, P928; Palepu A, 2008, J CRIT CARE, V23, P275, DOI 10.1016/j.jcrc.2007.04.001; Parry C.D., 2010, AFRICAN J DRUG ALCOH, V9, P81; Parry C. D. H., 2006, AFRICAN J DRUG ALCOH, V5, P140; Parry CD, 2007, CURR OPIN PSYCHIATR, V20, P235; Parsons JT, 2008, HEALTH PSYCHOL, V27, P628, DOI 10.1037/a0012664; Peltzer K, 2011, AFR J PSYCHIATRY, V14, P30; Peretti-Watel P, 2003, SUBST ALCOHOL DEP S1, V82, pS71; Schlebusch L, 2010, AFR J PSYCHIATRY, V13, P280; Schneider M., 2012, J AIDS CLIN RES, VS1:005, DOI [10.4712/2155-6113.S1-005, DOI 10.4172/2155-6113.S1-005]; Sebit M B, 2003, East Afr Med J, V80, P503; Sullivan LE, 2008, ADDICTION, V103, P1461, DOI 10.1111/j.1360-0443.2008.02245.x; Turner BJ, 2001, J GEN INTERN MED, V16, P625, DOI 10.1046/j.1525-1497.2001.016009625.x; Van Dyk AC, 2010, AJAR-AFR J AIDS RES, V9, P235, DOI 10.2989/16085906.2010.530177; Venkatesh KK, 2010, AIDS PATIENT CARE ST, V24, P795, DOI 10.1089/apc.2010.0153; Wagner GJ, 2000, AIDS CARE, V12, P405, DOI 10.1080/09540120050123800; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Yunusa MA, 2011, AFR J DRUG ALCOHOL S, V10, P11	35	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125088	10.1371/journal.pone.0125088	http://dx.doi.org/10.1371/journal.pone.0125088			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933422	Green Published, gold			2022-12-27	WOS:000353887100077
J	Singh, G; Dal Grande, F; Divakar, PK; Otte, J; Leavitt, SD; Szczepanska, K; Crespo, A; Rico, VJ; Aptroot, A; Caceres, MED; Lumbsch, HT; Schmitt, I				Singh, Garima; Dal Grande, Francesco; Divakar, Pradeep K.; Otte, Juergen; Leavitt, Steven D.; Szczepanska, Katarzyna; Crespo, Ana; Rico, Victor J.; Aptroot, Andre; da Silva Caceres, Marcela Eugenia; Lumbsch, H. Thorsten; Schmitt, Imke			Coalescent-Based Species Delimitation Approach Uncovers High Cryptic Diversity in the Cosmopolitan Lichen-Forming Fungal Genus Protoparmelia (Lecanorales, Ascomycota)	PLOS ONE			English	Article							GENETIC DIVERSITY; PARMELIACEAE LECANORALES; PHYLOGENETIC INFERENCE; PARMELIOID LICHENS; MOLECULAR-DATA; PRIMERS; DNA; IDENTIFICATION; AMPLIFICATION; MORPHOLOGY	Species recognition in lichen-forming fungi has been a challenge because of unsettled species concepts, few taxonomically relevant traits, and limitations of traditionally used morphological and chemical characters for identifying closely related species. Here we analyze species diversity in the cosmopolitan genus Protoparmelia s.l. The similar to 25 described species in this group occur across diverse habitats from the boreal - arctic/alpine to the tropics, but their relationship to each other remains unexplored. In this study, we inferred the phylogeny of 18 species currently assigned to this genus based on 160 specimens and six markers: mtSSU, nuLSU, ITS, RPB1, MCM7, and TSR1. We assessed the circumscription of species-level lineages in Protoparmelia s. str. using two coalescent-based species delimitation methods - BP&P and spedeSTEM. Our results suggest the presence of a tropical and an extra-tropical lineage, and eleven previously unrecognized distinct species-level lineages in Protoparmelia s. str. Several cryptic lineages were discovered as compared to phenotype-based species delimitation. Many of the putative species are supported by geographic evidence.	[Singh, Garima; Schmitt, Imke] Goethe Univ Frankfurt, Inst Ecol Evolut & Divers, Dept Biol Sci, D-60323 Frankfurt, Germany; [Singh, Garima; Dal Grande, Francesco; Otte, Juergen; Schmitt, Imke] Senckenberg Gesell Nat Forsch, Biodivers & Climate Res Ctr BiK F, D-60325 Frankfurt, Germany; [Divakar, Pradeep K.; Crespo, Ana; Rico, Victor J.] Univ Complutense, Fac Farm, Dept Biol Vegetal 2, E-28040 Madrid, Spain; [Leavitt, Steven D.; Lumbsch, H. Thorsten] Field Museum Nat Hist, Sci & Educ, Chicago, IL 60605 USA; [Szczepanska, Katarzyna] Wroclaw Univ Environm & Life Sci, Dept Bot & Plant Ecol, PL-50363 Wroclaw, Poland; [Aptroot, Andre] Advice Bur Bryol & Lichenol Herbarium, Soest, Netherlands; [da Silva Caceres, Marcela Eugenia] Univ Fed Sergipe, Dept Biociencias, Itabaiana, Sergipe, Brazil	Goethe University Frankfurt; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Complutense University of Madrid; Field Museum of Natural History (Chicago); Wroclaw University of Environmental & Life Sciences; Universidade Federal de Sergipe	Singh, G (corresponding author), Goethe Univ Frankfurt, Inst Ecol Evolut & Divers, Dept Biol Sci, Gruneburgpl 1, D-60323 Frankfurt, Germany.	garima.singh@senckenberg.de; imke.schmitt@senckenberg.de	Dal Grande, Francesco/K-1914-2016; Singh, Garima/ABF-5659-2021; Rico, Víctor J./AAA-2001-2019; Divakar, Pradeep K/E-5603-2014; Singh, Garima/P-1518-2017; Leavitt, Steven D./AAC-6462-2021; Crespo, Ana/N-6236-2014; Gulliford, Martin/I-8606-2018	Dal Grande, Francesco/0000-0002-1865-6281; Singh, Garima/0000-0003-3753-5431; Divakar, Pradeep K/0000-0002-0300-0124; Singh, Garima/0000-0003-3753-5431; Leavitt, Steven D./0000-0002-5034-9724; Crespo, Ana/0000-0002-5271-0157; , Marcela/0000-0002-5612-1309; Szczepanska, Katarzyna/0000-0002-7752-3024; Gulliford, Martin/0000-0003-1898-9075; Aptroot, Andre/0000-0001-7949-2594; Lumbsch, Thorsten/0000-0003-1512-835X	'LOEWE, Landes-Offensive zur Entwicklung Wissenschaftlicho-konomischer Exzellenz' of Hesse's Ministry of Higher Education, Research, and the Arts; German Academic Exchange Service (DAAD); Ministerio de Ciencia e Innovacion, Spain [CGL2011-25003, CGL2013-42498-P]	'LOEWE, Landes-Offensive zur Entwicklung Wissenschaftlicho-konomischer Exzellenz' of Hesse's Ministry of Higher Education, Research, and the Arts; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This study was funded by 'LOEWE, Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz' of Hesse's Ministry of Higher Education, Research, and the Arts. Garima Singh was supported by a fellowship from the German Academic Exchange Service (DAAD). P.K.D., V.J.R. and A.C. thanks the Ministerio de Ciencia e Innovacion, Spain for financial support (CGL2011-25003, CGL2013-42498-P).	Agarwal I, 2014, ZOOL SCR, V43, P455, DOI 10.1111/zsc.12062; AHMADJIAN V, 1965, ANNU REV MICROBIOL, V19, P1, DOI 10.1146/annurev.mi.19.100165.000245; Altermann S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097556; Aptroot A, 2008, BIODIVERSITY TROPICA, P220; Arguello A, 2007, BIOL J LINN SOC, V91, P455, DOI 10.1111/j.1095-8312.2007.00810.x; Arup U, 2007, MYCOLOGIA, V99, P42, DOI 10.3852/mycologia.99.1.42; Baloch E, 2009, MOL ECOL, V18, P2185, DOI 10.1111/j.1365-294X.2009.04183.x; Barbero M, 2006, MYCOTAXON, V97, P299; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Camargo A, 2012, EVOLUTION, V66, P2834, DOI 10.1111/j.1558-5646.2012.01640.x; Campbell V, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-64; Molina MC, 2011, ORG DIVERS EVOL, V11, P331, DOI 10.1007/s13127-011-0060-4; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; Carstens BC, 2013, BIOL J LINN SOC, V109, P737, DOI 10.1111/bij.12093; Carter BE, 2012, MOL PHYLOGENET EVOL, V63, P891, DOI [10.1016/j.ymPev.2012.03.002, 10.1016/j.ympev.2012.03.002]; Crespo A, 2007, MOL PHYLOGENET EVOL, V44, P812, DOI 10.1016/j.ympev.2006.11.029; Crespo A, 2010, IMA FUNGUS, V1, P167, DOI 10.5598/imafungus.2010.01.02.09; Crespo A, 2011, LICHENOLOGIST, V43, P511, DOI 10.1017/S0024282911000570; Crespo A, 2009, AN JARDIN BOT MADRID, V66, P71, DOI 10.3989/ajbm.2225; Cubero Oscar F., 2002, P381; Dal Grande F, 2014, MOL PHYLOGENET EVOL, V72, P54, DOI 10.1016/j.ympev.2013.12.010; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Del-Prado R, 2013, TAXON, V62, P928, DOI 10.12705/625.22; Divakar PK, EVOLUTION C IN PRESS; Domingos FMCB, 2014, MOL PHYLOGENET EVOL, V80, P113, DOI 10.1016/j.ympev.2014.07.022; Doring H, 2000, LICHENOLOGIST, V32, P200, DOI 10.1006/lich.1999.0250; Drummond A., 2011, GENEIOUS V5 5; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Elbert W, 2012, NAT GEOSCI, V5, P459, DOI 10.1038/ngeo1486; Ence DD, 2011, MOL ECOL RESOUR, V11, P473, DOI 10.1111/j.1755-0998.2010.02947.x; ERIKSSON O E, 1989, Systema Ascomycetum, V8, P59; Esslinger T.L., 1989, SYST BOT MONOGR, V28, P1, DOI DOI 10.2307/25027728; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; GALLOWAY DJ, 1992, BIODIVERS CONSERV, V1, P312, DOI 10.1007/BF00693767; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Giarla TC, 2014, MOL PHYLOGENET EVOL, V70, P137, DOI 10.1016/j.ympev.2013.09.019; Grube M, 2000, MYCOL RES, V104, P1284, DOI 10.1017/S0953756200003476; Grube M, 2012, MOL ECOL, V21, P3098, DOI 10.1111/j.1365-294X.2012.05647.x; Hafellner J., 1990, BIBL LICH, V38, P99; Hafellner J., 1984, NOVA HEDWIGIA S, V79, P241; Hale Jr M.E., 1987, SMITHSONIAN CONTR BO, V66, P1, DOI DOI 10.5479/SI.0081024X.66; Harrington RC, 2012, SYST BIOL, V61, P63, DOI 10.1093/sysbio/syr077; Hawksworth DL, 2007, MYCOL RES, V111, P999, DOI 10.1016/j.mycres.2007.10.002; HENSSEN A, 1973, LICHENES EINFUHRUNG, P1; Henssen A, 1995, FLECHTEN FOLLMANN CO; HERTEL H, 1987, Mitteilungen der Botanischen Staatssammlung Muenchen, V23, P377; Hertel H, 1984, NOVA HEDWIGIA S, V79, P399; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kantvilas G, 2010, LICHENOLOGIST, V42, P557, DOI 10.1017/S0024282910000174; Kantvilas G, 2007, LICHENOLOGIST, V39, P135, DOI 10.1017/S0024282907006469; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kubatko LS, 2009, BIOINFORMATICS, V25, P971, DOI 10.1093/bioinformatics/btp079; Leavitt SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085240; Leavitt SD, 2011, AM J BOT, V98, P175, DOI 10.3732/ajb.1000230; Lucking R, 2014, P NATL ACAD SCI USA, V111, P11091, DOI 10.1073/pnas.1403517111; Lucking R, 2009, AM J BOT, V96, P1409, DOI 10.3732/ajb.0800258; Lumbsch HT, 2011, FUNGAL DIVERS, V50, P59, DOI 10.1007/s13225-011-0123-z; Lumbsch HT, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-257; Lutzoni F, 2001, NATURE, V411, P937, DOI 10.1038/35082053; Matheny PB, 2002, AM J BOT, V89, P688, DOI 10.3732/ajb.89.4.688; Miller M.A., 2010, P GAT COMP ENV WORKS; MIYAWAKI H, 1991, Hikobia, V11, P29; Muggia L, 2011, FEMS MICROBIOL ECOL, V75, P255, DOI 10.1111/j.1574-6941.2010.01002.x; Murtagh GJ, 2002, MYCOL RES, V106, P1277, DOI 10.1017/S0953756202006615; Myllys L, 2003, MOL PHYLOGENET EVOL, V27, P58, DOI 10.1016/S1055-7903(02)00398-6; Papong K, 2011, LICHENOLOGIST, V43, P561, DOI 10.1017/S0024282911000284; Parnmen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052245; Pino-Bodas R, 2011, ORG DIVERS EVOL, V11, P343, DOI 10.1007/s13127-011-0062-2; POELT J, 1991, NOVA HEDWIGIA, V52, P39; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Printzen C, 2010, PROG BOT, V71, P233, DOI 10.1007/978-3-642-02167-1_10; Rambaut A., 2014, TRACER V1 6; Rambaut A, 2009, TREEANNOTATOR; Rambold G, 1989, BIBL LICHENOL, P34; Richardson DHS, 1999, MYCOL RES, V103, P641, DOI 10.1017/S0953756298008259; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ryan BD, 2004, LICHEN FLORA GREATER, P425; Satler JD, 2013, SYST BIOL, V62, P805, DOI 10.1093/sysbio/syt041; Schmitt I, 2009, PERSOONIA, V23, P35, DOI 10.3767/003158509X470602; Singh G, 2013, FUNGAL BIOL-UK, V117, P715, DOI 10.1016/j.funbio.2013.08.001; Sipman H., 1989, ECOSYST WORLD, V14, P303, DOI [10.1016/B978-0-444-42755-7.50001-8, DOI 10.1016/B978-0-444-42755-7.50001-8, DOI 10.1016/8978-0-444-42755-7.50001-8]; Spribille T, 2011, MOL PHYLOGENET EVOL, V59, P603, DOI 10.1016/j.ympev.2011.03.021; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stiller JW, 1997, P NATL ACAD SCI USA, V94, P4520, DOI 10.1073/pnas.94.9.4520; SUGIURA N, 1978, COMMUN STAT A-THEOR, V7, P13, DOI 10.1080/03610927808827599; Swafford DL, 2003, PAUP PHYLOGENETIC AN; Thell A, 2012, NORD J BOT, V30, P641, DOI 10.1111/j.1756-1051.2012.00008.x; Timdal E, 1990, BIBL LICHENOL, V38, P419; Velmala S, 2009, LICHENOLOGIST, V41, P231, DOI 10.1017/S0024282909008573; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Welton LJ, 2013, MOL ECOL, V22, P3495, DOI 10.1111/mec.12324; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Yang ZH, 2014, MOL BIOL EVOL, V31, P3125, DOI 10.1093/molbev/msu279; Zhou SG, 2001, MYCOL RES, V105, P1033, DOI 10.1016/S0953-7562(08)61965-6; Zoller S, 1999, MOL ECOL, V8, P2049, DOI 10.1046/j.1365-294x.1999.00820.x	95	65	69	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124625	10.1371/journal.pone.0124625	http://dx.doi.org/10.1371/journal.pone.0124625			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932996	Green Published, gold, Green Submitted			2022-12-27	WOS:000353887100052
J	Wintermans, B; Brandt, B; Vandenbroucke-Grauls, C; Budding, A				Wintermans, Bastiaan; Brandt, Bernd; Vandenbroucke-Grauls, Christina; Budding, Andries			TreeSeq, a Fast and Intuitive Tool for Analysis of Whole Genome and Metagenomic Sequence Data	PLOS ONE			English	Article								Next-generation sequencing is not yet commonly used in clinical laboratories because of a lack of simple and intuitive tools. We developed a software tool (TreeSeq) with a quaternary tree search structure for the analysis of sequence data. This permits rapid searches for sequences of interest in large datasets. We used TreeSeq to screen a gut microbiota metagenomic dataset and a whole genome sequencing (WGS) dataset of a strain of Klebsiella pneumoniae for antibiotic resistance genes and compared the results with BLAST and phenotypic resistance determination. TreeSeq was more than thirty times faster than BLAST and accurately detected resistance gene sequences in complex metagenomic data and resistance genes corresponding with the phenotypic resistance pattern of the Klebsiella strain. Resistance genes found by TreeSeq were visualized as a gene coverage heat map, aiding in the interpretation of results. TreeSeq brings analysis of metagenomic and WGS data within reach of clinical diagnostics.	[Wintermans, Bastiaan; Vandenbroucke-Grauls, Christina; Budding, Andries] Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands; [Brandt, Bernd] Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Prevent Dent, Amsterdam, Netherlands; [Brandt, Bernd] Vrije Univ Amsterdam, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Wintermans, B (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands.	bb.wintermans@vumc.nl	Vandenbroucke-Grauls, Christina/AAO-7953-2020	Vandenbroucke-Grauls, Christina/0000-0003-2074-1597; Budding, Andries/0000-0001-5128-5411; Brandt, Bernd/0000-0002-1155-1989				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ATCC website, ATCC ANT STRAINS; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; Chan JZM, 2012, NAT BIOTECHNOL, V30, P1068, DOI 10.1038/nbt.2410; Didelot X, 2012, NAT REV GENET, V13, P601, DOI 10.1038/nrg3226; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; TIBCO website, TIBCO SPOTF 6 0; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244	10	3	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0123851	10.1371/journal.pone.0123851	http://dx.doi.org/10.1371/journal.pone.0123851			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933115	gold, Green Published			2022-12-27	WOS:000353887100025
J	Lauwerys, BR; Hernandez-Lobato, D; Gramme, P; Ducreux, J; Dessy, A; Focant, I; Ambroise, J; Bearzatto, B; Toukap, AN; Van den Eynde, BJ; Elewaut, D; Gala, JL; Durez, P; Houssiau, FA; Helleputte, T; Dupont, P				Lauwerys, Bernard R.; Hernandez-Lobato, Daniel; Gramme, Pierre; Ducreux, Julie; Dessy, Adrien; Focant, Isabelle; Ambroise, Jerome; Bearzatto, Bertrand; Toukap, Adrien Nzeusseu; Van den Eynde, Benoit J.; Elewaut, Dirk; Gala, Jean-Luc; Durez, Patrick; Houssiau, Frederic A.; Helleputte, Thibault; Dupont, Pierre			Heterogeneity of Synovial Molecular Patterns in Patients with Arthritis	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; RHEUMATOLOGY/EUROPEAN LEAGUE; UNDIFFERENTIATED ARTHRITIS; AMERICAN-COLLEGE; THERAPY; CRITERIA	Objectives Early diagnosis of rheumatoid arthritis (RA) is an unmet medical need in the field of rheumatology. Previously, we performed high-density transcriptomic studies on synovial biopsies from patients with arthritis, and found that synovial gene expression profiles were significantly different according to the underlying disorder. Here, we wanted to further explore the consistency of the gene expression signals in synovial biopsies of patients with arthritis, using low-density platforms. Methods Low-density assays (cDNA microarray and microfluidics qPCR) were designed, based on the results of the high-density microarray data. Knee synovial biopsies were obtained from patients with RA, spondyloarthropathies (SA) or osteoarthritis (OA) (n = 39), and also from patients with initial undifferentiated arthritis (UA) (n = 49). Results According to high-density microarray data, several molecular pathways are differentially expressed in patients with RA, SA and OA: T and B cell activation, chromatin remodelling, RAS GTPase activation and extracellular matrix regulation. Strikingly, disease activity (DAS28-CRP) has a significant influence on gene expression patterns in RA samples. Using the low-density assays, samples from patients with OA are easily discriminated from RA and SA samples. However, overlapping molecular patterns are found, in particular between RA and SA biopsies. Therefore, prediction of the clinical diagnosis based on gene expression data results in a diagnostic accuracy of 56.8%, which is increased up to 98.6% by the addition of specific clinical symptoms in the prediction algorithm. Similar observations are made in initial UA samples, in which overlapping molecular patterns also impact the accuracy of the diagnostic algorithm. When clinical symptoms are added, the diagnostic accuracy is strongly improved. Conclusions Gene expression signatures are overall different in patients with OA, RA and SA, but overlapping molecular signatures are found in patients with these conditions. Therefore, an accurate diagnosis in patients with UA requires a combination of gene expression and clinical data.	[Lauwerys, Bernard R.; Ducreux, Julie; Focant, Isabelle; Toukap, Adrien Nzeusseu; Durez, Patrick; Houssiau, Frederic A.] Catholic Univ Louvain, Inst Rech Expt & Clin, Pole Pathol Rhumatismales, B-1200 Brussels, Belgium; [Lauwerys, Bernard R.; Ducreux, Julie; Focant, Isabelle; Toukap, Adrien Nzeusseu; Durez, Patrick; Houssiau, Frederic A.] Clin Univ St Luc, Dept Rheumatol, B-1200 Brussels, Belgium; [Hernandez-Lobato, Daniel; Dessy, Adrien; Dupont, Pierre] Catholic Univ Louvain, ICTEAM Inst, Machine Learning Grp, B-1348 Louvain La Neuve, Belgium; [Gramme, Pierre; Helleputte, Thibault] DNAlytics, Louvain La Neuve, Belgium; [Ambroise, Jerome; Bearzatto, Bertrand; Gala, Jean-Luc] Catholic Univ Louvain, Inst Rech Expt & Clin, Ctr Technol Mol Appl, B-1200 Brussels, Belgium; [Van den Eynde, Benoit J.] Catholic Univ Louvain, Inst Duve, B-1200 Brussels, Belgium; [Elewaut, Dirk] Ghent Univ Hosp, Dept Rheumatol, Ghent, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Ghent University; Ghent University Hospital	Lauwerys, BR (corresponding author), Catholic Univ Louvain, Inst Rech Expt & Clin, Pole Pathol Rhumatismales, B-1200 Brussels, Belgium.	Bernard.Lauwerys@uclouvain.be	Elewaut, Dirk/K-6831-2014	durez, patrick/0000-0002-7156-2356; Elewaut, Dirk/0000-0002-7468-974X	Region Wallonne (BioWin); Fondation Saint-Luc (Cliniques Universitaires Saint-Luc, Brussels, Belgium); UCB grant ("Chaire UCB sur les rhumatismes inflammatoires et systemiques"); DNAlytics	Region Wallonne (BioWin); Fondation Saint-Luc (Cliniques Universitaires Saint-Luc, Brussels, Belgium); UCB grant ("Chaire UCB sur les rhumatismes inflammatoires et systemiques"); DNAlytics	This work was supported by grants from the Region Wallonne (BioWin), and the Fondation Saint-Luc (Cliniques Universitaires Saint-Luc, Brussels, Belgium). JD is funded by a unrestricted UCB grant (" Chaire UCB sur les rhumatismes inflammatoires et systemiques "). BRL is a part-time research fellow (" Clinicien-chercheur ") of the Fonds National de la Recherche Scientifique (Communaute francaise de Belgique). DNAlytics provided support in the form of salaries for authors PG and TH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Badot V, 2011, J CELL MOL MED, V15, P2335, DOI 10.1111/j.1582-4934.2010.01228.x; Badot V, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2678; Britsemmer K, 2011, ANN RHEUM DIS, V70, P1468, DOI 10.1136/ard.2010.148619; de Hair MJH, 2012, ARTHRITIS RHEUM-US, V64, P389, DOI 10.1002/art.33348; Ducreux J, 2014, ARTHRITIS RHEUMATOL, V66, P15, DOI 10.1002/art.38202; Durbin B, 2003, BIOINFORMATICS, V19, P1360, DOI 10.1093/bioinformatics/btg178; Emery P, 2008, RHEUMATOLOGY, V47, P392, DOI 10.1093/rheumatology/kem257; Goekoop-Ruiterman YPM, 2007, ANN INTERN MED, V146, P406, DOI 10.7326/0003-4819-146-6-200703200-00005; Gutierrez-Roelens I, 2011, ARTHRITIS RHEUM-US, V63, P1246, DOI 10.1002/art.30292; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Machold KP, 2002, J RHEUMATOL, V29, P2278; Mottonen T, 2002, ARTHRITIS RHEUM, V46, P894, DOI 10.1002/art.10135; O'Dell JR, 2002, ARTHRITIS RHEUM, V46, P283, DOI 10.1002/art.10092; Quinn MA, 2001, RHEUMATOLOGY, V40, P1211, DOI 10.1093/rheumatology/40.11.1211; Toukap AN, 2007, ARTHRITIS RHEUM-US, V56, P1579, DOI 10.1002/art.22578; van Aken J, 2006, ANN RHEUM DIS, V65, P20, DOI 10.1136/ard.2005.038471; van Baarsen LGM, 2010, ARTHRITIS RHEUM-US, V62, P694, DOI 10.1002/art.27294; van der Helm-van Mil AHM, 2007, ARTHRITIS RHEUM-US, V56, P433, DOI 10.1002/art.22380	20	27	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0122104	10.1371/journal.pone.0122104	http://dx.doi.org/10.1371/journal.pone.0122104			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927832	Green Published, Green Submitted, gold			2022-12-27	WOS:000353713100007
J	Madina, BR; Kumar, V; Mooers, BHM; Cruz-Reyes, J				Madina, Bhaskara R.; Kumar, Vikas; Mooers, Blaine H. M.; Cruz-Reyes, Jorge			Native Variants of the MRB1 Complex Exhibit Specialized Functions in Kinetoplastid RNA Editing	PLOS ONE			English	Article							INDUCIBLE EXPRESSION SYSTEM; LIFE-CYCLE STAGES; TRYPANOSOMA-BRUCEI; U-DELETION; MESSENGER-RNA; GUIDE RNAS; MITOCHONDRIA; PROTEINS; BINDING; ARCHITECTURE	Adaptation and survival of Trypanosoma brucei requires editing of mitochondrial mRNA by uridylate (U) insertion and deletion. Hundreds of small guide RNAs (gRNAs) direct the mRNA editing at over 3,000 sites. RNA editing is controlled during the life cycle but the regulation of substrate and stage specificity remains unknown. Editing progresses in the 3' to 5' direction along the pre-mRNA in blocks, each targeted by a unique gRNA. A critical editing factor is the mitochondrial RNA binding complex 1 (MRB1) that binds gRNA and transiently interacts with the catalytic RNA editing core complex (RECC). MRB1 is a large and dynamic complex that appears to be comprised of distinct but related subcomplexes (termed here MRBs). MRBs seem to share a 'core' complex of proteins but differ in the composition of the 'variable' proteins. Since some proteins associate transiently the MRBs remain imprecisely defined. MRB1 controls editing by unknown mechanisms, and the functional relevance of the different MRBs is unclear. We previously identified two distinct MRBs, and showed that they carry mRNAs that undergo editing. We proposed that editing takes place in the MRBs because MRBs stably associate with mRNA and gRNA but only transiently interact with RECC, which is RNA free. Here, we identify the first specialized functions in MRBs: 1) 3010-MRB is a major scaffold for RNA editing, and 2) REH2-MRB contains a critical trans-acting RNA helicase (REH2) that affects multiple steps of editing function in 3010-MRB. These trans effects of the REH2 include loading of unedited mRNA and editing in the first block and in subsequent blocks as editing progresses. REH2 binds its own MRB via RNA, and conserved domains in REH2 were critical for REH2 to associate with the RNA and protein components of its MRB. Importantly, REH2 associates with a similar to 30 kDa RNA-binding protein in a novel similar to 15S subcomplex in RNA-depleted mitochondria. We use these new results to update our model of MRB function and organization.	[Madina, Bhaskara R.; Kumar, Vikas; Cruz-Reyes, Jorge] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Mooers, Blaine H. M.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA	Texas A&M University System; Texas A&M University College Station; University of Oklahoma System; University of Oklahoma Health Sciences Center	Cruz-Reyes, J (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	cruzrey@tamu.edu	Cruz-Reyes, Jorge/GQP-1338-2022; Mooers, Blaine/S-4383-2017	Mooers, Blaine/0000-0001-8181-8987; Cruz-Reyes, Jorge/0000-0003-0545-1508; Kumar, Vikas/0000-0002-2645-2983	National Science Foundation [NSF1122109]; NIH/National Institute of Allergies and Infectious Diseases [R01 AI088011]; National Institute of General Medical Sciences of the National Institutes of Health [P20 GM103640]; Texas AM; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103640] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NIH/National Institute of Allergies and Infectious Diseases; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Texas AM; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Grant No. NSF1122109 (PI: J. Cruz-Reyes), NIH/National Institute of Allergies and Infectious Diseases R01 AI088011 (PI: Blaine Mooers), and Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20 GM103640. The Open Access to Knowledge (OAK) Fund at Texas A&M underwrote the charges for this publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alatortsev VS, 2008, MOL CELL BIOL, V28, P2437, DOI 10.1128/MCB.01886-07; Ammerman ML, 2012, NUCLEIC ACIDS RES, V40, P5637, DOI 10.1093/nar/gks211; Ammerman ML, 2011, RNA, V17, P865, DOI 10.1261/rna.2446311; Ammerman ML, 2010, RNA, V16, P2239, DOI 10.1261/rna.2285510; Aphasizhev R, 2011, RES MICROBIOL, V162, P655, DOI 10.1016/j.resmic.2011.04.015; Aphasizheva I, 2014, MOL CELL BIOL, V34, P4329, DOI 10.1128/MCB.01075-14; Aphasizheva I, 2011, MOL CELL, V42, P106, DOI 10.1016/j.molcel.2011.02.021; BLUM B, 1990, CELL, V62, P391, DOI 10.1016/0092-8674(90)90375-O; Carnes J, 2007, METHOD ENZYMOL, V424, P25, DOI 10.1016/S0076-6879(07)24002-9; Cifuentes-Rojas C, 2005, NUCLEIC ACIDS RES, V33, P6610, DOI 10.1093/nar/gki943; Cruz-Reyes J, 2002, MOL CELL BIOL, V22, P4652, DOI 10.1128/MCB.22.13.4652-4660.2002; Cruz-Reyes J, 2001, MOL CELL BIOL, V21, P884, DOI 10.1128/MCB.21.3.884-892.2001; Cruz-Reyes J, 2007, METHOD ENZYMOL, V424, P107, DOI 10.1016/S0076-6879(07)24005-4; Cruz-Reyes J, 2013, RNA EDITING: CURRENT RESEARCH AND FUTURE TRENDS, P65; CruzReyes J, 1996, P NATL ACAD SCI USA, V93, P8901, DOI 10.1073/pnas.93.17.8901; Dhote V, 2012, P NATL ACAD SCI USA, V109, pE3150, DOI 10.1073/pnas.1208014109; Dunbrack RL, 1997, PROTEIN SCI, V6, P1661, DOI 10.1002/pro.5560060807; Fisk JC, 2008, J BIOL CHEM, V283, P23016, DOI 10.1074/jbc.M801021200; Grams J, 2002, J BIOL CHEM, V277, P16952, DOI 10.1074/jbc.M200662200; Hashimi H, 2013, TRENDS PARASITOL, V29, P91, DOI 10.1016/j.pt.2012.11.005; Hernandez A, 2010, J BIOL CHEM, V285, P1220, DOI 10.1074/jbc.M109.051862; Jarmoskaite I, 2014, ANNU REV BIOCHEM, V83, P697, DOI 10.1146/annurev-biochem-060713-035546; Kafkova L, 2012, RNA, V18, P1846, DOI 10.1261/rna.033852.112; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Koslowsky D., 2013, NUCL ACIDS RES; KOSLOWSKY DJ, 1991, CELL, V67, P537, DOI 10.1016/0092-8674(91)90528-7; KOSLOWSKY DJ, 1992, MOL CELL BIOL, V12, P2043, DOI 10.1128/MCB.12.5.2043; Kruse E, 2013, BBA-GENE REGUL MECH, V1829, P835, DOI 10.1016/j.bbagrm.2013.04.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madina BR, 2014, RNA, V20, P1142, DOI 10.1261/rna.044495.114; Madina BR, 2011, RNA, V17, P1821, DOI 10.1261/rna.2815911; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Ochsenreiter T, 2007, RNA, V13, P1, DOI 10.1261/rna.232907; Panigrahi AK, 2001, MOL CELL BIOL, V21, P6833, DOI 10.1128/MCB.21.20.6833-6840.2001; Patel RC, 1996, J BIOL CHEM, V271, P25657, DOI 10.1074/jbc.271.41.25657; Rusche LN, 1997, EMBO J, V16, P4069, DOI 10.1093/emboj/16.13.4069; Sacharidou A, 2006, RNA, V12, P1219, DOI 10.1261/rna.2295706; Simpson AGB, 2006, TRENDS PARASITOL, V22, P168, DOI 10.1016/j.pt.2006.02.006; Simpson L, 2000, P NATL ACAD SCI USA, V97, P6986, DOI 10.1073/pnas.97.13.6986; Simpson L, 2004, RNA, V10, P159, DOI 10.1261/rna.5170704; Stuart K, 1997, MICROBIOL MOL BIOL R, V61, P105, DOI 10.1128/.61.1.105-120.1997; Walbott H, 2010, EMBO J, V29, P2194, DOI 10.1038/emboj.2010.102; Weng J, 2008, MOL CELL, V32, P198, DOI 10.1016/j.molcel.2008.08.023; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	46	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0123441	10.1371/journal.pone.0123441	http://dx.doi.org/10.1371/journal.pone.0123441			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928631	Green Submitted, gold, Green Published			2022-12-27	WOS:000353713100017
J	Bonsch, C; Munteanu, M; Rossitto-Borlat, I; Furstenberg, A; Hartley, O				Boensch, Claudia; Munteanu, Mihaela; Rossitto-Borlat, Irene; Fuerstenberg, Alexandre; Hartley, Oliver			Potent Anti-HIV Chemokine Analogs Direct Post-Endocytic Sorting of CCR5	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; HIGHLY POTENT; ENTRY INHIBITORS; TRAFFICKING; ARRESTIN; RANTES; INTERNALIZATION; IDENTIFICATION; STIMULATION; INFECTIVITY	G protein-coupled receptors (GPCRs) are desensitized and internalized following activation. They are then subjected to post-endocytic sorting (degradation, slow recycling or fast recycling). The majority of research on post-endocytic sorting has focused on the role of sequence-encoded address structures on receptors. This study focuses on trafficking of CCR5, a GPCR chemokine receptor and the principal entry coreceptor for HIV. Using Chinese Hamster Ovary cells stably expressing CCR5 we show that two different anti-HIV chemokine analogs, PSC-RANTES and 5P14-RANTES, direct receptor trafficking into two distinct subcellular compartments: the trans-Golgi network and the endosome recycling compartment, respectively. Our results indicate that a likely mechanism for ligand-directed sorting of CCR5 involves capacity of the chemokine analogs to elicit the formation of durable complexes of CCR5 and arrestin2 (beta-arrestin-1), with PSC-RANTES eliciting durable association in contrast to 5P14-RANTES, which elicits only transient association.	[Boensch, Claudia; Munteanu, Mihaela; Rossitto-Borlat, Irene; Hartley, Oliver] Univ Geneva, Dept Pathol & Immunol, Fac Med, Geneva, Switzerland; [Fuerstenberg, Alexandre] Univ Geneva, Fac Med, Dept Human Prot Sci, Geneva, Switzerland	University of Geneva; University of Geneva	Hartley, O (corresponding author), Univ Geneva, Dept Pathol & Immunol, Fac Med, Geneva, Switzerland.	oliver.hartley@unige.ch	Fürstenberg, Alexandre/A-4245-2010; Fürstenberg, Alexandre/ABF-5551-2020	Fürstenberg, Alexandre/0000-0002-6227-3122; 	Swiss National Science Foundation [31_143789]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was funded by the Swiss National Science Foundation (Project 31_143789).	COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Delhaye M, 2007, MOL PHARMACOL, V72, P1497, DOI 10.1124/mol.107.038422; Diez LT, 2014, HISTOCHEM CELL BIOL, V142, P69, DOI 10.1007/s00418-014-1206-1; Escola JM, 2010, J BIOL CHEM, V285, P41772, DOI 10.1074/jbc.M110.153460; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gaertner H, 2008, PROTEIN ENG DES SEL, V21, P65, DOI 10.1093/protein/gzm079; Gaertner H, 2008, P NATL ACAD SCI USA, V105, P17706, DOI 10.1073/pnas.0805098105; Gagnon AW, 1998, J BIOL CHEM, V273, P6976, DOI 10.1074/jbc.273.12.6976; Groer CE, 2011, J BIOL CHEM, V286, P31731, DOI 10.1074/jbc.M111.248310; Han SO, 2012, J CELL BIOL, V199, P817, DOI 10.1083/jcb.201208192; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hartley O, 2005, CURR PROTEIN PEPT SC, V6, P207, DOI 10.2174/1389203054065400; Hartley O, 2004, P NATL ACAD SCI USA, V101, P16460, DOI 10.1073/pnas.0404802101; Hartley O, 2003, J VIROL, V77, P6637, DOI 10.1128/JVI.77.12.6637-6644.2003; Jacoby E, 2006, CHEMMEDCHEM, V1, P760, DOI 10.1002/cmdc.200600134; Kenakin T, 2002, NAT REV DRUG DISCOV, V1, P103, DOI 10.1038/nrd722; Kraft K, 2001, J BIOL CHEM, V276, P34408, DOI 10.1074/jbc.M102782200; Kuhmann SE, 2008, ANNU REV PHARMACOL, V48, P425, DOI 10.1146/annurev.pharmtox.48.113006.094847; Lederman MM, 2006, JAMA-J AM MED ASSOC, V296, P815, DOI 10.1001/jama.296.7.815; Lederman MM, 2004, SCIENCE, V306, P485, DOI 10.1126/science.1099288; Mack M, 1998, J EXP MED, V187, P1215, DOI 10.1084/jem.187.8.1215; Magalhaes AC, 2012, BRIT J PHARMACOL, V165, P1717, DOI 10.1111/j.1476-5381.2011.01552.x; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Marie N, 2003, J BIOL CHEM, V278, P22795, DOI 10.1074/jbc.M300084200; MCGRAW TE, 1993, J CELL PHYSIOL, V155, P579, DOI 10.1002/jcp.1041550316; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Oppermann M, 1999, J BIOL CHEM, V274, P8875, DOI 10.1074/jbc.274.13.8875; Oppermann M, 2004, CELL SIGNAL, V16, P1201, DOI 10.1016/j.cellsig.2004.04.007; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; Schaeuble K, 2012, J CELL SCI, V125, P4463, DOI 10.1242/jcs.097519; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Signoret N, 2000, J CELL BIOL, V151, P1281, DOI 10.1083/jcb.151.6.1281; Simmons G, 1997, SCIENCE, V276, P276, DOI 10.1126/science.276.5310.276; Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224; Trkola A, 1998, J VIROL, V72, P396, DOI 10.1128/JVI.72.1.396-404.1998; Truan Z, 2013, J STRUCT BIOL, V184, P329, DOI 10.1016/j.jsb.2013.09.019; Vila-Coro AJ, 1999, J IMMUNOL, V163, P3037; Wong SKF, 2003, NEUROSIGNALS, V12, P1, DOI 10.1159/000068914; Zidar David A., 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P120; Zidar DA, 2009, P NATL ACAD SCI USA, V106, P9649, DOI 10.1073/pnas.0904361106	41	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125396	10.1371/journal.pone.0125396	http://dx.doi.org/10.1371/journal.pone.0125396			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923671	Green Published, gold, Green Submitted			2022-12-27	WOS:000353711600148
J	De Keyser, R; Breuker, CJ; Hails, RS; Dennis, RLH; Shreeve, TG				De Keyser, Rien; Breuker, Casper J.; Hails, Rosemary S.; Dennis, Roger L. H.; Shreeve, Tim G.			Why Small Is Beautiful: Wing Colour Is Free from Thermoregulatory Constraint in the Small Lycaenid Butterfly, Polyommatus icarus	PLOS ONE			English	Article							MATE CHOICE; CLIMATE; PATTERN; DIVERSITY; POSTURE; PIGMENT	We examined the roles of wing melanisation, weight, and basking posture in thermoregulation in Polyommatus Icarus, a phenotypically variable and protandrous member of the diverse Polyommatinae (Lycaenidae). Under controlled experimental conditions, approximating to marginal environmental conditions for activity in the field (=infrequent flight, long duration basking periods), warming rates are maximised with fully open wings and maximum body temperatures are dependent on weight. Variation in wing melanisation within and between sexes has no effect on warming rates; males and females which differ in melanisation had similar warming rates. Posture also affected cooling rates, consistent with cooling being dependent on convective heat loss. We hypothesise that for this small sized butterfly, melanisation has little or no effect on thermoregulation. This may be a factor contributing to the diversity of wing colours in the Polyommatinae. Because of the importance of size for thermoregulation in this small butterfly, requirements for attaining a suitable size to confer thermal stability in adults may also be a factor influencing larval feeding rates, development time and patterns of voltinism. Our findings indicate that commonly accepted views of the importance of melanisation, posture and size to thermoregulation, developed using medium and large sized butterflies, are not necessarily applicable to small sized butterflies.	[De Keyser, Rien; Dennis, Roger L. H.; Shreeve, Tim G.] Oxford Brookes Univ, Fac Hlth & Life Sci, Ctr Ecol Environm & Conservat, Dept Biol & Med Sci, Oxford OX3 0BP, England; [Breuker, Casper J.] Oxford Brookes Univ, Fac Hlth & Life Sci, Dept Biol & Med Sci, Evolutionary Dev Biol Res Grp, Oxford OX3 0BP, England; [Hails, Rosemary S.] Ctr Ecol & Hydrol, Wallingford OX10 8BB, Oxon, England	Oxford Brookes University; Oxford Brookes University; UK Centre for Ecology & Hydrology (UKCEH)	Shreeve, TG (corresponding author), Oxford Brookes Univ, Fac Hlth & Life Sci, Ctr Ecol Environm & Conservat, Dept Biol & Med Sci, Oxford OX3 0BP, England.	tgshreeve@brookes.ac.uk	Hails, Rosemary S/E-9478-2010; Breuker, Casper/N-6582-2013; Breuker, Casper/P-8270-2019	Hails, Rosemary S/0000-0002-6975-1318; Breuker, Casper/0000-0001-7909-1950; Breuker, Casper/0000-0001-7909-1950	Oxford Brookes University; Natural Environment Research Council; Centre for Ecology and Hydrology; NERC [ceh020002] Funding Source: UKRI; Natural Environment Research Council [ceh020002] Funding Source: researchfish	Oxford Brookes University; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Centre for Ecology and Hydrology; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	RDK was funded jointly by Oxford Brookes University and the Natural Environment Research Council; Centre for Ecology and Hydrology. The other authors received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balint Z, 2004, SCANNING ELECT MICRO, P87; Balint Z, 2012, J R SOC INTERFACE, V9, P1745, DOI 10.1098/rsif.2011.0854; Biro LP, 2003, PHYS REV E, V67, P71; BRUNTON CFA, 1995, P ROY SOC B-BIOL SCI, V260, P199, DOI 10.1098/rspb.1995.0080; Clusella Trullas S, 2007, J THERM BIOL, V32, P235, DOI 10.1016/j.jtherbio.2007.01.013; de Keyser R., 2012, THESIS OXFORD BROOKE; DENNIS RLH, 1989, BIOL J LINN SOC, V38, P323, DOI 10.1111/j.1095-8312.1989.tb01581.x; ELIOT J N, 1973, Bulletin of the British Museum (Natural History) Entomology, V28, P371; Emmet AM, 1982, MOTHS BUTTERFLIES GR, V7, P249; Fordyce JA, 2002, J EVOLUTION BIOL, V15, P871, DOI 10.1046/j.1420-9101.2002.00432.x; Ghiradella H, 1998, MICROSCOPIC ANATOMY OF INVERTEBRATES, VOL 11 A-C, P257; HEINRICH B, 1986, PHYSIOL ZOOL, V59, P616, DOI 10.1086/physzool.59.6.30158609; Howe PD, 2007, OECOLOGIA, V153, P857, DOI 10.1007/s00442-007-0782-3; Howe PD, 2004, THESIS OXFORD BROOKE; Ingram AL, 2008, PHILOS T R SOC B, V363, P2465, DOI 10.1098/rstb.2007.2258; Kemp DJ, 2007, P R SOC B, V274, P1043, DOI 10.1098/rspb.2006.0043; Kemp DJ, 2011, ADV STUD BEHAV, V43, P55, DOI 10.1016/B978-0-12-380896-7.00002-2; Kertesz K, 2006, CURR APPL PHYS, V6, P252, DOI 10.1016/j.cap.2005.07.051; KINGSOLVER J G, 1985, Journal of Research on the Lepidoptera, V24, P1; Kingsolver JG, 1996, AM NAT, V147, P296, DOI 10.1086/285852; KINGSOLVER JG, 1982, OECOLOGIA, V53, P27, DOI 10.1007/BF00377132; Klingenberg C, 2008, ANAL ORGANISMAL FORM; Lyytinen A, 2004, P ROY SOC B-BIOL SCI, V271, P279, DOI 10.1098/rspb.2003.2571; Lyytinen A, 2003, OIKOS, V100, P373, DOI 10.1034/j.1600-0706.2003.11935.x; Morehouse NI, 2010, AM NAT, V176, P768, DOI 10.1086/657043; Nygren GH, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.4701; Oliver JC, 2009, P ROY SOC B-BIOL SCI, V276, P2369, DOI 10.1098/rspb.2009.0182; Olofsson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010798; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rasband W.S., 1997, IMAGE J; RUTOWSKI RL, 1985, Z TIERPSYCHOL, V70, P103; Rutowski RL, 2010, FUNCT ECOL, V24, P767, DOI 10.1111/j.1365-2435.2010.01693.x; SHREEVE TG, 1992, BIOL J LINN SOC, V45, P57, DOI 10.1111/j.1095-8312.1992.tb00631.x; Shreeve Tim, 2009, P171; Silberglied R.E., 1984, Symposia of the Royal Entomological Society of London, P207; Talloen W, 2004, EVOLUTION, V58, P360, DOI 10.1111/j.0014-3820.2004.tb01651.x; Van Dyck H, 1998, OECOLOGIA, V114, P326, DOI 10.1007/s004420050454; VanDyck H, 1997, ANIM BEHAV, V53, P39, DOI 10.1006/anbe.1996.0276; VANEWRIGHT RI, 1993, PHILOS T R SOC B, V340, P197; Vila R, 2011, P ROY SOC B-BIOL SCI, V278, P2737, DOI 10.1098/rspb.2010.2213; WASSERTHAL LT, 1975, J INSECT PHYSIOL, V21, P1921, DOI 10.1016/0022-1910(75)90224-3; WATT WB, 1968, EVOLUTION, V22, P437, DOI 10.1111/j.1558-5646.1968.tb03985.x; Zeuss D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4874	44	16	16	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0122623	10.1371/journal.pone.0122623	http://dx.doi.org/10.1371/journal.pone.0122623			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923738	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000353711600019
J	Tseng, ZJ; Flynn, JJ				Tseng, Zhijie Jack; Flynn, John J.			Are Cranial Biomechanical Simulation Data Linked to Known Diets in Extant Taxa? A Method for Applying Diet-Biomechanics Linkage Models to Infer Feeding Capability of Extinct Species	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; ESTIMATED BITING FORCES; PREDATORY BEHAVIOR; BITE FORCE; EVOLUTION; CARNIVORA; SKULL; PERFORMANCE; MAMMALIA; ADAPTATION	Performance of the masticatory system directly influences feeding and survival, so adaptive hypotheses often are proposed to explain craniodental evolution via functional morphology changes. However, the prevalence of "many-to-one" association of cranial forms and functions in vertebrates suggests a complex interplay of ecological and evolutionary histories, resulting in redundant morphology-diet linkages. Here we examine the link between cranial biomechanical properties for taxa with different dietary preferences in crown clade Carnivora, the most diverse clade of carnivorous mammals. We test whether hypercarnivores and generalists can be distinguished based on cranial mechanical simulation models, and how such diet-biomechanics linkages relate to morphology. Comparative finite element and geometric morphometrics analyses document that predicted bite force is positively allometric relative to skull strain energy; this is achieved in part by increased stiffness in larger skull models and shape changes that resist deformation and displacement. Size-standardized strain energy levels do not reflect feeding preferences; instead, caniform models have higher strain energy than feliform models. This caniform-feliform split is reinforced by a sensitivity analysis using published models for six additional taxa. Nevertheless, combined bite force-strain energy curves distinguish hypercarnivorous versus generalist feeders. These findings indicate that the link between cranial biomechanical properties and carnivoran feeding preference can be clearly defined and characterized, despite phylogenetic and allometric effects. Application of this diet-biomechanics linkage model to an analysis of an extinct stem carnivoramorphan and an outgroup creodont species provides biomechanical evidence for the evolution of taxa into distinct hypercarnivorous and generalist feeding styles prior to the appearance of crown carnivoran clades with similar feeding preferences.	[Tseng, Zhijie Jack; Flynn, John J.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Flynn, John J.] Amer Museum Nat Hist, Richard Gilder Grad Sch, New York, NY 10024 USA	American Museum of Natural History (AMNH); American Museum of Natural History (AMNH)	Tseng, ZJ (corresponding author), Amer Museum Nat Hist, Div Paleontol, Cent Pk West,79th St, New York, NY 10024 USA.	tsengzhijie@gmail.com			NSF [DEB-1257572]; AMNH Frick Postdoctoral Fellowship	NSF(National Science Foundation (NSF)); AMNH Frick Postdoctoral Fellowship	This research was funded by NSF DEB-1257572 to ZJT and JJF, and an AMNH Frick Postdoctoral Fellowship (to ZJT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; Adams DC, 2013, HYSTRIX, V24, P7, DOI 10.4404/hystrix-24.1-6283; Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; Arnold SJ, 2003, INTEGR COMP BIOL, V43, P367, DOI 10.1093/icb/43.3.367; Bright JA, 2011, ANAT REC, V294, P610, DOI 10.1002/ar.21358; Chamoli U, 2011, J THEOR BIOL, V283, P217, DOI 10.1016/j.jtbi.2011.05.020; DESSEM D, 1992, J MORPHOL, V213, P275, DOI 10.1002/jmor.1052130211; DESSEM D, 1989, J ANAT, V164, P101; Diaz-Uriarte R, 1998, SYST BIOL, V47, P654, DOI 10.1080/106351598260653; Dumont ER, 2009, J THEOR BIOL, V256, P96, DOI 10.1016/j.jtbi.2008.08.017; Dumont ER, 2005, ANAT REC PART A, V283A, P319, DOI 10.1002/ar.a.20165; Ellis JL, 2008, J ANAT, V212, P769, DOI 10.1111/j.1469-7580.2008.00911.x; Erickson GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031781; Ewer, 1998, CARNIVORES; Figueirido B, 2013, EVOLUTION, V67, P1975, DOI 10.1111/evo.12059; Flynn JJ, 2005, SYST BIOL, V54, P317, DOI 10.1080/10635150590923326; Flynn John J., 2005, P175; Flynn John J., 1998, P110; FUTUYMA DJ, 1997, EVOLUTIONARY BIOL; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; GARLAND T, 1993, SYST BIOL, V42, P265, DOI 10.2307/2992464; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Grosse IR, 2007, ANAT REC, V290, P1069, DOI 10.1002/ar.20568; Hartstone-Rose A, 2012, ANAT REC, V295, P1336, DOI 10.1002/ar.22518; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Kolmann MA, 2009, ZOOLOGY, V112, P351, DOI 10.1016/j.zool.2008.11.002; Maddison WP, 2011, MESQUITE MODULAR SYS; McHenry CR, 2007, P NATL ACAD SCI USA, V104, P16010, DOI 10.1073/pnas.0706086104; Nowak RM, 1999, WALKERS CARNIVORES W, V313; O'Leary MA, 2013, SCIENCE, V339, P662, DOI 10.1126/science.1229237; Rayfield EJ, 2007, ANNU REV EARTH PL SC, V35, P541, DOI 10.1146/annurev.earth.35.031306.140104; Schumacher GH., 1961, FUNKTIONELLE MORPHOL; Slater GJ, 2009, J EVOLUTION BIOL, V22, P2278, DOI 10.1111/j.1420-9101.2009.01845.x; Slater GJ, 2009, J ZOOL, V278, P181, DOI 10.1111/j.1469-7998.2009.00567.x; Slater GJ, 2008, PALEOBIOLOGY, V34, P403, DOI 10.1666/07061.1; Slater GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013870; Spaulding M, 2012, J SYST PALAEONTOL, V10, P653, DOI 10.1080/14772019.2011.630681; THOMASON JJ, 1991, CAN J ZOOL, V69, P2326, DOI 10.1139/z91-327; Tseng ZJ, 2015, J THEOR BIOL, V365, P112, DOI 10.1016/j.jtbi.2014.10.002; Tseng ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065305; Tseng ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019171; Tseng ZJ, 2011, BIOL J LINN SOC, V102, P540, DOI 10.1111/j.1095-8312.2010.01602.x; Tseng ZJ, 2010, J MORPHOL, V271, P1386, DOI 10.1002/jmor.10881; Tseng ZJ, 2009, BIOL J LINN SOC, V96, P51, DOI 10.1111/j.1095-8312.2008.01095.x; Turnbull W. D., 1970, Fieldiana (Geol.), V18, P147; Van Valkenburgh B., 1989, CARNIVORE BEHAV ECOL, P410, DOI DOI 10.1007/978-1-4757-4716-4; Van Valkenburgh B, 2007, INTEGR COMP BIOL, V47, P147, DOI 10.1093/icb/icm016; VanValkenburgh B, 1996, J MAMMAL, V77, P240, DOI 10.2307/1382725; Wainwright PC, 2007, ANNU REV ECOL EVOL S, V38, P381, DOI 10.1146/annurev.ecolsys.38.091206.095706; Wang XM, 1999, B AM MUS NAT HIST, P1; WANG XM, 1994, B AM MUS NAT HIST, P1; WERDELIN L, 1989, PALEOBIOLOGY, V15, P387, DOI 10.1017/S009483730000957X; Wesley-Hunt GD, 2005, PALEOBIOLOGY, V31, P35, DOI 10.1666/0094-8373(2005)031<0035:TMDOCI>2.0.CO;2; Wesley-Hunt GD, 2005, J SYST PALAEONTOL, V3, P1; Wiley D. F., 2005, P IEEE VIS C, P1; Wroe S, 2005, P ROY SOC B-BIOL SCI, V272, P619, DOI 10.1098/rspb.2004.2986	56	26	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124020	10.1371/journal.pone.0124020	http://dx.doi.org/10.1371/journal.pone.0124020			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923776	Green Published, gold, Green Submitted			2022-12-27	WOS:000353711600067
J	Guo, LX; Xu, XM; Liang, FR; Yuan, JP; Peng, J; Wu, CF; Wang, JH				Guo, Lian-Xian; Xu, Xiao-Ming; Liang, Fu-Rui; Yuan, Jian-Ping; Peng, Juan; Wu, Chou-Fei; Wang, Jiang-Hai			Morphological Observations and Fatty Acid Composition of Indoor-Cultivated Cordyceps sinensis at a High-Altitude Laboratory on Sejila Mountain, Tibet	PLOS ONE			English	Article							OPHIOCORDYCEPS-SINENSIS; MEDICINE; FUNGI	Cordyceps sinensis, a caterpillar entomopathogenic fungus-host larva complex, is a rare medicinal herb found in the Qinghai-Tibetan Plateau and its surrounding high-altitude areas. The alternation of generations in the life cycle, whatever the fungus or its host insect, requires special growth conditions. However, it is difficult to simulate the growth conditions of C. sinensis, which hinders its artificial cultivation. In this work, the life cycle from the host larva to C. sinensis was observed in an indoor-cultivation laboratory at 4,200 m a.s.l. on Sejila Mountain, Tibet. Comparative examinations between indoor-cultivated and wild C. sinensisdemonstrated that the indoor-cultivated C. sinensispreferred to germinate multiple long, slim stromata at diverse positions on dead larvae, including but not limited to their heads. Their fatty acid composition shows a significant difference in the levels of polyunsaturated fatty acids (PUFAs). In indoor-cultivated C. sinensis, PUFAs constituted 24.59% and 49.43%, respectively, of neutral and polar lipids; meanwhile, in wild C. sinensis, PUFAs represented 34.34% and 61.25% of neutral and polar lipids, respectively. These observations and fatty acid data suggest that environmental factors, particularly temperature, soil pressure and light intensity, strongly affect the growth of C. sinensis. Our new findings may provide important information for improving techniques for the large-scale artificial cultivation of C. sinensis.	[Guo, Lian-Xian] Guangdong Med Coll, Sch Publ Hlth, Dongguan, Guangdong, Peoples R China; [Guo, Lian-Xian; Xu, Xiao-Ming; Liang, Fu-Rui; Yuan, Jian-Ping; Peng, Juan; Wu, Chou-Fei; Wang, Jiang-Hai] Sun Yat Sen Univ, Guangdong Prov Key Lab Marine Resources & Coastal, Guangzhou 510275, Guangdong, Peoples R China	Guangdong Medical University; Guangdong Provincial Key Laboratory of Marine Resources & Coastal Engineering; Sun Yat Sen University	Wu, CF (corresponding author), Sun Yat Sen Univ, Guangdong Prov Key Lab Marine Resources & Coastal, Guangzhou 510275, Guangdong, Peoples R China.	wuchf3@mail.sysu.edu.cn; wangjhai@mail.sysu.edu.cn	Yuan, Jian-Ping/M-2920-2016; 吴, 酬飞/AAL-7440-2021		Specialized Research Fund for the Doctoral Program of Higher Education [20090171110015]; natural science foundation of China [81303155]; Program for Dongguan Higher Education, Science and Research, and Health Care Institutions [2011108102022]; Guangdong Medical College [B2010011]	Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); natural science foundation of China(National Natural Science Foundation of China (NSFC)); Program for Dongguan Higher Education, Science and Research, and Health Care Institutions; Guangdong Medical College	This work was supported by the Specialized Research Fund for the Doctoral Program of Higher Education (No. 20090171110015), natural science foundation of China (No. 81303155), the Program for Dongguan Higher Education, Science and Research, and Health Care Institutions (No. 2011108102022) and the funding (No. B2010011) from the Guangdong Medical College.	An JM, 2003, J SHANXI TU, V17, P72; Chen D, 2009, SCI CHINA SER D, V52, P655, DOI 10.1007/s11430-009-0068-1; Chen YQ, 2002, PLANTA MED, V68, P635, DOI 10.1055/s-2002-32892; Dong YZ, 2014, PLOS ONE, DOI [10.1371/journal.pone.0109083, DOI 10.1371/J0URNAL.P0NE.0109083]; Guo L., 2012, BIOMEDICINE PREVENTI, V2, P42, DOI [10.1016/j.bionut.2011.07.002, DOI 10.1016/J.BIONUT.2011.07.002]; Guo LX, 2014, FOOD SCI TECH, V30, P52; [何苏琴 He Suqin], 2011, [微生物学通报, Microbiology], V38, P1730; Lei W, 2013, J MICROBIOL, V51, P229, DOI 10.1007/s12275-013-2241-7; Li Jun-Feng, 2011, Huanjing Kunchong Xuebao, V33, P195; Li L, 1993, Zhongguo Zhong Yao Za Zhi, V18, P80; [李明财 LI MingCai], 2008, [生态学报, Acta Ecologica Sinica], V28, P3160; Li WQ, 2014, CHIN HERB MED, V6, P217, DOI 10.1016/S1674-6384(14)60031-9; Li Y, 2011, J MICROBIOL, V49, P913, DOI 10.1007/s12275-011-1193-z; Liang HH, 2008, J MICROBIOL, V46, P549, DOI 10.1007/s12275-008-0107-1; [刘飞 LIU Fei], 2007, [中草药, Chinese Traditional and Herbal Drugs], V38, P302; Morgan-Kiss RM, 2006, MICROBIOL MOL BIOL R, V70, P222, DOI 10.1128/MMBR.70.1.222-252.2006; Paterson RRM, 2008, PHYTOCHEMISTRY, V69, P1469, DOI 10.1016/j.phytochem.2008.01.027; Quan QM, 2014, PLOS ONE, DOI [10.1371/journal.pone.0092293, DOI 10.1371/J0URNAL.P0NE.0092293]; Roy HE, 2006, ANNU REV ENTOMOL, V51, P331, DOI 10.1146/annurev.ento.51.110104.150941; Shrestha UB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106405; Tu Y., 2010, EDIBLE FUNGI CHINA, V29, P24; Weinstein RN, 2000, MYCOLOGIA, V92, P222, DOI 10.2307/3761554; Winkler D, 2008, ECON BOT, V62, P291, DOI 10.1007/s12231-008-9038-3; Xing XK, 2008, MYCOLOGIA, V100, P616, DOI 10.3852/07-007R2; Yang Y.X., 1990, ZOOL RES, V3, P237; Yu Yong-xin, 2004, Journal of Fungal Research, V2, P42; Yue K, 2013, J PHARM PHARMACOL, V65, P474, DOI 10.1111/j.2042-7158.2012.01601.x; Zeng W, 2003, CHONGQING J RES CHIN, V48, P5; Zhang YongJie, 2012, Mycology - An International Journal on Fungal Biology, V3, P2; Zhang YongJun, 2001, Journal of Southwest Agricultural University, V23, P144; Zhao J, 2014, J PHARMACEUT BIOMED, V87, P271, DOI 10.1016/j.jpba.2013.04.025; Zhiwen Zou, 2010, Proceedings of the 2010 3rd International Conference on Biomedical Engineering and Informatics (BMEI 2010), P2560, DOI 10.1109/BMEI.2010.5639714; Zhou XW, 2014, CRIT REV BIOTECHNOL, V34, P233, DOI 10.3109/07388551.2013.791245; Zhu JS, 1998, J ALTERN COMPLEM MED, V4, P289, DOI 10.1089/acm.1998.4.3-289; Zou ZW, 2010, J HUNAN U SCI TECHNO, V25, P114, DOI DOI 10.3969/J.ISSN.1672-9102.2010.01.025	35	16	20	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0126095	10.1371/journal.pone.0126095	http://dx.doi.org/10.1371/journal.pone.0126095			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938484	Green Published, Green Submitted, gold			2022-12-27	WOS:000353943000137
J	Jackson, HM; Onos, KD; Pepper, KW; Graham, LC; Akeson, EC; Byers, C; Reinholdt, LG; Frankel, WN; Howell, GR				Jackson, Harriet M.; Onos, Kristen D.; Pepper, Keating W.; Graham, Leah C.; Akeson, Ellen C.; Byers, Candice; Reinholdt, Laura G.; Frankel, Wayne N.; Howell, Gareth R.			DBA/2J Genetic Background Exacerbates Spontaneous Lethal Seizures but Lessens Amyloid Deposition in a Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							MEMBRANE ATTACK COMPLEX; PRECURSOR PROTEIN; CELL-DEATH; DISTAL CHROMOSOME-1; ALPHA-SECRETASE; MICE; NEURODEGENERATION; STRAINS; SYSTEM; SUSCEPTIBILITY	Alzheimer's disease (AD) is a leading cause of dementia in the elderly and is characterized by amyloid plaques, neurofibrillary tangles (NFTs) and neuronal dysfunction. Early onset AD (EOAD) is commonly caused by mutations in amyloid precursor protein (APP) or genes involved in the processing of APP including the presenilins (e.g. PSEN1 or PSEN2). In general, mouse models relevant to EOAD recapitulate amyloidosis, show only limited amounts of NFTs and neuronal cell dysfunction and low but significant levels of seizure susceptibility. To investigate the effect of genetic background on these phenotypes, we generated APP(swe) and PSEN1(de9) transgenic mice on the seizure prone inbred strain background, DBA/2J. Previous studies show that the DBA/2J genetic background modifies plaque deposition in the presence of mutant APP but the impact of PSEN1(de9) has not been tested. Our study shows that DBA/2J. APP(swe)PSEN1(de9) mice are significantly more prone to premature lethality, likely to due to lethal seizures, compared to B6. APP(swe)PSEN1(de9) mice-70% of DBA/2J. APP(swe)PSEN1(de9) mice die between 2-3 months of age. Of the DBA/2J. APP(swe)PSEN1(de9) mice that survived to 6 months of age, plaque deposition was greatly reduced compared to age-matched B6. APP(swe)PSEN1(de9) mice. The reduction in plaque deposition appears to be independent of microglia numbers, reactive astrocytosis and complement C5 activity.	[Jackson, Harriet M.; Onos, Kristen D.; Pepper, Keating W.; Graham, Leah C.; Akeson, Ellen C.; Byers, Candice; Reinholdt, Laura G.; Frankel, Wayne N.; Howell, Gareth R.] Jackson Lab, Bar Harbor, ME 04609 USA; [Graham, Leah C.; Howell, Gareth R.] Tufts Univ, Sackler Sch Med, Boston, MA 02111 USA	Jackson Laboratory; Tufts University	Howell, GR (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	gareth.howell@jax.org	Jackson, Harriet/HGT-8937-2022	Onos, Kristen/0000-0001-6443-6557; Byers, Candice/0000-0003-2526-2843	NIH [EY021525]; Jane B. Cook Charitable Trust; NATIONAL EYE INSTITUTE [R01EY021525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS031348] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane B. Cook Charitable Trust; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by NIH EY021525 (G.R.H.) and the Jane B. Cook 1983 Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MG, 2002, NAT GENET, V30, P81, DOI 10.1038/ng794; [Anonymous], 1984, METHODS AND FINDINGS, V6, P531; Bessaih T, 2012, EPILEPSIA, V53, P1429, DOI 10.1111/j.1528-1167.2012.03512.x; Bubier JA, 2012, NEUROTHERAPEUTICS, V9, P338, DOI 10.1007/s13311-012-0111-3; Cabrejo L, 2006, BRAIN, V129, P2966, DOI 10.1093/brain/awl237; Chang B, 1999, NAT GENET, V21, P405, DOI 10.1038/7741; Chow VW, 2010, NEUROMOL MED, V12, P1, DOI 10.1007/s12017-009-8104-z; Cowley TR, 2013, NEUROCHEM RES, V38, P1190, DOI 10.1007/s11064-012-0884-0; ERWAY LC, 1993, HEARING RES, V65, P125, DOI 10.1016/0378-5955(93)90207-H; Extance A, 2010, NAT REV DRUG DISCOV, V9, P749, DOI 10.1038/nrd3288; Ferraro TN, 2002, BRAIN RES, V936, P82, DOI 10.1016/S0006-8993(02)02565-9; Ferraro TN, 2001, GENOMICS, V75, P35, DOI 10.1006/geno.2001.6577; Frankel WN, 2009, TRENDS GENET, V25, P361, DOI 10.1016/j.tig.2009.07.001; Frankel WN, 2001, GENOMICS, V74, P306, DOI 10.1006/geno.2001.6564; Gasque P, 2002, MOL NEUROBIOL, V25, P1, DOI 10.1385/MN:25:1:001; Grundman M, 2013, J NUTR HEALTH AGING, V17, P51, DOI 10.1007/s12603-013-0002-2; Howell GR, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-76; Howell GR, 2008, PROG BRAIN RES, V173, P303, DOI 10.1016/S0079-6123(08)01122-9; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; LAFERLA FM, 1995, NAT GENET, V9, P21, DOI 10.1038/ng0195-21; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lehman EJH, 2003, HUM MOL GENET, V12, P2949, DOI 10.1093/hmg/ddg322; Lesne SE, 2013, BRAIN, V136, P1383, DOI 10.1093/brain/awt062; Menendez M, 2005, BRAIN DEV-JPN, V27, P246, DOI 10.1016/j.braindev.2004.07.008; Morihara T, 2014, P NATL ACAD SCI USA, V111, P2638, DOI 10.1073/pnas.1307345111; Mukherjee P, 2000, J NEUROIMMUNOL, V105, P124, DOI 10.1016/S0165-5728(99)00261-1; Nilsson UR, 1967, THE JOURNAL OF EXPER, V125, P1; Norton S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1; Obregon D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1781; OOI YM, 1979, NATURE, V282, P207, DOI 10.1038/282207a0; Osaka H, 1999, NEUROSCIENCE, V88, P1073, DOI 10.1016/S0306-4522(98)00372-8; PAIGEN B, 1990, ARTERIOSCLEROSIS, V10, P316, DOI 10.1161/01.ATV.10.2.316; Pasinetti GM, 1996, NEUROBIOL DIS, V3, P197, DOI 10.1006/nbdi.1996.0020; Ramaglia V, 2007, J NEUROSCI, V27, P7663, DOI 10.1523/JNEUROSCI.5623-06.2007; Ryman D, 2008, NEUROBIOL AGING, V29, P1190, DOI 10.1016/j.neurobiolaging.2007.02.017; Ryman Davis, 2006, Current Alzheimer Research, V3, P465, DOI 10.2174/156720506779025198; Sattler R, 2001, MOL NEUROBIOL, V24, P107, DOI 10.1385/MN:24:1-3:107; Scarmeas N, 2009, ARCH NEUROL-CHICAGO, V66, P992, DOI 10.1001/archneurol.2009.130; Scharfman HE, 2012, EPILEPSY CURR, V12, P178, DOI 10.5698/1535-7511-12.5.178; Schauwecker PE, 2003, EPILEPSY RES, V55, P201, DOI 10.1016/S0920-1211(03)00115-3; Schor NF, 2011, ANN NEUROL, V69, P237, DOI 10.1002/ana.22365; Sloane PD, 2002, ANNU REV PUBL HEALTH, V23, P213, DOI 10.1146/annurev.publhealth.23.100901.140525; Sperling R, 2012, LANCET NEUROL, V11, P241, DOI 10.1016/S1474-4422(12)70015-7; Srivastava A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-367; Sun WZ, 2013, J PHYSIOL-LONDON, V591, P241, DOI 10.1113/jphysiol.2012.240168; Turner JG, 1998, HEARING RES, V118, P101, DOI 10.1016/S0378-5955(98)00024-0; Vogt DL, 2011, NEUROBIOL AGING, V32, P1725, DOI 10.1016/j.neurobiolaging.2009.09.002; Vossel KA, 2013, JAMA NEUROL, V70, P1158, DOI 10.1001/jamaneurol.2013.136; Wang Xiao-lin, 2009, Fudan Xuebao (Yixueban), V36, P79; Webster S, 1997, NEUROBIOL AGING, V18, P415, DOI 10.1016/S0197-4580(97)00042-0; Westmark CJ, 2008, INT J CLIN EXP PATHO, V1, P157; Whitehead GS, 2003, AM J PHYSIOL-LUNG C, V285, pL32, DOI 10.1152/ajplung.00390.2002; Williams PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072282; Wolff D, 2005, THE PRINCIPLES OF CL, P455; Xing SQ, 2009, AM J PHYSIOL-HEART C, V296, pH1907, DOI 10.1152/ajpheart.00681.2008	59	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125897	10.1371/journal.pone.0125897	http://dx.doi.org/10.1371/journal.pone.0125897			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933409	gold, Green Published, Green Submitted			2022-12-27	WOS:000353887100140
J	Li, ZX; Wang, YM; Tang, FB; Zhang, L; Zhang, Y; Ma, JL; Zhou, T; You, WC; Pan, KF				Li, Zhe-Xuan; Wang, Yu-Mei; Tang, Fu-Bing; Zhang, Lian; Zhang, Yang; Ma, Jun-Ling; Zhou, Tong; You, Wei-Cheng; Pan, Kai-Feng			NOD1 and NOD2 Genetic Variants in Association with Risk of Gastric Cancer and Its Precursors in a Chinese Population	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; PRECANCEROUS LESIONS; INNATE IMMUNITY; POLYMORPHISMS; SUSCEPTIBILITY; NOD1/CARD4; RECEPTORS; EVOLUTION; APOPTOSIS; DOMAIN	Background Genetic variants of nucleotide-binding oligomerization domain-containing protein (NOD) may influence the outcome of Helicobacter pylori (H. pylori) infection and gastric carcinogenesis. To explore genetic variants of NOD1 and NOD2 in association with gastric cancer (GC) and its precursors, a population-based study was conducted in Linqu County, China. Methods TagSNPs of NOD1 and NOD2 were genotyped by Sequenom MASS array in 132 GCs, and 1,198 subjects with precancerous gastric lesions, and were correlated with evolution of gastric lesions in 766 subjects with follow-up data. Results Among seven tagSNPs, NOD1 rs2709800 and NOD2 rs718226 were associated with gastric lesions. NOD1 rs2709800 TG genotype carriers had a decreased risk of intestinal metaplasia (IM, OR: 0.53; 95% CI: 0.31-0.92), while NOD2 rs718226 G allele (AG/GG) showed increased risks of dysplasia (DYS, OR: 2.96; 95% CI: 1.86-4.71) and GC (OR: 2.35; 95% CI: 1.24-4.46). Moreover, an additive interaction between rs718226 and H. pylori was found in DYS or GC with synergy index of 3.08 (95% CI: 1.38-6.87) or 3.99 (95% CI: 1.55-10.22), respectively. The follow-up data indicated that NOD2 rs2111235 C allele (OR: 0.52; 95% CI: 0.32-0.83) and rs7205423 G allele (OR: 0.56; 95% CI: 0.35-0.89) were associated with decreased risk of progression in H. pylori-infected subjects. Conclusions NOD1 rs2709800, NOD2 rs718226, rs2111235, rs7205423 and interaction between rs718226 and H. pylori infection may be related to risk of gastric lesions.	[Li, Zhe-Xuan; Wang, Yu-Mei; Tang, Fu-Bing; Zhang, Lian; Zhang, Yang; Ma, Jun-Ling; Zhou, Tong; You, Wei-Cheng; Pan, Kai-Feng] Peking Univ, Canc Hosp & Inst, Dept Canc Epidemiol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100142, Peoples R China	Peking University	You, WC (corresponding author), Peking Univ, Canc Hosp & Inst, Dept Canc Epidemiol, Key Lab Carcinogenesis & Translat Res,Minist Educ, 52 Fu Cheng Rd, Beijing 100142, Peoples R China.	weichengyou@yahoo.com; pankaifeng2002@yahoo.com	Li, Zhe-xuan/E-9182-2017	Li, Zhe-xuan/0000-0003-4023-6432; Pan, Kai-feng/0000-0002-3680-3126	Ministry of Science and Technology, China [2010DFB30310]; National Basic Research Program of China [973 program] [2010CB529303]; National Natural Science Foundation of China [81171989]	Ministry of Science and Technology, China(Ministry of Science and Technology, ChinaMinistry of Science, ICT & Future Planning, Republic of Korea); National Basic Research Program of China [973 program](National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from Ministry of Science and Technology, China [2010DFB30310], National Basic Research Program of China [973 program 2010CB529303], and National Natural Science Foundation of China [81171989].	Allison CC, 2013, J IMMUNOL, V190, P3706, DOI 10.4049/jimmunol.1200591; Allison CC, 2009, J IMMUNOL, V183, P8099, DOI 10.4049/jimmunol.0900664; Angeletti S, 2009, HUM IMMUNOL, V70, P729, DOI 10.1016/j.humimm.2009.04.026; Castano-Rodriguez N, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00336; Castano-Rodriguez N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098899; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; CORREA P, 1988, CANCER RES, V48, P3554; Correa P, 2007, GASTROENTEROLOGY, V133, P659, DOI 10.1053/j.gastro.2007.06.026; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Gonzalez CA, 2002, INT J CANCER, V100, P249, DOI 10.1002/ijc.10466; Hnatyszyn A, 2010, EXP MOL PATHOL, V88, P388, DOI 10.1016/j.yexmp.2010.03.003; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; Inohara N, 2001, ONCOGENE, V20, P6473, DOI 10.1038/sj.onc.1204787; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim DJ, 2013, EUR J IMMUNOL, V43, P2650, DOI 10.1002/eji.201243281; Kutikhin AG, 2011, HUM IMMUNOL, V72, P955, DOI 10.1016/j.humimm.2011.06.003; Li WQ, 2009, CARCINOGENESIS, V30, P500, DOI 10.1093/carcin/bgp018; Ma JL, 2012, J NATL CANCER I, V104, P488, DOI 10.1093/jnci/djs003; Nikolaou K, 2012, CANCER CELL, V21, P738, DOI 10.1016/j.ccr.2012.04.026; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Philpott DJ, 2014, NAT REV IMMUNOL, V14, P9, DOI 10.1038/nri3565; Rosenstiel P, 2006, CELL MICROBIOL, V8, P1188, DOI 10.1111/j.1462-5822.2006.00701.x; Rugge M, 2000, AM J SURG PATHOL, V24, P167, DOI 10.1097/00000478-200002000-00001; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Tsagaratou A, 2010, J IMMUNOL, V185, P2032, DOI 10.4049/jimmunol.0903919; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Wang F, 2014, CANCER LETT, V345, P196, DOI 10.1016/j.canlet.2013.08.016; Wang P, 2012, WORLD J GASTROENTERO, V18, P2112, DOI 10.3748/wjg.v18.i17.2112; Wex T, 2008, ANTICANCER RES, V28, P757; Wong BCY, 2012, GUT, V61, P812, DOI 10.1136/gutjnl-2011-300154; Yoshida T, 2014, INT J CANCER, V134, P1445, DOI 10.1002/ijc.28470; You WC, 1999, INT J CANCER, V83, P615, DOI 10.1002/(SICI)1097-0215(19991126)83:5&lt;615::AID-IJC8&gt;3.0.CO;2-L; You WC, 2000, J NATL CANCER I, V92, P1607, DOI 10.1093/jnci/92.19.1607; YOU WC, 1993, J GASTROEN HEPATOL, V8, P375, DOI 10.1111/j.1440-1746.1993.tb01531.x; YOU WC, 1993, CANCER RES, V53, P1317; You WC, 1998, INT J EPIDEMIOL, V27, P941, DOI 10.1093/ije/27.6.941; You WC, 2006, JNCI-J NATL CANCER I, V98, P974, DOI 10.1093/jnci/djj264; Zeng Hong-mei, 2012, Zhonghua Zhong Liu Za Zhi, V34, P525, DOI 10.3760/cma.j.issn.0253-3766.2012.07.011; Zhang L, 1996, CANCER EPIDEM BIOMAR, V5, P627	41	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124949	10.1371/journal.pone.0124949	http://dx.doi.org/10.1371/journal.pone.0124949			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933107	Green Submitted, Green Published, gold			2022-12-27	WOS:000353887100067
J	Ladwig, N; Franz-Wachtel, M; Hezel, F; Soufi, B; Macek, B; Wohlleben, W; Muth, G				Ladwig, Nils; Franz-Wachtel, Mirita; Hezel, Felix; Soufi, Boumediene; Macek, Boris; Wohlleben, Wolfgang; Muth, Guenther			Control of Morphological Differentiation of Streptomyces coelicolor A3(2) by Phosphorylation of MreC and PBP2	PLOS ONE			English	Article							CELL-DIVISION; SERINE/THREONINE KINASES; ESCHERICHIA-COLI; TEICHOIC-ACIDS; SER/THR KINASE; GROWTH; IDENTIFICATION; PEPTIDOGLYCAN; PROTEINS; PKNA	During morphological differentiation of Streptomyces coelicolor A3(2), the sporogenic aerial hyphae are transformed into a chain of more than fifty spores in a highly coordinated manner. Synthesis of the thickened spore envelope is directed by the Streptomyces spore wall synthesizing complex SSSC which resembles the elongasome of rod-shaped bacteria. The SSSC includes the eukaryotic type serine/threonine protein kinase (eSTPK) PkaI, encoded within a cluster of five independently transcribed eSTPK genes (SCO4775-4779). To understand the role of PkaI in spore wall synthesis, we screened a S. coelicolor genomic library for PkaI interaction partners by bacterial two-hybrid analyses and identified several proteins with a documented role in sporulation. We inactivated pkaI and deleted the complete SCO4775-4779 cluster. Deletion of pkaI alone delayed sporulation and produced some aberrant spores. The five-fold mutant NL.4775-4779 had a more severe defect and produced 18% aberrant spores affected in the integrity of the spore envelope. Moreover, overbalancing phosphorylation activity by expressing a second copy of any of these kinases caused a similar defect. Following co-expression of pkaI with either mreC or pbp2 in E. coli, phosphorylation of MreC and PBP2 was demonstrated and multiple phosphosites were identified by LC-MS/MS. Our data suggest that elaborate protein phosphorylation controls activity of the SSSC to ensure proper sporulation by suppressing premature cross-wall synthesis.	[Ladwig, Nils; Hezel, Felix; Wohlleben, Wolfgang; Muth, Guenther] Univ Tubingen, Interfak Inst Mikrobiol & Infektionsmed Tuebingen, Mikrobiol Biotechnol, D-72076 Tubingen, Germany; [Franz-Wachtel, Mirita; Soufi, Boumediene; Macek, Boris] Univ Tubingen, Interfak Inst Zellbiol, Proteome Ctr Tuebingen, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Muth, G (corresponding author), Univ Tubingen, Interfak Inst Mikrobiol & Infektionsmed Tuebingen, Mikrobiol Biotechnol, Morgenstelle 28, D-72076 Tubingen, Germany.	gmuth@biotech.uni-tuebingen.de	Macek, Boris/N-1442-2015	Macek, Boris/0000-0002-1206-2458	Deutsche Forschungsgemeinschaft (DFG) [SFB-766]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft (DFG), SFB-766.	Bean GJ, 2009, BIOCHEMISTRY-US, V48, P4852, DOI 10.1021/bi900014d; Borchert N, 2010, GENOME RES, V20, P837, DOI 10.1101/gr.103119.109; Brown S, 2013, ANNU REV MICROBIOL, V67, P313, DOI 10.1146/annurev-micro-092412-155620; Burger A, 2000, MOL GEN GENET, V263, P1053, DOI 10.1007/s004380050034; Cabeen MT, 2009, EMBO J, V28, P1208, DOI 10.1038/emboj.2009.61; Carballido-Lopez R, 2003, TRENDS CELL BIOL, V13, P577, DOI 10.1016/j.tcb.2003.09.005; Carballido-Lopez R, 2003, DEV CELL, V4, P19, DOI 10.1016/S1534-5807(02)00403-3; Chandra G, 2014, FEMS MICROBIOL REV, V38, P345, DOI 10.1111/1574-6976.12047; CHIN T, 1966, ARCH BIOCHEM BIOPHYS, V116, P358, DOI 10.1016/0003-9861(66)90042-7; Cole JL, 2007, TRENDS BIOCHEM SCI, V32, P57, DOI 10.1016/j.tibs.2006.12.003; Conzelmann M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-906; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; Del Sol R, 2006, J BACTERIOL, V188, P1540, DOI 10.1128/JB.188.4.1540-1550.2006; Dominguez-Escobar J, 2011, SCIENCE, V333, P225, DOI 10.1126/science.1203466; Eccleston M, 2006, J BACTERIOL, V188, P8189, DOI 10.1128/JB.01119-06; Fiuza M, 2008, J BIOL CHEM, V283, P36553, DOI 10.1074/jbc.M807175200; Flardh K, 2003, MOL MICROBIOL, V49, P1523, DOI 10.1046/j.1365-2958.2003.03660.x; Flett F, 1997, FEMS MICROBIOL LETT, V155, P223, DOI 10.1111/j.1574-6968.1997.tb13882.x; Fleurie A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004275; Formstone A, 2005, MOL MICROBIOL, V55, P1646, DOI 10.1111/j.1365-2958.2005.04506.x; Formstone A, 2008, J BACTERIOL, V190, P1812, DOI 10.1128/JB.01394-07; Fuchino K, 2013, P NATL ACAD SCI USA, V110, pE1889, DOI 10.1073/pnas.1305358110; Garner EC, 2011, SCIENCE, V333, P222, DOI 10.1126/science.1203285; GLAUNER B, 1988, J BIOL CHEM, V263, P10088; Grantcharova N, 2003, MOL MICROBIOL, V47, P645, DOI 10.1046/j.1365-2958.2003.03334.x; Heichlinger A, 2011, J BACTERIOL, V193, P1533, DOI 10.1128/JB.01100-10; Hempel AM, 2008, J BACTERIOL, V190, P7579, DOI 10.1128/JB.00839-08; Holmes NA, 2013, P NATL ACAD SCI USA, V110, pE397, DOI 10.1073/pnas.1210657110; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Jakimowicz D, 2012, MOL MICROBIOL, V85, P393, DOI 10.1111/j.1365-2958.2012.08107.x; Jolly L, 1999, EUR J BIOCHEM, V262, P202, DOI 10.1046/j.1432-1327.1999.00373.x; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kawai Y, 2009, MOL MICROBIOL, V73, P719, DOI 10.1111/j.1365-2958.2009.06805.x; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kim SY, 2006, P NATL ACAD SCI USA, V103, P10929, DOI 10.1073/pnas.0604503103; Kleinschnitz EM, 2011, MOL MICROBIOL, V79, P1367, DOI 10.1111/j.1365-2958.2010.07529.x; Kruse T, 2005, MOL MICROBIOL, V55, P78, DOI 10.1111/j.1365-2958.2004.04367.x; MANILOFF J, 1983, ANNU REV MICROBIOL, V37, P477, DOI 10.1146/annurev.mi.37.100183.002401; Manteca A, 2011, J PROTEOME RES, V10, P5481, DOI 10.1021/pr200762y; Mazza P, 2006, MOL MICROBIOL, V60, P838, DOI 10.1111/j.1365-2958.2006.05134.x; Mir M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002182; Molle V, 2010, PROTEOMICS, V10, P3910, DOI 10.1002/pmic.201000316; Molle V, 2010, MOL MICROBIOL, V75, P1064, DOI 10.1111/j.1365-2958.2009.07041.x; Nariya H, 2005, MOL MICROBIOL, V58, P367, DOI 10.1111/j.1365-2958.2005.04826.x; Noens EEE, 2005, MOL MICROBIOL, V58, P929, DOI 10.1111/j.1365-2958.2005.04883.x; Parker JL, 2010, PROTEOMICS, V10, P2486, DOI 10.1002/pmic.201000090; Pereira SFF, 2011, MICROBIOL MOL BIOL R, V75, P192, DOI 10.1128/MMBR.00042-10; Petrickova K, 2003, MICROBIOL-SGM, V149, P1609, DOI 10.1099/mic.0.26275-0; Petrickova K, 2000, BIOCHEM BIOPH RES CO, V279, P942, DOI 10.1006/bbrc.2000.4054; Pinho MG, 2013, NAT REV MICROBIOL, V11, P601, DOI 10.1038/nrmicro3088; Ravikumar V, 2014, MOL CELL PROTEOMICS, V13, P1965, DOI 10.1074/mcp.M113.035949; Sambrook J., 2001, MOL CLONING LAB MANU; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Shi L, 2004, MICROBIOL-SGM, V150, P2247, DOI 10.1099/mic.0.27057-0; Sigle S, 2015, INT J MED MICROBIOL, V305, P183, DOI 10.1016/j.ijmm.2014.12.014; Soares NC, 2013, J PROTEOME RES, V12, P2611, DOI 10.1021/pr3011843; Soufo HJD, 2004, EMBO REP, V5, P789, DOI 10.1038/sj.embor.7400209; Thakur M, 2008, BIOCHEM J, V415, P27, DOI 10.1042/BJ20080234; Thakur M, 2006, J BIOL CHEM, V281, P40107, DOI 10.1074/jbc.M607216200; Urabe H, 2008, BIOSCI BIOTECH BIOCH, V72, P778, DOI 10.1271/bbb.70658; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P287, DOI 10.1111/j.1574-6976.2007.00088.x; Yague P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060665	66	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125425	10.1371/journal.pone.0125425	http://dx.doi.org/10.1371/journal.pone.0125425			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927987	Green Published, Green Submitted, gold			2022-12-27	WOS:000353713100089
J	Lundstrom, E; Strand, R; Johansson, L; Bergsten, P; Ahlstrom, H; Kullberg, J				Lundstrom, Elin; Strand, Robin; Johansson, Lars; Bergsten, Peter; Ahlstrom, Hakan; Kullberg, Joel			Magnetic Resonance Imaging Cooling-Reheating Protocol Indicates Decreased Fat Fraction via Lipid Consumption in Suspected Brown Adipose Tissue	PLOS ONE			English	Article							COLD-EXPOSURE; IDENTIFICATION; ADULT; ACTIVATION	Objectives To evaluate whether a water-fat magnetic resonance imaging (MRI) cooling-reheating protocol could be used to detect changes in lipid content and perfusion in the main human brown adipose tissue (BAT) depot after a three-hour long mild cold exposure. Materials and Methods Nine volunteers were investigated with chemical-shift-encoded water-fat MRI at baseline, after a three-hour long cold exposure and after subsequent short reheating. Changes in fat fraction (FF) and R-2*, related to ambient temperature, were quantified within cervical-supraclavicular adipose tissue (considered as suspected BAT, denoted sBAT) after semi-automatic segmentation. In addition, FF and R-2* were quantified fully automatically in subcutaneous adipose tissue (not considered as suspected BAT, denoted SAT) for comparison. By assuming different time scales for the regulation of lipid turnover and perfusion in BAT, the changes were determined as resulting from either altered absolute fat content (lipid-related) or altered absolute water content (perfusion-related). Results sBAT-FF decreased after cold exposure (mean change in percentage points = -1.94 pp, P = 0.021) whereas no change was observed in SAT-FF (mean = 0.23 pp, P = 0.314). sBAT-R-2* tended to increase (mean = 0.65 s(-1), P = 0.051) and SAT-R-2* increased (mean = 0.40 s(-1), P = 0.038) after cold exposure. sBAT-FF remained decreased after reheating (mean = -1.92 pp, P = 0.008, compared to baseline) whereas SAT-FF decreased (mean = -0.79 pp, P = 0.008, compared to after cold exposure). Conclusions The sustained low sBAT-FF after reheating suggests lipid consumption, rather than altered perfusion, as the main cause to the decreased sBAT-FF. The results obtained demonstrate the use of the cooling-reheating protocol for detecting changes in the cervical-supraclavicular fat depot, being the main human brown adipose tissue depot, in terms of lipid content and perfusion.	[Lundstrom, Elin; Strand, Robin; Johansson, Lars; Ahlstrom, Hakan; Kullberg, Joel] Uppsala Univ, Dept Radiol, Uppsala, Sweden; [Strand, Robin] Uppsala Univ, Dept Informat Technol, Uppsala, Sweden; [Bergsten, Peter] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University	Lundstrom, E (corresponding author), Uppsala Univ, Dept Radiol, Uppsala, Sweden.	elin.lundstrom@radiol.uu.se	Johansson, Lars/AAF-4845-2019; Kullberg, Joel/ABE-3997-2021		Swedish Research Council [2012-2330]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Swedish Research Council (grant number: 2012-2330; http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba S, 2010, J NUCL MED, V51, P246, DOI 10.2967/jnumed.109.068775; Berglund J, 2012, MAGN RESON MED, V67, P1684, DOI 10.1002/mrm.23185; Chen YCI, 2013, J NUCL MED, V54, P1584, DOI 10.2967/jnumed.112.117275; Cinti S, 2006, NUTR METAB CARDIOVAS, V16, P569, DOI 10.1016/j.numecd.2006.07.009; Cypess AM, 2010, CURR OPIN ENDOCRINOL, V17, P143, DOI 10.1097/MED.0b013e328337a81f; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; DIXON WT, 1984, RADIOLOGY, V153, P189, DOI 10.1148/radiology.153.1.6089263; HEATON JM, 1972, J ANAT, V112, P35; Holstila M, 2013, METABOLISM, V62, P1189, DOI 10.1016/j.metabol.2013.03.002; Hu HCH, 2014, MAGN RESON IMAGING, V32, P107, DOI 10.1016/j.mri.2013.10.003; Hu HCH, 2013, J MAGN RESON IMAGING, V38, P885, DOI 10.1002/jmri.24053; Hu HH, 2013, AM J ROENTGENOL, V200, P177, DOI 10.2214/AJR.12.8996; Hu HCH, 2012, J MAGN RESON IMAGING, V35, P938, DOI 10.1002/jmri.23531; Hu HH, 2011, J COMPUT ASSIST TOMO, V35, P65, DOI 10.1097/RCT.0b013e3181fc2150; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Muzik O, 2013, J NUCL MED, V54, P523, DOI 10.2967/jnumed.112.111336; Orava J, 2011, CELL METAB, V14, P272, DOI 10.1016/j.cmet.2011.06.012; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Rasmussen JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077907; Reddy NL, 2014, J CLIN ENDOCR METAB, V99, pE117, DOI 10.1210/jc.2013-2036; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; van Rooijen BD, 2013, INVEST RADIOL, V48, P708, DOI 10.1097/RLI.0b013e31829363b8; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112; Yoneshiro T, 2011, OBESITY, V19, P1755, DOI 10.1038/oby.2011.125; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	26	42	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0126705	10.1371/journal.pone.0126705	http://dx.doi.org/10.1371/journal.pone.0126705			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928226	gold, Green Published, Green Submitted			2022-12-27	WOS:000353713100132
J	Mitchell, MW				Mitchell, Matthew W.			A Comparison of Aggregate P-Value Methods and Multivariate Statistics for Self-Contained Tests of Metabolic Pathway Analysis	PLOS ONE			English	Article								For pathway analysis of genomic data, the most common methods involve combining p-values from individual statistical tests. However, there are several multivariate statistical methods that can be used to test whether a pathway has changed. Because of the large number of variables and pathway sizes in genomics data, some of these statistics cannot be computed. However, in metabolomics data, the number of variables and pathway sizes are typically much smaller, making such computations feasible. Of particular interest is being able to detect changes in pathways that may not be detected for the individual variables. We compare the performance of both the p-value methods and multivariate statistics for self-contained tests with an extensive simulation study and a human metabolomics study. Permutation tests, rather than asymptotic results are used to assess the statistical significance of the pathways. Furthermore, both one and two-sided alternatives hypotheses are examined. From the human metabolomic study, many pathways were statistically significant, although the majority of the individual variables in the pathway were not. Overall, the p-value methods perform at least as well as the multivariate statistics for these scenarios.	Metabolon Inc, Durham, NC 27713 USA	Metabolon	Mitchell, MW (corresponding author), Metabolon Inc, Durham, NC 27713 USA.	mmitchell@metabolon.com		Mitchell, Matthew/0000-0002-2681-4091	Metabolon, Inc	Metabolon, Inc	The author received no funding for this work. Metabolon, Inc provided support in the form of salaries for author, Matthew W. Mitchell, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	[Anonymous], 1932, STAT METHODS RES WOR; Bai ZD, 1996, STAT SINICA, V6, P311; Chongchharoen S., 2012, J MATH STAT, V8, P274; Curran JM, 2003, HOTELLING HOTELLINGS; DEMPSTER AP, 1958, ANN MATH STAT, V29, P995, DOI 10.1214/aoms/1177706437; DEMPSTER AP, 1960, BIOMETRICS, V16, P41, DOI 10.2307/2527954; Evangelou M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041018; Evans AM, 2012, J POSTGENOM, V2, P3; Follmann D, 1996, J AM STAT ASSOC, V91, P854, DOI 10.2307/2291680; Fridley BL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012693; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Hotelling H, 1931, ANN MATH STAT, V2, P360, DOI 10.1214/aoms/1177732979; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; R Core Team, 2014, LANG ENV STAT COMP; Ramanan VK, 2012, TRENDS GENET, V28, P323, DOI 10.1016/j.tig.2012.03.004; Sen PK, 1999, J MULTIVARIATE ANAL, V68, P264, DOI 10.1006/jmva.1998.1791; Silvapulle MJ, 1995, J MULTIVARIATE ANAL, V55, P312, DOI 10.1006/jmva.1995.1081; Srivastava MS, 2008, J MULTIVARIATE ANAL, V99, P386, DOI 10.1016/j.jmva.2006.11.002; Taylor J, 2006, BIOSTATISTICS, V7, P167, DOI 10.1093/biostatistics/kxj009; Yu K, 2009, GENET EPIDEMIOL, V33, P700, DOI 10.1002/gepi.20422	21	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125081	10.1371/journal.pone.0125081	http://dx.doi.org/10.1371/journal.pone.0125081			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927705	Green Submitted, Green Published, gold			2022-12-27	WOS:000353713100066
J	Qin, L; Wang, MH; Zuo, J; Feng, XY; Liang, XJ; Wu, ZG; Ye, H				Qin, Lu; Wang, Meihuan; Zuo, Jia; Feng, Xiangyang; Liang, Xuejiao; Wu, Zhigeng; Ye, Hong			Cytosolic BolA Plays a Repressive Role in the Tolerance against Excess Iron and MV-Induced Oxidative Stress in Plants	PLOS ONE			English	Article							SULFUR PROTEINS; MONOTHIOL GLUTAREDOXINS; BIOGENESIS; EXPRESSION; IDENTIFICATION; HOMEOSTASIS; MECHANISMS; MORPHOGENE; ATGRXS17; REVEALS	The BolA-like protein is present in all eukaryotes, and it is able to form complex with monothiol glutaredoxin of the same subcellular compartments, suggesting that the BolA-like protein has essential function in eukaryotes, and that the function is associated with its partner glutaredoxin. Some studies have indicated a role for BolA proteins in Fe-S cluster synthesis or in redox homeostasis. However, the physiological function of BolA proteins remains to be elucidated. Here, we report the characterization of an insertion mutant of BolA3 in Arabidopsis. Among the four AtBolA proteins found in Arabidopsis, the AtBolA3 was the only BolA located in the cytosol of plant cells. It was highly expressed in roots. AtBolA3 was able to interact with the cytosolic monothiol glutaredoxin, AtGRXS17. The bola3 mutant did not show any notable phenotype under normal growth condition, but rather grew better than wild type under some stresses. The bola3 mutant was more tolerant to excess iron and the MV-induced oxidative stress than wild type. It displayed no necrosis in leaves, developed longer roots, accumulated more iron and higher Fe-S protein activities in roots. In addition, the mutant possessed a more potent antioxidant defense to scavenge ROS species. Taken together, our data indicated that the cytosolic AtBolA3 has a suppressive role in the tolerance to excess iron and the MV-induced oxidative stress in plants. AtBolA3 seems to be a repressor under some stress conditions.	[Qin, Lu; Wang, Meihuan; Zuo, Jia; Feng, Xiangyang; Liang, Xuejiao; Wu, Zhigeng; Ye, Hong] Chinese Acad Sci, Key Lab Plant Resources Conservat & Sustainable U, South China Bot Garden, Guangzhou 510650, Guangdong, Peoples R China; [Qin, Lu] Chinese Acad Agr Sci, Oil Crops Res Inst, Key Lab Biol & Genet Improvement Oil Crops, Minist Agr, Wuhan 430062, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Ye, H (corresponding author), Chinese Acad Sci, Key Lab Plant Resources Conservat & Sustainable U, South China Bot Garden, Guangzhou 510650, Guangdong, Peoples R China.	hye@scib.ac.cn			100-Talent Program of Chinese Academy of Sciences; National Basic Research Program of China (973 Program) [2013CB127102]; Foundation of Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences	100-Talent Program of Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Foundation of Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences(Chinese Academy of Sciences)	This work is funded by grants from the 100-Talent Program of Chinese Academy of Sciences, National Basic Research Program of China (973 Program 2013CB127102), Foundation of Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences.	ALDEA M, 1988, J BACTERIOL, V170, P5169, DOI 10.1128/jb.170.11.5169-5176.1988; Balk J, 2005, TRENDS PLANT SCI, V10, P324, DOI 10.1016/j.tplants.2005.05.002; Balk J, 2011, TRENDS PLANT SCI, V16, P218, DOI 10.1016/j.tplants.2010.12.006; Bandyopadhyay S, 2008, EMBO J, V27, P1122, DOI 10.1038/emboj.2008.50; Bernard DG, 2009, PLANT PHYSIOL, V151, P590, DOI 10.1104/pp.109.143651; BEYER WF, 1987, ANAL BIOCHEM, V161, P559, DOI 10.1016/0003-2697(87)90489-1; Cameron JM, 2011, AM J HUM GENET, V89, P486, DOI 10.1016/j.ajhg.2011.08.011; Cheng NH, 2011, FEBS J, V278, P2525, DOI 10.1111/j.1742-4658.2011.08178.x; Cheng NH, 2011, J BIOL CHEM, V286, P20398, DOI 10.1074/jbc.M110.201707; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Couturier J, 2014, MOL PLANT, V7, P187, DOI 10.1093/mp/sst156; Couturier J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00259; Fang WC, 2000, PLANT SCI, V158, P71, DOI 10.1016/S0168-9452(00)00307-1; Fukao Y, 2011, PLANT PHYSIOL, V155, P1893, DOI 10.1104/pp.110.169730; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Herrero E, 2007, CELL MOL LIFE SCI, V64, P1518, DOI 10.1007/s00018-007-6554-8; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jeong J, 2009, TRENDS PLANT SCI, V14, P280, DOI 10.1016/j.tplants.2009.02.006; Kobayashi T, 2012, ANNU REV PLANT BIOL, V63, P131, DOI 10.1146/annurev-arplant-042811-105522; Koshiba T, 1996, PLANT PHYSIOL, V110, P781, DOI 10.1104/pp.110.3.781; Krysan PJ, 1999, PLANT CELL, V11, P2283, DOI 10.1105/tpc.11.12.2283; Kumanovics A, 2008, J BIOL CHEM, V283, P10276, DOI 10.1074/jbc.M801160200; LEE JK, 1994, BIOCHEM BIOPH RES CO, V202, P1113, DOI 10.1006/bbrc.1994.2043; Li HR, 2012, BIOCHEMISTRY-US, V51, P4377, DOI 10.1021/bi300393z; Li HR, 2012, BIOCHEMISTRY-US, V51, P1687, DOI 10.1021/bi2019089; Li HR, 2011, J BIOL CHEM, V286, P867, DOI 10.1074/jbc.M110.184176; Li HR, 2009, BIOCHEMISTRY-US, V48, P9569, DOI 10.1021/bi901182w; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Nakamura M, 2013, NEW PHYTOL, V199, P925, DOI 10.1111/nph.12350; Ojeda L, 2006, J BIOL CHEM, V281, P17661, DOI 10.1074/jbc.M602165200; Palmer CM, 2009, NAT CHEM BIOL, V5, P333, DOI 10.1038/nchembio.166; Pilon M, 2009, CURR OPIN PLANT BIOL, V12, P347, DOI 10.1016/j.pbi.2009.04.011; Qu Y, 2011, J CLIN INVEST, V121, P212, DOI 10.1172/JCI43144; Rouhier N, 2010, TRENDS BIOCHEM SCI, V35, P43, DOI 10.1016/j.tibs.2009.08.005; Santos JM, 1999, MOL MICROBIOL, V32, P789, DOI 10.1046/j.1365-2958.1999.01397.x; Willems P, 2013, ANTIOXID REDOX SIGN, V18, P129, DOI 10.1089/ars.2011.4253; Wu QY, 2012, PLANT BIOTECHNOL J, V10, P945, DOI 10.1111/j.1467-7652.2012.00723.x; Ye H, 2006, J BIOL CHEM, V281, P8958, DOI 10.1074/jbc.M512737200	39	9	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124887	10.1371/journal.pone.0124887	http://dx.doi.org/10.1371/journal.pone.0124887			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928219	Green Published, Green Submitted, gold			2022-12-27	WOS:000353713100052
J	Song, JL; Tang, SH; Liu, X; Gao, YB; Yang, HJ; Lu, P				Song, Jianglong; Tang, Shihuan; Liu, Xi; Gao, Yibo; Yang, Hongjun; Lu, Peng			A Modularity-Based Method Reveals Mixed Modules from Chemical-Gene Heterogeneous Network	PLOS ONE			English	Article							COMMUNITY STRUCTURE; PHARMACOLOGY; MEDICINE; DATABASE	For a multicomponent therapy, molecular network is essential to uncover its specific mode of action from a holistic perspective. The molecular system of a Traditional Chinese Medicine (TCM) formula can be represented by a 2-class heterogeneous network (2-HN), which typically includes chemical similarities, chemical-target interactions and gene interactions. An important premise of uncovering the molecular mechanism is to identify mixed modules from complex chemical-gene heterogeneous network of a TCM formula. We thus proposed a novel method (MixMod) based on mixed modularity to detect accurate mixed modules from 2-HNs. At first, we compared MixMod with Clauset-Newman-Moore algorithm (CNM), Markov Cluster algorithm (MCL), Infomap and Louvain on benchmark 2-HNs with known module structure. Results showed that MixMod was superior to other methods when 2-HNs had promiscuous module structure. Then these methods were tested on a real drug-target network, in which 88 disease clusters were regarded as real modules. MixMod could identify the most accurate mixed modules from the drug-target 2-HN (normalized mutual information 0.62 and classification accuracy 0.4524). In the end, MixMod was applied to the 2-HN of Buchang naoxintong capsule (BNC) and detected 49 mixed modules. By using enrichment analysis, we investigated five mixed modules that contained primary constituents of BNC intestinal absorption liquid. As a matter of fact, the findings of in vitro experiments using BNC intestinal absorption liquid were found to highly accord with previous analysis. Therefore, MixMod is an effective method to detect accurate mixed modules from chemical-gene heterogeneous networks and further uncover the molecular mechanism of multicomponent therapies, especially TCM formulae.	[Song, Jianglong; Liu, Xi; Gao, Yibo; Lu, Peng] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China; [Tang, Shihuan; Yang, Hongjun] China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Automation, CAS; China Academy of Chinese Medical Sciences; Institute of Chinese Materia Medica, CACMS	Yang, HJ (corresponding author), China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing, Peoples R China.	hongjun0420@vip.sina.com; peng.lu@ia.ac.cn		Tang, Shihuan/0000-0003-0589-4499	National Science Foundation of China [81303152, 81330086, 81203005]; Fundamental Research Funds for the Central public welfare research institutes [ZZ070830]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central public welfare research institutes	This work was supported by National Science Foundation of China (grant nos. 81303152, 81330086, and 81203005) and the Fundamental Research Funds for the Central public welfare research institutes (grant no. ZZ070830).	Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Barber MJ, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.066102; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; Davis AP, 2013, NUCLEIC ACIDS RES, V41, pD1104, DOI 10.1093/nar/gks994; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Guimera R, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036102; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Keith CT, 2005, NAT REV DRUG DISCOV, V4, P71, DOI 10.1038/nrd1609; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Kitano H, 2007, NAT REV DRUG DISCOV, V6, P202, DOI 10.1038/nrd2195; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Lancichinetti A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016118; Lancichinetti A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046110; Li HY, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/495840; Li Jian, 2012, Evid Based Complement Alternat Med, V2012, P149762, DOI 10.1155/2012/149762; Li S, 2013, CHIN J NAT MEDICINES, V11, P110, DOI [10.3724/SP.J.1009.2013.00110, 10.1016/S1875-5364(13)60037-0]; Li S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S11-S6; Liang XJ, 2014, MOL BIOSYST, V10, P1014, DOI 10.1039/c3mb70507b; Meila M, 2001, MACH LEARN, V42, P9, DOI 10.1023/A:1007648401407; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; O'Boyle NM, 2008, CHEM CENT J, V2, DOI 10.1186/1752-153X-2-5; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Shi ZA, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-74; Song JL, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/731370; van Dongen SM, 2000, GRAPH CLUSTERING BY; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Zhang FB, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/802784; Zhao J, 2010, BRIEF BIOINFORM, V11, P417, DOI 10.1093/bib/bbp063	38	1	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125585	10.1371/journal.pone.0125585	http://dx.doi.org/10.1371/journal.pone.0125585			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927435	Green Published, gold, Green Submitted			2022-12-27	WOS:000353713100103
J	Yang, N; Gilman, P; Mirzayans, R; Sun, XJ; Touret, N; Weinfeld, M; Goping, IS				Yang, Ning; Gilman, Paul; Mirzayans, Razmik; Sun, Xuejun; Touret, Nicolas; Weinfeld, Michael; Goping, Ing Swie			Characterization of the Apoptotic Response Induced by the Cyanine Dye D112: A Potentially Selective Anti-Cancer Compound	PLOS ONE			English	Article							CYTOCHROME-C RELEASE; BCL-2 FAMILY-MEMBERS; CASPASE ACTIVATION; CELL-DEATH; PERMEABILITY TRANSITION; BH3-ONLY PROTEINS; MITOCHONDRIAL; CANCER; BAX; PHAGOCYTOSIS	Chemotherapeutic drugs that are used in anti-cancer treatments often cause the death of both cancerous and noncancerous cells. This non-selective toxicity is the root cause of untoward side effects that limits the effectiveness of therapy. In order to improve chemotherapeutic options for cancer patients, there is a need to identify novel compounds with higher discrimination for cancer cells. In the past, methine dyes that increase the sensitivity of photographic emulsions have been investigated for anti-cancer properties. In the 1970's, Kodak Laboratories initiated a screen of approximately 7000 dye structural variants for selective toxicity. Among these, D112 was identified as a promising compound with elevated toxicity against a colon cancer cell line in comparison to a non-transformed cell line. Despite these results changing industry priorities led to a halt in further studies on D112. We decided to revive investigations on D112 and have further characterized D112-induced cellular toxicity. We identified that in response to D112 treatment, the T-cell leukemia cell line Jurkat showed caspase activation, mitochondrial depolarization, and phosphatidylserine externalization, all of which are hallmarks of apoptosis. Chemical inhibition of caspase enzymatic activity and blockade of the mitochondrial pathway through Bcl-2 expression inhibited D112-induced apoptosis. At lower concentrations, D112 induced growth arrest. To gain insight into the molecular mechanism of D112 induced mitochondrial dysfunction, we analyzed the intracellular localization of D112, and found that D112 associated with mitochondria. Interestingly, in the cell lines that we tested, D112 showed increased toxicity toward transformed versus non-transformed cells. Results from this work identify D112 as a potentially interesting molecule warranting further investigation.	[Yang, Ning; Touret, Nicolas; Goping, Ing Swie] Univ Alberta, Dept Biochem, Edmonton, AB, Canada; [Gilman, Paul] Eastman Kodak Co Rochester, Res Labs, New York, NY USA; [Mirzayans, Razmik; Sun, Xuejun; Weinfeld, Michael; Goping, Ing Swie] Univ Alberta, Dept Oncol, Edmonton, AB, Canada	University of Alberta; Eastman Kodak; University of Alberta	Goping, IS (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB, Canada.	igoping@ualberta.ca			Women's and Children's Health Research Institute; Canadian Breast Cancer Foundation; Eastman Kodak Company	Women's and Children's Health Research Institute; Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Eastman Kodak Company	Support was provided by: the Women's and Children's Health Research Institute: [http://www.wchri.org]; Canadian Breast Cancer Foundation: [http://www.cbcf.org/Pages/default.aspx]. Both funders contribute to financial support of this study. Co-author Paul Gilman was employed by Eastman Kodak Company during the course of the study. Eastman Kodak Company provided support in the form of salary for author PG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bareford LA, 2007, ADV DRUG DELIVER REV, V59, P748, DOI 10.1016/j.addr.2007.06.008; Barry M, 2000, MOL CELL BIOL, V20, P3781, DOI 10.1128/MCB.20.11.3781-3794.2000; Bevers EM, 2010, FEBS LETT, V584, P2724, DOI 10.1016/j.febslet.2010.03.020; Borisenko GG, 2003, ARCH BIOCHEM BIOPHYS, V413, P41, DOI 10.1016/S0003-9861(03)00083-3; Brown JM, 1999, CANCER RES, V59, P1391; Brown JM, 2005, NAT REV CANCER, V5, P231, DOI 10.1038/nrc1560; Castedo M, 1996, J IMMUNOL, V157, P512; De Giorgi F, 2002, FASEB J, V16, P607, DOI 10.1096/fj.01-0269fje; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Denning MF, 2002, CELL DEATH DIFFER, V9, P40, DOI 10.1038/sj.cdd.4400929; Egger L, 2003, CELL DEATH DIFFER, V10, P1188, DOI 10.1038/sj.cdd.4401288; Estaquier J, 2012, ADV EXP MED BIOL, V942, P157, DOI 10.1007/978-94-007-2869-1_7; FERNANDESALNEMRI T, 1994, J BIOL CHEM, V269, P30761; Gilman P, 2006, USA patent, Patent No. [US20060099712 A1., 20060099712]; Goping IS, 2003, IMMUNITY, V18, P355, DOI 10.1016/S1074-7613(03)00032-3; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Han J, 2004, LEUKEMIA, V18, P1671, DOI 10.1038/sj.leu.2403496; Han ZY, 1997, J BIOL CHEM, V272, P13432, DOI 10.1074/jbc.272.20.13432; Hartman ML, 2012, ANTI-CANCER AGENT ME, V12, P966; Heibein JA, 2000, J EXP MED, V192, P1391, DOI 10.1084/jem.192.10.1391; Johnson VL, 2000, J CELL SCI, V113, P2941; Karch J, 2013, ELIFE, V2, DOI 10.7554/eLife.00772; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Lomonosova E, 2008, ONCOGENE, V27, pS2, DOI 10.1038/onc.2009.39; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Mirzayans R, 2013, INT J MOL SCI, V14, P22409, DOI 10.3390/ijms141122409; Nakamura K, 2002, LIFE SCI, V70, P791, DOI 10.1016/S0024-3205(01)01454-0; Ning Y, 2013, APOPTOSIS; Portt L, 2011, BBA-MOL CELL RES, V1813, P238, DOI 10.1016/j.bbamcr.2010.10.010; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Society AC, 2014, CANC FACTS FIG 2014; Society CC, 2013, NAT STAT GLANC CAN C; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Susin SA, 1997, J EXP MED, V186, P25, DOI 10.1084/jem.186.1.25; Takeyama N, 2002, EXP CELL RES, V274, P16, DOI 10.1006/excr.2001.5447; Tsujimoto Y, 1998, GENES CELLS, V3, P697, DOI 10.1046/j.1365-2443.1998.00223.x; Vercammen D, 1998, J EXP MED, V188, P919, DOI 10.1084/jem.188.5.919; Wang GQ, 2001, J EXP MED, V194, P1325, DOI 10.1084/jem.194.9.1325; Wang LX, 2006, ANN THORAC SURG, V81, P1817, DOI 10.1016/j.athoracsur.2005.11.029; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wong RSY, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-87; Yasuhara N, 1997, ONCOGENE, V15, P1921, DOI 10.1038/sj.onc.1201370; ZIGMAN S, 1980, SCIENCE, V208, P188, DOI 10.1126/science.7361115	43	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125381	10.1371/journal.pone.0125381	http://dx.doi.org/10.1371/journal.pone.0125381			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927702	Green Submitted, Green Published, gold			2022-12-27	WOS:000353713100086
J	Zhang, J; Tang, HJ; Deng, RY; Wang, N; Zhang, YQ; Wang, Y; Liu, Y; Li, FY; Wang, X; Zhou, LB				Zhang, Juan; Tang, Hongju; Deng, Ruyuan; Wang, Ning; Zhang, Yuqing; Wang, Yao; Liu, Yun; Li, Fengying; Wang, Xiao; Zhou, Libin			Berberine Suppresses Adipocyte Differentiation via Decreasing CREB Transcriptional Activity	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; LIPID-ACCUMULATION; AMPK ACTIVATION; 3T3-L1 CELLS; COMPOUND-C; C/EBP-BETA; ADIPOGENESIS; MECHANISM; PREADIPOCYTES; INHIBITION	Berberine, one of the major constituents of Chinese herb Rhizoma coptidis, has been demonstrated to lower blood glucose, blood lipid, and body weight in patients with type 2 diabetes mellitus. The anti-obesity effect of berberine has been attributed to its anti-adipogenic activity. However, the underlying molecular mechanism remains largely unknown. In the present study, we found that berberine significantly suppressed the expressions of CCAAT/enhancer-binding protein (C/EBP)alpha, peroxisome proliferators-activated receptor gamma 2 (PPAR gamma 2), and other adipogenic genes in the process of adipogenesis. Berberine decreased cAMP-response element-binding protein (CREB) phosphorylation and C/EBP beta expression at the early stage of 3T3-L1 preadipocyte differentiation. In addition, CREB phosphorylation and C/EBP beta expression induced by 3-isobutyl-1-methylxanthine (IBMX) and forskolin were also attenuated by berberine. The binding activities of cAMP responsive element (CRE) stimulated by IBMX and forskolin were inhibited by berberine. The binding of phosphorylated CREB to the promoter of C/EBP beta was abrogated by berberine after the induction of preadipocyte differentiation. These results suggest that berberine blocks adipogenesis mainly via suppressing CREB activity, which leads to a decrease in C/EBP beta-triggered transcriptional cascades.	[Zhang, Juan; Tang, Hongju; Deng, Ruyuan; Wang, Ning; Zhang, Yuqing; Wang, Yao; Liu, Yun; Li, Fengying; Wang, Xiao; Zhou, Libin] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med,Dept Endocrine & Metab Dis, Shanghai Clin Ctr Endocrine & Metab Dis,Shanghai, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Wang, X (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med,Dept Endocrine & Metab Dis, Shanghai Clin Ctr Endocrine & Metab Dis,Shanghai, Shanghai 200030, Peoples R China.	wangxiao1976@hotmail.com; libinzhou99@hotmail.com			National Natural Science Foundation of China [81070652, 81070617, 81170720, 81261120564, 81270910]; Shanghai Municipal Health Bureau [2011-217]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Health Bureau	This work was funded by grants from the National Natural Science Foundation of China (81070652, 81070617, 81170720, 81261120564, and 81270910) and Shanghai Municipal Health Bureau (2011-217). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae KH, 2012, BMB REP, V45, P700, DOI 10.5483/BMBRep.2012.45.12.235; Belmonte N, 2001, MOL ENDOCRINOL, V15, P2037, DOI 10.1210/me.15.11.2037; Brusq JM, 2006, J LIPID RES, V47, P1281, DOI 10.1194/jlr.M600020-JLR200; Clarke SL, 1997, BIOCHEM BIOPH RES CO, V240, P99, DOI 10.1006/bbrc.1997.7627; Fox KE, 2006, J BIOL CHEM, V281, P40341, DOI 10.1074/jbc.M605077200; Gao Y, 2008, BIOL PHARM BULL, V31, P1716, DOI 10.1248/bpb.31.1716; Habinowski SA, 2001, BIOCHEM BIOPH RES CO, V286, P852, DOI 10.1006/bbrc.2001.5484; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hu YS, 2010, PHYTOTHER RES, V24, P1831, DOI 10.1002/ptr.3204; Hwang JT, 2007, BIOCHEM BIOPH RES CO, V364, P1002, DOI 10.1016/j.bbrc.2007.10.125; Ikarashi N, 2012, PHYTOTHER RES, V26, P91, DOI 10.1002/ptr.3493; Kim EJ, 2012, J NUTR BIOCHEM, V23, P1552, DOI 10.1016/j.jnutbio.2011.10.008; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; LeBrasseur NK, 2006, AM J PHYSIOL-ENDOC M, V291, pE175, DOI 10.1152/ajpendo.00453.2005; Lee JW, 2012, J LIPID RES, V53, P1277, DOI 10.1194/jlr.M022897; Lee J, 2012, J BIOL CHEM, V287, P8839, DOI 10.1074/jbc.M111.263434; Lee YS, 2006, DIABETES, V55, P2256, DOI 10.2337/db06-0006; Moon HS, 2007, OBESITY, V15, P2571, DOI 10.1038/oby.2007.309; Nam M, 2008, ARCH BIOCHEM BIOPHYS, V479, P74, DOI 10.1016/j.abb.2008.07.029; Ono M, 2011, J AGR FOOD CHEM, V59, P13346, DOI 10.1021/jf203490a; Petersen RK, 2008, MOL CELL BIOL, V28, P3804, DOI 10.1128/MCB.00709-07; Pham TPT, 2011, BIOCHEM BIOPH RES CO, V413, P376, DOI 10.1016/j.bbrc.2011.08.110; Poulos SP, 2010, EXP BIOL MED, V235, P1185, DOI 10.1258/ebm.2010.010063; Reusch JEB, 2000, MOL CELL BIOL, V20, P1008, DOI 10.1128/MCB.20.3.1008-1020.2000; Stephens JM, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001436; Turner N, 2008, DIABETES, V57, P1414, DOI 10.2337/db07-1552; Vingtdeux V, 2011, MOL MED, V17, P1022, DOI 10.2119/molmed.2011.00163; Vogel CFA, 2004, J BIOL CHEM, V279, P8886, DOI 10.1074/jbc.M310190200; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1; Yang DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001540; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhang JW, 2004, J BIOL CHEM, V279, P4471, DOI 10.1074/jbc.M311327200; Zhang YF, 2008, J CLIN ENDOCR METAB, V93, P2559, DOI 10.1210/jc.2007-2404; Zhang ZG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6493; Zhou LB, 2008, ENDOCRINOLOGY, V149, P4510, DOI 10.1210/en.2007-1752; Zhou LB, 2007, METABOLISM, V56, P405, DOI 10.1016/j.metabol.2006.10.025; Zhou LB, 2011, BBA-MOL BASIS DIS, V1812, P527, DOI 10.1016/j.bbadis.2010.10.001	37	45	47	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125667	10.1371/journal.pone.0125667	http://dx.doi.org/10.1371/journal.pone.0125667			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928058	Green Submitted, Green Published, gold			2022-12-27	WOS:000353713100110
J	Chiu, CF; Chen, MH; Chang, FH				Chiu, Chun-Fu; Chen, Ming-Hung; Chang, Feng-Hsiang			Carbon Dioxide Concentrations and Temperatures within Tour Buses under Real-Time Traffic Conditions	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; AIR SUPPLY RATE; CO2 CONCENTRATIONS; SLEEP HABITS; RISK; VENTILATION; POPULATION; SYMPTOMS; EXPOSURE; INJURY	This study monitored the carbon dioxide (CO2) concentrations and temperatures of three 43-seat tour buses with high-passenger capacities in a course of a three-day, two-night school excursion. Results showed that both driver zones and passenger zones of the tour buses achieved maximum CO2 concentrations of more than 3000 ppm, and maximum daily average concentrations of 2510.6 and 2646.9 ppm, respectively. The findings confirmed that the CO2 concentrations detected in the tour buses exceeded the indoor air quality standard of Taiwan Environmental Protection Administration (8 hr-CO2: 1000 ppm) and the air quality guideline of Hong Kong Environmental Protection Department (1 hr-CO2: 2500 ppm for Level 1 for buses). Observations also showed that high-capacity tour bus cabins with air conditioning system operating in recirculation mode are severely lacking in air exchange rate, which may negatively impact transportation safety. Moreover, the passenger zones were able to maintain a temperature of between 20 and 25 degrees C during travel, which effectively suppresses the dispersion of volatile organic compounds. Finally, the authors suggest that in the journey, increasing the ventilation frequency of tour bus cabin, which is very beneficial to maintain the travel safety and enhance the quality of travel.	[Chiu, Chun-Fu] Tzu Hui Inst Technol, Dept Tourism Affairs, Pingtung, Taiwan; [Chiu, Chun-Fu] Natl Pingtung Univ Sci & Technol, Dept Trop Agr & Int Cooperat, Pingtung, Taiwan; [Chen, Ming-Hung] Natl Pingtung Univ Sci & Technol, Dept Recreat Sport & Hlth Promot, Pingtung, Taiwan; [Chang, Feng-Hsiang] Tzu Hui Inst Technol, Dept Leisure Recreat & Tourism Management, Pingtung, Taiwan	National Pingtung University Science & Technology; National Pingtung University Science & Technology	Chang, FH (corresponding author), Tzu Hui Inst Technol, Dept Leisure Recreat & Tourism Management, Pingtung, Taiwan.	chang.taiwan@gmail.com			Tzu Hui Institute of Technology Research Program [THIT-103010]	Tzu Hui Institute of Technology Research Program	The authors gratefully acknowledge the financial support of the Tzu Hui Institute of Technology Research Program (Grant No. THIT-103010). They also thank Mr. Wen-Chin Li, engineer of JS Environmental Technology and Energy Saving Co., Ltd., for his assistance in monitoring.	ACGIH (American Conference of Governmental Industrial Hygienists), 2011, TLVS AND BEIS; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], 1990, APPL OCCUP ENVIRON H; Chan MY, 2005, INDOOR BUILT ENVIRON, V14, P397, DOI 10.1177/1420326X05057254; Chen YY, 2010, INJURY PREV, V16, P172, DOI 10.1136/ip.2009.021840; Chien YC, 2007, SCI TOTAL ENVIRON, V382, P228, DOI 10.1016/j.scitotenv.2007.04.022; Connor J, 2002, BRIT MED J, V324, P1125, DOI 10.1136/bmj.324.7346.1125; Consumers' Foundation, 2011, STRENGTH CONTR LENGT; CORNAK J. U. Stefan, 2012, SCI MILITARY, V1, P50; Erdmann CA, 2004, INDOOR AIR, V14, P127, DOI 10.1111/j.1600-0668.2004.00298.x; Federspiel CC, 2004, INDOOR AIR, V14, P41, DOI 10.1111/j.1600-0668.2004.00299.x; Fedoruk MJ, 2003, J EXPO ANAL ENV EPID, V13, P31, DOI 10.1038/sj.jea.7500250; Horne JA, 1996, FALLING ASLEEP WHEEL; Hsu DJ, 2009, ATMOS ENVIRON, V43, P5723, DOI 10.1016/j.atmosenv.2009.08.039; Huang HL, 2009, INDOOR AIR, V19, P234, DOI 10.1111/j.1600-0668.2009.00587.x; Lipsett MJ, 1994, INORGANIC COMPOUNDS, P4621; MacLean AW, 2003, SLEEP MED REV, V7, P507, DOI 10.1016/S1087-0792(03)90004-9; Mathur GD, 2009, SAE INT J PASSEN CAR, V1, P757, DOI 10.4271/2008-01-0829; Milton DK, 2000, INDOOR AIR, V10, P212, DOI 10.1034/j.1600-0668.2000.010004212.x; Mudarri DH, 1997, T AM SOC HEATING REF, V103, P244; OSHA, 2012, SAMPL AN METH CARB D; Park SK, 2009, SAE TECHNICAL PAPER, DOI [10.4271/2009-01-0536, DOI 10.4271/2009-01-0536]; Perez-Chada D, 2005, SLEEP, V28, P1103, DOI 10.1093/sleep/28.9.1103; Persily A.K., 1997, ASHRAE T, V103, P193; Petridou E, 1997, ACCIDENT ANAL PREV, V29, P687, DOI 10.1016/S0001-4575(97)00038-9; Rajhans G, 1983, INDOOR AIR QUALITY C, P160; Rossello J, 2011, ACCIDENT ANAL PREV, V43, P675, DOI 10.1016/j.aap.2010.10.011; Satish U, 2012, ENVIRON HEALTH PERSP, V120, P1671, DOI 10.1289/ehp.1104789; Seo J, 2012, J AUTOMOBILE ENG, V227, P1162; Seppanen OA, 1999, INDOOR AIR, V9, P226, DOI 10.1111/j.1600-0668.1999.00003.x; Shendell DG, 2004, INDOOR AIR, V14, P333, DOI 10.1111/j.1600-0668.2004.00251.x; Taiwan CWB (Taiwan Central Weather Bureau), 2015, OBS DAT QUER SYST; Taiwan EPA (Taiwan Environmental Protection Administration), 2013, METH DET ATM CO2 INF; Taiwan EPA (Taiwan Environmental Protection Administration), 2012, IAQ STAND; Teng MC, 2013, EXPLORATION MAJOR AC; USDOE (U.S. Department of Energy), 2011, MAN FACT AFF MPG; Wargocki P, 2000, INDOOR AIR, V10, P222, DOI 10.1034/j.1600-0668.2000.010004222.x; Yoshida T, 2006, ENVIRON INT, V32, P58, DOI 10.1016/j.envint.2005.04.009; You KW, 2007, J ENVIRON SCI, V19, P1208, DOI 10.1016/S1001-0742(07)60197-1; Zabiegala B, 2006, POL J ENVIRON STUD, V15, P383; Zhang QF, 2010, ATMOS ENVIRON, V44, P253, DOI 10.1016/j.atmosenv.2009.09.044; Zhu SW, 2010, BUILD ENVIRON, V45, P2077, DOI 10.1016/j.buildenv.2010.03.004	43	11	11	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125117	10.1371/journal.pone.0125117	http://dx.doi.org/10.1371/journal.pone.0125117			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923722	Green Submitted, Green Published, gold			2022-12-27	WOS:000353711600126
J	Lin, C; Chu, CM; Lin, J; Yang, HY; Su, SL				Lin, Chin; Chu, Chi-Ming; Lin, John; Yang, Hsin-Yi; Su, Sui-Lung			Gene-Gene and Gene-Environment Interactions in Meta-Analysis of Genetic Association Studies	PLOS ONE			English	Article							INDIVIDUAL PATIENT DATA; RANDOMIZED-TRIALS; META-REGRESSION	Extensive genetic studies have identified a large number of causal genetic variations in many human phenotypes; however, these could not completely explain heritability in complex diseases. Some researchers have proposed that the "missing heritability" may be attributable to gene-gene and gene-environment interactions. Because there are billions of potential interaction combinations, the statistical power of a single study is often ineffective in detecting these interactions. Meta-analysis is a common method of increasing detection power; however, accessing individual data could be difficult. This study presents a simple method that employs aggregated summary values from a "case" group to detect these specific interactions that based on rare disease and independence assumptions. However, these assumptions, particularly the rare disease assumption, may be violated in real situations; therefore, this study further investigated the robustness of our proposed method when it violates the assumptions. In conclusion, we observed that the rare disease assumption is relatively nonessential, whereas the independence assumption is an essential component. Because single nucleotide polymorphisms (SNPs) are often unrelated to environmental factors and SNPs on other chromosomes, researchers should use this method to investigate gene-gene and gene-environment interactions when they are unable to obtain detailed individual patient data.	[Lin, Chin; Su, Sui-Lung] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Chu, Chi-Ming; Yang, Hsin-Yi; Su, Sui-Lung] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Lin, John] Kaohsiung Municipal Girls Senior High Sch, Math Teachers Off, Kaohsiung, Taiwan	National Defense Medical Center; National Defense Medical Center	Su, SL (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.	a131419@gmail.com	Lin, Chin/M-2832-2015	Lin, Chin/0000-0003-2337-2096; Chu, Cordia/0000-0002-3683-5638; Su, Sui-Lung/0000-0003-3122-1116				BALDING DJ, 1995, GENETICA, V96, P3, DOI 10.1007/BF01441146; Brookes ST, 2004, J CLIN EPIDEMIOL, V57, P229, DOI 10.1016/j.jclinepi.2003.08.009; Chu HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018108; Da LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082855; de Souza BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054259; Huang GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068457; Lambert PC, 2002, J CLIN EPIDEMIOL, V55, P86, DOI 10.1016/S0895-4356(01)00414-0; Lin C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087604; Lyman Gary H, 2005, BMC Med Res Methodol, V5, P14, DOI 10.1186/1471-2288-5-14; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; MCCLELLAND GH, 1993, PSYCHOL BULL, V114, P376, DOI 10.1037/0033-2909.114.2.376; Pan Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083415; Simmonds MC, 2005, CLIN TRIALS, V2, P209, DOI 10.1191/1740774505cn087oa; Song K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048924; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Xu J, 2013, NANOSCALE RES LETT, V8, P1, DOI 10.1186/1556-276X-8-54; Yang XK, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/041006; Zafarmand MH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002533	20	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124967	10.1371/journal.pone.0124967	http://dx.doi.org/10.1371/journal.pone.0124967			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923960	Green Published, gold, Green Submitted			2022-12-27	WOS:000353711600117
J	Pauciullo, A; Erhardt, G				Pauciullo, Alfredo; Erhardt, Georg			Molecular Characterization of the Llamas (Lama glama) Casein Cluster Genes Transcripts (CSN1S1, CSN2, CSN1S2, CSN3) and Regulatory Regions	PLOS ONE			English	Article							BETA-CASEIN; GLUCOCORTICOID-RECEPTOR; POINT MUTATION; PROTEIN; PROMOTER; SEQUENCE; VARIANTS; SITE; POLYMORPHISMS; FIBRINOGEN	In the present paper, we report for the first time the characterization of llama (Lama glama) caseins at transcriptomic and genetic level. A total of 288 casein clones transcripts were analysed from two lactating llamas. The most represented mRNA populations were those correctly assembled (85.07%) and they encoded for mature proteins of 215, 217, 187 and 162 amino acids respectively for the CSN1S1, CSN2, CSN1S2 and CSN3 genes. The exonic subdivision evidenced a structure made of 21, 9, 17 and 6 exons for the alpha s1-, beta-, alpha s2- and kappa-casein genes respectively. Exon skipping and duplication events were evidenced. Two variants A and B were identified in the as1- casein gene as result of the alternative out-splicing of the exon 18. An additional exon coding for a novel esapeptide was found to be cryptic in the kappa-casein gene, whereas one extra exon was found in the as2- casein gene by the comparison with the Camelus dromedaries sequence. A total of 28 putative phosphorylated motifs highlighted a complex heterogeneity and a potential variable degree of post-translational modifications. Ninety-six polymorphic sites were found through the comparison of the lama casein cDNAs with the homologous camel sequences, whereas the first description and characterization of the 5'- and 3'-regulatory regions allowed to identify the main putative consensus sequences involved in the casein genes expression, thus opening the way to new investigations -so far-never achieved in this species.	[Pauciullo, Alfredo] Univ Turin, Dept Agr Forest & Food Sci, Grugliasco, Italy; [Pauciullo, Alfredo; Erhardt, Georg] Univ Giessen, Inst Anim Breeding & Genet, D-35390 Giessen, Germany	University of Turin; Justus Liebig University Giessen	Pauciullo, A (corresponding author), Univ Turin, Dept Agr Forest & Food Sci, Grugliasco, Italy.	alfredo.pauciullo@unito.it	Pauciullo, Alfredo/AAF-7713-2020	Pauciullo, Alfredo/0000-0002-3140-9373	Institute for Animal Breeding and Genetics, Justus-Liebig University of Giessen (Germany); Agricola Project, Department of Agricultural, Forest and Food Sciences, University of Torino, Grugliasco (Italy)	Institute for Animal Breeding and Genetics, Justus-Liebig University of Giessen (Germany); Agricola Project, Department of Agricultural, Forest and Food Sciences, University of Torino, Grugliasco (Italy)	This research was financially supported by the Institute for Animal Breeding and Genetics, Justus-Liebig University of Giessen (Germany) and partially by Agricola Project, Department of Agricultural, Forest and Food Sciences, University of Torino, Grugliasco (Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER LJ, 1992, ANIM GENET, V23, P365, DOI 10.1111/j.1365-2052.1992.tb00159.x; Allain D, 2010, ANIMAL, V4, P1472, DOI 10.1017/S1751731110000029; BOISNARD M, 1991, EUR J BIOCHEM, V201, P633, DOI 10.1111/j.1432-1033.1991.tb16324.x; BONSING J, 1987, J DAIRY RES, V54, P447, DOI 10.1017/S0022029900025632; BOUNIOL C, 1993, GENE, V128, P289, DOI 10.1016/0378-1119(93)90577-P; Caroli A, 2006, J DAIRY SCI, V89, P3178, DOI 10.3168/jds.S0022-0302(06)72592-9; Caroli AM, 2009, J DAIRY SCI, V92, P5335, DOI 10.3168/jds.2009-2461; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Christoffels VM, 1998, MOL CELL BIOL, V18, P6305, DOI 10.1128/MCB.18.11.6305; Clark F, 2002, HUM MOL GENET, V11, P451, DOI 10.1093/hmg/11.4.451; Cosenza G, 2008, SMALL RUMINANT RES, V74, P84, DOI 10.1016/j.smallrumres.2007.03.010; Cosenza G, 2009, ANIM GENET, V40, P791, DOI 10.1111/j.1365-2052.2009.01897.x; Cosenza G, 2010, ITAL J ANIM SCI, V9, P206, DOI 10.4081/ijas.2010.e40; FERRANTI P, 1995, J DAIRY RES, V62, P281, DOI 10.1017/S0022029900030983; Fujita H, 2008, MOL BIOL CELL, V19, P1912, DOI 10.1091/mbc.E07-09-0973; Halper J, 2014, ADV EXP MED BIOL, V802, P31, DOI 10.1007/978-94-007-7893-1_3; Harvatine KJ, 2006, J NUTR, V136, P2468, DOI 10.1093/jn/136.10.2468; Holland JW, 2009, FOOD SCI TECH-INT SE, P107; Inman CK, 2005, MOL CELL BIOL, V25, P3182, DOI 10.1128/MCB.25.8.3182-3193.2005; Jiang Z, 2002, J CELL BIOL, V156, P185, DOI 10.1083/jcb.200106084; JOHNSEN LB, 1995, BIOCHEM J, V309, P237, DOI 10.1042/bj3090237; JOLLES P, 1978, J MOL EVOL, V11, P271, DOI 10.1007/BF01733837; JONES WK, 1985, J BIOL CHEM, V260, P7042; Kappeler S, 1998, J DAIRY RES, V65, P209, DOI 10.1017/S0022029997002847; Kappeler SR, 2003, J DAIRY SCI, V86, P498, DOI 10.3168/jds.S0022-0302(03)73628-5; LEROUX C, 1992, J BIOL CHEM, V267, P6147; Li SS, 2012, J INTEGR AGR, V11, P439, DOI 10.1016/S2095-3119(12)60029-X; Lisson M, 2014, J DAIRY SCI, V97, P1939, DOI 10.3168/jds.2013-7355; MAHE MF, 1982, ANN GENET SEL ANIM, V14, P401, DOI 10.1186/1297-9686-14-4-401; MARTIN P, 1992, BIOCHEM BIOPH RES CO, V183, P750, DOI 10.1016/0006-291X(92)90547-X; Martin P, 2002, REPROD NUTR DEV, V42, P433, DOI 10.1051/rnd:2002036; MENON RS, 1992, GENOMICS, V12, P13, DOI 10.1016/0888-7543(92)90400-M; MENON RS, 1992, MOL BIOL CELL, V3, pA323; MERCIER JC, 1993, J DAIRY SCI, V76, P3079, DOI 10.3168/jds.S0022-0302(93)77647-X; MOHR U, 1994, GENE, V143, P187, DOI 10.1016/0378-1119(94)90095-7; Ottenheijm CAC, 2008, FASEB J, V22, P2912, DOI 10.1096/fj.07-104372; Pauciullo A, 2014, GENE, V547, P159, DOI 10.1016/j.gene.2014.06.055; Pauciullo A, 2013, GENE, V513, P22, DOI 10.1016/j.gene.2012.10.083; PISANO A, 1994, GLYCOBIOLOGY, V4, P837, DOI 10.1093/glycob/4.6.837; Ramunno L, 2004, GENE, V334, P105, DOI 10.1016/j.gene.2004.03.006; Ramunno L, 2005, GENE, V345, P289, DOI 10.1016/j.gene.2004.12.003; Ramunno L, 2001, ANIM GENET, V32, P19, DOI 10.1046/j.1365-2052.2001.00710.x; Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133; Riek A, 2006, J DAIRY SCI, V89, P3484, DOI 10.3168/jds.S0022-0302(06)72387-6; Riek A, 2013, J DAIRY SCI, V96, P1815, DOI 10.3168/jds.2012-6323; Rijnkels M, 2002, J MAMMARY GLAND BIOL, V7, P327, DOI 10.1023/A:1022808918013; Saadaoui B, 2014, ELECTROPHORESIS, V35, P1406, DOI 10.1002/elps.201300383; Schild TA, 1996, THEOR APPL GENET, V93, P887, DOI 10.1007/BF00224090; Shuiep ES, 2013, INT DAIRY J, V28, P88, DOI 10.1016/j.idairyj.2012.09.002; SMITH CWJ, 1993, MOL CELL BIOL, V13, P4939, DOI 10.1128/MCB.13.8.4939; Subramaniam N, 2003, BIOCHEM J, V370, P1087, DOI 10.1042/BJ20020471; Tagliabracci VS, 2012, SCIENCE, V336, P1150, DOI 10.1126/science.1217817; Trinks Alexandra, 2012, P79; Wyszomierski SL, 2001, MOL ENDOCRINOL, V15, P228, DOI 10.1210/me.15.2.228; Zhang MQ, 2002, NAT REV GENET, V3, P698, DOI 10.1038/nrg890; Zhao FQ, 2002, BBA-GENE STRUCT EXPR, V1577, P27, DOI 10.1016/S0167-4781(02)00402-5	56	16	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124963	10.1371/journal.pone.0124963	http://dx.doi.org/10.1371/journal.pone.0124963			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923814	Green Published, gold, Green Submitted			2022-12-27	WOS:000353711600116
J	Wood, L; Martin, K; Christian, H; Nathan, A; Lauritsen, C; Houghton, S; Kawachi, I; McCune, S				Wood, Lisa; Martin, Karen; Christian, Hayley; Nathan, Andrea; Lauritsen, Claire; Houghton, Steve; Kawachi, Ichiro; McCune, Sandra			The Pet Factor - Companion Animals as a Conduit for Getting to Know People, Friendship Formation and Social Support	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; HUMAN HEALTH; DOGS; OWNERSHIP; RELIABILITY	Background While companion animals have been previously identified as a direct source of companionship and support to their owners, their role as a catalyst for friendship formation or social support networks among humans has received little attention. This study investigated the indirect role of pets as facilitators for three dimensions of social relatedness; getting to know people, friendship formation and social support networks. Methods A telephone survey of randomly selected residents in four cities, one in Australia (Perth; n = 704) and three in the U.S. (San Diego, n = 690; Portland, n = 634; Nashville, n = 664) was conducted. All participants were asked about getting to know people within their neighborhood. Pet owners were asked additional questions about the type/s of pet/s they owned, whether they had formed friendships as a result of their pet, and if they had received any of four different types of social support from the people they met through their pet. Results Pet owners were significantly more likely to get to know people in their neighborhood than non-pet owners (OR 1.61; 95%CI: 1.30, 1.99). When analyzed by site, this relationship was significant for Perth, San Diego and Nashville. Among pet owners, dog owners in the three U.S. cities (but not Perth) were significantly more likely than owners of other types of pets to regard people whom they met through their pet as a friend (OR 2.59; 95%CI: 1.94, 3.46). Around 40% of pet owners reported receiving one or more types of social support (i.e. emotional, informational, appraisal, instrumental) via people they met through their pet. Conclusion This research suggests companion animals can be a catalyst for several dimensions of human social relationships in neighborhood settings, ranging from incidental social interaction and getting to know people, through to formation of new friendships. For many pet owners, their pets also facilitated relationships from which they derived tangible forms of social support, both of a practical and emotionally supportive nature. Given growing evidence for social isolation as a risk factor for mental health, and, conversely, friendships and social support as protective factors for individual and community well-being, pets may be an important factor in developing healthy neighborhoods.	[Wood, Lisa; Martin, Karen; Lauritsen, Claire] Univ Western Australia, Sch Populat Hlth, Crawley, WA, Australia; [Christian, Hayley] Univ Western Australia, Ctr Built Environm & Hlth, Crawley, WA, Australia; [Christian, Hayley] Telethon Kids Inst, Perth, WA, Australia; [Nathan, Andrea] Queensland Univ Technol, Sch Publ Hlth & Social Work, Kelvin Grove, Qld, Australia; [Houghton, Steve] Univ Western Australia, Grad Sch Educ, Crawley, WA, Australia; [Kawachi, Ichiro] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Cambridge, MA USA; [McCune, Sandra] WALTHAM Ctr Pet Nutr, Melton Mowbray, Leics, England	University of Western Australia; University of Western Australia; Telethon Kids Institute; Queensland University of Technology (QUT); University of Western Australia; Harvard University; Harvard T.H. Chan School of Public Health; Mars; WALTHAM Petcare Science Institute	Wood, L (corresponding author), Univ Western Australia, Sch Populat Hlth, Crawley, WA, Australia.	lisa.wood@uwa.edu.au	Wood, Lisa Jane/C-1816-2012; Christian, Hayley/AAU-6163-2020; Martin, Karen/I-2048-2013	Wood, Lisa Jane/0000-0002-9196-8847; Christian, Hayley/0000-0001-8486-5746; Nathan, Andrea/0000-0002-9360-7228; Martin, Karen/0000-0003-2077-0929; Houghton, Stephen/0000-0002-6744-1068	WALTHAM Centre for Pet Nutrition	WALTHAM Centre for Pet Nutrition	This research was funded by a grant from the WALTHAM Centre for Pet Nutrition (a subsidiary of Mars Petcare). The funder had some input into the study design, but did not influence the data analysis or study findings. The interpretation of the results and the content of the manuscript remained the final decision of the authors.	Albery N, 2001, WORLDS GREATEST IDEA; Allen K, 2001, HYPERTENSION, V38, P815, DOI 10.1161/hyp.38.4.815; Allen K, 2002, ANGER HOSTILITY MARR; American Veterinary Association, 2012, 2012 US PET OWN DEM; Animal Health Alliance (Australia) Ltd, 2013, PET OWN AUSTR 2013 S; APPMA, 2011, 2011 2012 NATL PET O; Arambasic L, 2000, STUD PSYCHOL, V42, P135; Australian Bureau of Statistics, 2010, NAT REG PROF PERTH C; Beck AM, 1996, ANNU REV PUBL HEALTH, V17, P247, DOI 10.1146/annurev.pu.17.050196.001335; Brownson RC, 2004, AM J PUBLIC HEALTH, V94, P473, DOI 10.2105/AJPH.94.3.473; Caughy MO, 2003, SOC SCI MED, V57, P227, DOI 10.1016/S0277-9536(02)00342-8; Christian H, 2010, FAM COMMUNITY HEALTH, V33, P44, DOI 10.1097/FCH.0b013e3181c4e208; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; Collis G, 2003, COULD ENHANCED UNPUB; Current Results Nexus, 2015, AV ANN TEMP LARG US; Cutt H, 2008, HEALTH PROMOT J AUST, V19, P38; Cutt H, 2008, PREV MED, V46, P120, DOI 10.1016/j.ypmed.2007.08.015; Cutt H, 2008, AM J PUBLIC HEALTH, V98, P66, DOI 10.2105/AJPH.2006.103499; Cutt HE, 2008, J PHYS ACT HEALTH, V5, pS73, DOI 10.1123/jpah.5.s1.s73; Cutt HE, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-17; e.Rebublic, 2015, POP DENS US CIT MAP; Edney ATB, 1995, J ROY SOC MED, V88, pP704; Edwards V, 2006, UNDERSTANDING PSYCHO; FRIEDMANN E, 1995, AM J CARDIOL, V76, P1213, DOI 10.1016/S0002-9149(99)80343-9; Headey B, 2008, SOC INDIC RES, V87, P481, DOI 10.1007/s11205-007-9142-2; Headey B, 2007, SOC INDIC RES, V80, P297, DOI 10.1007/s11205-005-5072-z; Hirschauer S, 2005, J THEOR SOC BEHAV, V35, P41, DOI 10.1111/j.0021-8308.2005.00263.x; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; House JS, 1981, WORK STRESS SOCIAL S; HUNT SJ, 1992, J SOC PSYCHOL, V132, P245, DOI 10.1080/00224545.1992.9922976; ISRAEL BA, 1985, HEALTH EDUC QUART, V12, P65, DOI 10.1177/109019818501200106; Jofré M. Leonor, 2005, Rev. chil. infectol., V22, P257; Kazdin A.E., 2011, SINGLE CASE RES DESI, V2nd; Knight S, 2008, J AGING HEALTH, V20, P437, DOI 10.1177/0898264308315875; Landolt P., 1996, AM PROSPECT; Leigh A, 2011, DISCONNECTED; Mackay H, 2013, WHAT MAKES US TICK 1; McHarg M., 1995, NATL PEOPLE PETS SUR; McNicholas J, 2000, BRIT J PSYCHOL, V91, P61, DOI 10.1348/000712600161673; McNicholas J., 2006, HDB ANIMAL ASSISTED, P49; Messent P.R., 1983, NEW PERSPECTIVES OUR, P37; Mulcahy C, 2013, REV EVIDENCE PRISON; Newby J, 1997, PACT SURVIVAL HUMANS; Patterson ML, 2002, BASIC APPL SOC PSYCH, V24, P57, DOI 10.1207/S15324834BASP2401_5; Patton M, 2015, UTILIZATION FOCUSED, VFourth; Petcare, 2015, WHAT IS PETS CIT; Podberscek AL, 2000, RELATIONSHIPS PEOPLE; Putnam R.D., 2004, BETTER TOGETHER REST; Qureshi Adnan I, 2009, J Vasc Interv Neurol, V2, P132; ROBINS DM, 1991, J CONTEMP ETHNOGR, V20, P3, DOI 10.1177/089124191020001001; ROGERS J, 1993, J SOC PSYCHOL, V133, P265, DOI 10.1080/00224545.1993.9712145; Shankar A, 2011, HEALTH PSYCHOL, V30, P377, DOI 10.1037/a0022826; Shrapnel B, 2006, CONTRIBUTION PET CAR; Thoits PA, 2011, J HEALTH SOC BEHAV, V52, P145, DOI 10.1177/0022146510395592; Turner D. C, 1998, COMPANION ANIMALS HU, P3; U. S. Census Bureau, 2012, AM FACT FIND; U.S. Census Bureau, 2010, AM FACT FIND; Uchino BN, 2006, J BEHAV MED, V29, P377, DOI 10.1007/s10865-006-9056-5; Walljasper J., 2007, GREAT NEIGHBORHOOD B; Wells DL, 2007, BRIT J HEALTH PSYCH, V12, P145, DOI 10.1348/135910706X103284; Wood L, 2005, SOC SCI MED, V61, P1159, DOI 10.1016/j.socscimed.2005.01.017; Wood L, 2012, STREETS APART DOES S; Wood L, 2006, THESIS U W AUSTR; Wood LJ, 2007, SOC ANIM, V15, P43, DOI 10.1163/156853007X169333; Wood LL, 2011, NEW DIR HUM-ANIM BON, P51; Young R, 2009, USING SOCIAL NETWORK	66	127	128	5	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0122085	10.1371/journal.pone.0122085	http://dx.doi.org/10.1371/journal.pone.0122085			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0LO	25924013	Green Published, gold			2022-12-27	WOS:000353711600009
J	Bosch-Badia, MT; Montllor-Serrats, J; Tarrazon-Rodon, MA				Bosch-Badia, Maria-Teresa; Montllor-Serrats, Joan; Tarrazon-Rodon, Maria-Antonia			Corporate Social Responsibility: A Real Options Approach to the Challenge of Financial Sustainability	PLOS ONE			English	Article							COMPETITIVENESS; VALUATION	Background In contemporary complex societies, social values like ethics, corporate social responsibility, and being respectful with the environment, among others, are becoming social requirements. Corporations are expected to fulfill them and, according to empirical evidence, an overwhelming majority aspires to good social valuation. At the same time, the maximization of market share value in the long run continues to be the central corporate goal. Making environmental and social expenses compatible with value creation is a central challenge for corporations since it implies the financial sustainability of Corporate Social Responsibility (CSR). Methods and Results The value creation capacity of CSR projects, mainly through innovation, is widely acknowledged in economic literature and corporate practice. This fact arouses the need of having a quantitative framework capable of summarizing the value creation capacity of the variables involved in CSR projects. With this aim we build up a sensitivity analysis of real option ratios that studies and quantifies the value creation capacity of CSR projects connected with innovation. Ratio analysis has the advantage of being scale independent. Hence, it furnishes a homogeneous framework to express the interaction of value creation variables and, thus, supports strategic thinking quantitatively. Often, CSR expenses can be regarded as preliminary projects that create the opportunity to undertake a full future project. For them, we obtain the minimum expectations scenario that makes financially sustainable a preliminary project that can be interpreted as a call option. We propose a classification of CSR projects from the decision analysis perspective following a two-fold approach: Their relationship with value creation and their links with existing corporate activities. This classification of CSR projects aims at contributing to choose the best capital budgeting method to study the financial sustainability of the project and identifying those CSR projects that fulfill the required features to be studied from the real options perspective.	[Bosch-Badia, Maria-Teresa] Univ Girona, Dept Econ, Girona 17071, Spain; [Montllor-Serrats, Joan; Tarrazon-Rodon, Maria-Antonia] Univ Autonoma Barcelona, Business Dept, Bellaterra 08193, Cerdanyola Del, Spain	Universitat de Girona; Autonomous University of Barcelona	Montllor-Serrats, J (corresponding author), Univ Autonoma Barcelona, Business Dept, Campus Bellaterra, Bellaterra 08193, Cerdanyola Del, Spain.	joan.montllor@uab.cat	Montllor, Joan/AAN-4782-2021	Montllor, Joan/0000-0001-5984-293X; Tarrazon-Rodon, Maria-Antonia/0000-0001-8964-6219				[Anonymous], REAL OPTIONS; Avanzi B, 2013, EUR J FINANC, V19, P760, DOI 10.1080/1351847X.2012.681792; Bekefi T., 2011, ENV QUALITY MANAGEME, V20, P11, DOI [https://doi.org/10.1002/tqem.20286, DOI 10.1002/TQEM.20286]; Benabou R, 2010, ECONOMICA, V77, P1, DOI 10.1111/j.1468-0335.2009.00843.x; BLACK F, 1973, J POLIT ECON, V81, P637, DOI 10.1086/260062; Bouasker O, 2012, INT J BUS, V17, P141; Brooks R, 2014, J APPL FINANCE, V24, P94; Chance D M., 2008, J APPL FINANCE, V18, P38; Cobb B. R., 2004, Engineering Economist, V49, P119, DOI 10.1080/00137910490453392; Copeland T, 2004, HARVARD BUS REV, V82, P90; COX JC, 1979, J FINANC ECON, V7, P229, DOI 10.1016/0304-405X(79)90015-1; Eckhause J, 2014, ENERG POLICY, V66, P115, DOI 10.1016/j.enpol.2013.11.030; Favato G, 2008, CORPORATE FINANCIAL; Fichman K, 2005, CALIFORNIA MANAGEMEN, V47, P74; Godinho P., 2006, J APPL FINANCE, V16, P15; Herath H. S. B., 2002, Engineering Economist, V47, P1, DOI 10.1080/00137910208965021; Husted BW, 2007, LONG RANGE PLANN, V40, P594, DOI 10.1016/j.lrp.2007.07.001; Husted BW, 2005, J BUS ETHICS, V60, P175, DOI 10.1007/s10551-005-3777-1; Kasanen E., 1993, CAPITAL BUDGETING UN, P208; MARGRABE W, 1978, J FINANC, V33, P177, DOI 10.1111/j.1540-6261.1978.tb03397.x; Mason SP, 1985, RECENT ADV CORPORATE, P7; Merton R C., 1998, AM ECON REV, V88, P323; Mills RW, 2006, J GEN MANAGE, V31, P49, DOI 10.1177/030630700603100304; Nicholls GM, 2014, ENG MANAG J, V26, P49, DOI 10.1080/10429247.2014.11432010; PORTER ME, 1995, HARVARD BUS REV, V73, P120; Porter ME, 2011, HARVARD BUS REV, V89, P2, DOI DOI 10.1111/J.1467-9310.2011.00672.X; Porter ME, 2006, HARVARD BUS REV, V84, P78; Savage L.J., 1954, FDN STAT; Smit HTJ, 2006, R&D MANAGE, V36, P403, DOI 10.1111/j.1467-9310.2006.00440.x; TRIGEORGIS L, 1993, FINANC MANAGE, V22, P202, DOI 10.2307/3665939; Trigeorgis L, 1996, REAL OPTIONS; Vilanova M, 2009, J BUS ETHICS, V87, P57, DOI 10.1007/s10551-008-9812-2; Willigers BJA, 2008, R&D MANAGE, V38, P520, DOI 10.1111/j.1467-9310.2008.00530.x	33	12	12	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125972	10.1371/journal.pone.0125972	http://dx.doi.org/10.1371/journal.pone.0125972			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH3PP	25938410	Green Published, Green Submitted, gold			2022-12-27	WOS:000353943000124
J	Ho, WM; Chen, CM; Lee, YS; Chang, KH; Chen, HW; Chen, ST; Chen, YC				Ho, Wei-Min; Chen, Chiung-Mei; Lee, Yun-Shien; Chang, Kuo-Hsuan; Chen, Huei-Wen; Chen, Sien-Tsong; Chen, Yi-Chun			Association of MMP-9 Haplotypes and TIMP-1 Polymorphism with Spontaneous Deep Intracerebral Hemorrhage in the Taiwan Population	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; DUAL ROLE; MATRIX-METALLOPROTEINASE-9; GENE; DIAGNOSIS; PROTECTS; BLACKS; STROKE; WHITES; RISK	Background Spontaneous deep intracerebral hemorrhage (SDICH) is a devastating stroke subtype. The causes of SDICH are heterogeneous. Matrix metalloproteinase-9 (MMP-9, Gelantinase B) has been shown to relate to stroke and the development of aneurysm and may increase risks of intracerebral hemorrhage. MMP activities are modulated by their endogenous inhibitors, tissue inhibitors of metalloproteinases (TIMPs). We analyzed the genetic variants of MMP-9 and TIMP-1 and SDICH susceptibility. Methods Associations were tested by logistic regression or general linear models with adjusting for multiple covariables. Multiplicative terms between genes were applied to detect the interaction effects on SDICH. Permutation testing of 1,000 replicates was performed for empirical estimates. Results In the group of >= 65 years old (y/o), we found associations of SDICH with rs3787268 (Odds ratio [OR] = 0.48, 95% confidence interval [CI] 0.27 to 0.86, P = 0.01) and haplotype1 (Hap1) (OR = 0.48, 95% CI 0.26 to 0.86, P = 0.014). For TIMP1 gene, rs4898 was associated with SDICH in the elder male group (OR = 0.35, 95% CI 0.15 to 0.81, P = 0.015). In contrast, in the younger male group, there were associations of SDICH with rs2250889 (OR = 0.48, 95% CI 0.27 to 0.84, P = 0.01) and Hap3 (OR = 0.61, 95% CI 0.38 to 0.97, P = 0.04). We found significant genetic interaction between TIMP-1 and MMP-9 in SDICH susceptibility among younger male subjects (P = 0.004). In subjects carrying rs4898 minor allele, carriers with Hap3 had lower SDICH risk than non-carriers (OR = 0.19, 95% CI 0.07 to 0.51, P = 0.001). In addition, this study showed that when young males were exposed to alcohol, Hap3 was a protective factor of SDICH (OR = 0.06, 95% CI 0.01 to 0.27, P = 0.0002). In contrast, when they were exposed to smoke, Hap2 carriers had increased risk of SDICH (OR = 2.45, 95% CI 1.05 to 5.73, P = 0.04). Conclusions This study showed modest to moderate effects of MMP-9 and TIMP-1 polymorphisms on SDICH risks with significant age differences. MMP-9 may interact with alcohol to play a role in the SDICH risk in young men.	[Ho, Wei-Min] Chang Gung Mem Hosp, Dept Neurol, Keelung, Taiwan; [Ho, Wei-Min; Chen, Chiung-Mei; Chang, Kuo-Hsuan; Chen, Huei-Wen; Chen, Sien-Tsong; Chen, Yi-Chun] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Chen, Chiung-Mei; Chang, Kuo-Hsuan; Chen, Huei-Wen; Chen, Sien-Tsong; Chen, Yi-Chun] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Neurol, Taoyuan, Taiwan; [Lee, Yun-Shien] Ming Chuan Univ, Dept Biotechnol, Taoyuan, Taiwan; [Lee, Yun-Shien] Chang Gung Mem Hosp, Genom Med Res Core Lab, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Ming Chuan University; Chang Gung Memorial Hospital	Chen, YC (corresponding author), Chang Gung Mem Hosp, Linkou Med Ctr, Dept Neurol, Taoyuan, Taiwan.	asd108@adm.cgmh.org.tw	Chen, Chiung-Mei/AAL-6260-2020		National Science Council in Taiwan [NSC 101-2314-B-182A-064, 103-2314-B-182A-027]; Chang Gung Memorial Hospital, Taiwan [CMRPG3A0291, CMRPG3C174]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	All funding for this study was provided by the National Science Council in Taiwan (NSC 101-2314-B-182A-064, 103-2314-B-182A-027) and by Chang Gung Memorial Hospital, Taiwan (CMRPG3A0291 and CMRPG3C174). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Chang JJ, 2014, J STROKE CEREBROVASC, V23, P2498, DOI 10.1016/j.jstrokecerebrovasdis.2014.07.005; Chang KP, 2007, ORAL ONCOL, V43, P345, DOI 10.1016/j.oraloncology.2006.04.006; Chen YC, 2006, CEREBROVASC DIS, V22, P33, DOI 10.1159/000092335; Chen YC, 2009, CLIN CHIM ACTA, V408, P128, DOI 10.1016/j.cca.2009.08.004; Chyatte D, 1997, STROKE, V28, P799, DOI 10.1161/01.STR.28.4.799; Flaherty ML, 2006, NEUROLOGY, V66, P1182, DOI 10.1212/01.wnl.0000208400.08722.7c; Flaherty ML, 2006, NEUROLOGY, V66, P956, DOI 10.1212/01.wnl.0000218670.19577.4c; Florczak-Rzepka M, 2012, CEREBROVASC DIS, V34, P249, DOI 10.1159/000341686; Gaetani P, 1999, NEUROL RES, V21, P385, DOI 10.1080/01616412.1999.11740948; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Hashimoto T, 2003, STROKE, V34, P925, DOI 10.1161/01.STR.0000061888.71524.DF; Hsieh FI, 2010, CIRCULATION, V122, P1116, DOI 10.1161/CIRCULATIONAHA.110.936526; Hsieh HL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/484613; Johnson C, 2004, ARTERIOSCL THROM VAS, V24, P54, DOI 10.1161/01.ATV.0000100402.69997.C3; Labovitz DL, 2005, NEUROLOGY, V65, P518, DOI 10.1212/01.wnl.0000172915.71933.00; Lee CHZ, 2007, STROKE, V38, P2563, DOI 10.1161/STROKEAHA.106.481515; Lin HY, 2008, EUR J HUM GENET, V16, P735, DOI 10.1038/sj.ejhg.5202010; Lorente L, 2013, CRIT CARE, V17, DOI 10.1186/cc12739; Luttun A, 2004, CIRCULATION, V109, P1408, DOI 10.1161/01.CIR.0000121728.14930.DE; Mun-Bryce S, 1998, J CEREBR BLOOD F MET, V18, P1163, DOI 10.1097/00004647-199811000-00001; Nevzati Edin, 2015, Acta Neurochir Suppl, V120, P141, DOI 10.1007/978-3-319-04981-6_24; Newby AC, 2005, PHYSIOL REV, V85, P1, DOI 10.1152/physrev.00048.2003; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Prevention UCfDCa Health behaviors of adults: United States, 2005, VITAL AND HEALTH STA, V10, P80; Saenger AK, 2010, CLIN CHEM, V56, P21, DOI 10.1373/clinchem.2009.133801; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tada Y, 2014, HYPERTENSION, V63, P1339, DOI 10.1161/HYPERTENSIONAHA.114.03300; Tang JP, 2004, J CEREBR BLOOD F MET, V24, P1133, DOI 10.1097/01.WCB.0000135593.05952.DE; Todor DR, 1998, STROKE, V29, P1580, DOI 10.1161/01.STR.29.8.1580; Wang HX, 2014, INT J NEUROSCI, V124, P61, DOI 10.3109/00207454.2013.823604; Woo D, 2002, STROKE, V33, P1190, DOI 10.1161/01.STR.0000014774.88027.22; Yang J, 2014, J NEUROL SCI, V341, P55, DOI 10.1016/j.jns.2014.03.049; Zhang BP, 1999, CIRCULATION, V99, P1788, DOI 10.1161/01.CIR.99.14.1788; Zheng Y, 2015, STROKE, V46, P485, DOI 10.1161/STROKEAHA.114.006372	38	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125397	10.1371/journal.pone.0125397	http://dx.doi.org/10.1371/journal.pone.0125397			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932641	Green Submitted, Green Published, gold			2022-12-27	WOS:000353887100106
J	Kosinska, MK; Ludwig, TE; Liebisch, G; Zhang, RY; Siebert, HC; Wilhelm, J; Kaesser, U; Dettmeyer, RB; Klein, H; Ishaque, B; Rickert, M; Schmitz, G; Schmidt, TA; Steinmeyer, J				Kosinska, Marta Krystyna; Ludwig, Taryn E.; Liebisch, Gerhard; Zhang, Ruiyan; Siebert, Hans-Christian; Wilhelm, Jochen; Kaesser, Ulrich; Dettmeyer, Reinhard B.; Klein, Heiko; Ishaque, Bernd; Rickert, Markus; Schmitz, Gerd; Schmidt, Tannin A.; Steinmeyer, Juergen			Articular Joint Lubricants during Osteoarthritis and Rheumatoid Arthritis Display Altered Levels and Molecular Species	PLOS ONE			English	Article							SYNOVIAL-FLUID; BOUNDARY LUBRICATION; HYALURONIC-ACID; PROTEOGLYCAN 4; CARTILAGE; WEIGHT; PHOSPHOLIPASE; EXPRESSION; DISEASE; KNEE	Background Hyaluronic acid (HA), lubricin, and phospholipid species (PLs) contribute independently or together to the boundary lubrication of articular joints that is provided by synovial fluid (SF). Our study is the first reporting quantitative data about the molecular weight (MW) forms of HA, lubricin, and PLs in SF from cohorts of healthy donors, patients with early (eOA)- or late (lOA)-stage osteoarthritis (OA), and patients with active rheumatoid arthritis (RA). Methods We used human SF from unaffected controls, eOA, lOA, and RA. HA and lubricin levels were measured by enzyme-linked immunosorbent assay. PLs was quantified by electrospray ionization tandem mass spectrometry. Fatty acids (FAs) were analyzed by gas chromatography, coupled with mass spectrometry. The MW distribution of HA was determined by agarose gel electrophoresis. Results Compared with control SF, the concentrations of HA and lubricin were lower in OA and RA SF, whereas those of PLs were higher in OA and RA SF. Moreover, the MW distribution of HA shifted toward the lower ranges in OA and RA SF. We noted distinct alterations between cohorts in the relative distribution of PLs and the degree of FA saturation and chain lengths of FAs. Conclusions The levels, composition, and MW distribution of all currently known lubricants in SF-HA, lubricin, PLs-vary with joint disease and stage of OA. Our study is the first delivering a comprehensive view about all joint lubricants during health and widespread joint diseases. Thus, we provide the framework to develop new optimal compounded lubricants to reduce joint destruction.	[Kosinska, Marta Krystyna; Klein, Heiko; Ishaque, Bernd; Rickert, Markus; Steinmeyer, Juergen] Univ Giessen, Dept Orthoped, Orthoped Res Labs, D-35390 Giessen, Germany; [Ludwig, Taryn E.; Schmidt, Tannin A.] Univ Calgary, Fac Kinesiol, Calgary, AB T2N 1N4, Canada; [Ludwig, Taryn E.; Schmidt, Tannin A.] Univ Calgary, Biomed Engn Grad Program, Calgary, AB T2N 1N4, Canada; [Liebisch, Gerhard; Schmitz, Gerd] Univ Hosp, Dept Clin Chem & Lab Med, Regensburg, Germany; [Zhang, Ruiyan; Siebert, Hans-Christian] RI B NT Res Inst Bioinformat & Nanotechnol, Kiel, Germany; [Zhang, Ruiyan] Univ Kiel, Inst Zool, Ctr Biochem & Mol Biol, Struct Biol, D-24098 Kiel, Germany; [Wilhelm, Jochen] Univ Giessen, Med Clin 2 4, D-35390 Giessen, Germany; [Kaesser, Ulrich] Internist Praxiszentrum Krankenhaus Balser Stiftu, Giessen, Germany; [Dettmeyer, Reinhard B.] Univ Giessen, Inst Forens Med, D-35390 Giessen, Germany	Justus Liebig University Giessen; University of Calgary; University of Calgary; University of Regensburg; University of Kiel; Justus Liebig University Giessen; Justus Liebig University Giessen	Steinmeyer, J (corresponding author), Univ Giessen, Dept Orthoped, Orthoped Res Labs, D-35390 Giessen, Germany.	juergen.steinmeyer@ortho.med.uni-giessen.de	Schmidt, Tannin/AAE-3830-2019; Liebisch, Gerhard/G-6130-2010; Zhang, Ruiyan/HHC-5329-2022; Wilhelm, Jochen/AAX-4302-2021; Rickert, Markus/D-8731-2017	Liebisch, Gerhard/0000-0003-4886-0811; Wilhelm, Jochen/0000-0001-5544-9647; Rickert, Markus/0000-0001-7681-9918; Schmitz, Gerd/0000-0002-1325-1007; Steinmeyer, Juergen/0000-0002-4053-503X	DRB foundation; Natural Sciences and Engineering Research Council of Canada; Alberta Innovates Health Solutions; "LipidomicNet" project - Seventh Framework Programme of the European Union [202272]; Alberta Innovates [201400618] Funding Source: researchfish	DRB foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Innovates Health Solutions; "LipidomicNet" project - Seventh Framework Programme of the European Union; Alberta Innovates	Supported in part by a grant of the DRB foundation, the Natural Sciences and Engineering Research Council of Canada, and Alberta Innovates Health Solutions, and by the "LipidomicNet" project, funded within the Seventh Framework Programme of the European Union (Grant agreement number 202272). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate M, 2010, CURR PHARM DESIGN, V16, P631, DOI 10.2174/138161210790883859; Antonacci JM, 2012, ARTHRITIS RHEUM-US, V64, P2917, DOI 10.1002/art.34520; ARNETT FC, 1987, ARTHRITIS RHEUM, V31, P315; Barton KI, 2013, J ORTHOP RES, V31, P1549, DOI 10.1002/jor.22399; Brockmeier SF, 2006, SPORTS MED ARTHROSC, V14, P155, DOI 10.1097/00132585-200609000-00007; Chen Y, 2007, J ORTHOP SURG RES, V2, P14; DAHL LB, 1985, ANN RHEUM DIS, V44, P817, DOI 10.1136/ard.44.12.817; Dicker KT, 2014, ACTA BIOMATER, V10, P1558, DOI 10.1016/j.actbio.2013.12.019; Dunn S, 2009, PATHOBIOLOGY, V76, P322, DOI 10.1159/000245898; Ecker J, 2012, J CHROMATOGR B, V897, P98, DOI 10.1016/j.jchromb.2012.04.015; Elsaid KA, 2007, ARTHRITIS RHEUM, V56, P108, DOI 10.1002/art.22321; Estrella RP, 2010, BIOCHEM J, V429, P359, DOI 10.1042/BJ20100360; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Ghosh P, 2002, SEMIN ARTHRITIS RHEU, V32, P10, DOI 10.1053/sarh.2002.33720; Goldberg VM, 2005, OSTEOARTHR CARTILAGE, V13, P216, DOI 10.1016/j.joca.2004.11.010; Hills BA, 2003, J ARTHROPLASTY, V18, P499, DOI 10.1016/S0883-5403(03)00072-X; Hills BA, 2002, J RHEUMATOL, V29, P200; Hills BA, 1998, BRIT J RHEUMATOL, V37, P137, DOI 10.1093/oxfordjournals.rheumatology.a031463; Hui AY, 2012, WIRES SYST BIOL MED, V4, P15, DOI 10.1002/wsbm.157; Ikegawa S, 2000, CYTOGENET CELL GENET, V90, P291, DOI 10.1159/000056791; Jay GD, 2007, P NATL ACAD SCI USA, V104, P6194, DOI 10.1073/pnas.0608558104; Jay GD, 1999, J RHEUMATOL, V26, P2454; Jay GD, 2000, J RHEUMATOL, V27, P594; Jay GD, 2007, ARTHRITIS RHEUM-US, V56, P3662, DOI 10.1002/art.22974; Kataoka Y, 2013, BIOCHEM BIOPH RES CO, V432, P580, DOI 10.1016/j.bbrc.2013.02.043; Kosinska MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091769; Kosinska MK, 2013, ARTHRITIS RHEUM-US, V65, P2323, DOI 10.1002/art.38053; Laurent Torvard C., 1996, Immunology and Cell Biology, V74, pA1, DOI 10.1038/icb.1996.32; LEE HG, 1994, ANAL BIOCHEM, V219, P278, DOI 10.1006/abio.1994.1267; Liebisch G, 2013, J LIPID RES, V54, P1523, DOI 10.1194/jlr.M033506; Lord MS, 2012, CONNECT TISSUE RES, V53, P132, DOI 10.3109/03008207.2011.614364; Ludwig TE, 2012, ARTHRITIS RHEUM-US, V64, P3963, DOI 10.1002/art.34674; Mirea DA, 2013, TRIBOL INT, V59, P302, DOI 10.1016/j.triboint.2012.06.015; Murano E, 2011, NAT PROD COMMUN, V6, P555; Nitzan DW, 2001, RHEUMATOLOGY, V40, P336, DOI 10.1093/rheumatology/40.3.336; OUTERBRIDGE RE, 1961, J BONE JOINT SURG BR, V43, P752; PasqualiRonchetti I, 1997, J STRUCT BIOL, V120, P1, DOI 10.1006/jsbi.1997.3908; Sarma AV, 2001, J ORTHOP RES, V19, P671, DOI 10.1016/S0736-0266(00)00064-4; Scanzello CR, 2009, OSTEOARTHR CARTILAGE, V17, P1040, DOI 10.1016/j.joca.2009.02.011; Schmidt TA, 2007, ARTHRITIS RHEUM-US, V56, P882, DOI 10.1002/art.22446; Schmidt TA, 2009, BBA-GEN SUBJECTS, V1790, P375, DOI 10.1016/j.bbagen.2009.03.016; SCHUMACHER BL, 1994, ARCH BIOCHEM BIOPHYS, V311, P144, DOI 10.1006/abbi.1994.1219; Schwarz IM, 1996, BRIT J RHEUMATOL, V35, P821; Schwarz IM, 1998, BRIT J RHEUMATOL, V37, P21; Sun YL, 2008, J ORTHOP RES, V26, P1225, DOI 10.1002/jor.20624; Temple-Wong MM, 2010, T ORTHOP RES SOC, V56, P340; Trunfio-Sfarghiu AM, 2008, LANGMUIR, V24, P8765, DOI 10.1021/la8005234; Waller KA, 2013, P NATL ACAD SCI USA, V110, P5852, DOI 10.1073/pnas.1219289110	48	95	101	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125192	10.1371/journal.pone.0125192	http://dx.doi.org/10.1371/journal.pone.0125192			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933137	Green Published, gold			2022-12-27	WOS:000353887100089
J	Lei, BY; Tan, EL; Chen, SP; Zhuo, L; Li, SL; Ni, D; Wang, TF				Lei, Baiying; Tan, Ee-Leng; Chen, Siping; Zhuo, Liu; Li, Shengli; Ni, Dong; Wang, Tianfu			Automatic Recognition of Fetal Facial Standard Plane in Ultrasound Image via Fisher Vector	PLOS ONE			English	Article							CLASSIFICATION	Acquisition of the standard plane is the prerequisite of biometric measurement and diagnosis during the ultrasound (US) examination. In this paper, a new algorithm is developed for the automatic recognition of the fetal facial standard planes (FFSPs) such as the axial, coronal, and sagittal planes. Specifically, densely sampled root scale invariant feature transform (RootSIFT) features are extracted and then encoded by Fisher vector (FV). The Fisher network with multi-layer design is also developed to extract spatial information to boost the classification performance. Finally, automatic recognition of the FFSPs is implemented by support vector machine (SVM) classifier based on the stochastic dual coordinate ascent (SDCA) algorithm. Experimental results using our dataset demonstrate that the proposed method achieves an accuracy of 93.27% and a mean average precision (mAP) of 99.19% in recognizing different FFSPs. Furthermore, the comparative analyses reveal the superiority of the proposed method based on FV over the traditional methods.	[Lei, Baiying; Chen, Siping; Zhuo, Liu; Ni, Dong; Wang, Tianfu] Shenzhen Univ, Sch Med, Dept Biomed Engn,Guangdong Key Lab Biomed Measure, Natl Reg Key Technol Engn Lab Med Ultrasound, Shenzhen 518060, Guangdong, Peoples R China; [Li, Shengli] Nanfang Med Univ, Affiliated Shenzhen Maternal & Child Healthcare, Dept Ultrasound, Shenzhen, Peoples R China; [Tan, Ee-Leng] Nanyang Technol Univ, Sch Elect & Elect Engn, Singapore 639798, Singapore	Shenzhen University; Southern Medical University - China; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Ni, D (corresponding author), Shenzhen Univ, Sch Med, Dept Biomed Engn,Guangdong Key Lab Biomed Measure, Natl Reg Key Technol Engn Lab Med Ultrasound, Nanhai Ave 3688, Shenzhen 518060, Guangdong, Peoples R China.	nidong@szu.edu.cn; tfwang@szu.edu.cn	CHEN, SI/GZL-4800-2022; Lei, Baiying/GRE-9741-2022; Lei, Baiying/AAY-5515-2020	Lei, Baiying/0000-0002-3087-2550; Lei, Baiying/0000-0002-3087-2550; Wang, Tianfu/0000-0002-1248-1214	National Natural Science Foundation of China [61402296, 61101026, 61372006, 81270707, 61427806]; China Postdoctoral Science Foundation [2013M540663, 2014T70824]; National Natural Science Foundation of Guangdong Province [S2013040014448]; 48th Scientific Research Foundation for the Returned Overseas Chinese Scholars, Shenzhen Key Basic Research Project [JCYJ20130329105033277]; Shenzhen-Hong Kong Innovation Circle Funding Program [JSE201109150013A]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); 48th Scientific Research Foundation for the Returned Overseas Chinese Scholars, Shenzhen Key Basic Research Project(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Shenzhen-Hong Kong Innovation Circle Funding Program	This work was supported partly by National Natural Science Foundation of China (Nos. 61402296, 61101026, 61372006, 81270707 and 61427806), China Postdoctoral Science Foundation Funded Project (No. 2013M540663 and No. 2014T70824), National Natural Science Foundation of Guangdong Province (No. S2013040014448), 48th Scientific Research Foundation for the Returned Overseas Chinese Scholars, Shenzhen Key Basic Research Project (No. JCYJ20130329105033277), and Shenzhen-Hong Kong Innovation Circle Funding Program (No. JSE201109150013A).	Abuhamad A, 2008, ULTRASOUND OBST GYN, V31, P30, DOI 10.1002/uog.5228; Agarwal D, 2013, I S BIOMED IMAGING, P1368; Arandjelovic R, 2012, PROC CVPR IEEE, P2911, DOI 10.1109/CVPR.2012.6248018; Aschkenasy SV, 2006, ULTRASOUND MED BIOL, V32, P1047, DOI 10.1016/j.ultrasmedbio.2006.03.010; Carneiro G, 2008, IEEE T MED IMAGING, V27, P1342, DOI 10.1109/TMI.2008.928917; Chen B., 2013, IEEE T PATTERN ANAL, V35; Cinbis R., 2013, P INT C COMP VIS; Cuingnet R, 2013, I S BIOMED IMAGING, P768; Gorelick L, 2013, IEEE T MED IMAGING, V32, P1804, DOI 10.1109/TMI.2013.2265334; Guo ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088073; Jegou H, 2012, IEEE T PATTERN ANAL, V34, P1704, DOI 10.1109/TPAMI.2011.235; Jia YQ, 2009, IEEE T NEURAL NETWOR, V20, P729, DOI 10.1109/TNN.2009.2015760; Kumar R, 2009, PROC CVPR IEEE, P723, DOI 10.1109/CVPRW.2009.5206838; Lazebnik S., 2006, 2006 IEEE COMP SOC C, P2169; Lei B, 2014, P IEEE INT S BIOM IM; Ni D, 2013, LECT NOTES COMPUT SC, V8198, P203, DOI 10.1007/978-3-642-41083-3_23; Ni D, 2013, I S BIOMED IMAGING, P772; Nie F. P., 2014, P INT C MACH LEARN; Nie FP, 2007, 20TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P993; Rahmatullah B, 2012, LECT NOTES COMPUT SC, V7512, P402, DOI 10.1007/978-3-642-33454-2_50; Rahmatullah B, 2011, LECT NOTES COMPUT SC, V7009, P35, DOI 10.1007/978-3-642-24319-6_5; Roy A, 2008, IEEE T INF TECHNOL B, V12, P366, DOI 10.1109/TITB.2007.910352; Sanchez Garcia J. A., 2013, Insecta Mundi, P1; Shalev-Shwartz S, 2013, J MACH LEARN RES, V14, P567; Shalev-Shwartz S, 2011, MATH PROGRAM, V127, P3, DOI 10.1007/s10107-010-0420-4; Shen HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082409; Simonyan K., 2013, NEURAL INFORM PROCES, P163; Simonyan K, 2013, P BMVC; Vedaldi A, 2012, IEEE T PATTERN ANAL, V34, P480, DOI 10.1109/TPAMI.2011.153; Wein WG, 2008, MED IMAGE ANAL, V12, P577, DOI 10.1016/j.media.2008.06.006; Wu H, 2013, I S BIOMED IMAGING, P752; Zhang L, 2012, MED PHYS, V39, P5015, DOI 10.1118/1.4736415; Zhou S. K., 2006, P IEEE COMP SOC C CO, V2, P1559, DOI DOI 10.1109/CVPR.2006.146	34	22	27	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0121838	10.1371/journal.pone.0121838	http://dx.doi.org/10.1371/journal.pone.0121838			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933215	gold, Green Published			2022-12-27	WOS:000353887100005
J	Lisi, G; Morimoto, J				Lisi, Giuseppe; Morimoto, Jun			EEG Single-Trial Detection of Gait Speed Changes during Treadmill Walk	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; VIRTUAL-REALITY; BRAIN ACTIVITY; MOVEMENT; ARTIFACTS; LOCALIZATION; PERFORMANCE; TRANSFORM; INTERFACE; AGREEMENT	In this study, we analyse the electroencephalography (EEG) signal associated with gait speed changes (i.e. acceleration or deceleration). For data acquisition, healthy subjects were asked to perform volitional speed changes between 0, 1, and 2 Km/h, during treadmill walk. Simultaneously, the treadmill controller modified the speed of the belt according to the subject's linear speed. A classifier is trained to distinguish between the EEG signal associated with constant speed gait and with gait speed changes, respectively. Results indicate that the classification performance is fair to good for the majority of the subjects, with accuracies always above chance level, in both batch and pseudo-online approaches. Feature visualisation and equivalent dipole localisation suggest that the information used by the classifier is associated with increased activity in parietal areas, where mu and beta rhythms are suppressed during gait speed changes. Specifically, the parietal cortex may be involved in motor planning and visuomotor transformations throughout the online gait adaptation, which is in agreement with previous research. The findings of this study may help to shed light on the cortical involvement in human gait control, and represent a step towards a BMI for applications in post-stroke gait rehabilitation.	[Lisi, Giuseppe; Morimoto, Jun] ATR Computat Neurosci Labs, Dept Brain Robot Interface, Kyoto, Japan		Lisi, G (corresponding author), ATR Computat Neurosci Labs, Dept Brain Robot Interface, Kyoto, Japan.	glisi@atr.jp			MIC-SCOPE; Ministry of Internal Affairs and Communications entitled "Novel and innovative R&D making use of brain structures"; MEXT KAKENHI, ImPACT Program of Council for Science, Technology and Innovation (Cabinet Office, Government of Japan), Strategic International Cooperative Program, Japan Science and Technology Agency (JST) [23120004]; JSPS; MIZS: Japan-Slovenia research Cooperative Program	MIC-SCOPE; Ministry of Internal Affairs and Communications entitled "Novel and innovative R&D making use of brain structures"; MEXT KAKENHI, ImPACT Program of Council for Science, Technology and Innovation (Cabinet Office, Government of Japan), Strategic International Cooperative Program, Japan Science and Technology Agency (JST); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MIZS: Japan-Slovenia research Cooperative Program	This study is the result of "Development of BMI Technologies for Clinical Application," carried out under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan. Part of this research was supported by MIC-SCOPE and a contract with the Ministry of Internal Affairs and Communications entitled "Novel and innovative R&D making use of brain structures." This research was also partially supported by MEXT KAKENHI grant number 23120004, ImPACT Program of Council for Science, Technology and Innovation (Cabinet Office, Government of Japan), Strategic International Cooperative Program, Japan Science and Technology Agency (JST), and by JSPS and MIZS: Japan-Slovenia research Cooperative Program. The authors Giuseppe Lisi and Jun Morimoto are affiliated with the company ATR Computational Neuroscience Laboratories. ATR Computational Neuroscience Laboratories provided support in the form of salaries for authors GL and JM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar ZA, 2013, BRAIN TOPOGR, V26, P378, DOI 10.1007/s10548-012-0274-6; Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; Baillet S, 2001, IEEE SIGNAL PROC MAG, V18, P14, DOI 10.1109/79.962275; Bertrand A, 2013, BIOMED CIRC SYST C, P258, DOI 10.1109/BioCAS.2013.6679688; Billinger M., 2012, PRACTICAL BRAIN COMP, P333, DOI [10.1007/978-3-642-29746-5_17, DOI 10.1007/978-3-642-29746-5_17]; Blank A, 2013, I IEEE EMBS C NEUR E, P1159, DOI 10.1109/NER.2013.6696144; Blankertz B, 2002, ADV NEUR IN, V14, P157; Blankertz B, 2008, IEEE SIGNAL PROC MAG, V25, P41, DOI 10.1109/MSP.2008.4408441; Bolognini N, 2007, CURR BIOL, V17, P1890, DOI 10.1016/j.cub.2007.09.057; Brutsch K, 2011, J REHABIL MED, V43, P493, DOI 10.2340/16501977-0802; Brutsch K, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-15; Buneo CA, 2006, NEUROPSYCHOLOGIA, V44, P2594, DOI 10.1016/j.neuropsychologia.2005.10.011; Castermans T, 2014, NEUROSCI LETT, V561, P166, DOI 10.1016/j.neulet.2013.12.059; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cohen YE, 2002, NAT REV NEUROSCI, V3, P553, DOI 10.1038/nrn873; Cuffin BN, 2001, CLIN NEUROPHYSIOL, V112, P46, DOI 10.1016/S1388-2457(00)00488-0; Daly JJ, 2008, LANCET NEUROL, V7, P1032, DOI 10.1016/S1474-4422(08)70223-0; DAUBECHIES I, 1990, IEEE T INFORM THEORY, V36, P961, DOI 10.1109/18.57199; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Delorme A, 2007, NEUROIMAGE, V34, P1443, DOI 10.1016/j.neuroimage.2006.11.004; Delorme A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030135; Dietz V., 2001, Neural Plasticity, V8, P83, DOI 10.1155/NP.2001.83; Dornhege G, 2007, TOWARD BRAIN COMPUTE; Faller J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101168; Fatourechi M, 2007, CLIN NEUROPHYSIOL, V118, P480, DOI 10.1016/j.clinph.2006.10.019; Graimann B, 2006, PROG BRAIN RES, V159, P79, DOI 10.1016/S0079-6123(06)59006-5; Grandchamp R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00236; Grosse-Wentrup M, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/5/056015; Gwin JT, 2011, NEUROIMAGE, V54, P1289, DOI 10.1016/j.neuroimage.2010.08.066; Gwin JT, 2010, J NEUROPHYSIOL, V103, P3526, DOI 10.1152/jn.00105.2010; Haase-Fielitz A, 2009, CRIT CARE MED, V37, P553, DOI 10.1097/CCM.0b013e318195846e; Haefeli J, 2011, EUR J NEUROSCI, V33, P338, DOI 10.1111/j.1460-9568.2010.07494.x; Haggard P, 2008, NAT REV NEUROSCI, V9, P934, DOI 10.1038/nrn2497; Hwang HJ, 2009, J NEUROSCI METH, V179, P150, DOI 10.1016/j.jneumeth.2009.01.015; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Jankovic J, 2007, PARKINSONS DISEASE A; Jiang N, 2014, CLINICAL NEUROPHYSIO; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Joyce CA, 2004, PSYCHOPHYSIOLOGY, V41, P313, DOI 10.1111/j.1469-8986.2003.00141.x; Kaelin-Lang A, 2005, J NEUROPHYSIOL, V93, P1099, DOI 10.1152/jn.00143.2004; Koenraadt KLM, 2014, NEUROIMAGE, V85, P415, DOI 10.1016/j.neuroimage.2013.04.070; Krings T, 1999, CLIN NEUROPHYSIOL, V110, P106, DOI 10.1016/S0013-4694(98)00106-0; Lancaster JL, 1997, HUM BRAIN MAPP, V5, P238, DOI 10.1002/(SICI)1097-0193(1997)5:4<238::AID-HBM6>3.0.CO;2-4; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lisi G, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00085; Lotze M, 2003, BRAIN, V126, P866, DOI 10.1093/brain/awg079; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; Makeig S, 2004, PLOS BIOL, V2, P747, DOI 10.1371/journal.pbio.0020176; MAKEIG S, 1993, ELECTROEN CLIN NEURO, V86, P283, DOI 10.1016/0013-4694(93)90110-H; Min BK, 2008, NEUROSCI LETT, V438, P270, DOI 10.1016/j.neulet.2008.04.067; Miyakoshi M, 2013, IEEE ENG MED BIO, P3282, DOI 10.1109/EMBC.2013.6610242; Mognon A, 2011, PSYCHOPHYSIOLOGY, V48, P229, DOI 10.1111/j.1469-8986.2010.01061.x; Muller-Putz GR, 2007, BRAIN RES, V1137, P84, DOI 10.1016/j.brainres.2006.12.052; Muralidharan A, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00039; Perfetti B, 2011, J NEUROPHYSIOL, V105, P18, DOI 10.1152/jn.00778.2010; Petersen TH, 2012, J PHYSIOL-LONDON, V590, P2443, DOI 10.1113/jphysiol.2012.227397; Petzschner FH, 2012, J NEUROSCI, V32, P4703, DOI 10.1523/JNEUROSCI.0566-12.2012; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Presacco A, 2011, J NEUROPHYSIOL, V106, P1875, DOI 10.1152/jn.00104.2011; Quiroga RQ, 2006, J NEUROSCI, V26, P3615, DOI 10.1523/JNEUROSCI.3468-05.2006; Raiche G, 2013, METHODOLOGY-EUR, V9, P23, DOI 10.1027/1614-2241/a000051; Scherg M, 1990, ADV AUDIOL, P40, DOI DOI 10.1016/J.BSPC.2015.01.004; Schieppati M, 1999, J NEUROL NEUROSUR PS, V66, P313, DOI 10.1136/jnnp.66.3.313; Schlogl A, 2005, J NEURAL ENG, V2, pL14, DOI 10.1088/1741-2560/2/4/L02; Schuler T, 2011, NEUROREHABILITATION, V28, P401, DOI 10.3233/NRE-2011-0670; Seeber M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00485; Severens M, 2012, IEEE ENG MED BIO, P2764, DOI 10.1109/EMBC.2012.6346537; SHIK ML, 1976, PHYSIOL REV, V56, P465, DOI 10.1152/physrev.1976.56.3.465; Sipp AR, 2013, J NEUROPHYSIOL, V110, P2050, DOI 10.1152/jn.00744.2012; Suzuki M, 2004, NEUROIMAGE, V23, P1020, DOI 10.1016/j.neuroimage.2004.07.002; Tangermann M, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00055; Tombini M, 2009, NEUROIMAGE, V47, P1735, DOI 10.1016/j.neuroimage.2009.04.046; Wagner J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00093; Wagner J, 2012, NEUROIMAGE, V63, P1203, DOI 10.1016/j.neuroimage.2012.08.019; Wang D, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00151; Wang YJ, 2009, LECT NOTES ARTIF INT, V5638, P437, DOI 10.1007/978-3-642-02812-0_52; Warren WH, 2001, NAT NEUROSCI, V4, P213, DOI 10.1038/84054; Widmann A, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00233; Wieser M, 2010, EXP BRAIN RES, V203, P181, DOI 10.1007/s00221-010-2223-5; Wojcikiewicz W, 2011, INT CONF ACOUST SPEE, P577; Yamashita O, 2008, NEUROIMAGE, V42, P1414, DOI 10.1016/j.neuroimage.2008.05.050; Yuan H, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/2/026001; Zimmerli L, 2013, ARCH PHYS MED REHAB, V94, P1737, DOI 10.1016/j.apmr.2013.01.029	85	38	38	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125479	10.1371/journal.pone.0125479	http://dx.doi.org/10.1371/journal.pone.0125479			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932947	gold, Green Published, Green Submitted			2022-12-27	WOS:000353887100114
J	Sanzey, M; Rahim, SAA; Oudin, A; Dirkse, A; Kaoma, T; Vallar, L; Herold-Mende, C; Bjerkvig, R; Golebiewska, A; Niclou, SP				Sanzey, Morgane; Rahim, Siti Aminah Abdul; Oudin, Anais; Dirkse, Anne; Kaoma, Tony; Vallar, Laurent; Herold-Mende, Christel; Bjerkvig, Rolf; Golebiewska, Anna; Niclou, Simone P.			Comprehensive Analysis of Glycolytic Enzymes as Therapeutic Targets in the Treatment of Glioblastoma	PLOS ONE			English	Article							LARGE GENE LISTS; STEM-LIKE CELLS; PYRUVATE-KINASE; TUMOR-GROWTH; CANCER; BRAIN; HEXOKINASE; HYPOXIA; NORMALIZATION; MITOCHONDRIA	Major efforts have been put in anti-angiogenic treatment for glioblastoma (GBM), an aggressive and highly vascularized brain tumor with dismal prognosis. However clinical outcome with anti-angiogenic agents has been disappointing and tumors quickly develop escape mechanisms. In preclinical GBM models we have recently shown that bevacizumab, a blocking antibody against vascular endothelial growth factor, induces hypoxia in treated tumors, which is accompanied by increased glycolytic activity and tumor invasiveness. Genomewide transcriptomic analysis of patient derived GBM cells including stem cell lines revealed a strong up-regulation of glycolysis-related genes in response to severe hypoxia. We therefore investigated the importance of glycolytic enzymes in GBM adaptation and survival under hypoxia, both in vitro and in vivo. We found that shRNA-mediated attenuation of glycolytic enzyme expression interfered with GBM growth under normoxic and hypoxic conditions in all cellular models. Using intracranial GBM xenografts we identified seven glycolytic genes whose knockdown led to a dramatic survival benefit in mice. The most drastic effect was observed for PFKP ( PFK1, +21.8%) and PDK1 (+20.9%), followed by PGAM1 and ENO1 (+14.5% each), HK2 (+11.8%), ALDOA (+10.9%) and ENO2 (+7.2%). The increase in mouse survival after genetic interference was confirmed using chemical inhibition of PFK1 with clotrimazole. We thus provide a comprehensive analysis on the importance of the glycolytic pathway for GBM growth in vivo and propose PFK1 and PDK1 as the most promising therapeutic targets to address the metabolic escape mechanisms of GBM.	[Sanzey, Morgane; Rahim, Siti Aminah Abdul; Oudin, Anais; Dirkse, Anne; Bjerkvig, Rolf; Golebiewska, Anna; Niclou, Simone P.] Luxembourg Inst Hlth, Dept Oncol, NorLux Neurooncol Lab, Luxembourg, Luxembourg; [Kaoma, Tony; Vallar, Laurent] Luxembourg Inst Hlth, Genom Res Unit, Luxembourg, Luxembourg; [Herold-Mende, Christel] Heidelberg Univ, Dept Neurosurg, Expt Neurosurg, Heidelberg, Germany; [Bjerkvig, Rolf] Univ Bergen, Dept Biomed, NorLux Neurooncol Lab, Bergen, Norway; [Bjerkvig, Rolf; Niclou, Simone P.] Univ Bergen, Dept Biomed, KG Jebsen Brain Tumour Res Ctr, Bergen, Norway	Luxembourg Institute of Health; Luxembourg Institute of Health; Ruprecht Karls University Heidelberg; University of Bergen; University of Bergen	Niclou, SP (corresponding author), Luxembourg Inst Hlth, Dept Oncol, NorLux Neurooncol Lab, Luxembourg, Luxembourg.	simone.niclou@lih.lu	Golebiewska, Anna/E-1332-2015; Niclou, Simone/P-2304-2018	Golebiewska, Anna/0000-0002-4160-2521; Niclou, Simone/0000-0002-3417-9534; Dirkse, Anne/0000-0003-0778-6651; Vallar, Laurent/0000-0002-4404-1010; Oudin, Anais/0000-0001-5552-9823	Fonds National de la Recherche (FNR) of Luxembourg [ESCAPE 784322 BM]; AFR; Centre de Recherche Public de la Sante (CRP-Sante)	Fonds National de la Recherche (FNR) of Luxembourg(Luxembourg National Research Fund); AFR(Luxembourg National Research Fund); Centre de Recherche Public de la Sante (CRP-Sante)	This work was supported by the Fonds National de la Recherche (FNR) of Luxembourg (ESCAPE 784322 BM to SPN and AFR grant to SAAR) and the Centre de Recherche Public de la Sante (CRP-Sante). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed BY, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-4; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Campos B, 2010, CLIN CANCER RES, V16, P2715, DOI 10.1158/1078-0432.CCR-09-1800; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Chen W, 2007, J NUCL MED, V48, P1468, DOI 10.2967/jnumed.106.037689; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Chinot OL, 2014, NEW ENGL J MED, V370, P2049, DOI 10.1056/NEJMc1403303; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Du JL, 2014, MOL BIOSYST, V10, P2441, DOI 10.1039/c4mb00287c; Fack F, 2014, ACTA NEUROPATHOLOGIC; Ganapathy-Kanniappan S, 2010, CURR PHARM BIOTECHNO, V11, P510, DOI 10.2174/138920110791591427; Gao HS, 2013, J NEUROSURG, V118, P846, DOI 10.3171/2012.9.JNS112134; Gilbert MR, 2014, NEW ENGL J MED, V370, P699, DOI 10.1056/NEJMoa1308573; Goidts V, 2012, ONCOGENE, V31, P3235, DOI 10.1038/onc.2011.490; Golebiewska A, 2013, BRAIN, V136, P1462, DOI 10.1093/brain/awt025; Hamer PCDW, 2008, ONCOGENE, V27, P2091, DOI 10.1038/sj.onc.1210850; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kathagen A, 2013, ACTA NEUROPATHOL, V126, P763, DOI 10.1007/s00401-013-1173-y; Keunen O, 2011, P NATL ACAD SCI USA, V108, P3749, DOI 10.1073/pnas.1014480108; Kumar K, 2013, J MOL MED, V91, P749, DOI 10.1007/s00109-013-0996-2; Lal A, 2001, JNCI-J NATL CANCER I, V93, P1337, DOI 10.1093/jnci/93.17.1337; Marcondes MC, 2010, ARCH BIOCHEM BIOPHYS, V497, P62, DOI 10.1016/j.abb.2010.03.013; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Michelakis ED, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000677; Muller FL, 2012, NATURE, V488, P337, DOI 10.1038/nature11331; Niclou SP, 2008, FASEB J, V22, P3120, DOI 10.1096/fj.08-109611; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; Penso J, 1998, EUR J PHARMACOL, V342, P113, DOI 10.1016/S0014-2999(97)01507-0; Plate KH, 2012, ACTA NEUROPATHOL, V124, P763, DOI 10.1007/s00401-012-1066-5; Ren FL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-81; Stieber D, 2011, EXPERT OPIN THER TAR, V15, P1227, DOI 10.1517/14728222.2011.588211; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Sutendra G, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00038; Torsvik A, 2014, CANCER MED-US, V3, P812, DOI 10.1002/cam4.219; Velpula KK, 2013, CANCER RES, V73, P7277, DOI 10.1158/0008-5472.CAN-13-1868; Weller M, 2013, NEURO-ONCOLOGY, V15, P4, DOI 10.1093/neuonc/nos273; Wolf A, 2011, NEUROBIOL DIS, V44, P84, DOI 10.1016/j.nbd.2011.06.007; Wolf A, 2011, J EXP MED, V208, P313, DOI 10.1084/jem.20101470; Yan T, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-524; Zhang XD, 2009, ANTICANCER RES, V29, P1249	45	70	71	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0123544	10.1371/journal.pone.0123544	http://dx.doi.org/10.1371/journal.pone.0123544			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932951	gold, Green Submitted, Green Published			2022-12-27	WOS:000353887100023
J	Soyka, MB; Holzmann, D; Basinski, TM; Wawrzyniak, M; Bannert, C; Burgler, S; Akkoc, T; Treis, A; Ruckert, B; Akdis, M; Akdis, CA; Eiwegger, T				Soyka, Michael B.; Holzmann, David; Basinski, Tomasz M.; Wawrzyniak, Marcin; Bannert, Christina; Buergler, Simone; Akkoc, Tunc; Treis, Angela; Rueckert, Beate; Akdis, Muebeccel; Akdis, Cezmi A.; Eiwegger, Thomas			The Induction of IL-33 in the Sinus Epithelium and Its Influence on T-Helper Cell Responses	PLOS ONE			English	Article							IMPORTANT RESEARCH QUESTIONS; INNATE LYMPHOID-CELLS; CHRONIC RHINOSINUSITIS; EXPRESSION; INFLAMMATION; ALLERGY; ASTHMA; SUPPRESSION; ENDOTYPES; DIAGNOSIS	Background Chronic rhinosinusitis (CRS) is characterized by epithelial activation and chronic T-cell infiltration in sinonasal mucosa and nasal polyps. IL-33 is a new cytokine of the IL-1 cytokine family that has a pro-inflammatory and Th2 type cytokine induction property. The role of IL-33 in the pathomechanisms of CRS and its interaction with other T cell subsets remain to be fully understood. Methods The main trigger for IL-33 mRNA expression in primary human sinonasal epithelial cells was determined in multiple cytokine and T-cell stimulated cultures. The effects of IL-33 on naive, Th0 and memory T-cells was studied by PCR, ELISA and flow cytometry. Biopsies from sinus tissue were analyzed by PCR and immunofluorescence for the presence of different cytokines and receptors with a special focus on IL-33. Results IL-33 was mainly induced by IFN-gamma in primary sinonasal epithelial cells, and induced a typical CRSwNP Th2 favoring cytokine profile upon co-culture with T-helper cell subsets. IL-33 and its receptor ST2 were highly expressed in the inflamed epithelial tissue of CRS patients. While IL-33 was significantly up-regulated in the epithelium for CRSsNP, its receptor was higher expressed in sinus tissue from CRSwNP. Conclusions production, which could both contribute to a further increase of an established Th2 profile in CRSwNP.The present study delineates the influence of IL-33 in upper airway epithelium and a potential role of IL-33 in chronic inflammation of CRSwNP by enhancing Th2 type cytokine	[Soyka, Michael B.; Basinski, Tomasz M.; Wawrzyniak, Marcin; Buergler, Simone; Akkoc, Tunc; Treis, Angela; Rueckert, Beate; Akdis, Muebeccel; Akdis, Cezmi A.; Eiwegger, Thomas] Univ Zurich, Swiss Inst Allergy & Asthma Res SIAF, Davos, Switzerland; [Soyka, Michael B.; Holzmann, David] Univ Zurich Hosp, Dept Otorhinolaryngol, CH-8091 Zurich, Switzerland; [Akkoc, Tunc] Marmara Univ, Fac Med, Div Pediat Allergy & Immunol, Istanbul, Turkey; [Treis, Angela; Akdis, Cezmi A.] Christine Kuhne Ctr Allergy Res & Educ, Davos, Switzerland; [Bannert, Christina; Eiwegger, Thomas] Med Univ Vienna, Dept Pediat, Vienna, Austria	Swiss Institute of Allergy & Asthma Research; University of Zurich; University of Zurich; University Zurich Hospital; Marmara University; Medical University of Vienna	Eiwegger, T (corresponding author), Univ Zurich, Swiss Inst Allergy & Asthma Res SIAF, Davos, Switzerland.	thomas.eiwegger@meduniwien.ac.at	Wawrzyniak, Marcin/E-5878-2017; Wawrzyniak, Marcin/AAT-9094-2021; Holzmann, David/ABC-7620-2020; Akdis, Cezmi/AAV-4844-2020	Wawrzyniak, Marcin/0000-0002-6911-8010; Akdis, Cezmi/0000-0001-8020-019X; Eiwegger, Thomas/0000-0002-2914-7829; Holzmann, David/0000-0002-8176-8358	Swiss National Science Foundation [320030_140772, 320030_132899]; Muller-Gierok Foundation, Bern; Oesterreichische Nationalbank [13846ONB]; Christine Kuhne-Center for Allergy Research and Education, Davos; Austrian Science Fund Project [F4615-B19, F4605-B19]; European Respiratory Society Fellowship [312]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Muller-Gierok Foundation, Bern; Oesterreichische Nationalbank; Christine Kuhne-Center for Allergy Research and Education, Davos; Austrian Science Fund Project(Austrian Science Fund (FWF)); European Respiratory Society Fellowship	This work was supported by grants from: Swiss National Science Foundation Grants No. 320030_140772, 320030_132899; Muller-Gierok Foundation, Bern; funds from the Oesterreichische Nationalbank (Anniversary Fund, project number 13846ONB); Christine Kuhne-Center for Allergy Research and Education, Davos; and Austrian Science Fund Project, grant numbers F4615-B19, F4605-B19. Tomasz M. Basinski was the recipient of European Respiratory Society Fellowship (Number 312). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis CA, 2013, J ALLERGY CLIN IMMUN, V131, P1479, DOI 10.1016/j.jaci.2013.02.036; Baba S, 2014, LARYNGOSCOPE, V124, pE115, DOI 10.1002/lary.24462; Bachert C, 2009, ALLERGY, V64, P520, DOI 10.1111/j.1398-9995.2009.01964.x; Basinski TM, 2009, J ALLERGY CLIN IMMUN, V124, P74, DOI 10.1016/j.jaci.2009.04.019; Blom L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021695; Bonilla WV, 2012, SCIENCE, V335, P984, DOI 10.1126/science.1215418; Bousquet J, 2008, ALLERGY, V63, P842, DOI 10.1111/j.1398-9995.2008.01715.x; Bousquet J, 2009, J ALLERGY CLIN IMMUN, V124, P428, DOI 10.1016/j.jaci.2009.06.027; Burgler S, 2009, J ALLERGY CLIN IMMUN, V123, P588, DOI 10.1016/j.jaci.2008.12.017; Castano R, 2009, AMJ RHINOL ALLERGY, V23, P377, DOI 10.2500/ajra.2009.23.3303; Chan Y, 2009, CURR OPIN OTOLARYNGO, V17, P204, DOI 10.1097/MOO.0b013e32832ac393; Eiwegger T, 2008, CLIN EXP ALLERGY, V38, P1627, DOI 10.1111/j.1365-2222.2008.03080.x; Eiwegger T, 2006, CLIN EXP ALLERGY, V36, P1281, DOI 10.1111/j.1365-2222.2006.02565.x; Eiwegger T, 2011, ALLERGY, V66, P271, DOI 10.1111/j.1398-9995.2010.02475.x; Eiwegger T, 2010, PEDIAT ALLERG IMM-UK, V21, P1179, DOI 10.1111/j.1399-3038.2010.01062.x; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Fux M, 2014, ALLERGY, V69, P216, DOI 10.1111/all.12309; Jackson DJ, 2014, AM J RESP CRIT CARE, V190, P1373, DOI 10.1164/rccm.201406-1039OC; Klemens JJ, 2006, LARYNGOSCOPE, V116, P1236, DOI 10.1097/01.mlg.0000224526.43698.52; Kurowska-Stolarska M, 2008, J IMMUNOL, V181, P4780, DOI 10.4049/jimmunol.181.7.4780; Lamkanfi M, 2009, IMMUNITY, V31, P5, DOI 10.1016/j.immuni.2009.06.011; Li XY, 2010, J ALLERGY CLIN IMMUN, V125, P1061, DOI 10.1016/j.jaci.2010.02.023; Lotvall J, 2011, J ALLERGY CLIN IMMUN, V127, P355, DOI 10.1016/j.jaci.2010.11.037; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; Makrinioti H, 2014, LANCET RESP MED, V2, P226, DOI 10.1016/S2213-2600(13)70261-3; Marple BF, 2009, POSTGRAD MED, V121, P121, DOI 10.3810/pgm.2009.11.2081; Meephansan J, 2012, J INVEST DERMATOL, V132, P2593, DOI 10.1038/jid.2012.185; Meyer N, 2012, J ALLERGY CLIN IMMUN, V129, P964, DOI 10.1016/j.jaci.2011.12.1002; Meyer N, 2010, J ALLERGY CLIN IMMUN, V125, P858, DOI 10.1016/j.jaci.2010.01.016; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Pecaric-Petkovic T, 2009, BLOOD, V113, P1526, DOI 10.1182/blood-2008-05-157818; Reh DD, 2010, AM J RHINOL ALLERGY, V24, P105, DOI 10.2500/ajra.2010.24.3446; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Shan J, 2014, J GASTROENTEROL; Shaw JL, 2013, AM J RESP CRIT CARE, V188, P432, DOI 10.1164/rccm.201212-2227OC; Soyka MB, 2005, AM J RHINOL, V19, P274, DOI 10.1177/194589240501900311; Stevens WW, 2014, J ALLERGY CLIN IMMUN, V133, P1503, DOI 10.1016/j.jaci.2014.03.022; Tiringer K, 2014, EUR RESPIR J, V44, P802, DOI 10.1183/09031936.00046614; Van Bruaene N, 2008, J ALLERGY CLIN IMMUN, V121, P1435, DOI 10.1016/j.jaci.2008.02.018; Van Bruaene N, 2009, J ALLERGY CLIN IMMUN, V124, P253, DOI 10.1016/j.jaci.2009.04.013; Van Crombruggen K, 2011, J ALLERGY CLIN IMMUN, V128, P728, DOI 10.1016/j.jaci.2011.07.049; Zhang N, 2008, J ALLERGY CLIN IMMUN, V122, P961, DOI 10.1016/j.jaci.2008.07.008; Zimmermann M, 2011, J ALLERGY CLIN IMMUN, V127, P200, DOI 10.1016/j.jaci.2010.11.005	43	20	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0123163	10.1371/journal.pone.0123163	http://dx.doi.org/10.1371/journal.pone.0123163			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932636	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000353887100015
J	Tsulukidze, M; Grande, SW; Thompson, R; Rudd, K; Elwyn, G				Tsulukidze, Maka; Grande, Stuart W.; Thompson, Rachel; Rudd, Kenneth; Elwyn, Glyn			Patients Covertly Recording Clinical Encounters: Threat or Opportunity? A Qualitative Analysis of Online Texts	PLOS ONE			English	Article							HEALTH; CARE	Background The phenomenon of patients covertly recording clinical encounters has generated controversial media reports. This study aims to examine the phenomenon and analyze the underlying issues. Methods and Findings We conducted a qualitative analysis of online posts, articles, blogs, and forums (texts) discussing patients covertly recording clinical encounters. Using Google and Google Blog search engines, we identified and analyzed 62 eligible texts published in multiple countries between 2006 and 2013. Thematic analysis revealed four key themes: 1) a new behavior that elicits strong reactions, both positive and negative, 2) an erosion of trust, 3) shifting patient-clinician roles and relationships, and 4) the existence of confused and conflicting responses. When patients covertly record clinical encounters - a behavior made possible by various digital recording technologies - strong reactions are evoked among a range of stakeholders. The behavior represents one consequence of an erosion of trust between patients and clinicians, and when discovered, leads to further deterioration of trust. Confused and conflicting responses to the phenomenon by patients and clinicians highlight the need for policy guidance. Conclusions This study describes strong reactions, both positive and negative, to the phenomenon of patients covertly recording clinical encounters. The availability of smartphones capable of digital recording, and shifting attitudes to patient-clinician relationships, seems to have led to this behavior, mostly viewed as a threat by clinicians but as a welcome and helpful innovation by some patients, possibly indicating a perception of subordination and a lack of empowerment. Further examination of this tension and its implications is needed.	[Tsulukidze, Maka; Grande, Stuart W.; Rudd, Kenneth; Elwyn, Glyn] Dartmouth Ctr Hlth Care Delivery Sci, Hanover, NH 03755 USA; [Thompson, Rachel; Elwyn, Glyn] Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA; [Elwyn, Glyn] Radboud Univ Nijmegen, Med Ctr, Sci Inst Qual Improvement, NL-6525 ED Nijmegen, Netherlands	Dartmouth College; Dartmouth College; Radboud University Nijmegen	Elwyn, G (corresponding author), Dartmouth Ctr Hlth Care Delivery Sci, Hanover, NH 03755 USA.	glynelwyn@gmail.com	Elwyn, G./L-4292-2015; Elwyn, Glyn/B-4798-2009	Elwyn, Glyn/0000-0002-0917-6286; Grande, Stuart/0000-0002-6796-7991; Thompson, Rachel/0000-0002-1009-0746	Dartmouth Center for Health Care Delivery Science	Dartmouth Center for Health Care Delivery Science	This work was supported by the Dartmouth Center for Health Care Delivery Science. This research received no other funding.	Blackwell T, 2012, NATL POST; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Carman KL, 2013, HEALTH AFFAIR, V32, P223, DOI 10.1377/hlthaff.2012.1133; Delbanco T, 2010, ANN INTERN MED, V153, P121, DOI 10.7326/0003-4819-153-2-201007200-00008; Elwyn G, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2078; Goldstein R L, 1989, Bull Am Acad Psychiatry Law, V17, P367; Halpern SA, 2015, J HLTH POLIT POLICY, V29, P835; Halpern SA, 2015, J HLTH POLIT POLICY, V29, P1005; Mechanic D, 2003, JAMA-J AM MED ASSOC, V290, P941, DOI 10.1001/jama.290.7.941; Naslund JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110171; Pescosolido BA, 2001, J HEALTH SOC BEHAV, V42, P1, DOI 10.2307/3090224; Richards T, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2614; RODWIN MA, 1994, AM J LAW MED, V20, P147; Tsulukidze M, 2014, PATIENT EDUC COUNS, V95, P297, DOI 10.1016/j.pec.2014.02.007	14	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125824	10.1371/journal.pone.0125824	http://dx.doi.org/10.1371/journal.pone.0125824			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH2XA	25933002	Green Published, gold, Green Submitted			2022-12-27	WOS:000353887100136
J	Grant, EM; Young, DR; Wu, TT				Grant, Edward M.; Young, Deborah Rohm; Wu, Tong Tong			Predictors for Physical Activity in Adolescent Girls Using Statistical Shrinkage Techniques for Hierarchical Longitudinal Mixed Effects Models	PLOS ONE			English	Article							SCHOOL; MULTILEVEL; BLACK; TRIAL; DEPRESSION; ENJOYMENT; CHILDREN; SCALE	We examined associations among longitudinal, multilevel variables and girls' physical activity to determine the important predictors for physical activity change at different adolescent ages. The Trial of Activity for Adolescent Girls 2 study (Maryland) contributed participants from 8th (2009) to 11th grade (2011) (n=561). Questionnaires were used to obtain demographic, and psychosocial information (individual-and social-level variables); height, weight, and triceps skinfold to assess body composition; interviews and surveys for school-level data; and self-report for neighborhood-level variables. Moderate to vigorous physical activity minutes were assessed from accelerometers. A doubly regularized linear mixed effects model was used for the longitudinal multilevel data to identify the most important covariates for physical activity. Three fixed effects at the individual level and one random effect at the school level were chosen from an initial total of 66 variables, consisting of 47 fixed effects and 19 random effects variables, in additional to the time effect. Self-management strategies, perceived barriers, and social support from friends were the three selected fixed effects, and whether intramural or interscholastic programs were offered in middle school was the selected random effect. Psychosocial factors and friend support, plus a school's physical activity environment, affect adolescent girl's moderate to vigorous physical activity longitudinally.	[Grant, Edward M.; Wu, Tong Tong] Univ Maryland, Sch Publ Hlth, Dept Epidemiol & Biostat, College Pk, MD 20742 USA; [Young, Deborah Rohm] Kaiser Permanente So Calif, Dept Res & Evaluat, Pasadena, CA 91101 USA	University System of Maryland; University of Maryland College Park; Kaiser Permanente	Young, DR (corresponding author), Kaiser Permanente So Calif, Dept Res & Evaluat, Pasadena, CA 91101 USA.	Deborah.r.young@kp.org			National Heart, Lung, and Blood Institute at the National Institutes of Health [R01 HL094572, HL119058]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094572, R01HL119058] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart, Lung, and Blood Institute at the National Institutes of Health (Grants R01 HL094572 and HL119058 to DRY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandura A., 1986, SOCIAL FDN THOUGHT A; Barr-Anderson DJ, 2008, RES Q EXERCISE SPORT, V79, P18, DOI 10.5641/193250308X13086753542735; Birnbaum AS, 2005, AM J HEALTH BEHAV, V29, P250, DOI 10.5993/AJHB.29.3.6; Catellier DJ, 2005, MED SCI SPORT EXER, V37, pS555, DOI 10.1249/01.mss.0000185651.59486.4e; *CDCP, 2000, 2000 CDC GROWTH CHAR; Daniels SR, 2005, CIRCULATION, V111, P1999, DOI 10.1161/01.CIR.0000161369.71722.10; Duncan SC, 2007, ANN BEHAV MED, V33, P80, DOI 10.1207/s15324796abm3301_9; Elder JP, 2007, HEALTH EDUC RES, V22, P155, DOI 10.1093/her/cyl059; Evenson KR, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-28; GARRISON CZ, 1991, J AM ACAD CHILD PSY, V30, P636, DOI 10.1097/00004583-199107000-00017; Goodman RM, 1997, HLTH BEHAV HLTH ED T; Hearst MO, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-8; Heitzler CD, 2010, AM J HEALTH BEHAV, V34, P593; Kelly EB, 2010, J PHYS ACT HEALTH, V7, P184, DOI 10.1123/jpah.7.2.184; Kimm SYS, 2002, NEW ENGL J MED, V347, P709, DOI 10.1056/NEJMoa003277; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; LANGE N, 1989, J AM STAT ASSOC, V84, P241, DOI 10.2307/2289869; Loftin M, 2007, Int J Body Compos Res, V5, P1; Lytle LA, 2009, ANN BEHAV MED, V38, P124, DOI 10.1007/s12160-009-9127-2; MARSH HW, 1994, J SPORT EXERCISE PSY, V16, P43, DOI 10.1123/jsep.16.1.43; McCambridge TM, 2006, PEDIATRICS, V117, P1834, DOI 10.1542/peds.2006-0472; Mckay CM, 2007, PEDIATRICS, V119, pS84, DOI 10.1542/peds.2006-2089M; MCKENZIE TL, 1992, J TEACH PHYS EDUC, V11, P195, DOI 10.1123/jtpe.11.2.195; Motl RW, 2001, AM J PREV MED, V21, P110, DOI 10.1016/S0749-3797(01)00326-9; Motl RW, 2000, PREV MED, V31, P584, DOI 10.1006/pmed.2000.0735; Motl RW, 2003, MED SCI SPORT EXER, V35, P128, DOI 10.1097/00005768-200301000-00020; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Pate RR, 2009, J ADOLESCENT HEALTH, V44, P275, DOI 10.1016/j.jadohealth.2008.07.003; Patnode CD, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-79; Perry CK, 2012, J PRIM PREV, V33, P111, DOI 10.1007/s10935-012-0270-3; Pietilainen KH, 2008, OBESITY, V16, P409, DOI 10.1038/oby.2007.72; RADLOFF LS, 1991, J YOUTH ADOLESCENCE, V20, P149, DOI 10.1007/BF01537606; Raghunathan TE, 2001, SURV METHODOL, V27, P85; Rushovich BR, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-20; Saelens BE, 2000, BEHAV THER, V31, P365, DOI 10.1016/S0005-7894(00)80020-9; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Sallis JF, 1996, J CLIN EPIDEMIOL, V49, P125, DOI 10.1016/0895-4356(95)00514-5; Sallis JF., 1999, PHYS ACTIVITY BEHAV, Vvol. 3; Sallis JF, 2002, PEDIAT EXERC SCI, V2002, P418; Schmitz KH, 2002, PREV MED, V34, P266, DOI 10.1006/pmed.2001.0982; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Scott MM, 2007, J URBAN HEALTH, V84, P346, DOI 10.1007/s11524-007-9179-1; Skinner BF, 1953, SCI HLTH BEHAV; Stevens J, 2005, CONTEMP CLIN TRIALS, V26, P223, DOI 10.1016/j.cct.2004.12.011; STOKOLS D, 1992, AM PSYCHOL, V47, P6, DOI 10.1037/0003-066X.47.1.6; Taylor WC, 2002, PEDIAT EXERC SCI, V14, P30; Treuth MS, 2004, MED SCI SPORT EXER, V36, P198, DOI 10.1249/01.MSS.0000113666.98463.B0; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Wang S, 2010, U MICHIGAN WORKING P; Webber LS, 2008, AM J PREV MED, V34, P173, DOI 10.1016/j.amepre.2007.11.018; Young D, 2014, J PHYS ACT HEALTH, V11, P950, DOI 10.1123/jpah.2012-0192	51	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125431	10.1371/journal.pone.0125431	http://dx.doi.org/10.1371/journal.pone.0125431			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0MA	25928064	Green Submitted, Green Published, gold			2022-12-27	WOS:000353713100090
J	Korkmaz, S; Zararsiz, G; Goksuluk, D				Korkmaz, Selcuk; Zararsiz, Gokmen; Goksuluk, Dincer			MLViS: A Web Tool for Machine Learning-Based Virtual Screening in Early-Phase of Drug Discovery and Development	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; CLASSIFICATION; PREDICTION; INHIBITORS; FRAMEWORK; MODEL	Virtual screening is an important step in early-phase of drug discovery process. Since there are thousands of compounds, this step should be both fast and effective in order to distinguish drug-like and nondrug-like molecules. Statistical machine learning methods are widely used in drug discovery studies for classification purpose. Here, we aim to develop a new tool, which can classify molecules as drug-like and nondrug-like based on various machine learning methods, including discriminant, tree-based, kernel-based, ensemble and other algorithms. To construct this tool, first, performances of twenty-three different machine learning algorithms are compared by ten different measures, then, ten best performing algorithms have been selected based on principal component and hierarchical cluster analysis results. Besides classification, this application has also ability to create heat map and dendrogram for visual inspection of the molecules through hierarchical cluster analysis. Moreover, users can connect the PubChem database to download molecular information and to create two-dimensional structures of compounds. This application is freely available through www.biosoft.hacettepe.edu.tr/MLViS/.	[Korkmaz, Selcuk; Zararsiz, Gokmen; Goksuluk, Dincer] Hacettepe Univ, Fac Med, TR-06100 Ankara, Turkey	Hacettepe University	Korkmaz, S (corresponding author), Hacettepe Univ, Fac Med, TR-06100 Ankara, Turkey.	selcuk.korkmaz@hacettepe.edu.tr	ZARARSIZ, GOKMEN/ABH-7959-2020; GOKSULUK, Dincer/E-9175-2013; Korkmaz, Selçuk/AAU-4677-2020; Zararsız, Gökmen/E-8818-2013	GOKSULUK, Dincer/0000-0002-2752-7668; Korkmaz, Selçuk/0000-0003-4632-6850; Zararsız, Gökmen/0000-0001-5801-1835	Marmara University [FEN-C-DRP-120613-0273]	Marmara University(Marmara University)	This study was supported by the Research Fund of Marmara University [FEN-C-DRP-120613-0273]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo A, 2010, J CHEM INF MODEL, V50, P1012, DOI 10.1021/ci100090p; Agarwal S, 2010, J CHEM INF MODEL, V50, P716, DOI 10.1021/ci9003865; Ajay, 1998, J MED CHEM, V41, P3314, DOI 10.1021/jm970666c; Akbani R, 2004, LECT NOTES COMPUT SC, V3201, P39, DOI 10.1007/978-3-540-30115-8_7; Batista G.E., 2004, ACM SIGKDD EXPLOR NE, V6, P20, DOI 10.1145/1007730.1007735; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Byvatov E, 2003, J CHEM INF COMP SCI, V43, P1882, DOI 10.1021/ci0341161; Cao Y, 2008, BIOINFORMATICS, V24, P1733, DOI 10.1093/bioinformatics/btn307; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Chawla NV, 2003, LECT NOTES ARTIF INT, V2838, P107, DOI 10.1007/978-3-540-39804-2_12; Chen B, 2007, J COMPUT AID MOL DES, V21, P53, DOI 10.1007/s10822-006-9096-5; Cheng FX, 2011, J CHEM INF MODEL, V51, P996, DOI 10.1021/ci200028n; Ehrman TM, 2007, J CHEM INF MODEL, V47, P264, DOI 10.1021/ci600289v; Estabrooks A, 2004, COMPUT INTELL-US, V20, P18, DOI 10.1111/j.0824-7935.2004.t01-1-00228.x; Fang JS, 2013, J CHEM INF MODEL, V53, P3009, DOI 10.1021/ci400331p; Garcia-Sosa AT, 2012, J CHEM INF MODEL, V52, P2165, DOI 10.1021/ci200587h; Gertrudes JC, 2012, CURR MED CHEM, V19, P4289, DOI 10.2174/092986712802884259; Hastie T, 2009, ELEMENTS STAT LEARNI, DOI [10.1016/j.neunet.2009.04.005, DOI 10.1016/J.NEUNET.2009.04.005]; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Jorissen RN, 2005, J CHEM INF MODEL, V45, P549, DOI 10.1021/ci049641u; Keiser J, 2011, J ANTIMICROB CHEMOTH, V66, P1791, DOI 10.1093/jac/dkr178; Korkmaz S, 2014, COMPUT METH PROG BIO, V117, P51, DOI 10.1016/j.cmpb.2014.08.009; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Liew CY, 2009, J CHEM INF MODEL, V49, P877, DOI 10.1021/ci800387z; Lyne PD, 2002, DRUG DISCOV TODAY, V7, P1047, DOI 10.1016/S1359-6446(02)02483-2; Miller DW, 2001, J CHEM INF COMP SCI, V41, P168, DOI [10.1021/ci0003348, 10.1021/ci0000348]; Ozturk A, 2008, ERCIYES MED J, V30, P266; Plewczynski D, 2009, COMB CHEM HIGH T SCR, V12, P484, DOI 10.2174/138620709788489000; Pochet N, 2004, BIOINFORMATICS, V20, P3185, DOI 10.1093/bioinformatics/bth383; R Core Team, R LANG ENV STAT COMP; Rathke F, 2011, J CHEM INF MODEL, V51, P83, DOI 10.1021/ci100308f; RStudio Inc, SHIN WEB APPL FRAM R; Sadowski J, 1998, J MED CHEM, V41, P3325, DOI 10.1021/jm9706776; Seiffert C, 2010, IEEE T SYST MAN CY A, V40, P185, DOI 10.1109/TSMCA.2009.2029559; Sun HM, 2005, J MED CHEM, V48, P4031, DOI 10.1021/jm050180t; Tan P.-N., 2019, INTRO DATA MINING, V2nd ed.; Todorov V, 2009, J STAT SOFTW, V32, P1; Vapnik V.N., 1995, NATURE STAT LEARNING; Warnes G., GPLOTS VARIOUS R PRO; Wassermann AM, 2009, J CHEM INF MODEL, V49, P582, DOI 10.1021/ci800441c; Weidlich IE, 2015, J COMPUT CHEM, V36, P62, DOI 10.1002/jcc.23765; Weston S., CARET CLASSIFICATION; Wildenhain J, 2012, BIOINFORMATICS, V28, P2200, DOI 10.1093/bioinformatics/bts349; Xiao N, RCPI TOOLKIT COMPOUN; Zernov VV, 2003, J CHEM INF COMP SCI, V43, P2048, DOI 10.1021/ci0340916	45	28	28	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124600	10.1371/journal.pone.0124600	http://dx.doi.org/10.1371/journal.pone.0124600			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928885	Green Published, gold, Green Submitted			2022-12-27	WOS:000353713100040
J	Yang, XC; Wu, J; Lu, JS; Liu, GY; Di, GH; Chen, CM; Hou, YF; Sun, MH; Yang, WT; Xu, XJ; Zhao, Y; Hu, X; Li, DQ; Cao, ZG; Zhou, XY; Huang, XY; Liu, ZB; Chen, H; Gu, YZ; Chi, YY; Yan, X; Han, QX; Shen, ZZ; Shao, ZM; Hu, Z				Yang, Xiaochen; Wu, Jiong; Lu, Jingsong; Liu, Guangyu; Di, Genhong; Chen, Canming; Hou, Yifeng; Sun, Menghong; Yang, Wentao; Xu, Xiaojing; Zhao, Ying; Hu, Xin; Li, Daqiang; Cao, Zhigang; Zhou, Xiaoyan; Huang, Xiaoyan; Liu, Zhebin; Chen, Huan; Gu, Yanzi; Chi, Yayun; Yan, Xia; Han, Qixia; Shen, Zhenzhou; Shao, Zhimin; Hu, Zhen			Identification of a Comprehensive Spectrum of Genetic Factors for Hereditary Breast Cancer in a Chinese Population by Next-Generation Sequencing	PLOS ONE			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; REVISED BETHESDA GUIDELINES; GERMLINE MUTATIONS; LYNCH-SYNDROME; MICROSATELLITE INSTABILITY; TP53 MUTATIONS; GASTRIC-CANCER; BRCA2 GENES; FAMILY; SUSCEPTIBILITY	The genetic etiology of hereditary breast cancer has not been fully elucidated. Although germline mutations of high-penetrance genes such as BRCA1/2 are implicated in development of hereditary breast cancers, at least half of all breast cancer families are not linked to these genes. To identify a comprehensive spectrum of genetic factors for hereditary breast cancer in a Chinese population, we performed an analysis of germline mutations in 2,165 coding exons of 152 genes associated with hereditary cancer using next-generation sequencing (NGS) in 99 breast cancer patients from families of cancer patients regardless of cancer types. Forty-two deleterious germline mutations were identified in 21 genes of 34 patients, including 18 (18.2%) BRCA1 or BRCA2 mutations, 3 (3%) TP53 mutations, 5 (5.1%) DNA mismatch repair genemutations, 1 (1%) CDH1 mutation, 6 (6.1%) Fanconi anemia pathway gene mutations, and 9 (9.1%) mutations in other genes. Of seven patients who carried mutations inmore than one gene, 4 were BRCA1/2 mutation carriers, and their average onset age was much younger than patients with only BRCA1/2 mutations. Almost all identified high-penetrance genemutations in those families fulfill the typical phenotypes of hereditary cancer syndromes listed in the National Comprehensive Cancer Network (NCCN) guidelines, except two TP53 and threemismatch repair genemutations. Furthermore, functional studies of MSH3 germline mutations confirmed the association between MSH3 mutation and tumorigenesis, and segregation analysis suggested antagonism between BRCA1 and MSH3. We also identified a lot of low-penetrance gene mutations. Although the clinical significance of those newly identified low-penetrance gene mutations has not been fully appreciated yet, these new findings do provide valuable epidemiological information for the future studies. Together, these findings highlight the importance of genetic testing based on NCCN guidelines and a multi-gene analysis using NGS may be a supplement to traditional genetic counseling.	[Yang, Xiaochen; Wu, Jiong; Lu, Jingsong; Liu, Guangyu; Di, Genhong; Chen, Canming; Hou, Yifeng; Cao, Zhigang; Huang, Xiaoyan; Liu, Zhebin; Yan, Xia; Han, Qixia; Shen, Zhenzhou; Shao, Zhimin; Hu, Zhen] Fudan Univ, Dept Breast Surg, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; [Yang, Xiaochen; Wu, Jiong; Lu, Jingsong; Liu, Guangyu; Di, Genhong; Chen, Canming; Hou, Yifeng; Sun, Menghong; Yang, Wentao; Hu, Xin; Li, Daqiang; Cao, Zhigang; Zhou, Xiaoyan; Huang, Xiaoyan; Liu, Zhebin; Chen, Huan; Gu, Yanzi; Chi, Yayun; Yan, Xia; Han, Qixia; Shen, Zhenzhou; Shao, Zhimin; Hu, Zhen] Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Sun, Menghong; Chen, Huan; Gu, Yanzi] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Tissue Bank, Shanghai 200433, Peoples R China; [Yang, Wentao; Zhou, Xiaoyan] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai, Peoples R China; [Xu, Xiaojing; Zhao, Ying] Natl Engn Ctr Biochip Shanghai, Mol Biol Lab, Shanghai, Peoples R China; [Hu, Xin; Li, Daqiang; Chi, Yayun; Shao, Zhimin] Fudan Univ, Shanghai Canc Ctr, Key Lab Breast Canc Shanghai, Shanghai 200433, Peoples R China; [Zhou, Xiaoyan] Fudan Univ, Inst Pathol, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University; Fudan University	Hu, Z (corresponding author), Fudan Univ, Dept Breast Surg, Shanghai Canc Ctr, Shanghai 200433, Peoples R China.	hzhenhu@yahoo.com		Di, Genhong/0000-0003-1171-7907	Shanghai Committee of Science and Technology Funds [07ZR14025, 08QA14020]	Shanghai Committee of Science and Technology Funds(Shanghai Science & Technology Committee)	This work is supported by the Shanghai Committee of Science and Technology Funds (http://www.stcsm.gov.cn/) grant 07ZR14025 and 08QA14020. ZH received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Arai H, 2013, INT J CLIN EXP PATHO, V6, P395; Berg AO, 2009, GENET MED, V11, P35, DOI [10.1097/GIM.0b013e318181fa2ff, 10.1097/GIM.0b013e31818fa2ff]; Birch JM, 2001, ONCOGENE, V20, P4621, DOI 10.1038/sj.onc.1204621; Borg A, 2000, INT J CANCER, V85, P796; Cai Qi, 2003, Zhonghua Bing Li Xue Za Zhi, V32, P323; Cao AY, 2009, BREAST CANCER RES TR, V114, P457, DOI 10.1007/s10549-008-0036-z; Chompret A, 2001, J MED GENET, V38, P43, DOI 10.1136/jmg.38.1.43; Cunningham-Rundles C, 1999, CLIN IMMUNOL, V92, P34, DOI 10.1006/clim.1999.4725; D'Andrea AD, 2010, NEW ENGL J MED, V362, P1909, DOI 10.1056/NEJMra0809889; Debniak T, 2005, J MED GENET, V42, P763, DOI 10.1136/jmg.2005.031476; Domchek SM, 2010, JAMA-J AM MED ASSOC, V304, P967, DOI 10.1001/jama.2010.1237; Edelmann W, 2000, CANCER RES, V60, P803; Eng C, ANN REV MED, V2, p[52, 371]; FitzGerald MG, 1998, ONCOGENE, V17, P727, DOI 10.1038/sj.onc.1201984; Gonzalez KD, 2009, J CLIN ONCOL, V27, P1250, DOI 10.1200/JCO.2008.16.6959; Hampel H, 2008, J CLIN ONCOL, V26, P5783, DOI 10.1200/JCO.2008.17.5950; Haugen AC, 2008, CANCER RES, V68, P8465, DOI 10.1158/0008-5472.CAN-08-0002; Hopper JL, 2005, HUM MUTAT, V26, P298, DOI 10.1002/humu.20237; Hucl T, 2007, J GASTROENTEROL, V42, P599, DOI 10.1007/s00535-007-2065-5; Huelsenbeck JP, 1997, SCIENCE, V276, P227, DOI 10.1126/science.276.5310.227; Kwong A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043994; Lavie O, 2011, ANN ONCOL, V22, P964, DOI 10.1093/annonc/mdq460; Lee DSC, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3172; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Li SSL, 1999, HUM GENET, V104, P201, DOI 10.1007/s004390050936; Li WF, 2008, BREAST CANCER RES TR, V110, P99, DOI 10.1007/s10549-007-9708-3; Li XW, 2013, FAM CANCER, V12, P547, DOI 10.1007/s10689-013-9619-x; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McCuaig JM, 2012, FAM CANCER, V11, P607, DOI 10.1007/s10689-012-9557-z; Mouchawar J, 2010, CANCER RES, V70, P4795, DOI 10.1158/0008-5472.CAN-09-0851; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nielsen M, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.033217; Pan M, 2011, HUM MUTAT, V32, P1335, DOI 10.1002/humu.21588; Perez-Carbonell L, 2012, GUT, V61, P865, DOI 10.1136/gutjnl-2011-300041; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Pinol V, 2005, JAMA-J AM MED ASSOC, V293, P1986, DOI 10.1001/jama.293.16.1986; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Sahlin P, 2009, GENE CHROMOSOME CANC, V48, P285, DOI 10.1002/gcc.20637; Schrader KA, 2008, FAM CANCER, V7, P73, DOI 10.1007/s10689-007-9172-6; Sivakumaran S, 2011, AM J HUM GENET, V89, P607, DOI 10.1016/j.ajhg.2011.10.004; Stratton MR, 2008, NAT GENET, V40, P17, DOI 10.1038/ng.2007.53; Tao H, 2004, CARCINOGENESIS, V25, P1859, DOI 10.1093/carcin/bgh206; Thompson ER, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002894; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Vasen HFA, 2001, AM J HUM GENET, V68, P1533, DOI 10.1086/320610; Walsh T, 2007, CANCER CELL, V11, P103, DOI 10.1016/j.ccr.2007.01.010; Walsh T, 2010, P NATL ACAD SCI USA, V107, P12629, DOI 10.1073/pnas.1007983107; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang ZW, 2009, BREAST CANCER RES TR, V118, P169, DOI 10.1007/s10549-009-0327-z; Wiechec E, 2011, CANCER EPIDEM BIOMAR, V20, P397, DOI 10.1158/1055-9965.EPI-10-0514; Witt H, 2000, NAT GENET, V25, P213, DOI 10.1038/76088; Wu Y, 2001, NAT GENET, V29, P137, DOI 10.1038/ng1001-137; Zhang J, 2012, BREAST CANCER RES TR, V132, P421, DOI 10.1007/s10549-011-1596-x; Zhu ZG, 2004, EJSO-EUR J SURG ONC, V30, P531, DOI 10.1016/j.ejso.2004.03.004	57	34	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125571	10.1371/journal.pone.0125571	http://dx.doi.org/10.1371/journal.pone.0125571			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927356	gold, Green Published, Green Submitted			2022-12-27	WOS:000353713100102
J	Vandermeulen, J; Bahr, C; Tullo, E; Fontana, I; Ott, S; Kashiha, M; Guarino, M; Moons, CPH; Tuyttens, FAM; Niewold, TA; Berckmans, D				Vandermeulen, J.; Bahr, C.; Tullo, E.; Fontana, I.; Ott, S.; Kashiha, M.; Guarino, M.; Moons, C. P. H.; Tuyttens, F. A. M.; Niewold, T. A.; Berckmans, D.			Discerning Pig Screams in Production Environments	PLOS ONE			English	Article							DOMESTIC PIGLETS; SUS-SCROFA; VOCALIZATION; STRESS; COUGH; SOUND; RESPONSES; PAIN; TOOL	Pig vocalisations convey information about their current state of health and welfare. Continuously monitoring these vocalisations can provide useful information for the farmer. For instance, pig screams can indicate stressful situations. When monitoring screams, other sounds can interfere with scream detection. Therefore, identifying screams from other sounds is essential. The objective of this study was to understand which sound features define a scream. Therefore, a method to detect screams based on sound features with physical meaning and explicit rules was developed. To achieve this, 7 hours of labelled data from 24 pigs was used. The developed detection method attained 72% sensitivity, 91% specificity and 83% precision. As a result, the detection method showed that screams contain the following features discerning them from other sounds: a formant structure, adequate power, high frequency content, sufficient variability and duration.	[Vandermeulen, J.; Bahr, C.; Kashiha, M.; Berckmans, D.] Katholieke Univ Leuven, BIORES Measure Model & Manage Bioresponses M3, Leuven, Belgium; [Tullo, E.; Fontana, I.; Guarino, M.] Univ Milan, Dept Hlth Anim Sci & Food Safety, Milan, Italy; [Ott, S.; Niewold, T. A.] Katholieke Univ Leuven, Livestock Nutr Qual, Leuven, Belgium; [Ott, S.; Moons, C. P. H.; Tuyttens, F. A. M.] Univ Ghent, Ethol Lab, Dept Anim Nutr Genet & Ethol, Merelbeke, Belgium; [Tuyttens, F. A. M.] Inst Agr & Fisheries Res ILVO, Anim Sci Unit, Melle, Belgium	KU Leuven; University of Milan; KU Leuven; Ghent University; Institute For Agricultural & Fisheries Research	Berckmans, D (corresponding author), Katholieke Univ Leuven, BIORES Measure Model & Manage Bioresponses M3, Leuven, Belgium.	Daniel.Berckmans@biw.kuleuven.be	Moons, Christel/AAP-7977-2020; Tuyttens, Frank/HCH-1899-2022; Guarino, Marcella/K-8328-2017	Guarino, Marcella/0000-0003-4131-0016; Niewold, Theo/0000-0001-8838-750X; Tuyttens, Frank/0000-0002-1348-218X; Tullo, Emanuela/0000-0003-3645-3282; Fontana, Ilaria/0000-0003-3145-8252; Berckmans, Daniel/0000-0002-2974-6055	Agentschap voor Innovatie door Wetenschap en Technologie [080530/LBO]	Agentschap voor Innovatie door Wetenschap en Technologie	This research was part of a project funded by Agentschap voor Innovatie door Wetenschap en Technologie (project number: 080530/LBO). http://www.iwt.be/. The projects promotors received the funding (Berckmans, D., Bahr, C., Moons, C. P. H. and odberg F.(last person was replaced because of retirement by Tuyttens F. A. M.). These promotors paid the following PhD students: Vandermeulen, J, Ott, S and Kashiha, M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts JM, 2005, T ASAE, V48, P351, DOI 10.13031/2013.17948; Barry Samantha J, 2006, Cough, V2, P8, DOI 10.1186/1745-9974-2-8; Bogert B.P., 1963, TIME SER ANAL, P209; Bozkurt B, 2007, SPEECH COMMUN, V49, P159, DOI 10.1016/j.specom.2006.12.004; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Breiman L, 1993, CLASSIFICATION REGRE; Ceriani L, 2012, J ECON INEQUAL, V10, P421, DOI 10.1007/s10888-011-9188-x; Chan WY, 2011, ANIM BEHAV, V82, P767, DOI 10.1016/j.anbehav.2011.07.007; da Silva Cordeiro Alexandra Ferreira, 2013, Animals (Basel), V3, P923, DOI 10.3390/ani3030923; Dupjan S, 2008, APPL ANIM BEHAV SCI, V114, P105, DOI 10.1016/j.applanim.2007.12.005; Fant G, 1971, 2 ACOUSTIC THEORY SP; Ferrari S, 2013, LIVEST SCI, V151, P29, DOI 10.1016/j.livsci.2012.10.013; Ferrari S, 2008, COMPUT ELECTRON AGR, V64, P318, DOI 10.1016/j.compag.2008.07.003; Grauvogl A, 1957, VARIATIONS VERHALTEN; Green DM, 1966, SIGNAL DETECTION THE; Hillmann E, 2004, APPL ANIM BEHAV SCI, V89, P195, DOI 10.1016/j.applanim.2004.06.008; Hirtum A Van, 1999, J ACOUST SOC AM, V106, P2191, DOI DOI 10.1121/1.427428; Illmann G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083529; Kasanen S, 2002, APPL ANIM BEHAV SCI, V75, P93, DOI 10.1016/S0168-1591(01)00186-1; KILEY M, 1972, Zeitschrift fuer Tierpsychologie, V31, P171; MacLean SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082384; Manteuffel G, 2004, APPL ANIM BEHAV SCI, V88, P163, DOI 10.1016/j.applanim.2004.02.012; Marchant BP, 2003, BIOSYST ENG, V85, P261, DOI 10.1016/S1537-5110(03)00063-1; Marx G, 2003, J SOUND VIB, V266, P687, DOI 10.1016/S0022-460X(03)00594-7; Oppenheim AV, 1989, DISCRETE TIME SIGNAL, P447; Paliwal KK, 2010, PREFERENCE 20 40 MS, V2010, P1; Puppe B, 2005, APPL ANIM BEHAV SCI, V95, P67, DOI 10.1016/j.applanim.2005.05.001; Schon PC, 2004, ANIM WELFARE, V13, P105; Schon PC, 2001, J ACOUST SOC AM, V110, P1425, DOI 10.1121/1.1388003; Schon Peter-Christian, 1998, Bioacoustics, V9, P119; Schrader L, 1998, ETHOLOGY, V104, P859, DOI 10.1111/j.1439-0310.1998.tb00036.x; Silva M, 2008, COMPUT ELECTRON AGR, V64, P286, DOI 10.1016/j.compag.2008.05.024; Stevens SS, 1937, J ACOUST SOC AM, V8, P185, DOI 10.1121/1.1915893; Tallet C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071841; Tullo E., 2013, P 6 EUR C PREC LIV F, P30; Van Hirtum A, 2003, J SOUND VIB, V266, P677, DOI 10.1016/S0022-460X(03)00593-5; Van Hirtum A, 2002, INT CONF ACOUST SPEE, P493; Van Hirtum A, 2002, MED ENG PHYS, V24, P535, DOI 10.1016/S1350-4533(02)00055-3; Weary DM, 1998, APPL ANIM BEHAV SCI, V56, P161, DOI 10.1016/S0168-1591(97)00092-0; WEARY DM, 1995, ANIM BEHAV, V50, P1047, DOI 10.1016/0003-3472(95)80105-7; WHITE RG, 1995, J ANIM SCI, V73, P381; Wyman MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023296	43	26	27	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123111	10.1371/journal.pone.0123111	http://dx.doi.org/10.1371/journal.pone.0123111			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923725	Green Published, gold			2022-12-27	WOS:000353711600031
J	Chiang, CI; Huang, YL; Huang, CY; Shiue, HS; Chen, WJ; Pu, YS; Lin, YC; Hsueh, YM				Chiang, Chien-I; Huang, Ya-Li; Huang, Chao-Yuan; Shiue, Horng-Sheng; Chen, Wei-Jen; Pu, Yeong-Shiau; Lin, Ying-Chin; Hsueh, Yu-Mei			XRCC1 Polymorphisms and Urinary 8-Hydroxydeoxyguanine Levels Are Associated with Urothelial Carcinoma	PLOS ONE			English	Article							BLADDER-CANCER RISK; BASE EXCISION-REPAIR; LOW ARSENIC EXPOSURE; ARG399GLN POLYMORPHISM; GENETIC POLYMORPHISMS; TOBACCO-SMOKE; DNA-ADDUCTS; METAANALYSIS; 8-HYDROXY-2'-DEOXYGUANOSINE; SUSCEPTIBILITY	The aim of this study was to examine the associations between the combined effects of urinary 8-Hydroxydeoxyguanine (8-OHdG) level and polymorphisms of XRCC1 Arg194Trp and XRCC1 Arg399Gln on the risk of urothelial carcinoma (UC). We conducted a hospital-based case-control study that included 168 cases of UC and 336 age-and gender-matched healthy controls. We used polymerase chain reaction and restriction fragment length polymorphism analyses to examine the genotypes of XRCC1 Arg194Trp and XRCC1 Arg399Gln. We used a competitive in vitro enzyme-linked immunosorbent assay to determine urinary 8-OHdG levels. The XRCC1 399 Gln/Gln genotype and the XRCC1194 Arg/Arg genotype were positively correlated to UC (OR[95%CI] = 2.27 [1.20-4.27] and 1.59 [1.06-2.36], respectively). Urinary 8-OHdG levels were associated with UC in a dose-dependent manner. Participants with the XRCC1 (Arg399Gln) Gln/Gln genotype or the G-C/A-C haplotype of XRCC1 and a high urinary 8-OHdG level had a significantly higher risk of UC than those with the Arg/Arg + Arg/Gln genotype or the G-T haplotype and a low urinary 8-OHdG level. This is the first study to investigate the combined effect of urinary 8-OHdG level and XRCC1 polymorphisms on UC risk. The findings are especially meaningful for participants with XRCC1 399Gln or XRCC1 Arg194 genotypes and a high urinary 8-OHdG level, since these variables are associated with an increased risk of UC.	[Chiang, Chien-I; Chen, Wei-Jen; Hsueh, Yu-Mei] Taipei Med Univ, Sch Publ Hlth, Coll Publ Hlth & Nutr, Taipei, Taiwan; [Huang, Ya-Li; Hsueh, Yu-Mei] Taipei Med Univ, Sch Med, Dept Publ Hlth, Coll Med, Taipei, Taiwan; [Huang, Chao-Yuan; Pu, Yeong-Shiau] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan; [Shiue, Horng-Sheng] Chang Gung Mem Hosp, Dept Chinese Med, Taoyuan, Taiwan; [Shiue, Horng-Sheng] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; Taipei Med Univ, Shung Ho Hosp, Dept Family Med, Taipei, Taiwan; [Lin, Ying-Chin] Taipei Med Univ, Wan Fang Hosp, Dept Hlth Examinat, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; National Taiwan University; National Taiwan University Hospital; Chang Gung Memorial Hospital; Chang Gung University; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital	Hsueh, YM (corresponding author), Taipei Med Univ, Sch Med, Dept Publ Hlth, Coll Med, Taipei, Taiwan.	ymhsueh@tmu.edu.tw	Chen, Wei-Jen/AAF-1739-2019	Chen, Wei-Jen/0000-0003-0683-7904; PU, YEONG-SHIAU/0000-0002-2859-3966; HUANG, CHAO-YUAN/0000-0002-9322-6062	National Science Council of ROC [NSC 862314-B-038-038, NSC 87-2314-B-038-029, NSC-882314-B-038-112, NSC-89-2314-B038-049, SC-892320-B038-013]; NSC [100-2314-B-038-026];  [NSC-90-2320-B-038-021];  [NSC-913112-B-038-0019];  [NSC-92-3112-B-038-001];  [NSC-93-3112-B-038-001];  [NSC-94-2314-B-038-023];  [NSC-95-2314-B-038-007];  [NSC-96-2314-B038-003];  [NSC-97-2314-B-038-015-MY3 (1-3)];  [NSC-97-2314-B-038-015-MY3 (2-3)];  [NSC-97-2314-B-038-015-MY3 (3-3))]	National Science Council of ROC(Ministry of Science and Technology, Taiwan); NSC(Ministry of Science and Technology, Taiwan); ; ; ; ; ; ; ; ; ; 	This study was supported by grants from the National Science Council of the ROC (NSC 862314-B-038-038, NSC 87-2314-B-038-029, NSC-882314-B-038-112, NSC-89-2314-B038-049, SC-892320-B038-013, NSC-90-2320-B-038-021, NSC-913112-B-038-0019, NSC-92-3112-B-038-001, NSC-93-3112-B-038-001, NSC-94-2314-B-038-023, NSC-95-2314-B-038-007, NSC-96-2314-B038-003, NSC-97-2314-B-038-015-MY3 (1-3), NSC-97-2314-B-038-015-MY3 (2-3), NSC-97-2314-B-038-015-MY3 (3-3)), and NSC 100-2314-B-038-026. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcay T, 2003, UROL INT, V71, P271, DOI 10.1159/000072677; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Benhamou S, 2003, MUTAGENESIS, V18, P445, DOI 10.1093/mutage/geg020; Bjerregaard BK, 2006, INT J CANCER, V119, P2412, DOI 10.1002/ijc.22169; Bureau of Health Promotion, 2012, CANC REG ANN REP; Cappelli E, 1997, J BIOL CHEM, V272, P23970, DOI 10.1074/jbc.272.38.23970; Chiang CI, 2014, TOXICOL APPL PHARM; Chiang HC, 2012, SCI TOTAL ENVIRON, V414, P134, DOI 10.1016/j.scitotenv.2011.11.039; Chiou CC, 2003, CLIN CHIM ACTA, V334, P87, DOI 10.1016/S0009-8981(03)00191-8; Chung CJ, 2008, TOXICOL APPL PHARM, V226, P14, DOI 10.1016/j.taap.2007.08.021; Chung CJ, 2011, SCI TOTAL ENVIRON, V409, P1638, DOI 10.1016/j.scitotenv.2011.01.046; Colin P, 2009, BJU INT, V104, P1436, DOI 10.1111/j.1464-410X.2009.08838.x; Fang ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064001; FIELDING S, 1989, MUTAT RES, V214, P147, DOI 10.1016/0027-5107(89)90208-X; Freedman ND, 2011, JAMA-J AM MED ASSOC, V306, P737, DOI 10.1001/jama.2011.1142; Frosina G, 2004, FREE RADICAL RES, V38, P1037, DOI 10.1080/10715760400011445; Ghorbanihaghjo A, 2013, J HEALTH POPUL NUTR, V31, P343; Giberti C, 2010, BIOMED ENVIRON SCI, V23, P300, DOI 10.1016/S0895-3988(10)60067-0; Hecht SS, 2003, NAT REV CANCER, V3, P733, DOI 10.1038/nrc1190; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; Hu JJ, 2001, CARCINOGENESIS, V22, P917, DOI 10.1093/carcin/22.6.917; Hung RJ, 2005, AM J EPIDEMIOL, V162, P925, DOI 10.1093/aje/kwi318; Johansson SL, 1997, SEMIN SURG ONCOL, V13, P291; KASAI H, 1986, CARCINOGENESIS, V7, P1849, DOI 10.1093/carcin/7.11.1849; Lao T, 2008, MUTAGENESIS, V23, P523, DOI 10.1093/mutage/gen046; Lei YC, 2002, MUTAT RES-GEN TOX EN, V519, P93, DOI 10.1016/S1383-5718(02)00127-4; Li SH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0083037, 10.1371/journal.pone.0067928, 10.1371/journal.pone.0057604]; Liu C, 2013, CRIT REV EUKAR GENE, V23, P339; Loft S, 2006, CARCINOGENESIS, V27, P1245, DOI 10.1093/carcin/bgi313; Lowe FJ, 2009, CLIN CHEM LAB MED, V47, P311, DOI 10.1515/CCLM.2009.069; Lunn RM, 1999, CANCER RES, V59, P2557; Mao YQ, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-58; Marintchev A, 1999, NAT STRUCT BIOL, V6, P884; Matullo G, 2001, CARCINOGENESIS, V22, P1437, DOI 10.1093/carcin/22.9.1437; Nia AB, 2001, CARCINOGENESIS, V22, P395, DOI 10.1093/carcin/22.3.395; PHILLIPS DH, 1993, ENVIRON HEALTH PERSP, V99, P45, DOI 10.2307/3431456; Pu YS, 2007, TOXICOL APPL PHARM, V218, P99, DOI 10.1016/j.taap.2006.09.021; Pylvas M, 2011, ANTICANCER RES, V31, P1411; Rodriguez M, 2003, J BIOL CHEM, V278, P52914, DOI 10.1074/jbc.C300407200; Saito S, 2000, RES COMMUN MOL PATH, V107, P39; Soini Y, 2011, INT J CLIN EXP PATHO, V4, P267; Wada T, 2006, ANTICANCER RES, V26, P3403; Wang CY, 2008, UROLOGY, V72, P869, DOI 10.1016/j.urology.2007.12.059; Wang YF, 2003, DNA REPAIR, V2, P901, DOI 10.1016/S1568-7864(03)00085-5; Welty C.J., 2014, UROL ONCOL, V32, P25, DOI DOI 10.1016/J.UR0L0NC.2012.09.001; Weng HC, 2009, MUTAT RES-GEN TOX EN, V679, P59, DOI 10.1016/j.mrgentox.2009.07.005; Yang DF, 2014, GENE, V534, P17, DOI 10.1016/j.gene.2013.10.038; Yuen JWM, 2008, NUTR CANCER, V60, P109, DOI 10.1080/01635580701525869; Zhang F, 2013, TUMOR BIOL, V34, P2659, DOI 10.1007/s13277-013-0816-x; Zhuo WL, 2013, EXP BIOL MED, V238, P66, DOI 10.1258/ebm.2012.012209	50	2	2	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0124066	10.1371/journal.pone.0124066	http://dx.doi.org/10.1371/journal.pone.0124066			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938407	Green Published, gold, Green Submitted			2022-12-27	WOS:000353943000014
J	Da Costa, S; Bourquin, NMP; Knebel, JF; Saenz, M; Van der Zwaag, W; Clarke, S				Da Costa, Sandra; Bourquin, Nathalie M. -P.; Knebel, Jean-Francois; Saenz, Melissa; Van der Zwaag, Wietske; Clarke, Stephanie			Representation of Sound Objects within Early-Stage Auditory Areas: A Repetition Effect Study Using 7T fMRI	PLOS ONE			English	Article							ENVIRONMENTAL SOUNDS; TONOTOPIC ORGANIZATION; HUMAN BRAIN; NATURAL SOUNDS; ANIMAL VOCALIZATIONS; CYTOCHROME-OXIDASE; TEMPORAL DYNAMICS; CORTICAL NETWORKS; PLANUM TEMPORALE; COMPLEX SOUNDS	Environmental sounds are highly complex stimuli whose recognition depends on the interaction of top-down and bottom-up processes in the brain. Their semantic representations were shown to yield repetition suppression effects, i. e. a decrease in activity during exposure to a sound that is perceived as belonging to the same source as a preceding sound. Making use of the high spatial resolution of 7T fMRI we have investigated the representations of sound objects within early-stage auditory areas on the supratemporal plane. The primary auditory cortex was identified by means of tonotopic mapping and the non-primary areas by comparison with previous histological studies. Repeated presentations of different exemplars of the same sound source, as compared to the presentation of different sound sources, yielded significant repetition suppression effects within a subset of early-stage areas. This effect was found within the right hemisphere in primary areas A1 and R as well as two non-primary areas on the antero-medial part of the planum temporale, and within the left hemisphere in A1 and a non-primary area on the medial part of Heschl's gyrus. Thus, several, but not all early-stage auditory areas encode the meaning of environmental sounds.	[Da Costa, Sandra; Bourquin, Nathalie M. -P.; Clarke, Stephanie] Univ Lausanne, CHU Vaudois, Dept Neurosci Clin, Serv Neuropsychol & Neurorehabil, Lausanne, Switzerland; [Knebel, Jean-Francois] Univ Lausanne, CHU Vaudois, Natl Ctr Competence Res,SYNAPSY Synapt Bases Ment, Serv Neuropsychol & Neurorehabil,Dept Neurosci Cl, Lausanne, Switzerland; [Saenz, Melissa] Univ Lausanne, CHU Vaudois, Dept Neurosci Clin, Lab Rech Neuroimagerie, Lausanne, Switzerland; [Van der Zwaag, Wietske] Ecole Polytech Fed Lausanne, Ctr Imagerie Biomed, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Da Costa, S (corresponding author), Univ Lausanne, CHU Vaudois, Dept Neurosci Clin, Serv Neuropsychol & Neurorehabil, Lausanne, Switzerland.	Sandra.Borges-Da-Costa@chuv.ch	van der Zwaag, Wietske/AAU-6268-2020; Clarke, Stephanie/A-2845-2009; van der Zwaag, Wietske/I-4568-2015; Da Costa Monney, Sandra/AAB-5050-2022	van der Zwaag, Wietske/0000-0003-3223-9721; Clarke, Stephanie/0000-0001-9393-5718; Knebel, Jean-Francois/0000-0003-1665-1724; Da Costa, Sandra/0000-0003-1376-9233	Swiss National Science Foundation Grant [320030B-141177]; Foundation Biaggi de Blasys grant	Swiss National Science Foundation Grant(Swiss National Science Foundation (SNSF)); Foundation Biaggi de Blasys grant	Swiss National Science Foundation Grant 320030B-141177 and the Foundation Biaggi de Blasys grant to SC http://www.snf.ch/fr/encouragement/carrieres/professeurs-boursiers-fns/Pages/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriani M, 2003, EXP BRAIN RES, V153, P591, DOI 10.1007/s00221-003-1616-0; Ahveninen J, 2006, P NATL ACAD SCI USA, V103, P14608, DOI 10.1073/pnas.0510480103; Altmann CF, 2008, CEREB CORTEX, V18, P1350, DOI 10.1093/cercor/bhm166; Altmann CF, 2007, CEREB CORTEX, V17, P2601, DOI 10.1093/cercor/bhl167; Altmann CF, 2007, NEUROIMAGE, V35, P1192, DOI 10.1016/j.neuroimage.2007.01.007; Altmann CF, 2010, NEUROPSYCHOLOGIA, V48, P2824, DOI 10.1016/j.neuropsychologia.2010.05.024; Andics A, 2013, NEUROIMAGE, V69, P277, DOI 10.1016/j.neuroimage.2012.12.033; Andics A, 2010, NEUROIMAGE, V52, P1528, DOI 10.1016/j.neuroimage.2010.05.048; Barrett DJK, 2006, NEUROIMAGE, V32, P968, DOI 10.1016/j.neuroimage.2006.03.050; Baumann S, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00011; Baumann S, 2010, NEUROIMAGE, V50, P1099, DOI 10.1016/j.neuroimage.2009.12.103; Belin P, 2003, NEUROREPORT, V14, P2105, DOI 10.1097/00001756-200311140-00019; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Bergerbest D, 2004, J COGNITIVE NEUROSCI, V16, P966, DOI 10.1162/0898929041502760; Bidet-Caulet A, 2005, NEUROIMAGE, V28, P132, DOI 10.1016/j.neuroimage.2005.06.018; Bourquin NMP, 2013, NEUROIMAGE, V73, P40, DOI 10.1016/j.neuroimage.2013.01.026; Bourquin NMP, 2012, NEUROIMAGE, V62, P1800, DOI 10.1016/j.neuroimage.2012.04.055; BRUGGE JF, 1973, J NEUROPHYSIOL, V36, P1138, DOI 10.1152/jn.1973.36.6.1138; Cammoun L, 2015, BRAIN STRUCT FUNCT, V220, P3537, DOI 10.1007/s00429-014-0872-z; Chandrasekaran B, 2011, J COGNITIVE NEUROSCI, V23, P2690, DOI 10.1162/jocn.2011.21631; Chevillet M, 2011, J NEUROSCI, V31, P9345, DOI 10.1523/JNEUROSCI.1448-11.2011; Clarke S, 1998, EUR J NEUROSCI, V10, P741, DOI 10.1046/j.1460-9568.1998.00043.x; Clarke S, 2002, EXP BRAIN RES, V147, P8, DOI 10.1007/s00221-002-1203-9; Clarke S, 1996, NEUROPSYCHOLOGIA, V34, P587, DOI 10.1016/0028-3932(95)00142-5; Da Costa S, 2015, BRAIN TOPOGR, V28, P66, DOI 10.1007/s10548-014-0388-0; Da Costa S, 2013, J NEUROSCI, V33, P1858, DOI 10.1523/JNEUROSCI.4405-12.2013; Da Costa S, 2011, J NEUROSCI, V31, P14067, DOI 10.1523/JNEUROSCI.2000-11.2011; De Lucia M, 2012, NEUROIMAGE, V60, P1704, DOI 10.1016/j.neuroimage.2012.01.131; De Lucia M, 2010, CEREB CORTEX, V20, P1676, DOI 10.1093/cercor/bhp230; De Martino F, 2015, CEREB CORTEX, V25, P3394, DOI 10.1093/cercor/bhu150; De Martino F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060514; Dick F, 2012, J NEUROSCI, V32, P16095, DOI 10.1523/JNEUROSCI.1712-12.2012; Doehrmann O, 2008, NEUROPSYCHOLOGIA, V46, P2776, DOI 10.1016/j.neuropsychologia.2008.05.011; Engel LR, 2009, NEUROIMAGE, V47, P1778, DOI 10.1016/j.neuroimage.2009.05.041; Engel SA, 2012, NEUROIMAGE, V62, P1195, DOI 10.1016/j.neuroimage.2011.09.059; Formisano E, 2003, NEURON, V40, P859, DOI 10.1016/S0896-6273(03)00669-X; GALABURDA A, 1980, J COMP NEUROL, V190, P597, DOI 10.1002/cne.901900312; Giordano BL, 2013, CEREB CORTEX, V23, P2025, DOI 10.1093/cercor/bhs162; Giraud AL, 2000, J NEUROPHYSIOL, V84, P1588, DOI 10.1152/jn.2000.84.3.1588; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Gotts SJ, 2012, COGN NEUROSCI-UK, V3, P227, DOI 10.1080/17588928.2012.670617; Griffiths TD, 2004, NAT REV NEUROSCI, V5, P887, DOI 10.1038/nrn1538; Griffiths TD, 2002, TRENDS NEUROSCI, V25, P348, DOI 10.1016/S0166-2236(02)02191-4; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Grill-Spector K, 2006, NEURON, V49, P170, DOI 10.1016/j.neuron.2006.01.004; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Hackett TA, 2001, J COMP NEUROL, V441, P197, DOI 10.1002/cne.1407; Hackett TA, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00072; Hackett TA, 2011, J NEUROSCI, V31, P2983, DOI 10.1523/JNEUROSCI.5333-10.2011; Hall DA, 2005, J NEUROPHYSIOL, V94, P3181, DOI 10.1152/jn.00271.2005; Hart HC, 2004, HUM BRAIN MAPP, V21, P178, DOI 10.1002/hbm.10156; Henson RN, 2014, TRENDS COGN SCI, V18, P376, DOI 10.1016/j.tics.2014.03.004; Humphries C, 2010, NEUROIMAGE, V50, P1202, DOI 10.1016/j.neuroimage.2010.01.046; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; Knebel JF, 2008, BRAIN TOPOGR, V20, P284, DOI 10.1007/s10548-008-0046-5; Langers DRM, 2012, CEREB CORTEX, V22, P2024, DOI 10.1093/cercor/bhr282; Larsson J, 2012, CEREB CORTEX, V22, P567, DOI 10.1093/cercor/bhr119; Latinus M, 2012, BRAIN TOPOGR, V25, P194, DOI 10.1007/s10548-011-0207-9; Leaver AM, 2010, J NEUROSCI, V30, P7604, DOI 10.1523/JNEUROSCI.0296-10.2010; Lewis JW, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00027; Lewis JW, 2009, J NEUROSCI, V29, P2283, DOI 10.1523/JNEUROSCI.4145-08.2009; Lewis JW, 2005, J NEUROSCI, V25, P5148, DOI 10.1523/JNEUROSCI.0419-05.2005; Lewis JW, 2004, CEREB CORTEX, V14, P1008, DOI 10.1093/cercor/bhh061; Maeder PP, 2001, NEUROIMAGE, V14, P802, DOI 10.1006/nimg.2001.0888; Marie D, 2015, BRAIN STRUCT FUNCT, V220, P729, DOI 10.1007/s00429-013-0680-x; Marques JP, 2010, NEUROIMAGE, V49, P1271, DOI 10.1016/j.neuroimage.2009.10.002; Moerel M, 2012, J NEUROSCI, V32, P14205, DOI 10.1523/JNEUROSCI.1388-12.2012; MOREL A, 1993, J COMP NEUROL, V335, P437, DOI 10.1002/cne.903350312; MOREL A, 1992, J COMP NEUROL, V318, P27, DOI 10.1002/cne.903180104; Morosan P, 2001, NEUROIMAGE, V13, P684, DOI 10.1006/nimg.2000.0715; Murray MM, 2008, NEUROIMAGE, V39, P847, DOI 10.1016/j.neuroimage.2007.09.002; Murray MM, 2006, J NEUROSCI, V26, P1293, DOI 10.1523/JNEUROSCI.4511-05.2006; Petkov CI, 2006, PLOS BIOL, V4, P1213, DOI 10.1371/journal.pbio.0040215; Rademacher J, 2001, NEUROIMAGE, V13, P669, DOI 10.1006/nimg.2000.0714; Rauschecker JP, 1997, J COMP NEUROL, V382, P89; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Renvall H, 2012, NEUROIMAGE, V62, P1877, DOI 10.1016/j.neuroimage.2012.06.010; Rivier F, 1997, NEUROIMAGE, V6, P288, DOI 10.1006/nimg.1997.0304; Salomon R, 2014, BRAIN TOPOGR, V27, P209, DOI 10.1007/s10548-013-0298-6; Schadwinkel S, 2010, EUR J NEUROSCI, V32, P1970, DOI 10.1111/j.1460-9568.2010.07459.x; Schadwinkel S, 2010, CEREB CORTEX, V20, P2863, DOI 10.1093/cercor/bhq037; Sharda M, 2012, NEUROSCIENCE, V214, P49, DOI 10.1016/j.neuroscience.2012.03.053; Smith KR, 2010, J COGNITIVE NEUROSCI, V22, P632, DOI 10.1162/jocn.2009.21196; Specht K, 2003, NEUROIMAGE, V20, P1944, DOI 10.1016/j.neuroimage.2003.07.034; Staeren N, 2009, CURR BIOL, V19, P498, DOI 10.1016/j.cub.2009.01.066; Striem-Amit E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017832; Talavage TM, 2004, J NEUROPHYSIOL, V91, P1282, DOI 10.1152/jn.01125.2002; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; van der Zwaag W, 2011, NEUROIMAGE, V54, P1803, DOI 10.1016/j.neuroimage.2010.10.032; van der Zwaag W, 2009, J MAGN RESON IMAGING, V30, P1171, DOI 10.1002/jmri.21951; van der Zwaag W, 2009, NEUROIMAGE, V47, P1425, DOI 10.1016/j.neuroimage.2009.05.015; Viceic D, 2006, NEUROREPORT, V17, P1659, DOI 10.1097/01.wnr.0000239962.75943.dd; Wallace MN, 2002, EXP BRAIN RES, V143, P499, DOI 10.1007/s00221-002-1014-z; Warren JD, 2003, J NEUROSCI, V23, P5799; Warren JD, 2002, NEURON, V34, P139, DOI 10.1016/S0896-6273(02)00637-2; Woods DL, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00042; Woods DL, 2009, CURR OPIN OTOLARYNGO, V17, P407, DOI 10.1097/MOO.0b013e3283303330; Yacoub E, 2007, NEUROIMAGE, V37, P1161, DOI 10.1016/j.neuroimage.2007.05.020; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946; Zundorf IC, 2014, BRAIN, V137, P1410, DOI 10.1093/brain/awu044	101	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0124072	10.1371/journal.pone.0124072	http://dx.doi.org/10.1371/journal.pone.0124072			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938430	Green Submitted, Green Published, gold			2022-12-27	WOS:000353943000015
J	Gilbert, JA; Long, EF; Brooks, RP; Friedland, GH; Moll, AP; Townsend, JP; Galvani, AP; Shenoi, SV				Gilbert, Jennifer A.; Long, Elisa F.; Brooks, Ralph P.; Friedland, Gerald H.; Moll, Anthony P.; Townsend, Jeffrey P.; Galvani, Alison P.; Shenoi, Sheela V.			Integrating Community-Based Interventions to Reverse the Convergent TB/HIV Epidemics in Rural South Africa	PLOS ONE			English	Article							ISONIAZID PREVENTIVE THERAPY; DRUG-RESISTANT TUBERCULOSIS; ANTIRETROVIRAL THERAPY; MYCOBACTERIUM-TUBERCULOSIS; MDR-TB; HIV; SETTINGS; IMPACT; MODEL; TRANSMISSION	The WHO recommends integrating interventions to address the devastating TB/HIV co-epidemics in South Africa, yet integration has been poorly implemented and TB/HIV control efforts need strengthening. Identifying infected individuals is particularly difficult in rural settings. We used mathematical modeling to predict the impact of community-based, integrated TB/HIV case finding and additional control strategies on South Africa's TB/HIV epidemics. We developed a model incorporating TB and HIV transmission to evaluate the effectiveness of integrating TB and HIV interventions in rural South Africa over 10 years. We modeled the impact of a novel screening program that integrates case finding for TB and HIV in the community, comparing it to status quo and recommended TB/HIV control strategies, including GeneXpert, MDR-TB treatment decentralization, improved first-line TB treatment cure rate, isoniazid preventive therapy, and expanded ART. Combining recommended interventions averted 27% of expected TB cases (95% CI 18-40%) 18% HIV (95% CI 13-24%), 60% MDR-TB (95% CI 34-83%), 69% XDR-TB (95% CI 34-90%), and 16% TB/HIV deaths (95% CI 12-29). Supplementing these interventions with annual community-based TB/HIV case finding averted a further 17% of TB cases (44% total; 95% CI 31-56%), 5% HIV (23% total; 95% CI 17-29%), 8% MDR-TB (68% total; 95% CI 40-88%), 4% XDR-TB (73% total; 95% CI 38-91%), and 8% TB/HIV deaths (24% total; 95% CI 16-39%). In addition to increasing screening frequency, we found that improving TB symptom questionnaire sensitivity, second-line TB treatment delays, default before initiating TB treatment or ART, and second-line TB drug efficacy were significantly associated with even greater reductions in TB and HIV cases. TB/HIV epidemics in South Africa were most effectively curtailed by simultaneously implementing interventions that integrated community-based TB/HIV control strategies and targeted drug-resistant TB. Strengthening existing TB and HIV treatment programs is needed to further reduce disease incidence.	[Gilbert, Jennifer A.; Friedland, Gerald H.; Galvani, Alison P.] Yale Univ, Dept Epidemiol Microbial Dis, Sch Publ Hlth, New Haven, CT 06520 USA; [Gilbert, Jennifer A.; Galvani, Alison P.] Yale Univ, Ctr Infect Dis Modeling & Anal, Sch Publ Hlth, New Haven, CT USA; [Long, Elisa F.] Univ Calif Los Angeles, Anderson Sch Management, Los Angeles, CA USA; [Brooks, Ralph P.; Friedland, Gerald H.; Moll, Anthony P.; Shenoi, Sheela V.] Yale Univ, Sch Med, Dept Med, Sect Infect Dis,AIDS Program, New Haven, CT 06510 USA; [Moll, Anthony P.] Church Scotland Hosp, Tugela Ferry, Kwazulu Natal, South Africa; [Townsend, Jeffrey P.] Yale Univ, Dept Biostat, New Haven, CT USA; [Townsend, Jeffrey P.; Galvani, Alison P.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA; [Townsend, Jeffrey P.; Galvani, Alison P.] Yale Univ, Program Computat Biol & Informat, New Haven, CT USA	Yale University; Yale University; University of California System; University of California Los Angeles; Yale University; Yale University; Yale University; Yale University	Gilbert, JA (corresponding author), Yale Univ, Dept Epidemiol Microbial Dis, Sch Publ Hlth, New Haven, CT 06520 USA.	jennifer.gilbert@yale.edu	Townsend, Jeffrey/H-2747-2019; Shenoi, Sheela/GRY-6103-2022; Shenoi, Sheela/Z-2641-2019; Long, Elisa/AFQ-5915-2022	Townsend, Jeffrey/0000-0002-9890-3907; Shenoi, Sheela/0000-0001-7654-4344; 	National Institute on Drug Abuse [R01DA015612, R01DA025932]; Gilead Foundation [157201]; President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control (CDC) and Prevention [1U01GH000524-01]; National Institutes of Health [2U01GM087719, 5U01GM105627]; National Institute of Allergy and Infectious Diseases [1K23AI089260]; National Institutes of Health's Fogarty International Clinical Research Program [R24TW007988]; FOGARTY INTERNATIONAL CENTER [R24TW007988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI089260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM087719, U01GM105627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025932, R37DA015612, R01DA015612] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Gilead Foundation(Gilead Sciences); President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control (CDC) and Prevention; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health's Fogarty International Clinical Research Program; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	JAG was supported by the National Institute on Drug Abuse (R01DA015612, http://www.drugabuse.gov). GHF was supported by the National Institute on Drug Abuse (R01DA025932, http://www.drugabuse.gov). GHF, RPB, and SVS were supported by the Gilead Foundation (157201, http://www.gilead.com). GHF, RPB, APM, APG, and SVS were supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control (CDC) and Prevention (1U01GH000524-01, http://www.cdc.gov). APG was supported by the National Institutes of Health (2U01GM087719 and 5U01GM105627, http://nih.gov). SVS was supported by the National Institute of Allergy and Infectious Diseases (1K23AI089260, http://www.niaid.nih.gov) and the National Institutes of Health's Fogarty International Clinical Research Program (R24TW007988, http://nih.gov). Staff from the CDC participated in preparation of the manuscript. The remaining funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Actuarial Society of South Africa, 2011, ASSA2008 MOD; Andrews JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015735; [Anonymous], 2014, NAT TUB MAN GUID; [Anonymous], 2013, S AFR ANT TREATM GUI; [Anonymous], 2011, MULT RES TUB POL FRA; [Anonymous], 2003, LAB MED, DOI DOI 10.1046/J.1439-0477.2003.03049.X; [Anonymous], 2011, GUID INT TUB CAS FIN; Ayles H, 2013, LANCET, V382, P1183, DOI 10.1016/S0140-6736(13)61131-9; Ayles H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005602; Bassett IV, 2010, AIDS, V24, pS37, DOI 10.1097/01.aids.0000366081.91192.1c; Basu S, 2007, LANCET, V370, P1500, DOI 10.1016/S0140-6736(07)61636-5; Basu S, 2009, P NATL ACAD SCI USA, V106, P7672, DOI 10.1073/pnas.0812472106; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Brust JCM, 2012, INT J TUBERC LUNG D, V16, P998, DOI 10.5588/ijtld.11.0713; Chehab JC, 2012, INT J TUBERC LUNG D, V16, P903, DOI 10.5588/ijtld.11.0722; Churchyard G, 2014, 21 C RETR OPP INF BO; Churchyard GJ, 2014, SAMJ S AFR MED J, V104, P244, DOI [10.7196/samj.7689, 10.7196/SAMJ.7689]; Cohen T, 2006, P NATL ACAD SCI USA, V103, P7042, DOI 10.1073/pnas.0600349103; Cohen T, 2004, NAT MED, V10, P1117, DOI 10.1038/nm1110; Cohen T, 2007, J R SOC INTERFACE, V4, P523, DOI 10.1098/rsif.2006.0193; Currie CSM, 2003, AIDS, V17, P2501, DOI 10.1097/00002030-200311210-00013; Dowdy DW, 2008, P NATL ACAD SCI USA, V105, P11293, DOI 10.1073/pnas.0800965105; Dowdy DW, 2006, AIDS, V20, P751, DOI 10.1097/01.aids.0000216376.07185.cc; Dye C, 2000, P NATL ACAD SCI USA, V97, P8180, DOI 10.1073/pnas.140102797; Dye C, 1998, LANCET, V352, P1886, DOI 10.1016/S0140-6736(98)03199-7; Dye C, 2012, MODELLING TUBERCULOS; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Friedland G, 2012, 43 UN WORLD C LUNG H; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hernandez-Garduno E, 2004, THORAX, V59, P286, DOI 10.1136/thx.2003.011759; Holtz TH, 2006, INT J TUBERC LUNG D, V10, P649; Houben RMGJ, 2014, INT J TUBERC LUNG D, V18, P509, DOI 10.5588/ijtld.13.0773; Houben RMGJ, 2014, P NATL ACAD SCI USA, V111, P5325, DOI 10.1073/pnas.1317660111; Johnson LF, 2012, S AFR J HIV MED, P22; Lawn SD, 2011, INT J TUBERC LUNG D, V15, P571, DOI 10.5588/ijtld.10.0483; Lawn SD, 2010, LANCET INFECT DIS, V10, P489, DOI 10.1016/S1473-3099(10)70078-5; Loveday M, 2012, INT J TUBERC LUNG D, V16, P209, DOI 10.5588/ijtld.11.0401; Manasa J, 2012, AIDS RES HUM RETROV, V28, P558, DOI [10.1089/aid.2011.0284, 10.1089/AID.2011.0284]; MARTIN DJ, 1995, J ACQ IMMUN DEF SYND, V8, P386; Menzies NA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001347; Mills HL, 2013, SCI TRANSL MED, V5; Modjarrad K, 2010, LANCET INFECT DIS, V10, P455, DOI 10.1016/S1473-3099(10)70093-1; Mukherjee JS, 2004, LANCET, V363, P474, DOI 10.1016/S0140-6736(04)15496-2; Murray CJL, 1998, P NATL ACAD SCI USA, V95, P13881, DOI 10.1073/pnas.95.23.13881; Murray CJL, 1998, INT J TUBERC LUNG D, V2, pS9; Padian NS, 2011, LANCET, V378, P269, DOI 10.1016/S0140-6736(11)60877-5; Republic of South Africa, 2011, NAT STRAT PLAN HIV S; Republic of South Africa, 2011, MAN DRUG RES TUB POL; Republic of South Africa Department of Health, 2014, NAT CONS GUID PREV M; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Shean KP, 2008, INT J TUBERC LUNG D, V12, P1182; Shenoi SV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031786; South Africa Department of Health, 2006, THE KZN OUTBR; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; Wallengren K, 2011, EMERG INFECT DIS, V17, P1913, DOI 10.3201/eid1710.100952; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2010, ANT THER HIV INF AD; WHO, 1998, LABORATORY SERVICES; WHO, 2015, TB DIAGN LAB SER INF; WHO, 2014, WHO TB BURD EST; WHO, 2008, EPI SEM 2008; WHO, 2011, TECHN OP PRACT CONS; World Health Organization, 2012, WHO POL COLL TB HIV; Yaesoubi R, 2013, P NATL ACAD SCI USA, V110, P9457, DOI 10.1073/pnas.1218770110	68	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0126267	10.1371/journal.pone.0126267	http://dx.doi.org/10.1371/journal.pone.0126267			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938501	Green Submitted, gold, Green Published			2022-12-27	WOS:000353943000157
J	Bortolin, RH; Abreu, BJDA; Ururahy, MAG; de Souza, KSC; Bezerra, JF; Loureiro, MB; da Silva, FS; Marques, DED; Batista, AAD; Oliveira, G; Luchessi, AD; Lima, VMGDM; Miranda, CES; Fook, MVL; Almeida, MD; de Rezende, LA; de Rezende, AA				Bortolin, Raul Hernandes; da Graca Azevedo Abreu, Bento Joao; Galvao Ururahy, Marcela Abbott; Costa de Souza, Karla Simone; Bezerra, Joao Felipe; Loureiro, Melina Bezerra; da Silva, Flavio Santos; da Silva Marques, Dafiny Emanuele; de Sousa Batista, Angelica Amanda; Oliveira, Gisele; Luchessi, Andre Ducati; Duarte Moreira Lima, Valeria Morgiana Gualberto; Saraiva Miranda, Carlos Eduardo; Lia Fook, Marcus Vinicius; Almeida, Maria das Gracas; de Rezende, Luciana Augusto; de Rezende, Adriana Augusto			Protection against T1DM-Induced Bone Loss by Zinc Supplementation: Biomechanical, Histomorphometric, and Molecular Analyses in STZ-Induced Diabetic Rats	PLOS ONE			English	Article							OSTEOBLASTIC MC3T3-E1 CELLS; GENE-EXPRESSION; MINERAL DENSITY; ALKALINE-PHOSPHATASE; MESSENGER-RNA; BIOCHEMICAL MARKERS; GELATINASE-B; STREPTOZOTOCIN; INSULIN; TYPE-1	Several studies have established an association between diabetes and alterations in bone metabolism; however, the underlying mechanism is not well established. Although zinc is recognized as a potential preventive agent against diabetes-induced bone loss, there is no evidence demonstrating its effect in chronic diabetic conditions. This study evaluated the effects of zinc supplementation in a chronic (90 days) type 1 diabetes-induced bone-loss model. Male Wistar rats were distributed in three groups: control, type 1 diabetes mellitus (T1DM), and T1DM plus zinc supplementation (T1DMS). Serum biochemical analysis; tibia histomorphometric, biomechanical, and collagen-content analyses; and femur mRNA expression were evaluated. Relative to T1DM, the zinc-supplemented group showed increased histomorphometric parameters such as TbWi and BAr and decreased TbSp, increased biomechanical parameters (maximum load, stiffness, ultimate strain, and Young's modulus), and increased type I collagen content. Interestingly, similar values for these parameters were observed between the T1DMS and control groups. These results demonstrate the protective effect of zinc on the maintenance of bone strength and flexibility. In addition, downregulation of OPG, COL1A, and MMP-9 genes was observed in T1DMS, and the anabolic effects of zinc were evidenced by increased OC expression and serum ALP activity, both related to osteoblastogenesis, demonstrating a positive effect on bone formation. In contrast, T1DM showed excessive bone loss, observed through reduced histomorphometric and biomechanical parameters, characterizing diabetes-associated bone loss. The bone loss was also observed through upregulation of OPG, COL1A, and MMP-9 genes. In conclusion, zinc showed a positive effect on the maintenance of bone architecture and biomechanical parameters. Indeed, OC upregulation and control of expression of OPG, COL1A, and MMP-9 mRNAs, even in chronic hyperglycemia, support an anabolic and protective effect of zinc under chronic diabetic conditions. Furthermore, these results indicate that zinc supplementation could act as a complementary therapy in chronic T1DM.	[Bortolin, Raul Hernandes; Galvao Ururahy, Marcela Abbott; Costa de Souza, Karla Simone; Bezerra, Joao Felipe; Loureiro, Melina Bezerra; Luchessi, Andre Ducati; Almeida, Maria das Gracas; de Rezende, Adriana Augusto] Univ Fed Rio Grande do Norte, Dept Clin & Toxicol Anal, BR-59072970 Natal, RN, Brazil; [da Graca Azevedo Abreu, Bento Joao; da Silva, Flavio Santos; da Silva Marques, Dafiny Emanuele] Univ Fed Rio Grande do Norte, Dept Morphol, BR-59072970 Natal, RN, Brazil; [Duarte Moreira Lima, Valeria Morgiana Gualberto] State Univ Paraiba, Dept Pharm, Campina Grande, Paraiba, Brazil; [de Sousa Batista, Angelica Amanda; Oliveira, Gisele; de Rezende, Luciana Augusto] Univ Ribeirao Preto, Dept Chem, Ribeirao Preto, SP, Brazil; [Saraiva Miranda, Carlos Eduardo] Univ Ribeirao Preto, Dept Pharm, Ribeirao Preto, SP, Brazil; [Lia Fook, Marcus Vinicius] Univ Fed Campina Grande, Lab Evaluat & Dev Biomat, Campina Grande, Paraiba, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Estadual da Paraiba; Universidade de Ribeirao Preto; Universidade de Ribeirao Preto; Universidade Federal de Campina Grande	de Rezende, AA (corresponding author), Univ Fed Rio Grande do Norte, Dept Clin & Toxicol Anal, BR-59072970 Natal, RN, Brazil.	adrirezende@yahoo.com	Fook, Marcus Vinicius Lia/AAJ-4528-2021; Bortolin, Raul H/O-2277-2016; Fook, Marcus/AAD-2416-2019; Luchessi, André/S-6429-2019; de Souza, Karla Simone Costa/O-9186-2019; Ururahy, Marcela/R-4536-2018; Bezerra, Joao Felipe/AAE-2500-2020; Abreu, Bento J/E-2607-2015; Almeida, Maria das Graças/O-6579-2018; Costa de Souza, Karla Simone/R-3623-2018; Luchessi, André D/E-7019-2012; DE REZENDE, ADRIANA AUGUSTO/L-4170-2018; bezerra, joao/C-8867-2017	Fook, Marcus Vinicius Lia/0000-0002-8566-920X; Luchessi, André/0000-0002-2758-8102; de Souza, Karla Simone Costa/0000-0002-8541-1444; Ururahy, Marcela/0000-0003-0229-9416; Almeida, Maria das Graças/0000-0002-5587-0922; Costa de Souza, Karla Simone/0000-0002-8541-1444; Luchessi, André D/0000-0002-2758-8102; DE REZENDE, ADRIANA AUGUSTO/0000-0003-2452-4047; Bortolin, Raul Hernandes/0000-0003-3424-3281; bezerra, joao/0000-0002-9978-628X; Abreu, Bento Joao/0000-0001-8010-806X	National Council of scientific and technological development [475801/2010]	National Council of scientific and technological development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	BJGAA received financial support by National Council of scientific and technological development (protocol 475801/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo-El-Asrar M, 2011, J DIABETES METAB, V2, DOI 10.4172/2155-6156.1000128; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Anderson HC, 2004, AM J PATHOL, V164, P841, DOI 10.1016/S0002-9440(10)63172-0; ARREOLA F, 1990, ARCH INVEST MED, V21, P195; AUWERX J, 1988, DIABETES, V37, P8, DOI 10.2337/diabetes.37.1.8; Beattie John H., 1992, Nutrition Research Reviews, V5, P167, DOI 10.1079/NRR19920013; Black MJ, 2010, CARDIOVASC PATHOL, V19, P361, DOI 10.1016/j.carpath.2009.07.003; Botolin S, 2006, J CELL BIOCHEM, V99, P411, DOI 10.1002/jcb.20842; Botolin S, 2007, ENDOCRINOLOGY, V148, P198, DOI 10.1210/en.2006-1006; BOUILLON R, 1995, J CLIN ENDOCR METAB, V80, P1194, DOI 10.1210/jc.80.4.1194; Brzoska MM, 2008, CHEM-BIOL INTERACT, V171, P312, DOI 10.1016/j.cbi.2007.11.007; BUYSSCHAERT M, 1992, DIABETES METAB, V18, P32; Cunha JS, 2014, CELL TISSUE RES, V358, P249, DOI 10.1007/s00441-014-1913-x; Dantas Jailson Araujo, 2006, Acta Scientiarum Health Science, V28, P165; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Duarte VMG, 2005, J BONE MINER METAB, V23, P58, DOI 10.1007/s00774-004-0542-y; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; Erdal N, 2012, DIABETES RES CLIN PR, V97, P461, DOI 10.1016/j.diabres.2012.03.005; Fedde KN, 1999, J BONE MINER RES, V14, P2015, DOI 10.1359/jbmr.1999.14.12.2015; Fong L, 2009, BONE, V44, P1151, DOI 10.1016/j.bone.2009.02.011; GOODMAN WG, 1984, DIABETES, V33, P825, DOI 10.2337/diabetes.33.9.825; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Gur A, 2005, CLIN BIOCHEM, V38, P66, DOI 10.1016/j.clinbiochem.2004.10.001; Hadley KB, 2010, J NUTR BIOCHEM, V21, P297, DOI 10.1016/j.jnutbio.2009.01.002; Hamada Y, 2007, BONE, V40, P1408, DOI 10.1016/j.bone.2006.12.057; Hie M, 2011, INT J MOL MED, V28, P455, DOI 10.3892/ijmm.2011.697; Hofbauer LC, 2007, J BONE MINER RES, V22, P1317, DOI 10.1359/JBMR.070510; Iitsuka N, 2013, EUR J PHARMACOL, V714, P41, DOI 10.1016/j.ejphar.2013.05.020; Kemink SAG, 2000, J ENDOCRINOL INVEST, V23, P295, DOI 10.1007/BF03343726; Korres N, 2013, WORLD J ORTHOP, V4, P124, DOI 10.5312/wjo.v4.i3.124; Kwun IS, 2010, BONE, V46, P732, DOI 10.1016/j.bone.2009.11.003; LEVIN ME, 1976, NEW ENGL J MED, V294, P241, DOI 10.1056/NEJM197601292940502; de Amorim FPLG, 2008, J MOL HISTOL, V39, P401, DOI 10.1007/s10735-008-9178-x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LORENZO JA, 1992, MATRIX, V12, P282, DOI 10.1016/S0934-8832(11)80080-6; Loureiro MB, 2014, DIABETES RES CLIN PR, V103, P452, DOI 10.1016/j.diabres.2013.12.018; Marino R. H., 2012, SCI PLENA, V8, P1; Martin LM, 2007, HISTOCHEM CELL BIOL, V128, P125, DOI 10.1007/s00418-007-0308-4; Maser RE, 2008, DIABETES CARE, V31, P2279, DOI 10.2337/dc08-1068; McCabe LR, 2007, J CELL BIOCHEM, V102, P1343, DOI 10.1002/jcb.21573; McCabe LR, 1995, EXP CELL RES, V218, P255; Mizuno A, 1998, BIOCHEM BIOPH RES CO, V247, P610, DOI 10.1006/bbrc.1998.8697; MOHTAI M, 1993, J CLIN INVEST, V92, P179, DOI 10.1172/JCI116547; Motyl K, 2009, BIOL PROCED ONLINE, V11, P296, DOI 10.1007/s12575-009-9000-5; Motyl KJ, 2009, J CELL PHYSIOL, V218, P575, DOI 10.1002/jcp.21626; MunozTorres M, 1996, CALCIFIED TISSUE INT, V58, P316; National Research Council, 2011, GUIDE FOR THE CARE A; Nyman JS, 2011, J BONE MINER RES, V26, P1252, DOI 10.1002/jbmr.326; OKADA Y, 1995, LAB INVEST, V72, P311; Ovesen J, 2001, BONE, V29, P565, DOI 10.1016/S8756-3282(01)00616-0; OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304; Prisby RD, 2008, J ENDOCRINOL, V199, P379, DOI 10.1677/JOE-08-0046; Reddy G, 2001, DIABETES RES CLIN PR, V54, P1, DOI 10.1016/S0168-8227(01)00273-X; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Rich Lillian, 2005, Brazilian Journal of Morphological Sciences, V22, P97; Ryz NR, 2009, ANN NUTR METAB, V54, P218, DOI 10.1159/000224627; SEINO Y, 1995, DIABETES METAB REV, V11, P21, DOI 10.1002/dmr.5610110103; Starup-Linde Jakob, 2013, Front Endocrinol (Lausanne), V4, P21, DOI 10.3389/fendo.2013.00021; STEIN GS, 1990, FASEB J, V4, P3111, DOI 10.1096/fasebj.4.13.2210157; Sunar F, 2009, PAK J PHARM SCI, V22, P150; Thrailkill KM, 2005, DIABETES, V54, P2875, DOI 10.2337/diabetes.54.10.2875; Tsuchida T, 2000, CALCIFIED TISSUE INT, V66, P229, DOI 10.1007/PL00005838; Tuominen JT, 1999, DIABETES CARE, V22, P1196, DOI 10.2337/diacare.22.7.1196; Turner CH, 2006, ANN NY ACAD SCI, V1068, P429, DOI 10.1196/annals.1346.039; Uchiyama S, 2003, INT J MOL MED, V12, P949; Uchiyama S, 2008, MOL CELL BIOCHEM, V307, P209, DOI 10.1007/s11010-007-9600-9; Vandooren J, 2013, CRIT REV BIOCHEM MOL, V48, P222, DOI 10.3109/10409238.2013.770819; WEINREB M, 1990, J BONE MINER RES, V5, P831; Wittrant Y, 2008, BONE, V42, P1122, DOI 10.1016/j.bone.2008.02.006; Yamaguchi M, 2003, INT J MOL MED, V12, P755; Yamaguchi M, 2008, MOL CELL BIOCHEM, V312, P157, DOI 10.1007/s11010-008-9731-7; Yamaguchi M, 2012, MOL CELL BIOCHEM, V366, P201, DOI 10.1007/s11010-012-1298-7; Yamaguchi M, 2010, MOL CELL BIOCHEM, V338, P241, DOI 10.1007/s11010-009-0358-0; Zhang SQ, 2007, J BONE MINER METAB, V25, P293, DOI 10.1007/s00774-007-0759-7; Zhao HB, 1998, CHINESE MED J-PEKING, V111, P551	75	32	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125349	10.1371/journal.pone.0125349	http://dx.doi.org/10.1371/journal.pone.0125349			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933189	Green Published, gold, Green Submitted			2022-12-27	WOS:000353887100103
J	Chen, S; Chen, X; Xiu, YL; Sun, KX; Zhao, Y				Chen, Shuo; Chen, Xi; Xiu, Yin-Ling; Sun, Kai-Xuan; Zhao, Yang			Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; CANCER-CELLS; PROSTATE-CANCER; EXPRESSION; MMP2; METASTASIS; MECHANISM; MIGRATION; MARKER; GROWTH	Epithelial ovarian cancer (EOC) is the most lethal of the gynecological malignancies. Exploring the molecular mechanisms and major factors of invasion and metastasis could have great significance for the treatment and prognosis of EOC. Studies have demonstrated that microRNA 106b (miR-106b) may be a promising therapeutic target for inhibiting breast cancer bone metastasis, but the role of miR-106b in EOC is largely unknown. In this work, miRNA-106b expression was quantified in various ovarian tissues and tumors. Ovarian carcinoma cell lines were transfected with miR-106b, after which, cell phenotype and expression of relevant molecules was assayed. Dual-luciferase reporter assays and xenograft mouse models were also used to investigate miR-106b and its target gene. MiR-106b mRNA expression was found to be significantly higher in normal ovarian tissues and benign tumors than in ovarian carcinomas and borderline tumors (p<0.01), and was negatively associated with differentiation (Well vs. Por & Mod) and the International Federation of Gynecology and Obstetrics (FIGO) staging (stage I/II vs. stage III/IV) in ovarian carcinoma (p<0.05). MiR-106b transfection reduced cell proliferation; promoted G1 or S arrest and apoptosis (p<0.05); suppressed cell migration and invasion (p<0.05); reduced Ras homolog gene family member C (RhoC), P70 ribosomal S6 kinase (P70S6K), Bcl-xL, Matrix metallopeptidase 2 (MMP2), MMP9 mRNA and protein expression; and induced p53 expression (p<0.05). Dual-luciferase reporter assays indicated that miR-106b directly targets RhoC by binding its 3' UTR. MiR-106b transfection also suppressed tumor development and RhoC expression in vivo in xenograft mouse models. This is the first demonstration that miR-106b may inhibit tumorigenesis and progression of EOC by targeting RhoC. The involvement of miR-106b-mediated RhoC downregulation in EOC aggression may give extended insights into molecular mechanisms underlying cancer aggression. Approaches aimed at overexpressing miR-106b may serve as promising therapeutic strategies for treating EOC patients.	[Chen, Shuo; Chen, Xi; Xiu, Yin-Ling; Sun, Kai-Xuan; Zhao, Yang] China Med Univ, Affiliated Hosp 1, Dept Gynecol, Shenyang 110001, Peoples R China	China Medical University	Zhao, Y (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Gynecol, Shenyang 110001, Peoples R China.	yida.zhaoyang@163.com		Zhao, Yang/0000-0003-3226-8127; Shuo, Chen/0000-0002-5122-3656	Liaoning Science and Technology Grant [2013021077]; Natural Scientific Foundation of China [81202049, 81472440]	Liaoning Science and Technology Grant; Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	Liaoning Science and Technology Grant (2013021077); the Natural Scientific Foundation of China (81202049, 81472440). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2008, BIOMED RES-TOKYO, V29, P155, DOI 10.2220/biomedres.29.155; Allegra A, 2012, INT J ONCOL, V41, P1897, DOI 10.3892/ijo.2012.1647; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boone B, 2009, J CUTAN PATHOL, V36, P629, DOI 10.1111/j.1600-0560.2008.01117.x; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Deng S, 2008, CELL CYCLE, V7, P2643, DOI 10.4161/cc.7.17.6597; Farazi TA, 2013, ADV EXP MED BIOL, V774, P1, DOI 10.1007/978-94-007-5590-1_1; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Islam M, 2009, MOL CANCER RES, V7, P1771, DOI 10.1158/1541-7786.MCR-08-0512; Bueno MJ, 2011, BBA-MOL BASIS DIS, V1812, P592, DOI 10.1016/j.bbadis.2011.02.002; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Khuu C, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00246; Kleer CG, 2006, CLIN CANCER RES, V12, P4485, DOI 10.1158/1078-0432.CCR-06-0376; Lin Ya-Ling, 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P23, DOI 10.1016/S2221-1691(11)60063-4; Liu N, 2007, J MOL MED-JMM, V85, P1149, DOI 10.1007/s00109-007-0217-y; Moroz A, 2013, BIOCHEM BIOPH RES CO, V430, P1319, DOI 10.1016/j.bbrc.2012.12.031; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Ni XJ, 2014, CANCER SCI, V105, P18, DOI 10.1111/cas.12309; Ogden A, 2013, CANCER METAST REV, V32, P269, DOI 10.1007/s10555-012-9413-5; Park KS, 2011, J GASTROEN HEPATOL, V26, P391, DOI 10.1111/j.1440-1746.2010.06504.x; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Sampath D, 2009, BLOOD, V113, P3744, DOI 10.1182/blood-2008-09-178707; Sanchez-Diaz PC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061622; Sotillo E, 2011, PHARMACOL THERAPEUT, V131, P18, DOI 10.1016/j.pharmthera.2011.04.006; Stamenkovic I, 2003, J PATHOL, V200, P448, DOI 10.1002/path.1400; Tang Q, 2014, EUR J PHARMACOL, V741, P97, DOI 10.1016/j.ejphar.2014.07.051; Yoshizaki T, 1999, CLIN EXP METASTAS, V17, P431, DOI 10.1023/A:1006699003525; Zhao Y, 2013, GYNECOL ONCOL, V130, P570, DOI 10.1016/j.ygyno.2013.06.004; Zhao Y, 2010, GYNECOL ONCOL, V116, P563, DOI 10.1016/j.ygyno.2009.11.015	32	30	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125714	10.1371/journal.pone.0125714	http://dx.doi.org/10.1371/journal.pone.0125714			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933027	Green Submitted, gold, Green Published			2022-12-27	WOS:000353887100129
J	Marotta, L; Micciche, S; Fujiwara, Y; Iyetomi, H; Aoyama, H; Gallegati, M; Mantegna, RN				Marotta, Luca; Micciche, Salvatore; Fujiwara, Yoshi; Iyetomi, Hiroshi; Aoyama, Hideaki; Gallegati, Mauro; Mantegna, Rosario N.			Bank-Firm Credit Network in Japan: An Analysis of a Bipartite Network	PLOS ONE			English	Article							COMMUNITY STRUCTURE	We investigate the networked nature of the Japanese credit market. Our investigation is performed with tools of network science. In our investigation we perform community detection with an algorithm which is identifying communities composed of both banks and firms. We show that the communities obtained by directly working on the bipartite network carry information about the networked nature of the Japanese credit market. Our analysis is performed for each calendar year during the time period from 1980 to 2011. To investigate the time evolution of the networked structure of the credit market we introduce a new statistical method to track the time evolution of detected communities. We then characterize the time evolution of communities by detecting for each time evolving set of communities the overexpression of attributes of firms and banks. Specifically, we consider as attributes the economic sector and the geographical location of firms and the type of banks. In our 32-year-long analysis we detect a persistence of the over-expression of attributes of communities of banks and firms together with a slow dynamic of changes from some specific attributes to new ones. Our empirical observations show that the credit market in Japan is a networked market where the type of banks, geographical location of firms and banks, and economic sector of the firm play a role in shaping the credit relationships between banks and firms.	[Marotta, Luca; Micciche, Salvatore; Mantegna, Rosario N.] Univ Palermo, Dipartimento Fis & Chim, Palermo, Italy; [Fujiwara, Yoshi] Univ Hyogo, Grad Sch Simulat Studies, Kobe, Hyogo 6500044, Japan; [Iyetomi, Hiroshi] Niigata Univ, Dept Math, Niigata, Japan; [Aoyama, Hideaki] Kyoto Univ, Grad Sch Sci, Kyoto, Japan; [Gallegati, Mauro] Univ Politecn Marche, Dipartimento Sci Econ & Sociali, Ancona, Italy; [Mantegna, Rosario N.] Cent European Univ, Ctr Network Sci, Budapest, Hungary; [Mantegna, Rosario N.] Cent European Univ, Dept Econ, Budapest, Hungary	University of Palermo; University of Hyogo; Niigata University; Kyoto University; Marche Polytechnic University; Central European University; Central European University	Mantegna, RN (corresponding author), Univ Palermo, Dipartimento Fis & Chim, Palermo, Italy.	rn.mantegna@gmail.com	Mantegna, Rosario N/H-3652-2014; Miccichè, Salvatore/B-6575-2008; GALLEGATI, MAURO/A-4091-2016	Mantegna, Rosario N/0000-0003-4177-171X; Miccichè, Salvatore/0000-0003-3779-592X; 	JSPS [24243027, 25282094, 25400393]; Program for Promoting Methodological Innovation in Humanities and Social Sciences by Cross-Disciplinary Fusing of the JSPS; European Community Seventh Framework Programme [255987 (FOC-II), 297149 (FOC-INCO)]; Zengin Foundation for Studies on Economics and Finance; Kyoto University; Program for Interaction-based Initiative Team Studies: SPIRITS, Program for Promoting the Enhancement of Research Universities, MEXT, Japan; EU; INET	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for Promoting Methodological Innovation in Humanities and Social Sciences by Cross-Disciplinary Fusing of the JSPS; European Community Seventh Framework Programme(European Commission); Zengin Foundation for Studies on Economics and Finance; Kyoto University; Program for Interaction-based Initiative Team Studies: SPIRITS, Program for Promoting the Enhancement of Research Universities, MEXT, Japan; EU(European Commission); INET	LM, SM, MG, and RNM acknowledge support from the EU project CRISIS and the INET project "New tools in the credit network modeling with agents' heterogeneity." This work is partially supported by Grant-in-Aid for Scientific Research (KAKENHI) grant numbers 24243027, 25282094, and 25400393 by JSPS, the Program for Promoting Methodological Innovation in Humanities and Social Sciences by Cross-Disciplinary Fusing of the JSPS, by the European Community Seventh Framework Programme (FP7/2007-2013) under Socio-economic Sciences and Humanities, grant agreement no. 255987 (FOC-II) and 297149 (FOC-INCO), by Zengin Foundation for Studies on Economics and Finance, and by the Kyoto University Supporting Program for Interaction-based Initiative Team Studies: SPIRITS, as part of the Program for Promoting the Enhancement of Research Universities, MEXT, Japan.	Barber MJ, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.066102; Bargigli L, 2012, ECONOMICS DISCUSSION; De Masi G, 2011, EVOL INST ECON REV, V7, P209, DOI 10.14441/eier.7.209; Easley D, 2010, NETWORKS CROWDS MARK; Fujiwara Y, 2009, ECONOMICS-KIEL, V3, P7; Guimera R, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036102; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Larremore DB, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.012805; Matsuura Y, 2013, FRONT ARTIF INTEL AP, V255, P399, DOI 10.3233/978-1-61499-264-6-399; Melamed D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097823; Murata Tsuyoshi, 2009, 2009 International Conference on Computational Science and Engineering (CSE), P50, DOI 10.1109/CSE.2009.81; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Rosvall M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008694; Suzuki Kenta, 2009, 2009 International Conference on Computational Science and Engineering (CSE), P312, DOI 10.1109/CSE.2009.451; Tumminello M, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/01/P01019	15	20	20	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0123079	10.1371/journal.pone.0123079	http://dx.doi.org/10.1371/journal.pone.0123079			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933413	Green Published, Green Submitted, gold			2022-12-27	WOS:000353887100014
J	Peng, J; Wang, P; Ge, HS; Qu, XQ; Jin, XL				Peng, Jie; Wang, Ping; Ge, Hongshan; Qu, Xianqin; Jin, Xingliang			Effects of Cordycepin on the Microglia-Overactivation-Induced Impairments of Growth and Development of Hippocampal Cultured Neurons	PLOS ONE			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; PROINFLAMMATORY CYTOKINES; NERVOUS-SYSTEM; CONE FILOPODIA; FACTOR-ALPHA; IN-VIVO; INFLAMMATION; CELLS; BRAIN	Microglial cells are normally activated in response to brain injury or immunological stimuli to protect central nervous system (CNS). However, over-activation of microglia conversely amplifies the inflammatory effects and mediates cellular degeneration, leading to the death of neurons. Recently, cordycepin, an active component found in Cordyceps militarisa known as a rare Chinese caterpillar fungus, has been reported as an effective drug for treating inflammatory diseases and cancer via unclear mechanisms. In this study, we attempted to identify the anti-inflammatory role of cordycepin and its protective effects on the impairments of neural growth and development induced by microglial over-activation. The results indicate that cordycepin could attenuate the lipopolysaccharide (LPS)-induced microglial activation, evidenced by the dramatically reduced release of TNF-alpha and IL-1 beta, as well as the down-regulation of mRNA levels of iNOS and COX-2 after cordycepin treatment. Besides, cordycepin reversed the LPS-induced activation of NF-kappa B pathway, resulting in anti-inflammatory effects. Furthermore, by employing the conditioned medium (CM), we found cordycepin was able to recover the impairments of neural growth and development in the primary hippocampal neurons cultured in LPS-CM, including cell viability, growth cone extension, neurite sprouting and outgrowth as well as spinogenesis. This study expands our knowledge of the anti-inflammatory function of cordycepin and paves the way for the biomedical applications of cordycepin in the therapies of neural injuries.	[Peng, Jie; Wang, Ping] Wuzhong Hosp, Suzhou, Jiangsu, Peoples R China; [Ge, Hongshan; Jin, Xingliang] Wenzhou Med Univ, Affiliated Hosp 2, Wenzhou, Zhejiang, Peoples R China; [Jin, Xingliang] Univ Sydney, Sydney Med Sch, Kolling Inst Med Res, Sydney Ctr Regenerat & Dev Med, Sydney, NSW 2006, Australia; [Qu, Xianqin] Univ Technol Sydney, Sch Med & Mol Biosci, Sydney, NSW 2007, Australia	Wenzhou Medical University; University of Sydney; Kolling Institute of Medical Research; University of Technology Sydney	Qu, XQ (corresponding author), Univ Technol Sydney, Sch Med & Mol Biosci, Sydney, NSW 2007, Australia.	xianqin.qu@uts.edu.au; xljin123@163.com			National Natural Science Foundation of China [81471458]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (81471458). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; Aktan F, 2004, LIFE SCI, V75, P639, DOI 10.1016/j.lfs.2003.10.042; Aldskogius H, 1998, PROG NEUROBIOL, V55, P1, DOI 10.1016/S0301-0082(97)00093-2; Aloisi F, 1999, ADV EXP MED BIOL, V468, P123; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barron KD, 1995, J NEUROL SCI, V134, P57, DOI 10.1016/0022-510X(95)00209-K; Baugh J A, 2001, Curr Opin Drug Discov Devel, V4, P635; BEG AA, 1993, MOL CELL BIOL, V13, P3301, DOI 10.1128/MCB.13.6.3301; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Bianchi R, 2010, NEUROBIOL AGING, V31, P665, DOI 10.1016/j.neurobiolaging.2008.05.017; Block ML, 2007, BIOCHEM SOC T, V35, P1127, DOI 10.1042/BST0351127; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; BRAY D, 1978, P NATL ACAD SCI USA, V75, P5226, DOI 10.1073/pnas.75.10.5226; Cheng ZY, 2011, EUR J PHARMACOL, V664, P20, DOI 10.1016/j.ejphar.2011.04.052; Chevalier-Larsen E, 2006, BBA-MOL BASIS DIS, V1762, P1094, DOI 10.1016/j.bbadis.2006.04.002; Crofford LJ, 1997, J RHEUMATOL, V24, P15; Cuadros MA, 1998, PROG NEUROBIOL, V56, P173, DOI 10.1016/S0301-0082(98)00035-5; DAVENPORT RW, 1993, NATURE, V361, P721, DOI 10.1038/361721a0; DEITCH AD, 1979, EXP CELL RES, V118, P1, DOI 10.1016/0014-4827(79)90577-9; DINARELLO CA, 1994, EUR CYTOKINE NETW, V5, P517; Dinarello CA, 2005, J EXP MED, V201, P1355, DOI 10.1084/jem.20050640; Fetler L, 2005, SCIENCE, V309, P392, DOI 10.1126/science.1114852; Gao HM, 2008, TRENDS IMMUNOL, V29, P357, DOI 10.1016/j.it.2008.05.002; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; [盖国忠 Gui Guozhong], 2004, [中国新药杂志, Chinese Journal New Drugs], V13, P169; Hung J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003692; Jeong JW, 2010, INT IMMUNOPHARMACOL, V10, P1580, DOI 10.1016/j.intimp.2010.09.011; Kaltschmidt B, 2005, BBA-MOL CELL RES, V1745, P287, DOI 10.1016/j.bbamcr.2005.05.009; Kater S. B., 1995, Current Opinion in Neurobiology, V5, P68, DOI 10.1016/0959-4388(95)80089-1; Koss K, 2000, GENES IMMUN, V1, P185, DOI 10.1038/sj.gene.6363657; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Krum SA, 2010, NAT REV RHEUMATOL, V6, P607, DOI 10.1038/nrrheum.2010.133; Laflamme N, 1999, J NEUROCHEM, V73, P309, DOI 10.1046/j.1471-4159.1999.0730309.x; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; McGuire SO, 2001, EXP NEUROL, V169, P219, DOI 10.1006/exnr.2001.7688; Mongiu AK, 2007, J CELL SCI, V120, P1113, DOI 10.1242/jcs.03384; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Montine TJ, 2002, J NEUROCHEM, V83, P463, DOI 10.1046/j.1471-4159.2002.01157.x; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Noelker C, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-86; O'Neill LAJ, 2000, IMMUNOL TODAY, V21, P206, DOI 10.1016/S0167-5699(00)01611-X; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; Pusic KM, 2014, GLIA, V62, P1176, DOI 10.1002/glia.22672; QUAN N, 1994, J NEUROIMMUNOL, V49, P125, DOI 10.1016/0165-5728(94)90188-0; Russo I, 2011, J NEUROCHEM, V116, P947, DOI 10.1111/j.1471-4159.2010.07168.x; Schnieder TP, 2011, BIOL PSYCHIAT, V69, P134, DOI 10.1016/j.biopsych.2010.08.027; SEIBERT K, 1994, P NATL ACAD SCI USA, V91, P12013, DOI 10.1073/pnas.91.25.12013; Shin Seulmee, 2009, Immune Netw, V9, P255, DOI 10.4110/in.2009.9.6.255; Shin Seulmee, 2009, Immune Netw, V9, P98, DOI 10.4110/in.2009.9.3.98; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164; STREIT WJ, 1988, GLIA, V1, P301, DOI 10.1002/glia.440010502; Sugar AM, 1998, ANTIMICROB AGENTS CH, V42, P1424, DOI 10.1128/AAC.42.6.1424; Surh YJ, 2001, J KOREAN MED SCI, V16, pS38, DOI 10.3346/jkms.2001.16.S.S38; Wilkinson K., 2012, INT J ALZHEIMERS DIS, V2012, P489456, DOI [DOI 10.1155/2012/489456, 10.1155/2012/489456]; Wilms H, 2003, FASEB J, V17, P500, DOI 10.1096/fj.02-0314fje; Yao LH, 2011, NEUROSCI LETT, V503, P256, DOI 10.1016/j.neulet.2011.08.048; Yun YunHa, 2003, Natural Product Sciences, V9, P291; Zhang DW, 2014, INFLAMMATION, V37, P1044, DOI 10.1007/s10753-014-9827-z	58	24	26	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125902	10.1371/journal.pone.0125902	http://dx.doi.org/10.1371/journal.pone.0125902			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932642	Green Published, gold, Green Submitted			2022-12-27	WOS:000353887100141
J	Seok, J; Davis, RW; Xiao, WZ				Seok, Junhee; Davis, Ronald W.; Xiao, Wenzhong			A Hybrid Approach of Gene Sets and Single Genes for the Prediction of Survival Risks with Gene Expression Data	PLOS ONE			English	Article							BREAST-CANCER; MOLECULAR CLASSIFICATION; MULTIPLE-MYELOMA; LYMPHOMA; MICROARRAYS; SIGNATURES; PROGNOSIS; DISCOVERY; NETWORKS; DISEASE	Accumulated biological knowledge is often encoded as gene sets, collections of genes associated with similar biological functions or pathways. The use of gene sets in the analyses of high-throughput gene expression data has been intensively studied and applied in clinical research. However, the main interest remains in finding modules of biological knowledge, or corresponding gene sets, significantly associated with disease conditions. Risk prediction from censored survival times using gene sets hasn't been well studied. In this work, we propose a hybrid method that uses both single gene and gene set information together to predict patient survival risks from gene expression profiles. In the proposed method, gene sets provide context-level information that is poorly reflected by single genes. Complementarily, single genes help to supplement incomplete information of gene sets due to our imperfect biomedical knowledge. Through the tests over multiple data sets of cancer and trauma injury, the proposed method showed robust and improved performance compared with the conventional approaches with only single genes or gene sets solely. Additionally, we examined the prediction result in the trauma injury data, and showed that the modules of biological knowledge used in the prediction by the proposed method were highly interpretable in biology. A wide range of survival prediction problems in clinical genomics is expected to benefit from the use of biological knowledge.	[Seok, Junhee] Korea Univ, Sch Elect Engn, Seoul 136713, South Korea; [Davis, Ronald W.; Xiao, Wenzhong] Stanford Genome Technol Ctr, Palo Alto, CA USA; [Xiao, Wenzhong] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Xiao, Wenzhong] Shriners Hosp Children, Boston, MA USA	Korea University; Stanford University; Harvard University; Massachusetts General Hospital	Seok, J (corresponding author), Korea Univ, Sch Elect Engn, Seoul 136713, South Korea.	jseok14@korea.ac.kr; wenzhong.xiao@mgh.harvard.edu		xiao, wenzhong/0000-0003-4944-6380	National Research Foundation of Korea (NRF) - Korea government [NRF-2014R1A1A2A16050527]; Korea University; National Institutes of Health [PO1-HG00205, U54-GM62119, R01-GM101401]; Shriners Research Grant [85500-BOS]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062119, R01GM101401] Funding Source: NIH RePORTER	National Research Foundation of Korea (NRF) - Korea government(National Research Foundation of Korea); Korea University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Research Grant; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (NRF-2014R1A1A2A16050527) and Korea University grant, as well as grants from the National Institutes of Health (PO1-HG00205, U54-GM62119, R01-GM101401) and Shriners Research Grant (85500-BOS).	Abraham G, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-277; Acharya CR, 2008, JAMA-J AM MED ASSOC, V299, P1574, DOI 10.1001/jama.299.13.1574; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Bovelstad HM, 2007, BIOINFORMATICS, V23, P2080, DOI 10.1093/bioinformatics/btm305; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; COX DR, 1972, J R STAT SOC B, V34, P187; Dairkee SH, 2008, CANCER RES, V68, P2076, DOI 10.1158/0008-5472.CAN-07-6526; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Heller RA, 1997, P NATL ACAD SCI USA, V94, P2150, DOI 10.1073/pnas.94.6.2150; Holec M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S10-S15; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Krauthammer M, 2004, P NATL ACAD SCI USA, V101, P15148, DOI 10.1073/pnas.0404315101; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Mulligan G, 2007, BLOOD, V109, P3177, DOI 10.1182/blood-2006-09-044974; Nikitin A, 2003, BIOINFORMATICS, V19, P2155, DOI 10.1093/bioinformatics/btg290; Park PJ, 2002, BIOINFORMATICS, V18, P1576, DOI 10.1093/bioinformatics/18.12.1576; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Segal MR, 2006, BIOSTATISTICS, V7, P268, DOI 10.1093/biostatistics/kxj006; Seok J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S8; Seok J, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-78; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Zhan FH, 2007, BLOOD, V109, P1692, DOI 10.1182/blood-2006-07-037077; Zhan F, 2006, BLOOD, V108, P2020, DOI 10.1182/blood-2005-11-013458	35	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0122103	10.1371/journal.pone.0122103	http://dx.doi.org/10.1371/journal.pone.0122103			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933378	Green Submitted, Green Published, gold			2022-12-27	WOS:000353887100006
J	Simbiri, KO; Smith, NA; Otieno, R; Wohlford, EEM; Daud, II; Odada, SP; Middleton, F; Rochford, R				Simbiri, Kenneth O.; Smith, Nicholas A.; Otieno, Richard; Wohlford, Eric E. M.; Daud, Ibrahim I.; Odada, Sumba P.; Middleton, Frank; Rochford, Rosemary			Epstein-Barr Virus Genetic Variation in Lymphoblastoid Cell Lines Derived from Kenyan Pediatric Population	PLOS ONE			English	Article							NASOPHARYNGEAL CARCINOMA; STRAINS; VARIANTS; PROTEIN; IDENTIFICATION; REPLICATION; SEQUENCES; LYMPHOMA; EBNA1; BPLF1	Epstein-Barr virus (EBV) is associated with Burkitt's lymphoma (BL), and in regions of sub-Saharan Africa where endemic BL is common, both the EBV Type 1 (EBV-1) and EBV Type 2 strains (EBV-2) are found. Little is known about genetic variation of EBV strains in areas of sub-Saharan Africa. In the present study, spontaneous lymphoblastoid cell lines (LCLs) were generated from samples obtained from Kenya. Polymerase chain reaction (PCR) amplification of the EBV genome was done using multiple primers and sequenced by next-generation sequencing (NGS). Phylogenetic analyses against the published EBV-1 and EBV-2 strains indicated that one sample, LCL10 was closely related to EBV-2, while the remaining 3 LCL samples were more closely related to EBV-1. Moreover, single nucleotide polymorphism (SNP) analyses showed clustering of LCL variants. We further show by analysis of EBNA-1, BLLF1, BPLF1, and BRRF2 that latent genes are less conserved than lytic genes in these LCLs from a single geographic region. In this study we have shown that NGS is highly useful for deciphering detailed inter and intra-variations in EBV genomes and that within a geographic region different EBV genetic variations can co-exist, the implications of which warrant further investigation. The findings will enhance our understanding of potential pathogenic variants critical to the development and maintenance of EBV-associated malignancies.	[Simbiri, Kenneth O.; Smith, Nicholas A.; Wohlford, Eric E. M.; Rochford, Rosemary] Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY 13210 USA; [Otieno, Richard] Maseno Univ, Maseno, Kenya; [Daud, Ibrahim I.; Odada, Sumba P.] Kenya Govt Med Res Ctr, Kisumu, Kenya; [Middleton, Frank] Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Maseno University; Kenya Medical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Simbiri, KO (corresponding author), Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY 13210 USA.	simbirik@upstate.edu		Middleton, Frank/0000-0002-3107-7188	NIH [CA102667]; Alex's Lemonade Stand POST award; NATIONAL CANCER INSTITUTE [R01CA102667] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alex's Lemonade Stand POST award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by NIH CA102667 to RR, Alex's Lemonade Stand POST award to RO.	ADLDINGER HK, 1985, VIROLOGY, V141, P221, DOI 10.1016/0042-6822(85)90253-3; AITKEN C, 1994, J GEN VIROL, V75, P95, DOI 10.1099/0022-1317-75-1-95; Lorenzetti MA, 2010, J MED VIROL, V82, P1730, DOI 10.1002/jmv.21871; Bochkarev A, 1996, CELL, V84, P791, DOI 10.1016/S0092-8674(00)81056-9; Chang CM, 2009, VIRUS RES, V143, P209, DOI 10.1016/j.virusres.2009.07.005; Duarte M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053512; Edwards RH, 2004, J VIROL, V78, P868, DOI 10.1128/JVI.78.2.868-881.2004; Edwards RH, 1999, VIROLOGY, V261, P79, DOI 10.1006/viro.1999.9855; Gastaldello S, 2010, NAT CELL BIOL, V12, P351, DOI 10.1038/ncb2035; Gorzer I, 2006, VIRUS RES, V118, P105, DOI 10.1016/j.virusres.2005.11.020; Habeshaw G, 1999, J VIROL, V73, P965, DOI 10.1128/JVI.73.2.965-975.1999; Janz A, 2000, J VIROL, V74, P10142, DOI 10.1128/JVI.74.21.10142-10152.2000; Johannsen E, 2004, P NATL ACAD SCI USA, V101, P16286, DOI 10.1073/pnas.0407320101; Kelly BJ, 2009, VIRUS RES, V145, P173, DOI 10.1016/j.virusres.2009.07.007; Kutok JL, 2006, ANNU REV PATHOL-MECH, V1, P375, DOI 10.1146/annurev.pathol.1.110304.100209; Kwok H, 2014, J VIROL, V88, P10662, DOI 10.1128/JVI.01665-14; Kwok H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036939; LIN JC, 1993, BLOOD, V81, P3372; Lin Z, 2013, J VIROL, V87, P1172, DOI 10.1128/JVI.02517-12; Liu P, 2011, J VIROL, V85, P11291, DOI 10.1128/JVI.00823-11; Martini M, 2007, J INFECTION, V54, P298, DOI 10.1016/j.jinf.2006.04.015; McGeoch DJ, 2001, PHILOS T ROY SOC B, V356, P421, DOI 10.1098/rstb.2000.0775; McGeoch DJ, 2007, VIROLOGY, V359, P1, DOI 10.1016/j.virol.2006.10.009; MELLINGHOFF I, 1991, VIROLOGY, V185, P922, DOI 10.1016/0042-6822(91)90574-U; Montgomery RI, 1996, CELL, V87, P427, DOI 10.1016/S0092-8674(00)81363-X; NEMEROW GR, 1987, J VIROL, V61, P1416, DOI 10.1128/JVI.61.5.1416-1420.1987; Paludan C, 2002, J IMMUNOL, V169, P1593, DOI 10.4049/jimmunol.169.3.1593; Piriou E, 2012, J INFECT DIS, V205, P906, DOI 10.1093/infdis/jir872; Saito S, 2013, J VIROL, V87, P4060, DOI 10.1128/JVI.02020-12; SAMPLE J, 1990, J VIROL, V64, P4084, DOI 10.1128/JVI.64.9.4084-4092.1990; Sawada A, 2011, J GEN VIROL, V92, P1032, DOI 10.1099/vir.0.030023-0; Schmaus S, 2004, VIRUS GENES, V29, P267, DOI 10.1023/B:VIRU.0000036387.39937.9b; Song MJ, 2005, P NATL ACAD SCI USA, V102, P3805, DOI 10.1073/pnas.0404521102; THORLEYLAWSON DA, 1982, J VIROL, V43, P730, DOI 10.1128/JVI.43.2.730-736.1982; Tsang CW, 2006, J VIROL, V80, P8263, DOI 10.1128/JVI.00400-06; Tzellos S, 2012, PATHOGENS, V1, P156, DOI 10.3390/pathogens1020156; Wang XA, 2010, J GEN VIROL, V91, P2564, DOI 10.1099/vir.0.021881-0; Whitehurst CB, 2012, J VIROL, V86, P8097, DOI 10.1128/JVI.00588-12; Whitehurst CB, 2009, J VIROL, V83, P4345, DOI 10.1128/JVI.02195-08; Yao QY, 1996, J VIROL, V70, P4895, DOI 10.1128/JVI.70.8.4895-4903.1996; Zeng MS, 2005, J VIROL, V79, P15323, DOI 10.1128/JVI.79.24.15323-15330.2005	41	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125420	10.1371/journal.pone.0125420	http://dx.doi.org/10.1371/journal.pone.0125420			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933165	Green Submitted, Green Published, gold			2022-12-27	WOS:000353887100110
J	Tiwari, S; Reddy, VB; Bhargava, R; Raman, J				Tiwari, Saumya; Reddy, Vijaya B.; Bhargava, Rohit; Raman, Jaishankar			Computational Chemical Imaging for Cardiovascular Pathology: Chemical Microscopic Imaging Accurately Determines Cardiac Transplant Rejection	PLOS ONE			English	Article							FT-IR SPECTROSCOPY; NEAR-INFRARED SPECTROSCOPY; NEURAL-NETWORK APPROACH; ANALYZED EX-VIVO; RAMAN-SPECTROSCOPY; ENDOMYOCARDIAL BIOPSY; CLUSTER-ANALYSIS; RAT-HEART; DISEASE DIAGNOSIS; VASCULAR WALL	Rejection is a common problem after cardiac transplants leading to significant number of adverse events and deaths, particularly in the first year of transplantation. The gold standard to identify rejection is endomyocardial biopsy. This technique is complex, cumbersome and requires a lot of expertise in the correct interpretation of stained biopsy sections. Traditional histopathology cannot be used actively or quickly during cardiac interventions or surgery. Our objective was to develop a stain-less approach using an emerging technology, Fourier transform infrared (FT-IR) spectroscopic imaging to identify different components of cardiac tissue by their chemical and molecular basis aided by computer recognition, rather than by visual examination using optical microscopy. We studied this technique in assessment of cardiac transplant rejection to evaluate efficacy in an example of complex cardiovascular pathology. We recorded data from human cardiac transplant patients' biopsies, used a Bayesian classification protocol and developed a visualization scheme to observe chemical differences without the need of stains or human supervision. Using receiver operating characteristic curves, we observed probabilities of detection greater than 95% for four out of five histological classes at 10% probability of false alarm at the cellular level while correctly identifying samples with the hallmarks of the immune response in all cases. The efficacy of manual examination can be significantly increased by observing the inherent biochemical changes in tissues, which enables us to achieve greater diagnostic confidence in an automated, label-free manner. We developed a computational pathology system that gives high contrast images and seems superior to traditional staining procedures. This study is a prelude to the development of real time in situ imaging systems, which can assist interventionists and surgeons actively during procedures.	[Tiwari, Saumya] Univ Illinois, Beckman Inst Adv Sci & Technol, Dept Bioengn, Urbana, IL 61801 USA; [Reddy, Vijaya B.] Rush Univ, Med Ctr, Dept Pathol, Chicago, IL 60612 USA; [Bhargava, Rohit] Univ Illinois, Beckman Inst Adv Sci & Technol, Dept Bioengn Chem Mech Sci & Engn Chem & Biomol E, Urbana, IL 61801 USA; [Bhargava, Rohit] Univ Illinois, Univ Illinois, Ctr Canc, Urbana, IL 61801 USA; [Raman, Jaishankar] Rush Univ, Med Ctr, Adv Heart Failure Transplantat & Mech Circulatory, Cardiac Surg, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Urbana-Champaign; Rush University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Rush University	Raman, J (corresponding author), Rush Univ, Med Ctr, Adv Heart Failure Transplantat & Mech Circulatory, Cardiac Surg, 1725 West Harrison St, Chicago, IL 60612 USA.	jairaman2462@gmail.com	Raman, Jaishankar/K-1219-2019; Tiwari, Saumya/AAE-9786-2021	Tiwari, Saumya/0000-0001-5148-6539; Bhargava, Rohit/0000-0001-7360-994X	NIH grant; Rush University internal funds	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rush University internal funds	This work was supported by an NIH grant for instrumentation and Rush University internal funds for conduct of research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARETZ HT, 1987, HUM PATHOL, V18, P619; BARAGA JJ, 1991, APPL SPECTROSC, V45, P709, DOI 10.1366/0003702914337047; Bassan P, 2013, ANALYST, V138, P144, DOI 10.1039/c2an36090j; Bhargava R, 2001, ANAL CHEM, V73, P5157, DOI 10.1021/ac010380m; Bhargava R, 2007, ANAL BIOANAL CHEM, V389, P1155, DOI 10.1007/s00216-007-1511-9; Bhargava R, 2006, BBA-BIOMEMBRANES, V1758, P830, DOI 10.1016/j.bbamem.2006.05.007; Birarda G, 2013, BIOMED SPECTROSC IMA, V2, P301, DOI 10.3233/BSI-130057; BURCH GE, 1968, AM J CARDIOL, V21, P261, DOI 10.1016/0002-9149(68)90328-7; Buschman HP, 2000, ANAL CHEM, V72, P3771, DOI 10.1021/ac000298b; Cheheltani R, 2012, NORTHEAST BIOENGIN C, P305, DOI 10.1109/NEBC.2012.6207086; Dritsa V, 2014, IN VIVO, V28, P91; Edwards W D, 1985, Heart Vessels Suppl, V1, P138, DOI 10.1007/BF02072381; Ellis DI, 2006, ANALYST, V131, P875, DOI 10.1039/b602376m; FENOGLIO JJ, 1987, HUM PATHOL, V18, P609, DOI 10.1016/S0046-8177(87)80361-1; Fernandez DC, 2005, NAT BIOTECHNOL, V23, P469, DOI 10.1038/nbt1080; Ferrari M, 2004, CAN J APPL PHYSIOL, V29, P463, DOI 10.1139/h04-031; Filik J, 2012, ANALYST, V137, P853, DOI 10.1039/c2an15995c; Friedman SL, 2004, NAT CLIN PRACT GASTR, V1, P98, DOI 10.1038/ncpgasthep0055; Fung MFK, 1996, BIOSPECTROSCOPY, V2, P155, DOI 10.1002/(SICI)1520-6343(1996)2:3<155::AID-BSPY2>3.3.CO;2-F; German MJ, 2006, BIOPHYS J, V90, P3783, DOI 10.1529/biophysj.105.077255; Gough KM, 2003, ANAL BIOCHEM, V316, P232, DOI 10.1016/S0003-2697(03)00039-3; Hahn EA, 1995, EUR HEART J, V16, P162, DOI 10.1093/eurheartj/16.suppl_O.162; Hammond MEH, 2005, J HEART LUNG TRANSPL, V24, P2015, DOI 10.1016/j.healun.2005.08.014; HAUCK AJ, 1989, MAYO CLIN PROC, V64, P1235, DOI 10.1016/S0025-6196(12)61286-5; Holton SE, 2011, BIOPHYS J, V101, P1513, DOI 10.1016/j.bpj.2011.07.055; JACKSON M, 1995, BBA-MOL BASIS DIS, V1270, P1, DOI 10.1016/0925-4439(94)00056-V; Jastrzebska M, 2006, GEN PHYSIOL BIOPHYS, V25, P231; KODALI DR, 1991, APPL SPECTROSC, V45, P1310, DOI 10.1366/0003702914335878; Kole MR, 2012, ANAL CHEM, V84, P10366, DOI 10.1021/ac302513f; Krafft C, 2005, CYTOM PART A, V64A, P53, DOI 10.1002/cyto.a.20117; Kumar V, 2010, TISSUE RENEWAL REGEN, P79; LANGE LG, 1994, NEW ENGL J MED, V330, P1129; Liu KZ, 1996, BBA-MOL BASIS DIS, V1315, P73, DOI 10.1016/0925-4439(95)00118-2; Mackanos MA, 2010, TRENDS BIOTECHNOL, V28, P317, DOI 10.1016/j.tibtech.2010.04.001; Mackanos MA, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3174387; Majzner K, 2013, ANALYST, V138, P7400, DOI 10.1039/c3an00455d; MANOHARAN R, 1993, ATHEROSCLEROSIS, V103, P181, DOI 10.1016/0021-9150(93)90261-R; Martin FL, 2010, NAT PROTOC, V5, P1748, DOI 10.1038/nprot.2010.133; Moreno PR, 2002, CIRCULATION, V105, P923, DOI 10.1161/hc0802.104291; Motz JT, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2190967; Motz JT, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1920247; Nallala J, 2013, CYTOM PART A, V83A, P294, DOI 10.1002/cyto.a.22249; Nasse MJ, 2011, NAT METHODS, V8, P413, DOI [10.1038/NMETH.1585, 10.1038/nmeth.1585]; Parker FS, 1971, APPLICATIONS OF INFR; Patel JK, 2011, SURG-J R COLL SURG E, V9, P160, DOI 10.1016/j.surge.2010.11.023; Petrich W, 2009, ANALYST, V134, P1092, DOI 10.1039/b820923e; Petrich W, 2001, APPL SPECTROSC REV, V36, P181, DOI 10.1081/ASR-100106156; Pounder FN, 2009, PROC SPIE, V7186, DOI 10.1117/12.810122; Reddy RK, 2010, ANALYST, V135, P2818, DOI 10.1039/c0an00350f; Romer TJ, 1998, CIRCULATION, V97, P878, DOI 10.1161/01.CIR.97.9.878; SHANES JG, 1987, CIRCULATION, V75, P401, DOI 10.1161/01.CIR.75.2.401; Sionkowska A, 2004, BIOMATERIALS, V25, P795, DOI 10.1016/S0142-9612(03)00595-7; Stewart S, 2005, J HEART LUNG TRANSPL, V24, P1710, DOI 10.1016/j.healun.2005.03.019; Stone JR, 2012, CARDIOVASC PATHOL, V21, P2, DOI 10.1016/j.carpath.2011.01.001; Toyran N, 2008, FOOD CHEM, V110, P590, DOI 10.1016/j.foodchem.2008.02.044; Toyran N, 2007, SPECTROSC-INT J, V21, P269, DOI 10.1155/2007/269618; Toyran N, 2006, BIOCHEM J, V397, P427, DOI 10.1042/BJ20060171; Wald N, 2015, ANALYST ROYAL SOCIET, DOI [10.1039/c4an02247e, DOI 10.1039/C4AN02247E]; Walker RA, 2006, HISTOPATHOLOGY, V49, P406, DOI 10.1111/j.1365-2559.2006.02514.x; Walsh MJ, 2012, IEEE J SEL TOP QUANT, V18, P1502, DOI 10.1109/JSTQE.2011.2182635; Walsh MJ, 2012, HIGH RESOLUTION MID, V8219, DOI [10.1117/12.909339, DOI 10.1117/12.909339]; Wang L, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2714030; Wang Q, 2005, VIB SPECTROSC, V38, P217, DOI 10.1016/j.vibspec.2005.02.011; Wei L, 2011, EXP MOL PATHOL, V90, P74, DOI 10.1016/j.yexmp.2010.10.004; Wetzel DL, 2005, VIB SPECTROSC, V38, P53, DOI 10.1016/j.vibspec.2005.02.029; Wood BR, 1998, BIOSPECTROSCOPY, V4, P75, DOI 10.1002/(SICI)1520-6343(1998)4:2<75::AID-BSPY1>3.0.CO;2-R; Wrobel TP, 2012, SPECTROCHIM ACTA A, V96, P940, DOI 10.1016/j.saa.2012.07.103; Wrobel TP, 2011, ANALYST, V136, P5247, DOI 10.1039/c1an15311k; Yeh K, 2015, ANAL CHEM	69	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125183	10.1371/journal.pone.0125183	http://dx.doi.org/10.1371/journal.pone.0125183			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932912	Green Published, Green Submitted, gold			2022-12-27	WOS:000353887100086
J	de Castro, AI; Ehsani, R; Ploetz, RC; Crane, JH; Buchanon, S				de Castro, Ana I.; Ehsani, Reza; Ploetz, Randy C.; Crane, Jonathan H.; Buchanon, Sherrie			Detection of Laurel Wilt Disease in Avocado Using Low Altitude Aerial Imaging	PLOS ONE			English	Article							AUTOMATED CROP; IMAGERY; REFLECTANCE; IDENTIFICATION; CURCULIONIDAE; COLEOPTERA; SCOLYTINAE; INDEXES; BLIGHT; WEEDS	Laurel wilt is a lethal disease of plants in the Lauraceae plant family, including avocado (Persea americana). This devastating disease has spread rapidly along the southeastern seaboard of the United States and has begun to affect commercial avocado production in Florida. The main objective of this study was to evaluate the potential to discriminate laurel wilt-affected avocado trees using aerial images taken with a modified camera during helicopter surveys at low-altitude in the commercial avocado production area. The ability to distinguish laurel wilt-affected trees from other factors that produce similar external symptoms was also studied. R(mod)GB digital values of healthy trees and laurel wilt-affected trees, as well as fruit stress and vines covering trees were used to calculate several vegetation indices (VIs), band ratios, and VI combinations. These indices were subjected to analysis of variance (ANOVA) and an M-statistic was performed in order to quantify the separability of those classes. Significant differences in spectral values among laurel wilt affected and healthy trees were observed in all vegetation indices calculated, although the best results were achieved with Excess Red (ExR), (Red-Green) and Combination 1 (COMB1) in all locations. B/G showed a very good potential for separate the other factors with symptoms similar to laurel wilt-affected trees, such as fruit stress and vines covering trees, from laurel wilt-affected trees. These consistent results prove the usefulness of using a modified camera (R(mod)GB) to discriminate laurel wilt-affected avocado trees from healthy trees, as well as from other factors that cause the same symptoms and suggest performing the classification in further research. According to our results, ExR and B/G should be utilized to develop an algorithm or decision rules to classify aerial images, since they showed the highest capacity to discriminate laurel wilt-affected trees. This methodology may allow the rapid detection of laurel wilt-affected trees using low altitude aerial images and be a valuable tool in mitigating this important threat to Florida avocado production.	[de Castro, Ana I.; Ehsani, Reza; Buchanon, Sherrie] Univ Florida IFAS, Citrus Res & Educ Ctr, Lake Alfred, FL 33850 USA; [Ploetz, Randy C.; Crane, Jonathan H.] Univ Florida IFAS, Trop Res & Educ Ctr, Homestead, FL 33031 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Ehsani, R (corresponding author), Univ Florida IFAS, Citrus Res & Educ Ctr, 700 Expt Stn Rd, Lake Alfred, FL 33850 USA.	ehsani@ufl.edu	De Castro Megías, Ana Isabel/K-7429-2017	De Castro Megías, Ana Isabel/0000-0002-6699-2204	Florida Department of Agriculture and Consumer Services, USDA Specialty Block Grant [019730]	Florida Department of Agriculture and Consumer Services, USDA Specialty Block Grant	Florida Department of Agriculture and Consumer Services, USDA Specialty Block Grant No. 019730, funded this investigation.	Barton CVM, 2012, PLANT SOIL, V354, P41, DOI 10.1007/s11104-011-1051-0; Calderon R, 2013, REMOTE SENS ENVIRON, V139, P231, DOI 10.1016/j.rse.2013.07.031; Carrillo D, 2014, PLANT PATHOL, V63, P54, DOI 10.1111/ppa.12073; Carrillo D, 2012, FLA ENTOMOL, V95, P573, DOI 10.1653/024.095.0306; Dammer KH, 2011, CROP PROT, V30, P420, DOI 10.1016/j.cropro.2010.12.015; Dreaden TJ, 2014, PLANT DIS, V98, P379, DOI 10.1094/PDIS-07-13-0772-RE; Du Q, 2008, J ENVIRON MANAGE, V86, P14, DOI 10.1016/j.jenvman.2006.11.019; Evans EA, 2010, HORTTECHNOLOGY, V20, P234, DOI 10.21273/HORTTECH.20.1.234; EVERITT JH, 1987, WEED SCI, V35, P427; FAO , 2013, FAOSTAT FAO UN; Fraedrich SW, 2008, PLANT DIS, V92, P215, DOI 10.1094/PDIS-92-2-0215; Garcia-Ruiz F, 2013, COMPUT ELECTRON AGR, V91, P106, DOI 10.1016/j.compag.2012.12.002; Gitelson AA, 2002, REMOTE SENS ENVIRON, V80, P76, DOI 10.1016/S0034-4257(01)00289-9; Guerrero JM, 2012, EXPERT SYST APPL, V39, P11149, DOI 10.1016/j.eswa.2012.03.040; Guijarro M, 2011, COMPUT ELECTRON AGR, V75, P75, DOI 10.1016/j.compag.2010.09.013; Hague T, 2006, PRECIS AGRIC, V7, P21, DOI 10.1007/s11119-005-6787-1; HOEFFDING W, 1948, ANN MATH STAT, V19, P293, DOI 10.1214/aoms/1177730196; Inch SA, 2012, FOREST PATHOL, V42, P239, DOI 10.1111/j.1439-0329.2011.00749.x; de Castro AI, 2012, PRECIS AGRIC, V13, P302, DOI 10.1007/s11119-011-9247-0; Kataoka T, 2003, IEEE ASME INT C ADV, P1079, DOI 10.1109/aim.2003.1225492; KAUFMAN YJ, 1994, IEEE T GEOSCI REMOTE, V32, P672, DOI 10.1109/36.297984; Kumar A, 2012, J APPL REMOTE SENS, V6, DOI 10.1117/1.JRS.6.063542; Lopez-Granados F, 2011, WEED RES, V51, P1, DOI 10.1111/j.1365-3180.2010.00829.x; Mahlein AK, 2010, PRECIS AGRIC, V11, P413, DOI 10.1007/s11119-010-9180-7; Meyer GE, 1998, THE SPIE P, V3543; Meyer GE, 2008, COMPUT ELECTRON AGR, V63, P282, DOI 10.1016/j.compag.2008.03.009; Nebikera S., 2008, P INT ARCH PHOTOGRAM, VVolume XXXVII Part B1, P1193; Neto J.C., 2004, COMBINED STAT SOFT C; Pena-Barragan JM, 2007, WEED RES, V47, P164, DOI 10.1111/j.1365-3180.2007.00553.x; PENUELAS J, 1994, REMOTE SENS ENVIRON, V48, P135, DOI 10.1016/0034-4257(94)90136-8; Ploetz RC, 2012, PLANT PATHOL, V61, P801, DOI 10.1111/j.1365-3059.2011.02564.x; Ploetz RC, 2011, PLANT DIS, V95, P1589, DOI 10.1094/PDIS-08-11-0633; Ploetz R. C., 2011, RECOVERY PLAN LAUREL; Pozdnyakova L, 2002, COMPUT ELECTRON AGR, V37, P57, DOI 10.1016/S0168-1699(02)00119-9; Rabaglia RJ, 2006, ANN ENTOMOL SOC AM, V99, P1034, DOI 10.1603/0013-8746(2006)99[1034:ROAXCC]2.0.CO;2; Raikes C, 1998, PHYTOPATHOLOGY, V88, P446, DOI 10.1094/PHYTO.1998.88.5.446; Ribeiro A, 2005, PRECISION AGRICULTURE 05, P169; Sankaran S, 2012, PLANT DIS, V96, P1683, DOI 10.1094/PDIS-01-12-0030-RE; Sankaran S, 2010, COMPUT ELECTRON AGR, V72, P1, DOI 10.1016/j.compag.2010.02.007; Smith AMS, 2007, INT J REMOTE SENS, V28, P2753, DOI 10.1080/01431160600954704; Swain KC, 2010, T ASABE, V53, P21; Torres-Sanchez J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058210; USDA Forest Service, 2014, LAUR WILT DISTR MAP; Usha K, 2013, SCI HORTIC-AMSTERDAM, V153, P71, DOI 10.1016/j.scienta.2013.01.008; WOEBBECKE DM, 1995, T ASAE, V38, P271, DOI 10.13031/2013.27839; Zhang Minghua, 2005, Precision Agriculture, V6, P489, DOI 10.1007/s11119-005-5640-x	46	35	35	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124642	10.1371/journal.pone.0124642	http://dx.doi.org/10.1371/journal.pone.0124642			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927209	gold, Green Published, Green Submitted			2022-12-27	WOS:000353713100041
J	Flierl, U; Fraccarollo, D; Widder, JD; Micka, J; Neuser, J; Bauersachs, J; Schafer, A				Flierl, Ulrike; Fraccarollo, Daniela; Widder, Julian D.; Micka, Jan; Neuser, Jonas; Bauersachs, Johann; Schaefer, Andreas			The Nitric Oxide Donor Pentaerythritol Tetranitrate Reduces Platelet Activation in Congestive Heart Failure	PLOS ONE			English	Article							ENDOTHELIAL DYSFUNCTION; GUANYLYL CYCLASE; HEME OXYGENASE-1; NITRATE THERAPY; IN-VIVO; TOLERANCE; SYNTHASE; INHIBITION; GUIDELINES; INDUCTION	Background Platelet activation associated with endothelial dysfunction and impaired endogenous platelet inhibition is part of the cardiovascular phenotype of congestive heart failure (CHF) and contributes to the increased risk for thromboembolic complications. Pentaerythritol tetranitrate (PETN) has been shown to release nitric oxide without development of nitrate tolerance. We investigated the effect of chronic PETN treatment on platelet activation and aggregation in an experimental CHF model. Methods and Results Chronic ischemic heart failure was induced in male Wistar rats by coronary artery ligation. Starting 7 days thereafter, rats were randomised to placebo or PETN (80 mg/kg twice daily). After 9 weeks, activation of circulating platelets was determined measuring platelet bound fibrinogen, which requires activated glycoprotein IIb/IIIa on the platelet surface. Binding was quantified by flow-cytometry using a FITC-labelled anti-fibrinogen antibody. Platelet-bound fibrinogen was significantly increased in CHF-Placebo (mean fluorescence intensity: Sham 88 +/- 4, CHF-Placebo 104 +/- 6, p<0.05) and reduced following treatment with PETN (89 +/- 7, p<0.05 vs. CHF-Placebo). Maximal and final ADP-induced aggregation was significantly enhanced in CHF-Placebo vs. Sham-operated animals and normalized / decreased following chronic PETN treatment. Moreover, platelet adhesion was significantly reduced (number of adherent platelets: control: 85.6 +/- 5.5, PETN: 40 +/- 3.3; p<0.001) and VASP phosphorylation significantly enhanced following in vitro PETN treatment. Conclusion Chronic NO supplementation using PETN reduces platelet activation in CHF rats. Thus, PETN may constitute a useful approach to prevent thromboembolic complications in CHF.	[Flierl, Ulrike; Fraccarollo, Daniela; Widder, Julian D.; Micka, Jan; Neuser, Jonas; Bauersachs, Johann; Schaefer, Andreas] Hannover Med Sch, Klin Kardiol & Angiol, Hannover, Germany	Hannover Medical School	Schafer, A (corresponding author), Hannover Med Sch, Klin Kardiol & Angiol, Hannover, Germany.	Schaefer.andreas@mh-hannover.de	Schäfer, Andreas/AAQ-9512-2021		Actavis (Munich, Germany); University of Wurzburg	Actavis (Munich, Germany); University of Wurzburg	The study was partially supported by a research grant from Actavis (Munich, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The remaining funding was internal support by the University of Wurzburg, where the research had been performed.	Andrews NP, 2001, J AM COLL CARDIOL, V37, P510, DOI 10.1016/S0735-1097(00)01114-1; Bauersachs J, 2008, PHARMACOL REP, V60, P119; Begonja AJ, 2005, BLOOD, V106, P2757, DOI 10.1182/blood-2005-03-1047; Chirkov YY, 1999, CIRCULATION, V100, P129, DOI 10.1161/01.CIR.100.2.129; Chung I, 2006, EUR HEART J, V27, P2623, DOI 10.1093/eurheartj/ehl305; Dangel O, 2010, J THROMB HAEMOST, V8, P1343, DOI 10.1111/j.1538-7836.2010.03806.x; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; De Biase L, 2003, THROMB HAEMOSTASIS, V90, P317, DOI 10.1160/TH03-02-0105; de Meirelles LR, 2011, CLIN EXP PHARMACOL P, V38, P705, DOI 10.1111/j.1440-1681.2011.05580.x; Fink B, 1997, J CARDIOVASC PHARM, V30, P831, DOI 10.1097/00005344-199712000-00020; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; Fraccarollo D, 2008, CIRCULATION, V118, P818, DOI 10.1161/CIRCULATIONAHA.107.717702; Garcia-Souza LF, 2014, INT J BIOCHEM CELL B, V50, P156, DOI 10.1016/j.biocel.2014.02.015; Gibbs CR, 2001, CIRCULATION, V103, P1746, DOI 10.1161/01.CIR.103.13.1746; Gori T, 2009, AM J CARDIOVASC DRUG, V9, P7, DOI 10.2165/00129784-200909010-00002; Holmes AS, 2005, BRIT J CLIN PHARMACO, V60, P355, DOI 10.1111/j.1365-2125.2005.02437.x; Jurt U, 2001, J AM COLL CARDIOL, V38, P854, DOI 10.1016/S0735-1097(01)01414-0; Katz SD, 2005, CIRCULATION, V111, P310, DOI 10.1161/01.CIR.0000153349.77489.CF; Kojda G, 1998, EUR J PHARMACOL, V355, P23, DOI 10.1016/S0014-2999(98)00460-9; Loh E, 1997, NEW ENGL J MED, V336, P251, DOI 10.1056/NEJM199701233360403; Massie BM, 2009, CIRCULATION, V119, P1616, DOI 10.1161/CIRCULATIONAHA.108.801753; McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Munzel T, 2013, EUR HEART J, V34, P2666, DOI 10.1093/eurheartj/eht249; Munzel T, 2013, CURR OPIN PHARMACOL, V13, P251, DOI [10.1016/j.coph.2612.12.008, 10.1016/j.coph.2012.12.008]; Munzel T, 2011, CIRCULATION, V123, P2132, DOI 10.1161/CIRCULATIONAHA.110.981407; Munzel T, 2013, EUR HEART J; Peng L, 2004, ANTIOXID REDOX SIGN, V6, P729, DOI 10.1089/1523086041361677; Rutherford E, 2013, EUR HEART J; Schafer A, 2008, CURR VASC PHARMACOL, V6, P52, DOI 10.2174/157016108783331295; Schafer A, 2006, ARTERIOSCL THROM VAS, V26, P2813, DOI 10.1161/01.ATV.0000249407.92147.12; Schafer A, 2010, PHARMACOL RES, V62, P432, DOI 10.1016/j.phrs.2010.06.008; Schafer A, 2009, EUR J HEART FAIL, V11, P336, DOI 10.1093/eurjhf/hfp005; Schafer A, 2004, CIRCULATION, V109, P1819, DOI 10.1161/01.CIR.0000126837.88743.DD; Schnorbus B, 2010, CLIN RES CARDIOL, V99, P115, DOI 10.1007/s00392-009-0096-z; Schuhmacher S, 2010, HYPERTENSION, V55, P897, DOI 10.1161/HYPERTENSIONAHA.109.149542; Wenzel P, 2007, ARTERIOSCL THROM VAS, V27, P1729, DOI 10.1161/ATVBAHA.107.143909	37	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0123621	10.1371/journal.pone.0123621	http://dx.doi.org/10.1371/journal.pone.0123621			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928879	gold, Green Published, Green Submitted			2022-12-27	WOS:000353713100020
J	Mishra, D; Harrison, NR; Gonzales, CB; Schilstrom, B; Konradsson-Geuken, A				Mishra, Devesh; Harrison, Nicholas R.; Gonzales, Carolina B.; Schilstrom, Bjorn; Konradsson-Geuken, Asa			Effects of Age and Acute Ethanol on Glutamatergic Neurotransmission in the Medial Prefrontal Cortex of Freely Moving Rats Using Enzyme-Based Microelectrode Amperometry	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; NUCLEUS-ACCUMBENS; HIPPOCAMPAL-NEURONS; ADOLESCENT BRAIN; IN-VITRO; PLASTICITY; TRANSMISSION; ELIMINATION; INHIBITION; TRANSIENTS	Ethanol abuse during adolescence may significantly alter development of the prefrontal cortex which continues to undergo structural remodeling into adulthood. Glutamatergic neuro-transmission plays an important role during these brain maturation processes and is modulated by ethanol. In this study, we investigated glutamate dynamics in the medial prefrontal cortex of freely moving rats, using enzyme(based microelectrode amperometry. We analyzed the effects of an intraperitoneal ethanol injection (1 g/kg) on cortical glutamate levels in adolescent and adult rats. Notably, basal glutamate levels decreased with age and these levels were found to be significantly different between postnatal day (PND) 28(38 vs PND 44(55 (p<0.05) and PND 28(38 vs adult animals (p<0.001). We also observed spontaneous glutamate release (transients) throughout the recordings. The frequency of transients (per hour) was significantly higher in adolescent rats (PND 28(38 and PND 44(55) compared to those of adults. In adolescent rats, post(ethanol injection, the frequency of glutamate transients decreased within the first hour (p<0.05), it recovered slowly and in the third hour there was a significant rebound increase of the frequency (p<0.05). Our data demonstrate age(dependent differences in extracellular glutamate levels in the medial prefrontal cortex and suggest that acute ethanol injections have both inhibitory and excitatory effects in adolescent rats. These effects of ethanol on the prefrontal cortex may disturb its maturation and possibly limiting individuals' control over addictive behaviors.	[Mishra, Devesh; Harrison, Nicholas R.; Gonzales, Carolina B.; Schilstrom, Bjorn; Konradsson-Geuken, Asa] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Schilstrom, Bjorn] Gothenburg Univ, Sect Neuropsychiat, Dept Neurosci & Physiol, Gothenburg, Sweden; [Konradsson-Geuken, Asa] Karolinska Inst, Dept Neurosci, Stockholm, Sweden	Karolinska Institutet; University of Gothenburg; Karolinska Institutet	Konradsson-Geuken, A (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden.	asa.konradsson.geuken@ki.se	Harrison, Nicholas R./V-1200-2019; Mishra, Devesh Rajkumar/AAJ-9060-2021	Harrison, Nicholas R./0000-0003-1929-0266; Bengtsson Gonzales, Carolina/0000-0003-4084-2125	Alcohol Research Council of the Swedish Alcohol Retailing Monopoly (Centralforbundet for alkohol och narkotikaupplysning CAN-SRA); H. Lundbeck A/S: lent us the glutamate recording unit	Alcohol Research Council of the Swedish Alcohol Retailing Monopoly (Centralforbundet for alkohol och narkotikaupplysning CAN-SRA); H. Lundbeck A/S: lent us the glutamate recording unit	Support was provided by: Alcohol Research Council of the Swedish Alcohol Retailing Monopoly (Centralforbundet for alkohol och narkotikaupplysning CAN-SRA) [www.can.se]; H. Lundbeck A/S: lent us the glutamate recording unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adermark L, 2011, NEUROCHEM INT, V58, P693, DOI 10.1016/j.neuint.2011.02.009; Bastrikova N, 2008, P NATL ACAD SCI USA, V105, P3123, DOI 10.1073/pnas.0800027105; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Boyce PJ, 2009, BRAIN RES BULL, V79, P104, DOI 10.1016/j.brainresbull.2009.01.012; Burmeister JJ, 2001, ANAL CHEM, V73, P1037, DOI 10.1021/ac0010429; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Day BK, 2006, J NEUROCHEM, V96, P1626, DOI 10.1111/j.1471-4159.2006.03673.x; de Graaf-Peters VB, 2006, EARLY HUM DEV, V82, P257, DOI 10.1016/j.earlhumdev.2005.10.013; DeWit DJ, 2000, AM J PSYCHIAT, V157, P745, DOI 10.1176/appi.ajp.157.5.745; Furuta A, 1997, J NEUROSCI, V17, P8363; Grant BF, 1998, J SUBST ABUSE, V10, P163, DOI 10.1016/S0899-3289(99)80131-X; Hascup KN, 2011, NEUROPSYCHOPHARMACOL, V36, P1769, DOI 10.1038/npp.2011.60; Hendricson AW, 2003, J PHARMACOL EXP THER, V307, P550, DOI 10.1124/jpet.103.055137; Konradsson-Geuken A, 2010, NEUROSCIENCE, V169, P1848, DOI 10.1016/j.neuroscience.2010.05.052; Konradsson-Geuken A, 2009, SYNAPSE, V63, P1069, DOI 10.1002/syn.20693; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Melendez RI, 2005, ALCOHOL CLIN EXP RES, V29, P326, DOI 10.1097/01.ALC.0000156086.65665.4D; Mishra D, 2013, ADDICT BIOL, V18, P605, DOI 10.1111/j.1369-1600.2011.00350.x; Mitchell KM, 2004, ANAL CHEM, V76, P1098, DOI 10.1021/ac034757v; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; NIE ZG, 1994, J PHARMACOL EXP THER, V271, P1566; Othman T, 2002, NEUROCHEM RES, V27, P289, DOI 10.1023/A:1014955111742; Paxinos G, 2008, RAT BRAIN STEREOTAXI; Pyapali GK, 1999, ALCOHOL, V19, P107, DOI 10.1016/S0741-8329(99)00021-X; Roberto M, 2004, J NEUROSCI, V24, P1594, DOI 10.1523/JNEUROSCI.5077-03.2004; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Rutherford EC, 2007, J NEUROCHEM, V102, P712, DOI 10.1111/j.1471-4159.2007.04596.x; Selim M, 1996, BRAIN RES, V716, P157, DOI 10.1016/0006-8993(95)01385-7; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Steffensen SC, 2000, J PHARMACOL EXP THER, V294, P637; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Tu Y, 2007, J NEUROSCI, V27, P4765, DOI 10.1523/JNEUROSCI.5378-06.2007; Varlinskaya EI, 2006, ALCOHOL CLIN EXP RES, V30, P1833, DOI 10.1111/j.1530-0277.2006.00220.x; Wassum KM, 2012, J NEUROSCI, V32, P2734, DOI 10.1523/JNEUROSCI.5780-11.2012; Weitlauf C, 2008, ALCOHOL CLIN EXP RES, V32, P690, DOI 10.1111/j.1530-0277.2008.00625.x; White Aaron M, 2005, Recent Dev Alcohol, V17, P161, DOI 10.1007/0-306-48626-1_8	36	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125567	10.1371/journal.pone.0125567	http://dx.doi.org/10.1371/journal.pone.0125567			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927237	Green Submitted, gold, Green Published			2022-12-27	WOS:000353713100101
J	Lipo, CP; Madsen, ME; Dunnell, RC				Lipo, Carl P.; Madsen, Mark E.; Dunnell, Robert C.			A Theoretically-Sufficient and Computationally-Practical Technique for Deterministic Frequency Seriation	PLOS ONE			English	Article							SIMULTANEOUS CONFIDENCE-INTERVALS; CULTURAL TRANSMISSION; POPULATION-STRUCTURE; MICRO-SERIATION; CHRONOLOGY; SEQUENCE	Frequency seriation played a key role in the formation of archaeology as a discipline due to its ability to generate chronologies. Interest in its utility for exploring issues of contemporary interest beyond chronology, however, has been limited. This limitation is partly due to a lack of quantitative algorithms that can be used to build deterministic seriation solutions. When the number of assemblages becomes greater than just a handful, the resources required for evaluation of possible permutations easily outstrips available computing capacity. On the other hand, probabilistic approaches to creating seriations offer a computationally manageable alternative but rely upon a compressed description of the data to order assemblages. This compression removes the ability to use all of the features of our data to fit to the seriation model, obscuring violations of the model, and thus lessens our ability to understand the degree to which the resulting order is chronological, spatial, or a mixture. Recently, frequency seriation has been reconceived as a general method for studying the structure of cultural transmission through time and across space. The use of an evolution-based framework renews the potential for seriation but also calls for a computationally feasible algorithm that is capable of producing solutions under varying configurations, without manual trial and error fitting. Here, we introduce the Iterative Deterministic Seriation Solution (IDSS) for constructing frequency seriations, an algorithm that dramatically constrains the search for potential valid orders of assemblages. Our initial implementation of IDSS does not solve all the problems of seriation, but begins to moves towards a resolution of a long-standing problem in archaeology while opening up new avenues of research into the study of cultural relatedness. We demonstrate the utility of IDSS using late prehistoric decorated ceramics from the Mississippi River Valley. The results compare favorably to previous analyses but add new details into the structure of cultural transmission of these late prehistoric populations.	[Lipo, Carl P.] Calif State Univ Long Beach, Dept Anthropol, Long Beach, CA 90840 USA; [Lipo, Carl P.] Calif State Univ Long Beach, IIRMES, Long Beach, CA 90840 USA; [Madsen, Mark E.] Univ Washington, Dept Anthropol, Seattle, WA 98195 USA; [Dunnell, Robert C.] Mississippi State Univ, Dept Anthropol & Middle Eastern Cultures, Mississippi State, MS 39762 USA	California State University System; California State University Long Beach; California State University System; California State University Long Beach; University of Washington; University of Washington Seattle; Mississippi State University	Lipo, CP (corresponding author), Calif State Univ Long Beach, Dept Anthropol, 1250 Bellflower Blvd, Long Beach, CA 90840 USA.	clipo@csulb.edu	Lipo, Carl/C-9154-2013	Lipo, Carl/0000-0003-4391-3590; Madsen, Mark/0000-0001-9320-8377				Alberti G, 2013, ARCHEOL CALC, V24, P25; Arangala C, 2013, J MATH, V7, P1, DOI [10.2140/involve.2014.7.1, DOI 10.2140/INVOLVE.2014.7.1]; ASCHER M, 1959, AM ANTIQUITY, V25, P212, DOI 10.2307/277440; ASCHER M, 1963, AM ANTHROPOL, V65, P1045, DOI 10.1525/aa.1963.65.5.02a00040; Atkins JE, 1998, SIAM J COMPUT, V28, P297, DOI 10.1137/S0097539795285771; Beals RL, 1945, U CALIFORNIA PUBLICA, V44; Bjorke J. T., 1996, Computers, Environment and Urban Systems, V20, P427, DOI 10.1016/S0198-9715(97)00007-0; Bluhm E, 1951, AM ANTIQUITY, V16, P324, DOI 10.2307/276981; Brainerd GW, 1951, AM ANTIQUITY, V16, P301, DOI 10.2307/276979; Brower J.C., 1985, QUANTITATIVE STRATIG, P95; Buck CE, 2000, J R STAT SOC C-APPL, V49, P423, DOI 10.1111/1467-9876.00203; Buetow KH, 1987, AM J HUM GENET, V49, P423; Cochrane EE, 2010, PHILOS T R SOC B, V365, P3889, DOI 10.1098/rstb.2010.0091; Cochrane GWG, 2003, J ARCHAEOL SCI, V30, P837, DOI 10.1016/S0305-4403(02)00262-5; Collins Henry B., 1937, ARCHAEOLOGY ST LAWRE, V96; Cowgill George L., 1972, MODELS ARCHAEOLOGY, P381; Diestel Reinhard, 2010, GRAPH THEORY; Djindjian F, 1984, TO PATTERN THE PAST, P119; DRENNAN RD, 1976, AM ANTIQUITY, V41, P290, DOI 10.2307/279517; Driver H.E., 1932, U CALIFORNIA PUBLICA, P211; Duff AI, 1996, AM ANTIQUITY, V61, P89, DOI 10.2307/282304; Dunnell R.C., 1971, SYSTEMATICS PREHISTO; DUNNELL RC, 1978, AM ANTIQUITY, V43, P192, DOI 10.2307/279244; DUNNELL RC, 1982, J ANTHROPOL RES, V38, P1; DUNNELL RC, 1970, AM ANTIQUITY, V35, P305, DOI 10.2307/278341; Dunnell RC, 1981, MANEJO DATOS METODOS, P67; Eerkens JW, 2007, J ARCHAEOL RES, V15, P239, DOI 10.1007/s10814-007-9013-z; Eerkens JW, 2005, J ANTHROPOL ARCHAEOL, V24, P316, DOI 10.1016/j.jaa.2005.08.001; Evans C, 1955, BAE B, V160; Flament C., 1963, APPL GRAPH THEORY GR; Ford JA, 1938, AM ANTIQUITY, V3, P260, DOI 10.2307/275264; Ford J. A., 1962, TECHNICAL MANUAL; Ford J. A., 1949, ANTHR PAPERS, V43; Ford JA, 1935, CERAMIC DECORATION S; Gargano ML, 2006, C NUMERANTIUM, V180, P43; Gargano ML, 1996, C NUMERANTIUM, V119, P193; Glaz J, 1999, J STAT PLAN INFER, V82, P251, DOI 10.1016/S0378-3758(99)00047-6; GOODMAN LA, 1965, TECHNOMETRICS, V7, P247, DOI 10.2307/1266673; Halekoh U, 2004, COMPUT STAT DATA AN, V45, P651, DOI 10.1016/S0167-9473(03)00034-3; Halekoh U., 1999, ARCH AG INT CAA97 CO, P107; Harary F., 1969, GRAPH THEORY; Harpole J, 2002, MISSOURI ARCHAEOLOGI, V63, P21; HUBERT L, 1974, BRIT J MATH STAT PSY, V27, P133, DOI 10.1111/j.2044-8317.1974.tb00534.x; Husi P., 2008, J DATA SCI, V6, P135; Kadane JB, 1971, CHRONOLOGICAL ORDERI; KENDALL DG, 1970, PHILOS TR R SOC S-A, V269, P125, DOI 10.1098/rsta.1970.0091; KENDALL DG, 1969, WORLD ARCHAEOL, V1, P68, DOI 10.1080/00438243.1969.9979428; KENDALL DG, 1963, B INT STATIST INST, V40, P657; Kendall DG, 1971, MATH ARCHAEOLOGICAL, P214; Kidder AV, 1917, P NATL ACAD SCI USA, V3, P369, DOI 10.1073/pnas.3.5.369; Kroeber AL, 1919, AM ANTHROPOL, V21, P235, DOI 10.1525/aa.1919.21.3.02a00010; KROEBER AL, 1916, AM MUSEUM NATURAL HI, V18, P1; KUZARA RS, 1966, AM ANTHROPOL, V68, P1442, DOI 10.1525/aa.1966.68.6.02a00050; Laporte G., 1978, J COMPUT APPL MATH, V4, P259, DOI [10.1016/0771-050X(78)90024-4, DOI 10.1016/0771-050X(78)90024-4]; LEBLANC SA, 1975, AM ANTIQUITY, V40, P22, DOI 10.2307/279266; Liiv Innar, 2010, Statistical Analysis and Data Mining, V3, P70, DOI 10.1002/sam.10071; Lipo C., 2001, BRIT ARCHAEOLOGICAL, V918; Lipo C. P., 2001, STYLE FUNCTION CONCE, P91, DOI DOI 10.13140/RG.2.1.1676.2005; Lipo CP, 2006, Mapping Our Ancestors, P89; Lipo Carl P., 2008, CULTURAL TRANSMISSIO, P120; Lipo CP, 1997, J ANTHROPOL ARCHAEOL, V16, P301, DOI 10.1006/jaar.1997.0314; Lipo CP, 2000, THESIS U WASHINGTON; Lyman R.L., 1997, RISE FALL CULTURE HI; Lyman RL, 2006, MAPPING OUR ANCESTORS, P65; Lyman RL., 2006, MEASURING TIME ARTIF; Madsen ME, 2014, COMBINATORIAL STRUCT; Mallios S, 2014, J ANTHROPOL RES, V70, P69, DOI 10.3998/jar.0521004.0070.104; Marquardt W. H., 1978, ADV ARCHAEOLOGICAL M, V1, P257, DOI DOI 10.1016/B978-0-12-003101-6.50014-7; MATTHEWS J, 1963, NATURE, V198, P930, DOI 10.1038/198930a0; Mayer-Oakes WJ, 1955, PREHISTORY UPPER OHI, V34; MCNUTT CH, 1973, AM ANTIQUITY, V38, P45, DOI 10.2307/279310; McNutt CH, 2001, AM ANTHROPOL, V103, P225, DOI 10.1525/aa.2001.103.1.225; MEGGERS Betty, 1957, BUREAU AM ETHNOLOGY, V167; MICHELS JW, 1972, ANNU REV ANTHROPOL, V1, P113, DOI 10.1146/annurev.an.01.100172.000553; MULLER JC, 1983, PROF GEOGR, V35, P196, DOI 10.1111/j.0033-0124.1983.00196.x; NEIMAN FD, 1995, AM ANTIQUITY, V60, P7, DOI 10.2307/282074; Nelson NC, 1916, AM ANTHROPOL, V18, P159, DOI 10.1525/aa.1916.18.2.02a00010; O'Brien MJ, 1998, FORD GROWTH AM ARCHA; O'Brien MJ, 1999, REV ARCHAEOLOGY, V20, P14; O'Brien MJ, 1998, CHANGING PERSPECTIVE, P1; OBrien MJ, 2000, APPL EVOLUTIONARY AR; Peeples MA, 2012, J ARCHAEOL SCI, V39, P2818, DOI 10.1016/j.jas.2012.04.040; PETRIE WMF, 1899, J ANTHR I GREAT BRIT, V29, P295, DOI DOI 10.2307/2843012; Phillips P, 1951, ARCHAEOLOGICAL SURVE, V25; RAFFERTY J, 1994, AM ANTIQUITY, V59, P405, DOI 10.2307/282455; Rafferty J, 2008, SE ARCHAEOLOGY, V27, P253; Robinson WS, 1951, AM ANTIQUITY, V16, P293, DOI 10.2307/276978; Rouse I., 1939, PREHISTORY HAITI STU; Smith CS, 1950, ANTHR PAPERS, V43; Smith K, 2005, SE ARCHAEOLOGY, V26, P49; Spier L, 1917, P NATL ACAD SCI USA, V3, P280, DOI 10.1073/pnas.3.4.280; Spier L, 1917, ANTHROPOL PAP AM MUS, V18, P209; Stein J, 1973, RANDOM HOUSE DICT EN; Teltser P.A., 1995, EVOLUTIONARY ARCHAEO, P51; Usman A, 2003, AFR ARCHAEOL REV, V20, P149, DOI [10.1023/A:1025673401280, DOI 10.1023/A:1025673401280]; VvH Bordaz, 1970, ARCHEOLOGIE CALCULAT, P229; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Wikipedia, 2014, SER; Wilkinson EM, 1971, MATH ARCHAEOLOGICAL, P276	99	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124942	10.1371/journal.pone.0124942	http://dx.doi.org/10.1371/journal.pone.0124942			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923765	Green Submitted, gold, Green Published			2022-12-27	WOS:000353711600115
J	Pollet, T; Cloutier, O; Nozais, C; McKindsey, CW; Archambault, P				Pollet, Thomas; Cloutier, Olivier; Nozais, Christian; McKindsey, Christopher W.; Archambault, Philippe			Metabolic Activity and Functional Diversity Changes in Sediment Prokaryotic Communities Organically Enriched with Mussel Biodeposits	PLOS ONE			English	Article							LEVEL PHYSIOLOGICAL PROFILES; LA-MADELEINE QUEBEC; BIOGEOCHEMICAL FLUXES; NITROGEN DYNAMICS; CULTURE; LAGOON; WATER; CLASSIFICATION; AQUACULTURE; MEIOFAUNA	This experimental microcosm study reports the influence of organic enrichments by mussel biodeposits on the metabolic activity and functional diversity of benthic prokaryotic communities. The different biodeposit enrichment regimes created, which mimicked the quantity of faeces and pseudo-faeces potentially deposited below mussel farms, show a clear stimulatory effect of this organic enrichment on prokaryotic metabolic activity. This effect was detected once a certain level of biodeposition was attained with a tipping point estimated between 3.25 and 10 g day(-1) m(-2). Prokaryotic communities recovered their initial metabolic activity by 11 days after the cessation of biodeposit additions. However, their functional diversity remained greater than prior to the disturbance suggesting that mussel biodeposit enrichment may disturb the functioning and perhaps the role of prokaryotic communities in benthic ecosystems. This manipulative approach provided new information on the influence of mussel biodeposition on benthic prokaryotic communities and dose-response relationships and may support the development of carrying capacity models for bivalve culture.	[Pollet, Thomas; Cloutier, Olivier; Archambault, Philippe] Univ Quebec, Inst Sci de la Mer, Lab Ecol Benth, Rimouski, PQ G5L 3A1, Canada; [Nozais, Christian] Univ Quebec, Dept Biol Chim & Geog, Rimouski, PQ, Canada; [McKindsey, Christopher W.] Fisheries & Oceans Canada, Maurice Lamontagne Inst, Ocean & Environm Sci Div, Mont Joli, PQ G5H 3Z4, Canada	University of Quebec; University of Quebec; Fisheries & Oceans Canada	Pollet, T (corresponding author), Univ Quebec, Inst Sci de la Mer, Lab Ecol Benth, Rimouski, PQ G5L 3A1, Canada.	thomas.pollet@hotmail.fr	McKindsey, Chris/AAH-6773-2020; Pollet, Thomas/AAZ-2141-2021	McKindsey, Chris/0000-0002-3026-6454	Natural Sciences and Engineering Research Council of Canada (NSERC); NSERC; Fisheries and Oceans Canada	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fisheries and Oceans Canada	TP was supported by a RAQ-FONCER postdoctoral grant from the Natural Sciences and Engineering Research Council of Canada (NSERC). The study was also supported by other funding obtained by PA (NSERC and Fisheries and Oceans Canada) and CN (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brashears MM, 1995, J DAIRY SCI, V78, P2326, DOI 10.3168/jds.S0022-0302(95)76859-X; Callier MD, 2008, AQUACULTURE, V278, P77, DOI 10.1016/j.aquaculture.2008.03.026; Callier MD, 2007, MAR ECOL PROG SER, V348, P103, DOI 10.3354/meps07034; Callier MD, 2006, MAR ECOL PROG SER, V322, P129, DOI 10.3354/meps322129; Callier MD, 2009, MAR POLLUT BULL, V58, P1544, DOI 10.1016/j.marpolbul.2009.05.010; Christensen PB, 2003, AQUACULTURE, V218, P567, DOI 10.1016/S0044-8486(02)00587-2; Crawford CM, 2003, AQUACULTURE, V224, P117, DOI 10.1016/S0044-8486(03)00210-2; Danovaro R, 2004, MAR POLLUT BULL, V49, P325, DOI 10.1016/j.marpolbul.2004.02.038; Danovaro R, 2003, CHEM ECOL, V19, P391, DOI 10.1080/02757540310001596681; FABIANO M, 1994, MAR BIOL, V119, P375, DOI 10.1007/BF00347534; Foschino R, 1996, J DAIRY RES, V63, P295, DOI 10.1017/S0022029900031782; GARLAND JL, 1991, APPL ENVIRON MICROB, V57, P2351, DOI 10.1128/AEM.57.8.2351-2359.1991; Garland JL, 1997, FEMS MICROBIOL ECOL, V24, P289, DOI 10.1016/S0168-6496(97)00061-5; Gilbert F, 1997, MAR ECOL PROG SER, V151, P143, DOI 10.3354/meps151143; Giles H, 2004, MAR ECOL PROG SER, V282, P205, DOI 10.3354/meps282205; Gillan DC, 2012, SCI TOTAL ENVIRON, V419, P98, DOI 10.1016/j.scitotenv.2011.12.034; Glud RN, 2004, LIMNOL OCEANOGR, V49, P2073, DOI 10.4319/lo.2004.49.6.2073; Gomez E, 2004, APPL SOIL ECOL, V26, P21, DOI 10.1016/j.apsoil.2003.10.007; Grant C, 2012, AQUACULT ENV INTERAC, V2, P117, DOI 10.3354/aei00035; GRENZ C, 1990, HYDROBIOLOGIA, V207, P153, DOI 10.1007/BF00041452; Hargrave BT, 2008, MAR POLLUT BULL, V56, P810, DOI 10.1016/j.marpolbul.2008.02.006; HARRIS JM, 1993, MICROB ECOL, V25, P195, DOI 10.1007/BF00171889; Hartstein ND, 2004, MAR ENVIRON RES, V57, P339, DOI 10.1016/j.marenvres.2003.11.003; Kaiser MJ, 1998, J SHELLFISH RES, V17, P59; Kuwae T, 1999, APPL ENVIRON MICROB, V65, P3407; La Rosa T, 2001, ENVIRON POLLUT, V112, P427, DOI 10.1016/S0269-7491(00)00141-X; Lavrentyev PJ, 2000, AQUAT MICROB ECOL, V21, P187, DOI 10.3354/ame021187; Luna GM, 2013, WATER RES, V47, P1156, DOI 10.1016/j.watres.2012.11.036; McKindsey CW, 2006, AQUACULTURE, V261, P451, DOI 10.1016/j.aquaculture.2006.06.044; McKindsey CW, 2011, CAN J ZOOL, V89, P622, DOI [10.1139/Z11-037, 10.1139/z11-037]; McKindsey CW, 2009, AQUACULTURE, V295, P44, DOI 10.1016/j.aquaculture.2009.06.022; Mirto S., 1999, Biologia Marina Mediterranea, V6, P331; Mirto S, 2000, MAR POLLUT BULL, V40, P244, DOI 10.1016/S0025-326X(99)00209-X; Navarro JM, 1997, J EXP MAR BIOL ECOL, V209, P1, DOI 10.1016/0022-0981(96)02681-0; Newell RIE, 2004, J SHELLFISH RES, V23, P51; Pearson T.H., 1978, Oceanography and Marine Biology an Annual Review, V16, P229; Piot A, 2014, OIKOS, V123, P203, DOI 10.1111/j.1600-0706.2013.00631.x; Richard M, 2007, CAN J FISH AQUAT SCI, V64, P1491, DOI 10.1139/F07-116; Richard M, 2006, CAN J FISH AQUAT SCI, V63, P1198, DOI 10.1139/F06-030; Robert P, 2013, MAR POLLUT BULL, V66, P92, DOI 10.1016/j.marpolbul.2012.11.003; Sestanovic S., 2005, ACTA ADRIAT, V46, P177; Weise AM, 2009, AQUACULTURE, V288, P239, DOI 10.1016/j.aquaculture.2008.12.001; Zhou Y, 2006, MAR ECOL PROG SER, V317, P127, DOI 10.3354/meps317127	43	7	7	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123681	10.1371/journal.pone.0123681	http://dx.doi.org/10.1371/journal.pone.0123681			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923715	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600054
J	Rayner, RE; Savill, J; Hafner, LM; Huygens, F				Rayner, Rachael E.; Savill, John; Hafner, Louise M.; Huygens, Flavia			Modified MLVA for Genotyping Queensland Invasive Streptococcus pneumoniae	PLOS ONE			English	Article							TANDEM-REPEAT ANALYSIS; PNEUMOCOCCAL DISEASE; SEROTYPE REPLACEMENT; IDENTIFICATION; DISCOVERY; LOCI	Background Globally, over 800 000 children under five die each year from infectious diseases caused by Streptococcus pneumoniae. To understand genetic relatedness between isolates, study transmission routes, assess the impact of human interventions e.g. vaccines, and determine infection sources, genotyping methods are required. The 'gold standard' genotyping method, Multi-Locus Sequence Typing (MLST), is useful for long-term and global studies. Another genotyping method, Multi-Locus Variable Number of Tandem Repeat Analysis (MLVA), has emerged as a more discriminatory, inexpensive and faster technique; however there is no universally accepted method and it is currently suitable for short-term and localised epidemiology studies. Currently Australia has no national MLST database, nor has it adopted any MLVA method for short-term or localised studies. This study aims to improve S. pneumoniae genotyping methods by modifying the existing MLVA techniques to be more discriminatory, faster, cheaper and technically less demanding than previously published MLVA methods and MLST. Methods Four different MLVA protocols, including a modified method, were applied to 317 isolates of serotyped invasive S. pneumoniae isolated from sterile body sites of Queensland children under 15 years from 2007-2012. MLST was applied to 202 isolates for comparison. Results The modified MLVA4 is significantly more discriminatory than the 'gold standard' MLST method. MLVA4 has similar discrimination compared to other MLVA techniques in this study). The failure to amplify particular loci in previous MLVA methods were minimised in MLVA4. Failure to amplify BOX-13 and Spneu19 were found to be serotype specific. Conclusion We have modified a highly discriminatory MLVA technique for genotyping Queensland invasive S. pneumoniae. MLVA4 has the ability to enhance our understanding of the pneumococcal epidemiology and the changing genetics of the pneumococcus in localised and short-term studies.	[Rayner, Rachael E.; Hafner, Louise M.; Huygens, Flavia] Queensland Univ Technol, Sch Biomed Sci, Brisbane, Qld 4001, Australia; [Rayner, Rachael E.; Hafner, Louise M.; Huygens, Flavia] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Savill, John] Queensland Hlth Forens & Sci Serv, Publ Hlth Microbiol Lab, Brisbane, Qld, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT); Queensland Health	Huygens, F (corresponding author), Queensland Univ Technol, Sch Biomed Sci, Brisbane, Qld 4001, Australia.	f.huygens@qut.edu.au		Rayner, Rachael E/0000-0002-0659-559X; Huygens, Flavia/0000-0002-2737-2264	Queensland Health Forensic and Scientific Services, Coopers Plains, Australia	Queensland Health Forensic and Scientific Services, Coopers Plains, Australia	This work was supported by the Queensland Health Forensic and Scientific Services, Coopers Plains, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansaldi F, 2011, CLIN VACCINE IMMUNOL, V18, P343, DOI 10.1128/CVI.00383-10; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Bratcher PE, 2010, MICROBIOL-SGM, V156, P555, DOI 10.1099/mic.0.034116-0; Brueggemann AB, 2007, PLOS PATHOG, V3, P1628, DOI 10.1371/journal.ppat.0030168; Calix JJ, 2012, J BIOL CHEM, V287, P27885, DOI 10.1074/jbc.M112.380451; Calix JJ, 2010, J INFECT DIS, V202, P29, DOI 10.1086/653123; Centers for Disease Control Prevention, 2013, INV PNEUM DIS IPD ST; Croucher NJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-120; Elberse KEM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020390; Elberse KEM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019668; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Francisco AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-87; HERMANS PWM, 1995, J CLIN MICROBIOL, V33, P1606, DOI 10.1128/JCM.33.6.1606-1612.1995; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Jefferies J, 2003, MOL BIOTECHNOL, V24, P303, DOI 10.1385/MB:24:3:303; Johnson DR, 2012, VACCINE, V30, P2206, DOI 10.1016/j.vaccine.2011.12.119; KELLY T, 1994, INFECT IMMUN, V62, P1813, DOI 10.1128/IAI.62.5.1813-1819.1994; Knutsen E, 2006, J BACTERIOL, V188, P8307, DOI 10.1128/JB.00850-06; Ko KS, 2013, J CLIN MICROBIOL, V51, P3395, DOI 10.1128/JCM.01645-13; Koeck JL, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-66; Lehmann D, 2010, CLIN INFECT DIS, V50, P1477, DOI 10.1086/652440; Lindstedt BA, 2013, EUROSURVEILLANCE, V18, P7; Lindstedt BA, 2005, ELECTROPHORESIS, V26, P2567, DOI 10.1002/elps.200500096; Malachowa N, 2005, J CLIN MICROBIOL, V43, P3095, DOI 10.1128/JCM.43.7.3095-3100.2005; MARTIN B, 1992, NUCLEIC ACIDS RES, V20, P3479, DOI 10.1093/nar/20.13.3479; Mehr S, 2012, PAEDIATR RESPIR REV, V13, P258, DOI 10.1016/j.prrv.2011.12.001; NNDSS, 2013, DIS NOT RAT QLD 1991; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06; Pichon B, 2010, J CLIN MICROBIOL, V48, P1926, DOI 10.1128/JCM.02054-09; Rakov AV, 2011, INFECT GENET EVOL, V11, P1929, DOI 10.1016/j.meegid.2011.08.016; Sabharwal V, 2013, MICROBES IN IN PRESS; Sanchez-Beato AR, 1998, FEMS MICROBIOL LETT, V164, P207, DOI 10.1016/S0378-1097(98)00206-7; Schouls L, 2012, STREP PNEUM; Selvey C., 2011, INFORM PREVENAR 13 S; Severiano A, 2011, J CLIN MICROBIOL, V49, P3997, DOI 10.1128/JCM.00624-11; Spratt BG, 2000, LANCET, V356, P1210, DOI 10.1016/S0140-6736(00)02779-3; Statens Serum Institut, 2013, PNEUM ANT; van Cuyck H, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-241; Vu-Thien H, 2007, J CLIN MICROBIOL, V45, P3175, DOI 10.1128/JCM.00702-07; WALLACE DL, 1983, J AM STAT ASSOC, V78, P569, DOI 10.2307/2288118; Wyres KL, 2013, J INFECT DIS, V207, P439, DOI 10.1093/infdis/jis703; Yaro S, 2006, CLIN INFECT DIS, V43, P693, DOI 10.1086/506940	43	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0121870	10.1371/journal.pone.0121870	http://dx.doi.org/10.1371/journal.pone.0121870			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923909	gold, Green Published, Green Submitted			2022-12-27	WOS:000353711600008
J	De Rosa, FG; Corcione, S; Filippini, C; Raviolo, S; Fossati, L; Montrucchio, C; Aldieri, C; Petrolo, A; Cavallo, R; Di Perri, G				De Rosa, Francesco G.; Corcione, Silvia; Filippini, Claudia; Raviolo, Stefania; Fossati, Lucina; Montrucchio, Chiara; Aldieri, Chiara; Petrolo, Alessia; Cavallo, Rossana; Di Perri, Giovanni			The Effect on Mortality of Fluconazole or Echinocandins Treatment in Internal Medicine Wards	PLOS ONE			English	Article							BLOOD-STREAM INFECTION; INVASIVE CANDIDIASIS; CANDIDEMIA; EPIDEMIOLOGY; MANAGEMENT; OUTCOMES; MULTICENTER; PREDICTORS; CARE; SURVEILLANCE	The incidence of candidemia has increased over the past two decades, with an increased number of cases in Internal Medicine and a prevalence ranging from 24% to 57%. This single-center retrospective study was performed to evaluate the epidemiology and the risk factors associated with mortality of candidemia in patients admitted to Internal Medicine wards (IMWs) of the City of Health and Sciences, Molinette Hospital, Turin, from January 2004 to December 2012. For each patient, demographic, clinical and microbiological data were collected. A case of candidemia was defined as a patient with at least one blood culture positive for Candida spp. Amongst 670 episodes of candidemia, 274 (41%) episodes occurred in IMWs. The mortality was 39% and was associated at multivariate analysis with sepsis, cirrhosis and neurologic diseases, whilst removal of central venous catheter <= 48h was significantly associated with survival. In the 77 patients treated with early antifungal therapy the mortality was 29% and was not significantly different with caspofungin or fluconazole, whilst in patients with definitive therapy the mortality was significantly lower with echinocandins compared to fluconazole (11.7% Vs. 39%; p=0.0289), a finding confirmed by multivariate analysis. The mortality was significantly associated with sepsis, cirrhosis and neurologic diseases, whilst CVC removal <= 48h was associated with survival. In patients with early therapy, fluconazole or caspofungin were equally effective. However, echinocandins were significantly more effective as definitive treatment, a finding not explained by differences in treatment delays. Further studies are needed to understand the full potential of these different therapeutic strategies in IMWs.	[De Rosa, Francesco G.; Corcione, Silvia; Raviolo, Stefania; Montrucchio, Chiara; Aldieri, Chiara; Petrolo, Alessia; Di Perri, Giovanni] Univ Turin, Infect Dis Amedeo di Savoia Hosp, Dept Med Sci, Turin, Italy; [Filippini, Claudia] Univ Turin, Molinette Hosp, City Hlth & Sci, Dept Anesthesia & Crit Care, Turin, Italy; [Fossati, Lucina; Cavallo, Rossana] Univ Turin, Dept Publ Hlth & Pediat Sci, City Hlth & Sci, Lab Microbiol & Virol, Turin, Italy	University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin	De Rosa, FG (corresponding author), Univ Turin, Infect Dis Amedeo di Savoia Hosp, Dept Med Sci, Turin, Italy.	francescogiuseppe.derosa@unito.it	Cavallo, Rossana/AAL-4279-2020; Di Perri, Giovanni/AAC-1882-2019; DE ROSA, Francesco Giuseppe/AAC-7275-2022	Cavallo, Rossana/0000-0001-8655-8707; DE ROSA, Francesco Giuseppe/0000-0001-8338-0130; corcione, silvi/0000-0003-2949-4297; Filippini, Claudia/0000-0003-0194-142X				Almirante B, 2005, J CLIN MICROBIOL, V43, P1829, DOI 10.1128/JCM.43.4.1829-1835.2005; Andes DR, 2012, CLIN INFECT DIS, V54, P1110, DOI 10.1093/cid/cis021; Bassetti M, 2013, CLIN MICROBIOL INFEC, V19, pE281, DOI 10.1111/1469-0691.12155; Bassetti M, 2014, INTENS CARE MED, V40, P839, DOI 10.1007/s00134-014-3310-z; Bassetti M, 2013, J CLIN MICROBIOL, V51, P4167, DOI 10.1128/JCM.01998-13; Bassetti M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024198; Cisterna R, 2010, J CLIN MICROBIOL, V48, P4200, DOI 10.1128/JCM.00920-10; CLSI, 2012, M100S22 CLSI; Colombo AL, 2014, INTENS CARE MED, V40, P1489, DOI 10.1007/s00134-014-3400-y; Cornely OA, 2012, CLIN MICROBIOL INFEC, V18, P19, DOI 10.1111/1469-0691.12039; De Rosa FG, 2013, J ANTIMICROB CHEMOTH, V68, P927, DOI 10.1093/jac/dks480; Fernandez-Ruiz M, 2014, CLIN INFECT DIS, V58, P1413, DOI 10.1093/cid/ciu158; Fortun J, 2012, J INFECTION, V65, P64, DOI 10.1016/j.jinf.2012.02.011; Garey KW, 2006, CLIN INFECT DIS, V43, P25, DOI 10.1086/504810; Guimaraes T, 2012, INT J INFECT DIS, V16, pE442, DOI 10.1016/j.ijid.2012.02.005; Ha YE, 2012, ANTIMICROB AGENTS CH, V56, P3950, DOI 10.1128/AAC.06258-11; Leroy O, 2009, CRIT CARE MED, V37, P1612, DOI 10.1097/CCM.0b013e31819efac0; Lortholary O, 2011, ANTIMICROB AGENTS CH, V55, P532, DOI 10.1128/AAC.01128-10; Luzzati R, 2000, EUR J CLIN MICROBIOL, V19, P602, DOI 10.1007/s100960000325; Macphail GLP, 2002, MYCOSES, V45, P141, DOI 10.1046/j.1439-0507.2002.00741.x; Mora-Duarte J, 2002, NEW ENGL J MED, V347, P2020, DOI 10.1056/NEJMoa021585; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Pfaller M, 2012, DIAGN MICR INFEC DIS, V74, P323, DOI 10.1016/j.diagmicrobio.2012.10.003; Poikonen E, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-312; Reboli AC, 2007, NEW ENGL J MED, V356, P2472, DOI 10.1056/NEJMoa066906; Scudeller L, 2014, INFECTION, V42, P263, DOI 10.1007/s15010-013-0558-0; Tortorano AM, 2013, INFECTION, V41, P655, DOI 10.1007/s15010-013-0455-6; Tortorano AM, 2004, EUR J CLIN MICROBIOL, V23, P317, DOI 10.1007/s10096-004-1103-y	28	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125149	10.1371/journal.pone.0125149	http://dx.doi.org/10.1371/journal.pone.0125149			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938486	Green Published, Green Submitted, gold			2022-12-27	WOS:000353943000047
J	Guha, G; Lu, WL; Li, S; Liang, XB; Kulesz-Martin, MF; Mahmud, T; Indra, AK; Ganguli-Indra, G				Guha, Gunjan; Lu, Wanli; Li, Shan; Liang, Xiaobo; Kulesz-Martin, Molly F.; Mahmud, Taifo; Indra, Arup Kumar; Ganguli-Indra, Gitali			Novel Pactamycin Analogs Induce p53 Dependent Cell-Cycle Arrest at S-Phase in Human Head and Neck Squamous Cell Carcinoma (HNSCC) Cells	PLOS ONE			English	Article							PROLIFERATION MARKERS; MITOTIC CATASTROPHE; SENESCENT CELLS; METASTATIC HEAD; PARP CLEAVAGE; APOPTOSIS; PROTEIN; PHOSPHORYLATION; INHIBITION; EXPRESSION	Pactamycin, although putatively touted as a potent antitumor agent, has never been used as an anticancer drug due to its high cytotoxicity. In this study, we characterized the effects of two novel biosynthetically engineered analogs of pactamycin, de-6MSA-7-demethyl-7-deoxypactamycin (TM-025) and 7-demethyl-7-deoxypactamycin (TM-026), in head and neck squamous cell carcinoma (HNSCC) cell lines SCC25 and SCC104. Both TM-025 and TM-026 exert growth inhibitory effects on HNSCC cells by inhibiting cell proliferation. Interestingly, unlike their parent compound pactamycin, the analogs do not inhibit synthesis of nascent protein in a cell-based assay. Furthermore, they do not induce apoptosis or autophagy in a dose- or a time-dependent manner, but induce mild senescence in the tested cell lines. Cell cycle analysis demonstrated that both analogs significantly induce cell cycle arrest of the HNSCC cells at S-phase resulting in reduced accumulation of G(2)/M-phase cells. The pactamycin analogs induce expression of cell cycle regulatory proteins including master regulator p53, its downstream target p21(Cip1/WAF1), p27(kip21), p19, cyclin E, total and phospho Cdc2 (Tyr15) and Cdc25C. Besides, the analogs mildly reduce cyclin D1 expression without affecting expression of cyclin B, Cdk2 and Cdk4. Specific inhibition of p53 by pifithrin-alpha reduces the percentage of cells accumulated in S-phase, suggesting contribution of p53 to S-phase increase. Altogether, our results demonstrate that Pactamycin analogs TM-025 and TM-026 induce senescence and inhibit proliferation of HNSCC cells via accumulation in S-phase through possible contribution of p53. The two PCT analogs can be widely used as research tools for cell cycle inhibition studies in proliferating cancer cells with specific mechanisms of action.	[Guha, Gunjan; Lu, Wanli; Li, Shan; Liang, Xiaobo; Mahmud, Taifo; Indra, Arup Kumar; Ganguli-Indra, Gitali] Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA; [Lu, Wanli; Mahmud, Taifo; Indra, Arup Kumar; Ganguli-Indra, Gitali] Oregon State Univ, Mol & Cell Biol Program, Corvallis, OR 97331 USA; [Kulesz-Martin, Molly F.; Indra, Arup Kumar] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA; [Indra, Arup Kumar] Oregon Hlth & Sci Univ, Environm Hlth Sci Ctr, Portland, OR 97201 USA	Oregon State University; Oregon State University; Oregon Health & Science University; Oregon Health & Science University	Indra, AK (corresponding author), Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA.	arup.indra@oregonstate.edu; indrag@onid.orst.edu	Indra, Arup/AAG-2376-2019; Mahmud, Taifo/A-1492-2015; Guha, Gunjan/D-8197-2011; Indra, Gitali/G-2963-2016	Indra, Arup/0000-0001-6137-7555; Mahmud, Taifo/0000-0001-9639-526X; Guha, Gunjan/0000-0002-9224-0241; 	National Institutes of Health (NIH); Oregon Health & Science University (OHSU) Medical Research Foundation grant; College of Pharmacy General Research Fund; National Institute of Environmental Health Sciences (NIEHS) center grant [ES00210]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oregon Health & Science University (OHSU) Medical Research Foundation grant; College of Pharmacy General Research Fund; National Institute of Environmental Health Sciences (NIEHS) center grant; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	These studies were supported by grant 5R01AR056008-03 (AI) from the National Institutes of Health (NIH), Oregon Health & Science University (OHSU) Medical Research Foundation grant (AI), College of Pharmacy General Research Fund and the National Institute of Environmental Health Sciences (NIEHS) center grant (ES00210) to Environmental Health Sciences Center, Oregon State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin ARMR, 2009, J CLIN ONCOL, V27, P2712, DOI 10.1200/JCO.2008.20.6235; Auld CA, 2007, J CELL PHYSIOL, V211, P101, DOI 10.1002/jcp.20915; Aziz N, 2011, FERTIL STERIL, V95, P2481, DOI 10.1016/j.fertnstert.2011.03.095; Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Bhakta D, 2012, FOOD CHEM TOXICOL, V50, P2062, DOI 10.1016/j.fct.2012.03.045; Bharti AC, 2005, METH MOLEC MED, V111, P69; BHUYAN BK, 1962, APPL MICROBIOL, V10, P302, DOI 10.1128/AEM.10.4.302-304.1962; Bringold F, 2000, EXP GERONTOL, V35, P317, DOI 10.1016/S0531-5565(00)00083-8; Brown ET, 2008, RADIAT RES, V169, P595, DOI 10.1667/RR1129.1; Camats M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008513; Camphausen K, 2003, CANCER RES, V63, P1990; Cheng Y, 2009, ARCH BIOCHEM BIOPHYS, V490, P70, DOI 10.1016/j.abb.2009.08.011; Choi HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024312; COHEN LB, 1969, BIOCHEMISTRY-US, V8, P1327, DOI 10.1021/bi00832a005; Cong F, 2012, ANNU REV PHARMACOL, V52, P57, DOI 10.1146/annurev-pharmtox-010611-134639; Culmsee C, 2001, J NEUROCHEM, V77, P220, DOI 10.1046/j.1471-4159.2001.00220.x; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dotto GP, 2000, BIOCHIM BIOPHYS ACTA, P1471; Eom YW, 2005, ONCOGENE, V24, P4765, DOI 10.1038/sj.onc.1208627; FERNANDESALNEMRI T, 1994, J BIOL CHEM, V269, P30761; Fung C, 2010, EXPERT OPIN EMERG DR, V15, P355, DOI 10.1517/14728214.2010.497754; Ghaffari AR, 2011, HEPAT MON, V11, P463; Gillespie V, 2011, VET PATHOL, V48, P283, DOI 10.1177/0300985810380397; Grevelman EG, 2005, ANN ONCOL, V16, P352, DOI 10.1093/annonc/mdi088; Gruber HE, 1999, BIOTECH HISTOCHEM, V74, P141, DOI 10.3109/10520299909047966; Guha G, 2010, FOOD CHEM TOXICOL, V48, P2133, DOI 10.1016/j.fct.2010.05.017; Han YH, 2008, TOXICOL IN VITRO, V22, P1605, DOI 10.1016/j.tiv.2008.06.014; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanessian S, 2011, ANGEW CHEM INT EDIT, V50, P3497, DOI 10.1002/anie.201008079; Hanessian S, 2013, BIOORGAN MED CHEM, V21, P1775, DOI 10.1016/j.bmc.2013.01.037; Hanessian S, 2012, J ORG CHEM, V77, P9458, DOI 10.1021/jo301638z; HEICHMAN KA, 1994, CELL, V79, P557, DOI 10.1016/0092-8674(94)90541-X; Hoe KK, 2014, NAT REV DRUG DISCOV, V13, P217, DOI 10.1038/nrd4236; Hu D, 2012, ARCH OTOLARYNGOL, V138, P412, DOI 10.1001/archoto.2012.20; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jessus C, 1995, Prog Cell Cycle Res, V1, P215; Joe AK, 2002, CLIN CANCER RES, V8, P893; Kachnic LA, 1999, J BIOL CHEM, V274, P13111, DOI 10.1074/jbc.274.19.13111; Kadowaki M, 2009, METHOD ENZYMOL, V452, P199, DOI 10.1016/S0076-6879(08)03613-6; Kaldis P, 2005, CELL CYCLE, V4, P1491, DOI 10.4161/cc.4.11.2124; Kang JY, 2009, MOL CELLS, V28, P489, DOI 10.1007/s10059-009-0141-9; Kijima T, 2002, CELL GROWTH DIFFER, V13, P355; Konishi T, 2011, J RADIAT RES, V52, P433, DOI 10.1269/jrr.10097; KUNG AL, 1990, CANCER RES, V50, P7307; Kuroda J, 2005, INT J ONCOL, V26, P361; Lee HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036221; Lehner B, 2011, CELL TISSUE RES, V345, P313, DOI 10.1007/s00441-011-1213-7; Leker RR, 2004, EXP NEUROL, V187, P478, DOI 10.1016/j.expneurol.2004.01.030; Lin JT, 2012, ADV THER, V29, P71, DOI 10.1007/s12325-011-0085-2; Lu WL, 2011, CHEM BIOL, V18, P425, DOI 10.1016/j.chembiol.2011.01.016; Malinowski JT, 2013, SCIENCE, V340, P180, DOI 10.1126/science.1234756; Matsunaga H, 2010, CELL DEATH DIFFER, V17, P1760, DOI 10.1038/cdd.2010.52; Monroe MM, 2011, J ONCOL, V2011, DOI 10.1155/2011/762780; Moreno-Otero R, 2011, CURR DRUG SAF, V6, P197, DOI 10.2174/157488611797579221; Munro J, 2001, ONCOGENE, V20, P3541, DOI 10.1038/sj.onc.1204460; Nakashima N, 2012, LUNG CANCER, V76, P228, DOI 10.1016/j.lungcan.2011.10.007; NORBURY C, 1991, EMBO J, V10, P3321, DOI 10.1002/j.1460-2075.1991.tb04896.x; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Olivero OA, 2005, MUTAGENESIS, V20, P139, DOI 10.1093/mutage/gei019; Otoguro K, 2010, J ANTIBIOT, V63, P381, DOI 10.1038/ja.2010.50; Pactamycin White F., 1962, CANCER CHEMOTH REP, V24, P75; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Poon RYC, 1996, J BIOL CHEM, V271, P13283, DOI 10.1074/jbc.271.22.13283; Portugal J, 2009, TUMORI J, V95, P409; Price KAR, 2012, CURR TREAT OPTION ON, V13, P35, DOI 10.1007/s11864-011-0176-y; Prueksaritanond Nisa, 2012, J Med Assoc Thai, V95 Suppl 3, pS55; Romero Q, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-341; Roninson IB, 2003, CANCER RES, V63, P2705; Sanderson RJ, 2002, BMJ-BRIT MED J, V325, P822, DOI 10.1136/bmj.325.7368.822; Sarkar FH, 2009, CELL SIGNAL, V21, P1541, DOI 10.1016/j.cellsig.2009.03.009; Schafer T, 2003, FASEB J, V17, P660, DOI 10.1096/fj.02-0774com; Schwartz GK, 2005, J CLIN ONCOL, V23, P9408, DOI 10.1200/JCO.2005.01.5594; Sharpe RJ, 2013, J AM CHEM SOC, V135, P17990, DOI 10.1021/ja409944u; Singh R, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-4; Sultana S, 2012, J PHARM PHARMACOL, V64, P872, DOI 10.1111/j.2042-7158.2012.01470.x; TABER R, 1971, J VIROL, V8, P395, DOI 10.1128/JVI.8.4.395-401.1971; Tamaki T, 2003, J INT MED RES, V31, P6, DOI 10.1177/147323000303100102; Tang DG, 2000, J CELL BIOL, V148, P971, DOI 10.1083/jcb.148.5.971; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Tokgoz SA, 2012, J LARYNGOL OTOL, V126, P464, DOI 10.1017/S0022215112000382; Tyagi A, 2005, CARCINOGENESIS, V26, P1978, DOI 10.1093/carcin/bgi165; van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193; van Meerloo J, 2011, METHODS MOL BIOL, V731, P237, DOI 10.1007/978-1-61779-080-5_20; Walton MI, 2005, MOL CANCER THER, V4, P1369, DOI 10.1158/1535-7163.MCT-04-0341; Wang GH, 2009, J TOXICOL-US, V2009, DOI 10.1155/2009/634868; Wells NJ, 1999, J CELL SCI, V112, P3361; Wildemann B, 2003, J BIOMED MATER RES B, V65B, P150, DOI 10.1002/jbm.b.10512; Wilken R, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-12; Yin XF, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-46; Zhang YX, 2000, CANCER RES, V60, P2025; Zhang Z, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.182; Zhang Z, 2002, CHEM RES TOXICOL, V15, P950, DOI 10.1021/tx0255018	93	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125322	10.1371/journal.pone.0125322	http://dx.doi.org/10.1371/journal.pone.0125322			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938491	Green Published, Green Submitted, gold			2022-12-27	WOS:000353943000057
J	Pianta, TJ; Endre, ZH; Pickering, JW; Buckley, NA; Peake, PW				Pianta, Timothy J.; Endre, Zoltan H.; Pickering, John W.; Buckley, Nicholas A.; Peake, Philip W.			Kinetic Estimation of GFR Improves Prediction of Dialysis and Recovery after Kidney Transplantation	PLOS ONE			English	Article							DELAYED GRAFT FUNCTION; CYSTATIN-C; CREATININE CLEARANCE; RENAL-FUNCTION; BIOMARKERS; EQUATION; INJURY; IMPACT	Background The early prediction of delayed graft function (DGF) would facilitate patient management after kidney transplantation. Methods In a single-centre retrospective analysis, we investigated kinetic estimated GFR under non-steady-state conditions, KeGFR, in prediction of DGF. KeGFR(sCr) was calculated at 4h, 8h and 12h in 56 recipients of deceased donor kidneys from initial serum creatinine (sCr) concentrations, estimated creatinine production rate, volume of distribution, and the difference between consecutive sCr values. The utility of KeGFR(sCr) for DGF prediction was compared with, sCr, plasma cystatin C (pCysC), and KeGFR(pCysC) similarly derived from pCysC concentrations. Results At 4h, the KeGFR(sCr) area under the receiver operator characteristic curve (AUC) for DGF prediction was 0.69 (95% CI: 0.56-0.83), while sCr was not useful (AUC 0.56, (CI: 0.41-0.72). Integrated discrimination improvement analysis showed that the KeGFRsCr improved a validated clinical prediction model at 4h, 8h, and 12h, increasing the AUC from 0.68 (0.52-0.83) to 0.88 (0.78-0.99) at 12h (p = 0.01). KeGFR(pCysC) also improved DGF prediction. In contrast, sCr provided no improvement at any time point. Conclusions Calculation of KeGFR from sCr facilitates early prediction of DGF within 4 hours of renal transplantation.	[Pianta, Timothy J.; Endre, Zoltan H.; Peake, Philip W.] Univ New S Wales, Prince Wales Clin Sch, Sydney, NSW, Australia; [Pianta, Timothy J.] Univ Melbourne, Melbourne Med Sch, Melbourne, Vic, Australia; [Endre, Zoltan H.; Pickering, John W.] Univ Otago, Dept Med, Christchurch, New Zealand; [Buckley, Nicholas A.] Univ Sydney, Clin Pharmacol, Sydney, NSW 2006, Australia	University of New South Wales Sydney; University of Melbourne; University of Otago; University of Sydney	Pianta, TJ (corresponding author), Univ New S Wales, Prince Wales Clin Sch, Sydney, NSW, Australia.	timothy.pianta@nh.org.au	Pickering, John/ABC-8089-2021; Buckley, Nicholas A/D-4030-2012; Pickering, John W/A-9453-2009; Endre, Zoltan/A-3331-2009	Pickering, John/0000-0001-9475-0344; Buckley, Nicholas A/0000-0002-6326-4711; Pickering, John W/0000-0001-9475-0344; Pianta, Timothy/0000-0002-9196-4889; Endre, Zoltan/0000-0002-4782-8695	National Health and Medical Research Council (NHMRC, Australia) [1011772]; Jacquot Research Entry Scholarship; University of New South Wales Australian Postgraduate Award	National Health and Medical Research Council (NHMRC, Australia)(National Health and Medical Research Council (NHMRC) of Australia); Jacquot Research Entry Scholarship; University of New South Wales Australian Postgraduate Award	The research was in part funded by the National Health and Medical Research Council (NHMRC, Australia) project grant 1011772 www.nhmrc.gov.au. Stipend support for TJP was provided by the Jacquot Research Entry Scholarship and a University of New South Wales Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chapal M, 2014, KIDNEY INT, V86, P1130, DOI 10.1038/ki.2014.188; Chen S, 2013, J AM SOC NEPHROL, V24, P877, DOI 10.1681/ASN.2012070653; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Endre ZH, 2011, AM J PHYSIOL-RENAL, V301, pF697, DOI 10.1152/ajprenal.00448.2010; Fonseca I, 2014, TRANSPLANTATION, V97, P1058, DOI 10.1097/01.TP.0000438626.91095.50; Grubb A, 2010, CLIN CHEM LAB MED, V48, P1619, DOI 10.1515/CCLM.2010.318; Haase-Fielitz A, 2009, CRIT CARE MED, V37, P553, DOI 10.1097/CCM.0b013e318195846e; Hall IE, 2011, TRANSPLANTATION, V91, P48, DOI 10.1097/TP.0b013e3181fc4b3a; Hall IE, 2010, J AM SOC NEPHROL, V21, P189, DOI 10.1681/ASN.2009030264; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Irish WD, 2010, AM J TRANSPLANT, V10, P2279, DOI 10.1111/j.1600-6143.2010.03179.x; Jeldres C, 2009, CUAJ-CAN UROL ASSOC, V3, P377; JONES JD, 1974, CLIN CHEM, V20, P1204; Knight EL, 2004, KIDNEY INT, V65, P1416, DOI 10.1111/j.1523-1755.2004.00517.x; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Mallon DH, 2013, TRANSPLANTATION, V96, P885, DOI 10.1097/TP.0b013e3182a19348; OH MS, 1993, NEPHRON, V63, P255, DOI 10.1159/000187206; Pianta TJ, 2015, TRANSPLANTATION, V99, P171, DOI 10.1097/TP.0000000000000256; Pianta TJ, 2013, BIOMARK MED, V7, P441, DOI [10.2217/BMM.13.51, 10.2217/bmm.13.51]; Pickering JW, 2012, CLIN J AM SOC NEPHRO, V7, P1355, DOI 10.2215/CJN.09590911; Rodrigo E, 2012, AM J TRANSPLANT, V12, P240, DOI 10.1111/j.1600-6143.2011.03810.x; SCHLOERB PR, 1960, AM J PHYSIOL, V199, P661, DOI 10.1152/ajplegacy.1960.199.4.661; Schneider AG, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.12.017; Singh RP, 2011, CLIN TRANSPLANT, V25, P255, DOI 10.1111/j.1399-0012.2010.01241.x; Sjostrom P, 2005, SCAND J CLIN LAB INV, V65, P111, DOI 10.1080/00365510510013523; Tenstad O, 1996, SCAND J CLIN LAB INV, V56, P409, DOI 10.3109/00365519609088795; Waikar SS, 2009, J AM SOC NEPHROL, V20, P672, DOI 10.1681/ASN.2008070669; Yarlagadda SG, 2009, NEPHROL DIAL TRANSPL, V24, P1039, DOI 10.1093/ndt/gfn667; Yashiro M, 2012, CLIN EXP NEPHROL, V16, P570, DOI 10.1007/s10157-012-0602-x; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	32	37	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125669	10.1371/journal.pone.0125669	http://dx.doi.org/10.1371/journal.pone.0125669			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938452	gold, Green Published, Green Submitted			2022-12-27	WOS:000353943000086
J	Rioult-Pedotti, MS; Pekanovic, A; Atiemo, CO; Marshall, J; Luft, AR				Rioult-Pedotti, Mengia-Seraina; Pekanovic, Ana; Atiemo, Clement Osei; Marshall, John; Luft, Andreas Ruediger			Dopamine Promotes Motor Cortex Plasticity and Motor Skill Learning via PLC Activation	PLOS ONE			English	Article							D1-D2 RECEPTOR HETEROMER; LONG-TERM POTENTIATION; NUCLEUS-ACCUMBENS; D-1; D1; PHARMACOLOGY; INHIBITION; MODULATION; MECHANISMS; DEPRESSION	Dopaminergic neurons in the ventral tegmental area, the major midbrain nucleus projecting to the motor cortex, play a key role in motor skill learning and motor cortex synaptic plasticity. Dopamine D1 and D2 receptor antagonists exert parallel effects in the motor system: they impair motor skill learning and reduce long-term potentiation. Traditionally, D1 and D2 receptor modulate adenylyl cyclase activity and cyclic adenosine monophosphate accumulation in opposite directions via different G-proteins and bidirectionally modulate protein kinase A (PKA), leading to distinct physiological and behavioral effects. Here we show that D1 and D2 receptor activity influences motor skill acquisition and long term synaptic potentiation via phospholipase C (PLC) activation in rat primary motor cortex. Learning a new forelimb reaching task is severely impaired in the presence of PLC, but not PKA-inhibitor. Similarly, long term potentiation in motor cortex, a mechanism involved in motor skill learning, is reduced when PLC is inhibited but remains unaffected by the PKA inhibitor. Skill learning deficits and reduced synaptic plasticity caused by dopamine antagonists are prevented by co-administration of a PLC agonist. These results provide evidence for a role of intracellular PLC signaling in motor skill learning and associated cortical synaptic plasticity, challenging the traditional view of bidirectional modulation of PKA by D1 and D2 receptors. These findings reveal a novel and important action of dopamine in motor cortex that might be a future target for selective therapeutic interventions to support learning and recovery of movement resulting from injury and disease.	[Rioult-Pedotti, Mengia-Seraina; Pekanovic, Ana; Atiemo, Clement Osei; Luft, Andreas Ruediger] Univ Zurich, Dept Neurol, Clin Neurorehabil, Zurich, Switzerland; [Rioult-Pedotti, Mengia-Seraina; Pekanovic, Ana; Atiemo, Clement Osei; Luft, Andreas Ruediger] Rehabil Initiat & Technol Ctr Zurich RITZ, Zurich, Switzerland; [Luft, Andreas Ruediger] Univ Zurich Hosp, Dept Neurol, Div Vasc Neurol & Neurorehabil, CH-8091 Zurich, Switzerland; [Rioult-Pedotti, Mengia-Seraina; Marshall, John] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA	University of Zurich; University of Zurich; University Zurich Hospital; Brown University	Rioult-Pedotti, MS (corresponding author), Univ Zurich, Dept Neurol, Clin Neurorehabil, Zurich, Switzerland.	yfpgin@gmail.com	Rioult-Pedotti, Mengia-Seraina/AAF-1377-2021		Swiss National Science Foundation [310030_135471]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Funding came from the Swiss National Science Foundation 310030_135471. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awenowicz PW, 2002, J NEUROPHYSIOL, V88, P3439, DOI 10.1152/jn.00078.2002; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Buitrago MM, 2004, BEHAV BRAIN RES, V155, P249, DOI 10.1016/j.bbr.2004.04.025; Calabresi P, 2014, NAT NEUROSCI, V17, P1022, DOI 10.1038/nn.3743; Chun LS, 2013, MOL PHARMACOL, V84, P190, DOI 10.1124/mol.113.085175; DREHER JK, 1989, BRAIN RES, V487, P267, DOI 10.1016/0006-8993(89)90831-7; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Friedman E, 1997, MOL PHARMACOL, V51, P6, DOI 10.1124/mol.51.1.6; Furini CRG, 2014, BEHAV BRAIN RES, V271, P212, DOI 10.1016/j.bbr.2014.06.027; George Susan R, 2007, ScientificWorldJournal, V7, P58; Gorelova N, 2002, J NEUROPHYSIOL, V88, P3150, DOI 10.1152/jn.00335.2002; Hasbi A, 2014, FASEB J, V28, P4806, DOI 10.1096/fj.14-254037; Hasbi A, 2009, P NATL ACAD SCI USA, V106, P21377, DOI 10.1073/pnas.0903676106; Hernandez-Lopez S, 2000, J NEUROSCI, V20, P8987; Hosp JA, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00145; Hosp JA, 2011, J NEUROSCI, V31, P2481, DOI 10.1523/JNEUROSCI.5411-10.2011; Ikemoto S, 1997, J NEUROSCI, V17, P8580; Jin LQ, 2003, J NEUROCHEM, V85, P378, DOI 10.1046/j.1471-4159.2003.01698.x; Lee SM, 2014, J PHARMACOL EXP THER, V351, P9, DOI 10.1124/jpet.114.214411; Lee SP, 2004, J BIOL CHEM, V279, P35671, DOI 10.1074/jbc.M401923200; Lisman J., 2014, BRAIN RES; Lisman J, 2011, TRENDS NEUROSCI, V34, P536, DOI 10.1016/j.tins.2011.07.006; Manahan-Vaughan D, 2003, CEREB CORTEX, V13, P123, DOI 10.1093/cercor/13.2.123; Matsuda Y, 2006, J NEUROSCI, V26, P4803, DOI 10.1523/JNEUROSCI.5312-05.2006; Medvedev IO, 2013, J NEUROSCI, V33, P18125, DOI 10.1523/JNEUROSCI.2382-13.2013; Molina-Luna K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007082; Monte-Silva K, 2011, NEUROPSYCHOPHARMACOL, V36, P2097, DOI 10.1038/npp.2011.100; Nolan EB, 2007, SYNAPSE, V61, P279, DOI 10.1002/syn.20371; Otani S, 1998, NEUROSCIENCE, V85, P669, DOI 10.1016/S0306-4522(97)00677-5; Otmakhova NA, 1996, J NEUROSCI, V16, P7478; Perreault ML, 2014, DEV NEUROSCI-BASEL, V36, P287, DOI 10.1159/000360158; Perreault ML, 2014, NEUROPSYCHOPHARMACOL, V39, P156, DOI 10.1038/npp.2013.148; PLAZNIK A, 1989, PSYCHOPHARMACOLOGY, V99, P558, DOI 10.1007/BF00589908; Rashid AJ, 2007, P NATL ACAD SCI USA, V104, P654, DOI 10.1073/pnas.0604049104; Rioult-Pedotti MS, 1998, NAT NEUROSCI, V1, P230, DOI 10.1038/678; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Sahu A, 2009, MOL PHARMACOL, V75, P447, DOI 10.1124/mol.108.053017; Seamans JK, 2001, J NEUROSCI, V21, P3628, DOI 10.1523/JNEUROSCI.21-10-03628.2001; Surmeier DJ, 2011, NEUROSCIENCE, V198, P3, DOI 10.1016/j.neuroscience.2011.08.051; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Trantham-Davidson H, 2004, J NEUROSCI, V24, P10652, DOI 10.1523/JNEUROSCI.3179-04.2004; Undieh AS, 2010, PHARMACOL THERAPEUT, V128, P37, DOI 10.1016/j.pharmthera.2010.05.003; WHISHAW IQ, 1990, BEHAV BRAIN RES, V41, P49, DOI 10.1016/0166-4328(90)90053-H	43	39	40	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0124986	10.1371/journal.pone.0124986	http://dx.doi.org/10.1371/journal.pone.0124986			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938462	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000353943000036
J	Lemming, D; Borsbo, B; Sjors, A; Lind, EB; Arendt-Nielsen, L; Graven-Nielsen, T; Gerdle, B				Lemming, Dag; Borsbo, Bjorn; Sjors, Anna; Lind, Eva-Britt; Arendt-Nielsen, Lars; Graven-Nielsen, Thomas; Gerdle, Bjorn			Single-Point but Not Tonic Cuff Pressure Pain Sensitivity Is Associated with Level of Physical Fitness - A Study of Non-Athletic Healthy Subjects	PLOS ONE			English	Article							SEX-DIFFERENCES; EXERCISE; PERCEPTION; ALGOMETRY; THRESHOLD; GENDER; WOMEN; HYPERSENSITIVITY; SENSITIZATION; METAANALYSIS	Exercise is often used for pain rehabilitation but the link between physical activity level and pain sensitivity is still not fully understood. Pressure pain sensitivity to cuff algometry and conditioned pain modulation (CPM) were evaluated in highly active men (n=22), normally active men (n=26), highly active women (n=27) and normally active women (n=23) based on the Godin Leisure-Time Exercise Questionnaire. Cuff pressure pain sensitivity was assessed at the arm and lower leg. The subjects scored the pain intensity on an electronic Visual Analogue Scale (VAS) during ten minutes with 25 kPa constant cuff pressure and two minutes with zero pressure. The maximal VAS score and area under the VAS-curve were extracted. Pressure pain thresholds (PPT) were recorded by manual pressure algometry on the ipsilateral tibialis anterior muscle before, during and after the tonic arm stimulation. Tonic cuff stimulation of the arm and leg resulted in higher VAS peak scores in women compared with men (p<0.04). In all groups the PPTs were reduced during and after the cuff stimulation compared with baseline (p=0.001). PPT were higher in men compared with women (p=0.03) and higher in highly physical active compared with normal active (p=0.048). Besides the well-known gender difference in pressure pain sensitivity this study demonstrates that a high physical fitness degree in non-athletic subjects is associated with increased pressure pain thresholds but does not affect cuff pressure pain sensitivity in healthy people.	[Lemming, Dag; Borsbo, Bjorn; Sjors, Anna; Lind, Eva-Britt; Gerdle, Bjorn] Linkoping Univ, Dept Pain, SE-58185 Linkoping, Sweden; [Lemming, Dag; Borsbo, Bjorn; Sjors, Anna; Lind, Eva-Britt; Gerdle, Bjorn] Linkoping Univ, Rehabil Ctr, SE-58185 Linkoping, Sweden; [Lemming, Dag; Borsbo, Bjorn; Sjors, Anna; Lind, Eva-Britt; Gerdle, Bjorn] Linkoping Univ, Dept Med & Hlth Sci, SE-58185 Linkoping, Sweden; [Arendt-Nielsen, Lars; Graven-Nielsen, Thomas] Aalborg Univ, Dept Hlth Sci & Technol, Ctr Sensory Motor Interact SMI, Lab Expt Pain Res, DK-9220 Aalborg, Denmark	Linkoping University; Linkoping University; Linkoping University; Aalborg University	Lemming, D (corresponding author), Linkoping Univ, Dept Pain, SE-58185 Linkoping, Sweden.	dag.lemming@liu.se	Arendt-Nielsen, Lars/T-4885-2018	Sjors Dahlman, Anna/0000-0003-2530-4126; Arendt-Nielsen, Lars/0000-0003-0892-1579; Graven-Nielsen, Thomas/0000-0002-7787-4860	Swedish Research Council [K2011-69X-21874-01-6]; Swedish Council for Working Life and Social Research [2010-0913]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	This study was funded by the Swedish Research Council (K2011-69X-21874-01-6) and the Swedish Council for Working Life and Social Research (2010-0913). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berkley KJ, 1997, BEHAV BRAIN SCI, V20, P371, DOI 10.1017/S0140525X97221485; Chesterton LS, 2007, CLIN J PAIN, V23, P760, DOI 10.1097/AJP.0b013e318154b6ae; Chesterton LS, 2003, PAIN, V101, P259, DOI 10.1016/S0304-3959(02)00330-5; Ferreira ML, 2010, PHYS THER, V90, P1383, DOI 10.2522/ptj.20090332; Fillingim RB, 2009, J PAIN, V10, P447, DOI 10.1016/j.jpain.2008.12.001; Finocchietti S, 2011, EUR J PAIN, V15, P36, DOI 10.1016/j.ejpain.2010.05.010; GODIN G, 1985, Canadian Journal of Applied Sport Sciences, V10, P141; Goodin BR, 2009, PSYCHOSOM MED, V71, P1018, DOI 10.1097/PSY.0b013e3181bc62ba; Hoffman MD, 2004, ARCH PHYS MED REHAB, V85, P1183, DOI 10.1016/j.apmr.2003.09.010; JACOBS DR, 1993, MED SCI SPORT EXER, V25, P81, DOI 10.1249/00005768-199301000-00012; JENSEN K, 1986, PAIN, V25, P313, DOI 10.1016/0304-3959(86)90235-6; Jespersen A, 2007, PAIN, V131, P57, DOI 10.1016/j.pain.2006.12.012; Jespersen A, 2013, PAIN MED, V14, P297, DOI 10.1111/pme.12021; Koltyn KF, 1998, BRIT J SPORT MED, V32, P20, DOI 10.1136/bjsm.32.1.20; Koltyn KF, 2002, SPORTS MED, V32, P477, DOI 10.2165/00007256-200232080-00001; Lemming D, 2012, J REHABIL MED, V44, P648, DOI 10.2340/16501977-1006; Miller J, 2010, MANUAL THER, V15, P334, DOI 10.1016/j.math.2010.02.007; Oono Y, 2011, J OROFAC PAIN, V25, P364; Polianskis R, 2002, J PAIN, V3, P28, DOI 10.1054/jpai.2002.27140; Polianskis R, 2001, EUR J PAIN, V5, P267, DOI 10.1053/eujp.2001.0245; Popescu A, 2010, PAIN, V150, P309, DOI 10.1016/j.pain.2010.05.013; Racine M, 2012, PAIN, V153, P602, DOI 10.1016/j.pain.2011.11.025; Riley JL, 1998, PAIN, V74, P181, DOI 10.1016/S0304-3959(97)00199-1; Ring C, 2008, BIOL PSYCHOL, V78, P123, DOI 10.1016/j.biopsycho.2008.01.008; Schmitz AK, 2013, EUR J PAIN, V17, P124, DOI 10.1002/j.1532-2149.2012.00169.x; Skou ST, 2013, PAIN, V154, P1588, DOI 10.1016/j.pain.2013.04.033; Tesarz J, 2013, PAIN, V154, P1022, DOI 10.1016/j.pain.2013.03.014; Tesarz J, 2012, PAIN, V153, P1253, DOI 10.1016/j.pain.2012.03.005; Unruh AM, 1996, PAIN, V65, P123, DOI 10.1016/0304-3959(95)00214-6	29	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125432	10.1371/journal.pone.0125432	http://dx.doi.org/10.1371/journal.pone.0125432			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933412	Green Published, gold, Green Submitted			2022-12-27	WOS:000353887100112
J	Sham, A; Moustafa, K; Al-Ameri, S; Al-Azzawi, A; Iratni, R; AbuQamar, S				Sham, Arjun; Moustafa, Khaled; Al-Ameri, Salma; Al-Azzawi, Ahmed; Iratni, Rabah; AbuQamar, Synan			Identification of Arabidopsis Candidate Genes in Response to Biotic and Abiotic Stresses Using Comparative Microarrays	PLOS ONE			English	Article							TGA TRANSCRIPTION FACTORS; HIGH-SALINITY STRESSES; ABSCISIC-ACID; MACROPHOMINA-PHASEOLINA; EXPRESSION PROFILES; NECROTROPHIC FUNGI; DROUGHT TOLERANCE; BOTRYTIS-CINEREA; PLANT-RESPONSES; WATER RELATIONS	Plants have evolved with intricate mechanisms to cope with multiple environmental stresses. To adapt with biotic and abiotic stresses, plant responses involve changes at the cellular and molecular levels. The current study was designed to investigate the effects of combinations of different environmental stresses on the transcriptome level of Arabidopsis genome using public microarray databases. We investigated the role of cyclopentenones in mediating plant responses to environmental stress through TGA (TGACG motif-binding factor) transcription factor, independently from jasmonic acid. Candidate genes were identified by comparing plants inoculated with Botrytis cinerea or treated with heat, salt or osmotic stress with non-inoculated or non-treated tissues. About 2.5% heat-, 19% salinity- and 41% osmotic stress-induced genes were commonly upregulated by B. cinerea-treatment; and 7.6%, 19% and 48% of genes were commonly downregulated by B. cinerea-treatment, respectively. Our results indicate that plant responses to biotic and abiotic stresses are mediated by several common regulatory genes. Comparisons between transcriptome data from Arabidopsis stressed-plants support our hypothesis that some molecular and biological processes involved in biotic and abiotic stress response are conserved. Thirteen of the common regulated genes to abiotic and biotic stresses were studied in detail to determine their role in plant resistance to B. cinerea. Moreover, a T-DNA insertion mutant of the Responsive to Dehydration gene (rd20), encoding for a member of the caleosin (lipid surface protein) family, showed an enhanced sensitivity to B. cinerea infection and drought. Overall, the overlapping of plant responses to abiotic and biotic stresses, coupled with the sensitivity of the rd20 mutant, may provide new interesting programs for increased plant resistance to multiple environmental stresses, and ultimately increases its chances to survive. Future research directions towards a better dissection of the potential crosstalk between B. cinerea, abiotic stress, and oxylipin signaling are of our particular interest.	[Sham, Arjun; Al-Ameri, Salma; Al-Azzawi, Ahmed; Iratni, Rabah; AbuQamar, Synan] United Arab Emirates Univ, Dept Biol, Al Ain, U Arab Emirates; [Moustafa, Khaled] Conservatoire Natl Arts & Metiers, Paris, France	United Arab Emirates University; heSam Universite; Conservatoire National Arts & Metiers (CNAM)	AbuQamar, S (corresponding author), United Arab Emirates Univ, Dept Biol, Al Ain, U Arab Emirates.	sabuqamar@uaeu.ac.ae	AbuQamar, Synan/AAV-1229-2021; Sham, Arjun/AAF-2531-2019; Sham, Arjun/K-3691-2019	AbuQamar, Synan/0000-0002-2129-7689; Moustafa, Khaled/0000-0002-0819-9064; Sham, Arjun/0000-0003-1762-3709	UAEU [COS/IRG-05/14]; Khalifa Center for Biotechnology and Genetic Engineering-UAEU [KCGEB-2-2013]	UAEU; Khalifa Center for Biotechnology and Genetic Engineering-UAEU	This project was funded by the UAEU [COS/IRG-05/14]; and the Khalifa Center for Biotechnology and Genetic Engineering-UAEU [KCGEB-2-2013] to SAQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuQamar S, 2008, PLANT CELL, V20, P1964, DOI 10.1105/tpc.108.059477; AbuQamar S, 2006, PLANT J, V48, P28, DOI 10.1111/j.1365-313X.2006.02849.x; Abuqamar S, 2013, MOL PLANT PATHOL, V14, P813, DOI 10.1111/mpp.12049; AbuQamar S, 2009, PLANT J, V58, P347, DOI 10.1111/j.1365-313X.2008.03783.x; Achuo EA, 2006, PLANT PATHOL, V55, P178, DOI 10.1111/j.1365-3059.2006.01340.x; Atkinson NJ, 2013, PLANT PHYSIOL, V162, P2028, DOI 10.1104/pp.113.222372; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Aubert Y, 2010, PLANT CELL PHYSIOL, V51, P1975, DOI 10.1093/pcp/pcq155; Audebert A, 2000, PLANT SOIL, V220, P235, DOI 10.1023/A:1004734415254; Bechtold U, 2010, PLANT CELL ENVIRON, V33, P1959, DOI 10.1111/j.1365-3040.2010.02198.x; Blee E, 2014, PLANT PHYSIOL, V166, P109, DOI 10.1104/pp.114.245316; Bluhm BH, 2005, MOL PLANT MICROBE IN, V18, P1333, DOI 10.1094/MPMI-18-1333; Bouvier-Nave P, 2003, 1 EUR S PLANT LIP AA; Bray EA, 2004, J EXP BOT, V55, P2331, DOI 10.1093/jxb/erh270; Chen Z. Y., 2004, African Journal of Biotechnology, V3, P693; Craigon DJ, 2004, NUCLEIC ACIDS RES, V32, pD575, DOI 10.1093/nar/gkh133; DIOURTE M, 1995, PLANT PATHOL, V44, P196, DOI 10.1111/j.1365-3059.1995.tb02729.x; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Grover M, 2011, WORLD J MICROB BIOT, V27, P1231, DOI 10.1007/s11274-010-0572-7; Hanano A, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.4161/15592324.2014.991574; Howell SH, 2013, ANNU REV PLANT BIOL, V64, P477, DOI 10.1146/annurev-arplant-050312-120053; Institute SAS, 1999, SAS SYST WIND REL 8; Jung HW, 2009, SCIENCE, V324, P89, DOI 10.1126/science.1170025; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Laluk K, 2011, PLANT CELL, V23, P2831, DOI 10.1105/tpc.111.087122; LAM E, 1989, P NATL ACAD SCI USA, V86, P7890, DOI 10.1073/pnas.86.20.7890; Luo HL, 2010, PLANT PHYSIOL, V154, P1766, DOI 10.1104/pp.110.163915; Mayek-Perez N, 2002, PHYSIOL MOL PLANT P, V60, P185, DOI 10.1006/pmpp.2001.0388; Mengiste T, 2003, PLANT CELL, V15, P2551, DOI 10.1105/tpc.014167; Mitchell C, 2010, TOXICOL LETT, V195, P23, DOI 10.1016/j.toxlet.2010.02.020; Mittler R, 2010, ANNU REV PLANT BIOL, V61, P443, DOI 10.1146/annurev-arplant-042809-112116; Mohr PG, 2003, FUNCT PLANT BIOL, V30, P461, DOI 10.1071/FP02231; Mueller S, 2008, PLANT CELL, V20, P768, DOI 10.1105/tpc.107.054809; Noiriel A, 2004, EUR J BIOCHEM, V271, P3752, DOI 10.1111/j.1432-1033.2004.04317.x; Pietrowska E, 2015, PROTOPLASMA, V252, P307, DOI 10.1007/s00709-014-0680-6; Provart NJ., 2003, CURRENT COMPUTER MOL, V2003, P271; R Core Team, 2021, R LANGUAGE ENV STAT; Rabbani MA, 2003, PLANT PHYSIOL, V133, P1755, DOI 10.1104/pp.103.025742; Ramel F, 2012, P NATL ACAD SCI USA, V109, P5535, DOI 10.1073/pnas.1115982109; Rasmussen S, 2013, PLANT PHYSIOL, V161, P1783, DOI 10.1104/pp.112.210773; Rebeille F, 2006, P NATL ACAD SCI USA, V103, P15687, DOI 10.1073/pnas.0606195103; Ritter A, 2008, NEW PHYTOL, V180, P809, DOI 10.1111/j.1469-8137.2008.02626.x; Ritter A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-116; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Sela D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070146; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Sewelam N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070289; Shaik R, 2014, PLANT PHYSIOL, V164, P481, DOI 10.1104/pp.113.225862; Sham A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113718; Shao HB, 2007, COLLOID SURFACE B, V54, P37, DOI 10.1016/j.colsurfb.2006.07.002; Stotz HU, 2013, J EXP BOT, V64, P963, DOI 10.1093/jxb/ers389; Taki N, 2005, PLANT PHYSIOL, V139, P1268, DOI 10.1104/pp.105.067058; Tiwari M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03964; Truman W, 2006, PLANT J, V46, P14, DOI 10.1111/j.1365-313X.2006.02672.x; Trusov Y, 2009, PLANT J, V58, P69, DOI 10.1111/j.1365-313X.2008.03755.x; Veronese P, 2006, PLANT CELL, V18, P257, DOI 10.1105/tpc.105.035576; Wiese J, 2004, PLANT BIOLOGY, V6, P529, DOI 10.1055/s-2004-821176; Windram O, 2014, ANNU REV PHYTOPATHOL, V52, P93, DOI 10.1146/annurev-phyto-102313-050103; Yang WY, 2007, J BIOL CHEM, V282, P18116, DOI 10.1074/jbc.M700405200; Yang ZT, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004243; Zhang LX, 2011, PLANT PHYSIOL, V157, P854, DOI 10.1104/pp.111.179028; Zheng ZY, 2006, PLANT J, V48, P592, DOI 10.1111/j.1365-313X.2006.02901.x; Zhu YN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080218	63	46	48	0	143	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125666	10.1371/journal.pone.0125666	http://dx.doi.org/10.1371/journal.pone.0125666			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933420	Green Published, gold, Green Submitted			2022-12-27	WOS:000353887100126
J	Wang, SH; Cheng, CY; Tang, PC; Chen, CF; Chen, HH; Lee, YP; Huang, SY				Wang, Shih-Han; Cheng, Chuen-Yu; Tang, Pin-Chi; Chen, Chih-Feng; Chen, Hsin-Hsin; Lee, Yen-Pai; Huang, San-Yuan			Acute Heat Stress Induces Differential Gene Expressions in the Testes of a Broiler-Type Strain of Taiwan Country Chickens	PLOS ONE			English	Article							GERM-CELL APOPTOSIS; BARRIER DYNAMICS; CANCER-CELLS; IN-VIVO; PROTEIN; FERTILITY; BLOOD; SPERMATOGENESIS; IDENTIFICATION; HSP60	The expression of testicular genes following acute heat stress has been reported in layer-type roosters, but few similar studies have been conducted on broilers. This study investigated the effect of acute heat stress on the gene expression in the testes of a broiler-type strain of Taiwan country chickens. Roosters were subjected to acute heat stress (38 degrees C) for 4 h, and then exposed to 25 degrees C, with testes collected 0, 2, and 6 h after the cessation of heat stress, using non-heat-stressed roosters as controls (n = 3 roosters per group). The body temperature and respiratory rate increased significantly (p<0.05) during the heat stress. The numbers of apoptotic cells increased 2 h after the acute heat stress (79 +/- 7 vs. 322 +/- 192, control vs. heat stress; p<0.05), which was earlier than the time of increase in layer-type roosters. Based on a chicken 44 K oligo microarray, 163 genes were found to be expressed significantly different in the testes of the heat-stressed chickens from those of the controls, including genes involved in the response to stimulus, protein metabolism, signal transduction, cell adhesion, transcription, and apoptosis. The mRNA expressions of upregulated genes, including HSP25, HSP90AA1, HSPA2, and LPAR2, and of downregulated genes, including CDH5, CTNNA3, EHF, CIRBP, SLA, and NTF3, were confirmed through quantitative real-time polymerase chain reaction (qRT-PCR). Moreover, numerous transcripts in the testes exhibited distinct expressions between the heat-stressed broiler-type and layer-type chickens. We concluded that the transcriptional responses of testes to acute heat stress may differ between the broiler-type and layer-type roosters. Whether the differential expression patterns associate with the heat-tolerance in the strains require a further exploration.	[Wang, Shih-Han; Cheng, Chuen-Yu; Tang, Pin-Chi; Chen, Chih-Feng; Lee, Yen-Pai; Huang, San-Yuan] Natl Chung Hsing Univ, Dept Anim Sci, Taichung 40227, Taiwan; [Tang, Pin-Chi; Chen, Chih-Feng; Huang, San-Yuan] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan; [Tang, Pin-Chi; Chen, Chih-Feng; Huang, San-Yuan] Natl Chung Hsing Univ, iEGG Ctr, Ctr Integrat & Evolutionary Galliformes Genom, Taichung 40227, Taiwan; [Chen, Hsin-Hsin] Natl Chung Hsing Univ, Dept Vet Med, Taichung 40227, Taiwan; [Huang, San-Yuan] Natl Chung Hsing Univ, Ctr Nanosci & Nanotechnol, Taichung 40227, Taiwan	National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University	Huang, SY (corresponding author), Natl Chung Hsing Univ, Dept Anim Sci, Taichung 40227, Taiwan.	syhuang@dragon.nchu.edu.tw	Wang, Shih-Han/HGA-7092-2022		National Science Council (NSC) [99-2321-B-005-016-MY3]; Executive Yuan; Ministry of Education, Taiwan, Republic of China	National Science Council (NSC)(Ministry of Science and Technology, Taiwan); Executive Yuan; Ministry of Education, Taiwan, Republic of China(Ministry of Education, Taiwan)	This study was supported in part by grants from National Science Council (NSC# 99-2321-B-005-016-MY3), Executive Yuan and the Ministry of Education, Taiwan, Republic of China, under the ATU plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albino D, 2012, CANCER RES, V72, P2889, DOI 10.1158/0008-5472.CAN-12-0212; Bakker WJ, 2007, MOL CELL, V28, P941, DOI 10.1016/j.molcel.2007.10.035; BERGMANN M, 1987, INT J ANDROL, V10, P481, DOI 10.1111/j.1365-2605.1987.tb00222.x; Buaas FW, 2009, HUM MOL GENET, V18, P2989, DOI 10.1093/hmg/ddp237; Cai H, 2011, INT J ANDROL, V34, P352, DOI 10.1111/j.1365-2605.2010.01089.x; Chen M, 2008, ENDOCRINOLOGY, V149, P4871, DOI 10.1210/en.2007-1093; Dragone LL, 2006, J IMMUNOL, V176, P335, DOI 10.4049/jimmunol.176.1.335; Ikeda M, 1999, BIOL REPROD, V61, P393, DOI 10.1095/biolreprod61.2.393; Karaca AG, 2002, POULTRY SCI, V81, P1904, DOI 10.1093/ps/81.12.1904; Karaca AG, 2002, BRIT POULTRY SCI, V43, P621, DOI 10.1080/0007166022000004552; Kariya A, 2013, INT J MOL MED, V32, P195, DOI 10.3892/ijmm.2013.1366; Kas K, 2000, J BIOL CHEM, V275, P2986, DOI 10.1074/jbc.275.4.2986; Kawakubo T, 2007, CANCER RES, V67, P10869, DOI 10.1158/0008-5472.CAN-07-2048; Kim B, 2013, CELL MOL LIFE SCI, V70, P2623, DOI 10.1007/s00018-012-1165-4; Kim HJ, 2010, J CELL BIOCHEM, V110, P201, DOI 10.1002/jcb.22527; Lee NPY, 2008, OXID MED CELL LONGEV, V1, P25, DOI 10.4161/oxim.1.1.6856; LEE YP, 1990, PROCEEDINGS : THE 5TH AAAP ANIMAL SCIENCE CONGRESS, VOLS 1-3, P349; Lee YP, 2006, TAIWAN COUNTRY CHICK; LI GC, 1985, INT J RADIAT ONCOL, V11, P165, DOI 10.1016/0360-3016(85)90376-1; Li XY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-60; Li Y, 2009, J ANDROL, V30, P325, DOI 10.2164/jandrol.108.005934; Lui WY, 2003, ENDOCRINOLOGY, V144, P1139, DOI 10.1210/en.2002-0211; Lui WY, 2001, ENDOCRINOLOGY, V142, P1865, DOI 10.1210/en.142.5.1865; Luo QB, 2014, GENE, V546, P200, DOI 10.1016/j.gene.2014.06.017; MCDANIEL CD, 1995, POULTRY SCI, V74, P1029, DOI 10.3382/ps.0741029; MIEUSSET R, 1992, J REPROD FERTIL, V94, P337, DOI 10.1530/jrf.0.0940337; OSTERMANN J, 1989, NATURE, V341, P125, DOI 10.1038/341125a0; Paul C, 2008, REPRODUCTION, V136, P73, DOI 10.1530/REP-08-0036; Raymond MN, 2006, ENDOCRINOLOGY, V147, P5873, DOI 10.1210/en.2006-0291; Rockett JC, 2001, BIOL REPROD, V65, P229, DOI 10.1095/biolreprod65.1.229; Rosati A, 2007, INT J BIOCHEM CELL B, V39, P1337, DOI 10.1016/j.biocel.2007.03.007; Samali A, 1999, EMBO J, V18, P2040, DOI 10.1093/emboj/18.8.2040; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; SETCHELL BP, 1969, J PHYSIOL-LONDON, V200, P73, DOI 10.1113/jphysiol.1969.sp008682; SKINNER JD, 1966, J APPL PHYSIOL, V21, P1784, DOI 10.1152/jappl.1966.21.6.1784; Skoura A, 2009, J LIPID RES, V50, pS293, DOI 10.1194/jlr.R800047-JLR200; Tabuchi Y, 2003, INT J HYPERTHER, V29, P38; Wang SH, 2013, THERIOGENOLOGY, V79, P374, DOI 10.1016/j.theriogenology.2012.10.010; Wang ZP, 2009, EVOL BIOINFORM, V5, P119; WETTEMANN RP, 1976, J ANIM SCI, V42, P664, DOI 10.2527/jas1976.423664x; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wong CH, 2004, J CELL SCI, V117, P783, DOI 10.1242/jcs.00900; Ye XQ, 2008, BIOL REPROD, V79, P328, DOI 10.1095/biolreprod.108.068783; Yeh CC., 1992, J CHIN SOC ANIM SCI, V21, P57; Zaprjanova S, 2013, EUR J OBSTET GYN R B, V168, P54, DOI 10.1016/j.ejogrb.2012.12.021; Zhang XS, 2005, FRONT BIOSCI-LANDMRK, V10, P3110, DOI 10.2741/1767	46	35	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125816	10.1371/journal.pone.0125816	http://dx.doi.org/10.1371/journal.pone.0125816			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932638	gold, Green Published, Green Submitted			2022-12-27	WOS:000353887100134
J	Alagna, A; Vega Fernandez, T; D'Anna, G; Magliola, C; Mazzola, S; Badalamenti, F				Alagna, Adriana; Vega Fernandez, Tomas; D'Anna, Giovanni; Magliola, Carlo; Mazzola, Salvatore; Badalamenti, Fabio			Assessing Posidonia oceanica Seedling Substrate Preference: An Experimental Determination of Seedling Anchorage Success in Rocky vs. Sandy Substrates	PLOS ONE			English	Article							ZOSTERA-MARINA EELGRASS; L. DELILE; SEAGRASS REHABILITATION; GENETIC DIVERSITY; 1ST EVIDENCE; RESTORATION; SURVIVAL; GROWTH; RECRUITMENT; GERMINATION	In the last decades the growing awareness of the ecological importance of seagrass meadows has prompted increasing efforts to protect existing beds and restore degraded habitats. An in-depth knowledge of factors acting as major drivers of propagule settlement and recruitment is required in order to understand patterns of seagrass colonization and recovery and to inform appropriate management and conservation strategies. In this work Posidonia oceanica seedlings were reared for five months in a land-based culture facility under simulated natural hydrodynamic conditions to identify suitable substrates for seedling anchorage. Two main substrate features were investigated: firmness (i.e., sand vs. rock) and complexity (i.e., size of interstitial spaces between rocks). Seedlings were successfully grown in culture tanks, obtaining overall seedling survival of 93%. Anchorage was strongly influenced by substrate firmness and took place only on rocks, where it was as high as 89%. Anchorage occurred through adhesion by sticky root hairs. The minimum force required to dislodge plantlets attached to rocky substrates reached 23.830 N (equivalent to 2.43 kg), which would potentially allow many plantlets to overcome winter storms in the field. The ability of rocky substrates to retain seedlings increased with their complexity. The interstitial spaces between rocks provided appropriate microsites for seedling settlement, as seeds were successfully retained, and a suitable substrate for anchorage was available. In conclusion P. oceanica juveniles showed a clear-cut preference for hard substrates over the sandy one, due to the root system adhesive properties. In particular, firm and complex substrates allowed for propagule early and strong anchorage, enhancing persistence and establishment probabilities. Seedling substrate preference documented here leads to expect a more successful sexual recruitment on hard bottoms compared with soft ones. This feature could have influenced P. oceanica patterns of colonization in past and present time.	[Alagna, Adriana; Vega Fernandez, Tomas; D'Anna, Giovanni; Badalamenti, Fabio] CNR, IAMC, Inst Coastal Marine Environm, Castellammare Del Golfo, TP, Italy; [Magliola, Carlo] Saipem SpA, San Donato Milanese, MI, Italy; [Mazzola, Salvatore] CNR, IAMC, Inst Coastal Marine Environm, Torretta Granitola, TP, Italy	Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR); Eni SpA; Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR)	Alagna, A (corresponding author), CNR, IAMC, Inst Coastal Marine Environm, Castellammare Del Golfo, TP, Italy.	adriana.alagna@iamc.cnr.it	Fernández, Tomás Vega/AAT-5972-2020; Vega Fernández, Tomás/P-5693-2014; D'Anna, Giovanni/B-7995-2015; BADALAMENTI, FABIO/B-8508-2015	Fernández, Tomás Vega/0000-0002-8788-4253; Vega Fernández, Tomás/0000-0002-8788-4253; D'Anna, Giovanni/0000-0002-8644-8222; Mazzola, Salvatore/0000-0002-4622-8129; BADALAMENTI, FABIO/0000-0002-2395-454X; Alagna, Adriana/0000-0003-1697-0901	Saipem S.p.A.	Saipem S.p.A.	This research was funded by Saipem S.p.A. as part of scientific consultancy provided by the Laboratory of Marine Ecology of CNR-IAMC, Castellammare del Golfo (Tp), Italy. Carlo Magliola (Saipem S.p.A.) contributed to the design of the experiment. The funders as Saipem S.p.A. had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Alagna A, 2010, THESIS U SALENTO; Alagna A, 2013, ESTUAR COAST SHELF S, V119, P119, DOI 10.1016/j.ecss.2013.01.009; Badalamenti F, 2015, SCI REP-UK, V5, DOI 10.1038/srep08804; Badalamenti F, 2011, MAR POLLUT BULL, V62, P483, DOI 10.1016/j.marpolbul.2010.12.011; Balestri E, 2008, ESTUAR COAST SHELF S, V76, P634, DOI 10.1016/j.ecss.2007.07.048; Balestri E, 2011, BIOL CONSERV, V144, P1644, DOI 10.1016/j.biocon.2011.02.020; Balestri E, 1998, J EXP MAR BIOL ECOL, V228, P209, DOI 10.1016/S0022-0981(98)00027-6; Balestri E, 1998, AQUAT BOT, V60, P83, DOI 10.1016/S0304-3770(97)00017-X; Balestri E, 2015, ESTUAR COAST SHELF S, V154, P205, DOI 10.1016/j.ecss.2015.01.002; Balestri E, 2012, J APPL ECOL, V49, P1426, DOI 10.1111/j.1365-2664.2012.02197.x; Belzunce M, 2008, BOT MAR, V51, P1, DOI 10.1515/BOT.2008.005; Buia M. C., 2002, BIOL MAR MEDIT, V9, P600; BUIA MC, 1991, AQUAT BOT, V40, P343, DOI 10.1016/0304-3770(91)90080-O; Calvo S, 2006, MAR ECOL-EVOL PERSP, V27, P361, DOI 10.1111/j.1439-0485.2006.00132.x; Clarke S.M., 1989, BIOL SEAGRASSES, P304; Di Carlo G, 2005, MAR BIOL, V147, P1261, DOI 10.1007/s00227-005-0035-0; Almela ED, 2008, AQUAT BOT, V89, P397, DOI 10.1016/j.aquabot.2008.04.012; Gambi M.C., 1996, BIOL MAR MEDITERR, V3, P467; Golden RR, 2010, RESTOR ECOL, V18, P501, DOI 10.1111/j.1526-100X.2010.00691.x; Gonzalez-Correa JM, 2005, J EXP MAR BIOL ECOL, V320, P65, DOI 10.1016/j.jembe.2004.12.032; Infantes E, 2011, LIMNOL OCEANOGR, V56, P2223, DOI 10.4319/lo.2011.56.6.2223; Irving AD, 2010, J APPL ECOL, V47, P1119, DOI 10.1111/j.1365-2664.2010.01852.x; Koch EW, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P193; Lefevre J. R, 1984, 1 INT WORKSH POS OC, V2, P39; Marion SR, 2012, MAR ECOL PROG SER, V448, P197, DOI 10.3354/meps09612; Marion SR, 2010, RESTOR ECOL, V18, P514, DOI 10.1111/j.1526-100X.2010.00692.x; McGlathery KJ, 2012, MAR ECOL PROG SER, V448, P209, DOI 10.3354/meps09574; Olesen B, 2004, ESTUARIES, V27, P770, DOI 10.1007/BF02912039; Piazzi L, 1999, AQUAT BOT, V63, P103, DOI 10.1016/S0304-3770(98)00115-6; Reusch TBH, 2006, ESTUARIES COASTS, V29, P159, DOI 10.1007/BF02784707; Reynolds LK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038397; Reynolds LK, 2012, MAR ECOL PROG SER, V448, P223, DOI 10.3354/meps09386; Rivers DO, 2011, J EXP MAR BIOL ECOL, V401, P29, DOI 10.1016/j.jembe.2011.03.005; Sanchez-Lizaso JL, 2009, BOT MAR, V52, P471, DOI 10.1515/BOT.2009.052; Seddon S, 2010, ECOLOGICAL MANAGEMEN, V5, P167; Statton J, 2013, RESTOR ECOL, V21, P250, DOI 10.1111/j.1526-100X.2012.00873.x; Tanner C, 2010, RESTOR ECOL, V18, P538, DOI 10.1111/j.1526-100X.2010.00694.x; Tanner CE, 2010, RESTOR ECOL, V18, P527, DOI 10.1111/j.1526-100X.2010.00693.x; Terrados J, 2013, BOT MAR, V56, P185, DOI 10.1515/bot-2012-0200; Vangeluwe D, 2007, THESIS U LIEGE; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Wear RJ, 2010, MAR FRESHWATER RES, V61, P1123, DOI 10.1071/MF09314	43	24	25	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125321	10.1371/journal.pone.0125321	http://dx.doi.org/10.1371/journal.pone.0125321			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928898	Green Submitted, gold, Green Published			2022-12-27	WOS:000353713100080
J	Taddei, C; Gnesotto, R; Forni, S; Bonaccorsi, G; Vannucci, A; Garofalo, G				Taddei, Cristina; Gnesotto, Roberto; Forni, Silvia; Bonaccorsi, Guglielmo; Vannucci, Andrea; Garofalo, Giorgio			Cycling Promotion and Non-Communicable Disease Prevention: Health Impact Assessment and Economic Evaluation of Cycling to Work or School in Florence	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; PUBLIC TRANSPORT; BENEFITS; CAR; MORBIDITY; BURDEN; TRAVEL; RISK; VALIDATION; BARCELONA	Objective To estimate the effects of cycling promotion on major non-communicable diseases (NCDs) and costs from the public healthcare payer's perspective. Design Health impact assessment and economic evaluation using a dynamic model over a ten-year period and according to two cycling promotion scenarios. Setting Cycling to work or school in Florence, Italy. Population All individuals aged 15 and older commuting to work or school in Florence. Main outcome measures The primary outcome measures were changes in NCD incidence and healthcare direct costs for the Tuscany Regional Health Service (SST) due to increased cycling. The secondary outcome was change in road traffic accidents. Results Increasing cycling modal share in Florence from 7.5% to about 17% (Scenario 1) or 27% (Scenario 2) could decrease the incidence of type 2 diabetes by 1.2% or 2.5%, and the incidence of acute myocardial infarction (AMI) and stroke by 0.6% or 1.2%. Within 10 years, the number of cases that can be prevented is 280 or 549 for type 2 diabetes, 51 or 100 for AMI, and 51 or 99 for stroke in Scenario 1 or Scenario 2, respectively. Average annual discounted savings for the SST are estimated to amount to (sic)400,804 or (sic)771,201 in Scenario 1 or Scenario 2, respectively. In Florence, due to the high use of vulnerable motorized vehicles (such as scooters, mopeds, and motorcycles), road traffic accidents are expected to decline in both our scenarios. Sensitivity analyses showed that health benefits and savings for the SST are substantial, the most sensitive parameters being the relative risk estimates of NCDs and active commuting. Conclusions Effective policies and programs to promote a modal shift towards cycling among students and workers in Florence will contribute to reducing the NCD burden and helping long-term economic sustainability of the SST.	[Taddei, Cristina] Univ Florence, Specializat Sch Hyg & Prevent Med, Florence, Italy; [Gnesotto, Roberto; Forni, Silvia; Vannucci, Andrea] Reg Hlth Agcy Tuscany, Qual & Equ Unit, Florence, Italy; [Bonaccorsi, Guglielmo] Univ Florence, Dept Clin & Expt Med, Florence, Italy; [Garofalo, Giorgio] Florence Local Hlth Author, Dept Prevent, Florence, Italy	University of Florence; University of Florence	Taddei, C (corresponding author), Univ Florence, Specializat Sch Hyg & Prevent Med, Florence, Italy.	cristina.taddei@yahoo.it	bonaccorsi, guglielmo/AAR-6916-2020	bonaccorsi, guglielmo/0000-0002-5171-4308				Acciai F, 2012, ANNUARIO STAT COMUNE; [Anonymous], 2015, AZ SAN FIR ATT TOSC; [Anonymous], 2013, ARS TOSC REG PAT TOS; Barchielli A, 2012, J EPIDEMIOL COMMUN H, V66, P462, DOI 10.1136/jech.2010.110908; Bartolozzi M, 2012, MOBILITA CICLABILE T; Bauman A., 2008, CYCLING GETTING AUST; Baumann C, 2013, CYCLING LATIN AM CAR; Bonora E, 2004, DIABETES, V53, P1782, DOI 10.2337/diabetes.53.7.1782; BUECHLER R., 2010, SUST J ENV SUST ISSU, P36; Bull F.C., 2004, PHYS INACTIVITY, V1, P729; Capri S, 2005, CURR MED RES OPIN, V21, P913, DOI 10.1185/030079905x46331; City of Copenhagen, 2013, COP CIT CYCL BIC ACC; de Hartog JJ, 2010, ENVIRON HEALTH PERSP, V118, P1109, DOI 10.1289/ehp.0901747; Dekoster J., 1999, CYCLING WAY AHEAD TO; Dhondt S, 2013, ENVIRON INT, V51, P45, DOI 10.1016/j.envint.2012.10.005; Elvik R, 2009, ACCIDENT ANAL PREV, V41, P849, DOI 10.1016/j.aap.2009.04.009; Federazione Italiana Amici della Bicicletta Citta in Bici Legambiente, 2012, BICI CITT CITT IT SU; Fries James F, 2011, J Aging Res, V2011, P261702, DOI 10.4061/2011/261702; Fries JF, 2003, ANN INTERN MED, V139, P455, DOI 10.7326/0003-4819-139-5_Part_2-200309021-00015; Gerzeli S, 2005, NEUROL SCI, V26, P72, DOI 10.1007/s10072-005-0439-0; Gini R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-15; Goodman A, 2013, SOC SCI MED, V97, P228, DOI 10.1016/j.socscimed.2013.08.030; Grabow ML, 2012, ENVIRON HEALTH PERSP, V120, P68, DOI 10.1289/ehp.1103440; Hoevenaar-Blom MP, 2011, EUR J CARDIOV PREV R, V18, P41, DOI 10.1097/HJR.0b013e32833bfc87; Holm AL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001135; Hu G, 2003, DIABETOLOGIA, V46, P322, DOI 10.1007/s00125-003-1031-x; Hubert HB, 2002, J GERONTOL A-BIOL, V57, pM347, DOI 10.1093/gerona/57.6.M347; Institute for Transportation & Development Policy, 2012, ITDP ANN REP 2012; ISTAT, 2014, 100 STAT CAP PAES CU; ISTAT, 2014, DAT AMB NELL QUAL AM; Istituto Nazionale di Statistica, 2014, 15 CENS GEN POP AB 2; Istituto Nazionale di Statistica, 2013, TAV MORT TOSC 2010, DOI [10.1097/CCM.0b013e318169ed30.Building, DOI 10.1097/CCM.0B013E318169ED30]; Istituto Nazionale di Statistica, 2013, INFL IT 2002 2012; Jacobsen PL, 2003, INJURY PREV, V9, P205, DOI 10.1136/ip.9.3.205rep; Jarrett J, 2012, LANCET, V379, P2198, DOI 10.1016/S0140-6736(12)60766-1; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lindsay G, 2011, AUST NZ J PUBL HEAL, V35, P54, DOI 10.1111/j.1753-6405.2010.00621.x; Mantovani LG, 2011, INT J CARDIOL, V150, P111, DOI 10.1016/j.ijcard.2011.04.030; Marchesini G, 2011, NUTR METAB CARDIOVAS, V21, P339, DOI 10.1016/j.numecd.2009.10.009; Marescotti A, 2009, STUDIO SUI COSTI STI; Midgley P, 2011, 19 SESS COMM SUST DE; New York City Department of Transportation, 2013, MAK SAF STREETS; New York City Department of Transportation, 2013, CYCL CIT UPD NYC CYC; New York City Department of Transportation Division of Traffic Operations, 2011, 2011 NYC COMM CYCL I; OECD, 2013, HLTH GLANC 2013 OECD, DOI [10.1787/health_glance-2013-49-en, DOI 10.1787/HEALTH_GLANCE-2013-49-EN]; Ogilvie D, 2004, BMJ-BRIT MED J, V329, P763, DOI 10.1136/bmj.38216.714560.55; Ogilvie F, 2012, PREV MED, V55, P40, DOI 10.1016/j.ypmed.2012.05.002; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Pucher J, 2010, PREV MED, V50, pS106, DOI 10.1016/j.ypmed.2009.07.028; Rabl A, 2012, TRANSPORT POLICY, V19, P121, DOI 10.1016/j.tranpol.2011.09.008; Roglic G, 2010, DIABETES RES CLIN PR, V87, P15, DOI 10.1016/j.diabres.2009.10.006; Rojas-Rueda D, 2013, PREV MED, V57, P573, DOI 10.1016/j.ypmed.2013.07.021; Rojas-Rueda D, 2012, ENVIRON INT, V49, P100, DOI 10.1016/j.envint.2012.08.009; Rojas-Rueda D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4521; Rupprecht S., 2010, PRESTO CYCLING POLIC; Transport for London, 2011, CYCL SAF ACT PLAN EN; Transport for NSW, 2013, SYDN CYCL FUT CYCL E; Valeri E, 2012, GLI INCIDENTI STRADA; Valle Roberto, 2006, Monaldi Arch Chest Dis, V66, P63; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; WHO Regional Office for Europe, 2014, UNL NEW OPP JOBS GRE; WHO Regional Office for Europe, 2014, HLTH EC ASS TOOLS HE; Woodcock J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g425; Woodcock J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051462; Woodcock J, 2009, LANCET, V374, P1930, DOI 10.1016/S0140-6736(09)61714-1; Yang L, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5293	66	20	20	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125491	10.1371/journal.pone.0125491	http://dx.doi.org/10.1371/journal.pone.0125491			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0MA	25928421	Green Published, gold, Green Submitted			2022-12-27	WOS:000353713100095
J	Wu, LX; Chen, XL; Huang, LS; Tian, J; Ke, F; Xu, JH; Chen, YZ; Zheng, M				Wu, Lixian; Chen, Xianling; Huang, Lisen; Tian, Jue; Ke, Fang; Xu, Jianhua; Chen, Yuanzhong; Zheng, Ming			A Novobiocin Derivative, XN4, Inhibits the Proliferation of Chronic Myeloid Leukemia Cells by Inducing Oxidative DNA Damage	PLOS ONE			English	Article							CLINICAL RESISTANCE; REPAIR FOCI; STRESS; APOPTOSIS; ROS; GAMMA-H2AX; MECHANISM; CHROMATIN; ABSENCE; KINASE	XN4 might induce DNA damage and apoptotic cell death through reactive oxygen species (ROS). The inhibition of proliferation of K562 and K562/G01 cells was measured by MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide). The mRNA levels of NADPH oxidase 1-5 (Nox1-5) genes were evaluated by qRT-PCR. The levels of extracellular reactive oxygen species (ROS), DNA damage, apoptosis, and cell cycle progression were examined by flow cytometry (FCM). Protein levels were analyzed by immunoblotting. XN4 significantly inhibited the proliferation of K562 and K562/G01 cells, with IC50 values of 3.75 +/- 0.07 mu M and 2.63 +/- 0.43 mu M, respectively. XN4 significantly increased the levels of Nox4 and Nox5 mRNA, stimulating the generation of intracellular ROS, inducing DNA damage and activating ATM-gamma-H2AX signaling, which increased the number of cells in the S and G2/M phase of the cell cycle. Subsequently, XN4 induced apoptotic cell death by activating caspase-3 and PARP. Moreover, the above effects were all reversed by the ROS scavenger N-acetylcysteine (NAC). Additionally, XN4 can induce apoptosis in progenitor/stem cells isolated from CML patients' bone marrow. In conclusion, XN4-induced DNA damage and cell apoptosis in CML cells is mediated by the generation of ROS.	[Wu, Lixian; Huang, Lisen; Tian, Jue; Xu, Jianhua] Fujian Med Univ, Sch Pharm, Dept Pharmacol, Fuzhou, Peoples R China; [Wu, Lixian; Huang, Lisen; Tian, Jue; Xu, Jianhua] FMU, Inst Mat Med, Fuzhou, Peoples R China; [Wu, Lixian; Huang, Lisen; Tian, Jue; Xu, Jianhua] FMU, Fuijan Key Lab Nat Med Pharmacol, Fuzhou, Peoples R China; [Ke, Fang] FMU, Dept Pharmacochem, Sch Pharm, Fuzhou, Peoples R China; [Chen, Xianling; Chen, Yuanzhong] FMU, Fujian Inst Hematol, Union Hosp, Fuzhou, Peoples R China; [Zheng, Ming] FMU, Sch Basic Med, Dept Anat, Fuzhou, Peoples R China	Fujian Medical University	Wu, LX (corresponding author), Fujian Med Univ, Sch Pharm, Dept Pharmacol, Fuzhou, Peoples R China.	wlx-lisa@126.com; zming_1956@163.com	wu, lisa/ABE-8423-2020	, Fang/0000-0002-5970-2512	National Natural Science Foundation of China [30901824, 81273541]; Natural Science Foundation of Fujian Province of China [2011J06013]; Educational Bureau of Fujian Province of China [JA11101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province); Educational Bureau of Fujian Province of China	The authors gratefully acknowledge the National Natural Science Foundation of China (30901824, 81273541), the Natural Science Foundation of Fujian Province of China (Outstanding project 2011J06013), and the Educational Bureau of Fujian Province of China (JA11101) support for this project.	Bajrami I, 2014, CANCER RES, V74, P287, DOI 10.1158/0008-5472.CAN-13-2541; Bekker-Jensen S, 2010, DNA REPAIR, V9, P1219, DOI 10.1016/j.dnarep.2010.09.010; Brem R, 2010, ONCOGENE, V29, P3953, DOI 10.1038/onc.2010.140; Corbin AS, 2011, J CLIN INVEST, V121, P396, DOI 10.1172/JCI35721; Deavall DG, 2012, J TOXICOL-US, V2012, DOI 10.1155/2012/645460; Degtyareva NP, 2013, NUCLEIC ACIDS RES, V41, P8995, DOI 10.1093/nar/gkt671; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Ermolaeva MA, 2013, NATURE, V501, P416, DOI 10.1038/nature12452; Floyd SR, 2013, NATURE, V498, P246, DOI 10.1038/nature12147; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Hanot M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044367; Hu LC, 2013, NATURE, V501, P569, DOI 10.1038/nature12500; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Ko CH, 2005, BIOCHEM PHARMACOL, V69, P913, DOI 10.1016/j.bcp.2004.12.005; Kuo LJ, 2008, IN VIVO, V22, P305; Lange J, 2011, NATURE, V479, P237, DOI 10.1038/nature10508; Lu HF, 2007, ANTICANCER RES, V27, P117; Luo HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060065; Mansour WY, 2013, DNA REPAIR, V12, P1134, DOI 10.1016/j.dnarep.2013.10.005; Markus F., 2004, EUROPEAN JOURNAL OF, V40, P1934; Martin OA, 2013, DNA REPAIR, V12, P844, DOI 10.1016/j.dnarep.2013.07.002; Mroz RM, 2008, EUR RESPIR J, V31, P241, DOI 10.1183/09031936.00006707; Muller R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070430; Perl A, 2011, J CLIN INVEST, V121, P22, DOI 10.1172/JCI43605; Qi Jing, 2004, Zhonghua Xue Ye Xue Za Zhi, V25, P337; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Tallis M, 2014, CHROMOSOMA, V123, P79, DOI 10.1007/s00412-013-0442-9; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Tu WZ, 2013, FEBS LETT, V587, P3437, DOI 10.1016/j.febslet.2013.08.028; von Bubnoff N, 2002, LANCET, V359, P487, DOI 10.1016/S0140-6736(02)07679-1; Wang J, 2008, CANCER BIOL THER, V7, P1875, DOI 10.4161/cbt.7.12.7067; Wang SW, 2004, J BIOL CHEM, V279, P25535, DOI 10.1074/jbc.M400944200; Wu LX, 2008, LEUKEMIA, V22, P1402, DOI 10.1038/leu.2008.89; Wu LX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018447; Zhao H, 2013, CYTOM PART A, V83, P979, DOI 10.1002/cyto.a.22396	35	7	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0123314	10.1371/journal.pone.0123314	http://dx.doi.org/10.1371/journal.pone.0123314			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928540	Green Published, gold, Green Submitted			2022-12-27	WOS:000353713100016
J	Xie, XZ; Wang, YY				Xie, Xinzhou; Wang, Yuanyuan			Flow Regulation in Coronary Vascular Tree: A Model Study	PLOS ONE			English	Article							BLOOD-FLOW; THEORETICAL-MODEL; NITRIC-OXIDE; RESPONSES; MICROCIRCULATION; PRESSURE; PERFUSION; MUSCLE; ROLES	Background Coronary blood flow can always be matched to the metabolic demand of the myocardium due to the regulation of vasoactive segments. Myocardial compressive forces play an important role in determining coronary blood flow but its impact on flow regulation is still unknown. The purpose of this study was to develop a coronary specified flow regulation model, which can integrate myocardial compressive forces and other identified regulation factors, to further investigate the coronary blood flow regulation behavior. Method A theoretical coronary flow regulation model including the myogenic, shear-dependent and metabolic responses was developed. Myocardial compressive forces were included in the modified wall tension model. Shear-dependent response was estimated by using the experimental data from coronary circulation. Capillary density and basal oxygen consumption were specified to corresponding to those in coronary circulation. Zero flow pressure was also modeled by using a simplified capillary model. Result Pressure-flow relations predicted by the proposed model are consistent with previous experimental data. The predicted diameter changes in small arteries are in good agreement with experiment observations in adenosine infusion and inhibition of NO synthesis conditions. Results demonstrate that the myocardial compressive forces acting on the vessel wall would extend the auto-regulatory range by decreasing the myogenic tone at the given perfusion pressure. Conclusions Myocardial compressive forces had great impact on coronary auto-regulation effect. The proposed model was proved to be consistent with experiment observations and can be employed to investigate the coronary blood flow regulation effect in physiological and pathophysiological conditions.	[Xie, Xinzhou; Wang, Yuanyuan] Fudan Univ, Dept Elect Engn, Shanghai 200433, Peoples R China; [Wang, Yuanyuan] Key Lab Med Imaging Comp & Comp Assisted Interven, Shanghai, Peoples R China	Fudan University	Wang, YY (corresponding author), Fudan Univ, Dept Elect Engn, Shanghai 200433, Peoples R China.	yywang@fudan.edu.cn	Lv, Yuanjie/AER-0767-2022		National Basic Research Program of China [2015CB755500]; National Natural Science Foundation of China [11474071]; Science and Technology Commission of Shanghai Municipality [13441902800]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the National Basic Research Program of China (2015CB755500), the National Natural Science Foundation of China (No. 11474071) and the Science and Technology Commission of Shanghai Municipality (No. 13441902800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arciero JC, 2008, AM J PHYSIOL-HEART C, V295, pH1562, DOI 10.1152/ajpheart.00261.2008; Carlson BE, 2005, MICROCIRCULATION, V12, P327, DOI 10.1080/10739680590934745; Carlson BE, 2008, AM J PHYSIOL-HEART C, V295, pH1572, DOI 10.1152/ajpheart.00262.2008; CHILIAN WM, 1986, AM J PHYSIOL, V251, pH779, DOI 10.1152/ajpheart.1986.251.4.H779; Chilian WM, 1990, CORONARY CIRCULATION, P173; Cohen KD, 2000, AM J PHYSIOL-HEART C, V278, pH1916, DOI 10.1152/ajpheart.2000.278.6.H1916; Collins DM, 1998, MICROVASC RES, V56, P43, DOI 10.1006/mvre.1998.2076; Cornelissen AJM, 2002, AM J PHYSIOL-HEART C, V282, pH2224, DOI 10.1152/ajpheart.00491.2001; Duncker DJ, 2008, PHYSIOL REV, V88, P1009, DOI 10.1152/physrev.00045.2006; FARHI ER, 1991, CIRC RES, V68, P392, DOI 10.1161/01.RES.68.2.392; FELDBERG R, 1995, AM J PHYSIOL-RENAL, V269, pF581, DOI 10.1152/ajprenal.1995.269.4.F581; GONZALEZFERNANDEZ JM, 1994, MATH BIOSCI, V119, P127, DOI 10.1016/0025-5564(94)90074-4; JONES CJH, 1995, CIRCULATION, V91, P1807, DOI 10.1161/01.CIR.91.6.1807; JONES CJH, 1993, ADV EXP MED BIOL, V346, P181; Knaapen P, 2009, BASIC RES CARDIOL, V104, P485, DOI 10.1007/s00395-009-0037-z; KUO L, 1990, AM J PHYSIOL, V259, pH1063, DOI 10.1152/ajpheart.1990.259.4.H1063; KUO L, 1995, CIRCULATION, V92, P518, DOI 10.1161/01.CIR.92.3.518; Liao JC, 1997, AM J PHYSIOL-HEART C, V272, pH1571, DOI 10.1152/ajpheart.1997.272.4.H1571; MAYERS I, 1990, RESP PHYSIOL, V81, P63, DOI 10.1016/0034-5687(90)90070-F; MOSHER P, 1964, CIRC RES, V14, P250, DOI 10.1161/01.RES.14.3.250; Muller JM, 1996, CARDIOVASC RES, V32, P668, DOI 10.1016/0008-6363(96)00111-3; POHL U, 1991, BASIC RES CARDIOL, V86, P97; Secomb T, 2008, MICROCIRCULATION, V15, P765, DOI 10.1080/10739680802350112; Segal SS, 2005, MICROCIRCULATION, V12, P33, DOI 10.1080/10739680590895028; Sircar Sabyasachi, 2008, PRINCIPLES MED PHYSL; Spaan J, 2008, PHILOS T R SOC A, V366, P3137, DOI 10.1098/rsta.2008.0075; Stepp DW, 1999, CIRCULATION, V100, P1555, DOI 10.1161/01.CIR.100.14.1555; Tune JD, 2004, J APPL PHYSIOL, V97, P404, DOI 10.1152/japplphysiol.01345.2003; Westerhof N, 2006, PHYSIOL REV, V86, P1263, DOI 10.1152/physrev.00029.2005; Westerhof N, 2010, SNAPSHOTS OF HEMODYNAMICS: AN AID FOR CLINICAL RESEARCH AND GRADUATE EDUCATION, SECOND EDITION, P45, DOI 10.1007/978-1-4419-6363-5_9	30	2	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125778	10.1371/journal.pone.0125778	http://dx.doi.org/10.1371/journal.pone.0125778			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928718	Green Published, Green Submitted, gold			2022-12-27	WOS:000353713100118
J	Yang, L; Chan, KH; Suen, LKP; Chan, KP; Wang, XL; Cao, PH; He, DH; Peiris, JSM; Wong, CM				Yang, Lin; Chan, Kwok Hung; Suen, Lorna K. P.; Chan, King Pan; Wang, Xiling; Cao, Peihua; He, Daihai; Peiris, J. S. Malik; Wong, Chit Ming			Impact of the 2009 H1N1 Pandemic on Age-Specific Epidemic Curves of Other Respiratory Viruses: A Comparison of Pre-Pandemic, Pandemic and Post-Pandemic Periods in a Subtropical City	PLOS ONE			English	Article							INFLUENZA VACCINE EFFECTIVENESS; HONG-KONG; WAVELET ANALYSIS; INFECTIONS; CHILDREN; SYNCHRONY; SEVERITY; A/H1N1	Background The 2009 H1N1 influenza pandemic caused offseason peaks in temperate regions but coincided with the summer epidemic of seasonal influenza and other common respiratory viruses in subtropical Hong Kong. This study was aimed to investigate the impact of the pandemic on age-specific epidemic curves of other respiratory viruses. Methods Weekly laboratory-confirmed cases of influenza A (subtypes seasonal A(H1N1), A(H3N2), pandemic virus A(H1N1) pdm09), influenza B, respiratory syncytial virus (RSV), adenovirus and parainfluenza were obtained from 2004 to 2013. Age-specific epidemic curves of viruses other than A(H1N1) pdm09 were compared between the pre-pandemic (May 2004 - April 2009), pandemic (May 2009 - April 2010) and post-pandemic periods (May 2010 - April 2013). Results There were two peaks of A(H1N1) pdm09 in Hong Kong, the first in September 2009 and the second in February 2011. The infection rate was found highest in young children in both waves, but markedly fewer cases in school children were recorded in the second wave than in the first wave. Positive proportions of viruses other than A(H1N1) pdm09 markedly decreased in all age groups during the first pandemic wave. After the first wave of the pandemic, the positive proportion of A(H3N2) increased, but those of B and RSV remained slightly lower than their pre-pandemic proportions. Changes in seasonal pattern and epidemic peak time were also observed, but inconsistent across virus-age groups. Conclusion Our findings provide some evidence that age distribution, seasonal pattern and peak time of other respiratory viruses have changed since the pandemic. These changes could be the result of immune interference and changing health seeking behavior, but the mechanism behind still needs further investigations.	[Yang, Lin; Suen, Lorna K. P.] Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Hong Kong, Peoples R China; [Chan, Kwok Hung] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Chan, King Pan; Wang, Xiling; Cao, Peihua; Wong, Chit Ming] Univ Hong Kong, Sch Publ Hlth, Div Epidemiol & Biostat, Hong Kong, Hong Kong, Peoples R China; [He, Daihai] Hong Kong Polytech Univ, Dept Appl Math, Hong Kong, Hong Kong, Peoples R China; [Peiris, J. S. Malik] Univ Hong Kong, Sch Publ Hlth, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China	Hong Kong Polytechnic University; University of Hong Kong; University of Hong Kong; Hong Kong Polytechnic University; University of Hong Kong	Yang, L (corresponding author), Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Hong Kong, Peoples R China.	l.yang@polyu.edu.hk; hrmrwcm@hku.hk	YANG, Lin/F-9601-2014; Cao, Peihua/GYU-4280-2022; He, Daihai/AAT-8735-2021; Chan, Kwok Hung/ABD-5399-2021; Suen, Lorna KP/F-5077-2014; Peiris, Joseph Sriyal Malik/C-4380-2009	YANG, Lin/0000-0002-5964-3233; Suen, Lorna KP/0000-0002-0126-6674; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; He, Daihai/0000-0003-3253-654X	Health and Medical Research Fund [11100582, 12111232]; Area of Excellence Scheme of the University Grants Committee of the Hong Kong Special Administrative Region Government [AoE/M-12/-06]	Health and Medical Research Fund; Area of Excellence Scheme of the University Grants Committee of the Hong Kong Special Administrative Region Government	This work was supported by the Health and Medical Research Fund (grants 11100582 and 12111232) and the Area of Excellence Scheme of the University Grants Committee (grant AoE/M-12/-06) of the Hong Kong Special Administrative Region Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borja-Aburto VH, 2012, ARCH MED RES, V43, P563, DOI 10.1016/j.arcmed.2012.09.005; Casalegno JS, 2010, EUROSURVEILLANCE, V15, P5; Centre for Health Protection, 2013, SEAS INFL VACC COV S; Chan KH, 2008, J CLIN VIROL, V42, P65, DOI 10.1016/j.jcv.2007.12.003; Chiu SS, 2002, NEW ENGL J MED, V347, P2097, DOI 10.1056/NEJMoa020546; Chuang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036120; Cowling BJ, 2012, EPIDEMIOLOGY, V23, P930, DOI 10.1097/EDE.0b013e31826b300e; Cowling BJ, 2012, CLIN INFECT DIS, V54, P1778, DOI 10.1093/cid/cis307; Dierig A, 2014, INFLUENZA OTHER RESP, V8, P293, DOI 10.1111/irv.12229; Finkelman BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001296; Horby P, 2012, AM J EPIDEMIOL, V175, P1062, DOI 10.1093/aje/kws121; Lau JTF, 2005, PREV MED, V41, P454, DOI 10.1016/j.ypmed.2004.11.023; Maraun D, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.016707; Maraun D, 2004, NONLINEAR PROC GEOPH, V11, P505, DOI 10.5194/npg-11-505-2004; McGill J, 2009, J LEUKOCYTE BIOL, V86, P803, DOI 10.1189/jlb.0509368; Meningher T, 2014, INFLUENZA OTHER RESP, V8, P422, DOI 10.1111/irv.12249; Monto AS, 2004, PEDIATR INFECT DIS J, V23, pS58, DOI 10.1097/01.inf.0000108193.91607.34; Riley S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000442; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Sundaram ME, 2013, CLIN INFECT DIS, V57, P789, DOI 10.1093/cid/cit379; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Wu JT, 2010, CLIN INFECT DIS, V51, P1184, DOI 10.1086/656740; Yang L, 2012, EUROSURVEILLANCE, V17, P8; Yang L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001399; Yang YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045807	26	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125447	10.1371/journal.pone.0125447	http://dx.doi.org/10.1371/journal.pone.0125447			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928217	Green Published, gold, Green Submitted			2022-12-27	WOS:000353713100092
J	Yang, M; Xu, LM; Liu, YL; Yang, PF				Yang, Mei; Xu, Liming; Liu, Yanling; Yang, Pingfang			RNA-Seq Uncovers SNPs and Alternative Splicing Events in Asian Lotus (Nelumbo nucifera)	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SACRED LOTUS; MAPPING POPULATION; CAPSICUM-ANNUUM; TRANSCRIPTOME; ARABIDOPSIS; DISCOVERY; LINKAGE; SSR; CONSTRUCTION	RNA-Seq is an efficient way to comprehensively identify single nucleotide polymorphisms (SNPs) and alternative splicing (AS) events from the expressed genes. In this study, we conducted transcriptome sequencing of four Asian lotus (Nelumbo nucifera) cultivars using Illumina HiSeq2000 platform to identify SNPs and AS events in lotus. A total of 505 million pair-end RNA-Seq reads were generated from four cultivars, of which 86% were mapped to the lotus reference genome. Using the four sets of data together, a total of 357,689 putative SNPs were identified with an average density of one SNP per 2.2 kb. These SNPs were located in 1,253 scaffolds and 15,016 expressed genes. A/G and C/T were the two major types of SNPs in the Asian lotus transcriptome. In parallel, a total of 177,540 AS events were detected in the four cultivars and were distributed in 64% of the expressed genes of lotus. The predominant type of AS events was alternative 5' first exon, which accounted for 41.2% of all the observed AS events, and exon skipping only accounted for 4.3% of all AS. Gene Ontology analysis was conducted to analyze the function of the genes containing SNPs and AS events. Validation of selected SNPs and AS events revealed that 74% of SNPs and 80% of AS events were reliable, which indicates that RNA-Seq is an efficient approach to uncover gene-associated SNPs and AS events. A large number of SNPs and AS events identified in our study will facilitate further genetic and functional genomics research in lotus.	[Yang, Mei; Xu, Liming; Yang, Pingfang] Chinese Acad Sci, Key Lab Plant Germplasm Enhancement & Special Agr, Wuhan Bot Garden, Wuhan, Hunan, Peoples R China; [Liu, Yanling] Chinese Acad Sci, Key Lab Aquat Plant & Watershed Ecol, Wuhan Bot Garden, Wuhan, Hunan, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; Wuhan Botanical Garden, CAS	Yang, PF (corresponding author), Chinese Acad Sci, Key Lab Plant Germplasm Enhancement & Special Agr, Wuhan Bot Garden, Wuhan, Hunan, Peoples R China.	yangpf@wbgcas.cn	liu, yan/HGV-1365-2022; liu, yan/HCI-5542-2022; Yang, Mei/AAD-1550-2022		National Natural Science Foundation of China [31200268, 31471899]; Knowledge Innovation Project of Chinese Academy of Sciences [Y455421Z02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Project of Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences)	This research was financially supported by National Natural Science Foundation of China (31200268 and 31471899) and The Knowledge Innovation Project of Chinese Academy of Sciences (No. Y455421Z02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashrafi H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-571; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Bachlava E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029814; Beretta S, 2014, J COMPUT BIOL, V21, P16, DOI 10.1089/cmb.2013.0112; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blanca J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-280; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Brachi B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000940; Cadic E, 2013, THEOR APPL GENET, V126, P1337, DOI 10.1007/s00122-013-2056-2; Campbell MA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-327; Duangjit J, 2013, THEOR APPL GENET, V126, P2093, DOI 10.1007/s00122-013-2121-x; Esteras C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-80; Florea L, 2013, 1000S EXON SKIPPING, V2, P188; Fu J, 2011, J AM SOC HORTIC SCI, V136, P339, DOI 10.21273/JASHS.136.5.339; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Kump KL, 2011, NAT GENET, V43, P163, DOI 10.1038/ng.747; Lareau LF, 2004, CURR OPIN STRUC BIOL, V14, P273, DOI 10.1016/j.sbi.2004.05.002; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2013, NAT GENET, V45, P43, DOI 10.1038/ng.2484; Li WY, 2014, METHODS, V67, P313, DOI 10.1016/j.ymeth.2014.02.024; Lu FH, 2012, MOL BIOL REP, V39, P3327, DOI 10.1007/s11033-011-1102-x; Lu FH, 2011, SCI HORTIC-AMSTERDAM, V129, P38, DOI 10.1016/j.scienta.2011.03.003; Mandel JR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003378; Marquez Y, 2012, GENOME RES, V22, P1184, DOI 10.1101/gr.134106.111; McGuire AM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r50; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Ming R, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r41; Nicolai M, 2012, GENET MOL RES, V11, P2295, DOI 10.4238/2012.August.13.3; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Shen YT, 2014, PLANT CELL, V26, P996, DOI 10.1105/tpc.114.122739; Shen-Miller J, 2002, SEED SCI RES, V12, P131, DOI 10.1079/SSR2002112; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; VanBuren R, 2013, PLANT OMICS, V6, P311; Wang BB, 2006, P NATL ACAD SCI USA, V103, P7175, DOI 10.1073/pnas.0602039103; Wang L, 2013, PLANT MOL BIOL, V83, P365, DOI 10.1007/s11103-013-0093-5; Yang M, 2014, ANN APPL BIOL, V165, P73, DOI 10.1111/aab.12119; Yang M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-653; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang D, 2013, EUPHYTICA, V191, P23, DOI 10.1007/s10681-012-0840-8; Zhang GJ, 2010, GENOME RES, V20, P646, DOI 10.1101/gr.100677.109; Zhang Q, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-372; Zhang XY, 2011, NEW LOTUS FLOWER CUL, P278; Zou D, 2013, GENOMICS, V102, P57, DOI 10.1016/j.ygeno.2013.02.014	45	22	23	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125702	10.1371/journal.pone.0125702	http://dx.doi.org/10.1371/journal.pone.0125702			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928215	Green Published, Green Submitted, gold			2022-12-27	WOS:000353713100112
J	Aguero, J; Ishikawa, K; Fish, KM; Hammoudi, N; Hadri, L; Garcia-Alvarez, A; Ibanez, B; Fuster, V; Hajjar, RJ; Leopold, JA				Aguero, Jaume; Ishikawa, Kiyotake; Fish, Kenneth M.; Hammoudi, Nadjib; Hadri, Lahouaria; Garcia-Alvarez, Ana; Ibanez, Borja; Fuster, Valentin; Hajjar, Roger J.; Leopold, Jane A.			Combination Proximal Pulmonary Artery Coiling and Distal Embolization Induces Chronic Elevations in Pulmonary Artery Pressure in Swine	PLOS ONE			English	Article							HYPERTENSION; MODEL; MORTALITY	Pulmonary hypertension (PH) is associated with aberrant vascular remodeling and right ventricular (RV) dysfunction that contribute to early mortality. Large animal models that recapitulate human PH are essential for mechanistic studies and evaluating novel therapies; however, these models are not readily accessible to the field owing to the need for advanced surgical techniques or hypoxia. In this study, we present a novel swine model that develops cardiopulmonary hemodynamics and structural changes characteristic of chronic PH. This percutaneous model was created in swine (n= 6) by combining distal embolization of dextran beads with selective coiling of the lobar pulmonary arteries (2 procedures per lung over 4 weeks). As controls, findings from this model were compared with those from a standard weekly distal embolization model (n= 6) and sham animals (n= 4). Survival with the combined embolization model was 100%. At 8 weeks after the index procedure, combined embolization procedure animals had increased mean pulmonary artery pressure (mPA) and pulmonary vascular resistance (PVR) compared to the controls with no effect on left heart or systemic pressures. RV remodeling and RV dysfunction were also present with a decrease in the RV ejection fraction, increase in the myocardial performance index, impaired longitudinal function, as well as cardiomyocyte hypertrophy, and interstitial fibrosis, which were not present in the controls. Pulmonary vascular remodeling occurred in both embolization models, although only the combination embolization model had a decrease in pulmonary capacitance. Taken together, these cardiopulmonary hemodynamic and structural findings identify the novel combination embolization swine model as a valuable tool for future studies of chronic PH.	[Aguero, Jaume; Ishikawa, Kiyotake; Fish, Kenneth M.; Hammoudi, Nadjib; Hadri, Lahouaria; Hajjar, Roger J.] Icahn Sch Med Mt Sinai, Cardiovasc Res Ctr, New York, NY 10029 USA; [Aguero, Jaume; Garcia-Alvarez, Ana; Ibanez, Borja; Fuster, Valentin] Ctr Nacl Invest Cardiovasc Carlos III CNIC Epidem, Atherothrombosis & Imaging Dept, Madrid, Spain; [Fuster, Valentin] Icahn Sch Med Mt Sinai, Zena & Michael A Wiener Cardiovasc Inst, New York, NY 10029 USA; [Leopold, Jane A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc Med, Boston, MA 02115 USA	Icahn School of Medicine at Mount Sinai; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Icahn School of Medicine at Mount Sinai; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Aguero, J (corresponding author), Icahn Sch Med Mt Sinai, Cardiovasc Res Ctr, New York, NY 10029 USA.	jaimeaguero30@hotmail.com	Ishikawa, Kiyotake/I-6013-2015; Ibáñez, Borja/J-6993-2014; Hadri, Lahouaria/AAP-6415-2020; Aguero, Jaume/I-8582-2016; Alvarez, Ana García/AAB-4999-2021; Fuster, Valentin/H-4319-2015	Ibáñez, Borja/0000-0002-5036-254X; Hadri, Lahouaria/0000-0001-8108-7993; Aguero, Jaume/0000-0001-7416-871X; Alvarez, Ana García/0000-0002-1718-2424; Fuster, Valentin/0000-0002-9043-9986; ishikawa, kiyotake/0000-0002-8287-3483; Hammoudi, Nadjib/0000-0003-2085-8525; FISH, KENNETH/0000-0002-7781-0314	National Institutes of Health [RO1 HL083156, HL093183, HL119046, P20HL100396]; NHLBI Program of Excellence in Nanotechnology Award [HHSN268201000045C]; NIH [R01 105301]; Leducq Foundation; Fundacion Alfonso Martin-Escudero; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL125215, R01HL093183, R01HL083156, R01HL119046, P20HL100396] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI Program of Excellence in Nanotechnology Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leducq Foundation(Leducq Foundation); Fundacion Alfonso Martin-Escudero; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by National Institutes of Health RO1 HL083156, HL093183, HL119046, P20HL100396 and a NHLBI Program of Excellence in Nanotechnology Award, Contract # HHSN268201000045C (RJH) and NIH R01 105301 (JAL). Part of the work was funded by a Leducq Foundation grant (RJH). JA was supported by the Fundacion Alfonso Martin-Escudero.	Bauer NR, 2007, AM J PHYSIOL-LUNG C, V293, pL580, DOI 10.1152/ajplung.00281.2007; Burrowes K S, 2011, Pulm Circ, V1, P365, DOI 10.4103/2045-8932.87302; Champion HC, 2009, CIRCULATION, V120, P992, DOI 10.1161/CIRCULATIONAHA.106.674028; Garcia-Alvarez A, 2013, J AM COLL CARDIOL, V62, P1621, DOI 10.1016/j.jacc.2013.07.037; Gomez-Arroyo JG, 2012, AM J PHYSIOL-LUNG C, V302, pL363, DOI 10.1152/ajplung.00212.2011; Guihaire J, 2013, EUR HEART J-CARD IMG, V14, P1140, DOI 10.1093/ehjci/jet092; KELLEY KW, 1973, J ANIM SCI, V36, P927; Kim H, 2000, EUR RESPIR J, V15, P640, DOI 10.1034/j.1399-3003.2000.15d04.x; Mahapatra S, 2006, J AM COLL CARDIOL, V47, P799, DOI 10.1016/j.jacc.2005.09.054; Mercier O, 2013, PULM CIRC, V3, P908, DOI 10.1086/674757; Pereda D, 2014, J CARDIOVASC TRANSL, V7, P494, DOI 10.1007/s12265-014-9564-6; PERKETT EA, 1991, AM J PATHOL, V139, P1319; Pietra GG, 2004, J AM COLL CARDIOL, V43, p25S, DOI 10.1016/j.jacc.2004.02.033; Pohlmann JR, 2012, J SURG RES, V175, P44, DOI 10.1016/j.jss.2011.02.049; Rondelet B, 2003, CIRCULATION, V107, P1329, DOI 10.1161/01.CIR.0000053443.27512.33; Sato H, 2008, ASAIO J, V54, P396, DOI 10.1097/MAT.0b013e31817efa85; SHELUB I, 1984, J APPL PHYSIOL, V56, P810, DOI 10.1152/jappl.1984.56.3.810; SILOVE ED, 1972, CARDIOVASC RES, V6, P36, DOI 10.1093/cvr/6.1.36; Song JK, 2000, J NEUROSURG, V92, P955, DOI 10.3171/jns.2000.92.6.0955; Stenmark KR, 2005, CIRC RES, V97, P95, DOI 10.1161/01.RES.00000175934.68087.29; Stenmark KR, 2009, AM J PHYSIOL-LUNG C, V297, pL1013, DOI 10.1152/ajplung.00217.2009; Stevens GR, 2012, JACC-CARDIOVASC IMAG, V5, P378, DOI 10.1016/j.jcmg.2011.11.020; Weimann J, 1999, J CRIT CARE, V14, P133, DOI 10.1016/S0883-9441(99)90026-6; Zeng GQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078965; Zhou XQ, 2011, J SURG RES, V170, pE11, DOI 10.1016/j.jss.2011.04.030	25	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124526	10.1371/journal.pone.0124526	http://dx.doi.org/10.1371/journal.pone.0124526			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923775	Green Submitted, Green Published, gold			2022-12-27	WOS:000353711600090
J	Hu, RM; Tan, BH; Tester, DJ; Song, CH; He, Y; Dovat, S; Peterson, BZ; Ackerman, MJ; Makielski, JC				Hu, Rou-Mu; Tan, Bi-Hua; Tester, David J.; Song, Chunhua; He, Yang; Dovat, Sinisa; Peterson, Blaise Z.; Ackerman, Michael J.; Makielski, Jonathan C.			Arrhythmogenic Biophysical Phenotype for SCN5A Mutation S1787N Depends upon Splice Variant Background and Intracellular Acidosis	PLOS ONE			English	Article							CARDIAC SODIUM-CHANNEL; LONG-QT SYNDROME; SUDDEN-INFANT-DEATH; K-ATP CHANNEL; NA+-CHANNEL; TERMINAL DOMAIN; INACTIVATION; BRUGADA; EXPRESSION; PH	Background SCN5A is a susceptibility gene for type 3 long QT syndrome, Brugada syndrome, and sudden infant death syndrome. I-Na dysfunction from mutated SCN5A can depend upon the splice variant background in which it is expressed and also upon environmental factors such as acidosis. S1787N was reported previously as a LQT3-associated mutation and has also been observed in 1 of 295 healthy white controls. Here, we determined the in vitro biophysical phenotype of SCN5A-S1787N in an effort to further assess its possible pathogenicity. Methods and Results We engineered S1787N in the two most common alternatively spliced SCN5A isoforms, the major isoform lacking a glutamine at position 1077 (Q1077del) and the minor isoform containing Q1077, and expressed these two engineered constructs in HEK293 cells for electrophysiological study. Macroscopic voltage-gated I-Na was measured 24 hours after transfection with standard whole-cell patch clamp techniques. We applied intracellular solutions with pH7.4 or pH6.7. S1787N in the Q1077 background had WT-like I-Na including peak I-Na density, activation and inactivation parameters, and late I-Na amplitude in both pH 7.4 and pH 6.7. However, with S1787N in the Q1077del background, the percentages of I-Na late/peak were increased by 2.1 fold in pH 7.4 and by 2.9 fold in pH 6.7 when compared to WT. Conclusion The LQT3-like biophysical phenotype for S1787N depends on both the SCN5A splice variant and on the intracellular pH. These findings provide further evidence that the splice variant and environmental factors affect the molecular phenotype of cardiac SCN5A-encoded sodium channel (Na(v)1.5), has implications for the clinical phenotype, and may provide insight into acidosis-induced arrhythmia mechanisms.	[Hu, Rou-Mu] China Meitan Gen Hosp, Dept Cardiol, Beijing, Peoples R China; [Hu, Rou-Mu; Tan, Bi-Hua; He, Yang; Makielski, Jonathan C.] Univ Wisconsin, Dept Med, Div Cardiovasc Med, Madison, WI 53718 USA; [Tan, Bi-Hua; Song, Chunhua; Dovat, Sinisa; Peterson, Blaise Z.] Penn State Univ, Coll Med, Dept Pediat, Hershey, PA USA; [Tan, Bi-Hua; Song, Chunhua; Dovat, Sinisa; Peterson, Blaise Z.] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA USA; [Tester, David J.; Ackerman, Michael J.] Mayo Clin, Dept Med, Rochester, MN USA; [Tester, David J.; Ackerman, Michael J.] Mayo Clin, Dept Pediat, Rochester, MN USA; [Tester, David J.; Ackerman, Michael J.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA	University of Wisconsin System; University of Wisconsin Madison; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Mayo Clinic; Mayo Clinic; Mayo Clinic	Tan, BH (corresponding author), Univ Wisconsin, Dept Med, Div Cardiovasc Med, Madison, WI 53718 USA.	btan@hmc.psu.edu	song, chunhua/K-7882-2016; song, chunhua/K-7882-2016	song, chunhua/0000-0001-7563-0339; Dovat, Sinisa/0000-0003-3906-6165; song, chunhua/0000-0002-4081-2543	American Heart Association [0525806Z, 11SDG7470009]; National Heart, Lung, and Blood Institute [HL-71092, HL-42569]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095120, R56HL071092, R01HL071092] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the American Heart Association (0525806Z and 11SDG7470009 to B.-H. Tan) and the National Heart, Lung, and Blood Institute (HL-71092 to J. C. Makielski and HL-42569 to M. J. Ackerman). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman MJ, 2004, HEART RHYTHM, V1, P600, DOI 10.1016/j.hrthm.2004.07.013; Ackerman MJ, 2001, JAMA-J AM MED ASSOC, V286, P2264, DOI 10.1001/jama.286.18.2264; BENNETT PB, 1995, NATURE, V376, P683, DOI 10.1038/376683a0; Bezzina C, 1999, CIRC RES, V85, P1206; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Chandra R, 1998, AM J PHYSIOL-HEART C, V274, pH1643, DOI 10.1152/ajpheart.1998.274.5.H1643; Cheng JD, 2011, PHYSIOL GENOMICS, V43, P461, DOI 10.1152/physiolgenomics.00198.2010; Clancy CE, 1999, NATURE, V400, P566, DOI 10.1038/23034; Cormier JW, 2002, J BIOL CHEM, V277, P9233, DOI 10.1074/jbc.M110204200; Deschenes I, 2000, CARDIOVASC RES, V46, P55, DOI 10.1016/S0008-6363(00)00006-7; EFFROS RM, 1975, J CLIN INVEST, V55, P1100, DOI 10.1172/JCI108011; GELLENS ME, 1992, P NATL ACAD SCI USA, V89, P554, DOI 10.1073/pnas.89.2.554; Glaaser IW, 2006, J BIOL CHEM, V281, P24015, DOI 10.1074/jbc.M605473200; Hu RM, 2013, AM J PHYSIOL-HEART C, V304, pH994, DOI 10.1152/ajpheart.00705.2012; Kim J, 2004, J BIOL CHEM, V279, P45004, DOI 10.1074/jbc.M407286200; Lowe JS, 2012, CARDIOVASC RES, V95, P300, DOI 10.1093/cvr/cvs160; Makielski JC, 2003, CIRC RES, V93, P821, DOI 10.1161/01.RES.0000096652.14509.96; Makita N, 2002, CIRCULATION, V106, P1269, DOI 10.1161/01.CIR.0000027139.42087.B6; Makita N, 2008, J CLIN INVEST, V118, P2219, DOI [10.1172/JCl34057, 10.1172/JCI34057]; Mantegazza M, 2001, P NATL ACAD SCI USA, V98, P15348, DOI 10.1073/pnas.211563298; Medeiros-Domingo A, 2010, HEART RHYTHM, V7, P1466, DOI 10.1016/j.hrthm.2010.06.016; Medeiros-Domingo A, 2009, HEART RHYTHM, V6, P1170, DOI 10.1016/j.hrthm.2009.04.034; Motoike HK, 2004, J GEN PHYSIOL, V123, P155, DOI 10.1085/jgp.200308929; Plant LD, 2006, J CLIN INVEST, V116, P430, DOI 10.1172/JCI25618; POOLEWILSON PA, 1975, AM J PHYSIOL, V229, P1305, DOI 10.1152/ajplegacy.1975.229.5.1305; Rivolta I, 2001, J BIOL CHEM, V276, P30623, DOI 10.1074/jbc.M104471200; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Splawski I, 2002, SCIENCE, V297, P1333, DOI 10.1126/science.1073569; Tan BH, 2005, HEART RHYTHM, V2, P741, DOI 10.1016/j.hrthm.2005.04.021; Tan BH, 2007, CARDIOVASC RES, V76, P409, DOI 10.1016/j.cardiores.2007.08.006; Tan BH, 2006, AM J PHYSIOL-HEART C, V291, pH1822, DOI 10.1152/ajpheart.00101.2006; Tester DJ, 2011, CIRC-CARDIOVASC GENE, V4, P510, DOI 10.1161/CIRCGENETICS.111.960195; VASSILEV P, 1989, P NATL ACAD SCI USA, V86, P8147, DOI 10.1073/pnas.86.20.8147; VASSILEV PM, 1988, SCIENCE, V241, P1658, DOI 10.1126/science.2458625; Vatta M, 2002, HUM MOL GENET, V11, P337, DOI 10.1093/hmg/11.3.337; Vaughan-Jones RD, 2002, J PHYSIOL-LONDON, V541, P139, DOI 10.1113/jphysiol.2001.013267; Veldkamp MW, 2000, CIRC RES, V86, pE91, DOI 10.1161/01.RES.86.9.e91; Wang DW, 2007, CIRCULATION, V115, P368, DOI 10.1161/CIRCULATIONAHA.106.646513; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wang Q, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013300; Wei J, 1999, CIRCULATION, V99, P3165, DOI 10.1161/01.CIR.99.24.3165; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910	43	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124921	10.1371/journal.pone.0124921	http://dx.doi.org/10.1371/journal.pone.0124921			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923670	Green Published, gold, Green Submitted			2022-12-27	WOS:000353711600112
J	Mohan, A; Dabir, S; Yadav, NK; Kummelil, M; Kumar, RS; Shetty, R				Mohan, Ashwin; Dabir, Supriya; Yadav, Naresh Kumar; Kummelil, Matthew; Kumar, Rajesh S.; Shetty, Rohit			Normative Database of Retinal Oximetry in Asian Indian Eyes	PLOS ONE			English	Article							VESSEL OXYGEN-SATURATION	Objective To study the oxygen saturation profile in normal Asian Indian eyes. Design A cross sectional prospective study. Subjects Ninety eight consecutive patients presenting to our hospital with best corrected distance visual acuity (BCVA) of 20/20 and a normal ophthalmic examination were included in the study. Patients having any ocular or systemic disease were excluded from the study. Materials and Methods Oximetry was performed on all subjects with the Oxymap T1 retinal oximeter (Oxymap hf, Reykjavik, Iceland). Main Outcome Measures The images were analysed for oxygen saturation and diameter. Results The mean age was 33 years (Range: 18-63; SD: 12.4). The average arteriolar saturation was 90.3 +/- 6.6% and the venous saturation was 56.9% +/- 6.3. The average A-V (arterio-venous) difference was 33.2% +/- 5.2. There was an increase in arteriolar (R-2 = 0.264; p=0.001) and venous saturation (R2 = 0.151; p=0.001) with age. There was no significant change in the arterio-venous saturation difference (AVSD). The inferotemporal quadrant had the lowest saturations. Age correlated positively with ocular perfusion pressure (OPP)(R-2=0.07; p=0.007). OPP correlated positively with global arteriolar saturation (R-2=0.057, p=0.018). Conclusion This study provides the normative database for an Indian population and is comparable to previous studies. Age, vessel diameter and OPP were the significant factors that influenced the saturation. Arteriolar and venous saturations increased with age while the AVSD did not change significantly.	[Mohan, Ashwin; Dabir, Supriya; Yadav, Naresh Kumar; Kummelil, Matthew; Kumar, Rajesh S.; Shetty, Rohit] Narayana Nethralaya, Post Grad Inst Ophthalmol, Bangalore, Karnataka, India		Dabir, S (corresponding author), Narayana Nethralaya, Post Grad Inst Ophthalmol, Bangalore, Karnataka, India.	supriad@gmail.com	Mohan, Ashwin/W-9587-2019; Kumar, Rajesh S/L-2018-2019	Mohan, Ashwin/0000-0003-4054-1402; 				Bonnel S, 2003, EXP GERONTOL, V38, P825, DOI 10.1016/S0531-5565(03)00093-7; Geirsdottir A, 2014, ACTA OPHTHALMOL, V92, P27, DOI 10.1111/aos.12294; Geirsdottir A, 2012, INVEST OPHTH VIS SCI, V53, P5433, DOI 10.1167/iovs.12-9912; Hammer M, 2002, PHYS MED BIOL, V47, pN233, DOI 10.1088/0031-9155/47/17/403; Hammer M, 2012, INVEST OPHTH VIS SCI, V53, P4063, DOI 10.1167/iovs.12-9659; Hardarson SH, 2006, INVEST OPHTH VIS SCI, V47, P5011, DOI 10.1167/iovs.06-0039; Hardarson SH, 2013, ACTA OPHTHALMOL, V91, P489, DOI 10.1111/aos.12239; Hardarson SH, 2012, ACTA OPHTHALMOL, V90, P466, DOI 10.1111/j.1755-3768.2011.02109.x; Jani PD, 2014, RETINA-J RET VIT DIS, V34, P394, DOI 10.1097/IAE.0b013e3182979e7b; Kur J, 2012, PROG RETIN EYE RES, V31, P377, DOI 10.1016/j.preteyeres.2012.04.004; Vandewalle E, 2014, ACTA OPHTHALMOL, V92, P105, DOI 10.1111/aos.12011	11	15	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0126179	10.1371/journal.pone.0126179	http://dx.doi.org/10.1371/journal.pone.0126179			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923699	Green Published, gold, Green Submitted			2022-12-27	WOS:000353711600173
J	Saez-Jimenez, V; Acebes, S; Guallar, V; Martinez, AT; Ruiz-Duenas, FJ				Saez-Jimenez, Veronica; Acebes, Sandra; Guallar, Victor; Martinez, Angel T.; Ruiz-Duenas, Francisco J.			Improving the Oxidative Stability of a High Redox Potential Fungal Peroxidase by Rational Design	PLOS ONE			English	Article							ERYNGII-VERSATILE-PEROXIDASE; SITE-DIRECTED MUTAGENESIS; CYTOCHROME-C PEROXIDASE; HYDROGEN-PEROXIDE; PLEUROTUS-ERYNGII; LIGNIN PEROXIDASE; SUICIDE INACTIVATION; MANGANESE PEROXIDASE; COMPOUND-III; MICROBIAL-DEGRADATION	Ligninolytic peroxidases are enzymes of biotechnological interest due to their ability to oxidize high redox potential aromatic compounds, including the recalcitrant lignin polymer. However, different obstacles prevent their use in industrial and environmental applications, including low stability towards their natural oxidizing-substrate H2O2. In this work, versatile peroxidase was taken as a model ligninolytic peroxidase, its oxidative inactivation by H2O2 was studied and different strategies were evaluated with the aim of improving H2O2 stability. Oxidation of the methionine residues was produced during enzyme inactivation by H2O2 excess. Substitution of these residues, located near the heme cofactor and the catalytic tryptophan, rendered a variant with a 7.8-fold decreased oxidative inactivation rate. A second strategy consisted in mutating two residues (Thr45 and Ile103) near the catalytic distal histidine with the aim of modifying the reactivity of the enzyme with H2O2. The T45A/I103T variant showed a 2.9-fold slower reaction rate with H2O2 and 2.8-fold enhanced oxidative stability. Finally, both strategies were combined in the T45A/I103T/M152F/M262F/M265L variant, whose stability in the presence of H2O2 was improved 11.7-fold. This variant showed an increased half-life, over 30 min compared with 3.4 min of the native enzyme, under an excess of 2000 equivalents of H2O2. Interestingly, the stability improvement achieved was related with slower formation, subsequent stabilization and slower bleaching of the enzyme Compound III, a peroxidase intermediate that is not part of the catalytic cycle and leads to the inactivation of the enzyme.	[Saez-Jimenez, Veronica; Martinez, Angel T.; Ruiz-Duenas, Francisco J.] CSIC, Ctr Invest Biol, Madrid, Spain; [Acebes, Sandra; Guallar, Victor] Barcelona Supercomp Ctr, Inst Biomed Res, Program Computat Biol, Joint Barcelona Supercomp Ctr Ctr Genom Regulat, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Universitat Politecnica de Catalunya; Barcelona Supercomputer Center (BSC-CNS)	Ruiz-Duenas, FJ (corresponding author), CSIC, Ctr Invest Biol, Madrid, Spain.	fjruiz@cib.csic.es	Guallar, Victor/B-1579-2013; Martínez, Angel T/G-7284-2017; Ruiz-Dueñas, Francisco J/L-9837-2015	Guallar, Victor/0000-0002-4580-1114; Martínez, Angel T/0000-0002-1584-2863; Ruiz-Dueñas, Francisco J/0000-0002-9837-5665; Saez-Jimenez, Veronica/0000-0001-7043-5622; acebes, sandra/0000-0001-8854-654X	Commission of the European Communities through the INDOX project [KBBE-2013-7-613549]; Spanish Ministerio de Economia y Competitividad (MINECO) through the HIPOP project [BIO2011-26694]; Formacion de Personal Investigador, FPI; Ramon y Cajal contract of the Spanish MINECO	Commission of the European Communities through the INDOX project; Spanish Ministerio de Economia y Competitividad (MINECO) through the HIPOP project; Formacion de Personal Investigador, FPI(Spanish Government); Ramon y Cajal contract of the Spanish MINECO	This work was funded by the Commission of the European Communities through the INDOX project (KBBE-2013-7-613549, "Optimized oxidoreductases for medium and large scale industrial biotransformations"), and by the Spanish Ministerio de Economia y Competitividad (MINECO) through the HIPOP project (BIO2011-26694, "Screening and engineering of new high-redoxpotential peroxidases"). VS-J and FJR-D thank the financial support of a research fellowship (Formacion de Personal Investigador, FPI) and a Ramon y Cajal contract of the Spanish MINECO, respectively. The authors have no conflict of interest to declare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNAO MB, 1990, BIOCHIM BIOPHYS ACTA, V1041, P43, DOI 10.1016/0167-4838(90)90120-5; Ayala M, 2008, J MOL MICROB BIOTECH, V15, P172, DOI 10.1159/000121328; Bao X, 2014, ENZYME MICROB TECH, V54, P51, DOI 10.1016/j.enzmictec.2013.10.003; Bao X, 2012, BIOTECHNOL LETT, V34, P1537, DOI 10.1007/s10529-012-0940-5; Berglund GI, 2002, NATURE, V417, P463, DOI 10.1038/417463a; CAI DY, 1989, BIOCHEM BIOPH RES CO, V162, P464, DOI 10.1016/0006-291X(89)92020-2; Casadei CM, 2014, SCIENCE, V345, P193, DOI 10.1126/science.1254398; Cherry JR, 1999, NAT BIOTECHNOL, V17, P379, DOI 10.1038/7939; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Garcia-Ruiz E, 2012, BIOCHEM J, V441, P487, DOI 10.1042/BJ20111199; Gonzalez-Perez D, 2014, ACS CATAL, V4, P3891, DOI 10.1021/cs501218v; Heinfling A, 1998, FEBS LETT, V428, P141, DOI 10.1016/S0014-5793(98)00512-2; Cuadrado NH, 2011, INT J BIOL MACROMOL, V49, P1078, DOI 10.1016/j.ijbiomac.2011.09.001; Hiner ANP, 2002, J BIOL CHEM, V277, P26879, DOI 10.1074/jbc.M200002200; Hiner ANP, 2000, BIOCHEM J, V348, P321, DOI 10.1042/0264-6021:3480321; Hiner ANP, 2002, J INORG BIOCHEM, V91, P27, DOI 10.1016/S0162-0134(02)00390-2; Houborg K, 2003, ACTA CRYSTALLOGR D, V59, P997, DOI 10.1107/S0907444903006784; KIM K, 1988, BIOCHIM BIOPHYS ACTA, V954, P95, DOI 10.1016/0167-4838(88)90059-3; KIRK TK, 1987, ANNU REV MICROBIOL, V41, P465, DOI 10.1146/annurev.mi.41.100187.002341; LI D, 1995, APPL ENVIRON MICROB, V61, P341, DOI 10.1128/AEM.61.1.341-345.1995; Marques G, 2010, BIORESOURCE TECHNOL, V101, P5935, DOI 10.1016/j.biortech.2010.02.093; Martinez AT, 2009, CURR OPIN BIOTECH, V20, P348, DOI 10.1016/j.copbio.2009.05.002; Martinez AT, 2005, INT MICROBIOL, V8, P195; Miyazaki C, 2001, FEBS LETT, V509, P111, DOI 10.1016/S0014-5793(01)03127-1; Morales M, 2012, J BIOL CHEM, V287, P41053, DOI 10.1074/jbc.M112.405548; Moreira PR, 2007, INT BIODETER BIODEGR, V59, P234, DOI 10.1016/j.ibiod.2006.11.002; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; Ogola HJO, 2010, APPL MICROBIOL BIOT, V87, P1727, DOI 10.1007/s00253-010-2603-6; Paumann-Page M, 2013, ARCH BIOCHEM BIOPHYS, V539, P51, DOI 10.1016/j.abb.2013.09.004; Perez-Boada M, 2005, J MOL BIOL, V354, P385, DOI 10.1016/j.jmb.2005.09.047; Perez-Boada M, 2002, ENZYME MICROB TECH, V30, P518, DOI 10.1016/S0141-0229(02)00008-X; Riley R, 2014, P NATL ACAD SCI USA, V111, P9923, DOI 10.1073/pnas.1400592111; Ruiz-Duenas FJ, 1999, MOL MICROBIOL, V31, P223, DOI 10.1046/j.1365-2958.1999.01164.x; Ruiz-Duenas FJ, 1999, APPL ENVIRON MICROB, V65, P4458; Ruiz-Duenas FJ, 2007, BIOCHEMISTRY-US, V46, P66, DOI 10.1021/bi061542h; Ruiz-Duenas FJ, 2010, BIOCATALYSIS BASED ON HEME PEROXIDASES, P37, DOI 10.1007/978-3-642-12627-7_3; Ruiz-Duenas FJ, 2009, MICROB BIOTECHNOL, V2, P164, DOI 10.1111/j.1751-7915.2008.00078.x; Ruiz-Duenas FJ, 2009, J EXP BOT, V60, P441, DOI 10.1093/jxb/ern261; Salvachua D, 2013, ENZYME MICROB TECH, V52, P303, DOI 10.1016/j.enzmictec.2013.03.010; Sambrook J., 2001, MOL CLONING; Timofeevski SL, 1998, ARCH BIOCHEM BIOPHYS, V356, P287, DOI 10.1006/abbi.1998.0776; Valderrama B, 2002, CHEM BIOL, V9, P555, DOI 10.1016/S1074-5521(02)00149-7; Valderrama B, 2006, FASEB J, V20, P1233, DOI 10.1096/fj.05-4173fje; Villegas JA, 2000, CHEM BIOL, V7, P237, DOI 10.1016/S1074-5521(00)00098-3; VITELLO LB, 1993, BIOCHEMISTRY-US, V32, P9807, DOI 10.1021/bi00088a036; VOGT W, 1995, FREE RADICAL BIO MED, V18, P93, DOI 10.1016/0891-5849(94)00158-G; WARIISHI H, 1990, J BIOL CHEM, V265, P2070; WARIISHI H, 1989, FEBS LETT, V243, P165, DOI 10.1016/0014-5793(89)80122-X	48	25	25	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124750	10.1371/journal.pone.0124750	http://dx.doi.org/10.1371/journal.pone.0124750			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923713	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600102
J	Foulon, S; Pingault, JB; Larroque, B; Melchior, M; Falissard, B; Cote, SM				Foulon, Stephanie; Pingault, Jean-Baptiste; Larroque, Beatrice; Melchior, Maria; Falissard, Bruno; Cote, Sylvana M.			Developmental Predictors of Inattention-Hyperactivity from Pregnancy to Early Childhood	PLOS ONE			English	Article							RISK-FACTORS; DIFFICULTIES QUESTIONNAIRE; DEPRESSION SCALE; FAMILY INCOME; AGE; DISORDER; CHILDREN; BEHAVIOR; POPULATION; VALIDITY	Objective The objective of the study was to characterize the developmental sequence of pre-and postnatal risk factors for inattention-hyperactivity symptoms in preschoolers. Materials and Methods Longitudinal data came from a French population based birth cohort study (EDEN; N = 1311 mother-child pairs followed from the pregnancy onwards). Inattention-hyperactivity symptoms were assessed with the Strengths and Difficulties Questionnaire when participating children were 3 years of age. Potential risk factors were classified in four domains (fetal exposures and child somatic characteristics, child temperament, child neurodevelopmental status, psychosocial environment) and four periods (before pregnancy, prenatal/birth, infancy, toddlerhood). Their role as potential moderator or mediator was tested with path analysis to determine the developmental sequence. Results A low family socioeconomic status before pregnancy was the main environmental risk factor for inattention-hyperactivity symptoms at 3 years, and its effect occurred via two pathways. The first was a risk pathway, where lower SES was associated with higher maternal depression and anxiety during pregnancy; then to higher maternal and child distress and dysregulation in infancy; and in turn to higher levels of inattention-hyperactivity at 3 years. The second was a protective pathway, where higher SES was associated with longer duration of breastfeeding during infancy; then to better child neurodevelopmental status in toddlerhood; and in turn to lower levels of inattention-hyperactivity at 3 years. Discussion This study identified psychosocial factors at several developmental periods that represent potential targets for preventing the emergence of inattention-hyperactivity symptoms in early childhood.	[Foulon, Stephanie; Falissard, Bruno; Cote, Sylvana M.] Univ Paris Descartes & Paris Sud, INSERM, U669, Paris, France; [Pingault, Jean-Baptiste] UCL, Div Psychol & Language Sci, London, England; [Pingault, Jean-Baptiste] Kings Coll London, MRC Social, Genet & Dev Psychiat Ctr, Inst Psychiat, London, England; [Cote, Sylvana M.] Univ Montreal, Int Lab Child & Adolescent Hlth Dev, Montreal, PQ, Canada; [Cote, Sylvana M.] Tomsk State Univ, Tomsk, Russia; [Larroque, Beatrice] Beaujon Hosp, Epidemiol & Clin Res Unit, Clichy, France; [Larroque, Beatrice] INSERM, UMR S953, Paris, France; [Melchior, Maria] Pierre Louis Inst Epidemiol & Publ Hlth, INSERM, Social Epidemiol Res Team, UMR S 1136, Paris, France; [Melchior, Maria] Univ Paris 06, Sorbonne Univ, Pierre Louis Inst Epidemiol & Publ Hlth, Social Epidemiol Res Team,UMR S 1136, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of London; University College London; University of London; King's College London; Universite de Montreal; Tomsk State University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Cote, SM (corresponding author), Univ Paris Descartes & Paris Sud, INSERM, U669, Paris, France.	sylvana.cote.1@umontreal.ca	Cote, Silvana Maria/O-1356-2014; Côté, Sylvana M./T-4600-2019; Melchior, Maria/E-3992-2017	Côté, Sylvana M./0000-0001-7944-0647; Foulon, Stephanie/0000-0002-0213-0736; Pingault, Jean-Baptiste/0000-0003-2557-4716	Fondation pour la Recherche Medicale (FRM); French Ministry of Research: IFR program; INSERM Human Nutrition National Research Program; Diabetes National Research Program (via a collaboration with the Association for Diabetes Research); French Ministry of Health Perinatality Program; French Agency for Environment Security (AFFSET); French National Institute for Population Health Surveillance (INVS); Paris-Sud University; French National Institute for Health Education (INPES); Nestle; Mutuelle Generale de l'Education Nationale (MGEN); French Speaking Association for the Study of Diabetes and Metabolism (Alfediam); National Agency for Research (ANR nonthematic program); National Institute of Research in Public Health (IRESP: TGIR cohort sante program); Research Unit on Children's Psychosocial Maladjustment via a grant from the Fonds de la recherche et de la Sante du Quebec [16031]	Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); French Ministry of Research: IFR program(Ministry of Research, France); INSERM Human Nutrition National Research Program; Diabetes National Research Program (via a collaboration with the Association for Diabetes Research); French Ministry of Health Perinatality Program; French Agency for Environment Security (AFFSET)(French National Research Agency (ANR)); French National Institute for Population Health Surveillance (INVS); Paris-Sud University; French National Institute for Health Education (INPES)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Nestle(Nestle SA); Mutuelle Generale de l'Education Nationale (MGEN); French Speaking Association for the Study of Diabetes and Metabolism (Alfediam); National Agency for Research (ANR nonthematic program)(French National Research Agency (ANR)); National Institute of Research in Public Health (IRESP: TGIR cohort sante program); Research Unit on Children's Psychosocial Maladjustment via a grant from the Fonds de la recherche et de la Sante du Quebec	The EDEN study was supported by grants from Fondation pour la Recherche Medicale (FRM), French Ministry of Research: IFR program, INSERM Human Nutrition National Research Program, Diabetes National Research Program (via a collaboration with the Association for Diabetes Research), French Ministry of Health Perinatality Program, French Agency for Environment Security (AFFSET), French National Institute for Population Health Surveillance (INVS), Paris-Sud University, French National Institute for Health Education (INPES), Nestle, Mutuelle Generale de l'Education Nationale (MGEN), French Speaking Association for the Study of Diabetes and Metabolism (Alfediam), National Agency for Research (ANR nonthematic program) and the National Institute of Research in Public Health (IRESP: TGIR cohort sante 2008 program). Dr. Pingault received a post-doctoral fellowship from the Research Unit on Children's Psychosocial Maladjustment via a grant from the Fonds de la recherche et de la Sante du Quebec (# 16031) attributed to Dr. Cote. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Applegate B, 1997, J AM ACAD CHILD PSY, V36, P1211, DOI 10.1097/00004583-199709000-00013; Bertrais S, 1999, REV EPIDEMIOL SANTE, V47, P263; BIEDERMAN J, 1995, ARCH GEN PSYCHIAT, V52, P464; Biederman J, 2005, LANCET, V366, P237, DOI 10.1016/S0140-6736(05)66915-2; Bor W, 1997, AUST NZ J PSYCHIAT, V31, P664, DOI 10.3109/00048679709062679; Caspi A, 1996, ARCH GEN PSYCHIAT, V53, P1033; Delobel-Ayoub M, 2006, PEDIATRICS, V117, P1996, DOI 10.1542/peds.2005-2310; Donovan CL, 2000, CLIN PSYCHOL REV, V20, P509, DOI 10.1016/S0272-7358(99)00040-9; Drouillet P, 2009, PAEDIATR PERINAT EP, V23, P76, DOI 10.1111/j.1365-3016.2008.00982.x; Essex MJ, 2006, ARCH GEN PSYCHIAT, V63, P1246, DOI 10.1001/archpsyc.63.11.1246; Gibson J, 2009, ACTA PSYCHIAT SCAND, V119, P350, DOI 10.1111/j.1600-0447.2009.01363.x; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Green N, 2004, MENTAL HLTH CHILDREN; Harvey EA, 2007, J ABNORM CHILD PSYCH, V35, P97, DOI 10.1007/s10802-006-9087-y; Haute Autorite de Sante (French National Authority for Health), 2005, PROP PORT DEP IND CH; Hu L., STRUCTURAL EQUATION, V6, P1; Julvez J, 2007, ACTA PAEDIATR, V96, P842, DOI 10.1111/j.1651-2227.2007.00273.x; Kraemer HC, 2001, AM J PSYCHIAT, V158, P848, DOI 10.1176/appi.ajp.158.6.848; Kramer MS, 2008, PEDIATRICS, V121, pE435, DOI 10.1542/peds.2007-1248; Langley K, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-26; Larsson H, 2014, J CHILD PSYCHOL PSYC, V55, P428, DOI 10.1111/jcpp.12140; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; MCGEE R, 1992, J ABNORM CHILD PSYCH, V20, P487, DOI 10.1007/BF00916811; Meades R, 2011, J AFFECT DISORDERS, V133, P1, DOI 10.1016/j.jad.2010.10.009; Pingault JB, 2013, MOL PSYCHIATR, V18, P806, DOI 10.1038/mp.2012.87; Pingault JB, 2011, AM J PSYCHIAT, V168, P1164, DOI 10.1176/appi.ajp.2011.10121732; Smidts DP, 2007, CORTEX, V43, P710, DOI 10.1016/S0010-9452(08)70500-8; Snowling M, 2009, J CHILD PSYCHOL PSYC, V50, P1039, DOI 10.1111/j.1469-7610.2009.02145.x; Spira EG, 2005, J CHILD PSYCHOL PSYC, V46, P755, DOI 10.1111/j.1469-7610.2005.01466.x; Theunissen MHC, 2013, PEDIATRICS, V131, pE446, DOI 10.1542/peds.2012-0089; van Dam NT, 2011, PSYCHIAT RES, V186, P128, DOI 10.1016/j.psychres.2010.08.018; Willoughby MT, 2012, J ABNORM CHILD PSYCH, V40, P1301, DOI 10.1007/s10802-012-9641-8; Wright S, 1934, ANN MATH STAT, V5, P161, DOI 10.1214/aoms/1177732676	33	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125996	10.1371/journal.pone.0125996	http://dx.doi.org/10.1371/journal.pone.0125996			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938453	gold, Green Published, Green Submitted			2022-12-27	WOS:000353943000126
J	He, HW; Wang, LH; Zhou, WQ; Zhang, ZY; Wang, LX; Xu, S; Wang, D; Dong, J; Tang, CP; Tang, H; Yi, XM; Ge, JP				He, Haowei; Wang, Linhui; Zhou, Wenquan; Zhang, Zhengyu; Wang, Longxin; Xu, Song; Wang, Dong; Dong, Jie; Tang, Chaopeng; Tang, Hao; Yi, Xiaoming; Ge, Jingping			MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; HISTOLOGIC SUBTYPES; GENE-EXPRESSION; CANCER CELLS; PROGNOSTIC VALUE; INVASION; MIGRATION; ACTIVATION; SURVIVAL; MIR-210	Objective This study aims to profile dysregulated microRNA (miRNA) expression in clear cell renal cell carcinoma (ccRCC) and to identify key regulatory miRNAs in ccRCC. Methods and Results miRNA expression profiles in nine pairs of ccRCC tumor samples at three different stages and the adjacent, non-tumorous tissues were investigated using miRNA arrays. Eleven miRNAs were identified to be commonly dysregulated, including three up-regulated (miR-487a, miR-491-3p and miR-452) and eight down-regulated (miR-125b, miR-142-3p, miR-199a-5p, miR-22, miR-299-3p, miR-29a, miR-429, and miR-532-5p) in tumor tissues as compared with adjacent normal tissues. The 11 miRNAs and their predicted target genes were analyzed by Gene Ontology and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis, and three key miRNAs (miR-199a-5p, miR-22 and miR-429) were identified by microRNA-gene network analysis. Dysregulation of the three key miRNAs were further validated in another cohort of 15 ccRCC samples, and the human kidney carcinoma cell line 786-O, as compared with five normal kidney samples. Further investigation showed that over-expression of miR-199a-5p significantly inhibited the invasion ability of 786-O cells. Luciferase reporter assays indicated that miR-199a-5p regulated expression of TGFBR1 and JunB by directly interacting with their 3' untranslated regions. Transfection of miR-199a-5p successfully suppressed expression of TGFBR1 and JunB in the human embryonic kidney 293T cells, further confirming the direct regulation of miR-199a-5p on these two genes. Conclusions This study identified 11 commonly dysregulated miRNAs in ccRCC, three of which (miR-199a-5p, miR-22 and miR-429) may represent key miRNAs involved in the pathogenesis of ccRCC. Further studies suggested that miR-199a-5p plays an important role in inhibition of cell invasion of ccRCC cells by suppressing expression of TGFBR1 and JunB.	[He, Haowei; Zhou, Wenquan; Zhang, Zhengyu; Wang, Longxin; Xu, Song; Wang, Dong; Dong, Jie; Tang, Chaopeng; Tang, Hao; Yi, Xiaoming; Ge, Jingping] Nanjing Univ, Sch Med, Jinling Hosp, Dept Urol, Nanjing 210008, Jiangsu, Peoples R China; [Wang, Linhui] Second Mil Med Univ, Changzheng Hosp, Dept Urol, Shanghai, Peoples R China	Nanjing University; Naval Medical University	Ge, JP (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Urol, Nanjing 210008, Jiangsu, Peoples R China.	hehaowei1982@hotmail.com	tang, chaopeng/GQA-7639-2022; wang, lin/HHM-2225-2022; wang, lin/GSE-3040-2022; wang, lili/HDL-7210-2022	he, haowei/0000-0002-0358-4983				Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cheville JC, 2003, AM J SURG PATHOL, V27, P612, DOI 10.1097/00000478-200305000-00005; Chow TFF, 2010, J UROLOGY, V183, P743, DOI 10.1016/j.juro.2009.09.086; Chow TFF, 2010, CLIN BIOCHEM, V43, P150, DOI 10.1016/j.clinbiochem.2009.07.020; Coppin C, 2011, BJU INT, V108, P1556, DOI 10.1111/j.1464-410X.2011.10629.x; Fridman E, 2010, J MOL DIAGN, V12, P687, DOI 10.2353/jmoldx.2010.090187; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Goncalves JP, 2011, BIOINFORMATICS, V27, P3149, DOI 10.1093/bioinformatics/btr546; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gudbjartsson T, 2005, EUR UROL, V48, P593, DOI 10.1016/j.eururo.2005.04.016; Guo MM, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0542-7; Gupta K, 2008, CANCER TREAT REV, V34, P193, DOI 10.1016/j.ctrv.2007.12.001; Heinzelmann J, 2011, WORLD J UROL, V29, P367, DOI 10.1007/s00345-010-0633-4; Huang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033762; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Huang Y, 2009, EJSO-EUR J SURG ONC, V35, P1119, DOI 10.1016/j.ejso.2009.04.010; Jung M, 2009, J CELL MOL MED, V13, P3918, DOI 10.1111/j.1582-4934.2009.00705.x; Kanno T, 2012, ONCOGENE, V31, P3098, DOI 10.1038/onc.2011.475; Kong Y, 2012, INT J BIOCHEM CELL B, V44, P2321, DOI 10.1016/j.biocel.2012.08.006; Li B, 2013, ONCOL REP, V29, P1932, DOI 10.3892/or.2013.2300; Liu D, 2012, J BIOMED RES, V26, P389, DOI 10.7555/JBR.26.20120029; Meola Nicola, 2009, Pathogenetics, V2, P7, DOI 10.1186/1755-8417-2-7; Nakada C, 2008, J PATHOL, V216, P418, DOI 10.1002/path.2437; Patard JJ, 2005, J CLIN ONCOL, V23, P2763, DOI 10.1200/JCO.2005.07.055; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Petillo D, 2009, INT J ONCOL, V35, P109, DOI 10.3892/ijo_00000318; Rini BI, 2008, CURR OPIN ONCOL, V20, P300, DOI 10.1097/CCO.0b013e3282f9782b; Rosman DS, 2008, CANCER RES, V68, P1319, DOI 10.1158/0008-5472.CAN-07-5424; Schachter LR, 2007, J ENDOUROL, V21, P819, DOI 10.1089/end.2006.9937; Shen QL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-227; Shen WW, 2013, J MOL MED, V91, P989, DOI 10.1007/s00109-013-1037-x; Su SF, 2013, ONCOGENE, V32, P4694, DOI 10.1038/onc.2012.483; Sun TW, 2011, EUR J CANCER, V47, P2552, DOI 10.1016/j.ejca.2011.05.021; Taccoen X, 2007, EUR UROL, V51, P980, DOI 10.1016/j.eururo.2006.10.025; Valera VA, 2011, J CANCER, V2, P515, DOI 10.7150/jca.2.515; Vaziri SAJ, 2009, ANTICANCER RES, V29, P2961; Visone R, 2009, AM J PATHOL, V174, P1131, DOI 10.2353/ajpath.2009.080794; Wang LK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096765; Wang W, 2012, WORLD J GASTROENTERO, V18, P5442, DOI 10.3748/wjg.v18.i38.5442; White NMA, 2011, J UROLOGY, V186, P1077, DOI 10.1016/j.juro.2011.04.110; Wu XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035661; Yi ZJ, 2010, J CANCER RES CLIN, V136, P855, DOI 10.1007/s00432-009-0726-x; Youssef YM, 2011, EUR UROL, V59, P721, DOI 10.1016/j.eururo.2011.01.004; Zhu CL, 2013, CLIN BIOCHEM, V46, P49, DOI 10.1016/j.clinbiochem.2012.09.002; Zhu XC, 2012, INT J MOL MED, V30, P1321, DOI 10.3892/ijmm.2012.1140	45	43	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125672	10.1371/journal.pone.0125672	http://dx.doi.org/10.1371/journal.pone.0125672			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938468	Green Published, Green Submitted, gold			2022-12-27	WOS:000353943000087
J	Igarashi, J; Fukuda, N; Inoue, T; Nakai, S; Saito, K; Fujiwara, K; Matsuda, H; Ueno, T; Matsumoto, Y; Watanabe, T; Nagase, H; Bando, T; Sugiyama, H; Itoh, T; Soma, M				Igarashi, Jun; Fukuda, Noboru; Inoue, Takashi; Nakai, Shigeki; Saito, Kosuke; Fujiwara, Kyoko; Matsuda, Hiroyuki; Ueno, Takahiro; Matsumoto, Yoshiaki; Watanabe, Takayoshi; Nagase, Hiroki; Bando, Toshikazu; Sugiyama, Hiroshi; Itoh, Toshio; Soma, Masayoshi			Preclinical Study of Novel Gene Silencer Pyrrole-Imidazole Polyamide Targeting Human TGF-beta 1 Promoter for Hypertrophic Scars in a Common Marmoset Primate Model	PLOS ONE			English	Article							TRANSCRIPTIONAL INHIBITION; DNA; EXPRESSION; RECOGNITION; COLLAGEN	We report a preclinical study of a pyrrole-imidazole (PI) polyamide that targets the human transforming growth factor (hTGF)-beta 1 gene as a novel transcriptional gene silencer in a common marmoset primate model. We designed and then synthesized PI polyamides to target the hTGF-beta 1 promoter. We examined effects of seven PI polyamides (GB1101-1107) on the expression of hTGF-beta 1 mRNA stimulated with phorbol 12-myristate 13-acetate (PMA) in human vascular smooth muscle cells. GB1101, GB1105 and GB1106 significantly inhibited hTGF-beta 1 mRNA expression. We examined GB1101 as a PI polyamide to hTGF-beta 1 for hypertrophic scars in marmosets in vivo. Injection of GB1101 completely inhibited hypertrophic scar formation at 35 days post-incision and inhibited cellular infiltration, TGF-beta 1 and vimentin staining, and epidermal thickness. Mismatch polyamide did not affect hypertrophic scarring or histological changes. Epidermis was significantly thinner with GB1101 than with water and mismatch PI polyamides. We developed the PI polyamides for practical ointment medicines for the treatment of hypertrophic scars. FITC-labeled GB1101 with solbase most efficiently distributed in the nuclei of epidermal keratinocytes, completely suppressed hypertropic scarring at 42 days after incision, and considerably inhibited epidermal thickness and vimentin-positive fibroblasts. PI polyamides targeting hTGF-beta 1 promoter with solbase ointment will be practical medicines for treating hypertrophic scars after surgical operations and skin burns.	[Igarashi, Jun; Nakai, Shigeki; Saito, Kosuke; Fujiwara, Kyoko; Matsuda, Hiroyuki; Soma, Masayoshi] Nihon Univ, Sch Med, Dept Gen Med, Tokyo, Japan; [Fukuda, Noboru] Nihon Univ, Grad Sch, Adv Res Inst Sci & Humanities, Div Life Sci, Tokyo, Japan; [Fukuda, Noboru; Ueno, Takahiro; Soma, Masayoshi] Nihon Univ, Sch Med, Dept Med, Div Nephrol Hypertens & Endocrinol, Tokyo, Japan; [Inoue, Takashi; Itoh, Toshio] Cent Inst Expt Anim, Marmoset Res Dept, Kawasaki, Kanagawa, Japan; [Matsumoto, Yoshiaki] Nihon Univ, Coll Pharm, Dept Clin Pharmacokinet, Chiba, Japan; [Watanabe, Takayoshi; Nagase, Hiroki] Chiba Canc Ctr, Res Inst, Dept Canc Genet, Chiba 2608717, Japan; [Bando, Toshikazu; Sugiyama, Hiroshi] Kyoto Univ, Grad Sch, Dept Chem, Kyoto, Japan	Nihon University; Nihon University; Nihon University; Nihon University; Chiba Cancer Center; Kyoto University	Fukuda, N (corresponding author), Nihon Univ, Grad Sch, Adv Res Inst Sci & Humanities, Div Life Sci, Tokyo, Japan.	fukuda.noboru@nihon-u.ac.jp	Sugiyama, Hiroshi/C-7687-2011	Sugiyama, Hiroshi/0000-0001-8923-5946; Inoue, Takashi/0000-0003-4691-7255; Fukuda, Noboru/0000-0003-0098-054X	"Strategic Research Base Development" Program for Private Universities by MEXT; N. Research Project in Nihon University	"Strategic Research Base Development" Program for Private Universities by MEXT; N. Research Project in Nihon University	This work was partially supported by a Grant from the "Strategic Research Base Development" Program for Private Universities subsidized by MEXT (2010-2013) and the N. Research Project in Nihon University (2009-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadeu T, 2003, PATHOL RES PRACT, V199, P469, DOI 10.1078/0344-0338-00447; Chen M, 2010, MOL THER, V18, P519, DOI 10.1038/mt.2009.263; Chu YH, 2008, CONNECT TISSUE RES, V49, P92, DOI 10.1080/03008200801913924; Ehley JA, 2002, MOL CELL BIOL, V22, P1723, DOI 10.1128/MCB.22.6.1723-1733.2002; Fujimoto K, 2002, NUCLEIC ACIDS RES, V30, P3748, DOI 10.1093/nar/gkf486; Fukuda N, 2006, J AM SOC NEPHROL, V17, P422, DOI 10.1681/ASN.2005060650; Gottesfeld JM, 1997, NATURE, V387, P202, DOI 10.1038/387202a0; Grotendorst GR, 1996, CELL GROWTH DIFFER, V7, P469; Hargrove AE, 2012, J MED CHEM, V55, P5425, DOI 10.1021/jm300380a; Hasegawa T, 2005, J DERMATOL SCI, V39, P33, DOI 10.1016/j.jdermsci.2005.01.013; KIM SJ, 1989, J BIOL CHEM, V264, P402; Lai YM, 2005, J PHARMACOL EXP THER, V315, P571, DOI 10.1124/jpet.105.089086; Matsuda H, 2011, KIDNEY INT, V79, P46, DOI 10.1038/ki.2010.330; Meier Karen, 2006, Expert Opin Emerg Drugs, V11, P39, DOI 10.1517/14728214.11.1.39; Murty MSRC, 2004, BIOL PHARM BULL, V27, P468, DOI 10.1248/bpb.27.468; Peterson C, 2011, EUR J CLIN PHARMACOL, V67, P437, DOI 10.1007/s00228-011-1011-x; Roques Claude, 2008, Int J Low Extrem Wounds, V7, P137, DOI 10.1177/1534734608320786; Serie K, 2012, PERITON DIALYSIS INT, V32, P462, DOI 10.3747/pdi.2011.00092; Shigeki S, 1997, SCAND J PLAST RECONS, V31, P151, DOI 10.3109/02844319709085482; Trauger JW, 1996, NATURE, V382, P559, DOI 10.1038/382559a0; Washio H, 2011, J INVEST DERMATOL, V131, P1987, DOI 10.1038/jid.2011.150; White S, 1997, CHEM BIOL, V4, P569, DOI 10.1016/S1074-5521(97)90243-X; Yao EH, 2009, CARDIOVASC RES, V81, P797, DOI 10.1093/cvr/cvn355; Zhao R, 2013, MATRIX BIOL, V32, P265, DOI 10.1016/j.matbio.2013.02.004	24	23	27	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125295	10.1371/journal.pone.0125295	http://dx.doi.org/10.1371/journal.pone.0125295			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938472	Green Submitted, Green Published, gold			2022-12-27	WOS:000353943000056
J	Sun, DX; Tan, XD; Gao, F; Xu, J; Cui, DX; Dai, XW				Sun, Da-Xin; Tan, Xiao-Dong; Gao, Feng; Xu, Jin; Cui, Dong-Xu; Dai, Xian-Wei			Use of an Autologous Liver Round Ligament Flap Zeros Postoperative Bile Leak after Curative Resection of Hilar Cholangiocarcinoma	PLOS ONE			English	Article							RISK-FACTORS; HEPATECTOMY; MANAGEMENT; TRANSPLANTATION; GRAFT	Background Postoperative bile leak is a major surgical morbidity after curative resection with hepaticojejunostomy for hilar cholangiocarcinoma, especially in Bismuth-Corlette types III and IV. This retrospective study assessed the effectiveness and safety of an autologous hepatic round ligament flap (AHRLF) for reducing bile leak after hilar hepaticojejunostomy. Methods Nine type III and IV hilar cholangiocarcinoma patients were consecutively hospitalized for elective perihilar partial hepatectomy with hilar hepaticojejunostomy using an AHRLF between October 2009 and September 2013. The AHRLF was harvested to reinforce the perihilar hepaticojejunostomy. Main outcome measures included operative time, blood loss, postoperative recovery times, morbidity, bile leak, R0 resection rate, and overall survival. Results All patients underwent uneventful R0 resection with hilar hepaticojejunostomy. No patient experienced postoperative bile leak. Conclusions The AHRLF was associated with lack of bile leak after curative perihilar hepatectomy with hepaticojejunostomy for hilar cholangiocarcinoma, without compromising oncologic safety, and is recommended in selected patients.	[Sun, Da-Xin; Tan, Xiao-Dong; Gao, Feng; Xu, Jin; Cui, Dong-Xu; Dai, Xian-Wei] China Med Univ, Dept Gen Surg, Shengjing Hosp, Shenyang 110000, Liaoning, Peoples R China	China Medical University	Dai, XW (corresponding author), China Med Univ, Dept Gen Surg, Shengjing Hosp, Shenyang 110000, Liaoning, Peoples R China.	daixianwei@126.com						Suarez-Munoz MA, 2013, WORLD J GASTRO ONCOL, V5, P132, DOI 10.4251/wjgo.v5.i7.132; Aydin M, 2005, HEPATO-GASTROENTEROL, V52, P1019; Capussotti L, 2006, ARCH SURG-CHICAGO, V141, P690, DOI 10.1001/archsurg.141.7.690; Chen XP, 2009, BRIT J SURG, V96, P1167, DOI 10.1002/bjs.6618; Cheng QB, 2012, EJSO-EUR J SURG ONC, V38, P1197, DOI 10.1016/j.ejso.2012.08.009; COSTALAT G, 1991, SURG ENDOSC-ULTRAS, V5, P154, DOI 10.1007/BF02653225; DeOliveira ML, 2011, HEPATOLOGY, V53, P1363, DOI 10.1002/hep.24227; Geng ZM, 2013, MED SCI MONITOR, V19, P648, DOI 10.12659/MSM.889379; Hemming AW, 2005, ANN SURG, V241, P693, DOI 10.1097/01.sla.0000160701.38945.82; Iannitti DA, 2006, J AM COLL SURGEONS, V203, P857, DOI 10.1016/j.jamcollsurg.2006.08.021; Ikegami T, 2008, J HEPATO-BILIARY-PAN, V15, P581, DOI 10.1007/s00534-007-1319-1; Izbicki JR, 2013, J GASTROINTEST SURG, V17, P581, DOI 10.1007/s11605-012-2109-x; Koch M, 2011, SURGERY, V149, P680, DOI 10.1016/j.surg.2010.12.002; Lambe G, 2012, BRIT J SURG, V99, P964, DOI 10.1002/bjs.8759; Liang YL, 2012, WORLD J GASTROENTERO, V18, P5205, DOI 10.3748/wjg.v18.i37.5205; Lu BC, 2013, WSPOLCZESNA ONKOL, V17, P298, DOI 10.5114/wo.2013.35274; Nagino M, 2001, WORLD J SURG, V25, P1277, DOI 10.1007/s00268-001-0110-8; Nakatsuka Hideki, 2013, Gan To Kagaku Ryoho, V40, P1903; Okumura K, 2013, HEPATO-GASTROENTEROL, V60, P1717, DOI 10.5754/hge11295; Popescu I, 2014, LANGENBECK ARCH SURG, V399, P693, DOI 10.1007/s00423-014-1210-x; Ramia JM, 2013, WORLD J GASTRO ONCOL, V5, P113, DOI 10.4251/wjgo.v5.i7.113; Robles R, 2013, WORLD J GASTROENTERO, V19, P9209, DOI 10.3748/wjg.v19.i48.9209; Sanjay P, 2013, J GASTROINTEST SURG, V17, P829, DOI 10.1007/s11605-012-2055-7; Strucker B, 2013, WORLD J SURG, V37, P2629, DOI 10.1007/s00268-013-2161-z; Tsao JI, 2000, ANN SURG, V232, P166, DOI 10.1097/00000658-200008000-00003; Uchiyama K, 2003, ARCH SURG-CHICAGO, V138, P1012, DOI 10.1001/archsurg.138.9.1012; Wahab MA, 2006, HEPATO-GASTROENTEROL, V53, P5; Welling TH, 2014, LIVER TRANSPLANT, V20, P81, DOI 10.1002/lt.23757; Wu CT, 2013, HEPATOB PANCREAT DIS, V12, P651, DOI 10.1016/S1499-3872(13)60102-2; Ying DJ, 1997, SURG RADIOL ANAT, V19, P293, DOI 10.1007/BF01637594; Zhang CH, 2011, ANZ J SURG, V81, P572, DOI 10.1111/j.1445-2197.2011.05799.x	31	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125977	10.1371/journal.pone.0125977	http://dx.doi.org/10.1371/journal.pone.0125977			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938440	Green Submitted, gold, Green Published			2022-12-27	WOS:000353943000125
J	Shimizu, Y; Yoshimoto, J; Toki, S; Takamura, M; Yoshimura, S; Okamoto, Y; Yamawaki, S; Doya, K				Shimizu, Yu; Yoshimoto, Junichiro; Toki, Shigeru; Takamura, Masahiro; Yoshimura, Shinpei; Okamoto, Yasumasa; Yamawaki, Shigeto; Doya, Kenji			Toward Probabilistic Diagnosis and Understanding of Depression Based on Functional MRI Data Analysis with Logistic Group LASSO	PLOS ONE			English	Article							VERBAL FLUENCY; IMAGING BIOMARKERS; CLASSIFICATION; DISEASE; MACHINE; PATTERN; MARKERS; MEMORY	Diagnosis of psychiatric disorders based on brain imaging data is highly desirable in clinical applications. However, a common problem in applying machine learning algorithms is that the number of imaging data dimensions often greatly exceeds the number of available training samples. Furthermore, interpretability of the learned classifier with respect to brain function and anatomy is an important, but non-trivial issue. We propose the use of logistic regression with a least absolute shrinkage and selection operator (LASSO) to capture the most critical input features. In particular, we consider application of group LASSO to select brain areas relevant to diagnosis. An additional advantage of LASSO is its probabilistic output, which allows evaluation of diagnosis certainty. To verify our approach, we obtained semantic and phonological verbal fluency fMRI data from 31 depression patients and 31 control subjects, and compared the performances of group LASSO (gLASSO), and sparse group LASSO (sgLASSO) to those of standard LASSO (sLASSO), Support Vector Machine (SVM), and Random Forest. Over 90% classification accuracy was achieved with gLASSO, sgLASSO, as well as SVM; however, in contrast to SVM, LASSO approaches allow for identification of the most discriminative weights and estimation of prediction reliability. Semantic task data revealed contributions to the classification from left precuneus, left precentral gyrus, left inferior frontal cortex (pars triangularis), and left cerebellum (c rus1). Weights for the phonological task indicated contributions from left inferior frontal operculum, left post central gyrus, left insula, left middle frontal cortex, bilateral middle temporal cortices, bilateral precuneus, left inferior frontal cortex (pars triangularis), and left precentral gyrus. The distribution of normalized odds ratios further showed, that predictions with absolute odds ratios higher than 0.2 could be regarded as certain.	[Shimizu, Yu; Yoshimoto, Junichiro; Doya, Kenji] Grad Univ, Okinawa Inst Sci & Technol, Neural Computat Unit, Okinawa, Japan; [Yoshimoto, Junichiro] Nara Inst Sci & Technol, Grad Sch Informat Sci, Nara 6300101, Japan; [Toki, Shigeru; Takamura, Masahiro; Okamoto, Yasumasa; Yamawaki, Shigeto] Hiroshima Univ, Dept Psychiat & Neurosci, Hiroshima, Japan; [Yoshimura, Shinpei] Otemon Gakuin Univ, Fac Psychol, Ibaraki, Osaka, Japan	Okinawa Institute of Science & Technology Graduate University; Nara Institute of Science & Technology; Hiroshima University	Shimizu, Y (corresponding author), Grad Univ, Okinawa Inst Sci & Technol, Neural Computat Unit, Okinawa, Japan.	yu.shimizu@oist.jp	Yoshimoto, Junichiro/ABI-8028-2020; Takamura, Masahiro/AEJ-6059-2022; Shimizu, Yu/G-2906-2015; Yoshimoto, Junichiro/B-5884-2015; Yoshimura, Shinpei/AAG-5540-2019	Yoshimoto, Junichiro/0000-0001-7995-0321; Takamura, Masahiro/0000-0001-9742-152X; Shimizu, Yu/0000-0001-9324-014X; Yoshimoto, Junichiro/0000-0001-7995-0321; Yoshimura, Shinpei/0000-0001-9957-7982; Yoshimura, Shimpei/0000-0001-6756-4829	Grants-in-Aid for Scientific Research [25780413] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		APA, 1980, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890423349, DOI 10.1176/APPI.BOOKS.9780890423349]; Bom de Araujo N, 2011, CLINICS SAO PAULO, V66; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chris R, 2014, MRICRON NIFTI VIEWER; Collins PY, 2011, NATURE, V475, P27, DOI 10.1038/475027a; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Costafreda SG, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-18; Ebmeier K, 2009, NEUROTOX RES, V10, P1; Fairhall SL, 2010, BIOL PSYCHOL, V85, P499, DOI 10.1016/j.biopsycho.2010.09.002; Fiot JB, 2014, NEUROIMAGE-CLIN, V4, P718, DOI 10.1016/j.nicl.2014.02.002; Forbes EE, 2011, NEUROPSYCHOPHARMACOL, V36, P372, DOI 10.1038/npp.2010.164; Fossati P, 2003, PSYCHIAT RES, V117, P17, DOI 10.1016/S0165-1781(02)00300-1; Friedman J., 2010, TECHNICAL REPORT; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Fu CHY, 2008, BIOL PSYCHIAT, V63, P656, DOI 10.1016/j.biopsych.2007.08.020; Gilbert SJ, 2008, CURR BIOL, V18, pR110, DOI 10.1016/j.cub.2007.12.014; Gooren T, 2013, ACTA NEUROPSYCHIATR, V25; Heath S, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-98; Henry JD, 2005, J CLIN EXP NEUROPSYC, V27, P78, DOI 10.1080/138033990513654; Kipli K, 2013, IJBBB, V3, P444, DOI [10.7763/IJBBB.2013.V3.252, DOI 10.7763/IJBBB.2013.V3.252]; Kipli K, 2013, NEURORADIOLOGY, V55, P567, DOI 10.1007/s00234-013-1139-8; Krug A, 2010, NEUROIMAGE, V49, P1831, DOI 10.1016/j.neuroimage.2009.09.028; Liu J., 2009, SLEP SPARSE LEARNING; Liu MH, 2014, NEUROINFORMATICS, V12, P381, DOI 10.1007/s12021-013-9218-x; Lord A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041282; Lorenzetti V, 2009, J AFFECT DISORDERS, V117, P1, DOI 10.1016/j.jad.2008.11.021; Marquand AF, 2008, NEUROREPORT, V19, P1507, DOI 10.1097/WNR.0b013e328310425e; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; Milne AMB, 2012, J PSYCHIATR NEUROSCI, V37, P28, DOI 10.1503/jpn.110004; Montague PR, 2012, TRENDS COGN SCI, V16, P72, DOI 10.1016/j.tics.2011.11.018; Mwangi B, 2012, BRAIN, V135, P1508, DOI 10.1093/brain/aws084; Norris MP, 1995, AGING COGNITION, V2, P206, DOI 10.1080/13825589508256598; Nouretdinov I, 2011, NEUROIMAGE, V56, P809, DOI 10.1016/j.neuroimage.2010.05.023; Orru G, 2012, NEUROSCI BIOBEHAV R, V36, P1140, DOI 10.1016/j.neubiorev.2012.01.004; Palmer SM, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01045; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Tibshirani R., 2009, SPRINGER SERIES STAT, DOI [10.1007/978-0-387-84858-7, DOI 10.1007/978-0-387-84858-7]; Tipping ME, 2001, J MACH LEARN RES, V1, P211, DOI 10.1162/15324430152748236; Tsao S, 2014, P SOC PHOTO-OPT INST; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vapnik V. N., 1998, NATURE STAT LEARNING; Xin B, 2014, AAAI CONF ARTIF INTE, P2163; Zhou JY, 2013, NEUROIMAGE, V78, P233, DOI 10.1016/j.neuroimage.2013.03.073	45	37	40	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0123524	10.1371/journal.pone.0123524	http://dx.doi.org/10.1371/journal.pone.0123524			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932629	Green Published, Green Submitted, gold			2022-12-27	WOS:000353887100022
J	Urbinati, G; Ali, HM; Rousseau, Q; Chapuis, H; Desmaele, D; Couvreur, P; Massaad-Massade, L				Urbinati, Giorgia; Ali, Hafiz Muhammad; Rousseau, Quentin; Chapuis, Hubert; Desmaele, Didier; Couvreur, Patrick; Massaad-Massade, Liliane			Antineoplastic Effects of siRNA against TMPRSS2-ERG Junction Oncogene in Prostate Cancer	PLOS ONE			English	Article							PAPILLARY THYROID-CARCINOMA; SQUALENE NANOPARTICLES; FUSION TRANSCRIPTS; RNA INTERFERENCE; GENE ABERRATIONS; ERG; DELIVERY; CELLS; EXPRESSION; MET	TMPRSS2-ERG junction oncogene is present in more than 50% of patients with prostate cancer and its expression is frequently associated with poor prognosis. Our aim is to achieve gene knockdown by siRNA TMPRSS2-ERG and then to assess the biological consequences of this inhibition. First, we designed siRNAs against the two TMPRSS2-ERG fusion variants (III and IV), most frequently identified in patients' biopsies. Two of the five siRNAs tested were found to efficiently inhibit mRNA of both TMPRSS2-ERG variants and to decrease ERG protein expression. Microarray analysis further confirmed ERG inhibition by both siRNAs TMPRSS2-ERG and revealed one common down-regulated gene, ADRA2A, involved in cell proliferation and migration. The siRNA against TMPRSS2-ERG fusion variant IV showed the highest anti-proliferative effects: Significantly decreased cell viability, increased cleaved caspase-3 and inhibited a cluster of anti-apoptotic proteins. To propose a concrete therapeutic approach, siRNA TMPRSS2-ERG IV was conjugated to squalene, which can self-organize as nanoparticles in water. The nanoparticles of siRNA TMPRSS2-ERG-squalene injected intravenously in SCID mice reduced growth of VCaP xenografted tumours, inhibited oncoprotein expression and partially restored differentiation (decrease in Ki67). In conclusion, this study offers a new prospect of treatment for prostate cancer based on siRNA-squalene nanoparticles targeting TMPRSS2-ERG junction oncogene.	[Urbinati, Giorgia; Ali, Hafiz Muhammad; Rousseau, Quentin; Massaad-Massade, Liliane] Univ Paris 11, Lab Vectorol & Therapeut Anticancereuses, UMR 8203, F-94805 Villejuif, France; [Urbinati, Giorgia; Ali, Hafiz Muhammad; Rousseau, Quentin; Massaad-Massade, Liliane] CNRS Villejuif, Lab Vectorol & Therapeut Anticancereuses, UMR 8203, F-94805 Villejuif, France; [Urbinati, Giorgia; Ali, Hafiz Muhammad; Rousseau, Quentin; Massaad-Massade, Liliane] Gustave Roussy, Lab Vectorol & Therapeut Anticancereuses, UMR 8203, F-94805 Villejuif, France; [Rousseau, Quentin] Ghent Univ Hosp, Lab Expt Canc Res, B-9000 Ghent, Belgium; [Chapuis, Hubert; Desmaele, Didier; Couvreur, Patrick] Univ Paris 11, Fac Pharm, Inst Galien, UMR CNRS 8612, F-92296 Chatenay Malabry, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Ghent University; Ghent University Hospital; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay	Massaad-Massade, L (corresponding author), Univ Paris 11, Lab Vectorol & Therapeut Anticancereuses, UMR 8203, F-94805 Villejuif, France.	Liliane.MASSADE@gustaveroussy.fr	Ali, HM/AAH-3473-2021; COUVREUR, Patrick/AAY-7568-2020; Desmaële, Didier/X-9435-2019; Massaad, Massaad-Massade or Massade or/O-7226-2017; Patrick, COUVREUR/G-4844-2011	Ali, HM/0000-0001-9266-408X; Massaad, Massaad-Massade or Massade or/0000-0002-9636-4559; Patrick, COUVREUR/0000-0001-7961-5443	Agence Nationale de Recherche (ANR), Program P2N [NANO 00301]	Agence Nationale de Recherche (ANR), Program P2N(French National Research Agency (ANR))	The research leading to these results has received funding from the Agence Nationale de Recherche (ANR), Program P2N, Grant No NANO 00301.	Ali HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095964; Ali HM, 2014, THYROID, V24, P327, DOI 10.1089/thy.2012.0544; Ali HM, 2012, EXPERT REV CLIN PHAR, V5, P403, DOI [10.1586/ECP.12.33, 10.1586/ecp.12.33]; Attard G, 2008, ONCOGENE, V27, P253, DOI 10.1038/sj.onc.1210640; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Bolton EC, 2007, GENE DEV, V21, P2005, DOI 10.1101/gad.1564207; Clark J, 2007, ONCOGENE, V26, P2667, DOI 10.1038/sj.onc.1210070; Fitzpatrick JM, 2014, EUR J CANCER, V50, P1617, DOI 10.1016/j.ejca.2014.03.010; Furlan A, 2011, CELL DEATH DIFFER, V18, P1608, DOI 10.1038/cdd.2011.23; Gilbert-Sirieix M, 2010, THYROID, V20, P1053, DOI 10.1089/thy.2010.0006; Hu XY, 2006, APMIS, V114, P893, DOI 10.1111/j.1600-0463.2006.apm_271.x; Korenchuk S, 2001, IN VIVO, V15, P163; Kumar-Sinha C, 2008, NAT REV CANCER, V8, P497, DOI 10.1038/nrc2402; Leong, 2009, OVER EXPRESSION TRUN; Leus NGJ, 2014, INT J PHARMACEUT, V469, P121, DOI 10.1016/j.ijpharm.2014.04.041; Leus NGJ, 2014, INT J PHARMACEUT, V459, P40, DOI 10.1016/j.ijpharm.2013.11.008; Liu WN, 2007, GENE CHROMOSOME CANC, V46, P972, DOI 10.1002/gcc.20482; Mani RS, 2011, CANCER RES, V71, P5387, DOI 10.1158/0008-5472.CAN-11-0876; Mazaris Evangelos, 2013, Nephrourol Mon, V5, P792, DOI 10.5812/numonthly.9430; Mehra R, 2008, CANCER RES, V68, P3584, DOI 10.1158/0008-5472.CAN-07-6154; Mehra R, 2007, MODERN PATHOL, V20, P538, DOI 10.1038/modpathol.3800769; Nam RK, 2007, CANCER BIOL THER, V6, P40, DOI 10.4161/cbt.6.1.3489; Raouane M, 2012, BIOCONJUGATE CHEM, V23, P1091, DOI 10.1021/bc200422w; Raouane M, 2011, J MED CHEM, V54, P4067, DOI 10.1021/jm2000272; Reddy LH, 2009, ADV DRUG DELIVER REV, V61, P1412, DOI 10.1016/j.addr.2009.09.005; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Shao L, 2012, CLIN CANCER RES, V18, P6648, DOI 10.1158/1078-0432.CCR-12-2715; Spencer ES, 2013, PROSTATE, V73, P905, DOI 10.1002/pros.22636; Sun C, 2008, ONCOGENE, V27, P5348, DOI 10.1038/onc.2008.183; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tuschl T, 2002, NAT BIOTECHNOL, V20, P446, DOI 10.1038/nbt0502-446; Wang JH, 2008, CANCER RES, V68, P8516, DOI 10.1158/0008-5472.CAN-08-1147; Wang JH, 2006, CANCER RES, V66, P8347, DOI 10.1158/0008-5472.CAN-06-1966; Wang LG, 2013, INT J ONCOL, V42, P957, DOI 10.3892/ijo.2013.1767; White NM, 2013, CURR DRUG TARGETS, V14, P450; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Wu F, 2013, MED HYPOTHESES, V80, P490, DOI 10.1016/j.mehy.2012.12.012	37	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125277	10.1371/journal.pone.0125277	http://dx.doi.org/10.1371/journal.pone.0125277			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933120	Green Submitted, gold, Green Published			2022-12-27	WOS:000353887100095
J	Zou, GY; Zhang, ZT; Walley, J; Gong, WW; Yu, YX; Hu, RY; Yin, J; Yu, M; Wei, XL				Zou, Guanyang; Zhang, Zhitong; Walley, John; Gong, Weiwei; Yu, Yunxian; Hu, Ruying; Yin, Jia; Yu, Min; Wei, Xiaolin			Use of Medications and Lifestyles of Hypertensive Patients with High Risk of Cardiovascular Disease in Rural China	PLOS ONE			English	Article							PRIMARY PREVENTION; BEHAVIORAL-CHANGE; CONTROLLED-TRIAL; DOUBLE-BLIND; FOLLOW-UP; INTERVENTION; PREVALENCE; REDUCTION; AWARENESS; POLYPILL	Background Hypertension, with a global prevalence of 40%, is a risk factor for cardiovascular diseases (CVD). We conducted an exploratory study in Zhejiang China to understand the prevention of CVD among hypertensive patients with a 10 year CVD risk of 20% or higher. We assessed current practices in a rural 'township hospital' (a primary care facility), and compared them with international evidence-based practice. Methods A questionnaire survey was conducted to examine the use of modern drugs (antihypertensive drugs, statins and aspirin) and traditional drugs, compliance to medications and lifestyle among 274 hypertensive patients aged 40-74, with a CVD risk of 20% or higher (using the Asian Equation). Results The majority (72%) were diagnosed with hypertension at township hospitals. Only 15% of study participants used two anti-hypertensive drugs, 0.7% took statin and 2.9% aspirin. Only 2.9% combined two types of modern drugs, while 0.4% combined three types (antihypertensives, statins and aspirin). Herbal compounds, sometimes with internationally rarely recommended drugs such as Reserpine were taken by 44%. Analysis of drug adherence showed that 9.8% had discontinued their drug therapy by themselves. 16% had missed doses and these were on less anti-hypertensive drugs than those who did not (t=-5.217, P=0.003). Of all participants, 28% currently smoked, 39% drank regularly and only 21% exercised frequently. The average salt intake per day was 7.1 (+/- 3.8) g, while the national recommended level is 6g. Conclusion The study revealed outdated and inadequate treatment and health education for hypertensive patients, especially for those who have high risk scores for CVD. There is a need to review the community-based guidelines for hypertension management. Health providers and patients should make a transition from solely treating hypertension, towards prevention of CVD. Health system issues need addressing including improving rural health insurance cover and primary care doctors' capacity to manage chronic disease patients.	[Zou, Guanyang; Zhang, Zhitong] Univ Leeds, COMDIS Hlth Serv Delivery Res Program, China Program, Shenzhen, Peoples R China; [Walley, John] Univ Leeds, Nuffield Ctr Int Hlth & Dev, Leeds, W Yorkshire, England; [Gong, Weiwei; Hu, Ruying; Yu, Min] Zhejiang Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Yu, Yunxian] Zhejiang Univ, Schoo Publ Hlth, Hangzhou 310003, Zhejiang, Peoples R China; [Yin, Jia; Wei, Xiaolin] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China	University of Leeds; Zhejiang University; Chinese University of Hong Kong	Wei, XL (corresponding author), Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China.	xiaolinwei@cuhk.edu.hk	Walley, John D/AAY-1375-2021	Walley, John D/0000-0001-7290-0989	COMDIS Health Services Delivery Research Consortium (COMDIS-HSD); Department for International Development of the UK Government (UKAID); Department for International Development (DFID) [201025] Funding Source: researchfish	COMDIS Health Services Delivery Research Consortium (COMDIS-HSD); Department for International Development of the UK Government (UKAID); Department for International Development (DFID)	This study was supported by the COMDIS Health Services Delivery Research Consortium (COMDIS-HSD) hosted by the University of Leeds, UK. COMDIS-HSD is funded by the Department for International Development of the UK Government (UKAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barzi F, 2007, J EPIDEMIOL COMMUN H, V61, P115, DOI 10.1136/jech.2005.044842; Brindle P, 2006, HEART, V92, P1752, DOI 10.1136/hrt.2006.087932; Chang L, 2003, HEALTH PROMOT INT, V18, P219, DOI 10.1093/heapro/dag017; Chung VCH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/426360; Faghanipour S, 2013, INT J TELEMED APPL, V2013, DOI 10.1155/2013/785654; Feng XL, 2014, B WORLD HEALTH ORGAN, V92, P1; Fodor GJ, 2005, J HYPERTENS, V23, P1261, DOI 10.1097/01.hjh.0000170390.07321.ca; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Li H, 2010, J HYPERTENS, V28, P432, DOI 10.1097/HJH.0b013e328334b39e; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; Malekzadeh F, 2010, INT J CLIN PRACT, V64, P1220, DOI 10.1111/j.1742-1241.2010.02412.x; Ministry of Health China, 2009, REPORTS ON THE 2008; National Centre for Cardiovascular Disease, 2010, REPORT ON CARDIOVASC; Okoro RN., 2012, INT J BIOMED SCI, V3, P47; Raju N, 2011, AM J MED, V124, P621, DOI 10.1016/j.amjmed.2011.01.018; Ramli Azuana, 2012, Patient Prefer Adherence, V6, P613, DOI 10.2147/PPA.S34704; Seshasai SRK, 2012, ARCH INTERN MED, V172, P209, DOI 10.1001/archinternmed.2011.628; The Ministry of Health of the People's Republic of China China National Centre for Cardiovascular Diseases, 2010, CHINA NATIONAL GUIDE; The Ministry of Health of the People's Republic of China China National Centre for Cardiovascular Diseases, 2010, NATIONAL GUIDELINE O; Wang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062469; Wang J, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/978398; Wei XL, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-354; Wei XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054169; World Bank, 2011, TOWARD A HEALTHY AND; Wu YF, 2008, CIRCULATION, V118, P2679, DOI 10.1161/CIRCULATIONAHA.108.788166; Yusuf S, 2009, LANCET, V373, P1341, DOI 10.1016/S0140-6736(09)60611-5; Zhang JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070886; Zhou BA, 2010, EDUC GERONTOL, V36, P919, DOI 10.1080/03601271003689514; Zou G, 2014, J PUBLIC HEALTH-UK, V2, P2	31	10	10	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124484	10.1371/journal.pone.0124484	http://dx.doi.org/10.1371/journal.pone.0124484			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932640	Green Submitted, Green Published, gold			2022-12-27	WOS:000353887100043
J	Appolinario, PP; Medinas, DB; Chaves, AB; Genaro-Mattos, TC; Cussiol, JRR; Netto, LES; Augusto, O; Miyamoto, S				Appolinario, Patricia Postilione; Medinas, Danilo Bilches; Chaves-Filho, Adriano B.; Genaro-Mattos, Thiago C.; Rosa Cussiol, Jose Renato; Soares Netto, Luis Eduardo; Augusto, Ohara; Miyamoto, Sayuri			Oligomerization of Cu,Zn-Superoxide Dismutase (SOD1) by Docosahexaenoic Acid and Its Hydroperoxides In Vitro: Aggregation Dependence on Fatty Acid Unsaturation and Thiols	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; SUPEROXIDE-DISMUTASE; OXIDATIVE MODIFICATION; PROTEIN AGGREGATION; DISULFIDE BOND; MUTATIONS; TRIGGERS; PROTOFIBRILS; CYTOTOXICITY; MODEL	Docosahexaenoic acid (C22:6, n-3, DHA) is a polyunsaturated fatty acid highly enriched in the brain. This fatty acid can be easily oxidized yielding hydroperoxides as primary products. Cu, Zn-Superoxide dismutase (SOD1) aggregation is a common hallmark of Amyotrophic Lateral Sclerosis (ALS) and the molecular mechanisms behind their formation are not completely understood. Here we investigated the effect of DHA and its hydroperoxides (DHAOOH) on human SOD1 oligomerization in vitro. DHA induced the formation of high-molecular-weight (HMW) SOD1 species (>700 kDa). Aggregation was dependent on free thiols and occurred primarily with the protein in its apo-form. SOD1 incubation with DHA was accompanied by changes in protein structure leading to exposure of protein hydrophobic patches and formation of non-amyloid aggregates. Site-directed mutagenesis studies demonstrated that Cys 6 and Cys 111 in wild-type and Cys 6 in ALS-linked G93A mutant are required for aggregation. In contrast, DHAOOH did not induce HMW species formation but promoted abnormal covalent dimerization of apo-SOD1 that was resistant to SDS and thiol reductants. Overall, our data demonstrate that DHA and DHAOOH induce distinct types of apo-SOD1 oligomerization leading to the formation of HMW and low-molecular-weight species, respectively.	[Appolinario, Patricia Postilione; Medinas, Danilo Bilches; Chaves-Filho, Adriano B.; Genaro-Mattos, Thiago C.; Augusto, Ohara; Miyamoto, Sayuri] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [Rosa Cussiol, Jose Renato; Soares Netto, Luis Eduardo] Univ Sao Paulo, Inst Biociencias, Dept Biol, BR-01498 Sao Paulo, Brazil; [Medinas, Danilo Bilches] Univ Chile, Fac Med, Biomed Neurosci Inst, Santiago, Chile; [Medinas, Danilo Bilches] Univ Chile, Ctr Mol Studies Cell, Inst Biomed Sci, Program Cellular & Mol Biol, Santiago, Chile	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidad de Chile; Universidad de Chile	Miyamoto, S (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil.	miyamoto@iq.usp.br	Miyamoto, Sayuri/A-2144-2008; Netto, Luis/A-3783-2008; Chaves-Filho, Adriano B/V-5656-2017; Medinas, Danilo/ABA-1182-2021; Cussiol, José Renato/E-5142-2015; Augusto, Ohara/D-3839-2012	Miyamoto, Sayuri/0000-0002-5714-8984; Netto, Luis/0000-0002-4250-9177; Chaves-Filho, Adriano B/0000-0002-2321-6504; Cussiol, José Renato/0000-0001-5909-8215; Augusto, Ohara/0000-0002-7220-4286; Bilches Medinas, Danilo/0000-0002-1822-1974; Genaro-Mattos, Thiago/0000-0001-9377-2285	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [08/57721-0, 10/50891-0, 13/07937-8]; CNPq (Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico) [573530/2008-4]; PRPUSP (Pro-Reitoria de Pesquisa da Universidade de Sao Paulo) [2011.1.9352.1.8]; FAPESP [09/52702-3]	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PRPUSP (Pro-Reitoria de Pesquisa da Universidade de Sao Paulo); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by grants from: FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo: 08/57721-0, 10/50891-0 and 13/07937-8), CNPq (Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico, 573530/2008-4), and PRPUSP (Pro-Reitoria de Pesquisa da Universidade de Sao Paulo: 2011.1.9352.1.8). The authors are members of INCT Redoxoma (FAPESP/CNPq/CAPES), NAP Redoxoma (PRPUSP), and the CEPID Redoxoma (FAPESP). PPA was recipient of Ph.D. studentship from FAPESP (09/52702-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aisenbrey C, 2008, EUR BIOPHYS J BIOPHY, V37, P247, DOI 10.1007/s00249-007-0237-0; Antinone SE, 2013, J BIOL CHEM, V288, P21606, DOI 10.1074/jbc.M113.487231; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Banci L, 2009, P NATL ACAD SCI USA, V106, P6980, DOI 10.1073/pnas.0809845106; Banci L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001677; Bazan NG, ANN REV NUTR, V312011, P321; Benov LT, 1996, FREE RADICAL BIO MED, V21, P117, DOI 10.1016/0891-5849(95)02217-1; Broersen K, 2006, BIOCHEMISTRY-US, V45, P15610, DOI 10.1021/bi061743l; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Chen XP, 2012, NEUROCHEM RES, V37, P835, DOI 10.1007/s11064-011-0679-8; Choi I, 2011, BBA-MOL BASIS DIS, V1812, P41, DOI 10.1016/j.bbadis.2010.09.003; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Coelho FR, 2014, J BIOL CHEM, V289, P30690, DOI 10.1074/jbc.M114.586370; Cozzolino M, 2008, J BIOL CHEM, V283, P866, DOI 10.1074/jbc.M705657200; De Franceschi G, 2011, J BIOL CHEM, V286, P22262, DOI 10.1074/jbc.M110.202937; Derogis PBMC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077561; Ding F, 2008, P NATL ACAD SCI USA, V105, P19696, DOI 10.1073/pnas.0803266105; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Fu XM, 2005, BIOCHEM BIOPH RES CO, V329, P1087, DOI 10.1016/j.bbrc.2005.01.164; Fujiwara N, 2007, J BIOL CHEM, V282, P35933, DOI 10.1074/jbc.M702941200; Furukawa Y, 2006, P NATL ACAD SCI USA, V103, P7148, DOI 10.1073/pnas.0602048103; Furukawa Y, 2008, J BIOL CHEM, V283, P24167, DOI 10.1074/jbc.M802083200; Furukawa Y, 2011, AMYOTROPHIC LATERAL SCLEROSIS, P335; Gorbenko GP, 2006, CHEM PHYS LIPIDS, V141, P72, DOI 10.1016/j.chemphyslip.2006.02.006; Hwang YM, 2010, J BIOL CHEM, V285, P41701, DOI 10.1074/jbc.M110.113696; Johansson AS, 2007, FEBS J, V274, P990, DOI 10.1111/j.1742-4658.2007.05647.x; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Kato S, 2000, AMYOTROPH LATERAL SC, V1, P163, DOI 10.1080/14660820050515160; Kerman A, 2010, ACTA NEUROPATHOL, V119, P335, DOI 10.1007/s00401-010-0646-5; Kiaei M, 2005, J NEUROCHEM, V93, P403, DOI 10.1111/j.1471-4159.2005.03024.x; Kim HY, 2007, J BIOL CHEM, V282, P18661, DOI 10.1074/jbc.R700015200; Kim YJ, 2005, J BIOL CHEM, V280, P21515, DOI 10.1074/jbc.M502230200; Lelie HL, 2011, J BIOL CHEM, V286, P2795, DOI 10.1074/jbc.M110.186999; Martins IC, 2008, EMBO J, V27, P224, DOI 10.1038/sj.emboj.7601953; McGeer PL, 2002, MUSCLE NERVE, V26, P459, DOI 10.1002/mus.10191; Medinas DB, 2010, FREE RADICAL BIO MED, V49, P1046, DOI 10.1016/j.freeradbiomed.2010.06.018; Medinas DB, 2009, CHEM RES TOXICOL, V22, P639, DOI 10.1021/tx800287m; Miyamoto S, 2006, P NATL ACAD SCI USA, V103, P293, DOI 10.1073/pnas.0508170103; Morigaki K, 2007, CURR OPIN COLLOID IN, V12, P75, DOI 10.1016/j.cocis.2007.05.005; Mulligan VK, 2012, J MOL BIOL, V421, P631, DOI 10.1016/j.jmb.2012.04.016; Namani T, 2007, COLLOID SURFACE B, V54, P118, DOI 10.1016/j.colsurfb.2006.05.022; Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012; Orr SK, 2013, J NEUROCHEM, V127, P378, DOI 10.1111/jnc.12392; Perrin RJ, 2001, J BIOL CHEM, V276, P41958, DOI 10.1074/jbc.M105022200; Philips T, 2011, LANCET NEUROL, V10, P253, DOI 10.1016/S1474-4422(11)70015-1; Rakhit R, 2002, J BIOL CHEM, V277, P47551, DOI 10.1074/jbc.M207356200; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Serhan CN, 2011, CHEM REV, V111, P5922, DOI 10.1021/cr100396c; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; Shibata N, 2010, ACTA NEUROPATHOL, V119, P345, DOI 10.1007/s00401-009-0636-7; Taylor DM, 2007, J BIOL CHEM, V282, P16329, DOI 10.1074/jbc.M610119200; Tsiroulnikov K, 2009, BBA-PROTEINS PROTEOM, V1794, P506, DOI 10.1016/j.bbapap.2008.12.002; Turell L, 2009, BRAZ J MED BIOL RES, V42, P305, DOI 10.1590/S0100-879X2009000400001; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Wilcox KC, 2009, J BIOL CHEM, V284, P13940, DOI 10.1074/jbc.M809687200; Zhang M, 2009, CHEM-BIOL INTERACT, V180, P131, DOI 10.1016/j.cbi.2009.03.019	57	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125146	10.1371/journal.pone.0125146	http://dx.doi.org/10.1371/journal.pone.0125146			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928076	Green Submitted, Green Published, gold			2022-12-27	WOS:000353713100070
J	Kim, HJ; Hinchliffe, DJ; Triplett, BA; Chen, ZJ; Stelly, DM; Yeater, KM; Moon, HS; Gilbert, MK; Thyssen, GN; Turley, RB; Fang, DD				Kim, Hee Jin; Hinchliffe, Doug J.; Triplett, Barbara A.; Chen, Z. Jeffrey; Stelly, David M.; Yeater, Kathleen M.; Moon, Hong S.; Gilbert, Matthew K.; Thyssen, Gregory N.; Turley, Rickie B.; Fang, David D.			Phytohormonal Networks Promote Differentiation of Fiber Initials on Pre-Anthesis Cotton Ovules Grown In Vitro and In Planta	PLOS ONE			English	Article							GOSSYPIUM-HIRSUTUM L.; MYB TRANSCRIPTION FACTOR; GENE-EXPRESSION; CELL-WALL; ALLOTETRAPLOID COTTON; TRICHOME DEVELOPMENT; VACUOLAR INVERTASE; ABSCISIC-ACID; AUXIN; ELONGATION	The number of cotton (Gossypium sp.) ovule epidermal cells differentiating into fiber initials is an important factor affecting cotton yield and fiber quality. Despite extensive efforts in determining the molecular mechanisms regulating fiber initial differentiation, only a few genes responsible for fiber initial differentiation have been discovered. To identify putative genes directly involved in the fiber initiation process, we used a cotton ovule culture technique that controls the timing of fiber initial differentiation by exogenous phytohormone application in combination with comparative expression analyses between wild type and three fiberless mutants. The addition of exogenous auxin and gibberellins to pre-anthesis wild type ovules that did not have visible fiber initials increased the expression of genes affecting auxin, ethylene, ABA and jasmonic acid signaling pathways within 1 h after treatment. Most transcripts expressed differentially by the phytohormone treatment in vitro were also differentially expressed in the ovules of wild type and fiberless mutants that were grown in planta. In addition to MYB25-like, a gene that was previously shown to be associated with the differentiation of fiber initials, several other differentially expressed genes, including auxin/indole-3-acetic acid (AUX/IAA) involved in auxin signaling, ACC oxidase involved in ethylene biosynthesis, and abscisic acid (ABA) 8'-hydroxylase an enzyme that controls the rate of ABA catabolism, were co-regulated in the pre-anthesis ovules of both wild type and fiberless mutants. These results support the hypothesis that phytohormonal signaling networks regulate the temporal expression of genes responsible for differentiation of cotton fiber initials in vitro and in planta.	[Kim, Hee Jin; Hinchliffe, Doug J.; Triplett, Barbara A.; Moon, Hong S.; Gilbert, Matthew K.; Thyssen, Gregory N.; Fang, David D.] USDA ARS, SRRC, Cotton Fiber Biosci Res Unit, New Orleans, LA 70153 USA; [Chen, Z. Jeffrey] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Chen, Z. Jeffrey] Univ Texas Austin, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA; [Stelly, David M.] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA; [Yeater, Kathleen M.] USDA ARS, Plains Area, Ft Collins, CO 80522 USA; [Turley, Rickie B.] USDA ARS, Crop Genet Res Unit, Stoneville, MS 38776 USA	United States Department of Agriculture (USDA); University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Texas A&M University System; Texas A&M University College Station; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Kim, HJ (corresponding author), USDA ARS, SRRC, Cotton Fiber Biosci Res Unit, New Orleans, LA 70153 USA.	heejin.kim@ars.usda.gov	Kim, Heejin/HII-8568-2022; FANG, DAVID/AAV-5774-2020; Stelly, David/ABC-7400-2020	FANG, DAVID/0000-0003-0036-5459; Stelly, David/0000-0002-3468-4119; Turley, Rickie/0000-0002-1792-9559	USDA-ARS CRIS Project [6435-21000-016-00D]; NSF [DBI0624077, ISO1025947]; Cotton Incorporated [07-161]; Division Of Integrative Organismal Systems [1025947] Funding Source: National Science Foundation	USDA-ARS CRIS Project(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NSF(National Science Foundation (NSF)); Cotton Incorporated(Cotton R&D Corp); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by the USDA-ARS CRIS Project #6435-21000-016-00D, NSF DBI0624077 and ISO1025947, and Cotton Incorporated-sponsored project #07-161. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Applequist WL, 2001, EVOL DEV, V3, P3, DOI 10.1046/j.1525-142x.2001.00079.x; BASRA AS, 1984, INT REV CYTOL, V89, P65, DOI 10.1016/S0074-7696(08)61300-5; BEASLEY CA, 1974, AM J BOT, V61, P188, DOI 10.2307/2441189; BEASLEY CA, 1973, AM J BOT, V60, P130, DOI 10.2307/2441099; Clark G, 2010, PLANT PHYSIOL, V152, P1073, DOI 10.1104/pp.109.147637; Deng FL, 2012, PLANT PHYSIOL, V158, P890, DOI 10.1104/pp.111.186742; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Gialvalis S., 2001, Journal of Cotton Science, V5, P252; GRAVES DA, 1988, PLANTA, V175, P254, DOI 10.1007/BF00392435; Guan XY, 2008, PHYSIOL PLANTARUM, V134, P174, DOI 10.1111/j.1399-3054.2008.01115.x; Guilfoyle T, 1998, PLANT PHYSIOL, V118, P341, DOI 10.1104/pp.118.2.341; Hadiarto T, 2006, PLANTA, V223, P708, DOI 10.1007/s00425-005-0126-7; Han XY, 2012, GENE, V503, P83, DOI 10.1016/j.gene.2012.03.069; Hao J, 2012, J EXP BOT, V63, P6267, DOI 10.1093/jxb/ers278; Hinchliffe DJ, 2010, THEOR APPL GENET, V120, P1347, DOI 10.1007/s00122-010-1260-6; Ishida T, 2008, ANNU REV PLANT BIOL, V59, P365, DOI 10.1146/annurev.arplant.59.032607.092949; Ji XM, 2011, PLANT PHYSIOL, V156, P647, DOI 10.1104/pp.111.176164; Kim HJ, 2001, PLANT PHYSIOL, V127, P1361, DOI 10.1104/pp.010724; Kosmidou-Dimitropoulou K, 1986, COTTON PHYSL, P361; Kunihiro A, 2011, PLANT CELL PHYSIOL, V52, P1315, DOI 10.1093/pcp/pcr076; Lang AG, 1938, J AGRIC RES, V56, P0507; Lee JJ, 2007, ANN BOT-LONDON, V100, P1391, DOI 10.1093/aob/mcm232; Lee JJ, 2006, PLANTA, V223, P418, DOI 10.1007/s00425-005-0098-7; Leyser O, 2002, ANNU REV PLANT BIOL, V53, P377, DOI 10.1146/annurev.arplant.53.100301.135227; Li CH, 2002, PLANT SCI, V163, P1113, DOI 10.1016/S0168-9452(02)00320-5; Li CQ, 2009, EUPHYTICA, V165, P223, DOI 10.1007/s10681-008-9740-3; Loguercio LL, 1999, MOL GEN GENET, V261, P660; Machado A, 2009, PLANT J, V59, P52, DOI 10.1111/j.1365-313X.2009.03847.x; MEINERT MC, 1977, PLANT PHYSIOL, V59, P1088, DOI 10.1104/pp.59.6.1088; Mockaitis K, 2000, PLANT J, V24, P785, DOI 10.1046/j.1365-313x.2000.00921.x; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Potikha TS, 1999, PLANT PHYSIOL, V119, P849, DOI 10.1104/pp.119.3.849; Pu L, 2008, GENETICS, V180, P811, DOI 10.1534/genetics.108.093070; Rahman A, 2001, PLANT CELL PHYSIOL, V42, P301, DOI 10.1093/pcp/pce035; Robles LM, 2012, J EXPT BOT; Romano GB, 2011, J COTTON SCI, V15, P61; Ruan YL, 1998, PLANT PHYSIOL, V118, P399, DOI 10.1104/pp.118.2.399; Ruan YL, 2003, PLANT CELL, V15, P952, DOI 10.1105/tpc.010108; Ryser U, 1999, COTTON FIBERS: DEVELOPMENTAL BIOLOGY, QUALITY IMPROVEMENT, AND TEXTILE PROCESSING, P1; Saito S, 2004, PLANT PHYSIOL, V134, P1439, DOI 10.1104/pp.103.037614; Schiefelbein J, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00047; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; Shimizu Y, 1997, PLANT CELL PHYSIOL, V38, P375, DOI 10.1093/oxfordjournals.pcp.a029178; STEWART JM, 1975, AM J BOT, V62, P723, DOI 10.2307/2442061; Sun Y, 2005, PLANT CELL PHYSIOL, V46, P1384, DOI 10.1093/pcp/pci150; Suo JF, 2003, BBA-GENE STRUCT EXPR, V1630, P25, DOI 10.1016/j.bbaexp.2003.08.009; Taliercio EW, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-22; Tiwari SB, 2003, PLANT CELL, V15, P533, DOI 10.1105/tpc.008417; Turley RB, 2002, J HERED, V93, P359, DOI 10.1093/jhered/93.5.359; Turley RB, 2008, EUPHYTICA, V164, P123, DOI 10.1007/s10681-008-9670-0; Udall JA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-81; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Wakelyn PJ., 2010, COTTON FIBER CHEM TE; Walford S-A, 2012, PLANT J; Walford SA, 2011, PLANT J, V65, P785, DOI 10.1111/j.1365-313X.2010.04464.x; Wang L, 2014, PLANT J, V78, P686, DOI 10.1111/tpj.12512; Wang L, 2010, PLANT PHYSIOL, V154, P744, DOI 10.1104/pp.110.162487; Wang MY, 2013, PLANT PHYSIOL, V162, P1669, DOI 10.1104/pp.113.215673; Wang QQ, 2010, GENOMICS, V96, P369, DOI 10.1016/j.ygeno.2010.08.009; Wang S, 2004, PLANT CELL, V16, P2323, DOI 10.1105/tpc.104.024844; Wu Y, 2007, PLANTA, V226, P1475, DOI 10.1007/s00425-007-0580-5; Wu YR, 2006, PLANT CELL PHYSIOL, V47, P107, DOI 10.1093/pcp/pci228; Yang SS, 2006, PLANT J, V47, P761, DOI 10.1111/j.1365-313X.2006.02829.x; Yang ZR, 2014, NEW PHYTOL, V203, P437, DOI 10.1111/nph.12824; Zhang DY, 2007, J INTEGR PLANT BIOL, V49, P1038, DOI 10.1111/j.1672-9072.2007.00454.x; Zhang DY, 2010, J PLANT PHYSIOL, V167, P393, DOI 10.1016/j.jplph.2009.10.005; Zhang HP, 2009, ACTA PHYSIOL PLANT, V31, P979, DOI 10.1007/s11738-009-0313-4; Zhang M, 2011, NAT BIOTECHNOL, V29, P453, DOI 10.1038/nbt.1843; Zhang TZ, 1991, JIANGSU J AGR SCI, V7, P13	69	51	52	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125046	10.1371/journal.pone.0125046	http://dx.doi.org/10.1371/journal.pone.0125046			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927364	Green Published, Green Submitted, gold			2022-12-27	WOS:000353713100062
J	Terrasse, R; Amoroso, A; Vernet, T; Di Guilmi, AM				Terrasse, Remi; Amoroso, Ana; Vernet, Thierry; Di Guilmi, Anne Marie			Streptococcus pneumoniae GAPDH Is Released by Cell Lysis and Interacts with Peptidoglycan	PLOS ONE			English	Article							FIBRONECTIN-BINDING PROTEIN; ENDOPEPTIDASE O PEPO; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; ALPHA-ENOLASE; MOONLIGHTING PROTEINS; SUPEROXIDE-DISMUTASE; HUMAN PLASMINOGEN; ESCHERICHIA-COLI; SURFACE; LISTERIA	Release of conserved cytoplasmic proteins is widely spread among Gram-positive and Gram-negative bacteria. Because these proteins display additional functions when located at the bacterial surface, they have been qualified as moonlighting proteins. The GAPDH is a glycolytic enzyme which plays an important role in the virulence processes of pathogenic microorganisms like bacterial invasion and host immune system modulation. However, GAPDH, like other moonlighting proteins, cannot be secreted through active secretion systems since they do not contain an N-terminal predicted signal peptide. In this work, we investigated the mechanism of GAPDH export and surface retention in Streptococcus pneumoniae, a major human pathogen. We addressed the role of the major autolysin LytA in the delivery process of GAPDH to the cell surface. Pneumococcal lysis is abolished in the Delta lytA mutant strain or when 1% choline chloride is added in the culture media. We showed that these conditions induce a marked reduction in the amount of surface-associated GAPDH. These data suggest that the presence of GAPDH at the surface of pneumococcal cells depends on the LytA-mediated lysis of a fraction of the cell population. Moreover, we demonstrated that pneumococcal GAPDH binds to the bacterial cell wall independently of the presence of the teichoic acids component, supporting peptidoglycan as a ligand to surface GAPDH. Finally, we showed that peptidoglycan-associated GAPDH recruits C1q from human serum but does not activate the complement pathway.	[Terrasse, Remi; Vernet, Thierry; Di Guilmi, Anne Marie] Univ Grenoble Alpes, Inst Biol Struct IBS, F-38044 Grenoble, France; [Terrasse, Remi; Vernet, Thierry; Di Guilmi, Anne Marie] IBS, CNRS UMR5075, F-38044 Grenoble, France; [Terrasse, Remi; Vernet, Thierry; Di Guilmi, Anne Marie] IBS, DSV, CEA, F-38044 Grenoble, France; [Amoroso, Ana] Univ Liege, Ctr Prot Engn, Dept Life Sci, Liege, Belgium	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); University of Liege	Di Guilmi, AM (corresponding author), Univ Grenoble Alpes, Inst Biol Struct IBS, 71 Ave Martyrs, F-38044 Grenoble, France.	anne-marie.di-guilmi@ibs.fr		Di Guilmi, Anne Marie/0000-0001-7335-3470	Agence Nationale de la Recherche grant PiliPath [ANR11BSV800501]	Agence Nationale de la Recherche grant PiliPath(French National Research Agency (ANR))	R.T. was supported by a PhD grant from the Rhone-Alpes region, Cluster Infectiologie. This work was partly supported by Agence Nationale de la Recherche grant PiliPath (ANR11BSV800501).	Agarwal S, 2008, BBA-PROTEINS PROTEOM, V1784, P986, DOI 10.1016/j.bbapap.2008.03.017; Agarwal V, 2014, J BIOL CHEM, V289, P15833, DOI 10.1074/jbc.M113.530212; Agarwal V, 2013, J BIOL CHEM, V288, P6849, DOI 10.1074/jbc.M112.405530; Agarwal V, 2012, J IMMUNOL, V189, P3575, DOI 10.4049/jimmunol.1102934; Ali YM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002793; Antikainen J, 2007, J BACTERIOL, V189, P4539, DOI 10.1128/JB.00378-07; Archambaud C, 2006, J BIOL CHEM, V281, P31812, DOI 10.1074/jbc.M606249200; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Bergmann S, 2013, INT J MED MICROBIOL, V303, P452, DOI 10.1016/j.ijmm.2013.06.002; Black S, 2004, J BIOL CHEM, V279, P48487, DOI 10.1074/jbc.R400025200; Blau K, 2007, J INFECT DIS, V195, P1828, DOI 10.1086/518038; Boel G, 2005, INFECT IMMUN, V73, P6237, DOI 10.1128/IAI.73.10.6237-6248.2005; Boel G, 2004, J MOL BIOL, V337, P485, DOI 10.1016/j.jmb.2003.12.082; Boone TJ, 2011, MICROB PATHOGENESIS, V51, P255, DOI 10.1016/j.micpath.2011.06.005; Braunstein M, 2003, MOL MICROBIOL, V48, P453, DOI 10.1046/j.1365-2958.2003.03438.x; Carneiro CRW, 2004, MICROBES INFECT, V6, P604, DOI 10.1016/j.micinf.2004.02.003; CHAPUT M, 1988, NATURE, V332, P454, DOI 10.1038/332454a0; Christie PJ, 2014, BBA-MOL CELL RES, V1843, P1578, DOI 10.1016/j.bbamcr.2013.12.019; Dalbey RE, 2014, BBA-MOL CELL RES, V1843, P1489, DOI 10.1016/j.bbamcr.2013.12.022; Dalia AB, 2011, CELL HOST MICROBE, V10, P486, DOI 10.1016/j.chom.2011.09.009; DWORSCHACK R, 1961, APPL MICROBIOL, V9, P291, DOI 10.1128/AEM.9.4.291-294.1961; Egea L, 2007, INT J BIOCHEM CELL B, V39, P1190, DOI 10.1016/j.biocel.2007.03.008; Eldholm V, 2010, MOL MICROBIOL, V76, P905, DOI 10.1111/j.1365-2958.2010.07143.x; Ezkurdia I, 2014, HUM MOL GENET, V23, P5866, DOI 10.1093/hmg/ddu309; Frolet C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-190; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Guo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012680; Henderson B, 2014, BIOCH SOC; Henderson B, 2014, BIOCHEM SOC T, V42, P1720, DOI 10.1042/BST20140236; Henderson B, 2011, INFECT IMMUN, V79, P3476, DOI 10.1128/IAI.00179-11; Hernandez S, 2014, NUCLEIC ACIDS RES, V42, pD517, DOI 10.1093/nar/gkt1153; Holmes AR, 2001, MOL MICROBIOL, V41, P1395, DOI 10.1046/j.1365-2958.2001.02610.x; Houben ENG, 2014, BBA-MOL CELL RES, V1843, P1707, DOI 10.1016/j.bbamcr.2013.11.003; Jagadeesan B, 2010, MICROBIOL-SGM, V156, P2782, DOI 10.1099/mic.0.036509-0; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; Jin H, 2011, MBIO, V2, DOI 10.1128/mBio.00068-11; Kainulainen Veera, 2014, Biology (Basel), V3, P178, DOI 10.3390/biology3010178; Kinhikar AG, 2006, MOL MICROBIOL, V60, P999, DOI 10.1111/j.1365-2958.2006.05151.x; Lara B, 2005, MOL MICROBIOL, V55, P699, DOI 10.1111/j.1365-2958.2004.04432.x; Lenz LL, 2003, P NATL ACAD SCI USA, V100, P12432, DOI 10.1073/pnas.2133653100; Ling E, 2004, CLIN EXP IMMUNOL, V138, P290, DOI 10.1111/j.1365-2249.2004.02628.x; Lizcano A, 2012, MOL ORAL MICROBIOL, V27, P257, DOI 10.1111/j.2041-1014.2012.00653.x; Madureira P, 2007, J IMMUNOL, V178, P1379, DOI 10.4049/jimmunol.178.3.1379; Maier T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.38; Mani M., 2014, NUCLEIC ACIDS RES, DOI [10.1043/nar/gku954, DOI 10.1043/NAR/GKU954]; Matta SK, 2010, BBA-PROTEINS PROTEOM, V1804, P2111, DOI 10.1016/j.bbapap.2010.08.004; Mellroth P, 2014, MBIO, V5, DOI 10.1128/mBio.01120-13; Melville S, 2013, MICROBIOL MOL BIOL R, V77, P323, DOI 10.1128/MMBR.00063-12; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Oliveira L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029963; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; Pancholi V, 1997, J EXP MED, V186, P1633, DOI 10.1084/jem.186.10.1633; PANCHOLI V, 1992, J EXP MED, V176, P415, DOI 10.1084/jem.176.2.415; Pasztor L, 2010, J BIOL CHEM, V285, P36794, DOI 10.1074/jbc.M110.167312; Perez-Dorado I, 2010, NAT STRUCT MOL BIOL, V17, P576, DOI 10.1038/nsmb.1817; Schneewind O, 2014, BBA-MOL CELL RES, V1843, P1687, DOI 10.1016/j.bbamcr.2013.11.009; Seifert KN, 2003, CAN J MICROBIOL, V49, P350, DOI 10.1139/W03-042; Sun XS, 2010, J PROTEOME RES, V9, P275, DOI 10.1021/pr900612v; Terao Y, 2006, J BIOL CHEM, V281, P14215, DOI 10.1074/jbc.M513408200; Terrasse R, 2012, J BIOL CHEM, V287, P42620, DOI 10.1074/jbc.M112.423731; Trost M, 2005, PROTEOMICS, V5, P1544, DOI 10.1002/pmic.200401024; WISTOW GJ, 1988, J CELL BIOL, V107, P2729, DOI 10.1083/jcb.107.6.2729; Xia XX, 2008, PROTEOMICS, V8, P2089, DOI 10.1002/pmic.200700826; Yang CK, 2011, J BACTERIOL, V193, P5607, DOI 10.1128/JB.05897-11	64	18	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125377	10.1371/journal.pone.0125377	http://dx.doi.org/10.1371/journal.pone.0125377			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927608	Green Submitted, Green Published, gold			2022-12-27	WOS:000353713100085
J	Ud-Din, S; Sebastian, A; Giddings, P; Colthurst, J; Whiteside, S; Morris, J; Nuccitelli, R; Pullar, C; Baguneid, M; Bayat, A				Ud-Din, Sara; Sebastian, Anil; Giddings, Pamela; Colthurst, James; Whiteside, Sigrid; Morris, Julie; Nuccitelli, Richard; Pullar, Christine; Baguneid, Mo; Bayat, Ardeshir			Angiogenesis Is Induced and Wound Size Is Reduced by Electrical Stimulation in an Acute Wound Healing Model in Human Skin	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; VENOUS LEG ULCERS; HUMAN KERATINOCYTES; BLOOD-FLOW; VEGF; MECHANISMS; EXPRESSION; RECEPTORS; PERMEABILITY; THERAPY	Angiogenesis is critical for wound healing. Insufficient angiogenesis can result in impaired wound healing and chronic wound formation. Electrical stimulation (ES) has been shown to enhance angiogenesis. We previously showed that ES enhanced angiogenesis in acute wounds at one time point (day 14). The aim of this study was to further evaluate the role of ES in affecting angiogenesis during the acute phase of cutaneous wound healing over multiple time points. We compared the angiogenic response to wounding in 40 healthy volunteers (divided into two groups and randomised), treated with ES (post-ES) and compared them to secondary intention wound healing (control). Biopsy time points monitored were days 0, 3, 7, 10, 14. Objective non-invasive measures and H&E analysis were performed in addition to immunohistochemistry (IHC) and Western blotting (WB). Wound volume was significantly reduced on D7, 10 and 14 post-ES (p = 0.003, p = 0.002, p<0.001 respectively), surface area was reduced on days 10 (p = 0.001) and 14 (p<0.001) and wound diameter reduced on days 10 (p = 0.009) and 14 (p = 0.002). Blood flow increased significantly post-ES on D10 (p = 0.002) and 14 (p = 0.001). Angiogenic markers were up-regulated following ES application; protein analysis by IHC showed an increase (p<0.05) in VEGF-A expression by ES treatment on days 7, 10 and 14 (39%, 27% and 35% respectively) and PLGF expression on days 3 and 7 (40% on both days), compared to normal healing. Similarly, WB demonstrated an increase (p<0.05) in PLGF on days 7 and 14 (51% and 35% respectively). WB studies showed a significant increase of 30% (p>0.05) on day 14 in VEGF-A expression post-ES compared to controls. Furthermore, organisation of granulation tissue was improved on day 14 post-ES. This randomised controlled trial has shown that ES enhanced wound healing by reduced wound dimensions and increased VEGF-A and PLGF expression in acute cutaneous wounds, which further substantiates the role of ES in up-regulating angiogenesis as observed over multiple time points. This therapeutic approach may have potential application for clinical management of delayed and chronic wounds.	[Ud-Din, Sara; Sebastian, Anil; Bayat, Ardeshir] Univ Manchester, Plast & Reconstruct Surg Res, Manchester Inst Biotechnol, Manchester, Lancs, England; [Ud-Din, Sara; Baguneid, Mo; Bayat, Ardeshir] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Med & Human Sci, Univ Hosp South Manchester NHS Fdn Trust,Inst Inf, Manchester, Lancs, England; [Giddings, Pamela; Colthurst, James] Oxford Bioelect, Innovat Ctr, Abingdon, Oxon, England; [Whiteside, Sigrid; Morris, Julie] Univ S Manchester Hosp, Med Stat, Manchester M20 8LR, Lancs, England; [Nuccitelli, Richard] BioElectroMed Corp, Burlingame, CA USA; [Pullar, Christine] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester, Leics, England; [Bayat, Ardeshir] Univ Manchester, Inst Inflammat & Repair, Ctr Dermatol Res, Manchester, Lancs, England	University of Manchester; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of Leicester; University of Manchester	Bayat, A (corresponding author), Univ Manchester, Plast & Reconstruct Surg Res, Manchester Inst Biotechnol, Manchester, Lancs, England.	ardeshir.bayat@manchester.ac.uk		Baguneid, Mohamed/0000-0002-3819-4993; BAYAT, ARDESHIR/0000-0002-4116-6491	Fenzian Ltd.; William Henry Smith of Hambleden	Fenzian Ltd.; William Henry Smith of Hambleden	Partial funding was provided by Fenzian Ltd. Only authors P. Giddings and J. Colthurst are paid as employees of Fenzian Ltd. (URL - www.fenzian.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The remaining funding was a philanthropic donation which was funded by a generous donation from William Henry Smith of Hambleden.	Ardehali B, 2007, PLAST RECONSTR SURG, V119, P556, DOI 10.1097/01.prs.0000252505.52821.76; ARNOLD F, 1991, PHARMACOL THERAPEUT, V52, P407, DOI 10.1016/0163-7258(91)90034-J; Ascher B, 2012, J COSMET LASER THER, V14, P234, DOI 10.3109/14764172.2012.712700; Bai H, 2011, CYTOKINE, V55, P110, DOI 10.1016/j.cyto.2011.03.003; Benjamin LE, 1997, P NATL ACAD SCI USA, V94, P8761, DOI 10.1073/pnas.94.16.8761; BIRCHER A, 1994, CONTACT DERMATITIS, V30, P65, DOI 10.1111/j.1600-0536.1994.tb00565.x; Bloemen MCT, 2011, J AM ACAD DERMATOL, V64, P706, DOI 10.1016/j.jaad.2010.03.006; Bowling FL, 2009, DIABETIC MED, V26, P93, DOI 10.1111/j.1464-5491.2008.02611.x; BROWN LF, 1997, EXS, V79, P233; Carmeliet P, 1999, CURR TOP MICROBIOL, V237, P133; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Clover AJ, 2003, J VASC SURG, V38, P1309, DOI 10.1016/S0741-5214(03)00895-4; Di Peppe SR, 2002, GENE THER, V9, P1271, DOI 10.1038/sj.gt.3301798; Drinkwater SL, 2003, J VASC SURG, V38, P1106, DOI 10.1016/S0741-5214(03)01053-X; Failla CM, 2000, J INVEST DERMATOL, V115, P388, DOI 10.1046/j.1523-1747.2000.00085.x; FEEDAR JA, 1991, PHYS THER, V71, P639, DOI 10.1093/ptj/71.9.639; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; FOULDS IS, 1983, BRIT J DERMATOL, V109, P515, DOI 10.1111/j.1365-2133.1983.tb07673.x; Galiano RD, 2004, AM J PATHOL, V164, P1935, DOI 10.1016/S0002-9440(10)63754-6; Gentzkow GD, 1991, WOUNDS, V3, P158; Greaves NS, 2013, J DERMATOL SCI, V72, P206, DOI 10.1016/j.jdermsci.2013.07.008; HANG J, 1995, AM J PHYSIOL-HEART C, V269, pH1827, DOI 10.1152/ajpheart.1995.269.5.H1827; Houghton PE, 2003, PHYS THER, V83, P17, DOI 10.1093/ptj/83.1.17; Junger M, 2008, WOUND REPAIR REGEN, V16, P480, DOI 10.1111/j.1524-475X.2008.00393.x; Kanno S, 1999, CIRCULATION, V99, P2682, DOI 10.1161/01.CIR.99.20.2682; Korber Andreas, 2006, J Dtsch Dermatol Ges, V4, P848, DOI 10.1111/j.1610-0387.2006.06113.x; Laschke MW, 2006, TISSUE ENG, V12, P2093, DOI 10.1089/ten.2006.12.2093; Li J, 2007, CLIN DERMATOL, V25, P9, DOI 10.1016/j.clindermatol.2006.09.007; McGinnis M E, 1986, Prog Clin Biol Res, V210, P231; Nishimura KY, 1996, J CELL SCI, V109, P199; Nuccitelli R, 2011, WOUND REPAIR REGEN, V19, P645, DOI 10.1111/j.1524-475X.2011.00723.x; Odorisio T, 2006, J DERMATOL SCI, V41, P11, DOI 10.1016/j.jdermsci.2005.08.008; Odorisio T, 2002, J CELL SCI, V115, P2559; Petrofsky J., 2008, Journal of Medical Engineering & Technology, V32, P485, DOI 10.1080/03091900701574407; Pullar CE, 2011, BIOL EFF ELECTROMAGN, P1; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Sebastian A, 2015, J INVEST DERMATOL, V135, P1166, DOI 10.1038/jid.2014.502; Sebastian A, 2011, WOUND REPAIR REGEN, V19, P693, DOI 10.1111/j.1524-475X.2011.00736.x; Sebastian A, 2011, EXP DERMATOL, V20, P64, DOI 10.1111/j.1600-0625.2010.01150.x; Suh H, 2009, DIABETES TECHNOL THE, V11, P315, DOI 10.1089/dia.2008.0092; Syeda MM, 2012, AM J PATHOL, V181, P334, DOI 10.1016/j.ajpath.2012.03.012; Ud-Din S, 2012, EXP DERMATOL, V21, P758, DOI 10.1111/exd.12005; Varol AL, 2010, ARCH DERMATOL RES, V302, P383, DOI 10.1007/s00403-010-1043-6	43	79	81	6	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124502	10.1371/journal.pone.0124502	http://dx.doi.org/10.1371/journal.pone.0124502			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928356	Green Published, gold, Green Submitted			2022-12-27	WOS:000353713100034
J	Weiss, JD; Cotterill, FPD; Schliewen, UK				Weiss, Juliane D.; Cotterill, Fenton P. D.; Schliewen, Ulrich K.			Lake Tanganyika-A 'Melting Pot' of Ancient and Young Cichlid Lineages (Teleostei: Cichlidae)?	PLOS ONE			English	Article							SHORT INTERSPERSED ELEMENTS; AFRICAN RIFT SYSTEM; MITOCHONDRIAL PHYLOGENY; ADAPTIVE RADIATION; EXPLOSIVE SPECIATION; EVOLUTIONARY RELATIONSHIPS; MOLECULAR EVOLUTION; MAXIMUM-LIKELIHOOD; NUCLEAR SEQUENCES; FISHES	A long history of research focused on the East Africa cichlid radiations (EAR) revealed discrepancies between mtDNA and nuclear phylogenies, suggesting that interspecific hybridisation may have been significant during the radiation of these fishes. The approximately 250 cichlid species of Lake Tanganyika have their roots in a monophyletic African cichlid assemblage, but controversies remain about the precise phylogenetic origin and placement of different lineages and consequently about L. Tanganyika colonization scenarios. 3312 AFLP loci and the mitochondrial ND2 gene were genotyped for 91 species representing almost all major lacustrine and riverine haplotilapiine east African cichlid lineages with a focus on L. Tanganyika endemics. Explicitly testing for the possibility of ancient hybridisation events, a comprehensive phylogenetic network hypothesis is proposed for the origin and diversification of L. Tanganyika cichlids. Inference of discordant phylogenetic signal strongly suggests that the genomes of two endemic L. Tanganyika tribes, Eretmodini and Tropheini, are composed of an ancient mixture of riverine and lacustrine lineages. For the first time a strong monophyly signal of all non-haplochromine mouthbrooding species endemic to L. Tanganyika ("ancient mouthbrooders") was detected. Further, in the genomes of early diverging L. Tanganyika endemics Trematocarini, Bathybatini, Hemibatini and Boulengerochromis genetic components of other lineages belonging to the East African Radiation appear to be present. In combination with recent palaeo-geological results showing that tectonic activity in the L. Tanganyika region resulted in highly dynamic and heterogeneous landscape evolution over the Neogene and Pleistocene, the novel phylogenetic data render a single lacustrine basin as the geographical cradle of the endemic L. Tanganyika cichlid lineages unlikely. Instead a scenario of a pre-rift origin of several independent L. Tanganyika precursor lineages which diversified in ancient rivers and precursor lakes and then amalgamated in the extant L. Tanganyika basin is put forward as an alternative: the 'melting pot Tanganyika' hypothesis.	[Weiss, Juliane D.; Schliewen, Ulrich K.] Bavarian State Collect Zool, Dept Ichthyol, D-81247 Munich, Germany; [Cotterill, Fenton P. D.] Univ Stellenbosch, Dept Bot & Zool, Geoecodynam Res Hub, ZA-7602 Stellenbosch, South Africa	Stellenbosch University	Schliewen, UK (corresponding author), Bavarian State Collect Zool, Dept Ichthyol, Munchhausenstr 21, D-81247 Munich, Germany.	schliewen@zsm.mwn.de			Deutsche Forschungsgemeinschaft DFG [SCHL567/4]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft DFG (www.dfg.de) grant# SCHL567/4 to UKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], TRACER V1 6; Anseeuw Dieter, 2012, Int J Evol Biol, V2012, P865603, DOI 10.1155/2012/865603; Azuma Y, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-215; BANISTER KE, 1980, J NAT HIST, V14, P483, DOI 10.1080/00222938000770421; Bauer FU, 2010, INT J EARTH SCI, V99, P1575, DOI 10.1007/s00531-010-0549-7; Brandstatter A, 2005, MOL PHYLOGENET EVOL, V34, P382, DOI 10.1016/j.ympev.2004.10.019; Burgess CF, 1988, TRIASSIC JURASSIC RI, P859; Capart A, 1949, SONDAGES CARTE BATHM, V2; Clabaut C, 2005, J MOL EVOL, V61, P666, DOI 10.1007/s00239-004-0217-2; COHEN AS, 1993, GEOLOGY, V21, P511, DOI 10.1130/0091-7613(1993)021<0511:ETAOFO>2.3.CO;2; Cohen AS, 1997, BASIN RES, V9, P107, DOI 10.1046/j.1365-2117.1997.00038.x; Coulter G.W., 1991, P151; Day JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001730; De Vos Luc, 1998, Ichthyological Exploration of Freshwaters, V9, P371; Dixon CJ, 2009, MOL PHYLOGENET EVOL, V50, P74, DOI 10.1016/j.ympev.2008.10.009; Duftner N, 2005, J MOL EVOL, V60, P277, DOI 10.1007/s00239-004-0017-8; Dunz AR, 2013, MOL PHYLOGENET EVOL, V68, P64, DOI 10.1016/j.ympev.2013.03.015; Dunz AR., 2013, THESIS LUDWIG MAXIMI; Egger B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-137; Farias IP, 1999, J MOL EVOL, V48, P703, DOI 10.1007/PL00006514; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Friedman M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1733; Genner MJ, 2007, MOL BIOL EVOL, V24, P1269, DOI 10.1093/molbev/msm050; Genner MJ, 2012, MOL BIOL EVOL, V29, P195, DOI 10.1093/molbev/msr183; Goodier SAM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028775; Greenwood P.H., 1980, Bulletin of the British Museum (Natural History) Zoology, V38, P159; Greenwood PH, 1980, BRIT MUSEUM NATURAL, DOI [10.1099/ijs.0.045906-0, DOI 10.1099/IJS.0.045906-0]; Haldemann EG, 1969, GEOLOGICAL PHYSIOGRA, P20; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Herder F, 2006, P R SOC B, V273, P2209, DOI 10.1098/rspb.2006.3558; HOOGERHOUD RJC, 1984, NETH J ZOOL, V34, P539, DOI 10.1163/002829684X00281; Huelsenbeck JP, 2005, STAT BIOL HEALTH, P183, DOI 10.1007/0-387-27733-1_7; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Joyce DA, 2005, NATURE, V435, P90, DOI 10.1038/nature03489; Joyce DA, 2011, CURR BIOL, V21, pR108, DOI 10.1016/j.cub.2010.11.029; Kirchberger PC, 2014, MOL PHYLOGENET EVOL, V70, P57, DOI 10.1016/j.ympev.2013.09.005; Kirchberger Paul C, 2012, Int J Evol Biol, V2012, P716209, DOI 10.1155/2012/716209; Klett V, 2002, MOL BIOL EVOL, V19, P865, DOI 10.1093/oxfordjournals.molbev.a004144; Koblmuller S, 2008, HYDROBIOLOGIA, V615, P5, DOI 10.1007/s10750-008-9552-4; Koblmuller S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-7; Koblmuller S, 2007, MOL PHYLOGENET EVOL, V44, P1295, DOI 10.1016/j.ympev.2007.02.010; Koblmuller S, 2010, MOL PHYLOGENET EVOL, V55, P318, DOI 10.1016/j.ympev.2009.09.032; Koblmuller S, 2005, J MOL EVOL, V60, P297, DOI 10.1007/s00239-004-0033-8; Koblmuller S, 2004, J MOL EVOL, V58, P79, DOI 10.1007/s00239-003-2527-1; Kocher TD, 1995, MOL PHYLOGENET EVOL, V4, P420, DOI 10.1006/mpev.1995.1039; Kullander SO, 2011, ICHTHYOL EXPLOR FRES, V22, P355; Lezzar KE, 2002, AAPG BULL, V86, P1027; LINK W, 1995, THEOR APPL GENET, V90, P27, DOI 10.1007/BF00220992; Loh YHE, 2013, MOL BIOL EVOL, V30, P906, DOI 10.1093/molbev/mss326; Macgregor D, 2015, J AFR EARTH SCI, V101, P232, DOI 10.1016/j.jafrearsci.2014.09.016; McMahan CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071162; Meyer BS, 2015, MOL PHYLOGENET EVOL, V83, P56, DOI 10.1016/j.ympev.2014.10.009; Moore JES, 1903, GEOGR J, V21, P682, DOI 10.2307/1775673; Murray AM, 2001, BIOL J LINN SOC, V74, P517, DOI 10.1006/bijl.2001.0599; Muschick M, 2012, CURR BIOL, V22, P2362, DOI 10.1016/j.cub.2012.10.048; Musilova Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065047; Neumann Dirk, 2010, Abc Taxa, V8, P587; Nevado B, 2009, MOL ECOL, V18, P4240, DOI 10.1111/j.1365-294X.2009.04348.x; NISHIDA M, 1991, EXPERIENTIA, V47, P974, DOI 10.1007/BF01929896; Partridge TC., 2010, CENOZOIC MAMMALS AFR, P3, DOI DOI 10.1525/CALIFORNIA/9780520257214.003.0001; POLL M, 1986, Academie Royale de Belgique Memoires de la Classe des Sciences Collection in Octavo, V45, P1; Roller S, 2010, INT J EARTH SCI, V99, P1643, DOI 10.1007/s00531-010-0560-z; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruber L, 2001, MOL ECOL, V10, P1207, DOI 10.1046/j.1365-294X.2001.01259.x; Salzburger W, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-17; Salzburger W, 2002, SYST BIOL, V51, P113, DOI 10.1080/106351502753475907; Salzburger W, 2002, MOL ECOL, V11, P619, DOI 10.1046/j.0962-1083.2001.01438.x; SANDER S, 1989, J AFR EARTH SCI, V8, P323, DOI 10.1016/S0899-5362(89)80031-4; Schelly R, 2006, MOL PHYLOGENET EVOL, V38, P426, DOI 10.1016/j.ympev.2005.04.023; Schliewen Ulrich K., 2004, Frontiers in Zoology, V1, P1; Schliewen Ulrich K., 2003, Ichthyological Exploration of Freshwaters, V14, P61; SCHOLZ CA, 1988, SCIENCE, V240, P1645, DOI 10.1126/science.240.4859.1645; Schwarzer J, 2012, J EVOLUTION BIOL, V25, P138, DOI 10.1111/j.1420-9101.2011.02409.x; Schwarzer J, 2012, P ROY SOC B-BIOL SCI, V279, P4389, DOI 10.1098/rspb.2012.1667; Schwarzer J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022380; Schwarzer J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-186; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Seehausen O, 2006, P ROY SOC B-BIOL SCI, V273, P1987, DOI 10.1098/rspb.2006.3539; Sepulchre P, 2006, SCIENCE, V313, P1419, DOI 10.1126/science.1129158; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Smith SA, 2008, BIOINFORMATICS, V24, P715, DOI 10.1093/bioinformatics/btm619; Spiegel C, 2007, GEOLOGY, V35, P427, DOI 10.1130/G23108A.1; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stiassny M.L.J., 1991, CICHLID FISHES BEHAV, P1; STIASSNY MLJ, 1987, J NAT HIST, V21, P1311, DOI 10.1080/00222938700770811; Streelman JT, 1998, MOL BIOL EVOL, V15, P798, DOI 10.1093/oxfordjournals.molbev.a025985; STURMBAUER C, 1994, MOL BIOL EVOL, V11, P691; STURMBAUER C, 1993, MOL BIOL EVOL, V10, P751; Sturmbauer C, 1998, J FISH BIOL, V53, P18; Sturmbauer C, 2003, HYDROBIOLOGIA, V500, P51, DOI 10.1023/A:1024680201436; Sturmbauer C, 2010, MOL PHYLOGENET EVOL, V57, P266, DOI 10.1016/j.ympev.2010.06.018; Sturrock K., 2000, FIELD METHOD, V12, P49, DOI DOI 10.1177/1525822X0001200104; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Takahashi K, 1998, MOL BIOL EVOL, V15, P391, DOI 10.1093/oxfordjournals.molbev.a025936; Takahashi K, 2002, MOL BIOL EVOL, V19, P1303, DOI 10.1093/oxfordjournals.molbev.a004191; Takahashi K, 2001, MOL BIOL EVOL, V18, P2057, DOI 10.1093/oxfordjournals.molbev.a003747; Takahashi R, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-195; Takahashi T, 2003, ICHTHYOL RES, V50, P367, DOI 10.1007/s10228-003-0181-7; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Terai Y, 2004, J MOL EVOL, V58, P64, DOI 10.1007/s00239-003-2526-2; Terai Y, 2003, MOL BIOL EVOL, V20, P924, DOI 10.1093/molbev/msg104; Tiercelin JJ, 1991, GEOLOGY TANGANYIKA T, P7; Tukey JW, 1977, READ MA, V231; VANDEPEER Y, 1994, COMPUT APPL BIOSCI, V10, P569; Vences M, 2001, J BIOGEOGR, V28, P1091, DOI 10.1046/j.1365-2699.2001.00624.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Won YJ, 2006, MOL BIOL EVOL, V23, P828, DOI 10.1093/molbev/msj101; Won YJ, 2005, P NATL ACAD SCI USA, V102, P6581, DOI 10.1073/pnas.0502127102	110	28	28	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125043	10.1371/journal.pone.0125043	http://dx.doi.org/10.1371/journal.pone.0125043			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928886	Green Published, Green Submitted, gold			2022-12-27	WOS:000353713100060
J	Zhong, T; Guo, QL; Zou, WY; Zhu, XY; Song, ZB; Sun, B; He, X; Yang, Y				Zhong, Tao; Guo, Qulian; Zou, Wangyuan; Zhu, Xiaoyan; Song, Zongbin; Sun, Bei; He, Xin; Yang, Yong			Neonatal Isoflurane Exposure Induces Neurocognitive Impairment and Abnormal Hippocampal Histone Acetylation in Mice	PLOS ONE			English	Article							IMMEDIATE-EARLY GENES; C-FOS EXPRESSION; DEACETYLASE INHIBITORS; CONTEXTUAL FEAR; MEMORY CONSOLIDATION; ALZHEIMERS-DISEASE; MOUSE MODEL; NEURODEGENERATION; ACTIVATION; BRAIN	Background Neonatal exposure to isoflurane may induce long-term memory impairment in mice. Histone acetylation is an important form of chromatin modification that regulates the transcription of genes required for memory formation. This study investigated whether neonatal isoflurane exposure-induced neurocognitive impairment is related to dysregulated histone acetylation in the hippocampus and whether it can be attenuated by the histone deacetylase (HDAC) inhibitor trichostatin A (TSA). Methods C57BL/6 mice were exposed to 0.75% isoflurane three times (each for 4 h) at postnatal days 7, 8, and 9. Contextual fear conditioning (CFC) was tested at 3 months after anesthesia administration. TSA was intraperitoneally injected 2 h before CFC training. Hippocampal histone acetylation levels were analyzed following CFC training. Levels of the neuronal activation and synaptic plasticity marker c-Fos were investigated at the same time point. Results Mice that were neonatally exposed to isoflurane showed significant memory impairment on CFC testing. These mice also exhibited dysregulated hippocampal H4K12 acetylation and decreased c-Fos expression following CFC training. TSA attenuated isoflurane-induced memory impairment and simultaneously increased histone acetylation and c-Fos levels in the hippocampal cornu ammonis (CA) 1 area 1 h after CFC training. Conclusions Memory impairment induced by repeated neonatal exposure to isoflurane is associated with dysregulated histone H4K12 acetylation in the hippocampus, which probably affects downstream c-Fos gene expression following CFC training. The HDAC inhibitor TSA	[Zhong, Tao; Guo, Qulian; Zou, Wangyuan; Zhu, Xiaoyan; Song, Zongbin; Sun, Bei; He, Xin; Yang, Yong] Cent South Univ, Xiangya Hosp, Dept Anesthesiol, Changsha, Hunan, Peoples R China	Central South University	Yang, Y (corresponding author), Cent South Univ, Xiangya Hosp, Dept Anesthesiol, Changsha, Hunan, Peoples R China.	YangYong84327411@gmail.com	Song, Zongbin/GYD-5863-2022	Song, Zongbin/0000-0002-0447-8648; Zhong, Tao/0000-0002-6991-2521	Natural Science Foundation of China [81171053]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (No. 81171053; http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Antoine B, 2014, BRAIN STRUCT FUNCT, V219, P415, DOI 10.1007/s00429-013-0505-y; Bekinschtein P, 2010, NEUROTOX RES, V18, P377, DOI 10.1007/s12640-010-9155-5; Bester H, 2000, J COMP NEUROL, V428, P45, DOI 10.1002/1096-9861(20001204)428:1<45::AID-CNE5>3.0.CO;2-A; Bissiere S, 2011, SCIENCE, V331, P87, DOI 10.1126/science.1193785; Bousiges O, 2010, NEUROPSYCHOPHARMACOL, V35, P2521, DOI 10.1038/npp.2010.117; Calfa G, 2012, HIPPOCAMPUS, V22, P1493, DOI 10.1002/hipo.20990; Chen PS, 2007, NEUROSCIENCE, V149, P203, DOI 10.1016/j.neuroscience.2007.06.053; da Silva PF, 2012, NEUROSCIENCE, V200, P42, DOI 10.1016/j.neuroscience.2011.10.038; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Fabianova K, 2014, BEHAV BRAIN RES, V265, P38, DOI 10.1016/j.bbr.2014.01.023; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Flick RP, 2011, PEDIATRICS, V128, pE1053, DOI 10.1542/peds.2011-0351; Fontan-Lozano A, 2008, MOL CELL NEUROSCI, V39, P193, DOI 10.1016/j.mcn.2008.06.009; Francis YI, 2009, J ALZHEIMERS DIS, V18, P131, DOI 10.3233/JAD-2009-1134; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Goshen I, 2011, CELL, V147, P678, DOI 10.1016/j.cell.2011.09.033; Green KN, 2008, J NEUROSCI, V28, P11500, DOI 10.1523/JNEUROSCI.3203-08.2008; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Guzowski JF, 2002, HIPPOCAMPUS, V12, P86, DOI 10.1002/hipo.10010; Haettig J, 2011, LEARN MEMORY, V18, P71, DOI 10.1101/lm.1986911; Hall J, 2001, J NEUROSCI, V21, P2186, DOI 10.1523/JNEUROSCI.21-06-02186.2001; Holahan MR, 2004, BEHAV BRAIN RES, V152, P109, DOI 10.1016/j.bbr.2003.09.031; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Itzhak Y, 2012, NEUROBIOL LEARN MEM, V97, P409, DOI 10.1016/j.nlm.2012.03.005; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; KACZMAREK L, 1993, J NEUROSCI RES, V34, P377, DOI 10.1002/jnr.490340402; Kilgore M, 2010, NEUROPSYCHOPHARMACOL, V35, P870, DOI 10.1038/npp.2009.197; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kovacs KJ, 2008, J NEUROENDOCRINOL, V20, P665, DOI 10.1111/j.1365-2826.2008.01734.x; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Liang G, 2010, ANESTHESIOLOGY, V112, P1325, DOI 10.1097/ALN.0b013e3181d94da5; Loebrich S, 2009, PHYSIOL REV, V89, P1079, DOI 10.1152/physrev.00013.2009; Loepke AW, 2009, ANESTH ANALG, V108, P90, DOI 10.1213/ane.0b013e31818cdb29; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; McQuown SC, 2011, J NEUROSCI, V31, P764, DOI 10.1523/JNEUROSCI.5052-10.2011; Ming Z, 2001, BRAIN RES, V920, P117, DOI 10.1016/S0006-8993(01)03044-X; Misane I, 2013, BEHAV BRAIN RES, V238, P160, DOI 10.1016/j.bbr.2012.10.027; Murphy M, 2004, FRONT BIOSCI-LANDMRK, V9, P40, DOI 10.2741/1203; Neely KE, 2002, BBA-REV CANCER, V1603, P19, DOI 10.1016/S0304-419X(02)00067-7; Olney JW, 2004, TRENDS PHARMACOL SCI, V25, P135, DOI 10.1016/j.tips.2004.01.002; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Peter M, 2012, GENES BRAIN BEHAV, V11, P314, DOI 10.1111/j.1601-183X.2011.00761.x; Petrof I, 2010, BEHAV BRAIN RES, V211, P248, DOI 10.1016/j.bbr.2010.03.045; Radulovic J, 1998, J NEUROSCI, V18, P7452; Rahn EJ, 2013, NEUROBIOL LEARN MEM, V105, P133, DOI 10.1016/j.nlm.2013.06.008; Santin LJ, 2003, PHYSIOL BEHAV, V78, P733, DOI 10.1016/S0031-9384(03)00060-X; Stratmann G, 2010, ANESTHESIOLOGY, V112, P305, DOI 10.1097/ALN.0b013e3181ca33a1; Stratmann G, 2009, ANESTHESIOLOGY, V110, P834, DOI 10.1097/ALN.0b013e31819c463d; Tischmeyer W, 1999, CELL MOL LIFE SCI, V55, P564, DOI 10.1007/s000180050315; Turner BM, 2005, NAT STRUCT MOL BIOL, V12, P110, DOI 10.1038/nsmb0205-110; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Wilder RT, 2009, ANESTHESIOLOGY, V110, P796, DOI 10.1097/01.anes.0000344728.34332.5d; Zhang L, 2013, MINI-REV MED CHEM, V13, P1999, DOI 10.2174/13895575113136660102; Zhong T, 2014, BRIT J ANAESTH, V113, P634, DOI 10.1093/bja/aeu184	56	27	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125815	10.1371/journal.pone.0125815	http://dx.doi.org/10.1371/journal.pone.0125815			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928815	Green Published, Green Submitted, gold			2022-12-27	WOS:000353713100119
J	Hong, D; Li, LF; Gao, HC; Wang, X; Li, CC; Luo, Y; Bai, YP; Zhang, GG				Hong, Dan; Li, Ling-Fang; Gao, Hai-Chao; Wang, Xiang; Li, Chuan-Chang; Luo, Ying; Bai, Yong-Ping; Zhang, Guo-Gang			High-Density Lipoprotein Prevents Endoplasmic Reticulum Stress-Induced Downregulation of Liver LOX-1 Expression	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; APOPTOSIS; ER	Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) is a specific cell-surface receptor for oxidized-low-density lipoprotein (ox-LDL). The impact of high-density lipoprotein (HDL) on endoplasmic reticulum (ER) stress-mediated alteration of the LOX-1 level in hepatocytes remains unclear. We aimed to investigate the impact on LOX-1 expression by tunicamycin (TM)-induced ER stress and to determine the effect of HDL on TM-affected LOX-1 expression in hepatic L02 cells. Overexpression or silencing of related cellular genes was conducted in TM-treated cells. mRNA expression was evaluated using real-time polymerase chain reaction (PCR). Protein expression was analyzed by western blot and immunocytochemistry. Lipid uptake was examined by DiI-ox-LDL, followed by flow cytometric analysis. The results showed that TM induced the upregulation of ER chaperone GRP78, downregulation of LOX-1 expression, and lipid uptake. Knock down of IRE1 or XBP-1 effectively restored LOX-1 expression and improved lipid uptake in TM-treated cells. HDL treatment prevented the negative impact on LOX-1 expression and lipid uptake induced by TM. Additionally, 1-10 mu g/mL HDL significantly reduced the GRP78, IRE1, and XBP-1 expression levels in TM-treated cells. Our findings reveal that HDL could prevent the TM-induced reduction of LOX-1 expression via inhibiting the IRE1/XBP-1 pathway, suggesting a new mechanism for beneficial roles of HDL in improving lipid metabolism.	[Hong, Dan; Li, Ling-Fang; Wang, Xiang; Zhang, Guo-Gang] Cent S Univ, Xiangya Hosp, Dept Cardiovasc Med, Changsha, Hunan, Peoples R China; [Gao, Hai-Chao] Chengde Med Coll, Affiliated Hosp, Dept Cardiovasc Med, Chengde, Hebei, Peoples R China; [Li, Chuan-Chang; Luo, Ying; Bai, Yong-Ping] Cent S Univ, Xiangya Hosp, Dept Geriatr Med, Changsha, Hunan, Peoples R China	Central South University; Chengde Medical University; Central South University	Bai, YP (corresponding author), Cent S Univ, Xiangya Hosp, Dept Geriatr Med, Changsha, Hunan, Peoples R China.	baiyongping200613@163.com; xyzgg2006@sina.com	yongping, Bai/HHZ-4785-2022		National Natural Science Foundation of China [81100089, 81170261]; Central South University Doctor's Innovation Project [2013zzts090]; China Postdoctoral Science Foundation [2012M521566]; 973 Program [2014CB542402]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Central South University Doctor's Innovation Project; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); 973 Program(National Basic Research Program of China)	This study was supported by the National Natural Science Foundation of China (No. 81100089 and No. 81170261) and the Central South University Doctor's Innovation Project (No. 2013zzts090). This project was also supported by the China Postdoctoral Science Foundation (No. 2012M521566) and 973 Program (No. 2014CB542402).	Assmann G, 2004, CIRCULATION, V109, P8, DOI 10.1161/01.CIR.0000131512.50667.46; Assmann G, 2003, ANNU REV MED, V54, P321, DOI 10.1146/annurev.med.54.101601.152409; Chen XP, 2007, VASC PHARMACOL, V47, P1, DOI 10.1016/j.vph.2007.01.004; Cherng YG, 2008, J ORTHOP RES, V26, P1018, DOI 10.1002/jor.20578; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Hong D, 2014, ATHEROSCLEROSIS, V235, P310, DOI 10.1016/j.atherosclerosis.2014.04.028; Hotamisligil GS, 2010, NAT MED, V16, P396, DOI 10.1038/nm0410-396; Ishigaki Y, 2008, CIRCULATION, V118, P75, DOI 10.1161/CIRCULATIONAHA.107.745174; Ishiyama J, 2011, J LIPID RES, V52, P299, DOI 10.1194/jlr.m007104; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Lee AH, 2009, CELL MOL LIFE SCI, V66, P2835, DOI 10.1007/s00018-009-0049-8; Muller C, 2011, CELL DEATH DIFFER, V18, P817, DOI 10.1038/cdd.2010.149; Muller C, 2011, AUTOPHAGY, V7, P541, DOI 10.4161/auto.7.5.15003; Musso G, 2011, AM J CLIN NUTR, V94, P1033, DOI 10.3945/ajcn.111.015610; Niculescu LS, 2013, BIOCHEM BIOPH RES CO, V434, P173, DOI 10.1016/j.bbrc.2013.03.050; Petremand J, 2012, DIABETES, V61, P1100, DOI 10.2337/db11-1221; Pirillo A, 2012, BIOCHEM BIOPH RES CO, V428, P230, DOI 10.1016/j.bbrc.2012.10.020; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Tabas I, 2010, CIRC RES, V107, P839, DOI 10.1161/CIRCRESAHA.110.224766; Terpstra V, 2000, ARTERIOSCL THROM VAS, V20, P1860, DOI 10.1161/01.ATV.20.8.1860; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Yan ML, 2011, CARDIOVASC DRUG THER, V25, P469, DOI 10.1007/s10557-011-6335-3; Yoshimoto R, 2011, CARDIOVASC DRUG THER, V25, P379, DOI 10.1007/s10557-011-6324-6; Zhang Q, 2014, J MOL ENDOCRINOL, V53, P281, DOI 10.1530/JME-14-0049	24	9	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124285	10.1371/journal.pone.0124285	http://dx.doi.org/10.1371/journal.pone.0124285			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923692	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600076
J	Ishikawa, S; Okamoto, S; Isogai, K; Akiyama, Y; Yanagihara, N; Yamada, Y				Ishikawa, Shun; Okamoto, Shogo; Isogai, Kaoru; Akiyama, Yasuhiro; Yanagihara, Naomi; Yamada, Yoji			Assessment of Robotic Patient Simulators for Training in Manual Physical Therapy Examination Techniques	PLOS ONE			English	Article							STRETCH REFLEX THRESHOLD; MODIFIED ASHWORTH SCALES; HAPTIC ELBOW SPASTICITY; LEG-ROBOT; RELIABILITY; ACCURACY; CHILDREN; HESS	Robots that simulate patients suffering from joint resistance caused by biomechanical and neural impairments are used to aid the training of physical therapists in manual examination techniques. However, there are few methods for assessing such robots. This article proposes two types of assessment measures based on typical judgments of clinicians. One of the measures involves the evaluation of how well the simulator presents different severities of a specified disease. Experienced clinicians were requested to rate the simulated symptoms in terms of severity, and the consistency of their ratings was used as a performance measure. The other measure involves the evaluation of how well the simulator presents different types of symptoms. In this case, the clinicians were requested to classify the simulated resistances in terms of symptom type, and the average ratios of their answers were used as performance measures. For both types of assessment measures, a higher index implied higher agreement among the experienced clinicians that subjectively assessed the symptoms based on typical symptom features. We applied these two assessment methods to a patient knee robot and achieved positive appraisals. The assessment measures have potential for use in comparing several patient simulators for training physical therapists, rather than as absolute indices for developing a standard.	[Ishikawa, Shun; Okamoto, Shogo; Akiyama, Yasuhiro; Yamada, Yoji] Nagoya Univ, Grad Sch Engn, Dept Mech Sci & Engn, Nagoya, Aichi 4648601, Japan; [Isogai, Kaoru] Tokoha Univ, Fac Hlth & Med Sci, Dept Phys Therapy, Hamamatsu, Shizuoka, Japan; [Yanagihara, Naomi] Nagoya Univ, Grad Sch Med, Dept Phys & Occupat Therapy, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University	Okamoto, S (corresponding author), Nagoya Univ, Grad Sch Engn, Dept Mech Sci & Engn, Nagoya, Aichi 4648601, Japan.	okamoto-shogo@nagoya-u.jp	Akiyama, Yasuhiro/AAV-6248-2021	Akiyama, Yasuhiro/0000-0002-4169-3734	Naito Science & Engineering Foundation	Naito Science & Engineering Foundation	This work was supported by Naito Science & Engineering Foundation (no grant number), http://www.naitozaidan.or.jp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohannon R. W., 1987, PHYS THER, V67, P206; Calota A, 2008, CLIN NEUROPHYSIOL, V119, P2329, DOI 10.1016/j.clinph.2008.07.215; Dietz V, 2007, LANCET NEUROL, V6, P725, DOI 10.1016/S1474-4422(07)70193-X; Fleuren JF, 2009, JOURNAL OF NEUROLOGY, V81, P1; Fujisawa T, 2007, INT C REHAB ROBOT, P48, DOI 10.1109/ICORR.2007.4428405; Grow DI, 2008, SYMPOSIUM ON HAPTICS INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS 2008, PROCEEDINGS, P475; Ishikawa S., 2012, Proceedings of the 2012 IEEE International Conference on Robotics and Biomimetics (ROBIO), P1409, DOI 10.1109/ROBIO.2012.6491166; Ishikawa S, 2013, 2013 IEEE/SICE INTERNATIONAL SYMPOSIUM ON SYSTEM INTEGRATION (SII), P300, DOI 10.1109/SII.2013.6776731; Jobin A, 2000, DEV MED CHILD NEUROL, V42, P531, DOI 10.1017/S0012162200001018; Kaya T, 2011, INT J REHABIL RES, V34, P59, DOI 10.1097/MRR.0b013e32833d6cdf; Kikuchi T, 2010, J INTEL MAT SYST STR, V21, P1523, DOI 10.1177/1045389X10367838; Kikuchi T, 2010, ADV ROBOTICS, V24, P671, DOI 10.1163/016918610X493534; Kim J, 2011, IEEE ENG MED BIO, P8527, DOI 10.1109/IEMBS.2011.6092104; McCrea PH, 2003, J NEUROSCI METH, V128, P121, DOI 10.1016/S0165-0270(03)00169-9; Mehrholz J, 2005, CLIN REHABIL, V19, P751, DOI 10.1191/0269215505cr889oa; Mehrholz J, 2005, CLIN REHABIL, V19, P63, DOI 10.1191/0269215505cr824oa; Morita Y, 2011, P INT WORKSH ROB MOT, P393; Mouri T, 2008, J ROBOT MECHATRON, V20, P280, DOI 10.20965/jrm.2008.p0280; Mutlu A, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-44; Okumura H, 2013, PROC SICE ANN CONF, P2272; Pandyan AD, 1999, CLIN REHABIL, V13, P373, DOI 10.1191/026921599677595404; Park HS, 2012, IEEE T NEUR SYS REH, V20, P361, DOI 10.1109/TNSRE.2012.2195330; POWERS RK, 1988, ANN NEUROL, V23, P115, DOI 10.1002/ana.410230203; Stebbins GT, 1998, MOVEMENT DISORD, V13, P633, DOI 10.1002/mds.870130404; Takhashi Y., 2011, P IEEE INT C REH ROB, P1; Urban PP, 2010, STROKE, V41, P2016, DOI 10.1161/STROKEAHA.110.581991; Wakura S, 2006, Patient simulating robot for rehabilitation education and rehabilitation education method, Patent No. [JP2006204832 (A), 2006204832]; Wissel J, 2013, NEUROLOGY, V80, pS13, DOI 10.1212/WNL.0b013e3182762448	28	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0126392	10.1371/journal.pone.0126392	http://dx.doi.org/10.1371/journal.pone.0126392			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923719	Green Published, gold, Green Submitted			2022-12-27	WOS:000353711600174
J	Martinez, A; Sese, M; Losa, JH; Robichaud, N; Sonenberg, N; Aasen, T; Cajal, SRY				Martinez, Alba; Sese, Marta; Hernandez Losa, Javier; Robichaud, Nathaniel; Sonenberg, Nahum; Aasen, Trond; Ramon y Cajal, Santiago			Phosphorylation of eIF4E Confers Resistance to Cellular Stress and DNA-Damaging Agents through an Interaction with 4E-T: A Rationale for Novel Therapeutic Approaches	PLOS ONE			English	Article							INITIATION-FACTOR 4E; CAP-BINDING PROTEIN; MAMMARY EPITHELIAL-CELLS; TRANSLATION FACTOR EIF4E; MESSENGER-RNA; BREAST-CANCER; MALIGNANT-TRANSFORMATION; 4E-BINDING PROTEIN-1; FACTOR EIF-4E; SURVIVAL	Phosphorylation of the eukaryotic translation initiation factor eIF4E is associated with malignant progression and poor cancer prognosis. Accordingly, here we have analyzed the association between eIF4E phosphorylation and cellular resistance to oxidative stress, starvation, and DNA-damaging agents in vitro. Using immortalized and cancer cell lines, retroviral expression of a phosphomimetic (S209D) form of eIF4E, but not phospho-dead (S209A) eIF4E or GFP control, significantly increased cellular resistance to stress induced by DNA-damaging agents (cisplatin), starvation (glucose+glutamine withdrawal), and oxidative stress (arsenite). De novo accumulation of eIF4E-containing cytoplasmic bodies colocalizing with the eIF4E-binding protein 4E-T was observed after expression of phosphomimetic S209D, but not S209A or wild-type eIF4E. Increased resistance to cellular stress induced by eIF4E-S209D was lost upon knockdown of endogenous 4E-T or use of an eIF4E-W73A-S209D mutant unable to bind 4E-T. Cancer cells treated with the Mnk1/2 inhibitor CGP57380 to prevent eIF4E phosphorylation and mouse embryonic fibroblasts derived from Mnk1/2 knockout mice were also more sensitive to arsenite and cisplatin treatment. Polysome analysis revealed an 80S peak 2 hours after arsenite treatment in cells over-expressing phosphomimetic eIF4E, indicating translational stalling. Nonetheless, a selective increase was observed in the synthesis of some proteins (cyclin D1, HuR, and Mcl-1). We conclude that phosphorylation of eIF4E confers resistance to various cell stressors and that a direct interaction or regulation of 4E-T by eIF4E is required. Further delineation of this process may identify novel therapeutic avenues for cancer treatment, and these results support the use of modern Mnk1/2 inhibitors in conjunction with standard therapy.	[Martinez, Alba; Sese, Marta; Aasen, Trond; Ramon y Cajal, Santiago] Univ Autonoma Barcelona, VHIR, Hosp Univ Vall Hebron, Mol Pathol, E-08193 Barcelona, Spain; [Hernandez Losa, Javier; Ramon y Cajal, Santiago] Vall Hebron Univ Hosp, Dept Pathol, Barcelona, Spain; [Robichaud, Nathaniel; Sonenberg, Nahum] McGill Univ, Goodman Canc Res Ctr, Dept Biochem, Montreal, PQ, Canada	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Hospital Universitari Vall d'Hebron; McGill University	Aasen, T (corresponding author), Univ Autonoma Barcelona, VHIR, Hosp Univ Vall Hebron, Mol Pathol, E-08193 Barcelona, Spain.	trond.aasen@vhir.org; sramon@vhebron.net	Aasen, Trond/B-5279-2013; Ramon y Cajal, Santiago/H-4955-2016; Javier, Hernandez Losa/C-1173-2008; Sese, Marta/AAH-9749-2021	Aasen, Trond/0000-0003-0763-2695; Ramon y Cajal, Santiago/0000-0002-3867-1390; Javier, Hernandez Losa/0000-0003-1526-3201; Sese, Marta/0000-0003-1473-4833; Robichaud, Nathaniel/0000-0002-7653-0767	Fondo de Investigaciones Sanitarias [PI 11/00185, RD09/0076/00066]; Mutua Madrilena [FMMA/2011/11]; Redes Tematicas de Investigacion Cooperativa en Salud [RD06/0020/0104]; Generalitat de Catalunya [2009SGR756]; Instituto de Salud Carlos III [CP10/00624]; European Regional Development Fund (ERDF) [PI13/00763]	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Mutua Madrilena; Redes Tematicas de Investigacion Cooperativa en Salud; Generalitat de Catalunya(Generalitat de Catalunya); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Regional Development Fund (ERDF)(European Commission)	SRC is funded by the following grants: Fondo de Investigaciones Sanitarias (PI 11/00185, RD09/0076/00066), Mutua Madrilena (FMMA/2011/11), Redes Tematicas de Investigacion Cooperativa en Salud (Ref. RD06/0020/0104), and Generalitat de Catalunya (Ref. 2009SGR756). TA is funded by Instituto de Salud Carlos III, grant CP10/00624 and grant PI13/00763 co-financed by the European Regional Development Fund (ERDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2010, NAT PROTOC, V5, P371, DOI 10.1038/nprot.2009.241; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Armengol G, 2007, CANCER RES, V67, P7551, DOI 10.1158/0008-5472.CAN-07-0881; Avdulov S, 2004, CANCER CELL, V5, P553, DOI 10.1016/j.ccr.2004.05.024; Bilanges B, 2007, ONCOGENE, V26, P5973, DOI 10.1038/sj.onc.1210431; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Cargnello M, 2012, MOL CELL BIOL, V32, P4572, DOI 10.1128/MCB.00544-12; Castellvi J, 2006, CANCER-AM CANCER SOC, V107, P1801, DOI 10.1002/cncr.22195; Chen YC, 1998, J CELL PHYSIOL, V177, P324, DOI 10.1002/(SICI)1097-4652(199811)177:2<324::AID-JCP14>3.0.CO;2-9; Chen YJ, 2010, NUCLEIC ACIDS RES, V38, P764, DOI 10.1093/nar/gkp1034; Clemens MJ, 1999, INT J BIOCHEM CELL B, V31, P1, DOI 10.1016/S1357-2725(98)00127-7; Culjkovic B, 2006, J CELL BIOL, V175, P415, DOI 10.1083/jcb.200607020; DEBENEDETTI A, 1990, P NATL ACAD SCI USA, V87, P8212, DOI 10.1073/pnas.87.21.8212; Dong K, 2009, BREAST CANCER RES TR, V113, P443, DOI 10.1007/s10549-008-9956-x; Dostie J, 2000, EMBO J, V19, P3142, DOI 10.1093/emboj/19.12.3142; Dostie J, 2000, J CELL BIOL, V148, P239, DOI 10.1083/jcb.148.2.239; DUNCAN R, 1987, J BIOL CHEM, V262, P380; Duncan RF, 2003, BIOCHEM J, V369, P213, DOI 10.1042/BJ20020435; FLYNN A, 1995, J BIOL CHEM, V270, P21684, DOI 10.1074/jbc.270.37.21684; Fraser CS, 1999, BIOCHEM J, V342, P519, DOI 10.1042/0264-6021:3420519; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; Furic L, 2010, P NATL ACAD SCI USA, V107, P14134, DOI 10.1073/pnas.1005320107; Herdy B, 2012, NAT IMMUNOL, V13, P543, DOI 10.1038/ni.2291; Hong DS, 2011, CLIN CANCER RES, V17, P6582, DOI 10.1158/1078-0432.CCR-11-0430; JOSHI B, 1995, J BIOL CHEM, V270, P14597, DOI 10.1074/jbc.270.24.14597; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; KEREKATTE V, 1995, INT J CANCER, V64, P27, DOI 10.1002/ijc.2910640107; Konicek BW, 2011, CANCER RES, V71, P1849, DOI 10.1158/0008-5472.CAN-10-3298; Kubacka D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072761; Larsson O, 2007, CANCER RES, V67, P6814, DOI 10.1158/0008-5472.CAN-07-0752; LAZARISKARATZAS A, 1992, GENE DEV, V6, P1631, DOI 10.1101/gad.6.9.1631; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; McInerney GM, 2005, MOL BIOL CELL, V16, P3753, DOI 10.1091/mbc.E05-02-0124; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; Patel J, 2002, EUR J BIOCHEM, V269, P3076, DOI 10.1046/j.1432-1033.2002.02992.x; Pons B, 2011, INT J ONCOL, V39, P1337, DOI 10.3892/ijo.2011.1118; Robichaud N, ONCOGENE; Rojo F, 2007, CLIN CANCER RES, V13, P81, DOI 10.1158/1078-0432.CCR-06-1560; Rousseau D, 1996, P NATL ACAD SCI USA, V93, P1065, DOI 10.1073/pnas.93.3.1065; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Scheper GC, 2002, EUR J BIOCHEM, V269, P5350, DOI 10.1046/j.1432-1033.2002.03291.x; Slepenkov SV, 2006, J BIOL CHEM, V281, P14927, DOI 10.1074/jbc.M601653200; Sonenberg N, 1998, CURR OPIN CELL BIOL, V10, P268, DOI 10.1016/S0955-0674(98)80150-6; Stead RL, 2013, FEBS LETT, V587, P2623, DOI 10.1016/j.febslet.2013.06.045; Topisirovic I, 2004, CANCER RES, V64, P8639, DOI 10.1158/0008-5472.CAN-04-2677; Topisirovic I, 2009, MOL CELL BIOL, V29, P1152, DOI 10.1128/MCB.01532-08; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Volpon L, 2013, BIOCHEM BIOPH RES CO, V434, P614, DOI 10.1016/j.bbrc.2013.03.125; Walsh D, 2004, GENE DEV, V18, P660, DOI 10.1101/gad.1185304; Wang XR, 2007, MOL CELL BIOL, V27, P7405, DOI 10.1128/MCB.00760-07; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Wendel HG, 2007, GENE DEV, V21, P3232, DOI 10.1101/gad.1604407; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Wheater MJ, 2010, CANCER BIOL THER, V10, P728, DOI 10.4161/cbt.10.7.12965; Yoshizawa A, 2010, CLIN CANCER RES, V16, P240, DOI 10.1158/1078-0432.CCR-09-0986; Zhou FF, 2011, MED ONCOL, V28, P1302, DOI 10.1007/s12032-010-9630-0	56	29	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123352	10.1371/journal.pone.0123352	http://dx.doi.org/10.1371/journal.pone.0123352			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923732	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600042
J	Posthumus, EE; Koprowski, JL; Steidl, RJ				Posthumus, Erin E.; Koprowski, John L.; Steidl, Robert J.			Red Squirrel Middens Influence Abundance but Not Diversity of Other Vertebrates	PLOS ONE			English	Article							POPULATION; COMMUNITY; HABITAT; PRAIRIE; SITES; BIODIVERSITY; RESPONSES; MAMMALS; MARTEN; PLANT	Some animals modify the environment in ways that can influence the resources available to other species. Because red squirrels (Tamiasciurus hudsonicus) create large piles of conifer-cone debris (middens) in which they store cones, squirrels concentrate resources that might affect biodiversity locally. To determine whether other animals are attracted to midden sites beyond their affinity for the same resources that attract red squirrels, we assessed associations between middens, mammals, and birds at population and community levels. We surveyed 75 middens where residency rates of red squirrels varied during the previous five years; sampling along this residency gradient permitted us to evaluate the influence of resources at middens beyond the influence of a resident squirrel. At each location, we quantified vegetation, landscape structure, abundance of conifer cones, and midden structure, and used capture-recapture, distance sampling, and remote cameras to quantify presence, abundance, and species richness of mammals and birds. Red squirrels and the resources they concentrated at middens influenced mammals and birds at the population scale and to a lesser extent at the community scale. At middens with higher residency rates of red squirrels, richness of medium and large mammals increased markedly and species richness of birds increased slightly. After accounting for local forest characteristics, however, only species richness of medium-to-large mammals was associated with a red squirrel being resident during surveys. In areas where red squirrels were resident during surveys or in areas with greater amounts of resources concentrated by red squirrels, abundances of two of four small mammal species and two of four bird species increased. We conclude that the presence of this ecosystem modifier and the resources it concentrates influence abundance of some mammals and birds, which may have implications for maintaining biodiversity across the wide geographic range inhabited by red squirrels and other larderhoarding animals.	[Posthumus, Erin E.; Koprowski, John L.; Steidl, Robert J.] Univ Arizona, Sch Nat Resources & Environm, Wildlife & Fisheries Sci, Tucson, AZ 85721 USA	University of Arizona	Posthumus, EE (corresponding author), Univ Arizona, Sch Nat Resources & Environm, Wildlife & Fisheries Sci, Tucson, AZ 85721 USA.	eposthum@email.arizona.edu		Koprowski, John/0000-0003-1406-9853	United States Forest Service Rocky Mountain Research Station (University of Arizona) [10-JV-188]; T&E Incorporated's Grants for Conservation Research; American Society of Mammalogists' Grants-in-Aid Program	United States Forest Service Rocky Mountain Research Station (University of Arizona); T&E Incorporated's Grants for Conservation Research; American Society of Mammalogists' Grants-in-Aid Program	This work was supported by the United States Forest Service Rocky Mountain Research Station, #10-JV-188 (University of Arizona; www.fs.fed.us/rmrs); T&E Incorporated's Grants for Conservation Research (www.tandeinc.com); and the American Society of Mammalogists' Grants-in-Aid Program (http://www.mammalsociety.org/committees/grants-aid). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMARANTHUS M, 1994, CAN J FOREST RES, V24, P2157, DOI 10.1139/x94-278; ANDERSON DR, 1983, ECOLOGY, V64, P674, DOI 10.2307/1937188; Azeria ET, 2009, GLOBAL ECOL BIOGEOGR, V18, P333, DOI 10.1111/j.1466-8238.2009.00454.x; BUSKIRK SW, 1984, J WILDLIFE MANAGE, V48, P950, DOI 10.2307/3801445; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; CAREY AB, 1995, ECOL APPL, V5, P336, DOI 10.2307/1942026; Cottee-Jones H.E.W., 2012, FRONTIERS BIOGEOGRAP, V4, P117, DOI DOI 10.21425/F54312533; Edelman AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030914; Edelman Andrew J., 2005, U S Forest Service Rocky Mountain Research Station Proceedings RMRS-P, V36, P395; Elphick Chris, 2001, SIBLEY GUIDE BIRD LI; ESTES JA, 1974, SCIENCE, V185, P1058, DOI 10.1126/science.185.4156.1058; Fauteux D, 2012, FOREST ECOL MANAG, V266, P194, DOI 10.1016/j.foreco.2011.11.020; FINLEY RB, 1969, MISCELLANEOUS PUBLIC, V51, P233; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Fitzpatrick LA, 1993, MOUNT GRAHAM RED SQU; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; GURNELL J, 1984, ANIM BEHAV, V32, P1119, DOI 10.1016/S0003-3472(84)80228-6; Gurnell J, 1987, NATURAL HIST SQUIRRE; HART E B, 1992, Mammalian Species, P1, DOI 10.2307/3504238; Hastings KK, 2002, FISH B-NOAA, V100, P51; Hoffmeister D. F., 1986, MAMMALS ARIZONA; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kendall K.C., 1983, BEARS BIOL MANAG, V5, P166, DOI [10.2307/3872534, DOI 10.2307/3872534]; Knapp AK, 1999, BIOSCIENCE, V49, P39, DOI 10.2307/1313492; Koprowski John L., 2008, Endangered Species Research, V4, P227, DOI 10.3354/esr00026; Kotliar NB, 2000, CONSERV BIOL, V14, P1715, DOI 10.1111/j.1523-1739.2000.98384.x; Kotliar NB, 1999, ENVIRON MANAGE, V24, P177, DOI 10.1007/s002679900225; Lee SD, 2004, POL J ECOL, V52, P55; LEMMON PAUL E., 1956, FOREST SCI, V2, P314; Mattson DJ, 1997, J APPL ECOL, V34, P926, DOI 10.2307/2405283; McCain CM, 2011, ECOL LETT, V14, P1236, DOI 10.1111/j.1461-0248.2011.01695.x; McDiarmid RW, 1996, MEASURING MONITORING, P55; Merrick MJ, 2007, J WILDLIFE MANAGE, V71, P1958, DOI 10.2193/2006-260; MILLS LS, 1993, BIOSCIENCE, V43, P219, DOI 10.2307/1312122; NAIMAN RJ, 1986, ECOLOGY, V67, P1254, DOI 10.2307/1938681; PAINE RT, 1969, AM NAT, V103, P91, DOI 10.1086/282586; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Patton D. R., 1986, Western Journal of Applied Forestry, V1, P48; Pearson DE, 2001, CAN J ZOOL, V79, P1372, DOI 10.1139/cjz-79-8-1372; PLATT WJ, 1975, ECOL MONOGR, V45, P285, DOI 10.2307/1942425; Power ME, 1996, BIOSCIENCE, V46, P609, DOI 10.2307/1312990; Prugh LR, 2012, J ANIM ECOL, V81, P667, DOI 10.1111/j.1365-2656.2011.01930.x; Ralph C.J., 1993, PSWGTR144WWW USDA; Ramsey F. L., 2002, STAT SLEUTH COURSE M; Romero GQ, 2015, BIOL REV, V90, P877, DOI 10.1111/brv.12138; Sanderson H.R., 2009, LAST REFUGE MT GRAHA; Schauffert CA, 2002, SOUTHWEST NAT, V47, P498, DOI 10.2307/3672515; SHERBURNE SS, 1993, AM MIDL NAT, V129, P204, DOI 10.2307/2426449; SMITH AA, 1994, J WILDLIFE MANAGE, V58, P437, DOI 10.2307/3809314; Steele Michael A., 1998, Mammalian Species, V586, P1; Vander Wall SB., 1990, FOOD HOARDING ANIMAL; Whitford WG, 2010, J ARID ENVIRON, V74, P1450, DOI 10.1016/j.jaridenv.2010.05.025; Zugmeyer CA, 2009, J MAMMAL, V90, P175, DOI 10.1644/07-MAMM-A-399.1	53	8	8	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123633	10.1371/journal.pone.0123633	http://dx.doi.org/10.1371/journal.pone.0123633			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923695	gold, Green Published			2022-12-27	WOS:000353711600053
J	Barongo, MB; Stahl, K; Bett, B; Bishop, RP; Fevre, EM; Aliro, T; Okoth, E; Masembe, C; Knobel, D; Ssematimba, A				Barongo, Mike B.; Stahl, Karl; Bett, Bernard; Bishop, Richard P.; Fevre, Eric M.; Aliro, Tony; Okoth, Edward; Masembe, Charles; Knobel, Darryn; Ssematimba, Amos			Estimating the Basic Reproductive Number (R-0) for African Swine Fever Virus (ASFV) Transmission between Pig Herds in Uganda	PLOS ONE			English	Article							INFECTIOUS-DISEASES; INFLUENZA; EPIDEMIC; AUSTRALIA; OUTBREAKS	African swine fever (ASF) is a highly contagious, lethal and economically devastating haemorrhagic disease of domestic pigs. Insights into the dynamics and scale of virus transmission can be obtained from estimates of the basic reproduction number (R-0). We estimate R-0 for ASF virus in small holder, free-range pig production system in Gulu, Uganda. The estimation was based on data collected from outbreaks that affected 43 villages (out of the 289 villages with an overall pig population of 26,570) between April 2010 and November 2011. A total of 211 outbreaks met the criteria for inclusion in the study. Three methods were used, specifically; (i) GIS-based identification of the nearest infectious neighbour based on the Euclidean distance between outbreaks, (ii) epidemic doubling time, and (iii) a compartmental susceptible-infectious (SI) model. For implementation of the SI model, three approaches were used namely; curve fitting (CF), a linear regression model (LRM) and the SI/N proportion. The R-0 estimates from the nearest infectious neighbour and epidemic doubling time methods were 3.24 and 1.63 respectively. Estimates from the SI-based method were 1.58 for the CF approach, 1.90 for the LRM, and 1.77 for the SI/N proportion. Since all these values were above one, they predict the observed persistence of the virus in the population. We hypothesize that the observed variation in the estimates is a consequence of the data used. Higher resolution and temporally better defined data would likely reduce this variation. This is the first estimate of R-0 for ASFV in a free range smallholder pig keeping system in sub-Saharan Africa and highlights the requirement for more efficient application of available disease control measures.	[Barongo, Mike B.] Makerere Univ, ICT Div, Dept Acad Registrar, Kampala, Uganda; [Barongo, Mike B.; Bett, Bernard; Bishop, Richard P.; Fevre, Eric M.; Okoth, Edward; Ssematimba, Amos] Int Livestock Res Inst, Nairobi, Kenya; [Stahl, Karl] Natl Vet Inst, Dept Dis Control & Epidemiol, S-75007 Uppsala, Sweden; [Aliro, Tony] Minist Agr Anim Ind & Fisheries, Entebbe, Uganda; [Masembe, Charles] Makerere Univ, Dept Biol Sci, Coll Nat & Appl Sci, Kampala, Uganda; [Knobel, Darryn] Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, ZA-0002 Pretoria, South Africa; [Ssematimba, Amos] Gulu Univ, Fac Sci, Dept Math, Gulu, Uganda	Makerere University; CGIAR; International Livestock Research Institute (ILRI); National Veterinary Institute SVA; Makerere University; University of Pretoria	Barongo, MB (corresponding author), Makerere Univ, ICT Div, Dept Acad Registrar, Kampala, Uganda.	mbarongo@acadreg.mak.ac.ug	Ssematimba, Amos/S-3217-2019; Knobel, Darryn/O-7057-2014	Ssematimba, Amos/0000-0002-5407-2478; Masembe, Charles/0000-0002-9581-0414; Knobel, Darryn/0000-0002-0425-3799; Fevre, Eric/0000-0001-8931-4986	Commonwealth Scientific and Industrial Research Organisation (CSIRO); Consortium of International Agricultural Research Centers (CGIAR) Research Program for Agriculture for Nutrition and Health; Wellcome Trust [085308]; Swedish research council FORMAS [221-2009-1984]; CISA-INIA Grant [TF069018]; Australian Agency for International Development (AusAID) Africa; Australia Food Security Initiative	Commonwealth Scientific and Industrial Research Organisation (CSIRO)(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Consortium of International Agricultural Research Centers (CGIAR) Research Program for Agriculture for Nutrition and Health(CGIAR); Wellcome Trust(Wellcome TrustEuropean Commission); Swedish research council FORMAS(Swedish Research CouncilSwedish Research Council Formas); CISA-INIA Grant; Australian Agency for International Development (AusAID) Africa(CGIAR); Australia Food Security Initiative	This study was funded by support from the following institutions: 1. The Commonwealth Scientific and Industrial Research Organisation (CSIRO)-Australian Agency for International Development (AusAID) Africa-Australia Food Security Initiative (MBB, EAO, RPB); 2. Consortium of International Agricultural Research Centers (CGIAR) Research Program for Agriculture for Nutrition and Health, led by IFPRI (BB, AS); 3. Wellcome Trust (grant 085308) (EMF); 4. the Swedish research council FORMAS (Grant No. 221-2009-1984) (KS, CM, TA); and 5. CISA-INIA Grant no. TF069018 (MBB, RPB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliro T, 2012, EPIZONE 6 ANN M VIR; Anderson RM, 1991, INFECT DIS HUMANS DY; Bett B, 2014, TRANSBOUND EMERG DIS, V61, P60, DOI 10.1111/tbed.12003; Brooks-Pollock E, 2015, EPIDEMICS-NETH, V10, P1, DOI 10.1016/j.epidem.2014.08.005; Chiew M, 2014, B WORLD HEALTH ORGAN, V92, P171, DOI 10.2471/BLT.13.125724; Chowell G, 2008, EPIDEMIOL INFECT, V136, P852, DOI 10.1017/S0950268807009144; Costard S, 2009, PHILOS T R SOC B, V364, P2683, DOI 10.1098/rstb.2009.0098; de Koeijer A, 2004, J MATH BIOL, V48, P1, DOI 10.1007/s00285-003-0206-x; deJong MCM, 1995, PREV VET MED, V25, P183, DOI 10.1016/0167-5877(95)00538-2; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Dixon L.K., 2000, VIRUS TAXONOMY; Eble PL, 2008, PREV VET MED, V83, P98, DOI 10.1016/j.prevetmed.2007.06.004; FAO, 2013, EMPRES WATCH AFR SWI, V28; FAO, 2011, VAL CHAIN APPR AN DI; Farrington CP, 2001, J R STAT SOC C-APPL, V50, P251, DOI 10.1111/1467-9876.00233; Ferreira HCD, 2013, VET MICROBIOL, V165, P296, DOI 10.1016/j.vetmic.2013.03.026; Ferreira HCDC, 2012, VET MICROBIOL, V160, P327, DOI 10.1016/j.vetmic.2012.06.025; Food and Agriculture Organization, 2008, EMPRES WATCH AFR SWI; Gallardo C, 2011, AFR J BIOTECHNOL, V10, P3488; Gulenkin VM, 2011, PREV VET MED, V102, P167, DOI 10.1016/j.prevetmed.2011.07.004; Hage JJ, 1996, VET MICROBIOL, V53, P169, DOI 10.1016/S0378-1135(96)01245-X; Iglesias I., 2015, TRANSBOUND EMERG DIS; Li J, 2011, COMPUT MATH METHOD M, V2011, DOI 10.1155/2011/527610; Lloyd AL, 2001, P ROY SOC B-BIOL SCI, V268, P847, DOI 10.1098/rspb.2000.1572; MAAIF and UBOS, 2009, NAT LIV CENS REP 200; Matthews L, 1999, P ROY SOC B-BIOL SCI, V266, P1085, DOI 10.1098/rspb.1999.0747; MONTGOMERY R. Eustace, 1921, Journal of Comparative Pathology and Therapeutics, V34, P159; Muwonge A, 2012, TROP ANIM HEALTH PRO, V44, P1593, DOI 10.1007/s11250-012-0112-6; Nantima N, 2015, TROP ANIM HEALTH PRO, V47, P589, DOI 10.1007/s11250-015-0768-9; OIE, 2010, AFR SWIN FEV 1 4; Penrith M.L., 2005, INFECT DIS LIVESTOCK, P1087, DOI [10.4102/jsava.v76i4.435, DOI 10.4102/JSAVA.V76I4.435]; Penrith ML, 2013, VIRUS RES, V173, P228, DOI 10.1016/j.virusres.2012.10.011; Penrith ML, 2009, ONDERSTEPOORT J VET, V76, P91; Roberts MG, 2007, J R SOC INTERFACE, V4, P949, DOI 10.1098/rsif.2007.1031; Sanchez-Vizcaino JM, 2015, J COMP PATHOL, V152, P9, DOI 10.1016/j.jcpa.2014.09.003; Stegeman A, 1999, PREV VET MED, V42, P219, DOI 10.1016/S0167-5877(99)00077-X; Tejler E., 2012, OUTBREAKS AFRICAN SW; Thomas LF, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-46; Veness C, 2007, CALCULATE DISTANCE B; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; Ward MP, 2009, EPIDEMIOL INFECT, V137, P219, DOI 10.1017/S0950268808000885; Wearing J, 2005, PLOS MED, V2; Zsak L, 2005, J CLIN MICROBIOL, V43, P112, DOI 10.1128/JCM.43.1.112-119.2005	43	31	32	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125842	10.1371/journal.pone.0125842	http://dx.doi.org/10.1371/journal.pone.0125842			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938429	Green Published, gold, Green Submitted			2022-12-27	WOS:000353943000105
J	Sathanoori, R; Sward, K; Olde, B; Erlinge, D				Sathanoori, Ramasri; Sward, Karl; Olde, Bjorn; Erlinge, David			The ATP Receptors P2X7 and P2X4 Modulate High Glucose and Palmitate-Induced Inflammatory Responses in Endothelial Cells	PLOS ONE			English	Article							P38 MAPK PATHWAY; P2X(7) RECEPTOR; FATTY-ACIDS; ADHESION MOLECULES; OXIDATIVE STRESS; UP-REGULATION; EXPRESSION; ACTIVATION; RELEASE; DYSFUNCTION	Endothelial cells lining the blood vessels are principal players in vascular inflammatory responses. Dysregulation of endothelial cell function caused by hyperglycemia, dyslipidemia, and hyperinsulinemia often result in impaired vasoregulation, oxidative stress, inflammation, and altered barrier function. Various stressors including high glucose stimulate the release of nucleotides thus initiating signaling via purinergic receptors. However, purinergic modulation of inflammatory responses in endothelial cells caused by high glucose and palmitate remains unclear. In the present study, we investigated whether the effect of high glucose and palmitate is mediated by P2X7 and P2X4 and if they play a role in endothelial cell dysfunction. Transcript and protein levels of inflammatory genes as well as reactive oxygen species production, endothelial-leukocyte adhesion, and cell permeability were investigated in human umbilical vein endothelial cells exposed to high glucose and palmitate. We report high glucose and palmitate to increase levels of extracellular ATP, expression of P2X7 and P2X4, and inflammatory markers. Both P2X7 and P2X4 antagonists inhibited high glucose and palmitate-induced interleukin-6 levels with the former having a significant effect on interleukin-8 and cyclooxygenase-2. The effect of the antagonists was confirmed with siRNA knockdown of the receptors. In addition, P2X7 mediated both high glucose and palmitate-induced increase in reactive oxygen species levels and decrease in endothelial nitric oxide synthase. Blocking P2X7 inhibited high glucose and palmitate-induced expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 as well as leukocyte-endothelial cell adhesion. Interestingly, high glucose and palmitate enhanced endothelial cell permeability that was dependent on both P2X7 and P2X4. Furthermore, antagonizing the P2X7 inhibited high glucose and palmitate-mediated activation of p38-mitogen activated protein kinase. These findings support a novel role for P2X7 and P2X4 coupled to induction of inflammatory molecules in modulating high glucose and palmitate-induced endothelial cell activation and dysfunction.	[Sathanoori, Ramasri; Olde, Bjorn; Erlinge, David] Lund Univ, Dept Cardiol, Clin Sci, Lund, Sweden; [Sward, Karl] Lund Univ, Dept Expt Med Sci, Lund, Sweden	Lund University; Lund University	Sathanoori, R (corresponding author), Lund Univ, Dept Cardiol, Clin Sci, Lund, Sweden.	Ramasri.Sathanoori@med.lu.se		Sward, Karl/0000-0002-7255-5510	Swedish Heart and Lung Foundation; Swedish Scientific Research Council; ALF; Skane University Hospital funds	Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Scientific Research Council(Swedish Research Council); ALF; Skane University Hospital funds	The Swedish Heart and Lung Foundation, Swedish Scientific Research Council, ALF, and Skane University Hospital funds supported this work.	Arulkumaran N, 2011, EXPERT OPIN INV DRUG, V20, P897, DOI 10.1517/13543784.2011.578068; Azcutia V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010091; Barbera-Cremades M, 2012, FASEB J, V26, P2951, DOI 10.1096/fj.12-205765; Bartlett R, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/271813; Beigi RD, 2003, BRIT J PHARMACOL, V140, P507, DOI 10.1038/sj.bjp.0705470; Blasi C, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/346501; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Boden G, 2011, OBESITY, V19, P1366, DOI 10.1038/oby.2011.71; Boden G, 2011, CURR OPIN ENDOCRINOL, V18, P139, DOI 10.1097/MED.0b013e3283444b09; Bodin P, 1998, INFLAMM RES, V47, P351, DOI 10.1007/s000110050341; Braunersreuther V, 2007, THROMB HAEMOSTASIS, V97, P714, DOI 10.1160/TH07-01-0036; Chai WD, 2007, ENDOCRINOLOGY, V148, P1622, DOI 10.1210/en.2006-1068; Chen S, 2013, CRIT CARE MED, V41, pE466, DOI 10.1097/CCM.0b013e31829a8246; Chiao CW, 2013, CLIN SCI, V125, P131, DOI 10.1042/CS20120479; DECATERINA R, 1995, J CLIN INVEST, V96, P60, DOI 10.1172/JCI118074; Di Virgilio F, 2002, BRIT J PHARMACOL, V135, P831, DOI 10.1038/sj.bjp.0704524; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Erdogdu O, 2013, J MOL ENDOCRINOL, V50, P229, DOI 10.1530/JME-12-0166; Eringa EC, 2013, REV ENDOCR METAB DIS, V14, P39, DOI 10.1007/s11154-013-9239-7; Frank PG, 2008, AM J PHYSIOL-HEART C, V295, pH926, DOI 10.1152/ajpheart.00779.2008; Gao Z, 2014, BIOCHEM PHARMACOL, V91, P474, DOI 10.1016/j.bcp.2014.08.009; Garcia-Hernandez MH, 2011, CELL IMMUNOL, V269, P135, DOI 10.1016/j.cellimm.2011.03.022; Gidlof O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037491; Glas R, 2009, DIABETOLOGIA, V52, P1579, DOI 10.1007/s00125-009-1349-0; Glass R, 2002, CELL MOL LIFE SCI, V59, P870, DOI 10.1007/s00018-002-8474-y; Gustavsson C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012699; Hernandez-Olmos V, 2012, J MED CHEM, V55, P9576, DOI 10.1021/jm300845v; Humphreys BD, 1998, J LEUKOCYTE BIOL, V64, P265, DOI 10.1002/jlb.64.2.265; Hung SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070210; Kado S, 1999, ACTA DIABETOL, V36, P67, DOI 10.1007/s005920050147; Kaneto H, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/453892; Kawano A, 2012, BIOCHEM BIOPH RES CO, V419, P374, DOI 10.1016/j.bbrc.2012.01.156; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Kim SW, 2011, BIOCHEM BIOPH RES CO, V415, P602, DOI 10.1016/j.bbrc.2011.10.115; Koenen TB, 2011, DIABETES, V60, P517, DOI 10.2337/db10-0266; Krogmann A, 2011, MICROVASC RES, V81, P52, DOI 10.1016/j.mvr.2010.11.008; Kubota T, 2011, CELL METAB, V13, P294, DOI 10.1016/j.cmet.2011.01.018; Labasi JM, 2002, J IMMUNOL, V168, P6436, DOI 10.4049/jimmunol.168.12.6436; Langer HF, 2009, J CELL MOL MED, V13, P1211, DOI 10.1111/j.1582-4934.2009.00811.x; Loomis WH, 2003, J BIOL CHEM, V278, P4590, DOI 10.1074/jbc.M207868200; Michel AD, 2007, BRIT J PHARMACOL, V152, P523, DOI 10.1038/sj.bjp.0707417; Miyoshi T, 2010, IMMUNOLOGY, V131, P331, DOI 10.1111/j.1365-2567.2010.03303.x; Narcisse L, 2005, GLIA, V49, P245, DOI 10.1002/glia.20110; Parodi J, 2002, CIRC RES, V90, P570, DOI 10.1161/01.RES.0000012582.11979.8B; Pfeiffer ZA, 2004, J LEUKOCYTE BIOL, V75, P1173, DOI 10.1189/jlb.1203648; Robinson LE, 2014, J BIOL CHEM, V289, P31983, DOI 10.1074/jbc.M114.574699; Sakowicz-Burkiewicz M, 2013, IMMUNOBIOLOGY, V218, P591, DOI 10.1016/j.imbio.2012.07.010; Sathanoori R, 2015, PURINERG SIGNAL, V11, P139, DOI 10.1007/s11302-014-9442-3; Seye Cheikh I, 2006, Purinergic Signal, V2, P471, DOI 10.1007/s11302-006-9015-1; Shiraki A, 2012, ATHEROSCLEROSIS, V221, P375, DOI 10.1016/j.atherosclerosis.2011.12.039; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Sluyter R, 2004, GENES IMMUN, V5, P588, DOI 10.1038/sj.gene.6364127; Solini A, 2004, ARTERIOSCL THROM VAS, V24, P1240, DOI 10.1161/01.ATV.0000133193.11078.c0; Solini A, 2013, J PATHOL, V231, P342, DOI 10.1002/path.4237; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Staiger H, 2004, DIABETES, V53, P3209, DOI 10.2337/diabetes.53.12.3209; Staiger K, 2006, DIABETES, V55, P3121, DOI 10.2337/db06-0188; Stokes L, 2006, BRIT J PHARMACOL, V149, P880, DOI 10.1038/sj.bjp.0706933; Sugiyama T, 2004, INVEST OPHTH VIS SCI, V45, P1026, DOI 10.1167/iovs.03-1062; Tabit CE, 2010, REV ENDOCR METAB DIS, V11, P61, DOI 10.1007/s11154-010-9134-4; Tang Y, 2008, J PHARMACOL SCI, V107, P419, DOI 10.1254/jphs.08073FP; Toulme E, 2012, J BIOL CHEM, V287, P14734, DOI 10.1074/jbc.M111.329334; Trang T, 2009, J NEUROSCI, V29, P3518, DOI 10.1523/JNEUROSCI.5714-08.2009; Troseid M, 2009, DIABETES CARE, V32, P486, DOI 10.2337/dc08-1710; Trueblood KE, 2011, AM J PHYSIOL-CELL PH, V301, pC1213, DOI 10.1152/ajpcell.00265.2011; Trang T, 2012, EXP NEUROL, V234, P354, DOI 10.1016/j.expneurol.2011.11.012; Ulmann L, 2010, EMBO J, V29, P2290, DOI 10.1038/emboj.2010.126; Vaccari JPD, 2012, J NEUROSCI, V32, P3058, DOI 10.1523/JNEUROSCI.4930-11.2012; Vallance P, 1997, LANCET, V349, P1391, DOI 10.1016/S0140-6736(96)09424-X; Wang F, 2010, CARDIOVASC RES, V87, P127, DOI 10.1093/cvr/cvq051; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Wende AR, 2012, CURR HYPERTENS REP, V14, P517, DOI 10.1007/s11906-012-0307-2; Wesselius A, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-64; Wilson HL, 2007, BRIT J PHARMACOL, V151, P96, DOI 10.1038/sj.bjp.0707213; Witting PK, 2007, CELL PHYSIOL BIOCHEM, V20, P255, DOI 10.1159/000107512; Xu H, 2013, BRAIN RES BULL, V94, P63, DOI 10.1016/j.brainresbull.2013.02.002; Zhang HR, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-011-0237-1; Zhu MM, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-13	79	49	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125111	10.1371/journal.pone.0125111	http://dx.doi.org/10.1371/journal.pone.0125111			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938443	gold, Green Published, Green Submitted			2022-12-27	WOS:000353943000045
J	Yang, N; Yao, Z; Miao, L; Liu, J; Gao, X; Fan, H; Hu, YJ; Zhang, H; Xu, Y; Qu, AJ; Wang, G				Yang, Ning; Yao, Zhi; Miao, Li; Liu, Jia; Gao, Xia; Fan, Hui; Hu, Yanjin; Zhang, Heng; Xu, Yuan; Qu, Aijuan; Wang, Guang			Novel Clinical Evidence of an Association between Homocysteine and Insulin Resistance in Patients with Hypothyroidism or Subclinical Hypothyroidism	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ENDOPLASMIC-RETICULUM STRESS; POLYCYSTIC-OVARY-SYNDROME; PLASMA HOMOCYSTEINE; ENDOTHELIAL FUNCTION; METABOLIC SYNDROME; THYROID-DISORDERS; ADIPOSE-TISSUE; HYPERHOMOCYSTEINEMIA; ATHEROSCLEROSIS	Objective Hypothyroidism (HO) can induce significant metabolic dysfunction and increase cardiovascular disease risk. In the present study, we investigated the relationship between homocysteine (Hcy) and insulin resistance (IR) in patients with HO or subclinical hypothyroidism (SHO). Methods A total of 270 subjects were enrolled. All subjects were divided into the following three groups: HO, SHO and control. Plasma levels of Hcy were measured, and each patient's homeostatic index of insulin resistance (HOMA-IR) was calculated. Statistical analyses were carried out to evaluate the correlations among groups and to determine the predictors of IR in patients with HO or SHO. Results The HOMA-IR value was significantly higher in the HO group than in the SHO and control groups. Plasma levels of Hcy were markedly increased in the HO group compared with those of the SHO group and controls. In addition, plasma levels of Hcy were positively correlated with the HOMA-IR values in both the HO and SHO groups. Multiple linear regression models showed that plasma levels of Hcy and free thyroxine (FT4) were the only predictors of HOMA-IR in patients with HO or SHO. Conclusions Plasma levels of Hcy and HOMA-IR were increased in patients with HO or SHO. Our results suggest that HO and SHO may increase the risk for atherogenesis and cardiovascular disease by increased IR. The increased IR induced by hyperhomocysteinemia in patients with HO or SHO may partially explain this adverse effect.	[Yang, Ning; Yao, Zhi; Miao, Li; Liu, Jia; Gao, Xia; Fan, Hui; Hu, Yanjin; Zhang, Heng; Xu, Yuan; Wang, Guang] Capital Med Univ, Dept Endocrinol, Beijing Chaoyang Hosp, Beijing, Peoples R China; [Qu, Aijuan] Capital Med Univ, Dept Physiol & Pathophysiol, Sch Basic Med Sci, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Qu, AJ (corresponding author), Capital Med Univ, Dept Physiol & Pathophysiol, Sch Basic Med Sci, Beijing, Peoples R China.	aijuanqu@ccmu.edu.cn; drwg6688@126.com			Major National Basic Research Program of China [2011CB503904]; Beijing Natural Science Foundation [7142060]; Chinese National Natural Science Foundation [81270369, 81070244]	Major National Basic Research Program of China(National Basic Research Program of China); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	Our work was supported by grants from the Major National Basic Research Program of China (No. 2011CB503904), the Beijing Natural Science Foundation (No.7142060) and the Chinese National Natural Science Foundation (No. 81270369, 81070244) to Guang Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamashmoos SA, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-423; Bautista LE, 2002, J CLIN EPIDEMIOL, V55, P882, DOI 10.1016/S0895-4356(02)00434-1; Bornfeldt KE, 2011, CELL METAB, V14, P575, DOI 10.1016/j.cmet.2011.07.015; Cappola AR, 2003, J CLIN ENDOCR METAB, V88, P2438, DOI 10.1210/jc.2003-030398; Catena C, 2015, AM J HYPERTENS, V28, P943, DOI 10.1093/ajh/hpu248; Chiang JK, 2011, J CELL PHYSIOL, V226, P1017, DOI 10.1002/jcp.22415; Cui RZ, 2008, ATHEROSCLEROSIS, V198, P412, DOI 10.1016/j.atherosclerosis.2007.09.029; Deyneli O, 2014, ANN ENDOCRINOL-PARIS, V75, P220, DOI 10.1016/j.ando.2014.06.002; Dimitriadis G, 2006, J CLIN ENDOCR METAB, V91, P4930, DOI 10.1210/jc.2006-0478; Duntas LH, 2012, MED CLIN N AM, V96, P269, DOI 10.1016/j.mcna.2012.01.012; Edirimanne VER, 2007, CAN J PHYSIOL PHARM, V85, P1236, DOI 10.1139/Y07-112; Falk E, 2001, LIPIDS, V36, pS3, DOI 10.1007/s11745-001-0676-x; Garber JR, 2012, ENDOCR PRACT, V18, P989, DOI 10.4158/EP12280.GL; Gursu MF, 2002, ARCH MED RES, V33, P305, DOI 10.1016/S0188-4409(01)00379-4; He LY, 2010, AM J PHYSIOL-ENDOC M, V299, pE1061, DOI 10.1152/ajpendo.00367.2010; Ichiki T, 2010, VASC PHARMACOL, V52, P151, DOI 10.1016/j.vph.2009.09.004; Ji C, 2004, WORLD J GASTROENTERO, V10, P1699; Johnstone T, 2014, AUST VET J, V92, P437, DOI 10.1111/avj.12237; Jones DD, 2010, AM J MED, V123, P502, DOI 10.1016/j.amjmed.2009.12.023; Karrowni W, 2013, ARTERIOSCL THROM VAS, V33, P2245, DOI 10.1161/ATVBAHA.113.301585; Kim SR, 2002, MED HYPOTHESES, V59, P660, DOI 10.1016/S0306-9877(02)00211-6; Li Y, 2013, J BIOL CHEM, V288, P9583, DOI 10.1074/jbc.M112.431627; Li Y, 2008, DIABETES, V57, P817, DOI 10.2337/db07-0617; Liu J, 2014, J HUM HYPERTENS, V28, P743, DOI 10.1038/jhh.2014.22; Maratou E, 2009, EUR J ENDOCRINOL, V160, P785, DOI 10.1530/EJE-08-0797; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McCully KS, 1996, NAT MED, V2, P386, DOI 10.1038/nm0496-386; Morris MS, 2001, ATHEROSCLEROSIS, V155, P195, DOI 10.1016/S0021-9150(00)00537-2; Neves Celestino, 2008, Rev Port Cardiol, V27, P1211; Nygard O, 1997, NEW ENGL J MED, V337, P230, DOI 10.1056/NEJM199707243370403; Rochon C, 2003, CLIN SCI, V104, P7, DOI 10.1042/CS20020154; Rodondi N, 2006, AM J MED, V119, P541, DOI 10.1016/j.amjmed.2005.09.028; Roos A, 2007, J CLIN ENDOCR METAB, V92, P491, DOI 10.1210/jc.2006-1718; Sadeghian Saeed, 2006, BMC Cardiovasc Disord, V6, P38, DOI 10.1186/1471-2261-6-38; Schachter M, 2003, HUM REPROD, V18, P721, DOI 10.1093/humrep/deg190; Setola E, 2004, EUR J ENDOCRINOL, V151, P483, DOI 10.1530/eje.0.1510483; Singh S, 2008, INT J CARDIOL, V125, P41, DOI 10.1016/j.ijcard.2007.02.027; Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228; Wang DJ, 2012, CELL BIOL INT, V36, P511, DOI 10.1042/CBI20110235; Wang G, 2005, ATHEROSCLEROSIS, V179, P395, DOI 10.1016/j.atherosclerosis.2004.10.033; Wang G, 2004, CHINESE MED J-PEKING, V117, P1650; Wang H, 2003, BLOOD, V101, P3901, DOI 10.1182/blood-2002-08-2606; Yilmaz N, 2008, J OBSTET GYNAECOL RE, V34, P384, DOI 10.1111/j.1447-0756.2007.00699.x	43	51	55	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125922	10.1371/journal.pone.0125922	http://dx.doi.org/10.1371/journal.pone.0125922			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938439	Green Published, gold, Green Submitted			2022-12-27	WOS:000353943000115
J	Bawa, P; Zackaria, S; Verma, M; Gupta, S; Srivatsan, R; Chaudhary, B; Srinivasan, S				Bawa, Pushpinder; Zackaria, Sajna; Verma, Mohit; Gupta, Saurabh; Srivatsan, R.; Chaudhary, Bibha; Srinivasan, Subhashini			Integrative Analysis of Normal Long Intergenic Non-Coding RNAs in Prostate Cancer	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; BREAST-CANCER; TUMOR-SUPPRESSOR; HUMAN GENOME; CELLS; PROGRESSION; BIOCONDUCTOR; ENHANCER; PCAT-1; GENES	Recently, large numbers of normal human tissues have been profiled for non-coding RNAs and more than fourteen thousand long intergenic non-coding RNAs (lincRNAs) are found expressed in normal human tissues. The functional roles of these normal lincRNAs (nlincRNAs) in the regulation of protein coding genes in normal and disease biology are yet to be established. Here, we have profiled two RNA-seq datasets including cancer and matched non-neoplastic tissues from 12 individuals from diverse demography for both coding genes and nlincRNAs. We find 130 nlincRNAs significantly regulated in cancer, with 127 regulated in the same direction in the two datasets. Interestingly, according to Illumina Body Map, significant numbers of these nlincRNAs display baseline null expression in normal prostate tissues but are specific to other tissues such as thyroid, kidney, liver and testis. A number of the regulated nlincRNAs share loci with coding genes, which are either co-regulated or oppositely regulated in all cancer samples studied here. For example, in all cancer samples i) the nlincRNA, TCONS_00029157, and a neighboring tumor suppressor factor, SIK1, are both down regulated; ii) several thyroid-specific nlincRNAs in the neighborhood of the thyroid-specific gene TPO, are both up-regulated; and iii) the TCONS_00010581, an isoform of HEIH, is down-regulated while the neighboring EZH2 gene is up-regulated in cancer. Several nlincRNAs from a prostate cancer associated chromosomal locus, 8q24, are up-regulated in cancer along with other known prostate cancer associated genes including PCAT-1, PVT1, and PCAT-92. We observe that there is significant bias towards up-regulation of nlincRNAs with as high as 118 out of 127 up-regulated in cancer, even though regulation of coding genes is skewed towards down-regulation. Considering that all reported cancer associated lincRNAs (clincRNAs) are biased towards up-regulation, we conclude that this bias may be functionally relevant.	[Bawa, Pushpinder; Zackaria, Sajna; Verma, Mohit; Gupta, Saurabh; Srivatsan, R.; Chaudhary, Bibha; Srinivasan, Subhashini] IBAB, Bangalore, Karnataka, India; [Bawa, Pushpinder] Manipal Univ, Manipal, Karnataka, India	Manipal Academy of Higher Education (MAHE)	Srinivasan, S (corresponding author), IBAB, Bangalore, Karnataka, India.	ssubha@ibab.ac.in	Bawa, Pushpinder/AAH-2397-2021; Verma, Mohit/ABB-7093-2020; Bawa, Pushpinder Singh/AAV-4265-2021	Verma, Mohit/0000-0002-0438-5396; Bawa, Pushpinder Singh/0000-0002-8370-3638; Gupta, Saurabh/0000-0002-5984-852X	Department of Biotechnology, Government of India; Department of Information technology, Government of India; DST-FIST, Government of India; Department of Information Technology, Government of Karnataka	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Information technology, Government of India(Ministry of Electronics and Information Technology (MEITY), Government of India); DST-FIST, Government of India(Department of Science & Technology (India)); Department of Information Technology, Government of Karnataka	This study was funded by the Department of Biotechnology, Government of India; Department of Information technology, Government of India; DST-FIST, Government of India; and Department of Information Technology, Government of Karnataka. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Basu A, 2012, PROSTATE, V72, P597, DOI 10.1002/pros.21463; Bensen JT, 2013, PROSTATE, V73, P11, DOI 10.1002/pros.22532; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Burdova A, 2014, BIOMED PAP, V158, P502, DOI 10.5507/bp.2014.065; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cal S, 2002, GENE, V283, P49, DOI 10.1016/S0378-1119(01)00861-7; Cheng W, 2013, CANCER LETT, V339, P8, DOI 10.1016/j.canlet.2013.07.008; Ciampa J, 2011, CANCER RES, V71, P3287, DOI 10.1158/0008-5472.CAN-10-2646; Couch FJ, 2009, CANCER EPIDEM BIOMAR, V18, P3044, DOI 10.1158/1055-9965.EPI-09-0306; Fan C, 2013, INT J BIOL MARKER, V28, P71, DOI 10.5301/JBM.2013.10568; Ge XS, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0588-6; Han Y, 2015, INT J CANCER, V136, P1210, DOI 10.1002/ijc.29066; Jones JO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074102; Kannan K, 2011, P NATL ACAD SCI USA, V108, P9172, DOI 10.1073/pnas.1100489108; Kim JH, 2007, CANCER RES, V67, P8229, DOI 10.1158/0008-5472.CAN-07-1297; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Mishra DK, 2010, MOL CANCER THER, V9, P33, DOI 10.1158/1535-7163.MCT-09-0486; Mourtada-Maarabouni M, 2009, ONCOGENE, V28, P195, DOI 10.1038/onc.2008.373; Perez-Stable CM, 2000, MOL CELL ENDOCRINOL, V167, P43, DOI 10.1016/S0303-7207(00)00300-2; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Ren SC, 2012, CELL RES, V22, P806, DOI 10.1038/cr.2012.30; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saito Y, 2009, BIOCHEM BIOPH RES CO, V379, P726, DOI 10.1016/j.bbrc.2008.12.098; Shaw RJ, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.286pe55; Shi XF, 2013, CANCER LETT, V339, P159, DOI 10.1016/j.canlet.2013.06.013; Tessema M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034850; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; White NM, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0429-8; Yang F, 2011, HEPATOLOGY, V54, P1679, DOI 10.1002/hep.24563; Zhou YL, 2012, J MOL ENDOCRINOL, V48, pR45, DOI 10.1530/JME-12-0008	34	25	27	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0122143	10.1371/journal.pone.0122143	http://dx.doi.org/10.1371/journal.pone.0122143			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933431	Green Published, Green Submitted, gold			2022-12-27	WOS:000353887100007
J	Holand, H; Jensen, H; Tufto, J; Parn, H; Saether, BE; Ringsby, TH				Holand, Hakon; Jensen, Henrik; Tufto, Jarle; Parn, Henrik; Saether, Bernt-Erik; Ringsby, Thor Harald			Endoparasite Infection Has Both Short- and Long-Term Negative Effects on Reproductive Success of Female House Sparrows, as Revealed by Faecal Parasitic Egg Counts	PLOS ONE			English	Article							PASSER-DOMESTICUS; GAPEWORM SYNGAMUS; SPATIAL VARIATION; RED DEER; POPULATION; METAPOPULATION; SURVIVAL; HOST; CONSEQUENCES; DEMOGRAPHY	Parasites have the potential to severely reduce host reproductive success. However, the effects of endoparasites on reproductive success have not received the same amount of attention as the effects of parasites on host survival. We investigated the relationship between an avian endoparasite (gapeworm, Syngamus trachea) and both current and future reproductive success of female house sparrows (Passer domesticus) in a population on the coast of Helgeland, northern Norway. We found that the proportion of eggs in a nest that failed to develop into fledglings increased as the faecal parasitic egg count of the mothers increased. We also found that juvenile females with high numbers of parasitic eggs in their faeces had lower lifetime reproductive success as adults. However, we did not find a relationship between maternal parasite infection and clutch size or recruitment rate of offspring. To our knowledge this is the first study to find a relationship between reproductive success of an avian host and faecal egg count of an endoparasite. The present study indicates that infection by an endoparasite may be associated with lower individual reproductive success in both the short-term and long-term in a wild population of hosts.	[Holand, Hakon; Jensen, Henrik; Parn, Henrik; Saether, Bernt-Erik; Ringsby, Thor Harald] Norwegian Univ Sci & Technol, Ctr Biodivers Dynam, Dept Biol, NO-7491 Trondheim, Norway; [Tufto, Jarle] Norwegian Univ Sci & Technol, Ctr Biodivers Dynam, Dept Math, NO-7491 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Holand, H (corresponding author), Norwegian Univ Sci & Technol, Ctr Biodivers Dynam, Dept Biol, NO-7491 Trondheim, Norway.	hakon.holand@ntnu.no	Jensen, Henrik/B-5085-2011	Jensen, Henrik/0000-0001-7804-1564	Norwegian Research Council [204303, 221956]; Norwegian University of Science and Technology	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian University of Science and Technology	This study was funded by the Norwegian Research Council (http://www.forskningsradet.no/en/Home_page/1177315753906) (grants no. 204303 and 221956) and the Norwegian University of Science and Technology (www.ntnu.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALATALO RV, 1986, EVOLUTION, V40, P574, DOI 10.1111/j.1558-5646.1986.tb00508.x; Altizer S, 2013, SCIENCE, V341, P514, DOI 10.1126/science.1239401; Anderson TR, 2006, BIOLOGY OF THE UBIQU, Vi-xi, P1; Atkinson CT, 2008, PARASITIC DISEASES O, Vi-xi, P1; Audige L, 1999, ANIM REPROD SCI, V55, P239, DOI 10.1016/S0378-4320(99)00018-4; BARUS V, 1966, Helminthologia (Bratislava), V7, P103; BARUS V, 1966, Folia Parasitologica (Ceske Budejovice), V13, P274; Bonds MH, 2006, AM NAT, V168, P281, DOI 10.1086/506922; Brown CR, 1995, P ROY SOC B-BIOL SCI, V262, P313, DOI 10.1098/rspb.1995.0211; Burnham K. P., 2002, MODEL SELECTION AND; Campbell JW, 1935, J ANIM ECOL, V4, P208, DOI 10.2307/1010; Clapham PA, 1934, P R SOC LOND B-CONTA, V115, P18, DOI 10.1098/rspb.1934.0027; Fitze PS, 2004, ECOLOGY, V85, P2018, DOI 10.1890/03-0138; Hall SR, 2007, INTEGR COMP BIOL, V47, P295, DOI 10.1093/icb/icm057; Holand H, 2014, J AVIAN BIOL, V45, P365, DOI 10.1111/jav.00354; Holand H, 2013, PARASITOLOGY, V140, P1275, DOI 10.1017/S0031182013000735; Hudson PJ, 1998, SCIENCE, V282, P2256, DOI 10.1126/science.282.5397.2256; Hudson PJ, 2002, THE ECOLOGY OF WILDL, Vi-xii, P1; Husby A, 2006, J ANIM ECOL, V75, P1128, DOI 10.1111/j.1365-2656.2006.01132.x; Jensen H, 2004, J ANIM ECOL, V73, P599, DOI 10.1111/j.0021-8790.2004.00837.x; Jensen H, 2008, EVOLUTION, V62, P1275, DOI 10.1111/j.1558-5646.2008.00395.x; Mageroy JH, 2011, PARASITOLOGY, V138, P1910, DOI 10.1017/S0031182011001302; Martin LB, 2003, P ROY SOC B-BIOL SCI, V270, P153, DOI 10.1098/rspb.2002.2185; Marzal A, 2005, OECOLOGIA, V142, P541, DOI 10.1007/s00442-004-1757-2; MAY RM, 1978, J ANIM ECOL, V47, P249, DOI 10.2307/3934; MCCULLAGH P, 1980, J ROY STAT SOC B MET, V42, P109; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Nager RG, 2006, ARDEA, V94, P323; Nussey DH, 2007, CURR BIOL, V17, pR1000, DOI 10.1016/j.cub.2007.10.005; Nussey DH, 2013, AGEING RES REV, V12, P214, DOI 10.1016/j.arr.2012.07.004; Owen JP, 2010, TRENDS PARASITOL, V26, P530, DOI 10.1016/j.pt.2010.06.005; Patterson JEH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055779; Pedersen AB, 2008, J ANIM ECOL, V77, P370, DOI 10.1111/j.1365-2656.2007.01321.x; Poulin R., 2007, EVOL ECOL, V2; R Core Team, 2013, R A LANGUAGE AND ENV, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; Redpath SM, 2006, ECOL LETT, V9, P410, DOI 10.1111/j.1461-0248.2006.00895.x; Reed TE, 2008, SCIENCE, V321, P1681, DOI 10.1126/science.1159466; Ringsby TH, 2002, ECOLOGY, V83, P561, DOI 10.1890/0012-9658(2002)083[0561:ASDOAH]2.0.CO;2; Ringsby TH, 1999, OIKOS, V85, P419, DOI 10.2307/3546691; Ringsby TH, 2009, J ORNITHOL, V150, P469, DOI 10.1007/s10336-008-0365-z; Saether BE, 1999, J ANIM ECOL, V68, P628, DOI 10.1046/j.1365-2656.1999.00314.x; Tompkins DM, 2011, J ANIM ECOL, V80, P19, DOI 10.1111/j.1365-2656.2010.01742.x; Wilson K, 2002, THE ECOLOGY OF WILDL; WISSLER K, 1975, Journal of Wildlife Diseases, V11, P245	44	11	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125773	10.1371/journal.pone.0125773	http://dx.doi.org/10.1371/journal.pone.0125773			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933371	gold, Green Submitted, Green Published			2022-12-27	WOS:000353887100132
J	Leinonen, A; Koponen, M; Hartikainen, S				Leinonen, Anne; Koponen, Marjaana; Hartikainen, Sirpa			Systematic Review: Representativeness of Participants in RCTs of Acetylcholinesterase Inhibitors	PLOS ONE			English	Review							PLACEBO-CONTROLLED TRIAL; ALZHEIMERS-DISEASE; DOUBLE-BLIND; CLINICAL-TRIALS; GLOBAL FUNCTION; RIVASTIGMINE PATCH; DONEPEZIL; EFFICACY; GALANTAMINE; SAFETY	Objective To determine whether there are differences in age and sex distribution and presence of comorbidities between participants included in randomized controlled trials of acetylcholinesterase inhibitors and nationwide cohort of persons with Alzheimer's disease. Methods PubMed, Scopus and Cochrane Library databases were searched for original articles from their inception to January 4, 2015. Double-blind randomized controlled trials with donepezil, rivastigmine or galantamine compared to placebo in participants with Alzheimer's disease were included. Data from a nationwide cohort of persons with clinically verified diagnoses of Alzheimer's disease was defined as a reference population. Results 128 full-text articles were assessed for eligibility, 31 of them fulfilled criteria. Mean age of participants in randomized controlled trials (n = 15,032) was 5.8 years lower (95% CI 5.7 to 5.9, P < 0.001), compared to the mean age of 79.7 years in the reference population with Alzheimer's disease (n = 28,093). Most of the articles did not report age distribution of participants. The proportion of women was 63.2% (9,475/14,991) in randomized controlled trials and 67.8% (19,043/28,093) (P < 0.001) in the reference population. Information on comorbidities and use of concomitant drugs were lacking or poorly reported in most articles. Conclusions There is a discrepancy between participants in randomized controlled trials of acetylcholinesterase inhibitors and real-life population with Alzheimer's disease. Participants in randomized controlled trials were significantly younger. Further, more detailed reporting of age distribution, comorbidities and concomitant drugs would be important information for clinicians when evaluating conclusions from randomized controlled trials to real-life practice. The existing recommendations of inclusion of older people should be followed to ensure safe pharmacotherapy for older people.	[Leinonen, Anne; Koponen, Marjaana; Hartikainen, Sirpa] Univ Eastern Finland, Fac Hlth Sci, Sch Pharm, Kuopio, Finland	University of Eastern Finland	Koponen, M (corresponding author), Univ Eastern Finland, Fac Hlth Sci, Sch Pharm, Kuopio, Finland.	marjaana.koponen@uef.fi						Agid Y, 1998, CURR THER RES CLIN E, V59, P837, DOI 10.1016/S0011-393X(98)85048-0; Alzheimer's Disease International, 2009, WORLD ALZHEIMER REPO; American Psychiatric Association, 1994, DIAGNOSTIC AND STATI; Anthony S, 2014, DEMENT GERIATR COGN, V38, P271, DOI 10.1159/000360281; Black SE, 2007, NEUROLOGY, V69, P459, DOI 10.1212/01.wnl.0000266627.96040.5a; Brodaty H, 2005, DEMENT GERIATR COGN, V20, P120, DOI 10.1159/000086613; Burns A, 1999, DEMENT GERIATR COGN, V10, P237, DOI 10.1159/000017126; Cerreta F, 2012, NEW ENGL J MED, V367, P1972, DOI 10.1056/NEJMp1209034; Cherubini A, 2010, J AM GERIATR SOC, V58, P1791, DOI 10.1111/j.1532-5415.2010.03032.x; COHEN AC, 1950, ANN MATH STAT, V21, P557, DOI 10.1214/aoms/1177729751; COREYBLOOM J, 1998, INT J GERIATR PSYCHO, V1, P55; Crome P, 2011, DRUG AGING, V28, P667, DOI 10.2165/11591990-000000000-00000; Dodd KS, 2011, J AM GERIATR SOC, V59, P506, DOI 10.1111/j.1532-5415.2010.03305.x; EFGCP Geriatric Medicines Working Party, 2013, EFGCP GUIDELINES ON; European Commission, 2013, THE 2012 AGEING REPO; European Medicines Agency, 2011, EMA GERIATRIC MEDICI; Feldman H, 2001, NEUROLOGY, V57, P613, DOI 10.1212/WNL.57.4.613; Feldman HH, 2007, J NEUROL NEUROSUR PS, V78, P1056, DOI 10.1136/jnnp.2006.099424; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forette F, 1999, EUR J NEUROL, V6, P423, DOI 10.1046/j.1468-1331.1999.640423.x; Gill Sudeep S, 2004, Can J Clin Pharmacol, V11, pe274; Giron MST, 2005, INT J GERIATR PSYCH, V20, P201, DOI 10.1002/gps.1273; Greenberg SM, 2000, ARCH NEUROL-CHICAGO, V57, P94, DOI 10.1001/archneur.57.1.94; Hager K, 2014, NEUROPSYCH DIS TREAT, V10, P391, DOI 10.2147/NDT.S57909; Heiat A, 2002, ARCH INTERN MED, V162, P1682, DOI 10.1001/archinte.162.15.1682; Herrmann N, 2007, J AM GERIATR SOC, V55, P1517, DOI 10.1111/j.1532-5415.2007.01377.x; Homma A, 2000, DEMENT GERIATR COGN, V11, P299, DOI 10.1159/000017259; Homma A, 2008, DEMENT GERIATR COGN, V25, P399, DOI 10.1159/000122961; Hutchins LF, 1999, NEW ENGL J MED, V341, P2061, DOI 10.1056/NEJM199912303412706; International conference on harmonization (ICH) expert working group, 1993, ICH HARMONIZED TRIPA; Karaman Y, 2005, DEMENT GERIATR COGN, V19, P51, DOI 10.1159/000080972; Konrat C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033559; Krishnan KRR, 2003, AM J PSYCHIAT, V160, P2003, DOI 10.1176/appi.ajp.160.11.2003; Lee PY, 2001, JAMA-J AM MED ASSOC, V286, P708, DOI 10.1001/jama.286.6.708; Lewis JH, 2003, J CLIN ONCOL, V21, P1383, DOI 10.1200/JCO.2003.08.010; Lopez-Pousa S, 2004, BRAIN AGING, V4, P26; Lyketsos CG, 2004, ALZ DIS ASSOC DIS, V18, P171; Masoudi FA, 2003, AM HEART J, V146, P250, DOI 10.1016/S0002-8703(03)00189-3; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mohs RC, 2001, NEUROLOGY, V57, P481, DOI 10.1212/WNL.57.3.481; Nakamura Y, 2011, DEMENT GER COGN D EX, V1, P163, DOI 10.1159/000328929; Raskind MA, 2000, NEUROLOGY, V54, P2261, DOI 10.1212/WNL.54.12.2261; ROCHON PA, 1993, ARCH INTERN MED, V153, P243, DOI 10.1001/archinte.153.2.243; Rockwood K, 2006, CAN MED ASSOC J, V174, P1099, DOI 10.1503/cmaj.051432; Rockwood K, 2001, J NEUROL NEUROSUR PS, V71, P589, DOI 10.1136/jnnp.71.5.589; Rogers SL, 1998, NEUROLOGY, V50, P136, DOI 10.1212/WNL.50.1.136; Rogers SL, 1998, ARCH INTERN MED, V158, P1021, DOI 10.1001/archinte.158.9.1021; Rogers SL, 1996, DEMENTIA, V7, P293, DOI 10.1159/000106895; Rosler M, 1999, BMJ-BRIT MED J, V318, P633, DOI 10.1136/bmj.318.7184.633; Schneider LS, 1997, J AM GERIATR SOC, V45, P923, DOI 10.1111/j.1532-5415.1997.tb02960.x; Schoenmaker N, 2004, LANCET NEUROL, V3, P627, DOI 10.1016/S1474-4422(04)00884-1; Seltzer B, 2004, ARCH NEUROL-CHICAGO, V61, P1852, DOI 10.1001/archneur.61.12.1852; Sramek JJ, 1996, LIFE SCI, V58, P1201, DOI 10.1016/0024-3205(96)00081-1; Suhonen Jaana, 2010, Duodecim, V126, P2167; Tariot PN, 2000, NEUROLOGY, V54, P2269, DOI 10.1212/WNL.54.12.2269; Tolppanen Anna-Maija, 2013, Clin Epidemiol, V5, P277, DOI 10.2147/CLEP.S46622; Townsley CA, 2005, J CLIN ONCOL, V23, P3112, DOI 10.1200/JCO.2005.00.141; Wilcock GK, 2000, BRIT MED J, V321, P1445, DOI 10.1136/bmj.321.7274.1445; Wilkinson D, 2001, INT J GERIATR PSYCH, V16, P852, DOI 10.1002/gps.409; Winblad B, 2001, NEUROLOGY, V57, P489, DOI 10.1212/WNL.57.3.489; Winblad B, 2007, INT J GERIATR PSYCH, V22, P456, DOI 10.1002/gps.1788; Working group set up by the Finnish Medical Society Duodecim, 2010, MEMORY DISORDERS CUR	63	35	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124500	10.1371/journal.pone.0124500	http://dx.doi.org/10.1371/journal.pone.0124500			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933023	Green Submitted, Green Published, gold			2022-12-27	WOS:000353887100045
J	Mansouri, A; Sarayani, A; Ashouri, A; Sherafatmand, M; Hadjibabaie, M; Gholami, K				Mansouri, Ava; Sarayani, Amir; Ashouri, Asieh; Sherafatmand, Mona; Hadjibabaie, Molouk; Gholami, Kheirollah			Is 'Self-Medication' a Useful Term to Retrieve Related Publications in the Literature? A Systematic Exploration of Related Terms	PLOS ONE			English	Article							THE-COUNTER DRUGS; COMMUNITY PHARMACIES; CLARIFICATION; TERMINOLOGY; MEDICINES; ILLNESSES; SAFETY; ADULTS; PAPER; CARE	Background Self-Medication (SM), i.e. using medications to treat oneself, is a major concern for health researchers and policy makers. The terms "self medication" or "self-medication" (SM terms) have been used to explain various concepts while several terms have also been employed to define this practice. Hence, retrieving relevant publications would require exhaustive literature screening. So, we assessed the current situation of SM terms in the literature to improve the relevancy of search outcomes. Methods In this Systematic exploration, SM terms were searched in the 6 following databases and publisher's portals till April 2012: Web of Science, Scopus, PubMed, Google scholar, ScienceDirect, and Wiley. A simple search query was used to include only publications with SM terms. We used Relative-Risk (RR) to estimate the probability of SM terms use in related compared to unrelated publications. Sensitivity and specificity of SM terms as keywords in search query were also calculated. Relevant terms to SM practice were extracted and their Likelihood Ratio positive and negative (LR+/-) were calculated to assess their effect on the probability of search outcomes relevancy in addition to previous search queries. We also evaluated the content of unrelated publications. All mentioned steps were performed in title (TI) and title or abstract (TIAB) of publications. Results 1999 related and 1917 unrelated publications were found. SM terms RR was 4.5 in TI and 2.1 in TIAB. SM terms sensitivity and specificity respectively were 55.4% and 87.7% in TI and 84.0% and 59.5% in TIAB. "OTC" and "Over-The-Counter Medication", with LR+ 16.78 and 16.30 respectively, provided the most conclusive increase in the probability of the relevancy of publications. The most common unrelated SM themes were self-medication hypothesis, drug abuse and Zoopharmacognosy. Conclusions Due to relatively low specificity or sensitivity of SM terms, relevant terms should be employed in search queries and clear definitions of SM applications should be applied to improve the relevancy of publications.	[Mansouri, Ava; Sarayani, Amir; Ashouri, Asieh; Hadjibabaie, Molouk; Gholami, Kheirollah] Univ Tehran Med Sci, Res Ctr Rat Use Drugs, Tehran, Iran; [Ashouri, Asieh] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran; [Sherafatmand, Mona; Hadjibabaie, Molouk; Gholami, Kheirollah] Univ Tehran Med Sci, Fac Pharm, Tehran, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences	Hadjibabaie, M (corresponding author), Univ Tehran Med Sci, Res Ctr Rat Use Drugs, Tehran, Iran.	hajibaba@tums.ac.ir	Ashouri, Asieh/H-3630-2018	Ashouri, Asieh/0000-0002-3791-8451; Sarayani, Amir/0000-0003-2790-9938	Tehran University of Medical Sciences (TUMS) [18373-156-02-91]	Tehran University of Medical Sciences (TUMS)(Tehran University of Medical Sciences)	This work was supported by Tehran University of Medical Sciences (TUMS) (Grant number: 18373-156-02-91). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasdy D, 2011, ARCH PHARM PRACT, V2, P95; Aronson JK, 2005, DRUG SAFETY, V28, P851, DOI 10.2165/00002018-200528100-00003; Blenkinsopp A, 1996, BRIT MED J, V312, P629; Brata C, 2013, RES SOC ADMIN PHARM, V9, P370, DOI 10.1016/j.sapharm.2012.08.001; Cavaco AM, 2012, RES SOC ADMIN PHARM, V8, P87, DOI 10.1016/j.sapharm.2011.07.004; Du Y, 2009, BRIT J CLIN PHARMACO, V68, P599, DOI 10.1111/j.1365-2125.2009.03477.x; Elliott Rohan A, 2009, BMC Geriatr, V9, P27, DOI 10.1186/1471-2318-9-27; Ferner RE, 2006, DRUG SAFETY, V29, P1011, DOI 10.2165/00002018-200629110-00001; Fried PW, 2001, J THORAC CARDIOV SUR, V121, pS3, DOI 10.1067/mtc.2001.114493; Gambescia Stephen F, 2013, Educ Health (Abingdon), V26, P122, DOI 10.4103/1357-6283.120706; Geissler PW, 2000, SOC SCI MED, V50, P1771, DOI 10.1016/S0277-9536(99)00428-1; Godfrey CM, 2011, JBI DATABASE SYSTEMA, V8, P1351; Goh LY, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-42; Grigoryan L, 2006, EMERG INFECT DIS, V12, P452, DOI 10.3201/eid1203.050992; Hall DH, 2007, J PSYCHOACTIVE DRUGS, V39, P151, DOI 10.1080/02791072.2007.10399873; Huffman MA, 2003, P NUTR SOC, V62, P371, DOI 10.1079/PNS2003257; Hughes CM, 2001, DRUG SAFETY, V24, P1027, DOI 10.2165/00002018-200124140-00002; Hughes GF, 1999, PHARM WORLD SCI, V21, P251, DOI 10.1023/A:1008788726842; Jamali HR, 2011, SCIENTOMETRICS, V88, P653, DOI 10.1007/s11192-011-0412-z; Jenkins Michelle, 2004, Health Info Libr J, V21, P148, DOI 10.1111/j.1471-1842.2004.00511.x; Kaizer F, 2010, J REHABIL MED, V42, P239, DOI 10.2340/16501977-0523; Landers TF, 2010, J AM ACAD NURSE PRAC, V22, P488, DOI 10.1111/j.1745-7599.2010.00539.x; Lawrence S, 1999, INT TECHN SERV 1999; Lefebvre C, 2011, COCHRANE COLLABORATI; Masic Izet, 2011, Acta Inform Med, V19, P68, DOI 10.5455/aim.2011.19.68-79; McKenna L, 2006, J ADV NURS, V56, P636, DOI 10.1111/j.1365-2648.2006.04037.x; Montgomery AJ, 2011, OCCUP MED-OXFORD, V61, P490, DOI 10.1093/occmed/kqr098; Morgan DJ, 2011, LANCET INFECT DIS, V11, P692, DOI 10.1016/S1473-3099(11)70054-8; Ryan A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-96; Sallam S. A., 2009, Eastern Mediterranean Health Journal, V15, P683; Sanz F, 2000, AM J HEALTH-SYST PH, V57, P1601, DOI 10.1093/ajhp/57.17.1601; Schroeder K, 2009, EVID BASED CHILD HLT, V4, P65; Segarra R, 2011, EUR ARCH PSY CLIN N, V261, P241, DOI 10.1007/s00406-010-0146-6; Setiati Siti, 2007, Acta Med Indones, V39, P50; Vrijens B, 2012, BRIT J CLIN PHARMACO, V73, P691, DOI 10.1111/j.1365-2125.2012.04167.x; Wertheimer AI, 2008, PHARM WORLD SCI, V30, P309, DOI 10.1007/s11096-007-9187-y; Wimpenny P., 2010, JBI LIB SYST REV, V8, P405, DOI [10.11124/jbisrir-2010-123, DOI 10.11124/JBISRIR-2010-123]	37	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125093	10.1371/journal.pone.0125093	http://dx.doi.org/10.1371/journal.pone.0125093			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH2XA	25932634	Green Published, Green Submitted, gold			2022-12-27	WOS:000353887100078
J	Sulzgruber, P; Koller, L; Reiberger, T; El-Hamid, F; Forster, S; Rothgerber, DJ; Goliasch, G; Wojta, J; Niessner, A				Sulzgruber, Patrick; Koller, Lorenz; Reiberger, Thomas; El-Hamid, Feras; Forster, Stefan; Rothgerber, David-Jonas; Goliasch, Georg; Wojta, Johann; Niessner, Alexander			Butyrylcholinesterase Predicts Cardiac Mortality in Young Patients with Acute Coronary Syndrome	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; ARTERY-DISEASE; RISK-FACTORS; COLLABORATION; GUIDELINES; SURVIVAL	Background The incidence of acute coronary syndrome (ACS) in young people (<= 65 years) is continuously rising. While prognostic factors in ACS are well-investigated less attention has been paid to their age-dependent prognostic value and their particular relevance in younger patients. The aim of our study was to assess the age-dependent prognostic impact of butyrylcholinesterase (BChE). Methods Retrospective cohort study including 624 patients with ACS. Patients were stratified by age into equal groups (n = 208) corresponding to "young patients" (45-64 years), "middle-aged patients" (65-84 years) and "old patients" (85-100 years). Cox regression hazard analysis was used to assess the influence of BChE on survival. Results After a mean follow-up time of 4.0 (interquartile range [IQR] 2.0-6.4) years, 154 patients (24.7%) died due to a cardiac cause. In the overall cohort, BChE was indirectly associated with cardiac mortality-free survival (adjusted hazard ratio (HR): 0.70 (95% confidence interval [CI] 0.53-0.93, p = 0.01). The primary-analysis of BChE by age strata showed the strongest effect in the age group 45-64 years with an adjusted HR per 1-SD of 0.28 (95% CI 0.12-0.64, p = 0.003), a weaker association with mortality in middle aged (65-84 years: adjusted HR per 1-SD 0.66 [95% CI: 0.41-1.06], p = 0.087), and no association in older patients (85-100 years: adjusted HR per 1-SD 0.89 [95% CI: 0.58-1.38], p = 0.613). Conclusion BChE is a strong predictor for cardiac mortality specifically in younger patients with ACS aged between 45 and 64 years. No significant association of BChE with cardiac-mortality was detected in other age classes.	[Sulzgruber, Patrick; Koller, Lorenz; El-Hamid, Feras; Forster, Stefan; Rothgerber, David-Jonas; Goliasch, Georg; Wojta, Johann; Niessner, Alexander] Med Univ Vienna, Dept Internal Med 2, Div Cardiol, Vienna, Austria; [Reiberger, Thomas] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Vienna, Austria; [Reiberger, Thomas] Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Lab, Boston, MA 02114 USA; [Reiberger, Thomas] Harvard Univ, Sch Med, Boston, MA USA	Medical University of Vienna; Medical University of Vienna; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Niessner, A (corresponding author), Med Univ Vienna, Dept Internal Med 2, Div Cardiol, Vienna, Austria.	alexander.niessner@meduniwien.ac.at	Wojta, Johann/AAC-8433-2020; Reiberger, Thomas/H-7613-2019	Wojta, Johann/0000-0002-1282-9276; Reiberger, Thomas/0000-0002-4590-3583; Goliasch, Georg/0000-0002-6219-6104; Sulzgruber, Patrick/0000-0001-5146-0099	Verein zur Forderung der Forschung - ATVB (Vienna, Austria)	Verein zur Forderung der Forschung - ATVB (Vienna, Austria)	The authors received funding from Verein zur Forderung der Forschung - ATVB (Vienna, Austria) to support this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara VM, 2002, SCAND J CLIN LAB INV, V62, P399, DOI 10.1080/00365510260296564; Alexander KP, 2007, CIRCULATION, V115, P2549, DOI 10.1161/CIRCULATIONAHA.107.182615; [Anonymous], 2000, EUR HEART J, V21, P1502; BARBASH GI, 1995, EUR HEART J, V16, P313; Basoor Abhijeet, 2011, Am Heart Hosp J, V9, pE37; BRAMER G R, 1988, World Health Statistics Quarterly, V41, P32; Calderon-Margalit R, 2006, CLIN CHEM, V52, P845, DOI 10.1373/clinchem.2005.059857; Distelmaier K, 2014, CRIT CARE, V18, DOI 10.1186/cc13711; Fuhrmann V, 2010, WIEN KLIN WOCHENSCHR, V122, P129, DOI 10.1007/s00508-010-1357-6; Goliasch G, 2013, EUR J CLIN INVEST, V43, P332, DOI 10.1111/eci.12049; Goliasch G, 2012, CLIN CHEM, V58, P1055, DOI 10.1373/clinchem.2011.175984; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; Johnson G, 2012, NEUROCHEM INT, V61, P783, DOI 10.1016/j.neuint.2012.06.016; MAGARIAN EO, 1987, J CLIN PHARMACOL, V27, P819, DOI 10.1002/j.1552-4604.1987.tb03004.x; Mandorfer M, 2014, J VIRAL HEPATITIS, V21, P33, DOI 10.1111/jvh.12118; Ryden L, 2013, EUR HEART J, V34, P3035, DOI 10.1093/eurheartj/eht108; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397	17	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0123948	10.1371/journal.pone.0123948	http://dx.doi.org/10.1371/journal.pone.0123948			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933219	Green Submitted, Green Published, gold			2022-12-27	WOS:000353887100026
J	Ramalho, FS; Malaquias, JB; Lira, ACS; Oliveira, FQ; Zanuncio, JC; Fernandes, FS				Ramalho, Francisco S.; Malaquias, Jose B.; Lira, Aline C. S.; Oliveira, Flavia Q.; Zanuncio, Jose C.; Fernandes, Francisco S.			Temperature-Dependent Fecundity and Life Table of the Fennel Aphid Hyadaphis foeniculi (Passerini) (Hemiptera: Aphididae)	PLOS ONE			English	Article							PERSICAE SULZER HOMOPTERA; GOSSYPII GLOVER; POPULATION PARAMETERS; NASONOVIA-RIBISNIGRI; ASHMEAD HYMENOPTERA; AULACORTHUM-SOLANI; DEVELOPMENTAL RATE; REPRODUCTION; GROWTH; BRACONIDAE	Hyadaphis foeniculi (Passerini) (Hemiptera: Aphididae) is a cosmopolitan species and the main pest of fennel in northeastern Brazil. Understanding the relationship between temperature variations and the population growth rates of H. foeniculi is essential to predict the population dynamics of this aphid in the fennel crop. The aim of this study was to measure the effect of constant temperature on the adult prereproductive period and the life table fertility parameters (infinitesimal increase ratio (r(m)), gross reproduction rate (GRR), net reproduction rate (R-0), finite increase ratio (lambda), generation time (GT), the time required for the population to double in the number of individuals (DT), and the reproduction value (RVx)) of the fennel pest H. foeniculi. The values of lx (survival of nymphs at age x) increased as the temperature rose from 15 to 28 degrees C and fell at 30 degrees C, whereas mx (number of nymphs produced by each nymph of age x) increased from 15 to 25 degrees C and fell at 28 and 30 degrees C. The net reproduction rates (R-0) of populations of H. foeniculi increased with temperature and ranged from 1.9 at 15 degrees C to 12.23 at 28 degrees C for each generation. The highest population increase occurred with the apterous aphids at 28 degrees C. The rate of population increase per unit time (r(m)) (day) ranged from 0.0033 (15 degrees C) to 0.1995 (28 degrees C). The highest values of r(m) were recorded at temperatures of 28 degrees C and 30 degrees C. The rm values were a good fit to the models tested, with R-2 > 0.91 and R-adj(2) > 0.88. The models tested (Davidson, Sharpe and DeMichele modified by Schoolfield et al., Logan et al., Lamb, and Briere et al.) were very good fits for the rm values observed, with R-2 > 0.91 and R-adj(2) > 0.88. The only exception was the Davidson model. Of the parameters studied, the reproductive capacity was higher in the apterous aphids, with the unique exception of daily fecundity at 28 degrees C, which was higher in the alate aphids of H. foeniculi. Parameters relating to the age-specific fertility table for H. foeniculi were heavily influenced by temperature, with the highest biotic potential and population growth capacity found at 34 degrees C. Therefore, the results obtained in this study could be of practical significance for predicting outbreaks of fennel aphids and improving the management of this aphid in fennel crops.	[Ramalho, Francisco S.; Malaquias, Jose B.; Lira, Aline C. S.; Fernandes, Francisco S.] Embrapa Algodao, Unidade Controle Biol, Campina Grande, Paraiba, Brazil; [Oliveira, Flavia Q.] Univ Estadual Paulista Jaboticabal, Sao Paulo, Brazil; [Zanuncio, Jose C.] Univ Fed Vicosa, Vicosa, MG, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Estadual Paulista; Universidade Federal de Vicosa	Ramalho, FS (corresponding author), Embrapa Algodao, Unidade Controle Biol, Campina Grande, Paraiba, Brazil.	ramalhohvv@globo.com	Malaquias, José Bruno B/I-1945-2015; FS, Ramalho/AAC-8058-2019; Lira, Aline/C-2354-2017; Fernandes, Francisco/E-4608-2016	Malaquias, José Bruno B/0000-0003-3937-9575; Lira, Aline/0000-0002-8592-2068; Fernandes, Francisco/0000-0002-0592-2536	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This project was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq and the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2006, J THERM BIOL, V31, P541, DOI 10.1016/j.jtherbio.2006.06.002; Aprotosoaie AC, 2010, FARMACIA, V58, P46; Bale JS, 2007, APHIDS AS CROP PESTS, P287, DOI 10.1079/9780851998190.0287; Bernardi D, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.2801; Briere JF, 1998, ENVIRON ENTOMOL, V27, P94, DOI 10.1093/ee/27.1.94; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Chakravarty N. V. K., 2004, Journal of Agrometeorology, V6, P215; Chattopadhyay C, 2005, CROP PROT, V24, P1042, DOI 10.1016/j.cropro.2005.02.010; Chi H, 2006, ENVIRON ENTOMOL, V35, P10, DOI 10.1603/0046-225X-35.1.10; Cividanes Francisco J., 2003, Neotrop. entomol., V32, P413, DOI 10.1590/S1519-566X2003000300005; Cividanes Francisco J., 2003, Bragantia, V62, P61, DOI 10.1590/S0006-87052003000100008; Cividanes FJ, 2012, PESQUI AGROPECU BRAS, V47, P505, DOI 10.1590/S0100-204X2012000400005; COFFELT MA, 1989, ENVIRON ENTOMOL, V18, P46, DOI 10.1093/ee/18.1.46; Davidson J., 1942, AUSTRALIAN JOUR EXP BIOL AND MED SCI, V20, P233, DOI 10.1038/icb.1942.39; Davidson J, 1944, J ANIM ECOL, V13, P26, DOI 10.2307/1326; DAY RK, 1995, INSECT MIGRATION: TRACKING RESOURCES THROUGH SPACE AND TIME, P323; De Conti BF, 2010, REV BRAS ENTOMOL, V54, P654, DOI 10.1590/S0085-56262010000400018; Diaz BM, 2005, ENVIRON ENTOMOL, V34, P527, DOI 10.1603/0046-225X-34.3.527; DIXON AFG, 1971, OECOLOGIA, V8, P179, DOI 10.1007/BF00345812; Dixon AFG, 1998, APHID ECOLOGY OPTIMI; Fernandes FS, 2013, FLA ENTOMOL, V96, P92, DOI 10.1653/024.096.0112; Ferreira RG, 2004, PESQUI AGROPECU BRAS, V39, P1265, DOI 10.1590/S0100-204X2004001200015; GODOY KARLLA B., 2002, Neotrop. entomol., V31, P41, DOI 10.1590/S1519-566X2002000100006; HUTCHISON WD, 1984, ENVIRON ENTOMOL, V13, P1173, DOI 10.1093/ee/13.5.1173; KEULS M., 1952, Euphytica, V1, P112, DOI 10.1007/BF01908269; Krebs CJ, 1994, ECOLOGY EXPT ANAL DI; Kuo MH, 2006, APPL ENTOMOL ZOOL, V41, P171, DOI 10.1303/aez.2006.171; La Rossa FR, 2013, NEOTROP ENTOMOL, V42, P634, DOI 10.1007/s13744-013-0166-9; LAMB RJ, 1992, ENVIRON ENTOMOL, V21, P10, DOI 10.1093/ee/21.1.10; LOGAN JA, 1976, ENVIRON ENTOMOL, V5, P1133, DOI 10.1093/ee/5.6.1133; Lotka AJ, 1907, AM J SCI, V24, P199; Maia AHN, 2000, J ECON ENTOMOL, V93, P511, DOI 10.1603/0022-0493-93.2.511; Malaquias JB, 2015, PEST MANAG SCI, V71, P744, DOI 10.1002/ps.3845; Malaquias JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100983; Malaquias JB, 2010, TURK J AGRIC FOR, V34, P235, DOI 10.3906/tar-0811-18; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; McCornack BP, 2004, J ECON ENTOMOL, V97, P854, DOI 10.1603/0022-0493(2004)097[0854:DOSAHA]2.0.CO;2; Mehrparvar M, 2007, EUR J ENTOMOL, V104, P631, DOI 10.14411/eje.2007.078; Nielsen AL, 2008, ENVIRON ENTOMOL, V37, P348, DOI 10.1603/0046-225X(2008)37[348:DREALT]2.0.CO;2; NOWIERSKI RM, 1983, ENVIRON ENTOMOL, V12, P680, DOI 10.1093/ee/12.3.680; Opender Koul, 2008, Biopesticides International, V4, P63; Price PW., 1997, INSECT ECOLOGY, V3rd edn; RABASSE JM, 1999, DEV PLANT PATHOL, V14, P235; Ramalho FS, 2012, J ECON ENTOMOL, V105, P113, DOI 10.1603/EC11219; Ramalho FS, 2011, AN ACAD BRAS CIENC, V83, P1021, DOI 10.1590/S0001-37652011005000026; ROOT RB, 1973, ECOL MONOGR, V43, P95, DOI 10.2307/1942161; Sanchez JA, 2007, J ECON ENTOMOL, V100, P123, DOI 10.1603/0022-0493(2007)100[123:TAMSFA]2.0.CO;2; SAS Institute, 2006, SAS STAT US GUID; Satar S, 2008, J PLANT DIS PROTECT, V115, P69, DOI 10.1007/BF03356241; Satar S., 1998, Turkiye Entomoloji Dergisi, V22, P187; Satar S, 2005, J PEST SCI, V78, P133, DOI 10.1007/s10340-005-0082-9; SCHOOLFIELD RM, 1981, J THEOR BIOL, V88, P719, DOI 10.1016/0022-5193(81)90246-0; SHARPE PJH, 1977, J THEOR BIOL, V64, P649, DOI 10.1016/0022-5193(77)90265-X; Takalloozadeh Hadji Mohammad, 2010, Middle-East Journal of Scientific Research, V6, P25; Vasicek A, 2002, PESQUI AGROPECU BRAS, V37, P407, DOI 10.1590/S0100-204X2002000300023; WAGNER TL, 1984, ANN ENTOMOL SOC AM, V77, P208, DOI 10.1093/aesa/77.2.208; Wilson L. T., 1983, California Agriculture, V37, P4; Zamani AA, 2006, J APPL ENTOMOL, V130, P453, DOI 10.1111/j.1439-0418.2006.01088.x	58	15	16	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0122490	10.1371/journal.pone.0122490	http://dx.doi.org/10.1371/journal.pone.0122490			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927991	Green Submitted, Green Published, gold			2022-12-27	WOS:000353713100009
J	Castaneda-Alvarez, NP; de Haan, S; Juarez, H; Khoury, CK; Achicanoy, HA; Sosa, CC; Bernau, V; Salas, A; Heider, B; Simon, R; Maxted, N; Spooner, DM				Castaneda-Alvarez, Nora P.; de Haan, Stef; Juarez, Henry; Khoury, Colin K.; Achicanoy, Harold A.; Sosa, Chrystian C.; Bernau, Vivian; Salas, Alberto; Heider, Bettina; Simon, Reinhard; Maxted, Nigel; Spooner, David M.			Ex Situ Conservation Priorities for the Wild Relatives of Potato (Solanum L. Section Petota)	PLOS ONE			English	Article							GLOBODERA-PALLIDA STONE; LATE BLIGHT RESISTANCE; TUBER-BEARING SOLANUM; SOMATIC HYBRIDS; CULTIVATED POTATO; PHYTOPHTHORA-INFESTANS; RALSTONIA-SOLANACEARUM; SPECIES DISTRIBUTIONS; ORTHOLOG SEQUENCES; GENETIC-RESOURCES	Crop wild relatives have a long history of use in potato breeding, particularly for pest and disease resistance, and are expected to be increasingly used in the search for tolerance to biotic and abiotic stresses. Their current and future use in crop improvement depends on their availability in ex situ germplasm collections. As these plants are impacted in the wild by habitat destruction and climate change, actions to ensure their conservation ex situ become ever more urgent. We analyzed the state of ex situ conservation of 73 of the closest wild relatives of potato (Solanum section Petota) with the aim of establishing priorities for further collecting to fill important gaps in germplasm collections. A total of 32 species (43.8%), were assigned high priority for further collecting due to severe gaps in their ex situ collections. Such gaps are most pronounced in the geographic center of diversity of the wild relatives in Peru. A total of 20 and 18 species were assessed as medium and low priority for further collecting, respectively, with only three species determined to be sufficiently represented currently. Priorities for further collecting include: (i) species completely lacking representation in germplasm collections; (ii) other high priority taxa, with geographic emphasis on the center of species diversity; (iii) medium priority species. Such collecting efforts combined with further emphasis on improving ex situ conservation technologies and methods, performing genotypic and phenotypic characterization of wild relative diversity, monitoring wild populations in situ, and making conserved wild relatives and their associated data accessible to the global research community, represent key steps in ensuring the long-term availability of the wild genetic resources of this important crop.	[Castaneda-Alvarez, Nora P.; Khoury, Colin K.; Achicanoy, Harold A.; Sosa, Chrystian C.; Bernau, Vivian] CIAT, Decis & Policy Anal Program, Cali, Colombia; [Castaneda-Alvarez, Nora P.; Maxted, Nigel] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [de Haan, Stef; Juarez, Henry; Salas, Alberto; Heider, Bettina] CIP, Global Program Genet Resources, Lima, Peru; [Khoury, Colin K.] Wageningen Univ, Ctr Crop Syst Anal, NL-6700 AP Wageningen, Netherlands; [Simon, Reinhard] CIP, Integrated IT & Computat Res Unit, Lima, Peru; [Spooner, David M.] Univ Wisconsin, USDA ARS, Dept Hort, Vegetable Crop Res Unit, Madison, WI 53706 USA	Alliance; International Center for Tropical Agriculture - CIAT; University of Birmingham; CGIAR; International Potato Center (CIP); Wageningen University & Research; CGIAR; International Potato Center (CIP); United States Department of Agriculture (USDA); University of Wisconsin System; University of Wisconsin Madison	Castaneda-Alvarez, NP (corresponding author), CIAT, Decis & Policy Anal Program, Cali, Colombia.	n.p.castaneda@cgiar.org	Álvarez, Nora Patricia Castañeda/I-8026-2015; Arango, Chrystian Camilo Sosa/N-3989-2019; Juarez, Henry/AFN-7756-2022; Sosa, Chrystian Camilo/I-6787-2016; Khoury, Colin K./AAA-1864-2020	Álvarez, Nora Patricia Castañeda/0000-0003-1827-4782; Arango, Chrystian Camilo Sosa/0000-0002-3734-3248; Juarez, Henry/0000-0002-8535-7089; Sosa, Chrystian Camilo/0000-0002-3734-3248; Khoury, Colin K./0000-0001-7893-5744; Simon, Reinhard/0000-0002-4608-9077; Heider, Bettina/0000-0002-9792-8512; Bernau, Vivian/0000-0002-2393-8101	Government of Norway; aforementioned initiative; CGIAR Research Program on Roots, Tubers and Bananas; CGIAR Research Program on Climate Change, Agriculture, and Food Security in Cali, Colombia; ARS [ARS-0424614] Funding Source: Federal RePORTER	Government of Norway; aforementioned initiative; CGIAR Research Program on Roots, Tubers and Bananas; CGIAR Research Program on Climate Change, Agriculture, and Food Security in Cali, Colombia; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was undertaken as part of the initiative "Adapting Agriculture to Climate Change: Conserving, Protecting and Preparing Crop Wild Relatives," which is supported by the Government of Norway. The project is managed by the Global Crop Diversity Trust with the Millennium Seed Bank of the Royal Botanic Gardens, Kew UK and implemented in partnership with national and international genebanks and plant breeding institutes around the world. For further information, go to the project website: http://www.cwrdiversity.org/. Funding was provided by the aforementioned initiative; the CGIAR Research Program on Roots, Tubers and Bananas; and the CGIAR Research Program on Climate Change, Agriculture, and Food Security in Cali, Colombia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames M, 2010, TAXON, V59, P1091, DOI 10.1002/tax.594009; Azurdia C, 2011, ATLAS GUATEMALTECO D; Bivand R, 2014, RGDAL BINDINGS FOR T; Bivand R.S., 2013, APPL SPATIAL DATA AN, DOI 10.1007/978-1-4614-7618-4; Bradshaw JE, 2005, EUPHYTICA, V146, P9, DOI 10.1007/s10681-005-3881-4; Bradshaw JE., 2006, POTATO RES, V49, P49, DOI [10.1007/s11540-006-9002-5, DOI 10.1007/S11540-006-9002-5]; Cadima X, 2014, J NAT CONSERV, V22, P113, DOI 10.1016/j.jnc.2013.09.007; Cai DY, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-70; Camadro E.L, 2014, BAG, J. basic appl. genet., V25, P41; Camadro EL, 2004, THEOR APPL GENET, V109, P1369, DOI 10.1007/s00122-004-1753-2; Camadro EL, 2012, BOTANY, V90, P1065, DOI 10.1139/b2012-090; CARDI T, 1993, THEOR APPL GENET, V87, P193, DOI 10.1007/BF00223764; Carputo D., 1996, Journal of Genetics and Breeding, V50, P221; Carputo D, 1997, AM POTATO J, V74, P161, DOI 10.1007/BF02851595; delRio AH, 1997, THEOR APPL GENET, V95, P191, DOI 10.1007/s001220050547; delRio AH, 1997, THEOR APPL GENET, V95, P199, DOI 10.1007/s001220050548; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Estrada N, 1991, SOLANACEAE III TAXON; ESTRADA RN, 1980, AM POTATO J, V57, P609, DOI 10.1007/BF02854131; Fajardo D, 2011, SYST BOT, V36, P163, DOI 10.1600/036364411X553252; Frost KE, 2006, EUPHYTICA, V149, P281, DOI 10.1007/s10681-005-9076-1; Gonzalez M, 2013, AGROCIENCIA-URUGUAY, V17, P45; Guarino L, 2011, NAT CLIM CHANGE, V1, P374, DOI 10.1038/nclimate1272; Hanneman RE, 1999, POTATO RES, V42, P283, DOI 10.1007/BF02357859; HARLAN J R, 1971, Taxon, V20, P509, DOI 10.2307/1218252; Hawkes J. G., 1979, Broadening the genetic base of crops. Proceedings of the conference, Wageningen, Netherlands, 3-7 July 1978, P19; Hawkes JG, 2000, THE EX SITU CONSERVA; Hijmans R.J., 2014, DISMO SPECIES DISTRI; Hijmans R. J., 2014, R PACKAGE VERSION; Hijmans RJ, 2003, EUPHYTICA, V130, P47, DOI 10.1023/A:1022344327669; Hijmans RJ, 2001, AM J BOT, V88, P2101, DOI 10.2307/3558435; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2000, CONSERV BIOL, V14, P1755, DOI [10.1046/j.1523-1739.2000.98543.x, 10.1111/j.1523-1739.2000.98543.x]; Hijmans RJ, 2002, ATLAS OF WILD POTATO, P143; Hijmans RJ, 2007, GLOBAL ECOL BIOGEOGR, V16, P485, DOI 10.1111/j.1466-8238.2007.00308.x; Hodgkin T., 2008, P535, DOI 10.1079/9781845930998.0535; Iriondo JM, 2012, AGROBIODIVERSITY CONSERVATION: SECURING THE DIVERSITY OF CROP WILD RELATIVES AND LANDRACES, P72, DOI 10.1079/9781845938512.0072; Jansky SH, 2013, CROP SCI, V53, P746, DOI 10.2135/cropsci2012.11.0627; Jansky SH, 2006, CROP SCI, V46, P2561, DOI 10.2135/cropsci2005.12.0461; Jansky SH, 2011, AM J POTATO RES, V88, P218, DOI 10.1007/s12230-011-9186-3; Jarvis A, 2008, AGR ECOSYST ENVIRON, V126, P13, DOI 10.1016/j.agee.2008.01.013; Jo KR, 2011, THEOR APPL GENET, V123, P1331, DOI 10.1007/s00122-011-1670-0; Jones JDG, 2014, PHILOS T R SOC B, V369, DOI [10.1098/rstb.2013.0087, 10.1098/rstb.2013.008]; Khoury CK, 2014, P NATL ACAD SCI USA, V111, P4001, DOI 10.1073/pnas.1313490111; Kraak A., 1992, Industrial Crops and Products, V1, P107, DOI 10.1016/0926-6690(92)90007-I; Laferriere LT, 1999, THEOR APPL GENET, V98, P1272, DOI 10.1007/s001220051193; Lewin-Koh N, 2014, MAPTOOLS TOOLS FOR R; Lindqvist-Kreuze H, 2010, MOL PLANT PATHOL, V11, P513, DOI [10.1111/J.1364-3703.2010.00622.X, 10.1111/j.1364-3703.2010.00622.x]; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Liu ZY, 2009, AM J POTATO RES, V86, P476, DOI 10.1007/s12230-009-9103-1; Luthra S. K., 2009, Potato Journal (Shimla), V36, P115; MATTHEIJ WM, 1992, THEOR APPL GENET, V83, P459, DOI 10.1007/BF00226534; Maxted N, 2012, BOCCONEA, V24, P115, DOI DOI 10.7320/B0CC25.005); Maxted N, 2008, DIVERS DISTRIB, V14, P1018, DOI 10.1111/j.1472-4642.2008.00512.x; MENDOZA H A, 1974, Hortscience, V9, P328; Naess SK, 2000, THEOR APPL GENET, V101, P697, DOI 10.1007/s001220051533; Narancio R, 2013, EUR J PLANT PATHOL, V136, P823, DOI 10.1007/s10658-013-0210-y; Nix H.A., 1986, ATLAS ELAPID SNAKES, P4; Ochoa C, 1999, LAS PAPAS DE SUDAMER, P1036; Ochoa C., 1990, THE POTATOES OF SOUT; Ochoa C, 2003, LAS PAPAS DEL PERU B; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Ovchinnikova A, 2011, BOT J LINN SOC, V165, P107, DOI 10.1111/j.1095-8339.2010.01107.x; Pavek JJ, 2001, AM J POTATO RES, V78, P433, DOI 10.1007/BF02896375; Pebesma E.J., 2005, R NEWS, V5, P9; Pelletier Y, 2007, AM J POTATO RES, V84, P143, DOI 10.1007/BF02987137; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; R Core Team, 2014, R A LANGUAGE AND ENV, DOI [10.1016/j.jneumeth.2014.06.019, DOI 10.1016/J.JNEUMETH.2014.06.019]; Ramirez-Villegas J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013497; Rodriguez F, BMC EVOL BIOL; Ross H., 1979, Broadening the genetic base of crops. Proceedings of the conference, Wageningen, Netherlands, 3-7 July 1978, P237; Ross H, 1986, FORTSCHRITTE DER PFL, V13; RUDORF W., 1958, EUROPEAN POTATO JOUR, V1, P10; Santini M, 2000, AM J POTATO RES, V77, P211, DOI 10.1007/BF02855788; Shan F, 2005, THEOR APPL GENET, V110, P381, DOI 10.1007/s00122-004-1849-8; Simon R, 2011, SYST BOT, V36, P1062, DOI 10.1600/036364411X605065; Simon R, 2010, INVAS PLANT SCI MANA, V3, P286, DOI 10.1614/IPSM-D-09-00043.1; Smyda P, 2013, PLANT CELL REP, V32, P1231, DOI 10.1007/s00299-013-1422-5; Spooner DM, 2014, BOT REV, V80, P283, DOI 10.1007/s12229-014-9146-y; Spooner DM, 2009, AM J BOT, V96, P1177, DOI 10.3732/ajb.0800246; Spooner DM, 2001, AM J POTATO RES, V78, P237, DOI 10.1007/BF02875691; Stevenson W, 2001, COMPENDIUM OF POTATO; Storlie C., 2014, SDMTOOLS SPECIES DIS; Suarez SI, 2009, J NEMATOL, V41, P5; Thieme R, 2008, THEOR APPL GENET, V116, P691, DOI 10.1007/s00122-007-0702-2; Tucci M, 1996, POTATO RES, V39, P345, DOI 10.1007/BF02357938; UHRIG H, 1981, Z PFLANZENZUCHT, V86, P148; Uitdewillgen J, 2013, PLOS ONE, V8, P1; van der Vossen E, 2003, PLANT J, V36, P867, DOI 10.1046/j.1365-313X.2003.01934.x; Vice-ministry for the environment biodiversity and climate change (VMABCC), 2009, RED BOOK OF CROP WIL, P340; Villamon FG, 2005, THEOR APPL GENET, V111, P1201, DOI 10.1007/s00122-005-0053-9; Vincent H, 2013, BIOL CONSERV, V167, P265, DOI 10.1016/j.biocon.2013.08.011; Wale SJ, 2008, DISEASES PESTS AND D; Wang Fang, 2011, Molecular Plant Breeding, V2011, P04; Wang MX, 2008, HEREDITY, V101, P527, DOI 10.1038/hdy.2008.61; WATANABE KN, 1995, GENOME, V38, P27, DOI 10.1139/g95-004; WATANABE KN, 1994, THEOR APPL GENET, V88, P135, DOI 10.1007/BF00225888; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wiersema JH, 2012, ACTA HORTIC, V948, P285, DOI 10.17660/ActaHortic.2012.948.33	99	38	43	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0122599	10.1371/journal.pone.0122599	http://dx.doi.org/10.1371/journal.pone.0122599			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923711	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600018
J	Dong, CJ; Zhou, M; Liu, DX; Long, X; Guo, T; Kong, XQ				Dong, Chengjun; Zhou, Min; Liu, Dingxi; Long, Xi; Guo, Ting; Kong, Xiangquan			Diagnostic Accuracy of Computed Tomography for Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							DUAL-ENERGY CT; ART IMAGING TECHNIQUES; INITIAL-EXPERIENCE; HELICAL CT; ANGIOGRAPHY; PERFUSION; SCINTIGRAPHY; EMBOLISM; DISEASE; PROBABILITY	This study aimed to determine the diagnostic accuracy of computed tomography imaging for the diagnosis of chronic thromboembolic pulmonary hypertension (CTEPH). Additionally, the effect of test and study characteristics was explored. Studies published between 1990 and 2015 identified by PubMed, OVID search and citation tracking were examined. Of the 613 citations, 11 articles (n=712) met the inclusion criteria. The patient-based analysis demonstrated a pooled sensitivity of 76%(95% confidence interval [CI]: 69% to 82%), and a pooled specificity of 96% (95% CI: 93% to 98%). This resulted in a pooled diagnostic odds ratio (DOR) of 191 (95% CI: 75 to 486). The vessel-based analyses were divided into 3 levels: total arteries. main+lobar arteries and segmental arteries. The pooled sensitivity were 88% (95% CI: 87% to 90%). 95% (95% CI: 92% to 97%) and 88% (95% CI: 87% to 90%), respectively, with a pooled specificity of 90%(95% CI: 88% to 91%). 96% (95% CI: 94% to 97%) and 89% (95% CI: 87% to 91%). This resulted in a pooled diagnostic odds ratio of 76 (95% CI: 23 to 254), 751 (95% CI: 57 to 9905) and 189 (95% CI: 21 to 1072), respectively. In conclusion, CT is a favorable method to rule in CTEPH and to rule out pulmonary endarterectomy (PEA) patients for proximal branches. Furthermore, dual-energy and 320-slices CT can increase the sensitivity for subsegmental arterials, which are promising imaging techniques for balloon pulmonary angioplasty (BPA) approach. In the near future, CT could position itself as the key for screening consideration and for surgical and interventional operability.	[Dong, Chengjun; Zhou, Min; Liu, Dingxi; Long, Xi; Guo, Ting; Kong, Xiangquan] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Radiol, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology	Kong, XQ (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Radiol, Wuhan 430074, Hubei, Peoples R China.	kxq0525@126.com						Auger W R, 1999, Semin Thorac Cardiovasc Surg, V11, P179; Bailey CL, 2000, AM J RESP CRIT CARE, V162, P1974, DOI 10.1164/ajrccm.162.5.2003045; Bartalena T, 2008, INVEST RADIOL, V43, P368, DOI 10.1097/RLI.0b013e31816901e2; Bergin CJ, 1997, RADIOLOGY, V204, P695, DOI 10.1148/radiology.204.3.9280245; Coulden Richard, 2006, Proc Am Thorac Soc, V3, P577, DOI 10.1513/pats.200605-119LR; Dartevelle P, 2004, EUR RESPIR J, V23, P637, DOI 10.1183/09031936.04.00079704; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; Dentali F, 2009, THROMB RES, V124, P256, DOI 10.1016/j.thromres.2009.01.003; DIAMOND GA, 1979, NEW ENGL J MED, V300, P1350, DOI 10.1056/NEJM197906143002402; Dournes G, 2014, EUR RADIOL, V24, P42, DOI 10.1007/s00330-013-2975-y; Fedullo PF, 2001, CLIN CHEST MED, V22, P561, DOI 10.1016/S0272-5231(05)70292-6; Feinstein JA, 2001, CIRCULATION, V103, P10; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; He J, 2012, NUCL MED COMMUN, V33, P459, DOI 10.1097/MNM.0b013e32835085d9; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hoeper MM, 2006, CIRCULATION, V113, P2011, DOI 10.1161/CIRCULATIONAHA.105.602565; Hoey ETD, 2009, CLIN RADIOL, V64, P414, DOI 10.1016/j.crad.2008.11.007; Hoey ETD, 2011, AM J ROENTGENOL, V196, P524, DOI 10.2214/AJR.10.4842; Jamieson SW, 2003, ANN THORAC SURG, V76, P1457, DOI 10.1016/S0003-4975(03)00828-2; Kearon C, 2003, CAN MED ASSOC J, V168, P183; Kim SS, 2014, INT J CARDIOVAS IMAG, V30, P113, DOI 10.1007/s10554-014-0508-7; Lewczuk J, 2001, CHEST, V119, P818, DOI 10.1378/chest.119.3.818; Ley S, 2003, EUR RADIOL, V13, P2365, DOI 10.1007/s00330-003-1878-8; Ley S, 2012, EUR RADIOL, V22, P607, DOI 10.1007/s00330-011-2290-4; Manecke GR, 2006, SEMIN THORAC CARDIOV, V18, P236, DOI 10.1053/j.semtcvs.2006.09.005; Nakazawa T, 2011, J COMPUT ASSIST TOMO, V35, P590, DOI 10.1097/RCT.0b013e318224e227; Pengo V, 2004, NEW ENGL J MED, V350, P2257, DOI 10.1056/NEJMoa032274; Pitton MB, 1996, CIRCULATION, V94, P2485, DOI 10.1161/01.CIR.94.10.2485; Rajaram S, 2012, EUR RADIOL, V22, P310, DOI 10.1007/s00330-011-2252-x; Reichelt A, 2009, EUR J RADIOL, V71, P49, DOI 10.1016/j.ejrad.2008.03.016; Rosman AS, 2007, ADV MED SCI, V52, P76; Soler X, 2011, RESPIROLOGY, V16, P131, DOI 10.1111/j.1440-1843.2010.01867.x; Sugiura T, 2013, CHEST, V143, P1070, DOI 10.1378/chest.12-0407; Tunariu N, 2007, J NUCL MED, V48, P680, DOI 10.2967/jnumed.106.039438; Wirth G, 2014, ROFO-FORTSCHR RONTG, V186, P751, DOI 10.1055/s-0034-1366425; Zhang Z, 2013, JOURNAL OF THORACIC, V28, pW94	36	37	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0126985	10.1371/journal.pone.0126985	http://dx.doi.org/10.1371/journal.pone.0126985			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923810	gold, Green Published, Green Submitted			2022-12-27	WOS:000353711600176
J	Haustein, M; Hannes, T; Trieschmann, J; Verhaegh, R; Koster, A; Hescheler, J; Brockmeier, K; Adelmann, R; Khalil, M				Haustein, Moritz; Hannes, Tobias; Trieschmann, Jan; Verhaegh, Rabea; Koester, Annette; Hescheler, Juergen; Brockmeier, Konrad; Adelmann, Roland; Khalil, Markus			Excitation-Contraction Coupling in Zebrafish Ventricular Myocardium Is Regulated by Trans-Sarcolemmal Ca2+ Influx and Sarcoplasmic Reticulum Ca2+ Release	PLOS ONE			English	Article							FORCE-FREQUENCY-RELATIONSHIP; MODEL; MYOCYTES; EXCHANGE; SLICES	Zebrafish (Danio rerio) have become a popular model in cardiovascular research mainly due to identification of a large number of mutants with structural defects. In recent years, cardiomyopathies and other diseases influencing contractility of the heart have been studied in zebrafish mutants. However, little is known about the regulation of contractility of the zebrafish heart on a tissue level. The aim of the present study was to elucidate the role of trans-sarcolemmal Ca2+-flux and sarcoplasmic reticulum Ca2+-release in zebrafish myocardium. Using isometric force measurements of fresh heart slices, we characterised the effects of changes of the extracellular Ca2+-concentration, trans-sarcolemmal Ca2+-flux via L-type Ca2+-channels and Na+-Ca2+-exchanger, and Ca2+-release from the sarcoplasmic reticulum as well as beating frequency and beta-adrenergic stimulation on contractility of adult zebrafish myocardium. We found an overall negative force-frequency relationship (FFR). Inhibition of L-type Ca2+-channels by verapamil (1 mu M) decreased force of contraction to 22 +/- 7% compared to baseline (n=4, p<0.05). Ni2+ was the only substance to prolong relaxation (5 mM, time after peak to 50% relaxation: 73 +/- 3 ms vs. 101 +/- 8 ms, n=5, p<0.05). Surprisingly though, inhibition of the sarcoplasmic Ca2+-release decreased force development to 54 +/- 3% in ventricular (n=13, p<0.05) and to 52 +/- 8% in atrial myocardium (n=5, p<0.05) suggesting a substantial role of SR Ca2+-release in force generation. In line with this finding, we observed significant post pause potentiation after pauses of 5 s (169 +/- 7% force compared to baseline, n=8, p<0.05) and 10 s (198 +/- 9% force compared to baseline, n=5, p<0.05) and mildly positive lusitropy after beta-adrenergic stimulation. In conclusion, force development in adult zebrafish ventricular myocardium requires not only trans-sarcolemmal Ca2+-flux, but also intact sarcoplasmic reticulum Ca2+-cycling. In contrast to mammals, FFR is strongly negative in the zebrafish heart. These aspects need to be considered when using zebrafish to model human diseases of myocardial contractility.	[Haustein, Moritz; Hannes, Tobias; Brockmeier, Konrad; Adelmann, Roland] Univ Cologne, Fac Med, Cologne Heart Ctr, Dept Paediat Cardiol, D-50931 Cologne, North Rhine Wes, Germany; [Hannes, Tobias; Trieschmann, Jan; Koester, Annette; Hescheler, Juergen] Univ Cologne, Fac Med, Inst Neurophysiol, D-50931 Cologne, North Rhine Wes, Germany; [Verhaegh, Rabea] Univ Hosp Essen, Inst Physiol Chem, Essen, North Rhine Wes, Germany; [Khalil, Markus] Univ Giessen & Marburg, Dept Paediat Cardiol, Univ Hosp Giessen & Marburg, D-35390 Giessen, Hessen, Germany	University of Cologne; University of Cologne; University of Duisburg Essen; University Hospital of Giessen & Marburg	Hannes, T (corresponding author), Univ Cologne, Fac Med, Cologne Heart Ctr, Dept Paediat Cardiol, D-50931 Cologne, North Rhine Wes, Germany.	tobias.hannes@uk-koeln.de	Khalil, Markus/AFS-7292-2022	Khalil, Markus/0000-0001-8897-7200; Haustein, Moritz/0000-0003-4493-6161; Hannes, Tobias/0000-0002-8550-2282	Universitat zu Koln [288/2013]	Universitat zu Koln	Koeln Fortune 288/2013 Fund of Universitat zu Koln, http://www.medfak.uni-koeln.de/195.html?&L=0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus JA, 2000, J PHARMACOL TOX MET, V44, P395, DOI 10.1016/S1056-8719(00)00121-0; Arnaout R, 2007, P NATL ACAD SCI USA, V104, P11316, DOI 10.1073/pnas.0702724104; Bakkers J, 2011, CARDIOVASC RES, V91, P279, DOI 10.1093/cvr/cvr098; Barrionuevo WR, 1999, AM J PHYSIOL-REG I, V276, pR505, DOI 10.1152/ajpregu.1999.276.2.R505; Bergson P, 2011, MOL PHARMACOL, V79, P411, DOI 10.1124/mol.110.069492; Bers DM, 2001, EXCITATION CONTRACTI; Bovo E, 2013, PFLUG ARCH EUR J PHY, V465, P1775, DOI 10.1007/s00424-013-1312-2; Brette F, 2008, BIOCHEM BIOPH RES CO, V374, P143, DOI 10.1016/j.bbrc.2008.06.109; Denvir MA, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-21; Endoh M, 2004, EUR J PHARMACOL, V500, P73, DOI 10.1016/j.ejphar.2004.07.013; HAN XQ, 1995, CIRC RES, V76, P664, DOI 10.1161/01.RES.76.4.664; Haverinen J, 2009, AM J PHYSIOL-REG I, V297, pR1180, DOI 10.1152/ajpregu.00022.2009; Hinde AK, 1999, CELL CALCIUM, V25, P321, DOI 10.1054/ceca.1999.0035; Hove-Madsen L, 1998, AM J PHYSIOL-REG I, V275, pR2070, DOI 10.1152/ajpregu.1998.275.6.R2070; Hu N, 2001, ANAT REC, V264, P1, DOI 10.1002/ar.1111; MALECOT CO, 1987, CIRC RES, V60, P560, DOI 10.1161/01.RES.60.4.560; MORAD M, 1971, J PHYSIOL-LONDON, V219, P167, DOI 10.1113/jphysiol.1971.sp009656; Pieperhoff S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096771; Pillekamp F, 2007, CELL PHYSIOL BIOCHEM, V20, P837, DOI 10.1159/000110443; Rottbauer W, 2006, CIRC RES, V99, P323, DOI 10.1161/01.RES.0000234807.16034.fe; SCHWINGER RHG, 1992, AM HEART J, V123, P116, DOI 10.1016/0002-8703(92)90755-K; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Shiels HA, 2006, J GEN PHYSIOL, V128, P37, DOI 10.1085/jgp.200609543; Shiels HA, 1997, J EXP BIOL, V200, P1607; Shiels HA, 2002, COMP BIOCHEM PHYS A, V132, P811, DOI 10.1016/S1095-6433(02)00050-8; TADA M, 1982, ANNU REV PHYSIOL, V44, P401, DOI 10.1146/annurev.ph.44.030182.002153; Tessadori F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047644; Wang K, 2014, PROG BIOPHYS MOL BIO, V115, P314, DOI 10.1016/j.pbiomolbio.2014.08.006; Xu XL, 2002, NAT GENET, V30, P205, DOI 10.1038/ng816; Zhang PC, 2011, AM J PHYSIOL-REG I, V300, pR56, DOI 10.1152/ajpregu.00377.2010; Zhao L, 2008, CARDIOVASC RES, V80, P200, DOI 10.1093/cvr/cvn177	31	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125654	10.1371/journal.pone.0125654	http://dx.doi.org/10.1371/journal.pone.0125654			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938412	Green Published, Green Submitted, gold			2022-12-27	WOS:000353943000084
J	Western, MJ; Peacock, OJ; Stathi, A; Thompson, D				Western, Max J.; Peacock, Oliver J.; Stathi, Afroditi; Thompson, Dylan			The Understanding and Interpretation of Innovative Technology-Enabled Multidimensional Physical Activity Feedback in Patients at Risk of Future Chronic Disease	PLOS ONE			English	Article							HEALTH BEHAVIOR; ENERGY-EXPENDITURE; INACTIVITY; EXERCISE; ARMBAND	Background Innovative physical activity monitoring technology can be used to depict rich visual feedback that encompasses the various aspects of physical activity known to be important for health. However, it is unknown whether patients who are at risk of chronic disease would understand such sophisticated personalised feedback or whether they would find it useful and motivating. The purpose of the present study was to determine whether technology-enabled multidimensional physical activity graphics and visualisations are comprehensible and usable for patients at risk of chronic disease. Method We developed several iterations of graphics depicting minute-by-minute activity patterns and integrated physical activity health targets. Subsequently, patients at moderate/high risk of chronic disease (n=29) and healthcare practitioners (n=15) from South West England underwent full 7-days activity monitoring followed by individual semi-structured interviews in which they were asked to comment on their own personalised visual feedback Framework analysis was used to gauge their interpretation and of personalised feedback, graphics and visualisations. Results We identified two main components focussing on (a) the interpretation of feedback designs and data and (b) the impact of personalised visual physical activity feedback on facilitation of health behaviour change. Participants demonstrated a clear ability to understand the sophisticated personal information plus an enhanced physical activity knowledge. They reported that receiving multidimensional feedback was motivating and could be usefully applied to facilitate their efforts in becoming more physically active. Conclusion Multidimensional physical activity feedback can be made comprehensible, informative and motivational by using appropriate graphics and visualisations. There is an opportunity to exploit the full potential created by technological innovation and provide sophisticated personalised physical activity feedback as an adjunct to support behaviour change.	[Western, Max J.; Peacock, Oliver J.; Stathi, Afroditi; Thompson, Dylan] Univ Bath, Dept Hlth, Bath BA2 7AY, Avon, England	University of Bath	Thompson, D (corresponding author), Univ Bath, Dept Hlth, Bath BA2 7AY, Avon, England.	D.Thompson@bath.ac.uk	STATHI, AFRODITI/AAM-4377-2020	STATHI, AFRODITI/0000-0003-2162-777X; Western, Max James/0000-0003-1107-8498	National Preventative Research Initiative (NPRI); Alzheimer's Research Trust; Alzheimer's Society; Biotechnology and Biological Sciences Research Council; British Heart Foundation; Cancer Research UK; Chief Scientists Office, Scottish Government Health Directorate; Department of Health; Diabetes UK; Economic and Social Research Council; Health and Social Care Research and Development Division of the Public Health Agency; Medical Research Council; Stroke Association; Wellcome Trust; Welsh Assembly Government; World Cancer Research Fund; Medical Research Council [MR/J00040X/1] Funding Source: researchfish; MRC [MR/J00040X/1] Funding Source: UKRI	National Preventative Research Initiative (NPRI); Alzheimer's Research Trust; Alzheimer's Society; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Chief Scientists Office, Scottish Government Health Directorate; Department of Health; Diabetes UK(Diabetes UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Health and Social Care Research and Development Division of the Public Health Agency; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Stroke Association; Wellcome Trust(Wellcome Trust); Welsh Assembly Government; World Cancer Research Fund(World Cancer Research Fund International (WCRF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding for the project was provided by the National Preventative Research Initiative (NPRI, http://www.mrc.ac.uk/research/initiatives/national-prevention-research-initiative-npri/). Funding partners are: Alzheimer's Research Trust, Alzheimer's Society, Biotechnology and Biological Sciences Research Council, British Heart Foundation; Cancer Research UK; Chief Scientists Office, Scottish Government Health Directorate; Department of Health; Diabetes UK; Economic and Social Research Council; Health and Social Care Research and Development Division of the Public Health Agency; Medical Research Council; The Stroke Association; Wellcome Trust; Welsh Assembly Government and World Cancer Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen KY, 2012, MED SCI SPORT EXER, V44, pS13, DOI 10.1249/MSS.0b013e3182399bc8; Chu S, 2014, INTERNATIONAL DIGITA; Consolvo S, 2008, PROCEEDINGS OF THE 10TH INTERNATIONAL CONFERENCE ON UBIQUITOUS COMPUTING (UBICOMP 2008), P54; Consolvo S, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P405; Design Council T, 2007, ELEVEN LESSONS MANAG; DiClemente CC, 2001, AM J HEALTH BEHAV, V25, P217, DOI 10.5993/AJHB.25.3.8; Dombrowski SU, 2012, HEALTH PSYCHOL REV, V6, P7, DOI 10.1080/17437199.2010.513298; Edwards A, 2002, BMJ-BRIT MED J, V324, P827, DOI 10.1136/bmj.324.7341.827; Erikssen G, 2001, SPORTS MED, V31, P571, DOI 10.2165/00007256-200131080-00001; Fruin ML, 2004, MED SCI SPORT EXER, V36, P1063, DOI 10.1249/01.MSS.0000128144.91337.38; Greaves CJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-119; Houts PS, 2006, PATIENT EDUC COUNS, V61, P173, DOI 10.1016/j.pec.2005.05.004; Johannsen DL, 2010, MED SCI SPORT EXER, V42, P2134, DOI 10.1249/MSS.0b013e3181e0b3ff; KIRSCHENBAUM DS, 1987, CLIN PSYCHOL REV, V7, P77, DOI 10.1016/0272-7358(87)90005-5; Kohl HW, 2012, LANCET, V380, P294, DOI 10.1016/S0140-6736(12)60898-8; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lee J.-M., 2014, MED SCI SPORTS EXERC; Michie S, 2013, HEALTH PSYCHOL, V32, P581, DOI 10.1037/a0030205; Michie S, 2009, HEALTH PSYCHOL, V28, P690, DOI 10.1037/a0016136; Patel MS, 2015, JAMA-J AM MED ASSOC, V313, P459, DOI 10.1001/jama.2014.14781; Ritchie JSL., 1994, QUALITATIVE DATA ANA, DOI DOI 10.4324/9780203413081_CHAPTER_9; Scheers T, 2012, EUR J APPL PHYSIOL, V112, P1653, DOI 10.1007/s00421-011-2131-9; Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5; Standage M., 2012, ADV MOTIVATION SPORT, P233, DOI DOI 10.5040/; Thompson D, 2015, EXERCISE AND SPORT S; Thompson D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056427; Turner JE, 2010, AM J CLIN NUTR, V92, P1009, DOI 10.3945/ajcn.2010.29471; van Gemert-Pijnen JE, 2011, JOURNAL OF MEDICAL I, V13; Weinstein ND, 1998, HEALTH PSYCHOL, V17, P290, DOI 10.1037/0278-6133.17.3.290; Yardley L, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4055	30	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0126156	10.1371/journal.pone.0126156	http://dx.doi.org/10.1371/journal.pone.0126156			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH3PP	25938455	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000353943000146
J	Yan, LM; Zhang, J; Guo, H; Yan, SC; Chen, QX; Zhang, FX; Fang, Q				Yan, Liming; Zhang, Jie; Guo, Hong; Yan, Shicui; Chen, Qingxiu; Zhang, Fuxian; Fang, Qin			Aquareovirus NS80 Initiates Efficient Viral Replication by Retaining Core Proteins within Replication-Associated Viral Inclusion Bodies	PLOS ONE			English	Article							GRASS CARP REOVIRUS; RICE-DWARF-VIRUS; MU-NS; SIGMA-NS; BLUETONGUE VIRUS; MAMMALIAN REOVIRUSES; RNA-SYNTHESIS; STRANDED-RNA; IN-VITRO; ROTAVIRUS	Viral inclusion bodies (VIBs) are specific intracellular compartments for reoviruses replication and assembly. Aquareovirus nonstructural protein NS80 has been identified to be the major constituent for forming globular VIBs in our previous study. In this study, we investigated the role of NS80 in viral structural proteins expression and viral replication. Immunofluorescence assays showed that NS80 could retain five core proteins or inner-capsid proteins (VP1-VP4 and VP6), but not outer-capsid proteins (VP5 and VP7), within VIBs in co-transfected or infected cells. Further co-immunoprecipitation analysis confirmed that NS80 could interact with each core protein respectively. In addition, we found that newly synthesized viral RNAs co-localized with VIBs. Furthermore, time-course analysis of viral structural proteins expression showed that the expression of NS80 was detected first, followed by the detection of inner shell protein VP3, and then of other inner-capsid proteins, suggesting that VIBs were essential for the formation of viral core frame or progeny virion. Moreover, knockdown of NS80 by shRNA not only inhibited the expression of aquareovirus structural proteins, but also inhibited viral infection. These results indicated that NS80-based VIBs were formed at earlier stage of infection, and NS80 was able to coordinate the expression of viral structural proteins and viral replication.	[Yan, Liming; Zhang, Jie; Guo, Hong; Yan, Shicui; Chen, Qingxiu; Zhang, Fuxian; Fang, Qin] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China; [Yan, Liming; Yan, Shicui; Chen, Qingxiu] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Fang, Q (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China.	qfang@wh.iov.cn	fang, qin/GQA-8223-2022		National Natural Science Foundation of China [31172434, 31372565, 31370190]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by National Natural Science Foundation of China 31172434, 31372565, and 31370190.	ACS G, 1971, J VIROL, V8, P684, DOI 10.1128/JVI.8.5.684-689.1971; Arnold MM, 2008, VIROLOGY, V375, P412, DOI 10.1016/j.virol.2008.02.024; Arnoldi F, 2007, J VIROL, V81, P2128, DOI 10.1128/JVI.01494-06; Attoui H, 2002, J GEN VIROL, V83, P1941, DOI 10.1099/0022-1317-83-8-1941; BANERJEE AK, 1970, J VIROL, V6, P1; Becker MM, 2003, J VIROL, V77, P5948, DOI 10.1128/JVI.77.10.5948-5963.2003; Brandariz-Nunez A, 2010, J VIROL, V84, P4289, DOI 10.1128/JVI.02534-09; Broering TJ, 2005, J VIROL, V79, P6194, DOI 10.1128/JVI.79.10.6194-6206.2005; Broering TJ, 2004, J VIROL, V78, P1882, DOI 10.1128/JVI.78.4.1882-1892.2004; Broering TJ, 2002, J VIROL, V76, P8285, DOI 10.1128/JVI.76.16.8285-8297.2002; BROOKES SM, 1993, J GEN VIROL, V74, P525, DOI 10.1099/0022-1317-74-3-525; Busch LK, 2011, J GEN VIROL, V92, P2566, DOI 10.1099/vir.0.036459-0; Cheng LP, 2010, J MOL BIOL, V397, P852, DOI 10.1016/j.jmb.2009.12.027; Cheung W, 2010, J VIROL, V84, P6782, DOI 10.1128/JVI.01757-09; Contin R, 2010, J GEN VIROL, V91, P1782, DOI 10.1099/vir.0.019133-0; Criglar JM, 2014, J VIROL, V88, P786, DOI 10.1128/JVI.03022-13; DALES S, 1965, AM J MED, V38, P699, DOI 10.1016/0002-9343(65)90191-9; DALES S, 1963, P NATL ACAD SCI USA, V50, P268, DOI 10.1073/pnas.50.2.268; Desmet EA, 2014, MBIO, V5, DOI 10.1128/mBio.01463-14; EATON BT, 1987, VIROLOGY, V157, P107, DOI 10.1016/0042-6822(87)90319-9; Eichwald C, 2004, J GEN VIROL, V85, P625, DOI 10.1099/vir.0.19611-0; Fabbretti E, 1999, J GEN VIROL, V80, P333, DOI 10.1099/0022-1317-80-2-333; Fan C, 2010, ARCH VIROL, V155, P1755, DOI 10.1007/s00705-010-0753-6; Fan Liming, 2014, Virologica Sinica, V29, P86, DOI 10.1007/s12250-014-3366-5; Fang Q, 2008, ARCH VIROL, V153, P675, DOI 10.1007/s00705-008-0048-3; FANG Q, 1989, Virologica Sinica, V4, P315; Gillian AL, 2000, J VIROL, V74, P5939, DOI 10.1128/JVI.74.13.5939-5948.2000; Guo H, 2013, VIRUS RES, V171, P129, DOI 10.1016/j.virusres.2012.11.011; Heath CM, 2001, J CELL BIOL, V153, P449, DOI 10.1083/jcb.153.3.449; Javed Amjad, 2004, Methods Mol Biol, V285, P29; Kar AK, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-4; Ke F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063737; Kobayashi T, 2006, J VIROL, V80, P9053, DOI 10.1128/JVI.00276-06; Kobayashi T, 2009, J VIROL, V83, P2892, DOI 10.1128/JVI.01495-08; LEVIN DH, 1970, NATURE, V227, P603, DOI 10.1038/227603a0; Li Xiaoming, 2013, Virologica Sinica, V28, P318, DOI 10.1007/s12250-013-3341-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez T, 2005, J GEN VIROL, V86, P1609, DOI 10.1099/vir.0.80827-0; MCNULTY MS, 1976, J GEN VIROL, V33, P503, DOI 10.1099/0022-1317-33-3-503; Mertens PPC, 2011, VIRUS TAXONOMY, P497; Miller CL, 2007, MOL CELL PROTEOMICS, V6, P1027, DOI 10.1074/mcp.M700056-MCP200; Miller CL, 2010, J VIROL, V84, P867, DOI 10.1128/JVI.01571-09; Miller CL, 2003, J VIROL, V77, P4566, DOI 10.1128/JVI.77.8.4566-4576.2003; Modrof J, 2005, J VIROL, V79, P10023, DOI 10.1128/JVI.79.15.10023-10031.2005; Nibert ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068607; Novoa RR, 2005, BIOL CELL, V97, P147, DOI 10.1042/BC20040058; Parker JSL, 2002, J VIROL, V76, P4483, DOI 10.1128/JVI.76.9.4483-4496.2002; PETRIE BL, 1984, VIRUS RES, V1, P133, DOI 10.1016/0168-1702(84)90069-8; Rangel AAC, 1999, J GEN VIROL, V80, P2399, DOI 10.1099/0022-1317-80-9-2399; REED L. J., 1938, AMER JOUR HYG, V27, P493; Shao L, 2011, VIROLOGY J, V8; Shao L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055334; SHARPE AH, 1982, VIROLOGY, V120, P399, DOI 10.1016/0042-6822(82)90040-X; Shimizu T, 2009, PLANT BIOTECHNOL J, V7, P24, DOI 10.1111/j.1467-7652.2008.00366.x; Silvestri LS, 2004, J VIROL, V78, P7763, DOI 10.1128/JVI.78.14.7763-7774.2004; SKEHEL JJ, 1969, VIROLOGY, V39, P822, DOI 10.1016/0042-6822(69)90019-1; SPENDLOVE RS, 1963, J IMMUNOL, V90, P548; Touris-Otero F, 2004, J MOL BIOL, V341, P361, DOI 10.1016/j.jmb.2004.06.026; Touris-Otero F, 2004, VIROLOGY, V319, P94, DOI 10.1016/j.virol.2003.10.034; Wei TY, 2006, J GEN VIROL, V87, P429, DOI 10.1099/vir.0.81425-0; Wen DW, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-133; Wileman T, 2006, SCIENCE, V312, P875, DOI 10.1126/science.1126766; Wileman T, 2007, ANNU REV MICROBIOL, V61, P149, DOI 10.1146/annurev.micro.57.030502.090836; Yan LM, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-89; Zhang X, 2010, CELL, V141, P472, DOI 10.1016/j.cell.2010.03.041; ZWEERINK HJ, 1970, VIROLOGY, V41, P501, DOI 10.1016/0042-6822(70)90171-6	66	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0126127	10.1371/journal.pone.0126127	http://dx.doi.org/10.1371/journal.pone.0126127			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938226	Green Published, gold, Green Submitted			2022-12-27	WOS:000353943000143
J	Banu, S; Rahman, MT; Uddin, MKM; Khatun, R; Khan, MSR; Rahman, MM; Uddin, SI; Ahmed, T; Heffelfinger, JD				Banu, Sayera; Rahman, Md. Toufiq; Uddin, Mohammad Khaja Mafij; Khatun, Razia; Khan, Md. Siddiqur Rahman; Rahman, Md. Mojibur; Uddin, Syed Iftekhar; Ahmed, Tahmeed; Heffelfinger, James D.			Effect of Active Case Finding on Prevalence and Transmission of Pulmonary Tuberculosis in Dhaka Central Jail, Bangladesh	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; MOLECULAR EPIDEMIOLOGY; PRISON; STRAIN	Background Understanding tuberculosis (TB) transmission dynamics is essential for establishing effective TB control strategies in settings where the burden and risk of transmission are high. The objectives of this study were to evaluate the effect of active screening on controlling TB transmission and also to characterize Mycobacterium tuberculosis strains for investigating transmission dynamics in a correctional setting. Methods The study was carried out in Dhaka Central Jail (DCJ), from October 2005 to February 2010. An active case finding strategy for pulmonary TB was established both at the entry point to the prison and inside the prison. Three sputum specimens were collected from all pulmonary TB suspects and subjected to smear microscopy, culture, and drug susceptibility testing as well as genotyping which included deletion analysis, spoligotyping and analysis of mycobacterial interspersed repetitive units (MIRU). Results A total of 60,585 inmates were screened during the study period. We found 466 inmates with pulmonary TB of whom 357 (77%) had positive smear microscopy results and 109 (23%) had negative smear microscopy results but had positive results on culture. The number of pulmonary TB cases declined significantly, from 49 cases during the first quarter to 8 cases in the final quarter of the study period (p=0.001). Deletion analysis identified all isolates as M. tuberculosis and further identified 229 (70%) strains as 'modern' and 100 (30%) strains as 'ancestral'. Analysis of MIRU showed that 347 strains (85%) exhibited unique patterns, whereas 61 strains (15%) clustered into 22 groups. The largest cluster comprised eight strains of the Beijing M. tuberculosis type. The rate of recent transmission was estimated to be 9.6%. Conclusions Implementation of active screening for TB was associated with a decline in TB cases in DCJ. Implementation of active screening in prison settings might substantially reduce the national burden of TB in Bangladesh.	[Banu, Sayera; Rahman, Md. Toufiq; Uddin, Mohammad Khaja Mafij; Khatun, Razia; Khan, Md. Siddiqur Rahman; Ahmed, Tahmeed; Heffelfinger, James D.] Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh; [Rahman, Md. Mojibur] Directorate Gen Hlth Serv, Natl TB Control Program, Dhaka, Bangladesh; [Uddin, Syed Iftekhar] Directorate Prisons, Dhaka, Bangladesh; [Heffelfinger, James D.] US Ctr Dis Control & Prevent, Global Dis Detect Branch, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA USA	International Centre for Diarrhoeal Disease Research (ICDDR); Centers for Disease Control & Prevention - USA	Banu, S (corresponding author), Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh.	sbanu@icddrb.org	Rahman Khan, Mohammad Siddiqur/J-3025-2018	Rahman Khan, Mohammad Siddiqur/0000-0003-2479-6405; Banu, Sayera/0000-0002-5121-1962	Government of the People's Republic of Bangladesh (GoB);  [GR-00410]	Government of the People's Republic of Bangladesh (GoB); 	This research protocol was funded by Government of the People's Republic of Bangladesh (GoB). The grant number was GR-00410 and SB received the grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES H, 1970, AM REV RESPIR DIS, V101, P706; [Anonymous], 1901, PRISONS RULES LOCAL, P4; Bangladesh Go, 2013, NAT GUID OP MAN TUB; Banu S, 2004, J CLIN MICROBIOL, V42, P674, DOI 10.1128/JCM.42.2.674-682.2004; Banu S, 2012, INT J TUBERC LUNG D, V16, P319, DOI 10.5588/ijtld.11.0426; Banu S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010759; Banu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040545; Baussano I, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000381; Brudey K, 2004, J CLIN MICROBIOL, V42, P3046, DOI 10.1128/JCM.42.7.3046-3051.2004; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; CHEVRELDELLAGI D, 1993, J CLIN MICROBIOL, V31, P2446, DOI 10.1128/JCM.31.9.2446-2450.1993; Dara M, 2009, GUIDELINES CONTROL T; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; Ignatova A, 2006, J MED MICROBIOL, V55, P1413, DOI 10.1099/jmm.0.46575-0; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; KING L, 1977, JAMA-J AM MED ASSOC, V237, P791, DOI 10.1001/jama.237.8.791; Kononets A S, 2004, Probl Tuberk Bolezn Legk, P18; Mazars E, 2001, P NATL ACAD SCI USA, V98, P1901, DOI 10.1073/pnas.98.4.1901; Mihret A, 2013, AFR HEALTH SCI, V12, P339; Niveau G, 2006, PUBLIC HEALTH, V120, P33, DOI 10.1016/j.puhe.2005.03.017; Petroff SA, 1915, J EXP MED, V21, P38, DOI 10.1084/jem.21.1.38; Reyes H, 1997, BRIT MED J, V315, P1447, DOI 10.1136/bmj.315.7120.1447; Reyes H, 2007, INT J PRISON HEALTH, V3, P43, DOI 10.1080/17449200601149148; SKOLER DL, 1975, J INT LAW ECON, V10, P453; STEAD WW, 1978, JAMA-J AM MED ASSOC, V240, P2544, DOI 10.1001/jama.240.23.2544; Supply P, 2000, MOL MICROBIOL, V36, P762, DOI 10.1046/j.1365-2958.2000.01905.x; Trebucq A, 1999, LANCET, V353, P2244, DOI 10.1016/S0140-6736(05)76293-0; Tuberculosis Coalition for Technical Assistance and the International Committee of the Red Cross, 2009, GUID CONTR TUB PRIS; Uddin Mohammad Khaja Mafij, 2013, BMC Res Notes, V6, P291, DOI 10.1186/1756-0500-6-291; VALWAY SE, 1994, AM J EPIDEMIOL, V140, P113, DOI 10.1093/oxfordjournals.aje.a117222; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; WHO, 2014, JOINT MON MISS BANGL	32	19	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124976	10.1371/journal.pone.0124976	http://dx.doi.org/10.1371/journal.pone.0124976			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933377	gold, Green Submitted, Green Published			2022-12-27	WOS:000353887100069
J	Forn, M; Diez-Villanueva, A; Merlos-Suarez, A; Munoz, M; Lois, S; Carrio, E; Jorda, M; Bigas, A; Batlle, E; Peinado, MA				Forn, Marta; Diez-Villanueva, Anna; Merlos-Suarez, Anna; Munoz, Mar; Lois, Sergi; Carrio, Elvira; Jorda, Mireia; Bigas, Anna; Batlle, Eduard; Peinado, Miguel A.			Overlapping DNA Methylation Dynamics in Mouse Intestinal Cell Differentiation and Early Stages of Malignant Progression	PLOS ONE			English	Article							CPG ISLAND METHYLATION; STEM-CELLS; COLORECTAL-CANCER; HUMAN COLON; IN-VITRO; CHROMOSOMAL INSTABILITY; GENE-EXPRESSION; HYPOMETHYLATION; GENOME; METHYLOME	Mouse models of intestinal crypt cell differentiation and tumorigenesis have been used to characterize the molecular mechanisms underlying both processes. DNA methylation is a key epigenetic mark and plays an important role in cell identity and differentiation programs and cancer. To get insights into the dynamics of cell differentiation and malignant transformation we have compared the DNA methylation profiles along the mouse small intestine crypt and early stages of tumorigenesis. Genome-scale analysis of DNA methylation together with microarray gene expression have been applied to compare intestinal crypt stem cells (EphB2(high)), differentiated cells (EphB2(negative)), Apc(Min/+) adenomas and the corresponding non-tumor adjacent tissue, together with small and large intestine samples and the colon cancer cell line CT26. Compared with late stages, small intestine crypt differentiation and early stages of tumorigenesis display few and relatively small changes in DNA methylation. Hypermethylated loci are largely shared by the two processes and affect the proximities of promoter and enhancer regions, with enrichment in genes associated with the intestinal stem cell signature and the PRC2 complex. The hypermethylation is progressive, with minute levels in differentiated cells, as compared with intestinal stem cells, and reaching full methylation in advanced stages. Hypomethylation shows different signatures in differentiation and cancer and is already present in the non-tumor tissue adjacent to the adenomas in Apc(Min/+) mice, but at lower levels than advanced cancers. This study provides a reference framework to decipher the mechanisms driving mouse intestinal tumorigenesis and also the human counterpart.	[Forn, Marta; Diez-Villanueva, Anna; Munoz, Mar; Lois, Sergi; Carrio, Elvira; Jorda, Mireia; Peinado, Miguel A.] IMPPC, Badalona 08916, Barcelona, Spain; [Merlos-Suarez, Anna; Batlle, Eduard] IRB Barcelona, Barcelona 08028, Spain; [Bigas, Anna] Inst Hosp Mar Invest Med IMIM, Barcelona 08003, Spain; [Batlle, Eduard] ICREA, Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); ICREA	Peinado, MA (corresponding author), IMPPC, Badalona 08916, Barcelona, Spain.	map@imppc.org	Forn, Marta/R-2808-2016; Bigas, Anna/A-7457-2014; Jordà, Mireia/Z-4519-2019; Peinado, Miguel A./A-5591-2008; Carrio Gaspar, Elvira/R-3371-2018; Batlle, Eduard/K-8080-2014	Forn, Marta/0000-0002-0230-0141; Peinado, Miguel A./0000-0002-4090-793X; Carrio Gaspar, Elvira/0000-0002-0435-3423; Batlle, Eduard/0000-0003-2422-0326; Bigas, Anna/0000-0003-4801-6899; Jorda, Mireia/0000-0003-3709-1850	Ministerio de Economia y Competitividad [PTC2011-1091, SAF2011/23638]; ERC; ICREA Funding Source: Custom	Ministerio de Economia y Competitividad(Spanish Government); ERC(European Research Council (ERC)European Commission); ICREA(ICREA)	MF and EC were supported by respective FPI fellowships from the Ministerio de Economia y Competitividad. AMS held an AECC postdoctoral fellowship. AD-V was supported in part by a contract PTC2011-1091 from Ministerio de Economia y Competitividad. This work was supported by grants from the Ministerio de Economia y Competitividad (SAF2011/23638) to MAP; and an ERC grant to EB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Antequera F, 2003, CELL MOL LIFE SCI, V60, P1647, DOI 10.1007/s00018-003-3088-6; Aran D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r21; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Barrera V, 2012, NUCLEIC ACIDS RES, V40, P11490, DOI 10.1093/nar/gks928; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Berman BP, 2012, NAT GENET, V44, P40, DOI 10.1038/ng.969; Bock C, 2012, MOL CELL, V47, P633, DOI 10.1016/j.molcel.2012.06.019; Booth C, 2000, J CLIN INVEST, V105, P1493, DOI 10.1172/JCI10229; Brunner AL, 2009, GENOME RES, V19, P1044, DOI 10.1101/gr.088773.108; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; Carrio E, 2015, STEM CELLS IN PRESS; Chandra Sruti, 2014, Biology (Basel), V3, P426, DOI 10.3390/biology3020426; Clark SJ, 2007, HUM MOL GENET, V16, pR88, DOI 10.1093/hmg/ddm051; Coolen MW, 2010, NAT CELL BIOL, V12, P235, DOI 10.1038/ncb2023; Cortese R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026002; de Sousa e Melo F, 2011, CELL STEM CELL, V9, P476, DOI 10.1016/j.stem.2011.10.008; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Ehrlich M, 2009, EPIGENOMICS-UK, V1, P239, DOI 10.2217/EPI.09.33; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Forn M, 2013, MOL ONCOL, V7, P1129, DOI 10.1016/j.molonc.2013.08.008; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Frigola J, 2006, NAT GENET, V38, P540, DOI 10.1038/ng1781; Frigola J, 2005, ONCOGENE, V24, P7320, DOI 10.1038/sj.onc.1208883; Frigola J, 2005, HUM MOL GENET, V14, P319, DOI 10.1093/hmg/ddi028; Frigola J, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.7.e28; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Graham TA, 2011, GASTROENTEROLOGY, V140, P1241, DOI 10.1053/j.gastro.2010.12.036; Grimm C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003250; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Hon GC, 2013, NAT GENET, V45, P1198, DOI 10.1038/ng.2746; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2009, MAMM GENOME, V20, P674, DOI 10.1007/s00335-009-9222-5; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Issa JPJ, 2001, CANCER RES, V61, P3573; Jackson M, 2004, MOL CELL BIOL, V24, P8862, DOI 10.1128/MCB.24.20.8862-8871.2004; Javierre BM, 2011, MOL CANCER RES, V9, P1139, DOI 10.1158/1541-7786.MCR-10-0515; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jorda M, 2010, MUTAT RES-FUND MOL M, V693, P84, DOI 10.1016/j.mrfmmm.2010.06.010; Jorda Mireia, 2009, V507, P107, DOI 10.1007/978-1-59745-522-0_9; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Kaaij LTJ, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r50; Kulis M, 2012, NAT GENET, V44, P1236, DOI 10.1038/ng.2443; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Mallona I, 2014, SOURCE CODE BIOL MED, V9, DOI 10.1186/1751-0473-9-11; Mayor R, 2009, BRIT J CANCER, V100, P1534, DOI 10.1038/sj.bjc.6605045; McCabe MT, 2009, CANCER RES, V69, P282, DOI 10.1158/0008-5472.CAN-08-3274; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Merlos-Suarez A, 2008, CURR OPIN CELL BIOL, V20, P194, DOI 10.1016/j.ceb.2008.01.011; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; MOSER AR, 1992, J CELL BIOL, V116, P1517, DOI 10.1083/jcb.116.6.1517; Muto Y, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-466; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Ong CT, 2012, EMBO REP, V13, P423, DOI 10.1038/embor.2012.52; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Paz MF, 2003, HUM MOL GENET, V12, P2209, DOI 10.1093/hmg/ddg226; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Rodilla V, 2009, P NATL ACAD SCI USA, V106, P6315, DOI 10.1073/pnas.0813221106; Rodriguez J, 2006, CANCER RES, V66, P8462, DOI 10.1158/0008-5472.CAN-06-0293; Rodriguez J, 2008, P NATL ACAD SCI USA, V105, P19809, DOI 10.1073/pnas.0810133105; Sadikovic B, 2004, BREAST CANCER RES, V6, pR329, DOI 10.1186/bcr799; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Sheaffer KL, 2014, GENE DEV, V28, P652, DOI 10.1101/gad.230318.113; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Steine EJ, 2011, J CLIN INVEST, V121, P1748, DOI 10.1172/JCI43169; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Taberlay PC, 2014, GENOME RES, V24, P1421, DOI 10.1101/gr.163485.113; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Vermeulen L, 2014, NAT REV CANCER, V14, P468, DOI 10.1038/nrc3744; Wang Y, 2006, SCIENCE, V314, P645, DOI 10.1126/science.1135213; Yamada Y, 2007, CANCER SCI, V98, P6, DOI 10.1111/j.1349-7006.2006.00348.x; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109; Yatabe Y, 2001, P NATL ACAD SCI USA, V98, P10839, DOI 10.1073/pnas.191225998; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	84	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0123263	10.1371/journal.pone.0123263	http://dx.doi.org/10.1371/journal.pone.0123263			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933092	gold, Green Published, Green Submitted			2022-12-27	WOS:000353887100018
J	Hu, HB; Zhu, XY; Joshi, S; Lu, L; Xia, CQ; Patel, JM				Hu, Hanbo; Zhu, Xiaoyan; Joshi, Sunil; Lu, Li; Xia, Chang-Qing; Patel, Jawaharlal M.			Thioredoxin Priming Prolongs Lung Allograft Survival by Promoting Immune Tolerance	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; IMMATURE DENDRITIC CELLS; CD4(+) T-CELLS; REJECTION; TRANSPLANTATION; INDUCTION; ACTIVATION; EXPRESSION; THERAPY; MICE	Tolerance to allograft antigen is the major challenge and final goal of transplant medicine. Our previous study demonstrated that thioredoxin-1 (Trx) priming of donor lung significantly protected allogeneic lung graft. To determine whether Trx priming of donor lung inhibits allograft rejection, extends allograft survival and induces immune tolerance, orthotopic left lung transplantation was performed from Lewis to Sprague-Dawley rats without immunosuppression. Donor lungs were primed with Trx at 4 degrees C for 4 hr prior to transplantation. After up to 37 days post-transplantation, allograft lung morphology, recipient T cell and humoral alloantigen-specific immune responses were examined. We found that Trx-primed lungs exhibited much reduced acute rejection and associated lung injuries resulting in loss of graft functional area at 5-37 days post-transplant in contrast to the control groups. CD4(+) T cells from the recipients with Trx-primed grafts responded to the stimulation of dendritic cells (DCs) of donor origin, in contrast to DCs from the third party, with significantly reduced proliferation. Consistent with above findings, we observed that CD4(+)Foxp3(+) regulatory T cells in spleen cells from the recipients with Trx-primed grafts were significantly increased compared to controls, and CD4(+) T cells from the recipients with Trx-primed grafts produced much higher levels of immunosuppressive cytokine, IL-10 when stimulated with allogeneic donor DCs. In addition, humoral immune tolerance was also induced as there was no significant increase levels of serum antibodies against donor antigens in Trx-lung recipients when re-challenged with allogeneic donor antigens. Our results demonstrate that one-time Trx-priming of donor lung grafts prior to transplantation significantly prolongs the survival of the grafts through inducing or promoting cellular and humoral alloantigen-specific immune tolerance, which might be associated with the induction of immunosuppressive regulatory T cells.	[Hu, Hanbo; Zhu, Xiaoyan; Patel, Jawaharlal M.] Univ Florida, Coll Med, Dept Med, Gainesville, FL 32608 USA; [Joshi, Sunil; Lu, Li; Xia, Chang-Qing] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32608 USA; [Lu, Li; Patel, Jawaharlal M.] North Florida South Georgia Vet Hlth Syst, Res Serv, Gainesville, FL 32608 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Xia, CQ (corresponding author), Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32608 USA.	xia@pathology.ufl.edu; Pateljm@medicine.ufl.edu		Joshi, Sunil/0000-0001-8230-980X	Department of Medicine's Gatorade [00100966]; Research Service of the VHS	Department of Medicine's Gatorade; Research Service of the VHS	This study was supported by the Department of Medicine's Gatorade funding project #00100966 and the Research Service of the VHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andolfi G, 2012, MOL THER, V20, P1778, DOI 10.1038/mt.2012.71; Bhorade SM, 2010, TRANSPLANTATION, V90, P540, DOI 10.1097/TP.0b013e3181e8dabe; BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; Bozulic LD, 2011, TRANSPLANTATION, V91, P908, DOI 10.1097/TP.0b013e31820fafb4; Christie JD, 2010, J HEART LUNG TRANSPL, V29, P1104, DOI 10.1016/j.healun.2010.08.004; Fan HM, 2009, INT J CLIN EXP MED, V2, P212; Glantzounis GK, 2006, CURR PHARM DESIGN, V12, P2891, DOI 10.2174/138161206777947641; Gregori S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00030; Hattori I, 2004, ANTIOXID REDOX SIGN, V6, P81, DOI 10.1089/152308604771978372; Hirayama S, 2013, AM J TRANSPLANT, V13, P1586, DOI 10.1111/ajt.12230; Hu HB, 2008, J HEART LUNG TRANSPL, V27, P1142, DOI 10.1016/j.healun.2008.07.006; Jeon SG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002714; Kaminski MM, 2012, CELL REP, V2, P1300, DOI 10.1016/j.celrep.2012.10.009; Kasuno K, 2003, KIDNEY INT, V64, P1273, DOI 10.1046/j.1523-1755.2003.00224.x; Lemaitre PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070236; Mauiyyedi S, 2001, J AM SOC NEPHROL, V12, P574, DOI 10.1681/ASN.V123574; McManigle W, 2013, SEMIN RESP CRIT CARE, V34, P320, DOI 10.1055/s-0033-1348471; Nakamura T, 2005, ANTIOXID REDOX SIGN, V7, P60, DOI 10.1089/ars.2005.7.60; Regateiro FS, 2012, J IMMUNOL, V189, P3947, DOI 10.4049/jimmunol.1200449; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Shibuki H, 1998, INVEST OPHTH VIS SCI, V39, P1470; Shibuki H, 2000, INVEST OPHTH VIS SCI, V41, P3607; Tang QZ, 2012, J MOL CELL BIOL, V4, P11, DOI 10.1093/jmcb/mjr047; Tolar J, 2014, EXP DERMATOL, V23, P97, DOI 10.1111/exd.12227; Xia CQ, 2005, TRANSFUSION, V45, P181, DOI 10.1111/j.1537-2995.2004.04137.x; Yoon IH, 2008, TRANSPLANTATION, V86, P1352, DOI 10.1097/TP.0b013e31818aa43c; Yousem SA, 1996, J HEART LUNG TRANSPL, V15, P1; Zhi L, 2012, J IMMUNOL, V189, P1639, DOI 10.4049/jimmunol.1200528; Zhou F, 2013, IMMUNOL RES, V56, P1, DOI 10.1007/s12026-012-8382-7	29	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124705	10.1371/journal.pone.0124705	http://dx.doi.org/10.1371/journal.pone.0124705			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933390	Green Submitted, Green Published, gold			2022-12-27	WOS:000353887100056
J	Lorente, L; Martin, MM; Abreu-Gonzalez, P; Ramos, L; Argueso, M; Sole-Violan, J; Riano-Ruiz, M; Jimenez, A				Lorente, Leonardo; Martin, Maria M.; Abreu-Gonzalez, Pedro; Ramos, Luis; Argueso, Monica; Sole-Violan, Jordi; Riano-Ruiz, Marta; Jimenez, Alejandro			Serum Malondialdehyde Levels in Patients with Malignant Middle Cerebral Artery Infarction Are Associated with Mortality	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; MITIGATES OXIDATIVE DAMAGE; LIPID-PEROXIDATION; ANTIOXIDANT SUPPLEMENTATION; COMPENSATORY REACTIONS; PLASMA; CAPACITY; OUTCOMES; DISEASE; STRESS	Objective Malondialdehyde (MDA) is an end-product formed during lipid peroxidation, due to degradation of cellular membrane phospholipids. MDA is released into extracellular space and finally into the blood; it has been used as an effective biomarker of lipid oxidation. High circulating levels of MDA have been previously described in patients with ischemic stoke than in controls, and an association between circulating MDA levels and neurological functional outcome in patients with ischemic stoke. However, an association between serum MDA levels and mortality in patients with ischemic stroke has not been previously reported, and that was the objective of this study. Methods Observational, prospective and multicenter study performed in six Intensive Care Units. We included patients with severe malignant middle cerebral artery infarction (MMCAI) defined as Glasgow Coma Scale (GCS) lower than 9. We measured serum MDA levels in 50 patients with severe MMCAI at the time of diagnosis and in 100 healthy subjects. Mortality at 30 days was the end point of the study. Results We found that patients with severe MMCAI showed higher serum MDA levels than healthy subjects (p < 0.001). We found higher serum MDA levels (p < 0.001) in non-surviving MMCAI patients (n = 26) than in survivors (n = 24). The area under the curve for prediction of 30-day mortality for serum MDA levels was 0.77 (95% CI = 0.63-0.88; p < 0.001). Serum MDA levels >2.27 nmol/mL were associated with 30-day mortality (OR = 7.23; 95% CI = 1.84-28.73; p=0.005) controlling for GCS and age on multiple binomial logistic regression analysis. Conclusions To our knowledge, this is the first study showing that serum malondialdehyde levels in patients with MMCAI are associated with early mortality.	[Lorente, Leonardo] Hosp Univ Canarias, Intens Care Unit, Santa Cruz De Tenerife, Spain; [Martin, Maria M.] Hosp Univ Nuestra Senora Candelaria, Intens Care Unit, Santa Cruz De Tenerife, Spain; [Abreu-Gonzalez, Pedro] Univ La Laguna, Fac Med, Dept Phisiol, E-38207 San Cristobal la Laguna, Santa Cruz De T, Spain; [Ramos, Luis] Hosp Gen La Palma, Intens Care Unit, Brena Alta, La Palma, Spain; [Argueso, Monica] Univ Valencia, Hosp Clin, Intens Care Unit, Valencia, Spain; [Sole-Violan, Jordi] Hosp Univ Dr Negrin, CIBERES, Intens Care Unit, Las Palmas Gran Canaria, Spain; [Riano-Ruiz, Marta] Univ Insular Materno Infantil, Complejo Hosp, Serv Bioquim Clin, Las Palmas Gran Canaria, Spain; [Jimenez, Alejandro] Hosp Univ Canarias, Res Unit, San Cristobal la Laguna, Santa Cruz De T, Spain	Universidad de la Laguna; Universidad de la Laguna; University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Universidad de la Laguna	Lorente, L (corresponding author), Hosp Univ Canarias, Intens Care Unit, Santa Cruz De Tenerife, Spain.	lorentemartin@msn.com	Martín, María/HDL-9512-2022; Abreu-Gonzalez, Pedro/AAC-7790-2020	Abreu-Gonzalez, Pedro/0000-0002-7553-1784; Argueso, Monica/0000-0001-5917-1056	Fundacion Canaria de Investigacion Sanitaria (FUNCANIS) (La Laguna, Tenerife, Spain)	Fundacion Canaria de Investigacion Sanitaria (FUNCANIS) (La Laguna, Tenerife, Spain)	Fundings from Fundacion Canaria de Investigacion Sanitaria (FUNCANIS) (La Laguna, Tenerife, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; Alferova VV, 2011, ZH NEVROL PSIKHIATR, V111, P36; Alferova VV, 2010, ZH NEVROL PSIKHIATR, V110, P36; Bir LS, 2006, TOHOKU J EXP MED, V208, P33, DOI 10.1620/tjem.208.33; Bolokadze N, 2004, CLIN HEMORHEOL MICRO, V30, P99; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Chen Jian-hua, 2003, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V15, P232; Correa MD, 2008, BIOMED PHARMACOTHER, V62, P317, DOI 10.1016/j.biopha.2007.10.002; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; DRAPER HH, 1990, METHOD ENZYMOL, V186, P421; FRANCESCO V, 1985, STROKE, V16, P14, DOI 10.1161/01.STR.16.1.14; IMRE SG, 1994, STROKE, V25, P2416, DOI 10.1161/01.STR.25.12.2416; Katzan IL, 2014, STROKE, V45, P918, DOI 10.1161/01.str.0000441948.35804.77; KIKUGAWA K, 1992, ANAL BIOCHEM, V202, P249, DOI 10.1016/0003-2697(92)90102-D; Lorente L, 2015, J NEUROTRAUM, V32, P1, DOI 10.1089/neu.2014.3456; Lorente L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053741; Ozkul A, 2007, J CLIN NEUROSCI, V14, P1062, DOI 10.1016/j.jocn.2006.11.008; Polidori MC, 2002, FREE RADICAL RES, V36, P265, DOI 10.1080/10715760290019273; SANTOS MT, 1980, J CLIN PATHOL, V33, P973, DOI 10.1136/jcp.33.10.973; Silina EV, 2011, ZH NEVROL PSIKHIATR, V111, P36; TEASDALE G, 1974, LANCET, V2, P81; Thanoon Imad A-J, 2012, Sultan Qaboos Univ Med J, V12, P197; Ullegaddi R, 2005, EUR J CLIN NUTR, V59, P1367, DOI 10.1038/sj.ejcn.1602248; Ullegaddi R, 2004, CLIN SCI, V107, P477, DOI 10.1042/CS20040134; Ullegaddi R, 2006, JPEN-PARENTER ENTER, V30, P108, DOI 10.1177/0148607106030002108; Warner DS, 2004, J EXP BIOL, V207, P3221, DOI 10.1242/jeb.01022; Yang TH, 2004, CLIN BIOCHEM, V37, P494, DOI 10.1016/j.clinbiochem.2004.02.006; Yavorskaya VA, 2000, ZH NEVROPATOL PSIKH, V100, P48; Zhang JL, 1994, CHUNG KUO CHUNG HIS, V14, P478	29	29	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125893	10.1371/journal.pone.0125893	http://dx.doi.org/10.1371/journal.pone.0125893			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933254	gold, Green Published, Green Submitted			2022-12-27	WOS:000353887100139
J	Yamaguchi, Y; Li, ZQ; Zhu, XF; Liu, CC; Zhang, DW; Dou, XM				Yamaguchi, Yoshinori; Li, Zhenqing; Zhu, Xifang; Liu, Chenchen; Zhang, Dawei; Dou, Xiaoming			Polyethylene Oxide (PEO) and Polyethylene Glycol (PEG) Polymer Sieving Matrix for RNA Capillary Electrophoresis	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; POLY(ETHYLENE OXIDE); DNA SEPARATION; NUCLEIC-ACIDS; BEHAVIOR; DYNAMICS; TEMPERATURE; MORPHOLOGY; FRAGMENTS; SIZE	The selection of sieving polymer for RNA fragments separation by capillary electrophoresis is imperative. We investigated the separation of RNA fragments ranged from 100 to 10,000 nt in polyethylene glycol (PEG) and polyethylene oxide (PEO) solutions with different molecular weight and different concentration. We found that the separation performance of the small RNA fragments (<1000 nt) was improved with the increase of polymer concentration, whereas the separation performance for the large ones (>4000 nt) deteriorated in PEG/PEO solutions when the concentration was above 1.0%/0.6%, respectively. By double logarithmic plot of mobility and RNA fragment size, we revealed three migration regimes for RNA in PEG (300-500k) and PEO (4,000k). Moreover, we calculated the smallest resolvable nucleotide length (N-min) from the resolution length analysis.	[Li, Zhenqing; Liu, Chenchen; Zhang, Dawei] E China Univ Sci & Technol, Grad Sch Sci, IPBM, Shanghai 200237, Peoples R China; [Yamaguchi, Yoshinori; Dou, Xiaoming] Univ Shanghai Sci & Technol, Engn Res Ctr Opt Instrument & Syst, Shanghai Key Lab Modern Opt Syst, Minist Educ, Shanghai 200093, Peoples R China; [Yamaguchi, Yoshinori] Osaka Univ, Grad Sch Engn, Dept Appl Phys, Suita, Osaka 5650871, Japan; [Zhu, Xifang] Changzhou Inst Technol, Coll Photoelect Engn, Changzhou 213002, Peoples R China	East China University of Science & Technology; University of Shanghai for Science & Technology; Osaka University; Changzhou Institute of Technology	Li, ZQ (corresponding author), E China Univ Sci & Technol, Grad Sch Sci, IPBM, 130 Meilong Rd, Shanghai 200237, Peoples R China.	zhenqingli@163.com; xiaomingdou@yeah.net	Zhang, Dawei/K-4719-2018	li, zhenqing/0000-0001-9060-7305; Liu, Chenchen/0000-0001-9148-8029	JSPS, Japan [25600049]; National Natural Science Foundation of China [21205078, 61378060]; Research Fund for the Doctoral Program of Higher Education of China [20123120110002]; Innovation Fund Project for Graduate Student of Shanghai, China [JWCXSL1401]	JSPS, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Innovation Fund Project for Graduate Student of Shanghai, China	This project was partly supported by Grant-in-Aid for Scientific Research (Houga) (No. 25600049 (Y.Y.)), JSPS, Japan. The authors also gratefully acknowledge support from National Natural Science Foundation of China (No. 21205078 and No. 61378060), Research Fund for the Doctoral Program of Higher Education of China (No. 20123120110002), and the Innovation Fund Project for Graduate Student of Shanghai (No. JWCXSL1401), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GJ, 2011, ANAL CHEM, V83, P1350, DOI 10.1021/ac102671n; Balijepalli S, 1996, MACROMOLECULES, V29, P6601, DOI 10.1021/ma960678s; BARRON AE, 1993, J CHROMATOGR A, V652, P3, DOI 10.1016/0021-9673(93)80639-P; Bernard Tinland AP, 1997, MACROMOLECULES, V30, P5763; BIEZE TWN, 1994, MACROMOLECULES, V27, P1355, DOI 10.1021/ma00084a013; Briscoe B, 1996, MACROMOLECULES, V29, P6208, DOI 10.1021/ma960667z; CHEN JH, 1995, J POLYM SCI POL PHYS, V33, P1851, DOI 10.1002/polb.1995.090331301; CHENG SZD, 1991, J POLYM SCI POL PHYS, V29, P311, DOI 10.1002/polb.1991.090290306; Guttman A, 1996, NATURE, V380, P461, DOI 10.1038/380461a0; Heller C, 2001, ELECTROPHORESIS, V22, P629, DOI 10.1002/1522-2683(200102)22:4<629::AID-ELPS629>3.0.CO;2-S; HJERTEN S, 1985, J CHROMATOGR, V347, P191, DOI 10.1016/S0021-9673(01)95485-8; Kan CW, 2003, ELECTROPHORESIS, V24, P55, DOI 10.1002/elps.200390031; KARGER BL, 1989, NATURE, V339, P641, DOI 10.1038/339641a0; Kim Y, 1997, J CHROMATOGR A, V781, P315, DOI 10.1016/S0021-9673(97)00472-X; Kim YS, 1997, ELECTROPHORESIS, V18, P2901, DOI 10.1002/elps.1150181530; Li Q, 2010, ANAL CHEM, V82, P5260, DOI 10.1021/ac100669z; Li ZQ, 2014, ANALYST, V139, P6113, DOI 10.1039/c4an01649a; Li ZQ, 2014, ANAL METHODS-UK, V6, P2473, DOI 10.1039/c3ay41965g; Li ZQ, 2014, J CHROMATOGR A, V1331, P100, DOI 10.1016/j.chroma.2014.01.021; Li ZQ, 2012, J CHROMATOGR A, V1229, P274, DOI 10.1016/j.chroma.2012.01.056; Li ZQ, 2011, ANAL BIOANAL CHEM, V401, P1661, DOI 10.1007/s00216-011-5228-4; Li ZQ, 2010, ELECTROPHORESIS, V31, P3531, DOI 10.1002/elps.201000175; Li ZQ, 2010, J SEP SCI, V33, P2811, DOI 10.1002/jssc.201000188; Lines JA, 2014, BIOCHEM BIOPH RES CO, V443, P308, DOI 10.1016/j.bbrc.2013.11.095; Liu P, 2007, ANAL CHEM, V79, P1881, DOI 10.1021/ac061961k; Masubuchi Y, 1996, ELECTROPHORESIS, V17, P1065, DOI 10.1002/elps.1150170615; Merdas A, 1996, J PHYS CHEM-US, V100, P15180, DOI 10.1021/jp960628p; Mitchelson KR, 2004, CAPILLARY ELECTROPHO; OANA H, 1994, MACROMOLECULES, V27, P6061, DOI 10.1021/ma00099a019; SHI XL, 1995, ANAL CHEM, V67, P3219, DOI 10.1021/ac00114a018; SLATER GW, 1993, ELECTROPHORESIS, V14, P1, DOI 10.1002/elps.1150140102; Slater GW, 2001, METH MOL B, V162, P27; Slater GW, 2000, ELECTROPHORESIS, V21, P3873, DOI 10.1002/1522-2683(200012)21:18<3873::AID-ELPS3873>3.3.CO;2-#; Sumitomo K, 2009, ELECTROPHORESIS, V30, P3607, DOI 10.1002/elps.200900255; Sumitomo K, 2009, ELECTROPHORESIS, V30, P1538, DOI 10.1002/elps.200800457; Tinoco I, 2002, BIOPHYS CHEM, V101, P513, DOI 10.1016/S0301-4622(02)00177-1; Todorov TI, 2003, ANAL CHEM, V75, P1837, DOI 10.1021/ac026325a; Todorov TI, 2002, ELECTROPHORESIS, V23, P1033, DOI 10.1002/1522-2683(200204)23:7/8<1033::AID-ELPS1033>3.0.CO;2-7; VIOVY JL, 1993, ELECTROPHORESIS, V14, P322, DOI 10.1002/elps.1150140155; Yamaguchi Y, 2004, ELECTROPHORESIS, V25, P999, DOI 10.1002/elps.200305783; Yu ZQ, 2013, J AM CHEM SOC, V135, P2883, DOI 10.1021/ja311090e; Yu ZQ, 2010, ANAL BIOCHEM, V397, P197, DOI 10.1016/j.ab.2009.10.030	42	6	7	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0123406	10.1371/journal.pone.0123406	http://dx.doi.org/10.1371/journal.pone.0123406			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933347	Green Submitted, gold, Green Published			2022-12-27	WOS:000353887100020
J	Brand, B; Hadlich, F; Brandt, B; Schauer, N; Graunke, KL; Langbein, J; Repsilber, D; Ponsuksili, S; Schwerin, M				Brand, Bodo; Hadlich, Frieder; Brandt, Bettina; Schauer, Nicolas; Graunke, Katharina L.; Langbein, Jan; Repsilber, Dirk; Ponsuksili, Siriluk; Schwerin, Manfred			Temperament Type Specific Metabolite Profiles of the Prefrontal Cortex and Serum in Cattle	PLOS ONE			English	Article							OXIDATIVE STRESS; 5-ALPHA-REDUCED GLUCOCORTICOIDS; N-ACYLETHANOLAMINES; MILK-PRODUCTION; FLIGHT SPEED; ALLOPREGNANOLONE; BRAIN; CONSISTENCY; FEAR; IDENTIFICATION	In the past decade the number of studies investigating temperament in farm animals has increased greatly because temperament has been shown not only to affect handling but also reproduction, health and economically important production traits. However, molecular pathways underlying temperament and molecular pathways linking temperament to production traits, health and reproduction have yet to be studied in full detail. Here we report the results of metabolite profiling of the prefrontal cortex and serum of cattle with distinct temperament types that were performed to further explore their molecular divergence in the response to the slaughter procedure and to identify new targets for further research of cattle temperament. By performing an untargeted comprehensive metabolite profiling, 627 and 1097 metabolite features comprising 235 and 328 metabolites could be detected in the prefrontal cortex and serum, respectively. In total, 54 prefrontal cortex and 51 serum metabolite features were indicated to have a high relevance in the classification of temperament types by a sparse partial least square discriminant analysis. A clear discrimination between fearful/neophobic-alert, interested-stressed, subdued/uninterested-calm and outgoing/neophilic-alert temperament types could be observed based on the abundance of the identified relevant prefrontal cortex and serum metabolites. Metabolites with high relevance in the classification of temperament types revealed that the main differences between temperament types in the response to the slaughter procedure were related to the abundance of glycerophospholipids, fatty acyls and sterol lipids. Differences in the abundance of metabolites related to C21 steroid metabolism and oxidative stress indicated that the differences in the metabolite profiles of the four extreme temperament types could be the result of a temperament type specific regulation of molecular pathways that are known to be involved in the stress and fear response.	[Brand, Bodo; Hadlich, Frieder; Brandt, Bettina; Ponsuksili, Siriluk; Schwerin, Manfred] Leibniz Inst Farm Anim Biol, Inst Genome Biol, Dummerstorf, Germany; [Schauer, Nicolas] Metabol Discoveries GmbH, Golm, Germany; [Graunke, Katharina L.; Langbein, Jan] Leibniz Inst Farm Anim Biol, Inst Behav Physiol, Dummerstorf, Germany; [Schwerin, Manfred] Univ Rostock, Inst Farm Anim Res & Technol, D-18055 Rostock, Germany; [Repsilber, Dirk] Leibniz Inst Farm Anim Biol, Inst Genet & Biometry, Dummerstorf, Germany	Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN); University of Rostock; Forschungsinstitut fur Nutztierbiologie (FBN)	Schwerin, M (corresponding author), Leibniz Inst Farm Anim Biol, Inst Genome Biol, Dummerstorf, Germany.	schwerin@fbn-dummerstorf.de	Langbein, Jan/AFO-8965-2022	Langbein, Jan/0000-0002-1170-5431	German Federal Ministry of Education and Research (BMBF) [0315535, 0315536A, 0315536G]; Metabolomic Discoveries GmbH	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Metabolomic Discoveries GmbH	This work is part of the project "PHENOMICS - a system biological approach of genotype-phenotype-distinction in the context of farm animal performance, health and welfare in cattle and pig" (0315535 (BBt), 0315536A and 0315536G (KLG)) (http://www.phaenomics.auf.uni-rostock.de/enhome.html) funded by the German Federal Ministry of Education and Research (BMBF). Metabolomic Discoveries GmbH provided support in the form of salary for author NS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of the author is articulated in the 'author contributions' section.	Adamczyk K, 2013, LIVEST SCI, V154, P1, DOI 10.1016/j.livsci.2013.01.016; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Backstrom T, 2013, PROG NEUROBIOL, V113, DOI [10.1016/j.pneurobio.2013.09.003, DOI 10.1016/J.PNEUROBIO.2013.09.003]; Bernardi F, 1998, EUR J ENDOCRINOL, V138, P316, DOI 10.1530/eje.0.1380316; Bicikova M, 2013, J STEROID BIOCHEM, V133, P77, DOI 10.1016/j.jsbmb.2012.08.009; Black TE, 2013, J ANIM SCI, V91, P2254, DOI [10.2527/jas.2012-5242, 10.2527/jas2012-5242]; Boissy A, 2005, LIVEST PROD SCI, V93, P23, DOI 10.1016/j.livprodsci.2004.11.003; Bolten EE, 2008, ANN REPORTS COMPUTAT, V4; Brambilla P, 2003, MOL PSYCHIATR, V8, P721, DOI 10.1038/sj.mp.4001362; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; BROWN GK, 1987, J INHERIT METAB DIS, V10, P367, DOI 10.1007/BF01799979; Burdick N. C., 2011, International Journal of Zoology, V2011, P373197, DOI 10.1155/2011/373197; Burdick NC, 2009, J ANIM SCI, V87, P3202, DOI 10.2527/jas.2009-1931; Cao KAL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-253; Chong IG, 2005, CHEMOMETR INTELL LAB, V78, P103, DOI 10.1016/j.chemolab.2004.12.011; Coombes SV, 2014, MEAT SCI, V98, P815, DOI 10.1016/j.meatsci.2014.06.029; Curley KO, 2006, J ANIM SCI, V84, P3100, DOI 10.2527/jas.2006-055; Degn M, 2007, J NEUROCHEM, V103, P1907, DOI 10.1111/j.1471-4159.2007.04892.x; Dejean S, MIXOMICS OMICS DATA; Exton J H, 1979, Monogr Endocrinol, V12, P535; Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200; FAROOQUI AA, 1991, BRAIN RES REV, V16, P171, DOI 10.1016/0165-0173(91)90004-R; Ferguson DM, 2008, MEAT SCI, V80, P12, DOI 10.1016/j.meatsci.2008.05.004; Filiou MD, 2014, J PSYCHIATR RES, V58, P115, DOI 10.1016/j.jpsychires.2014.07.019; FORDYCE G, 1988, AUST J EXP AGR, V28, P689, DOI 10.1071/EA9880683; Forkman B, 2007, PHYSIOL BEHAV, V92, P340, DOI 10.1016/j.physbeh.2007.03.016; Grandin T, 1997, J ANIM SCI, V75, P249; Graunke KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074579; Gruber SL, 2010, J ANIM SCI, V88, P1148, DOI 10.2527/jas.2009-2183; Gutierrez-Gil B, 2008, J HERED, V99, P629, DOI 10.1093/jhered/esn060; Hammon HM, 2010, J DAIRY SCI, V93, P3007, DOI 10.3168/jds.2009-2931; Hanna LLH, 2014, LIVEST SCI, V161, P17, DOI 10.1016/j.livsci.2013.12.012; HANSEN HS, 1995, BBA-LIPID LIPID MET, V1258, P303, DOI 10.1016/0005-2760(95)00134-X; Hansen HS, 1998, BIOCHEM PHARMACOL, V55, P719, DOI 10.1016/S0006-2952(97)00396-1; Hastie T., 2009, UNSUPERVISED LEARNIN; Hemsworth PH, 2000, J ANIM SCI, V78, P2821; Henn FA, 2005, NEUROSCI BIOBEHAV R, V29, P799, DOI 10.1016/j.neubiorev.2005.03.019; Hiendleder S, 2003, J HERED, V94, P496, DOI 10.1093/jhered/esg090; James SJ, 2004, AM J CLIN NUTR, V80, P1611, DOI 10.1093/ajcn/80.6.1611; Jiang P., 2014, PSYCHOPHARMACOLOGY, P1; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Khisti RT, 2000, PHARMACOL BIOCHEM BE, V67, P137, DOI 10.1016/S0091-3057(00)00300-2; Koolhaas JM, 2010, FRONT NEUROENDOCRIN, V31, P307, DOI 10.1016/j.yfrne.2010.04.001; Kramer M, 2014, J DAIRY SCI, V97, P1774, DOI 10.3168/jds.2013-7054; Kromer SA, 2005, J NEUROSCI, V25, P4375, DOI 10.1523/JNEUROSCI.0115-05.2005; Kuhn C, 2002, ARCH TIERZUCHT, V45, P317; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Lu YR, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-123; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P89, DOI 10.1016/0306-4522(95)00259-L; Makkar SR, 2010, NEUROPSYCHOPHARMACOL, V35, P1625, DOI 10.1038/npp.2010.53; MCCORMICK DA, 1989, J NEUROPHYSIOL, V62, P1018, DOI 10.1152/jn.1989.62.5.1018; McEwen BS, 2000, NEUROCHEM RES, V25, P1219, DOI 10.1023/A:1007687911139; McInnes KJ, 2004, J BIOL CHEM, V279, P22908, DOI 10.1074/jbc.M402822200; Miller EK, 2002, PHILOS T R SOC B, V357, P1123, DOI 10.1098/rstb.2002.1099; Muller R, 2006, APPL ANIM BEHAV SCI, V99, P193, DOI 10.1016/j.applanim.2005.05.012; Munhoz CD, 2008, BRAZ J MED BIOL RES, V41, P1037, DOI 10.1590/S0100-879X2008001200001; Nixon M, 2012, J ENDOCRINOL, V212, P111, DOI 10.1530/JOE-11-0318; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oresic M, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.55; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Paul BD, 2014, NATURE, V509, P96, DOI 10.1038/nature13136; PAUL SM, 1992, FASEB J, V6, P2311, DOI 10.1096/fasebj.6.6.1347506; Pinna G, 2005, P NATL ACAD SCI USA, V102, P2135, DOI 10.1073/pnas.0409643102; R Development Core Team, R LANG ENV STAT COMP; Raymond D, 2014, BASIC NEUROCHEMISTRY; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Sanchez NCB, 2014, J ANIM PHYSIOL AN N, V98, P178, DOI 10.1111/jpn.12074; Sarro EC, 2014, NEUROSCIENCE, V258, P147, DOI 10.1016/j.neuroscience.2013.10.064; Schmutz SM, 2001, J HERED, V92, P290, DOI 10.1093/jhered/92.3.290; Schule C, 2014, PROG NEUROBIOL, V113, P79, DOI 10.1016/j.pneurobio.2013.09.003; Schulz D, 2013, INT J NEUROPSYCHOPH, V16, P199, DOI 10.1017/S1461145711001994; Schulz JB, 2000, EUR J BIOCHEM, V267, P4904, DOI 10.1046/j.1432-1327.2000.01595.x; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Smaga I, 2012, PROG NEURO-PSYCHOPH, V39, P280, DOI 10.1016/j.pnpbp.2012.06.018; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Sripada RK, 2013, BIOL PSYCHIAT, V73, P1045, DOI 10.1016/j.biopsych.2012.12.008; Sutherland MA, 2012, PHYSIOL BEHAV, V107, P329, DOI 10.1016/j.physbeh.2012.07.013; Terlouw EMC, 2008, ANIMAL, V2, P1501, DOI 10.1017/S1751731108002723; Terlouw EMC, 2012, ANIM WELFARE, V21, P43, DOI 10.7120/096272812X13353700593482; Van Reenen CG, 2005, PHYSIOL BEHAV, V85, P557, DOI 10.1016/j.physbeh.2005.06.015; Van Reenen CG, 2013, APPL ANIM BEHAV SCI, V147, P55, DOI 10.1016/j.applanim.2013.04.020; Vervoort LMT, 1997, BIOCHEM PHARMACOL, V54, P871, DOI 10.1016/S0006-2952(97)00254-2; Vitvitsky V, 2006, J BIOL CHEM, V281, P35785, DOI 10.1074/jbc.M602799200; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Wood PL, 2014, NEUROPSYCHOPHARMACOL, V39, P24, DOI 10.1038/npp.2013.167; Yang C, 2011, BRIT J PHARMACOL, V164, P1661, DOI 10.1111/j.1476-5381.2011.01465.x; Zaidi SMKR, 2004, CLIN CHIM ACTA, V340, P229, DOI 10.1016/j.cccn.2003.11.003; Zhang J, 2013, NEUROSCI LETT, V545, P132, DOI 10.1016/j.neulet.2013.04.035	88	13	13	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125044	10.1371/journal.pone.0125044	http://dx.doi.org/10.1371/journal.pone.0125044			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927228	Green Published, gold, Green Submitted			2022-12-27	WOS:000353713100061
J	Khakshour, S; Beischlag, TV; Sparrey, C; Park, EJ				Khakshour, Samaneh; Beischlag, Timothy V.; Sparrey, Carolyn; Park, Edward J.			Probing Mechanical Properties of Jurkat Cells under the Effect of ART Using Oscillating Optical Tweezers	PLOS ONE			English	Article							CARCINOMA; APOPTOSIS; TARGETS	Acute lymphoid leukemia is a common type of blood cancer and chemotherapy is the initial treatment of choice. Quantifying the effect of a chemotherapeutic drug at the cellular level plays an important role in the process of the treatment. In this study, an oscillating optical tweezer was employed to characterize the frequency-dependent mechanical properties of Jurkat cells exposed to the chemotherapeutic agent, artesunate (ART). A motion equation for a bead bound to a cell was applied to describe the mechanical characteristics of the cell cytoskeleton. By comparing between the modeling results and experimental results from the optical tweezer, the stiffness and viscosity of the Jurkat cells before and after the ART treatment were obtained. The results demonstrate a weak power-law dependency of cell stiffness with frequency. Furthermore, the stiffness and viscosity were increased after the treatment. Therefore, the cytoskeleton cell stiffness as the well as power-law coefficient can provide a useful insight into the chemo-mechanical relationship of drug treated cancer cells and may serve as another tool for evaluating therapeutic performance quantitatively.	[Khakshour, Samaneh; Sparrey, Carolyn; Park, Edward J.] Simon Fraser Univ, Fac Sci Appl, Sch Mechatron Syst Engn, Surrey, BC, Canada; [Beischlag, Timothy V.; Park, Edward J.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada	Simon Fraser University; Simon Fraser University	Park, EJ (corresponding author), Simon Fraser Univ, Fac Sci Appl, Sch Mechatron Syst Engn, Surrey, BC, Canada.	ed_park@sfu.ca		Sparrey, Carolyn/0000-0002-5524-4577	Natural Sciences and Engineering Research Council of Canada [RGPIN/298219-2012]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by the Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca/) under Grant RGPIN/298219-2012 (PI: EJP). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B., 2010, MOL BIOL CELL; Baek JH, 2007, AS S PREC ENG NAN; Cai P, 2013, BIOPHYS J, V105, P1093, DOI 10.1016/j.bpj.2013.07.035; Cai XF, 2009, SCANNING, V31, P83, DOI 10.1002/sca.20144; Efferth T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000693; Fabry B, 2003, PHYS REV E, V68, P1, DOI [10.1103/PhysRevE.68.041914, DOI 10.1103/PhysRevE.68.041914]; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Goldmann WH, 1996, EXP CELL RES, V226, P234, DOI 10.1006/excr.1996.0223; Grzanka A, 2003, BIOCHEM PHARMACOL, V66, P1611, DOI 10.1016/S0006-2952(03)00532-X; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jordan MA, 1998, CURR OPIN CELL BIOL, V10, P123, DOI 10.1016/S0955-0674(98)80095-1; Knudsen PB, 2014, LEUKEMIA, V28, P1289, DOI 10.1038/leu.2013.360; Kollmannsberger P, 2011, SOFT MATTER, V7, P3127, DOI 10.1039/c0sm00833h; Lam WA, 2007, BLOOD, V109, P3505, DOI 10.1182/blood-2006-08-043570; Levee M, 1996, AM J PHYSIOL, V271, P1982; Li LN, 2007, INT J CANCER, V121, P1360, DOI 10.1002/ijc.22804; Maksym GN, 2000, J APPL PHYSIOL, V89, P1619, DOI 10.1152/jappl.2000.89.4.1619; Marin-Esteban V, 2010, J IMMUNOTHER, V33, P364, DOI 10.1097/CJI.0b013e3181cd1094; Miyoshi H, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.120223; Neuman KC, 2004, REV SCI INSTRUM, V75, P2787, DOI 10.1063/1.1785844; Puig-de-Morales M, 2001, J APPL PHYSIOL, V91, P1152, DOI 10.1152/jappl.2001.91.3.1152; Purves WK, 1994, LIFE SCI BIOL; SHROFF SG, 1995, AM J PHYSIOL-CELL PH, V269, pC286, DOI 10.1152/ajpcell.1995.269.1.C286; Stehn JR, 2013, CANCER RES, V73, P5169, DOI 10.1158/0008-5472.CAN-12-4501; Wuang SC, 2011, CELL MOL BIOENG, V4, P466, DOI 10.1007/s12195-011-0163-1; Yamada S, 2000, BIOPHYS J, V78, P1736, DOI 10.1016/S0006-3495(00)76725-7	26	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0126548	10.1371/journal.pone.0126548	http://dx.doi.org/10.1371/journal.pone.0126548			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928073	Green Submitted, Green Published, gold			2022-12-27	WOS:000353713100130
J	Kolby, JE; Ramirez, SD; Berger, L; Richards-Hrdlicka, KL; Jocque, M; Skerratt, LF				Kolby, Jonathan E.; Ramirez, Sara D.; Berger, Lee; Richards-Hrdlicka, Kathryn L.; Jocque, Merlijn; Skerratt, Lee F.			Terrestrial Dispersal and Potential Environmental Transmission of the Amphibian Chytrid Fungus (Batrachochytrium dendrobatidis)	PLOS ONE			English	Article							NATIONAL-PARK; CHYTRIDIOMYCOSIS; PATHOGEN; DISEASE; INFECTION; DECLINES; HISTORY; POPULATION; PREVALENCE; ABUNDANCE	Dispersal and exposure to amphibian chytrid fungus (Batrachochytrium dendrobatidis, Bd) is not confined to the aquatic habitat, but little is known about pathways that facilitate exposure to wild terrestrial amphibians that do not typically enter bodies of water. We explored the possible spread of Bd from an aquatic reservoir to terrestrial substrates by the emergence of recently metamorphosed infected amphibians and potential deposition of Bd-positive residue on riparian vegetation in Cusuco National Park, Honduras (CNP). Amphibians and their respective leaf perches were both sampled for Bd presence and the pathogen was detected on 76.1% (35/46) of leaves where a Bd-positive frog had rested. Although the viability of Bd detected on these leaves cannot be discerned from our quantitative PCR results, the cool air temperature, closed canopy, and high humidity of this cloud forest environment in CNP is expected to encourage pathogen persistence. High prevalence of infection (88.5%) detected in the recently metamorphosed amphibians and frequent shedding of Bd-positive residue on foliage demonstrates a pathway of Bd dispersal between aquatic and terrestrial habitats. This pathway provides the opportunity for environmental transmission of Bd among and between amphibian species without direct physical contact or exposure to an aquatic habitat.	[Kolby, Jonathan E.; Berger, Lee; Skerratt, Lee F.] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Hlth Res Grp 1, Townsville, Qld 4811, Australia; [Kolby, Jonathan E.; Ramirez, Sara D.; Jocque, Merlijn] Operat Wallacea, Old Bolingbroke PE23 4EX, Lincs, England; [Ramirez, Sara D.] Ramapo Coll, Sustainabil Studies Program, Mahwah, NJ USA; [Richards-Hrdlicka, Kathryn L.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Jocque, Merlijn] Royal Belgian Inst Nat Sci, B-1000 Brussels, Belgium	James Cook University; Ramapo College New Jersey (RCNJ); Yale University; Royal Belgian Institute of Natural Sciences	Kolby, JE (corresponding author), James Cook Univ, Coll Publ Hlth Med & Vet Sci, Hlth Res Grp 1, Townsville, Qld 4811, Australia.	jonathan.kolby@my.jcu.edu.au	Kolby, Jonathan/GWV-5557-2022; Kolby, Jonathan/GWZ-3092-2022	Skerratt, Lee/0000-0003-3471-7512; Berger, Lee/0000-0001-9227-5439	Operation Wallacea	Operation Wallacea	Operation Wallacea provided support in the form of salaries for authors Jonathan E. Kolby, Sara D. Ramirez and Merlijn Jocque but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Becker CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048205; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Burrowes PA, 2008, HERPETOTROPICOS, V4, P51; Carey C, 2006, ECOHEALTH, V3, P5, DOI 10.1007/s10393-005-0006-4; Caruso NM, 2013, DIVERS DISTRIB, V19, P38, DOI 10.1111/j.1472-4642.2012.00938.x; Catenazzi A, 2011, CONSERV BIOL, V25, P382, DOI 10.1111/j.1523-1739.2010.01604.x; Chestnut T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106790; Crawford AJ, 2010, P NATL ACAD SCI USA, V107, P13777, DOI 10.1073/pnas.0914115107; Cummer Michelle R., 2005, Herpetological Review, V36, P248; Daszak P, 2004, HERPETOL J, V14, P201; DiRenzo GV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093356; Doherty-Bone TM, 2013, DIS AQUAT ORGAN, V102, P187, DOI 10.3354/dao02557; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Fiers F, 2013, ZOOTAXA, V3630, P270, DOI 10.11646/zootaxa.3630.2.4; Fisher MC, 2009, MOL ECOL, V18, P415, DOI 10.1111/j.1365-294X.2008.04041.x; Garland S, 2010, DIS AQUAT ORGAN, V92, P113, DOI 10.3354/dao02053; Garmyn A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035038; Gilbert M, 2012, ECOHEALTH, V9, P386, DOI 10.1007/s10393-013-0817-7; Gower DJ, 2013, ECOHEALTH, V10, P173, DOI 10.1007/s10393-013-0831-9; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Jocque M, 2013, J CRUSTACEAN BIOL, V33, P451, DOI 10.1163/1937240X-00002161; Johnson ML, 2005, DIS AQUAT ORGAN, V65, P181, DOI 10.3354/dao065181; Kirshtein JD, 2007, DIS AQUAT ORGAN, V77, P11, DOI 10.3354/dao01831; Kolby JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090750; Kolby Jonathan E., 2009, Herpetological Review, V40, P307; Kolby JE, 2010, DIS AQUAT ORGAN, V92, P245, DOI 10.3354/dao02055; Kolby Jonathan E., 2009, Herpetological Review, V40, P282; Kriger KM, 2007, J ZOOL, V271, P352, DOI 10.1111/j.1469-7998.2006.00220.x; Kriger KM, 2007, DIVERS DISTRIB, V13, P781, DOI 10.1111/j.1472-4642.2007.00394.x; Langhammer PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077630; Lips KR, 2008, PLOS BIOL, V6, P441, DOI 10.1371/journal.pbio.0060072; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; McCracken Shawn, 2009, Herpetological Review, V40, P190; Olson DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056802; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Piovia-Scott J, 2011, BIOL CONSERV, V144, P2913, DOI 10.1016/j.biocon.2011.08.008; Puschendorf R, 2006, BIOL CONSERV, V132, P136, DOI 10.1016/j.biocon.2006.03.010; Puschendorf R, 2006, ECOHEALTH, V3, P178, DOI 10.1007/s10393-006-0026-8; Rachowicz LJ, 2004, DIS AQUAT ORGAN, V61, P75, DOI 10.3354/dao061075; Richards-Hrdlicka KL, 2013, DIS AQUAT ORGAN, V102, P169, DOI 10.3354/dao02552; Rollins-Smith Louise A, 2009, Front Biosci (Schol Ed), V1, P68; Rosenblum EB, 2013, P NATL ACAD SCI USA, V110, P9385, DOI 10.1073/pnas.1300130110; Rowley JJL, 2007, DIS AQUAT ORGAN, V77, P1, DOI 10.3354/dao01830; Rowley Jodi J. L., 2007, Herpetological Review, V38, P308; Russell DM, 2010, DIS AQUAT ORGAN, V92, P223, DOI 10.3354/dao02286; Schloegel LM, 2012, MOL ECOL, V21, P5162, DOI 10.1111/j.1365-294X.2012.05710.x; Schloegel LM, 2009, BIOL CONSERV, V142, P1420, DOI 10.1016/j.biocon.2009.02.007; Seimon TA, 2007, GLOBAL CHANGE BIOL, V13, P288, DOI 10.1111/j.1365-2486.2006.01278.x; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Speare R, 2004, AUST VET J, V82, P300, DOI 10.1111/j.1751-0813.2004.tb12710.x; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Voyles J, 2012, ECOL EVOL, V2, P2241, DOI 10.1002/ece3.334; Weinstein SB, 2009, COPEIA, P653, DOI 10.1643/CH-08-180; WILSON L. D., 2003, AMPHIB REPTILE CONSE, V3, P6; Wimsatt J, 2014, ZOO BIOL, V33, P577, DOI 10.1002/zoo.21154	58	44	45	4	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125386	10.1371/journal.pone.0125386	http://dx.doi.org/10.1371/journal.pone.0125386			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927835	gold, Green Published, Green Accepted			2022-12-27	WOS:000353713100087
J	Lezzerini, M; van de Ven, K; Veerman, M; Brul, S; Budovskaya, YV				Lezzerini, Marco; van de Ven, Koen; Veerman, Martijn; Brul, Stanley; Budovskaya, Yelena V.			Specific RNA Interference in Caenorhabditis elegans by Ingested dsRNA Expressed in Bacillus subtilis	PLOS ONE			English	Article							LIFE-SPAN; GENE-EXPRESSION; ESCHERICHIA-COLI; RESISTANCE; LONGEVITY; HEALTHSPAN; LIPOFUSCIN; PROTEINS; BACTERIA; RECEPTOR	In nematodes, genome-wide RNAi-screening has been widely used as a rapid and efficient method to identify genes involved in the aging processes. By far the easiest way of inducing RNA interference (RNAi) in Caenorhabditis elegans is by feeding Escherichia coli that expresses specific double stranded RNA (dsRNA) to knockdown translation of targeted mRNAs. However, it has been shown that E. coli is mildly pathogenic to C. elegans and this pathogenicity might influence aging and the accuracy of the RNAi-screening during aging may as well be affected. Here, we describe a novel system that utilizes the non-pathogenic bacterium Bacillus subtilis, to express dsRNA and therefore eliminates the effects of bacterial pathogenicity from the genetic analysis of aging.	[Lezzerini, Marco; van de Ven, Koen; Veerman, Martijn; Brul, Stanley; Budovskaya, Yelena V.] Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands	University of Amsterdam	Budovskaya, YV (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands.	y.budovskaya@uva.nl		van de Ven, Koen/0000-0001-7549-5683	MacGillavry fellowship	MacGillavry fellowship	This research was funded my MacGillavry fellowship awarded to Yelena Budovskaya at the University of Amsterdam, Netherlands. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; BRENNER S, 1974, GENETICS, V77, P71; Brunk UT, 2002, FREE RADICAL BIO MED, V33, P611, DOI 10.1016/S0891-5849(02)00959-0; Budovskaya YV, 2008, CELL, V134, P291, DOI 10.1016/j.cell.2008.05.044; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; DAVIS BO, 1982, BIOCHEMISTRY-US, V21, P4089, DOI 10.1021/bi00260a027; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Felix MA, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-59; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Garigan D, 2002, GENETICS, V161, P1101; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gems D, 2000, GENETICS, V154, P1597; Gerstbrein B, 2005, AGING CELL, V4, P127, DOI 10.1111/j.1474-9726.2005.00153.x; Gu T, 1998, MOL CELL BIOL, V18, P4556, DOI 10.1128/MCB.18.8.4556; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Herskovitz MA, 2000, MOL MICROBIOL, V38, P1027, DOI 10.1046/j.1365-2958.2000.02185.x; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Iwasa H, 2010, AGING CELL, V9, P490, DOI 10.1111/j.1474-9726.2010.00575.x; Joseph P, 2001, FEMS MICROBIOL LETT, V205, P91; Jung T, 2007, ANN NY ACAD SCI, V1119, P97, DOI 10.1196/annals.1404.008; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Laaberki MH, 2008, J BACTERIOL, V190, P6197, DOI 10.1128/JB.00623-08; Laaberki MH, 2008, SYMBIOSIS, V46, P95; LAWLESS JF, 1982, MODELS METHODS LIFET; Lehner B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-1-r4; MacNeil LT, 2013, CELL, V153, P240, DOI 10.1016/j.cell.2013.02.049; McCormick M, 2012, AGING CELL, V11, P192, DOI 10.1111/j.1474-9726.2011.00768.x; McGee MD, 2011, AGING CELL, V10, P699, DOI 10.1111/j.1474-9726.2011.00713.x; Montalvo-Katz S, 2013, INFECT IMMUN, V81, P514, DOI 10.1128/IAI.00653-12; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Quisel JD, 2001, J BACTERIOL, V183, P6573, DOI 10.1128/JB.183.22.6573-6578.2001; Sanchez-Blanco A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002047; Smith ED, 2008, GENOME RES, V18, P564, DOI 10.1101/gr.074724.107; SULSTON JE, 1980, DEV BIOL, V78, P577, DOI 10.1016/0012-1606(80)90353-X; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Tissenbaum HA, 2002, DEV CELL, V2, P9, DOI 10.1016/S1534-5807(01)00098-3; Van Auken K, 2002, DEVELOPMENT, V129, P5255; Van Nostrand EL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003325; YANSURA DG, 1984, P NATL ACAD SCI-BIOL, V81, P439, DOI 10.1073/pnas.81.2.439	47	6	7	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124508	10.1371/journal.pone.0124508	http://dx.doi.org/10.1371/journal.pone.0124508			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928543	Green Submitted, Green Published, gold			2022-12-27	WOS:000353713100036
J	Moreira, A; Pereira, SS; Costa, M; Morais, T; Pinto, A; Fernandes, R; Monteiro, MP				Moreira, Angela; Pereira, Sofia S.; Costa, Madalena; Morais, Tiago; Pinto, Ana; Fernandes, Ruben; Monteiro, Mariana P.			Adipocyte Secreted Factors Enhance Aggressiveness of Prostate Carcinoma Cells	PLOS ONE			English	Article							PERIPROSTATIC ADIPOSE-TISSUE; CANCER-CELLS; OBESITY; DIFFERENTIATION; PROLIFERATION; PROMOTE; CULTURE; GROWTH; PHENOTYPE	Obesity has been associated with increased incidence and risk of mortality of prostate cancer. One of the proposed mechanisms underlying this risk association is the change in adipokines expression that could promote the development and progression of the prostate tumor cells. The main goal of this study was to evaluate the effect of preadipocyte and adipocyte secretome in the proliferation, migration and invasion of androgen independent prostate carcinoma cells (RM1) and to assess cell proliferation in the presence of the adiposity signals leptin and insulin. RM1 cells were co-cultured in with preadipocytes, adipocytes or cultured in their respective conditioned medium. Cell proliferation was assessed by flow cytometry and XTT viability test. Cell migration was evaluated using a wound healing injury assay of RM1 cells cultured with conditioned media. Cellular invasion of RM1 cells co-cultured with adipocytes and preadipocytes was assessed using matrigel membranes. Preadipocyte conditioned medium was associated with a small increase in RM1 proliferation, while adipocytes conditioned media significantly increased RM1 cell proliferation (p<0.01). Adipocytes also significantly increased the RM1 cells proliferation in co-culture (p <0.01). Cell migration was higher in RM1 cells cultured with preadipocyte and adipocyte conditioned medium. RM1 cell invasion was significantly increased after co-culture with preadipocytes and adipocytes (p <0.05). Insulin also increased significantly the cell proliferation in contrast to leptin, which showed no effect. In conclusion, prostate carcinoma cells seem to be influenced by factors secreted by adipocytes that are able to increase their ability to proliferate, migrate and invade.	[Moreira, Angela; Pereira, Sofia S.; Costa, Madalena; Morais, Tiago; Pinto, Ana; Monteiro, Mariana P.] Univ Porto, Inst Biomed Sci Abel Salazar ICBAS, Unit Multidisciplinary Res Biomed UMIB, Dept Anat, P-4100 Porto, Portugal; [Fernandes, Ruben] Inst Politecn Porto, Escola Super Tecnol Saude Porto, Ciencias Quim & Biomol, Vila Nova De Gaia, Portugal; [Fernandes, Ruben] Inst Politecn Porto, Escola Super Tecnol Saude Porto, Ctr Invest Saude & Ambiente, Vila Nova De Gaia, Portugal	Universidade do Porto; Polytechnic Institute of Porto; Polytechnic Institute of Porto	Monteiro, MP (corresponding author), Univ Porto, Inst Biomed Sci Abel Salazar ICBAS, Unit Multidisciplinary Res Biomed UMIB, Dept Anat, Rua Campo Alegre 823, P-4100 Porto, Portugal.	mpmonteiro@icbas.up.pt	Pereira, Sofia S/D-9006-2017; Monteiro, Mariana P./AFP-7479-2022; Fernandes, Ruben/L-5753-2013	Pereira, Sofia S/0000-0001-6947-4560; Monteiro, Mariana P./0000-0002-0662-1831; Fernandes, Ruben/0000-0001-8933-3984; Pinto, Ana/0000-0001-8860-7090; Moreira, Angela Marisa/0000-0001-9660-0200; Santos, Madalena/0000-0002-1101-3515; Morais, Tiago/0000-0003-4905-706X	Fundacao para a Ciencia e a Tecnologia (FCT) of Portugal [Fcomp-01-0124-FEDER-015893]; Sociedade Portuguesa de Endocrinologia Diabetes e Metabolismo (SPEDM)	Fundacao para a Ciencia e a Tecnologia (FCT) of Portugal(Portuguese Foundation for Science and Technology); Sociedade Portuguesa de Endocrinologia Diabetes e Metabolismo (SPEDM)	This study was supported by grants Fcomp-01-0124-FEDER-015893 of the Fundacao para a Ciencia e a Tecnologia (FCT) of Portugal to The Unit for Multidisciplinary Research in Biomedicine (UMIB) and by a research grant from the Sociedade Portuguesa de Endocrinologia Diabetes e Metabolismo (SPEDM) to Angela Moreira. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Sacca PA, 2012, CELL PHYSIOL BIOCHEM, V30, P113, DOI 10.1159/000339051; Amemori Sadahiro, 2007, Am J Physiol Gastrointest Liver Physiol, V292, pG923; Asmar R, 2013, PROSTATE CANCER P D, V16, P61, DOI 10.1038/pcan.2012.32; BALEY PA, 1995, J STEROID BIOCHEM, V52, P403, DOI 10.1016/0960-0760(95)00001-G; Bray F, 2010, EUR J CANCER, V46, P3040, DOI 10.1016/j.ejca.2010.09.013; Cheetham PJ, 2013, PROSTATE CANC COMPRE, P355; Cheung Wai W, 2012, ISRN Endocrinol, V2012, P536905, DOI 10.5402/2012/536905; Dirat B, 2011, CANCER RES, V71, P2455, DOI 10.1158/0008-5472.CAN-10-3323; Donohoe CL, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-12; Forte V, 2012, CARDIORENAL MED, V2, P143, DOI 10.1159/000337314; Fowke JH, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-23; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Gunter JH, 2012, ADVANCES IN UROLOGY, V2012, P11; Hefetz-Sela S, 2013, PHARMACOL THERAPEUT, V138, P197, DOI 10.1016/j.pharmthera.2013.01.008; Heidegger I, 2012, ENDOCRINOLOGY, V153, P4633, DOI 10.1210/en.2012-1348; Hoda MR, 2012, J ONCOL, V2012, DOI 10.1155/2012/280386; Kaidar-Person O, 2011, OBES SURG, V21, P1792, DOI 10.1007/s11695-011-0490-2; Kanasaki K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/197636; Kaneko A, 2010, INT J UROL, V17, P369, DOI 10.1111/j.1442-2042.2010.02472.x; Koochekpour S, 2011, IRAN RED CRESCENT ME, V13, P80; Leitzmann Michael F, 2012, Clin Epidemiol, V4, P1, DOI 10.2147/CLEP.S16747; Manabe Y, 2003, J PATHOL, V201, P221, DOI 10.1002/path.1430; Manvar AM, 2013, PROSTATE CANC COMPRE, P285; Mistry T, 2007, EUR UROL, V52, P46, DOI 10.1016/j.eururo.2007.03.054; Moreira A, 2014, INT J CLIN EXP PATHO, V7, P348; Nieman KM, 2013, BIOCH BIOPHYS ACTA; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Onuma M, 2003, J BIOL CHEM, V278, P42660, DOI 10.1074/jbc.M304984200; Park J, 2011, ENDOCR REV, V32, P550, DOI 10.1210/er.2010-0030; Paz G, 2011, FRONT BIOSCI-LANDMRK, V16, P1634, DOI 10.2741/3810; Philippou Anastassios, 2013, Front Endocrinol (Lausanne), V4, P31, DOI 10.3389/fendo.2013.00031; Price RS, 2012, PROSTATE CANCER P D, V15, P135, DOI 10.1038/pcan.2011.54; Prieto-Hontoria PL, 2011, BBA-BIOENERGETICS, V1807, P664, DOI 10.1016/j.bbabio.2010.11.004; Ribeiro AM, 2012, PATHOL ONCOL RES, V18, P499, DOI 10.1007/s12253-011-9473-9; Ribeiro AM, 2010, INT J EXP PATHOL, V91, P374, DOI 10.1111/j.1365-2613.2010.00726.x; Ribeiro R, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-32; Ribeiro RJT, 2012, CELL PHYSIOL BIOCHEM, V29, P233, DOI 10.1159/000337604; Sayeed A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076513; Shafi AA, 2013, PHARMACOL THERAPEUT, V140, P223, DOI 10.1016/j.pharmthera.2013.07.003; Tan JX, 2011, INT J DEV BIOL, V55, P851, DOI 10.1387/ijdb.113365jt; Tokuda Y, 2003, BJU INT, V91, P716, DOI 10.1046/j.1464-410X.2003.04218.x; van Kruijsdijk RCM, 2009, CANCER EPIDEM BIOMAR, V18, P2569, DOI 10.1158/1055-9965.EPI-09-0372; Verma Mukesh, 2011, Cancers (Basel), V3, P3773, DOI 10.3390/cancers3043773; Zebisch K, 2012, ANAL BIOCHEM, V425, P88, DOI 10.1016/j.ab.2012.03.005	44	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0123217	10.1371/journal.pone.0123217	http://dx.doi.org/10.1371/journal.pone.0123217			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928422	Green Published, gold, Green Submitted			2022-12-27	WOS:000353713100015
J	Gao, F; Wang, JY; Wei, SJ; Li, ZL; Wang, N; Li, HY; Feng, JC; Li, HJ; Zhou, YJ; Zhang, FX				Gao, Fei; Wang, Jianyue; Wei, Shanjun; Li, Zhanglei; Wang, Ning; Li, Huayun; Feng, Jinchao; Li, Hongjie; Zhou, Yijun; Zhang, Feixiong			Transcriptomic Analysis of Drought Stress Responses in Ammopiptanthus mongolicus Leaves Using the RNA-Seq Technique	PLOS ONE			English	Article							ZIP CLASS-I; GENE; EXPRESSION; LEGUMINOSAE; ACCLIMATION; PROTEINS; PLANTS; CHINA; LEAF; TOOL	Ammopiptanthus mongolicus (Maxim. Ex Kom.) Cheng f., a relic tree of the Tertiary period, plays a critical role in maintaining desert ecosystems in the Mid-Asia region. Genome-scale gene expression profiling studies will provide deep insight into the molecular mechanism underlying the drought tolerance of A. mongolicus. In the present study, we investigated the transcriptional changes induced by drought treatment in A. mongolicus leaves by establishing a comprehensive transcriptome database and then performing a Digital Gene Expression (DGE) analysis using Solexa sequencing technology. A comprehensive transcriptome database was obtained by assembling the Illumina unigenes with expressed sequence tags (EST) available publicly, and other high throughput sequencing data. To analyze the dynamic and complicated gene regulation network during PEG6000-induced drought treatment in leaves of A. mongolicus, a time-course gene expression analysis was performed using tag-based DGE technology, which identified 437, 1,247 and 802 differentially expressed transcripts in 1, 24 and 72 h drought stress libraries, respectively. GO and KEGG analyses revealed hormone signal transduction and phenylpropanoid biosynthesis were enriched during drought treatment. A batch of drought-regulated transcription factor transcripts were identified, including the subsets of HD-ZIP, bZIP, WRKY, AP2/ERF and bHLH family members, which may play roles in drought response in A. mongolicus. The sequence collection assembled in the present study represents one of the most comprehensive transcriptome databases for A. mongolicus currently. The differentially expressed transcripts identified in our study provide a good start for identifying the key genes in stress response and performing functional analysis to reveal their roles in stress adaptation in planta.	[Gao, Fei; Wei, Shanjun; Li, Zhanglei; Wang, Ning; Li, Huayun; Feng, Jinchao; Zhou, Yijun] Minzu Univ China, Coll Life & Environm Sci, Beijing 100081, Peoples R China; [Wang, Jianyue; Zhang, Feixiong] Capital Normal Univ, Coll Life Sci, Beijing 100048, Peoples R China; [Li, Hongjie] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100081, Peoples R China	Minzu University of China; Capital Normal University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Zhou, YJ (corresponding author), Minzu Univ China, Coll Life & Environm Sci, Beijing 100081, Peoples R China.	queenzhou@263.net; fxzhang@hotmail.com	Gao, Fei/I-5768-2019	Gao, Fei/0000-0003-3600-4970	National Natural Science Foundation of China [31370356, 31100507]; Ministry of Education of China [B08044, MUC985, YLDX01013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China)	This work was supported by the National Natural Science Foundation of China (31370356 and 31100507), the Ministry of Education of China through 111 and 985 projects (B08044, MUC985, YLDX01013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagna F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-399; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Chaves MM, 2002, ANN BOT-LONDON, V89, P907, DOI 10.1093/aob/mcf105; Chen JH, 2011, PLANT GROWTH REGUL, V63, P259, DOI 10.1007/s10725-010-9523-4; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; Deikman J, 2012, CURR OPIN BIOTECH, V23, P243, DOI 10.1016/j.copbio.2011.11.003; Derelle R, 2007, EVOL DEV, V9, P212, DOI 10.1111/j.1525-142X.2007.00153.x; Dugas DV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-514; Gao C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-570; Ge XJ, 2005, ANN BOT-LONDON, V95, P843, DOI 10.1093/aob/mci089; Gordon D, 2013, BIOINFORMATICS, V29, P2936, DOI 10.1093/bioinformatics/btt515; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Harris JC, 2011, NEW PHYTOL, V190, P823, DOI 10.1111/j.1469-8137.2011.03733.x; Hussain SS, 2011, BIOTECHNOL PROGR, V27, P297, DOI 10.1002/btpr.514; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kosova K, 2011, J PROTEOMICS, V74, P1301, DOI 10.1016/j.jprot.2011.02.006; Kozlowski TT, 2002, BOT REV, V68, P270, DOI 10.1663/0006-8101(2002)068[0270:AAAROW]2.0.CO;2; Lawlor DW, 2013, J EXP BOT, V64, P83, DOI 10.1093/jxb/ers326; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; LIU J-Q, 1982, Acta Botanica Sinica, V24, P568; Liu MQ, 2006, DNA SEQUENCE, V17, P342, DOI 10.1080/10425170600908484; Liu RL, 2010, PLANT GROWTH REGUL, V60, P163, DOI 10.1007/s10725-009-9432-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mochida K, 2011, PLANT CELL PHYSIOL, V52, P2017, DOI 10.1093/pcp/pcr153; Mooney M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061088; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Pang T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-488; Peleg Z, 2011, CURR OPIN PLANT BIOL, V14, P290, DOI 10.1016/j.pbi.2011.02.001; Shang Y, 2010, PLANT CELL, V22, P1909, DOI 10.1105/tpc.110.073874; Shi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063993; Song J, 2013, GENE, V513, P118, DOI 10.1016/j.gene.2012.10.058; Su ZQ, 2011, CHEM RES TOXICOL, V24, P1486, DOI 10.1021/tx200103b; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Valdes AE, 2012, PLANT MOL BIOL, V80, P405, DOI 10.1007/s11103-012-9956-4; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; Wang W, 2007, BOT STUD, V48, P55; Wang W, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-465; Wang Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-841; Wei Q, 2012, PLANT CELL TISS ORG, V110, P359, DOI 10.1007/s11240-012-0157-2; Wei Q, 2011, PLANT CELL TISS ORG, V105, P309, DOI 10.1007/s11240-010-9869-3; Wei Q, 2012, PLANT CELL TISS ORG, V110, P299, DOI 10.1007/s11240-012-0151-8; Yan Shun, 2000, Acta Micropalaeontologica Sinica, V17, P165; Yang XP, 2004, QUATERN INT, V118, P69, DOI 10.1016/S1040-6182(03)00131-9; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhou JL, 2007, PLANT MOL BIOL, V63, P591, DOI 10.1007/s11103-006-9111-1; Zhu JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081096	51	39	46	3	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124382	10.1371/journal.pone.0124382	http://dx.doi.org/10.1371/journal.pone.0124382			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923822	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600080
